text,label
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.743;	OD280: 0.932;	Ratio: 1.84;	Dilution: 1:5;	RNA Integrity Number: 8.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 65;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Cbx2_KO_XY_2,pert
"patient: 227;	current medication: Asacol Prednisolone 5 Omeprazole Warfarin Cal VitD;	birth date: 4/17/28;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/90;	diagnosis date: 1/1/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/72;	smoking amount: 5-14;	other illnesses: Prostate cancer 1985, Previous DVT's on warfarin;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed",pert
Male Sprague-Dawley (Crl:CD(SD)IGS Br;	Age: between 5 and 6 weeks old,pert
striatum_Pink1 knockout_12 weeks_replicate 2,pert
"seminoma specimen, pT1, patient age: 40y; W00 047",pert
strain: mixed C57BL6;	genotype/variation: Rptrflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: BaCl2 muscle injury;	tissue: hindlimb muscle contralateral to BaCl2 muscle injury;	cell type: CSC;	time: 2.5 days post injury,pert
"ME16C, 12h, sham",ctrl
IFC 02,pert
"Sfrp5 KO HFD 8 weeks, biological rep8",pert
cell type: peripheral blood mononuclear cell (PBMC);	disease status: healthy,ctrl
Bone marrow-derived macrophages from mice deficient in signaling adaptor molecule MyD88,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 24 hours with concentration of 0.17 uM (EC50).,pert
Osteoblasts_Lrp5_Control_Day7_rep3,ctrl
phenotype: alcoholic;	gender: female;	case_id: 304;	age: 58;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 58.5;	brain ph at time of freezing: 6.4;	labeling_batch: 1,pert
"2102Ep cells SOX2 siRNA, biological replicate 1",pert
cell line: um-uc-3 (atcc# crl-1749);	cell type: bladder cancer cells;	genotype/variation: transfected with gfp-tagged rhogdi2,pert
PFR3_replicate_1,ctrl
strain: C57BL/6J;	day: 12;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 3,pert
220D6,pert
1705-383_24hr,pert
"human nonfailing LV myocardium, NonFailing7",ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 6.1;	colon weight (mg): 159;	colon ratio (mg/mm): 2.607;	myeloperoxidase activity (u/mg): 0.477;	tissue: colon;	treatment: 5% DSS,pert
Pediatric_GBM_4,pert
healthy CD4 T cells 9,ctrl
19A;pretreatment;female;breast tumor; responder,ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs induced with doxycycline and cultured for another 12h,pert
E81-/-SRFVP16-2,pert
cell type: dermal fibroblast;	genotype: CCALD patient,pert
Control_AF_4,ctrl
phenotype: alcoholic;	gender: male;	case_id: 256;	age: 37;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 17;	brain ph at time of freezing: 6.33;	labeling_batch: 2,pert
Bone-Marrow_MGUS_G1702,pert
siControl_5,ctrl
"fibroblast, control subject NM5 rep 1",ctrl
11: FCHL patient #99-0308,pert
"knockout liver, biological rep 1",pert
tissue: Biceps muscle;	patient: C.b.5;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
57A;pretreatment;female;breast tumor,ctrl
HF0510_U133P2,pert
Shn2_Mutant_1,pert
Pool 4 Convalescent stage,pert
microdissected breast cancer cells from case 1363,ctrl
MOLM14_luc_Replicate3,ctrl
"fibroblast, control subject NM10 rep 2",ctrl
genotype: WT;	strain: C57BL/6;	treatment: regular diet,ctrl
"fibroblast, MFS subject FB969 rep 5",pert
"brain, Entorhinal Cortex: 99-28 normal_e1_le1",ctrl
CF (D508) subject7,pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: WT,ctrl
"normal skeletal muscle, biological rep5",ctrl
E14 molar DMSO 1,ctrl
SLE CD4 T cells 14,pert
cumulus_PCOS_Lean_rep1,pert
Nrl-ko-Gfp 4 weeks replicate 4,ctrl
4 h,pert
CLL5-CD4,pert
Dengue Fever Patient 42,pert
C57BL10 soleus sample 2,ctrl
Wild type saline rep2,ctrl
Zfx-flox TC1 ESC;	Cultured in 15% KO + LIF without feeders,ctrl
EGF 12h replicate 1,pert
MDS11,pert
A375 cells 24h Vemurafenib rep1,pert
42A;pretreatment;female;breast tumor; nonresponder,ctrl
normal 1112,ctrl
LOX1 Untreated 2hr 282295553,pert
duration of untreated disease in month:8.5;	age at onset:4.5,pert
01-0044A_Day1_3,pert
Sample 1 Posterior  -/-,pert
HCT116_shBgal-rep1,ctrl
control participant P327,ctrl
"human failing LV myocardium, Ischemic47",pert
"Acute Myeloid Leukemia, sample 30",ctrl
"wildtype pancreas, biological rep1",ctrl
tissue: white blood cells;	age: 9.84;	Sex: male,pert
scrambled biological rep2,ctrl
Epididymal adipose WT ND #686,ctrl
Dilated cardiomyopathy_G54,pert
"brain, hippocampus: Ctr-24h-P15-II_e1_le1",ctrl
"vector d0, rep 2",ctrl
"Spi-21, biological rep 6",pert
IM122_case,pert
Patient: A;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
gender: F;	age at blood draw: 55;	tissue: whole blood,pert
"205, MUSCLE, Before",ctrl
Large cell carcinoma 015,pert
R3,pert
"affected status (disease state): control;	gender: male;	age-at-examination: 69;	age-at-onset: n/a;	geographical origin: Vila-Real;	lifestyle characteristics: ever smoker, ever drinker",ctrl
BMM_BalbC_time0h,ctrl
treatment: siRNA LMG2,pert
KU_01T,pert
Kidney_Aqp11+/+_P7_4-2,ctrl
shRNA2-4-noDox-rep1,pert
"mouse aorta cross strain comparison, C3H_T04_NC_03",ctrl
"fibroblast, control subject NF6 rep 4",ctrl
V5-P051,pert
"FA6 transiently transfected with non-targeting siRNA, transfection C",ctrl
BCell_lymphoma_marginal_sample6,pert
age: 6 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),ctrl
cDNA ak 04,pert
"ALL_NDS, K33 011609",ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 78 years,ctrl
lymphoma_5783_ADR,pert
med2d_1,pert
chip number: 12;	transfection plate: 3B;	target gene: YY1;	kd level: 0.66;	rin: 9.6;	transfection date: 2012-03-26,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_3 months_replicate 3,pert
retina_DBA_543L_8mo_rep1,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 4,pert
T146 U133p2,pert
"Untreated TG2 knockout NB4, biological rep3",ctrl
PKBa-/- MEF time 2 replicate 1,pert
tissue: Brain;	genotype: Npc1+/+;	age: 60 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
cell type: Peripheral blood leukocytes;	strain: DBA/2,ctrl
Normal mucosa 20,ctrl
"Acute Myeloid Leukemia, sample 62",pert
striatum SNCA knockout 6 month replicate 3,ctrl
IM46_control,ctrl
HDAC1_G10-rep2,pert
D_Ctrl_1,ctrl
mef2a_2,pert
P60 Vax2-/- 2,pert
cell line: A2780;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
Expression data from liver of the KRAP deficient mice (KO1),pert
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 7.03;	Post mortem interval (hours): 24;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
HeLa SCY1-like 1 knock down 1,pert
14-week-old WT liver_464WT,ctrl
"MCF7/BUS, 30 pM E2, 48 hours, biological replication 5",pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 23.9589,ctrl
cell line: GIST882;	agent: Imatinib;	dose: 1μM;	replicate: Rep3,pert
umbilical cord_bpd: 5B,pert
Individual_4368_PP_sample,pert
NPC18,pert
M24met_Wnt1_5,pert
Healthy controls; individual=CM; time=2; beverage=alcohol,pert
"C57BL/10 TA, replicate 1",ctrl
Tendon_lesional_rep12,pert
Run1.a10a.000608jd.2.SkMNor924.CEL-IS stimulate,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 26;	gender: male,ctrl
siERK2Veh24h_3500,ctrl
"Runx1KO, biological replicate 2",pert
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 29;	maternal age: 30,ctrl
"Wild type used for MAT1A 8 month, replicate 4",ctrl
Liver_untreated_wild type_rep2,ctrl
"Gender: female, Age: 37 years, Tissue: normal vulva,",ctrl
"Normal T-cells, CD3+, donor 8",ctrl
liver_co_6M_rep3,ctrl
suppressed induction of AICD,ctrl
MO32_12,ctrl
WT_PLACEBO_12hours_4,ctrl
"Autoimmune pancreatic islets before cyclophosphamide treatment, rep 4",ctrl
Pool 3 Acute stage,ctrl
HF0670_U133P2,pert
LT 434 +/T after nicotine-induced seizures,pert
DMN-NF1Hippo20d-1bAv2-s2,pert
BS2011051057,pert
Human.AZ.CTRL.ECRB,ctrl
293TsiLL-1,pert
newborn (P0) Krt1-/- skin_replicate 1,pert
P2C Progranulin-hippocampus,pert
age: 54;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
chip number: 11;	transfection plate: 4;	target gene: IRF7;	kd level: 0.7;	rin: 9.4;	transfection date: 2011-10-17,pert
"ID: MLL_00266;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
"Undifferentiated Dicer -/- ES cell line, passage 18",pert
3560-2 E2F2 Null,pert
"amnion mesenchymal cells, 1h interleukin-1-beta, biological rep3",pert
MH1C1_low_rep4,pert
"Wild type used for MAT1A 8 month, replicate 5",ctrl
cell type: BMDM;	strain: C57BL/6;	genotype: No2 -/-;	infection status: uninfected,pert
Ecad_Mut_3,pert
disease state: healthy control;	tissue: epidermis;	age: 46;	gender: female;	treatment: untreated;	time: control,ctrl
4_Hr_No_MGd_1,ctrl
A2780-(2),ctrl
"cochlea at P7, wt, biological rep 3",ctrl
Ad infected murine liver-MO30k-(667)-6 hpi,pert
"breast tumor epithelium,19",pert
KU_18N,ctrl
Wild_Type Circadian_Time_14,ctrl
"Patient 5, Atheroma plaque",pert
shGFP-rep-2,pert
cell line: rtTA-Dmrt5;	differentiation: 7 days;	treatment: +Dox,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M2;	flt3 status: internal tandem duplication (ITD),pert
Normal Cervix N10,ctrl
Nrl-ko-Gfp P10 replicate 2,pert
cell type: B-cell;	cell line: Pfeiffer DLBCL,ctrl
microdissected breast cancer cells from case 651,pert
ve_M63B,pert
"650nM MLN4924 after 4hr, replicate 2",pert
Wild type_liver _1,ctrl
V5-P385,pert
K562 cells CREB Knock-out replicate 3,pert
020112-2,pert
Healthy individual of twinpair #8,ctrl
puroB replicate 1,ctrl
reduction mammoplasty patient 309,ctrl
age: 12 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
Liver GPR120KO ND #718,pert
Normal-N_LJ_6,ctrl
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b(jmjc) retrovirus,pert
"ShamC-21, biological rep 3",ctrl
Sle1a R4,pert
treatment: siRNA against ETS2;	cell line: H441,ctrl
control-noDox-rep2,ctrl
Cell culture. A549 treated by MK886 1,pert
"control endometrium, patient 3",ctrl
10-0021A_Day1_19,pert
Neuroblastoma SH-SY5Y cells_cloneM_scramble control_replicate2,pert
lung_E18_sftpc-nmyc_rep1,pert
chip number: 22;	transfection plate: 3B;	target gene: E2F6;	kd level: 0.63;	rin: 9.4;	transfection date: 2012-03-26,pert
JIA PBMC Pre treatment A235_L112,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 46.63562,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
Gender:F;	Age:47;	Tissue: Mucosa,pert
"Normal Cervix, microdissected epithelium, Age 54",ctrl
wild-type control 3,ctrl
"spc-c-raf transgenic mice, age: 6 month old, Gender: male, Tissue: tumor",pert
3275-1 E2F WT,pert
Subject 2 / lung subsegment instillated by Saline,ctrl
HP-22,pert
SZ7,pert
Patient 4 a,pert
BV2_Curcumin_rep2,pert
Human.AT.CP.ECRB,pert
colon_adenoma_995,pert
"control, subject 8",ctrl
V5-P481,pert
Ishikawa_VeryLowDose_BPA_8h_rep2,pert
Thyroid_ unaffected_paired with PTC69T,ctrl
"cell line: Hec50co endometrial cancer cell line;	cell line traits: Loss of p53, loss of hormone receptors ER and PR;	disease state: Grade 3 endometrioid adenocarcinoma;	genotype/variation: MTDH knockdown",pert
ko 13.5d replicate 1,pert
L1 062502 Rosi2,pert
pt. HCL E treated with DMSO for 48h,ctrl
blood_day0_patient1,pert
PCOS Endometrium Mesenchymal Cell_120.PC11++,pert
"patient: 233;	current medication: Asacol 1.2g Asprin 75mg Amilodipine 10mg;	birth date: 2/2/29;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/92;	diagnosis date: 1/1/92;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/1/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/86;	smoking amount: 15-24;	other illnesses: MI 1986, Prostate cancer 1994;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",pert
"Genotype: B6.Alb/cre,Pdss2loxP/loxP(Liver-conditional knock-out);	Age: 178-day-old male;	40 mg liver used for RNA extraction",pert
EA_Control2_CD4,ctrl
"Uninfected treated with 1,25D, replicate 1",pert
463MM,pert
"DBA/2J SAL, Rep1",ctrl
LY2 control-siRNA tamoxifen treated rep2,ctrl
strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 3 months;	tissue: liver;	disease status: steatosis,pert
"Pool of two samples (n=2);;	cells: CD3+ T cells, bone marrow;;	healthy volunteers; gender: one male, one female; age: 58 and 42 years old",ctrl
3880-2 E2F WT,ctrl
"shControl clone 2, rep 1",ctrl
RORasg/sg WAT_HFD_rep5,pert
Haloperidol treated 4weeks AffyGC RMA rep1,pert
shNANOG_2,pert
HF0471_U133P2,pert
A VIS _B031,pert
cell type: Primary hepatocytes;	donor: 1;	agent: control;	time: 6h;	gender: Male;	age: 63 years old,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T3, N3, M0, G4",pert
BCell_lymphoma_marginal_sample3,pert
cell type: neuron progenitor cells (NPC);	disease group: healthy control,ctrl
"Control siRNA - 2 days adipocyte differentiation, rep1",ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: female;	age: 20 weeks;	genotype/variation: VhlhKO",pert
HeLa_06_21_04 TP-4,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 14 months,pert
patient: 26;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
ko 13.5d replicate 5,pert
lesion_postUV_patient8,pert
KM-final,pert
Healthy control_sample7,ctrl
PBMC from T cell LGL leukemia patient #123 (TLGL123),pert
Gene expression profiles of Lkb1 KO #7 HSCs,pert
ab064 N,ctrl
4T1.2-BV-1,ctrl
Patient: I;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
cell line: A549;	cell type: Lung adenocarcinoma,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 207;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
MDS patient 9,pert
16C-ER-D,ctrl
striatum SNCA knockout 6 month replicate 2,pert
"203, MUSCLE, Before",ctrl
S4C Sporadic-hippocampus,ctrl
L_LS_Wk2,pert
CA2 NoCre Sox17E,ctrl
tissue: peripheral blood from 8-10 E12.5 embryos;	genotype: Cbfb+/+;	progeny from cross: Cbfb+/- x Cbfb+/-,ctrl
01LRK_ERA,pert
diagnosis: HP;	fvc-group: FVC3;	tissue: lung,pert
"P60_C-DGCR8 KO cones, replicate 2 [array]",pert
PBMC_S6,pert
U937_luc_Replicate3,ctrl
"Uninvolved Skin, NS-9",pert
cell type: PBMC;	disease state: Acute,ctrl
SKNSH eGFP3,ctrl
"gender: Male;	age: 63;	post-mortem delay: 30h;	ph: 6.5;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"121, MUSCLE, Before",ctrl
Normal-ERα-positive breast cancer 36,ctrl
tisue: cleared mammary fat pad;	genotype: Rarb -/-;	age: four weeks,pert
MacularDegen-injured-1cAv2-s2,pert
COV434 Control [RR1016],ctrl
cell line: MCF-7 breast cancer cell line;	sirna: control (scrambled siRNA);	agent: 4-hydroxytamoxifen;	dose: 100 nM,pert
IDTC 2,pert
"CRT knockout mouse embryonic stem cell, biological rep5",pert
PGA-MAH-C3H_OVA6h-3aA-s2,pert
Subject #8017-8hr Postinfection,ctrl
"tissue: kidney;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: control 72 hr",ctrl
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 67",pert
"fibroblast, MFS subject FB1234 rep 3",pert
"Autoimmune pancreatic islets before cyclophosphamide treatment, rep3",ctrl
Normoxic Adeno treated Control N1,ctrl
MCL_IGHV_MUT (02_201),pert
CME-LaminA3d-3MA-S2,pert
"EBF1 d2, rep 4",pert
"human failing LV myocardium, Ischemic107",pert
C4med,ctrl
Untreated Melan-Ink4a #2,ctrl
4010-4 E2F2 Null,pert
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, bone marrow;;	disease: (severe) aplastic anemia (SAA)",pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 6h ID205,pert
"Cerebral Palsy, Gracilis, Patient Replicate 4",pert
fresh tissue: splenocytes;	strain: DBA/2,ctrl
genetic background: FVB;	cell type: DN2;	genotype: E2A deficient,pert
CuFi cell line treated at DMNQ biological rep2,pert
"Acute Myeloid Leukemia, sample 2",pert
CML Patient 5 before therapy,ctrl
GM19238_Kd_POU2F1_2,pert
V5-P131,pert
FHCRCAML169017,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 2,pert
ancestral background: European-American (EA);	gender: Female;	subject condition: healthy control;	tissue: Peripheral blood;	surface markers used in facs: CD20-APC;	cell type: CD20 positive B cells,ctrl
"Control 2, biological rep2",ctrl
RV83.10_CHF_day10_Slide60,pert
Knockout day 3 Air replicate 1,pert
wildtype Tcof1 [B],ctrl
"human failing LV myocardium, Ischemic23",pert
"Muscle from WT, biological rep4",ctrl
CH2125,ctrl
IMR-32_pCMV-DPP3_48hr_rep 2,pert
"TCF-1 KO CD8 memory T cells, biological rep1",pert
IMR-32_pCMV-SQSTM1_48hr_rep 2,pert
Cervical cancer_CaCx54,pert
lymphocytes_HD_F_56y,pert
CTRL_3_CMP,ctrl
Parkinson's disease sample x176,pert
MCL_IGHV_MUT (R1301),pert
Ishikawa_LowDose_BPA_48h_rep4,pert
Sample ID: TP28;	Twin Pair ID: CCN5.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 34;	Current Age (2007): 37;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
KN-sham-5 month-R1,pert
Sample Group: HD patient; Gender: female; Age: 43; Tissue: lymphocytes (blood); IT15 CAG repeats: 26/47,pert
Pertuzumab treated after 4 days (P2_1),pert
"Creatine-treated, biological rep3",pert
T117,pert
2d-sham-72,ctrl
Scd1+/+ on very low fat diet (TD03045 from Harlan Teklad) replicate 3,ctrl
whole tissue section from case 633,pert
S6,pert
1124-02-A,pert
GEIM58-U133A-DM,pert
"Patient 24, Macroscopically intact tissue",ctrl
WT-smoke-high-5 month-R1,ctrl
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.17 uM (EC50), biological rep2",pert
X_p4_rep3,pert
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 4;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
disease: psoriasis;	skin: lesional,pert
"IKK2 WT cell line, biological replicate 2",ctrl
INSENS 1 4hr,pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: MeCP2 shRNA,pert
"Healthy volunteer, Control_11695",ctrl
strain: C57BL/6;	gender: male;	develpmental stage: embryonic day E15.5;	genotype/variation: Gadd45a-/-;	cell type: mouse embryonic fibroblasts (MEF cells),pert
Superior Frontal Gyrus_2y_normal,ctrl
"human failing LV myocardium, Idiopathic48",pert
LCL Unaffected MZ twin pair 4 (CCN4.2)(TP26),ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L014,pert
genotype/variation: Gsk-3a-/-;	cell type: embryonic stem cells,pert
9: NORMAL #00-0504,ctrl
cell type: monocyte;	disease state: control participant,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 41.51233,pert
"Liver from Nrf2 wt mice, biological replicate 2",pert
"siSCR ES, biological rep1",ctrl
CBA1,ctrl
shSOX2_1,pert
patient: 41027;	sample: tumor,pert
"non-AD_TC, biological rep13",ctrl
whole blood_101369,pert
"ARD842, CAIS, F, GOF, 6 x 100nM DHT, 14d",pert
129_Sv_2_Runx1_Ko_d6_4302,pert
a_NY7,pert
"Wild-type-neocortex, biological rep3 (male)",ctrl
"EGFP KD, replicate B",ctrl
GM19238_Kd_GTF2B_1,pert
race: african america;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
"Wild type used for GNMT 3 month, replicate 1",ctrl
GM19238_Kd_CEBPG_3,pert
Moderate rep4 (retina),pert
tumor cell line HepG2 with knockdown of HIF-2α rep2,pert
N40741,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 27.26575,ctrl
WT_TER119-_rep3,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: ;	choa: ;	fata: ;	eea: ;	wtkg: 69.9;	perfat: 10.4;	lbm: 61.2;	fat_mass: 726.96,ctrl
DUSP1+/+ control replicate 1,ctrl
Muscle PCOS pioglitazone 271,ctrl
Ishikawa_VeryLowDose_BPA_8h_rep4,pert
control virus-infected replicate 2 (monocytes),ctrl
Cal27_PBS1,ctrl
Untreated Control 12weeks AffyGC RMA rep3,ctrl
HepG2 cells control 2h,ctrl
Skin_Control E16.5_rep1,ctrl
"granulocyte, patient. Mtx rep7",pert
BALB/c d3 (191msn),pert
Y HID_B039,ctrl
JIA PBMC Pre treatment A235_L016,ctrl
69A;pretreatment;female;breast tumor; responder,ctrl
"SWR/J CHR, Rep2",pert
"103, ADIPOOSE TISSUE, Before",ctrl
Bronchial Epithelial Cells MMA biological 2156P,pert
PHM-DM-2aUA-s2,pert
34A;pretreatment;female;breast tumor; responder,ctrl
N30068,ctrl
SCLC cell line Lu-134a,pert
Patient 3,ctrl
"shCDK8, low glucose, replicate 1",pert
HLA risk: Low;	Height: 134.6 cm;	Weight: 30.6 kg;	BMI: 16.7;	Age: 9.27 years;	Gender: Male;	Race: White;	Glucose: 245 mg/dl;	HbA1c: 7.5%,pert
CH1804,pert
"Wild-type retina, biological rep1",ctrl
THRB 15b mutant + T3 replicate 2,pert
Patient: L;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
"Patient 8, Macroscopically intact tissue",ctrl
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIa;	Sex: M;	age: 65,pert
tissue: liver;	genotype: ClpP KO;	genetic background: C57BL/6,pert
control AU1327303,ctrl
"wt total RNA LSK, rep 3",ctrl
KO621,pert
monolayer chondrocytes from OA donor 2,pert
Normal Pleura 4,ctrl
"AD_TC, biological rep6",pert
"SFM control cells (24hr), biological rep_1",ctrl
DNGM-5,pert
KOC 67 PBS treated,ctrl
Parkinson's disease sample x001,pert
"Subject 12, Family 4, Control",ctrl
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: 10μM ATRA;	treatment time: 1 hour",pert
mouse jejunum_hnf1alphamutant_rep2,pert
12 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxi;24727,pert
"Cervical cancer cell line, C4-I",pert
K562 STI sample 8,pert
THP1-shGSK3B-Construct2-rep1,pert
NPC2,pert
Liver_hyperglycima_no.3,pert
Muscle control 12,ctrl
"KSR1 Alone, Replicate 2",ctrl
RNA from HCC_11T,pert
"siThoc5-2, biological rep2",pert
R6/1 22 week wildtype_C835,ctrl
"HME-CC, 12h, sham B",ctrl
D4 patient,pert
"non-AD_FC, biological rep15",ctrl
Seguin_IDR_BrownNorway_Liver_treated1,pert
Bronchial Epithelial Cells MMA biological 1774K,pert
WT_MEF_un.1,ctrl
Intestine_Ctrl_biological rep4,ctrl
Bronchial Epithelial Cells SA biological 1623P,pert
GM19238_Kd_IRF3_1,pert
"tissue: heart;	strain: mixed background of C57BL/6, 129/sv, and Balb/c",pert
CT-receptor-KO osteoclasts untreated 2,ctrl
pediatric AML GP7,pert
MDS patient 78,pert
NZM15_media_control_30hrs_rep1,ctrl
Spleen_wt_4m_rep3,ctrl
"cell type: Primary chondrocytes;	genotype: Wt;	antibody: Ago2 antibody;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant;	antibody manufacturer: Wako biochemicals;	antibody catalog #: 292-67301;	antibody lot #: PEK486",ctrl
DOV13+(3),pert
KO-control-3,pert
condition: Psoriasis;	patient: PS-A;	tissue: LS skin biopsy;	kit: Affy,pert
cell line: OVCAR-10;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
strain/background: mix of 129Sv and C57BL/6;	genotype: conditional keratinocyte-specific ADAM17 knockout;	tissue: back skin;	age: 10 days,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
DIA-n7-2; normal diaphragm 7 month,ctrl
"disease group: Psoriasis;	Sex: m;	age: 30s;	race: African American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 34;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 360;	ige (kiu/l): normal (0-48.5 kIU/L): 224;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 22.80822,pert
01LQH: normal control,ctrl
HEK293 transiently pIRES2-EGFP-transfected 2,ctrl
Muscle-5 month-Myc heterozygous-technical replicate 2,pert
sample: #21;	subject: PD case #5;	brain: T-72;	age: 81;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
EosKOCD25+#1,pert
treatment: DMSO;	time: Day10;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,ctrl
Sex: female;	Age at operation: 76 years;	Site: thigh;	Size in cm: 38.5x17.5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
Uninjured Control - Epicenter Rep3,ctrl
pediatric AML S31,pert
S-IIP(UIP)2_Cy3,pert
WT Hippocampus - 1,ctrl
strain: C57Bl6;	age: 4 weeks;	cell type: BCR-ABL1 transformed pre-B cells;	disease state: BCR-ABL1-driven ALL;	genotype/variation: Wild-type,ctrl
tissue: white blood cells;	age: 7;	Sex: female,ctrl
U87-mC1,ctrl
KM_053T,pert
KU_23T,pert
V5-P408,ctrl
Pax3 WT E14.5 palatal shelves 2,ctrl
cell type: HeLa;	genotype/variation: nucleofacted with Dharmacon control siRNA,ctrl
BTBR+tf/J Vehicle liver sample batch 2,ctrl
"wildtype (GFP-negative) kidney cells, biological rep1",ctrl
"Crohn 03, CD03",pert
individual: patient2;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
disease state: mPIN (mouse prostatic intraepithelial neoplasia);	age: 20 weeks;	tissue: ventral prostate;	strain: FVB,pert
male;	CABG patient atrial tissue;	baseline before CABG surgery,ctrl
wildtype HUES6 2,ctrl
HC-WT-23A,ctrl
136A,ctrl
race: hispanic;	age (years): 47;	stage: IB;	grade: 1;	histology: endometrioid,pert
erStress_twins_AA_1743twin2_DMSO_4h,ctrl
WT-smoke-high-5 month+1d-R2,ctrl
TB 3,pert
pMX-Oct4 vitamin C Oct4Vc+_1,pert
"sirna: Dhamracon negative siGENOME Non-Targeting siRNA;	cell line: Human epithelial colonic adenocarcinoma, Caco-2",ctrl
tissue: skin;	individual: Patient P10;	condition: ANL;	eczema severity: SCORAD: 0,pert
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep8,pert
"GNMT knockout at 8 month age, biological replicate 3",pert
Normal-ERα-positive breast cancer 31,ctrl
SEB-1 treated biological replicate 2,pert
MEF E2F4 KO 1-rep1,pert
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: P,pert
Rsk2-KO Hippocampus - 1,pert
MPM tumor 26,pert
"Transgenic mice with water, replicate 1",pert
V5-P101,pert
PCOS Endometrium Mesenchymal Cell_106.PC07++,pert
3 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24714,ctrl
"AD_TC, biological rep10",pert
"Embryonic cerebral cortex, Trnp1 knockdown, biological replicate 1",pert
cell line: prostate cancer cell line PC-3;	telomere status: Long;	exogenous htert: present,pert
cerebellum_WT_0d_rep2,ctrl
"treatment with MeOPP, replicate 3",pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 6.2;	colon weight (mg): 177;	colon ratio (mg/mm): 2.855;	myeloperoxidase activity (u/mg): 0.217;	tissue: colon;	treatment: 5% DSS,pert
"RNF40 siRNA - Undifferentiated, rep1",pert
disease status: controls;	tissue (brain region): Cerebellum,ctrl
Psoriatic arthritis PsA 9,pert
colon_IBD_1118,pert
healthy myeloid cells 4,ctrl
Normal Adrenal Gland (AN14),ctrl
background strain: mixed (C57BL6/6J and 129);	genotype: Dmrt1 flox/flox with no Cre;	gender: male;	tissue: testis;	age: postnatal day 28 (P28),ctrl
SOCS3 Cre plus B,pert
Kidney_saline ip_mouse #062,ctrl
"breast tumor epithelium,40",pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 6 months,ctrl
Cultured TM cells-A,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of SUZ12. Sample C,pert
cell type: breast cancer cells;	agent: none,ctrl
Cultured HTM cells-C,ctrl
"Cell type: neuronal, age:45, gender:male, diagnostic group: schizophrenia, PMI:35h",pert
"miR-148b-C (miR-148b-2+, biological replicate 3)",pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-13;	Primary Site:Floor of Mouth;	Age:54;	Sex:M;	TNM:;	;	Abbreviation:TNM,Tumor-node-metastasis",pert
NSC12,pert
Sox3 null Sample 2,pert
BAL_43_A0B0,ctrl
"granulocyte, healthy control, biological rep4",ctrl
Untreated Control 4weeks AffyGC RMA rep3,ctrl
Subject 1 / lung subsegment instillated by LPS,pert
"Carcinoma in situ_1 (CIS, double transgene)",pert
Control d10 (3),ctrl
"Wildtype luminal mammary epithelial cells, MD642",ctrl
TAC 6,pert
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: HIGH;	genome/variation: no mutation detected,ctrl
A505 Sham 1 day,ctrl
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P11;	clone: C18,pert
454MM,pert
erStress_twins_AA_1734twin2_500nM_thapsigargin_4h,pert
Pias1 null IFN-beta 2 h,pert
"Patient 17, Macroscopically intact tissue",ctrl
intestine_PPARa-knockout_control_rep3,pert
Sex: male;	Age at operation: 37 years;	Site: thigh;	Size in cm: 7x14x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: yes,pert
Normal Sample 2,ctrl
A431 PR 2,pert
"healthy breast 4, biological rep. 4",ctrl
HDAC2 KO mice colon rep 1,pert
"mouse aorta cross strain comparison, C3H_T24_NC_01",ctrl
THP1-shGSK3B-Construct1-rep2,pert
Normal_2169,ctrl
"cochlea at P3, wt, biological rep 1",ctrl
cell line: KGN;	transfection: GC matched control,ctrl
"Peripheral blood, normal control [N53]",ctrl
BAL_37_A1B1,pert
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 89;	Usage number: 5;	Exposures: 3,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 96 hrs;	time course: 3,pert
6h kin- Cel.07,pert
"10mg/kg/day PFOA, Rep 1, Block 2, liver (high dose)",pert
Allo-14-2,pert
CLL10-CD4,pert
H17_S_B2,pert
MSE_N_617,ctrl
"LSD2 knockdown, replicate 2",ctrl
695_EV_4hr_repeat1,ctrl
WT(Rnh1+/+) -3,ctrl
Ago2-IP RNA Mir140 KO-2,pert
Postnatal 3 weeks control heart biological rep2,ctrl
con-13_A,ctrl
Cell line expressing inducible wt-GFP-lamin A. Induction: day 5. Replicate A,ctrl
KN-smoke-med-1 day-R4,pert
EOM 14 Day mdx rep 1,pert
male_alcoholic_212,pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep6,pert
061HZ: normal control,ctrl
type_of_rx: AF;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 56;	baseline tumor size (cm): 8x7;	patient id (to identify the 2 chips from the same patient): 16281659,ctrl
"schizophrenia, BA46-100",pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 16 hrs;	time course: 3,pert
D2-Gpnmb+ control rep10 (retina),ctrl
WT liver_HFD_rep3,ctrl
MDS patient 24,pert
BxPC3-KO111 rep 5,pert
MiaPaCa2 rep-3,ctrl
rd1_P4_rep4,pert
siCtrlVeh24h rep2,ctrl
KM_015T,pert
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-1,ctrl
801B.INV,pert
Individual_5143_NN_sample,ctrl
01J43_Systemic,pert
10 days TAC-4,pert
No or early 2 rep6 (retina),pert
gender: male;	batch: 1;	age (years): 46;	patient id: Control_4;	fev1 (% predicted): 92;	fvc (% predicted): 105;	medication: None;	cell type: CD4+ T-cells,ctrl
IRS-1 KO (jos0649),pert
siNEG replicate 1,ctrl
Gender:female,ctrl
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 0,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 28.105;	Ratio: 2.13,ctrl
"DMSO treated THP-1 cells, biological replicate 1",ctrl
"vector d0, rep 1",ctrl
A673_CloneAsp14_Dox_72h_1,pert
"control, BA10-43",ctrl
BT474-J4_Lap_24-2,pert
Muscle FC2,ctrl
"MaF pre-iPSC9P2, Vc-, D3",ctrl
CLS14_T5_PP_day7_059,pert
PsOEt-20-Week 2,pert
"Patient 112, 12 month of REBIF",pert
3 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24715,pert
HCC005T,pert
shRNA6-16-plusDox-rep1,pert
CON14,ctrl
sample 1:;	age: 32;	gender: female;	sample 2;	age: 47;	gender: male;	sample 3;	age: 75;	gender: female,ctrl
strain: C57BL/6;	Gender: male;	Age: 8-12 week;	Weight: 20-25g;	Wild type,ctrl
Moderate rep9 (OHN),pert
n8t30m,pert
age: 21 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),ctrl
Human skeletal muscle biopsy sample;	Patient #57 with NORM,ctrl
M473 SKM-Tg,ctrl
Liver CTR replicate 1,ctrl
V5-P379,ctrl
MCF-10A shCHK2-2 replicate 1 [set 5],pert
Gata4Loxp/-VillinCre adult male jejunum (6-8wk). Gata4 conditional knockout (mutant) sample.,pert
wild-type control 2,ctrl
cerebellum wild type 6 month replicate 3,ctrl
N30617,ctrl
CDK9 Knock Down3,pert
"acutely admitted, severely psychotic schizophrenia patient  A16",pert
Cervical Cancer C542,pert
"cochlea at P60, ko, biological rep 1",pert
LOXL2 3,pert
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 9,pert
"108, ADIPOOSE TISSUE, After",pert
"Exp A, Animal #257, 50mg/kg D-Serine",pert
"59B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
colon_IL10mouse_6weeks_rep1,pert
Mic33_muscle_control,ctrl
cell type: T cell;	disease state: homozygote FH,pert
HCT116 STAG2 knockout clone 7 (STAG2 deficient),pert
whole blood_101611,pert
F-IIP(UIP)7_Cy3,pert
F_LS_Wk2,pert
Human Acute HIV Sample A144-CD8+ T cells,pert
Control (C268),ctrl
liver_co_14M_rep2,ctrl
TGFBeta Transcriptome Profiling {rpt},pert
12B,pert
"testis, Repro9 mutant, 14dpp, Rep5",pert
female;	29 yr old;	Black,ctrl
treatment: naïve;	transgenic variant: FVB/N;	tissue: Pre-Frontal Cortex;	genetic background: FVB/N,ctrl
12485 UC Inflamed ascending colon,pert
RNA from HCC_26N,ctrl
B10.H2g7 Idd3_S2,ctrl
Sample: nontransgenic control (NTG);	Replicate: 1;	Pool: NP,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: CITCO; 6-(4-chlorophenyl)imidazo[2-1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime",pert
7: NORMAL #00-0267,ctrl
ET 4,pert
tissue: normal colonic mucosa,ctrl
Muscle PCOS control 13,ctrl
"brain, Entorhinal Cortex: 96-31 tangle_e1_le1",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day2,pert
"NPCxhIPSC CON, replicate 5",ctrl
cell line: E14;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 7,pert
PCOS Endometrium Stromal Cell_104.PC07-+,pert
"ICR10 mouse strain (Nrf2-/-)  gender- female, age- 2 months, n = 1, # of tissue = 1, tissue: Lung, Cell:Type II.",pert
KO mouse 1_heart_basal,pert
non-CF subject 32,ctrl
"NC1, biological replicate 5",ctrl
"atRA WT, set 4",pert
F9 TSA sample #2,pert
strain: 129SV;	gender: female;	age: 6 months;	tissue: right ventricle;	genotype: plakoglobin (+/-),pert
Itk knockout CD4+ unstimulated 2,pert
patient: 801B;	disease state: LGSC;	component: Invasive,pert
patient: 255;	current medication: Asacol 800mg BD;	birth date: 3/14/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/01;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
ve_NY26,pert
"strain: C57BL/6;	genotype variation: Il10+/+;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 48 hours;	agent: air;	exposure dose: 0 ppm O3",ctrl
"brain, cochlea: [2] Sample #2_le1",pert
siControl_3,ctrl
GLY replicate 3,pert
siTNIK+7hr Wnt (Experiment 2; dye swap),pert
hsa-mir-30a/30d inhibitor_24-5,pert
C_Ctrl_2,ctrl
MSC_VUB01_3,ctrl
PBS Treated Cells 2,ctrl
Ifng-/- biological rep 3,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-tu2,pert
race: caucasian;	age (years): 75-80;	stage: n/a;	grade: n/a;	histology: atrophic endometrium,ctrl
Phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject C (CAcCD8),ctrl
"Autoimmune pancreatic islets, day 3 cyclophosphamide treatment, rep 1",pert
mdx5cv EDL sample 1,pert
cell line: TYK-nu;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
11406 Normal Uninflamed sigmoid colon,ctrl
MOLT4_ctrl_A,ctrl
duration of untreated disease in month:7.7;	age at onset:1.6,pert
Disease_status: Bipolar disorder;	Age (years): 51;	Gender: Male;	Age of onset (years): 23;	Duration of illness (years): 28;	Brain pH: 6.67;	Post mortem interval (hours): 23;	Side of brain: Right;	Fluphenazine mg. Equivalents: 1200;	Lithium treatment: Yes;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
RNA from HCC_33N,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 210min;	race: White;	sex: Male,pert
Gene expression profiles of Lkb1 KO #4 HSCs,pert
cell type: Immortalized AR positive myofibroblast,pert
"alveolar macrophages, smoker 063",pert
"WT heart, CRE, biological rep1",ctrl
Rejecting allografts 7 days No.2,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 35 yr;	population: white;	dsm-iv: 296.54;	age of onset: 21 yr,pert
"breast tumor epithelium,18",pert
NALT_infected_24h_90-226att_rep3,pert
AtT20 cells overexpressing NSBP1WT protein rep3,pert
PML Knockout Mice fed Low Fat Diet 1,pert
Individual_5905_NN_sample,ctrl
01-0058A_Day1_4,pert
Male mouse 60 day old,ctrl
3D-cultured chondrocytes from OA donor 2,pert
CON30,ctrl
3550-1 E2F WT,ctrl
6 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24722,pert
sparse HUVECs stimulated with Angiopoietin for 1 hour,pert
patient: 40843;	sample: normal,ctrl
PGA-MAH-C3H_OVA24h-2aA-s2,pert
H4-II-E-C3_low_rep3,pert
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 2,pert
TMRI AO 24hr,ctrl
Estrogen treated ipsilateral to stroke E6IC-1a,pert
HUVEC_TSA_rep3,pert
"spleen follicular B in WT, biological rep4",ctrl
LUC KD #1,ctrl
HT29,ctrl
striatum_Pink1 knockout_24 weeks_replicate 1,pert
SCLC cell line DMS79,pert
cell line: HTB-58;	gender: male;	age: 65 years;	race: Caucasian;	disease: squamous cell carcinoma of the lung;	sirna: control,ctrl
strain: C57BL/6;	genotype/variation: IkkβF/F,ctrl
"Global gene expression of NASH patients, P37",pert
MA_309,pert
Superior Frontal Gyrus from a 6 year-old girl suffering from Rett Syndrome.,pert
No or early 1 rep10 (retina),pert
Normal Biological Replicate 6,ctrl
OSCE-15T,pert
ROS1,pert
"Cells: U2OS, Treatment: infected with control shRNA_pLenti, blasticidin selection",ctrl
"HSCs from female mice treated with E2, replicate 2",pert
n9t24h,pert
"Male F344 rats, sacrificed at the age 18 weeks",pert
patient: 235;	current medication: Asacol Predfoam Lanzoprazole;	birth date: 1/9/47;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/24/97;	diagnosis date: 8/26/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/11/05;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/11/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/97;	smoking amount: 15-24;	other illnesses: TURP;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
strain: C57BL/6J;	genotype: Homozygous dumbo;	developmental stage: P15,pert
OSE_563,ctrl
SZ12,pert
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 63 dpi,ctrl
"Donor 1, mock infected 1hr",ctrl
gender: Male;	tissue: liver;	genotype: Wild Type;	treatment: DMSO 3-day;	genetic background: C57BL/6,ctrl
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-1502;	gender: male;	passage: P11;	clone: C29,ctrl
"Pancreas from adult Rkip-1 KO mice, biological replicate 1",pert
NFIA E18WT1,ctrl
KO - knock-out Treated - 2 hrs - repeat 2 - Cy5 - mAdbID:62609,pert
Animal 8,pert
5284 UC Uninflamed ascending colon,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 6,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 42 yr;	population: white;	dsm-iv: 296.8;	age of onset: 18 yr,pert
sample =Healthy1 treatment=Control time=0 (min),ctrl
DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma) Replicate 2,pert
CME-Ctr_LaminA4d-1MA-S2,ctrl
WT STR Veh 5,ctrl
RelA_siRNA_0a,pert
CML Patient 1 7 days therapy,pert
KU_04T,pert
MDA-MB-231 - MTDH-WT-KD-2,pert
Mening UNSTIM WB NP 6b,ctrl
A549 AZA 1 uM (3213),pert
strain: Sprague-Dawley;	gender: Female;	tissue: ovary;	developmental stage: day P4 cultured for 2 more days,pert
4112-2 E2F WT,ctrl
strain: C57/Bl6;	gender: male;	genotype: Egr-1 wildtype;	age: 30 days;	tissue: retina,ctrl
GLY replicate 6,pert
SHANK3_3,pert
PsOEt-16-Week 1,pert
con-50_B,ctrl
Normal_2222,ctrl
VPA Treated Rep 3,pert
"DBA/2J CHR, Rep2",pert
39A;pretreatment;female;breast tumor; responder,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 64 yr;	population: white;	dsm-iv: 295.7;	age of onset: 19 yr,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 80;	time: 0;	batch: 2,ctrl
gfp control sample 1,ctrl
Gsk-3a-/- ESCs Rep2,pert
NPC1,pert
MCF7_Control_Array_1,ctrl
CD19_selected_B-cells_before_R_rep10,ctrl
PGA-RMM-5h-1aA-s2,pert
tissue: retina;	disease state: Control,ctrl
"MLD, biallelic AML MLL_00268",pert
H1299 RBP2 KD1_rep 1,pert
cell line: NALM1;	tissue: Human B cell precursor leukemia,ctrl
"fibroblast, control subject NF4 rep 1",ctrl
SUBSTANCE P 24 HOURS,pert
WT(Rnh1+/+) -2,ctrl
PC-3_basalhTERT_ShortTelomeres_mockcre_2,ctrl
strain: C57/Bl6;	genotype: Akt1+/+;	gender: PND70 female,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 145min;	race: White;	sex: Female,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: healthy;	Sex: F;	age: 45,ctrl
"3T3-L1 siControl 48h, biological rep 1",pert
Skin_Control E16.5_rep2,ctrl
OE control 19A n,ctrl
T40975,pert
WT_R6_rep3,ctrl
V5-P208,pert
RV63.01_CONTROL_day19_Slide33,ctrl
normal esophageal epithelium (N1),ctrl
"Crohn's Disease subject (56 year old caucasian female, SAK_1315817415)",pert
K562 AMN107 sample 4,pert
"NASP Overexpression, sample #4",pert
Expression data from BAT of the KRAP deficient mice (KO2),pert
genotype/variation: wild type;	tissue: Brain Tissues,ctrl
ColonProx_022XAC3F_070.txt,ctrl
"Atm-/- 120 min post IR, B",ctrl
LZ10,ctrl
123B,ctrl
Hunk Knock-Out rep 2,pert
KO - knock-out Treated - 12 hrs - repeat 3 - Cy3 - mAdbID:61764,pert
"acutely admitted, severely psychotic schizophrenia patient  A02",pert
"Spi-21, biological rep 1",pert
Aldosterone-producing adenoma (APA7),pert
"disease group: Psoriasis;	Sex: f;	age: 30s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 9.1;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 10;	ige (kiu/l): normal (0-48.5 kIU/L): 49.3;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
gender: Female;	age: 54;	post-mortem delay: 4h;	ph: 6.5,ctrl
parental cell line: WA;	vector: pBabe-puro (empty vector);	replicate: 2,ctrl
Stain: RPE65-/-;	Age: 2 months;	Tissue: retina,pert
"Biceps, control, cohort 18, subject 18U",ctrl
"seminoma specimen, pT3, patient age: 49y",pert
siCITED1#1 replicate3,pert
Esophagus CTR replicate 1,ctrl
cell line: SCC-40;	cell line origin: Oral cancer;	genotype/variation: control,ctrl
695-EV_16hr,ctrl
strain: C57BL/6J;	gender: male,pert
"C57Bl/6, CD-1",pert
cell line: OVCAR3;	transfection: eukaryotic expression vector pcDNA3.1 containing no insert,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 32 yr;	population: white;	dsm-iv: 295.9;	age of onset: 29 yr,pert
"brain, hippocampus: KA-24h-P15-III_e1_le1",pert
Individual_5324_NN_sample,ctrl
Kidney_colistin_5,pert
brain_DLPFC_bipolar C_mr423,pert
HeLa cells transfected with siSp1 rep 3,pert
P58 Non failing heart biopsy,ctrl
Brain_nAChRbeta4SubunitDeficent_MiceNob4363,pert
BCell_lymphoma_aggressive_sample4,pert
"Control, biological replicate 3",ctrl
expression array - O2,pert
"Deltoid, FSHD, cohort 22, subject 22A",pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 38 yr;	population: white,pert
HeLa cells;	(cervical cancer cells),pert
PGC-1a-/-bf/f/MerCre rep4,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 32;	maternal age: 35,ctrl
mutant_POST_PDE_060,pert
"seminoma specimen, pT1, pN1, patient age: 34y",pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 6 months,ctrl
"cultured PBMC, nontreated",ctrl
C2C12 myotubes 1000uM H2O2 rep 4,pert
Tobacco abuse,pert
Patient identifyier: R;	Sex: male;	Age of patient: 56 years;	Duration of psoriasis: 16 years;	Body surface area: 30 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
genetic background: FVB;	cell type: DN2;	genotype: wild type,ctrl
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 5.5;	colon weight (mg): 164;	colon ratio (mg/mm): 2.982;	myeloperoxidase activity (u/mg): 0.301;	tissue: colon;	treatment: 5% DSS,pert
"Ott1 knock out, biological rep 2",pert
"Monuron-treated NRK-52E cells at 72h, biological rep 3",pert
genotype/variation: Gb5-deficient;	tissue: Brain Tissues,pert
OCT4 shRNA_2 Days knockdown_rep3,pert
STV_G,pert
Adrenocortical adenoma with wild-type CTNNB1-4,ctrl
MIC4,ctrl
ID: MLL_00112;	cell type: PBMC;	disease state: control,ctrl
Diseased individual (ulcerative colitis) of twinpair #4,pert
"19B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
MO32_10,pert
"gender: male;	batch: 2;	age (years): 35;	patient id: Non_severe_3;	fev1 (% predicted): 77;	fvc (% predicted): 89;	medication: Becotide, Ventolin;	cell type: CD4+ T-cells",pert
"control, subject 1",ctrl
p107-/-;	age: newborn;	strain: FVB;	tissue: skin,pert
Lung-normal-rep2,ctrl
SA_51,pert
"Control, biological rep 1",ctrl
AQA C,ctrl
wild type parietal cell replicate 3,ctrl
treatment: vehicle;	genotype: wild type;	treatement time: 4 hours,ctrl
"Ovol1 KO, biological rep2 (with calcium)",pert
FR-control-2,ctrl
HeTH-4 rep-1,ctrl
MCF-10A shCHK1-3 replicate 3 [set 5],pert
cerebrum_PS-/-_ 0d_rep1,pert
passage: 10;	cell type: fibroblast;	treatment: overexpressing prelamin A;	cell line: GM00038,pert
colon_CRC_1494,pert
"pt. HCL A treated with Vemurafenib 1000 nM for 72h, replicate1",pert
"pancreas, control diet, replicate 3",ctrl
"Liver from MON exposed rats, biological rep 1",pert
At Risk: -;	Age: 11;	Sex: F,pert
"Ulcerative Colitis (55 year old caucasian female, SAK_1319013894)",pert
quiescent p27WT MEFs 3,ctrl
Muscle PCOS after pioglitazone 272,pert
ndf + progerin,pert
RNA-DHL4-R406-6H-2,pert
166-01-C,ctrl
BE-rep3,pert
control-4,ctrl
control-control rep 2,ctrl
Jak2VF vehicle (7991003040_B),pert
"brain, brainstem: CB3_e1_le1",ctrl
GM19238_Kd_IKZF3_3,pert
SCC25_rep1,ctrl
MCF-10A shATM-3 replicate 2 [set 5],pert
11380 Normal Uninflamed ascending colon,ctrl
CON - LV22,ctrl
"human failing LV myocardium, Ischemic41",pert
lrrk2 genotype: WT / LRRK2 GS,pert
Disease_status: Healthy control;	Age (years): 41;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.0;	Post mortem interval (hours): 11;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
disease: type 1 diabetes;	gender: female;	cell type: endothelial progenitor cell,ctrl
51m1,ctrl
chip number: 23;	transfection plate: 5;	target gene: TAF1;	kd level: 0.65;	rin: 9.3;	transfection date: 2011-10-17,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 0,pert
male_control_211,ctrl
Clcn5 knockout,pert
Patient 6 skin treated,pert
ndf + preLA + ZMPSTE24,pert
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 1,ctrl
"treatment: control;	batch: 7;	donor: 53;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
"Patient 28, Macroscopically intact tissue",ctrl
8 week old EOM MDX rep 3,pert
"AD_FC, biological rep3",pert
Snell 6 month Dwarf Liver 89dw,pert
parental HeLa cells rep 1,ctrl
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 32;	Usage number: 1;	Exposures: 4,pert
HF0615_U133P2,pert
LIVER_diclofenac_repl5,pert
NHE3-/- replicate 3,pert
Map3k7 (TAK1) knockout replicate 3,pert
Clozapine treated 12weeks AffyGC RMA rep4,pert
microdissected breast cancer cells from case 1405,ctrl
Neocortex_Eomes_WT.2,ctrl
wt_P6_rep4,ctrl
tissue: cerebellum;	strain: wild type;	age: 3 months;	genetic background: C57Bl/6,ctrl
"Empty vector, biological rep2",ctrl
Pt38_Post,pert
ctrl- rep2,ctrl
"BOEC, not_at_risk 1",pert
WT-control-2 (DFW),ctrl
"HEK293E cells, TDP-43 siRNA, replicate 4",pert
KO-Nrf2-Female-1,pert
"Cell line SLM2, mutant status WT, condition Control 1",ctrl
"Vldlr knockout saline, biological rep4",pert
"vestibualr organ at E18.5 of Igf1 -/-, biological rep 2",pert
PGA-RMM-72h-3aA-s2,pert
"WT liver, biological rep1",ctrl
NINDS-RHS-Kainate_240h-1aUA-s2,pert
B6_Pseudomonas_overexpressor_48,pert
Strain: FVB;	Genotype: MMTV-iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: not treated (0 hour),ctrl
Wildtype 1 (jos0677),ctrl
tumor cell line HepG2 with knockdown of HIF-1α rep1,pert
"E2F-1, #1 repeat",pert
NFIA E18KO1,pert
"Normal skin from Tie2_control mouse, biological replicate 3",ctrl
Atxn1L HSC 1,pert
A YOKE_B027,pert
KM_028T,pert
E17.5 preB cells_Smchd1 wildtype_Rep 3,ctrl
Human Chronic HIV Sample C102-CD4+ T cells,pert
TscWT3_brain,ctrl
wt-Gfp E16 replicate 4,ctrl
S/LV5,pert
SKBR3_1uM_Lapatinib_2,pert
DU145/NC siRNA #1,ctrl
heart_co_14M_rep1,ctrl
gender: Female;	age: 78;	post-mortem delay: 8h;	ph: 6.7,ctrl
Saline treated mouse gallbladder 4,pert
mESCs_EGFPcontrol_rep2,ctrl
"125, MUSCLE, Before",ctrl
subject id: 34;	infection: DENV;	status: DHF;	tissue: whole blood,pert
KO_cycling_rep3,pert
BALB/c d3 (187msn),pert
Liver antiangiogenic-treatment rep3,pert
WSD-first,ctrl
erStress_twins_AA_1725twin2_500nM_thapsigargin_4h,pert
liver_wild type_24 weeks_replicate_3,ctrl
Bone-Marrow_SMM_S1340,pert
Calu3-Parental_3,ctrl
BS2011051055,ctrl
HeLa cells transiently transfected with a Stau1 siRNA.,pert
"Acute Myeloid Leukemia, sample 7",pert
"Control #4, Untreated",ctrl
pMX-Oct4 and pMX-jhdm1b(jmjc) no vitamin C O+JMJCVc-_2,ctrl
Myh11-CreERT2.Tgfbr2f/f Control 3,ctrl
cumulus_PCOS_Obese_rep3,pert
16A;pretreatment;female;breast tumor,ctrl
GM19238_Kd_IRF5_3_rep,pert
c 4-3,pert
Moderate rep7 (retina),pert
Leptin treated mouse gallbladder 8,pert
PBMCs from normal control subject C,ctrl
HepG2_VehicleA_24hr,ctrl
strain: C57BL/6;	tissue: Spleen;	genotype: WT,ctrl
"fibroblast, wild-type, untreated, biological replicate 2",ctrl
"25B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Cerebellum_transgenic nuclear localization signal Htt exon1 18Q x50_16 months_replicate 2,pert
Individual_5849_PP_sample,pert
sample: #11;	subject: PD case #1;	brain: T-243;	age: 77;	sex: Female;	region: Dorsal motor nucleus of the vagus,pert
"S1P2-KO-hippocampus, biological rep9 (female)",pert
K_LS_Time0,ctrl
liver_STZ 0.1% quercetin diet_rep2,pert
L-540_Perifosine 10µM_24hrs_2B,pert
cerebellum_PSNA_ 0d_rep1,pert
patient id: 42;	tissue: Normal cortex;	gender: Male;	age: 45;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
"Mouse bone marrow-derived mast cells treated with IL3, rep 5",ctrl
NMRI_24h_Wy,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L003,pert
GV oocyte_Ring1 mut_rep2,pert
age_years: 43;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
Muscle PCOS after pioglitazone 102,pert
Untreated wild type C,ctrl
cell line: HL60;	disease state: promyelocytic leukemia,pert
CCRPKO-PBS_rep-2,pert
"Acute Myeloid Leukemia, sample 44",pert
"genetic background: B6/129;	genotype: WT;	cell type: Lineage negative, c-Kit and Sca1 (LSK) positive expressing bone marrow progenitors",ctrl
TF1_controlsiRNA_2,ctrl
disease state:NHM;,ctrl
Peripheral blood mononuclear cells;	TTF=110min;	Race=White;	Sex=Male,pert
PBMC from T cell Large granular lymphocyte leukemia patient#106,pert
"208, ADIPOOSE TISSUE, Before",ctrl
CD4DecTp1-8,pert
"Control 1, biological rep4",ctrl
HD 4,ctrl
BAT_KO_1,pert
"T-cell prolymphocytic leukemia, inv(14)(q11q32), case 1",pert
Strain: 129Sv (wildtype);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,ctrl
BM_02300,ctrl
Gender: Male;	AJCC Stage: IV;	Pathological T: 4;	Pathological N: 1;	Pathological M: 1;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: NO,ctrl
Undifferentiated Dicer -/- (27H) ES cell line replicate_2,pert
Gender: male;	Source tissue: foreskin,ctrl
tissue: Peripheral blood;	disease status: patient with recurrent events,pert
E9.5 embryo_Cop1KO_rep1,pert
"array 30, xenograft, DBP 500 mg/kg/d",pert
quiescent ulcerative colitis_UCN1,ctrl
GLIP1,pert
KO PGC rep1,pert
umbilical cord_nobpd: 9B,ctrl
MDS patient 32,pert
5198 Normal Uninflamed sigmoid colon,ctrl
UC-55-un,pert
chip number: 16;	transfection plate: 5;	target gene: TAF1;	kd level: 0.68;	rin: 9.4;	transfection date: 2011-10-17,pert
strain: C57BL/6J;	tissue: skin;	cell type: melanocyte;	genotype/variation: Ink4a-ARF1 null,ctrl
"Patient P, lesional skin",pert
CXCL4_B,pert
genotype: Villin-Claudin-2 transgenic (Cl-2TG);	cell type: colon epithelial cells;	gender: male;	treatment: water,pert
whole tissue section from case 772,pert
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: STAG2 knockout clone 7 (STAG2 deficient),pert
FACS-purified B cells_129SV/EV_influenza-infected_rep4,ctrl
Tendon_lesional_rep17,pert
Moderate rep10 (OHN),pert
"PDK1 null CTL, biological replicate 1",pert
EA_Case13_CD4,pert
BAL_27b_A2B1,pert
Gata4LoxP/+VillinCre adult male jejunum (6-8 wk). Control sample.,ctrl
BC9 TC,ctrl
normal 3370,ctrl
Replication 2 Aldosterone,pert
HSL-null 2,pert
gender: Male;	tissue: Tendon;Biceps;	age: 50;	donor: 24;	disease state: Non-lesional,ctrl
1209-03-A,pert
chip number: 19;	transfection plate: 4;	target gene: IRF3;	kd level: 0.9;	rin: 9.2;	transfection date: 2011-10-17,pert
liver_Pink1 knockout_24 weeks_replicate_2,pert
shCypB3,pert
cell line: SKBR3 parental;	treatment: basal conditions,ctrl
Patient identifyier: N;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 20 years;	Body surface area: 25 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
A_AN17138_F,pert
"genotype/variation: Brg1_cKO1;	strain: mixed background (Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med. 2003 Dec 15;198(12):1937-49.);	age: P1",pert
LCH7ani,pert
Sprague Dawley rats;	Gender: male;	Weight: 250-350 g,pert
"Aorta, saline 14d, #5",ctrl
Cav3 knockout,pert
miR122-WT-103,ctrl
MPM tumor 40,pert
Evi1-1,pert
gender: male;	strain: SV129;	tissue: heart;	genotype: PKCZ -/-;	age: 32 weeks,pert
Control Endometrium Stromal Cell_ETB65 -+,ctrl
10A;pretreatment;female;breast tumor; responder,ctrl
p300+/- Rep3,pert
colonic_mucosa_inflamation_93,pert
cell line: KARPAS-231;	cell type: diffuse large B-cell lymphoma (DLBCL) cells;	treatment: LITAF-specific siRNA,pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: none;	vector: none;	activation: 2 h 100 ng/ml TNP-BSA,ctrl
knockdown: estrogen receptor alpha KD;	cell line: MCF7,pert
cell line: U251;	transduction: stably expressing shRNA against cyclophilin B,pert
"Endometrium, postmenopausal, estradiol, 28",pert
control AU081206,ctrl
expression array - AO3,pert
BRCA1 KD #2,pert
R26Pax3/Pax3 E14.5 palatal shelves 1,pert
C027_Control_M_90,ctrl
8 hour tunicamycin wild type C,ctrl
Bronchial Epithelial Cells MMA biological 1142Z,pert
RV82.03_CONTROL_day10_Slide54,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 132;	genotype/variation: WT;	age: 8 weeks,ctrl
Strain: C57BL/6: PGC1beta mutant; Tissue: liver,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 52;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
NoKD_SerumStarved->1hrEGF_rep1,pert
braak stage: BR56;	rin: 81;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
Muscle-AMPKgamma3-mutant(R225Q)transgenic-6,pert
non-transgenic,ctrl
heart_QH2_14M_rep1,pert
strain: C57BL/6J;	day: 18;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 1,ctrl
cell line: LICR HN1;	treatment: Cetuximab 15 nm Cetuximab for 13 hours,pert
0516-01-C,ctrl
LOX1 Untreated 6hr 282295653,pert
H295R _Control_rep3,ctrl
WT2,ctrl
KM_066N,ctrl
"45B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Exon3_T3,pert
non-malignant FTEb_patient 12,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 69 years,pert
cell line: LICR HN1;	treatment: PBS,ctrl
KM_049T,pert
FSH-NHM-4UA-s2,ctrl
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 1 - Technical Replicate 2,pert
LICR_HN1_PBS3,ctrl
DBA d18 (123msn),pert
CD34+ cells without fenretinide treatment from CML35,pert
Hippocampus 1981 15 month Old,pert
CAR.KO_phenobarbitol_rep1,pert
"E2-treated cells (3hr), biological rep_3",pert
"scr-Rosi, biological rep2",ctrl
e_B13,pert
colon_IL10mouse_12weeks_rep2,pert
strain: C57BL/6;	Gender: male;	Age: 8-12 week;	Wild type,ctrl
"Affymetrix chip HG-U133A, siPTHrP 3",pert
F_Kin_2,pert
Individual_3777_PP_sample,pert
Normal-N_LJ_2,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 5",ctrl
Liver_hyperglycima_no.4,pert
K14deltaNB-cateninER  Time 1 replicate 3,pert
MDA_Parental_4,ctrl
Cavin-1/PTRF KO #237,pert
siTNIK+7hr Wnt (Experiment 1; dye swap),pert
PGA-HMO-NonObese-8aUA-s2,ctrl
BCells_Transgenic_day0_REP2,pert
7A;pretreatment;female;breast tumor; responder,ctrl
WT_IL-6_100_rep3,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 32.96164,ctrl
5246 UC Uninflamed sigmoid colon,pert
C007_Control_M_54,ctrl
background mouse strain: C57BL/6;	source: liver;	genotype: wildtype,ctrl
scan batch: Batch 1;	group: autism;	subject age: 8;	paternal age: 34;	maternal age: 37,pert
Age: 45;	Sex: M;	Ancestry: Hispanic;	Smoking status: non-smoker,ctrl
Ngn3 EB10 OFF replicate 2,pert
cell type: embryonic stem cells [E14];	transfected with: siRNA targeting the pCIP proteins,pert
timepoint: 2h;	drug: Morphine;	group no.: 4;	large batch: X;	plate: 1957998117;	hybridization batch: I,pert
Patient no. 5: treated,pert
"MDA-MB-231 (human, Caucasian, breast, adenocarcinoma)",ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: A;	experimental sample name: PC1-R,ctrl
reduction mammoplasty patient 310,ctrl
A549 siRNA FAM60A CNTRL 3,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 214,pert
OVCA433-(1),ctrl
Liver_KnockOut_4,pert
"SR-A mutant, 6 weeks old",pert
PCOS Endometrium Endothelial Cell_107.PC07+-,pert
EA_Control3_CD8,ctrl
IFNb-treated MEF 2,pert
PsOEt-15-Week 1,pert
HSC-Evi1-KO-1,pert
Rybp#15 (OHT+)_12d_rep1,pert
HEK293_hCdc73siRNASparse_rep1,pert
Dental pulp cells control sample triplicate 2,ctrl
HTH83 SCR 3,ctrl
SeroTest-2,pert
Mouse_Retina_P7_Rs1h_KO 1,pert
H5 HA 2h 1,pert
mock C,ctrl
transfected with FoxP1 siRNA_2,pert
04SAGEA,pert
Nrl-ko-Gfp P10 replicate 1,pert
S4-040517-SA,pert
P0 - epsilon129s6 3,pert
background strain: Derived from BL6 blastcysts.;	cell line: WD44;	cell type: ES cell;	passage: 14-18,ctrl
Caco2-siRNA-control2-rep2,ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 29;	maternal age: 33,pert
ILD Study Number 1235,pert
Subject #8041-8hr Postinfection,pert
MSE_N_659,ctrl
01MHB,pert
HSF1+/+ T cells at 37oC replicate #2,ctrl
m1-WT6,ctrl
ERRa KO biological replicate 2,pert
PCOS Endometrium Endothelial Cell_103.PC01+-,pert
RE550_DU145_7-Medi5117,pert
strain: mixed background of 129/SV and C57BL/6;	cell type: macrophage;	genotype/variation: PPARg KO,pert
n8t7d,pert
211/4,ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 6h, biological rep4",pert
"Patient CV, stable renal transplant recipients, male, 58 years old, T1 (3 months after the switching of the therapy)",pert
G392E_off_rep2,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 3;	psoriasis duration: 8.89390828199863;	age of psoriasis onset: 38,pert
patient: 12;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
T8E-LU,pert
nmd untreated 3,pert
"Ulcerative Colitis (41 year old caucasian female, SAK_1318969188)",pert
RV16;	Age = 18;	Sex = F,pert
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P5,pert
H2bt5,pert
A_LS_Wk4,pert
"testis wt, 17dpp, Rep4",ctrl
colonic_mucosa_non_inflamed_758,pert
T7,pert
KN-smoke-med-5 month+13d-R4,pert
wildtype 1,ctrl
4 hour tunicamycin CHOP-/- C,pert
C4_HypM,ctrl
"Control, replicate 1",ctrl
Tumor_18w_vechicle_DEN_129,ctrl
PCOS Endometrium Stromal Cell_101.PC01-+,pert
disease state: control;	patient: 32,ctrl
cell type: Endothelial cells,ctrl
cell line: HL-60 promyelocytic leukemia cell line;	leukemia type by fab: M2;	agent: control,ctrl
PBMCs enriched for CD8+ cells from normal control subject C,ctrl
64A;pretreatment;female;breast tumor,ctrl
"Wild type used for MAT1A 15 month, replicate 5",ctrl
strain: CD-1;	genotype/variation: Pkd1null/null mutant;	developmental stage: embryo;	age: E14.5;	tissue: kidney,pert
U937_ROS_curcumin_18h_rep2,pert
IEC_GF-HDAC3FF -3,ctrl
MyD88_LPS_M2-0,ctrl
PBMC from T cell LGL leukemia patient #124 (TLGL124),pert
age	52;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	4.4;	leukocyte count (/nl)	30.5;	hemoglobin (g/dl)	12.8;	platelet count (/nl)	359,pert
age: 65;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
PC-3M/NC siRNA #1,ctrl
HA99-96A,pert
AZ-521_doxycycline_18h_rep2,pert
"AG825-treated, 6h after UV, Replicate E",pert
XmO1,pert
disease state: Healthy;	cell type: CD4+T;	twin: T,ctrl
WT-smoke-med-5 month-R1,ctrl
MCL_IGHV_MUT (R1341),pert
strain: C57BL/6;	genotype: wildtype;	age: 0 days;	tissue: muscle;	muscle type: Quadriceps,ctrl
"OuJ, air, biological rep 3",ctrl
Uninduced control 01-14-03_Lee_U133A_Tet,ctrl
"Cbfb-/-, technical replicate 1",pert
Leg 23 Day control rep 3,ctrl
LOX1 Untreated 24hr 282295893,pert
cell line: prostate cancer cell line DU145;	genotype/variation: MYB siRNA,pert
4mo tg8,pert
Peripheral blood mononuclear cells (PBMC)-Patient GM T1,pert
0561-01-A,pert
"Wild type mouse aorta with placebo, biological rep2",ctrl
FMR1_3,pert
"human peripheral blood derived monocytes, 24 hour LPS stimulation, biological rep2",pert
age: 12 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 knockout,pert
"DMSO-treated, sham UV exposed",pert
"Age: 46;	Sex: M;	Ancestry: European;	Smoking status: smoker, 21 pack-years",pert
1203-03-A,pert
A549 vehicle control (3206),ctrl
jzo009-rp1-v5-u74av2-met,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 52;	gender: male;	tumor grade: IV,pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 22;	maternal age: 23,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 165min;	race: White;	sex: Female,pert
"HEK293E cells, scrambled siRNA, replicate 1",ctrl
220D1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.748;	OD280: 0.861;	Ratio: 2.01;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 76;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"3 uM EPZ004777 treated, DAY 6, biological rep.1, MOLM-13 cells",pert
whole tissue section from case 1363,ctrl
WT-Fibr1 1,ctrl
PBMCs_IS_15 [IS],pert
age: 47;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Tissue: Spleen;	Type: Sham;	Strain: C57BL/6;	Batch: 8/1/03,ctrl
c57BL/6JTCE liver sample batch 6,pert
"Global gene expression of NASH patients, P41",pert
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14501;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
"U373-MAML1-dn, rep 3",pert
Day: 18; Drug: Heroin; Phase: Withdrawal; Replicate: 2,pert
"vector d0, rep 3",ctrl
Brain area 8/9_6y_RTT,pert
Septic shock;	gender: Male;	Non survivor;	organism: Neisseria,pert
NTG mouse_tamoxifen2,ctrl
"Tip60 KD, replicate A",pert
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 2",pert
P74 dilated cardiomyopathy heart biopsy,pert
"human failing LV myocardium, Ischemic14",pert
PTEN_mutant_2_intestinal_polyp_30days,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (14),pert
Nerve_Diabetic_Rosi_717,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 8d ID221,pert
siWTAP 1,pert
KO618,pert
HUVEC exposure 1 ug/ml colchicine 12hr_2,pert
HF0488_U133P2,pert
695_EV_24hr_repeat,ctrl
t09,pert
"cell line: hgps-fib_1: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository",pert
cell line: MH1C1,ctrl
MDS14,pert
N11A Normal-frontal,ctrl
Diagnosis: AML M5;	Age: 41y ;	Gender: Male;	Blast %: 90;	Source: BM;	Cyto: Complex;	FLT3 ITD: 1;	FLT3 TKD: No Data,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.14;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
"Control Day 3, biological rep2",ctrl
BAT_WT_3,ctrl
Individual_5256_NN_sample,ctrl
"C8161, 48h treatment with 5 AzadC",pert
"Untreated ES cells, Rep 1",ctrl
lesion_preUV_patient5,pert
PND28 Rat Testis_Rat230-2_1hr MEHP_Animal#37_04005,pert
Run7.aUa.001206d.SkMInS1072D.CEL-IS basal,ctrl
RNAi -Transgenic replicate 11,pert
CAR.AH_corn oil_rep1,pert
"schizophrenia, BA46-88",pert
Genotype: Mdr2-KO homozygous mouse;	Age: 12 month,pert
GM19238_Kd_TCF12_3,pert
Strain: C57BL/6J;	Gender: M;	Age: 8 weeks;	Treatment: untreated,ctrl
Pooled litter samples were collected 24 hrs after the final compound dose.,pert
"Normal Skin, Normal-12",ctrl
Ishikawa_VeryLowDose_BPA_24h_rep1,pert
untreated-sample3,ctrl
striatum_Pink1 knockout_12 weeks_replicate 1,pert
strain: C57BL/6J;	Sex: male;	expression: sh-scr;	agent: rosiglitazone at 1uM,ctrl
HeLa_TP082505-26_HG-U133A_2_IMFGN0023,ctrl
cell type: lymphoblastic leukemia;	gc resistant: TRUE;	treatment: EtOH,ctrl
pancreatic cancer cell line MiaPaCa2 stabley transfected with empty vector pCEP4,ctrl
Mouse old heart w/ a-tocopherol aT-Ht-4,pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,ctrl
PlagL2KO2,pert
SiTIF- rep2,pert
WT_R6_rep2,ctrl
1163-03-A,pert
Normal subject 1,ctrl
"SLE patient, 1021V1",pert
RI59,pert
"control, BA46-71",ctrl
BCell_activated_sample2,ctrl
HMEC X BC1257,pert
Control with WY14643 replicate 1,pert
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14502;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
LJMJDW17,ctrl
Strain: C57BL;	Gender: male;	Age: 9-10 weeks;	Tissue: liver;	Developmental stage: adult;	Cell type: Primary hepatocytes,ctrl
Control N2B27 sample 3,ctrl
siERK2E24h_2662,pert
Braak α-synuclein stage 1-2 BR12_3SN,pert
BE-rep1,pert
H10 Ctrl 6h 4,ctrl
"Normal subject (47 year old caucasian female, SAK_1289471570)",ctrl
c57BL/6J Vehicle liver sample batch 2,ctrl
Wt_ liver_fasted_refed_3hr_ rep3,ctrl
brain_DLPFC_bipolar B_mr304,pert
U-87MG-PK19 set 2,pert
WT mouse (WT_Tal3),ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 5d ID218,pert
"MIST1-null pancreas, biological rep3",pert
ovaries dissected from 0-day old Sprague-Dawley rats and cleaned of ovarian bursa.,pert
colon_normal_1024,ctrl
healthy control H27,ctrl
strain: ICR;	cell type: bronchoalveolar stem cells (BASC);	genotype/variation: Myc-depleted,pert
"117, ADIPOOSE TISSUE, Before",ctrl
"brain, adrenal medulla: Sample#B2 (Ctrl Pt2)_e1_le1",ctrl
Strain:  B6.V-Lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,pert
RNA mix 5 of nomarl lungs,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: DMSO for 48h,ctrl
PGA-lv_4h_509,ctrl
Subject #8041-Preinfection,pert
disease state: healthy control;	tissue: epidermis;	age: 73;	gender: female;	treatment: untreated;	time: control,ctrl
PC-3M/NC siRNA #3,ctrl
MEF Wild Type 1-rep3,ctrl
CTL2 AO 24hr,ctrl
"Control shRNA, rep1",ctrl
3172-scrape,pert
status: Control;	gender: Male;	age: 49;	tissue: Blood,ctrl
strain: C57/BL6;	genotype/variation: NEMO knockout (NemoΔhepa);	gender: male;	age: 8-9 weeks;	tissue: liver,pert
Time of Surgery:Pre;,pert
strain/background: C57B6SJL;	genotype/variation: GNMT knockout;	age: 8 months;	tissue: liver;	disease status: hepatocellular carcinoma,pert
cell line: MCF7 breast cancer;	treatment: RL silenced and LIF-stimulated,pert
brain wild type replicate2,ctrl
Adult 7d SNI; Biological replicate 2,pert
tetracycline inducible Ngn3 ESC differentiated for 3 days as EB without doxycycline,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 65min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 242,pert
tissue: Temporal cortex;	age: 82;	Sex: M,ctrl
"cochlea at P3, ko, biological rep 2",pert
Nuclear RNA_WT_rep2,ctrl
"5B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
B_cell_pool_melanoma_M09+M10,pert
BTBR+tf/JTCE liver sample batch 6,pert
WT 2 1509,ctrl
THRB wt + vehicle replicate 3,ctrl
"Lesional skin from K5-Tie2 mouse, biological replicate 2",pert
"brain, hippocampus: C6-II_e1_le1",ctrl
"SLE patient, 1023V1",pert
pediatric AML S12,pert
04_ADL,pert
LRRK2 (G2019S) heterozygous fibroblast sample 2,pert
Bone-Marrow_SMM_S1420,pert
Strain: C57BL/6J;	Gender: M;	Age: 9 weeks;	Treatment: untreated,pert
GFP Untreated 6hr 282295593,ctrl
Patient 2 c,pert
4_Hr_No_MGd_3,ctrl
AO 48hr,ctrl
"Patient E, uninvolved skin",ctrl
heart MHC-Plin5 3,pert
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: mir126 overexpression,ctrl
"WKY adrenals, replicate 3",ctrl
Diabetes 1b,pert
"brain, hippocampus: LH5_e1_le1",pert
PBMCs_Control_16 [IS],ctrl
KU_08T,pert
Gender: Male;	Age: 32;	Ethnicity: Hispanic,pert
"Wild type,pancreas",ctrl
brain_OFC_bipolar B_mr212,pert
Adipose-5 month-wild type-technical replicate 2,ctrl
PGA-RMM-8h-3aA-s2,pert
Control_2h_rep2,ctrl
SEB-1 vehicle control biological replicate 3,ctrl
MCF10A 5days,ctrl
chip number: 11;	transfection plate: 3B;	target gene: DIP2B;	kd level: 0.83;	rin: 9.6;	transfection date: 2012-03-26,pert
Control for EGF 4h replicate 2,ctrl
"D425-shOTX2_1, t=24",pert
Phan_010_KO.bleomycin rep1,pert
subject: 40;	disease: CP;	muscle: GR;	gender: M;	age: 10.1;	gmfcs: 2;	popliteal angle: 120,pert
WT_rep_4,ctrl
MDS31,pert
treatment: 0.1 μM CDKI-73 for 4h;	cell type: CLL B-cells,pert
b93,ctrl
heart control 2,ctrl
patient: 19;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Muscle 50 eccentric contractions 12 hours WT Adult 07271,ctrl
Human squamous cell lung cancer cells,ctrl
Strain: C57BL/6J;	Gender: female;	Age: 8 weeks;	Tissue: whole brain,pert
Gastrin Knockout parietal cell replicate 2,pert
cell type: B220+ cells from preB colonies;	genotype/variation: Hspa9+/+,ctrl
cell line: Hep G2;	genotype: wild-type THRB and;	treatment: with vehicle for 6h,ctrl
"Pool of four samples (n=4);;	gender: three female/one male;;	age: 19/57/40/70 years old;;	cells: CD3+ T cells, bone marrow;;	disease: (severe) aplastic anemia (SAA)",pert
SALINE 24 HOURS,ctrl
microdissected breast cancer cells from case 297,ctrl
colon_CRC_1146,pert
chip number: 22;	transfection plate: 3B;	target gene: NFE2L1;	kd level: 0.84;	rin: 9.5;	transfection date: 2012-03-26,pert
strain: 116;	Disorder: normal;	Condition: no hydrocortisone,ctrl
liver_Pink1 knockout_6 weeks_replicate_2,pert
subset: HDAC2 siRNA subset;	cell line: HCC cell line Huh7;	treatment: scrambled siRNA,ctrl
Control siRNA rep3,ctrl
Fetal heart 1.5 ug/kg TCDD rep3,pert
sample =XCGD5 treatment=Control time=180 (min),pert
PGA-HMO-NonObese-6aUA-s2,ctrl
"Strain: B6CF1 x C57BL/6, Tissue: Bone marrow, Age: 7 weeks",ctrl
01L4P: normal control,ctrl
Klf9KO_jejunum_PND30_3,pert
"Healthy control, biological rep1",ctrl
IRF4_2,pert
Halothane 10 exposures-3,pert
"Tg brain, biological rep4",pert
sample I 18.5 wt,ctrl
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 53;	age-at-onset: 45;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",pert
"schizophrenia, BA46-9",pert
JURL-MK1 non-treated,ctrl
umbilical cord_nobpd: 4A,ctrl
Laser Capture Microdissection (LCM) to isolate tissue sections of the hippocampus area of wild type mice brains,ctrl
age: 63;	gender: male,pert
biopsy specimen,pert
cell line: U2OS;	cell type: human osteosarcoma cells;	transfected with: shCHK1-3,pert
HEK293 transiently EWS-FLI1-transfected 1,pert
Hippocampus 1987 15 month Old,pert
TTP_WT_0ActD_BioRep4,ctrl
"MCF7/BUS, 30 pM E2, 48 hours, biological replication 3",pert
HepG2_DMNQ rep1,pert
homozygous_TGFb_24hr_1,pert
GM19238_Kd_E2F6_2,pert
E14wt-SRFdM-VP16-2,ctrl
Fibroblasts_DBApatient_3,pert
Discoid Lupus-L3,pert
"control mice, whole uterine tissues, replicate 1",ctrl
non-malignant FTEb_patient 7,ctrl
Mouse No Cldn16 B9 451,pert
colon_IBD_1665,pert
10 week mutant OMN rep 3,pert
Gender: Female;	AJCC Stage: I;	Pathological T: 1;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: YES,pert
"brain, hippocampus: PH7_e1_le1",pert
"Ovol2 KO, biological rep2",pert
01UMX_PolyRF-,pert
Atm+/+ untreated A,pert
"twin pair: #8;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
r3,pert
"CD14+ at baseline, biological replicate 1",ctrl
WT - Cre Treated - 2 hrs - repeat 1 - Cy5 - mAdbID:62602,ctrl
Diagnosis: AML M4;	Age: 67y ;	Gender: Male;	Blast %: 75;	Source: PB;	Cyto: tris8;	FLT3 ITD: 1;	FLT3 TKD: No data,pert
blood_day6_patient5,pert
mouselung_scid_control_rep01,pert
HO_1,pert
amygdala long access to cocaine replicate 3,pert
"non-AD_TC, biological rep10",ctrl
Healthy control_sample1,ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: luciferase shRNA,ctrl
U937_shSYK_2_Replicate2,pert
"patient 047b, normal, homogenized",ctrl
ab040 N,ctrl
P60_TR_2,pert
antimicroRNA-140_rep3,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 30;	maternal age: 21,pert
Individual_4269_PN_sample,pert
MCF-10A shCHK2-2 replicate 3 [set 5],pert
Run1.a10a.000607jd.2.SkMNor919.CEL-IS basal,ctrl
"Uninvolved Skin, NS-6",pert
wildtype_hypoxia,pert
breast tumor 6,pert
condition: Normal;	patient: N_LJ_9;	tissue: Normal skin biopsy;	kit: Affy,ctrl
ic22 -- APF on membrane A,ctrl
day 3 5-FU HSC 2,pert
30B,pert
THRB wt + vehicle replicate 1,ctrl
Braak α-synuclein stages 5-6  BR56_8SN,pert
A2780+(3),pert
"healthy control fibroblast, biological rep1",ctrl
tissue: Hippocampus;	age: 80;	Sex: F,ctrl
Heart_WT_03,ctrl
Pt_6 Acne Lesion,pert
patient: 122;	current medication: Venlafaxine;	birth date: 7/10/61;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 26;	gender: male,pert
Mouse E10.5 urogenital epithelium +/+ #1,ctrl
colon_Runx1-KO_Cy3_15447,pert
Liver-5 month-Myc heterozygous-technical replicate 3,pert
42B,pert
Sex: male;	Age: 7;	SL: 3.37;	House: -;	Severity: C;	Ashworth: 1;	Zancolli: 0;	PEFF: 90;	PESF: 90;	AEFF: 90,ctrl
cumulus_nonPCOS_Obese_rep1,ctrl
"postnatal 3~5 days, mixed gender, C57BL6/129 mixed background",pert
male;	38 yr old;	White,ctrl
"EtOH treated, Vehicle",ctrl
KL5_muscle_control,ctrl
S019_Scz_M_79,pert
HCC011N,ctrl
40A,pert
untreated AML 8 blasts,ctrl
treatment: naïve;	transgenic variant: AChE-S;	tissue: Pre-Frontal Cortex;	genetic background: FVB/N,pert
HCC002N,ctrl
3T3 Vector Control A-928605 2,pert
Oct4GipES_Luc_esiRNA_72h_rep3,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: other,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 50 yr;	population: white;	dsm-iv: 295.3;	age of onset: 31 yr,pert
cell line: A2780;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
Cervical Cancer C540,pert
siERK5Veh 1,pert
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 18;	dfs-event: 1;	distant metastasis: 1",pert
disease: type 1 diabetes;	gender: male;	cell type: endothelial progenitor cell,ctrl
microdissected breast cancer cells from case 1045,ctrl
HCC1954 Cell Control 3,ctrl
ApoD transgenic mouse rep_2 (CTG2),pert
"Exp A, Animal #263, 20mg/kg D-Serine",pert
siHic5_2_4h_2,pert
B-CLL PB P255,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 5d ID217,pert
Treated with 25uM Zinc for 4 hrs -- replicate #2,pert
Sarc_1,pert
chip number: 11;	transfection plate: 5;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-10-17,ctrl
KM_051N,ctrl
BE-rep2,pert
01UN7_Oligo,pert
humanMBC_FOXP1 overexpression_1,pert
"Vehicle treated, DAY 6, biological rep.2, MOLM-13 cells",ctrl
tissue: Frontal cortex;	age: 83;	Sex: M,pert
treatment: naïve;	transgenic variant: AChE-R;	tissue: Caudate-Putamen;	genetic background: FVB/N,pert
"Empty vector, plastic plate, rep3",ctrl
PGK12.1_Kdm6a RNAi-4,pert
cerebellum wild type 21 month replicate 2,ctrl
5IDC_tumor ductal,pert
MacularDegen-injured-5bAv2-s2,pert
cerebellum_wild type_12 weeks_replicate 1,ctrl
"ALL_DS, K56 011409",pert
race: caucasian;	age (years): 55;	stage: IB;	grade: 2;	histology: endometrioid,pert
"46, XY",ctrl
GC resistant clone C7H2-R19E7 treated for 6 hours with EtOH,ctrl
agent: EFNA4-Fc conjugate;	time: 48h,pert
OA 4,pert
HL60_shSYK_2_Replicate2,pert
Individual_5660_NN_sample,ctrl
"PBMC, healthy control, biological rep10",ctrl
KO9-3,pert
in vitro differentiated DCs,ctrl
3D-cultured chondrocytes from normal donor 3,ctrl
14m8,ctrl
Panc-1 Gli3T 2,pert
HES2_Mir122Mut_rep3,ctrl
cell line: HCT116 Human colon cancer;	shRNA expressing: NFX1-91,pert
159A,ctrl
MF-21,pert
Subject #8001-2d Postinfection,pert
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 31;	maternal age: n/a,ctrl
brain_OFC_bipolar B_mr351,pert
H441 transfected with ETS2-specific siRNA 3,pert
"brain, Entorhinal Cortex: 99-33 normal_e1_le1",ctrl
tissue: bone marrow;	genotype: E2A-KO;	strain: C57bl/6;	age: 10-13 weeks old;	cell type: FACS sorted LY6D- CLP cells (LIN-FLT3+CD127+),pert
KGN Control  [RR1003],ctrl
strain: C57BL/6J;	cell type: MEP;	genotype/varation: wildtype,ctrl
WT_ANT_PDE_2-wt,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 46;	sex: M,ctrl
Bl6_Mock_3,ctrl
3 h-apra-10 nM,pert
P123,ctrl
MDS patient 131,pert
H09_S_B1,ctrl
HDAC2 siRNA_1_Huh7 [HDAC2 siRNA subset],pert
WT CFTR unexposed replicate 3,ctrl
"Wild type fibroblasts, biological rep1",ctrl
tissue: sciatic nerve;	age: 2 months;	genotype: MPZ-Tfam KO,pert
PB_preTherapy_IIa,pert
CD4_T_cell_pool_healthy_H01+H02,ctrl
"Mammary gland, IGF1R-overexpressed, biological rep2",pert
oocyte_Brwd1_mutant_rep2,pert
"EBF1 d4, rep 7",pert
Severe rep4 (retina),pert
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: monuron 6 hr,pert
TAp63 alpha 24h without induction s1,ctrl
thyroid_normal_2,ctrl
strain: FVB/NHsd;	tissue type: back skin,ctrl
Mutc-Met_2,pert
CEM11_T6_PP_day14_042,pert
Plate vs. Nail:  1 Week Sham,ctrl
m1-adenoma5,pert
obtained from RIKEN CELL BANK,ctrl
"Crohn 01, CD01",pert
heart-30 months of age-control diet-biological replicate2,ctrl
Parkinson's disease sample x189,pert
"depression, BA10-39",pert
S006_Scz_M_79,pert
GM19238_Kd_RAD21_3,pert
V5-P536,pert
"Wild type, biological rep4",ctrl
Mouse_WT_colon_DSS_rep2,ctrl
A_LS_Wk12,pert
122A,ctrl
RatLung_H6h_4,pert
NoKD_SerumStarved_rep3,pert
Syracuse High Avoidance (SHA) learing rats 2,ctrl
brain_DLPFC_bipolar C_mr523,ctrl
"Atm-/- untreated, B",pert
Gender: Male;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate to poor;	Tumor Site: Descending;	Drug Treatment: YES,pert
Wildtype iPSC sample 1,ctrl
MDS8,pert
"Peripheral blood, normal control [N75]",ctrl
BxPC3_JMJD3KD_rep3,pert
Normal mucosa 5,ctrl
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 36;	maternal age: 30,pert
Ovalbumin-induced inflammation 4 hours,pert
GM19238_Kd_EP300_3,pert
uterus_veh_PRKO_4hrs_rep3,pert
HCC012N,ctrl
cMetKO QSC Technical Rep.1,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 206,ctrl
Saline T00278946,ctrl
acne skin sample,pert
1-WT,ctrl
E14 - WTMixA 2,ctrl
48h_c1,ctrl
"48 hour-treated TG2 knockout NB4, biological rep2",pert
"WT, biological rep2",ctrl
healthy control sample x169,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 38 yr;	population: white,ctrl
IPMA 3,pert
"129P3/J CHR, Rep3",pert
MLL_00116,ctrl
ILD Study Number 1164,pert
H157 siCTL1,ctrl
Erythroblast_SOD2+/+_repWT33,ctrl
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_4 months_replicate 2,pert
17L,pert
MH1C1_low_rep2,pert
HCC001T,pert
cerebellum_WT_12w_rep2,ctrl
Telencephalon cKO 3,pert
tissue: freshly isolated human monocyte;	gender:male; age: 41 yr; weight: 92 kg,ctrl
wildtype 3,ctrl
NPC Brain 25d Mouse1,pert
WT_04,ctrl
MDS patient 5,pert
Caco2-siRNA-control2-rep1,ctrl
"DMD skeletal muscle, biological rep10",pert
patient: 30057;	sample: tumor,pert
BP patient 88_biological replicate 2,pert
Mist1KO saline rep2,ctrl
Cav1KO 1761,pert
"BA OBCs, post doxycyclin withdrawal, rep4",pert
"wdNHBE uninfected at 36hpi, biological rep1",ctrl
4121-1 E2F1 Null,pert
"Crohn's Disease subject (34 year old caucasian female, SAK_1275478033)",pert
B final PC3 ctrl,ctrl
Atm+/+ untreated C,pert
01N4P,pert
A HID U_B049,pert
Mutated-ERα-positive breast cancer 42,pert
human esophageal squamous cell carcinoma cell line_KYSE70,pert
disease state: Chronic hepatitis B;	cell type: Peripheral blood mononuclear cells,pert
Waldenström’s macroglobulinemia (WM-PC 32833),pert
@52055800697862121408403718160406,pert
fibroblast_Slow_D123_Media_10,pert
HF0816_U133P2,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case1,pert
status: Control;	gender: Female;	age: 51;	tissue: Blood,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 29;	gender: male,ctrl
strain: mixed C57BL6;	genotype/variation: TSC1flox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,pert
KN-smoke-med-5 month+13d-R3,pert
tissue: retina;	age: postnatal day 6;	genotype: rd1,pert
HEK293_pLKO_R2,ctrl
GM19238_Kd_IRF3_3,pert
Diagnosis: AML M1;	Age: 64y ;	Gender: Male;	Blast %: 93;	Source: PB;	Cyto: t(2;12)del16;	FLT3 ITD: 1;	FLT3 TKD: No data,pert
female,ctrl
"breast tumor epithelium,13",pert
Ischemic cardiomyopathy_G5,pert
non-malignant FTEb_patient 6,ctrl
NSC18,pert
baseline control 02,ctrl
heart female pbs 10 dpi rep3,ctrl
11m2,ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,pert
Patient 3 b,pert
untreated_24hr_rep3,ctrl
WT Hippocampus - 3,ctrl
0164-01-c,ctrl
patient id: T163;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 52;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 4;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
cell line: HTB-58;	gender: male;	age: 65 years;	race: Caucasian;	disease: squamous cell carcinoma of the lung;	sirna: anti-Evi1,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_10 months_replicate 3,pert
DBA control (121msn),ctrl
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 3 - Technical Replicate 1,pert
HP-12C,pert
Day: 18; Drug: Heroin; Phase: Withdrawal; Replicate: 1,pert
"Crohn's Disease subject (49 year old caucasian female, SAK_1304617942)",pert
DBTRG 10 uM Y15 rep1,pert
Lung-normal-rep3,ctrl
c.4,ctrl
HT29 PLX Day8 rep2,pert
Nerve_Control_Vehicle_705,ctrl
No or early 1 rep9 (OHN),pert
"control_B3, empty vector",ctrl
subject id: c8;	infection: control;	status: control;	tissue: whole blood,ctrl
cell type: human peripheral blood memory B cells (MBCs);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339033,pert
WT MEFs at passage 3_biological replicate 4,ctrl
8-Mut_1,pert
genotype/variation: Cbx2_KO_XY;	tissue: gonads;	age: E11.5,pert
Liver sample of WT mouse 1,ctrl
expression array - O4,pert
sample type: HeLa-Ctrl-siRNA-3d;	cell line: HeLa;	knockdown: Ctrl-siRNA;	time: 3d interferon alpha;	treatment: interferon alpha,ctrl
FW_6a_BV7625,pert
RNA from HCC_22T,pert
C57BL10 soleus sample 1,ctrl
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.17 uM (EC50), biological rep2",pert
"Mepenzolate treatment, 25 hours (replication 1)",pert
n2a-Pou3f3-cont-2,ctrl
si Control and vehicle replicate 3,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 50.98904,pert
whole tissue section from case 297,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous saline challenge""",ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous saline challenge""",ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 41;	maternal age: 40,ctrl
"genotype/variation: ApoE-/- RAGE-/-;	strain: C57BL/6;	mouse provider: Ann Marie Schmidt laboratory, Columbia University;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: diabetic",pert
RNA: whole lung;	strain: C57BL/6;	genotyp: myd88 -/-;	infected: no;	replicate: C,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 2 month;	treatment: fresh air, treatment over 2 month, 4x1h exposure per day",ctrl
strain: Fisher 344;	gender: male;	age: 18 months;	tissue: hippocampal CA1 brain;	treament group: Intermediate-CORT (ADX),pert
Individual_3992_PP_sample,pert
Run1.a10a.000609jd.2.SkMNor914.CEL-IS stimulate,pert
Md02h034,pert
STAT1-deficient naïve T cells stimulated for 3 hours with medium alone 2,pert
Cbx2_KO_XY_1,pert
b8.2,pert
primary cell culture,pert
phenotype: alcoholic;	gender: female;	case_id: 285;	age: 67;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 68;	brain ph at time of freezing: 6.3;	labeling_batch: 2,pert
RNA from HCC_11N,ctrl
Epididymal adipose WT ND #687,ctrl
"Patient 20, Macroscopically intact tissue",ctrl
"Mouse LV, WT 3",ctrl
"Cnr1-/-/Cnr2-/- female number 2, untreated control ear (#8_Ko-C-5)",pert
cell line: H1299;	agent: azacitidine;	dose: 1 uM,pert
"GSL30, PR04M005v0",pert
Lmx1b -/- E11.5 proximal hindlimb pool 3,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 60,pert
Fibroblasts_DBApatient_1,pert
Pooled litter samples were collected 24 hrs after the final compound dose.,ctrl
C1_transgenic but unaltered,pert
NL A,ctrl
"Mice_non trans, biological rep2",ctrl
"female Spargue-Dawley rats, Targretin, 60 mg/kg BW gavage for 7 days, tissue: liver",pert
"human failing LV myocardium, Ischemic38",pert
Silberg2 (S4) 23100NE,ctrl
cell type: monocyte;	disease state: heterozygote FH,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 19d ID77,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: Schistosoma japonicum;	time point: 4 weeks post infection 20 cercariae,pert
P1 mouse eyeball extracted total RNA_Snf2h_cKO2,pert
V5-P037,pert
Wildtype 1,ctrl
Substantia nigra PD rep3,pert
SIRT4 KO liver_7211-2,pert
Osteoblasts_Lrp5_Control_Day7_rep2,ctrl
age: 46;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"WT, biological rep3",ctrl
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-14;	Primary Site:Floor of mouth;	Age:60;	Sex:F;	TNM:T4N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis",ctrl
"BA OBCs, post doxycyclin withdrawal, rep1",pert
strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 8 months;	tissue: liver;	disease status: non-alcoholic steatohepatitis,pert
Pediatric_GBM_37,ctrl
MDS patient 21,pert
PGA-MAH-OuJO3-1aAv2-s1,ctrl
"cell type: Human mammary epithelial cells infected with retrovirus carrying hTERT and the oncogenic allele of H-Ras, H-RasV12 described in (Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, and Weinberg RA (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50-65)",ctrl
Kidney_colistin_1,pert
"Control 03, NC03",ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: REBIF;	time: 3 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
"Normal T-cells, CD3+, donor 6",ctrl
"Patient 31, Atheroma plaque",pert
tissue: small intestine;	genotype/variation: wildtype,ctrl
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA2+dox,pert
sample =Healthy1 treatment=Control time=180 (min),ctrl
liver_male wt_rep2,ctrl
Braak α-synuclein stages 5-6  BR56_2SN,pert
"age at diagnosis: 50;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N1mi;	er: 1;	pgr: NA;	dfs-month: 8;	dfs-event: 0;	distant metastasis: 0",pert
"cell line: prostate cancer, PPC1",pert
S6_Sham_wildtype_12,ctrl
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14584;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
Healthy control 9,ctrl
MDS patient 110,pert
cell line: MLL-AF9 AML cell line 10977 (Zfx wt);	treatment protocol: vehicle;	genotype/variation: wt,ctrl
hippocampus: Sample #4_e1_le1,ctrl
Subject #8018-Preinfection,pert
normal with no hydrocortisone treatment-1,ctrl
chip number: 8;	transfection plate: 1;	target gene: CLOCK;	kd level: 0.86;	rin: 9.1;	transfection date: 2011-03-29,pert
mortality: alive;	ethnicity: Hispanic;	gender: M;	age (yrs): 26;	tissue: Normal_Kidney_Biopsy,ctrl
"Diclofenac treated THP-1 cells, biological replicate 1",pert
"Strain : 75% C57BL/6, 25% CBAJ;	Gender: Male;	Age: 9 weeks (Moderate stage);	WILD  TYPE",ctrl
tissue: prefrontal cortex from adult APLP2 knock-out mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,pert
genotype/variation: wt;	age: P8;	tissue: Whole eye,ctrl
cumulus_PCOS_Obese_rep4,pert
Synovial fluid macrophages,pert
PND28 Rat Testis_Rat230-2_3hr MEHP_Animal#51_04005,pert
ACC Xenograft X16,pert
SKBR3-R_1uM_Lapatinib_2,pert
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 4,pert
tissue: lung;	genotype: knock out,pert
"EtOH, RARaKO, set 4",pert
"Cnr1-/-/Cnr2-/- female number 1, untreated control ear (#7_Ko-C-4)",pert
MDS6,pert
OSCE-7T,pert
YFP+Foxp3+ r2,ctrl
Amniocytes_trisomy 21_1575,pert
"tissue: bone marrow;	disease status: B-precursor acute lymphoblastic leukemia, Non-Down syndrome",ctrl
"Mouse heart, control, replicate 3",ctrl
Individual_3140_PP_sample,pert
siNS_0h_2,ctrl
MPM tumor 23,pert
25SMOKEH,ctrl
strain: Mixed;	genotype/variation: Nrf1 Control;	gender: Female;	tissue: Liver;	age: 6weeks,ctrl
Phan_004_WT.bleomycin rep1,pert
"spinal cord, ventral spinal cord: EP132/L - hSOD1(Chan)/e14-wildtype hSOD1_le2",ctrl
Tissue:tumor; Gender:female; Age:48  Tumor stage:T3N1bMx,pert
Wild-type mice rep2,ctrl
E11_WT2,ctrl
01N3X_ERA,pert
"seminoma specimen, pT3, patient age: 49y; W01 134",pert
ILD Study Number 93,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: spleen;	sample name: 4-sp1,pert
3 PC3 2hr,pert
healthy CD19 B cells 1,ctrl
"medulloblastoma, M2_cMYC_silenced, rep1",pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 13,pert
"non-AD_TC, biological rep9",ctrl
Kidney_Aqp11-/-_P7_1-2,pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T2N2,pert
"Wild-type, biological rep2",ctrl
Cyclophosphamide-treated spleen 1 day - Biological Replicate 3 - Technical Replicate 2,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 29 yr;	population: white;	dsm-iv: 296.44;	age of onset: 18 yr,pert
Mnk_3214-S-7,pert
wild-type MEF 1,ctrl
"vector d10, rep 3",ctrl
ve_2m57,pert
Heart_WT_1,ctrl
Chondrogenic progenitor cells from OA female 3,pert
colon_epithelium_C57 mouse_12weeks_rep1_2,ctrl
"ME16C, 12h, 0.06mM 5FU",pert
MDS42,pert
65A;pretreatment;female;breast tumor; nonresponder,ctrl
BxPC3_Ctrl_rep3,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 59 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
Thyroid_papillary carcinoma 14,pert
tissue: Pancreas;	strain: C57BL/6;	genotype: wildtype;	age: 8 weeks,ctrl
"KM-H2 Non-silencing, technical rep2",ctrl
HP-3,pert
cell line: U937;	shRNA construct: GSK3B Construct 1,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with acetaminophen (APAP)_17,pert
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.34 uM (2 x EC50), biological rep3",pert
vehicle treated rep 2,ctrl
"twin pair: #6;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
"BOEC, not_at_risk 3",pert
24h WT Cel.04,ctrl
H157 siDJ-1 #2,pert
G519-lcm,pert
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: tumor;	sample name: 3-tu1,pert
"Normal Skin, Normal-16",ctrl
Cmah KO_lung_3,pert
type 2 diabetes subject 05,pert
N40977,ctrl
Epididymal adipose WT ND #690,ctrl
KM_076N,ctrl
"normal nasopharyngeal tissue, specimen N8",ctrl
Cervical cancer_1721T,pert
B6 Control R4,ctrl
major non-tumor5,pert
tissue: pancreas;	genotype: Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 9 weeks-old,ctrl
GFP-progerin Induction: day 10 Replicate B (6b_progerin_10d_B),pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 1,ctrl
LNCaP R1881 rep 1,pert
race: caucasian;	age (years): 64;	stage: IA;	grade: 2;	histology: endometrioid,pert
U937_shSYK_1_Replicate1,pert
Sex: male;	Age at operation: 60 years;	Site: thigh;	Size in cm: 7.5x6x5.5;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
Crx-Nr2e3-Nrl-ko-Gfp4W-3,pert
cell type: Normal Human Epidermal Keratinocytes (NHEK);	transfected with: scrambled siRNA (control),ctrl
"Normal subject (47 year old caucasian female, SAK_1289248024)",ctrl
GEIM110-U133A-Norm,ctrl
"experiment IV, hTERT transduced, replicate 1",pert
Rat fatty liver9,pert
age: 6 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
MDS patient 89,pert
sepsis patient #10,ctrl
E14 - nudelcko/ko 3,pert
FTO2_D4_48h,pert
gender: Male;	age: 77;	post-mortem delay: 3h;	ph: 6.1,pert
condition: Psoriasis;	patient: 287;	tissue: LS skin biopsy;	kit: Ovation,pert
gender: Female;	age: 68;	post-mortem delay: 6h;	ph: 6.4,ctrl
"Ott1 knock out, biological rep 1",pert
"brain, lateral and medial ganglionic eminences: Arx+/Y #3_le1",ctrl
cell line: LNCaP-abl;	transfection: siControl,ctrl
wild-type_corn oil_rep2,ctrl
age: 55;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
LNCaP/MYB siRNA #3,pert
GM19238_Kd_E2F1_3,pert
FmrWT3_brain,ctrl
K562_ICL670_50uM_dup1,pert
Liver-Cpr-null_pool 3,pert
"Crohn's Disease subject (56 year old caucasian male, SAK_1260008280)",pert
HPB-ALL NBD 1,pert
Mouse RSK2 mutant mandibular molar [AZN_MolairesMutant1],pert
Hematopoietic Stem Cells,pert
"array 24, xenograft, DBP 500 mg/kg/d",pert
Gata4loxP/+VillinCre adult male jejunum (6-8 wk). Control sample.,ctrl
HNF6_1+,pert
"SLE patient, 1024V2",pert
"PBMC, healthy control, biological rep5",ctrl
scpk/ikLL/57,ctrl
Healthy individual of twinpair #7,ctrl
normal B cell 3,ctrl
061J3_CTRL,ctrl
genotype: EFLmDREAM;	stimulation: stimulated with LPS and mouse recombinant IL-4 (day 2);	cell type: B cells,pert
cell type: fibroblast;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P8;	clone: 0,ctrl
quiescent p27WT MEFs 2,ctrl
cell line: Breast carcinoma cell line Cal51;	genotype/variation: control;	agent: untreated,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 52 yr;	population: white;	dsm-iv: 295.9;	age of onset: 19 yr,pert
HCT 116  siChe-1 rep1,pert
healthy CD19 B cells 9,ctrl
major HCC4,ctrl
5258 UC Uninflamed terminal ileum,pert
1194-03-A,pert
"RES-enriched Grape extract group, 12 months, patient number 22",pert
"Cadmium 1.2 µM, biological rep2",pert
thyroid_normal_6,ctrl
Normal testis 9014,ctrl
OA 5,pert
IM28_control,ctrl
10 days sham-2,ctrl
"human failing LV myocardium, Idiopathic85",pert
CD19_selected_B-cells_before_R_rep6,ctrl
1138-03-A-b,pert
PC-3 human prostate cancer cell line,ctrl
01UP0_PolyRF-,pert
"patient: 101;	current medication: Paracetamol;	birth date: 10/5/63;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: Weight loss, altered bowel habbit.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
cell type: Embryonic Stem Cell;	genotype: Mkl2-/-;	strain: C57BL/6,pert
"Wild type fetal liver 3, embryo at 12.5 days of development",ctrl
KO - 3 mo - repeat 2 - Cy5 - mAdbID:74595,pert
"EAE, placebo-treated #10",pert
Raji_mi-Ctrl_4,ctrl
Individual_3586_PN_sample,pert
Strain: FVB/N;	Genotype: SP-C-hCFTR+|+/mCftr+|+,pert
Mening UNSTIM WB SW 24b,ctrl
SON siRNA rep2,ctrl
colon_IBD_1175,pert
Series 3; adult; 1 week after fracture,pert
224 Day 2 siMut10 transfected biological rep1,pert
strain: C57BL/6J;	Sex: male;	expression: sh-PRDM16;	agent: none,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 27;	sex: F,ctrl
MSC_VUB03_DM1_1,pert
OC1-KO embryo 2,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_4_17_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
3 h-control (EtOH),ctrl
HNF1b_2b+,pert
GEIM45-U133A-Norm,ctrl
"EtOH, WT, set 2",ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 37;	gender: male;	tumor grade: AII,pert
Muscle control (YJD-JDM-50UA-s2),ctrl
Whisker pad mutant biological rep2,pert
Differentiation of hES cells line SA01 towards MPC-like cells;	Mesenchymal stem cells phenotype,ctrl
"MCF7, biological rep1",ctrl
First shYY2,pert
Keratinocytes treated with EFNA4 for 4h,pert
patient: 32054;	disease state: LGSC;	component: Borderline,ctrl
HMEC X BC16 : 0095-5k,pert
wild type rep-2,ctrl
HD11,pert
lesion_postUV_patient7,pert
Day: 12; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 1,pert
"Epidydimal white adipose tissue from ASC-/- after 16 weeks of high fat diet feeding, replicate 1",pert
brain_DLPFC_bipolar C_mr869,ctrl
cell type: granulocytes;	group: Patient;	patient treatment: Mtx,pert
Polyamide1_2,ctrl
06R038 Control,ctrl
cell line: MCF-7;	cell line: breast cancer cells;	transfected with: TOX3 Vector,pert
NINDS-RHS-Ctr_72h-2aUA-s2,ctrl
"human failing LV myocardium, Idiopathic3",pert
MEF Wild Type 1-rep1,ctrl
sex: Female;	Age: 6 months;	additional patient information found in Series supplementary file,ctrl
patient: 265;	current medication: Pentaza 500mg TDS;	birth date: 8/17/71;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/5/04;	diagnosis date: 3/22/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/19/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/19/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
0118-01-C,ctrl
MGHU3 Cells_Control siRNA_Biological Replicate 1,ctrl
"15B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"Liver from Nrf2 wt mice, biological replicate 3",pert
Nasal Epithelium Instilation Formaldehyde 0mM 6h ID352,ctrl
clone type: AtT20 clone types infected with empty vector rep1,ctrl
SKNSH eGFP2,ctrl
Fertility Status: Infertile,pert
Differentiation of hES cells line VUB01 towards MPC-like cells;	Mesenchymal stem cells phenotype,ctrl
Thyroid_ unaffected_paired with PTC71T,ctrl
"brain, cochlea: [8] Sample #8_le1",pert
01LMV_Oligo,pert
"siRNA, collagen plate, rep2",pert
Raji_mi-142-3p_2,pert
LPS + CyP 3hr 1,pert
treatment group: untreated in parallel to cadmium treated cells;	cell line: TK6 cells,ctrl
genotype: Nf1Prx1;	tissue: triceps muscle;	age: 3 months,pert
B7hi mTEC B6/129 wt1,ctrl
C57BL/6 heart left ventrical (LAD ligation 30 day),pert
01LNJ_CTRL,ctrl
H1299 AZA 3 uM (3233),pert
HW_436,pert
Silberg3 ( S1) 120902NE,ctrl
E14.5 Tgfbr2 Wildtype Mouse Model Palate 4,ctrl
FHCRCAML2619,pert
"48 hour-treated wild-type NB4, biological rep2",pert
12461 Normal Inflamed sigmoid colon,ctrl
ccRCC tumor of patient T166,pert
MacularDegen-healthy-8cAv2-s2,ctrl
Cervical cancer_56-04T,pert
"ShamC-21, biological rep 1",ctrl
Control liver_4 pm_rep1,ctrl
NCI-H716_Control.3,ctrl
Gender:female,pert
human_hepatocyte_vehicle_donorA_24hr_prep2,ctrl
race: caucasian;	age (years): 49;	stage: IA;	grade: 1;	histology: endometrioid,pert
"12-week-old 12-week-old spontaneously hypertensive rats (SHR), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump",pert
tissue: white blood cells;	age: 13.33;	Sex: male,pert
treatment: BirA control;	cell line: J1 ES cells,ctrl
Wtepi_infect_0h_rep2,ctrl
Brain_nAChRbeta4SubunitDeficent_MiceNob4437,pert
liver 1.0% quercetin diet rep4,pert
gender: female;	age (years): 63;	evolution time (years): 10;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
"CTR-C (CTR-2+, biological replicate 3)",ctrl
"Uninvolved Skin, NS-19",pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 0,ctrl
db/db mice,pert
Sex: male;	Age at operation: 74 years;	Site: thigh;	Size in cm: 16.5x9x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
treatment: scrambled vector;	cell line: Esophagus cell line OE33;	array id: 5617835005,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 168;	fata: 71;	eea: 1780;	wtkg: 89.3;	perfat: 27.6;	lbm: 62.9;	fat_mass: 2464.68,ctrl
RatLung_Con_1,ctrl
background strain: C57Bl/6;	developmental stage: E11.5;	tissue: fore-limb;	genotype/variation: wild-type,ctrl
"breast, pre AF treatment (H23_2233)",ctrl
10SAGEA2,pert
race: caucasian;	age (years): unknown;	stage: IA;	grade: 2;	histology: papillary serous,pert
cell line: SUP-B15;	tissue: Human B cell precursor leukemia,ctrl
1.25uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate B,pert
"fibroblast, control subject NF9 rep 2",ctrl
"114, ADIPOOSE TISSUE, Before",ctrl
V5-P271,pert
Bronchial Epithelial Cells MMA biological 1780F,pert
"Crohn 10, CD10",pert
cDNA scc 14,pert
Dengue Fever Patient 66,pert
"Resveratrol treatment exp 3T3-L1 cells, T1",pert
3T3 cells,pert
Tgfbr2 fl/fl Control Posterior Palate 2,ctrl
CD4DecTp2-7,pert
sex: Male;	family: 4;	age: 16;	disease status: Control;	tissue: Muscle: Biceps,ctrl
B6.IL10 72 O3 2,pert
TTP_WT_60ActD_BioRep4,pert
WTT 161 bleomycin treated,ctrl
Wt_ liver_fasted_refed_3hr_ rep2,ctrl
"wild-type P9 hair follicle, biological rep1",ctrl
Liver_WT_Vehicle_Rep3,ctrl
cell line: SLM2;	mutation: WT;	treatment: Treated with Sorafenib,pert
Globin_C2,ctrl
U937_naive_untreated_4h_rep3,ctrl
cell line: A375 melanoma cell-line;	genotype/variation: wild type;	treatment: control,ctrl
"Alk2 cKO mice, whole uterine tissues, replicate 2",pert
mortality: alive;	ethnicity: White;	gender: F;	age (yrs): 32;	tissue: Normal_Kidney_Biopsy,ctrl
ColonTum_022AAFC8_cta.txt,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.04;	OD280: 0.53;	Ratio: 1.97;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 286;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Individual_4999_NN_sample,ctrl
P1 mouse eyeball extracted total RNA_wildtype1,ctrl
endothelial_rep11,pert
PGA-MAH-AJ_OVA6h-3aA-s2,pert
Parkinson's disease sample x188,pert
tissue: heart;	genotype: ClpP KO;	genetic background: C57BL/6,pert
U937_naive_curcumin_4h_rep3,pert
293TsiLL-4,pert
B/OVX/no inj/0h/UTX 129/SvImJ WT,ctrl
Placenta_nl3,ctrl
RNA from HCC_27T,pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 6h, biological rep2",pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 5d ID297,pert
"Liver from control exposed rats, biological rep 2",ctrl
"normal nasopharyngeal tissue, specimen N10",ctrl
tissue: hepatocellular carcinoma tumor;	treatment: vehicle;	strain: Wistar,ctrl
Insm1 control #10,ctrl
sex: Male;	Age: 50 months;	additional patient information found in Series supplementary file,ctrl
siRNA-140_rep2,pert
atopic eczema P7,pert
IRAK2 KO_macrophages_8h,pert
AP-2 gamma targetting siRNA 2: GCGGCCCAGCAACUGUGUAAA Technical Replicate 2,pert
12477 UC Inflamed ascending colon,pert
"0mg/kg/day PFOA, Rep 3, Block 2, liver (low dose)",ctrl
HC12E4,pert
treatment: DMSO;	time: Day3;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,ctrl
"12 weeks old normal mice, cerebellum",ctrl
Untreated Control 12weeks AffyGC RMA rep10,ctrl
Gata1KO25+#2,pert
RV83.02_CONTROL_day10_Slide52,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 9.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 58;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
E_LS_Wk4,pert
MDS patient 144,pert
TGF-alpha 979-CLA-33,pert
strain: C57BL/6J;	day: 18;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: Vemurafenib 1000 nM for 72h,pert
"female,21,Caucasian",pert
Control male 5,ctrl
M325 C,ctrl
WFS1 WT USHT_03_335_wt,ctrl
Parkinson's disease sample x024,pert
CD4IncTp1-8,pert
Gastrocnemius Muscle Galgt2 Transgenic rep1,pert
"Creatine-treated, biological rep5",pert
"p38alpha knock out fetal liver E13.5, biological rep3",pert
01N43_ERA,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 59 yr;	population: white;	dsm-iv: 296.5;	age of onset: 48 yr,pert
"Monuron-treated NRK-52E cells at 24h, biological rep 2",pert
HGPS Fibroblast replicate 2,pert
CD8+_Tcells_healthy_donor_8,ctrl
EVI_GFP negative Lin- cells replicate 2,ctrl
adenocarcinoma (ADC6),pert
"A673 treated with Puromycin for 3 days with concentration of 0.09 uM (EC50), biological rep1",pert
Tissue: lung,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 131;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
8 hr KLF4 Time Course Control,ctrl
"human nonfailing LV myocardium, NonFailing9",ctrl
MLL_00134,pert
Txnip deficient tumor 22 months sample 3,pert
MCF-10A shATR-4 replicate 3 [set 5],pert
F_LS_Time0,ctrl
"Kdm2b KD E14, rep2",pert
MDS51,pert
Sample ID: TP35;	Twin Pair ID: CCE3.1;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-7;	Age at interview & blood sampling: 57;	Current Age (2007): 60;	Sex: MALE;	Medication at blood sampling : Epilim,pert
"schizophrenia, BA10-6(2)",pert
Evi1-2,pert
Control 3 a,ctrl
"Control, biological rep 2",ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: ZMYM2/FGFR1;	biological replicate: 2,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 19 yr;	population: white;	dsm-iv: 296.73;	age of onset: 17 yr,ctrl
Mnk_3213-S-B,ctrl
WT #142,ctrl
breast normal 6,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 8d ID64,ctrl
Bronchial Epithelial Cells SA biological 2118H,pert
B6_Male_CF_rep2,pert
Control 13,ctrl
PBMCs_Control_20 [IS],ctrl
tissue type: Primary lung tumor;	histology: LA,pert
cell line: H295R adrenocortical carcinoma cells;	tissue: Cells derived from Adrenal gland;	agent: test compound CP-529414 (CETP+ /BP+ THQ+);	dose: 100 nM;	time: 3 hr,pert
ASO T00278948,pert
E16.5 Vax2-/- 1,pert
C2E-LU,ctrl
"lymphoblastoid cell line from T4.02, one out of seven of insensitive group, 50*10e6 cells",ctrl
OE control 3,ctrl
"mouse aorta cross strain comparison, C3H_T04_NC_02",ctrl
Untreated Control 12weeks AffyGC RMA rep8,ctrl
HCC017T,pert
memory P14 T cells #1,ctrl
"Heart, MAT1 CKO, 4 wk, sample 2",pert
GC resistant clone C7H2-R3B5 treated for 6 hours with EtOH,ctrl
microdissected breast cancer cells from case 1279,ctrl
"Control Day 0, biological rep1",ctrl
Lung myd88 mock repA,pert
Normospermic individual: Sample N12,ctrl
"9B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Strain:C57BL/6;	Gender:male;	Age:8 weeks,pert
MCE301 cells treated with SB for 12 h-2,pert
MCL_IGHV_MUT (R1591),pert
strain: C57Bl/6;	genotype: Myc(F/F);CreER;	cell type: CD8+ T cells,pert
"Lesional skin from K5-Tgfbeta mouse, biological replicate 1",pert
major non-tumor3,ctrl
Tk6 untreated controls for cadmium exposure rep1,ctrl
microdissected breast cancer cells from case 25,pert
"RPMI8226_shLuc, replicate1",ctrl
PC-3_overexpresshTERT_LongTelomeres_LhTERTL_3,pert
PE_D_651,pert
WT-smoke-high-5 month-R3,ctrl
RAW_1.4mM_HOCl_#3,pert
"control, BA46-103",ctrl
cell line: Hep G2;	genotype: RCCC-THRA mutant 15b;	treatment: with vehicle for 6h,ctrl
Sample ID: TP27;	Twin Pair ID: CCN5.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 34;	Current Age (2007): 37;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
individual: patient10;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 147;	genotype/variation: WT;	age: 8 weeks,ctrl
Age: 47;	Sex: M;	Ancestry: African;	Smoking status: non-smoker,ctrl
Huh7 cells_Mock Infected 18 hours_ rep1,ctrl
healthy control C8,ctrl
Untreated Control 12weeks AffyGC RMA rep4,ctrl
RNAi -Transgenic replicate 6,pert
EA_Control5_CD4,ctrl
3IDC_normal_ductal,ctrl
treatment: Non-specific shRNA (shNS);	cell line: MDA-MB-231,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: WT,pert
01UP9_ERA,pert
CLL19-CD8,pert
"CD14+ at baseline, biological replicate 2",ctrl
3DKD_SerumStarved->3hrEGF_rep1,pert
wild type parietal cell replicate 1,ctrl
KO2,pert
normal adjacent esophageal tissue from patient E1635,ctrl
jzo032-rp1-v5_u74av2-met,pert
"48 hour-treated TG2 knockout NB4, biological rep1",pert
B7m3,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous endotoxin challenge""",pert
"213, ADIPOOSE TISSUE, Before",ctrl
"Age: 48;	Sex: M;	Ancestry: European;	Smoking status: smoker, 15 pack-years",pert
Human hepatocellular carcinoma cell line infected with GFP protein (control) 1,ctrl
TAF4b knockout 2,pert
Neocortex_Eomes_KO.8,pert
MCL_IGHV_UNMUT (R1394),ctrl
"HME-CC, 12h, 0.01mM 5FU",pert
"granulocyte, healthy control, biological rep9",ctrl
Large cell carcinoma 009,pert
optineurin expression-a02,pert
JIA PBMC Post treatment A235_L221(2),pert
tissue: brain;	genotype: mutant Ndel ko/+;	age: E14,pert
colon_epithelium_C57 mouse_12weeks_rep1_1,ctrl
Double_positive_thymocytes_Dexamethasone (1E-07M) _3h_rep2,pert
"schizophrenia, BA46-10",pert
57SageA,pert
cell line: MLL-AF9 AML cell line 10986 (Zfx fl);	treatment protocol: vehicle;	genotype/variation: fl,ctrl
liver_Akt1+/-_8wk_rep2,pert
RV82.01_CONTROL_day10_Slide53,ctrl
"Typically Developing Control, Semitendinosus, Patient Replicate 4",ctrl
Ero1-WT non-induced biological repB,ctrl
Disease_status: Bipolar disorder;	Age (years): 64;	Gender: Male;	Age of onset (years): 19;	Duration of illness (years): 45;	Brain pH: 6.10;	Post mortem interval (hours): 16;	Side of brain: Right;	Fluphenazine mg. Equivalents: 130000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Pancreatic Sample -Tumor,pert
Peripheral blood mononuclear cells;	TTF=137min;	Race=White;	Sex=Male,pert
ILD Study Number S033,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 2x1h exposure per day",pert
A HID B_B082,pert
autism with dup(15q) AU010604,pert
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ shNotch3;	treatment: Ca 0.09mM, 72 h",pert
"mouse liver sample, WT strain, biological replicate 1",ctrl
first-episode BP patient 74_biological replicate 2,pert
Subject 9_t=30days_placebo,ctrl
"BioBreeding DR+/+ rat, day 65, mast cells derived from pancreatic lymph node",ctrl
strain: C57BL/6J;	day: 12;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 3,ctrl
"depression, BA10-3",pert
tissue: white blood cells;	age: 13.75;	Sex: male,pert
ILD Study Number 1226,pert
RTX1 T12,pert
strain: C57/Bl6;	genotype: Akt1¬-/-;	gender: PND70 female,pert
Patient no. 16: treated,pert
tissue: white blood cells;	age: 8;	Sex: male,ctrl
Ngn3 EB3 ON replicate 2,pert
"human failing LV myocardium, Idiopathic14",pert
Cardiac Muscle_Cmah KO_mdx_rep2,pert
amygdala long access to cocaine replicate 4,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 2;	bead chip array sentrix code: 4421339046,ctrl
siRNA scramble_control  MDA-MB-231 sample 2,ctrl
01LKV_CTRL,ctrl
tissue: testis;	genotype: repro9/repro9;	age: 17dpp,pert
N40899,ctrl
B_Ctrl_3,ctrl
HMEC X BC790,pert
whole tissue section from case 289,pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: shRNA against β-catenin;	time: 72hr,pert
CD4IncDec-test-3,pert
"BMDM, Tpl2 KO, unstimulated, biological replicate 1",pert
"Crohn's Disease subject (20 year old caucasian female, SAK_1287906498)",pert
A39 WT3	F7/3	A39	wild type	Mouse	4 months	Cerebellum	Male,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous endotoxin challenge""",pert
"nasopharyngeal carcinoma, specimen T12",pert
uterus_P4_WT_4hrs_rep1,ctrl
01LMY_Oligo,pert
"WildType mice with water, replicate 1",ctrl
Colon_Wild Type+Quercetin_1,pert
P7A Progranulin-frontal,pert
"breast tumor epithelium,54",pert
5922012038_F,ctrl
U937_ROS_untreated_18h_rep3,ctrl
Normal cervix epithelium_03-5438,ctrl
Nonspecific siRNA1,ctrl
IDCM6,pert
FMR1_1,pert
"cell type: MYC negative B-cell;	transgene: MycEGFP (a Myc reporter allele, in which a MYC-EGFP fusion protein (MYCEGFP) is expressed from the endogenous Myc locus);	genetic background: C57/Bl6",ctrl
DC-7,ctrl
Liver_Nrf1 Control_rep2.,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 40, stage IA, HPV 45",pert
TMRI AO 48hr,ctrl
"Patient M030-230, MSI colorectal tumor",pert
prefrontal cortex (BA46);	schizophrenia,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: internal tandem duplication (ITD)/D835 mutation,pert
NESG1-negative C6-5-8F NPC cells rep1,ctrl
rheumatoid arthritis 9252,pert
PsOEt-22-LS,ctrl
Glucosamine Transcriptome Profiling {rpt},pert
PBMC;	Age: day 14,pert
Retina wildtype 42 days 3,ctrl
10 week control spinal cord rep 1,ctrl
G4D_Sham_Rep1,pert
individual: patient13;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
cell line: Hep G2;	genotype: HCC-THRA mutant bN;	treatment: with vehicle for 6h,pert
H1299 vehicle control (3224),ctrl
"peripheral ganglion, unknown: nicotine 24 hr_2",pert
subject: 21U;	cohort: 21;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 63kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
tMLL01,ctrl
unstimulated confluent HUVECs,ctrl
Multiple sclerosis CD4+T cells 15-US,pert
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
WT-MAC-UV-1,ctrl
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_4 months_replicate 1,pert
ubb_d28_ko_1,pert
Control with WY14643 replicate 4,pert
Liver of pup from control group rep2,ctrl
NOD Aire WT MEC rep3,ctrl
Sample ID: TP18;	Twin Pair ID: CCN2.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 27;	Current Age (2007): 30;	Sex: MALE;	Medication at blood sampling : None,ctrl
E2-GemKD,pert
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 6h;	donor: 3,pert
"Whole ovary from 8 Month Old FORKO mice_01, biological rep1",pert
Panc0403 rep-1,pert
11_0018C_Day1_27,ctrl
"Lesional skin from K5-Stat3c mouse, biological replicate 1",pert
"seminoma specimen, pT2, patient age: 30y",pert
Large cell neuroendocrine carcinoma 002,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 2,pert
"siPRMT8 neuron, biological rep2",pert
siSPDEF_4,pert
"fibroblast, MFS subject FB1286 rep 2",pert
"vector d2, rep 4",ctrl
25SAGEA2,pert
female_alcoholic_443,pert
Bone-Marrow_SMM_S1336,pert
BALB/cByJ Vehicle liver sample batch 5,ctrl
"MCF7/BUS, 10 pM E2, 48 hours, biological replication 1",pert
umbilical cord_bpd: 5H,pert
BP patient 56_biological replicate 2,pert
"disease state: Nasopharyngeal carcinoma;	stage: IIB, T2, N1, M0, G4",pert
A39 WT7	F2/14	A39	wild type	Mouse	10 months	Cerebellum	Male,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, VEH treated, biological rep2",ctrl
patient: 5;	disease state: hypertension;	tissue: Atheroma plaque,pert
PBMC from T cell Large granular lymphocyte leukemia patient#101,pert
WT-smoke-med-5 month+1d-R2,ctrl
brain_DLPFC_bipolar C_mr537,pert
Gastric_cancer_patient_5_dye_swap,ctrl
Postnatal 3 weeks control heart biological rep3,ctrl
HLA risk: Low;	Height: 171.7 cm;	Weight: 66.4 kg;	BMI: 22.5;	Age: 13.4 years;	Gender: Female;	Race: White;	Glucose: 101 mg/dl;	HbA1c: NA,ctrl
"genetic background: B6;	genotype/variation: Gata1 knockout;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",pert
c 4-4,pert
aneurysmal tissue: sample #2,pert
"Exp A, Animal #269, 5mg/kg D-Serine",pert
"DMSO-treated, 24h after UV, Replicate A",ctrl
"Donor 3, Ebola infected 1hr",pert
treatment: ethanol,pert
"normal skeletal muscle, biological rep10",ctrl
ve_NY6,pert
3881-1 E2F WT,pert
tissue: Frontal cortex;	age: 72;	Sex: F,ctrl
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: 24;	maternal age: 24,ctrl
"E18.5 lung WT1, biological rep2",ctrl
Bone-Marrow_MM_M1070,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: ZXDC1 knockdown;	agent: PMA,pert
"Patient 7, lesion tissue",pert
Adult Sham; Biological replicate 1,ctrl
gender: male;	disease state: healthy,pert
ccRCC tumor of patient T183,pert
control participant P306wdh,ctrl
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: control siRNA;	agent (treatment): EtOH vehicle,ctrl
PND28 Rat Testis_Rat230-2_6hr MEHP_Animal#32_04005,pert
L428-PAX5+M_rep1,ctrl
Txnip deficient tumor 27 months sample 3,pert
hNHEPS_control_0 h_rep4,ctrl
cell line: HCT116;	shRNA: non-target;	treatment: untreated,ctrl
cerebellum wild type 6 month replicate 3,pert
BT474_DMSO_24-3,ctrl
m1-carcinoma4,pert
"101, MUSCLE, Before",ctrl
GEIM177-U133A-DM,pert
MDS15,pert
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 1;	time: 6h,pert
HW_450,pert
"WT, untreated whole heart, individual 2",ctrl
AAA neck (Sample 4),pert
Velcade I2,pert
"Wild type used for GNMT 3 month, replicate 2",ctrl
K562 cells CREB Knock-out replicate 5,pert
"PBMC, healthy control, biological rep1",ctrl
"mouse aorta cross strain comparison, C3H_T08_HF_02",pert
1IDC_tumor_ductal,pert
MKK7D control female replicate 10 late timepoint,pert
age: 12 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
PGA-lv_1h_511,ctrl
WT STR PDE10i 13,pert
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: non-recombinant clone 27 (STAG2 wild-type),ctrl
Dexamethasone 3,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_8_3_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
disease state: Control;	gender: Male,ctrl
Subject #8030-2d Postinfection,pert
"Peripheral blood, patient with recurrent events [N28]",pert
"brain, hippocampus: CH3_e1_le1",ctrl
cell line: SF539;	transfection: Scramble siRNA,ctrl
MCF-10A sh53BP1-1 replicate 3 [set 5],pert
"A673 treated with DMSO vehicle control for 24 hours, biological rep2",ctrl
A61 NES 142Q TG3	F6/23	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
cell type: hepatoma cells;	cell line: Huh7,pert
"BOEC, normal 27",ctrl
0h WT Sample 16,ctrl
breast cancer patient 318,pert
ovary_cultured_control_rep2,ctrl
MCF7_Sangivamycin_Array_2,pert
pD  is a clonal control (puromycin resitant) stably-expressing stem cell line,pert
pSUPER-scramble replicate 3,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
strain: C57BL6,ctrl
LICR_HN1_PBS2,ctrl
CD4+_Tcells_severe_asthmatic_8,pert
MPM tumor 18,pert
FK3,ctrl
c_NY104,ctrl
Liver-5 month-wild type-technical replicate 3,ctrl
Organism: Rattus norvegicus;	Strain: Brown Norway;	Weight: 150-170 grams;	Tissue: liver;	Gender: male;	Sacrifice Time: 6 hours,ctrl
Thyroid_ unaffected_paired with PTC14T,ctrl
"Normal subject (51 year old caucasian female, SAK_1290253859)",ctrl
473MM,pert
HT29 resistant cells replicate 3,pert
whole blood_102321,pert
tissue: skin;	individual: Patient P10;	condition: AL;	eczema severity: SCORAD: 37,pert
patient: 51176;	sample: tumor,pert
cell line: MDA-MB-231;	cell line origin: Breast cancer;	genotype/variation: control,ctrl
IMR-32_pCMV-DPP3_48hr,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 50,pert
Subject #8028-8hr Postinfection,pert
Nasal Epithelium Instilation Formaldehyde 0mM 6h ID355,ctrl
Xid primary splenic B-cells (sample1),pert
mouse jejunum_hnf1alphacontrol_rep1,ctrl
fresh tissue: splenocytes;	strain: DBA/2,pert
age: 24 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 wild type,ctrl
RNA from HCC_14N,ctrl
HET Brain 37d Mouse1,ctrl
cell type: embryonic stem cells;	genetic modification: Dicer knockout,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 21;	gender: male,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.4;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
erStress_twins_AA_1733twin1_500nM_thapsigargin_4h,pert
126KD 18A n,pert
DRG_Capsaicin_10microM_Rep3,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 24 hrs;	time course: 1,pert
"TH cells from LC, wild type control, biological replicate 3",ctrl
dex24hr_2,pert
"Strain: mixed genetic background, predominantly (>87.5%) C57BL/6 with some CD1. Genotype: PTEN mutant = Mx1-Cre positive: PTENfx/fx. Sex: Female. Age: Eight and a half weeks (at tissue isolation). Tissue: Intestinal polyp from small intestine (jejunum/ileum region).",pert
strain: C57BL/6J;	genotype/variation: WT;	gender: Male;	age: embryonic day 15;	tissue: frontal cortex,ctrl
"control, BA46-15",ctrl
GFP4_1578J,ctrl
"array 21, xenograft, 0.3% Tween-20 vehicle",pert
S5-040803-SA,pert
SHP-/-_rep1,pert
RNA from HCC_5T,pert
HL60-shControl-rep3,ctrl
695_383_0hr_repeat,ctrl
"Deltoid, FSHD, cohort 13, subject 13B",pert
control sample 1,ctrl
"MGSKO, PR03M008v0",pert
Replication 3 Control,ctrl
"Acute Myeloid Leukemia, sample 33",ctrl
shGFP-rep-1,ctrl
C2C12 myotubes 1uM H2O2 rep 4,pert
4112-1 E2F WT,pert
HD12E1,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.318;	OD280: 1.187;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 66;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 8 hr AP20187,pert
VillinCreERT2-_Rep3,ctrl
E100-/-SRFdM-VP16-1,pert
MDS patient 112,pert
"brain, cochlea: [16] Sample #16_le1",ctrl
Mammary Gland_Cav-3KO_rep1,pert
"alveolar macrophages, non-smoker 021",ctrl
ND_1,ctrl
prostate normal 5,ctrl
CD19_selected_B-cells_after_R_rep5,pert
Phytohemagglutinin-activated PBMCs from normal control subject J (JAcPBMC),ctrl
CEPI_IIb_413,pert
"CCM3 shRNA cells passage 11, rep 4",pert
Normal cortex of patient T166,ctrl
strain: C57BL/6;	tissue: small intestine;	genotype: cftr-tm1Unc (cftr null);	treatment: none,ctrl
cell line: D3;	genotype/variation: scrambled sequence control (siSCR);	cell type: undifferentiated embryonic stem cells,ctrl
construct: Luciferase Control shRNA;	cell type: Primary human erythroid progenitor cells,ctrl
cell type: Primary hepatocytes;	donor: 5;	agent: control;	time: 6h;	gender: Male;	age: 73 years old,ctrl
"RES-enriched Grape extract group, 6 months, patient number 62",pert
"D425-control, t=48",ctrl
background strain: CD1;	age: p23;	tissue: pancreas;	genotype/variation: Sox9-EGFP;	facs: GFP-,ctrl
"LckCre Dicer lox/lox KO, biological rep3",pert
HD5,pert
MDS4,pert
race: caucasian;	age (years): 57;	stage: IB;	grade: 1;	histology: endometrioid,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 55, stage IIIB, HPV 16",pert
cerebellum_PS-/-_ 20d_rep1,pert
Muscle JDM (YJD-JDM-2UA-s2),pert
"Crohn's Disease subject (27 year old caucasian female, SAK_1275500386)",pert
"AD_FC, biological rep2",pert
Squamous cell carcinoma 030,pert
Ischemic cardiomyopathy_G19,pert
N1+2,ctrl
normal B lymphocytes (NBL 534),ctrl
"Patient SE, stable renal transplant recipients, male, 31 years old, T1 (3 months after the switching of the therapy)",pert
Muscle 50 eccentric contractions 12 hours WT Aged 0121,ctrl
Liver Experiment 2,pert
Array Type: HG-U133A_2;	Ratio: 1.98;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
gastrocnemius-30 months of age-control diet-biological replicate3,ctrl
wild-type+PQ rep_3 (PQWT3),ctrl
No or early 1 rep6 (OHN),pert
"WT mouse heart at 6-weeks old, biological rep2",ctrl
"peripheral ganglion, unknown: control 1 hr",ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 3",ctrl
Neocortex_Eomes_KO.4,pert
N51628,ctrl
3274-2 E2F WT,ctrl
MDS patient 93,pert
H1 Ctrl 2h 1,ctrl
"Cadmium 1.2 µM, biological rep3",pert
HET Brain 81d Mouse1,ctrl
WT-Fibr2 6,ctrl
NIH3T3_0h_exp1_rep1,ctrl
microdissected breast cancer cells from case 1507,ctrl
Liver_Control _Rep1,ctrl
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 14",pert
"Patient #7, Untreated",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: healthy control,ctrl
Septic shock;	gender: Male;	Survivor;	organism: Staph aureus;	organism class: Gram pos,pert
sample description: pool of total RNA from 10 human cell lines,ctrl
NCCIT-Mock-rep1,ctrl
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: OE-SOX2,pert
C_AN12240_T,ctrl
wild type rep-1,ctrl
tissue: Terminal end bud (mammary gland);	gender: female;	age: 4.5 week old;	genotype: Ovol2flox/-;K14-Cre;	strain: C57/BL6,pert
Bone-Marrow_SMM_S1331,pert
"Patient 3, lesion tissue",pert
"Endometrium, postmenopausal, control, 22",ctrl
Wild type LSK (3),ctrl
Chronic active plaque 1 (CAP1),pert
MEKi 16h biological replicate 1,pert
liver cells from wildtype 8wk male mouse 8 challenged with acetaminophen (APAP)_14,pert
"MCF-10A cells, shRNA targetting p63 TA, biological rep1",pert
HVS-CD4-control_unstim_rep2,ctrl
CD19_selected_B-cells_before_R_rep9,ctrl
LCH1ani,pert
HEK001_pLKO_R2,ctrl
Superior Frontal Gyrus_5y_normal,ctrl
"fibroblast, MFS subject FB890 rep 2",pert
LY2 control-siRNA untreated rep1,ctrl
"30B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"22B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 12961346,ctrl
Cerebellum_nontransgenic control A39_10 months_replicate 1,ctrl
Lung WT-PBS replicate 3,ctrl
WT_PLACEBO_48hours_2,ctrl
EOM 112 Day Control rep 2,ctrl
HE_2,pert
D_LS_Time0,ctrl
MDS patient 65,pert
Wt1-null MEFs-5,pert
strain background: C57/129S;	genotype/variation: Fra-1+/+; wild type;	gender: female;	age: 2 months;	treated with: 30 µl of PBS containing bleomycin (0.075U/mouse) for 5 days;	tissue: lung,pert
"117, MUSCLE, Before",ctrl
H295R_Group_A_Dose_NA_TIMEPT1_001,ctrl
tMLL07,ctrl
"RES-enriched Grape extract group, 12 months, patient number 41",pert
strain: FVB/N;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Fibroblasts;	genotype: PtenloxP/loxP,ctrl
"Lesional ear skin from K14-Areg mouse, biological replicate 2",pert
Lamp3 KD 3d 1,pert
Patient: A;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
Wt1-null MEFs-4,pert
Erythroblast_SOD2-/-_repKO35,pert
Tendon_lesional_rep3,pert
cell line: GIST882;	agent: Imatinib;	dose: 1μM;	replicate: Rep1,pert
ANL Chip#27,pert
"3T3-L1 siControl 48h, biological rep 1",ctrl
9SC- nbc,pert
jzo003-v5-u74av2-met,ctrl
patient: 40645;	sample: tumor,pert
Run3.aUa.010110d.SkMDbt1138D.CEL-DB basal,ctrl
SW480 Snail (1),pert
Nonlesional Epithelium Nonatopic Control rep2b,ctrl
Fiona Biological Replicate2,pert
WT4-iPS 3,ctrl
"IDC 5, biological rep. 5",pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3KO;	age: 12 weeks;	nutrient state: 24h fasted;	diet: Standard diet,pert
Mutant_liver_4,pert
A431 WT 1,ctrl
patient: 16;	disease state: hypertension;	tissue: Atheroma plaque,pert
Control 2 b,ctrl
cumulus_PCOS_Obese_rep2,pert
Ishikawa_LowDose_BPA_8h_rep3,pert
platelet_sickle_8,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: MIG control;	biological replicate: 3,ctrl
BAL_20b_A1B1,pert
"spinal cord, ventral spinal cord: EP142/L - G93R(Roth)/e14-mutant hSOD1_le2",pert
bulk normal breast or normal bresat organoid,ctrl
MIY_day_7-4,ctrl
A507 Sham 1 day,ctrl
Kidney_200 mg/kg VCM ip_mouse #090,pert
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 6 h;	dose: 0;	agent: none,ctrl
Age (mean +- SE),pert
liver wild type replicate2,pert
LECs from cirrhotic rats 2,pert
The Caco-2 cell line is derived from a male Caucasian with a colon tumor,pert
ref,pert
Heart RNA,ctrl
P70 Non failing heart biopsy,ctrl
"fibroblast, wild-type, untreated, biological replicate 4",ctrl
"MCF7/BUS, 0 pM E2, 48 hours, biological replication 1",ctrl
whole tissue section from case 1405,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M5a;	flt3 status: WT,pert
Run1.a10a.000608jd.2.SkMNor926.CEL-IS stimulate,pert
DBA/2JTCE liver sample batch 6,pert
siLMO3_oligo2_FM_rep2,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
normal plasma cells (NPC 547),ctrl
cell type: Primary hepatocytes;	strain: NMRI;	agent: Wy14643;	time: 24h;	gender: Male;	age: 4 months,pert
strain: CD1;	tissue type: back skin,ctrl
BAL_27a_A0B0,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A09",pert
Gender: male;	Age: 40;	Ethnicity: black,ctrl
gender: Female;	age: 97;	post-mortem delay: 3.5h;	ph: 6.2,pert
siNEG replicate 4,ctrl
GB 8 63B NO LPA,pert
CAR.AH_CITCO_rep2,pert
siControl repeat,ctrl
CA2 Cre Sox17E,pert
RE550_KPL4_un1,ctrl
Patient: A;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
"C3H/HeJBir-Il10tm1Cgn, sample 2",pert
"gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
cell type: Embryonic stem cells;	genotype: wild type;	culture condition: 3 days in N2B27,ctrl
WT 2 cerebellum 3 month,ctrl
Kidney_Aqp11+/+_P7_2-2,ctrl
rd1_P6_rep1,pert
Control gray matter 2,ctrl
"PTEN inducible MEFs at T0, biological rep2",pert
"A549, +TNFα, control siRNA, rep3",ctrl
chip number: 23;	transfection plate: 4;	target gene: IRF7;	kd level: 0.76;	rin: 9.3;	transfection date: 2011-10-17,pert
liver_NEMO_KO_replicate3,pert
patient5,pert
M12 - non-infected MBT/Pas fibroblasts,ctrl
"ALL_DS, K18 011409",pert
N3_Cy3,ctrl
"granulocyte, healthy control, biological rep1",ctrl
Peripheral Blood Mononuclear Cells;	Unknown Age and Gender,ctrl
NPC_SA01_1,ctrl
Turner_AF_1,pert
M7KOepi_infect_0h_rep1,pert
CD11b+Gr1- cell sample_2 (derived from IL17RC Knock out mouse),pert
HeyA8-(2)b,ctrl
Individual_3690_PN_sample,pert
DNMT1-3,pert
WT(Rnh1+/+) -1,ctrl
Fetal heart control 6,ctrl
Cancer 13,pert
OSE4 shARID1A at 72h,pert
GIST Pre Treatment Biopsy 27,pert
whole tissue section from case 662,pert
Septic shock;	gender: Female;	Survivor;	organism: None,pert
MCF-10A shControl replicate 2 [set 5],ctrl
HLA risk: High;	Height: 125 cm;	Weight: 23.3 kg;	BMI: 14.7;	Age: 8.02 years;	Gender: Female;	Race: White;	Glucose: 328 mg/dl;	HbA1c: 6.5%,pert
sample type: no history of asthma;	tissue: smooth muscle cells;	treatment: dexamethasone for 24 hr,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P3,pert
cumulus_nonPCOS_Obese_rep4,ctrl
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_4;	fev1 (% predicted): 65;	fvc (% predicted): 81;	medication: Prednisolone 10mg od,Spiriva 18mcg od,Methotrexate 12.5mg wkly, Seretode 500 1pbd,Fosamax 70mg once/wk,Folic acid 5mg od,Calchichew,Cocodamol prn;	cell type: CD8+ T-cells",pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 51 yr;	population: white,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 74;	Sex: male;	region: LC;	age: 39;	genotype: Y/Mecp2-;TH/-,pert
"patient: 106;	current medication: None;	birth date: 5/29/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: Abdominal pain, upper GI symptoms.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
strain: C57BL/6;	diet: normal chow (normal);	tissue: liver,ctrl
MDS20,pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 52;	gender: m;	treatment: NSAIDs,ctrl
WT - Cre Treated - 0.5 hrs - repeat 2 - Cy3 - mAdbID:62542,ctrl
HD 3,ctrl
Squamous cell carcinoma 020,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 3x1h exposure per day",pert
Placenta_PE(LO)4,pert
T-REx293-NPAP1-uninduced-1,ctrl
whole tissue section from case 420,pert
Ls174T-pTER-β-catenin con3,ctrl
11_0020C_Day1_29,ctrl
chip number: 11;	transfection plate: 6;	target gene: JUND;	kd level: 0.77;	rin: 9.1;	transfection date: 2012-03-26,pert
strain: C57BL/6;	tissue: visceral_fat;	gender: female;	age: 8week,ctrl
01L4N: normal control,ctrl
"Normal subject (52 year old caucasian female, SAK_1290097388)",ctrl
cerebellum_PSNA_ 12w_rep1,pert
4-Vinylcyclohexene Diepoxide (50uM) rep 1,pert
"seminoma specimen, pT2, patient age: 31y; W03 033",pert
tissue: Temporal cortex;	age: 88;	Sex: F,pert
E2_ethanol_36,pert
DMSO Treated Control 4,ctrl
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 86;	Usage number: 4;	Exposures: 3,pert
"Control siRNA - 5 days osteoblast differentiation, rep1",ctrl
Pediatric_GBM_6,pert
NL C,ctrl
Mut+/+ rep3,ctrl
SKMEL28_t48h_rep2,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 35;	gender: male,ctrl
Individual_5935_NN_sample,ctrl
sample =XCGD2 treatment=Stimulated time=180 (min),pert
wt-Gfp E16 replicate 2,ctrl
A HID B_B017,pert
"WI-38 cells, at 24 h after exposure to 1 uM BPDE, biological rep3",pert
Kidney_50 mg/kg VCM ip_mouse #070,pert
"age at diagnosis: 64;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIC;	t (extent of primary tumor): T2;	n (lymph node metastasis): N3a;	er: 1;	pgr: 1;	dfs-month: 26;	dfs-event: 0;	distant metastasis: 0",pert
A673 cell line that has been treated with Puromycin for 5 days with concentration of 0.09 uM (EC50).,pert
WT-sham-5 month-R3,ctrl
Neuroblastoma SH-SY5Y cells_cloneG_stably transfected with RNAi against DJ-1_replicate2,ctrl
01UN2_Systemic,pert
strain: C57BL/6;	tissue: Spleen;	genotype: Xbp1 KO,pert
MCF7/XBP1 p.3,pert
condition: Discoid Lupus;	patient: L5;	tissue: LS skin biopsy;	kit: Ovation,pert
CD34-920082,ctrl
HUVEC/NmenMC58_pilD_1h_rep2_1107,pert
RTX7 T12,pert
"A673 treated with Puromycin for 24 hours with concentration of 0.09 uM (EC50), biological rep1",pert
c 4-2,pert
HRas-v12 transgenic female replicate 2 late timepoint,pert
E12.5 Lim1 mutant embryo renal vesicles isolated by laser capture microdissection,pert
Individual_5257_NN_sample,ctrl
5SC-nbc,pert
AtT20 cells overexpressing NSBP1SE protein rep1,pert
PBMC from T cell LGL leukemia patient #117 (TLGL117),pert
cell type: Primary hepatocytes;	strain: FVB;	agent: control;	time: 6h;	gender: Female;	age: 5 months,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 69,pert
PGA-MAH-HeJO3-1bAv2-s1,pert
reduction mammoplasty patient 347,ctrl
"siNC-BMSCs , biological rep3",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 19.40822,pert
11090 Normal Uninflamed descending colon,ctrl
"CFU-PreB colonies Hspa9+/-, biological replicate 3",pert
Large cell carcinoma 016,pert
LNCaP + vehicle rep 2,ctrl
cell line: SUM149,ctrl
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_4 months_replicate 4,pert
1195-03-A,pert
cell line: MCF10A;	gender: female;	tissue: breast;	expression: HER2 over-expression,pert
"Endometrium, postmenopausal, tibolone, 11",pert
Human Uninfected Sample N141-CD8+ T cells,ctrl
SZ11,pert
4mo tg1,pert
PBMCs_IS_7 [IS],pert
CEPI_IV_542,pert
Strain: (129S4/SvJae) (PPARalpha knockout);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,pert
MDS48,pert
Wild type IFN-beta 2 h,ctrl
sample =Healthy1 treatment=Stimulated time=90 (min),ctrl
Skin_SKO_Rep3,pert
Pancreatic Sample 16-Normal,ctrl
subject: 33;	disease: TD;	muscle: ST;	gender: M;	age: 13;	gmfcs: N/A;	popliteal angle: N/A,ctrl
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shControl.1,ctrl
KU_34N,ctrl
Individual_4163_PN_sample,pert
"control for Abca1 +/- ES, RNA 78",ctrl
Insig1 flox/flox /Insig2 -/- InsigKO_C1,ctrl
SKMEL28_t48h_rep3,pert
MDS43,pert
WT #187,ctrl
Run2.aUa.001206d.SkMInS1090D.CEL-IS basal,ctrl
Control spleen - Biological Replicate 2 - Technical Replicate 2,ctrl
H4-II-E-C3_untreated_rep4,ctrl
b143,ctrl
"experiment 2, ethanol-treated 3",pert
GM19238_Kd_YY1_1,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-sp3,pert
BT474-J4_DMSO_24-3,ctrl
lesion_postUV_patient6,pert
sample E 18.5 homo,pert
con-41_B,ctrl
Wild type unstimulated 2,ctrl
E81-/-SRFdM-VP16-2,pert
S8A Sporadic-frontal,ctrl
miR122-WT-125,ctrl
Septic shock;	gender: Male;	Non survivor;	organism: Group B Strep;	organism class: Gram pos,pert
Tgfbr2 Wildtype Mouse Model MEPM 4,ctrl
APOE_KO_DM_9W_2,ctrl
"Wildtype, biological rep3",ctrl
Human Chronic HIV Sample C101-CD4+ T cells,pert
Wt Mouse_cerebellum_Old_saline treatment_Replicate-1,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 4;	psoriasis duration: 14.0;	age of psoriasis onset: 11,pert
TGF-alpha 979-CLA-31,pert
"HCT116 cells with enforced miR-34a expression, technical replicate 2",pert
"IL22KO4_ileum, 5 days post-infection with T. gondii",pert
Individual_4505_PN_sample,pert
tissue: testis;	gestational age: 16 weeks;	xenografted into host: control (unimplanted samples were snap-frozen immediately);	host treatment: N/A,ctrl
Ramos pRTS-CA-IKK2 F+,pert
fat_Wt_8wk_rep2,ctrl
CUTLL1 MigR1 GSIwash2h-rep3,pert
N8_Cy3,ctrl
untreated_6hr_rep2,ctrl
U-87MG-V22 set 5,ctrl
I_LS_Wk1,pert
V5-P354,pert
"PCOS, biological rep 7",pert
"granulocyte, healthy control, biological rep8",ctrl
Caco2-siRNA2-rep3,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 1,ctrl
"220, ADIPOOSE TISSUE, Before",ctrl
S3-040330-SA,pert
"PMA treated, no doxycycline; biological replicate 3",pert
con-13_B,ctrl
sample =Healthy1 treatment=Control time=360 (min),ctrl
"MCF7/BUS, 0 pM E2, 48 hours, biological replication 4",ctrl
Muscle PCOS pioglitazone 101,ctrl
Elf4 KO1 activated CD8 T cells,pert
heart female pbs 10 dpi rep2,ctrl
prostate_Klf5 ko_rep4,pert
RE550_H1650_4-Medi5117,pert
Nerve_Diabetic_Vehicle_708,pert
SLE myeloid cells 3,pert
genotype/variation: C57BL/KLS-leprdb/leprdb (db/db),ctrl
PGA-MAH-AJ_PBS6h-4aA-s2,ctrl
E14.5 Tgfbr2 Wildtype Mouse Model Palate 5,ctrl
KU_42T,pert
"sh3293 (to target ERBB3) T47D cell line, replicate 1",pert
T61 dilated cardiomyopathy heart biopsy,pert
cell line: DAOY M2.1;	cell type: medulloblastoma;	genetic modification: siRNA scrambled,ctrl
AR-CO-24-2-549,pert
Lung dnCREB-PBS replicate 3,pert
157_SIO,pert
Rybp#10 (OHT-)_4d_rep2,ctrl
T51722,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep5,ctrl
cell line: BaF3;	infected with: MPLW515L3;	pretreated with: normal condition (Naïve);	treated with: 0.8 uM INCB18424 for 4 hrs;	sample type: acute,pert
"normal colorectal mucosa, biological rep 2",ctrl
C13-(3),ctrl
Bone Marrow Mononuclear Cells;	27y Male,ctrl
"gender: Female;	age: 87;	post-mortem delay: 14.5h;	ph: 6.5;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Time:0 day; condition:ctr;,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATM-3,pert
RA_x,pert
AA_Case21_CD8,pert
Liver_WT_Rep4,ctrl
con-13_C,ctrl
RI34,pert
con-37_B,ctrl
genotype: Btk KO;	strain: CBA;	cell type: Splenic B-cells;	developmental stage: Transitional Type 1,pert
"Control 09, NC09",ctrl
cell type: F442A cultured adipocyte;	cell line: 3T3L1;	back ground strain: Swiss,ctrl
LJMJDW3,pert
48 hrs TAC-4,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 8h,ctrl
Untreated Melan-Ink4a #1,ctrl
ILD Study Number 1239,pert
"mental retardation or developmental delay, Male",pert
chip number: 20;	transfection plate: 4;	target gene: HCST;	kd level: 0.88;	rin: 9.7;	transfection date: 2011-10-17,pert
BALB_Male_Control_rep1,ctrl
Patient: D;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
34_C57_WT,ctrl
cell type: Primary hepatocytes;	strain: BalbC;	agent: Wy14643;	time: 6h;	gender: Male;	age: 6 months,pert
Bone-Marrow_MM_M687,pert
"MCF7/BUS, 10 pM E2, 48 hours, biological replication 5",pert
MacularDegen-healthy-8dAv2-s2,ctrl
Dental pulp cells idipopathic autistic patient triplicate 3,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 47.06301,pert
5L,pert
Trasnsformed Lymphocytes Unaffected Twin Pair 1(DCBD1.2)(TP6),ctrl
H_Kin_2,pert
"siSCR ES, biological rep3",ctrl
Pediatric_GBM_40,ctrl
SKMEL28_t1h_rep2,pert
cell line: IOSE80pc;	knockdown: ARID1A;	cell type: ovarian surface epithelial cells,pert
"liver_LDLr-KO, biological replicate 1",ctrl
48 hrs sham-3,ctrl
Replication 2 Control,ctrl
"2 months, contralateral group, biological replicate 2",pert
PBMCs_Control_14 [IS],ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 122;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
"IkB, LPS 5hr",ctrl
KU_12N,ctrl
HSC-3_TAT-2_48hr culture_ rep2,pert
"breast tumor epithelium,38",pert
Normal_MS 36D4,ctrl
Neuroblastoma SH-SY5Y cells_cloneB_stably transfected with RNAi against DJ-1_replicate1,ctrl
HF12E1,pert
B_Kin_3,pert
"WT Heart with no treatment, biological rep2",ctrl
CD-58-Aff,pert
231_GATA3_rep2,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: B;	experimental sample name: PC12-R,pert
tissue: Aorta;	genotype/variation: SRF-flex2neo -SM22CreERT2ki/+;	genotype/variation: smooth muscle specific SRF knockout;	age: 4 month-old,pert
FW_3a_BV8771,pert
cell line: non-clonal BMSC cultures,ctrl
"129/B6 background, 6-10 weeks",pert
BE-rep9,pert
sXBP3_1578S,pert
12P-ER,pert
"Typically Developing Control, Gracilis, Patient Replicate 8",ctrl
RatLung_H24h_1,pert
wt_rep2,ctrl
MacularDegen-injured-7aAv2-s2,pert
"Epidydimal white adipose tissue from Casp1-/- after 16 weeks of high fat diet feeding, replicate 1",pert
KU_08N,ctrl
PCOS Endometrium Stromal Cell_134.UC271-+,pert
35/OVX/oil/6h/UTX 129 Hoxa-10+/+,ctrl
type 2 diabetes subject 10,pert
liver knock out replicate1,pert
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: untreated; biological replicate: 1,ctrl
"FOXP3, mut, REP1, 0h",pert
cell type: tumor nodule cells;	ikk2 status: IKK2 -/-,pert
"control, BA46-86",ctrl
cell line: MCF7;	treatment: none,ctrl
"Cell type: endothelial, age:42, gender:male, diagnostic group: schizophrenia, PMI:37h",pert
WT-Nrf2-Female-1,ctrl
"Patient S120, MSI colorectal tumor",pert
tissue: Spleen;	genotype: TRAF3flox/flox (littermate control),ctrl
Keratinocytes_siRNA control_rep2,ctrl
heart-ko-2,pert
"Control KD, rep1",ctrl
gender: Female;	age: 90;	post-mortem delay: 12.5h;	ph: 5.7,ctrl
"EBF1 d4, rep 1",pert
Bone-Marrow_MM_M797,pert
H4-II-E-C3_low_rep1,pert
scan batch: Batch 1;	group: control;	subject age: 10;	paternal age: 26;	maternal age: 27,ctrl
"Cerebral Palsy, Semitendinosus, Patient Replicate 9",pert
3638-lcm,pert
SUM149_siTIG1_rep2,pert
"control, BA10-21",ctrl
MA_13,pert
tissue: brain;	genotype: WT inbred background;	age: P0,ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case1,pert
Day: 1; Drug: Saline; Phase: Drug treatment; Replicate: 3,ctrl
cadmium_32hr_rep1,pert
"Sh2b3 KO, biological rep2",pert
"Keratinocytes untreated control, 1h",ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_24_5_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
c 4-5,pert
Strain : 100% C57BL/6;	Gender: Male;	Age: 9 weeks (Moderate stage);	Transgene: Mutant ataxin-7,pert
01MCY_Systemic,pert
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 21;	gender: m;	treatment: -,ctrl
4 hour tunicamycin wild type A,ctrl
lineage: colorectal;	cell line: SW480;	treatment: treated with MEK inhibitor for 16h,pert
8L,pert
T51628,pert
cell type: ovarian cancer;	ets-1 expression status (western blot): High levels of Ets-1 protein expression,pert
siEGFP (72 hr) _2,ctrl
"patient 011b, cancer, homogenized",pert
PPAR WT_ctr_54,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 35;	maternal age: 36,ctrl
MPM tumor 8,pert
3551-1 E2F WT,pert
"control for Abca1 +/- ES, RNA 80",ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 32;	maternal age: 29,pert
Age: 44;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 5382insC;	Family History: Yes,ctrl
Control accumbens,ctrl
Disease_status: Bipolar disorder;	Age (years): 41;	Gender: Male;	Age of onset (years): 21;	Duration of illness (years): 20;	Brain pH: 6.60;	Post mortem interval (hours): 39;	Side of brain: Left;	Fluphenazine mg. Equivalents: 4000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
Patient 10,ctrl
6-C_1,ctrl
"fibroblast, MFS subject FB773 rep 3",pert
CH2111,pert
40 year old male,ctrl
sal-PVH_2,ctrl
"breast, pre AFI treatment (H9_1575)",ctrl
SLE CD4 T cells 8,pert
patient: 225;	current medication: Asacol;	birth date: 5/30/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/2/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/99;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
5253 UC Uninflamed sigmoid colon,pert
Mouse old brain C30-Br-5,ctrl
muscle WT 2 control,ctrl
ILD Study Number S034,ctrl
NCI-H716_Control.2,ctrl
cell line: HUES6;	treatment: control,ctrl
b9.2,pert
PHM-DM-1aUA-s2,pert
chip number: 20;	transfection plate: 6;	target gene: RAD21;	kd level: 0.9;	rin: 9.7;	transfection date: 2012-03-26,pert
tissue type: normal thyroid;	matched/unmatched: matched to T16,ctrl
treatment: control;	cell line: MCF7-FR,ctrl
Mening UNSTIM WB SW 0a,ctrl
Extract:LOX-1:213501;	Extract Description:LOX1_Untreated_24hr:213501;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.65;	Quality: Background Mean Dev.:0.43;	Quality: Absent (%):59.43;	Quality: Absent (%) Dev.:0.91;	Quality: Scaling Factor:0.75;	Quality: Scaling Factor Dev.:1.18;	Pretreatment [C]:LOX1;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213501;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_24hr;	RNA extraction source key [A]:282295893,pert
T56 U133p2,pert
cell line: L-540;	cell type: Human Hodgkin Lymphoma,ctrl
ColonDistal0224AC3G_071.txt,ctrl
"Control Day 5, biological rep3",ctrl
Pancreatic Sample 36-Tumor,pert
"MCF-10A cells, shRNA targetting p63 DBD, biological rep2",pert
MDA-MB-231_TR20003: transfected with the original vector plasmid,ctrl
BSKO 1,pert
J_LS_Wk4,pert
CAR.KO_CITCO_rep2,pert
tissue: primary brain tumor;	cell type: astrocytoma;	age: 43;	gender: male;	tumor grade: AIII,pert
"2B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"gender: Female;	age: 88;	post-mortem delay: 7h;	ph: 5.7;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
gender: female;	age (years): 45;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
Injured 7 day Rat Retina 2,pert
06SAGEA,pert
No_abuse_1,ctrl
Wild type_heart_2,ctrl
P14 - nudelcko/ko 2,pert
Genotype: p38alpha wt;	Age: E13.5,ctrl
disease state: paediatric glioblastoma;	age: 2;	gender: F;	h3.3_status: wt,ctrl
C57 48 air 1,ctrl
"Pancreas from adult WT mice, biological replicate 2",ctrl
"HeLa treated with Cas-II-gly, biological rep2",pert
P76 dilated cardiomyopathy heart biopsy,pert
CRC_celecoxib_M4861,pert
P78 dilated cardiomyopathy heart biopsy,pert
age: 61;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"villin-creERT2:beta-catenin-/lox, induced by tamoxifen for 2days",pert
HLA risk: Low;	Height: 178 cm;	Weight: 81.7 kg;	BMI: 25.6;	Age: 32.78 years;	Gender: Male;	Race: White;	Glucose: 114 mg/dl;	HbA1c: NA,ctrl
agent: EphB2-Fc conjugate;	time: 24h,pert
"human failing LV myocardium, Ischemic48",pert
MCF7 Control cells Array 1,ctrl
s5t1c,ctrl
Control spleen - Biological Replicate 2 - Technical Replicate 1,ctrl
KM_019T,pert
Ishikawa_HighDose_BPA_48h_rep3,pert
"Atm-/- untreated, C",pert
Carbo Day14 (301L),pert
CD4+_Tcells_severe_asthmatic_3,pert
DBA control (203msn),ctrl
RTX11 T0,ctrl
"mouse aorta cross strain comparison, C3H_T24_HF_03",pert
infection status: mock-transduced control;	cell type: human ccRCC cell line,ctrl
cell line: AGS;	tissue origin: stomach;	cell type: human gastric carcinoma cells;	treated with: 20μM celecoxib for 24hrs,pert
INHA2,pert
"Mutant in the absence of tetracycline, rep1",pert
pt. HCL A treated with DMSO for 72h,ctrl
Patient no. 3: control,ctrl
GIST 2,pert
"Testes, 8 hours after cadmium treatment, biological rep 2",pert
Braak α-synuclein 3-4 BR34_3SN,pert
Wildtype_TAC_Rep3,pert
1a_b,pert
Run4.aUa.010110d.SkMDbt1141D.CEL-DB stimulate,pert
"MAT1A knockout at 3 month age, biological replicate 1",pert
"affected status (disease state): control;	gender: male;	age-at-examination: 66;	age-at-onset: n/a;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",ctrl
MZ1774 mock rep 2,ctrl
MDS patient 39,pert
Day: 15; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 3,pert
wild-type littermate of B6.BKS Ighmbp2nmd-2J mice;	6 weeks of age;	male,ctrl
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.59;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,ctrl
Sample Group: HD patient; Gender: male; Age: 51; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/45,pert
ATM_siRNA_0b,pert
"Patient 65N, normal colonic mucosa",ctrl
Wt Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-1,pert
"Patient #3, Untreated",pert
IMR-32_pCMV-SQSTM1_48hr,pert
"Cervical cancer cell line, SW756",pert
con-9_A,ctrl
8DKD_SerumStarved->1hrEGF_rep2,pert
healthy control C10,ctrl
Preglaucoma control rep9 (OHN),ctrl
Targretin_mammary_2,pert
MDS38,pert
WT 3 cerebellum 3 month,ctrl
"NC1, biological replicate 3",ctrl
Msgn1_24hPlusDox-biological rep3,pert
PsOEt-18-Week 1,pert
model: model: Fischer  344;	gender: Male;	age: 21 to 22 months old,pert
cell line: LNCap;	sirna transfection: siRNA COP1,pert
genotype: wild type;	strain: CBA;	cell type: Splenic B-cells;	developmental stage: Transitional Type 1,ctrl
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: siRNA against TET3 transcript,pert
WT mouse 1_heart_basal,ctrl
"brain, hippocampus: KA-6h-P15-I_e1_le1",pert
Donor6_6h_Wy,pert
CT-receptor-KO osteoclasts untreated 3,ctrl
Mening SWB WB NP 6a,pert
H1299 SC_rep 2,ctrl
tissue: skin;	individual: Patient N-3;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
T2_pitM,pert
PZA treated-63d-2,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P60,pert
HeTH-4 +DOX rep-3,pert
Gastrocnemius Muscle_mdx_rep3,pert
KU_43N,ctrl
BP23,pert
28n,ctrl
Time of Surgery:Post;,ctrl
Normal cervix_05-1981,ctrl
CD4_T_cell_pool_melanoma_M11+M12,pert
3702-1 E2F3 Heterozygous,pert
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P4,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: LSD1;	transfection time: 48h,ctrl
Hippocampus_Soman_3h_rep6,pert
"Control #8, Untreated",ctrl
"PCB77 treated HepG2 cells at T0, biological replicate 2",ctrl
DN2 replicate 3,ctrl
OE-NANOG_2,pert
muscle_Wt_8wk_rep1,ctrl
strain: C57BL/6;	gender: male;	develpmental stage: embryonic day E15.5;	genotype/variation: wild type;	cell type: mouse embryonic fibroblasts (MEF cells),ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 361;	age-at-biopsy-years: 57,ctrl
gender: male;	agent: E2;	cell type: Hematopoietic stem cells,pert
"fibroblast, MFS subject FB837 rep 1",pert
Vit-WT,ctrl
FTO1_C1_48h,pert
minor HCC5,pert
"Liver, Intermittent Hypoxia 2",pert
RL_siRNA_LIF1h_rep1,pert
LacZ control_0b,ctrl
mouse: 3;	strain: C57Bl/6;	genotype/variation: Wild-type;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,ctrl
affected status (disease state): IS patient;	gender: male;	age-at-examination: 74;	age-at-onset: 72;	geographical origin: Mirandela;	clinical characteristics: Hypertension;	lifestyle characteristics: ever drinker,pert
cell line: HT1080;	clone: 21;	genotype: Knockout,pert
cardiomyocyte control 3,ctrl
tissue: testis;	gestational age: 16 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: corn oil vehicle,pert
cell type: Anaplastic thyroid carcinoma;	expression: TL3 LAMC2 shRNA;	cell line: TL3,pert
19GOBMUC2H,ctrl
"mouse liver, RNA B6999A",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.789;	OD280: 0.949;	Ratio: 1.83;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 132;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Vit A sufficient 1a,ctrl
"107, ADIPOOSE TISSUE, Before",ctrl
Seguin_IDR_BrownNorway_Liver_treated2,pert
"CCM3 shRNA cells passage 11, rep 3",pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: vehicle,pert
hdh genotype: Q111/Q111;	tissue: striatum;	age: 3~10 weeks,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 2,pert
Individual_5325_PN_sample,pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 48 hrs,ctrl
cell line: MOLM-14;	replicate: Replicate2;	treatment: shSYK_1,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: F;	experimental sample name: PC14-R,pert
Endometrium-Normal 10,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 19d ID76,ctrl
Placenta Adra2bWT 2,ctrl
MDS patient 1,pert
Cochlea_D257A_9mo_1,pert
"GNMT knockout at 8 month age, biological replicate 4",pert
24h PTD-DRBD GAPDH siRNA (SAMPLE 10),pert
con-41_A,ctrl
"1mg/kg/day PFOA, Rep 2, Block 3, lung (low dose)",pert
ANL Chip#40,pert
tissue: Embryonic lung E18.5;	genotype: C57BL/6 Hmga2 KO;	age: Embryonic Day 18.5,pert
Rat heart ventricle,ctrl
3589-1 E2F1 Null,ctrl
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug TAK1 siRNA;	treated with: 100nM PD173074 for 48 hrs,pert
sample type: Primary culture of type II cells collected from SPC WT lung (adult);	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C WT;	genetic background: 129S6/SvEvTac,ctrl
HLA risk: High;	Height: 170 cm;	Weight: 59 kg;	BMI: 20.4;	Age: 40.56 years;	Gender: Female;	Race: White;	Glucose: 74 mg/dl;	HbA1c: NA,ctrl
ILD Study Number 1243,pert
"AD_TC, biological rep3",pert
06R028 RA,pert
strain: backcrossed 3-5 generations on C57BL/6 from FVB;	rna: TRAP;	driver: S100a10;	line: ES691/p11 KO;	tissue: cortex;	treatment: fluoxetine,pert
age: 52;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
treatment: vehicle;	genotype: progesterone receptor knockout;	treatement time: 4 hours,pert
APOE_KO_RAGE_KO_NODM_9W_13,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.92;	choa: 190;	fata: 15;	eea: 1160;	wtkg: 71.1;	perfat: 33.2;	lbm: 45.3;	fat_mass: 2360.52,ctrl
lymphoma_9250_ADR,pert
Kidney_Aqp11+/+_P7_4-1,ctrl
"Deltoid, control, cohort 22, subject 22U",ctrl
Pt24_Pre,ctrl
BirA control replicate 1,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: Treg;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 110min;	race: White;	sex: Female,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
model: Fischer 344;	gender: Male;	age: 7 to 8 months old,pert
Human mammary epithelial MCF10A cells,pert
CONTROL;	Age = 18;	Sex = F,ctrl
NSCL/P sample 5,pert
E17.5 preB cells_Smchd1 null_Rep 3,pert
"Mepenzolate treatment, 7 hours (replication 1)",pert
cell line: RPMI8226;	cell type: Myeloma cells;	transduced with: shRNAs targeting KDM3A,pert
baseline control 06,ctrl
Liver_PXR KO_Vehicle_Rep4,pert
tissue: skeletal muscle;	disease status: healthy control,ctrl
CC1 21d replicate 3,pert
460A.INV,pert
"E2A CLP LY6D-, biological rep4",pert
PBMC from T cell Large granular lymphocyte leukemia patient#111,pert
Duoden22VAFBA_066.txt,ctrl
Cardiac Muscle_mdx_rep3,ctrl
409MM,pert
110A,ctrl
Carboplatin 30 hours set 2,pert
4-HPR_LIVER_3,pert
"fibroblast, MFS subject FB837 rep 3",pert
Rat fatty liver18,pert
WKY16-1,ctrl
cell line: Abelson B cell line,pert
NPC_VUB03_DM1_3,pert
disease state: ovarian adenocarcinoma;	specimen: ovarian cancer epithelia cells,pert
Ulk1/2+/+ + IFNβ 1,ctrl
Mononcyte-healthy-untreated-4,ctrl
strain: FVB/N;	tissue: forebrain,pert
438: control mouse 3,ctrl
Cerebellum_nontransgenic control X50_16 months_replicate 2,ctrl
high grade serous carcinoma_patient 3_sample 2,pert
control sample 5,ctrl
"KM-H2 cells, CIITA-BX648577 knockdown, replicate 1",pert
WIld-type control 3,ctrl
Squamous cell lung cancer X42sqm,pert
uterus_veh_PRKO_4hrs_rep2,pert
control virus-infected replicate 1 (monocytes),ctrl
GM19238_Kd_ZHX2_2,pert
tissue: Temporal cortex;	age: 83;	Sex: M,pert
mouse cerebellar granule cells knockout 1,pert
SW1736_t1h_rep1,pert
AtT20 cells infected with empty vector rep3,ctrl
"HSCs from male mice treated with oil, replicate 3",ctrl
EA_Case4_CD4,pert
MLL_00128,pert
Vehicle 12 hours_1,ctrl
patient: 112;	current medication: None;	birth date: 7/5/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
T147 U133p2,pert
treatment: STI (Imatinib);	cell line: K562,pert
T1E-LU,pert
Septic shock;	gender: Female;	Survivor;	organism: Strep pneumo,pert
affected status (disease state): control;	gender: female;	age-at-examination: 47;	age-at-onset: n/a;	geographical origin: Porto;	clinical characteristics: Hypertension;	lifestyle characteristics: ever smoker,ctrl
tissue: Temporal cortex;	age: 77;	Sex: M,ctrl
phytohemagglutinin-activated PBMCs from normal control subject K,ctrl
H69_TGX221_5,pert
CRC_celecoxib_F4871,pert
HF0332_U133P2,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 24.0;	age of psoriasis onset: 31,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 1;	choa: 379;	fata: ;	eea: 1510;	wtkg: 63.2;	perfat: 25.7;	lbm: 41.6;	fat_mass: 1624.24,ctrl
"human peripheral blood derived monocytes, 24 hour LPS stimulation, biological rep1",pert
tDEA001.CEL,pert
"human failing LV myocardium, Idiopathic72",pert
P54 Non failing heart biopsy,ctrl
"Patient 18, Macroscopically intact tissue",ctrl
ACC Xenograft X9,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 12h,ctrl
"WT brain, biological rep4",ctrl
sirna: control;	plate: plastic;	cell line: MCF10A,pert
KM_103T,pert
GEIM17-PM,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 76,pert
"Spi-21, biological rep 4",pert
Gastric_cancer_patient_1_dye_swap,ctrl
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 0,pert
EA_Case21_CD8,pert
"Male, 49 years old, HIV infection of ~3 months",pert
CTL2 E2 72hr,pert
CD46+/STAT1-KO hippo - Untreated-E,pert
tDEA004.CEL,pert
Patient 7 skin treated,pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 54;	age-at-onset: 49;	geographical origin: Vila-Real;	clinical characteristics: Hypertension, diabetes, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
"Liver, Normoxia 4",ctrl
"cells treated with Scrambled siRNA, biological replicate 3",ctrl
TB 8,pert
CHB PBMC_sample 1,pert
race: caucasian;	age (years): 61;	stage: IB;	grade: 1;	histology: endometrioid,pert
"Lesion Skin, LS-31",pert
strain: C57BL/6J;	day: 18;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
Human Chronic HIV Sample C102-CD8+ T cells,pert
"cells treated with Vamp7 siRNA, biological replicate 2",pert
"TMD_GL, T2",pert
"Vldlr knockout saline, biological rep2",pert
"human failing LV myocardium, Ischemic44",pert
quiescent p27KO MEFs 3,pert
11388 Normal Uninflamed descending colon,ctrl
GEIM179-U133A-DM,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 05/07/06;	# cells: 39;	Sex: male;	region: M1;	age: 44;	genotype: Y/Mecp2-;G42/-,pert
mES cells rep3,ctrl
colon_adenoma_1700,pert
cell line: Huh7.5.1;	tissue: liver;	agent: Ribavirin,pert
Bronchial Epithelial Cells SA biological 2030T,pert
Ctrl siRNA 3d 2,ctrl
N9_Cy3,ctrl
IMR-32_pCMV_48hr,ctrl
Tissue:Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes;	2nd technical replicate,pert
FoxM1 B,pert
"'cervical cancer cell line C4-I' , 'squamous cell cancer'",pert
control participant P350,ctrl
LT 344 +/T untreated,pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case5,pert
"Mouse LV, WT 2",ctrl
S10A Sporadic-frontal,ctrl
T2-FP_spleen_KO_rep1,pert
cell type: Primary hepatocytes;	strain: DBA;	agent: Wy14643;	time: 6h;	gender: Female;	age: 3 months,pert
P4_TR_2,pert
BCell_lymphoma_marginal_sample1,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 9.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 38;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
Subject #8027-Preinfection,ctrl
siLRH-1_#3_rep_2,pert
E16.5 wt1,ctrl
whole blood_101726,ctrl
"3mg/kg/day PFOA, Rep 4, Block 4, liver (low dose)",pert
MH1C1_high_rep3,pert
affected status (disease state): control;	gender: male;	age-at-examination: 68;	age-at-onset: n/a;	geographical origin: Lisboa;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever drinker,ctrl
Pcgf6_2_shRNA1-dox,ctrl
RORasg/sg liver_HFD_rep1,pert
Extract:LOX-1:213302;	Extract Description:LOX1_Untreated_6hr:213302;	Quality: Classification:Bad;	Quality: Gradient Severity:0.08;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.67;	Quality: Background Mean Dev.:0.99;	Quality: Absent (%):60.73;	Quality: Absent (%) Dev.:1.92;	Quality: Scaling Factor:1.1;	Quality: Scaling Factor Dev.:4.2;	Pretreatment [C]:LOX1;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213302;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_6hr;	RNA extraction source key [A]:282295663,pert
PKBa-/- MEF time 0 replicate 3,pert
14-week-old WT liver_613WT,ctrl
HIF-1-/- S. aureus 5,pert
Wild-type mice rep3,ctrl
HeLa_TP082505-25_HG-U133A_2_IMFGN0023,ctrl
jejunum_control_3,ctrl
"MCF7, shRNA knockdown PDEF, biological rep2",pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: BETAFERON;	time: 3 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Age: 40;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Unknown,ctrl
"human failing LV myocardium, Idiopathic58",pert
tissue: Terminal end bud (mammary gland);	gender: female;	age: 4.5 week old;	genotype: Ovol2flox/+;	strain: C57/BL6,ctrl
MDS patient 101,pert
C2C12 myotubes 1ulMH202 rep 1,pert
"Scarmbled control knockdown, replicate 1",pert
INS-1 cell line (FLP-In T-REx clone #1-1.16),ctrl
protocol: Transfection Reagent;	cell line: MCF7,ctrl
wildtype 5,ctrl
tissue type: Normal lung;	histology: Normal lung,ctrl
whole tissue section from case 1507,ctrl
heart-wt-1,ctrl
Bone-Marrow_MGUS_G403,pert
XBP1s B cells 1,pert
CUTLL1 wash4h-CHX_rep2,pert
"brain, frontal cortex: Sample62_e1_le1",ctrl
wt 13.5d replicate 9,ctrl
cell line: SLM2;	mutation: WT;	treatment: Control,ctrl
siSPDEF_1,pert
b44-,pert
scan batch: Batch 2;	group: control;	subject age: 4;	paternal age: 24;	maternal age: n/a,ctrl
"brain, frontal cortex: Sample44_e1_le1",pert
GEIM128-U133A-Norm,ctrl
H03_P_B1,ctrl
1085PBMC,ctrl
"C57BL/6 female 3 weeks, 125",pert
B7hi mTEC B6/129 wt3,ctrl
siGFP-transfected sample 1,ctrl
Empty vector control embryoid body sample_1 (Vector_EB_1),ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 40.06301,pert
tissue: Temporal cortex;	age: 89;	Sex: M,pert
BP patient 101_biological replicate 1,pert
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1mi;	er: 1;	pgr: 1;	dfs-month: 35;	dfs-event: 1;	distant metastasis: 0",pert
pool of thyroids from 6 months old wild type mice,ctrl
Chondrogenic progenitor cells from OA male 2,pert
9-cis-retinoic-acid_LIVER_4,pert
HF1348_U133P2,pert
Trib1 #1 KO macrophage treated with LPS,pert
Male 6-8 week BALB/c trachea,ctrl
Pax_C1,ctrl
gender: male;	individual: patient 5;	treatment: control,ctrl
Cpr-lox_pool 1,ctrl
MDS patient 171,pert
"breast tumor epithelium,2",pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 1 day;	treatment: fresh air, treatment over 1 day, 3x1h exposure per day",pert
S6A Sporadic-frontal,ctrl
BL Day 2 siSC transfected biological rep2,ctrl
Treated with 10uM Motexafin gadolinium for 4 hrs -- replicate #2,pert
protocol: NGN1 overexpression;	cells: Human Neural Stem Cell Line F3,pert
"S1P3-KO-hippocampus, biological rep3 (female)",pert
age: 6 month postnatal;	tissue: striatum;	genotype: SNCA knockout,pert
amygdala no access to cocaine replicate 3,ctrl
MF-14,ctrl
Normal Cervix N17,ctrl
Epididymal adipose GPR120KO ND #720,pert
cell line: D3;	treatment: siPRMT1,pert
siRNA-140_rep3,pert
BM_preTherapy_IIa,pert
"KSR1 Alone, Replicate 1",ctrl
LY2 SRC1-siRNA untreated rep4,pert
MCL_IGHV_MUT (R1626),pert
"65B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Mammary gland R1 16 hr rep1,pert
Metastatic prostate cancer tissue pool WX2,pert
"Control siRNA - 2 days adipocyte differentiation, rep2",ctrl
brain_QH2_14M_rep1,pert
WT_P14_D3_Effector_rep2,ctrl
Human.AZ.CTRL.FCU,ctrl
cell line: MCF-7;	agent: control,ctrl
"patient 032b, cancer, homogenized",pert
3979-1 E2F1 Null,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_6h_1mM_HG-U133A_2_YCHSUP501,pert
Nrl-ko-Gfp 4 weeks replicate 3,pert
B2KO; No Treatment #7,pert
AO 8hr,ctrl
11091 Normal Uninflamed descending colon,ctrl
U87 10 uM Y15 rep1,pert
tissue: gastrointestinal stromal tumor (GIST);	cell type: freshly sorted tumor associated macrophages (TAMs),ctrl
"Dermatomyositis, biological rep4",pert
"Peripheral blood was obtained by venipuncture from healthy adult volunteers. Blood samples from umbilical cords of the placentas of healthy, full-term infants after scheduled caesarean section or vaginal delivery were obtained by puncture of the cord immediately after delivery",pert
Mut-/- rep1,pert
gender: female;	age (years): 46;	evolution time (years): 0;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
A_AN12457_T,pert
GM19238_Kd_STAT6_1,pert
cell type: Primary hepatocytes;	donor: 5;	agent: Wy14643;	time: 6h;	gender: Male;	age: 73 years old,pert
pcdh12-deficient mice rep5,pert
2008 cells_rep2,ctrl
n24,ctrl
"Vehicle treatment, 7 hours (replication 1)",ctrl
Muscle_control_3,ctrl
cell line: MDA-231;	transfection: pCMV-TARBP2,pert
"YPFH cells from M1, Mecp2 null, biological replicate 1",pert
GAS-t7; transgenic gastrocnemus 7 month,pert
Kidney_200 mg/kg VCM ip_mouse #088,pert
IDTC 1,pert
SZ22,pert
pancreas,ctrl
Individual_4213_PP_sample,pert
"TNFa-OMe-P siRNA-C, replicate 3",pert
TMRI AO 2hr,ctrl
KN-smoke-low-5 month+1d-R3,pert
subject: 15A;	cohort: 15;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 28kb;	age (y): 66;	Sex: M;	batch: Batch_5,pert
tissue: blood;	control: 5;	gender: male;	age: 41,ctrl
11A;pretreatment;female;breast tumor; nonresponder,ctrl
"MEKi 4 days, biological rep1",pert
cell type: fibroblast;	disease state: normal;	cell line: CRL-1502;	gender: female;	passage: P9;	clone: 0,ctrl
"Cell line SLM2, mutant status WT, condition Treated with Sorafenib 1",pert
39A;pretreatment;female;breast tumor,ctrl
HUVEC_control_rep3,ctrl
healthy control H09,ctrl
Huh7 cells_Mock Infected 6 hours_ rep3,ctrl
GM19238_Kd_RXRA_2,pert
Caries 2,pert
"brain, cerebellum: KCx12w#1_e1_le1",pert
"CD8 DC Xbp1 KO (DC conditional KO), biological replicate 2",pert
whole blood_100409,ctrl
ATF2 WT-1,ctrl
Cardian muscle Healthy 5 week C5,ctrl
Cervical Cancer C564,pert
WT - Cre Untreated - 0 hrs - repeat 1 - Cy5 - mAdbID:61713,ctrl
cell: MCF-7;	treatment: control siRNA and vehicle (control),ctrl
age: 45;	gender: male;	ejection fraction: 34;	left ventricular end diastolic diameter: 62;	inflammation/PVB19: positive,pert
HepG2_5-aza_rep4,pert
from Lim1 mutant mice E 12.5 renal vesicle,pert
pool of thyroids from 2 months old RET-PTC transgenic mice,pert
Peripheral blood mononuclear cells;	TTF=150min;	Race=Black/African American;	Sex=Male,pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: Trim28CKO,pert
DMN-NF1Hippo15d-1dAv2-s2,pert
"WT liver, biological rep3",ctrl
Strain: C3H/HeN;	Gender: female;	Age: 4 weeks;	Tissue: thymus,pert
"212, MUSCLE, Before",ctrl
multiple sclerosis_7,pert
LSK cells from wild type mouse rep4,ctrl
jejunum_1h_rep2,pert
"650nM MLN4924 after 2hr, replicate 2",pert
Recent-onset T1D_sample12,pert
Itk knockout unstimulated 2,pert
SENS 3 4hr,pert
A_AN06420_F,pert
C57/BL6 C3KO murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock).,ctrl
midbrain_Pink1 knockout_12 weeks_replicate 3,pert
E14wt-vector-2,ctrl
DMSO Control 3,ctrl
Barrett's esophagus (B4),pert
age	24;	gender	female;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	5.2;	hemoglobin (g/dl)	12.5;	platelet count (/nl)	235,ctrl
DIA-n10; normal diaphragm 10 month,ctrl
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days.  . The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
U2OS_control_shRNA_pLenti_3_2007,ctrl
Cerebellum_nontransgenic control S25_3 months_replicate 2,ctrl
WT 0h TPA rep3,ctrl
"ALL_NDS, K50 011409",ctrl
"Donor 2, mock infected 6hr",ctrl
chip number: 17;	transfection plate: 4;	target gene: IRF8;	kd level: 0.64;	rin: 9.7;	transfection date: 2011-10-17,pert
BP patient 101_biological replicate 2,pert
V5-P291,pert
"brain, frontal cortex: Sample53_e1_le1",pert
"Vldlr knockout saline, biological rep1",pert
KO - knock-out Untreated - 0 hrs - repeat 2 - Cy3 - mAdbID:61727,pert
Pancreatic Sample 15-Tumor,pert
patient id: 233;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 79;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0Mx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
LacZ control_4c,ctrl
Substantia nigra PD rep11,pert
sample =XCGD1 treatment=Stimulated time=90 (min),pert
"MelJuSo, no treatment",ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 9.5;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 62;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
FW_4a_BV4281,pert
Hippocampus_Rasgrf1KO_rep2,pert
GLY replicate 1,pert
Bone Marrow Mononuclear Cells;	Unknown Age;	Unknown Gender,ctrl
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: p400,pert
chip number: 12;	transfection plate: 3A;	target gene: NS;	kd level: NA;	rin: 9.5;	transfection date: 2012-03-26,ctrl
patient: 261;	current medication: Asacol 800mg BD;	birth date: 1/7/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/98;	diagnosis date: 1/1/98;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
KJD+doxorubicin_rep2,pert
Klf9WT_jejunum_PND30_5,ctrl
umbilical cord_bpd: 3B,pert
"septic CD4+ splenocytes at 6h, biological replicate 1",pert
12h_RA2,pert
GM19238_Kd_ZBTB38_3,pert
A VIS _B033,pert
"PPARg d4, rep 4",pert
ET 27,pert
GM19238_Kd_YY1_2,pert
Amniocytes_euploid_1563,ctrl
subject id: 45;	infection: DENV;	status: DHF;	tissue: whole blood,pert
"human ES cells line from Cellartis, Sweden; commercial line derived from normal embryos;	Karyotype: X,Y",ctrl
individual: patient17;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"human ES cells line from AZ-VUB laboratory, Belgium; derived from a blastocyst obtained after an in vitro fertilization carried out during a PGD procedure for DM1;	Karyotype: X,X",pert
KU_32T,pert
disease state: Healthy;	cell type: CD4+T;	twin: U,ctrl
S7,pert
mouse cerebellum at P30 wild type 1,ctrl
"Primary, localized, pooled, prostate cancer",pert
"Control ES cells 96hr, replicate 3",ctrl
HeLa_TP090705_29_HG-U133A_2_IMFGN0023,ctrl
01LKT_CTRL,ctrl
array 6 minus E,pert
Psoriatic arthritis PsA 6,pert
"C57BL/6J female number 2, 2 months old, whole ear tissue, untreated control ear",ctrl
KOT 81 bleomycin treated,pert
RNA from HCC_36N,ctrl
A61 NES 142Q TG4	F5/1	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
DNGM-10,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: spleen;	sample name: 2-sp2,pert
patient: 51294;	sample: tumor,pert
normal B lymphocytes (NBL 002),ctrl
NCCIT siTET3 rep2,pert
"E18.5 lung KO2, biological rep2",pert
con-50_A,ctrl
patient: 206;	current medication: Asacol 800mg BD;	birth date: 9/10/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/80;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,pert
"P207 HCT-116, DNMT1 knockout, U0126-treated",pert
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: Wt;	tissue: Skeletal muscle (quadriceps),ctrl
strain: C57BL/6;	gender: male;	genotype/variation: CCRPKO;	treatment: PBS;	tissue: liver,pert
Glucosamine Transcriptome Profiling,pert
"TH cells from LC, Mecp2 null, biological replicate 2",pert
Individual_4688_PP_sample,pert
CML Patient 2 7 days therapy,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 24;	maternal age: n/a,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 0 hrs;	time course: 1,pert
"Strain: Wild-type Polg+/+;	Gender: male;	Age: 9 months old;	Tissue: cochlea;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",ctrl
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 92;	Usage number: 4;	Exposures: 3,pert
128A,ctrl
"SUDHL-1, control repl 2",ctrl
Adult 7d SNI; Biological replicate 6,pert
jzo030-rp1-v5_u74av2-met,pert
ILD Study Number S011,ctrl
cerebellum_wild type_18 month_replicate 3,ctrl
tissue: liver;	treatment: CCl4 and erlotinib 2mg;	strain: A/J,pert
SW480 Vector (2),ctrl
"Rescue pancreas, biological rep2",pert
Primary neonatal keratinocytes_ACTL6a_i_rep2,pert
vehicle treated experiment B (4mM HCL/1% BSA) 24 hours,ctrl
R7_Pseudomonas_wildtype_422,ctrl
Colo-205 DMSO Day 1,ctrl
THRB 15b mutant + vehicle replicate 3,pert
Normal_MS 36A4,ctrl
Cancer 10,pert
A535 Sham 1 day,ctrl
SLE6-TC,pert
"acutely admitted, severely psychotic schizophrenia patient  A11",pert
siRNA Smc3 [M1],pert
LNCaP prostate cancer epithelial cell line,ctrl
heart control 3,ctrl
ploidy: Ts1Cje (segmental trisomy of chromosome 16);	tissue: cerebellum;	developmental stage: P30 postnatal stage,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 37.89315,pert
"Wild type used for GNMT 8 month, replicate 5",ctrl
microdissected breast cancer cells from case 280,pert
TMRI AO 72hr,ctrl
Run5.aUa.010110d.SkMDbt1154D.CEL-DB basal,ctrl
SV129_6h_Wy,pert
"Pineal gland from NeuroD1 cKO mouse at ZT6, biological rep 2",pert
Huntington's disease 820D,pert
SeroTest-1,pert
"control, BA46-27",ctrl
Individual_4952_NN_sample,ctrl
"CL1-0, biological rep1",ctrl
"Patient F, lesional skin",pert
HT29 sensitive cells replicate 1,ctrl
P14 - WTMixA 3,ctrl
cell type: tumor-derived cell line;	ikk2 status: WT,ctrl
hair bulbs only from 9-day-old mice,ctrl
"Gender: Female, Age: 35, BMI: 22, Tissue: luteinized cumulus cells",pert
"nasopharyngeal carcinoma, specimen T21",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 65 years,pert
PB_DON034,ctrl
isoflurane 01,pert
cDNA ak 09+15,pert
LmnaG609G/G609G KI #3. 463,pert
"seminoma specimen, pT1, patient age: 25y; W01 075",pert
strain/background: C57B6SJL;	genotype/variation: wild type;	age: 3 months;	tissue: liver;	disease status: healthy,ctrl
Pt34_Post,pert
V5-P490,pert
cell type: ovarian cancer;	ets-1 expression status (western blot): No detectable Ets-1 protein expression,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_8_33_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339046,ctrl
Control Day7 (335R),ctrl
Lung-sarcoidosis-rep1,pert
IFNb treated,pert
Pt24_Post,pert
liver cells from wildtype 8wk male mouse 8 challenged with vehicle (saline)_10,ctrl
"Keratinocytes untreated control, 24h",ctrl
KO 569 R2,pert
Individual_4934_PN_sample,pert
Patient: B;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_2h_1mM_HG-U133A_2_YCHSUP501,pert
IRS-1 KO (jos0669),pert
b156,ctrl
Sample isolated from loxP flanked Foxp3 CD4+YFP+Ly5.2+ T cells following treatment with HR-MMPCreGFP and six week adoptive transfer.,pert
N18,ctrl
genotype/variation: control;	strain: mlc1f-Cre/ Rpt3-floxed;	gender: female;	age: 6weeks;	tissue: tibialis anterior,ctrl
"Normal, biological rep 1",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 30.79726,pert
4 hour tunicamycin CHOP-/- B,pert
9837_CNTL,ctrl
Gender: male;	Age: 80;	Source: left arm,pert
"Monuron-treated NRK-52E cells at 24h, biological rep 3",pert
MacularDegen-healthy-14aAv2-s2,ctrl
Cell line HeLa_control_expt2,ctrl
male_alcoholic_274,pert
subject: 28;	disease: TD;	muscle: ST;	gender: M;	age: 14.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Squamous cell carcinoma 026,pert
ICM pool 1 (n=2),pert
cell line: Mkn28;	cell type: human gastric tubular adenocarcinoma;	tissue origin: stomach (70 year-old female),ctrl
6h WT Cel.03,ctrl
TF1_antiEvi1siRNA_1,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 59;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: pre-UV,pert
wt_rep3,ctrl
MDS19,pert
Sex: female;	Age at operation: 57 years;	Site: thorax;	Size in cm: 4.9x4x3;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,ctrl
Muscle_Rpt3 null_1,pert
coronary smooth muscle cells control replicate 1,ctrl
"Wild-type HFD 8 weeks, biological rep5",ctrl
3125-lcm,pert
KJD_rep2,ctrl
CD8+_Tcells_severe_asthmatic_7,pert
N51677,ctrl
disease state: endometrioma;	patient: M2,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 5 days with concentration of 0.34 uM (2 x EC50).,pert
Wild type_kidney_2,ctrl
SCD1 -/- liver rep1,pert
MDA-MB-231-pcDNA6 cell culture 1,pert
Muscle-AMPKgamma3-ko-4,pert
Patient no. 3: treated,pert
"214, ADIPOOSE TISSUE, Before",ctrl
Muscle PCOS after pioglitazone 252,pert
whole blood_100652,pert
FmrKO3_blood,pert
3896-1 E2F1 Null,pert
Pancreatic Sample 16-Tumor,pert
cell type: Embryonic stem cells;	genotype: wild type;	culture condition: ESC media,ctrl
CON - R19,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.588;	OD280: 0.789;	Ratio: 1.99;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 127;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
control11,ctrl
VillinCreERT2-_Rep4,ctrl
tri_CH1_hypoxia,pert
LCL Unaffected MZ twin pair 3 (CCN3.1)(TP23),ctrl
Knockout liver DEN-injected 12weeks repl3,pert
PTC BRAF mut 9,pert
Mouse WT mandibular molar [AZN_MolairesWT2],ctrl
"208, ADIPOOSE TISSUE, After",pert
MO32_16,ctrl
E14wt-SRFdM-VP16-1,ctrl
mdx5cv gastroc sample 1,pert
"lymphoblastoid cell line from F16.01, one out of seven of insensitive group, 50*10e6 cells",pert
63A;pretreatment;female;breast tumor,ctrl
8 week old EOM control rep 1,ctrl
"gene expression of CTCF-depleted oocyte, replicate 5",pert
db/db 13-4,ctrl
PU.1 KD HSC 3,pert
Negative Control 1,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 7,pert
F-IIP(UIP)10_Cy3,pert
"Wild type, snap frozen, tibialis anterior muscle, 10 month age animal",ctrl
WT_rep_2,ctrl
SIRT4 WT liver_7577,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK2-1,pert
A HID B_B012,pert
"MCF7 silenced Estrogen receptor, biological rep1",pert
DBA/2JTCE_5 liver sample batch 5,pert
tissue: white blood cells;	age: 15.72;	Sex: male,pert
PGA-MAH-AJ_OVA24h-2aA-s2,pert
HCT 116 control rep3,ctrl
Biceps_Control_8,ctrl
tissue: resected liver tumor;	genotype: minor [rs8099917 TG/GG],pert
Liver Rosi3,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 195min;	race: White;	sex: Male,pert
cell line: HepG2;	cell type: Human hepatocellular liver carcinoma cells;	genotype/variation: wild type;	cell subtype: 10 days old tumor spheroids,ctrl
microdissected breast cancer cells from case 829,ctrl
CD19_selected_B-cells_before_R_rep4,ctrl
BALB/c_PBS Replicate 4,ctrl
"Acute Myeloid Leukemia, sample 41",pert
"S1P2-KO-neocortex, biological rep8 (female)",pert
"SKO-transduced MEFs, Vc-, D4",ctrl
CH1803,pert
Wild type CD8+ unstimulated,ctrl
patient1,pert
J1_minus LIF_rep1,ctrl
Phan_003_WT.saline rep3,ctrl
Pt_5 Acne Lesion,pert
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 2 days osteoblast differentiation,ctrl
"patient 7, baseline",ctrl
"tissue: Cardiac, ventricular tissue;	genotype: caAkt;	age: 8 weeks-old",pert
developmental stage: E14.5;	genotype: Prmt5F/FNes;	genetic background: mixed C57BL/6 X 129S1/SvlmJ;	cell type: NPC;	treatment: Prmt5 depletion,pert
Carbo Day4 (413L),pert
KO - knock-out Untreated - 0 hrs - repeat 1 - Cy5 - mAdbID:61724,pert
Control pool 2 (n=5),ctrl
Kidney_400 mg/kg VCM ip_mouse #106,pert
XBP1s B cells 3,pert
06_PAH,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 98min;	race: White;	sex: Male,ctrl
c57BL/6JTCE liver sample batch 4,pert
"sh2608 (to target ERBB3) T47D cell line, replicate 2",pert
Injured 3 day Rat Retina 3,pert
HMEC_TNF-stimulated experiment 1,pert
HF0822_U133P2,pert
"SPC-c-raf transgenic mice, 14 month old, male, tumor",pert
CLL 361-01 Control,ctrl
Bronchial Epithelial Cells MMA biological 1397G,pert
Mut_P_2,pert
EOM 28 Day mdx rep 2,pert
strain: Swiss;	tissue: Ovary;	agent: Menadione (5uM);	replicate: 3;	age: Post natal day 3-15,pert
cell line: A549;	cell type: human lung cancer;	sirna: FAM60A targeting,pert
subject id: 55;	infection: DENV;	status: DF;	tissue: whole blood,pert
tissue: sciatic nerve;	age: 2 months;	genotype: Bl6 wild type,ctrl
BxPC3-KO4 rep 3,pert
treatment: siYAP RNA #1 transfected;	cell type: Primary cell line,pert
skin.KO.replicate5,pert
MLL_00135,ctrl
Carboplatin 36 hours set 2,pert
BS2011051056,pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate 4,pert
HWC13,ctrl
Human prolactinoma 87,pert
RPE25,pert
pMX-Oct4 and pMX-jhdm1b(jmjc) no vitamin C O+JMJCVc-_1,ctrl
"control_B2, empty vector",ctrl
Healthy chondroctyes 2,ctrl
female JAK2 WT liver sample 147,ctrl
Healthy Pulp 2,ctrl
age: 60;	gender: male;	ejection fraction: 34;	left ventricular end diastolic diameter: 76;	inflammation/PVB19: positive,pert
Sample Group: HD patient; Gender: female; Age: 36; Tissue: lymphocytes (blood); IT15 CAG repeats: 18/51,pert
treatment: si222;	cell line: MCF7-FR,pert
FASSc1 medium only,pert
MCF7 cell line_resveratrol_250mM_biological replicate 1,pert
Discoid Lupus-L4,pert
"normal skeletal muscle, biological rep6",ctrl
No_abuse_8,ctrl
sample: #8;	subject: Control case #3;	brain: T-638;	age: 78;	sex: Male;	region: Inferior olivary nucleus,ctrl
disease state: healthy;	tissue: tibialis posterior;	age at biopsy: 76;	Sex: male;	individual identifier: 1,ctrl
2022T,pert
Psoriasis-Patient-K,pert
age: 58;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 33 yr;	population: white,ctrl
control_0525-1,ctrl
WT_01,ctrl
ALS gray matter 3 Sporadic,pert
HP-23c,ctrl
Thyroid_papillary carcinoma 26,pert
treatment: control;	cell line: NTERA2/D1,ctrl
"51B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
midbrain_wild type_6 weeks_replicate 2,ctrl
ME180 3 hours rep 2,pert
diet_mammary_2,ctrl
MDA-MB-231 cells siRhoGDIbeta transfected rep1 HG-U133A,pert
Rat fatty liver3,pert
S6C Sporadic-hippocampus,ctrl
FVB_MMTV_Wnt1_2495_1L_Rosen,ctrl
optineurin expression-b03,ctrl
"MDA-MB-231/shDBC1, biological rep2",pert
disease state: control;	patient: 3,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_6h_0.4mM_HG-U133A_2_YCHSUP501,pert
Wild type MEFs from 13.5 day embryos,pert
Ring1b_KD_1,pert
Postnatal 12 weeks mutant heart biological rep2,pert
MPM tumor 42,pert
HF0141_U133P2,ctrl
cell line: KYSE140;	cell type: squamous cell carcinoma,pert
T51176,pert
JIA PBMC Post treatment A235_L014(2),pert
J_LS_Wk1,pert
Gene expression profiles of Lkb1 KO #5 HSCs,pert
KN-smoke-med-1 day-R3,pert
OA5,ctrl
WT HPC Veh 2,ctrl
"expression at 4hr, bio rep2",pert
2 hr KLF4 Time Course Induced,pert
cell type: Primary hepatocytes;	donor: 2;	agent: Wy14643;	time: 6h;	gender: Male;	age: 44 years old,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous saline challenge""",ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: kidney;	age: 12 weeks,ctrl
uterus_veh_PRKO_40hrs_rep2,pert
"Neuroretina 8-week lean non-diabetic, Biological replica_2",ctrl
neocortex-30 months of age-control diet-biological replicate3,ctrl
Normal PBMC Sample 9,ctrl
cell line: Mc3T3-E1;	cell type: osteoblastic cells,ctrl
SCC10,pert
lymphocytes_ctl_F_68y,ctrl
T1_HypM,pert
chip number: 13;	transfection plate: 5;	target gene: STAT2;	kd level: 0.78;	rin: 8.9;	transfection date: 2011-10-17,pert
E2 48hr,pert
N10B Normal-cerebellum,ctrl
lesion_midUV_patient3,pert
CD34+ cells with fenretinide treatment from CML35,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 86min;	race: White;	sex: Female,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 97min;	race: White;	sex: Female,pert
"Setd2 knockout mESCs, biological rep2",pert
whole blood_100354,ctrl
"fibroblast, control subject NM9 rep 1",ctrl
Nerve_Control_Rosi_714,ctrl
Nrl ko 2 mon replicate 1,pert
28A,pert
"non-AD_FC, biological rep14",ctrl
WT 541 L3,ctrl
L1 062502 Rosi1,pert
Bronchial Epithelial Cells MMA biological 1751Y,pert
Untreated Control 12weeks AffyGC RMA rep5,ctrl
cadmium_08hr_rep2,pert
BALB/cByJ Vehicle liver sample batch 3,ctrl
minor non-tumor6,pert
"Gender: Female, Age: 32, BMI: 30, Tissue: luteinized cumulus cells",ctrl
MDS patient 133,pert
untreated_24hr_rep1,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.381;	OD280: 0.716;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 222;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
ab061a IM,pert
genotype/variation: Vax2-/-;	age: E12.5;	tissue: whole eye,pert
"Acute Myeloid Leukemia, sample 70",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.843;	OD280: 0.95;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 52;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
b158,ctrl
"HEK293E cells, scrambled siRNA, replicate 2",ctrl
Satb1-/- clone 2-1,pert
"healthy breast 1, biological rep. 1",ctrl
pSuper vector control 3,ctrl
astrocytes from second trimester human fetal brains,pert
V5-P176,pert
100uM H2O2,pert
Kidney_Biopsy_Liver_Disease_1,pert
b86+,pert
strain: C57BL/6;	tissue: visceral_fat;	gender: female;	age: 8week,pert
sample =XCGD3 treatment=Control time=90 (min),pert
treatment group: air;	tissue: left lung lobe;	gender: Male;	strain: C3H/ HeOuJ,ctrl
HA98-146B,pert
m1-WT3,ctrl
V5-P144,ctrl
E14 - WTMixB 3,ctrl
Disease_status: Bipolar disorder;	Age (years): 35;	Gender: Female;	Age of onset (years): 21;	Duration of illness (years): 14;	Brain pH: 6.10;	Post mortem interval (hours): 17;	Side of brain: Right;	Fluphenazine mg. Equivalents: 3000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 48h, biological rep4",pert
LT340 wild-type untreated,ctrl
EP49_adipose_control,ctrl
Z5_Cont_TA,pert
HCC PBMC Sample 8,pert
control female replicate 2,ctrl
Tendon_non-lesional_rep4,ctrl
wild type MEF time 6 replicate 1,ctrl
Ischemic cardiomyopathy_G1,pert
18 olanzapine,pert
human_hepatocyte_400uM_Trovafloxacin_donorB_24hr_prep1,pert
RENT1-2,pert
FHCRCAML16908,pert
genetic background strain: C57BLKS/J;	tissue: Neuroretina;	age: 8-week old;	genotype: db/db;	phenotype: diabetic,pert
P7C Progranulin-hippocampus,pert
Syracuse High Avoidance (SHA) learning rats 3,ctrl
32n,ctrl
Basal IFE epidermal stem cells from KO mice 3,pert
"Immortalized MEFs WA, v-src expression retroviral vector infected, rep1",pert
Endothelial cells 3,ctrl
Subject #8034-Preinfection,pert
05_NOR,ctrl
Mouse WT mandibular molar [AZN_MolairesWT],ctrl
Colonic_mucosa_inflammation_26,pert
"Lesion Skin, LS-28",pert
coc-14_B,pert
"P30_C-DGCR8 KO cones, replicate 2 [array]",pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 1,ctrl
NESG1-negative C6-5-8F NPC cells rep2,ctrl
"Vehicle treated, doxycycline treated; biological replicate 1",pert
db/db 12-2,pert
6-KO,pert
Healthy chondrocytes 1,ctrl
RNA from HCC_18T,pert
Healthy individual of twinpair #2,ctrl
MDS patient 18,pert
"seminoma specimen, pT1, patient age: 36y",pert
B6_Male_Control_rep3,ctrl
Wild-type_macrophages_4h,ctrl
17A,pert
"BMMs, untreated control, ko, Replicate 3",pert
patient: 219;	current medication: Sulphasalazine 1.2g Colifoam;	birth date: 1/5/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/81;	diagnosis date: 1/1/81;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/7/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"mouse aorta cross strain comparison, C3H_T08_HF_03",pert
Postnatal 12 weeks control heart biological rep1,ctrl
"expression at 4hr, bio rep3",pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 2,pert
sampleID: SAM630144;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
strain: Myd88 KO;	gender: n/a;	weight: 25-30g;	age: 4 month;	tissue: whole trachea,pert
CD34+ hemopoietic progenitors purified from bone marrow of healthy controls,ctrl
SARRC-0248-01-A,pert
RA_D,pert
patient: 13;	disease state: hypertension;	tissue: Atheroma plaque,pert
INSENS 3 0hr,ctrl
12473 UC Inflamed sigmoid colon,pert
tissue: inner ear;	genotype/variation: Dlx5-null;	age: E10,pert
age: 56;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
11397 Normal Uninflamed descending colon,ctrl
Sample Group: control; Gender: male; Age: 60; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
Injured 4h Rat Retina,pert
Cell line MDA-MB-231_c-myc KD_expt2,pert
"breast tumor epithelium,15",pert
Grhl2 downregulation in MLE 15 cells 1,pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 46;	donor: 32;	disease state: Lesional,pert
scan batch: Batch 1;	group: control;	subject age: 8;	paternal age: 29;	maternal age: 27,ctrl
"AALE-Vector uninfected, biological rep3",ctrl
"brain, brainstem: PB5_e1_le1",pert
major non-tumor8,ctrl
tissue: brain;	genotype: WT;	genetic background: C57BL/6,ctrl
DMN-NF1Hippo28d-1aAv2-s2,pert
Surgical Sham Control Tail Skin 3,ctrl
P16_WT_pancreas_rep1,ctrl
Muscle-AMPKgamma3-wt-10,ctrl
striatum wild type 6 month replicate 1,ctrl
Placenta_PE(EO)1,pert
KU_25N,ctrl
EOM 14 Day mdx rep 2,pert
TAp63 alpha 24h without induction s2,ctrl
c48 is a clonal Nurr1 stably-expressing stem cell line,ctrl
CTIP 20 #2,pert
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/85;	differentiation status: undifferentiated;	cell line: Q91,pert
J_LS_Time0,ctrl
Tmod3 KO-2,pert
Pooled normal myocardium sold commercially (N),ctrl
"schizophrenia, BA46-87",pert
"patient 028b, normal, homogenized",ctrl
sirna: NR2F2 knockdown;	cell line: ES2;	cell type: Ovarian cancer cell line,pert
Series 3; old; 3 days after fracture,pert
Kidney_200 mg/kg VCM ip_mouse #089,pert
Dexamethasone 2,pert
"metastasis: metastatic recurrence;	Stage: 2b;	tissue: cancer, homogenized",pert
HeLa_06_21_04 TP-11,pert
"S1P2-KO-hippocampus, biological rep6 (female)",pert
3-ONS76_c,pert
patient: 265;	current medication: Pentaza 500mg TDS;	birth date: 8/17/71;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/5/04;	diagnosis date: 3/22/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/19/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/19/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
midbrain_wild type_18 month_replicate 1,ctrl
01UP5_ERA,pert
"brain, hippocampus: KA-24h-P15-II_e1_le1",pert
U-87MG-V22 set 1,ctrl
CLL5-CD8,pert
strain: C57BL6J;	genotype: H3f3b -/-;	age: E12.5;	tissue: 1 of 2 mouse testes,pert
"Control #3, Untreated",ctrl
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His-ZNF217 plasmid,ctrl
strain: C57Bl/6;	genotype: Myc(F/F);	cell type: CD8+ T cells,ctrl
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep2,pert
T40741,pert
heart_QH2_6M_rep2,pert
umbilical cord_nobpd: 8F,ctrl
C57BL/6J_Islet_rep1,ctrl
erStress_twins_AA_1744twin2_DMSO_4h,ctrl
GC13_skin_5dpn_3,pert
Patient identifyier: R;	Sex: male;	Age of patient: 56 years;	Duration of psoriasis: 16 years;	Body surface area: 30 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 27,ctrl
APOE_KO_RAGE_KO_NODM_9W_14,pert
"normal nasopharyngeal tissue, specimen N9",ctrl
Human Acute HIV Sample A189-CD8+ T cells,pert
HeyA8-(2),ctrl
NB60 U133p2,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.515;	OD280: 0.791;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 232;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"cell line: 5850, control, skin fibroblasts;	gender: female;	age at biopsy: 3 years",ctrl
"Immortalized MEFs WC, empty retroviral vector infected, rep2",ctrl
Md02h033,pert
5850_CNTL,ctrl
48A;pretreatment;female;breast tumor,ctrl
cell line: HepG2;	genotype/variation: HNF4a knockdown,ctrl
strain: CD-1;	tissue: lung;	age: 20 week;	genotype: dominant negative CREB1 driven by cardiomyocyte-specific myosin heavy chain-alpha promoter,pert
3716-lcm,pert
HeLa Cells,pert
Control (C272),ctrl
PBMC from T cell LGL leukemia patient #116 (TLGL116),pert
Patient: A;	Time: 0;	Group: responder;	Condition: lesional,ctrl
"Normal cervix epithelium, Age 64",ctrl
9-cis-retinoic-acid_Lung_4,pert
Liver_untreated_HESKOL_rep1,pert
siIPMK no DNA Damage experiment 2,pert
cell line: HEK293T;	transfection: si-control;	induction agent: CM;	induction time: 7 hours,ctrl
"brain, hippocampus: Aldh5a1-/- #3389 Hippo_e1_le1",pert
strain: myd88 KO;	weight: 25-30g;	age: 4 month;	gender: n/a;	tissue: whole trachea,pert
genotype/variation: WT;	strain: C57BL6/N,ctrl
Ischemic cardiomyopathy_G60,pert
Control male 3,ctrl
11376 Normal Uninflamed ascending colon,ctrl
Gastrocnemius Muscle_mdx_rep1,pert
CML Patient 1 before therapy,ctrl
KO - 5 mo - repeat 5 - Cy5 - mAdbID:74140,pert
S46 WT2	F5/8	S46	wild type	Mouse	3.5 months	Cerebellum	Female,ctrl
cell type: peripheral blood mononuclear cell (PBMC);	disease status: pancreatic cancer,pert
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14454;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
breast adenocarcinoma from 69yr old female caucasian,ctrl
cell line: MCF-7 breast cancer cell line;	agent: SFM (control);	time: 3hr,ctrl
race: caucasian;	age (years): 75-80;	stage: n/a;	grade: n/a;	histology: weakly proliferative w/cystic changes,ctrl
"RPMI8226_shKLF2#1, replicate2",pert
ab156 IM,pert
C598,pert
061K3_CTRL,ctrl
HF0920_U133P2,pert
cell culture: grade VI GBM short term cultures,ctrl
A_AN12457_F,pert
UnInfected-1,ctrl
PTEN_3,pert
Chronic plaque 2 (CP2),pert
PsOEt-17-Week 2,pert
Healthy individual of twinpair #6,ctrl
BJ-fib_1,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATR-3,pert
Subject 6 / lung subsegment instillated by LPS,pert
liver 0.1% quercetin diet rep3,pert
"control, BA46-43",ctrl
01N27_Oligo,pert
"Spi-21, biological rep 3",pert
Kidney_colistin_2,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 359;	age-at-biopsy-years: 48,pert
coronary smooth muscle cells nebivolol replicate 1,pert
"Cell type: neuronal, age:49, gender:female, diagnostic group: control, PMI:45h",ctrl
"brain, cochlea: [5] SAmple #5_le1",pert
4_day_old_wildtype_mouse_rep3,ctrl
V5-P604,pert
background strain: C57Bl6;	genotype/variation: WT;	age: 9 weeks old;	tissue: whole heart ventricle,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 218,pert
female_control_299,ctrl
agent: ConA;	time point: 1 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
Monocyte control rep 3,ctrl
"MLD, biallelic AML MLL_00261",pert
"vehicle treatment, 72 hour time point, biological replicate 2",ctrl
E18.5 top2b-/- brain,pert
NB58 U133p2,ctrl
TB 6,pert
"dy/dy dystrophic diaphragm 3, 8 week",pert
Normal-ERα-positive breast cancer 29,ctrl
GIST Pre Treatment Biopsy 47,ctrl
homozygot FH P270wh,pert
Mouse: strain C57,ctrl
db/db 14-4,ctrl
Bronchial Epithelial Cells SA biological 1744B,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 147;	time: 0;	batch: 2,ctrl
cell line: prostate cancer cell line PC-3;	telomere status: Short;	exogenous htert: absent,ctrl
28m1,ctrl
Normal cortex of patient 26,ctrl
NE-rep4,ctrl
BL Day 2 siMut12 transfected biological rep4,pert
"metastasis: none;	Stage: 3c;	tissue: cancer, homogenized",pert
HUVEC/NmenMC58_pilD_6h_rep1_1103,pert
MSC_VUB01_1,ctrl
strain/background: mixed B6/129/FVB;	genotype: MMTV-Cre;Runx1+/+;R26Y;	gender: female;	developmental stage: adult virgin;	cell type: mammary gland luminal epithelial cells,ctrl
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: None,ctrl
sample =XCGD6 treatment=Stimulated time=360 (min),pert
"Chromium 10 µM, biological rep3",pert
"patient: 203;	current medication: Asacol 800mg BD, Simvastatin;	birth date: 1/10/35;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/92;	diagnosis date: 3/23/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/1/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 14;	crp: 0;	hb: 147;	wcc: 6;	neutrophils: 4;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: HISTOLOGICAL;	diagnosis recto sigmoid: HISTOLOGICAL;	diagnosis splen flex: HISTOLOGICAL;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/50;	smoking stop date: 1/1/57;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",pert
"age at diagnosis: 53;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 16;	dfs-event: 0;	distant metastasis: 0",pert
patient: 3;	disease state: hypertension;	tissue: Atheroma plaque,pert
n8t0h,pert
"age at diagnosis: 42;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1bi;	er: 0;	pgr: NA;	dfs-month: 15;	dfs-event: 1;	distant metastasis: NA",pert
U-87MG-V22 set 2,ctrl
HLA risk: Low;	Height: 181.1 cm;	Weight: 76 kg;	BMI: 23.2;	Age: 16.82 years;	Gender: Male;	Race: White;	Glucose: 75 mg/dl;	HbA1c: NA,ctrl
Mouse old brain w/ a-tocopherol aT-Br-5,pert
"treatment: diclofenac;	batch: 4;	donor: 30;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
background mouse strain: C57B16;	genotype: WT;	treatment: Vehicle,ctrl
0151-01-C,ctrl
Leg 56 Day control rep 3,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.946;	OD280: 0.992;	Ratio: 1.92;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 129;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
jzo021-rp1-v5-u74av2-met,ctrl
"PPARg d4, rep 1",pert
sample B 18.5 homo,pert
strain: C57/BL6;129Ola mixed;	genotype/variation: Insm1 +/-;	developmental stage: embryo;	age: E17.5;	tissue: pituitary gland,ctrl
06SAGEA2,pert
U133A_G2,ctrl
01LR0_PolyRF+,pert
strain background: C57BL/6;	genotype/variation: Runx1-knockout mice (Runx1floxed/floxedMxCre+/-);	tissue: bone marrow;	cell type: sorted c-Kit+/Sca-1+/Lin-/IL7Ra- (KSL) cells;	experimental procedure: 3 months after poly IC treatment,pert
Wild-type CS_12_29_2_WT_2,ctrl
A509 Sham 1 day,ctrl
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 2,pert
"Autism no regression, Male",pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #2.,pert
gender: Female;	age (y): N/A;	tissue: normal pituitary,ctrl
"brain, brainstem: LB6_e1_le1",pert
MDS patient 7,pert
"Patient 19, Atheroma plaque",pert
PLT-n7; normal plantaris 7 month,ctrl
MIY_day_3-2,ctrl
"MCF-10A cells, overexpression vector control, biological rep2",ctrl
MCI-010,ctrl
V5-P503,pert
Liver_nash_no.3,ctrl
"Amoxicillin treated Distal, Small Intestine 1 17 days old",pert
U-87MG-V22 set 4,ctrl
MPM tumor 39,pert
"Adult mouse, C57black background, left ventricle of heart",ctrl
WT_PMΦ_rep3,ctrl
SLE patient,pert
patient: 116;	current medication: Clomiprimine;	birth date: 1/19/56;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: FH Colon cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
ve_NY41,pert
thyroid_normal_1,ctrl
"Trained diabetic mice, time point 3 week",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 43.59178,pert
Liver antiangiogenic-treatment rep2,pert
strain background: CD1;	genotype/variation: Raldh2 null mutant; Raldh2 -/-;	tissue: embryonic brain;	tissue region: posterior;	developmental stage: 4 somite stage,pert
"H69 tumor untreated, biological rep3",ctrl
23d wt11,ctrl
Normal_MS 36C7,ctrl
WT-control-3 (DFW),ctrl
"granulocyte, patient. Mtx rep10",pert
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 2,ctrl
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 21;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"human nonfailing LV myocardium, NonFailing8",ctrl
GB 7 63A NO LPA,ctrl
sample =Healthy3 treatment=Control time=90 (min),ctrl
patient: 244;	current medication: Seratide Bricanyl BFZ;	birth date: 1/29/55;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/16/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 15-24;	other illnesses: Asthma Hypertension;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: overexpression control,pert
Normal Chip#1,ctrl
CRG,pert
Nrl-ko-Gfp P6 replicate 3,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/FGFR1;	biological replicate: 3,pert
RAW LPS 2,pert
siRNA Stau1 Duplicate 2,pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 4",ctrl
gender: male;	strain: SV129;	tissue: heart;	genotype: wild-type;	age: 32 weeks,pert
con_B043,ctrl
B2KO; No Treatment #4,pert
P0 - WTMixB 2,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 219,pert
"ZR-75-1, 12h, 3.0mM 5FU B",pert
BCells_WildType_day2_REP1,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 32, stage IIIB, HPV 16",pert
rtTA-Dmrt5_d9_+Dox_rep_2,pert
V5-P364,pert
disease state: healthy control;	tissue: epidermis;	age: 40;	gender: male;	treatment: untreated;	time: control,ctrl
"IN1472 siPD treated, Biological replicate2",pert
OC1-KO embryo 1,pert
genotype: wild type;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: LPS;	tissue: liver,ctrl
"Cerebral Palsy, Semitendinosus, Patient Replicate 6",pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 24h ID290,pert
Pt32_Post,pert
"control, BA46-33",ctrl
PsOEt-11-Week 2,pert
WT_Mstn_1,ctrl
S010_Scz_M_82,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 7",pert
endothelial_rep2,pert
"MaF pre-iPSC9P2, Vc+, D5",pert
NOD_T1,pert
tissue: white blood cells;	age: 18.57;	Sex: female,pert
"Transgenic, snap frozen, diaphragm muscle, 7month age animal",pert
WT / Reference_13425630,ctrl
Mnk_3142-T-B,ctrl
"A549, +TNFα, Claudin 1 siRNA, rep3",pert
12476 UC Inflamed sigmoid colon,pert
"Pten null, biological rep3",pert
95 year old male,pert
"male;	CABG patient, atrial tissue;	baseline before CABG surgery",ctrl
Sample 4 Posterior  +/+,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: tumor;	sample name: 5-tu2,pert
chip number: 23;	transfection plate: 4;	target gene: RDBP;	kd level: 0.79;	rin: 9.5;	transfection date: 2011-10-17,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.77534,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 33 yr;	population: white;	dsm-iv: 296.53;	age of onset: 15 yr,pert
Subject 10_t=30days_placebo,ctrl
08SE1181,pert
healthy control H12,ctrl
Discoid Lupus-L2,pert
cell line: JCRB0033 [CEM];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
A61 NES 142Q TG2	F6/22	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
Seguin_IDR_BrownNorway_Liver_treated8,pert
shRNA4-1-noDox-rep2,ctrl
SCC-2_siScramble_rep.1,ctrl
Mening SWB WB SW 1a,pert
Run1.a10a.000606jd.2.SkMNor912.CEL-IS stimulate,pert
Muscle KO Adult 0713,pert
POAG-TM-A,pert
patient id: 324;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 60;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
"C57BL/6J female number 1, untreated control ear (#1_Wt-C-3)",ctrl
"liver_ABCA1-TG, biological replicate 3",pert
"Vehicle treated, DAY 6, biological rep.1, MOLM-13 cells",ctrl
"fibroblast, MFS subject FB1234 rep 1",pert
Prostate Cancer_MS 36A1,pert
Arid3a KD replicate 2,pert
Carboplatin treated cells Rep2,pert
456MM,pert
"E2A CLP LY6D-, biological rep3",pert
CD-76-un,pert
individual: Control1;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A13",pert
P7 Patient None,pert
G_LS_Time0,ctrl
SCC9,pert
"53B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
C2C12 myotubes 10uM H2O2 rep 2,pert
patient: 40836;	sample: normal,ctrl
disease group: normal;	cell type: chondrocytes;	cell culture: monolayer,ctrl
Normal cortex of patient T127,ctrl
gender: male;	age (years): 39;	evolution time (years): 3;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
NonIR-KO_Rep1,pert
H24 Ctrl 24h 4,ctrl
background strain: Derived from BL6 blastcysts.;	cell line: WD44;	cell type: ES cell;	passage: 14-18,pert
SCC-40_siScramble_rep.1,ctrl
Patient no. 19: control,ctrl
U2OS_PRC_shRNA1_pLenti_1_2007,pert
PGA-RMM-Ctr-4aA-s2,ctrl
Cdh1_cKO_1,pert
"schizophrenia, BA46-78",pert
PBMC_S2,pert
OVCAR-8-(2),ctrl
"PC-3 Luteolin, biological rep1 [mRNA]",pert
Muscle KO Adult 01271,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.279;	Ratio: 2.12,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 62.05479,pert
PsOEt-19-Week 1,pert
HLA risk: High;	Height: 145.1 cm;	Weight: 32.1 kg;	BMI: 15.2;	Age: 10.16 years;	Gender: Female;	Race: White;	Glucose: 188 mg/dl;	HbA1c: 6.1%,pert
"control, BA46-60",ctrl
MO32_9,pert
"WT cells, replicate 1",ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 288;	age-at-biopsy-years: 52,ctrl
age: 7dpp;	genotype/variation: wild type;	tissue: testis,ctrl
gender: Male;	tissue: Tendon;Biceps;	age: 46;	donor: 29;	disease state: Non-lesional,ctrl
n2a-Pou3f3-kd-3,pert
age_years: 35;	sex: M;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
Wild Type B cells Spleen 3,ctrl
"Fibroblasts, baseline, time 0, patient 1, rep 1",ctrl
remitted schizophrenia patient  S02,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 140min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 311,pert
XBP1s Tumor 4,pert
"BALB/c BMDM infected with WA(pTTS, pP60)",pert
"Hereditary gingival fibromatosis (HGF) is a benign disorder manifested by a slowly progressive enlargement of the oral gingival tissues, which results in the teeth being partially or totally engulfed by keratinized gingiva.Affected gingiva tissues were removed from HGF volunteers during surgical procedure.",pert
"human failing LV myocardium, Idiopathic35",pert
cell line: HL-60;	replicate: Replicate2;	treatment: shSYK_1,pert
1116-03-A,pert
HCC011T,pert
Sample from retroviral MSCV-GFP control infected cyclin D1 knockout 3T3 cells (line 7).,pert
FR-si221-3,pert
tissue: embryonic fibroblasts,ctrl
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 40;	maternal age: 39,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 5,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 3,ctrl
Bronchial Epithelial Cells control biological 1619Y,ctrl
Mening SWB WB NP 1a,pert
"Patient 9, Atheroma plaque",pert
"Wild type GM-BMMs, biological rep3",ctrl
"siPRMT1 ES, biological rep2",pert
54_129_KO,pert
gender: Female;	age: 67;	post-mortem delay: 6h;	ph: 6.7,ctrl
"ID: MLL_00230;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
"WT mouse skin treated once with TPA and collected 24 hr later, replicate 2",ctrl
S5A Sporadic-frontal,ctrl
heart knock out replicate1,ctrl
CON21,ctrl
"Kidney from control rats, biological rep 3",ctrl
Individual_4990_NN_sample,ctrl
Healthy 1 week C1,ctrl
disease state: healthy control;	cell type: Peripheral blood mononuclear cells,ctrl
"mouse aorta cross strain comparison, C3H_T40_HF_02",pert
gender: male;	strain: SV129;	tissue: heart;	genotype: wild-type;	age: 32 weeks,ctrl
chip number: 11;	transfection plate: 3B;	target gene: KLF13;	kd level: 0.79;	rin: 9.6;	transfection date: 2012-03-26,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 147;	time: 0;	batch: 4,ctrl
"Normal subject (42 year old caucasian male, SAK_1265954246)",ctrl
Control 820B,ctrl
colonic_mucosa_inflamation_95,pert
Healthy donor_biological replicate3,ctrl
P8 wt2,ctrl
pediatric AML S19,pert
"brain, Entorhinal Cortex: 97-01 normal_e1_le1",ctrl
cell line: prostate cancer cell line DU145;	genotype/variation: negative control siRNA,ctrl
CON_B,ctrl
neocortex-30 months of age-control diet-biological replicate4,ctrl
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 1,ctrl
"Sciatic nerve, acrylamide treated, biological rep2",pert
"Peripheral blood, normal control [N71]",ctrl
CTRL_esiGFP_rep2,ctrl
J1_plus LIF_rep2,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: HIGH;	genome/variation: KIT mutation detected,pert
Normal bladder 9-99,ctrl
liver wild type replicate1,ctrl
"Wild-type-hippocampus, biological rep7 (female)",ctrl
GSK3B shRNA replicate 1,pert
subject: 38;	disease: CP;	muscle: GR;	gender: M;	age: 9.4;	gmfcs: 2;	popliteal angle: 100,pert
"Control, high-fat diet, rep1",ctrl
cell line: MCF7;	condition: siRNA Med12 + Estrogen,pert
batch: B;	knock-in: Twist-DQD;	cell line: MycCap prostate cancer cells,pert
thyroid_normal_7,ctrl
Dilated cardiomyopathy_G24,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 24h ID288,pert
15L,pert
"Exp A, Animal #255, 200mg/kg D-Serine",pert
"Peripheral blood, normal control [N70]",ctrl
CHB PBMC_sample 6,pert
1212-6heart_Control,ctrl
Patient no. 10: treated,pert
C_AN01410_F,ctrl
CDF1-c (196msn),ctrl
"Control, biological rep11",ctrl
heart_QH2_6M_rep1,pert
"TNFa siRNA-A, replicate 2",pert
normal adjacent esophageal tissue from patient E1542,ctrl
"ShamC-21, biological rep 6",ctrl
MDA-MB-231 control clone #1,ctrl
New El-Ashry 007.CEL,ctrl
"Dicer lox/lox control, biological rep3",ctrl
"brain, cerebellum: RNA#10S_le1",ctrl
Gata1WT25+#2,ctrl
"SFM control cells (24hr), biological rep3",ctrl
HCT116_shBgal-rep3,ctrl
Normal PBMC Sample 10,ctrl
"Healthy volunteer, Control_11694",ctrl
SLE4,pert
E10.5 Vax2-/- 2,pert
histology: chronic plaque;	disease state: multiple sclerosis after inflammation has subsided-late stage;	tissue: multiple sclerosis brain lesion,pert
MCF7 cells treated with 2uM Sangivamycin for 24 hours Array 1,pert
"human failing LV myocardium, Idiopathic81",pert
FVB_MMTV_Wnt1_iFGFR2_2960_5L_ROSEN,pert
genotype/variation: PtenL/L (isogenic wildtype);	cell type: embryonic fibroblasts;	time: control;	genetic background: C57BL\6,ctrl
"WT mouse skin treated once with TPA and collected 24 hr later, replicate 3",ctrl
wild type MEF time 0 replicate 4,ctrl
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 30,ctrl
RTX10 T12,pert
K562_1R-Chl_24hrs_rep2,pert
db/db 14-5,ctrl
V5-P307,pert
"runx1-null luminal mammary epithelial cells, MD640",pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 25;	maternal age: 27,ctrl
"breast, post AF treatment (H16_1717)",pert
S020_Scz_F_82,pert
OVCA433+(3),pert
multiple sclerosis_5,pert
hnf4KD_H9_d20_hepatic differentiated_3,pert
lymphocytes_HD_M_62y,pert
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 27;	maternal age: 24,pert
VillinCreERT2+_Brg1fl/fl_Rep1,pert
Old Control;	female,ctrl
Ad+TOT replicate2,pert
liver 1.0% quercetin diet rep2,pert
lesion_postUV_patient1,pert
"cell line: hgps-fib_2: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository",pert
392MM,pert
T183 U133p2,pert
EA_Case6_CD20,pert
3DKD_SerumStarved_rep2,pert
Normal-ERα-positive breast cancer 62,ctrl
Squamous cell carcinoma 014,pert
gender: Female;	age: 82;	post-mortem delay: 8.5h;	ph: 5.9,pert
Subject #8038-Preinfection,pert
"120, ADIPOOSE TISSUE, Before",ctrl
heart wild type replicate3,ctrl
"HSCs from male mice treated with E2, replicate 3",pert
NK_cell_pool_melanoma_M09+M10,pert
Monocyte-RCC-untreated-1,pert
"0mg/kg/day PFOA, Rep 3, Block 2 lung (low dose)",ctrl
"gender: Female;	age: 46;	post-mortem delay: 4h;	ph: 6.6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Control (shControl-2),ctrl
Muscle KO Aged 1215,pert
"Undifferentiated C2C12 myoblasts, passage #11;	",pert
Cochlea_WT_9mo_1,ctrl
erStress_twins_AA_1720twin2_500nM_thapsigargin_4h,pert
"MCF-7 cells-40mM g-T3, biological rep 4",pert
Astrocytoma_8,pert
"fibroblast, control subject NF8 rep 2",ctrl
BP patient 60_biological replicate 2,pert
"213, MUSCLE, Before",ctrl
224 Day 3 siMut10 transfected biological rep2,pert
strain background: mixed (SV 129/C57BL/6);	genotype/variation: wild type (Rnh1 +/+);	age: embryonic day E9.5;	tissue: yolk sac,ctrl
V5-P285,pert
Parkinson's disease sample x185,pert
Ad+TOT replicate1,pert
Cultured human trabecular meshwork cells (passage 3) obtained from a donor with no known history of glaucoma. 25y/female/caucasian. Cause of death: pneumonia.,ctrl
"DCIS 3, biological rep. 3",pert
Insm1 control #5,ctrl
microdissected breast cancer cells from case 1370,ctrl
Healthy control c7,ctrl
Diaphragm 56 Day mdx rep 1,pert
RL_siRNA_LIF1h_rep3,pert
SIRT1 LKO liver_4 pm_rep1,pert
No_abuse_5,ctrl
"NTera-2 cells SOX2 siRNA, biological replicate 3",pert
"D425-control, t=24",ctrl
"Normal Skin, Normal-14",ctrl
Sample Group: HD patient; Gender: female; Age: 41; Tissue: lymphocytes (blood); IT15 CAG repeats: 24/49,pert
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14502;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
NK_cell_pool_healthy_H07+H08,ctrl
"wild type CTL, biological replicate 1",ctrl
92.1 - siBAP1 - replicate3,pert
"Pool of four samples (n=4);;	gender: three female/one male;;	age: 19/57/40/70 years old;;	cells: CD3+ T cells, peripheral blood;;	disease: (severe) aplastic anemia (SAA)",pert
C57_LF_2,ctrl
age: 21 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),pert
AZ-521_uninduced_18h_rep1,ctrl
subject: 1;	disease: TD;	muscle: ST;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
N28,ctrl
"mouse liver sample, KO strain, biological replicate 2",pert
patient: 220;	current medication: Asacol 800mg BFZ 2.5mg Metformin Simvastatin;	birth date: 6/28/48;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/10/95;	diagnosis date: 3/25/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/10/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/10/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/90;	smoking amount: 5-14;	other illnesses: Type 2 DM.;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
Subject #8011-2d Postinfection,ctrl
G_LS_Wk4,pert
PGA-MAH-HeJAir-1aAv2-s1,pert
Control bone marrow - Biological Replicate 2 - Technical Replicate 1,ctrl
brain_DLPFC_bipolar C_mr545,pert
"spinal cord, ventral spinal cord: EP141/L - G93R(Roth)/e14-mutant hSOD1",pert
Vit A deficient 2b,pert
MDS7,pert
cell type: Follicular (FO) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: WT,ctrl
"SUDHL-1, Treated by ALK inhibitor repl 2",pert
E_Kin_1,pert
tissue: lung adenocarcinoma;	cell line: A549;	transfection: pcDNA-NME2-MYC,pert
retina_DBA_544R_8mo_rep2,pert
abl control at VEH rep 0,ctrl
Control_1_intestine_30days,ctrl
H12_SS10_01Nov07,pert
"spleen marginal zone B in IRF8 conditional KO, biological rep4",pert
subject id: 32;	infection: DENV;	status: DHF;	tissue: whole blood,pert
"Nrl-ko, purified Gfp+ photoreceptor cell",ctrl
"control embryonic stem cells, biological replicate 6",ctrl
FACS-purified B cells_wildtype_non-infected_rep1,ctrl
Leptin treated mouse gallbladder 8,ctrl
diet_Lung_3,ctrl
ET 6,pert
"CCM3 shRNA cells passage 11, rep 5",pert
BATF_KO_P14_D3_Effector_rep2,pert
strain/background: mixed B6/129/FVB;	genotype: MMTV-Cre;Runx1L/L;R26Y;	gender: female;	developmental stage: adult virgin;	cell type: mammary gland luminal epithelial cells,pert
"15B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"nasopharyngeal carcinoma, specimen T25",pert
jejunum_control_2,ctrl
Hippocampus 1978 15 month Old,pert
ESO1644_muscle_mutation,pert
"Testes, 20 hours after cadmium treatment, biological rep 2",pert
gender: female;	batch: 1;	age (years): 26;	patient id: Control_3;	fev1 (% predicted): 105;	fvc (% predicted): 115;	medication: None;	cell type: CD4+ T-cells,ctrl
12A;pretreatment;female;breast tumor; responder,ctrl
"siSCR neuron, biological rep3",ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 38;	maternal age: 37,pert
Control A549 cell Replicate1,ctrl
EA_Case16_CD20,pert
brain_DLPFC_bipolar C_mr407,ctrl
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T1N0,pert
"CL1-0 mock control, biological rep3",ctrl
"Peripheral blood, patient without recurrent events [N40]",pert
Expression data from BAT of the KRAP deficient mice (KO1),pert
208/0,ctrl
ILD_15,pert
WFS1 KO USHT_13_312_ko,pert
WT_uninf_2,ctrl
"patient 024b, cancer, homogenized",pert
CHB PBMC_sample 12,pert
129/BSw wt2 heart,ctrl
Cochlea_WT_9mo_5,ctrl
GFP 0hr 282295413,ctrl
GIST_PDGFRA_8,pert
Squamous cell lung cancer X42nml,ctrl
"Deltoid, FSHD, cohort 20, subject 20A",pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 12h,pert
GM19238_Kd_PAX5_2,pert
MDS patient 75,pert
chip number: 17;	transfection plate: 3B;	target gene: DIP2B;	kd level: 0.83;	rin: 9.4;	transfection date: 2012-03-26,pert
Silberg3 ( S2) 120902BE,pert
GM19238_Kd_PAX5_1,pert
"Acute Myeloid Leukemia, sample 49",pert
Polyamide1_1,ctrl
"12-week-old 12-week-old spontaneously hypertensive rats (SHR), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump.",pert
Biceps_Control_10,ctrl
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC,ctrl
patient: 242;	current medication: Salazopyrin Folic acid;	birth date: 10/18/39;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/75;	diagnosis date: 1/1/75;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/22/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/22/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"Control siRNA - 2 days osteoblast differentiation, rep1",ctrl
tissue: white blood cells;	age: 11;	Sex: male,ctrl
"brain, Entorhinal Cortex: 96-18 normal_e1_le1",ctrl
"Endometrium, postmenopausal, control, 38",ctrl
"Nickel 40 µM, biological rep3",pert
Liver sample from Alcoholic hepatitis group (CA20),pert
Treated with 5% mannitol for 4 hrs -- replicate #1,ctrl
"Patient 3, Macroscopically intact tissue",ctrl
FR-si221-2,pert
transgene strong 2,ctrl
01N70_CTRL,ctrl
PsOEt-23-Week 12,pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 7",pert
THP1-shControl-rep2,ctrl
27 weeks female,ctrl
subject: 15V;	cohort: 15;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 107kb;	age (y): 60;	Sex: F;	batch: Batch_5,ctrl
50A;pretreatment;female;breast tumor; responder,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: untreated; biological replicate: 3,ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 8d ID301,pert
aa_NY234,pert
"mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 61;	ld: HCV;	creatnine: 1.7;	mdrd: 47;	gfr: UN;	protein: 3;	hematuria: 1;	c3: 1;	c4: 1;	rf: 1420;	hcv: POS;	htn: 0;	dm: NEG;	hba1c: 5.7;	meld: 14;	ana: POS;	gp: Mild mesangial immune complex glomerulonephritis, Severe tubular atrophy;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 2;	if (interstital fibrosis): 2;	as (arteiosclerosis): 0;	igg: 1;	iga: 0;	igm: 1;	c: 1;	empe: 1;	bmwid: 0;	bmd: 0;	edd: 1;	no of glomeruli: 9;	glomerulosclerosis: 0.11;	intact t: 0.3;	arteries: intimal duplication;	if: IGM+IGG+C3+C1Q++mesangial;	mesangium ig: MGC;	tissue: Kidney_Biopsy_Liver_disease",pert
"brain, hippocampus: PH6_e1_le1",pert
RV16;	Age = 22;	Sex = M,pert
WT-smoke-low-5 month+1d-R4,ctrl
GEIM19-U133A-DM,pert
Control spleen - Biological Replicate 4 - Technical Replicate 2,ctrl
jzo012-rp1-v5-u74av2-met,pert
Lmna H222P homozygous male 5,pert
Mnk_3137-T-7,pert
"KO mouse heart at 6-weeks old, biological rep3",pert
subject id: c5;	infection: control;	status: control;	tissue: whole blood,ctrl
PGC-1alpha -/- differentiated brown fat cells (rep2),pert
male,pert
microdissected breast cancer cells from case 823,pert
P4_PMP22TG_2,pert
MGHU3 Cells_Control siRNA_Biological Replicate 3,ctrl
"Untreated wild-type NB4, biological rep1",ctrl
S009_Scz_M_87,pert
WAT from wild-type control fed high fat diet Replicate 2,ctrl
Nonlesional Epithelium Atopic Dermatitis rep5,pert
"cochlea at P13, wt, biological rep 2",ctrl
Ileum_Wild Type+Quercetin_3,pert
"1833 shHMGA2, biological replicate 2",pert
sex: Female;	family: 2;	age: 38;	disease status: Control;	tissue: Muscle: Deltoid,ctrl
chip number: 11;	transfection plate: 4;	target gene: IRF9;	kd level: 0.77;	rin: 9.1;	transfection date: 2011-10-17,pert
"Testosterone treated, HIV-1 positive male, day 14 (7)",pert
Bronchial Epithelial Cells MMA biological 0211F,pert
HCC PBMC Sample 10,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 49;	gender: male,pert
intestine_PPARa_kockout_24hfasted_rep1,pert
4033-1 E2F WT,pert
Patient: L;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
remitted schizophrenia patient  S01,pert
gender: male;	disease state: healthy,ctrl
age: 7dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
cell line: HEK293E,pert
15C-M4-D,ctrl
BP1,pert
HCC PBMC_sample 5,pert
B_cell_pool_healthy_H01+H02,ctrl
Insm1 control #7,ctrl
Gastrocnemius Muscle_Cmah KO_rep3,pert
NSCLC cell line H157. Transfected with siRNA oligomers targeting DJ-1 - #1,pert
DOV13-(1)b,ctrl
SW1736_t0h_rep1,ctrl
SRF silenced R1881 rep 2,pert
knockout rep-4,pert
strain: C57BL/6;	cell type: bone marrow-derived mast cells;	treatment: interleukin 3 and stem cell factor,pert
race: caucasian;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: atrophic endometrium,ctrl
V5-P055,pert
siOGT 12 hours_3,pert
brain_DLPFC_bipolar B_mr288,pert
PTC BRAF wt 6,pert
Txnip deficient tumor 22 months sample 1,pert
healthy CD4 T cells 3,ctrl
M249_B_PLX,pert
1uM H2O2 rep 4,pert
AT2_control_rep1,ctrl
HEK293 transiently pIRES2-EGFP-transfected 1,ctrl
CD25+Xbp1KO#2,pert
Normal Chip#6,ctrl
01N1N_PolyRF-,pert
Cpr-low_pool 3,pert
strain/background: C57BL/6N;	genotype: wild-type;	tissue: liver,ctrl
Healthy-5 baseline,ctrl
"WT HSC, biological rep1",ctrl
neocortex-30 months of age-resveratrol diet-biological replicate2,pert
Endometrial stromal cell - Jag1 retrovirus infected 3,pert
DES D2,pert
11099 UC Uninflamed descending colon,pert
"human failing LV myocardium, Idiopathic36",pert
patient17,pert
SeV 3483,pert
KN-sham-5 month+1d-R2,pert
GM19238_Kd_IRF8_1,pert
PIK3CA.DMSO.3,pert
Control subject 32_biological replicate 2,ctrl
Brain CD8 T cells that are IL-10+ rep2,ctrl
siCtrlE24h_2656,pert
MB231 con-SCM,ctrl
C015_Control_M_91,ctrl
cell type: Embrionic stem cell line;	genotype: wild-type,ctrl
Human Neural Stem Cell Line F3 Wild Type,ctrl
"mouse aorta cross strain comparison, C3H_T04_HF_03",pert
CD19_selected_B-cells_after_R_rep7,pert
430MM,ctrl
mESCs_EGFPcontrol_rep4,ctrl
Diagnosis: AML M5;	Age: 38y;	Gender: Female;	Blast %: 97;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: 1,pert
"Kidney from control rats, biological rep 2",ctrl
Keratinocytes treated with EFNA4 for 48h,pert
"shCDK19, normal growth, replicate 3",pert
"spleen marginal zone B in IRF8 conditional KO, biological rep1",pert
"fibroblast, control subject NF5 rep 1",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 31;	gender: male,pert
MDS patient 57,pert
chip number: 21;	transfection plate: 6;	target gene: JUND;	kd level: 0.79;	rin: 9.3;	transfection date: 2012-03-26,pert
brain_DLPFC_bipolar C_mr407,pert
mouse liver C1,pert
Cervical Cancer C512,pert
"fibroblast, MFS subject FB783 rep 2",pert
cell type: MEF derived stable cell line;	genotype/variation: Tet-off control cells,ctrl
Benign prostate tissue N2,ctrl
ICL670 10uM for 16hrs,pert
No or early 2 rep7 (retina),pert
Tk6 treated with arsenic rep1,pert
Muscle-24 month-wild type-technical replicate 2,ctrl
WT-EtOH-5 (DFW),pert
BP6,pert
T21_1,pert
S25 WT2	F41/390	S25	wild type	Mouse	2.5 months	Cerebellum	Female,ctrl
Carboplatin;	Carboplatin 30 hours set 2,pert
Biceps_Control_3,ctrl
"Keratinocytes untreated control, 4h",ctrl
"MAT1A knockout at 3 month age, biological replicate 2",pert
Control spleen - Biological Replicate 1 - Technical Replicate 1,ctrl
25 uM chlorpyrifos batch 2,pert
BxPC3-WT rep 5,ctrl
224 Day 1 siMut10 transfected biological rep2,pert
15KD_SerumStarved_rep1,pert
XX19_InX,ctrl
Wt Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-3,pert
newborn (P0) Krt1+/+ skin_replicate 1,ctrl
microdissected breast cancer cells from case 374,pert
tissue type: brown adipose;	gender: male;	genotype/variation: ob/ob;	harvest time: 4 day post injection;	age: 3 months,pert
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-3,pert
Control biological rep3,ctrl
HF0523_U133P2,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 4,ctrl
457MM,pert
"cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: 100 nM 1,25(OH)2D;	time point: 48 hours",pert
Run7.aUa.001206d.SkMInS1075D.CEL-IS stimulate,pert
RTX3 T0,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 24h",pert
"1mg/kg/day PFOA, Rep 3, Block 4, lung (low dose)",pert
"Patient H-c615T, MSI colorectal tumor",pert
whole tissue section from case 317,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q plus monosomy7/del7q plus trisomy8 plus other,pert
Endothelial cells 2,ctrl
Sample 14 Kidney Hyp Mouse - Low Phosphate Diet,pert
MF-11,ctrl
CD4_T_cell_pool_melanoma_M07+M08,pert
tissue type: Malignant prostate tissue;	tmprss2: ERG fusion status: negative,pert
Pfeiffer NTshRNA 1,ctrl
AFFS084-2-291004,ctrl
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.5;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,ctrl
T4F-LU,pert
tissue: Temporal cortex;	age: 80;	Sex: F,ctrl
Sex: male;	Age at operation: 60 years;	Site: thigh;	Size in cm: 7.5x6x5.5;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
gender: Female;	age: 88;	post-mortem delay: 5h;	ph: 6.8,ctrl
"fibroblast, control subject NF11 rep 1",ctrl
Tak1_2,pert
SIRT4 KO liver_7245,pert
"1833 control, biological replicate 3",ctrl
Glioblastoma_11,pert
IFC 04,pert
tissue: skin;	individual: Patient P2;	condition: AL;	eczema severity: SCORAD: 28,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIb;	Sex: F;	age: 52,pert
race: african american;	age (years): 37;	stage: IA;	grade: 2;	histology: endometrioid,pert
Strain C57BL/6;	Tissue: Backskin;	Age: e18,ctrl
c_NY103,ctrl
puroD replicate 1,ctrl
Muscle PCOS case 31,pert
BL Day 1 siMut10 transfected biological rep1,pert
scan batch: Batch 1;	group: autism;	subject age: 9;	paternal age: 33;	maternal age: 29,pert
Cell line,pert
Extract:LOX-1:213503;	Extract Description:LOX1_Untreated_24hr:213503;	Quality: Classification:Bad;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0.03;	Quality: Outlier Area (%):0.02;	Quality: 3'/5' Mean:1.74;	Quality: Background Mean Dev.:2.24;	Quality: Absent (%):61.27;	Quality: Absent (%) Dev.:2.34;	Quality: Scaling Factor:1.66;	Quality: Scaling Factor Dev.:9.07;	Pretreatment [C]:LOX1;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213503;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_24hr;	RNA extraction source key [A]:282295913,pert
LIVER_CONTROL_repl2,ctrl
01LS8_PolyRF-,pert
cerebellum_wild type_18 month_replicate 2,ctrl
2 PC3 0hr,ctrl
age_years: 57;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
siCtrl.exp3,ctrl
"206, ADIPOOSE TISSUE, Before",ctrl
V5-P155,pert
SA_61,pert
"Benign, Prostate tissue",ctrl
"human failing LV myocardium, Ischemic85",pert
"KM-H2 cells, CIITA-BX648577 knockdown, replicate 2",pert
cell line: FOXO null,pert
BP patient 98_biological replicate 1,pert
"BOEC, normal 14",ctrl
non-CF subject 34,ctrl
whole tissue section from case 648,ctrl
untreated Rb-/- MEFs-1,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 40;	gender: male;	tumor grade: IV,pert
Tmod3 KO-3,pert
Control Male SM22-rtTA only Lung,ctrl
H20 HA 12h 4,pert
Day3 Estrogen treatment replicate 1,pert
age: 18 month postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
KU_02T,pert
patient: 231;	current medication: prednisolone 40mg heparin clarithromycin;	birth date: 10/29/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/00;	diagnosis date: 11/19/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/28/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
SLE CD19 B cells 3,pert
"Atria, Mutant, biological replicate 3",pert
V5-P170,pert
Individual_5293_NN_sample,ctrl
disease state: control;	patient: 18,ctrl
"Biological Material: Cell line, grown invitro; Tissue derivation: Adenoid cystic carinoma of the parotid gland",pert
AA_Case8_CD8,pert
genotype: E-mu-BRD2;	cell-type: lymphoma_marginal;	splenomegaly: moderate;	Ig clonality: oligoclonal,pert
"A673 treated with DMSO vehicle control for 5 days, biological rep1",ctrl
WT - Cre Untreated - 0 hrs - repeat 2 - Cy3 - mAdbID:61716,ctrl
"normal skeletal muscle, biological rep9",ctrl
potilas_DC_C,pert
Treated with 5% mannitol for 4 hrs -- replicate #2,ctrl
Fat Tro2,pert
"Uninvolved Skin, NS-7",pert
JJ1717_muscle_mutation,pert
SU8686 rep-2,ctrl
cell line: BL2;	transfection: scrb siRNA;	batch: 2,ctrl
"Acute Myeloid Leukemia, sample 38",ctrl
"control, BA46-80",ctrl
PBS Treated Cells 1,ctrl
ShKdm2b replicate 2,pert
CD70Tg biological rep 2,pert
midbrain_Pink1 knockout_6 weeks_replicate 3,pert
WAT from Ahnak knockout fed regular chow diet Replicate 1,pert
muscle_Akt1+/-_35wk_rep2,pert
ESE_N_650,ctrl
VMM-WT_MyoD24h-1MP-s2,ctrl
V5-P065,pert
8DKD,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 81 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
H_Kin_3,pert
tetracycline inducible Ngn3 ESC differentiated for 10 days as EB without doxycycline,pert
"breast tumor epithelium,48",pert
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 99;	Usage number: 4;	Exposures: 3,pert
C5-7,pert
NINDS-RHS-Kainate_24h-2aUA-s2,pert
Individual_5849_PN_sample,pert
St6gal1-/- tumor #3151,pert
Fetal heart 6 ug/kg TCDD rep3,pert
202/0,ctrl
CML-BM 2,pert
microdissected breast cancer cells from case 260,pert
Liver_D3T _Rep1,pert
cell line: DBTRG;	treatment: untreated;	cell type: glioblastoma cancer cell line,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 23;	gender: male,ctrl
tissue: isolated from spleen;	cell type: memory CD8 T cells;	strain: C57/BL6;	genome/variation: TCF-1-deficient;	age: over 80 days after infection,pert
"spleen marginal zone B in IRF8 conditional KO, biological rep6",pert
cell line: MDA-MB231;	treatment: control shRNA;	media: DMEM,pert
strain: C57BL/6J;	tissue: skin;	cell type: melanocyte;	genotype/variation: Ink4a-ARF1 null,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 19d ID156,pert
pediatric AML S05,pert
NZW/LacJ Vehicle liver sample batch 4,ctrl
MOLT4_GSI_C,pert
Kidney_saline ip_mouse #061,ctrl
RNA-DHL4-R406-48H-3,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 74;	gender: female;	years of disease: 2 y;	treatment: phototherapy;	time: post-UV,pert
Dominant negative cJun  VZ16,pert
Strain: C57BL/6;	Gender:male;	Tissue:liver,pert
db/db 16 wk 2,pert
WT-Nrf2-Female-2,ctrl
PGA-RMM-2h-1aA-s2b,pert
Muscle Pio1,pert
transfection: CDK8-2;	cell line: HeLa S3,pert
"patient 045b, cancer, homogenized",pert
KO - knock-out Treated - 2 hrs - repeat 3 - Cy5 - mAdbID:51302,pert
normal adjacent esophageal tissue from patient E1589,ctrl
"WT brain, biological rep5",ctrl
XBP1s B cells 2,pert
KD control 21A n,ctrl
thyroid_normal_4,ctrl
Kidney_Aqp11-/-_P7_2-4,pert
Strain:  C57BL/6,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 49 yr;	population: white,ctrl
KU_29N,ctrl
CKO Wild Type V2,ctrl
MyD88_PIC_C-0,ctrl
"Lesion Skin, LS-1",pert
anti-FGFR1_rep1,pert
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 6,pert
Strain C57BL/6;	Tissue: Backskin;	Age: e18,pert
MDS patient 2,pert
patient: 125;	current medication: OCP;	birth date: 3/17/78;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: Diarrhoea predominant IBS;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
"breast tumor epithelium,22",pert
Carbo Day7 (417R),pert
myocardium sold commercially,ctrl
3 wks TAC-4,pert
wt-Gfp P6 replicate 2,ctrl
SENS 2 4hr,pert
0192-01-C,ctrl
cell line: SKMEL28;	time point: 6h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 6 h,pert
FVB_MMTV_Wnt1_iFGFR1_4004_3L_ROSEN,pert
age: 15;	sex: F;	disease status: control subject;	Filter number: 95;	Usage number: 1;	Exposures: 3,ctrl
B_cell_pool_healthy_H11+H12,ctrl
"Lesion Skin, LS-13",pert
"control, BA46-29",ctrl
lesion_preUV_patient9,pert
Bronchial Epithelial Cells MMA biological 1945L,pert
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep1,pert
"fibroblast, MFS subject FB773 rep 2",pert
435MM,ctrl
"patient 047b, cancer, homogenized",pert
Control biological rep1,ctrl
NPC Brain 84d Mouse1,pert
"acutely admitted, severely psychotic schizophrenia patient  A23",pert
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P4,pert
Clinically localized primary prostate cancer tissue pool PX2,pert
"Wild-type HFD 8 weeks, biological rep4",ctrl
BIO586220,ctrl
MCF10A-Myc-rep2,pert
Sham 14 replicate 1,ctrl
442MM,pert
lymphocytes_HD_M_51y,pert
KO_PMΦ_rep3,pert
Normal_003,ctrl
THRB 15b mutant + vehicle replicate 1,pert
"Cell line:  Fibroblast TTP WT cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",pert
"Diclofenac treated THP-1 cells, biological replicate 2",pert
"Fibroblasts, baseline, time 0, patient 2, rep 1",ctrl
"wild type, prenatal stress, biological rep3",pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_4_2_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
V5-P221,ctrl
Nontransgenic littermate mouse;	Strain: C57 BL/6;	Gender: male;	Age: ~30wk;	Tissue: heart LV;	Treatment: tamoxifen,ctrl
"Epidydimal white adipose tissue from WT after 16 weeks of high fat diet feeding, replicate 2",ctrl
CAR.KO_corn oil_rep1,pert
Disease_status: Bipolar disorder;	Age (years): 33;	Gender: Female;	Age of onset (years): 15;	Duration of illness (years): 18;	Brain pH: 6.51;	Post mortem interval (hours): 24;	Side of brain: Left;	Fluphenazine mg. Equivalents: 3000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
Normal-BM 1,ctrl
lesion_postUV_patient10,pert
Diaphragm 112 Day control rep 2,ctrl
"normal nasopharyngeal tissue, specimen N1",ctrl
Nrf2 KO rep2,pert
Mtb infected-63d-1,pert
266D1,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: LSD1;	transfection time: 48h,pert
"CD8 DC wild type, biological replicate 3",ctrl
"Autoimmune pancreatic islets, no cyclophosphamide treatment, rep 7",ctrl
10 week mutant spinal cord rep 1,pert
MO_CTa_SON_NCBI,ctrl
H2 Ctrl 2h 2,ctrl
"WT+Empty, biological rep1",ctrl
3587-1 E2F1 Null,ctrl
reduction mammoplasty patient 328,ctrl
cell type: peripheral blood mononuclear;	disease state: healthy,ctrl
HP-2,ctrl
EA_Case20_CD20,pert
sample =XCGD6 treatment=Control time=180 (min),pert
A HID B_B013,pert
R6/1 18 week transgenic_5D42,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 13.666;	Ratio: 2.07,ctrl
Normal-ERα-positive breast cancer 33,ctrl
Diagnosis: AML M5;	Age: 60y ;	Gender: Male;	Blast %: 71;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: No Data,pert
OVCAR-10+(2),pert
43SAGEA,pert
strain: C57Bl6;	gender: female;	age: 6 months;	tissue: white adipose tissue;	genotype: KSR2-/-,pert
tissue: skin;	cell line: NZM12;	tumour stage: metastatic melanoma;	tumour site: small intestine;	treatment: media-only control,ctrl
race: caucasian;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
HN_109,ctrl
cDNA no 02+05+08,ctrl
"Patient 28, Atheroma plaque",pert
PND28 Rat Testis_Rat230-2_1hr Corn Oil_Animal#40_04005,ctrl
ADHD_untreat,ctrl
"AD_FC, biological rep9",pert
"4302_CD133+, laminin treated",pert
Nonlesional Epithelium Nonatopic Control rep1,ctrl
C5star_CLP_wildtype_8,ctrl
Control_R_-Dox_rep3,ctrl
EA_Control1_CD4,ctrl
sample: #23;	subject: PD case #6;	brain: T-227;	age: 76;	sex: Female;	region: Dorsal motor nucleus of the vagus,pert
gender: male;	strain: C57BL/6J;	genotype/variation: Scd1 knockout (SKO);	tissue: Dorsal skin;	age: 8-9 wks old,pert
3976-1 E2F1 Null,ctrl
"Mouse Embryonice Stem Cells, pCIP siRNA 1, Rep1",pert
SNRK_1,pert
ndf + FTI,pert
HeLa cells transfected with siSp1 rep 1,pert
MSC_VUB01_2,ctrl
heart wild type replicate2,ctrl
strain: C57/Bl6;	age: 4 month;	gender: n/a;	weight: 25-30g;	tissue: whole trachea,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 47;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
sample =XCGD4 treatment=Control time=0 (min),pert
0922-01-A,pert
RO36,ctrl
age: 12 wk;	tissue: whole heart;	genotype: Pitx2 Flox/Flox,ctrl
mixed background e18.5 male cardiac ventricle,ctrl
"Uninfected treated with 1,25D, replicate 3",pert
C026_Control_M_58,ctrl
MCF7_ARC_Array_2,pert
"cochlea at P13, ko, biological rep 1",pert
"iPSC derived from healthy control fibroblast WT2, biological rep7",ctrl
IFN_Gamma_6hr_rep3,pert
H17 Ctrl 12h 3,ctrl
Gender:M;	Age:44;	Tissue: Mucosa;	,pert
wild type MEF time 24 replicate 4,ctrl
Mouse WT mandibular molar [ABH_13A],ctrl
"Epithelial prostate primary cells from fresh explant from normal tissue, obtained from a cystoprostatectomy of a patient with a bladder carcinoma with no lesions in the prostate",ctrl
FBooth-CON-4Av2-s2,ctrl
Cancer 15,pert
Benign Prostate tissue N1,ctrl
PsOEt-23-LS,ctrl
cell line: U937;	shRNA construct: GSK3A Construct 6,pert
Patient: F;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
POAG-TM-B,pert
WT heart 2,ctrl
"Wild-type-hippocampus, biological rep6 (female)",ctrl
Bone-Marrow_NPC_N1645,ctrl
age_years: 58;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
strain: B6/C3H hybrid;	gender: male;	age: 30-month-old,ctrl
Disease_status: Healthy control;	Age (years): 34;	Gender: Male;	Post mortem interval (hours): 22;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
Strain: C57BL/6;	Gender: male;	Age: 9 - 12 weeks;	Tissue: liver;	Treatment: vehicle only (5% DMSO in corn oil),ctrl
pediatric AML GP3,pert
PND28 Rat Testis_Rat230-2_6hr Corn Oil_Animal#36_04005,ctrl
"Rat liver, treated with NMF, 1000 mg/kg in saline i.p., extrated 48 hours after treatment, biological rep2",pert
N2_Cy3,ctrl
H4-II-E-C3_low_rep4,pert
Luciferase shRNA_2 Days knockdown_rep1,ctrl
"brain, adrenal medulla: Sample#A1(Exp pt 1)_e1_le1",pert
01LLB: normal control,ctrl
Pax3 WT E14.5 palatal shelves 6,ctrl
"Inclusion body myositis, biological rep3",pert
age: 34;	sex: F;	disease status: control subject;	Filter number: 88;	Usage number: 5;	Exposures: 3,ctrl
Patient 4,ctrl
GM19238_Kd_SREBF2_1,pert
Emd KO male 2,pert
cell line: H1;	cell type: embryonic stem cells;	shRNA: control,ctrl
"A673 treated with Puromycin for 24 hours with concentration of 0.18 uM (2 x EC50), biological rep3",pert
TTF=127min;	Race=Caucasian/White;	Sex=Female;	Group=Con;	Prototype_N,pert
APOE_KO_RAGE_KO_NODM_9W_15,pert
1000uM H2O2 rep 2,pert
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 36;	maternal age: 30,pert
"genetic background: B6/129;	genotype: WT;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor Low CD34 positive expressing bone marrow progenitors CMP",ctrl
strain: C57BL/6J;	cell type: LSK cells;	genotype/variation: Nfix depleted,pert
ADH1,ctrl
human_LIMA_artery_patient5_paclitaxel-eluting_stent,pert
A4_tumor,pert
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 3,pert
"fibroblast, control subject NF10 rep 1",ctrl
RatLung_H6h_3,pert
Bronchial Epithelial Cells SA biological 2016Z,pert
GM19238_Kd_E2F1_1,pert
Control Day0 (76L),ctrl
normal esophageal epithelium (N2),ctrl
disease state: endometrioma;	patient: 9,pert
"twin pair: #10;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
siRNA Smc3 [M2],pert
THRA 6a mutant + vehicle replicate 1,pert
VGLL4 HUES6 2,pert
"breast tumor epithelium,3",pert
"1833 expressing Tet1, biological replicate 1",pert
"Aorta, Ang II 14d, #3",pert
PPAR WT_ctr_55,ctrl
HCC006T,pert
Cal27_CETU3,pert
06R025 RA,pert
MDS patient 150,pert
"Acute Myeloid Leukemia, sample 29",pert
"human failing LV myocardium, Idiopathic74",pert
"gender: Female;	age: 89;	post-mortem delay: 5h;	ph: 6.5;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
C_AN00544_F,ctrl
SeroNeg-2,ctrl
tissue: heart;	developmental stage: E10.5;	genotype/variation: Dbh+/+,ctrl
"Patient 18, Atheroma plaque",pert
SALL4 shRNA biological rep2,pert
genotype:Rb null;	Age: e12.5,ctrl
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shControl.2,ctrl
Bone-Marrow_SMM_S1221,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 3,pert
Human.BP.CTRL.FCU,ctrl
cell line: DOV13;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Colon",pert
"Setd2 wild type mESCs, biological rep1",ctrl
strain:C57BL/6; VillinCRE-HNF4loxp; female; tissue colon; mutant,pert
Human prostate cancer primary culture C11sx,pert
LIVER_CONTROL_repl3,ctrl
brain_DLPFC_bipolar C_mr283,pert
N3+4,ctrl
V5-P278,pert
"344SQ with PIK3CA shRNA, replicate 3",pert
long-Rif1 KD rep2,pert
PBMC from T cell LGL leukemia patient #102 (TLGL102),pert
6A,pert
Gastrocnemius Muscle_mdx_rep2,pert
cell line: Hep G2;	genotype: wild-type THRB and;	treatment: with 100 nM T3 for 6h,pert
CAR.AH_TCPOBOP_rep2,pert
"Normal Skin, Normal-13",ctrl
tissue type: normal esophageal tissue of surgically resected human esophagus;	cell type: fibroblast,ctrl
Individual_5142_NN_sample,ctrl
"BioBreeding  DRlyp/lyp rat, day 65, mast cells derived from pancreatic lymph node",pert
6 h-apra-2 nM,pert
THRA 6a mutant + vehicle replicate 3,ctrl
GM19238_Kd_NR3C1_1,pert
tissue: Temporal cortex;	age: 55;	Sex: M,ctrl
8_b,pert
treatment: control;	cell line: NuLi;	genotype: no-Cystic Fibrosis deltaF508 mutation,ctrl
Mening UNSTIM WB NP 3a,ctrl
"AD_HI, biological rep7",pert
"fibroblast, MFS subject FB992 rep 2",pert
Strain: C57BL/6J;	Gender: Male;	Age: 2-3 months;	Tissue: heart,ctrl
Z5_TA,ctrl
ADHD_MPH,pert
0790-01-A,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 33;	maternal age: 38,pert
Vector control 1,ctrl
PlagL2WT2,ctrl
26GOBMUC2H,ctrl
Mnk_3214-S-B,ctrl
"Aorta, Ang II 7d, #1",pert
Aorta_non-transgenic C57BL/6J control_1,ctrl
Human skeletal muscle biopsy sample;	Patient #50 with NORM,ctrl
Bronchial Epithelial Cells SA biological 1918I,pert
M249_R4_B_PLX,pert
"spleen follicular B in IRF8 conditional KO, biological rep5",pert
"Distal and Proximal Large Intestine, 8week old Eeyore mouse 2",pert
"Gata4-KO heart, CRE, biological rep1",pert
RKO_liver_fasted_refed_3hr_rep4,pert
MB231 con-DMEM,ctrl
tissue source: patients with a mutation (Arg1174Gln) in the tyrosine kinase domain of the insulin receptor gene (INSR);	tissue: Vastus lateralis muscle;	tissue state: basal state,pert
H4-II-E-C3_untreated_rep2,ctrl
siERK2Veh24h_3495,pert
"HA-Fbxl10 cell, Replicate 1",pert
3765-1 E2F1 Null,ctrl
CD11b+Gr1+ cell sample_3 (derived from wild type mouse),ctrl
KO - 5 mo - repeat 2 - Cy3 - mAdbID:74110,pert
BTBR+tf/J Vehicle liver sample batch 1,ctrl
siNS_4h_1,ctrl
"Fibroblasts from UIP histology lung tissue, IPF-21",pert
"patient: 254;	current medication: Asacol 800mg TDS, Predfoam;	birth date: 7/25/59;	gender: F;	ethnicity: ASIAN;	symptoms onset date: 1/1/00;	diagnosis date: 11/1/00;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
control to Sample 7,ctrl
RNA from HCC_15N,ctrl
"Control, biological rep9",ctrl
Post Transduction:24 hr; treatment:WT;,ctrl
C57BL/6 heart left ventrical (LAD ligation 3 day),pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 0 hrs,ctrl
chronic lymphocytic leukemia (CLL 68148),pert
diagnosis: healthy;	tissue: blood,ctrl
"Endometrium, postmenopausal, tibolone, 6",pert
"Acute Myeloid Leukemia, sample 12",pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 44 yr;	population: white;	dsm-iv: 296.53;	age of onset: 33 yr,pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 7",ctrl
PGA-MAA-ctr-1cAv2-s2,ctrl
mESC_undifferentiated_wild type_rep3,ctrl
ku86(ko)_Terc(wt)_1,pert
Sox9egfpneg_p23-1,ctrl
DE1483_muscle_mutation,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 4",pert
"Wild type, snap frozen, tibialis anterior muscle, 7month age animal",ctrl
tissue: brain;	genotype: WT mix background A;	age: P14,ctrl
MCE301 cells treated with SB for 24 h-1,pert
Panc-1 Gli3T 3,pert
Waldenström’s macroglobulinemia (WM-BL 30639),pert
44m3,ctrl
Nrl-ko-Gfp P6 replicate 2,pert
BL Day 2 siMut10 transfected biological rep4,pert
patient: 40726;	sample: tumor,pert
HepG2_Sb rep3,pert
Mouse_Klf5 KO_ES_clone 2,pert
Tk6 untreated controls for cadmium exposure rep2,ctrl
WT V6.5 ESCs on day 7 #1,ctrl
"liver, ATP7B KO mouse, sample KO904",pert
Time 240 mins rep 2,pert
age: 12 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
control participant P311,ctrl
R7E 7,pert
"C2C12 Myotubes treated with BSA, rep3",ctrl
"human failing LV myocardium, Ischemic108",pert
type 2 diabetes subject 04,pert
knockout rep-2,pert
sXBP4_1578T,pert
24h_RA1,pert
mdx Biological Replicate 4,ctrl
"non-AD_HI, biological rep9",ctrl
"Mouse Embryonice Stem Cells, pCIP siRNA 2, Rep2",pert
WT-control-4,ctrl
"Aorta, saline 14d, #3",ctrl
"human failing LV myocardium, Idiopathic7",pert
"Epidydimal white adipose tissue from WT after 16 weeks of high fat diet feeding, replicate 4",ctrl
"D425-shOTX2_2, t=96",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 47 yr;	population: white;	dsm-iv: 295.9;	age of onset: 20 yr,pert
n6t30m,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.11;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
C57BL/6 BMDM naive,ctrl
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 32;	maternal age: n/a,pert
"Testosterone treated, HIV-1 positive male, day 14 (9)",pert
HepG2-PARP2 depleted-2,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: ;	choa: 128;	fata: 117;	eea: 1790;	wtkg: 78.3;	perfat: 20;	lbm: 60.4;	fat_mass: 1566,ctrl
strain: C57BL/6J;	day: 15;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 1,ctrl
"non-AD_TC, biological rep19",ctrl
"TH cells from LC, Mecp2 null, biological replicate 3",pert
01LQD_CTRL,ctrl
224 Day 1 siMut10 transfected biological rep3,pert
umbilical cord_nobpd: 5A,ctrl
High weight gainer Kozak1_ABI_ING_H1,pert
MLL_00131,pert
tissue: Brain;	genotype: Npc1+/-;	age: 37 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
Prdm14 knockout 2,pert
T51572,pert
MEF Wild Type 2-rep3,ctrl
P16_exPKO_pancreas_rep1,pert
0974-01-C,ctrl
"GFP Alone, Replicate 1",pert
..SAL_II_1,ctrl
"DMSO Control after 8hr, replicate 1",ctrl
adenocarcinoma (ADC5),pert
Waldenström’s macroglobulinemia (WM-BL 32833),pert
Diseased individual (ulcerative colitis) of twinpair #10,pert
M_LS_Wk4,pert
"wild type, control, biological rep2",ctrl
FHCRCAML16906,pert
normal B lymphocytes (NBL 001),ctrl
CD11b+Gr1- cell sample_3 (derived from IL17RC Knock out mouse),pert
65A;pretreatment;female;breast tumor,ctrl
uninvolved skin from cases,pert
Neocortex_Eomes_KO.1,pert
A_AN17777_T,pert
RNA: whole lung;	strain: C57BL/6;	genotyp: wt;	infected: no;	replicate: C,ctrl
PFR3_replicate_4,ctrl
NS2-031009-SA,ctrl
striatum wild type 21 month replicate 1,ctrl
"KO liver, biological rep2",pert
gender: Male;	tissue: Tendon;Subscapularis;	age: 66;	donor: 31;	disease state: Non-lesional,ctrl
LNCaP/MYB siRNA #1,pert
Individual_4688_PN_sample,pert
mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 42;	tissue: Normal_Kidney_Biopsy,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 1;	gender: male,ctrl
FBooth-CON-3Av2-s2,ctrl
VEC A,pert
PBMCs enriched for CD8+ cells from normal control subject K (KCD8),ctrl
Individual_4165_PP_sample,pert
tissue: cerebellum;	strain: tia1 knock out;	age: 3 months;	genetic background: C57Bl/6,pert
33A;pretreatment;female;breast tumor; nonresponder,ctrl
cell type: Erythroid progenitors on day 6 of differentiation;	genotype/variation: transduced with control empty vector,ctrl
HSC-3_vector_48hr culture_rep3,ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 6",ctrl
LSK control 1,ctrl
Nasal Epithelium Instilation Formaldehyde 0mM 6h ID354,ctrl
Whisker pad WT biological rep3,ctrl
Disease_status: Down syndrome;	Age (years): 76;	Gender: Female;	Post mortem interval (hours): 18;	Braak stage: VI;	Cause of death: Unknown,pert
Nr1_pre221,pert
5285 UC Inflamed ascending colon,pert
control_00hr_rep2,ctrl
cell type: PBMCs;	disease state: remitted schizophrenia patient;	gender: male,pert
cell line: OVCA433;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
Severe rep7 (OHN),pert
colon_epithelium_C57mouse_6weeks_rep2,ctrl
Bronchial Epithelial Cells MMA biological 1943H,pert
Liver_normoglycima_no.3,ctrl
MCI-006,pert
Pten cKO rep2,pert
WT-ac-1,ctrl
condition: control;	tissue: decidous teeth dental pulp;	gender: male,ctrl
SA_62,pert
Genotype: HtrA2 knockout,pert
treatment: no DOX,pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: sigenome non-targeting siRNA;	genotype/variation: negative control,ctrl
LCH2ani,pert
IL8.1,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L016,ctrl
Pediatric_GBM_27,ctrl
genotype/variation: Wildtype_XX;	tissue: gonads;	age: E11.5,ctrl
Psoriasis-Patient-B,pert
"WI-38 cells, at 24 h after exposure to DMSO vehicle control, biological rep1",ctrl
"18B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
tissue: liver;	treatment: CCl4 and erlotinib 5 mg;	strain: A/J,pert
03SAGEA,pert
"5mg/kg/day PFOA, Rep 1, Block 5, lung (high dose)",pert
Control ITP chip B,ctrl
"Ad(moi10)-infected, vehicle-treated for 24hr",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.088;	OD280: 0.579;	Ratio: 1.8;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 289;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Ad+veh replicate2 b,ctrl
MCF-10A shCHK2-1 replicate 1 [set 5],pert
Wild type_liver _2,ctrl
cMyb virus-infected replicate 2 (MCF7),pert
"N-58, NORM, M, GSF, 1 x 1000nM DHT, 24h",ctrl
11-0054A_Day1_32,pert
Mouse_ESC_Pcl2_shRNA_sample 2,pert
475MM,pert
Contralateral 3,ctrl
08SE1180,ctrl
"patient: 204;	current medication: AZA 200mg, Insulin, Asprin, Atenolol, Simvastatin;	birth date: 8/15/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 7/1/02;	diagnosis date: 8/1/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 11/1/04;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 0;	nod 702: 0;	nod 908: 0;	dlg5 133a: 0;	nod 1007 fs: 0;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/58;	smoking stop date: 1/1/01;	smoking amount: 25+;	other illnesses: Type 2 DM 02/2004.-Gout.;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 44 yr;	population: white;	dsm-iv: 295.3;	age of onset: 9 yr,pert
cell line: HCT116;	clone: 21;	genotype: Knockout,pert
"Biceps, control, cohort 15, subject 15V",ctrl
Trastuzumab treated after 4 days (T3_1),pert
Liver CTR replicate 2,ctrl
TOV112D NT-1,ctrl
C1_2,ctrl
liver_control_diet_rep2,ctrl
Gene expression profiling of Phgdh knockout embryo KO2,pert
Oct4 KD replicate 1,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P7,ctrl
Control + LPS 5,ctrl
subject: 34;	disease: CP;	muscle: ST;	gender: M;	age: 15.2;	gmfcs: 2;	popliteal angle: 120,pert
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 18",pert
tissue: left lung;	genotype: Wild Type;	age: 8-week-old,ctrl
strain: BALB/C;	age: 8-10 weeks;	treatment: PBS;	gender: Female;	time: 10 dpi;	tissue: heart,ctrl
Untreated after 4 days (C2_1),ctrl
"Nod2-UN3,experimental replicate 3",pert
normal muscle replicate 1,ctrl
NK_cell_pool_healthy_H05+H06,ctrl
Untreated WT - repeat 2 - mAdbID:102766,ctrl
4031-1 E2F3 Heterozygous,pert
"AD_FC, biological rep6",pert
HEL_JAK2 knockdown (Jak2-10 shRNA)_2,pert
cell line: A549;	cell type: adenocarcinomic human alveolar basal epithelial cells,ctrl
CML_4_HSC,pert
WT STR Veh 4,ctrl
Primary combined SCLC-AD 1870,pert
"3T3-L1 siLSD1 24h, biological rep 1",pert
treatment: control scrambled siRNA;	cell line: H441,pert
Age: 61;	Sex: M;	Ancestry: European;	Smoking status: non-smoker,ctrl
C33KD2_with doxycycline_1,pert
11428 UC Inflamed ascending colon,pert
E14 molar TCDD 2,pert
healthy CD19 B cells 2,ctrl
A549 non-small cell lung cancer (NSCLC) cell line,pert
siIPMK no DNA Damage experiment 3,pert
cell line: MCF10A;	gender: female;	tissue: breast;	expression: Myc over-expression,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 10 nM;	treatment time: 48 hours,pert
Muscle PCOS pioglitazone 31,ctrl
GM19238_Kd_NFE2L1_2,pert
RIP-Aire transgenic,pert
"ALL_NDS, K13 011609",ctrl
major non-tumor9,pert
braf status: not determined;	tissue: normal thyroid tissue,ctrl
Age: 41;	Sex: M;	Ancestry: African;	Smoking status: non-smoker,ctrl
"strain: C57BL/6;	genotype variation: Il10+/+;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 72 hours;	agent: ozone;	exposure dose: 0.3 ppm O3;	test article cas no: 10028-15-6",ctrl
"Patient 26, Macroscopically intact tissue",ctrl
Jurkat-KD3,pert
Mammary gland R1 24 hr S rep1,pert
Capan2_siLLGL1-2 biological rep1,pert
Akt1 double transgenic mice on a high fat diet (DH 3),pert
129/BSw wt1 heart,ctrl
individual: patient7;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
Cont subject 07,ctrl
Advanced IPF_explant_upper lobe_rep158,pert
"twin pair: #2;	individual: healthy individual, non-inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",ctrl
"strain background: mixed 129S6/SvEvTac, C57BL/6J, Balb/c;	genotype/variation: WildType;	age: 3-4 months;	gender: Male;	tissue: whole lung tissue",ctrl
cell line: Hep G2;	genotype: RCCC-THRA mutant 6a;	treatment: with vehicle for 6h,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.222;	OD280: 1.139;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 64;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Wild type mouse pDCs,ctrl
"Mdr2-KO homozygous mouse, 12 month old mouse 1",pert
NZM15_siPAX3_30hrs_rep1,pert
"patient: 121;	current medication: Cp-tenedone, Enalapril, Loperamide.;	birth date: 4/8/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: Diarrhoea, Blastocytitis on stool cultures.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
Psoriatic arthritis PsA 13,pert
Monocyte ATV rep 1,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 7",pert
"mutant mouse embryonic fibroblast, biological rep 1",pert
"wild type, control, biological rep3",ctrl
"cultured PBMC, treated with Bt5",pert
Individual_5147_NN_sample,ctrl
treatment group: cadmium chloride 0.1 uM;	cell line: TK6 cells,pert
cell line: C13;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
patient: CEM11;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
Genotype: C57Bl/6 mice;	Age: 8-12 weeks old,pert
"human failing LV myocardium, Ischemic12",pert
"normal mouse kidney E12.5, biological rep 1",ctrl
Patient: L;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 1;	dfs-month: 35;	dfs-event: 0;	distant metastasis: 0",pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection;	vector: pLKO.1;	activation: none,ctrl
cell line: MCF7-ADR;	treatment: Multi-step doxorubicin-selected subline,pert
astrocytes from second trimester human fetal brains,ctrl
liver_male ko_rep2,pert
5410-lcm,pert
Liver_TAK1KO_Rep3,pert
SENS 5 0hr,ctrl
transgene strong 3,ctrl
Mening UNSTIM WB NP 0a,ctrl
Human prostate cancer primary culture C25dx,pert
OSCE-10T,pert
CLL8-CD8,pert
Donor2_6h_DMSO,ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case2,pert
Dengue Fever Patient 44,pert
Mutated-ERα-positive breast cancer 57,pert
RNA-DHL6-R406-24H-3,pert
"BOEC, normal 26",ctrl
Gata3_A3,ctrl
TGF-alpha 979-CLA-32,pert
platelet_Ctrl_4,ctrl
V5-P163,pert
Cardian muscle Trained diabetic 5 week DT5,pert
"Kinin B1 receptor knockout, biological rep3",pert
Bcl6 KO 2 sample A,pert
"spleen marginal zone B in IRF8 conditional KO, biological rep3",pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous endotoxin challenge""",pert
genotype: Fog2flox/delta;	treatment: alpha MHC Cre;	age: 6-7 wks old;	gender: male;	tissue: heart,pert
CXCL4_A,pert
Blood_Control 1,ctrl
Sarcoma cell line  - Dicer Null -rep3,pert
H1299 DAC 1 uM (3238),pert
Patient no. 5: control,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 209,ctrl
X_p8_rep3,pert
in vitro differentiated DCs,pert
47SAGEA,pert
"Rat liver, treated with Caerulein, 50 µg/kg in saline i.p., extrated 48 hours after treatment, biological rep5",pert
Amniocytes_Euploid_1559,ctrl
"colonic tissue from floxed mouse, biological rep2",ctrl
chip number: 21;	transfection plate: 5;	target gene: RXRA;	kd level: 0.86;	rin: 9.1;	transfection date: 2011-10-17,pert
"disease state: Nasopharyngeal carcinoma;	stage: I, T1, N0, M0, G4",pert
Liver_Control _Rep3,ctrl
Luciferase control 2,ctrl
Cerebellum_nontransgenic control S25_3 months_replicate 3,ctrl
"EAE, 1,25(OH)2D3-treated #7",pert
"brain, hippocampus: wildtype 3_e1_le1",ctrl
"Rat Schwannoma cell line that express genes associated with glial characteristics including Sox10, p75, GFAP, and S100.  For additional information please see: Hai, M., Muja, N., DeVries, G.H., Quarles, R.H. and Patel, P.I.;	(2002) Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J Neurosci Res 69:497–.508.",ctrl
AA_128,pert
CO_2,ctrl
"Patient M030-55B, MSI colorectal tumor",pert
tissue: Frontal cortex;	age: 101;	Sex: F,pert
EA_Case8_CD4,pert
KU_12T,pert
strain: F1 (C57BL6 X 129/SvEv);	genotype: AGTR1A-KO mice;	tissue: kidney;	gender: male;	treatment: NS diet,pert
N65s2,ctrl
Disease_status: Bipolar disorder;	Age (years): 37;	Gender: Female;	Age of onset (years): 14;	Duration of illness (years): 23;	Brain pH: 6.5;	Post mortem interval (hours): 29;	Side of brain: Right;	Fluphenazine mg. Equivalents: 1200;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: Yes;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 4;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 6,pert
Panc1 rep-3,ctrl
TP06-998,ctrl
RT4D6_wild type Sox10 siRNA_rep1,pert
sample L 18.5 wt,ctrl
Waldenström’s macroglobulinemia (WM-PC 30381),pert
cell line: MCF-7;	cell type: Breast Cancer Cells,pert
PsOEt-21-Week 12,pert
Skinbiopsy_48hoursnickel_nickel_allergic_subject_P4,pert
cerebellum wild type 21 month replicate 1,pert
U87 20 uM Temozolomide rep1,pert
A2058 CT16 siRNA Rep3,pert
cell line: SBC-5 cells;	treatment: siEGR4 (target);	time: 48 hr,pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate 1,pert
"vestibualr organ at E18.5 of Igf1 +/+, biological rep 1",ctrl
44A;pretreatment;female;breast tumor,ctrl
Gastrocnemius muscle from integrin alpha7 transgenic mouse;	Strain: SJ6/C57BL6 background;	Genotype: integrin alpha7 transgenic;	Gender: Female;	Age: 5 week;	Tissue: gastrocnemius and soleus muscle;	Feeding condition: non-fasted,pert
47B,pert
"FVB/N genetic background. 4-month old;	virgin female mice were used, mice were kept on a 12-hour;	light/dark cycle with ad libitum access to chow and water",pert
Individual_5331_PP_sample,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_1_36_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep7,pert
Z138-shSOX11.3,pert
AtT20 cells infected with empty vector rep2,ctrl
normal B lymphocytes (NBL 006),ctrl
"Crohn's Disease subject (20 year old black male, SAK_1259851809)",pert
Fetal heart 6 ug/kg TCDD rep4,pert
Control male 6,ctrl
HNF6_1-,ctrl
"seminoma specimen, pT1, patient age: 36y; W03 014",pert
gender: male;	age (years): 58;	evolution time (years): 10;	disease extension: Left-sided colitis;	treatment: No treatment,ctrl
mutant_crypt_day2_sample1,pert
fibroblast_5azacontrol_rep3,ctrl
siRNA-96_rep3,ctrl
MDS patient 107,pert
"human failing LV myocardium, Idiopathic37",pert
whole blood_100315,pert
sample type: normal breast cell line with stably transfected full-length chimeric human HER2 receptor with FKBP and HA tags;	cell line: MCF10A;	treatment: Untreated,ctrl
RAW Untreated 1,ctrl
C_AN12240_C,ctrl
"Uninfected treated with 1,25D, replicate 2",pert
SIRT4 WT liver_7244,ctrl
"Wild type used for MAT1A 3 month, replicate 5",ctrl
chip number: 16;	transfection plate: 5;	target gene: ZHX2;	kd level: 0.55;	rin: 7.8;	transfection date: 2011-10-17,pert
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119+;	genotype/variation: wildtype,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 73;	gender: female;	years of disease: Unknown;	treatment: phototherapy;	time: post-UV,pert
Control A549 cell Replicate3,ctrl
HP-9C,pert
Wild type mice on a high fat diet (CH 2),ctrl
"siPRMT8 neuron, biological rep1",pert
"human failing LV myocardium, Ischemic55",pert
Control (C50),ctrl
SENS 7 0hr,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: Trim28CKO,pert
chronic lymphocytic leukemia (CLL 45205),pert
"PC from MM patient,isolated using CD38-APC.",pert
chip number: 13;	transfection plate: 3A;	target gene: NFYC;	kd level: 0.61;	rin: 9.6;	transfection date: 2012-03-26,pert
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 6,pert
MCF10A_HER3_2,pert
M304 SKM-KO,ctrl
Multiple Myeloma Patient 1,pert
Colon_Wild Type_2,ctrl
ko 13.5d replicate 3,pert
ILD Study Number 1078,pert
umbilical cord_bpd: 9C,pert
Strain: C57BL/6;	Age: 4 months;	Tissue: retina,ctrl
patient: 237;	current medication: Omep 20mg Losartan 50mg Bisoprolol 5mg Prav 40mg;	birth date: 11/12/28;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/95;	diagnosis date: 11/13/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/18/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/5/03;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/50;	smoking stop date: 1/1/52;	smoking amount: 0-4;	other illnesses: Hypercholesteremia Prev CABG;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
Transgenic nr 657,pert
erlot5_CT37,pert
"C3H/HeJBir-Il10tm1Cgn, sample 1",pert
Tgfbr2 fl/fl Control Posterior Palate 1,ctrl
cell line: NCI-H716;	treatment: none,ctrl
T2-FP_spleen_KO_rep3,pert
"Prdm14(+/+): 2i, rep2",ctrl
Tissue:tumor; Gender:female; Age:31; Tumor stage:T4aN1bMx,pert
Neuroblastoma SH-SY5Y cells_cloneB_stably transfected with RNAi against DJ-1_replicate2,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT1 knockout, U0126-treated",pert
8 Ko,pert
Cervical cancer_1875T,pert
E10.5 ko.1,pert
Embryonal carcinoma 1017,pert
gender: female;	age (years): 55;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
cell line: JURL-MK1;	tissue: Myeloid leukemia cells;	agent: Imatinib,pert
normal control 5,ctrl
VIN_B017,pert
Normal urothelium_1 (Wild-type),ctrl
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 6;	gender: male,pert
C_AN03217_F,ctrl
"Ulcerative Colitis (47 year old caucasian male, SAK_1286408661)",pert
Sample 6,pert
HCC004N,ctrl
Intestine_KO_biological rep4,pert
age	64;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	7.1;	leukocyte count (/nl)	38.3;	hemoglobin (g/dl)	14.1;	platelet count (/nl)	212,pert
Subject 6 Post allergen challenge,pert
Nasal Epithelium Inhalation Formaldehyde 15ppm 6h ID338,pert
skeletal muscle Crhr2+/+ replicate1,ctrl
"Acute Myeloid Leukemia, sample 18",pert
strain: C57BL/6;	genotype/variation: Wildtype;	tissue: whole embryonic kidney;	age: gestational day 12.5 (E12.5),ctrl
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S25_3 months_replicate 3,pert
MDS patient 73,pert
Parkinson's disease sample x108,pert
"brain, cerebellum: RNA#4S_le1",ctrl
Sample 8,ctrl
genotype/variation: K14CREER:SOX2fl/fl mice treated with tamoxifen for 1 week;	tumour stage: Benign tumour,pert
sample =XCGD4 treatment=Control time=180 (min),pert
FACS-purified B cells_129SV/EV_non-infected_rep4,ctrl
ko 13.5d replicate 8,pert
brain_DLPFC_bipolar C_mr538,pert
"PMA treated, doxycycline treated; biological replicate 1",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.408;	OD280: 1.228;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 342;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"gene expression of wild type oocyte, replicate 4",ctrl
"breast tumor epithelium,23",pert
HGPS Fibroblast replicate 1,pert
OVCA420+(2),pert
SV129_24h_Wy,pert
normal B lymphocytes (NBL 004),ctrl
Normal-ERα-positive breast cancer 47,ctrl
Ngn3 EB10 ON replicate 2,pert
Sarcoma cell line - Dicer Null -rep1,pert
tissue: Liver;	genotype: wild-type;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 546,ctrl
age: 62;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
AZ-521_doxycycline_18h_rep3,pert
Trim28CKO unstimulated CD4 positve T cell rep1,pert
strain: C57BL/6J;	genotype/variation: CD70TG;	tissue: Bone marrow;	cell type: CD71+ cells (MACS-enriched),pert
HT29 sensitive cells replicate 3,ctrl
Huh7 cells_Mock Infected 12 hours_ rep3,ctrl
DU145_NCsh_rep1,ctrl
WT1-iPS 1,ctrl
11081 Normal Uninflamed descending colon,ctrl
Mening SWB WB SW 24b2,pert
skin.wt.replicate4,ctrl
Liver_KnockOut_1,pert
V5-P504,pert
colon_IBD_1368,pert
D2-Gpnmb+ control rep7 (retina),ctrl
Atm+/+ untreated A,ctrl
HEK293_HNF1b_#1_induced,pert
KU_48N,ctrl
"vestibualr organ at P15 of Igf1 +/+, biological rep 1",ctrl
b12.2,pert
Sample from retroviral MSCV-GFP control infected cyclin D1 knockout 3T3 cells (line 12).,pert
strain: Ola129;	cell type: Embryonic Stem Cells;	genotype/variation: control,ctrl
TMRI AO 8hr,ctrl
WT5,pert
wild-type_phenobarbitol_rep1,ctrl
V5-P255,pert
BALB-RAG_PBS Replicate 1,pert
AEP-final,pert
BC4 TC_NOC,pert
"brain, frontal cortex: Sample56_e1_le1",pert
"Gender: Female, Age: 25, BMI: 31, Tissue: luteinized cumulus cells",pert
sex: Male;	Age: 7 months;	additional patient information found in Series supplementary file,pert
Control gray matter 4,ctrl
LJMJDW13,ctrl
SynovCTRL_0227ACID_150.txt,ctrl
CLL 377-01 LMP-420,pert
"NPTX1 shRNA Day 0, biological rep2",pert
11430 UC Inflamed sigmoid colon,pert
cell type: Melanoma cell line;	cell line name: A375P;	expression: PGC1a shRNA 65,pert
monocytes_T14_rep2,pert
TAF4b knockout 1,pert
"mutant triceps, biological rep4",pert
"Ifitm1-deficient lung tissue, biological replicate 4",pert
Liver sample of WT mouse 2,ctrl
strain: C57BL/6;	tissue: Lung;	agent: bleomycin;	genotype/variation: wild type,pert
Control subject 102_biological replicate 1,ctrl
"human failing LV myocardium, Idiopathic10",pert
Pool Ts1Cje_P0_hyb2,pert
patient: 40730;	sample: tumor,pert
gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.3,pert
"55B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Biceps_Pompe_7,pert
CF (D508) subject12,pert
MCF7_Doxorubicin_Array_1,pert
Psoriasis-Patient-A,pert
tissue: white blood cells;	age: 16.57;	Sex: female,pert
"shKDM4C 1, clone 2, rep 1",pert
0195-01-C,ctrl
OTT1 knockout mouse;	sacrificed at gestational age,pert
Animal 7,pert
healthy CD4 T cells 4,ctrl
CD4+_Tcells_healthy_donor_4,ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 4 - Technical Replicate 2,pert
UV-SeV 3659,ctrl
"Quercetin, sample 1",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 73 years,pert
retina_DBA_1026L_3mo_rep3,ctrl
SLE myeloid cells 9,pert
"patient 006b, cancer, homogenized",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 99;	Sex: male;	region: M1;	age: 39;	genotype: Y/X;YFPH/-,ctrl
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 100,pert
"RWPE-PCAT1 cMyc siRNA #4, replicate 1",pert
3DKD_SerumStarved->1hrEGF_rep4,pert
control IgG_rep2,ctrl
clone 42 replicate 1,pert
cell type: ESC;	genotype/variation: control,ctrl
IRS-2 KO (jos0929),pert
Keratinocytes treated with EphB2 for 4h,pert
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: sensitive,ctrl
BCell_lymphoma_aggressive_sample3,pert
Hes6_Castrated OWJ72,pert
gender: male;	strain: BALB/c;	tissue: liver;	diet: Western diet containing 0.05% quercetin for 20 weeks,pert
"Control, replicate 3",ctrl
CUTLL1 MigR1 GSIwash2h-rep2,pert
"BMMCs from NTAL WT, pLKO.1 infected, nonactivated, biological rep2",ctrl
C57BL10 diaphragm sample 1,ctrl
HDAC1_A3-rep1,pert
"IKK2 -/- tumor, biological replicate 3",pert
CD8_T_cell_pool_melanoma_M01+M02,pert
gender: Male;	strain: C57BL/10ScNJ;	genotype: TLR4-/-;	tissue: Kidney;	surgery: Sham;	reperfusion time: 4hr,pert
wt_P8_rep4,ctrl
EA_Control4_CD4,ctrl
Wt_cycling_rep2,ctrl
HF0232_U133P2,ctrl
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA1+dox,pert
47SAGEA2,pert
T5C-LU,pert
C1 Control None,ctrl
48h_c2,ctrl
shRNA4-1-noDox-rep1,ctrl
"KM-H2 Non-silencing, technical rep1",ctrl
SZ28,pert
F_LS_Wk12,pert
"Endometrium, postmenopausal, estradiol, 13",pert
"alveolar macrophages, smoker 025",pert
normal control 3,ctrl
heart-30 months of age-resveratrol diet-biological replicate3,pert
>95% CD3+ T cells negatively isolated with Dynal kit,ctrl
heart of mouse subjected 1 week to chronic intermittent hypoxia (1A),pert
"Patient 112, 3 month of REBIF",pert
SynovCTRL_022HACIZ_150.txt,ctrl
siControl_rep_4,ctrl
BP11,pert
"Rat liver, treated with ANIT, 125 mg/kg in corn oil per orally, extrated 48 hours after treatment, biological rep1",pert
untreated_24hr_rep4,ctrl
Control9,ctrl
E10_otic_vesicle_wt_replicate1,ctrl
3895-2 E2F1 Null,pert
ASC_lean_biological rep3,ctrl
"brain, hippocampus: KA-72h-P15-III_e1_le1",pert
WT White adipose tissue (WAT)_HFD_rep4,ctrl
Setdb1 2lox/1lox/Cre minus tamoxifen 1,ctrl
HNF4 Null_278,pert
cell line: HL-60;	shRNA construct: GSK3B Construct 2,pert
sample type: Primary culture of typeII cells collected from SPC KO lung adult;	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C KO;	genetic background: 129S6/SvEvTac,pert
wt_on_rep2,ctrl
"Liver from Nrf2 wt mice, biological replicate 1",ctrl
Nrl-ko-Gfp E16 replicate 3,pert
BAT_WT_2,ctrl
B6.IL10 72 O3 3,pert
"Crohn's Disease subject (43 year old black male, SAK_1287548671)",pert
patient: 51091;	sample: tumor,pert
CONTROL;	Age = 22;	Sex = M,ctrl
"Mouse bone marrow-derived mast cells treated with IL3, rep 2",ctrl
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"Typically Developing Control, Semitendinosus, Patient Replicate 1",ctrl
age: 50;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
control-2,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 35 yr;	population: white,ctrl
Tumor-WT-rep2,ctrl
ACI DES-treated replicate 3,pert
C26_heart 3,pert
Human mammary epithelial MCF10A cells,ctrl
patient: 255;	current medication: Asacol 800mg BD;	birth date: 3/14/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/01;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
cell line: U2OS;	cell type: human osteosarcoma cells;	transfected with: shControl,ctrl
EP71_adipose_control,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#113,pert
Adipose-24 month-wild type-technical replicate 2,ctrl
"Control 05, NC05",ctrl
cell line: NG4;	cell type: embryonic stem cells;	transfection: siSox2,pert
Mnk_3226-T-7,pert
ILD_14,pert
tissue: white blood cells;	age: 17.74;	Sex: female,pert
Sirt1 siRNA KD1 2,pert
gender: Male;	age: 61;	post-mortem delay: 16.5h;	ph: 6.2,ctrl
TTF=103min;	Race=Caucasian/White;	Sex=Female;	Group=A;	Prototype_N,pert
strain: C57BL/6J;	day: 1;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 3,ctrl
SLE CD19 B cells 11,pert
Blood_Control 6,ctrl
cerebrum_PS-/-_ 0d_rep2,pert
patient: 10;	disease state: hypertension;	tissue: Atheroma plaque,pert
218/0,pert
treatment protocol: control,ctrl
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 82;	Usage number: 4;	Exposures: 3,pert
2a_b,pert
Individual_4164_PP_sample,pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days",ctrl
hES_SA01_3,ctrl
"PIO, subject 15",pert
"DMSO Control after 24hr, replicate 2",ctrl
CF control DMW CHN313,ctrl
"human failing LV myocardium, Ischemic37",pert
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 2,ctrl
KM_001T,pert
"Subject 2, Family 1, Asymptomatic",pert
BMM_C3H/HeJ_time0h,ctrl
BP patient 75_biological replicate 1,pert
Patient no. 15: treated,pert
ApoD KO rep_2 (CKO2),pert
CXCR4 knockout 4,pert
HMEC X BC1369,pert
K562 DMSO sample 11,ctrl
Pooled PBMC sample from normal control subjects (139PBMC),ctrl
"RES-enriched Grape extract group, 6 months, patient number 41",pert
breast cancer patient 258,pert
erStress_twins_AA_1733twin1_DMSO_4h,ctrl
HD 6,ctrl
GM19238_Kd_NS_P6_12,ctrl
E2A-deficient DN2 replicate 3,pert
"Control cells, rep1",ctrl
DS1-iPS 6,pert
X6752318020 F MYC negative#3397,ctrl
genotype: Kdm2b knockdown;	strain: inbred 129;	cell line: E14;	cell type: embryonbic stem cells,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 206,ctrl
chip number: 21;	transfection plate: 5;	target gene: ZHX2;	kd level: 0.51;	rin: 9;	transfection date: 2011-10-17,pert
PDAC_3,pert
GNMT-KO mouse hepatocytes (sample 3),pert
subject id: 35;	infection: DENV;	status: DF;	tissue: whole blood,pert
SKNSH MECP2_e1 2,pert
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 1;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
genotype: wild type;	tissue: triceps muscle;	age: 3 months,ctrl
G_LS_Wk1,pert
heart_co_6M_rep3,ctrl
siCtrl.exp1,ctrl
MCF-10A shATR-3 replicate 3 [set 5],pert
X6752318020 E MYC positive#3397,pert
3T3F442A-shGFP-rep1,ctrl
MacularDegen-healthy-8bAv2-s2,ctrl
M24met_Wnt1_2,pert
chip number: 14;	transfection plate: 3B;	target gene: NFE2L1;	kd level: 0.83;	rin: 9.5;	transfection date: 2012-03-26,pert
Disease_status: Healthy control;	Age (years): 49;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.72;	Post mortem interval (hours): 45;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Bl6_Mock_2,ctrl
gender: Male;	age: 25;	post-mortem delay: 12h;	ph: 6.6,ctrl
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: siRNA against TET1 transcript,pert
tissue type: Malignant prostate tissue;	tmprss2: ERG fusion status: positive,pert
patient: 270;	current medication: Becotide inhaler;	birth date: 4/30/52;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/99;	diagnosis date: 8/24/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 8/24/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 8/24/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: NEW;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Asthma;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
Cas 1,pert
Adult Sham; Biological replicate 4,ctrl
strain background: BALB/c;	cell line: 4T1.2;	stably transfected with: pMSCV retroviral expression vector system the base vector (BV);	expressing: base vector (BV);	tissue: Mammary Tumour,ctrl
Glioblastoma_12,pert
cell type: bone marrow cells;	strain: DBA/2,ctrl
"Acute Myeloid Leukemia, sample 59",pert
age: 49;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
GFP-kd_ES_rep2,ctrl
PGA_MI_nilv_1h_394,pert
"nasopharyngeal carcinoma, specimen T11",pert
cell line: IGROV-1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
WT_P60,ctrl
nmMLCK-/- -SB replicate 1,pert
lymphoma_7890_nt,ctrl
OVCAR3_rep2/CD157_norm,pert
B6C3F1/J Vehicle liver sample batch 1,ctrl
"Nickel 40 µM, biological rep1",pert
MDA-MB-231 RRP1B over-expressing clone #10,pert
Cell line established from CA2 HESC using pClip vector,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 24h ID133,pert
"3T3-L1 siLSD1 48h, biological rep 2",pert
expression array - O3,pert
tMLL09,ctrl
Mtb infected-42d-4,pert
mESC_undifferentiated_Alkb1-/-_rep3,pert
"patient 044b, normal, homogenized",ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 3x1h exposure per day",pert
"Primary, localized, pooled tissue, prostate cancer",pert
control appendix,ctrl
"treatment: diclofenac;	batch: 2;	donor: 28;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
C57BL,ctrl
"amnion mesenchymal cells, no treatment, biological rep2",ctrl
SKBR3_0.1uM_Lapatinib_1,ctrl
K14deltaNB-cateninER Time 0 replicate 1,pert
diagnosis: NSIP;	fvc-group: FVC3;	tissue: lung,pert
FBooth-MDX-4Av2-s2,pert
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 2,pert
ATF2 WT-3,ctrl
T1C-LU,pert
cell line: HEK293 cells;	transgene: NPAP1/C15orf2;	treatment: induced,pert
"fibroblast, MFS subject GDO32 rep 2",pert
"AD_HI, biological rep6",pert
strain: 129/Sv;	group: control;	genotype (hdh cag repeat length): 7/7;	differentiation status: undifferentiated,ctrl
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: resistant,ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 23;	maternal age: 22,pert
Patient 11,ctrl
U87 untreated rep1,ctrl
gender: Male;	tissue: Tendon;Subscapularis;	age: 44;	donor: 33;	disease state: Non-lesional,ctrl
siEGFP (72 hr) _1,ctrl
mdx gastroc sample 2,pert
Control 4 b,ctrl
"Deltoid, control, cohort 09, subject 09U",ctrl
HA96-61B,pert
agent: Chromium 1 µM,pert
microdissected breast cancer cells from case 763,ctrl
patient: 22;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
PGA-MAH-C3H_PBS24h-5aA-s2,ctrl
tissue: aorta;	genetic background: C57BL/6J;	genotype: APOE-deficient;	treatment: vitamin E;	sample type: aortas from vitamin E-treated APOE-deficient mice,pert
db/db 8wk 2,pert
Healthy CD4+T cells 1-TP,ctrl
tissue: liver;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
Wildtype liver DEN-injected 12weeks repl1,ctrl
"Donor 2, mock infected 1hr",ctrl
BP26,pert
PBMCs_Control_7 [IS],ctrl
chip number: 18;	transfection plate: 3A;	target gene: SP3;	kd level: 0.62;	rin: 9.7;	transfection date: 2012-03-26,pert
RKO_liver_fasted_refed_3hr_rep2,pert
"wildtype liver, biological rep 2",ctrl
chondrocyte_5azatreated_rep1,pert
EA_Case1_CD4,pert
ALS gray matter 7 Sporadic,pert
Infergen_6hr,pert
MA_16,pert
strain/background: C57BL/6N;	genotype: Ctnnb1 flox(ex3)/+;	tissue: tumor,pert
Lung WT-PBS replicate 2,ctrl
"human failing LV myocardium, Ischemic45",pert
phenotype: control;	gender: female;	case_id: 477;	age: 52;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 11;	brain ph at time of freezing: 6.21;	labeling_batch: 1,ctrl
Genotype: MMTV-c-myc/Hunk KO; Gender: Female; Tissue: Mammary gland tumors; Strain: FVB,pert
"subjects: heart-beating, brain-dead donor;	tissue type: normal aortic tissue",ctrl
Intestine_Ctrl_biological rep1,ctrl
Allo-14-3,pert
Clozapine treated 4weeks AffyGC RMA rep1,pert
tissue: kidney;	protocol: intravenous;	agent: vancomycin;	dose: 200 mg/kg,pert
tissue: Temporal cortex;	age: 90;	Sex: M,pert
Scd1+/+ on very low fat diet (TD03045 from Harlan Teklad) replicate 1,ctrl
14-week-old Trim24-/- liver_395M,pert
cMetKO CSC Technical Rep.1,pert
HUVEC/NmenMC58_WT_6h_rep1_1102,pert
VMM-MUT_MyoD24h-3MP-s2,pert
Cyclophosphamide-treated spleen 1 day - Biological Replicate 1 - Technical Replicate 1,pert
mutant_ANT_PDE_9-1,pert
Mut+/- rep2,pert
"WT CD8 memory T cells, biological rep3",ctrl
brain_OFC_control C_mr381,ctrl
"brain, cerebellum: KCx12w#2_e1_le1",pert
Normal PBMC Sample 1,ctrl
"patient: 233;	current medication: Asacol 1.2g Asprin 75mg Amilodipine 10mg;	birth date: 2/2/29;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/92;	diagnosis date: 1/1/92;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/1/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/86;	smoking amount: 15-24;	other illnesses: MI 1986, Prostate cancer 1994;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
H1P_8,ctrl
MDS patient 180,pert
striatum SNCA knockout 6 month replicate 1,pert
cell line: non-small cell lung carcinoma cell line H1299;	protocol: PTD-DRBD-mediated siRNA delivery;	time: 24hr,pert
Ishikawa_Control_48h_rep3,ctrl
"SWR/J SAL, Rep1",ctrl
CD4IncTp1-2,pert
OVCA433+(2),pert
MPM tumor 41,pert
FBooth-CON-1Av2-s2,ctrl
"brain, cochlea: [10] Sample #10_le1",ctrl
Normal cervix epithelium_03-3505,ctrl
"human failing LV myocardium, Idiopathic77",pert
high grade serous carcinoma_patient 6,pert
Diaphragm 112 Day control rep 3,ctrl
GIST_WT_3,ctrl
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with acetaminophen (APAP)_2,pert
Wild type 3,ctrl
Skin_Tcfap2c Mutant E16.5_rep2,pert
14: FCHL patient #99-0712,pert
H1P_4,ctrl
1IDC_normal_ductal,ctrl
MPA 6,pert
gender: female;	batch: 2;	age (years): 44;	patient id: Non_severe_2;	fev1 (% predicted): 87;	fvc (% predicted): 92;	medication: flixotide;	cell type: CD8+ T-cells,pert
WildType_3,ctrl
pediatric AML S35,pert
7 Ko,pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: abiraterone,pert
pt. HCL F treated with Vemurafenib 1000 nM for 72h,pert
"E2-treated cells (24hr), biological rep_1",pert
ab147 N,ctrl
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 15",pert
RNA-DHL4-R406-24H-1,pert
HF0931_U133P2,pert
Waldenström’s macroglobulinemia (WM-PC 33161),pert
Untreated Myd88 knockout - repeat 3 - mAdbID:102773,pert
s2t1c,ctrl
"brain, Entorhinal Cortex: 00-28 tangle_e1_le1",pert
normal liver tissue,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: untreated; biological replicate: 2,ctrl
RptorKO CSC Technical Rep.2,pert
3449-1 E2F WT,pert
tissue: non-neoplastic salivary gland;	organ site at which tumor arose: submandibular salivary gland;	donor sex: unknown,ctrl
BCR-ABL1-control rep 2,pert
Day 14 (T3+4),pert
Subject 5 Post allergen challenge,pert
"cells treated with Vamp7 siRNA, biological replicate 3",pert
MLL_00120,pert
Wild type IFN-gamma 4 h,ctrl
Fog2flox/delta; alpha MHC Cre biological replicate 3,pert
Mutc-Met_1,pert
Blood_Control 7,ctrl
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P7,pert
tissue: white blood cells;	age: 15.23;	Sex: male,pert
a10a.000606jd.2.SkMNor911.CEL-IS basal,ctrl
CA1 Cre Sox7I,pert
1011-03-A-b,pert
"Normal skin from lmq_control mouse, biological replicate 2",ctrl
"human failing LV myocardium, Idiopathic57",pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 24 hrs AP20187,pert
WT4 SPLEEN,ctrl
human_hepatocyte_400uM_Trovafloxacin_donorB_24hr_prep2,pert
cell line: OVCA433;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
tissue: neocortex;	developmental stage: E14.5;	genotype: Eomes KO;	genetic background: C57BL\6,pert
KO_IL-6_100_rep3,pert
type_of_rx: AF;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 68;	baseline tumor size (cm): 8x8;	patient id (to identify the 2 chips from the same patient): 12781328,ctrl
Liver_Female_WT_rep1,ctrl
24A;pretreatment;female;breast tumor,ctrl
Wild type 1,ctrl
"A673 treated with DMSO vehicle control for 24 hours, biological rep6",ctrl
Wildtype iPSC sample 2,ctrl
"wild-type DP cells, biological rep 1",ctrl
T2D-LU,pert
"SKO-transduced MEFs, Vc-, D6",ctrl
SKMEL28_t6h_rep2,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: E;	experimental sample name: PC7-R,ctrl
28GOBMUC2A,pert
5223 UC Inflamed sigmoid colon,pert
CD11b+Gr1- cell sample_5 (derived from wild type mouse),ctrl
"Patient I-u58T, MSI colorectal tumor",pert
gender: male;	age (years): 50;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
healthy control H07,ctrl
"Endometrium, postmenopausal, control, 33",ctrl
MCF7_E2_24h_rep2,pert
GM19238_Kd_RXRA_3,pert
strain: BALB/cByJ;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: non-infected,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 4x1h exposure per day",ctrl
DND41 NBD 1,pert
"SWR/J ACU, Rep2",pert
25 uM cyfluthrin batch 2,pert
208/4,ctrl
K562_ICL670_10uM_dup1,pert
PGK12.1_control RNAi-1,ctrl
EA_Case16_CD4,pert
scram_lo_1,ctrl
sample 1:;	age: 45;	gender: female;	sample 2;	age: 81;	gender: female,pert
Epididymal adipose GPR120KO ND #718,pert
cell type: Primary hepatocytes;	donor: 6;	agent: control;	time: 6h;	gender: Male;	age: 73 years old,ctrl
Normal mucosa 15,ctrl
cell line: HuT-102;	cell type: human cutaneous T cell lymphoma cells;	transfection vector: shRNA expression vector against TAK1,pert
"human failing LV myocardium, Idiopathic29",pert
osteoblast_5azatreated_rep2,pert
"A673 treated with Puromycin for 24 hours with concentration of 0.18 uM (2 x EC50), biological rep2",pert
WT Tibialis Anterior at 4 weeks biological rep2,ctrl
"Control, standard diet, rep3",ctrl
MS25_4A_LV_220307,ctrl
GM19238_Kd_E2F6_1,pert
MCF7_CHX_EtOH_24h_rep3,pert
TTE3 cells treated with BPA for 6 h-1,pert
subject: 12;	disease: TD;	muscle: GR;	gender: M;	age: 15.6;	gmfcs: N/A;	popliteal angle: N/A,ctrl
cadmium_08hr_rep1,pert
62 y/o male,ctrl
cell type: Primary hepatocytes;	strain: SV129;	agent: control;	time: 24h;	gender: Male;	age: 4 months,ctrl
"seminoma specimen, pT1, patient age: 51y",pert
F9 con sample #1,ctrl
"patient 027b, normal, homogenized",ctrl
cell line: Du145-PCAT1 (HTB-81);	age: < 20 cell passages from derivation,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.767;	OD280: 1.439;	Ratio: 1.87;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 133;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"13B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
age: 35;	sex: M;	disease status: control subject;	Filter number: 87;	Usage number: 5;	Exposures: 3,ctrl
WT White adipose tissue (WAT)_HFD_rep2,ctrl
CHF - LV09,pert
TARBP2 over-expression (pCMV-TARBP2-2)_MDA-231,pert
sXBP2_1578R,pert
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 6hr.;	Mouse supplier: Charles River.  Cultures were completed in Frank Beiers laborartory by Veronica Ulici and Claudine James",ctrl
"from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE, CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
0198-01-c,ctrl
"49B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 18h,ctrl
Donor6_6h_DMSO,ctrl
ILD Study Number 1236,pert
mock-4,ctrl
2h 4OHT-treated-sample3,pert
"E12.5 wild-type embryonic kidney, biological rep2",ctrl
LY2 SRC1-siRNA untreated rep1,ctrl
mdx Biological Replicate 5,pert
"DMD skeletal muscle, biological rep11",pert
A SIT_B035,pert
tissue: colon;	cell line: HT29,pert
R4_saline_wildtype_422,ctrl
ubb_d7_wt_2,ctrl
breast cancer patient 316,pert
"brain, cerebellum: RNA#1S_le1",pert
ko 13.5d replicate 11,pert
Normal cervix epithelium_CaCx5,ctrl
"female,21,Caucasian",ctrl
CME-LaminA0d-2MA-S2,pert
age: 67;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
ME180 1 hour rep 4,pert
10 week mutant spinal cord rep 2,pert
Day: 6; Drug: Saline; Phase: Drug treatment; Replicate: 2,ctrl
Cutaneous psoriasis without arthritis PsC 13,pert
CONTROL;	Age = 24;	Sex = F,ctrl
strain: C57 BL6NCr;	tissue: Distal colon;	genotype: Myd88-/-,pert
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14476;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
MDS patient 95,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 14 months,ctrl
Normal heart_G67,ctrl
Tendon_lesional_rep13,pert
Gata-1 Knock Down B,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Supraoptic nucleus,ctrl
strain: C57BL/6J;	genotype: HDC-EGFP/HDC-KO;	age: 7 months;	tissue: colon tumor;	cell type: CD11b+Gr-1+ myeloid cells in the tumor stroma,pert
"age at diagnosis: 66;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N2a;	er: 0;	pgr: 0;	dfs-month: 25;	dfs-event: 1;	distant metastasis: 1",pert
HEK001_A08_R1,pert
"p63shRNA_B1, p63-depleted",pert
Snell 22 month Dwarf Liver 3dw,pert
"WM35, no treatment",ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: DMSO for 48h,ctrl
"spleen marginal zone B in WT, biological rep1",ctrl
colon_adenoma_1748,pert
source: Breast adenocarcinoma;	cell line: MCF-7;	treatment: ethanol;	knockdown: FOXM siRNA,pert
Sample ID: TP23;	Twin Pair ID: CCN3.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 25;	Current Age (2007): 28;	Sex: MALE;	Medication at blood sampling : None,ctrl
pre-iPSC- siRNA to luciferase- biological replicate3,ctrl
"AD_FC, biological rep8",pert
"age at diagnosis: 35;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 5;	dfs-event: 1;	distant metastasis: 1",pert
cell type: CFBE41o-  wt-CFTR,ctrl
heart_WT_rep2,ctrl
major non-tumor4,ctrl
LNCaP + vehicle rep 1,ctrl
Native wt biological replicate 3,ctrl
MCI-018,pert
"Patient 6, Atheroma plaque",pert
12487 UC Uninflamed ascending colon,pert
thyroid sample containing tumor cells,pert
"Control cells, rep3",ctrl
"Cell type: endothelial, age:55, gender:male, diagnostic group: control, PMI:31h",ctrl
genetic background: c57/bl;	gender: male;	tissue: heart;	genotype: control,ctrl
PBMCs_Control_2 [IS],ctrl
"Affymetrix chip HG-U133A, siLuc 3",ctrl
cell type: Melanoma cell line;	cell line name: A375P;	expression: Control shScr,ctrl
P62 Non failing heart biopsy,ctrl
liver_Wt_35wk_rep2,ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 4,ctrl
AhR-KO2 melanocytes,pert
"Strain: Wild-type, C57Bl/6 background;	Gender: female;	Age: 28 days;	Eye: Left",ctrl
Human Acute HIV Sample A064-CD8+ T cells,pert
RAW_3.5mM_HOCl_#2,pert
"ADAM17 cKO skin, rep1",pert
R2_saline_wildtype_48,ctrl
E14 - 14-3-3Epsilon 3,pert
Individual_5030_NN_sample,ctrl
"non-AD_TC, biological rep15",ctrl
C_AN00142_C,ctrl
C57BL6,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A07",pert
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T3, N3, G4",pert
NPC25,pert
tissue: skin;	individual: Patient N-8;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
"brain, hippocampus: C1-I_e1_le1",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 72h",pert
"Strain: C57BL/6, Tissue: Airway Epithlium, Culture: Organotypic Air Liquid Interface",pert
AAA neck (Sample 1),pert
Tissue: brain (frontal cortex);	Disease state: HIVE,pert
Genotype: p38alpha KO;	Age: E13.5,pert
A HID U_B016,pert
MGHU3 Cells_TAK1 siRNA + PD173074_Biological Replicate 3,pert
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 48h,pert
LPS-PVH_1,pert
A_Ctrl_1,ctrl
S25 NLS 142Q TG1	F4/23	S25	NLS Htt exon 1 142Q	Mouse	3 months	Cerebellum	Male,pert
Normal Sample 1,ctrl
"alveolar macrophages, smoker 041",pert
3880-1 E2F WT,pert
"Pineal gland from control mouse at ZT20, biological rep 1",ctrl
agent: Nickel 40 µM,pert
"seminoma specimen, pT3, patient age: 42y; W00 048",pert
"PBMC, healthy control, biological rep15",ctrl
AKT_PLACEBO_12hours_3,pert
coc-38_C,pert
liver 0.1% quercetin diet rep4,pert
SLE CD19 B cells 4,pert
Eed KO E14 ESCs on day 0 #2,pert
129_Sv_3_Runx1_Ko_d6_4302,pert
"TNFa-OMe siRNA-B, replicate 3",pert
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 1 - Technical Replicate 1,pert
HA01-57A,pert
Muscle KO Adult 01031,pert
Kidney_KO_baseline_rep1,pert
VGLL4 HUES6 3,pert
Individual_5281_NN_sample,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 90min;	race: White;	sex: Female,pert
NCI-H69 human small cell lung cancer,pert
"Deltoid, control, cohort 15, subject 15V",ctrl
colon_adenoma_983,pert
Ovalbumin-induced inflammation 24 hourS,pert
"0mg/kg/day PFOA, Rep 1, Block 5 liver (low dose)",ctrl
male_control_335,ctrl
H14_P_B1,ctrl
DC3 RSG,pert
Squamous cell carcinoma 010,pert
AP-920051,pert
PND28 Rat Testis_Rat230-2_12hr MEHP_Animal#59_04005,pert
scan batch: Batch 1;	group: autism;	subject age: 3;	paternal age: 46;	maternal age: 42,pert
tissue: brain;	genotype: mutant Ndel ko/cko;	age: E14,pert
HDAC2 WT E17.5 Ventricle 2A,ctrl
Human Acute HIV Sample A189-CD4+ T cells,pert
"MLD, biallelic AML MLL_00235",pert
WFS1 WT USHT_14_317_ko,pert
Itk knockout unstimulated 1,pert
TAp63 alpha 24h without induction s3,ctrl
Vehicle-Control 24 hours set 1,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 29;	maternal age: 32,pert
Muscle Experiment 2,pert
"prdm-control, biological rep2",ctrl
"PCB77 treated HepG2 cells at T0.5, biological replicate 2",pert
PE_N_562,ctrl
si FoxA1 and vehicle replicate 1,pert
condition: Psoriasis;	patient: PS-B;	tissue: LS skin biopsy;	kit: Affy,pert
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep1,pert
cell type: sorted LSK cells;	strain: C57BL/6;	genotype/variation: SRF KO,pert
Ramos pRTS-GFP C+,ctrl
36/OVX/oil/6h/UTX 129 Hoxa-10-/-,pert
patient: 17;	disease state: hypertension;	tissue: Atheroma plaque,pert
6 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24719,ctrl
cell line: A549;	agent: azacitidine;	dose: 0.3uM,pert
"fibroblast, MFS subject FB836 rep 2",pert
brain_DLPFC_bipolar B_mr547,pert
homozygot FH P269,pert
U937_ROS_curcumin_4h_rep2,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 4;	gender: male,pert
Tgfbr2 fl/fl Control Posterior Palate 6,ctrl
PCOS Endometrium Endothelial Cell_140.UC271+-,pert
Endometrium/Ovary-Disease 7,pert
T7F-LU,pert
Ls174T-L8 con1,ctrl
control rep 4,ctrl
patient: 40899;	sample: tumor,pert
sample: #19;	subject: PD case #4;	brain: T-9;	age: 74;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
66 year old male,pert
chip number: 16;	transfection plate: 4;	target gene: HCST;	kd level: 0.86;	rin: 9.2;	transfection date: 2011-10-17,pert
MEF E2F4 KO 1-rep2,pert
PGC-1a-/-bf/f/MerCre rep5,pert
HepG2_As rep1,pert
Donor3_6h_Wy,pert
Liver Experiment 3,pert
UC-71-Aff,pert
rtTA-Dmrt5_d9_-Dox_rep_1,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 202,ctrl
MDS patient 71,pert
Postmenopausal female. Tibolone treated. Patient 16.,pert
"Quercetin, sample 3",pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep8,pert
"control, BA46-49",ctrl
Normal Adrenal Gland (AN26),ctrl
APLP2_R6_rep1,pert
S-IIP(UIP)3_Cy3,pert
BALB-RAG_PBS Replicate 3,pert
Pediatric_GBM_2,pert
BP7,pert
Msgn1_24hPlusDox-biological rep1,pert
disease state: Control;	tissue: peripheral blood,ctrl
Ad infected murine liver-MO30k-(666)-6 hpi,pert
NLGN1_1,pert
3T3F442A-shTRPV4-rep2,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.02;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 31;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: NG4;	cell type: embryonic stem cells;	transfection: siNonTarget,ctrl
scram_lo_3,ctrl
"2 months, sham group, biological replicate 2",ctrl
"vector d0, rep 4",ctrl
430: control mouse 1,ctrl
subjectid: 5258;	imatinib: NoIM;	lbh589: NoLBH,ctrl
GM19238_Kd_KLF13_2,pert
"Patient #8, Untreated",pert
Control (0.1% DMSO) rep 1,ctrl
Mist1KO saline rep3,pert
"Wild type GM-BMMs, biological rep2",ctrl
"KARPAS-231, non-targeting siRNA, REP3",ctrl
Nrl-ko-Gfp E16 replicate 2,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: trisomy8,pert
"CTR-B (CTR-2, biological replicate 2)",ctrl
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 49;	age-at-onset: 48;	geographical origin: Porto;	clinical characteristics: Diabetes, hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",pert
Normal-N_LJ_10,ctrl
WT7,pert
SeroTest-10,pert
34n,ctrl
Control (C80),ctrl
IFN/Vit-KO,pert
M249_R4_A_PLX,pert
2.5uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate B,pert
MLL_PTD03,pert
strain background: C57BL/6N;	genotype/variation: Sta1 Wildtype (wt);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),ctrl
chip number: 12;	transfection plate: 3B;	target gene: ESRRA;	kd level: 0.82;	rin: 9.2;	transfection date: 2012-03-26,pert
Muscle JDM (YJD-JDM-19UA-s2),pert
Common Reference 2 round amplification 2 ug,ctrl
coc-51_A,pert
"Sv129/C57B6 hybrid strain, 12 week old male",pert
S3C Sporadic-hippocampus,ctrl
24h Lipofection GAPDH siRNA (SAMPLE 11),pert
4-HPR_LUNG_1,pert
OA 3,pert
mouse liver D1,pert
"Diclofenac treated HL-60 cells, biological replicate 2",pert
IDCM2,pert
brain_DLPFC_bipolar B_mr520,pert
Patient 7,pert
1 PC3 0hra,ctrl
Zfx fl MA9 cells + Vehicle [10950],ctrl
"brain, frontal cortex: Sample43_e1_le1",pert
Pancreatic Sample 22-Tumor,pert
EA_Case3_CD8,pert
"wt total RNA LSK, rep 1",ctrl
STAT1-deficient naïve T cells stimulated for 3 hours with medium alone 3,pert
MSE_D_678,pert
"TH cells from LC, Mecp2 null, young time point, biological replicate 3",pert
imanitib8,pert
"breast, pre AFI treatment (H2_1279)",ctrl
01LNY_PolyRF+,pert
KO - knock-out Untreated - 0 hrs - repeat 3 - Cy5 - mAdbID:51300,pert
"control, subject 4",ctrl
CD8 KLF13 WT 1,ctrl
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14501;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Ileum",pert
Ls174T-pTER-β-catenin dox2,pert
Patient: D;	Time: 0;	Group: responder;	Condition: lesional,ctrl
Nonspecific siRNA4,ctrl
control10,ctrl
MS25_5B_MEK5_220307,pert
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep5,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 3,pert
cell line: HepG2;	genotype/variation: control,pert
Control day 05 sample 2,ctrl
DBA d3 (184msn),pert
CAB10_T5_PP_day7_035,pert
C2C12 myotubes 1000uM H2O2 rep 2,pert
PTEN-111 (-/-),pert
gender: Female;	tissue: Tendon;Subscapularis;	age: 61;	donor: 16;	disease state: Non-lesional,ctrl
Tissue: Lung,ctrl
"Undifferentiated C2C12 myoblasts, passage #11",ctrl
Colon_Wild Type_3,ctrl
Muscle-AMPKgamma3-wt-6,ctrl
HSC-3_vector_48hr culture_rep1,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 100 pM;	treatment time: 8 hours,pert
pediatric AML S09,pert
strain: C57BL/6;	genotype/variation: Wild type;	cell type: Regulatory T cells,ctrl
BL Day 1 siSC transfected biological rep4,ctrl
Psoriasis-8 baseline,pert
sample 1:;	age: 51;	gender: male;	sample 2;	age: 84;	gender: female;	sample 3:;	age: 74;	gender: female,pert
"Control, biological rep12",ctrl
GM19238_Kd_E2F1_2,pert
"5 x 10^4 Zfx-cko LSK (Lin-, Sca1+, c-Kit+) cells were sorted directly into Trizol Reagent (Invitrogen) form pooled bone marrow cells from Zfx-cko mice.",pert
Interleukin_6_3,pert
V5-P355,pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EED. Sample A,pert
KU-812 Imatinib-treated,pert
Wild Type 8,ctrl
cell line: SCC25;	tissue: tongue;	cell type: epidermal keratinocyte,ctrl
OE-NANOG_1,pert
cell line: HEK293 cells WTX inducible clone F18;	agent: doxycycline,pert
Run3.aUa.010110d.SkMDbt1136D.CEL-DB basal,ctrl
"schizophrenia, BA46-40",pert
age_years: 34;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
LNCaP + vehicle rep2,ctrl
scan batch: Batch 1;	group: autism;	subject age: 8;	paternal age: 33;	maternal age: 29,pert
KO PBS2,pert
MCE301 cells treated with SB for 6 h-2,pert
HC CJ 2 water,ctrl
jzo013-rp1-v5-u74av2-met,ctrl
short-Rif1 KD rep1,pert
"10mg/kg/day PFOA, Rep 3, Block 3, lung (high dose)",pert
"normal skeletal muscle, biological rep3",ctrl
Severe rep2 (retina),pert
reduction mammoplasty patient 357,ctrl
"nasopharyngeal carcinoma, specimen T10",pert
non-transgenic spleen B cells_20 weeks,ctrl
Muscle WT Aged 0121,ctrl
sex: Male;	Age: 15 months;	additional patient information found in Series supplementary file,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 99min;	race: White;	sex: Female,pert
siRNA-96_rep2,ctrl
normal plasma cells (NPC 545),ctrl
MPA-treatment for 48hrs,pert
ALS gray matter 6 Sporadic,pert
hippocampus: Sample #6_e1_le1,ctrl
VEC C,pert
strain: C57BL/6J;	cell type: bone marrow derived macrophage,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_2h_Con_HG-U133A_2_YCHSUP501,ctrl
HeLa_TP082505_23_HG-U133A_2_IMFGN0023,ctrl
Large cell carcinoma 013,pert
224 Day 2 siSC transfected biological rep2,ctrl
15DKD_SerumStarved->3hrEGF_rep2,pert
BCell_lymphoma_transitional_sample1,pert
18.5 dpc mouse small intestine wild type,ctrl
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: control,ctrl
cell type: mammary epithelial cells;	cell line: MCF10A Cells;	genotype/variation: Ctr MCF10A.B2,ctrl
DRG_Capsaicin_10microM_Rep2,pert
Healthy CD4+T cells 11-RP,ctrl
ve_M47,pert
strain: C57BL/6N;	genotype: wildtype;	tissue: liver;	age: 5-6 months;	gender: male;	treatment: streptozotocin,pert
FU-OV-1+(2),pert
Muscle JDM (YJD-JDM-30UA-s2),pert
"CD8 DC Xbp1 KO (DC conditional KO), biological replicate 1",pert
Sex: female;	Age at operation: 69 years;	Site: lower arm;	Size in cm: 4.5x3.5x2.2;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,pert
ab171 IM,pert
01LLB_CTRL,ctrl
"MGSKO, PR03M006v0",pert
ILD Study Number S020,ctrl
MDS patient 19,pert
Targretin_LIVER_2,pert
Septic shock;	gender: Female;	Non survivor;	organism: Strep pneumo,pert
shRNA4-1-plusDox-rep1,pert
C2C12 myotubes 10uM H2O2 rep 3,pert
A HID I_B056,pert
Monocyte-RCC-untreated-4,pert
Postmenopausal female. Tibolone treated. Patient 30.,pert
Klf9 wild type (Klf9WT) and mutant (Klf9KO) mice jejunum; Age: PND 30,pert
Sample 9,ctrl
0978-01-C,ctrl
Silberg2 (S2) 021101NE,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 3;	gender: male,ctrl
Wt_ liver_fasted_refed_3hr_ rep4,ctrl
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: standard AIN-93G diet (SD; carbohydrate:protein:fat ratio of 64:19:17 percent of kcal) ad libitum for 8 months,ctrl
NOD Aire WT MEC rep2,ctrl
Differentiation of hES cells line VUB03_DM1 towards MPC-like cells;	Mesenchymal stem cells phenotype,pert
Strain: NMRI mouse;	Age: 14 d embryo;	Tissue: molar tooth germs,ctrl
Cervical Cancer C494,pert
V5-P343,pert
Tendon_non-lesional_rep8,ctrl
MCL_IGHV_UNMUT (R1680),ctrl
WT_IL-6_400_rep1,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 37;	maternal age: 32,pert
quiescent ulcerative colitis_UCN3,ctrl
"Histidine decarboxylase null myeloid-derived suppressor cell from bone marrow, rep1",pert
KO Tibialis Anterior at 4 weeks biological rep1,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 4;	biological rep: 2,pert
Fibroid_2525A,pert
"A673 treated with Doxorubicin for 3 days with concentration of 59.88 nM (EC50), biological rep2",pert
HRas-v12 transgenic male replicate 1 early timepoint,pert
PTC BRAF mut 4,pert
"E18.5 ERRg +/- heart, biological rep 2",pert
whole tissue section from case 1037,ctrl
Infergen_6hr_rep4,pert
non-malignant FTEb_patient 2,ctrl
treatment: siThoc5;	cell line: HeLa,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 10",ctrl
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: DMSO 72 hr,ctrl
2B1_Dlx5_replicate1,pert
wt #4. 464,ctrl
"Biceps, FSHD, cohort 18, subject 18A",pert
shRNA6-16-plusDox-rep2,pert
Mouse fetal liver_E14.5_WT_rep2,ctrl
HEL_Control shRNA (GFP)_2,ctrl
patient id: T79;	tissue: Normal cortex;	gender: Male;	age: 59;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
BALB/c BMDM infected with WA(pYV),pert
"Uninvolved Skin, NS-3",pert
PND28 Rat Testis_Rat230-2_6hr MEHP_Animal#31_04005,pert
Ulk1/2+/+ + IFNβ 3,ctrl
NALM-1 Imatinib-treated,pert
tissue: white blood cells;	age: 13.87;	Sex: female,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 318;	age-at-biopsy-years: 38,pert
colon_C57 mouse_12weeks_rep2,ctrl
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S25_3 months_replicate 2,pert
THP1-shGSK3A-Construct5-rep2,pert
baseline control 08,ctrl
hair bulbs only from 9-day-old mice,pert
remitted schizophrenia patient  S16,pert
Male wild-type BALB/c,pert
MCF7 - MTDH_WT_KD_1,pert
"Patient H-c340T, MSI colorectal tumor",pert
801B.LMP,ctrl
Huh7 cells_JFH-1 Infected 6 hours_ rep3,pert
MDA_PR_Paclitaxel_1,pert
fat_Akt1+/-_8wk_rep1,pert
Pancreatic Sample 35-Tumor,pert
"Crohn's Disease subject (38 year old caucasian male, SAK_1316800947)",pert
HeyC2-(3),ctrl
Liver_normoglycima_no.5,ctrl
DP AA4+ replicate 2,pert
autism with FMR1-FM AU066703,pert
coronary smooth muscle cells nebivolol replicate 3,pert
male;	36 yr old;	Hispanic,pert
RatLung_Con_3,ctrl
"4302_CD133-, laminin treated",pert
Patient identifyier: E;	Sex: male;	Age of patient: 51 years;	Duration of psoriasis: 24 years;	Body surface area: 8 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
"Normal Skin, Normal-18",ctrl
mouse cerebellum at P30 knockout 1,ctrl
Msgn1_48hMinDox-biological rep2,ctrl
original diagnosis: PolyRF+;	cell type: Peripheral blood mononuclear cells,pert
"Ulcerative colitis patient, biopsy taken from the descending colon, macroscopic inflammation vissible",pert
MOLF/EiJTCE liver sample batch 2,pert
"C3H/HeJBir, sample 2",ctrl
OCI-Ly7_ctrloverexpression,ctrl
PCOS Endometrium Epithelial Cell_138.UC271 EpCAM,pert
"vestibualr organ at E18.5 of Igf1 +/+, biological rep 3",ctrl
Tendon_lesional_rep4,pert
MDA-MB-231 control clone #4,ctrl
Liver Rosi1,pert
"p38alpha wild type fetal liver E13.5, biological rep3",ctrl
disease state: endometrioma;	patient: 14,pert
obtained from RIKEN CELL BANK,pert
disease affected colon of an adult with bacterial infectious colitis (INF).,pert
race: caucasian;	age (years): 60;	stage: IB;	grade: 3;	histology: endometrioid,pert
38n,ctrl
N5A Normal-frontal,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 80min;	race: White;	sex: Female,pert
N_LS_Wk2,pert
age: 6 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,ctrl
ku86(wt)_Terc(ko)_1,pert
"YAP-overexpressing cells, biological rep2",pert
sample =Healthy4 treatment=Control time=360 (min),ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID322,ctrl
neocortex-30 months of age-resveratrol diet-biological replicate3,pert
"Bmi1 shRNA, biological rep1",pert
"WKY adrenals, replicate 1",ctrl
SKI-DLCL cells_untreated_24h_1rpt,ctrl
age: 12 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 wild type,ctrl
HUVEC/NmenMC58_WT_6h_rep2_1108,pert
heart-30 months of age-control diet-biological replicate5,ctrl
CTL2 AO 8hr,ctrl
OA 2,pert
"nasopharyngeal carcinoma, specimen T7",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: monosomy7/del(7q),pert
"48 hour-treated TG2 knockout NB4, biological rep3",pert
H1299 AZA 1 uM (3231),pert
P138,ctrl
"CD8 DC wild type, biological replicate 2",ctrl
HNF4 Control_1192,ctrl
INCB18424 Acute 2,pert
cell line: MCF7 breast cancer;	treatment: SIN3A silenced,pert
Patient: O;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
strain: C57BL/6J;	Sex: male;	expression: sh-scr;	agent: rosiglitazone at 1uM,pert
muscle_Akt1+/-_35wk_rep1,pert
Ishikawa_VeryLowDose_BPA_48h_rep2,pert
"HA-Fbxl10 cell, Replicate 2",pert
"VHL null MEFs, biological rep1",pert
Fetal heart TCDD 3 ug/kg TCDD rep1,pert
"Grape extract group, 6 months, patient number 32",ctrl
SKBR3-R_0.1uM_Lapatinib_1,pert
PML Knockout Mice fed Low Fat Diet 3,pert
MOLM14-shGSK3B-Construct1-rep2,pert
K562_ICL670_untreated_dup2,ctrl
strain: FVB;	genotype/variation: ErbB3 DOX-KO;	tissue: Mammary epithelial organoids;	treatment: DOX,pert
microdissected breast cancer cells from case 1389,ctrl
Muscle PCOS pioglitazone 231,ctrl
Normal myocardium sold commercially,ctrl
"Biceps, control, cohort 22, subject 22U",ctrl
nucleus accumbens long access to cocaine replicate 1,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-5;	Primary Site:Tongue;	Age:64;	Sex:M;	TNM:T1N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
MDS37,pert
tissue: retina;	age: postnatal day 2;	genotype: wild type,ctrl
Disease_status: Bipolar disorder;	Age (years): 49;	Gender: Female;	Age of onset (years): 20;	Duration of illness (years): 29;	Brain pH: 6.39;	Post mortem interval (hours): 38;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
Tgfbr2 Wildtype Mouse Model MEPM 1,ctrl
ic11 -- cell line 2 treated with APF#2,ctrl
ID4+/+TCL1-tg spleen CD19+ B cells collected from 3 mice 3,ctrl
"seminoma specimen, pT1, patient age: 29y; W03 022",pert
N51292,ctrl
AA_71,pert
BMM_C3H/ARC_time21h,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.98904,ctrl
Glioblastoma_1,pert
V5-P288,pert
Squamous cell carcinoma 009,pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 1",ctrl
MDA-MB-231-ZNF217 cell culture 2,ctrl
Cervical Cancer C538,pert
Run1.a10a.000608jd.2.SkMNor923.CEL-IS basal,ctrl
CKO Wild Type V3,ctrl
13,pert
Treated with 10uM Motexafin gadolinium for 4 hrs -- replicate #3,pert
HepG2_control_rep1,ctrl
Phan_008_KO.saline rep2,pert
EVI_GFP positive Lin- cells replicate 1,pert
1082PBMC,ctrl
AP-2 gamma targetting siRNA 1: AAUGAGAUGGCAGCUAGGAAG Technical Replicate 1,pert
Liver-5 month-wild type-technical replicate 2,ctrl
New El-Ashry 010.CEL,pert
"72 hour-treated TG2 knockout NB4, biological rep3",pert
Male 8weekBL6 shamrep2,ctrl
Diagnosis: Secondary AML;	Age: 36y ;	Gender: Female;	Blast %: 67;	Source: BM;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: No Data,pert
Testis CREMKO 0h batch 4 [TeKOh00.29],pert
"fibroblast, control subject NF6 rep 2",ctrl
CME-Ctr_LaminA4d-2MA-S2,ctrl
treatment: Sirt1 Overexpression;	cell line: Caco-2,pert
Dominant negative cJun  VZ19,pert
Seguin_IDR_BrownNorway_Liver_control4,ctrl
Hippocampus 2001 2 month Old,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 70 years,pert
WT - Cre Treated - 12 hrs - repeat 1 - Cy5 - mAdbID:61753,ctrl
DC3 AM,pert
"PCB153 treated HepG2 cells at T0, biological replicate 1",ctrl
"Testosterone treated, HIV-1 positive male, day 14 (4)",pert
SZ5,pert
IRAK2 KO_macrophages_0h,pert
N8,ctrl
Liver sample of p14 KO mouse 2,pert
H22 Ctrl 24h 2,ctrl
5270 UC Inflamed sigmoid colon,pert
age: 6 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
striatum_ctip2_KO_1,pert
tissue type: adjacent non-tumorous liver,ctrl
PGK12.1_control RNAi-2,ctrl
"patient 15, arm treated with pimecrolimus",pert
5204 Normal Uninflamed sigmoid colon,ctrl
Bronchial Epithelial Cells control biological 1070A,ctrl
MacularDegen-injured-3cAv2-s2,pert
"Liver from Nrf2 wt mice, biological replicate 1",pert
A39 WT6	F2/11	A39	wild type	Mouse	10 months	Cerebellum	Male,ctrl
S1,pert
DOV13-(1),ctrl
control sample 4,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 40 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
strain background: mixed (SV 129/C57BL/6);	genotype/variation: Rnh1 Knock out (Rnh1-/-);	age: embryonic day E9.5;	tissue: yolk sac,pert
"Gender: Female, Age: 27, BMI: 19, Tissue: luteinized cumulus cells",pert
siGL3E2 2,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_6h_1mM_HG-U133A_2_YCHSUP501,pert
Control (pCMV-GFP-1)_MDA-231,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: vehicle control;	treatment time: 8 hours,ctrl
CIS,pert
NOD2-L1007fsinsC_0h_MDP_biological replicate 3,pert
"WT HSC, biological rep3",ctrl
pediatric AML S23,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 1 day;	treatment: 2R4F whole mainstream smoke 125 µg/ml, treatment over 1 day, 3x1h exposure per day",ctrl
15DKD_SerumStarved->3hrEGF_rep1,pert
s6,ctrl
Normal-N_AJ1,ctrl
Mnk_3201-R-B,ctrl
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
"Male, 27 years old, HIV infection of ~1 months",pert
E8.5 ko.2,pert
V5-P451,pert
X_p4_rep4,pert
Wild Type Mice fed Low fat diet 1,ctrl
GLIP3,pert
HEK293_HNF1b_#2_induced,pert
Jejunum_Wild Type_2,ctrl
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shSOX11.3,pert
Liver_Female_WT_rep4,ctrl
race: african american;	age (years): 91;	stage: IB;	grade: 3;	histology: papillary serous,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 21.1863,ctrl
HC JR 2 alcohol,pert
"52B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
Age: 57;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: Yes,pert
monocytes_Q10H2_1,pert
strain: C57BL/6;	genotype/variation: Fcg-chain KO;	cell type: Peritoneal MF,pert
C_AN00544_T,ctrl
0h Kin Cel.44,pert
465MM,pert
CD positive WT T cell unstimulated rep4,ctrl
aa_NY224,pert
strain: C57BL6 mixed FVB;	genotype/variation: cMetflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,pert
C_AN19760_T,ctrl
"seminoma specimen, pT3, patient age: 42y",pert
PBMC from T cell Large granular lymphocyte leukemia patient#100,pert
"Uninfected TG at 5 d.p.i., rep3",pert
Kidney_400 mg/kg VCM iv_mouse #047,pert
"3mg/kg/day PFOA, Rep 3, Block 5, liver (low dose)",pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 24 hr AP20187,pert
"HL-60 + 10 nM TCDD, biological replicate 1",pert
"ES cell control, RNA 296",ctrl
CLL21-CD4,pert
EA_Case12_CD4,pert
heart tissue,ctrl
cell type: Immortalized lung epithelial cells,pert
"Genetic background: mixed 129 and C57BL/6J; Age: 6 weeks old; Gender: female; Diet: chow, non-fasted; Genetic modification: Scd1 -/-.",pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID321,ctrl
wild_type_embryonic_stem cells_biological_rep3,ctrl
2107-03-A,pert
reduction mammoplasty patient 288,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 6 weeks;	Treatment: untreated,ctrl
Diagnosis: AML M5;	Age: 58y ;	Gender: Male;	Blast %: 75;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: No Data,pert
Control d 10 (5),ctrl
SLE myeloid cells 7,pert
F_LS_Wk1,pert
H441 transfected with scrambled siRNA 2,pert
Sirt1 siRNA KD2 3,pert
P4_PMP22KO_1,pert
105A,ctrl
Contralateral 2,ctrl
4: FCHL patient #98-1056,pert
HeLa SCY1-like 1 knock down 2,pert
Normal esophageal epithelium (N8),ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 54, stage IIIB, HPV 16",pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates taken 48 hours after nickel exposure",pert
"iPSC derived from CCALD patient fibroblast CCALD2, biological rep5",pert
"non-AD_FC, biological rep1",ctrl
Human Chronic HIV Sample C080-CD4+ T cells,pert
Fiona Biological Replicate 1,pert
PBMCs_IS_18 [IS],pert
Kidney_200 mg/kg VCM iv_mouse #028,pert
"JCAM1 Lck negative 0 hours, #1",pert
"female Spargue-Dawley rats, Targretin, 60 mg/kg BW gavage for 7 days, tissue: mammary gland",pert
WT V6.5 ESCs on day 3 #2,ctrl
Ileum_Wild Type_1,ctrl
Subject 6 Pre allergen challenge,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 52 years,ctrl
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
scpk/ikLLtumor/90,pert
PBMCs from normal control subject J (JPBMC),ctrl
"liver sample of Wistar rat fed for 12 weeks with lard diet, after overnight fast",pert
gender: Female;	tissue: Tendon;Subscapularis;	age: 49;	donor: 35;	disease state: Non-lesional,ctrl
tissue: skeletal muscle;	disease status: dermatomyositis,pert
shRNA6-16-noDox-rep3,ctrl
Wild-type postnatal day 10 rep 1,ctrl
SZ23,pert
03_PAH,pert
4472-1 E2F3 Heterozygous,pert
Vitamin A fed at age 35-days,pert
NPC_p5ko_rep3,pert
41A;pretreatment;female;breast tumor,ctrl
"Exp A, Animal #246, control (0mg/kg) D-Serine",ctrl
S46 WT3	F5/11	S46	wild type	Mouse	3.5 months	Cerebellum	Female,ctrl
mdx5cv quadriceps sample 2,pert
gender: male;	tissue: heart;	tissue: Transmural sample taken from near the apex of the left ventricle,ctrl
RA2,ctrl
Extract:LOX-1:113201;	Extract Description:GFP_Untreated_2hr:113201;	Quality: Classification:Medium;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.1;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.56;	Quality: Background Mean Dev.:1.93;	Quality: Absent (%):59.17;	Quality: Absent (%) Dev.:0.71;	Quality: Scaling Factor:0.64;	Quality: Scaling Factor Dev.:0.22;	Pretreatment [C]:GFP;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113201;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_2hr;	RNA extraction source key [A]:282295473,ctrl
"Muscle from WT, biological rep2",ctrl
"Sfrp5 KO HFD 8 weeks, biological rep5",pert
"age at diagnosis: 33;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1mi;	er: 0;	pgr: 0;	dfs-month: 51;	dfs-event: 0;	distant metastasis: 0",pert
FACS-purified B cells_IFNAR1-/-_influenza-infected_rep4,pert
MDS patient 67,pert
BP9,pert
"Subject 13, Family 5, Affected",pert
E2C,ctrl
P60_WT_3,ctrl
Aged 9,pert
PGA-MAH-AJ_PBS6h-3aA-s2,ctrl
Patient no. 17: control,ctrl
32SAGEA,pert
"Neurons overexpressing Hes1 and GFP, biological rep2",pert
subject: 2830 WT;	type: wild type;	tissue: Mouse skeletal muscle,ctrl
MDS36,pert
db/db 8-4,pert
patient: 105;	current medication: None;	birth date: 7/29/84;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
Waldenström’s macroglobulinemia (WM-PC 31489),pert
58_129_KO,pert
"disease group: Psoriasis;	Sex: f;	age: 30s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 6.6;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 140;	ige (kiu/l): normal (0-48.5 kIU/L): 18.2;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
Individual_4298_PN_sample,pert
"Peripheral blood, patient with recurrent events [N38]",pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_3 months_replicate 2,pert
"Infected with H37Rv, replicate 2",ctrl
strain: FVB;	genotype: E2F3 heterozygous;	tissue: mammary gland tumor,pert
"human peripheral blood derived monocytes, 2 hour LPS stimulation, biological rep3",pert
T-REx293-NPAP1-uninduced-2,ctrl
Z6_Cont_TA,pert
subject: 8;	disease: CP;	muscle: GR;	gender: M;	age: 16.7;	gmfcs: 5;	popliteal angle: 90,pert
negative control inhibitor (NTC1)_24-12,ctrl
"control_B1, empty vector",ctrl
"G9a knockdown cells, rep3",pert
Embryonic age 14.5 wild-type rep1 (PKD1_58),ctrl
KO 0h TPA rep2,pert
MCF7 cell line_resveratrol_150mM_biological replicate 3,pert
Healthy donor_biological replicate2,ctrl
HF0329_U133P2,pert
KU_41N,ctrl
NPC3,pert
Jurkat Biological Replicate 3,ctrl
RNA from HCC_40N,ctrl
"Monuron-treated NRK-52E cells at 6h, biological rep 1",pert
AAA neck (Sample 7),pert
MEF.WT.E,ctrl
Pt23_Post,pert
14SC-pbo,ctrl
NB4 INFECTED 2,pert
221/0,pert
"HME-CC, 12h, 0.2uM DOX",pert
cell line: HEK293;	genotype/variation: tranfected with SNRK-pEGFPN3,pert
EA_Case2_CD8,pert
"RPMI8226_shKDM3A#2, replicate2",pert
minor non-tumor7,pert
cell line: JCRB0086 [TALL-1];	cell type: human T-ALL cell line;	agent: control,ctrl
"nasopharyngeal carcinoma, specimen T13",pert
chip number: 12;	transfection plate: 3A;	target gene: BATF;	kd level: 0.52;	rin: 9.9;	transfection date: 2012-03-26,pert
mES cells TR71 KD rep1,pert
"Normal cervix, microdissected epithelium, Age 45",ctrl
MKK3bE transgenic male replicate 2 late timepoint,pert
18SAGEA,pert
Healthy untreated rats 2,ctrl
Wt Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-2,pert
esophageal squamous cell carcinoma from patient E1614,pert
sample: #7;	subject: Control case #3;	brain: T-638;	age: 78;	sex: Male;	region: Dorsal motor nucleus of the vagus,ctrl
"A673 treated with DMSO vehicle control for 3 days, biological rep6",ctrl
VCaP/MYB siRNA #3,pert
"Cell type: neuronal, age:44, gender:female, diagnostic group: schizophrenia, PMI:26h",pert
cell type: bone marrow derived mast cells;	genotype: NTAL knock out;	genetic background: C57BL/6;	treatment: none;	vector: none;	activation: 2 h 100 ng/ml TNP-BSA,pert
Moderate rep1 (OHN),pert
KU_38T,pert
"Ada3FL/FL MEF, Cre, biological replicate 2",pert
hNHEPS_control_6 h_rep4,ctrl
"Lesion Skin, LS-22",pert
cell line: A549;	cell type: human lung cancer;	sirna: non-targeting,ctrl
strain: C57BL/6J;	day: 18;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/22,pert
"BOEC, normal 17",ctrl
Control spleen - Biological Replicate 1 - Technical Replicate 2,ctrl
"BL6/C57 mouse heart, control, rep3",ctrl
strain: Fisher 344;	gender: male;	age: 18 months;	tissue: hippocampal CA1 brain;	treament group: Sham (intact) control,ctrl
Nerve_Diabetic_Vehicle_709,pert
"non-AD_HI, biological rep8",ctrl
treatment: baseline;	gender: M;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
"knockout white adipose tissue, biological rep 2",pert
"cell type: Primary chondrocytes;	genotype: Mir140 KO;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant",pert
"CCM3 shRNA cells passage 11, rep 1",pert
CXCR4 knockout 3,pert
"EGFP KD, replicate A",ctrl
tDEA006.CEL,pert
"uninfected primary RPE, biological replicate 2",ctrl
HUVEC/NmenMC58_WT_4h_rep1_1102,pert
Cervical Cancer C525,pert
"344SQ with control shRNA, replicate 1",ctrl
Strain: C57BL/6J;	Gender: male;	Age: 2-3 months;	Tissue: heart,ctrl
Strain: C57BL/6J;	Gender: M;	Age: 7 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
SIRT4 WT liver_7213,ctrl
mdx5cv quadriceps sample 1,pert
cell line: TOV112D;	cell type: epithelial ovarian cancer cell;	treatment: NSC319726 (1 µM) for 24 hrs,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M4;	flt3 status: WT,ctrl
control IgG_rep6,ctrl
NK_cell_pool_melanoma_M11+M12,pert
HepG2_control rep2,ctrl
hESC H1 wt rep2 (H1B),ctrl
"control mouse cerebral microvascular fragments, biological rep2",ctrl
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 105;	medication: Flixotide 500mcg 2pbd,Oxis 12 1pbd,Loratadine 1 tab od,Beconase 2pbd;	cell type: CD4+ T-cells",pert
Genotype: Wild type,ctrl
control;	control,ctrl
cell line: MDA-MB-231 breast cancer cell line;	genotype/variation: ARF1 siRNA,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 23;	maternal age: 19,pert
"Wild type, biological rep3",ctrl
blank_6,ctrl
Sample 13 Kidney Hyp Mouse - Control Diet,pert
Fibroblasts_HealthyControl_6,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: monosomy7/del(7q),pert
Jurkat T-cells transfected with siRNA #6 for Sp3 for 48 hours,pert
P16_exPKO_pancreas_rep2,pert
abl control at VEH rep 2,ctrl
BALB/c_PBS Replicate 1,ctrl
Placenta_nl4,ctrl
Gata3_Cdx2_null_11,pert
genotype: Wildtype;	Sex: Male;	tissue: Liver;	compound: vehicle;	route: IP;	dose: 0 mg/kg,ctrl
shRNA6-16-noDox-rep3,pert
Liver_POR-null_1,ctrl
GEIM175-PM,pert
"mouse strain: C57B/SV129;	genotype: Nrf2 wt;	tissue: mouse liver, 10 weeks",ctrl
tissue: Epididymal adipose;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 720,pert
LJMJDW10,pert
gender: male;	individual: patient 1;	treatment: control,ctrl
GEIM133-NORM,ctrl
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14583;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"RET-PTC, 10 months",pert
Liver sample from Control group (N17),ctrl
lateral hypothalamus long access to cocaine replicate 4,pert
TYK-nu+(1),pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 132min;	race: White;	sex: Female,pert
MH1C1_high_rep2,pert
patient: 51721;	sample: normal,ctrl
cell line: A549;	agent: DMSO;	dose: control,ctrl
IRAK4-KD_BoneMarrowMacrophages_unstimulated_4hours_rep2,pert
"Neuroretina 8-week lean non-diabetic, Biological replica_1",ctrl
"IGF-treated cells (24hr), biological rep1",pert
Ls174T-L8 con2,ctrl
cell line: KM-H2;	treatment: Non-silencing control,ctrl
6112 KSR2-/- Mouse White Adipose Tissue,pert
"Control Proximal, Small Intestine 3 17 days old",ctrl
Muscle-AMPKgamma3-wt-9,ctrl
"human failing LV myocardium, Ischemic89",pert
T151 U133p2,pert
Control Endometrium Stromal Cell_013.UC182-+,ctrl
AL Chip#30,pert
3L,pert
"SWR/J ACU, Rep3",pert
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/flox, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",ctrl
MDA_PR_4,ctrl
Wildtype_Sham_Rep2,ctrl
FVB; No Treatment #2,ctrl
Severe rep3 (OHN),pert
strain: C57BL/6;	tissue: colon;	genotype: PPAR g fl/fl; Lysozyme M cre-;	phenotype: wild-type;	treatment: dextran sodium sulfate (DSS),ctrl
microdissected breast cancer cells from case 638,ctrl
Liver Control 2,ctrl
7d-IR-47,pert
tissue: brain;	strain: C57/BL6 Vert-X;	genotype: IL-10eGFP;	age: 6-8 weeks;	cell type: CD8 T cells that are IL-10+,ctrl
"vestibualr organ at P15 of Igf1 +/+, biological rep 2",ctrl
"Normal skin from Tgfbeta_control mouse, biological replicate 2",ctrl
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14480;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
tissue: kidney;	protocol: intraperitoneal;	agent: vancomycin;	dose: 50 mg/kg,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: ZXDC1 knockdown;	agent: PMA,ctrl
Human_macrophages_normoxia_repA,ctrl
V5-P222,pert
A2AR_WT_saline_24h_rep1,ctrl
"mouse strain: C57B/SV129;	genotype: Nrf2 ko;	tissue: mouse liver, 10 weeks",ctrl
4h 4OHT-treated-sample1,pert
"TNFa siRNA-A, replicate 5",pert
"Patient 4, 3 month of BETAFERON",pert
5266 UC Uninflamed sigmoid colon,pert
Series 3; adult; no fracture control,ctrl
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 wild type mouse, Harlan Teklad TD03045 diet, liver",ctrl
cell line: MCF7;	condition: siRNA Smc3 + Estrogen,pert
DMN-CtrHippo18d-1dAv2-s2,ctrl
gender: Female;	tissue: Tendon;Biceps;	age: 65;	donor: 21;	disease state: Non-lesional,ctrl
WKY16-3,ctrl
t14,pert
IR-WT_Rep3,ctrl
chip number: 20;	transfection plate: 4;	target gene: IRF9;	kd level: 0.75;	rin: 9.2;	transfection date: 2011-10-17,pert
"tissue: whole lung;	strain: SPC(+)Cre(-), Dox E6.5-12.5, PN15;	genotype/variation: Foxa2-/-",pert
male_alcoholic_322,pert
Control Replicate 2,ctrl
ctrl.2,ctrl
42 year old male,ctrl
Monocyte FCH rep 2,ctrl
carcinoma,pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 7,ctrl
Subject #8002-2d Postinfection,ctrl
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:wildtype,Treatment:cornoil,Batch:Batch3",ctrl
Sample 16 Kidney Normal Mouse - Low Phosphate Diet,ctrl
Parkinson's disease sample x020a,pert
No or early 2 rep2 (OHN),pert
3586-1 E2F1 Null,ctrl
PPARg KO macrophages rep 1,pert
Tumor_18w_erlotinib2_DEN_127,pert
"human failing LV myocardium, Idiopathic4",pert
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 72;	tissue: Blood,pert
age: 49;	sex: M;	disease status: Marfan subject;	Filter number: 95;	Usage number: 5;	Exposures: 3,pert
rd1_P8_rep4,pert
T4D-LU,pert
"lymphoblastoid cell line from P910, one out of seven of sensitive group, 50*10e6 cells",pert
BTBR_Islet_rep2,pert
Testicular seminoma 0737,pert
428A.LMP,ctrl
IP RNA_KO_rep1,pert
Reh_shCBFA2T3_2,pert
S9A Sporadic-frontal,ctrl
CT-receptor-KO osteoclasts untreated 2,pert
Cbfb-deficient Treg_rep1,pert
cell type: leukemic spleen cells;	genotype: CBFb-SMMHC chimera,ctrl
Human prostate cancer primary culture C19sx,pert
genetic background: C57BL/6;	gender: female;	tissue: left hippocampus;	age: P100;	genotype: 5HTT +/-;	treatment: control,pert
220C0,ctrl
con-56_C,ctrl
age_years: 55;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
control siRNA rep2,pert
genotype: Atxn1L-null;	strain: C57Bl/6;	cell type: HSC,pert
Mock infected murine liver-MO30k-(210)-6hpi,ctrl
cell line: RT112;	transduced: FGFR3 shRNA 2-4;	doxycycline treatment: no,pert
duration of untreated disease in month:3.2;	age at onset:8.4,pert
TN 4,ctrl
"G42 cells from Cerebellum, wild type control, biological replicate 1",ctrl
CD positive WT T cell unstimulated rep1,ctrl
cell line: HT1080;	clone: 2;	genotype: Wild type,ctrl
"CD11b DC Xbp1 KO (DC conditional KO), biological replicate 2",pert
Bone-Marrow_MM_M1148,pert
Hes6_Castrated OWJ42,pert
tissue: bone marrow;	genotype: Wild type;	strain: C57bl/6;	age: 10-13 weeks old;	cell type: FACS sorted LY6D- CLP cells (LIN-FLT3+CD127+),ctrl
MLL_PTD08,pert
"Pten F341V epithelials cells, biological rep3",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 42.15616,pert
Jejunum_POR-null_1,pert
Pancreatic Sample 28-Tumor,pert
Ctr MCF10A.B2 3,ctrl
Clozapine treated 12weeks AffyGC RMA rep9,pert
Panc-1 Untreated Control 3,ctrl
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure.",ctrl
CUTLL1 wash4h-CHX_rep1,pert
RNA-DHL4-DMSO-1,ctrl
cerebrum_WT_0d_rep1,ctrl
HCC827 WT 2,ctrl
AA_Case1_CD8,pert
Targretin_Lung_3,pert
"gender: Female;	age: 65;	post-mortem delay: 3h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Adipose-5 month-wild type-technical replicate 1,ctrl
Gene expression of murine fibroblast-like synoviocytes Grp2_C57BL6_1_FLS_TNFtg,ctrl
heart wild type replicate1,ctrl
V5-P091,pert
"D425-shOTX2_3, t=0",pert
wild type rep-3,ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: MEF2A shRNA,pert
"S1P2-KO-hippocampus, biological rep8 (female)",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day1,ctrl
cell line: HCT116;	clone: 23;	genotype: Wild type,ctrl
Control  VZ14,ctrl
Muscle control 3,ctrl
Hippocampus_Soman_96h_rep2,pert
0991-01-C,ctrl
KO - knock-out Treated - 24 hrs - repeat 2 - Cy3 - mAdbID:61777,pert
"mouse strain: C57B/SV129;	genotype: Nrf2 ko;	tissue: mouse liver, 10 weeks",pert
genotype/variation: Tsc2 wildtype;	tissue: cerebellum;	gender: Female,ctrl
WAT from Ahnak knockout fed high fat diet Replicate 3,pert
"ALL_NDS, K49 011509",ctrl
WTGFP QSC Biological Rep.2 Technical Rep.1,ctrl
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l -/-;	days after transduction: 5,pert
PGA-MAA-ctr-1bAv2-s2,ctrl
Subject #8023-Preinfection,ctrl
"Female (age range 33-49), skin biopsy from upper nates taken 48 hours after nickel exposure",ctrl
Strain: C57BL/6;	Gender: male;	Age: 9 - 12 weeks;	Tissue: liver;	Treatment: 50 mg/kg of phenobarbital,pert
Untreated wild type B,ctrl
CF (D508) subject15,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 71 years,pert
jzo025-rp1-v5-u74av2-met,ctrl
Patient no. 12: control,ctrl
"P40_C-DGCR8 KO cones, replicate 2 [array]",pert
control AU1215303,ctrl
"SUDHL-1, Treated by ALK inhibitor repl 1",pert
A549 siRNA FAM60A 1,pert
pediatric AML S07,pert
"Cell type: neuronal, age:51, gender:male, diagnostic group: bipolar disorder, PMI:23h",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 125min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 94,pert
"Healthy volunteer, Control_11820",ctrl
"IN1760 siPD treated, Biological replicate2",pert
"breast tumor epithelium,43",pert
protocol: hsa-mir-30a/30d depletion,pert
TG KLS 2,pert
Donor6_24h_Wy,pert
SKMEL28_t0h_rep1,ctrl
strain: C57/BL6;129Ola mixed;	genotype/variation: Insm1 -/-;	developmental stage: embryo;	age: E17.5;	tissue: pituitary gland,pert
"vestibualr organ at P90 of Igf1 -/-, biological rep 1",pert
autism with FMR1-FM AU046707,pert
Normal Chip#5,ctrl
B-CLL PB P33,pert
KM_008N,ctrl
OCT4 shRNA_2 Days knockdown_rep1,pert
strain: BALB/c;	genotype/variation: Rag1-deficient;	treatment: WT nTreg + WT iTreg;	cell type (sorted): nTreg,ctrl
5 wt,ctrl
CLL3-CD4,pert
patient id: 260;	tissue: Normal cortex;	gender: Female;	age: n/a;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
treatment: treated with R1881 and control shRNA;	cell line: LNCaP,ctrl
tissue: whole whisker pad;	genotype: homozygous Trps1 mutant;	age: E12.5,pert
"WT heart, CRE, biological rep2",ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 25 days;	subject: Mouse1;	genetic background: BALB/c,pert
ctrl_509,ctrl
R7E 10,pert
pt. HCL D treated with DMSO for 48h,ctrl
Peripheral blood mononuclear cells (PBMC)-Patient CCo T1,pert
"Whole ovary from 8 Month Old FORKO mice_03, biological rep3",pert
BAL_29_A1B0,ctrl
Muscle control 9,ctrl
Capan2_NC-2 biological rep1,ctrl
cell line: bj-ipsc_2: BJ normal human fibroblasts (CRL-2522) were from ATCC and reprogrammed to iPSC with the protocol defined below,ctrl
cell type: CFBE41o-  ∆F508-CFTR,pert
Colon_POR-null_3,pert
GM19238_Kd_CREBBP_2,pert
cell type: Mouse embryonic fibroblasts (MEFs);	genome/variation: wild type,ctrl
"nasopharyngeal carcinoma, specimen T28",pert
OVCA429-(2),ctrl
27 weeks male,pert
ShKdm2b replicate 4,pert
XX2_Paf,ctrl
Liver_WildType_4,ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: untreated,ctrl
E9.5 KLF1-/- erythroid-8,pert
Metastatic prostate cancer W2,pert
08_C57_KO,pert
PZA treated-63d-1,pert
WKY-vehicle pool sample2,ctrl
57 wt E11.5 heart,ctrl
Subject #8011-8hr Postinfection,ctrl
Severe rep6 (retina),pert
3068-scrape,pert
control AU1157302,ctrl
"Crohn's Disease subject (58 year old caucasian female, SAK_1275433327)",pert
40B,pert
genotype: WT;	genetic background: Balb/c;	cell type: Regulatory T-cells CD4+CD25+,ctrl
Hippocampus 2007 2 month Old,ctrl
Neuroblastoma cell line,pert
unstimulated(sparse)-1,ctrl
Run1.a10a.000609jd.2.SkMNor913.CEL-IS basal,ctrl
sirna: Syk siRNA knockdown;	plate: collagen coated;	cell line: MCF10A,ctrl
FACS-purified B cells_wildtype_influenza-infected_rep1,pert
"liver, wt mouse, sample WT4",ctrl
"64B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Retina homozygous KO 42 days 1,pert
"Wild type fetal liver 1, embryo at 12.5 days of development",ctrl
No_abuse_2,ctrl
Total RNA Mir140 KO-2,pert
Ishikawa_VeryHighDose_BPA_8h_rep1,pert
WT1 CD11b,ctrl
P1 mouse eyeball extracted total RNA_Brg1_cKO2_GSM618319,pert
Gender:M;	Age:44;	Tissue: Mucosa,ctrl
04_PAH,pert
Tendon_lesional_rep21,pert
SeroNeg-6,ctrl
7L,pert
WT-sham-5 month+1d-R3,ctrl
"Lesion Skin, LS-15",pert
LOX1 Untreated 6hr 282295663,pert
"Lesion Skin, LS-10",pert
"PPARg d10, rep 2",pert
Bronchial Epithelial Cells MMA biological 1752A,pert
"Normal tail skin from control mouse, biological replicate 2",ctrl
"Control cell, Replicate 2",ctrl
"Control, biological rep. 2",ctrl
"mutant triceps, biological rep1",pert
Sample from retroviral MSCV-D1a infected cyclin D1 knockout 3T3 cells (line 7).,ctrl
0986-01-C,ctrl
cell line: HepG2;	genotype/variation: control,ctrl
"BOEC, at_risk 1",pert
Haloperidol treated 12weeks AffyGC RMA rep9,pert
liver_Pink1 knockout_6 weeks_replicate_3,pert
genotype/variation: Gfi1b wt,ctrl
C_AN14757_C,ctrl
BCell_resting_sample2,pert
01N46_PolyRF-,pert
Normal Rat Retina 2,ctrl
minor non-tumor9,pert
WT-GFP-lamin A Induction: day 5 Replicate A (2a_WT_5d_A),ctrl
Peripheral Blood Mononuclear Cells;	unknown age and gender,ctrl
Healthy-6 baseline,ctrl
Cerebellum_nontransgenic control A39_4 months_replicate 1,ctrl
thyroid_tumor_6,pert
MacularDegen-injured-10aAv2-s2,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID52,ctrl
AO 72hr,ctrl
"Control, rep 2",ctrl
Control 4 a,ctrl
F191G B,ctrl
Normal-1 - mAdbID:91503,ctrl
normal donors XCH1,ctrl
"brain, adrenal medulla: Sample#B1(Ctrl Pt1)_e1_le1",ctrl
RatLung_H16h_2,pert
"Normal Skin, Normal-9",ctrl
N/LV2,ctrl
MO_DH3a_SON_NCBI,pert
RO37,ctrl
"fibroblast, MFS subject FB890 rep 1",pert
1705-EV_16hr,pert
patient id: T158;	tissue: Normal cortex;	gender: Female;	age: 82;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
Scd1+/+ on very low fat diet (TD03045 from Harlan Teklad) replicate 4,ctrl
mouse strain: C57BL/6J;	genotype/variation: AhR-d,pert
Liver_normal_no.4,ctrl
MCF7/XBP1 p.2,pert
Normospermic individual: Sample N4,ctrl
U138MG shVEGFR-2 2,pert
"spc-c-raf transgenic mice, age: 7 month old, Gender: male, Tissue: unaltered",pert
cell type: Primary neonatal keratinocytes;	genotype/variation: control,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L016,pert
6_b,pert
293T cells stably transfected with 2 shRNA constructs (si1340/si1428) against LEDGF transcript (PSIP1 gene).,pert
patient: 109;	current medication: None;	birth date: 10/10/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: FH of Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/FGFR1;	biological replicate: 1,pert
DU145/MYB siRNA #2,pert
STING tumor DNA,pert
01LRH_ERA,pert
Interleukin_6_1,pert
siHic5_2_2h_4,pert
GM19238_Kd_YY1_3,pert
"Distal and Proximal Large Intestine, 8week old Eeyore mouse 3",pert
Gastrocnemius Muscle_WT_rep1,ctrl
pediatric AML S03,pert
HE_1,pert
Healthy control 16,ctrl
DN2 replicate 1,ctrl
whole blood_100247,pert
cell line: U373;	cell type: glioma;	vector: EGFP,ctrl
AAA neck (Sample 11),pert
secondary glioblastoma_2,pert
8 week old EOM MDX rep 4,pert
F4,pert
mammary stoma-4w-KO-rep3,pert
Hippocampus 1983 15 month Old,pert
"NTera-2 cells negative control, biological replicate 2",ctrl
"Male, 40 years old, HIV infection of 7 years",pert
"vehicle treatment, 72 hour time point, biological replicate 1",ctrl
AA_Case2_CD8,pert
CD4_T_cell_pool_healthy_H07+H08,ctrl
WT STR Veh 3,ctrl
WT-4,ctrl
"C2C12 Myotubes treated with BSA, rep1",ctrl
Astrocytoma_6,pert
Wt Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-2,pert
"depression, BA10-28(2)",pert
striatum_Pink1 knockout_12 weeks_replicate 3,pert
myoblasts-expt1_lentiDUX4fl-rep2,pert
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: untreated,pert
gender: female;	age (years): 40;	evolution time (years): 13;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
MDS patient 161,pert
lesion_postUV_patient9,pert
genotype/variation: Pou4f1+/+;	agent: MSCV-Pou4f1 virus;	tissue type: fetal liver,pert
heterozygot FH P387neu,pert
NOD.scid,ctrl
"Ptenloxp/loxp + pBP-Cre, biological rep 1",pert
con_B131,ctrl
embryonic fibroblasts from male IRAK4 kinase dead Balb/c mice,pert
Bone-Marrow_MGUS_G683,pert
"NPCxhIPSC SCZP, replicate 2",pert
"Wild Type, 1",ctrl
"48 hour-treated wild-type NB4, biological rep2",ctrl
"siCFIm68-1, biological rep1",pert
gastrocnemius-30 months of age-resveratrol diet-biological replicate1,pert
SENS 6 4hr,pert
HNF4 CONTROL_191,ctrl
"Age: 50;	Sex: M;	Ancestry: European;	Smoking status: smoker, 38 pack-years",pert
"Wild-type-hippocampus, biological rep5 (male)",ctrl
"Control 1, 4hrs",ctrl
V5-P433,pert
"HL-60 + 10 nM TCDD, biological replicate 2",pert
Muscle PCOS control 7,ctrl
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Endothelial Cell,ctrl
Kidney_Aqp11-/-_P7_3-2,pert
Pool 2 Convalescent stage,pert
treatment: progesterone;	genotype: wild type;	treatement time: 40 hours,ctrl
LRRK2 (G2019S) heterozygous iPSC sample 1,pert
FVB_MMTV_Wnt1_iFGFR2_3855_3R_ROSEN,pert
"fibroblast, MFS subject FB783 rep 3",pert
umbilical cord_nobpd: 4B,ctrl
Subject 5 / lung subsegment instillated by Saline,ctrl
MCL_IGHV_MUT (R1938),pert
Disease_status: Healthy control;	Age (years): 35;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 52;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
cell line: HUES6;	treatment: VGLL4 overexpression,pert
WT 2,ctrl
U937_naive_curcumin_4h_rep2,pert
"Patient 22, Atheroma plaque",pert
3510-lcm,pert
control shRNA replicate 1,ctrl
CD11b+Gr1+ cell sample_3 (derived from IL17RC Kock out mouse),pert
Basal IFE epidermal stem cells from WT mice 2,ctrl
U2OS_PRC_shRNA1_pLenti_3_2007,pert
sample =XCGD5 treatment=Stimulated time=180 (min),pert
affected status (disease state): control;	gender: male;	age-at-examination: 53;	age-at-onset: n/a;	geographical origin: Vila-Real;	lifestyle characteristics: ever smoker,ctrl
Allo-14-4,pert
JIA PBMC Post treatment A235_L017(2),pert
subject: 03U;	cohort: 3;	tissue: Biceps;	disease state: control;	ecori/blni allele length: >40kb;	age (y): 42;	Sex: F;	batch: Batch_1,ctrl
"Normal tail skin from control mouse, biological replicate 3",ctrl
Bone-Marrow_MM_M1054,pert
tissue source: matched healthy control;	tissue: Vastus lateralis muscle;	tissue state: basal state,ctrl
genotype/variation: wildtype ThPOK (control),ctrl
MDA-MB-231 breast cancer cell line,pert
Muscle WT Aged 0123,ctrl
HCaRG-9_HG-U133_Plus_2_Rep2,pert
heterozygot FH P266,pert
AZ-521_doxycycline_12h_rep1,pert
PTC BRAF mut 12,pert
E10.5 ko.2,pert
Saline_2,ctrl
Low_M_1,pert
"MCF-10A cells, shRNA vector control, biological rep2",ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 30;	maternal age: 27,pert
CON23,ctrl
Native wt biological replicate 1,ctrl
WT Tibialis Anterior at 4 weeks biological rep1,ctrl
Colon_POR-null+quercetin_2,pert
CT-receptor-KO osteoclasts untreated 1,ctrl
CLL 145-04 LMP-420,pert
H26 HA 24h 2,pert
gender: F;	age at blood draw: 41;	tissue: whole blood,ctrl
microdissected breast cancer cells from case 420,pert
patient: 214;	current medication: NONE;	birth date: 1/10/37;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/59;	diagnosis date: 1/10/61;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 1;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 11/12/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 12/9/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: CENTRAL RETINAL VEIN OCCLUSION 01/04;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"Acute Myeloid Leukemia, sample 55",pert
C1C-LU,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-10;	Primary Site:Tongue;	Age:64;	Sex:M;	TNM:T4N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis",pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 5d ID61,ctrl
colonic_mucosa_inflamation_76,pert
Hippocampus Fluoxetine group 2,pert
SCD1 -/- liver rep2,pert
chip number: 19;	transfection plate: 5;	target gene: NS;	kd level: NA;	rin: 9.4;	transfection date: 2011-10-17,ctrl
atopic eczema P2,pert
patient: 243;	current medication: Atenolol Pravastatin Asprin Adalat BFZ Balsalizide;	birth date: 2/17/25;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 8/1/04;	diagnosis date: 3/29/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Deaf;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
cell line: ARPE-19;	clone: parental;	genotype: Wild type,ctrl
"prdm-control, biological rep1",ctrl
Sample Group: control; Gender: male; Age: 42; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
92.1 - control #1 - replicate1,ctrl
cell line: H1299;	agent: decitabine;	dose: 0.3 uM,pert
ubb_d28_wt_2,ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 84 days;	subject: Mouse1;	genetic background: BALB/c,pert
"650nM MLN4924 after 8hr, replicate 1",pert
"Subject 10, Family 4, Affected",pert
"transfected with pSuper-shMTDH, cultured with HMVEC-L and then purified by FACS",pert
2h Kin- Cel.45,pert
SKI-DLCL cells_untreated_24h_2rpt,ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 31;	maternal age: 34,pert
wildtype 7,ctrl
"Wild-type iPSCs, NAS2",ctrl
normal control 4,ctrl
CLL 361-01 LMP-420,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 37;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
IRS-4 KO (jos0700),pert
WFS1 KO USHT_06_333_wt,ctrl
Ngn3 ES3 ON replicate 2,pert
Hippocampus Control group 1,ctrl
experiment II untransduced replicate 1,ctrl
"D425-shOTX2_2, t=24",pert
treatment: Overexpression Control;	cell line: Caco-2,ctrl
CTRL_1_GMP,ctrl
Patient no. 14: treated,pert
U2OS shControl replicate 2 [set 4],ctrl
con-50_C,ctrl
LNCaP/NC siRNA #3,ctrl
0301-01-A,pert
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug Control siRNA;	treated with: 100nM PD173074 for 48 hrs,ctrl
Patient identifyier: E;	Sex: male;	Age of patient: 51 years;	Duration of psoriasis: 24 years;	Body surface area: 8 percent;	Overall erythema: mild;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
Control liver_4 pm_rep3,ctrl
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Tongue 1,pert
cell line: PC-3;	treatment: gefitinib;	treatment duration: 24h,pert
"IRF6 wt, biological rep3",ctrl
18L,pert
Setleis Syndrome patient 3,pert
"Primary aortic endothelial cells, Non_transgenic_control_3",ctrl
12484 UC Inflamed sigmoid colon,pert
chronic lymphocytic leukemia (CLL 26212),pert
Myoblast-GATA4-Wt-day0-1,ctrl
E_Ctrl_1,ctrl
siNonTarget replicate2,ctrl
"human failing LV myocardium, Ischemic19",pert
Teratoma 0696,pert
"Lesion Skin, LS-8",pert
"48B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 55 years,ctrl
"Cell type: neuronal, age:42, gender:male, diagnostic group: bipolar disorder, PMI:32h",pert
tissue: skin;	individual: Patient P14;	condition: ANL;	eczema severity: SCORAD: 0,pert
E14.5_Control_Kidney_array2,ctrl
tissue: brain;	strain: C57/BL6 Vert-X;	genotype: IL-10eGFP;	age: 6-8 weeks;	cell type: CD8 T cells that are IL-10-,pert
"ME16C, 12h, sham B",ctrl
MCF7 CHX+EtOH,pert
cell line: DOV13;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
Ishikawa_LowDose_BPA_48h_rep3,pert
"Peripheral blood, patient without recurrent events [N51]",pert
IR-WT_Rep1,ctrl
tissue: tumor;	cell line: SK-BR-3;	origin: luminal-like;	transfector: empty vector,ctrl
Plate vs. Nail:  3 Day Plate,pert
colon_C57 mouse_12weeks_rep6,ctrl
37_C57_WT,ctrl
Tmod3 WT-3,ctrl
"patient 6, baseline",ctrl
platelet_sickle_13,pert
Menadione (5uM) rep 1,pert
age: 24 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
treatment: Cyclin D1 siRNA Vehicle;	cell line: MCF7,pert
Wtepi_infect_0h_rep1,ctrl
KO_PMΦ_rep2,pert
sMPNST_shBrd4.552_3day_rep1,pert
MSC_SA01_2,ctrl
MDS patient 105,pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 42;	maternal age: 32,pert
cell line: LNCaP-abl;	transfection: siMED19,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous endotoxin challenge""",pert
sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta;	agent: control (saline);	time: 7d,ctrl
"shKDM4C 1, clone 1, rep 2",pert
"MS patient 11, technical replicate 2",pert
Liver sample from Control group (C7),ctrl
strain: C57BL/6J;	day: 1;	drug: Heroin;	phase: Drug treatment;	tissue: striatum;	replicate: 3,pert
3415-scrape,pert
"3T3-L1 siControl 24h, biological rep 2",ctrl
phenotype: control;	gender: male;	case_id: 335;	age: 44;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 50;	brain ph at time of freezing: 6.6;	labeling_batch: 2,ctrl
4194-2 E2F3 Heterozygous,pert
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: arteriosclerotic cardiovascular disease,ctrl
HMEC X Matrigel,ctrl
Heart left ventricle WT-PBS replicate 1,ctrl
Control  VZ11,ctrl
DIA-t10-2; transgenic diaphragm 10 month,pert
"Exp A, Animal #251, 500mg/kg D-Serine",pert
Bone-Marrow_SMM_S1586,pert
"siYAP RNA #2 transfected, biological rep 2",pert
"gender: Male;	age: 71;	post-mortem delay: 6.5h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
age_years: 61;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
"COP strain, male, age 21 weeks",ctrl
MS patient 5,pert
RNA from HCC_38N,ctrl
CML-BM 6,pert
Day: 6; Drug: Saline; Phase: Drug treatment; Replicate: 1,ctrl
brain_DLPFC_bipolar C_mr276,pert
C589,ctrl
VGLL4 HUES6 4,pert
76_129_WT,ctrl
EA_Control2_CD8,ctrl
Anti-scramble replicate 3,ctrl
E14 - nudelcko/ko 1,pert
V5-P340,ctrl
mixed reference (MR = CRG + FR),pert
Bl6 - Control - rep2,ctrl
U-87MG-V22 set 3,ctrl
180C1,ctrl
"MDA-MB-231/shDBC1, biological rep1",pert
Insig1 ∆/∆ /Insig2 -/- InsigKO_E2,pert
"Acute Myeloid Leukemia, sample 52",pert
treatment: DMSO;	time: Day1;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,ctrl
11N,ctrl
6114 KSR2-/- Mouse White Adipose Tissue,pert
1053-03-A,pert
cell line: SV589;	knockdown (days): 0;	treatment: Serum Starved; 1h EGF,pert
gender: male;	strain: BL6/C57;	genotype/variation: wildtype;	age: 12 weeks,ctrl
"Peripheral blood, patient without recurrent events [N34]",pert
"C57BL/6 mice, thymus and spleen pooled",pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 55;	gender: m;	treatment: -,ctrl
"CD4+ splenocytes at 6h, biological replicate 1 sham-1",ctrl
Ramos pRTS-GFP A+,ctrl
cell line: NCI-H1299;	cell type: lung cancer cells;	transfected with: control hairpins targeting luciferase,ctrl
2h 4OHT-treated-sample2,pert
tissue: liver;	genotype: IR flox/flox albumin:CRE -,ctrl
"nasopharyngeal carcinoma, specimen T3",pert
disease state: control;	patient: 24,ctrl
strain: HNF4 null;	age: 1 month;	tissue: small intestine;	sex: female,pert
"Wild Type, biological rep3",ctrl
Luciferase-rep3,ctrl
Biceps_Pompe_8,pert
Embryonal carcinoma 1740,pert
PGA-RMM-30h-1aA-s2,pert
A_AN08166_C,pert
129A,ctrl
"Lesion Skin, LS-23",pert
PBMC from T cell Large granular lymphocyte leukemia patient#130,pert
Placental tissue from normal pregnancy,ctrl
MDS patient 94,pert
VMH of WT-3 mice,ctrl
Brain_nAChRbeta4SubunitDeficent_MiceNob4398,pert
treatment: Mepenzolate;	time: 25,pert
array 8 minus E,pert
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 49days;	genotype/variation: NSun2 KO,pert
strain: C57/Bl6;	genotype/variation: Caspase 1 null;	gender: male;	tissue: epididymal white adipose tissue,pert
A673 cell line that has been treated with Doxorubicin for 24 hours with concentration of 119.76 nM (2 x EC50).,pert
Normal Chip#3,ctrl
GIST_KIT_4,pert
HCC PBMC_sample 9,pert
Vehicle 24 hours_2,ctrl
treatment: after Rituximab,pert
1005-01-A,pert
ctrl_516,ctrl
Mutant biological rep1,pert
Human skeletal muscle biopsy sample;	Patient #16 with PM,pert
"Distal and Proximal Large Intestine, 8week old Winnie mouse 2",pert
"female Spargue-Dawley rats, 4-hydroxyphenylretinamide, 782 mg/kg diet for 7 days, tissue: lung",pert
Tet2 KO GMP rep1,pert
MBD1 KO #1,pert
C_AN17425_F,ctrl
Anti-scramble replicate 2,ctrl
"medulloblastoma, M2_cMYC_silenced, rep3",pert
phenotype: alcoholic;	gender: male;	case_id: 303;	age: 67;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 48;	brain ph at time of freezing: 6.4;	labeling_batch: 2,pert
4P-M4-ND,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: P1,pert
human_hepatocyte_400uM_clinafloxacin_donorA_24hr_prep2,pert
1052-03-A,pert
SOCS3 Cre plus A,pert
cell line: MCF-7;	sirna knockdown: siControl,ctrl
tissue: glioblastoma xenografts,pert
V5-P303,pert
GNMT-WT mouse hepatocytes (sample 2),ctrl
HF1613_U133P2,pert
"Mouse Embryonice Stem Cells, pCIP siRNA 2, Rep1",pert
"imr-32,cdk4 siRNA,t=48,3",pert
"Mdr2-KO heterozygous mouse, 3 month old mouse 1",ctrl
CD8_T_cell_pool_healthy_H03+H04,ctrl
Normal esophageal epithelium (N3),ctrl
ctrl- rep1,ctrl
Control (C285),ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 130min;	race: White;	sex: Female,pert
IL8.3,pert
Tendon_non-lesional_rep17,ctrl
Genotype: KO,pert
Peripheral blood mononuclear cells;	TTF=65min;	Race=White;	Sex=Female,ctrl
Strain: (129S1/SvImJ) (wildtype);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,ctrl
"wdNHBE with KY/136 at 36hpi, biological rep3",pert
GFP Untreated 24hr 282295853,ctrl
TP06-708,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_4_37_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
male;	41 yr old;	White,ctrl
"Sfrp5 KO HFD 8 weeks, biological rep4",pert
"MCF-10A cells, shRNA vector control, biological rep1",ctrl
TTP_KO_0ActD_BioRep3,ctrl
subject: 18A;	cohort: 18;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 21kb;	age (y): 36;	Sex: F;	batch: Batch_4,pert
strain: C57BL/6;	genotype/variation: Foxo1KO;	cell type: Regulatory T cells,pert
Mouse RSK2 mutant mandibular molar [ABH_15A],pert
strain: C57BL/6;	genotype: RORalpha1delDE;	replicate: 3,pert
WT_PLACEBO_12hours_3,ctrl
BCR/FGFR1 biological replicate 3,pert
WT-GFP-lamin A Induction: day 5 Replicate B (2b_WT_5d_B),ctrl
TL3 LAMC2 KO 1,pert
12GOBMUC2A,pert
"eye, cornea: TRizol Extraction_le1 7",ctrl
CTRL_1_HSC,ctrl
"Whole ovary from 8 Month Old Wild Type mice_01, biological rep1",ctrl
Male 8week BL6 CBDLrep1,pert
Dicer KO replicate 2,pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of BMI-1. Sample A,pert
umbilical cord_nobpd: 3D,ctrl
Wildtype_TAC_Rep2,pert
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 5 days osteoblast differentiation,pert
WT - Cre Treated - 2 hrs - repeat 3 - Cy3 - mAdbID:62607,ctrl
HF1156_U133P2,pert
WAT from wild-type control fed high fat diet Replicate 3,ctrl
hESC H1 B2M KO c2,pert
Cbx2_KO_XX_2,pert
S46 NLS 142Q TG5	F4/1	S46	NLS Htt exon 1 142Q	Mouse	10 months	Cerebellum	Female,pert
IFN_Gamma_6hr,pert
Strain: C57BL/6J;	Gender: Male;	Tissue: primary culture tracheal epithelial cells,pert
sepsis patient #2,ctrl
"brain, cochlea: [18] Sample #18_le1",ctrl
Individual_4079_PN_sample,pert
"Ulcerative Colitis (65 year old caucasian male, SAK_1291908052)",pert
"Ad(moi10)-infected, TOT-treated for 24hr",pert
"schizophrenia, BA46-17",pert
Control_AF_5,ctrl
agent: control (untreated);	time: 1h,ctrl
A HID I_B052,pert
Hippocampus 2008 2 month Old,ctrl
Individual_4177_PN_sample,pert
Muscle-AMPKgamma3-mutant(R225Q)transgenic-4,pert
T73 U133p2,pert
Neuroblastoma SH-SY5Y cells_cloneG_stably transfected with RNAi against DJ-1_replicate1,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 79,pert
A_AN08873_C,pert
Healthy10-CD8,ctrl
WT-smoke-low-5 month-R4,ctrl
Bone-Marrow_MGUS_G417,pert
The placenta (E 10.5) of a congenic adra2B+/+ mouse embryo (maternal genotype Adra2b+/-) was rapidly dissected and flash frozen.,ctrl
"Healthy volunteer, Control_11817",ctrl
cell line: H4-II-E-C3,pert
tissue: skeletal muscle;	status: diabetic;	agent: untreated,ctrl
subject: 30;	disease: CP;	muscle: GR;	gender: M;	age: 4.1;	gmfcs: 2;	popliteal angle: 125,pert
ES2 COUP-TFII-4 25nM,pert
B-CLL PB P249,pert
Run3.aUa.010110d.SkMDbt1140D.CEL-DB basal,ctrl
"DMSO-treated, 24h after UV, Replicate C",ctrl
Gata-1 Wild Type C,ctrl
"Ulcerative Colitis (73 year old caucasian male, SAK_1285313364)",pert
A375 cells 24h Vemurafenib rep3,pert
Hippocampus_Rasgrf1KO_rep3,pert
Ishikawa_LowDose_BPA_8h_rep1,pert
"JurkatNegative (Mock stim)  0 hours, #1",ctrl
Dental pulp cells idipopathic autistic patient triplicate 2,pert
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 0;	dose: 0;	agent: none,ctrl
RA_B,pert
healthy control H18,ctrl
isoflurane 02,pert
genotype/variation: Zfx fl/y CreER;	treatment: infected with control retrovirus with GFP selectable marker,pert
"brain, Entorhinal Cortex: 99-21 tangle_e1_le1",pert
PGA-MAH-AJ_OVA6h-4aA-s2,pert
"strain: B6.129P2-Il10tmlCgn/J;	genotype variation: Il10-/-;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 24 hours;	agent: air;	exposure dose: 0 ppm O3",pert
Control sample 23 weeks,ctrl
"N-56, NORM, M, GSF, 1 x 1000nM DHT, 24h",ctrl
"Acute Myeloid Leukemia, sample 64",pert
Ad infected murine liver-MO30k-(466)-6 hpi,pert
BxPC3-WT rep 2,ctrl
"Rat_Tracheal_Control_2hr, rep3",ctrl
PBMCs_Control_9 [IS],ctrl
LCH6ani,pert
ACC Xenograft X5,pert
5922012047_C,pert
"MCF-10A cells, shRNA targetting p63 DBD, biological rep1",pert
F-IIP(NSIP)1_Cy3,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 357;	age-at-biopsy-years: 49,ctrl
PGA-lv_24h_517,ctrl
control male replicate 2,ctrl
"heart of mouse, 2 week control (2B)",ctrl
Clinically localized primary prostate cancer P5,pert
disease state: healthy;	tissue: extensor digitorum longus;	age at biopsy: 76;	Sex: male;	individual identifier: 1,ctrl
"E12.5 Ret-deficient embryonic kidney, biological rep1",pert
Normal skin 3,ctrl
8003PBMC,pert
7A;pretreatment;female;breast tumor,ctrl
A SIT_B100,pert
V5-P257,pert
C57 48 air 2,ctrl
Mammary gland R1 16 hr rep4,pert
FVB; No Treatment #1,ctrl
P8 wt1,ctrl
PCOS Endometrium Mesenchymal Cell_102.PC01++,pert
C57BL10 diaphragm sample 2,ctrl
Cultured human trabecular meshwork cells (passage 3) obtained from a donor with no known history of glaucoma. 45y/female/caucasian. Cause of death: multi-system organ failure,ctrl
RKO_HSF1siRNA_6hDMSO_REP1,pert
chip number: 13;	transfection plate: 3B;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2012-03-26,ctrl
patient: 51722;	sample: normal,ctrl
K562 STI sample 6,pert
Pool 1 Acute stage,ctrl
"patient 041b, normal, homogenized",ctrl
DIA-n10-2; normal diaphragm 10 month,ctrl
MCI-014,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.975;	OD280: 1.082;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 338;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Weight:High;	CFstatus:control;	Sex:Female,ctrl
"Patient 113, 24 month of REBIF",pert
Day: 18; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 2,pert
Dengue Fever Patient 68,pert
CTL2 E2 48hr,pert
"GFPMYC positive GC B cells, Biological replicate 4",pert
"human failing LV myocardium, Idiopathic33",pert
LJMJDW15,pert
Endometrium/Ovary-Disease 4,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G48,ctrl
2h WT Cel.02,ctrl
PCOS Endometrium Epithelial Cell_109.PC08_EpCAM,pert
HeLa_TP082505_24_HG-U133A_2_IMFGN0023,ctrl
Buffy Coat blood of healthy donors,ctrl
Mock infected murine liver-MO30k-(209)-6hpi,ctrl
WT - Cre Treated - 12 hrs - repeat 3 - Cy3 - mAdbID:61758,ctrl
A_2m25,pert
Biceps_Pompe_9,pert
Bach2 KO - Thymus - biological repeat 1,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 24h ID132,pert
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep5,pert
"human failing LV myocardium, Idiopathic62",pert
Mouse fetal liver_E14.5_KO_rep5,pert
wild-type_rep2,ctrl
lymphocytes_ctl_F_30y,ctrl
NMRI_6h_DMSO,ctrl
Scd1+/+ on very low fat diet (TD03045 from Harlan Teklad) replicate 5,ctrl
CD-59-un,pert
14-week-old WT liver_616WT,ctrl
Basal IFE epidermal stem cells from KO mice 2,pert
ctrl_504,ctrl
Control siRNA 2,ctrl
strain/background: C57BL/6;	genotype/variation: non-transgenic;	tissue: brain (right cerebral hemisphere);	age: 7 days;	treatment: PBS control;	time post-infection: 5,ctrl
HeyA8-(1)b,ctrl
Squamous cell lung cancer X35sqm,pert
"disease status: non allergic non asthmatic subject, without any stimulation;	tissue: bronchial biopsies",ctrl
Wildtype_XY_3,ctrl
CD8_T_cell_pool_melanoma_M07+M08,pert
CD4IncTp2-7,pert
pcdh12-deficient mice rep2,pert
GM19238_Kd_SP3_1,pert
liver_wild type_6 weeks_replicate_1,ctrl
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 knock out mouse, chow diet, liver",ctrl
ESC_Zfx-flox_Replicate1,ctrl
ES cells_OE_rep1,pert
24h_c1,ctrl
"PCB77 treated HepG2 cells at T0, biological replicate 1",ctrl
Sham 2,ctrl
Normal bladder 272-99,ctrl
normal 2841,ctrl
"schizophrenia, BA10-26",pert
Huh7 cells_JFH-1 Infected 12 hours_ rep1,pert
Endometrium-Normal 6,ctrl
6P-M4-ND,pert
CME-LaminA4d-1MA-S2,pert
Conditional Sample 4,ctrl
"Strain: Bl6, Tissue: Bone marrow, Age: 7 weeks",pert
Mouse old heart C30-Ht-4,ctrl
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl; Wnt1-Cre;	tissue: Tongue;	age: E14.5;	gender: Not determined,pert
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA2-dox,ctrl
"Control animal, biological repeat 3",ctrl
healthy CD19 B cells 7,ctrl
Normal mucosa 14,ctrl
GM19238_Kd_USF1_1,pert
NALT_infected_24h_90-226-dM_rep4,pert
"IRF6 wt, biological rep1",ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#104,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: exon 11;	tissue: GIST Tumor,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.469;	OD280: 1.802;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 355;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 215,pert
Halothane 10 exposures-2,pert
SLE CD19 B cells 9,pert
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P12;	clone: C11,pert
12h Control (SAMPLE 2),ctrl
WT J1 ESCs on day 0 #1,ctrl
Liver_untreated_HESKOL_rep2,pert
N6,ctrl
Cisplatin-treated wildtype MEFs-b,pert
"brain, hippocampus: KA-72h-P15-II_e1_le1",pert
"HEK293E cells, scrambled siRNA, replicate 4",ctrl
"Placebo treated, HIV-1 positive male, day 14 (7)",ctrl
Patient 5,ctrl
Ngn3 EB10 OFF replicate 1,ctrl
At Risk: +;	Age: 13;	Sex: M,pert
Prostate Cancer_MS 36C1,pert
strain: C57BL/6;	genotype: wildtype;	tissue: liver;	age: 12 weeks,ctrl
31A;pretreatment;female;breast tumor,ctrl
EA_Case16_CD8,pert
MCI-019,ctrl
treatment: treated with vehicle and control shRNA;	cell line: LNCaP,ctrl
D3 patient,pert
M249_A_DMSO,ctrl
hES_VUB01_1,ctrl
Wild Type Skeletal Muscle Sample (forelimb),ctrl
"202, ADIPOOSE TISSUE, Before",ctrl
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T3N2,pert
strain: CD-1;	genotype/variation: Pkd1null/null mutant;	developmental stage: embryo;	age: E17.5;	tissue: kidney,pert
"Pineal gland from NeuroD1 cKO mouse at ZT20, biological rep 3",pert
"220, MUSCLE, Before",ctrl
Mouse WT mandibular molar [ABH_12A],ctrl
Strain: C57BL/6J;	Gender: Male;	Age: 16 weeks;	Tissue: testis,pert
Control subject 40_biological replicate 2,ctrl
GAS-n10; normal gastrocnemus 10 month,ctrl
cell line: RT112;	transduced: FGFR3 shRNA 4-1;	doxycycline treatment: no,ctrl
"Line A39 control cerebellum, mouse, male, 10 months",ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
gender: Males;	strain: C57/B6;	age: 3 months old;	tissue: Brain,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 40;	gender: male,pert
9-cis-retinoic-acid_LIVER_1,pert
"age at diagnosis: 63;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N2a;	er: 1;	pgr: 1;	dfs-month: 0;	dfs-event: 1;	distant metastasis: 1",pert
genotype: C57BL/6;	gender: male;	age: 10 weeks;	tissue: Liver;	diet: chow diet,ctrl
Normal PBMC Sample 4,ctrl
"hepatic gene expression at ""6 hr"" (rep1)",pert
CHF - R09,pert
tissue: skin;	individual: Patient P1;	condition: AL;	eczema severity: SCORAD: 36,pert
"NPCxhIPSC CON, replicate 4",ctrl
mouse cerebellum at P7 knockout 1,pert
"age at diagnosis: 66;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 30;	dfs-event: 0;	distant metastasis: 0",pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: G;	transfectant type: stably transfected with RNAi against DJ-1,pert
"human failing LV myocardium, Idiopathic70",pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 6h, biological rep3",pert
Cutaneous psoriasis without arthritis PsC 12,pert
HepG2_DMNQ rep3,pert
"FA6 transiently transfected with AGR2 siRNA, transfection A",pert
RPE23,ctrl
patient code: 105;	gender: Male;	age: 68;	tumor grade: 3;	t-stage: 2;	n-stage: 0;	ajcc classif. (2002): 1b,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: tumor;	sample name: 5-tu3,pert
treatment: SCY1-like 1 esiRNA;	cell line: HeLa,pert
cell line: Mkn28;	cell type: human gastric tubular adenocarcinoma;	tissue origin: stomach (70 year-old female),pert
cell type: embryonic fibroblasts (MEFs);	genotype: VHL null,pert
"Control siRNA, 1",ctrl
"Strain: C57BL/6, Gender: female, Age: 6-10 weeks;	Tissue: nasal-associated lymphoid tissue (NALT)",ctrl
"JAG1 overexpressed CL1-0, biological rep3",pert
original diagnosis: ExtendedOligo;	cell type: Peripheral blood mononuclear cells,pert
"DMSO-treated, Sham UV, Replicate C",ctrl
FHCRCAML1818,pert
shNANOG_1,pert
MBD1 KO #3,pert
cerebellum_Pink1 knockout_24 weeks_replicate 2,pert
ab074 IM,pert
"Grape extract group, 12 months, patient number 15",ctrl
PC-3_basalhTERT_ShortTelomeres_mockcre_4,ctrl
affected status (disease state): control;	gender: male;	age-at-examination: 69;	age-at-onset: n/a;	geographical origin: Lisboa,ctrl
"Untreated Testes, biological rep 1",ctrl
"0mg/kg/day PFOA, Rep 5, Block 5, lung (high dose)",ctrl
R2_saline_wildtype_422,ctrl
24C-ER,ctrl
Cerebellum_nontransgenic control S46_10 months_replicate 2,ctrl
COLO829_shSCR_PLX4032_A,pert
Endometrium-Normal 7,ctrl
Bone-Marrow_MM_M801,pert
"Dermatomyositis, biological rep2",pert
Tendon_non-lesional_rep7,ctrl
Pt25_Pre,ctrl
5273 UC Inflamed sigmoid colon,pert
Normal PBMC Sample 5,ctrl
B_Ctrl_2,ctrl
Heart-Base_KO-3,pert
TF_1_control_d2.5_rep1,ctrl
race: caucasian;	age (years): 70-75;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
S4_sham_overexpressor_12,pert
pt. HCL E treated with Vemurafenib 1000 nM for 48h,pert
Biceps_Pompe_4,pert
siEGR4 (24 hr) _2,pert
AZ-521_doxycycline_8h_rep2,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 60;	sex: M,ctrl
GM19238_Kd_NFE2L1_3,pert
K14deltaNB-cateninER  Time 7 replicate 1,pert
Cervical cancer_103-04T,pert
chip number: 7;	transfection plate: 1;	target gene: CEBPG;	kd level: 0.79;	rin: 9.7;	transfection date: 2011-03-29,pert
"gender: Female;	age: 67;	post-mortem delay: 6h;	ph: 6.7;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
RNA from HCC_35T,pert
age: 12 wk;	tissue: whole heart;	genotype: MCKcre Pitx2 Flox/Flox,pert
CD4+ cells IL1RN knockout 1 month rep1,pert
"Normal subject (60 year old caucasian male, SAK_1287302781)",ctrl
4_c,ctrl
Squamous cell lung cancer X31sqm,pert
Pancreatic Sample 53-Normal,ctrl
GM19238_Kd_IRF9_3,pert
Patient: C;	Time: 0;	Group: responder;	Condition: lesional,ctrl
LKR13_Control-2,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 31;	age of psoriasis onset: 25,pert
cell type: Heptaocellular carcinoma cell line (non-target control cells),ctrl
"E2A-deficient (E2AKO) DP cells, biological rep 2",pert
"Biceps, FSHD, cohort 03, subject 03A",pert
CLL16-CD4,pert
patient: 30162;	sample: tumor,pert
Pfeiffer BCL6siRNA 3,pert
Haloperidol treated 12weeks AffyGC RMA rep6,pert
Extract:LOX-1:113103;	Extract Description:GFP_0hr:113103;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.49;	Quality: Absent (%):58.03;	Quality: Absent (%) Dev.:0.17;	Quality: Scaling Factor:0.63;	Quality: Scaling Factor Dev.:0.13;	Pretreatment [C]:GFP;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113103;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_0hr;	RNA extraction source key [A]:282295433,ctrl
EP1_adipose_pcos_rep1,pert
human_hepatocyte_400uM_Trovafloxacin_donorA_24hr_prep2,pert
Sex: male;	Age at operation: 74 years;	Site: thigh;	Size in cm: 16.5x9x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-C104A/C131A;	overexpression induced with doxycline: Yes,pert
DMSO2_24H,ctrl
patient: 15;	disease state: hypertension;	tissue: Atheroma plaque,pert
"wdNHBE with KY/136 at 36hpi, biological rep2",pert
EOM 56 Day Control rep 2,ctrl
Exercised-1,pert
Ago2-IP RNA Mir140 KO-1,pert
"ALL_DS, K16 011409",pert
"Human Umbilical Vein Endothelial Cell, Single Donor, Passage_3",ctrl
Muscle WT Adult 07272,ctrl
Mammary gland R1 16 hr rep3,pert
Kidney_Aqp11+/+_P7_2-1,ctrl
KO-992,pert
Allo-25-1,pert
MCF-7 cell_tRA_12hr_biological rep2,pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 38;	Usage number: 4;	Exposures: 2,pert
"treatment: diclofenac;	batch: 7;	donor: 53;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p28;	strain: E14,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-15;	Primary Site:Floor of Mouth;	Age:51;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
12mo APPSw #1,pert
EDL-t10; transgenic extensor digitorum longus 10 month,pert
tissue: blood;	patient: 2;	gender: male;	age: 38,pert
liver western diet rep5,ctrl
BP patient 88_biological replicate 1,pert
"27B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
NSC_FOXO_WT-1,ctrl
Normal Gingiva replicate1,ctrl
"schizophrenia, BA46-41",pert
"Patient 4, 12 month of BETAFERON",pert
Gender: Male;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: poor;	Tumor Site: Cecum;	Drug Treatment: YES,pert
DP AA4+ replicate 1,pert
"Please refer to Lilly et al., Am J Respir Crit Care Med. 2005 Mar 15;171(6):579-86",pert
Ezh2-Vec1,ctrl
T56 Non failing heart biopsy,ctrl
"Wild type mouse aorta with placebo, biological rep5",ctrl
Mening UNSTIM WB SW 3b,ctrl
HCT116 human colon cancer cells with PTEN -/-,pert
TAF4b knockout 3,pert
mutant_ANT_PDE_22,pert
Untreated Control 12weeks AffyGC RMA rep7,ctrl
"Cell type: neuronal, age:35, gender:male, diagnostic group: bipolar disorder, PMI:35h",pert
"seminoma specimen, pT2, patient age: 35y",pert
Wild Type 9,ctrl
Disease_status: Bipolar disorder;	Age (years): 42;	Gender: Male;	Age of onset (years): 18;	Duration of illness (years): 24;	Brain pH: 6.65;	Post mortem interval (hours): 32;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
"disease group: Atopic Dermatitis;	Sex: f;	age: 20s;	race: African American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 15.2;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 290;	ige (kiu/l): normal (0-48.5 kIU/L): 2578;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
cell line: RT112;	transduced: FGFR3 shRNA 4-1;	doxycycline treatment: yes,pert
Diaphragm 28 Day mdx rep 3,pert
"Crohn's Disease subject (47 year old caucasian female, SAK_1263249533)",pert
cell line: BT474-J4;	cell type: breast cancer;	lapatinib sensitivity: acquired lapatinib-resistant;	her2 status: HER2-positive;	treatment: foretinib,pert
cell line: U937;	shRNA construct: Scrambled Control,ctrl
wt_off_rep1,ctrl
Human Uninfected Sample N141-CD4+ T cells,ctrl
cell line: MOLM-14;	replicate: Replicate3;	treatment: shLuciferase,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous saline challenge""",ctrl
COP DES-treated replicate 4,pert
cell line: A375 melanoma cell-line;	genotype/variation: Wnt-1 overexpressing;	treatment: control,pert
wild type MEF time 0 replicate 1,ctrl
Ischemic cardiomyopathy_G33,pert
normal main pancreatic duct 1,ctrl
PlagL2KO3,pert
MCF10A-Her2-rep1,pert
patient id: 1393;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 83;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 1;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
tissue: retina;	age: postnatal day 4;	genotype: rd1,pert
"DMSO-treated, Sham UV, Replicate D",ctrl
Mc3T3 control_ 5day_rep1,ctrl
"Control, biological replicate 2",ctrl
"Cbfb-/-, technical replicate 2",pert
N30364,ctrl
patient: 31;	disease state: hypertension;	tissue: Atheroma plaque,pert
1-WT_RD1a,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 100 pM;	treatment time: 48 hours,pert
subject: 18U;	cohort: 18;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 37;	Sex: M;	batch: Batch_4,ctrl
Panc-1 TGFβ Treated 2 48 hr,pert
Mening SWB WB SW 3a,pert
Stable lentiviral shRNA;	,pert
"KO VSV infected, biological replicate 2",pert
BT474_Lap_24-2,pert
HF0211_U133P2,ctrl
PsOEt-18-Week 12,pert
shCypB2,pert
ctrl_untreat,ctrl
17_C57_KO,pert
9-cis-retinoic-acid_Lung_3,pert
tissue: murine embryonic stem cells;	genotype: Wild type;	strain: 129SV/C57BL/6,ctrl
"Tg brain, biological rep5",pert
"Heart, MAT1 CKO, 2 wk, sample 4",pert
PC-3_basalhTERT_ShortTelomeres_mock_2,ctrl
KCL-22 Imatinib-treated,pert
disease state: endometrioma;	patient: 7,pert
CHF - R15,pert
MCF10A-Her2-rep3,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 3,pert
tissue: muscle;	genotype: ClpP KO;	genetic background: C57BL/6,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 54;	tissue: Blood,pert
Vit A sufficient 2b,ctrl
"human failing LV myocardium, Ischemic53",pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep2,pert
Wildtype liver DEN-injected 12weeks repl2,ctrl
untreated Rb-/- MEFs-2,pert
Sample ID: TP39;	Twin Pair ID: CCE4.1;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-11.5;	Age at interview & blood sampling: 31;	Current Age (2007): 34;	Sex: MALE;	Medication at blood sampling : Epilim & Lamictal,pert
HN_127,ctrl
strain: FVB/N;	genotype/variation: Bmpr2-R899X mutation;	cell type: pulmonary vascular microendothelial cells (PMVEC),pert
"Heart, MAT1 CKO, 2 wk, sample 3",pert
32023.INV,pert
Floxed_Mstn_2,pert
Normal cervix epithelium_03-4508,ctrl
SW480_ezrin RNAi_rep1,pert
strain: C57BL/6J;	genotype: Tmod3+/+;	phenotype: normal,ctrl
Scd1-/- on chow diet replicate 1,ctrl
Strain: B6129;	Gender: male;	Age: 12 weeks;	Tissue: liver;	Developmental stage: adult,ctrl
strain: C57BL/6J;	cell type: LSK cells;	genotype/variation: wt,ctrl
V5-P549,pert
lesion_preUV_patient2,pert
erStress_twins_AA_1717twin1_DMSO_4h,ctrl
"Patient D, uninvolved skin",ctrl
WT-3,ctrl
"heterozygous, control, biological rep3",pert
Normal-ERα-positive breast cancer 26,ctrl
PGA-MLS-RA-1bAv2-s1,pert
"C2C12 Myotubes treated with BSA, rep2",ctrl
ku86(wt)_Terc(ko)_2,pert
Mouse RSK2 mutant mandibular molar [AZN_MolairesMutant3],pert
Scd1-/- on chow diet replicate 5,pert
"Deltoid, control, cohort 19, subject 19U",ctrl
Bl6_Mock_1,ctrl
cell line: sh2608 T47D;	sherbb3: +,pert
A2058 CT16 siRNA Rep2,pert
disease: cardiopathy;	gender: male;	age: 30 days;	tissue: thymus,ctrl
strain background: Mixed;	genotype/variation: VMH-specific FoxO1 Knockout;	tissue: ventromedial hypothalamus (VMH),pert
hdh genotype: Q7/Q7;	tissue: striatum;	age: 3~10 weeks,ctrl
LDLR_HF_3,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 87min;	race: White;	sex: Male,ctrl
"Donor 1, Ebola infected 6hr",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-sp2,ctrl
K562_ICL670_50uM_dup2,pert
"wild type, prenatal stress, biological rep2",pert
"12-week-old Wistar Kyoto (WKY), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump.",ctrl
K14deltaNB-cateninER  Time 1 replicate 1,pert
Cont subject 08,ctrl
quiescent p27KO MEFs 2,pert
12L,pert
Patient: J;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
5922012038_C,ctrl
HTB58_controlsiRNA_1,ctrl
Rosi-treated diabetic-1,pert
status: Control;	gender: Female;	age: 63;	tissue: Blood,ctrl
Cervical Cancer C482,pert
Muscle PCOS control 10,ctrl
Pool 5 Acute stage,ctrl
WT - Cre Treated - 12 hrs - repeat 2 - Cy3 - mAdbID:61757,ctrl
cell type: R1/E ESC;	RNAi: Luciferase,ctrl
genotype: WT;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Female,ctrl
SKBR3-R_Control_2,ctrl
LOX1 Untreated 2hr 282295533,pert
PTEN25+_rep3,pert
cerebellum SNCA knockout 21 month replicate 2,ctrl
"fibroblast, MFS subject FB890 rep 4",pert
No or early 2 rep1 (retina),pert
Squamous cell lung cancer X36sqm,pert
SCC25+doxorubicin_rep2,pert
P0 - nudel129s6 2,pert
U-87MG-PK25 set 2,pert
mdx quadriceps sample 2,pert
Day: 12; Drug: Saline; Phase: Drug treatment; Replicate: 2,ctrl
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P6,pert
"genetic background: Cebpa-Cre;R26-LSL-Eyfp;Dicer1wt/fl/Dicer1fl/fl (donror), C57BL/6 (recipient);	genotype: Dicer heterozygous deletion;	cell type: YFP-positive  granulocyte-macrophage progenitor",pert
Liver_Wildtype_Rep1,ctrl
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: n/a;	maternal age: n/a,ctrl
Day 4 (T29),pert
tissue: Liver;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 686,ctrl
phenotype: control;	gender: male;	case_id: 339;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 37;	brain ph at time of freezing: 6.76;	labeling_batch: 1,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 43;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
BATF_KO_P14_Naive_rep1,pert
"WT cells, replicate 2",ctrl
age in weeks: 8-10wk;	gender: Male;	strain: C57BL/6,ctrl
OSCE-14N,ctrl
liver-AHRKO-cornoil-rep1,pert
normal 1361,ctrl
20SAGEA,pert
GM19238_Kd_NS_P2_23,ctrl
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 4 hours,pert
"p53-, rep3",pert
Waldenström’s macroglobulinemia (WM-BL 32395),pert
OVCAR-10-(1),ctrl
Colo 668 SCLC cell line,pert
Wt Mouse_cerebellum_Old_saline treatment_Replicate-2,ctrl
KU_05T,pert
"SIN3A siRNA, biological replicate 1",pert
C9 Control None,ctrl
GM19238_Kd_IKZF3_1,pert
cell line: SV589;	knockdown (days): 3;	treatment: Serum Starved; 1h EGF,pert
Control_Castrated OWJ75,ctrl
Untreated Myd88 knockout - repeat 6 - mAdbID:102776,pert
"U2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression",ctrl
Kidney_400 mg/kg VCM iv_mouse #045,pert
homozygot FH P254,pert
"control, BA10-53",ctrl
1295-1C,ctrl
mdx Biological Replicate 1,ctrl
Pancreatic Sample 54-Normal,ctrl
T1+2,pert
"empty vector, biological rep1",ctrl
Cervical Cancer C451,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_1_6_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
HCT116 human colon cancer cells with PTEn -/-,pert
"Ulcerative Colitis (59 year old caucasian female, SAK_1286565132)",pert
siEGR4 (72 hr) _1,pert
heart_Q10_14M_rep2,pert
"pancreas, control diet, replicate 1",ctrl
4N,ctrl
"GM8839, affected sister",pert
SF539 PARK2 siRNA#2 replicate 2,pert
cerebrum_PS-/-_ 20d_rep2,pert
Cervical Cancer C348,pert
WT-sham-5 month+13d-R3,ctrl
CN3,ctrl
Txnip deficient normal 24 months sample 3,ctrl
individual: patient12;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
.SAL_II_1,ctrl
kidney_QH2_6M_rep3,pert
P60_PMP22KO_1,pert
"wild type CTL, biological replicate 3",ctrl
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 105;	Usage number: 4;	Exposures: 2,pert
"Trained diabetic mice, time point 1 week",pert
A/JTCE liver sample batch 4,pert
HDAC1_A3-rep3,pert
healthy CD4 T cells 2,ctrl
TB 4,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 6,ctrl
01LPG_Systemic,pert
"breast tumor epithelium,37",pert
healthy CD4 T cells 6,ctrl
prostate tumor 2,pert
"Wild type mouse aorta with placebo, biological rep1",ctrl
Metastatic prostate cancer W3,pert
Gastrocnemius muscle wild-type mouse: control mouse for integrin alpha7 overexpressing;	Strain: SJ6/C57BL6 background;	Genotype: wild type;	Gender: Female;	Age: 5 week;	Tissue: gastrocnemius and soleus muscle;	Feeding condition: non-fasted,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 63;	tissue: Blood,pert
"xenograft: Panc-1 human pancreatic carcinoma cell line, grown in mice;	treatment: GSK3B shRNA",pert
KU_36N,ctrl
normal;	Adjacent pair of T20,ctrl
WT-MAC-UV-2,ctrl
patient: 214;	current medication: NONE;	birth date: 1/10/37;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/59;	diagnosis date: 1/10/61;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 1;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 11/12/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 12/9/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: CENTRAL RETINAL VEIN OCCLUSION 01/04;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
14-week-old Trim24-/- liver_466M,pert
"Untreated wild-type NB4, biological rep2",ctrl
DRG_DMSO_0.1%_Rep3,ctrl
disease state: B-CLL;	tissue: peripheral blood,pert
chip number: 2;	transfection plate: 1;	target gene: CEBPG;	kd level: 0.79;	rin: 9.7;	transfection date: 2011-03-29,pert
"empty vector, biological rep2",ctrl
"fibroblast, control subject NF12 rep 2",ctrl
"Mutator, biological rep1",pert
breast tumor 5,pert
subject: 20U;	cohort: 20;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 39kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
1 Wild-type control macrophage,ctrl
Bone-Marrow_MGUS_G727,pert
INF-157,pert
"FOXP3, WT, REP3, 72h",ctrl
Control day 10 sample 2,ctrl
Ischemic cardiomyopathy_G15,pert
MDS patient 140,pert
"TMD_TA, T7",pert
"Crohn's Disease subject (22 year old black female, SAK_1259740044)",pert
Normal mucosa 19,ctrl
Human Chronic HIV Sample C062-CD4+ T cells,pert
wildtype Tcof1 [A],ctrl
T40728_rep,pert
treatment: Control siRNA Estradiol;	cell line: MCF7,ctrl
Untreated wild type A,ctrl
WT - Thymus - biological repeat 3,ctrl
tissue: Liver;	genotype: wild-type;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 560,ctrl
Genotype: B6.Pdss2loxP/loxP;	Age: 209-day-old male (concurrent control to Alb73);	90 mg liver used for RNA extraction,ctrl
"CD14+ after 2 wk quercetin supplementation, biological replicate 1",pert
SimvaVeh1,pert
Fibroid_2540B,pert
HRas-v12 transgenic male replicate 1 late timepoint,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day14,pert
normal brain_2,ctrl
hBSMC_vitamin D_rep2,pert
26 mt E11.5 heart,pert
P328L329_del6a+,pert
whole tissue section from case 1370,ctrl
"VPA 2, 16hrs",pert
"650nM MLN4924 after 1hr, replicate 1",pert
Wild-type control 1,ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 40;	gender: male;	tumor grade: AII,pert
strain: C57BL/6;	genotype/variation: RORasg/sg;	gender: male;	age: 5 Month old;	tissue: White adipose tissue (WAT);	diet: 35% Fat Diet (High Fat Diet; HFD),pert
"Luc control esiRNA, biological rep3",ctrl
24h Control (SAMPLE 8),ctrl
COV434 Wildtype [RR1018],pert
Pooled PBMC sample enriched for CD8+ cells from normal control subjects,ctrl
"brain, hippocampus: Ctr-240h-P15-I_e1_le1",ctrl
MNR 1-2 WT 3,ctrl
U87-mC2,ctrl
"normal skeletal muscle, biological rep4",ctrl
49A;pretreatment;female;breast tumor,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.853;	OD280: 0.955;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 290;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
patient: 260;	current medication: asacol 800mg TDS Asprin coproxamol;	birth date: 1/1/54;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/79;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/9/05;	indictation for procedure: ;	ucss: 12;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/9/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Arthritis Depression Alcohol excess;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
brain_OFC_control C_mr131,ctrl
"eye, retina: Diabetes 2_le1",pert
Ishikawa_LowDose_BPA_48h_rep2,pert
Itk knockout CD4+ unstimulated 3,pert
Non_Target_1,ctrl
Quercetin day 10 sample 1,pert
GIST_KIT_11,pert
strain: C57BL/6;	age: 1 year old;	tissue: liver,ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 328;	age-at-biopsy-years: 39,ctrl
cell line expressing inducible wt-GFP-lamin A. Induction: Day 0. Replicate A,ctrl
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl; Wnt1-Cre;	tissue: Primary palate mesenchyme;	age: E13.5  + P2,pert
MLL_00115,ctrl
HK12B7,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (33),pert
"brain, hippocampus: Ctr-240h-P15-III_e1_le1",ctrl
"DSS colon tissue, biological rep2",pert
"RNF40 siRNA - 5 days osteoblast differentiation, rep3",pert
"Crohn's Disease subject (58 year old caucasian female, SAK_1316890359)",pert
E18.5_Control_Kidney_array1,ctrl
Liver_normal_no.1,ctrl
Waldenström’s macroglobulinemia (WM-PC 32131),pert
Normal cervix_05-31,ctrl
HMEC X NB2,pert
IEC_GF-HDAC3ΔIEC -2,pert
b45+,pert
KD control replicate 1,ctrl
condition: Discoid Lupus;	patient: L2;	tissue: LS skin biopsy;	kit: Ovation,pert
Patient: B;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
tissue: testis;	gender: male;	age: 2-3 months;	genotype: Ing2 KO,pert
diabetic muscle replicate 1,pert
Nerve_Control_Vehicle_705,pert
pcDNA3(CT1),ctrl
"Resveratrol treatment exp 3T3-L1 cells, CT2",ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype squamoid cell;	matched/unmatched: unmatched,pert
Genotype: Homo sapiens,ctrl
Wildtype fibroblast sample 1,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 77;	time: 0;	batch: 2,pert
Cutaneous psoriasis without arthritis PsC 8,pert
Plate vs. Nail:  4 Week Sham,ctrl
"Donor 2, Ebola infected 1hr",pert
Ishikawa_VeryHighDose_BPA_24h_rep4,pert
Run4.aUa.010110d.SkMDbt1145D.CEL-DB stimulate,pert
AR-CO-24-3-571,pert
CONTROL;	Age = 19;	Sex = F,ctrl
WT2R2,pert
Postmenopausal female. Untreated control. nr 2.,ctrl
sepsis patient #20,ctrl
SARRC-2089-02-A,pert
Tretinoin1,pert
YFP-pos GMP Dicer wt rep2,ctrl
ILD Study Number S001,ctrl
healthy control sample x198,ctrl
db/db mice,ctrl
microdissected breast cancer cells from case 1343,pert
gender: male;	age: 6 months old;	genotype: Pdx1flox/flox (Ctrl);	litter: brother of the same litter,ctrl
E4C,ctrl
B6.BKS Ighmbp2nmd-2J mouse;	6 weeks of age;	male,pert
HB1.F3,ctrl
Genotype: E2F4 Null,pert
C2C12 myotubes 1uM H2O2 rep2,pert
CD11b+Gr1+ cell sample_2 (derived from wild type mouse),ctrl
c_NY106,ctrl
strain: B6129SF2/J;	tissue: lung;	genotype: wild-type,ctrl
"seminoma specimen, pT3, patient age: 48y",pert
"experiment II, untransduced, replicate 2",ctrl
braak stage: CTRL;	rin: 70;	tissue: substantia nigra;	disease state: control,ctrl
umbilical cord_nobpd: 3G,ctrl
"Strain: C57BL/6 X SV129, Age: Embryonic Day 14.5, Tissue: Palatal Shelves",ctrl
patient: 27;	disease state: hypertension;	tissue: Atheroma plaque,pert
siRNA LMG2 treated HeLa cells 2,pert
"Lens epithelium, WT, #5L",ctrl
chip number: 19;	transfection plate: 3B;	target gene: ESRRA;	kd level: 0.84;	rin: 9.4;	transfection date: 2012-03-26,pert
APLP2_R1_rep1,pert
cell type: myoblast;	transduction: untransduced,ctrl
N27,ctrl
"N-BMSCs, biological rep3",ctrl
DNGM-2,pert
"Patient 5, Macroscopically intact tissue",ctrl
CF (D508) subject2,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 130min;	race: White;	sex: Male,ctrl
eNOS Knockout Mice-M140,pert
"Patient 150N, normal colonic mucosa",ctrl
"Overexpress TFPIbeta, biological rep. 2",pert
patient: 11;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"Pineal gland from NeuroD1 cKO mouse at ZT20, biological rep 2",pert
MCF10A_Empty vector_2,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 2;	psoriasis duration: 28;	age of psoriasis onset: 16,pert
SBVGA3 1,ctrl
"3T3-L1 siLSD1 48h, biological rep 3",ctrl
LNCaP/NC siRNA #1,ctrl
transfected with control siRNA_5,ctrl
genotype: Villin-Cre - / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 63,ctrl
"Rat_Tracheal_Dex_2hr, rep3",pert
treatment: treated with vehicle and ELK1-shRNA;	cell line: LNCaP,pert
pancreatic cancer cell line FA6 transiently transfected with non-targeting siRNA,ctrl
patient: 51104;	disease state: LGSC;	component: Borderline,ctrl
WT_IL-6_100_rep1,ctrl
tissue type: Bone Marrow;	cell type: Multiple Myeloma (MM) plasma cells,pert
Sex: female;	Age at operation: 70 years;	Site: upper arm;	Size in cm: 3x5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
"ID: MLL_00261;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
"Diabetic mice, time point 1 week",pert
PIK3CA.DMSO.2,pert
n2a-Pou3f3-cont-3,ctrl
LNT-6,pert
dex24hr_3,pert
Gastrocnemius Muscle WT rep2,ctrl
H03_P_B2,pert
Subject 4 / lung subsegment instillated by Saline,ctrl
11_0013C_Day1_25,ctrl
T5D-LU,pert
At Risk: +;	Age: 16;	Sex: F,pert
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: control; biological replicate: 2,ctrl
gender: female;	genotype: Homozygous for the Q119X mutation in the TWIST2 gene;	ethnicity: Puerto Rican,pert
Cardian muscle Trained 1 week T1,ctrl
cell line: MDA-MB231;	treatment: control shRNA;	media: SCM,ctrl
"eye, retina: Myoc 1_e1_le1",pert
Sarcoma cell line  - Dicer Heterozygote -rep3,ctrl
"brain, hippocampus: wildtype 1_e1_le1",ctrl
s2t2c,ctrl
pcdh12-deficient mice rep3,pert
Allogen,ctrl
con-15_A,ctrl
PGA-MAH-C3H_PBS24h-2aA-s2,ctrl
"non-AD_HI, biological rep2",ctrl
Fetal heart control 4,ctrl
SBVGA3 2,ctrl
disease state: paediatric glioblastoma;	age: 5.4;	gender: M;	h3.3_status: wt,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 21.169;	Ratio: 2.11,pert
LT 436 +/T untreated,ctrl
KO_MEF_un.2,pert
"MCF-7, 12h, 0.9uM DOX B",pert
Cell line MDA-MB-231_c-myc KD_expt1,pert
midbrain_wild type_18 month_replicate 3,ctrl
tissue: brain;	genotype: mutant Lis1 ko/+;	age: P0,pert
"ALL_DS, K12 012109",pert
"depression, BA10-33",pert
Injured 1 day Rat Retina 3,pert
"ICR10 mouse strain (WT,)  gender- female, age- 2 months, n = 1, # of tissue = 1, tissue: Lung, Cell:Type II.",ctrl
MCF-7 breast cancer cells,pert
"Gender: Female, Age: 28, BMI: 17.1, Tissue: luteinized cumulus cells",pert
patient: 30308;	sample: normal,ctrl
Plate vs. Nail:  2 Week Sham,ctrl
C020_Control_M_25,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT wildtype, non-treated",ctrl
striatum_wild type_24 weeks_replicate 2,ctrl
Individual_5223_NN_sample,ctrl
tissue: Liver;	strain: C57BL/6;	genotype/variation: PXR-/-;	treatment group: vehicle 0 mg/kg,pert
Sex: female;	Age: 15;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
L428-PAX5+M_rep2,ctrl
"Gata4_S105Amut, untreated whole heart, individual 6",pert
Shn2_Wildtype_3,ctrl
444MM,pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 65;	age-at-onset: 65;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia",pert
01-0059A_Day1_5,pert
Cas 3,pert
patient: 27;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14504;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
Txnip deficient normal 24 months sample 1,ctrl
V5-P427,pert
liver-AHRWT-cornoil-rep1,ctrl
G4D_Sham_Rep2,pert
"Neurons overexpressing Hes1 and GFP, biological rep1",pert
Cervical Cancer C502,pert
tissue: Primary human lung fibroblasts;	treatment: None;	patient: 2;	time: Baseline,ctrl
Sedentary-17,ctrl
Tissue: normal thyroid; Gender:male; Age:43,ctrl
B6.IL10 24 air 1,pert
CONTROL 3,ctrl
P328L329_del5a-,ctrl
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 3,ctrl
pediatric AML S24,pert
PBMCs_Control_1 [IS],ctrl
Squamous cell lung cancer X33sqm,pert
IRS-3 KO (jos0953),pert
RV63.04_CONTROL_day19_Slide35,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 3x1h exposure per day",ctrl
SLE myeloid cells 2,pert
blood_day0_patient5,pert
ko 13.5d replicate 13,pert
BAL_13_A0B0,ctrl
Subject #8032-Preinfection,pert
genotype/variation: Fmr1 knockout;	tissue: cerebellum;	gender: Female,pert
O_LS_Wk2,pert
MED1 overexpression #1,pert
1205-01-A,pert
39GOBMUC2A,pert
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 35;	Usage number: 4;	Exposures: 2,pert
VIN_B027,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_2h_4mM_HG-U133A_2_YCHSUP501,pert
normal adjacent esophageal tissue from patient E1521,ctrl
Pax_S3,pert
16GOBMUC2A,pert
WT-SB replicate 2,ctrl
SCLC cell line SBC-2,pert
H_LS_Wk2,pert
Control subject 34_biological replicate 2,ctrl
brain_control_sampleid_mr284,ctrl
Muscle control 15,ctrl
Sham 50d replicate 1,ctrl
PBMCs_IS_8 [IS],pert
KM_051T,pert
scpk/ikLLtumor/77,pert
"SWR/J CHR, Rep1",pert
H08_P_B1,ctrl
striatum SNCA knockout 6 month replicate 1,ctrl
"109, MUSCLE, Before",ctrl
Treg Trim28 conditional KO rep3,pert
"control, subject 6",ctrl
Leg 28 Day mdx rep 3,pert
"Patient I-c532T, MSI colorectal tumor",pert
"NPCxhIPSC SCZP, replicate 5",pert
liver western diet rep3,ctrl
V5-P048,pert
Mammary gland R1 24 hr rep1,pert
HD10,pert
RptorKO QSC Technical Rep.1,pert
gender: Male;	tissue: Tendon;EDC;	age: 48;	donor: 9;	disease state: Non-lesional,ctrl
Kidney_Aqp11-/-_P7_3-3,pert
3D cultured chondrocytes from OA donor 3,pert
jos1988,ctrl
siHic5_2_0h_4,pert
"Normal cervix epithelium, Age 53",ctrl
tissue: Mouse heart;	genotype: wild type;	strain: C57BL/6,ctrl
FR-control-1,ctrl
KGN Knockdown [RR1007],pert
IEC_GF-HDAC3ΔIEC -3,pert
Strain: mixed;	Tissue: liver;	Age: 28 days,pert
Histopathological diagnostic: non-tumor,ctrl
"10B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Jurkat 4,pert
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: retina;	time: ZT6,pert
Background: mixed genetic backgroud of C57Bl/6 and 129/SvJ;	Genotype: IRF6 null;	Age: Embryonic day 17.5,pert
Insm1 control #3,ctrl
siRNA Control Duplicate 1,ctrl
180D3,pert
I_LS_Wk12,pert
"Biceps, control, cohort 12, subject 12V",ctrl
SW1736_t6h_rep2,pert
"human failing LV myocardium, Idiopathic31",pert
DNGL-2,pert
Negative Control 2,ctrl
human_LIMA_artery_patient5_control,ctrl
Patient no. 12: treated,pert
sampleID: SAM630146;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
optineurin expression-a01,pert
PGA-MAH-AJ_OVA24h-4aA-s2,pert
cell type: AML blasts;	fab classification: M2,pert
RPE65_KO_2months_retina2,pert
HeLa control knock down 2,ctrl
"cell type: Primary chondrocytes;	genotype: Mir140 KO;	antibody: Ago2 antibody;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant;	antibody manufacturer: Wako biochemicals;	antibody catalog #: 292-67301;	antibody lot #: PEK486",pert
"Wild type used for MAT1A 8 month, replicate 3",ctrl
MKK7D control female replicate 9 late timepoint,pert
strain: C57BL/6J;	genotype/variation: Transgenic;	gender: Male;	age: embryonic day 15;	tissue: frontal cortex,pert
tissue: heart;	developmental stage: E10.5;	genotype/variation: Dbh-/-,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: nasal cavity;	donor sex: male,pert
microdissected breast cancer cells from case 1206,pert
"Global gene expression of NASH patients, P64",pert
"non-transgenic mice, 7 month old, female",ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 scrambled;	treatment: tamoxifen for 120 min,ctrl
colon_IBD_1017,pert
HCaRG-8_HG-U133 Plus 2,pert
Human Chronic HIV Sample C080-CD8+ T cells,pert
EOM 112 Day Control rep 3,ctrl
"mouse aorta cross strain comparison, C3H_T24_HF_02",pert
"Nrl-ko-Gfp, Gfp+ photoreceptor cells",ctrl
Fertility Status: Fertile,ctrl
parental cell line: WA;	vector: pBabe-puro (empty vector);	replicate: 3,ctrl
KN-smoke-med-5 month+1d-R1,pert
F_Ctrl_1,ctrl
"scr-control, biological rep2",ctrl
Patient: F;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
"Ifitm1-deficient lung tissue, biological replicate 1",pert
"47, XX, +21",pert
Braf 1,pert
chip number: 12;	transfection plate: 3B;	target gene: TCF12;	kd level: 0.86;	rin: 9.5;	transfection date: 2012-03-26,pert
5224 UC Uninflamed sigmoid colon,pert
sirna: control (siSTABLE V2 non-targeting siRNA#1);	treated with tnfα: YES,ctrl
1212-4heart_Control,ctrl
Wild Type 11,ctrl
scpk/ikLLtumor/126,pert
Day: 1; Drug: Heroin; Phase: Drug treatment; Replicate: 2,pert
patient: 51084;	sample: tumor,pert
3526-lcm,pert
Bone-Marrow_SMM_S1306,pert
age: 38;	sex: F;	disease status: control subject;	Filter number: 105;	Usage number: 5;	Exposures: 3,ctrl
448MM,pert
Tg34,pert
Muscle KO Aged 1027,pert
A VIS _B096,pert
"RNF40 siRNA - 5 days adipocyte differentiation, rep1",pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 24h, biological rep2",pert
"patient: 210;	current medication: Mesalazine 800mg B, Prednisolone Supps;	birth date: 6/28/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/73;	diagnosis date: 1/10/74;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/19/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/14/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Scarlet Fever 1964;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.254;	OD280: 0.641;	Ratio: 1.98;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 296;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
OVCA420+(1),pert
age: 18 month postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: SCM,pert
Against CDK8-1 rep1,pert
T-REx293-NPAP1-induced-1,pert
sample: #15;	subject: Control case #5;	brain: T-2017;	age: 74;	sex: Male;	region: Inferior olivary nucleus,ctrl
OE-OCT4_1,pert
ES2 NT-5 25nM,ctrl
day 10 5-FU HSC 2,pert
MCL_IGHV_UNMUT (R1306),ctrl
Bronchial Epithelial Cells SA biological 1941D,pert
ApoD transgenic mouse rep_1 (CTG1),pert
cell type: Primary hepatocytes;	donor: 1;	agent: control;	time: 24h;	gender: Male;	age: 63 years old,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK2-2,pert
wtPrE serumfree 1,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M1;	flt3 status: WT,pert
CTRL_3_HSC,ctrl
Ecad_Con_3,ctrl
266C1,ctrl
"Patient 23, Macroscopically intact tissue",ctrl
"Trained mice, time point 3 week",ctrl
brain_DLPFC_bipolar C_mr448,ctrl
colonic_mucosa_non_inflamed_93,pert
Klf9 mutant (Klf9KO) mouse jejunum; Age: PND 30,pert
"seminoma specimen, pT2, patient age: 34y",pert
"HL-60 + 100 µM curcumin, biological replicate 1",pert
PGA-RMM-Ctr-2aA-s2,ctrl
"wild type saline, biological rep1",ctrl
HNF4a2_2-,ctrl
Cav3KO 1505,pert
siDdb1 replicate1,pert
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.34 uM (2 x EC50), biological rep1",pert
"Control 06, NC06",ctrl
remitted schizophrenia patient  S10,pert
No or early 1 rep4 (OHN),pert
ILD_21,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: spleen;	sample name: 4-sp3,pert
WildType_1_2,ctrl
Tissue: Spleen;	Type: CLP;	Strain: C57BL/6;	Batch: 12/1/03,ctrl
agent: Nickel 400 µM,pert
pcDNA3(CT2),ctrl
"breast tumor epithelium,51",pert
3560-4 E2F2 Null,pert
KO - knock-out Treated - 24 hrs - repeat 2 - Cy5 - mAdbID:61773,pert
"wild-type control (littermate) of ""P16_exPKO_pancreas""; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #2.",ctrl
CD8+_Tcells_non_severe_asthmatic_1,pert
source tissue: lymphoid;	cell type: Splenic CD11b+Gr-1 cells;	disease state: no tumor;	genotype: wild type;	genetic background: H-2b,ctrl
VMH of KO2 mice,pert
tissue: brain;	genotype: mutant Lis1 ko/+;	age: E14,pert
Cochlea_WT_9mo_3,ctrl
"Spi-60, biological rep 3",pert
OVCA420+(3),pert
Cav1KO 1758,pert
brain_DLPFC_bipolar C_mr701,ctrl
BC7 TC,ctrl
"U-87 glioma cell line with shcontrol, biological rep1",ctrl
Wildtype liver_saline-injected 12weeks repl1,ctrl
SCC11,pert
FO_spleen_wt_rep1,ctrl
"A673 treated with Puromycin for 24 hours with concentration of 0.09 uM (EC50), biological rep2",pert
Control replicate 2,ctrl
U937-shGSK3B-Construct1-rep1,pert
con_B135,ctrl
HaCaT_Control_ biological rep2,ctrl
MCF-7 +scrambled siRNA + vehicle rep2 (MD32),ctrl
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 5 months;	genotype: Myc heterozygous,pert
WT Control Sample B,ctrl
shCDK8_Time_0_2,pert
GIST Pre Treatment Biopsy 29,pert
53SageA2,pert
cumulus_PCOS_Lean_rep5,pert
Control Day7 (316L),ctrl
ATP-treated AML 6B blasts,pert
ku86(ko)_Terc(wt)_2,pert
diet_mammary_1,ctrl
Cbfb-deficient Treg_rep3,pert
gender: F;	age at blood draw: 59;	tissue: whole blood,pert
pediatric AML GP2,pert
vehicle treated rep 3,ctrl
BCells_Transgenic_day2_REP3,pert
"iPSC derived from healthy control fibroblast WT1, biological rep3",ctrl
5922012047_E,ctrl
C_C6,ctrl
V5-P090,ctrl
MDS patient 132,pert
FGF21KO.DMSO_2,pert
scan batch: Batch 1;	group: control;	subject age: 8;	paternal age: 25;	maternal age: 27,ctrl
Y YOKE_B022,ctrl
Etoh 5,ctrl
Pancreatic Sample 33-Normal,ctrl
BM_02619,ctrl
"Patient H-c614T-W, MSI colorectal tumor",pert
tissue: white blood cells;	age: 8.31;	Sex: male,pert
PGA-HMO-MObese-1aUA-s2,pert
KO MEF 2,pert
Cell line expressing inducible GFP-progerin. Induction: day 0. Replicate A,pert
condition: Normal;	patient: N_LJ_8;	tissue: Normal skin biopsy;	kit: Affy,ctrl
V5-P332,pert
"non-SS control gland, patient 18, batch 2",ctrl
H720 cell line control 3,ctrl
LNCaP EtOH rep 1,ctrl
01LNK_CTRL,ctrl
ND_3,ctrl
THRB bN mutant + vehicle replicate 1,pert
"Normal cervix, Age 50",ctrl
brain_Down_syndrome_sampleid_jg1737,pert
"human failing LV myocardium, Ischemic59",pert
HCC827 PR 1,pert
AIRE-ko-CD80hi-mTEC-sample2,pert
BCell_lymphoma_aggressive_sample6,pert
"This allele contains a deletion of the second coding exon of Gata4, including the start codon and the Nterminal 46% of the coding region. The mice used in this study were all male and on a uniform F1 genetic background resulting from the cross of Gata4WT/Δex2 (abbreviated;	G4D) mice, backcrossed for greater than 8 generations into C57BL6/J, to wild-type FVB/N mice. G4D progeny from this cross were present at weaning at the expected Mendelian ratio (104/218, 48%), survived normally to 18 months of age, and had no evidence of structural heart disease (0 out of 15 embryos examined histologically at E15.5-E18.5). Gata4WT/WT littermates (WT) from these crosses were used as controls.",pert
affected status (disease state): IS patient;	gender: male;	age-at-examination: 46;	age-at-onset: 45;	geographical origin: Vila-Real;	clinical characteristics: Hypertension;	lifestyle characteristics: ever drinker,pert
Skinbiopsy_7hoursnickel_nickel_allergic_subject_P7,pert
m1-adenoma3,pert
strain: FVB/N;	genotype/variation: Wild-type;	cell type: pulmonary vascular microendothelial cells (PMVEC),ctrl
gender: male;	age: adult;	tissue: liver;	genotype: wild type;	treatment: fasted 16hr then given ad libitum access to food for 3 hr,ctrl
erStress_twins_AA_1725twin1_500nM_thapsigargin_4h,pert
MCF-10A shATM-3 replicate 1 [set 5],pert
N51572,ctrl
Gender:F;	Age:48;	Tissue: Mucosa,pert
"BMMCs from NTAL KO, noninfected, 2 h activated, biological rep1",pert
Sample Group: HD patient; Gender: female; Age: 44; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/48,pert
"patient 027b, cancer, homogenized",pert
"Patient 999, 24 month of BETAFERON",pert
umbilical cord_nobpd: 5I,ctrl
0184-01-1,ctrl
"vector d4, rep 4",ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 4",ctrl
Leg 23 Day mdx rep 1,pert
cell line: HSC-3;	cell type: human tongue squamous cell carcinoma;	genotype/variation: control vector (no trypsin-2 expression),ctrl
subject: 03U;	cohort: 3;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: >40kb;	age (y): 42;	Sex: F;	batch: Batch_1,ctrl
Patient: J;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
control1,ctrl
HF1345_U133P2,pert
GM19238_Kd_CREBBP_3,pert
36A;pretreatment;female;breast tumor,ctrl
NOD non-transgenic islet rep3,ctrl
P60 wt2,ctrl
"experiment 1, control 1",ctrl
"Patient 998, 12 month of BETAFERON",pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: SHANK3 shRNA,pert
WT.DMSO_2,ctrl
Patient identifyier: W;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 27 years;	Body surface area: 6 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
condition: Normal;	patient: N_AJ2;	tissue: Normal skin biopsy;	kit: Ovation,ctrl
3765-1 E2F1 Null,pert
siERK2Veh24h_3495,ctrl
Sample 3 Posterior  -/-,pert
cell line: U937;	shRNA construct: GSK3A Construct 5,pert
muscle WT 3 control,ctrl
MEFs-1,ctrl
Bach2 KO - Thymus - biological repeat 3,pert
Human prostate cancer primary culture C22dx,pert
"RNF40 siRNA - 2 days osteoblast differentiation, rep2",pert
KN-smoke-med-5 month-R3,pert
hES_VUB01_3,ctrl
cell line: HCT116 Human colon cancer;	shRNA expressing: B-Galactosidase,ctrl
3036,pert
"tissue: whole brain;	strain: C57BL/6J;	genotype/variation: wild type;	age: 8 weeks, 5 days;	infection: 107 pfu of VSV-Indiana strain",ctrl
TOV112D NT-2,ctrl
strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: corn oil,pert
tissue: hepatocellular carcinoma tumor;	treatment: erlotinib 2mg;	strain: Wistar,pert
Untreated Myd88 knockout - repeat 2 - mAdbID:102772,pert
b45-,pert
X_p4_rep2,pert
"ALL_NDS, K59 011509",ctrl
tissue: Barrett's,pert
HC-KO-21A,pert
Eed KO J1 ESCs on day 0 #1,pert
"41B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
MDA-MB-231 RRP1B over-expressing clone #5,pert
"brain, Entorhinal Cortex: 97-01 tangle_e1_le1",pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
"E18.5 ERRg +/- heart, biological rep 1",pert
GV oocyte_control_rep3,ctrl
patient: 51294;	sample: normal,ctrl
transgene: FTO;	treatment: 24h after induced espression of integrated copy of the FTO gene,pert
PGA-MPF-C57-saline-24h-2aAv2-s1,ctrl
treatment: baseline;	gender: F;	age (y): 47;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,ctrl
Sample 17 Kidney Hyp Mouse - Control Diet,pert
strain background: C57BL/6;	genotype/variation: Parp-2-/-;	cell type: sorted Ter119+CD71+ bone marrow cells,pert
01LM4_PolyRF-,pert
MDS patient 92,pert
"brain, hippocampus: Ctr-24h-P15-III_e1_le1",ctrl
Liver_POR-null_3,pert
"Subject 3, Family 1, Control",ctrl
HSC-3_TAT-2_48hr culture_ rep1,pert
Individual_4616_PP_sample,pert
Myh11-CreERT2.Tgfbr2f/f Control 2,ctrl
Healthy Donors 2,ctrl
strain: Gata4tm1.1Sad/J;	infection: Nuclear β-galactosidase;	culture: Differentiation medium for 3 days,ctrl
5: FCHL patient #98-1281,pert
cell line: SKM-1,pert
cell type: Primary hepatocytes;	donor: 3;	agent: Wy14643;	time: 24h;	gender: Female;	age: 70 years old,pert
480MM,pert
miR122-KO-318-T,pert
mdx Biological Replicate 4,pert
H1299 DAC 0.3 uM (3236),pert
Leg 7 Day mdx rep 3,pert
Wildtype_XX_2,ctrl
Control 2 c,ctrl
HeLa_06_21_04 TP-3,pert
brain_DLPFC_bipolar B_mr420,pert
passage: 10;	cell type: fibroblast;	treatment: overexpressing progerin;	cell line: GM00038,pert
E9_Embryo_Heterozygous_1,pert
ubb_d14_ko_2,pert
8 Weeks Heart MDX rep 2,pert
C033_Control_M_81,ctrl
COV434 Wildtype [RR1022],pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 24h ID57,ctrl
BIO586224,pert
Cadherin-11 siRNA (RNAi 6A)_1of2,pert
CML_2_MEP,pert
"control, BA46-59",ctrl
wt_P2_rep3,ctrl
affected status (disease state): IS patient;	gender: female;	age-at-examination: 73;	age-at-onset: 70;	geographical origin: Vila-Real,pert
LKR13_Control-4,ctrl
Endometrial stromal cell - Jag1 retrovirus infected 2,pert
med2d_2,pert
HET Brain 55d Mouse1,ctrl
umbilical cord_nobpd: 5F,ctrl
normal,ctrl
untreated or induced,ctrl
CME-Emerin0d-2MA-S2,pert
Normal mucosa 18,ctrl
MacularDegen-injured-14aAv2-s2,pert
Quercetin day 10 sample 2,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 5d ID219,pert
genotype: STAT1-KO;	time (h): 0;	cell type: primary hippocampal neuron;	treatment: untreated;	genetic background: C57BL/6,pert
HT29 PLX Day1 rep1,pert
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 6h;	donor: 1,pert
2062T,pert
Subject 6_t=30days_placebo,ctrl
"BL from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE, CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
cell line: mNB-A1;	strain/background: mixed C57BL/6 x 129X1/SvJ;	cell type: MYCN-driven neuroblastoma;	treatment: DMSO,ctrl
NSCL/P sample 2,pert
genotype/variation: bitransgenic Pdx1-cre/Kras*A;	cell type: pancreatic tumor,pert
wt_TGFb_4hr_2,ctrl
Pool Eu_P15_hyb1,ctrl
CLL2-CD8,pert
HP-54,ctrl
"testis with regular spermatogenesis from orchiectomy cases due to prostate carcinoma, patient age: 58y",ctrl
BL Day 2 siSC transfected biological rep1,ctrl
SF539 PARK2 siRNA#1 replicate 2,pert
OE33 Control rep3,ctrl
"Foxd3 conditional knockout cells treated with DMSO, biological rep1",ctrl
"Wild-type retina, biological rep4",ctrl
platelet_Ctrl_7,ctrl
GM19238_Kd_WHSC1_2,pert
C2 Control None,ctrl
liver 0.1% quercetin diet rep6,pert
SeroTest-9,pert
subjectid: 5278;	imatinib: IM;	lbh589: NoLBH,pert
CML-BM 5,pert
"MCF7/BUS, 100 pM E2, 48 hours, biological replication 2",pert
sample P term wt,ctrl
CTRL_2_MEP,ctrl
Haloperidol treated 12weeks AffyGC RMA rep4,pert
ILD Study Number 1281,pert
V5-P588,pert
Velcade I3,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 8.5;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 40;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
reduction mammoplasty patient 352,ctrl
"patient: 103;	current medication: None;	birth date: 6/30/65;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/9/04;	indictation for procedure: Diarrhoea, now settled, Mum has UC;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
"array 25, unimplanted",ctrl
BAT_WT_5,ctrl
protocol: AP-2 gamma targetting siRNA 1;	cell line: MCF7,pert
IGROV-1+(1),pert
Psoriasis-Patient-H,pert
"Gender: female, Age: 33 years, Tissue: VIN 3",pert
age: 51;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
cell line: SBC-5 cells;	treatment: siEGFP (control);	time: 24 hr,ctrl
Strain: In-house BALB/c mice; Gender: Male; Age: 4 months old; Tissue: Brain; Treatment: 4 hours post LPS 0.33mg/kg BW ip.,pert
K562_NoTreatmentControl_24hrs_rep3,ctrl
FVB_MMTV_Wnt1_3718.3R_Rosen,ctrl
MRF CKO Oligodendrocyte Replicate 1,pert
GAS-n7-2; normal gastrocnemus 7 month,ctrl
"MCF7/BUS, 100 pM E2, 48 hours, biological replication 5",pert
HCV_Core_3,pert
disease state: Diamond-Blackfan anaemia;	gender: Female,pert
Healthy controls; individual=CM; time=2; beverage=water,ctrl
"Male, 33 years old, HIV infection of >3 years",pert
Dengue Fever Patient 35,pert
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 1,pert
cell type: Primary hepatocytes;	donor: 4;	agent: control;	time: 24h;	gender: Female;	age: 54 years old,ctrl
sampleID: SAM630139;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
ccRCC tumor of patient T165,pert
miR122-WT-104,ctrl
LJMJDW8,pert
KGN Knockdown [RR1004],pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 159,pert
hur status: KO;	rna subtype: nuclear RNA after HnRNPA1 Immunoprecipitation,pert
condition: Psoriasis;	patient: 252;	tissue: LS skin biopsy;	kit: Ovation,pert
cell line: HeLa,pert
colon_CRC_1486,pert
sal-PVH3_1,ctrl
"brain, cerebellum: RNA#5S_le1",pert
"Gender: Female, Age: 37, BMI: 31, Tissue: luteinized cumulus cells",pert
strain: Sprague-Dawley;	tissue: spinal cord (ipsilateral dorsal horn);	developmental stage: Adult (8-12wks);	treatment group: 7 day post sciatic nerve SNI injury,pert
mouse cerebellar granule cells knockout 2,pert
01LNX_Oligo,pert
hESC H1 B2M KO c1,pert
Subtype: RAEB2;	Karyotype: normal,pert
agent: pristane;	time: 3 days;	strain: DBA;	tissue: mesentery,pert
HeLa_01-04-05 TP12_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
"MAT1A knockout at 15 month age, peritumoral tissues, biological replicate 4",pert
gender: male;	dietary group: grape extract (B);	time point: 12 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),ctrl
AVC_control_rep1,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	RNA Integrity Number: 9.6;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 41;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Hippocampus 1985 15 month Old,pert
"TLR4 null sham kidney, biological rep3",pert
strain: C57BL/6;	genotype: Captain Morgan (DOCK8 deficient animal strain),pert
Young 2,ctrl
strain: Swiss;	tissue: Ovary;	agent: Methoxychlor (50uM);	replicate: 3;	age: Post natal day 3-12,pert
SLE myeloid cells 11,pert
Wild Type B cells Spleen 2,ctrl
MCF10A-Vector-rep2,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 200min;	race: White;	sex: Female,pert
n4t7d,pert
3765-2 E2F1 Null,ctrl
5922012038_D,pert
transfection: CDK8-1;	cell line: HeLa S3,pert
Dexamethasone 1,pert
age: 12 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
Calu3-GemR_Veh_2,pert
Psoriatic arthritis PsA 12,pert
Brain_Aged_Salineip_4hr_mouse1 (OP1_#61),ctrl
"twin pair: #4;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
Age: 66 yrs Gender: Female  Ethnicity: Caucasian,pert
"A673 treated with Doxorubicin for 5 days with concentration of 119.76 nM (2 x EC50), biological rep1",pert
"Lesional skin from imiquimod-treated mouse, biological replicate 2",pert
S-IIP(NSIP)1_Cy3,pert
"Kinin B1 receptor knockout, biological rep2",pert
strain: FVB/NCrIBR;	tissue type: tail skin,pert
"MCF7/BUS, 60 pM E2, 48 hours, biological replication 4",pert
cell line: BV-173;	tissue: Human B cell precursor leukemia,pert
ARF1 siRNA knockdown MDA-MB-231 sample 9,pert
microdissected breast cancer cells from case 1093,ctrl
siSPDEF_6,pert
duration of untreated disease in month:2.1;	age at onset:8.3,pert
race: caucasian;	age (years): 52;	stage: IB;	grade: 1;	histology: endometrioid,pert
stomach_0h_rep1,ctrl
Run4.aUa.010110d.SkMDbt1143D.CEL-DB stimulate,pert
maternal diet: Control;	genotype/variation: Wildtype;	strain: C57BL6/J;	developmental stage: Embryonic (8.5 days post coitum),ctrl
cell line: LN229;	expression: control,ctrl
MacularDegen-injured-7bAv2-s2,pert
"Patient G, lesional skin",pert
Fibroblasts_HealthyControl_3,ctrl
coc-42_B,pert
"SiRNA-scrambled, replicate 6",ctrl
P14 - WTMixB 2,ctrl
MLL_PTD09,pert
Carbo Day1 (397L),pert
BP patient 54_biological replicate 2,pert
phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject C,ctrl
whole tissue section from case 1047,ctrl
4031-2 E2F3 Heterozygous,pert
TFEB_Overexpression(S1),pert
"Patient CCa, stable renal transplant recipients, female, 70 years old, T1 (3 months after the switching of the therapy)",pert
"Global gene expression of NASH patients, P66",pert
Myoblast-GATA4-OE-day0-1,pert
siLRH-1_#3_rep_4,pert
cerebellum_Pink1 knockout_6 weeks_replicate 3,pert
ACC 3 cell line Sox4-RNAi replicate 3,pert
N30162_rep,ctrl
Series 1; adult; no fracture,ctrl
SLE CD4 T cells 10,pert
subject: 31;	disease: TD;	muscle: ST;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
blood_day0_patient3,pert
Animal 3,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 4;	psoriasis duration: 19.0;	age of psoriasis onset: 17,pert
age: 18 month postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
CBMNC.LPS+.3,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 47 yr;	population: white;	dsm-iv: 295.3;	age of onset: 20 yr,pert
WildType_2,ctrl
strain background: ICR;	genotype/variation: alpha-cre;	developmental stage: E12;	tissue: Embryonic retina/optic cup,ctrl
P4_Ovary_NT3_biological rep1,pert
"Peripheral blood, normal control [N52]",ctrl
umbilical cord_bpd: 2I,pert
PTC BRAF mut 5,pert
"Pool of three samples (n=3);;	cells: CD3+ T cells, peripheral blood;;	healthy volunteers; gender: two females, one male; age: 25 and 37 years old ",ctrl
"10 week, mutant;	SOD1(G93A);	Male",pert
PTC BRAF mut 10,pert
AL Chip#45,pert
Strain: C57BL/6J;	Gender: male;	Age: 6 weeks;	Tissue: whole brain,ctrl
MEF.FHL2mutJ,pert
MCL_IGHV_UNMUT (R1338),ctrl
"2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression",ctrl
U937-shGSK3B-Construct2-rep1,pert
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: cisplatin;	timepoint: 2 hours,pert
"schizophrenia, BA10-14(2)",pert
E14.5_Mutant_Kidney_array2,pert
CuFi cell line treated at DMNQ biological rep3,pert
"A pool of two pure subsets of peripheral blood CD4+ T cells (CD19- CD3+ CD4+ CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
condition: Normal;	patient: N_AJ3;	tissue: Normal skin biopsy;	kit: Ovation,ctrl
129S1/SvImJTCE liver sample batch 1,pert
ATP-treated AML 7C blasts,pert
Rat fatty liver1,pert
"Normal T-cells, CD3+, donor 4",ctrl
"dy/dy dystrophic diaphragm 1, 8 week",pert
CD11b+Gr1- cell sample_4 (derived from IL17RC Knock out mouse),pert
Control subject 24_biological replicate 1,ctrl
Normal heart_G16,ctrl
"DEX-treated embryonic primary chondrocyte cultures, incubated for 24hr.;	Timed-pregnant CD1 mice were purchased from Charles River Laboratories at embryonic day E15.5 mice (E15.5). Dexamethasone was obtained from Calbiochem and reconstituted in Dimethyl sulfoxide (DMSO, vehicle).",pert
con-11_B,ctrl
colon_normal_1357,ctrl
siCITED1#3 replicate4,pert
"eye, retina: Diabetic 1_le1",pert
Disease_status: Healthy control;	Age (years): 55;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
"Endometrium, postmenopausal, tibolone, 1",pert
Run7.aUa.001206d.SkMInS1073D.CEL-IS stimulate,pert
WT 2 mon replicate 1,ctrl
"AD_FC, biological rep11",pert
HA99-96B,pert
Testis CREMKO 0h batch 4 [TeKOh00.5],pert
WT_cells_rep2,pert
MIY_day_5-5,ctrl
Hippocampus_Soman_3h_rep4,pert
timepoint: Pre-Cediranib treatment,ctrl
MIY_day_3-1,ctrl
human_hepatocyte_400uM_levofloxacin_donorA_24hr_prep2,pert
"brain, cochlea: [17] Sample #17_le1",ctrl
CHB PBMC_sample 7,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_4,pert
RNA-DHL4-DMSO-2,ctrl
"S1P2-KO-neocortex, biological rep3 (male)",pert
TTF=70min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
cell line: H1299;	agent: DMSO;	dose: control,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 100min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 118,pert
Disease_status: Down syndrome;	Age (years): 47;	Gender: Female;	Post mortem interval (hours): 8;	Braak stage: II;	Cause of death: Unknown,pert
Human Non-progressor HIV Sample L134-CD8+ T cells,pert
"bcatGOF  mouse kidney E12.5, biological rep 1",pert
mixed reference (CRG + FR),ctrl
Patient 5 skin treated,pert
MDS patient 58,pert
Retina wildtype 42 days 4,ctrl
EmptyVector 3,ctrl
B2KO; No Treatment #10,pert
Healthy6-CD4,ctrl
GM19238_Kd_NS1_21A,ctrl
Strain: Long-Evans;	Gender: Male;	Age: Adult (PND62-PND64);	Tissue:  Cerebrocortex,pert
SZ14,pert
S013_Scz_F_65,pert
T30308,pert
Cervical cacner_654T,pert
Msgn1_48hPlusDox-biological rep3,pert
siHic5 VC 2,pert
normally functioning myocardium from unused donor heart,ctrl
3872-1 E2F WT,pert
Strain:B6.V-Lepob;	gender: female;	age: 12 weeks;	tissue: gallbladder,ctrl
IL8.2,pert
Md02h021,ctrl
Wild Type Control for Pit-1 mutant (Snell) resulting in long lived dwarf pheontype,ctrl
bone marrow macrophages from 1 female and 1 male IRAK4 kinase dead Balb/c mouse,pert
injection: IP 8hr 1 mg/kg sodium arsenite in saline;	diet: AIN-76A,pert
MCF10A_Vehicle_rep3,ctrl
Psoriatic arthritis PsA 3,pert
"MCF7 cells stably transfected with pCDNA3.1, passage 1",ctrl
cell type: PBMC;	group: Healthy control;	patient treatment: not applicable,ctrl
Ishikawa_Control_24h_rep3,ctrl
"Inclusion body myositis, biological rep2",pert
WT HPC PDE10i 13,pert
patient: 51308;	sample: tumor,pert
5_DMSO-5,ctrl
"brain, hippocampus: Aldh5a1-/- #3389 Cort_e1_le1",pert
ROS3,pert
"Control, biological rep6",ctrl
NRG Melan-Ink4a #3,pert
"seminoma specimen, pT2, patient age: 34y; W03 013",pert
"A673 treated with Doxorubicin for 24 hours with concentration of 59.88 nM (EC50), biological rep1",pert
Jurkat with Nef Biological Replicate 2,pert
chip number: 14;	transfection plate: 3A;	target gene: IKZF3;	kd level: 0.64;	rin: 9.5;	transfection date: 2012-03-26,pert
HO_2,pert
"AD_HI, biological rep4",pert
REH_control_rep3,ctrl
"KO VSV infected, biological replicate 3",pert
Sample ID: TP15;	Twin Pair ID: CCN1.1R;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.1**,ctrl
180C0,ctrl
Kyoto rat liver tissue following animal exposure to orotic acid for 3 days,ctrl
cell line: BxPC3;	genotype: CTNNB1 KO;	beta-catenin gene (ctnnb1): gene disrupted,pert
Control Braak α- synuclein Stage 0 C5SN,ctrl
"Crohn's Disease subject (54 year old caucasian male, SAK_1275522739)",pert
CHF - R11,pert
A7_C7_nasal_stem_cell_rep1,pert
GATA6 KO #2,pert
5922012008_C,ctrl
A11_C11_nasal_stem_cell_rep1,pert
Clozapine treated 12weeks AffyGC RMA rep10,pert
"Foxd3 conditional knockout cells treated with Tamoxifen, biological rep2",pert
"twin pair: #8;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
"Crohn's Disease subject (27 year old caucasian male, SAK_1313693880)",pert
Allo-4-2,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
cell type: Mouse embryonic fibroblasts;	genotype: wild type;	time: CT30,ctrl
male_control_277,ctrl
"Gata6-KO heart, CRE, biological rep2",pert
12h Lipofection GAPDH siRNA (SAMPLE 6),pert
11402 Normal Inflamed sigmoid colon,ctrl
"0mg/kg/day PFOA, Rep 2, Block 1 liver (low dose)",ctrl
race: african american;	age (years): 74;	stage: IA;	grade: 2;	histology: endometrioid,pert
CML Patient 4 7 days therapy,pert
STV_H,pert
No or early 2 rep3 (OHN),pert
E1 clone infected with Deaf-1-expressing retrovirus.,pert
Patient: C;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
"affected sister,",pert
RNA from HCC_1T,pert
organ: Liver;	age: 14-week-old;	genotype: Trim24-/-,pert
strain: FVB;	developmental stage: newborn (4-day-old);	tissue: hippocampus;	genotype/variation: Prnp0/0,pert
MOLM14-shControl-rep2,ctrl
3274-2 E2F WT,pert
FmrKO4_blood,pert
tissue: breast;	disease state: healthy,ctrl
"normal breast epithelium,3",ctrl
SKBR3_1uM_Lapatinib_2,ctrl
WT - Cre Control - 5 mo - repeat 3 - Cy5 - mAdbID:74101,ctrl
Intronic WT control rep3,ctrl
SUM149_siTIG1_rep1,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 1,pert
age_years: 60;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
E14 molar DMSO 2,ctrl
"non-AD_FC, biological rep5",ctrl
blood_day0_patient4,pert
Kidney_Biopsy_Liver_Disease_3,pert
HEK293 cells siRNA BAHD1 biological rep2,pert
"Male, 27 years old",ctrl
Patient 9,ctrl
Bronchial Epithelial Cells SA biological 1929N,pert
Primary combined SCLC-AD 4544,pert
"shControl cells, rep1",ctrl
striatum wild type 6 month replicate 3,ctrl
MDS24,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 40;	sex: F,ctrl
Cell line MCF-7_control_expt2,ctrl
12469 UC Inflamed ascending colon,pert
Nonspecific siRNA3,ctrl
prostate normal 1,ctrl
Postnatal 12 weeks control heart biological rep2,ctrl
Control Colon 3 21 days old,ctrl
"genotype/variation: ApoE-/- RAGE-/-;	strain: C57BL/6;	mouse provider: Ann Marie Schmidt laboratory, Columbia University;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: non-diabetic",pert
"Pb-Cre+;PtenL/W;K-rasG12D/W, biological rep2",ctrl
pt. HCL D treated with Vemurafenib 1000 nM for 72h,pert
MDS patient 82,pert
"mouse aorta cross strain comparison, C3H_T40_NC_03",ctrl
Strain: C57BL/6;	Genotype: AMPK gamma3 mutant (R225Q) transgenic;	Generation: F5;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 28.88767,pert
Patient 6 after folic acid,pert
X78-,pert
Normal Unoperated,ctrl
VMM-WT_MyoD24h-3MP-s2,ctrl
"Muscle from DS, biological rep4",pert
NFIA P16KO3,pert
"CBP, p300, CH1, TAZ1, hypoxia, MEF",pert
"BMMCs from NTAL WT, NTAL shRNA infected, 2 h activated, biological rep3",pert
tissue: Temporal cortex;	age: 84;	Sex: M,pert
"SFM control cells (24hr), biological rep_3",ctrl
SW1736_t1h_rep3,pert
Control Day1 (392L),ctrl
coronary smooth muscle cells control replicate 2,ctrl
Brain_Aged_LPSip_4hr_mouse3 (OL3_#69),pert
U-87MG-PK19 set 1,pert
Mammary gland R1 8 hr rep4,pert
aa_NY39,pert
"MaF pre-iPSC9P2, Vc-, D5",ctrl
CRC_nodrug_F4864,ctrl
WT_TER119-_rep2,ctrl
WT MEF CT30-1,ctrl
PGA-RMM-30m-1aA-s2,pert
05SAGEA2,pert
cell line: COV434;	transfection: pFOXL2wt,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 70min;	race: White;	sex: Female,pert
"Deltoid, control, cohort 12, subject 12V",ctrl
hNHEPS_control_0 h_rep3,ctrl
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 24hr,ctrl
2103-03-A,pert
"Liver from Nrf2 k.o. mice, biological replicate 3",pert
CD11b+Gr1- cell sample_1 (derived from IL17RC Knock out mouse),pert
"PIO, subject 10",pert
Normal-BM 6,ctrl
CAST/EiJTCE liver sample batch 3,pert
whole tissue section from case 1218,pert
"nasopharyngeal carcinoma, specimen T24",pert
"non-AD_FC, biological rep9",ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: fresh air, treatment over 5 month + 1 day recovery, 4x1h exposure per day",ctrl
CD8+_Tcells_severe_asthmatic_8,pert
MDS patient 155,pert
RV63.12_CHF_day19_Slide43,pert
"wild type CTL+AktI, biological replicate 3",pert
BH4,ctrl
lung_E18_wildtype_rep1,ctrl
MDS52,pert
"48 hour-treated wild-type NB4, biological rep3",pert
patient id: 260;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: n/a;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0Mx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
Gender: Male; Tissue: prostate.,pert
strain: ICR;	cell type: bronchoalveolar stem cells (BASC);	genotype/variation: control,ctrl
Cmah KO_lung_1,pert
PsOEt-17-LS,ctrl
"kn muscle 2, biological rep 2",pert
01N28_Oligo,pert
8 week old EOM control rep 2,ctrl
PGA-FVB_3m_2f-m5,ctrl
Saline T00278944,ctrl
"MCF7/BUS, 0 pM E2, 48 hours, biological replication 3",ctrl
Individual_4391_NN_sample,ctrl
RA_z,pert
GIST882 DMSO Rep2,ctrl
4_Hr_No_MGd_2,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: normal,pert
cerebrum_WT_20d_rep2,ctrl
prostate_Klf5 ko_rep3,pert
cell type: Primary hepatocytes;	strain: DBA;	agent: Wy14643;	time: 24h;	gender: Female;	age: 3 months,pert
subject id: 40;	infection: DENV;	status: DHF;	tissue: whole blood,pert
Colo-205 PLX Day 3,pert
DDR-1-KO mouse (KO_Tal5),pert
OC1-KO embryo 3,pert
Untreated Control 4weeks AffyGC RMA rep2,ctrl
"Mdr2-KO homozygous mouse, 3 month old mouse 1",pert
PC-3_basalhTERT_ShortTelomeres_mockcre_1,ctrl
siNS_2h_1,ctrl
"Control, biological rep3",ctrl
Control_liver_4,ctrl
Injured 4h Rat Retina 2,pert
HP-8,ctrl
Patient: E;	Time: 1 week;	Group: responder;	Condition: lesional,pert
Bc_WAP_2,pert
"Wild-type-hippocampus, biological rep2 (male)",ctrl
C597,ctrl
Substantia nigra PD rep6,pert
Lmna H222P heterozygous male 2,pert
"scr-Rosi, biological rep1",ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,pert
A2780+(1),pert
"KO liver, biological rep3",pert
Liver_KnockOut_3,pert
gender: Male;	tissue: liver;	genotype: FGF21-/-;	treatment: DMSO 3-day;	genetic background: C57BL/6,pert
sample =Healthy3 treatment=Control time=180 (min),ctrl
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep7,pert
WT mouse (WT_Tal4),ctrl
Patient 5,pert
SARRC-0994-01-C,ctrl
Ngn3 EB10 OFF replicate 1,pert
tissue type: Lesional skin;	time: Week1_etanercept,pert
genotype: MLL partial tandem duplication,pert
Bone-Marrow_NPC_N1351,ctrl
XDP caudate nucleus,pert
mouse liver B2,ctrl
RNA from HCC_4T,pert
VCaP/NC siRNA #1,ctrl
Normal bladder 81-99,ctrl
treatment: Cyclin D1 siRNA Estradiol;	cell line: MCF7,pert
umbilical cord_bpd: 4I,pert
"RWPE1 cells, vehicle, 48h, biological rep4",ctrl
H1299 RBP2 KD2_rep 1,pert
5261 UC Uninflamed descending colon,pert
SNRK_3,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L221,pert
"human failing LV myocardium, Ischemic102",pert
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
MDA_PR_3,ctrl
"Data 2, Vbeta5",pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 49;	donor: 35;	disease state: Lesional,pert
ILD_12,pert
A549 siRNA FAM60A 2,pert
Wildtype 3 (jos0534),ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 6h ID286,pert
ID: MLL_00116;	cell type: PBMC;	disease state: control,ctrl
Individual_4641_NN_sample,ctrl
OV90+(3),pert
"WT, PR02M003v0",ctrl
K_LS_Wk1,pert
INCB18424 Persistent 3,pert
Isoflurane 10 exposures-2,pert
Brain_Wild-type_MiceNoB4394,ctrl
"UACC903, no treatment",ctrl
genotype: WT;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Male,ctrl
Genotype: Genotype: FORKO (FSH Recptor Knock Out). FORKO mice was generated by deleting all variants of FSH-Receptor,pert
LRRK2 mutant knockin H9 hESC derived NSC 3,pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: WT;	treatment: DSS for 3 days,ctrl
N79s,ctrl
5922012038_B,pert
"Control ES cells 96hr, replicate 1",ctrl
08SE1183,pert
Pancreatic Sample 54-Tumor,pert
31GOBMUC2A,pert
"D425-shOTX2_3, t=16",pert
8DKD_SerumStarved_rep3,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: ;	choa: 56;	fata: 125;	eea: 1860;	wtkg: 74;	perfat: 26;	lbm: 52;	fat_mass: 1924,ctrl
tissue: pancreatic ductal adenocarcinoma tumor;	genotype: Pdx1-Cre; Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 8.5 weeks-old,pert
age: 6 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,pert
CA01-103A,ctrl
"ID: MLL_00255;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
H07_S_B1,ctrl
heart_QH2_6M_rep3,pert
"MCF7/BUS, 30 pM E2, 48 hours, biological replication 1",pert
"genetic background/strain: C57BL/6;	genotype: Alkbh1-/-;	cell type: embryonic stem cells;	developmental stage: day 0, undifferentiated;	passage: 8",pert
Mammary gland R1 NT rep3,ctrl
tissue: Temporal cortex;	age: 74;	Sex: M,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.377;	OD280: 0.716;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 211;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
hES_VUB03_DM1_3,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 46;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
genotype: EFLmDREAM;	stimulation: non stimulated;	cell type: B cells,pert
Kidney_saline_5,ctrl
CLL6-CD4,pert
Patient: G;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
autism with FMR1-FM AU046703,pert
Control 60 days sample 3,ctrl
"patient 031b, normal, homogenized",ctrl
patient: 258;	current medication: Azathioprine 200mg Pentaza 1g TDS;	birth date: 10/26/64;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/1/87;	diagnosis date: 6/1/88;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/7/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/7/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"Knockout sham, biological rep3",pert
PsOEt-19-LS,ctrl
5871841165_C,pert
tissue: small intestine;	genotype/variation: E-cadherin cKO,pert
"Aorta, saline 14d, #6",ctrl
"Normal cervix epithelium, Age 52",ctrl
8 hour tunicamycin CHOP-/- B,pert
5197 Normal Uninflamed sigmoid colon,ctrl
M238_R1_B_DMSO,ctrl
0148-01-C,ctrl
Spleen_infected_4weeks_rep1,pert
"Endometrium, postmenopausal, tibolone, 32",pert
OCI-Ly7 BCL6siRNA 2,pert
Vastus lateralis muscle,ctrl
sample =Healthy4 treatment=Control time=90 (min),ctrl
"PCOS, biological rep 6",pert
patient12,pert
"P16 mutant OC apex, biological rep 2",pert
RAW LPS 1,pert
"wildtype white adipose tissue, biological rep 2",ctrl
ADHC3,pert
subject id: 7;	infection: DENV;	status: DF;	tissue: whole blood,pert
NCCIT-SNF5oe-rep1,pert
CEM-C1 T-ALL cell line treated with DMSO,ctrl
cell type: B-cell;	cell line: OCI-Ly7 DLBCL,ctrl
BALB_Male_CF_rep3,pert
U2OS shControl replicate 3 [set 4],ctrl
GEIM186-U133A-Norm,ctrl
Discoid Lupus-L8,pert
"alveolar macrophages, smoker 023",pert
Snell 6 month Wild Type Liver 88c,ctrl
Testis_Taf7l knockout_rep2,pert
cell type: Mouse embryonic fibroblasts;	genotype: MLL1 KO;	time: CT18,pert
Mnk_3133-S-7,pert
5216 UC Inflamed descending colon,pert
"SFM control cells (3hr), biological rep_2",ctrl
"Patient 22, Macroscopically intact tissue",ctrl
"human failing LV myocardium, Idiopathic15",pert
"siPRMT1 ES, biological rep1",pert
"MLD, biallelic AML MLL_00255",pert
cell line: OVCA429;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
KO mouse 2_heart_basal,pert
Control LM2 Cell Replicate 1,ctrl
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 32;	maternal age: 29,ctrl
Retina ko/wt rep2,pert
nt S. aureus 12,ctrl
Mouse_ATF6aKO_colon_UT_rep2,pert
G93A 60 days sample 1,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.86;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.5;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
"P209 HCT-116, DNMT3B knockout, DMSO-treated",pert
cell type: Neuronal Stem Cells;	developmental stage: E14.5;	strain: CD-1 albino,pert
Mist1KO saline rep1,ctrl
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 48h,pert
"Fourth ventricular choroid plexus from wildtype mice at E13, biological replicate 4",ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 57, stage IIB, HPV 18",pert
"fibroblast, MFS subject FB783 rep 1",pert
untreated WT MEFs-2,ctrl
MF-33,pert
Huh7 cells_JFH-1 Infected 18 hours_ rep2,pert
Bicalutamide_3,pert
"P205 HCT-116, DNMT1 knockout, non-treated",pert
Sample ID: TP24;	Twin Pair ID: CCN3.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 25;	Current Age (2007): 28;	Sex: MALE;	Medication at blood sampling : None,ctrl
E14 - Lis1ko/+ 1,pert
Ulk1/2-/- + IFNβ 3,pert
CD4DecTp2-11,pert
"Deltoid, FSHD, cohort 18, subject 18A",pert
TRPM2-AS siRNA rep3,pert
"C57BL/6 male 3w, 100",pert
"PC from healthy donors, isolated using CD38-APC.",ctrl
Tissue: normal thyroid; Gender: male; Age:42,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 154;	fata: 54;	eea: 1420;	wtkg: 81.5;	perfat: 41.9;	lbm: 44.1;	fat_mass: 3414.85,ctrl
EP69_adipose_control,ctrl
Vit A deficient 1a,pert
control-3,pert
DS1-iPS 2,pert
A1_tumor,pert
Strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue:  gallbladder,ctrl
K562_NoTreatmentControl_24hrs_rep2,ctrl
Endometrium/Ovary-Disease 3,pert
U87-20.2,pert
age: 38;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
prostate normal 3,ctrl
"FA6 transiently transfected with AGR2 siRNA, transfection B",pert
MH1C1_low_rep1,pert
Liver_hyperglycima_no.2,pert
CLL6-CD8,pert
Ex1_cells_rep3,pert
brain_QH2_6M_rep3,pert
A HID U_B020,pert
thyroid_tumor_7,pert
"Estradiol, rep 2",pert
strain background: C57/129S;	genotype/variation: Fra-1+/+; wild type;	gender: female;	age: 2 months;	treated with: 30 µl of PBS containing bleomycin (0.075U/mouse) for 5 days;	tissue: lung,ctrl
3587-1 E2F1 Null,pert
Individual_3591_PN_sample,pert
Psoriasis-Patient-E,pert
Sox2-shRNA-2,pert
Y VIS _B028,ctrl
"control for Abca1 +/- ES, RNA 77",ctrl
SOCS3 Cre plus C,pert
Strain: C57BL/6;	Genotype: wild type;	Generation: F7;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
"PBMC, patient. Mtx rep10",pert
age_years: 37;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
HSC cells from control rtTA mouse rep1,ctrl
skin.wt.replicate28,ctrl
"GFPMYC positive GC B cells, Biological replicate 7",pert
01LPG: new onset sJIA,pert
E10_otic_vesicle_mut_replicate1,pert
WT biological rep 1,ctrl
"Empty vector, biological rep1",ctrl
KU_22T,pert
02_NML,ctrl
"Transgenic, snap frozen, tibialis anterior muscle, 10 month age animal",pert
"C57BL/6J, 4 week old, sample 2",ctrl
mdx5cv gastroc sample 2,pert
DMN-NF1Hippo18d-1bAv2-s2,pert
112B,ctrl
PGA-MAH-AJ_PBS6h-5aA-s2,ctrl
18: FCHL patient #98-1479,pert
esiOgt_rep2,pert
PBMCs_Control_6 [IS],ctrl
female_alcoholic_402,pert
patient: 107;	current medication: None;	birth date: 07/28/1060;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
"Creatine-treated, biological rep4",pert
"brain, adrenal medulla: Sample#B4(Ctrl Pt4)_e1_le1",ctrl
T118 U133p2,pert
"Cells transfected with sirtuin 6, biological rep3",pert
EGF12h replicate 3,pert
"RWPE1 cells, vehicle, 48h, biological rep2",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 6h",pert
cell type: NPC 5-8F cells;	genotype/variation: control,ctrl
Subtype: RAEB2;	Karyotype: del(5q),pert
"siRNA, collagen plate, rep3",ctrl
cell line: HL-60;	replicate: Replicate1;	treatment: shSYK_2,pert
cell line: SV589;	knockdown (days): 0;	treatment: Serum Starved; 3h EGF,pert
sampleID: SAM630133;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
"human nonfailing LV myocardium, NonFailing2",ctrl
strain: Swiss;	tissue: Ovary;	agent: Menadione (5uM);	replicate: 1;	age: Post natal day 3-13,pert
HaCaT_Control_ biological rep2,pert
heterozygot FH P249,pert
liver_wild type_6 weeks_replicate_3,ctrl
control_16hr_rep2,ctrl
MSE_D_516,pert
Tissue: whole retina,pert
Sample: nontransgenic control (NTG);	Replicate: 3;	Pool: P;	Sample: nontransgenic control (NTG);	Replicate: 3;	Pool: P,ctrl
CD4IncTp1-6,pert
CD4DecTp2-4,pert
"MCF-7 cells-control, biological rep 2",ctrl
aa_NY31,pert
"liver_ABCA1-TG, biological replicate 2",pert
intestine_wildtype_24hfasted_rep2,ctrl
clone 48 replicate 1,pert
4-HPR_mammary_3,pert
brain_DLPFC_bipolar B_mr697,pert
strain: wt;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 7-9 wk,ctrl
patient: 249;	current medication: Azathioprine 150mg Salazopyrine;	birth date: 1/12/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/90;	diagnosis date: 3/24/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/8/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 4/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
shSOX2_2,pert
untreated WT MEFs-3,ctrl
patient: 240;	current medication: Asacol 800mg BD;	birth date: 1/10/59;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 8/2/04;	diagnosis date: 12/14/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/3/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Gene expression profiles of Lkb1 WT #5 HSCs,ctrl
brownfat_KO4_day3,pert
Mock infected murine liver-MO30k-(A)-6 hpi,ctrl
phenotype: alcoholic;	gender: male;	case_id: 274;	age: 81;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Ex;	post-mortem-interval (hrs): 36;	brain ph at time of freezing: 6.44;	labeling_batch: 1,pert
SLE CD4 T cells 6,pert
01-0036A_Day1_1,pert
Mutated-ERα-positive breast cancer 69,pert
tissue: Spleen;	genotype: TRAF3flox/flox-CD19+/cre (B-TRAF3-/-),pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 1,pert
Subject #8038-2d Postinfection,pert
CH2117,pert
HRas-v12 transgenic female replicate 3 late timepoint,pert
RNA mix 2 of nomarl lungs,ctrl
coronary smooth muscle cells nebivolol replicate 2,pert
GNMT-WT mouse hepatocytes (sample 1),ctrl
MiaPaCa2 pCEP4 clone 3,ctrl
"human failing LV myocardium, Idiopathic45",pert
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His-ZNF217 plasmid,pert
tissue: Frontal cortex;	age: 105;	Sex: F,pert
Diaphragm 23 Day mdx rep 3,pert
wt_P4_rep4,ctrl
C5 Control None,ctrl
Calu3-Parental_2,ctrl
"IN1760 siNT treated, Biological replicate1",ctrl
"Acute Myeloid Leukemia, sample 8",pert
cell type: HeLa;	genotype/variation: Transfected with G392E Neuroserpin,pert
STV_F,pert
"C57BL/10-SJL.Dysf TA, replicate 2",pert
206/4,ctrl
Bone-Marrow_MGUS_G779,pert
harmane 1uM batch 1,pert
01UNM_PolyRF+,pert
"TH cells from LC, wild type control, biological replicate 2",ctrl
DOV13+(2),pert
C18-1,pert
C57 24 air 2,ctrl
"RNF40 siRNA - 2 days adipocyte differentiation, rep2",pert
"MEKi 4 days, biological rep4",pert
TTP_KO_60ActD_BioRep3,pert
pMX-Oct4 and pMX-jhdm1b(jmjc) vitamin C O+JMJCVc+_2,pert
"gender: Female;	age: 89;	post-mortem delay: 8h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: tumor;	sample name: 6-tu3,pert
"201, ADIPOOSE TISSUE, Before",ctrl
HMEC X HMEC -EGF for 2days,ctrl
whole tissue section from case 829,ctrl
V5-P600,pert
MDS patient 12,pert
reduction mammoplasty patient 360,ctrl
"normal skeletal muscle, biological rep1",ctrl
colon_epithelium_IL10mouse_12weeks_rep6,pert
Hippocampus_Soman_3h_rep5,pert
224 Day 1 siSC transfected biological rep1,ctrl
Parkinson's disease sample x153,pert
ILD Study Number 1259,pert
"brain, brainstem: CB5_e1_le1",ctrl
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_3 months_replicate 1,pert
A HID U_B007,pert
thyroid_tumor_5,pert
cell line: HeyC2;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
wild-type #3,ctrl
CLL2-CD4,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 209,ctrl
B6.IL10 48 air 1,pert
model: Fischer 344;	gender: Male;	age: 21 to 22 months old,ctrl
E12 wt.1,ctrl
CML_2_CMP,pert
esophageal squamous cell carcinoma from patient E1521,pert
TOV112D COUP-TFII-1,pert
Liver_Nrf1 Control_rep3.,ctrl
iA50clone6-,pert
Phan_011_KO.bleomycin rep2,pert
"control pancreas, biological rep2",ctrl
cerebellum SNCA knockout 6 month replicate 2,ctrl
"Autoimmune pancreatic islets, no cyclophosphamide treatment, rep 8",ctrl
CON29,ctrl
N13B Normal-cerebellum,ctrl
testis knock out replicate2,ctrl
PTC BRAF mut 7,pert
Extract:LOX-1:213202;	Extract Description:LOX1_Untreated_2hr:213202;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.03;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.8;	Quality: Background Mean Dev.:0.27;	Quality: Absent (%):57.58;	Quality: Absent (%) Dev.:0.52;	Quality: Scaling Factor:0.62;	Quality: Scaling Factor Dev.:0.05;	Pretreatment [C]:LOX1;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213202;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_2hr;	RNA extraction source key [A]:282295543,pert
Disease_status: Healthy control;	Age (years): 31;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.13;	Post mortem interval (hours): 11;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Keratinocytes_siRNA control_rep1,ctrl
patient: 51783;	sample: tumor,pert
strain: C57BL6 mixed FVB;	genotype/variation: cMetflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: BaCl2 muscle injury;	tissue: hindlimb muscle contralateral to BaCl2 muscle injury;	cell type: CSC;	time: 2.5 days post injury,pert
"U2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression",pert
WT CFTR unexposed replicate 4,ctrl
patient code: 123;	gender: Male;	age: 74;	tumor grade: 3;	t-stage: 1;	n-stage: 1;	ajcc classif. (2002): 2b,ctrl
Bone-Marrow_MGUS_G626,pert
Haloperidol treated 12weeks AffyGC RMA rep5,pert
heterozygot FH P560,pert
Y YOKE_B060,ctrl
G4D_Sham_Rep5,pert
cell type: fibroblast;	disease state: normal;	cell line: CRL-1502;	gender: female;	passage: 0;	clone: 0,ctrl
siERK1Veh4h_2658,ctrl
WT-Fibr1 2,ctrl
5243 UC Inflamed sigmoid colon,pert
10 week control spinal cord rep 3,ctrl
Uninfected control_4a,pert
1199-01-A,pert
"Uninvolved Skin, NS-12",pert
puroD replicate 1,pert
Time:4 day; condition:Emerin ko;,pert
cell line: HM1 embryonic stem cell line;	genotype/variation: control,ctrl
Control 1 medium only,ctrl
cell line: M12;	treatment: EGR3 knockdown,pert
A549_Nrf2 siRNA_biological rep1,pert
WT V6.5 ESCs on day 3 #1,ctrl
12mo Control #1,ctrl
H04_P_B2,pert
"brain, Entorhinal Cortex: 98-18 normal_e1_le1",ctrl
untreated 24 hr,ctrl
CD8-IGF1R 3T3 Vehicle 1,ctrl
"72 hour-treated wild-type NB4, biological rep3",pert
s9129_2,pert
siLRH-1_#2_rep_4,pert
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p31;	strain: E14,ctrl
KO-Nrf2-Male-1,pert
Lung-normal-rep4,ctrl
24h_c3,ctrl
minor non-tumor8,pert
tissue: colon biopsie,pert
Control 5,ctrl
cDNA ak 03,pert
BCR-ABL1-control rep 4,pert
"patient: 103;	current medication: None;	birth date: 6/30/65;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/9/04;	indictation for procedure: Diarrhoea, now settled, Mum has UC;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
tissue: adipose tissue;	sample group: resveratrol;	treatment: after;	gender: Female,pert
"TNFa-OMe-P siRNA-C, replicate 5",pert
Adipose-24 month-Myc heterozygous-technical replicate 1,pert
"Strain: C57BL/6, Tissue: Airway Epithlium, Culture: Organotypic Air Liquid Interface",ctrl
RNA from HCC_29T,pert
Tendon_non-lesional_rep23,ctrl
KU_35N,ctrl
MDS patient 80,pert
Dicer WT CD4 T cells 3,ctrl
AVC_control_rep3,ctrl
Muscle-AMPKgamma3-mutant(R225Q)transgenic-1,pert
Strain: In-house BALB/c mice; Gender: Male; Age: 4 months old; Tissue: Brain; Treatment: 4 hours post saline ip.,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: del5q,pert
M327 SKM-KO,ctrl
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 29;	maternal age: 26,pert
"seminoma specimen, pT1, patient age: 37y",pert
WT-1 (EPLM),ctrl
Cutaneous psoriasis without arthritis PsC 20,pert
Muscle_Rpt3 null_2,pert
DMSO Treated Control 3,ctrl
LIVER_CONTROL_repl1,ctrl
ubb_d28_wt_1,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 160min;	race: White;	sex: Female,pert
3_month_old_wildtype_mouse_rep2,ctrl
WT1-iPS 2,ctrl
OCI-Ly10_sictrl,ctrl
ICM pool 3 (n=4),pert
HEK293_HNF1a_#1_induced,pert
PBMC from T cell LGL leukemia patient #106 (TLGL106),pert
blood_day6_patient2,pert
11400 Normal Uninflamed sigmoid colon,ctrl
ME180 6 hours rep 4,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Liver",pert
sirna: Syk siRNA knockdown;	plate: plastic;	cell line: MCF10A,ctrl
Wildtype 2 (jos0927),ctrl
HCT116_shN91_rep2,pert
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: 10μM ATRA;	treatment time: 6 hours",pert
Bone-Marrow_SMM_S1496,pert
"DSS + L-Arg colon tissue, biological rep2",pert
JIA PBMC Pre treatment A235_L017,ctrl
MCAD + LPS 5,pert
CH2123,ctrl
"Prkaca+/- caudal vertebral bone, rep2",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: del5q plus other,pert
TN 3,ctrl
Normal-ERα-positive breast cancer 30,ctrl
cells origin: subcutaneous white adipose tissue;	individual characteristics: Morbidly obese patient,pert
wt-Gfp 4 weeks replicate 2,ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 4h,ctrl
"Rat_Tracheal_Control_2hr, rep2",ctrl
01LKV: normal control,ctrl
5062-scrape,pert
Liver_D3T _Rep4,pert
Muscle control (YJD-JDM-48UA-s2),ctrl
tissue: pancreatic ductal adenocarcinoma tumor;	genotype: Pdx1-Cre; Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 7 weeks-old,pert
cell line: HeLa,ctrl
sex: Male;	Age: 5 months;	additional patient information found in Series supplementary file,pert
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use: Yes,pert
CD4+_Tcells_healthy_donor_2,ctrl
CRC_nodrug_F4863,ctrl
"A549, -TNFα, control siRNA, rep2",ctrl
scan batch: Batch 2;	group: autism;	subject age: 9;	paternal age: 37;	maternal age: 30,pert
"MCF7/BUS, 30 pM E2, 48 hours, biological replication 4",pert
Haloperidol treated 12weeks AffyGC RMA rep8,pert
K562_NoTreatmentControl_24hrs_rep1,ctrl
"mouse aorta cross strain comparison, C3H_T08_NC_02",ctrl
01LQE_CTRL,ctrl
NPC8,pert
WT HPC Veh 3,ctrl
"AD_HI, biological rep1",pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 45, stage IB2, HPV negative",pert
tissue: Hodgkin lymphoma;	cell line: KM-H2,ctrl
"gender: Female;	age: 70;	post-mortem delay: 4.5h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
A519 MI 7 day,pert
Disease_status: Bipolar disorder;	Age (years): 63;	Gender: Female;	Age of onset (years): 43;	Duration of illness (years): 20;	Brain pH: 6.97;	Post mortem interval (hours): 32;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"control + L-Arg colon tissue, biological rep3",ctrl
SW1736_t48h_rep1,pert
"P200 HCT-116, DNMT wildtype, non-treated",ctrl
3IDC_tumor ductal,pert
Liver_nash_no.2,ctrl
strain: C57BL/6;	gender: male;	genotype/variation: WT;	treatment: PBS;	tissue: liver,ctrl
strain: 129SvEv;	developmental stage: E11.5;	tissue: ventricle,pert
Trained 5 weeks T5,ctrl
mdx EDL sample 2,pert
B4 424 b4-/- untreated,ctrl
Wild type unstimulated 1,ctrl
Animal 11,ctrl
01LNK: normal control,ctrl
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep3,pert
patient: 226;	current medication: Azathioprine 150mg Asacol 1.6g Ca Vit D B12;	birth date: 6/15/74;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 1/11/05;	indictation for procedure: ;	ucss: 8;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/11/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
m1-WT4,ctrl
brain_OFC_bipolar B_mr94,pert
"RES-enriched Grape extract group, 6 months, patient number 28",pert
"PBMC, patient. Mtx rep3",pert
liver_Akt1+/-_35wk_rep2,pert
Peripheral blood mononuclear cells;	TTF=75min;	Race=White;	Sex=Male,pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 36;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Psoriasis-7 baseline,pert
"fibroblast, control subject NM5 rep 2",ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 5d ID62,ctrl
AtT20 cells treated with control siRNA rep 3,ctrl
"tissue: bone marrow;	disease status: B-precursor acute lymphoblastic leukemia, Down syndrome",pert
NCI-H716_YAP1.1,pert
HUVEC_TSA_rep2,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 195min;	race: White;	sex: Female,pert
Strain: 129SV/EV;	Gender: Female;	Age: 8-12weeks;	Tissue: Mediastinal lymph node B cell;	Influenza A/Mem71 48h;		,ctrl
PTC BRAF wt 5,pert
"Wild type, snap frozen, diaphragm muscle,10 month age animal",ctrl
Ero1-C104A/C131A non-induced biological repB,ctrl
"Exp A, Animal #259, 50mg/kg D-Serine",pert
Barrett's esophagus (B5),pert
Placenta_PE(EO)2,pert
Bone marrow-derived macrophages from mice deficient in signaling adaptor molecule MyD88,ctrl
"WT, PR02M005v0",ctrl
"Healthy volunteer, Control_11815",ctrl
MO_DH1b_SON_NCBI,pert
"The Identification of gene expression changes in human embryonic fibroblast cells, background. Sample A",ctrl
sample 1;	age: 68;	gender: male;	sample 2;	age: 77;	gender: female;	sample 3;	age: 72;	gender: male;	sample 4;	age: unknown;	gender: unknown,ctrl
"human failing LV myocardium, Ischemic101",pert
"Nod2-UN1,experimental replicate 1",pert
WT - Cre Treated - 2 hrs - repeat 1 - Cy3 - mAdbID:62605,ctrl
Clozapine treated 12weeks AffyGC RMA rep8,pert
"control, BA46-53",ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 48;	age-at-onset: n/a;	geographical origin: Mirandela;	lifestyle characteristics: ever drinker,ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 5",pert
3116-scrape,pert
Karyotype: inv(14)(q11q32);	Age: 54 years;	Gender: female,pert
cell type: fibroblast;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P8;	clone: 0,pert
chip number: 23;	transfection plate: 3B;	target gene: TCF12;	kd level: 0.86;	rin: 9.6;	transfection date: 2012-03-26,pert
Mtb infected-63d-1,ctrl
126OE 16A,pert
LCL Unaffected MZ twin pair 1 (CCN1.2)(TP14),ctrl
HF0835_U133P2,pert
Day: 12; Drug: Saline; Phase: Drug treatment; Replicate: 3,ctrl
PGA-MAH-AJ_OVA24h-5aA-s2,pert
MOLM14-shControl-rep1,ctrl
H2009_shGFP,ctrl
liver_Akt1+/-_35wk_rep4,pert
BALB/c BMDM naive,ctrl
rheumatoid arthritis 1032,pert
Patient: O;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
Cell line MCF-7_c-myc KD_expt1,pert
"DMD skeletal muscle, biological rep12",pert
G93A-SOD1 mouse spinal cord 110 day,pert
NPC12,pert
"55B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Series 3; young; 4 weeks after fracture,pert
siTNIK+7hr Wnt (Experiment 1),pert
"PMA treated, no doxycycline; biological replicate 1",ctrl
GIST_PDGFRA_5,pert
postmortem brain,pert
c42 is aclonal Nurr1 stably-expressing stem cell line,pert
"GM8922A, affected sister",pert
"healthy control fibroblast, biological rep2",ctrl
tissue: minor salivary gland;	disease status: non-SS control,ctrl
sex: Male;	family: 2;	age: 30;	disease status: Affected;	tissue: Muscle: Deltoid,pert
M229_A_DMSO,ctrl
siTNIK+4hr Wnt (dye swap),pert
n3_lo_4,pert
"Placebo treated, HIV-1 positive male, day 14 (9)",ctrl
Psoriasis-2 baseline,pert
si FoxA1 and vehicle replicate 3,pert
INCB18424 Persistent 1,pert
tissue: Frontal cortex;	age: 95;	Sex: F,pert
"U87MG - CASP2siRNA, biological rep1",pert
"Pou4f1+/+ cells, transduced with MSCV-Pou4f1 virus_WT-POU_80",pert
Uninjured Control - Epicenter Rep2,ctrl
gender: female;	age (years): 36;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EZH2. Sample B,pert
array type: Affymetrix Mouse 430_2;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7,ctrl
03_NML,ctrl
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Female;	Age of onset (years): 33;	Duration of illness (years): 15;	Brain pH: 6.50;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
1: FCHL #98-1176,pert
genetic background: B6/129;	genotype: Tet2 KO;	cell type: Tet2 deficient CD150+ sorted LSKs,pert
control MLL_00116,ctrl
"wt total RNA LSK, rep 4",ctrl
n10t6h,pert
WT MEF CT18-1,ctrl
disease state: healthy control;	tissue: epidermis;	age: 43;	gender: male;	treatment: untreated;	time: control,ctrl
BP14,pert
MCF10A-HER2(+) 5days,pert
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T1N0,pert
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: myocardium,pert
WT #3,ctrl
12: FCHL patient #99-1191,pert
VMM-MUT_MyoD12h-1MP-s2,pert
"BPH adrenals, replicate 3",pert
"HEK293E cells, TDP-43 siRNA, replicate 2",pert
"Vehicle treatment, 25 hours (replication 2)",ctrl
Ls174T-L8 con3,ctrl
liver control diet rep2,ctrl
MEF E2F4 KO 4-rep1,pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: control; biological replicate: 2,ctrl
"Ulcerative Colitis (53 year old caucasian male, SAK_1285246305)",pert
EOM 112 Day mdx rep 1,pert
"650nM MLN4924 after 2hr, replicate 1",pert
"C57BL/10 control TA, replicate 2",ctrl
ALI patient #13,pert
Control subject 32_biological replicate 1,ctrl
813.3PBMC,ctrl
strain: Swiss Webster;	treatment: Saline;	tissue: substantia nigra,ctrl
Individual_649_PP_sample,pert
normal bone marrow NBM3,ctrl
H_LS_Time0,ctrl
10 week control OMN rep 1,ctrl
"nasopharyngeal carcinoma, specimen T6",pert
MH1C1_low_rep3,pert
Normal cortex of patient 265,ctrl
K562 DMSO sample 9,ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs cultured for another 12h,ctrl
CD47 null Endothelial cells 3,pert
gender: male;	individual: patient 1;	treatment: paclitaxel-eluting stent,pert
"Healthy control, biological rep3",ctrl
NCCIT siTET2 rep1,pert
"Control, biological rep13",ctrl
Healthy control 12,ctrl
DBA/2J Vehicle liver sample batch 2,ctrl
"brain, hippocampus: Ctr-24h-P15-I_e1_le1",ctrl
13a_c,ctrl
Individual_4247_PP_sample,pert
H1993 BRMS1 KD_2,pert
Aurka_R_-Dox_rep1,ctrl
01MH9_PolyRF+,pert
Mening SWB WB NP 24a,pert
"Acute Myeloid Leukemia, sample 61",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 67;	Sex: male;	region: LC;	age: 40;	genotype: Y/X;TH/-,ctrl
sample =Healthy1 treatment=Stimulated time=360 (min),ctrl
"Cell type: endothelial, age:47, gender:female, diagnostic group: schizophrenia, PMI:35h",pert
"Untreated, biological rep1",ctrl
Wt Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-4,pert
293TsiScram-4,ctrl
cell line: SW1736;	time point: 0h;	mutation: BRAFV600E;	treatment: untreated,ctrl
cell type: MEF derived stable cell line;	genotype/variation: Tet-off HA-Fbxl10,pert
healthy control H25,ctrl
genotype/variation: wt;	age: E10.5;	tissue: whole eye,ctrl
8 hour tunicamycin CHOP-/- D,pert
5922012008_B,pert
brain wild type replicate1,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/15/07;	# cells: 84;	Sex: male;	region: CB (cerebellum);	genotype: Y/Mecp2-;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,pert
sex: Male;	Age: 1.5 months;	additional patient information found in Series supplementary file,pert
"brain, brainstem: LB5_e1_le1",pert
pool of thyroids from 10 months old wild type mice,ctrl
ACC Xenograft X11,pert
"105, MUSCLE, Before",ctrl
"Control cells unstimulated, biological rep3",ctrl
MSC_SA01_1,ctrl
H12_P_B1,ctrl
"breast tumor epithelium,52",pert
A549 AZA 0.3uM (3210),pert
N10,ctrl
wildtype strong 1,pert
MRF CKO Oligodendrocyte Replicate 3,pert
knockdown: siRNA-scrambled;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 151;	colon ratio (mg/mm): 2.52;	myeloperoxidase activity (u/mg): 1.06;	tissue: colon;	treatment: 5% DSS,ctrl
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: Dicer1 conditional knockout, Atoh1-Cre;Dicer1(flox/flox);	tissue: organ of Corti from cochlea, apical half;	age: postnatal day 16",pert
"non-SS control gland, patient 16, batch 2",ctrl
mESCs_Tip60KD_rep1,pert
BC5 TC,ctrl
12462 Normal Uninflamed sigmoid colon,ctrl
HT-KO-21A,pert
Z4_TA,ctrl
XBP1s Tumor 6,pert
"Placebo treated, HIV-1 positive male, day 14 (5)",ctrl
H11 HA 6h 1,pert
SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1),ctrl
"human failing LV myocardium, Ischemic13",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.172;	OD280: 1.137;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 214;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
treatment: DMSO;	time: Day1;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,ctrl
20GOBMUC2H,ctrl
umbilical cord_nobpd: 2E,ctrl
Patient 5 skin baseline,ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 1,ctrl
Control_2months_retina9,ctrl
"Sfrp5 KO HFD 8 weeks, biological rep2",pert
Kidney_50 mg/kg VCM iv_mouse #007,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 27;	sex: M,ctrl
ILD_10,pert
"Control Day 5, biological rep1",ctrl
"BOEC, not_at_risk 2",pert
18SAGEA2,pert
HEK293_HNF1a_#4_uninduced,ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 24h, biological rep1",pert
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-WT;	overexpression induced with doxycline: Yes,pert
mdx Biological Replicate 3,ctrl
Cre_day_3-4,pert
126KD 14A n,pert
N51681,ctrl
Control 3 b,ctrl
15d Dicer cKO_Pool 10,pert
sidroshaC-transfected sample,pert
treatment group: untreated in parallel to arsenic treated cells;	cell line: TK6 cells,ctrl
ALS gray matter 5 Sporadic,pert
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/+; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 14.5; Tissue: whole kidneys from 23 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Mist1KO caerulein rep3,pert
whole tissue section from case 342,pert
Braak α-synuclein stage 1-2 BR12_5SN,pert
Untreated Jurkat cells (replicate 1),ctrl
"CFU-PreB colonies Wildtype littermate, biological replicate 5",ctrl
reduction mammoplasty patient 314,ctrl
4112-2 E2F WT,pert
CCI 14d replicate 2,pert
HCC PBMC Sample 5,pert
disease affected colon of an adult with ulcerative colitis (UC).,pert
cell line: ONS76;	cell type: medulloblastoma;	treatment: KDM5A siRNA;	transfectant: ONS76_si_KDM5A,pert
strain: C57BL6/J;	genotype/variation: wild type;	gender: male;	age: 12 weeks;	diet: 8 wks of high-fat diet;	tissue: gonadal white adipose tissue (WAT),ctrl
"new born normal mice, cerebrum",ctrl
CONTROL;	Age = 22;	Sex = F,ctrl
Lung-normal-rep1,ctrl
A SIT_B036,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: tumor;	sample name: 2-tu1,pert
"brain, hippocampus: Aldh5a1-/- #3389 Cereb_e1_le1",pert
T3C-LU,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 37;	maternal age: 35,ctrl
cell type: embryonic stem cells;	genotype/variation: Satb1 knockout,pert
status: Rapid;	age: 48;	gender: male;	tissue: cultured human fibroblasts,pert
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.17 uM (EC50), biological rep1",pert
sample =Healthy2 treatment=Control time=90 (min),ctrl
Fibroid_2525C,pert
"CD11b DC wild type, biological replicate 2",ctrl
"brain, cerebellum: WCb4w#2_e1_le1",ctrl
RAW_3.5mM_HOCl_#3,pert
214/4,pert
NOMO-1 control 1,ctrl
PTC BRAF mut 2,pert
"Pancreatic tumor cells, replicate 1",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 34.37808,pert
"tissue: neurectoderm derived from embryonic stem cells;	treatment: control, shRNAmir #9;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",ctrl
Mut1,pert
Wild type naïve T cells stimulated for 3 hours with medium alone 3,ctrl
t13,pert
Control_2_intestine_30days,ctrl
SLE9-TC,pert
MCF-10A shCHK1-3 replicate 2 [set 5],pert
WT rep3,ctrl
57SageA2,pert
122B,ctrl
Rybp#10 (OHT+)_4d_rep1,pert
4_KO_1,pert
"famale Sprague-Dawley rat, 4-hydroxyphenylretinamide, 782 mg/kg diet for seven days, tissue: liver",pert
tissue: Biceps muscle;	patient: P.b.1;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 7m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
11424 UC Uninflamed ascending colon,pert
MSE_D_97A,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 3,ctrl
"human failing LV myocardium, Ischemic83",pert
Scd1+/+ on chow diet replicate 4,ctrl
lesion_midUV_patient11,pert
INSENS 2 4hr,pert
intestine_PPARa_kockout_24hfasted_rep2,pert
Individual_4378_NN_sample,ctrl
siAgo1 repeat,pert
5280 UC Uninflamed ascending colon,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 95min;	race: UK;	sex: Male,ctrl
293TsiScram-3,ctrl
Human prostate cancer primary culture C39dx,pert
HepG2 cells quercetin 12h,pert
"DEX-treated embryonic primary chondrocyte cultures, incubated for 6hr.",pert
amygdala long access to cocaine replicate 1,pert
B_cell_pool_melanoma_M11+M12,pert
"mouse aorta cross strain comparison, C3H_T24_NC_02",ctrl
mock B,ctrl
Knockout day 3 Air replicate 3,pert
"normal nasopharyngeal tissue, specimen N2",ctrl
"Untreated, biological rep7",ctrl
Placental tissue from late onset Preeclampsia,pert
strain background: C57BL/6N;	genotype/variation: Stat1 KO (ko);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),pert
FW_14c_BV5933,ctrl
01MLB_Systemic,pert
age: 5;	sex: F;	disease status: control subject;	Filter number: 80;	Usage number: 1;	Exposures: 2,ctrl
Wild Type 12,ctrl
MDA-MB-231_TR30003: transfected with a vector containing a non-effective shRNA cassette against GFP,ctrl
C_AN13295_C,ctrl
Donor2_24h_DMSO,ctrl
wild type MEF time 24 replicate 1,ctrl
tMLL04,ctrl
PGA-lv_8w_339,ctrl
"E18.5 brain, wild-type, rep 6",ctrl
485MM,ctrl
B_cell_pool_healthy_H03+H04,ctrl
Chondrogenic progenitor cells from OA female 2,pert
Uninfected control_4c,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-7;	Primary Site:Floor of mouth;	Age:48;	Sex:M;	TNM:;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
LNCaP EtOH rep 3,ctrl
Sample: alpha-TM180;	Replicate: 2;	Pool: NP,pert
FTO2_D4_24h,pert
"27B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
K562_1R-Chl_24hrs_rep1,pert
"WT mouse heart at 6-weeks old, biological rep4",ctrl
Individual_953_PP_sample,pert
Strain: DBA/2J Sex: Male Age: 8-10 weeks Treatment: Control,ctrl
Txnip deficient tumor 27 months sample 2,pert
cell type: Immortalized human neural stem cell;	cell line: HB-1;	treatment: control,ctrl
colon_adenoma_1832,pert
NSCL/P sample 4,pert
"Testosterone treated, HIV-1 positive male, day 14 (2)",pert
PBMC from T cell LGL leukemia patient #136 (TLGL136),pert
rd1_P8_rep1,pert
CD11b+Gr1+ cell sample_5 (derived from wild type mouse),ctrl
Arid3a OE-Pool replicate 1,pert
"brain, cerebellum: KCb4w#2_e1_le1",pert
A HID U_B053,pert
Control mouse 2,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 1,pert
scan batch: Batch 2;	group: autism;	subject age: n/a;	paternal age: 25;	maternal age: n/a,pert
B4 367 wild-type untreated,ctrl
"TIG3 diploid lung embryonic fibroblasts, background.",ctrl
"Exp A, Animal #247, 500mg/kg D-Serine",pert
s4t3c,ctrl
MDA-MB-231-ZNF217 cell culture 2,pert
NoKD_SerumStarved_rep1,pert
K562 cells CREB Knock-out replicate 1,pert
"iPSC derived from CCALD patient fibroblast CCALD1, biological rep3",pert
disease state: homozygous Nxnl1 null;	strain: BALB/c AJ,pert
cerebellum SNCA knockout 21 month replicate 4,pert
subject id: 36;	infection: DENV;	status: DF;	tissue: whole blood,pert
Peripheral blood mononuclear cells;	TTF=119min;	Race=White;	Sex=Male,pert
Subject #8008-8hr Postinfection,ctrl
"Immortalized MEFs WB, empty retroviral vector infected, rep2",ctrl
WT_rep_5,ctrl
treatment: 1 ug/ml doxycyline;	time: 96 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
sex: Male;	Age: 3 months;	additional patient information found in Series supplementary file,pert
N3,ctrl
Pertuzumab treated after 4 days (P2_2),pert
Y HID_B037,ctrl
"Lesion Skin, LS-21",pert
Neuroblastoma SH-SY5Y cells_cloneM_scramble control_replicate1,pert
Wild-type rep3,ctrl
"Benign, prostate tissue",ctrl
tissue: lymph node;	genotype: Dicer KO;	cell type: CD4+CD62L- resting T cells,pert
M11 - non-infected MBT/Pas fibroblasts,ctrl
B6_Female_Control_rep2,ctrl
SIRT4 KO liver_7581-2,pert
Md02h035,pert
CTRL_esiGFP_rep1,ctrl
"peripheral ganglion, unknown: nicotine 24 hr_3",pert
Allo-25-5,pert
"Sh2b3 WT, biological rep1",ctrl
WT Non stim 1,ctrl
Mannitol_3,ctrl
H3bt5,pert
FoxO deficient LSK (4),pert
ADH3,ctrl
Kidney_colistin_6,pert
"Wild Type, biological rep1",ctrl
Control Treg_rep2,ctrl
Muscle 50 eccentric contractions 12 hours WT Adult 0629,ctrl
"Empty vector, plastic plate, rep2",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.301;	OD280: 0.666;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 136;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Squamous cell carcinoma 004,pert
Hippocampus 2010 2 month Old,ctrl
GIST Pre Treatment Biopsy 18,ctrl
Human.AN.CP.FCU,pert
SKMEL28_t1h_rep1,pert
breast cancer patient 320,pert
non-malignant FTEb_patient 9,ctrl
age: 45;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Liver WT3,ctrl
ST045849 12 hours_1,pert
"Spi-21, biological rep 5",pert
Control day 05 sample 1,ctrl
"female,20,Caucasian",pert
V5-P399,pert
Aged 10,pert
E18.5_Mutant_Kidney_array2,pert
Liver TG replicate 2,pert
HCC827 PR 2,pert
E14.5_Control_Kidney_array1,ctrl
MCF-10A shATR-3 replicate 1 [set 5],pert
Cardian muscle Healthy 3 week C3,ctrl
MCF7_CHX_EtOH_24h_rep4,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 6 months,ctrl
PBMCs enriched for CD8+ cells from normal control subject J (JCD8),ctrl
"siTERC-BMSCs, biological rep1",pert
HUVEC/NmenMC58_pilD_4h_rep2_1107,pert
BL136,ctrl
Control subject 87_biological replicate 1,ctrl
K562 cells control replicate 5,ctrl
A3243G-MELAS subject 2,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: control;	other: RNAi-1B,ctrl
strain/background: C57BL/6;	genotype/variation: Wnt7aCre+;Esr1f/f (uterine epithelial ERα conditional knockout);	age: 8-10 weeks;	gender: female;	tissue: uterus;	treatment: saline;	time point: 24h,pert
Liver of pup from control group rep3,ctrl
cell type: Human melanoma cell line;	cell line: M249_R4;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
liver sample group: : Alcoholic hepatitis,pert
Muscle-AMPKgamma3-wt-4,ctrl
"human failing LV myocardium, Ischemic87",pert
PGA-MAH-AJ_OVA24h-3aA-s2,pert
subject: 12V;	cohort: 12;	tissue: Biceps;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 45;	Sex: F;	batch: Batch_3,ctrl
brain_DLPFC_bipolar B_mr553,pert
DMSO3,ctrl
"human failing LV myocardium, Ischemic95",pert
NOD_T2,pert
E14 cells_control RNAi-rep2,ctrl
miR122-KO-T,pert
"WT in the presence of tetracycline, rep1",ctrl
Gender: F;	Age: 49;	Tissue: Mucosa,pert
gender: F;	age at blood draw: 49;	tissue: whole blood,ctrl
Strain: BALB/c;	Age: postnatal day 0;	Genotype: Wild type,ctrl
Angiopoietin-1(confluent)-2,pert
K14deltaNB-cateninER  Time 1 replicate 2,pert
Crx-Nr2e3-Nrl-ko-Gfp4W-1,pert
Bone-Marrow_MGUS_G1356,pert
S6B Sporadic-cerebellum,ctrl
"Human male subjects with familial combined hyperlipidemia  after treatment with atorvastatin (ATV), peripheral blood monocytes",pert
"brain, cerebellum: RNA#39*_le1",pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 27;	gender: male,ctrl
Frontal_Cerebrocortex_Vehicle_6hr_rep9,ctrl
Wild-type rep2,ctrl
Sex: female;	Age at operation: 58 years;	Site: pelvis retroperitoneal;	Size in cm: 4x7x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: metastasis;	Previous radiation: no;	Previous chemotherapy: no,pert
129_Sv_1_WT_d6_4302,ctrl
Nrl ko 2 mon replicate 3,pert
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 1;	time: 3h,pert
B-CLL PB P271,pert
M833 / Reference_13425520,pert
LSK cells from wild type mouse rep2,ctrl
NSC15,pert
CF (D508) subject14,pert
MNR 6-2 KO 3,pert
chronic lymphocytic leukemia (CLL 528),pert
RNA from HCC_28T,pert
"Pou4f1+/+ cells, transduced with MSCV-Pou4f1 virus_WT-POU_87",pert
"Heart, MAT1 CKO, 4 wk, sample 4",pert
MDS patient 28,pert
"strain background: C57BL/6J;	genotype/variation: IRF4 +/-;	tissue: spleen;	cell type: Naïve CD4+, CD62L hi, CD25 - T cells;	differentiation condition: Th17;	timepoint: 42 hrs",ctrl
cell line: AINV15;	strain background: 129P2/OlaHsd;	genotype/variation: Aurka;	condition: +Dox,pert
ID4+/+TCL1-tg spleen CD19+ B cells collected from 3 mice 2,ctrl
"Cerebral Palsy, Gracilis, Patient Replicate 2",pert
11396 Normal Uninflamed ascending colon,ctrl
Undifferentiated Dicer -/- (27H) ES cell line replicate_3,pert
CD8_T_cell_pool_healthy_H01+H02,ctrl
RE550_H1650_6-Medi5117,pert
OCI-Ly7_sictrl,ctrl
Strain: C57BL/6J;	Gender: male	;	Age: day3;	Genotype: WT;	Tissue: brown fat ,ctrl
MDS patient 135,pert
449MM,pert
CON - R21,ctrl
"12B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
tissue: white blood cells;	age: 13;	Sex: male,ctrl
Mouse_E14 ES cell_Undifferentialted,ctrl
patient: 228;	current medication: None;	birth date: 11/22/48;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/80;	diagnosis date: 1/1/82;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Migraines;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"colonic tissue from macrophage-specific PPARgamma-deficient mouse, biological rep2",pert
gender: male;	strain: C57BL/6J;	genotype/variation: Scd1flox/flox (Lox) control;	tissue: Dorsal skin;	age: 8-9 wks old,ctrl
"bipolar disorder, BA10-5",pert
11442 UC Uninflamed descending colon,pert
Healthy control c5,ctrl
Amoxicillin treated Colon 2 21 days old,pert
Heart_caAkt_03,pert
Sample ID: TP21;	Twin Pair ID: CCE1.1;	Clinical Status:  Childhood Absence Epilepsy;	Age of Onset:-5;	Age at interview & blood sampling: 22;	Current Age (2007):25;	Sex: FEMALE;	Medication at blood sampling : Epilim,pert
Control Treg_rep1,ctrl
"miR-148b-A (miR-148b-1, biological replicate 1)",pert
HNF6_2-,ctrl
AP-2 gamma targetting siRNA 1: AAUGAGAUGGCAGCUAGGAAG Technical Replicate 2,pert
Jak2VF vehicle (7991003040_F),pert
"Undifferentiated Dicer +/- ES cell line, passage 20",ctrl
GM19238_Kd_PAX5_3,pert
Experimental 1,pert
Cal27_PBS3,ctrl
Wild-type postnatal day 10 rep 3,ctrl
RV82.09_CHF_day10_Slide58,pert
01LLX: normal control,ctrl
"Sv129/C57B6 intercrossed hybrid line, 12 week old male",ctrl
"Normal cervix, commercial_Ambion",ctrl
S005_Scz_M_82,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.02;	RNA Integrity Number: 10;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
strain: C57BL/6;	gender: male;	genotype/variation: CCRPKO;	treatment: non-treated;	tissue: liver,pert
7d-IR-48,pert
GIST882 DMSO Rep1,ctrl
Md02h031,ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: retina;	time: ZT20,ctrl
CON5,ctrl
age: 42;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
normal lung,ctrl
A549 stretch 4hr Jan 31 2003,pert
R26Pax3/Pax3 E14.5 palatal shelves 4,pert
07R060 RA,pert
CuFi cell line biological rep2,ctrl
Msgn1_12hMinDox-biological rep3,ctrl
BCells_Transgenic_day2_REP1,pert
Rybp#10 (OHT-)_12d_rep2,ctrl
s2t4c,ctrl
tissue: liver;	gender: male;	disease status: normal glucose tolerance,ctrl
WT-PB_rep-2,ctrl
thyroid_tumor_1,pert
age_years: 47;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
C26_skeletal 3,pert
T8B-LU,pert
LPS 1 HOUR,pert
Time:3 day; condition:LaminA ko;,pert
HW_1090,pert
cell type: Melanoma cell line;	cell line: A375,ctrl
MS patient 3,pert
nmd untreated 1,pert
CRC_celecoxib_F4873,pert
"Acute Myeloid Leukemia, sample 24",pert
Sample ID: TP17;	Twin Pair ID: CCN2.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 27;	Current Age (2007): 30;	Sex: MALE;	Medication at blood sampling : None,ctrl
"4 weeks normal mice, cerebrum",ctrl
genotype/variation: Vax2-/-;	age: P8;	tissue: Whole eye,pert
PTC BRAF mut 1,pert
SKMEL28_t6h_rep1,pert
tissue: heart;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
cell line: HEK-293;	genotype: NOD2 wt;	stimulation: Muramyl-dipeptide (MDP) 10 µg/ml;	time point: 0 h,ctrl
human_hepatocyte_400uM_Ciprofloxacin_donorA_24hr_prep1,pert
cell line: HEK293;	genotype/variation: tranfected with pEGFPN3,ctrl
CTR 1,ctrl
Psoriasis-10 baseline,pert
MPM tumor 19,pert
V5-P330,ctrl
"vector d2, rep 1",ctrl
jejunum_GATA4mutant_1,pert
cMyb virus-infected replicate 2	(monocytes),pert
Individual_3983_PP_sample,pert
cell line: NB4;	genotype: wild-type;	treatment: untreated;	biological replicate: 2,ctrl
"patient: 103;	current medication: None;	birth date: 6/30/65;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/9/04;	indictation for procedure: Diarrhoea, now settled, Mum has UC;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
INHA3,pert
"Patient 16, Atheroma plaque",pert
"sh3293 (to target ERBB3) T47D cell line, replicate 2",pert
amygdala no access to cocaine replicate 2,ctrl
"imr-32,cdk4 siRNA,t=48, 2",pert
"WT HSC, biological rep2",ctrl
2 hr vehicle repl 2,ctrl
tissue: blood;	control: 4;	gender: male;	age: 26,ctrl
P67 Non failing heart biopsy,ctrl
Pooled normal myocardium sold commercially,ctrl
XX1_InX,ctrl
siERK5Veh 2,pert
t06,pert
PGC-1a-/- rep3,ctrl
PTEN+/- ep_C,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: DMSO for 48h,ctrl
Control Endometrium Stromal Cell_033.UC-209-+,ctrl
P60_WT_1,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, VEH treated, biological rep3",ctrl
"Heart, MAT1 CKO, 2 wk, sample 1",pert
6 h-apra-10 nM,pert
"breast, post AF treatment (H14_1659)",pert
Bone-Marrow_MM_M1017,pert
Extract:LOX-1:213401;	Extract Description:LOX1_Untreated_12hr:213401;	Quality: Classification:Medium;	Quality: Gradient Severity:0.12;	Quality: Distortion Severity:0.05;	Quality: Defective Area (%):0.27;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.51;	Quality: Background Mean Dev.:0.52;	Quality: Absent (%):56.98;	Quality: Absent (%) Dev.:0.98;	Quality: Scaling Factor:0.6;	Quality: Scaling Factor Dev.:0.12;	Pretreatment [C]:LOX1;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213401;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_12hr;	RNA extraction source key [A]:282295773,pert
Run7.aUa.001206d.SkMInS1077D.CEL-IS stimulate,pert
"Autoimmune pancreatic islets before cyclophosphamide treatment, rep 2",ctrl
strain: Myd88 KO;	gender: N/A;	age: 4 month;	weight: 25-30g;	tissue: whole trachea,pert
expression array - O1,pert
Wild-type Rep3,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 215,pert
"cochlea at P60, wt, biological rep 1",ctrl
Huh7 cells_JFH-1 Infected 48 hours_ rep3,pert
KO - knock-out Treated - 2 hrs - repeat 2 - Cy3 - mAdbID:62611,pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 5",pert
patient: 51721;	sample: tumor,pert
0 h (control sample),ctrl
"fibroblast, MFS subject 60FR rep 4",pert
tissue: Frontal cortex;	age: 81;	Sex: F,ctrl
sample =Healthy4 treatment=Stimulated time=180 (min),ctrl
"ID: MLL_00252;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
cell line: SV589;	knockdown (days): 15;	treatment: Serum Starved; 1h EGF,pert
The caudate nucleus from an XDP Filipino (aged 52 yr) .,pert
striatum_wild type_6 weeks_replicate 1,ctrl
genotype: Sox3 null;	cell line: R1;	cell type: Embryonic stem cells differentiated into neural progenitor cells,pert
MZ1774 YAPshRNA rep 2,pert
tissue: Melanoma Lymph node Metastasis;	cell line: WM164;	treatment: 500nM PLX4032 for 16 days,pert
"Tissue: peripheral blood, Subject:Healthy Control",ctrl
Panc-1 Ctrl 3,ctrl
chip number: 9;	transfection plate: 1;	target gene: E2F1;	kd level: 0.78;	rin: 9.9;	transfection date: 2011-03-29,pert
181C6,ctrl
Cancer 21,pert
Tmod3 WT-2,ctrl
"breast tumor epithelium,26",pert
"human failing LV myocardium, Ischemic52",pert
"Acute Myeloid Leukemia, sample 16",pert
WFS1 WT USHT_05_318_ko,ctrl
Cyclophosphamide-treated spleen 1 day - Biological Replicate 4 - Technical Replicate 1,pert
A39 NES 142Q TG1	F5/51	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Female,pert
Seguin_IDR_BrownNorway_Liver_treated5,pert
T21 U133p2,pert
"BOEC, normal 6",ctrl
Control subject 43_biological replicate 1,ctrl
SCARKO d 10 (5),pert
cell type: splenic CD11c+ dendritic cells;	strain: C57Bl/6strain: C57Bl/6;	genotype/variation: Map3k7CreER;	treatment: tamoxifen,pert
"Mouse Embryonice Stem Cells, pCIP siRNA 1, Rep2",pert
Vehicle-Control 36 hours set 1,ctrl
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: DMSO (Vehicle);	treatment time: NA",ctrl
"Gata4_S105Amut, untreated whole heart, individual 5",pert
Bone-Marrow_SMM_S1395,pert
Mouse No Cldn16 B9 442,ctrl
Day6 Estrogen treatment replicate 1,pert
Hippocampus 2006 2 month Old,ctrl
involved skin from cases,pert
cell type: Mouse embryonic fibroblasts (MEFs);	genome/variation: Wt1-null,pert
4 hr unpooled 2 vs PBS 4hrpooled,pert
Mnk_3220-S-B,ctrl
cerebellum_wildtype_3,ctrl
patient: 234;	current medication: Aza 150mg Atenolol Atorvastatin BFZ Clopidogril;	birth date: 9/29/46;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/1/88;	diagnosis date: 9/29/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 2/3/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Angina;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
erStress_twins_AA_1736twin2_500nM_thapsigargin_4h,pert
treatment: TRAF6 knockdown,pert
Tissue: tumor; Gender: male; Age:42  Tumor stage: T3NxMx,pert
KO PBS4,ctrl
Mutant_liver_3,pert
cell line: Y79;	passage: 25;	cell type: Retinoblastoma,pert
Run4.aUa.010110d.SkMDbt1142D.CEL-DB basal,ctrl
PlagL2WT3,ctrl
Barrett's esophagus (B2),pert
NZW/LacJTCE liver sample batch 2,pert
"ESCs overexpressed Foxd3, biological rep3",pert
DNMT1-2,pert
"Mouse heart, control, replicate 4",ctrl
"brain, brainstem: LB3_e1_le1",pert
status: Rapid;	age: 66;	gender: male;	tissue: cultured human fibroblasts,pert
umbilical cord_nobpd: 8D,ctrl
PC-3_basalhTERT_ShortTelomeres_mock_1,ctrl
NSC16,pert
cell line: U937;	replicate: Replicate2;	treatment: shSYK_1,pert
disease state: normal;	age: 20 weeks;	tissue: ventral prostate;	strain: FVB,ctrl
H15_S_B2,pert
BALB/cByJTCE liver sample batch 1,pert
MLL1-KO MEF CT18-2,pert
GM19238_Kd_RXRA_1,pert
tissue: amnion;	cell type: mesenchymal;	agent: vehicle;	time: control,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.226;	OD280: 1.154;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 223;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
M238_A_DMSO,ctrl
Adrenal WT 0h batch 1 [AdWTh00.4],ctrl
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of saline for one week,ctrl
MCF-10A shCHK1-4 replicate 2 [set 5],pert
10 days sham-4,ctrl
whole tissue section from case 280,pert
agent: 0.03% ethanol (control);	tissue: mammary epithelium adenocarcinoma;	cell line: MCF7,ctrl
chip number: 17;	transfection plate: 6;	target gene: NS;	kd level: NA;	rin: 9.1;	transfection date: 2012-03-26,ctrl
"brain, brainstem: CB2_e1_le1",ctrl
GFP-progerin Induction: day 5 Replicate A (5a_progerin_5d_A),pert
CCC103B,ctrl
Control subject 107_biological replicate 2,ctrl
AZ-521_doxycycline_24h_rep2,pert
cell line: HSC-3;	cell type: human tongue squamous cell carcinoma;	genotype/variation: overexpressing trypin-2,pert
Hunk WT rep3,ctrl
Series 3; adult; 2 weeks after fracture,pert
MDA-MB-231_TR6196: transfected with a vector containing a shRNAs against CD146,pert
"SFM control cells (24hr), biological rep1",pert
pediatric AML S13,pert
Cardiac Progenitor MUT1,pert
Individual_4294_PN_sample,pert
"age at diagnosis: 40;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N2a;	er: 0;	pgr: 0;	dfs-month: 47;	dfs-event: 0;	distant metastasis: 0",pert
EA_Case8_CD20,pert
WT-PBS_rep-2,ctrl
siHic5_2_4h_3,pert
strain: Swiss;	tissue: Ovary;	agent: Methoxychlor (50uM);	replicate: 2;	age: Post natal day 3-11,pert
40A;pretreatment;female;breast tumor,ctrl
patient: 105;	current medication: None;	birth date: 7/29/84;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"spleen follicular B in WT, biological rep3",ctrl
control shRNA replicate 3,ctrl
pt. HCL D treated with Vemurafenib 1000 nM for 48h,pert
Control_Castrated OWJ2,ctrl
"age at diagnosis: 62;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 1;	dfs-month: 37;	dfs-event: 0;	distant metastasis: 0",pert
TEx15ni,pert
cell line: D3;	treatment: scrambled,ctrl
"Luc control esiRNA, biological rep4",ctrl
cell line: SNB19;	transfection: PARK2 siRNA#2,pert
"brain, hippocampus: CH1_e1_le1",ctrl
WT1R2,pert
10EXPLANTH,ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 19d ID308,pert
Ishikawa_HighDose_BPA_8h_rep4,pert
UC-32-un,pert
D1,pert
Animal 10,ctrl
"fibroblast, MFS subject FB837 rep 4",pert
subject: 18;	disease: TD;	muscle: GR;	gender: F;	age: 17.4;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Individual_4247_PN_sample,pert
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 3,pert
cell type: late passage (LP50) LNCaP,pert
age: 63;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
chip number: 22;	transfection plate: 5;	target gene: STAT2;	kd level: 0.64;	rin: 9.2;	transfection date: 2011-10-17,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 60 yr;	population: white,ctrl
shRNA4-1-noDox-rep2,pert
Normal cervix_05-1308,ctrl
Patient identifyier: B;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 15 years;	Body surface area: 6 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
wt 13.5d replicate 6,ctrl
"Mutator, biological rep3",pert
PBMC from T cell Large granular lymphocyte leukemia patient#122,pert
Bronchial Epithelial Cells MMA biological 1908F,pert
strain background: B6/C3H;	genotype/variation: wildtype;	developmental stage: germinal vesicle (GV) stage;	tissue: oocytes (100 cells),ctrl
47A;pretreatment;female;breast tumor,ctrl
"control pancreas, biological rep1",ctrl
"ES cell mutant, RNA 306",pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 4",pert
"breast tumor epithelium,29",pert
Control 874E,ctrl
P0 Quadriceps Klhl40 WT 2,ctrl
A3_C3_nasal_stem_cell_rep1,pert
U937_naive_curcumin_18h_rep1,pert
Human Acute HIV Sample A144-CD4+ T cells,pert
tissue: secondary brain tumor;	cell type: glioblastoma;	age: 64;	gender: female;	tumor grade: IV,pert
"A673 treated with Doxorubicin for 5 days with concentration of 59.88 nM (EC50), biological rep3",pert
Control (C62),ctrl
Normospermic individual: Sample N1,ctrl
WT V6.5 ESCs on day 7 #2,ctrl
mouse_islets_ctrl_03,ctrl
cell line: L428;	treatment: Mifepristone + 5-aza-2′-deoxycytidine + Trichostatin A (MAT);	duration of treatment: 5 days,pert
CONTROL 4,ctrl
"Acute Myeloid Leukemia, sample 11",pert
Bmi1 embryoid body sample_1 (Bmi1_EB_1),pert
"NF-YC KD ES cells 96hr, replicate 2",pert
FSH-NHM-1UA-S2,ctrl
"CD11b DC wild type, biological replicate 3",ctrl
A549 Stretch 1hr Jan 31 2003,pert
background strain: C57Bl/6;	genotype/variation: Notch1 knockout,pert
MDA-MB-231-pcDNA6 cell culture 1,ctrl
strain: C57Bl/6;	genotype/variation: : control ROSA(N1IC) mice (NICD wild-type),ctrl
"Patient P, uninvolved skin",ctrl
sex: Male;	family: 5;	age: 39;	disease status: Control;	tissue: Muscle: Biceps,ctrl
"3T3-L1 siLSD1 48h, biological rep 3",pert
"A673 treated with DMSO vehicle control for 5 days, biological rep2",ctrl
microdissected breast cancer cells from case 687,ctrl
Tet2 KO CMP rep2,pert
01LKZ_ERA,pert
"Trained mice, time point 1 week",ctrl
"p38alpha wild type fetal liver E15.5, biological rep3",ctrl
m1-WT1,ctrl
WTC 157 PBS treated,ctrl
cell line: E14;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 3,pert
E14 - WTMixB 1,ctrl
Gastrocnemius muscle for transgenic mouse overexpressing PPARalpha in a skeletal muscle-specific manner,pert
BL307,pert
control AU1348302,ctrl
"E18.5 brain, Meg3 knock-out, rep 2",pert
REH_control_rep2,ctrl
e5 Ez f/wt,ctrl
Ecad_Con_1,ctrl
Retina ko/wt rep1,pert
293TsiLL-2,pert
"Liver from MON exposed rats, biological rep 2",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 42.82192,pert
DEX4_24H,pert
Sprague Dawley rats;	Gender: male;	Weight: 250-350 g,ctrl
ubb_d7_wt_1,ctrl
RTX5 T12,pert
strain: C57/Bl6;	gender: male;	genotype: Egr-1 knock-out;	age: 30 days;	tissue: retina,pert
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 1,ctrl
"Acute Myeloid Leukemia, sample 6",pert
"S1P3-KO-neocortex, biological rep2 (male)",pert
knockdown: Control;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 7.9;	colon weight (mg): 167;	colon ratio (mg/mm): 2.11;	myeloperoxidase activity (u/mg): 0.088;	tissue: colon;	treatment: 5% DSS,ctrl
MV 4,pert
tissue: prefrontal cortex from adult APPsa knock-in mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,pert
Run7.aUa.001206d.SkMInS1081D.CEL-IS stimulate,pert
shRNA4-1-plusDox-rep3,pert
PKBa-/- MEF time 24 replicate 4,pert
Series 1; adult; 3 days,pert
INCB18424 Acute 1,pert
07R068 Control,ctrl
Leptin treated mouse gallbladder 7,pert
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: High fat diet,ctrl
strain: Sprague-Dawley;	cell type: aortic valve interstitial cells,ctrl
Squamous cell carcinoma 031,pert
"Patient H-c558T, MSI colorectal tumor",pert
cell type: B220+ cells from preB colonies;	genotype/variation: Hspa9+/-,pert
INS-1 cell line (FLP-In T-REx clone #5-3.19),ctrl
healthy control H06,ctrl
"4 weeks old PS-NA mice, cerebrum",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 75min;	race: White;	sex: Male,ctrl
EVI_GFP negative Lin- cells replicate 3,ctrl
Individual_5331_PN_sample,pert
Bone-Marrow_MM_M1105,pert
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 1",pert
"Overexpress TFPIalpha, biological rep. 3",pert
CD11b+Gr1+ cell sample_1 (derived from IL17RC Knock out mouse),pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (29),pert
"nasopharyngeal carcinoma, specimen T29",pert
"P90_C-DGCR8 KO cones, replicate 1 [array]",pert
strain: 129SV;	gender: female;	age: 10 months;	tissue: right ventricle;	genotype: wt,ctrl
THRA 6a mutant + vehicle replicate 2,ctrl
cell type: WAO9 human embryonic stem cells;	growth protocol: subjected to a hepatic differentiation protocol;	time: d15,ctrl
26 weeks male,ctrl
3T3 cells,ctrl
"FOXP3, WT, REP2, 0h",ctrl
"Untreated, biological rep6",ctrl
HMEC X HMEC+Interferon alpha 24hrs,ctrl
5193 Normal Uninflamed sigmoid colon,ctrl
"breast tumor epithelium,50",pert
"TNFa-OMe-P siRNA-C, replicate 6",pert
whole tissue section from case 687,ctrl
tissue: lung;	lung source: routine lung volume reduction;	phenotype: healthy;	gender: unknown;	age: unknown,ctrl
Control 12,ctrl
5218 UC Inflamed descending colon,pert
"patient 031b, cancer, homogenized",pert
T8A-LU,pert
"Healthy volunteer, Control_11697",ctrl
R1 ES cells expressing mouse Cdx2 T2ER fusion,ctrl
agent: untreated;	time point: 0 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,ctrl
Ribavirin Treated Cells 3,pert
Parkinson's disease sample x098,pert
Cyclophosphamide-treated spleen 1 day - Biological Replicate 4 - Technical Replicate 2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.236;	OD280: 1.154;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 374;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
strain: C57Bl/6;	genotype/variation: WT;	cell type: cDC;	cell type subset: CD11b+,ctrl
Liver WT HFD #560,ctrl
E_LS_Wk1,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_2h_0.4mM_HG-U133A_2_YCHSUP501,pert
061K0: normal control,ctrl
MIC2,ctrl
pediatric AML S15,pert
Patient 19,pert
"control + L-Arg colon tissue, biological rep1",ctrl
siRNA Med12 + Estrogen [L1],pert
Ring1b_KD_3,pert
CML_6_MEP,pert
"Autoimmune pancreatic islets, day 2 cyclophosphamide treatment, rep 3",pert
24B,pert
SKM WT4,ctrl
"Uninvolved Skin, NS-17",pert
"Donor 3, mock infected 6hr",ctrl
Normal-N_LJ_7,ctrl
wild type MEF time 24 replicate 3,ctrl
cell type: Primary hepatocytes;	donor: 3;	agent: control;	time: 6h;	gender: Female;	age: 70 years old,ctrl
MB231 con-DMEM,pert
LNT-2,ctrl
Eed KO J1 ESCs on day 3 #2,pert
Papilloma_tumour_epithelial_cells_Sox2cKO_rep1,pert
age: 48;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
spleens from mice on C57/Bl6 x 129 Sv background,pert
EA_Case6_CD4,pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 3 - Technical Replicate 2,pert
R6_Pseudomonas_wildtype_422,ctrl
MCSF_B,ctrl
"Fibroblasts, formoterol, time 3h, patient 2, rep 1",pert
Control (C282),ctrl
ILD Study Number S010,ctrl
Control_2months_retina10,ctrl
wtPrE serum 2,ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 144;	time: 0;	batch: 4,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 40,pert
"Gender: female, Age: 48 years, Tissue: VIN 3",pert
"213, ADIPOOSE TISSUE, After",pert
tissue: Hippocampus;	age: 88;	Sex: F,pert
liver_Q10_14M_rep2,pert
tissue: spleen Ter19+CD71high sorted cells;	genotype: Rb KO;	age: 3-month,pert
gastrocnemius-30 months of age-control diet-biological replicate5,ctrl
agent: Chromium 10 µM,pert
MDS patient 142,pert
Individual_4697_PN_sample,pert
Psoriatic arthritis PsA 19,pert
Rat fatty liver5,pert
age: 40;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
treatment: siDsRed;	cell line: HeLa,ctrl
age: 14;	sex: M;	disease status: control subject;	Filter number: 97;	Usage number: 1;	Exposures: 3,ctrl
patient id: 83;	tissue: Normal cortex;	gender: Female;	age: 85;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
"A673 treated with DMSO vehicle control for 5 days, biological rep3",ctrl
male JAK2 KO liver sample 122,pert
sample G term homo,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: other,pert
JIA PBMC Post treatment A235_L112(2),pert
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: valproic acid (VPA);	treatment time: 4 hours,pert
Liver FC1,ctrl
PKBa-/- MEF time 48 replicate 4,pert
Wild Type Skeletal Muscle Sample (Hind limb 2),ctrl
cumulus_nonPCOS_Obese_rep5,ctrl
"brain, cerebellum: KCb12w#2_e1_le1",pert
Wildtype 3 (jos1525),ctrl
OVCAR-10+(3),pert
colon_CRC_1316,pert
CD4+ cells IL1RN wild type 1 month rep2,ctrl
"TGCT cell line 2102Ep/clone 2A6, treated 3 days with retinoic acid, undifferentiated",pert
HA01-149B,pert
WT2 activated CD8 T cells,ctrl
race: african american;	age (years): unknown;	stage: IB;	grade: 3;	histology: papillary serous,pert
Control_Time_30_2,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.708;	OD280: 0.905;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 53;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"Control siRNA - 2 days adipocyte differentiation, rep3",ctrl
genotype: MBD2–/–;	genetic background: Balb/c;	cell type: Regulatory T-cells CD4+CD25+,pert
"Typically Developing Control, Gracilis, Patient Replicate 6",ctrl
non-malignant FTEn_patient 11,ctrl
Backskin_Get1_e18_WT2,ctrl
cell line: MCF7;	condition: Estrogen,ctrl
8DKD_rep3,ctrl
Subject #8013-2d Postinfection,ctrl
3 Wild-type control macrophage,ctrl
MNR 2-2 WT 4,ctrl
Gastrocnemius Muscle mdx PBS-Treated rep2,ctrl
Multiple Myeloma Patient 4,pert
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 1h;	donor: 1,ctrl
treatment: Sirt1 siRNA Knockdown 2;	cell line: Caco-2,pert
"Mkl2-/-, sample 3",pert
HDAC6_1,ctrl
Donor (Sample 15),ctrl
injury stage: Sham 60 days;	gender: male;	strain: Wistar,ctrl
Muscle-AMPKgamma3-mutant(R225Q)transgenic-5,pert
Strain: C57BL/6;	Gender: mixed;	Age:E9;	Tissue: whole embryonic body  ,ctrl
HRas-v12 transgenic male replicate 3 late timepoint,pert
cell line: OSE4;	knockdown: ARID1A;	cell type: ovarian surface epithelial cells,pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 16 hrs,ctrl
C4_CLP_wildtype_8,ctrl
"Healthy volunteer, Control_11818",ctrl
3DKD_SerumStarved->3hrEGF_rep2,pert
ubb_d14_wt_2,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: DMSO for 72h,ctrl
Postmenopausal female. Estradiol treated. Patient 28.,pert
B_cell_pool_healthy_H05+H06,ctrl
cell type: Primary hepatocytes;	donor: 6;	agent: control;	time: 24h;	gender: Male;	age: 73 years old,ctrl
"experiment I, passage 13, replicate 1",ctrl
strain: 58;	Disorder: normal;	Condition: no hydrocortisone,ctrl
"brain, cochlea: [12] Sample #12_le1",ctrl
"IL22KO2_ileum, 5 days post-infection with T. gondii",pert
ILD Study Number S017,ctrl
mouse colon_hnf4mutant_rep3,pert
strain: C57BL/6;	Gender: male;	Age: 8-12 week;	nmMLCK-/-,pert
5922012038_A,ctrl
Normal B cell 2,ctrl
15-0012A_Day1_39,pert
"spinal cord, ventral spinal cord: EP134/L - hSOD1(Chan)/e14-wildtype hSOD1_le2",ctrl
Muscle-AMPKgamma3-wt-12,ctrl
"219, ADIPOOSE TISSUE, Before",ctrl
B10.H2g7_T2,ctrl
A_AN08792_F,pert
GC resistant clone C7H2-R19F2 treated for 6 hours with GC,pert
ACI control replicate 2,ctrl
chip number: 11;	transfection plate: 4;	target gene: RDBP;	kd level: 0.78;	rin: 8.9;	transfection date: 2011-10-17,pert
LSK control 2,ctrl
Oct4 KD replicate 2,pert
Control 4 c,ctrl
106B,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 14 months,ctrl
PGA_MI_nilv_48h_355,pert
MDS3,pert
Tumor from MYF-5 CRE/SSM2 mouse CC17-B,pert
Dilated cardiomyopathy,pert
control participant P330,ctrl
Animal 12,ctrl
"Patient 30, Macroscopically intact tissue",ctrl
"Cerebral Palsy, Semitendinosus, Patient Replicate 3",pert
Vehicle 12 hours_2,ctrl
LPS-PVH3_2,pert
phenotype: severe glaucoma;	gender: female;	strain: DBA/2J;	tissue: retina;	age: 10.5 months,pert
MDA_PR_3,pert
KO9-2,pert
"ALL_DS, K31 012109",pert
Brg1 mutant 2 cell embryo rep1,pert
sip53mut.exp2,pert
strain/background: C57/B6x129 mixed background;	genotype/variation: control;	age: 12.5 dpc;	cell type: mouse embryonic fibroblasts,ctrl
cell type: Primary neonatal keratinocytes,pert
"S1P3-KO-hippocampus, biological rep1 (male)",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.007;	OD280: 0.497;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 67;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"Aorta, saline 7d, #1",ctrl
JURL-MK1 Imatinib-treated,pert
nucleus accumbens long access to cocaine replicate 4,pert
gender: Male;	age: 82;	post-mortem delay: 19.5h;	ph: 5.8,pert
MDA_PR_1,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 1;	psoriasis duration: 39.807665982204;	age of psoriasis onset: 25,pert
liver_male ko_rep3,pert
2N,ctrl
A_AN16641_C,pert
08SAGEA,pert
DC-8,ctrl
F_Ctrl_2,ctrl
01LZD_Oligo,pert
Benign prostate tissue N3,ctrl
Healthy individual of twinpair #4,ctrl
cell line: HCC1954 cells;	subtype: HER2 Positive;	treatment type: Vehicle Only;	treatment time: 3 Days,ctrl
THRA wt + vehicle replicate 3,ctrl
KM_025T,pert
"healthy control fibroblast, biological rep4",ctrl
"kn muscle 3, biological rep 3",pert
CLL 164-02 Control,ctrl
Subject #8007-8hr Postinfection,pert
"Human Umbilical Vein Endothelial Cell, Single Donor, Passage _3",ctrl
pediatric AML S34,pert
"seminoma specimen, pT1, pN1, patient age: 42y; W95 194",pert
female;	33 yr old;	White,pert
HeLa control knock down 1,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 72h",pert
shRNA2-4-noDox-rep2,pert
"Acute Myeloid Leukemia, sample 36",ctrl
Mouse_ESC_Pcl2_mismatch_control_sample 1,ctrl
Huh7 cells_JFH-1 Infected 6 hours_ rep2,pert
CD4DecTp1-6,pert
VehVeh3,ctrl
"age at diagnosis: 48;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N2;	er: 1;	pgr: 1;	dfs-month: 58;	dfs-event: 0;	distant metastasis: 0",pert
3080-lcm,pert
"treatment with MDBP, replicate 3",pert
PC-3M/NC siRNA #2,ctrl
Individual_4503_PN_sample,pert
"human failing LV myocardium, Idiopathic25",pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (2),pert
age: 40;	sex: F;	disease status: control subject;	Filter number: 93;	Usage number: 1;	Exposures: 3,ctrl
"Control shRNA, rep3",ctrl
27 weeks female,pert
"normal breast epithelium,4",ctrl
rheumatoid arthritis 121102,pert
HO_3,pert
BCell_lymphoma_transitional_sample3,pert
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 5 months;	genotype: Wild type,ctrl
Huh7 cells_JFH-1 Infected 48 hours_ rep2,pert
patient: 801B;	disease state: LGSC;	component: Borderline,ctrl
Patient 1 b,pert
patient: 249;	current medication: Azathioprine 150mg Salazopyrine;	birth date: 1/12/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/90;	diagnosis date: 3/24/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/8/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 4/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"Cadmium 1.2 µM, biological rep4",pert
RE550_DU145_9-Medi5117,pert
H5_SS11_01Nov07,pert
"Wt, biological rep1",ctrl
"14B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
L-540_CTRL_24hrs_1B,ctrl
strain: mixed C57BL6;	genotype/variation: Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,ctrl
A VIS _B069,pert
treatment: baseline;	gender: F;	age (y): 33;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
mESC_undifferentiated_wild type_rep2,ctrl
PGA_MI_nilv_1w_663,pert
CEPI_IIIc_588,pert
"non-AD_HI, biological rep3",ctrl
Bronchial Epithelial Cells MMA biological 2154L,pert
Rat fatty liver16,ctrl
"Hdh knock-in embryonic stem cells, Q20 line, biological replicate 3",pert
mdx Biological Replicate 2,pert
MEF.WT.I,ctrl
TTP_KO_0ActD_BioRep2,pert
ic patient 6,pert
cerebellum SNCA knockout 21 month replicate 1,pert
cell line: J1;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 3,ctrl
33_C57_WT,ctrl
SHR12-2,pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 59;	donor: 17;	disease state: Lesional,pert
2117-01-A,pert
B10.H2g7_S2,ctrl
Pt_5 Normal Skin,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 48h",pert
GFP C,ctrl
"bipolar disorder, BA10-11",pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A61_8 months_replicate 4,pert
healthy control sample x050,ctrl
"Sv129/C57B6 intercrossed hybrid strain, 12 week old male",pert
day 10 5-FU HSC 1,pert
"Control, replicate 8",ctrl
1% dmso batch 1,ctrl
"SIRT3KO, high-fat diet, rep2",pert
Mature mice skeletal muscle sample from the hind limb,ctrl
cell line: RT112;	transduced: FGFR3 shRNA 2-4;	doxycycline treatment: no,ctrl
MDS23,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 3;	psoriasis duration: 37.0;	age of psoriasis onset: 11,pert
"Subject 8, Family 3, Asymptomatic",pert
Diaphragm 7 day mdx rep 1,pert
Liver FC3,ctrl
sample type: HeLa-LAMP3siRNA-4d;	cell line: HeLa;	knockdown: LAMP-3 siRNA;	time: 4d interferon alpha;	treatment: interferon alpha,pert
tissue: Liver;	genotype/variation: Hmgn1+/+;	treatment: injection of 10 µg/g body weight of saline,ctrl
Liver KO6,pert
Substantia nigra PD rep13,pert
"111, MUSCLE, Before",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, mock",ctrl
Metastatic prostate cancer W4,pert
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 1",pert
H32 HA 12h 4,pert
8h 4OHT-treated-sample3,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 24h ID212,pert
U133A_B3,pert
GFP Zfx wt 1,ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siCtrl;	agent: E2;	time: 4h,pert
siDdb1 replicate2,pert
CUTLL1 MigR1 GSI-rep1,ctrl
"DMSO treated HL60 cells, biological replicate 1",ctrl
MDS patient 182,pert
treatment: DMNQ;	cell line: CuFi;	genotype: Cystic Fibrosis deltaF508 mutation,pert
NSC_ X5050_24h_biological rep2,pert
WT-Fibr2 2,ctrl
tissue: brain;	genotype: mutant Ndel ko/cko;	age: P14,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 24;	gender: male,ctrl
Aurka_R_+Dox_rep3,pert
"D425-shOTX2_3, t=96",pert
C26_heart 2,pert
del337TR replicate 7,pert
Plate vs. Nail:  1 Day Sham,ctrl
Transgenic 3,pert
Infergen_6hr_rep3,pert
"Sh2b3 WT, biological rep3",ctrl
WildType B cells Spleen 1,ctrl
memory HD-/- P14 T cells #2,pert
EOM 112 Day Control rep 1,ctrl
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-1502;	gender: female;	passage: P55;	clone: C32,ctrl
cell line: neuro 2A (N2A);	cell type: neuroblastoma cell line;	genotype/variation: transiently transfected with Pou3f3 knockdown construct,pert
PBMC from T cell Large granular lymphocyte leukemia patient#108,pert
SZ8,pert
Lung from SM22-dnBMPR2 inducible transgenic males activated 8 weeks,pert
strain: C57BL6/J;	genotype/variation: wildtype;	age: 8wks;	developmental stage: adult;	gender: male;	agent: acetaminophen (APAP);	tissue: liver,pert
11SAGEA2,pert
MDA_PR_1,pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection;	vector: pLKO.1;	activation: 2 h 100 ng/ml TNP-BSA,ctrl
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: JAK2 knockdown (Jak2-10 shRNA),pert
CON - R22,ctrl
strain: C57BL/6;	tissue: Lung;	agent: saline;	genotype/variation: wild type,ctrl
EA_Case14_CD4,pert
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P7;	clone: C16,ctrl
"tissue: lung, upper lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 68",pert
T1F-LU,pert
Csbm/m Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-1,pert
pediatric AML S01,pert
LY2 SRC1-siRNA untreated rep1,pert
Human.AI.CP.FCU,pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: STZ,pert
Disease_status: Down syndrome;	Age (years): 61;	Gender: Female;	Post mortem interval (hours): Unknown;	Braak stage: Unknown;	Cause of death: Unknown,pert
Individual_5575_NN_sample,ctrl
MCF7 control siRNA Estradiol Rep2,ctrl
Nuclear RNA_WT_rep1,ctrl
Normal cortex of patient 14,ctrl
"NPCxhIPSC SCZP, replicate 4",pert
brain_QH2_14M_rep3,pert
patient: 1;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Adult Sham; Biological replicate 3,ctrl
LCL Concordant for Epilepsy twin pair 4 (CCE4.2)(TP40),pert
Subject #8045-Preinfection,ctrl
GFP1_1578G,ctrl
Plate vs. Nail:  6 Week Sham,ctrl
Huntington's disease 874F,pert
intestine_wildtype_control_rep1,ctrl
confluent HUVECs stimulated with Angiopoietin for 1 hour,pert
RNA from HCC_28N,ctrl
Patient 2 a,pert
"AD_FC, biological rep7",pert
Genotype: NHE3-/-;	Age: 6-8 weeks,pert
Postmenopausal female. Tibolone treated. Patient 6.;	Replicate,pert
genetic background: C57BL/6;	tissue: liver;	genotype: wt;	gender: female;	age: 3 mo,ctrl
SLE CD4 T cells 13,pert
"human failing LV myocardium, Ischemic68",pert
Strain: C57BL/6; Tissue: liver,ctrl
HP-11,pert
01N71_CTRL,ctrl
White adipose tissue in wild-type mice (rep1),ctrl
"Normal subject (53 year old caucasian male, SAK_1288621868)",ctrl
PA-1+(3),pert
01LQH_CTRL,ctrl
Karyotype: no inv(14)(q11q32);	Age: 62 years;	Gender: male,pert
gender: male;	age (years): 34;	evolution time (years): 7;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
tMLL05,ctrl
U937_naive_curcumin_4h_rep1,pert
"Acute Myeloid Leukemia, sample 39",ctrl
individual: patient1;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
Jejunum_Wild Type_3,ctrl
control siRNA (siCon) tranfected into C2C12 myoblasts rep3,ctrl
"patient 7, arm treated with pimecrolimus",pert
patient id: T127;	tissue: Normal cortex;	gender: Male;	age: 35;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
Normal heart_G75,ctrl
T30364,pert
0 h (2) (Control sample),ctrl
34A;pretreatment;female;breast tumor,ctrl
FU-OV-1+(3),pert
cumulus_PCOS_Lean_rep3,pert
FACS-purified B cells_IFNAR1-/-_influenza-infected_rep1,pert
HepG2_control rep3,ctrl
"Amoxicillin treated Distal, Small Intestine 1 21 days old",pert
WT - Cre Control - 3 mo - repeat 2 - Cy5 - mAdbID:74588,ctrl
BRCA1_1,pert
"WT, biological rep1",ctrl
3883-1 E2F WT,ctrl
"Lesion Skin, LS-24",pert
CD4IncTp2-5,pert
HeLa_01-04-05 TP6_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
ME180 DMSO rep 2,ctrl
"treatment: control;	batch: 3;	donor: 29;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
strain: C57BL/6;	genotype: Klhl40 knock out;	age: 0 days;	tissue: muscle;	muscle type: Quadriceps,pert
Mouse old heart C30-Ht-3,ctrl
FVB_MMTV_Wnt1_2494.2L_Rosen,ctrl
NFIA P16WT1,ctrl
Cpr-low_pool 2,pert
control-control rep 3,ctrl
cell type: Melanoma cell line;	cell line name: A375P;	expression: PGC1a shRNA 66,pert
Scd1+/+ on chow diet replicate 3,ctrl
Scd1-/- on very low fat diet (TD03045 from Harlan Teklad) replicate 4,pert
RNA from HCC_35N,ctrl
GIST Pre Treatment Biopsy 09,ctrl
THRB bN mutant + vehicle replicate 3,pert
GEIM176-U133A-Norm,ctrl
Muscle control 13,ctrl
"BPL adrenals, replicate 2",ctrl
"spinal cord, ventral spinal cord: EP143/L - G93R(Roth)/e14-mutant hSOD1_le2",pert
"Biceps, FSHD, cohort 21, subject 21B",pert
"C2C12 Myotubes treated with Palmitate, rep2",pert
gender: male;	age: 6 months old;	genotype: Pdx1flox/flox;VilCre (KO);	litter: brother of the same litter,pert
cell line: HCT116;	shRNA: CDK8;	treatment: untreated,pert
Colon_POR-null_3,ctrl
H11_SS10_01Nov07,pert
GIST882 Imatinib Rep3,pert
"granulocyte, healthy control, biological rep11",ctrl
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 knock out mouse, Harlan Teklad TD03045 diet, liver",pert
V5-P299,pert
Patient: G;	Time: 0;	Group: responder;	Condition: lesional,ctrl
cell line: AGS;	tissue origin: stomach;	cell type: human gastric carcinoma cells;	treated with: none (control),ctrl
27SMOKEH,ctrl
WT - Cre Treated - 0.5 hrs - repeat 2 - Cy5 - mAdbID:62545,ctrl
reference: whole mouse total RNA,pert
ILD Study Number 890,pert
"10 days old prosaposin knockout mice, cerebrum",pert
"brain, hippocampus: PH5_e1_le1",pert
Wt Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-1,pert
Liver_POR-null_1,pert
WT-sham-5 month-R4,ctrl
SKI-DLCL cells treated with Aplidin (3nM) for 24h. Total RNA was extracted.,pert
Liver_Nrf1 CKO_rep3.,pert
testis wild type replicate3,ctrl
brain_DLPFC_bipolar C_mr700,ctrl
HF0899_U133P2,pert
EP18_adipose_pcos,pert
"3 uM EPZ004777 treated, DAY 6, biological rep.3, MV4-11 cells",pert
cell line: HEK293 human embryonic kidney cell line;	protocol: control (untreated),ctrl
PGA_MI_nilv_4h_389,pert
cell type: peripheral blood mononuclear cells;	disease state: multiple sclerosis,pert
cell line: IEC-6;	tissue: colon epithelium,ctrl
Cochlea_D257A_9mo_5,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Jejunum",pert
male_control_329,ctrl
"Cell type: endothelial, age:45, gender:male, diagnostic group: schizophrenia, PMI:18h",pert
"Spi-60, biological rep 5",pert
"Patient 3, control tissue",ctrl
"DOCK8 knockout, thymic, NK1.1+ NKT cells replicate3",pert
"BOEC, not_at_risk 4",pert
CML_4_MEP,pert
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b retrovirus,pert
HCC008N,ctrl
GB 1 63A +LPA,pert
E2-uninduced (no Dox) control,ctrl
Squamous cell carcinoma 008,pert
Healthy-7 baseline,ctrl
Individual_4368_PN_sample,pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK1-3,pert
139B,ctrl
Day: 24; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 1,pert
tissue: Temporal cortex;	age: 91;	Sex: F,pert
mixed reference (CRG+ FR),pert
wt PBS3,ctrl
WT MEF CT18-2,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: B;	experimental sample name: PC8-R,pert
scan batch: Batch 2;	group: autism;	subject age: 14;	paternal age: 30;	maternal age: 32,pert
WT_d00_e0_vs_WT_d21_e9,ctrl
NFIA E18KO3,pert
Healthy10-CD4,ctrl
MKK7D control female replicate 1 early timepoint,pert
"breast tumor epithelium,42",pert
PGA-HMO-MObese-5aUA-s2,pert
"125, ADIPOOSE TISSUE, Before",ctrl
ccRCC tumor of patient 209,pert
ctrl_507,ctrl
nmMLCK-/- -VILI replicate 3,pert
Run1.a10a.000607jd.2.SkMNor921.CEL-IS basal,ctrl
M249_R4_B_DMSO,ctrl
Testis_KO_rep3,pert
01UMY_PolyRF-,pert
U937_naive_curcumin_18h_rep2,pert
"Human Umbilical Vein Endothelial Cell, Single Donor, Passage_3",pert
3DKD_SerumStarved->1hrEGF_rep3,pert
Gender: Male;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: YES,pert
MCF7/c p.1,ctrl
WT_PMΦ_rep2,ctrl
TMRI E2 1hr,pert
"fibroblast, MFS subject 60FR rep 1",pert
3749-lcm,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 10",pert
fully differentiated (day 6) myotubes,pert
tissue: skin;	individual: Patient P3;	condition: ANL;	eczema severity: SCORAD: 0,pert
"Male, 32 years old, HIV infection of >2 years",pert
SLE10-TC,pert
Control Colon 1 21 days old,ctrl
RV64.09_CHF_day25_Slide40,pert
Parkinson's disease sample x014,pert
Untreated after 4 days (C1_1),ctrl
15d Dicer cKO_Pool 12,pert
15KD_SerumStarved->1hrEGF_rep3,pert
U87-20.1,pert
"Aorta, saline 7d, #5",ctrl
EA_Case20_CD4,pert
"Patient I-c406T, MSI colorectal tumor",pert
"Pten null epithelials cells, biological rep4",pert
Fibroblasts_HealthyControl_5,ctrl
Thoracic mammary glands were collected from three virgin F1 CF-1/FVB LH-overexpressing (transgenic) mice at 16 weeks of age; RNA was pooled before synthesis of cDNA,pert
siCtrlVeh24h_3490,ctrl
"peripheral ganglion, unknown: control 24 hr",ctrl
Cutaneous psoriasis without arthritis PsC 5,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: n/a;	maternal age: 27,pert
non-malignant FTEn_patient 1,ctrl
"lymphoblastoid cell line from T3.02, one out of seven of insensitive group, 50*10e6 cells",pert
"mouse aorta cross strain comparison, C3H_T00_NC_02",ctrl
HMEC_TNF-stimulated experiment 3,pert
"breast tumor epithelium,30",pert
MDS27,pert
50uM_Zn_3,pert
MDA-MB-231 cells siLuc (ctrl) transfected rep2 HG-U133A,ctrl
minor HCC6,pert
A549 RNA Static Control 4hr Jan 31 2003,ctrl
LSK cells from wild type mouse rep1,ctrl
ABH4,ctrl
"alveolar macrophages, smoker 001",pert
mixed reference,ctrl
"WT BM LT-HSC, biological rep2",ctrl
445MM,pert
Pediatric_GBM_30,ctrl
129S1/SvImJTCE liver sample batch 3,pert
aa.1,pert
"Patient 6, Macroscopically intact tissue",ctrl
cell line: HEK293T;	transfection: si-TNIK;	induction agent: Wnt3A;	induction time: 7 hours,pert
"alveolar macrophages, smoker 033",pert
Bronchial Epithelial Cells SA biological 1970K,pert
"Liver from Nrf2 k.o. mice, biological replicate 1",pert
Diabetic untreated rats 2,pert
"gender: Male;	age: 91;	post-mortem delay: 4.5h;	ph: 6.3;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
sample C 18.5 homo,pert
"N-56, NORM, M, GSF, 1 x ETOH, 24h",ctrl
remitted schizophrenia patient  S06,pert
Snell 6 month Wild Type Liver 82c,ctrl
tissue: Biceps muscle;	patient: C.b.7;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y 3m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
Control_Castrated OWJ5,ctrl
Squamous cell carcinoma 017,pert
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: Wt;	tissue: Skeletal muscle (quadriceps),pert
APBMNC.LPS+.3,pert
tissue: secondary brain tumor;	cell type: glioblastoma;	age: 40;	gender: female;	tumor grade: IV,pert
HWS18,pert
B_LS_Wk2,pert
sepsis patient #12,ctrl
Prostate Cancer_NUGEN TEST07,pert
GV oocyte_Ring1 mut_rep3,pert
Normal-N_LJ_9,ctrl
Bone-Marrow_SMM_S1495,pert
Liver-24 month-Myc heterozygous-technical replicate 2,pert
"schizophrenia, BA46-68",pert
muscle_Akt1+/-_35wk_rep4,pert
B7n,ctrl
46A,pert
"bipolar disorder, BA10-49",pert
cell type: Immortalized lung epithelial cells,ctrl
"schizophrenia, BA46-73",pert
MCAD 2,pert
Msgn1_12hPlusDox-biological rep3,pert
tumor cell line HepG2 rep1,ctrl
PTEN 121 (-/-),ctrl
heart knock out replicate2,ctrl
Sle1a R3,pert
"ALL_NDS, K55 012109",ctrl
PGA-RMM-1h-3aA-s2,pert
healthy control sample x171,ctrl
Yolk sac tumor 0307,pert
STHdhQ7/Q7-A,ctrl
2 hr EE repl 2,pert
Patient 7,ctrl
MKO_rep_3,pert
Wild Type Time 7 replicate 1,ctrl
cell line: SA-01;	treatment: with X5050 (100 µM final),pert
Patient 2 skin treated,pert
12h_RA1,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 55,ctrl
A61 NES 142Q TG1	F6/13	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
batch: A;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,pert
"wild-type control (littermates) of ""P32_exPKO_pancreas""; mixed genetic background; postnatal day 32; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.",ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
strain: C57BL/6J;	tissue: E13.5 embryonic fibroblasts;	genotype/variation: Tfam+/-,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-tu2,pert
"human nonfailing LV myocardium, NonFailing14",ctrl
06R030 RA,pert
heart wild type replicate1,pert
disease state: Healthy Control;	gender: Female,ctrl
H5_SS9_01Nov07,pert
MDS54,pert
Transgenic 2,pert
"siTERC-BMSCs, biological rep2",pert
"Vehicle treated, no doxycycline; biological replicate 2",ctrl
NK_cell_pool_melanoma_M01+M02,pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep8,pert
Nrl ko P2 replicate 1,pert
"seminoma specimen, pT3, patient age: 48y; W00 023",pert
4A;pretreatment;female;breast tumor,ctrl
strain: C57BL/6J;	day: 6;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 2,ctrl
Septic shock;	gender: Female;	Survivor;	organism: Group B Strep,pert
"Strain: C57BL/6 X SV129, Age: Embryonic Day 17.5, Tissue: Heart Venticle",pert
sex: Male;	family: 4;	age: 12;	disease status: Affected;	tissue: Muscle: Biceps,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 6a;	treatment: with vehicle for 6h,pert
SLE3,pert
B7m1,pert
Endometrium-Normal 1,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 3,pert
treatment: siRNA LMG4,pert
kidney_co_6M_rep1,ctrl
"Control siRNA - 5 days adipocyte differentiation, rep3",ctrl
EDL-n7-2; normal extensor digitorum longus 7 month,ctrl
C13+(1),pert
Normal Cervix N9,ctrl
Naive (control) #3,ctrl
cell type: E9.0 embryonic cardiac progenitors,pert
Plate vs. Nail:  1 Day Plate,pert
RO36,pert
"17B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
IPMC 1,pert
MLL2 siRNA biological rep 1,pert
"Patient S-337-N, normal colonic mucosa",ctrl
Carbo Day4 (413R),pert
11390 Normal Uninflamed terminal ileum,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EED. Sample B,pert
Dgcr8 KO replicate 2,pert
6169 Wild Type Mouse White Adipose Tissue,ctrl
TREx_Flp_Scrambled_siRNA_1,ctrl
cell line: OVCAR-8;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
MCE301 cells treated with SB for 0 h-2,ctrl
brain_DLPFC_bipolar C_mr871,ctrl
rd1_P2_rep4,pert
T30162,pert
WT-Fibr1 7,ctrl
"brain, frontal cortex: Sample45_e1_le1",pert
ESE_D_489,pert
cell type: Human melanoma cell line;	cell line: M249;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
uterus_veh_WT_4hrs_rep2,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 54 yr;	population: white;	dsm-iv: 296.89;	age of onset: 45 yr,pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 48h, biological rep2",pert
Tak1_1,pert
1.25uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate C,pert
colon_CRC_1883,pert
scpk/WT/83,ctrl
"age at diagnosis: 56;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0;	er: 0;	pgr: NA;	dfs-month: 18;	dfs-event: 0;	distant metastasis: 0",pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: LPA,pert
agent: ConA;	time point: 3 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
"222, ADIPOOSE TISSUE, Before",ctrl
"NPTX1 shRNA Day 3, biological rep2",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 204,ctrl
"DMSO Control after 1hr, replicate 1",ctrl
"patient 042b, cancer, homogenized",pert
B3_saline_overexpressor_422,pert
118B,ctrl
cell line: SCC25;	tissue: tongue;	cell type: epidermal keratinocyte;	treatment: doxorubicin,pert
Cell line MCF-7_control_expt3,ctrl
"C57BL/6 mice, thymus and spleen pooled",ctrl
genotype/variation: Vax2-/-;	age: E16.5;	tissue: Whole eye,pert
cortex_WT_rep1,ctrl
BN control replicate 2,ctrl
CD19_selected_B-cells_after_R_rep1,pert
BC8 TC,ctrl
Differentiation of hES cells line SA01 towards neural rosettes;	Neural precursor phenotype,ctrl
MRL/MpJ heart left ventrical (LAD ligation 3 day),pert
Parkinson's disease sample x110,pert
"Deltoid, control, cohort 13, subject 13U",ctrl
11_0009C_Day1_22,ctrl
BxPC3_Ctrl_rep1,ctrl
XBP1s Tumor 1,pert
tissue: brain;	genotype: mutant Lis1 ko/cko;	age: E14,pert
Ileum_POR-null+quercetin_1,pert
siRNA Med12 + Estrogen [L2],pert
"Wild-type-neocortex, biological rep4 (male)",ctrl
colon_epithelium_IL10mouse_6weeks_rep3,pert
"Immortalized MEFs WB, v-src expression retroviral vector infected, rep3",pert
ubb_d21_wt_2,ctrl
"nTreg Foxo1 WT, rep2",ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 4h,pert
"alveolar macrophages, non-smoker 003",ctrl
E14.5 Tgfbr2 Wildtype Mouse Model Tongue 3,ctrl
Patient: H;	Time: 0;	Group: responder;	Condition: lesional,ctrl
cell line: BL2;	transfection: LEF siRNA;	batch: 1,pert
Strain: C57BL/6 wildtype;	P7,ctrl
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Rosiglitazone,pert
WT Non stim 2,ctrl
NPC22,pert
liver_male wt_rep3,ctrl
colon_C57 mouse_12weeks_rep5,ctrl
s3t0c,ctrl
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14532;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
0 hr KLF4 Time Course,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 14 months,pert
"Exp A, Animal #244, control (0mg/kg) D-Serine",ctrl
wild type CBA (sample1),ctrl
CD34+ cells with fenretinide treatment from CML32,ctrl
age_years: 55;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
cell line: DAOY;	cell type: medulloblastoma;	genetic modification: none (wildtype),ctrl
P14 - WTMixB 3,ctrl
RE550_H1650_un3,ctrl
HepG2_Cr rep3,pert
NSCLC cell line H157. Transfected with scrambeled control non-targetting oligomer siRNA - #1,ctrl
47A;pretreatment;female;breast tumor; responder,ctrl
09_PAH,pert
HT29 resistant cells replicate 2,ctrl
"HEK293 stably EWS-FLI1-transfected, BULK",pert
antimicroRNA-140_rep1,pert
Dengue Fever Patient 54,pert
ATL-1 - mAdbID:91501,pert
ATF2 WT-2,ctrl
"gene expression of CTCF-depleted oocyte, replicate 1",pert
tissue: Pancreas;	cell line: Panc-1;	treatment group: TGFβ Treated 48 hr,pert
Bl6_WAP_2,pert
mdx TA sample 1,pert
Severe rep8 (retina),pert
KU_30T,pert
A_AN16115_C,pert
Commercial RNA from normal cervix,ctrl
S002_Scz_M_82,pert
Control mouse 1,ctrl
Control ppar_beta_floxed_rep1,ctrl
Tia-1 122973 cerebellum 3 month,pert
SHANK3_2,pert
MF-45,pert
patient: 1;	disease state: hypertension;	tissue: Atheroma plaque,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 9.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 34;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
DMN-NF1Hippo28d-1bAv2-s2,pert
"Pten F341V epithelials cells, biological rep2",pert
MEF E2F4 KO 3-rep1,pert
KM_057N,ctrl
MDA-MB-231-pcDNA6 cell culture 2,ctrl
age: 24 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
WT - Cre Control - 5 mo - repeat 2 - Cy5 - mAdbID:74099,ctrl
"RISC-free control transfected, biological rep 3",ctrl
M_LS_Wk1,pert
S-IIP(NSIP)10_Cy3,pert
LNCaP.GFP.3,ctrl
MGP1,pert
"vector control cells, biological rep2",ctrl
CD positive WT T cell unstimulated rep3,ctrl
KU_48T,pert
ANL Chip#44,pert
"normal breast epithelium,1",ctrl
WT / Reference_13425676,ctrl
genotype: wildtype;	diet: high fat;	muscle hypertrophy: none;	sex: male;	tissue: liver;	treatment: doxycycline 3wks,ctrl
Native ko biological replicate 2,pert
reduction mammoplasty patient 350,ctrl
KO Ang4,ctrl
Sample 09 Kidney Hyp Mouse - Control Diet,pert
"human failing LV myocardium, Idiopathic63",pert
"human nonfailing LV myocardium, NonFailing1",ctrl
N30277,ctrl
ADH2,ctrl
PBMCs_Control_19 [IS],ctrl
Myoblast-GATA4-OE-day3-3,pert
Trim33-KD-SB-1,pert
MDS patient 54,pert
db/m 5-3,ctrl
AZ-521_doxycycline_24h_rep3,pert
affection: ADHD;	treatment: untreated;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 7 ADHD patients,ctrl
siERK2Veh4h_2650,pert
"breast, pre AF treatment (H12_1628)",ctrl
male_alcoholic_326,pert
Reference RNA e17.5 embryo,pert
Individual_4093_PN_sample,pert
age_years: 32;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
patient: 51628;	sample: tumor,pert
Diabetes 1a,pert
G_Ctrl_3,ctrl
Control_liver_5,ctrl
Control Braak α- synuclein Stage 0 C7SN,ctrl
shCON2,ctrl
"Testosterone treated, HIV-1 positive male, day 14 (1)",pert
chip number: 21;	transfection plate: 3B;	target gene: EP300;	kd level: 0.73;	rin: 9.1;	transfection date: 2012-03-26,pert
cell line: SV589;	knockdown (days): 8;	treatment: Serum Starved; 1h EGF,pert
Rsk2-KO Hippocampus - 2,pert
Normal PBMC Sample 6,ctrl
Normal cortex of patient 260,ctrl
Endometrium-Normal 4,ctrl
Braak α-synuclein stages 5-6  BR56_7SN,pert
neuron_rep13,pert
cell line: MCF7;	treatment: control,ctrl
M16 - infected MBT/Pas fibroblasts (9 h post inf),pert
15-0011A_Day1_38,pert
"DMSO-treated NRK-52E cells at 24h, biological rep 2",ctrl
DS-Fibr 4,pert
"AG825-treated, 24h after UV, Replicate C",pert
B6.IL10 72 O3 1,pert
Sex: female;	Age at operation: 67 years;	Site: thigh;	Size in cm: 35x15x12;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
JIA PBMC Post treatment A235_L003(2),pert
cDNA no 22,ctrl
SW480_ezrin RNAi_rep2,pert
P4,pert
WT tumor DNA III,ctrl
ShKdm2b replicate 1,pert
MDS patient 137,pert
1N,ctrl
"TMD_SOL, T5",pert
V5-P259,pert
T7C-LU,pert
"AG825-treated, 6h after UV, Replicate D",pert
"bipolar disorder, BA10-31",pert
Gastrocnemius Muscle_Cmah KO_mdx_rep2,pert
LIVER_diclofenac_repl4,pert
D2-Gpnmb+ control rep2 (retina),ctrl
"Wild type used for MAT1A 15 month, replicate 3",ctrl
"acutely admitted, severely psychotic schizophrenia patient  A10",pert
"A673 treated with Doxorubicin for 24 hours with concentration of 59.88 nM (EC50), biological rep3",pert
PGA-MAH-C3H_OVA6h-2aA-s2,pert
cell line: H295R adrenocortical carcinoma cells;	tissue: Cells derived from Adrenal gland;	agent: DMSO (control);	dose: n/a;	time: 3 hr,ctrl
Patient: K;	Time: 0;	Group: responder;	Condition: lesional,ctrl
MDS5,pert
Tendon_non-lesional_rep21,ctrl
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 31;	maternal age: 29,ctrl
"testis with regular spermatogenesis from orchiectomy cases due to prostate carcinoma, patient age: 67y",ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
1025-04-A,pert
"lymphoblastoid cell line from R, one out of seven of sensitive group, 50*10e6 cells",ctrl
"shBAP1 #1 cells, rep3",pert
PPAR KO_ctr_118,pert
HMEC X LN5,pert
WFS1 KO USHT_01_337_wt,pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 96 hrs,ctrl
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Epithelial Cell,ctrl
OSCE-17T,pert
3879-1 E2F WT,ctrl
GEIM197-PM,pert
"A673 treated with Puromycin for 24 hours with concentration of 0.09 uM (EC50), biological rep3",pert
H1993 shRNA Control _1,ctrl
"PCB153 treated HepG2 cells at T18, biological replicate 3",pert
chip number: 21;	transfection plate: 4;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-10-17,ctrl
tissue: Melanoma Lymph node Metastasis;	cell line: WM164;	treatment: DMSO,ctrl
colon_normal_1456,ctrl
CD4DecTp2-13,pert
NINDS-RHS-Ctr_72h-1aUA-s2,ctrl
V5-P281,pert
CKO V4,pert
bone marrow macrophages from 1 female and 2 male wild type Balb/c mice,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M2;	flt3 status: WT,ctrl
P14 - WTMixB 1,ctrl
C2 corrected_A2_tumor,pert
Parkinson's disease sample x036,pert
Muscle Tro2,pert
strain: C57BL/6J;	genotype: Homozygous Wild-type;	developmental stage: P15,ctrl
"brain, hippocampus: KA1-III_e1_le1",pert
tissue: spleen Ter19+CD71high sorted cells;	genotype: E2f8 KO;	age: 3-month,pert
strain: C57BL/6 * 129;	age: 3 wk;	tissue: whole heart;	genotype: Pitx2 Flox/Flox,ctrl
tissue: Frontal cortex;	age: 84;	Sex: F,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 39;	age of psoriasis onset: 7,pert
C032_Control_M_76,ctrl
ILD_9,pert
RI36,pert
Liver_untreated_HESKOL_rep3,pert
BTBR_Liver_rep1,pert
"WT BM LT-HSC, biological rep3",ctrl
"mortality: alive;	ethnicity: White;	gender: M;	age (yrs): 60;	ld: HCV;	creatnine: 1.3;	mdrd: 57;	gfr: 50;	protein: 0;	hematuria: 1;	c3: 1;	c4: 1;	rf: neg;	hcv: POS;	htn: 0;	dm: NEG;	hba1c: 5.1;	meld: 11;	ana: UN;	gp: ATN, mild IFTA, moderate arterisclerosis;	mm (mesangial matrix expansion): 0;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 1;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 1;	igm: 0;	c: 0;	empe: 3;	bmwid: 0;	bmd: 0;	edd: 0;	no of glomeruli: 12;	glomerulosclerosis: 0;	intact t: 0.7;	arteries: moderate intimal fibrois;	if: IGG+IGA+;	mesangium ig: A;	tissue: Kidney_Biopsy_Liver_disease",pert
01LLX_CTRL,ctrl
"genetic background: B6/129;	genotype: Tet2 KO;	cell type: Lineage negative, c-Kit and Sca1 (LSK) positive expressing bone marrow progenitors",pert
age: 15;	sex: M;	disease status: control subject;	Filter number: 82;	Usage number: 1;	Exposures: 3,ctrl
"E18.5 brain, wild-type, rep 2",ctrl
N30162,ctrl
mouse cerebellum at P30 wild type 1,pert
control participant P335,ctrl
VIN_B040,pert
Balb/c WT_3,ctrl
pediatric AML PP4,pert
C2C12 myotubes 0uM H202 rep1,ctrl
n9t30m,pert
aneurysmal tissue: sample #1,pert
Discoid Lupus-L9,pert
SBVGA1 3,pert
brain_DLPFC_bipolar C_mr532,ctrl
"Crohn's Disease subject (34 year old caucasian female, SAK_1288107729)",pert
01N0Y_Systemic,pert
Cpr-lox_pool 2,ctrl
S/SM4,pert
Snell 22 month Dwarf Liver 8dw,pert
VMH of WT-2 mice,ctrl
"liver, ATP7B KO mouse, sample KO903",pert
Human Non-progressor HIV Sample L004-CD8+ T cells,pert
cerebellum_wild type_18 month_replicate 1,ctrl
pre-iPSC- siRNA to Cbx3- biological replicate3,pert
"Pineal gland from control mouse at ZT6, biological rep 2",ctrl
TGFBeta Transcriptome Profiling,pert
"Gender: Female, Age: 28, BMI: 34, Tissue: luteinized cumulus cells",ctrl
BALB_Male_CF_rep2,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 1;	gender: male,pert
colon_CRC_1708,pert
Mouse E10.5 urogenital epithelium -/- #3,pert
brain knock out replicate3,pert
ATF2 Genotype: WT,ctrl
sample =XCGD4 treatment=Stimulated time=360 (min),pert
Tissue: normal thyroid; Gender:female; Age:65,ctrl
Panc-1 TGFβ Treated 3 48 hr,pert
Septic shock;	gender: Male;	Survivor;	organism: None;	organism class: None,pert
29SAGEA,pert
"Patient G, uninvolved skin",ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 8.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 47;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
21GOBMUC2H,ctrl
"array 22, xenograft, abiraterone 75 mg/kg/d",pert
KM_057T,pert
parental cell line: WA;	vector: pBabe-human v-src (v-src vector);	replicate: 2,pert
Vit-KO,pert
ct-1,ctrl
patient: 14;	disease state: hypertension;	tissue: Atheroma plaque,pert
Atxn1L HSC 2,pert
"A673 treated with Doxorubicin for 5 days with concentration of 59.88 nM (EC50), biological rep2",pert
Pancreatic Sample 32-Tumor,pert
Control6,ctrl
"CBFb-SMMHC animal 2, replicate 1",ctrl
"Cell type: endothelial, age:19, gender:male, diagnostic group: schizophrenia, PMI:28h",pert
"344SQ with PIK3CA shRNA, replicate 1",pert
19SAGEA2,pert
NuLi cell line treated at DMNQ biological rep1,pert
cumulus_nonPCOS_Lean_rep3,ctrl
original diagnosis: PolyRF-;	cell type: Peripheral blood mononuclear cells,pert
male_control_339,ctrl
age: 49;	sex: M;	disease status: Marfan subject;	Filter number: 92;	Usage number: 5;	Exposures: 3,pert
MA_19,pert
12h PTD-DRBD GAPDH siRNA (SAMPLE 3),pert
NS5-040401-SA,ctrl
LT 410 +/T after nicotine-induced seizures,pert
Genetic background: mixed 129 and C57BL/6J; Age: 6 weeks old; Gender: female; Diet: chow; Non-fasted; Genetic modification: Scd1 -/-.,pert
strain: C57BL/6J;	day: 1;	drug: Heroin;	phase: Drug treatment;	tissue: striatum;	replicate: 2,pert
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: DMEM,ctrl
Gastrocnemius Muscle_Cmah KO_rep1,pert
MacularDegen-healthy-9aAv2-s2,ctrl
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 63,ctrl
siHic5_2_0h_3,pert
Control 9,ctrl
RE550_H1650_un2,ctrl
AVC_mutant_rep2,pert
cell line: BaF3;	infected with: MPLW515L3;	pretreated with: 0.8 uM INCB18424 for 4 wks (Persistent);	treated with: 0.8 uM INCB18424 for 4 hrs;	sample type: persistent,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 3,pert
"HepG2 cells at T18 Control, biological replicate 3",ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_2h_4mM_HG-U133A_2_YCHSUP501,pert
strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue: gallbladder,ctrl
agent: ConA;	time point: 6 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 35;	sex: M,ctrl
PGA-RMM-72h-2aA-s2,pert
treatment: shVEGFR-2;	cell line: U138MG,pert
Control Endometrium Stromal Cell_029.UC208-+,ctrl
Human.AT.CP.FCU,pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 36;	Usage number: 4;	Exposures: 3,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient B;	treatment: DMSO for 48h,ctrl
aa_NY218,pert
"RWPE-PCAT1 cMyc siRNA #3, replicate 2",pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 31;	maternal age: 29,pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 168;	colon ratio (mg/mm): 2.82;	myeloperoxidase activity (u/mg): 1.157;	tissue: colon;	treatment: 5% DSS,pert
siRNA Control Duplicate 2,ctrl
"Heart, MAT1 control, 2 wk, sample 2",ctrl
PLT-n7-2; normal plantaris 7 month,ctrl
RNA from HCC_26T,pert
colon_Runx1-WT_Cy3_15550,ctrl
Patient no. 17: treated,pert
T12,pert
Wild Type Control Set A,ctrl
V5-P401,pert
whole tissue section from case 374,pert
SNRK_2,pert
E16.5 top2b-/- brain,pert
CME-LaminA4d-2MA-S2,pert
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: knockdown control,ctrl
"Crohn's Disease subject (33 year old caucasian male, SAK_1260857762)",pert
"Mkl2-/-, sample 2",pert
db/m 3-1,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 95min;	race: White;	sex: Female,ctrl
MDS patient 68,pert
patient: 217;	current medication: Asacol 1.2g daily;	birth date: 2/9/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/10/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/26/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/26/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
Endometrium/Ovary-Disease 5,pert
"normal skeletal muscle, biological rep13",ctrl
MO_CTC_SON_NCBI,ctrl
ccRCC tumor of patient T79,pert
MBD2_2,pert
mdx TA sample 2,pert
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: DMSO 24 hr,ctrl
"Exp A, Animal #254, 200mg/kg D-Serine",pert
Wildtype H9 hESC derived NSC 2,ctrl
"Placebo treated, HIV-1 positive male, day 14 (2)",ctrl
Advanced IPF_explant_upper lobe_rep152,pert
A549 DAC 0.3 uM (3218),pert
A_AN09730_F,pert
strain: C57BL/6J;	day: 15;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 3,ctrl
TTF=156min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
FR-si222-2,pert
gender: female;	age (years): 50;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
"twin pair: #3;	individual: diseased individual, inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",pert
phenotype: control;	gender: male;	case_id: 211;	age: 50;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 29;	brain ph at time of freezing: 6.68;	labeling_batch: 2,ctrl
WT - Cre Control - 3 mo - repeat 1 - Cy3 - mAdbID:74587,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_24_25_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
U937_ROS_untreated_4h_rep1,ctrl
11098 UC Uninflamed descending colon,pert
TTP_KO_60ActD_BioRep5,pert
tissue: white blood cells;	age: 12;	Sex: male,ctrl
No or early 2 rep4 (retina),pert
miR122-KO-91,pert
tissue: Peripheral blood;	disease status: patient without recurrent events,pert
E14 cells_Zfp322a RNAi-rep2,pert
Brain area 8/9 from two 8 year-old girls suffering from Rett Syndrome.,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.265;	OD280: 1.203;	Ratio: 1.85;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 144;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Donor4_24h_DMSO,ctrl
L428+M_rep1,ctrl
"Exp A, Animal #253, 200mg/kg D-Serine",pert
"DMD skeletal muscle, biological rep16",pert
gender: male;	individual: patient 2;	treatment: control,ctrl
A3243G-MELAS subject 4,pert
age: 7 weeks old;	strain: C57Bl/6;	phenotype markers: CD4+ Foxp3+ CD25+;	separation method: FACSAria;	Sex: Female,pert
512MM,pert
El-Ashry 005.CEL,pert
"brain, hippocampus: PH1_e1_le1",pert
RV63.03_CONTROL_day19_Slide34,ctrl
P3,pert
Control5,ctrl
"Jurkat cells stably transfected with shRNA constructs (si1340) against LEDGF transcript (PSIP1 gene), derived from Jurkat si1340JK Cl-2 which was established and described in LLano et al. (2004). J. Virol. 78 (17):9524-9537.",pert
X_p8_rep2,pert
"WM1205, 48h treatment with 5 AzadC",pert
mammary stoma-4w-wt-rep1,ctrl
"breast tumor epithelium,31",pert
scpk/ikLL/192,pert
tissue: retina;	age: postnatal day 8;	genotype: wild type,ctrl
NB4 CONTROL 3,ctrl
Sex: female;	Age: 12;	SL: 5.31;	House: 6;	Severity: SM;	Ashworth: 3;	Zancolli: 2A;	PEFF: 85;	PESF: 85;	AEFF: 55,pert
BIO586218,ctrl
Subject 8_t=30days_resveratrol,pert
DMSO Control 1,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L003,ctrl
gender: male;	strain: SV129;	tissue: heart;	genotype: PKCZ -/-;	age: 32 weeks,ctrl
multiple myeloma (MM 501),pert
CD4+_Tcells_healthy_donor_6,ctrl
01LNH: normal control,ctrl
10 days sham-3,ctrl
A61 WT2	F6/21	A61	wild type	Mouse	8 months	Cerebellum	Male,ctrl
connective tissue,ctrl
strain: C57 BL6NCr;	tissue: Distal colon,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 2x1h exposure per day",ctrl
brain_DLPFC_bipolar C_mr546,pert
CLL11-CD8,pert
ASC_lean_biological rep1,ctrl
"Wild-type HFD 8 weeks, biological rep7",ctrl
sample =XCGD5 treatment=Control time=0 (min),pert
KU_21T,pert
liver_control_diet_rep1,ctrl
disease state: healthy;	group: baseline,ctrl
Age: 36;	Sex: M;	Ancestry: European;	Smoking status: non-smoker,ctrl
V5-P421,pert
SZ21,pert
SIRT4 KO liver_7236-2,pert
"BMMs, untreated control, ko, Replicate 1",pert
"brain, adrenal medulla: Sample#A3 (Exp pt 3)_e1_le1",pert
Wtc-Met_1,ctrl
brain_OFC_bipolar B_mr221,pert
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep6,pert
Liver of pup from control group rep6,ctrl
SKBR3_Control_3,ctrl
WT8,pert
wild-type anterior prostate 3,ctrl
"Hdh knock-out embryonic stem cells, biological replicate 6",pert
"Affymetrix chip HG-U133A, siPTHrP 1",pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #1.,pert
race: caucasian;	age (years): 85;	stage: IB;	grade: 3;	histology: endometrioid,pert
CLL 141-08 LMP-420,pert
treatment: 12 weeks of RTX therapy;	gender: M;	age (y): 44;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
Pediatric_GBM_46,ctrl
tMLL06,ctrl
cell line: V6.5;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 7,ctrl
ccRCC tumor of patient 233,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: B;	transfectant type: stably transfected with RNAi against DJ-1,pert
"RES-enriched Grape extract group, 6 months, patient number 51",pert
BL Day 2 siMut12 transfected biological rep2,pert
11436 UC Inflamed descending colon,pert
"Healthy volunteer, Control_11690",ctrl
human_LIMA_artery_patient2_control,ctrl
CME-Emerin4d-1MA-S2,pert
HNF4 Null_1195,pert
patient: 40975;	sample: normal,ctrl
genetic modification:;	tissue: breast adenocarcinoma,ctrl
"Sfrp5 KO HFD 8 weeks, biological rep7",pert
Strain: Top2b+/+ in 129SvEv (minor 129SvJ) background;;	Age: E16.5 embryo;;	Gender: male;;	Tissue: whole brain,ctrl
Subject #8046-Preinfection,ctrl
LY2 SRC1-siRNA untreated rep3,ctrl
sample =Healthy3 treatment=Stimulated time=180 (min),ctrl
"patient: 212;	current medication: Pred 10mg, AZA150mg, ADCAL D3;	birth date: 8/3/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/97;	diagnosis date: 9/1/01;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 11/9/04;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 0;	igr2198: 11;	igr2230: 12;	octn1: 11;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/9/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
"brain, hippocampus: C1-III_e1_le1",ctrl
11398 Normal Uninflamed sigmoid colon,ctrl
OSCE-11T,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 30;	gender: male,ctrl
"Dicer lox/lox control, biological rep1",ctrl
"Deltoid, control, cohort 21, subject 21U",ctrl
Megacaryocyte-Erythrocyte Progenitors,pert
KO - knock-out Treated - 0.5 hrs - repeat 1 - Cy3 - mAdbID:62496,pert
chip number: 19;	transfection plate: 3A;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2012-03-26,ctrl
Cervical cancer_98-04T,pert
FGF21KO.DMSO_4,pert
parental cell line: WC;	vector: pBabe-human v-src (v-src vector);	replicate: 2,pert
Healthy1-CD4,ctrl
PGA-RMM-Ctr-1aA-s2,ctrl
"Control 04, NC04",ctrl
WT-PBS_rep-3,ctrl
cell line: HEK293;	sirna: hCdc73;	condition: confluent cell density,pert
GAS-t10; transgenic gastrocnemus 10 month,pert
ACC 3 cell line Sox4-RNAi replicate 1,pert
ND_4,ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_L027,ctrl
tissue: normal skin;	urticaria status: non-afffected;	patient: 15,ctrl
PGA-HMO-MObese-2aUA-s2a,pert
CON27,ctrl
cerebellum_wildtype_1,ctrl
MCF7_EtOH_24h_rep2,ctrl
"wild type, prenatal stress, biological rep1",pert
batch: B;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,ctrl
Liver sample from Alcoholic hepatitis group (CA22),pert
skin.wt.replicate29,ctrl
"male, healthy, no medicamentation",ctrl
strain: C57BL/6;	tissue: Skin;	cell type: keratinocyte;	gender: female;	age: E18.5;	genotype/variation: Ovol1 KO;	treatment: calcium,pert
"Crohn's Disease subject (52 year old caucasian male, SAK_1280775705)",pert
WT mouse 3_heart_basal,ctrl
8 week old wild type mice spleen,ctrl
NS1,ctrl
"mouse strain: C57B/SV129;	genotype: Nrf2 wt;	tissue: mouse liver, 10 weeks",pert
01UPE_Systemic,pert
patient3,pert
CLL4-CD4,pert
Tobacco_abuse_4,pert
Healthy control 13,ctrl
"Liver from Nrf2 k.o. mice, biological replicate 3",ctrl
"Crohn's Disease subject (33 year old caucasian male, SAK_1280753352)",pert
uterus_veh_WT_40hrs_rep1,ctrl
Ifng-/- biological rep 1,pert
Tia-1 122970 cerebellum 3 month,pert
Cells:U-33 cells stably transfected with a PPARg2 expression construct (U-33/g2 cells);	Time: 72 hrs;	Drug: No Rosiglitazone present,pert
"N-56, NORM, M, GSF, 1 x 100nM DHT, 24h",ctrl
platelet_sickle_4,pert
"wildtype (GFP-negative) kidney cells, biological rep2",ctrl
01N3H_ERA,pert
A HID U_B084,pert
2008 cells_rep3,ctrl
Non-transgenic mouse rep 1,ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle/giant cell;	matched/unmatched: unmatched,pert
KM_009T,pert
MCF-10A sh53BP1-2 replicate 2 [set 5],pert
n3_hi_12,pert
FVB_skin_5dpn_1,ctrl
ESE_D_27A,pert
"BMDM, Tpl2 WT, unstimulated, biological replicate 2",ctrl
Adrenal CREMKO 0h batch 2 [AdKOh00.16],pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: n/a;	maternal age: n/a,ctrl
"8 wk old BALB/c (or BALB-RAG) mice were sensitized to ovalbumin (or PBS)]on days 1 and 7, and challenged with aerosolized ovalbumin (or PBS) on days 15-21, and samples harvested on day 22",ctrl
monolayer chondrocytes from OA donor 1,pert
TOV112D cells_untreated_biological rep2,ctrl
Subject #8034-8hr Postinfection,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 21.123;	Ratio: 2.13,pert
HF1227_U133P2,pert
Wild type caerulein rep3,pert
"Patient W, lesional skin",pert
patient11,pert
P14 - Lis1ko/+ 1,pert
"Lesion Skin, LS-3",pert
"array 26, xenograft, corn oil vehicle",pert
Cancer 22,pert
t04,pert
cell line: HL-60;	shRNA construct: GSK3A Construct 6,ctrl
2091N,ctrl
genetic background: C57BL/6;	gender: male;	cell type: primary murine fibroblast-like synoviocytes (FLS);	genotype: human TNF transgenic and knockout in Rsk2 gene (Rsk2-/y FLS);	flow cytometric cell sorting: CD90.2pos/VCAM1pos/CD11bneg,pert
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: High fat diet,pert
Cardiac Progenitor WT3,ctrl
GEIM80-PM,pert
Substantia nigra normal rep4,ctrl
"C57BL/6J ACU, Rep1",pert
MiaPaCa2 pCEP4 clone 5,ctrl
liver_STZ treated diabetic_rep3,pert
M473 SKM-Tg,pert
"MCF-7 transfected with pcDNA3.2-BP1, rep.1",pert
pSuper vector control 2,ctrl
V5-P598,pert
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 3;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
age: 21 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,ctrl
SM12,ctrl
"BMMs, untreated control, da, Replicate 2",pert
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case1,ctrl
"Retina from NeuroD1 cKO mouse at ZT6, biological rep 1",pert
EBS_1,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 14 months,ctrl
AGS cells - Celecoxib treated biological rep 1,pert
"Transgenic, snap frozen, extensor digitorum longus muscle, 10 month age animal",pert
"SKI-DLCL cells untreated, cultured for 24h, total RNA was isolated using RNeasy kit",ctrl
A SIT_B099,pert
MDS2,pert
GM19238_Kd_POU2F1_1,pert
"age at diagnosis: 71;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1c;	er: 1;	pgr: 1;	dfs-month: 36;	dfs-event: 0;	distant metastasis: 0",pert
"patient: 114;	current medication: None;	birth date: 6/27/36;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Altered bowel habit, Alcohol excess;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
"Male, 36 years old, HIV infection of >1 year",pert
10 days TAC-2,pert
SUBSTANCE P 4 HOURS,pert
"IKK2 -/- cell line, biological replicate 1",pert
Csbm/m Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-4,pert
"N-33, NORM, M, GSF, 6 x ETOH, 14d",ctrl
homozygous_TGFb_4hr_2,pert
ndf control 2,ctrl
"WT in the presence of tetracycline, rep2",ctrl
BS2011051059,ctrl
"Gender: female, Age: 54 years, Tissue: normal vulva,",ctrl
SON siRNA rep1,ctrl
cont_OO12,ctrl
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 1",pert
ccRCC tumor of patient T22,ctrl
Tolerizing allografts 7 days No.1,ctrl
MB231 PIAS1 shRNA-DMEM,ctrl
Biceps_Pompe_3,pert
Liver_Female_CF_rep3,pert
WT-smoke-med-1 day-R3,ctrl
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. vehicle (ethanol) + 1 uM vehicle (ethanol) for 24hr;	batch: 1,ctrl
VEC C,ctrl
ubb_d28_ko_2,pert
MF-31,pert
APLP2_R1_rep3,pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: control siRNA;	agent (treatment): R1881,ctrl
age_years: 40;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/wt, Foxp3-ires-Cre;	gender: male;	age: 16 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",ctrl
"patient 006b, normal, homogenized",ctrl
GFP Replicate A,ctrl
whole tissue section from case 1205,ctrl
"G42 cells from M1, Mecp2 null, biological replicate 2",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
C57BL/6J-ob/ob;	Liver ;	Age: 14 weeks;	Gender: Male,ctrl
STAT3-deficient naïve T cells stimulated for 3 hours with medium alone 2,pert
"brain, Entorhinal Cortex: 96-31 normal_e1_le1",ctrl
whole tissue section from case 763,ctrl
OA3,ctrl
Disease_status: Down syndrome;	Age (years): 52;	Gender: Male;	Post mortem interval (hours): 24;	Braak stage: VI;	Cause of death: Bronchopnuemonia,pert
Donor3_24h_DMSO,ctrl
"Ulcerative Colitis (57 year old caucasian male, SAK_1285291011)",pert
asthma_saline_3,ctrl
@52055800697862121408403718160409,ctrl
Colo-205 PLX Day 10,pert
con-52_C,ctrl
O_LS_Wk4,pert
Liver vehicle rep1,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 44 yr;	population: white;	dsm-iv: 296.74;	age of onset: 26 yr,pert
"human failing LV myocardium, Ischemic63",pert
OA 1,pert
liver_Akt1+/-_8wk_rep1,pert
"H69 tumor untreated, biological rep1",ctrl
patient: 257;	current medication: 6MP 50mg;	birth date: 5/16/64;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/2/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/2/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 2/1/05;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
"KM-H2 PTPN1 Knockdown, technical rep1",pert
"amnion mesenchymal cells, 1h interleukin-1-beta, biological rep2",pert
colon_epithelium_IL10mouse_12weeks_rep2,pert
No_abuse_6,ctrl
adult male,pert
Shn2_Wildtype_1,ctrl
age: 50;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"control, BA10-4(2)",ctrl
KCL-22 non-treated,ctrl
"wild-type control (littermate) of ""P16_exPKO_pancreas""; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #1.",ctrl
Kidney_saline_1,ctrl
ns DHT 1,ctrl
"D425-shOTX2_1, t=0",pert
retina_DBA_1024L_3mo_rep1,ctrl
array 2 plus E,ctrl
AZ-521_uninduced_12h_rep2,ctrl
1119-03-A,pert
Strain: C57BL/6;	Gender: female;	Age: 110 days;	Tissue: mammary tumor;	Days after tumor onset: 14 days,pert
ErbB2  3,pert
"Pancreas from adult Rkip-1 KO mice, biological replicate 2",pert
180D6,pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: siRNA targeting FOXP1;	genotype/variation: siRNA-mediated FOXP1 knockdown,pert
disease state: paediatric glioblastoma;	age: 7;	gender: F;	h3.3_status: wt,ctrl
GEIM133-U133A-Norm,ctrl
THRA aI mutant + vehicle replicate 2,pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: STZ and Rosiglitazone,pert
"liver, ATP7B KO mouse, sample KO905",pert
E16.5 wt2,ctrl
Control subject 33_biological replicate 1,ctrl
"MAT1A knockout at 15 month age, tumoral tissue, biological replicate 3",pert
cell line: NCI-H1299;	cell type: lung cancer cells;	transfected with: control hairpins targeting GFP,ctrl
4121-1 E2F1 Null,ctrl
"Nickel 40 µM, biological rep4",pert
"SIRT3KO, high-fat diet, rep3",pert
Untreated Control 12weeks AffyGC RMA rep2,ctrl
ku86(wt)_Terc(wt)_1,ctrl
"110, ADIPOOSE TISSUE, After",pert
brain_DLPFC_bipolar B_mr953,pert
Bone-Marrow_SMM_S1530,pert
LPS-PVH3_1,pert
BM_02347,ctrl
Clozapine treated 12weeks AffyGC RMA rep3,pert
Vehicle-Control;	Vehicle-Control 24 hours set 2,ctrl
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1tetO-Nanog/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: esophagus,pert
Kidney_saline_2,ctrl
Ppif-/- heart 1,pert
PBMCs_IS_20 [IS],pert
protocol: control,ctrl
array 9 minus E,pert
"testis with regular spermatogenesis with status after vasectomy, patient age: 34y; W03 020",ctrl
Nrl-ko-Gfp 4 weeks replicate 4,pert
GIST Pre Treatment Biopsy 45,ctrl
strain: C57BL/6;	tissue: cerebral cortex;	age: E14;	gender: not determined;	genotype: Trnp1 knockdown,pert
PGA-RMM-12h-2aA-s2,pert
WT biological replicate 2,ctrl
Control with WY14643 replicate 5,pert
subject: 31;	disease: TD;	muscle: GR;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
HF1551_U133P2,pert
Globin_S4,pert
2 Ctrl 2,ctrl
THRB bN mutant + vehicle replicate 2,pert
14 olanzapine,pert
Strain: NMRI mouse;	Age: 14 day embryo;	Tissue: molar tooth germ,ctrl
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14474;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
Liver_Wild Type+Quercetin_2,pert
PBMC from T cell LGL leukemia patient #104 (TLGL104),pert
CLS14_T4_PP_day3_058,pert
Patient: E;	Time: 0;	Group: responder;	Condition: lesional,ctrl
pool of thyroids from 6 months old RET-PTC transgenic mice,pert
liver_male wt_rep1,ctrl
AP-2 gamma targetting siRNA 3: CCACACUGGAGUCGCCGAAUA Technical Replicate 2,pert
DBA_6h_Wy,pert
"S1P3-KO-neocortex, biological rep4 (female)",pert
chip number: 23;	transfection plate: 4;	target gene: GTF2B;	kd level: 0.53;	rin: 9.8;	transfection date: 2011-10-17,pert
PsOEt-14-Week 2,pert
CON26,ctrl
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 16",pert
healthy control sample x182,ctrl
Cont subject 02,ctrl
BCR/FGFR1 biological replicate 1,pert
U-87MG-V8 set 2,ctrl
"ALL_NDS, K34 011409",ctrl
KO_IL-6_100_rep2,pert
SHR16-2,pert
N4,ctrl
CD4DecTp2-10,pert
ANL Chip#42,pert
AGS control biological rep 1,ctrl
MA_237,pert
Trained diabetic 1 week DT1,pert
TA-n10; normal tibialis anterior 10 month,ctrl
kidney_Q10_14M_rep3,pert
cell line: Embryonic kidney cell line HEK;	genotype/variation: WT channel;	agent: tetracycline,ctrl
Nuclear RNA_KO_rep3,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 63 yr;	population: white;	dsm-iv: 296.89;	age of onset: 43 yr,pert
brain_DLPFC_bipolar B_mr946,pert
cell line: U-87MG;	treatment: parkin,pert
genotype/variation: ACTL6a knock down,pert
ILD Study Number S032,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 2 days adipocyte differentiation,ctrl
Hereditary gingival fibromatosis(HGF) patient Gingiva replicate2,pert
HP-87,pert
"RNF40 siRNA - 5 days adipocyte differentiation, rep2",pert
"vector d4, rep 7",ctrl
DS1-iPS 4,pert
TLW18_T3_PP_day1_015,pert
24h_c4,ctrl
"CBFb-SMMHC animal 2, replicate 2",ctrl
"MTDH knockdown, biological replicate 2",pert
"AALE-Vector + shTBK1, biological rep3",pert
VMM-WT_MyoD24h-2MP-s2,ctrl
siRNA Med12 [K2],pert
"Crohn's Disease subject (51 year old caucasian female, SAK_1287951234)",pert
23 weeks female,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_24_40_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
Disease_status: Bipolar disorder;	Age (years): 31;	Gender: Male;	Age of onset (years): 21;	Duration of illness (years): 10;	Brain pH: 6.3;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: 30000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 5;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 6,pert
Control + LPS 1,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 41, stage IIIB, HPV 16",pert
Sample ID:DCBD2.1;	Twin Pair ID:TP7 ;	Clinical Status:BD1 with psychotic features ;	Age of Onset:19 ;	Age at interview & blood sampling:20 ;	Current Age (2007):24;	Sex: Male ;	Medication at interview (duration) :lithium & olanzapine (64 weeks),pert
"Crohn 07, CD07",pert
P328L329_del6a-,ctrl
genotype/variation: control,ctrl
"MTDH control, biological replicate 3",ctrl
MZ1774 mock rep 3,ctrl
HeyA8+(3),pert
Dengue Fever Patient 41,pert
umbilical cord_nobpd: 2G,ctrl
Oga_KO_MEF_E7_rep2,pert
Squamous cell carcinoma 025,pert
"S1P2-KO-hippocampus, biological rep3 (male)",pert
"DMSO-treated NRK-52E cells at 24h, biological rep 1",ctrl
"Ring1B deficient ES cells, biological replicate 1",pert
cell line: COLO829 melanoma cell line;	genotype/variation: control;	agent: control,ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 67 days;	subject: Mouse1;	genetic background: BALB/c,pert
RatLung_H48h_2,pert
"KO liver, biological rep1",pert
subject: 15A;	cohort: 15;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 28kb;	age (y): 66;	Sex: M;	batch: Batch_5,pert
"Patient 4, Atheroma plaque",pert
Hippocampus_Soman_24h_rep2,pert
HeLa_06_21_04 TP-9,pert
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_5;	fev1 (% predicted): 44;	fvc (% predicted): 61;	medication: Prednisolone 5mg od,Montelukast 10mg od,Symbicort 400/12 2pbd,Omeprazole 20mg od,Uniphyllin 400mg bd,Bricanyl prn;	cell type: CD4+ T-cells",pert
PFC FVB/N control 2,ctrl
"brain, hippocampus: Aldh5a1-/- #3403 Cort_e1_le1",pert
Tolerizing allografts 70 days No.1,ctrl
11393 Normal Uninflamed ascending colon,ctrl
cell type: prostate cancer cell;	cell line: LNCaP;	transfection: empty vector,ctrl
Liver Control 1,ctrl
Sham 4,ctrl
"Neuroretina 8-week diabetic, Biological replica_4",pert
MEFs-4,ctrl
"brain, cerebellum: RNA#11*_le1",ctrl
healthy control sample x177,ctrl
GBM_differentiation_4 days_2,pert
BxPC3-KO111 rep 4,pert
5A;pretreatment;female;breast tumor; responder,ctrl
Psoriasis-Patient-L,pert
Infergen_24hr_rep2,pert
age: 55;	gender: female;	ejection fraction: 31;	left ventricular end diastolic diameter: 61;	inflammation/PVB19: positive,pert
age_years: 54;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
MOLM14_luc_Replicate2,ctrl
genotype: Male;	age: 15 years adolescent male,ctrl
HDAC2 WT E17.5 Ventricle 1A,ctrl
WT-control-5,ctrl
cell type: lymphoblastic leukemia;	gc resistant: TRUE;	treatment: GC,pert
Healthy control_sample13,ctrl
"Crohn 05, CD05",pert
Pediatric_GBM_22,ctrl
PC-3_overexpresshTERT_LongTelomeres_LhTERTL_2,pert
Ad-rep3,pert
strain: C57BL/6J;	genotype: APOE-deficient;	tissue: aorta;	treatment: none;	disease: atherosclerosis;	age: 32-34 weeks,ctrl
S3_sham_overexpressor_12,pert
MLL_00117,ctrl
U2OS shCHK1-3 replicate 1 [set 4],pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 2;	psoriasis duration: 7.0;	age of psoriasis onset: 41,pert
patient: 2;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
INS-1,ctrl
U2OS_PRC_shRNA4_pLenti_2,pert
pediatric AML S33,pert
Aged 4,pert
Liver GPR120KO ND #720,pert
GM19238_Kd_BATF_1,pert
"NPCxhIPSC CON, replicate 3",ctrl
mdx diaphragm sample 2,pert
WT 4,ctrl
C2C12 myotubes 0uM H2O2 rep4,ctrl
Fetal heart control 7,ctrl
"patient: 101;	current medication: Paracetamol;	birth date: 10/5/63;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: Weight loss, altered bowel habbit.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",ctrl
P60_TR_1,pert
SW1736_t1h_rep2,pert
NPC16,pert
"ALL_DS, K15 011509",pert
"H69 tumor post-PDT, biological rep3",pert
H69_Ctr_5,ctrl
"Wild type epithelials cells, biological rep1",ctrl
genotype variation: Nrf+/+;	treatment: air;	developmental stage: neonate,ctrl
[Aiolos]-1,pert
Normal Adrenal Gland (AN11),ctrl
"39B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
n11t0h,pert
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle cell;	matched/unmatched: matched to N16,pert
sample description: pool of total RNA from 10 human cell lines,pert
"19B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Cutaneous psoriasis without arthritis PsC 14,pert
Conditional Sample 2,ctrl
Ls174T-pTER-β-catenin con2,pert
strain: C57BL/6;	tissue: liver;	gender: female;	age: 8week,ctrl
XBP1s_Tumor,pert
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 3,ctrl
"genetic background: B6/129;	genotype: Tet2 KO;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor Low CD34 positive expressing bone marrow progenitors CMP",pert
con_B004,ctrl
"ERRa ko baseline heart, sample 2",ctrl
KO - knock-out Untreated - 0 hrs - repeat 3 - Cy3 - mAdbID:51962,pert
KM_065N,ctrl
T-REx293-NPAP1-uninduced-3,ctrl
age_years: 66;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
IFN-WT,ctrl
normal adjacent esophageal tissue from patient E1709,ctrl
siLRH-1_#2_rep_3,pert
Brg1 mutant 2 cell embryo rep4,pert
Cre_day_5-5,pert
Chondrogenic progenitor cells from OA male 3,pert
whole blood_101074,ctrl
Bronchial Epithelial Cells SA biological 1628Z,pert
WT - Cre Treated - 24 hrs - repeat 3 - Cy3 - mAdbID:54725,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-sp1,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 46.25205,pert
AA_Case4_CD8,pert
shCDK8_Time_30_2,pert
"siPRMT1 neuron, biological rep2",pert
Time:4 day; condition:ctr;,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 47.74521,pert
#2,ctrl
695_383_2hr_repeat,pert
S034_Scz_F_70,pert
TG MEP 2,pert
treatment: atRA + cycloheximide;	genotype: WT;	cell line: F9,pert
M229_B_DMSO,ctrl
"Patient 113, baseline",ctrl
strain: C57BL/6;	treatment: Cebpa knockdown;	cell type: lineage-negative marrow progenitors,pert
spleens from mice on C57/Bl6 x 129 Sv background,ctrl
C_Ctrl_3,ctrl
strain: MBT/Pas;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: infected,pert
"fibroblast, MFS subject GDO32 rep 1",pert
V5-P535,ctrl
siLRH-1_#2_rep_1,pert
Huntington's disease 820E,pert
435_CreER: mutant mouse 2,pert
Embryonal carcinoma 1838,pert
"Cervical cancer cell line, HeLa, adenocarcinoma",pert
Ishikawa_VeryLowDose_BPA_8h_rep1,pert
background mouse strain: C57BL/6;	source: white adipose tissue;	genotype: Rap1 knockout,pert
"BMDM, Tpl2 WT, unstimulated, biological replicate 1",ctrl
"age: Embryonic day 14.5;	genotype: wild type (WT);	tissue type: fetal liver;	strain: b6, 129 mixed background strain",ctrl
jejunum_control_1,ctrl
Intestine_Ctrl_biological rep3,ctrl
liver western diet 0.05% quercetin rep4,pert
patient code: 117;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,ctrl
Prostate-specific Pten deletion anterior prostate tumor 3,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: PMA,ctrl
Gene expression profiling of Phgdh knockout embryo KO1,pert
monocytes_T14_rep1,pert
KO MEF 1,pert
age	69;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	8.2;	leukocyte count (/nl)	9;	hemoglobin (g/dl)	14.3;	platelet count (/nl)	283,pert
cell line: BL2;	transfection: LEF siRNA;	batch: 3,pert
Hippocampus 2004 2 month Old,ctrl
"HSCs from female mice treated with E2, replicate 3",pert
Subject 2_t=30days_placebo,ctrl
Control ppar_beta_floxed_rep2,ctrl
Sample M548,ctrl
PsOEt-21-LS,ctrl
NESG1-overexpressed 2F4-5-8F NPC cells rep2,pert
"Mouse heart, IDH2 R140Q mutant, replicate 2",pert
ES_Suz12KO_rep1,pert
ESE_N_664,ctrl
tissue: whole blood;	disease state: global developmental delay and autistic features,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 10 nM;	treatment time: 24 hours,pert
cell line: H1299 lung cancer cell line;	genotype/variation: RBP2 depletion;	shRNA: RBP2 KD2,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 65 years,ctrl
Braak α-synuclein 3-4 BR34_4SN,pert
Septic shock;	gender: Female;	Non survivor;	organism: Staph aureus,pert
Control Day0 (425L),ctrl
5871841165_F,pert
Mut+/+ rep2,ctrl
HeLa cells transfected with siSp1 rep 2,pert
"MCF7/BUS, 10 pM E2, 48 hours, biological replication 4",pert
MCF7_siRNA_ESR1_24h_AM0009_9.1,pert
"Control, biological rep. 1",ctrl
Gsk-3b-/- ESCs Rep3,pert
pRb+/+.1,ctrl
pre-iPSC- siRNA to Cbx3- biological replicate1,pert
cDeaf,pert
Grhl2 downregulation in MLE 15 cells 2,pert
ES2 NT-4 25nM,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 8d ID65,ctrl
"GM9023, unaffected brother",ctrl
LUC 20 KD #2,ctrl
HL60_shSYK_1_Replicate1,pert
Patient: F;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
"patient 033b, cancer, homogenized",pert
"Peripheral blood, patient without recurrent events [N37]",pert
Mut_P_1,pert
strain: C57BL/6;	cell type: MACS-purified mature B cells;	genotype: irf4-/-,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 30.0411,pert
Cervical cancer_CC128,pert
"fibroblast, MFS subject FB1211 rep 1",pert
brain_OFC_control C_mr202,ctrl
monolayer chondrocytes from normal donor 3,ctrl
sample =Healthy2 treatment=Control time=180 (min),ctrl
Mammary Gland_Cav-3KO_rep3,pert
X50 NLS 18Q TG2	F2/35	X50	NLS Htt exon 1 18Q	Mouse	16 months	Cerebellum	Male,pert
major HCC7,ctrl
"Wild-type-hippocampus, biological rep10 (female)",ctrl
SLE CD19 B cells 8,pert
pt. HCL C treated with Vemurafenib 1000 nM for 72h,pert
tissue: heart;	genotype: WT;	genetic background: C57BL/6,ctrl
GM19238_Kd_IRF7_3,pert
Syngen,ctrl
ILD Study Number S031,ctrl
IRS-2 KO (jos0698),pert
"Mouse heart, control, replicate 2",ctrl
Individual_4908_NN_sample,ctrl
UC-55-Aff,pert
AA_Case17_CD8,pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 2,ctrl
Individual_3937_PP_sample,pert
H11_S_B2,pert
Subtype: RARS;	Karyotype: other,pert
"siPRMT1 neuron, biological rep1",pert
01LL3_ERA,pert
GM19238_Kd_HCST_2,pert
H06_S_B1,ctrl
01LLA_PolyRF+,pert
KN-smoke-med-5 month+1d-R3,pert
"A2BAR -/- mouse heart, control, rep2",pert
Run7.aUa.010110d.SkMDbt1132D.CEL-DB basal,ctrl
Day: 24; Drug: Saline; Phase: Withdrawal; Replicate: 2,ctrl
Scd1-/- on chow diet replicate 3,pert
P0 - lis1ko/+ Mix 3,pert
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 101;	Usage number: 5;	Exposures: 3,pert
V5-P374,pert
Nrl ko P2 replicate 4,pert
mouselung_wt_control_rep03,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 36.89315,pert
cell line: MDA-MB-231 1833;	cell type: breast cancer cells;	genotype/variation: expressing induced Tet1,pert
GM19238_Kd_ESRRA_1,pert
Transfection Reagent Only Technical Replicate 1,ctrl
WT_rep_1,ctrl
HT-WT-9A,ctrl
01_0052A_Day1_14,pert
ILD Study Number 917,pert
r24,pert
Bronchial Epithelial Cells SA biological 2177X,pert
MacularDegen-injured-7cAv2-s2,pert
ANL Chip#46,pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: naïve,ctrl
"lymphoblastoid cell line from T6.01, one out of seven of insensitive group, 50*10e6 cells",pert
"MAT1A knockout at 15 month age, tumoral tissue, biological replicate 2",pert
H1299 AZA 1 uM (3230),pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 46.39726,pert
CD4+ cells IL1RN wild type 1 month rep1,ctrl
Control Day1 (380R),ctrl
colon_IBD_1060,pert
scan batch: Batch 1;	group: autism;	subject age: 3;	paternal age: 23;	maternal age: 24,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 3,pert
scrambled control-1,ctrl
"p38alpha knock out fetal liver E15.5, biological rep1",pert
56_129_KO,pert
Glioblastoma_8,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 21.45479,pert
Strain: C57BL/6 wildtype P7,ctrl
Brain CD8 T cells that are IL-10- rep3,pert
"acutely admitted, severely psychotic schizophrenia patient  A15",pert
Low weight gainer KOZAK2_ABI_HYP_L4,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro technologies;	Cause of Death: Hypoxia;	Tobacco Use: None,ctrl
FBooth-MDX-1Av2-s2,pert
HF0295_U133P2,ctrl
"AD_TC, biological rep1",pert
Genotype: MMTV-c-myc/Hunk WT; Gender: Female; Tissue: Mammary gland tumors; Strain: FVB,ctrl
"A673 treated with Puromycin for 3 days with concentration of 0.18 uM (2 x EC50), biological rep2",pert
strain: C57BL6/J;	genotype/variation: wildtype;	age: 8wks;	developmental stage: adult;	gender: male;	agent: vehicle (saline);	tissue: liver,ctrl
H3f3b KO 3973,pert
wild type MEF time 48 replicate 4,ctrl
"IRF6 wt, biological rep2",ctrl
11413 UC Uninflamed ascending colon,pert
SEB-1 treated biological replicate 3,pert
DS-Fibr 1,pert
Tendon_lesional_rep8,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 150min;	race: Caucasian/White;	sex: Female;	group: Con;	prototype: N,pert
Jejunum_Wild Type+Quercetin_3,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 17;	maternal age: n/a,ctrl
sample type: Negative control;	cell line: H1;	cell type: embryonic stem cell;	protocol: control;	time: 2 Days,ctrl
Vehicle 24 hours_3,ctrl
Human Uninfected Sample N050-CD4+ T cells,ctrl
"p53-, rep1",pert
diabetic muscle replicate 4,pert
A3243G-MELAS subject 1,pert
DNMT1-1,pert
HF0163_U133P2,ctrl
SynovAcAr_022HACJ0_151.txt,pert
patient: 205;	current medication: Pentaza 3g/d;	birth date: 6/8/79;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/03;	diagnosis date: 8/30/04;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 15;	crp: 19;	hb: 110;	wcc: 5;	neutrophils: 3;	albumin: 43;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: NEW;	smoking status: ex;	smoking start date: 1/1/85;	smoking stop date: 3/1/03;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
patient code: 138;	gender: Male;	age: 50;	tumor grade: 2;	t-stage: 2;	n-stage: 1;	ajcc classif. (2002): 2b,pert
"breast tumor epithelium,4",pert
3D-cultured chondrocytes from normal donor 2,ctrl
Ainv15 EB3 replicate 2,ctrl
strain: C57/BL6;	genotype/variation: wild type;	gender: male;	age: 8-9 weeks;	tissue: liver,ctrl
"imr-32,gfp siRNA,t=48,3",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 72;	Sex: male;	region: LC (locus coeruleus);	age: P22;	genotype: Y/Mecp2-;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,pert
wild type,ctrl
WT-smoke-high-5 month+1d-R4,ctrl
V5-P569,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 110min;	race: Black/African American;	sex: Male,pert
Skin_ K5IKKb_1,pert
E12.5 heart_wildtype_sample a,ctrl
3T3F442A-shTRPV4-rep1,pert
NIH3T3,ctrl
Bulun 3-3h-,ctrl
06R004 Control,ctrl
Moderate rep8 (retina),pert
DU145_NCsh_rep2,ctrl
Saline treated mouse gallbladder 2,pert
"ALL_NDS, K58 011509",ctrl
134A,ctrl
10609 Normal Uninflamed terminal ileum,ctrl
patient: 218;	current medication: Sulphasalazine Asprin Metoprolol Atorvastatin;	birth date: 9/27/24;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/58;	diagnosis date: 1/1/58;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/3/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Breast cancer;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
Vehicle-Control 36 hours set 2,ctrl
wt-Gfp P2 replicate 4,ctrl
CF (D508) subject13,pert
Run5.aUa.010110d.SkmDbt1959D.CEL-DB basal,ctrl
"brain, hippocampus: Ctr-1h-P15-III_e1_le1",ctrl
Bone-Marrow_MGUS_G1720,pert
untreated AML 13 blasts,ctrl
BAL_15b_A0B0,ctrl
"Cnr1-/-/Cnr2-/- female number 3, 2 months old, whole ear tissue, untreated control ear",pert
15SAGEA2,pert
C57BL/6J_Muscle_rep2,ctrl
PPAR WT_ctr_52,ctrl
GM19238_Kd_IRF8_3,pert
liver_STZ treated diabetic_rep5,ctrl
Cnah KO_heart_3,pert
control MLL_00118,ctrl
"Sh2b3 KO, biological rep3",pert
colonic_mucosa_non_inflamed_95,pert
3987-1 E2F1 Null,pert
"human failing LV myocardium, Ischemic28",pert
"23B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
05_ADL,pert
Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model MEPM 1,pert
"Dermatomyositis, biological rep5",pert
REH_shG1_rep3,pert
cell type: Primary hepatocytes;	strain: BL6;	agent: Wy14643;	time: 24h;	gender: Male;	age: 2 months,pert
NIL,pert
Liver-24 month-Myc heterozygous-technical replicate 1,pert
Ad infected murine liver-MO30k-(465)-6 hpi,pert
gender: female;	genotype: Wild type for TWIST2;	ethnicity: Puerto Rican,ctrl
tissue: brain;	genotype: mutant Ndel ko/+;	age: P14,pert
Prostate-specific Pten deletion anterior prostate tumor 2,pert
treatment: si221;	cell line: MCF7-FR,pert
"Spi-21, biological rep 7",pert
chip number: 17;	transfection plate: 4;	target gene: NR3C1;	kd level: 0.67;	rin: 8.7;	transfection date: 2011-10-17,pert
WT kidney pool 2,ctrl
male;	38 yr old;	White,pert
"MCF7/BUS, 0 pM E2, 48 hours, biological replication 2",ctrl
Myoblast-GATA4-Wt-day0-3,ctrl
NPC21,pert
Healthy donor_biological replicate6,ctrl
cell line: SV589;	knockdown (days): 15;	treatment: no treatment,ctrl
PTEN 121 (-/-),pert
coc-38_B,pert
heart knock out replicate2,pert
"BOEC, not_at_risk 7",pert
WT_TER119+_rep1,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case5,ctrl
treatment: siYAP RNA #2 transfected;	cell type: Primary cell line,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 10,pert
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 1;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
normal B lymphocytes (NBL 531),ctrl
umbilical cord_nobpd: 2A,ctrl
thyroid_normal_5,ctrl
RKO_rep_5,pert
KO - knock-out Treated - 2 hrs - repeat 1 - Cy3 - mAdbID:62610,pert
"Cell type: endothelial, age:47, gender:female, diagnostic group: schizophrenia, PMI:30h",pert
con_B132,ctrl
RNA: whole lung;	strain: C57BL/6;	genotyp: myd88 -/-;	infected: no;	replicate: B,pert
Age: 47;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
cell line: SV589;	knockdown (days): 8;	treatment: Serum Starved; no EGF,pert
miR122-KO-266-T,pert
"Strain: C57BL/6, ADNP+/- Gender: mixed Age:E9 Tissue: whole embryonic body;	Please refer to: Activity-dependent neuroprotective protein: a novel gene essential for brain formation.;	Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90. ;	PMID: 12888219 [PubMed - indexed for MEDLINE] ",pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: BETAFERON;	time: 12 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Knockout 1,pert
MOLM14-shGSK3B-Construct1-rep1,pert
"Control 1, biological rep3",ctrl
E14.5 top2b-/- brain,pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection - NTAL knock down;	vector: pLKO.1/TRCN0000127243;	activation: 2 h 100 ng/ml TNP-BSA,pert
"Quercetin, sample 2",pert
s3t1c,ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs induced with doxycycline and cultured for another 48h,pert
CD4IncTp1-5,pert
cell line: MOLM-14;	replicate: Replicate1;	treatment: shSYK_1,pert
"NTera-2 cells negative control, biological replicate 3",ctrl
DEX treated rep 3,pert
normal B cell 4,ctrl
chip number: 6;	transfection plate: 1;	target gene: E2F1;	kd level: 0.8;	rin: 9.6;	transfection date: 2011-03-29,pert
Lung-sarcoidosis-rep6,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep10,ctrl
Human Chronic HIV Sample C138-CD8+ T cells,pert
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 8",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 216,pert
"human failing LV myocardium, Idiopathic21",pert
"C2C12 Myotubes treated with Palmitate, rep1",pert
ApoE-/- mouse infected with a control adenovirus expressing GFP,ctrl
HW_437,ctrl
Healthy control_sample15,ctrl
"Hdh knock-out embryonic stem cells, biological replicate 5",pert
BP patient 52_biological replicate 1,pert
BP12,pert
MSE_N_M158,ctrl
"Cerebral Palsy, Gracilis, Patient Replicate 9",pert
wild type MEF time 0 replicate 2,ctrl
WT 2 mon replicate 4,ctrl
Oga_KO_MEF_E7_rep1,pert
RNA from HCC_23N,ctrl
"testis, Repro9 mutant, 14dpp, Rep4",pert
Frontal_Cerebrocortex_Vehicle_6hr_rep8,ctrl
age_years: 34;	sex: F;	ethnicity: Black;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
4-HPR_mammary_4,pert
C2C12 myotubes 10uM H2O2 rep 4,pert
cell type: T cell;	disease state: control participant,ctrl
DMN-NF1Hippo10d-2aAv2-s2,pert
Seguin_IDR_BrownNorway_Liver_control2,ctrl
SCC4,pert
Paclitaxel-sensitive,ctrl
GM19238_Kd_NFKB2_3,pert
tissue: pancreas;	cell type: epithelial cells;	disease status: intraductal papillary-mucinous neoplasm (IPMN),pert
Cardiac Muscle_WT_rep2,ctrl
"cell line: HEK293 human embryonic kidney cell line;	protocol: MIF depletion, siRNA-mediated;	siRNA concentration = 100pmol/ml",pert
Endometrium-Normal 3,ctrl
Nerve_Diabetic_Vehicle_707,pert
strain: mixed background;	age: 4 months;	genotype: wildtype;	tissue: jejunum;	sample type: control littermate,ctrl
chondrocyte_5azatreated_rep3,pert
RNA-DHL6-R406-6H-3,pert
N30057,ctrl
Muscle PCOS 14,pert
GM19238_Kd_SREBF2_3,pert
migratory cells only found in diseased OA tissue with stem cell characteristics,pert
CBMNC.LPS+.2,pert
"Mouse bone marrow-derived mast cells treated with IL3, rep 3",ctrl
PZA treated-42d-2,pert
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: REBIF;	time: 3 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
"disease group: Atopic Dermatitis;	Sex: f;	age: 30s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 4.5;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 100;	ige (kiu/l): normal (0-48.5 kIU/L): 36;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
Liver sample from Control group (N54),ctrl
AA_Case14_CD8,pert
FHCRCAML1038,pert
Muscle-AMPKgamma3-ko-3,pert
treatment: transfected with Ambion Silencer Select Negative Control #1;	cell type: embryonal carcinoma;	cell line: 2102Ep;	passage: 35-50,ctrl
Bone-Marrow_MM_M1042,pert
Control Female FVB/N,ctrl
human_LIMA_artery_patient1_control,ctrl
B4 398 b4-/- untreated,pert
BRCA1-KD-1 (total RNA),pert
diseased cells unstimulated,ctrl
CML_2_GMP,pert
Exercised-9,pert
DuodTumor022YAFBV_dtb.txt,pert
normal 1319,ctrl
HL60-shControl-rep2,ctrl
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	treatment: Pyrazinamide;	time: 42 dpi,pert
Normal Chip#7,ctrl
3_CD34+_12h_TCDD-,ctrl
"Cell type: endothelial, age:44, gender:female, diagnostic group: control, PMI:10h",ctrl
"Cell type: neuronal, age:37, gender:male, diagnostic group: schizophrenia, PMI:30h",pert
CAB10_T4_PP_day3_034,pert
BAL_33_A0B1,ctrl
Strain: C57BL/6J;	Gender: M;	Age: 9 weeks;	Treatment: untreated,ctrl
4P-ER-ND,pert
Pooled total RNAs from lymphoblastoid cells of 14 individuals,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.86027,pert
"lymphoblastoid cell line from F23.05, one out of seven of insensitive group, 50*10e6 cells",pert
cell line: SW1736;	time point: 48h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 48 h,pert
muscle knock out replicate2,pert
"CFU-PreB colonies Wildtype littermate, biological replicate 2",ctrl
Wt1-null MEFs-3,pert
Manca 4,pert
U2-OS-ERa vehicle control 2,ctrl
G_Kin_3,pert
"2102Ep cells negative control, biological replicate 2",ctrl
THRA aI mutant + vehicle replicate 3,ctrl
"Male, 39 years old, HIV infection of 2 years",pert
strain: C57BL/6;	tissue: liver;	genotype/variation: Nrg4 knockout;	diet: high-fat diet fed starting at 3 months of age for eight weeks.,pert
n10t0h,pert
genotype: Villin-Cre + / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 101,pert
"5mg/kg/day PFOA, Rep 3, Block 2, lung (high dose)",pert
"brain, forebrain: WCx4w#1_e1_le1",ctrl
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: 35;	maternal age: 28,ctrl
Gender: female;	Age: 63;	Source: left lower leg,pert
SKMEL28_t0h_rep3,ctrl
age: 35;	sex: M;	disease status: control subject;	Filter number: 103;	Usage number: 1;	Exposures: 3,ctrl
"imr-32,t=0,2",ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 39.88219,pert
chip number: 19;	transfection plate: 4;	target gene: RDBP;	kd level: 0.73;	rin: 9.1;	transfection date: 2011-10-17,pert
H1299 DAC 3 uM (3241),pert
71_129_WT,ctrl
Bronchial Epithelial Cells control biological 2170J,ctrl
Muscle-24 month-Myc heterozygous-technical replicate 1,pert
"37B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
affected status (disease state): control;	gender: male;	age-at-examination: 72;	age-at-onset: n/a;	geographical origin: Vila-Real;	lifestyle characteristics: ever drinker,ctrl
TF1_antiEvi1siRNA_2,pert
Mock infected murine liver-MO30k-(275)-6hpi,ctrl
WT3 CD11b,ctrl
"Trained mice, time point 5 week",ctrl
VMH of WT-1 mice,ctrl
Csbm/m Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-2,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 4;	psoriasis duration: 44.2600958247776;	age of psoriasis onset: 8,pert
Individual_4160_PP_sample,pert
Individual_5942_NN_sample,ctrl
Ing1-/-_MEF_rep2,pert
2d-sham-74,ctrl
"HSCs from female mice treated with oil, replicate 2",ctrl
Muscle-AMPKgamma3-wt-8,ctrl
Caco2-siRNA-control1-rep1,ctrl
FHCRCAML2557,pert
"breast tumor epithelium,10",pert
sample 1:;	age: 46;	gender: male;	sample 2;	age: unknown;	gender: unknown,ctrl
mouse colon_hnf4control_rep1,ctrl
27SAGEA,pert
race: caucasian;	age (years): 57;	stage: IA;	grade: 1;	histology: endometrioid,pert
THRB bN mutant + vehicle replicate 1,ctrl
MCE301 cells treated with SB for 24 h-2,pert
Cardian muscle Diabetic 3 week D3,pert
Panc0403 rep-3,pert
07_PAH,pert
sample =XCGD2 treatment=Control time=360 (min),pert
Individual_4093_PP_sample,pert
cell line: NB4;	genotype: wild-type;	treatment: untreated;	biological replicate: 3,ctrl
Diaphragm 23 Day control rep 2,ctrl
Silberg3 ( S5) 191102-1BE,pert
t03,pert
liver wild type replicate1,pert
"brain, brainstem: CB7_e1_le1",ctrl
5210 Normal Uninflamed terminal ileum,ctrl
"Organism: Homo sapiens (human) Morphology: lymphoblast;	Source: Organ: bone marrow;	Disease: chronic myelogenous leukemia (CML) ;	Age: 53 years ;	Gender: female ;	Cytogenetic Analysis: The stemline chromosome number is triploid with the 2S component occurring at 4.2%. Fifteen markers (M1 and M(15)) occurred in nearly all S metaphases. Spontaneous non-specific dicentrics occurred, but rarely. Unstable markers were also rarely seen. The X was disomic, and N9 was nullisomic.",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 49.07945,pert
01LMJ_Systemic,pert
Kidney_colistin_3,pert
Brain (Inferior Olivary Nucleus)_Control_case2,ctrl
Yy1_siRNA_rep1,pert
"proband k, past exhaustive exercise",pert
patient: 120;	current medication: Minicycline;	birth date: 5/6/54;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/18/05;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
WT6,pert
RE550_H1650_5-Medi5117,pert
A375 control-2,ctrl
Disease_status: Healthy control;	Age (years): 54;	Gender: Male;	Post mortem interval (hours): 10;	Braak stage: II;	Cause of death: Aortic aneurysm,ctrl
Tissue: lung;;	Genetics: Familial IIP;;	Histology: Nonspecific Interstitial Pneumonia,pert
WT - Cre Untreated - 0 hrs - repeat 2 - Cy5 - mAdbID:61714,ctrl
"Female (age range 33-49), skin biopsy from upper nates. No nickel exposure",ctrl
normal skin from controls,ctrl
ILD Study Number 1237,pert
type_of_rx: AF;	pre_or_post_treatment: post;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 6x5;	patient id (to identify the 2 chips from the same patient): 16821717,pert
"WT BM LT-HSC, biological rep1",ctrl
sex: Male;	family: 2;	age: 66;	disease status: Asymptomatic;	tissue: Muscle: Deltoid,pert
LCL Concordant for Epilepsy twin pair 1 (CCE1.1)(TP21),pert
Subject 4_t=30days_resveratrol,pert
10 week mutant spinal cord rep 3,pert
"female Spargue-Dawley rats, Targretin, 60 mg/kg BW gavage for 7 days, tissue: lung",pert
SCLC cell line SBC-3,pert
BP patient 92_biological replicate 1,pert
HDAC1_knock_out_embryonic_stem_cells_biological_rep3,pert
"pancreas, control diet, male Wistar rat",ctrl
"Male, Wistar, 6hrs/day access to cocaine, amygdala",pert
cell line: E14;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 0,pert
cell line: Lung Epithelial Cell Line MLE15;	genotype/variation: control,ctrl
03SAGEA2,pert
"211, MUSCLE, Before",ctrl
WT #177,ctrl
ASO T00278950,pert
"Tip60 KD, replicate B",pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 143;	time: 0;	batch: 3,pert
Wild Type Skeletal Muscle Sample (Hind limb),ctrl
blood_day0_patient6,pert
Retina wildtype 42 days 2,ctrl
liver_NEMO_KO_replicate1,pert
3-WT,ctrl
lesion_midUV_patient10,pert
Src-overexpression - replicate 2,pert
batch: B;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,pert
"lymphoblastoid cell line from R, one out of seven of sensitive group, 50*10e6 cells",pert
genotype: DTG;	diet: high fat;	muscle hypertrophy: +;	sex: male;	tissue: liver;	treatment: doxycycline 3wks,pert
siAgo1,pert
Exon3_T4,pert
BASC-Control-1 [mRNA],ctrl
Human Non-progressor HIV Sample L128-CD4+ T cells,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 13 days;	treatment: fresh air, treatment over 5 month + 15 days recovery, 4x1h exposure per day",pert
12h_c3,ctrl
"p63shRNA_B3, p63-depleted",pert
Control (C270),ctrl
Large cell carcinoma 018,pert
normal adjacent esophageal tissue from patient E2644,ctrl
Metastatic prostate cancer W1,pert
Individual_3059_PN_sample,pert
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep6,pert
Bronchial Epithelial Cells SA biological 1998G,pert
EA_Case8_CD8,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 48 yr;	population: white,ctrl
ILD Study Number S037,ctrl
"PMA treated, doxycycline treated; biological replicate 2",pert
Muscle control 8,ctrl
genetic background: CD1;	genotype: WT;	Sex: male;	age: 14 weeks;	tissue: ventricular myocardium;	treatment: saline,ctrl
subjects: patient with AAA undergoing open surgery to treat AAA;	tissue type: non-aneurysmal AAA neck tissue,pert
prostate_Klf5 wt_rep3,ctrl
cell line: MCF-7;	cell type: Breast Cancer Cells,ctrl
platelet_sickle_9,pert
"Acute Myeloid Leukemia, sample 57",pert
control_crypt_day2_sample1,ctrl
treatment: control siRNA;	cell line: PC3,ctrl
CO_1,ctrl
INSENS 6 0hr,ctrl
A506 MI 1 day,pert
Sh-control-1,ctrl
T11,pert
T7A-LU,pert
"p38alpha wild type fetal liver E13.5, biological rep1",ctrl
PsOEt-16-LS,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_12_34_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
CD8+_Tcells_non_severe_asthmatic_2,pert
"202, MUSCLE, After",pert
CHF - R10,pert
C594,pert
Huh7 cells_JFH-1 Infected 12 hours_ rep3,pert
C57_HF_2,ctrl
"Donor 3, Ebola infected 6hr",pert
"human failing LV myocardium, Ischemic88",pert
"DMD skeletal muscle, biological rep9",pert
Klf9KO_jejunum_PND30_4,pert
knockdown: Control;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 7.7;	colon weight (mg): 157;	colon ratio (mg/mm): 2.04;	myeloperoxidase activity (u/mg): 0.038;	tissue: colon;	treatment: 5% DSS,ctrl
nodex_4,ctrl
erStress_twins_AA_1724twin2_500nM_thapsigargin_4h,pert
Pancreatic Sample 4-Normal,ctrl
treatment: Sirt1 siRNA Knockdown 1;	cell line: Caco-2,pert
"0mg/kg/day PFOA, Rep 4, Block 4, liver (low dose)",ctrl
Lmna H222P heterozygous male 1,pert
01LQJ: normal control,ctrl
"age at diagnosis: 67;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1bi;	er: 1;	pgr: 1;	dfs-month: 29;	dfs-event: 1;	distant metastasis: 1",pert
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 24 months;	genotype: Wild type,ctrl
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-jhdm1b retrovirus,ctrl
Wt Mouse_cerebellum_Standard diet Ad Lib_Replicate-4,ctrl
WT-SB-1,ctrl
whole tissue section from case 651,pert
22GOBMUC2H,ctrl
WT_BoneMarrowMacrophages_unstimulated_4hours_rep1,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 66,pert
"Control animal, biological repeat 1",ctrl
"fibroblast, TSG6-knockout, untreated, biological replicate 5",pert
"WT, PR03M003v0",ctrl
"brain, brainstem: CB4_e1_le1",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.042;	OD280: 1.079;	Ratio: 1.95;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 216;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
MH1C1_untreated_rep4,ctrl
Striatum of 8-10 week old SWR/J mice,pert
"Ovol2 BT, biological rep2 (E17.5)",pert
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 96;	Usage number: 4;	Exposures: 3,pert
CD8+_Tcells_severe_asthmatic_6,pert
Patient 8 after folic acid,pert
"MCF7 silenced Estrogen receptor, biological rep3",pert
cerebellum_WT_4w_rep2,ctrl
"Empty vector control, 72 hrs, No Rosiglitazone (NONE_72_2)",ctrl
Gender: female;	Age: 10 weeks,ctrl
01N0Z_ERA,pert
RKO_NEGsiRNA_6hDMSO_REP3,ctrl
"liver_ABCA1-TG, biological replicate 4",pert
MC3T3 cell line,ctrl
race: asian;	age (years): unknown;	stage: IB;	grade: 3;	histology: papillary serous,pert
Healthy5-CD4,ctrl
OE33 Control rep2,ctrl
transfection: shPARP-2 transfected,pert
"YWHAZ overexpressed CL1-0, biological rep2",pert
MCF10A_Vehicle_rep2,ctrl
Leptin treated mouse gallbladder 5,ctrl
"BOEC, normal 19",ctrl
siCONTROL no DNA Damage experiment 1,ctrl
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 73;	baseline tumor size (cm): 7x6;	patient id (to identify the 2 chips from the same patient): 15751594,ctrl
Control Colon 2 21 days old,ctrl
pediatric AML GP4,pert
Run7.aUa.001206d.SkMInS1083D.CEL-IS stimulate,pert
Sample 02 Kidney Normal Mouse - Low Phosphate Diet,ctrl
55SageA2,pert
transgene strong 1,ctrl
RAW_2.1mM_HOCl_#3,pert
BCells_WildType_day0_REP2,ctrl
strain background: Sprague Dawley;	gender: male;	diet: isocaloric control diet without EtOH for 6wks;	sample group: Control;	cell type: Alveolar type 2 cells,ctrl
1202-03-A,pert
No or early 2 rep8 (OHN),pert
FACS-purified B cells_wildtype_non-infected_rep2,ctrl
MCI-005,ctrl
cell line: Breast carcinoma cell line Cal51;	genotype/variation: IPMK depletion;	agent: MMC,pert
"human failing LV myocardium, Ischemic103",pert
FC 01,ctrl
"brain, hippocampus: KA240-III_e1_le1",pert
genotype: p300+/-;	replicate: 3;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,pert
CRG,ctrl
sirna: Claudin 1;	treated with tnfα: YES,pert
Pancreatic Sample 38-Normal,ctrl
RNA: whole lung;	strain: C57BL/6;	genotyp: wt;	infected: no;	replicate: A,ctrl
sample type: Sample;	cell line: H1;	cell type: embryonic stem cell;	protocol: OCT4 knockdown;	time: 3 Days,pert
01N6Z: normal control,ctrl
NALT_sham_24h_rep2,ctrl
"brain, lateral and medial ganglionic eminences: Arx-/Y #4_le1",pert
C2_HypM,ctrl
"NASP Overexpression, sample #2",pert
cell line: H1993;	tissue: Lung adenocarcinoma,pert
cell type: MCF-7;	sirna: SPDEF,pert
Differentiation of hES cells line VUB01 towards neural rosettes;	Neural precursor phenotype,ctrl
25 weeks female,pert
"Control shRNA cells passage 7, rep 2",ctrl
NTG replicate 6,ctrl
"Patient #4, Untreated",pert
T7E-LU,pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Typical antipsychotic Haloperidol, Dose: 1.6mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking Water, Period of treatment: 4 weeks, Method of sacrificing: cervical dislocation.",pert
14A;pretreatment;female;breast tumor; responder,ctrl
Wild Type Time 1 replicate 2,ctrl
"PIO, subject 12",pert
KU_20N,ctrl
disease state: normal skin,ctrl
C3 patient,ctrl
BP5,pert
genotype: WT;	tissue: brown adipose;	genetic background: 129,ctrl
"JurkatNegative (Mock stim)  0 hours, #2",ctrl
MDS10,pert
PKBa-/- MEF time 48 replicate 3,pert
"runx1-null luminal mammary epithelial cells, MD869",pert
genotype/variation: Fbn1 wild-type;	tgfbr2 status: conditional disruption of Tgfbr2;	tissue: ascending aorta;	age: 6 weeks,pert
"testis, Repro9 mutant, 17dpp, Rep5",pert
siNS_0h_1,ctrl
Recent-onset T1D_sample8,pert
disease status: autism;	tissue (brain region): Temporal cortex,pert
Patient identifyier: D;	Sex: male;	Age of patient: 61 years;	Duration of psoriasis: 21 years;	Body surface area: 12 percent;	Overall erythema: mild;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
type 2 diabetes subject 08,pert
Obese Control-3,ctrl
oocyte_Brwd1_mutant_rep1,pert
mouse liver A1,pert
mT6,pert
HeLa_06_21_04 TP-7,pert
6n,ctrl
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 52;	age-at-onset: 48;	geographical origin: Mirandela;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",pert
"T-cell prolymphocytic leukemia, inv(14)(q11q32), case 4",pert
"uninfected primary RPE, biological replicate 3",ctrl
coc-12_B,pert
IEC_GF-HDAC3ΔIEC -1,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 69,pert
"129 Wildtype mice, pineal glands taken at postnatal day zero",ctrl
NTac_liver_vehicle 0 mg/kg_96 hr_4,pert
t18,pert
Trasnsformed Lymphocytes Bipolar Disorder Affected Twin Pair 1 (DCBD1.1)(TP5),pert
WT1-iPS 3,ctrl
PGA-lv_8w_329,ctrl
Cpr-lox_pool 3,ctrl
Wild type saline rep1,ctrl
"HCT116 cells with empty vector, technical replicate 2",ctrl
hBSMC_control_rep2,ctrl
Isoflurane 10 exposures-3,pert
Normal cervix_03-5657,ctrl
P5A Progranulin-frontal,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M0;	flt3 status: WT,pert
"WT Heart with no treatment, biological rep1",ctrl
Sample 08 Kidney Hyp Mouse - Low Phosphate Diet,pert
Allo-25-3,pert
Cmah KO_liver _2,pert
IGROV-1-(3),ctrl
"Acute Myeloid Leukemia, sample 72",ctrl
Muscle JDM (YJD-JDM-21UA-s2),pert
MH1C1_high_rep1,pert
cell line: NB4;	genotype: wild-type;	treatment: untreated;	biological replicate: 1,ctrl
Clinically localized primary prostate cancer P2,pert
A HID B_B043,pert
gender: male;	dietary group: grape extract (B);	time point: 6 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),ctrl
Sex: male;	Age at operation: 76 years;	Site: thigh;	Size in cm: 3.5x3x3;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: non-recombinant clone 24 (STAG2 wild-type),ctrl
individual: patient9;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"18 weeks old normal mice, cerebellum",ctrl
WT-control-2,ctrl
JIA PBMC Post treatment A235_L010(2),pert
"Affymetrix chip HG-U133A, siLuc 2",ctrl
Panc0504 rep-3,pert
WT - Cre Treated - 0.5 hrs - repeat 3 - Cy3 - mAdbID:62543,ctrl
"Empty vector control, 2 hrs, No Rosiglitazone (NONE_2_1)",ctrl
strain: C57BL/6J;	Sex: male;	expression: sh-PRDM16;	agent: rosiglitazone at 1uM,pert
Cadmium_00hr_rep1,pert
6 h-control (EtOH),ctrl
KM_056N,ctrl
"Strain: Mixed genetic background, predominantly (>87.5%) C56BL/6 with some CD1. Genotype: Mx1-Cre negative: PTENfx/+. Sex: Female;	Age: eight and a half weeks (at tissue isolation). Tissue: Small Intestine (jejunum/ileum region). ",ctrl
HepG2_Sb rep1,pert
Mock infected murine liver-MO30k-(270)-6hpi,ctrl
strain: C57BL/6J;	genotype/variation: WT;	tissue: Bone marrow;	cell type: CD71+ cells (MACS-enriched),ctrl
"testis, Repro9 mutant, 17dpp, Rep3",pert
LT 341 +/T untreated,ctrl
tissue: Temporal cortex;	age: 54;	Sex: F,ctrl
"Cadmium 1.2 µM, biological rep1",pert
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/16;	differentiation status: undifferentiated;	cell line: Q20,pert
Bone-Marrow_NPC_N1610,ctrl
"Normal subject (54 year old caucasian female, SAK_1276103927)",ctrl
Lrp5 Retina Rep3,pert
NS3-040213-SA,ctrl
CD4DecTp1-10,pert
DNGL-1,pert
3010-lcm,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 44 yr;	population: white;	dsm-iv: 295.9;	age of onset: 19 yr,pert
C_AN17425_C,ctrl
H29 Ctrl 6h 3,ctrl
HCaRG-9_HG-U133 Plus 2_Rep,pert
genetic background: C57BL/6;	gender: female;	tissue: left hippocampus;	age: P100;	genotype: wild type;	treatment: prenatal stress,pert
EA_Case7_CD20,pert
LECs from control rats,ctrl
Mouse_Retina_P7_Control 3,ctrl
heart_Q10_6M_rep3,pert
V5-P563,ctrl
Strain: RPE65-/-;	Age: 4 months;	Tissue: retina,pert
"33B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: sigenome non-targeting siRNA;	genotype/variation: negative control,ctrl
mir-26b overexpression 2,pert
PBMCs_Control_8 [IS],ctrl
sex: Male;	Age: 60 months;	additional patient information found in Series supplementary file,ctrl
liver_Wt_35wk_rep4,ctrl
"fibroblast, MFS subject FB1627 rep 2",pert
erStress_twins_AA_1757twin2_500nM_thapsigargin_4h,pert
siNEG replicate 2,ctrl
Silberg2 (S1) 021101BE,pert
"disease state: Nasopharyngeal carcinoma;	stage: III, T3, N2, M0, G4",pert
Human normal prostate primary culture C16sx,ctrl
Healthy controls; individual=CJ; time=2; beverage=alcohol,pert
SW1736_t0h_rep2,ctrl
clone type: AtT20 clone types overexpressing NSBP1SE protein rep2,pert
C002_Control_F_87,ctrl
"Amoxicillin treated Distal, Small Intestine 2 21 days old",pert
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2+/+;	agent: IFNβ,ctrl
"Age: 59;	Sex: M;	Ancestry: European;	Smoking status: smoker, 60 pack-years",pert
control MLL_00117,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.631;	OD280: 0.833;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 146;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
KO_TER119-_rep3,pert
cell type: embryonic stem cell;	genetic background: C57BL/6;	genotype: Prdm14 knockout,pert
Patient 6 skin baseline,ctrl
0810-01-A,pert
MDS patient 98,pert
APBMNC.LPS+.1,pert
KO - 3 mo - repeat 3 - Cy3 - mAdbID:74674,pert
P1,pert
Cell line MCF-7_c-myc KD_expt3,pert
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 2,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 24 hrs;	time course: 2,pert
H06_S_B2,pert
A HID U_B089,pert
gender: Male;	tissue: Tendon;Quadriceps;	age: 41;	donor: 10;	disease state: Non-lesional,ctrl
race: caucasian;	age (years): 63;	stage: IC;	grade: 3;	histology: endometrioid,pert
CD4DecTp2-3,pert
"Rad21 esiRNA, biological rep2",pert
tetO-Satb2 #1,ctrl
disease: Down syndrome;	gender: female;	age: 6 months;	tissue: thymus,pert
ab177 IM,pert
Mtb infected-42d-3,ctrl
"DMSO Control after 24hr, replicate 1",ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: pineal gland;	time: ZT20,ctrl
phytohemagglutinin-activated PBMCs from normal control subject J,ctrl
knockdown Tcof1 [C],pert
brain_Down_syndrome_sampleid_jg1734,pert
E10.5 Vax2-/- 1,pert
Individual_4213_PN_sample,pert
cell type: Embryonic Stem Cell;	genotype: wild type;	strain: C57BL/6,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 43 yr;	population: white;	dsm-iv: 296.64;	age of onset: 25 yr,pert
e_NY2,pert
481MM,pert
Peripheral blood mononuclear cells (PBMC)-Patient CCa T0,ctrl
38m5,ctrl
HL60-shGSK3A-Construct5-rep1,pert
"fibroblast, control subject NF7 rep 1",ctrl
"mental retardation or developmental delay, Female",pert
A673_CloneAsp14_Dox_36h_1,pert
9-cis-retinoic-acid_Lung_1,pert
"brain, hippocampus: KA-240h-P15-I_e1_le1",pert
11429 UC Inflamed descending colon,pert
Patient 2 b,pert
"E2-treated cells (24hr), biological rep_2",pert
01_0051A_Day1_13,pert
"MN1VP16, 2",pert
Cisplatin-treated wildtype MEFs-c,pert
cell line: H1299;	agent: decitabine;	dose: 3 uM,pert
subject: 12V;	cohort: 12;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 45;	Sex: F;	batch: Batch_3,ctrl
Sample ID: TP40;	Twin Pair ID: CCE4.2;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-10.5;	Age at interview & blood sampling: 31;	Current Age (2007): 34;	Sex: MALE;	Medication at blood sampling : Epilim,pert
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Pioglitazone,pert
Gender: Male;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: YES,pert
"Control siRNA - 2 days osteoblast differentiation, rep2",ctrl
C57BL/6J_Liver_rep1,ctrl
Skin removed from back region of embryonic day 16.5 mouse,ctrl
"human failing LV myocardium, Idiopathic60",pert
Targretin_Lung_2,pert
U2OS shCHK1-3 replicate 2 [set 4],pert
CTIP 20 #1,pert
scan batch: Batch 1;	group: control;	subject age: 8;	paternal age: 24;	maternal age: 25,ctrl
"0mg/kg/day PFOA, Rep 1, Block 2 lung (high dose)",ctrl
"nasopharyngeal carcinoma, specimen T2",pert
E14 - DCXko/Y 1,pert
siHic5_2_2h_2,pert
heart-30 months of age-resveratrol diet-biological replicate1,pert
DN4 cells sorted from mouse n°131 (Cre-),ctrl
tumor cell line HepG2 with knockdown of HIF-2α rep3,pert
RPE30,pert
T2,pert
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep1,pert
1200-03-A,pert
Muscle JDM (YJD-JDM-8UA-s2),pert
HeLa_06_21_04 TP-10,pert
cell line: SV589;	knockdown (days): 15;	treatment: Serum Starved; 3h EGF,pert
kidney_co_14M_rep1,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 9.7;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 54;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
"Control #9, Untreated",ctrl
tumor cell line HepG2 with knockdown of HIF-1α rep3,pert
strain background: C57/129S;	genotype/variation: Fra-1-/-: Fra-1 KO;	gender: female;	age: 2 months;	treated with: 30 µl of PBS for 5 days;	tissue: lung,ctrl
heart-30 months of age-control diet-biological replicate4,ctrl
tissue: Whole pancreas;	genotype: WT;	background: C57BL/6;	age: 8 weeks,ctrl
Mouse colonic epithelial cell line MCE301,pert
"infected primary RPE, biological replicate 4",pert
DC3,ctrl
1212-1heart_OTT1KO,pert
tissue: Liver;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 719,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty,pert
FmrWT4_blood,ctrl
A375 Wnt1-1,pert
Patient identifyier: Z;	Sex: female;	Age of patient: 42 years;	Duration of psoriasis: 36 years;	Body surface area: 5 percent;	Overall erythema: mild;	Induration: minimal (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
Gender: Female;	AJCC Stage: I;	Pathological T: 2;	Pathological N: 0;	Pathological M: 0;	Grade: well;	Tumor Site: Sigmoid;	Drug Treatment: YES,pert
Saline_1,ctrl
Normal Cervix N6,ctrl
Msgn1_48hPlusDox-biological rep2,pert
"new born PS-NA mice, cerebrum",pert
major non-tumor7,ctrl
Bronchial Epithelial Cells MMA biological 1926H,pert
IEC_GF-HDAC3FF -2,ctrl
7P-ER-ND,pert
"BA OBCs, post doxycyclin withdrawal, rep5",pert
"Crohn's Disease subject (49 year old caucasian female, SAK_1313179761)",pert
BAL_17_A0B0,ctrl
age_years: 35;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
MDS28,pert
SALINE 1 HOUR,ctrl
HEK001_A08_R3,pert
NSCL/P sample 6,pert
"EBF1 d4, rep 5",pert
condition: Normal;	patient: N_LJ_7;	tissue: Normal skin biopsy;	kit: Affy,ctrl
"MCF-7 cells-control, biological rep 4",ctrl
normal adjacent esophageal tissue from patient E1614,ctrl
CON11,ctrl
CXCR4 knockout 8,pert
"fibroblast, MFS subject FB837 rep 2",pert
male_alcoholic_330,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Colon",ctrl
Leg 7 Day Control rep 3,ctrl
Mouse No Cldn16 B9 450,ctrl
liver_STZ treated diabetic_rep6,pert
Bone-Marrow_MM_M828,pert
STAT1-deficient naïve T cells stimulated for 3 hours with medium alone 1,pert
"PMA treated, no doxycycline; biological replicate 1",pert
DBA d18 (120msn),pert
liver_STZ 0.5% quercetin diet_rep6,pert
Cisplatin-treated wildtype MEFs-a,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 2;	psoriasis duration: 0.770020533880903;	age of psoriasis onset: 39,pert
0201-01-C-RR,ctrl
WT 1,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#129,pert
Cardian muscle Diabetic 1 week D1,pert
"DOX, rep3",pert
construct: HDAC1 A3 shRNA;	cell type: Primary human erythroid progenitor cells,pert
KO - knock-out Treated - 0.5 hrs - repeat 2 - Cy5 - mAdbID:62539,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_16,pert
ST045849 24 hours_3,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: tumor;	sample name: 1-tu1,ctrl
GM19238_Kd_CEBPG_1,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 75,pert
"control, rep2",ctrl
Control subject 97_biological replicate 2,ctrl
3589-1 E2F1 Null,pert
Cell line MDA-MB-231_control_expt1,ctrl
4x' Ez f/fMef2c-cre,pert
V5-P226,pert
11394 Normal Uninflamed descending colon,ctrl
Strain: C57BL/6J;	Gender: Male;	Age: 16 weeks;	Tissue: testis,ctrl
"Wild-type, biological rep1",ctrl
"YPFH cells from M1, Mecp2 null, biological replicate 2",pert
"mouse liver sample, WT strain, biological replicate 2",ctrl
B_LS_Wk12,pert
NPC Brain 55d Mouse1,pert
C57BL10 quadriceps sample 1,ctrl
8 Weeks Heart MDX rep 3,pert
"S1P2-KO-hippocampus, biological rep1 (male)",pert
Haloperidol treated 4weeks AffyGC RMA rep3,pert
Granulocyte-Macrophage Progenitors,pert
cell line: SF539;	transfection: PARK2 siRNA#1,pert
D1,ctrl
"Untreated, biological rep2",ctrl
Tissue:tumor; Gender:female; Age:65  Tumor stage:T2NxMx,pert
age: 14;	sex: M;	disease status: control subject;	Filter number: 86;	Usage number: 1;	Exposures: 3,ctrl
477MM,pert
"fibroblast, MFS subject GDO21 rep 3",pert
19: NORMAL #99-0834,ctrl
Ad infected murine liver-MO30k-(469)-6 hpi,pert
COLO829_shMITF_DMSO_B,ctrl
Peripheral blood mononuclear cells (PBMC)-Patient CCo T0,ctrl
"Gender: male;	Age: 75;	Source: skin, left heel",pert
tissue: Brain;	genotype: Npc1+/+;	age: 60 days;	subject: Mouse2;	genetic background: BALB/c,ctrl
Bone-Marrow_SMM_S1415,pert
KU_13N,ctrl
Gender: male;	Age: 46;	Source: back,pert
pancreatic cancer cell line FA6 transiently transfected with AGR2 siRNA,pert
"Age: 45;	Sex: M;	Ancestry: African;	Smoking status: smoker, 70 pack-years",pert
shGFP-rep-2,ctrl
Hippocampus_Soman_72h_rep3,pert
O_LS_Wk1,pert
"Liver, Intermittent Hypoxia 4",pert
PGA-MAH-AJ_OVA6h-5bA-s2,pert
Papilloma_tumour_epithelial_cells_CTRL_rep1,ctrl
mouse cerebellum at P7 knockout 3,pert
mammary_16wkLH_ker74,pert
BAL_25_A0B0,ctrl
cell line: HeyA8;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
wt_P4_rep1,ctrl
WT-smoke-med-5 month-R2,ctrl
"seminoma specimen, pT1, patient age: 31y",pert
BALB_Male_Control_rep2,ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 3",pert
patient id: T22;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 67;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3N0M0;	Stage: III;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
cell line: prostate cancer cell line PC-3M;	genotype/variation: negative control siRNA,ctrl
P0 Quadriceps Klhl40 WT 3,ctrl
"gene expression of CTCF-depleted oocyte, replicate 3",pert
"Mouse invivo nTreg cells, replicate pool 1",ctrl
OSE_567,ctrl
"Peripheral blood, patient with recurrent events [N31]",pert
heart_co_6M_rep2,ctrl
"C8161, no treatment",ctrl
"spleen follicular B in WT, biological rep5",ctrl
ILD_11,pert
GM19238_Kd_ZBTB38_1,pert
strain: C57BL/6J;	genotype: wild type;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle,ctrl
MLL_PTD14,pert
MGP2,pert
Subject 8_t=30days_placebo,ctrl
wild-type+PQ rep_2 (PQWT2),ctrl
GFP-progerin Induction: day 0 Replicate A (4a_progerin_0d_A),pert
Nrl-ko-Gfp P2 replicate 1,pert
Spleen_uninfected_control_rep2,ctrl
con-7_A,ctrl
"Crohn's Disease subject (43 year old caucasian male, SAK_1315906827)",pert
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1+/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: esophagus,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: D;	experimental sample name: PC13-R,pert
Moderate rep4 (OHN),pert
S-IIP(UIP)5_Cy3,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/FGFR1;	biological replicate: 2,pert
Skinbiopsy_48hoursnickel_controlsubject_k3,ctrl
"Grape extract group, 12 months, patient number 14",ctrl
12486 UC Inflamed descending colon,pert
Hereditary gingival fibromatosis(HGF) patient Gingiva replicate1,pert
cell type: Endothelial cells;	strain: C57Bl/6;	genotype/variation: wild type,ctrl
23d tg5,pert
"18 weeks old PS-NA mice, cerebellum",pert
"Kidney from control rats, biological rep 1",ctrl
chip number: 21;	transfection plate: 3B;	target gene: PAX5;	kd level: 0.75;	rin: 9.5;	transfection date: 2012-03-26,pert
Bone-Marrow_MM_M880,pert
muscle_Wt_35wk_rep2,ctrl
Nrl ko P2 replicate 2,pert
cell type: Embryonic stem cells;	genotype: Bmpr1a-/-;	culture condition: 3 days in N2B27,pert
Individual_4294_PP_sample,pert
3_month_old_Prnp_knockout_mouse_rep2,pert
GIST_KIT_12,pert
Control for EGF 4h replicate 1,ctrl
136B,ctrl
A549 AZA 0.3uM (3211),pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 24h ID54,ctrl
"shBAP1 #1 cells, rep2",pert
67 y/o female,ctrl
ACC Xenograft MAD04-385,pert
non-malignant FTEn_patient 2,ctrl
Mesenchymal derived mouse cell line,ctrl
"spinal cord, ventral spinal cord: EP 151/L - SDneg e14",ctrl
THRA wt + vehicle replicate 2,ctrl
Argyrin A treated 24h,pert
C33KD2_without doxycycline_3,ctrl
NSC1,pert
Tissue: lung;;	Genetics: Sporadic IIP;;	Histology: Nonspecific Interstitial Pneumonia,pert
"129P3/J CHR, Rep1",pert
gender: male;	genetic background: C57BL/6x129;	age: 6.5 months;	tissue: Crhr2+/+;	genotype: Gastrocnemius and Soleus muscles,ctrl
gender: Male;	tissue: Tendon;ECRB;	age: 52;	donor: 30;	disease state: Lesional,pert
"nasopharyngeal carcinoma, specimen T15",pert
"patient: 111;	current medication: Paracetamol;	birth date: 9/5/82;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: FH of CD, Path Increased lymphiod in TI Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: Dicer1 conditional knockout, Atoh1-Cre;Dicer1(flox/flox);	tissue: organ of Corti from cochlea, basal half;	age: postnatal day 16",pert
Tissue: normal thyroid; Gender:male; Age:36,ctrl
MDS patient 176,pert
"Patient H-137-N, normal colonic mucosa",ctrl
1198-03-A,pert
WT2 CD11b,ctrl
Dengue Hemorrhagic Fever Patient 32,pert
midbrain_Pink1 knockout_24 weeks_replicate 1,pert
12480 UC Inflamed descending colon,pert
0998-01-C,ctrl
14C-ER,ctrl
"Endometrium, postmenopausal, tibolone, 26",pert
FHCRCAML482,pert
"ARD291, CAIS, F, GOF, 6 x ETOH, 14d",pert
U2OS_control_shRNA_pLenti_2_2007,ctrl
Human prolactinoma 273,pert
WT littermat3,ctrl
ATM_siRNA_0a,pert
Bone-Marrow_MM_M1089,pert
Liver_D3T _Rep3,pert
"Normal Skin, Normal-15",ctrl
"HUVEC, untreated",ctrl
MDS patient 70,pert
"RNF40 siRNA - 2 days osteoblast differentiation, rep1",pert
"treatment: control;	batch: 2;	donor: 28;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
Setdb1 2lox/1lox/Cre minus tamoxifen 2,ctrl
CPU FVB/N control 1,ctrl
patient: 2;	disease state: hypertension;	tissue: Atheroma plaque,pert
NTG mouse_tamoxifen3,ctrl
BL Day 1 siSC transfected biological rep1,ctrl
CD4DecTp2-1,pert
GM19238_Kd_WHSC1_1,pert
patient: 30057;	sample: normal,ctrl
knockdown: TNFa siRNA-A;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6.3;	colon weight (mg): 195;	colon ratio (mg/mm): 3.1;	myeloperoxidase activity (u/mg): 0.703;	tissue: colon;	treatment: 5% DSS,pert
Age: 42;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 5382insC;	Family History: Yes,ctrl
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 retrovirus,pert
"Crohn's Disease subject (47 year old caucasian female, SAK_1315705650)",pert
S3B Sporadic-cerebellum,ctrl
Vehicle-Control 30 hours set 1,ctrl
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 68",pert
Strain: Fischer 344;	Gender: Male;	Age: 6;	Tissue: Liver of vehicle treated rat,ctrl
Injured 4h Rat Retina 3,pert
siControl_6,ctrl
MDA-MB-231 - Control-3,ctrl
r8,pert
Wild type_heart_1,ctrl
gender: male;	individual: patient 4;	treatment: control,ctrl
Btk KO primary splenic B-cells (sample1),pert
race: caucasian;	age (years): 46;	stage: IB;	grade: 1;	histology: endometrioid,pert
Tk6 treated with cadmium rep1,pert
Embryonic age 17.5 mutant rep4 (PKD1_42),pert
colon_IL10mouse_12weeks_rep6,pert
patient id: T144;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 74;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N1M0;	Stage: III;	fuhrman grade: 4;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
"age at diagnosis: 42;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 0;	pgr: 0;	dfs-month: 26;	dfs-event: 1;	distant metastasis: 0",pert
diabetic muscle replicate 5,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: REBIF;	time: 12 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
strain: FVB/NHsd;	tissue type: back skin,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
P104,ctrl
5871841165_E,ctrl
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_6;	fev1 (% predicted): 55;	fvc (% predicted): 69;	medication: Prednisolone 10-20mg od,Combivent neb 2-4/day,Cetirizine 10mg od,Terbutaline 500mcg od,Budesonide 400mcg 2pbd, Aminophylline SR 450mg bd, Formoterol 12mcg 2pbd;	cell type: CD4+ T-cells",pert
Muscle 50 eccentric contractions 12 hours WT Adult 07273,ctrl
ethanol_ethanol_91,ctrl
V5-P158,pert
224 Day 1 siSC transfected biological rep2,ctrl
tissue: neocortex;	developmental stage: E14.5;	genotype: Eomes WT;	genetic background: C57BL\6,ctrl
dental pulp cell from control 3,ctrl
HES2_Mir122WT_rep1,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 3,pert
WT1,ctrl
pMX-Oct4 no vitamin C Oct4Vc-_2,ctrl
OSE_541,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 3x1h exposure per day",ctrl
Kyoto rat liver tissue following animal exposure to orotic acid for 1 day,pert
"Resveratrol treatment exp 3T3-L1 cells, T3",pert
Subject #8001-Preinfection,pert
BP patient 54_biological replicate 1,pert
"Patient 998, baseline",ctrl
"Vehicle treatment, 7 hours (replication 2)",ctrl
"brain, hippocampus: KA-1h-P15-III_e1_le1",pert
Normal Cervix N5,ctrl
Replicate 2 - Vehicle,ctrl
"medulloblastoma, wt, rep1",ctrl
renal_vesicle_wild_type_3,ctrl
Total RNA Mir140 KO-1,pert
cell type: Melanoma cell line;	cell line name: A375P;	expression: Control shGFP,pert
E14 - 14-3-3Epsilon 2,pert
ALI patient #2,pert
Brain_Aged_Salineip_4hr_mouse3(OP3_#63),ctrl
"WKY adrenals, replicate 2",ctrl
"Normal Skin, Normal-2",ctrl
3348-scrape,pert
Contusion - 35 Day Epicenter Rep1,pert
"tissue: lung, upper lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 67",pert
Subject #8002-8hr Postinfection,ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 48h, biological rep1",pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 3,ctrl
Cervical cancer_CC205,pert
age: 29;	sex: F;	disease status: Marfan subject;	Filter number: 90;	Usage number: 5;	Exposures: 3,pert
"AD_HI, biological rep5",pert
siNS_4h_2,ctrl
Wildtype 3 (jos0928),ctrl
"metastasis: metastasis;	Stage: 4;	tissue: cancer, homogenized",pert
C57_HF_1,ctrl
E10.5 Vax2-/- 3,pert
strain: CD-1;	age: 20 week;	genotype: Wild type;	tissue: heart left ventricle,ctrl
cell type: CD4+ T;	strain: C57BL/6J;	genotype/variation: Cd4-Cre_C57BL6-STAT3<tm1Dlv> (STAT3KO);	treatment: stimulated for 3 hours with medium alone,pert
AtT20 cells treated with NSBP1 siRNA rep 3,pert
11_0014C_Day1_26,ctrl
"MTDH control, biological replicate 1",ctrl
cell type: Primary hepatocytes;	strain: BalbC;	agent: control;	time: 24h;	gender: Male;	age: 6 months,ctrl
CD positive WT T cell TCR-stimulated rep4,ctrl
Flp-InTMT-RExTM-293 (Invitrogen) cell line derived from the human embryonic kidney cell line HEK293 carrying tetracycline inducible transgene,ctrl
healthy control sample x004,ctrl
"ALL_DS, K2 011609",pert
BP patient 51_biological replicate 1,pert
Control_pancreas_3,ctrl
non-malignant FTEn_patient 9,ctrl
"Pou4f1+/+ cells, transduced with control virus_Wt-MSCV_79",ctrl
Mut+/- rep1,pert
MDS patient 145,pert
V5-P085,pert
A_AN08166_T,pert
T51084,pert
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_6;	fev1 (% predicted): 55;	fvc (% predicted): 69;	medication: Prednisolone 10-20mg od,Combivent neb 2-4/day,Cetirizine 10mg od,Terbutaline 500mcg od,Budesonide 400mcg 2pbd, Aminophylline SR 450mg bd, Formoterol 12mcg 2pbd;	cell type: CD8+ T-cells",pert
Muscle-5 month-Myc heterozygous-technical replicate 1,pert
U-87MG-V17 set 3,ctrl
gender: female;	age (years): 34;	evolution time (years): 13;	disease extension: Pancolitis;	treatment: 5-ASA,pert
RNA from HCC_29N,ctrl
Gastrocnemius Muscle Galgt2 Transgenic rep2,pert
Tumor_18w_erlotinib2_DEN_126,pert
strain/background: mix of 129Sv and C57BL/6;	genotype: control;	tissue: back skin;	age: 10 days,ctrl
MDS53,pert
brain_co_6M_rep2,ctrl
age: 6 month postnatal;	tissue: striatum;	genotype: SNCA knockout,ctrl
"Cells transfected with sirtuin 6, biological rep2",pert
PU.1 KD HSC 1,pert
breast normal 1,ctrl
Phan_009_KO.saline rep3,ctrl
NOD Aire WT MEC rep1,ctrl
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p30;	strain: E14,ctrl
"brain, hippocampus: Aldh5a1-/- #3403 Cereb_e1_le1",pert
Karyotype: inv(14)(q11q32);	Age: 90 years;	Gender: female,pert
genotype: wild type;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: vehicle;	tissue: liver,ctrl
lung_CLP_wildtype_rep1,ctrl
liver knock out replicate2,pert
P5,pert
MCF-7-Pit-1 rep 1,pert
"WT, rep1",ctrl
disease state: control;	patient: 1,ctrl
Bone-Marrow_MM_M856,pert
Control 6,ctrl
E8C,ctrl
3894-2 E2F WT,ctrl
Control 3,ctrl
NINDS-RHS-Ctr_240h-2aUA-s2,ctrl
KM_066T,pert
5222 UC Inflamed sigmoid colon,pert
Liver WT ND #690,ctrl
PBMC from T cell LGL leukemia patient #129 (TLGL129),pert
HWS17,pert
"WT mouse lung, biological rep1",ctrl
pediatric AML S02,pert
age: 65;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Scrambled 24 hours_3,ctrl
CD8-IGF1R 3T3 Vehicle 3,ctrl
P5C Progranulin-hippocampus,pert
Kidney_saline ip_mouse #064,ctrl
"PPARg d10, rep 1",pert
Ex1_cells_rep2,pert
07R083 RA,pert
6h WT cel.38,ctrl
Sample ID: TP31;	Twin Pair ID: CCE2.1;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-4.5;	Age at interview & blood sampling: 34;	Current Age (2007): 36;	Sex: FEMALE;	Medication at blood sampling : None,pert
Ishikawa_VeryLowDose_BPA_24h_rep4,pert
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 31;	gender: f;	treatment: -,pert
tissue type: hepatocellular carcinoma,pert
"transfection: pRTS-CA-IKK2;	cell type: human Burkitt lymphoma;	dsmz no.: ACC 603;	origin: established from the ascitic fluid of a 3-year-old boy with American-type Burkitt lymphoma in 1972; cells were described to be EBV-negative but EBV infectible, to carry the (8;14) translocation and p53 mutations",pert
PC3 Wee1 Rep3,pert
cell line: MCF7;	condition: siRNA Med12,pert
V5-P541,pert
"E18.5 brain, wild-type, rep 5",ctrl
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: SD supplemented with 100 mg/kgchow resveratrol ad libitum,pert
siEGFP (24 hr) _2,ctrl
CML_4_CMP,pert
HLA risk: High;	Height: 170.2 cm;	Weight: 63.9 kg;	BMI: 21.8;	Age: 30.94 years;	Gender: Female;	Race: White;	Glucose: 93 mg/dl;	HbA1c: NA,ctrl
H8 HA 2h 4,pert
2h 4OHT-treated-sample1,pert
P 25 Control,ctrl
STING tumor DNA II,pert
background: C57BL/6x129Sv/B6 hybrid;	genotype: Prkaca+/-;	age: 9 months;	tissue: caudal vertebral bone,pert
Genetic background: C57BL/6J; Age: 6 weeks old; Gender: female; Diet: chow; Non-fasted; Genetic modification: None (Scd1 +/+; wide type control).,ctrl
Tissue: brain (frontal cortex);	Disease State: HIVE,pert
CUTLL1 GSI-rep1,ctrl
LKR13_Kras sh-4,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6;	colon weight (mg): 167;	colon ratio (mg/mm): 2.78;	myeloperoxidase activity (u/mg): 0.056;	tissue: colon;	treatment: 5% DSS,pert
"Autoimmune pancreatic islets, day 1 cyclophosphamide treatment, rep 3",pert
8 week old leg control rep 4,ctrl
"Rat liver, treated with NMF, 1000 mg/kg in saline i.p., extrated 48 hours after treatment, biological rep5",pert
"E18.5 ERRg +/+ heart, biological rep 1",ctrl
50uM_Zn_1,pert
C021_Control_M_25,ctrl
Bone-Marrow_SMM_S1258,pert
Sirt1 siRNA KD2 2,pert
CD19_selected_B-cells_after_R_rep8,pert
0711-04-A,pert
Dilated cardiomyopathy_G63,pert
Spleen_infected_7weeks_rep1,pert
"E12.5 Ret-deficient embryonic kidney, biological rep2",pert
"Mutant in the absence of tetracycline, rep2",pert
siCONTROL + MMC experiment 3,ctrl
SeroNeg-11,ctrl
whole blood_100190,ctrl
129S1/SvImJ Vehicle liver sample batch 4,ctrl
Scrambled 24 hours_1,ctrl
U937-shGSK3B-Construct2-rep2,pert
Setleis Syndrome patient 4,pert
subject: 9;	disease: CP;	muscle: ST;	gender: M;	age: 11.2;	gmfcs: 2;	popliteal angle: 110,pert
liver_female wt_rep1,ctrl
B4 398 b4-/- untreated,ctrl
colon_adenoma_1154,pert
HF0291_U133P2,pert
LNCaP.GFP.2,ctrl
"MCF7, non specific control, biological rep2",ctrl
"proband k, before exhaustive exercise",ctrl
control siRNA rep4,ctrl
individual: patient4;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"human failing LV myocardium, Idiopathic71",pert
GFP 0hr 282295423,ctrl
NOD non-transgenic islet rep1,ctrl
anti-FGFR1_rep5,pert
shOCT4_2,pert
Shn2_Mutant_3,pert
Liver-24 month-Myc heterozygous-technical replicate 3,pert
"Patient H-s124T, MSI colorectal tumor",pert
"Patient Z, lesional skin",pert
Parkinson's disease sample x023,pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 61;	donor: 16;	disease state: Lesional,pert
U-87MG-V8 set 3,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 16 hrs AP20187,pert
cell line: SBC-5 cells;	treatment: siEGR4 (target);	time: 72 hr,pert
cell line: sh3293 T47D;	sherbb3: +,pert
brain_OFC_bipolar B_mr91,pert
"AD_FC, biological rep15",pert
H441 transfected with ETS2-specific siRNA 1,ctrl
BM_02879,ctrl
ndf + preLA,pert
"granulocyte, healthy control, biological rep10",ctrl
"Ulcerative Colitis (57 year old caucasian female, SAK_1286542779)",pert
CUTLL1 DNMAML1 GSIwash2h-rep3,pert
knockout mouse kidney - 1,pert
1212-5heart_Control,ctrl
Placenta Adra2bKO 2,pert
AP-2 gamma targetting siRNA 3: CCACACUGGAGUCGCCGAAUA Technical Replicate 1,pert
Cell line expressing inducible wt-GFP-lamin A. Induction: day 5. Replicate B,ctrl
NINDS-RHS-Kainate_24h-1aUA-s2,pert
Subject 5 / lung subsegment instillated by LPS,pert
NoKD_SerumStarved->3hrEGF_rep1,pert
A39 WT4	F25/17	A39	wild type	Mouse	4 months	Cerebellum	Female,ctrl
Array Type; Affymetrix Mouse 430_2;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7,ctrl
"MCF-10A cells, overexpression vector control, biological rep1",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 25.79452,pert
HDAC2 siRNA_3_Huh7 [HDAC2 siRNA subset],pert
"BOEC, normal 11",ctrl
"D425-shOTX2_1, t=16",pert
multiple sclerosis_6,pert
IM63_case,pert
V5-P120,pert
"Murine 3T3-L1 progenitor adipocytes cell cultures, Control 2 (untreated with resveratrol)",ctrl
braak stage: CTRL;	rin: 81;	tissue: substantia nigra;	disease state: control,ctrl
Strain: C57BL/6J;	Gender: Male;	age: 3days;	genotype:KO;	tissue: brown fat,pert
BxPC3-KO4 rep 1,pert
tetO-Satb1 #2,ctrl
1000uM H2O2,pert
treatment: Control siRNA Vehicle;	cell line: MCF7,ctrl
tissue: muscle;	sample group: resveratrol;	treatment: before;	gender: Female,ctrl
"202, MUSCLE, Before",ctrl
HF0512_U133P2,ctrl
Untreated WT - repeat 6 - mAdbID:102770,ctrl
homozygous_TGFb_24hr_2,pert
C57/BL6 murine Liver RNA- 6 hours post-injection with PBS;	,ctrl
"TGCT cell line NTera2/clone D1, treated 3 days with retinoic acid, differentiated",pert
Bmpr1a-/- ESC media sample 3,pert
Jurkat-J3,ctrl
tissue: white blood cells;	age: 16.53;	Sex: female,pert
patient: 222;	current medication: Prednisolone 20mg Balsalazide;	birth date: 4/13/52;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 9/1/85;	diagnosis date: 6/20/86;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 12/16/04;	indictation for procedure: ;	ucss: 9;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/16/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
WT_d00_eX_vs_KO_d00_eX,ctrl
wildtype 8,ctrl
T65 dilated cardiomyopathy heart biopsy,pert
Endometrium/Ovary-Disease 6,pert
Wild type Retina Rep2,ctrl
No or early 2 rep4 (OHN),pert
GIST Pre Treatment Biopsy 02,ctrl
tissue type: Lesional skin;	time: Pre-dose,ctrl
sample =Healthy3 treatment=Control time=360 (min),ctrl
"MCF-10A cells, overexpression TAp63γ, biological rep3",pert
"KARPAS-231, LITAF-specific siRNA, REP1",pert
Tumor_setB_Ker80,pert
Replicate 3 - Vehicle,ctrl
Syracuse Low Avoidance (SLA) learning rats 3,pert
sampleID: SAM630135;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
"vestibualr organ at P15 of Igf1 +/+, biological rep 3",ctrl
cerebellum_PSNA_ 18w_rep1,pert
Liver_POR-null_2,ctrl
SKI-DLCL cells_AraC 20nM_24h_rpt1,pert
M229_A_PLX,pert
CML_7_HSC,pert
SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1),pert
A HID I_B051,pert
"strain:BALB/c WT, gender:male, age:8wks, tissue: whole lung, condition: uninfected control",ctrl
EA_Case7_CD4,pert
55A;pretreatment;female;breast tumor; responder,ctrl
Normal esophageal epithelium (N4),ctrl
"Ada3FL/FL MEF, Cre, biological replicate 1",pert
Donor4_6h_DMSO,ctrl
control to Sample 17,ctrl
Array Type: HG-U133A_2;	Ratio: 1.97;	RNA Integrity Number: 9.9;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Mening UNSTIM WB SW 6b,ctrl
"eye, cornea: TRizol Extraction_le1 1",pert
Menadione (5uM) rep 3,pert
"Oral Squamous cell epithelium tissue;	Patient code:OSCC-2;	Age:58;	Sex:F;	TNM:T2N0M0;	;	ABBREVIATION:TNM,TUMOR-NODE-METASTASIS",pert
strain: C57BL/6;	tissue: cerebral cortex;	age: E14;	gender: not determined;	genotype: WT,ctrl
"Femal C57BL/6, ovariectomized",pert
2h Kin Cel.06,pert
CF CFTR unexposed replicate 2,pert
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 83;	Sex: male;	region: LC (locus coeruleus);	age: P22;	genotype: Y/Mecp2-;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,pert
D2-Gpnmb+ control rep5 (retina),ctrl
optineurin expression-b01,ctrl
2075N,ctrl
FVB_MMTV_Wnt1_iFGFR2_3861_3L_ROSEN,pert
cell type: Embryonic stem cells;	genotype: Bmpr1a-/-;	culture condition: ESC media,pert
FHCRCAML7216,pert
"SiRNA-scrambled, replicate 4",ctrl
LJMJDW5,ctrl
brain_Down_syndrome_sampleid_jg1742,pert
LacZ control_4b,ctrl
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 4,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: del5q,pert
scan batch: Batch 2;	group: control;	subject age: 8;	paternal age: 34;	maternal age: n/a,ctrl
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 79;	Usage number: 4;	Exposures: 2,pert
Skinbiopsy_96hoursnickel_controlsubject_k1,ctrl
Control LM2 Cell on HMVEC-L Replicate 1,ctrl
"human failing LV myocardium, Ischemic21",pert
56 year old female,ctrl
race: caucasian;	age (years): 88;	stage: IC;	grade: 3;	histology: endometrioid,pert
strain: C57Bl/6;	genotype: wt;	treatment: Freshly isolated cells,ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 24h, biological rep4",pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 58 yr;	population: white;	dsm-iv: 296.54;	age of onset: 27 yr,pert
major HCC1,ctrl
JGB-Pre-3UP_Run2-S2,pert
DU145/NC siRNA #2,ctrl
V5-P397,pert
genotype/variation: wildtype;	strain: C57/Bl6;	age: newborn 0-6 h;	tissue: Lung,ctrl
protocol: control;	cells: Human Neural Stem Cell Line F3,ctrl
25_C57_WT,ctrl
H1993 shRNA Control _2,ctrl
Bronchial Epithelial Cells control biological 2034B,ctrl
SU8686 rep-1,ctrl
cell line: H1299 lung cancer cell line;	genotype/variation: control;	shRNA: scramble,ctrl
FSH-NHM-3UA-s2,ctrl
gender: Male;	age: 75;	post-mortem delay: 9h;	ph: 6.3,pert
Bc_p60_1,pert
background strain: B6/129;	genotype/variation: mir-122 knockout;	age: 14 Month;	tissue type: Tumor,pert
"MCF-7 cells-40mM g-T3, biological rep 1",pert
Y YOKE_B059,ctrl
Wild-type mice rep5,ctrl
Age: 47;	Cycle: Follicular;	BRCA1/2 mutation: BRCA2 6174delT;	Family History: Yes,ctrl
KN-sham-1 day-R4,pert
Tumor from MYF-5 CRE/SSM2 mouse SSM4,pert
V5-P381,ctrl
Normospermic individual: Sample N2,ctrl
WT_MEF_rep1,ctrl
"Acute Myeloid Leukemia, sample 60",pert
Vastus lateralis muscle,pert
iA50clone6+,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous endotoxin challenge""",pert
C1E-LU,ctrl
8N,ctrl
colonic_mucosa_non_inflamed_722,ctrl
"Data 2, overnight control",ctrl
Itk knockout CD4+ CD3-stimulated 2,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 53 yr;	population: white;	dsm-iv: 295.9;	age of onset: 23 yr,pert
Tissue: brain (frontal cortex);	Disease state: HIVE-control,ctrl
heart of mouse subjected 4 week to chronic intermittent hypoxia (4B),pert
TAC 3,pert
"Peripheral blood, patient without recurrent events [N29]",pert
genetic background: C57Bl/6;	genotype: Calcr-/-;	cell type: Osteoclasts;	treatment: Calcitonin,pert
Mic34_muscle_control,ctrl
M452 SKM-Tg,pert
GEIM50-U133A-Norm,ctrl
"Foxd3 conditional knockout cells treated with DMSO, biological rep2",ctrl
age: 69;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
ZF6B7,ctrl
"strain: Swiss;	tissue: adult mouse intestine, kidney, and liver plus fetus tissue",pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: Vemurafenib 1000 nM for 72h,pert
"adenocarcinoma at 20wk, biological rep 3",pert
"FIH null MEFs, biological rep1",pert
Manca 3,pert
"Sciatic nerve, acrylamide treated, biological rep1",pert
CD11b+Gr1- cell sample_1 (derived from wild type mouse),ctrl
HMEC_control experiment 3,ctrl
phenotype: no or early glaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 10.5 months,pert
Wild-type ESCs Rep3,ctrl
PPARg WT macrophages rep 1,ctrl
Skinbiopsy_48hoursnickel_controlsubject_k5,ctrl
ab072 IM,pert
Pooled_1,pert
"105, ADIPOOSE TISSUE, After",pert
S/SM2,pert
ES2 COUP-TFII-3 25nM,pert
FO_spleen_wt_rep3,ctrl
wt 13.5d replicate 7,ctrl
01UNJ_Oligo,pert
5282 UC Uninflamed ascending colon,pert
knockdown: Control;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 7.2;	colon weight (mg): 154;	colon ratio (mg/mm): 2.14;	myeloperoxidase activity (u/mg): 0.019;	tissue: colon;	treatment: 5% DSS,ctrl
T51091,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.652;	OD280: 0.857;	Ratio: 1.92;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 215;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
HNF4 CONTROL_277,ctrl
tissue: brain,ctrl
normal adjacent esophageal tissue from patient E1603,ctrl
Plate vs. Nail:  6 Week Nail,pert
KO PBS3,ctrl
platelet_Ctrl_9,ctrl
14A;pretreatment;female;breast tumor,ctrl
colon_CRC_1479,pert
autism with FMR1-FM AU046706,pert
TA-t10-2; transgenic tibialis anterior 10 month,pert
Sample 06 Kidney Normal Mouse - Low Phosphate Diet,ctrl
foxp3 expression: NO;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 2T>C(mut);	gender: female;	treatment: none,pert
12h Lipofection GAPDH siRNA (SAMPLE 5),pert
"wild type ES cells, biological replicate 3",ctrl
GFP Untreated 24hr 282295833,ctrl
Disease_status: Down syndrome;	Age (years): 63;	Gender: Male;	Post mortem interval (hours): Unknown;	Braak stage: Unknown;	Cause of death: Unknown,pert
OCI-Ly7_FOXP1 overexpression,pert
@52055800697862121408403718160364,ctrl
"Control #2, Untreated",ctrl
MCL_IGHV_MUT (269-01-5TR),pert
HP-9,pert
U2-OS-ERa E2 4 hrs 2,pert
"cell type: Normal human diploid WI-38 lung fibroblasts, CCL-75(TM), passage 7-12.",pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 5,pert
"Endometrium, postmenopausal, tibolone, 11-2",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.908;	OD280: 1.959;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 356;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
NRG Melan-Ink4a #2,pert
cell: Cultured oligodendrocytes;	genotype: Myelin-gene Regulatory Factor conditional knockout,pert
A2AR_KO_saline_24h_rep2,pert
UV-SeV 3480,ctrl
MDS patient 33,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 36, stage IIB, HPV 16",pert
N_LS_Wk4,pert
Cervical Cancer C290,pert
"patient: 108;	current medication: Asacol 400mg BD;	birth date: 8/30/33;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: Altered bowel habbit, ? UC 1974, never on Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
ab119 IM,pert
Individual_5242_PP_sample,pert
WT-PB_rep-1,ctrl
A HID I_B050,pert
3702-2 E2F3 Heterozygous,pert
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T2N2,pert
"Vehicle, biological rep1",ctrl
CONTROL 2,ctrl
scan batch: Batch 2;	group: control;	subject age: 5;	paternal age: 35;	maternal age: 34,ctrl
"heart of mouse, 1 week control (1B)",ctrl
"control colon tissue, biological rep2",ctrl
Fog2flox/delta; no Cre biological replicate 2,ctrl
DQD A,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 26.040;	Ratio: 2.11,pert
BP patient 79_biological replicate 2,pert
T6,pert
"Normal subject (47 year old caucasian male, SAK_1279993350)",ctrl
strain background: CD1;	genotype/variation: wild type; Raldh2 +/+;	tissue: embryonic brain;	tissue region: Rostral/Anterior;	developmental stage: 14 somite stage,ctrl
liver_STZ treated diabetic_rep4,pert
reduction mammoplasty patient 340,ctrl
Muscle-AMPKgamma3-wt-11,ctrl
pediatric AML PP9,pert
liver control diet rep5,ctrl
"gene expression of CTCF-depleted oocyte, replicate 2",pert
B11 - non-infected BALB/cByJ fibroblasts,ctrl
B7hi mTEC B6/129 aire-/- 3,pert
siPin1.exp3,pert
Diabetic untreated rats 1,pert
age_years: 46;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
32023.LMP,ctrl
WT-4 (Large PreB),ctrl
lateral hypothalamus no access to cocaine replicate 1,ctrl
"A673 treated with Puromycin for 3 days with concentration of 0.09 uM (EC50), biological rep2",pert
siCtrlVeh4h_2649,ctrl
WT.DMSO.1,ctrl
PWD/PhJ Vehicle liver sample batch 2,ctrl
treatment protocol: GSK-3 inhibitor (SB216763) treated for 20 hours,pert
"seminoma specimen, pT1, patient age: 25y",pert
liver_Akt1+/-_35wk_rep1,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 4h,pert
206/0,ctrl
RNA from HCC_16T,pert
"Pancreas from adult WT mice, biological replicate 1",pert
11-0057A_Day1_33,pert
HSC-wildtype-1,ctrl
C013_Control_M_61,ctrl
Subject #8038-8hr Postinfection,pert
"U373-DTX1-myc, rep 2",pert
WT LSK rep1,ctrl
agent: control (untreated);	time: 48h,ctrl
individual: Control9;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
Disease_status: Healthy control;	Age (years): 34;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.48;	Post mortem interval (hours): 22;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
92.1 - control #1 - replicate2,ctrl
cell line: HEK293 cells WTX inducible clone F18;	agent: control,pert
AAA neck (Sample 6),pert
Control_3,ctrl
HL60_luc_Replicate2,ctrl
MDA-MB-231_siScramble_rep.2,ctrl
wt_2,ctrl
Parkinson's disease,pert
AIRE-ko-CD80lo-mTEC-sample1,pert
Liver_SRC-2 Knockout_Rep1,pert
MSC_SA01_3,ctrl
B2KO; No Treatment #3,pert
gender: Female;	tissue: Tendon;Subscapularis;	age: 62;	donor: 13;	disease state: Non-lesional,ctrl
Pediatric_GBM_11,pert
Patient 6,pert
mammary stoma-4w-KO-rep2,pert
platelet_sickle_15,pert
Tet2 KO LSK rep2,pert
KU_31T,pert
cerebellum_wild type_24 weeks_replicate 1,ctrl
Individual_4339_PN_sample,pert
"imr-32, cdk4 siRNA, t=48, 4",pert
tissue: bone marrow;	cell type: macrophage;	genotype/variation: IFNAR2-/-;	infection: uninfected,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_12_39_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
NFIa E18KO2,pert
Ishikawa_VeryHighDose_BPA_24h_rep2,pert
Individual_4136_PP_sample,pert
Muscle Control 1,ctrl
LKR13_Kras sh-2,pert
THRB 15b mutant + T3 replicate 3,pert
Normal-N_AJ2,ctrl
WTGFP QSC Biological Rep.1 Technical Rep.1,ctrl
"PBMC, patient. Mtx rep9",pert
SIN3A_siRNA_NS_rep1,pert
"granulocyte, patient. Mtx rep2",pert
HL60-shControl-rep3,pert
695_383_0hr_repeat,pert
age_years: 60;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
cell line: TF-1;	gender: male;	age: 35 years;	disease: erythroleukemia (AML M6);	sirna: control,ctrl
"treatment with MDBP, replicate 1",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.592;	OD280: 1.273;	Ratio: 2.03;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 341;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
THRA aI mutant + vehicle replicate 3,pert
sample =Healthy4 treatment=Control time=0 (min),ctrl
"Setd2 wild type mESCs, biological rep3",ctrl
CF (D508) subject10,pert
MCF-7 +ER siRNA + vehicle rep2 (MD38),pert
phenotype: control;	gender: male;	case_id: 190;	age: 68;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 16.75;	brain ph at time of freezing: 6.59;	labeling_batch: 1,ctrl
"WI-38 cells, at 24 h after exposure to DMSO vehicle control, biological rep2",ctrl
"human failing LV myocardium, Ischemic32",pert
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:73;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
brain knock out replicate1,pert
"Control 08, NC08",ctrl
pediatric AML S17,pert
K14deltaNB-cateninER  Time 7 replicate 2,pert
MDS patient 104,pert
Superior Frontal Gyrus from 2 and 4 year-old girls suffering from Rett Syndrome.,pert
K562 cells CREB Knock-out replicate 4,pert
Muscle-AMPKgamma3-ko-1,pert
Diagnosis: AML M1;	Age: 54y ;	Gender: Female;	Blast %: 89;	Source: PB;	Cyto: Normal;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
BALB/c control (200msn),ctrl
Gastric_cancer_patient_1,pert
CUTLL1 MigR1 GSI-rep3,ctrl
Placenta_PE(LO)2,pert
rheumatoid arthritis 2-21,pert
genotype: ILKS343D Tg;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Female,pert
6h_RA1,pert
E14.5 Tgfbr2 Wildtype Mouse Model Palate 2,ctrl
Cardiomyocyte control 2,ctrl
FVB; No Treatment #3,ctrl
heart MHC-Plin5 1,pert
high grade serous carcinoma_patient 2_sample 1,pert
Substantia nigra normal rep8,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.615;	OD280: 0.851;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 73;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
cell type: Primary human epidermal melanocytes (neonatal),pert
A HID U_B042,pert
SARRC-1100-03-Aq,pert
"human peripheral blood derived monocytes, 8 hour LPS stimulation, biological rep2",pert
"DMSO-treated, Sham UV, Replicate A",ctrl
WT-smoke-low-5 month+1d-R1,ctrl
V5-P566,pert
"N-56, NORM, M, GSF, 6 x 100nM DHT, 14d",ctrl
brain_control_sampleid_mr283,ctrl
"TNFa siRNA-A, replicate 4",pert
MDS patient 117,pert
ctrl_514,ctrl
NPC13,pert
"Other: Equal quantities of total RNA from each cell line (brain, breast, B-lymphocyte, cervix, liver, liposarcoma, macrophages, skin, testis, Y-lymphocyte) were pooled together.",pert
"fibroblast, control subject NM8 rep 2",ctrl
"BOEC, normal 22",ctrl
chip number: 7;	transfection plate: 2;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2011-03-29,ctrl
Series 3; adult; 4 weeks after fracture,pert
Pt_2 Acne Lesion,pert
Patient no. 13: treated,pert
Csbm/m Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-1,pert
MDS patient 138,pert
TF_1_shTRAF6_d2.5_rep1,pert
"RES-enriched Grape extract group, 12 months, patient number 51",pert
"Wildtype, thymic, NK1.1+ NKT cells replicate3",ctrl
Ulk1/2-/- (untreated) 1,pert
Day3 Genistein treatment replicate 2,pert
sample type: no history of asthma;	tissue: smooth muscle cells;	treatment: dexamethasone for 4 hr,pert
T3D-LU,pert
"A673 treated with DMSO vehicle control for 3 days, biological rep2",ctrl
"bipolar disorder, BA10-8(2)",pert
transfected with FoxP1 siRNA_1,pert
PBMC from T cell Large granular lymphocyte leukemia patient#1352,pert
Trim33-KD-ac-1,pert
scpk/ikLLtumor/146,pert
01N72_CTRL,ctrl
tissue: brain;	genotype: mutant 14-3-3 ko/ko;	age: E14,pert
NINDS-RHS-Ctr_72h-3aUA-s2,ctrl
Normal_MS 36D2,ctrl
KU_26T,pert
"Cell line SLM2, mutant status WT, condition Control 2",ctrl
"D425-shOTX2_2, t=0",pert
con_B148,ctrl
Saline T00278943,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_6h_4mM_HG-U133A_2_YCHSUP501,pert
SKMEL28_t0h_rep2,ctrl
whole blood_101644,ctrl
striatum_wild type_12 weeks_replicate 3,ctrl
Liver antiangiogenic-treatment rep4,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID323,ctrl
DMSO Control 2,ctrl
11m1,ctrl
whole tissue section from case 878,ctrl
A2AR_WT_saline_24h_rep2,ctrl
"C57BL/6, Female, Contol",ctrl
"Wild-type-hippocampus, biological rep8 (female)",ctrl
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/8,pert
CD-76-Aff1,pert
Subject 5_t=30days_placebo,ctrl
shRNA6-16-noDox-rep2,ctrl
Disease_status: Healthy control;	Age (years): 39;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.46;	Post mortem interval (hours): 58;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,ctrl
strain:C57BL/6; VillinCRE-HNF4loxp; female; tissue colon; control,ctrl
P72 dilated cardiomyopathy heart biopsy,pert
cMyb virus-infected replicate 1 (MCF7),pert
Brain_nAChRbeta4SubunitDeficent_MiceNob4365,pert
Control ITP chip A,ctrl
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 35;	Usage number: 1;	Exposures: 4,pert
WT-GFP-lamin A Induction: day 10 Replicate B (3b_WT_10d_B),ctrl
Control subject 29_biological replicate 2,ctrl
MCF10A 3days,ctrl
HNF4 Null_1191,pert
"Immortalized MEFs WA, v-src expression retroviral vector infected, rep2",pert
"U-87 glioma cell line with shp105, biological rep2",pert
wt-Gfp E16 replicate 1,ctrl
age: 3 wk;	tissue: whole heart;	genotype: Pitx2 Flox/Flox,ctrl
"A pool of RNA from lung from three female mice, raised at Denver altitude (nearly normoxic), with SM22-rtTA x tetO7-BMPR2delx4+ transgene activated for 8 weeks",pert
age_years: 51;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
"Peripheral blood, patient without recurrent events [N48]",pert
CDF1-p3 (177msn),pert
VillinCreERT2-_Rep1,ctrl
cell line: L428-PAX5;	treatment: Mifepristone (M);	duration of treatment: 5 days,ctrl
"genetic control Alb-Cre:Keap1(flox/+), gender- male, age- 9 weeks, n = 1, # of tissue = 1 tissue: Liver",ctrl
tissue: white blood cells;	age: 9.66;	Sex: male,pert
patient: 428;	disease state: LGSC;	component: Borderline,ctrl
ubb_d14_wt_1,ctrl
KO - knock-out Treated - 12 hrs - repeat 2 - Cy3 - mAdbID:61763,pert
Sham-operated,ctrl
immortalized cells derived from brown fat tissue of mouse of mixed background.;	passage number: 4,ctrl
Wild Type B cells Spleen 5,ctrl
"Mdr2-KO homozygous mouse, 3 month old mouse 3",pert
cell line: C13;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
"Gender: female, Age: 32 years, Tissue: VIN 3",pert
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 39;	Usage number: 4;	Exposures: 3,pert
CF knockout HFCF CHN308,pert
"Cbfb+/+, technical replicate 2",ctrl
"peripheral ganglion, unknown: nicotine 24 hr",pert
tissue: whole blood;	disease state: healthy,ctrl
tissue: resected liver tumor;	genotype: major [rs8099917 TT],ctrl
tisue: cleared mammary fat pad;	genotype: Rarb +/+;	age: four weeks,ctrl
source: JAX stock # 005823;	strain: B6.129P2-Lrp5tm1Dgen/J;	tissue: retina;	age: P8;	genotype: Lrp5 KO,pert
MEF_WT_rep2,ctrl
M327 SKM-KO,pert
KO.ES. rep2,pert
50A;pretreatment;female;breast tumor,ctrl
THRB 15b mutant + vehicle replicate 3,ctrl
kidney_Q10_14M_rep1,pert
Bone-Marrow_MGUS_G492,pert
T30162_rep,pert
Dilated cardiomyopathy_G59,pert
colon_CRC_1158,pert
PsOEt-17-Week 1,pert
CH2113,pert
"3T3-L1 siControl 48h, biological rep 2",pert
"human failing LV myocardium, Idiopathic46",pert
Treg WT rep3,ctrl
shOCT4_4,pert
HT29 PLX Day3 rep2,pert
Sample M559,ctrl
Muscle 50 eccentric contractions 12 hours KO Aged 1215,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT wildtype, DMSO-treated",ctrl
S032_Scz_M_77,pert
individual: Control4;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
patient id: T183;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 56;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxM1;	Stage: IV;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
RE550_H1650_Un1_REHYB,ctrl
timepoint: 2h;	drug: Saline;	group no.: 37;	large batch: Y;	plate: 4164379045;	hybridization batch: IV,ctrl
MCF7_Doxorubicin_Array_2,pert
ic21 -- mockAPF on membrane A,ctrl
Akt1 wild type 1,ctrl
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 84;	Usage number: 4;	Exposures: 3,pert
cerebellum_WT_0d_rep1,ctrl
HCC PBMC_sample 10,pert
E2 2hr,pert
Globin_C4,ctrl
CD-76-Aff2,pert
KU_25T,pert
Aurka_R_-Dox_rep3,ctrl
A511 MI 1 day,pert
type_of_rx: AF;	pre_or_post_treatment: pre;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 6x5;	patient id (to identify the 2 chips from the same patient): 16821717,ctrl
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2-/-;	agent: IFNβ,pert
whole tissue section from case 319,pert
BALB_Male_Control_rep3,ctrl
brain_DLPFC_bipolar C_mr945,ctrl
KN-sham-2 month-R3,pert
cell line: NG4;	cell type: embryonic stem cells;	transfection: siDdb1,pert
BL Day 1 siSC transfected biological rep3,ctrl
Individual_5305_NN_sample,ctrl
"Sfrp5 KO HFD 8 weeks, biological rep6",pert
157B,ctrl
HC JR 2 water,ctrl
GFP-KD-3 (mRNA),ctrl
SZ4,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.469;	OD280: 0.766;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 139;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell type: PGC;	genotype/variation: control,ctrl
strain: C57/Bl6;	genotype/variation: ASC1 null;	gender: male;	tissue: epididymal white adipose tissue,pert
MDS patient 17,pert
"wildype 129 mice, pineal glands disected at postnatal day zero.",ctrl
"treated with Roziglitazone, 1000 mg/kg in Methylcellulose soln per orally, extracted 48h after treatment, biol. rep3",pert
KU_09T,pert
Cell line BT-474_c-myc KD_expt2,pert
FW_15c_BV5830,ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 4;	biological rep: 3,pert
A HID U_B004,pert
Mutant_liver_5,pert
erStress_twins_AA_1727twin2_DMSO_4h,ctrl
P0 - lis1cko/ko Mix 1,pert
Normal Chip#4,ctrl
"mutant triceps, biological rep3",pert
Mouse_Retina_P7_Control 1,ctrl
"WT, PE treated whole heart, individual 4",ctrl
KM_079T,pert
cell line: HL-60;	replicate: Replicate3;	treatment: shLuciferase,ctrl
CD8-IGF1R 3T3 Vehicle 2,ctrl
C4_transgenic but unaltered,pert
"BMMs, untreated control, db, Replicate 1",pert
Normal_Kidney_Biopsy_1,ctrl
strain: 21;	Disorder: normal;	Condition: no hydrocortisone,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 48;	gender: male,pert
"Murine 3T3-L1 progenitor adipocytes cell cultures, Control 1 (untreated with resveratrol)",ctrl
Bone-Marrow_SMM_S1433,pert
lucif_4,ctrl
A375 control-4,ctrl
Clozapine treated 12weeks AffyGC RMA rep7,pert
"NPTX1 shRNA Day 5, biological rep2",pert
strain/background: C57BL6J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: sham surgery,ctrl
race: african american;	age (years): unknown;	stage: IA;	grade: 3;	histology: papillary serous,pert
EA_Case17_CD8,pert
cell line: MDA-LM2-shTARBP2;	transfection: shControl,ctrl
Sample ID: TP32;	Twin Pair ID: CCE2.2;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-5;	Age at interview & blood sampling: 34;	Current Age (2007): 36;	Sex: FEMALE;	Medication at blood sampling : None,pert
Liver_TAK1KO_Rep1,pert
c57BL/6JTCE liver sample batch 5,pert
wt-Gfp P2 replicate 2,ctrl
E9_Embryo_Wild Type_1,ctrl
NSC6,pert
patient: 9;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Rybp#10 (OHT-)_12d_rep1,ctrl
"Wild type fibroblasts, biological rep4",ctrl
ATF2 Genotype: KO,pert
anti-FGFR1_rep6,pert
tissue: Whole pancreas;	genotype: Rkip-1 KO;	background: C57BL/6;	age: 8 weeks,pert
Disease_status: Bipolar disorder;	Age (years): 56;	Gender: Female;	Age of onset (years): 14;	Duration of illness (years): 42;	Brain pH: 6.58;	Post mortem interval (hours): 26;	Side of brain: Left;	Fluphenazine mg. Equivalents: 25000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
Patient no. 6: treated,pert
01J48_PolyRF-,pert
New El-Ashry 012.CEL,pert
Control Braak α- synuclein Stage 0 C2SN,ctrl
OSE4 shGFP Ctr at 72h,ctrl
cell line: MCF7;	condition: siRNA Smc3,pert
Treg cells Ptenfl/flFoxp3-Cre replicate 3,pert
10 week control spinal cord rep 2,ctrl
"in vivo,2 cell stage, embryo",ctrl
12468 UC Inflamed sigmoid colon,pert
THRA wt + vehicle replicate 1,ctrl
"Cell type: neuronal, age:39, gender:female, diagnostic group: control, PMI:58h",ctrl
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 1h;	donor: 1,pert
3406-lcm,pert
"WT LSC, biological rep2",ctrl
"Rat Schwannoma cell line that express genes associated with glial characteristics including Sox10, p75, GFAP, and S100.  For additional information please see: Hai, M., Muja, N., DeVries, G.H., Quarles, R.H. and Patel, P.I.;	(2002) Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J Neurosci Res 69:497–.508.",pert
WT #2,ctrl
cerebellum_WT_10d_rep1,ctrl
TA-t10; transgenic tibialis anterior 10 month,pert
Shn2_Mutant_4,pert
Normal_Kidney_Biopsy_9,ctrl
U138MG shcontrol 3,ctrl
endothelial_rep7,pert
KO PBS4,pert
CRC_nodrug_M4876,ctrl
"S1P3-KO-neocortex, biological rep5 (female)",pert
SLE1,pert
48h_RA2,pert
HT29 siRNAc.G,pert
tissue: skin;	individual: Patient N-1;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
placebo treated ipsilateral to stroke replicate,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: vehicle control;	treatment time: 48 hours,ctrl
"HSCs from male mice treated with E2, replicate 2",pert
brownfat_WT4_day3,ctrl
sex: Male;	Age: 108 months;	additional patient information found in Series supplementary file,ctrl
tissue: xenograft tumor,ctrl
cell line: HEK293,ctrl
cell type: Primary hepatocytes;	donor: 2;	agent: control;	time: 24h;	gender: Male;	age: 44 years old,ctrl
c 2-3,pert
tissue: lung;	strain: CD-1;	age: 20 week;	genotype: Wild type,ctrl
B5_pseudomonas_overexpressor_422,pert
"strain: Swiss;	tissue: adult mouse intestine, kidney, and liver plus fetus tissue",ctrl
strain: FVB;	genotype/variation: ErbB3 DOX-KO;	tissue: Mammary epithelial organoids;	treatment: control,ctrl
sal-PVH3_2,ctrl
c_NY101,ctrl
GM19238_Kd_IRF9_1,pert
CD-53-Aff,pert
XBP1s Tumor 5,pert
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Stromal Cell,pert
umbilical cord_bpd: 6F,pert
Bmpr1a-/- N2B27 sample 1,pert
Wild type IFN-beta 4 h,ctrl
WT.DMSO.3,ctrl
Normal-N_AJ3,ctrl
24 hr KLF4 Time Course Control,ctrl
cell line: ACC525 [DND41];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
Embryonic age 14.5 wild-type rep1 (PKD1_57),ctrl
YFP+Foxp3delta r2,pert
SZ26,pert
"Crohn's Disease subject (47 year old caucasian female, SAK_1280820411)",pert
"BOEC, at_risk 8",pert
K562_1R-Chl_24hrs_rep3,pert
"GNMT knockout at 3 month age, biological replicate 2",pert
MLL1-KO MEF CT18-3,pert
chip number: 18;	transfection plate: 3B;	target gene: DIP2B;	kd level: 0.83;	rin: 9.5;	transfection date: 2012-03-26,pert
testis knock out replicate1,ctrl
Time:4 day; condition:LaminA ko;,pert
"Patient H-s115T, MSI colorectal tumor",pert
A61 WT4	F24/5	A61	wild type	Mouse	8 months	Cerebellum	Female,ctrl
cell type: placental trophoblast;	developmental stage: E12.5;	genotype/variation: wild type,ctrl
E1-uninduced (no Dox) control,ctrl
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P2,pert
BP25,pert
Luciferase shRNA_2 Days knockdown_rep3,ctrl
Expression data from liver of the KRAP deficient mice (WT3),ctrl
"experiment II, hTERT, replicate 2",pert
s4t4c,ctrl
"Dumbo retina, biological rep4",pert
"normal nasopharyngeal tissue, specimen N4",ctrl
"60B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/43;	differentiation status: undifferentiated;	cell line: Q50,pert
ID: MLL_00118;	cell type: PBMC;	disease state: control,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 16 hrs AP20187,pert
"alveolar macrophages, smoker 044",pert
Genotype: wild type;	Strain: C57BL/6J;	Age: 8-weeks,ctrl
Normal cortex of patient T164,ctrl
EA_Control4_CD8,ctrl
WT_cells_rep3,pert
Psoriasis-Patient-I,pert
Zfx fl MA9 cells + 4-OHT [10986],pert
cell line: ACC483 [HPB-ALL];	cell type: human T-ALL cell line;	agent: control,ctrl
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 65;	gender: f;	treatment: NSAIDs,ctrl
Patient: A;	Time: 1 week;	Group: responder;	Condition: lesional,pert
healthy control H13,ctrl
"imr-32,gfp siRNA,T=48,2",ctrl
erStress_twins_AA_1743twin2_500nM_thapsigargin_4h,pert
A2AR_KO_saline_24h_rep3,pert
"WI-38 cells, at 24 h after exposure to 0.1 uM BPDE, biological rep3",pert
"IGF-treated cells (3hr), biological rep3",pert
CD25+Xbp1KO,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 2,pert
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
MDA_PR_4,pert
Day: 15; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 2,pert
Amoxicillin treated Colon 3 17 days old,pert
Ishikawa_Control_8h_rep1,ctrl
3509-scrape,pert
11085 Normal Uninflamed descending colon,ctrl
BP patient 57_biological replicate 1,pert
ccRCC tumor of patient T158,pert
subject: 22A;	cohort: 22;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 27kb;	age (y): 71;	Sex: F;	batch: Batch_5,pert
DRG_Capsaicin_10microM_Rep4,pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep5,pert
"wild type saline, biological rep4",ctrl
GIST Pre Treatment Biopsy 15,pert
SCD1 +/+ liver rep5,ctrl
subject: 2;	disease: TD;	muscle: ST;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
IGROV-1+(3),pert
subject: 5;	disease: TD;	muscle: ST;	gender: F;	age: 12.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
ILKS343D2,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G52,ctrl
Insm1 control #1,ctrl
12488 UC Inflamed sigmoid colon,pert
Sample 18 Kidney Hyp Mouse - Low Phosphate Diet,pert
"Wild type used for MAT1A 8 month, replicate 2",ctrl
ILD_19,pert
Uninfected control_0c,ctrl
Adult Sham; Biological replicate 2,ctrl
brain_control_sampleid_mr523,ctrl
pMX-Oct4 and pMX-jhdm1b(jmjc) vitamin C O+JMJCVc+_1,pert
"Cell type: endothelial, age:37, gender:male, diagnostic group: schizophrenia, PMI:30h",pert
gender: female;	batch: 2;	age (years): 23;	patient id: Non_severe_4;	fev1 (% predicted): 84;	fvc (% predicted): 81;	medication: Salbutamol;	cell type: CD8+ T-cells,pert
A HID B_B086,pert
"Biceps, FSHD, cohort 15, subject 15A",pert
chip number: 22;	transfection plate: 3B;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2012-03-26,ctrl
ccRCC tumor of patient 1393,ctrl
"Pancreas from adult WT mice, biological replicate 1",ctrl
Brain_Wild-type_MiceNoB4395,ctrl
CD-59-un2,pert
Against CDK8-1 rep3,pert
endothelial_rep14,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 90min;	race: White;	sex: Female,ctrl
Third shYY1,pert
Diabetic Male Wistar rat  after 28 days of diabetes induced with streptozotocin,pert
LECs from control rats 2,ctrl
cell type: iPSC;	genotype: CCALD patient,pert
BASC-Myc-depletion-2 [mRNA],pert
cell type: HUVEC;	treatment: empty lentiviral vector pLVX-IRES-puro,pert
treatment: progesterone;	genotype: progesterone receptor knockout;	treatement time: 40 hours,pert
Rat fatty liver14,pert
Advanced IPF_explant_upper lobe_rep157,pert
LRRK2 mutant knockin H9 hESC derived NSC 2,pert
Liver-24 month-wild type-technical replicate 1,ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 3 - Technical Replicate 2,pert
Wild type (untreated) 5241,ctrl
3 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24718,pert
RNA from HCC_30T,pert
BACH2-/- ALL (Sample3),pert
Bone-Marrow_MM_M1093,pert
A_AN00764_F,pert
Pediatric_GBM_41,ctrl
"PMA treated, doxycycline treated; biological replicate 3",pert
433MM,ctrl
Ls174T-pTER-β-catenin dox3,pert
cerebrum_WT_12w_rep1,ctrl
H1299 RBP2 KD2_rep 2,pert
Human prostate cancer primary culture C40dx,pert
patient13,pert
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
patient: 40728;	sample: tumor,pert
Sex: male;	Age at operation: 38 years;	Site: knee;	Size in cm: 8.3x4x7;	Histological Subtype: myxoid liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
Wild-type control 2,ctrl
T37 U133p2,pert
"fibroblast, wild-type, untreated, biological replicate 1",ctrl
"Uninvolved Skin, NS-24",pert
gender: female;	cell type: peritoneal macrophages;	strain: C57Bl/6,ctrl
cell line: Embryonic kidney cell line HEK;	genotype/variation: mutant channel;	agent: tetracycline,ctrl
LSK cells from heterozygous JAK2V617F mouse rep3,pert
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.17 uM (EC50), biological rep3",pert
tissue: white blood cells;	age: 16.13;	Sex: male,pert
diet_mammary_4,ctrl
"IKK2 -/- tumor, biological replicate 2",pert
Subject 7 / lung subsegment instillated by LPS,pert
2_b,pert
"pancreas, ethanol diet, replicate 3",pert
phenotype: control;	gender: female;	case_id: 393;	age: 71;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 16;	brain ph at time of freezing: 6.2;	labeling_batch: 2,ctrl
pMX-Oct4 and pMX-jhdm1b no vitamin C O+Jhdm1BVc-_2,ctrl
minor non-tumor1,pert
181C3,ctrl
PGA-lv_1w_674,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 63,pert
"2 month old, double transgenic (InsMycER+,RIP-BclXL+)",ctrl
"Normal cervix, commercial_BioChain",ctrl
siCITED1#1 replicate1,pert
cell line: bj-fib_2: BJ (CRL-2522) fibroblasts were purchased from ATCC.,ctrl
"4302_CD133+, untreated",ctrl
GEIM30-U133A-DM,pert
Parkinson's disease sample x017a,pert
GFP Untreated 24hr 282295843,ctrl
tissue: Pancreas;	cell line: Panc-1;	treatment group: Untreated Control,ctrl
gender: male;	age: 7.5 mo +/-2.5 weeks;	genotype/variation: PPAR WT;	treatment: control,ctrl
siNS_4h_3,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 1",pert
BP patient 53_biological replicate 2,pert
G_Ctrl_1,ctrl
gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6.4,pert
Sex: female;	Age: 13;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
Liver of pup from control group rep1,ctrl
"expression at 0hr, bio rep2",ctrl
fat_Akt1+/-_8wk_rep3,pert
GM19238_Kd_SP3_3,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 144;	time: 0;	batch: 1,pert
H07_S_B2,pert
MDS patient 165,pert
181D0,pert
Tobacco_abuse_3,pert
braak stage: CTRL;	rin: 60;	tissue: substantia nigra;	disease state: control,ctrl
MOLM14-shGSK3A-Construct5-rep2,pert
GNMT-WT mouse hepatocytes (sample 3),ctrl
A673_CloneAsp14_Dox_53h_2,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 46;	tissue: Blood,pert
Patient: G;	Time: 1 week;	Group: responder;	Condition: lesional,pert
cell line: HEK293T,ctrl
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
MO_DH1a_SON_NCBI,pert
chip number: 12;	transfection plate: 4;	target gene: NFKB2;	kd level: 0.81;	rin: 9.2;	transfection date: 2011-10-17,pert
Aldosterone-producing adenoma (APA12),pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Control spleen - Biological Replicate 3 - Technical Replicate 1,ctrl
Knock-out postnatal day 10 rep 3,pert
"MGSKO, PR02M008v0",pert
tissue: white blood cells;	age: 14.58;	Sex: male,pert
4332-1 E2F2 Null,pert
age: 35;	sex: F;	disease status: control subject;	Filter number: 97;	Usage number: 4;	Exposures: 3,ctrl
"brain, cochlea: [15] Sample #15_le1",ctrl
SA_201,pert
control AU060003,ctrl
con-52_A,ctrl
M24met_Wnt1_4,pert
Genotype: Mdr2-KO heterozygous mouse;	Age: 12 month,ctrl
genotype/variation: Control (wild-type);	tissue: liver;	gender: male;	strain: mixed C57BL6 and 129SV,ctrl
disease state: paediatric glioblastoma;	age: 9;	gender: F;	h3.3_status: wt,ctrl
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 33;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
"WT brain, biological rep3",ctrl
Kidney_50 mg/kg VCM iv_mouse #011,pert
Silberg2 (9) 021301NE,ctrl
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 71;	age-at-onset: 65;	geographical origin: Porto;	clinical characteristics: Hypertension;	lifestyle characteristics: ever smoker, ever drinker",pert
C57BL/6 female control,ctrl
"Uninvolved Skin, NS-11",pert
Aged 5,pert
Pancreatic Sample 11-Tumor,pert
healthy myeloid cells 11,ctrl
M833 / Reference_13425475,pert
IPMC 6,pert
"peripheral ganglion, unknown: control 1 hr_2",ctrl
miR122-WT-27,ctrl
Gata1WT25+#1,ctrl
Lung wt mock repA,ctrl
Healthy 5 weeks C5,ctrl
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 81;	Usage number: 5;	Exposures: 3,pert
S4A Sporadic-frontal,ctrl
strain: C57BL6  X 129sv mixed;	tissue: liver;	genotype: WT,ctrl
"3mg/kg/day PFOA, Rep 5, Block 2, liver (low dose)",pert
WT GMP rep1,ctrl
24h WT Cel.19,ctrl
H3_SS11_01Nov07,pert
"Control shRNA cells passage 11, rep 1",ctrl
untreated_6hr_rep1,ctrl
Parkinson's disease sample x200,pert
08SE1178,ctrl
N40730,ctrl
Human skeletal muscle biopsy sample;	Patient #175 with PM,pert
strain: B6/129;	gender: male;	age: 6 months;	tissue: dorsal prostate;	genotype: Klf5-/-; Pten-/-;PB-Cre4,pert
tissue: thymus;	genotype: E2Aflox/flox Cd4-cre+;	age: 8 weeks,pert
A_AN01570_T,pert
Nasal Epithelium Instilation Formaldehyde 0mM 6h ID356,ctrl
cell line: Panc1;	cell type: dasatinib-resistant pancreatic cancer cell line,ctrl
ploidy: Ts1Cje (segmental trisomy of chromosome 16);	tissue: cerebellum;	developmental stage: P15 postnatal stage,pert
11440 UC Uninflamed sigmoid colon,pert
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.17 uM (EC50), biological rep3",pert
genotype: p300+/-;	replicate: 1;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,pert
HN_97,ctrl
Naive (control) #4,ctrl
patient: 122;	current medication: Venlafaxine;	birth date: 7/10/61;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
nmMLCK-/- -VILI replicate 1,pert
tissue: tumor;	cell line: SK-BR-3;	origin: luminal-like;	transfector: TFPI beta,pert
"non-AD_TC, biological rep17",ctrl
BL Day 0 Untransfected biological rep1,ctrl
wild-type macrophages stimulated with MALP-2 for 4 h,ctrl
APOE_KO_RAGE_KO_DM_9W_12,pert
Subject #8027-2d Postinfection,ctrl
con_B124,ctrl
HMEC_50 vs ZR_75_1,pert
Gnmt_KO_2,pert
non-CF subject 31,ctrl
ATF2 KO-3,pert
ApoD transgenic mouse+PQ rep_3 (PQTG3),pert
Lrp5 Retina Rep2,pert
a10a.000606jd.2.SkMNor907.CEL-IS basal,ctrl
BE-rep8,pert
mn cells sample 3,pert
CD19_selected_B-cells_before_R_rep7,ctrl
pediatric AML GP8,pert
Cutaneous psoriasis without arthritis PsC 9,pert
"schizophrenia, BA46-11",pert
TRO-4--71602,pert
IFN_Gamma_24hr_rep1,pert
sepsis patient #18,ctrl
"human failing LV myocardium, Ischemic72",pert
PBMC from T cell LGL leukemia patient #122 (TLGL122),pert
"Subject 14, Family 5, Asymptomatic",pert
Wild type day 3 Air replicate 3,ctrl
"Lesion Skin, LS-17",pert
"MCF-7 transfected with pcDNA3.2, rep.2",ctrl
Y YOKE_B023,ctrl
NTG replicate 4,ctrl
"Alk shRNA, biological rep1",pert
"vestibualr organ at P15 of Igf1 -/-, biological rep 3",pert
Kidney_50 mg/kg VCM ip_mouse #071,pert
01L4J: normal control,ctrl
Clint-Cont-1-011411,ctrl
cell type: splenic CD11c+ dendritic cells;	strain: C57Bl/6strain: C57Bl/6;	genotype/variation: WT;	treatment: tamoxifen,ctrl
Setdb1 2lox/1lox/Cre plus tamoxifen 3,pert
10: NORMAL #00-0386,ctrl
age: 6 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),pert
GEIM57-NORM,ctrl
E2 1hr,pert
Run1.a10a.000609jd.2.SkMNor910.CEL-IS stimulate,pert
HUVEC exposure 1 ug/ml colchicine 12 hr_1,pert
A502 Sham 7 day,ctrl
Cardiac Progenitor WT1,ctrl
Retina wt/wt rep2,ctrl
cell line: LICR HN2;	treatment: PBS,ctrl
gender: Male;	age: 58;	post-mortem delay: 15h;	ph: 6.5,ctrl
cell line: NALM1;	tissue: Human B cell precursor leukemia,pert
V5-P561,pert
Against CDK19-1 rep2,pert
chip number: 11;	transfection plate: 6;	target gene: USF1;	kd level: 0.77;	rin: 9.3;	transfection date: 2012-03-26,pert
"wt total RNA LSK, rep 6",ctrl
"E18.5 ERRg -/- heart, biological rep 2",pert
FTO1_C1_24h,pert
"human failing LV myocardium, Idiopathic27",pert
braf status: BRAFmutant;	tissue: PTC with a BRAF mutation,pert
SIRT4 KO liver_7235,pert
heart of mouse subjected 1 week to chronic constant hypoxia (C1B),pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M0;	flt3 status: WT,ctrl
age_years: 31;	sex: M;	ethnicity: Asian;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
Parkinson's disease sample x184,pert
"Gata4-KO heart, CRE, biological rep2",pert
SHR16-1,pert
patient: 30;	disease state: hypertension;	tissue: Atheroma plaque,pert
C57_LF_3,ctrl
DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma) Replicate 1,pert
Control 894B,ctrl
DC1,ctrl
disease: psoriasis;	skin: non-lesional,pert
CML_5_HSC,pert
CON9,ctrl
56A;pretreatment;female;breast tumor; not assessable,ctrl
SKBR3_1uM_Lapatinib_3,ctrl
"BMMCs from NTAL WT, pLKO.1 infected, nonactivated, biological rep1",ctrl
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T3N2,pert
patient: 51681;	sample: tumor,pert
Chondrocyte_control_rep2,ctrl
"40B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Leg 56 Day mdx rep 2,pert
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 6h;	donor: 2,ctrl
"seminoma specimen, pT2, patient age: 30y; W03 036",pert
HA96-112B,pert
CEPI_IV_489,pert
wild-type_phenobarbitol_rep2,ctrl
cell line: SKBR3 resistant;	treatment: basal conditions,ctrl
KOC 53 PBS treated,pert
HA96-37B,pert
Human normal pituitary -N4,ctrl
"Cervical cancer cell line, SiHa",pert
Strain: DBA/2J Sex: Male Age: 8-10 weeks Treatment: Fluoxetine,pert
SCLC cell line SBC-5,pert
brain_DLPFC_bipolar C_mr444,ctrl
"non-AD_FC, biological rep4",ctrl
"344SQ with control shRNA, replicate 3",ctrl
"Muscle from WT, biological rep3",ctrl
transfected with control siRNA_6,ctrl
695_383_24hr_repeat,pert
"Wt, biological rep3",ctrl
Y YOKE_B058,ctrl
RO37,pert
MS25_3B_MEK5_220307,pert
"218, ADIPOOSE TISSUE, Before",ctrl
6 weeks old,ctrl
parental Ainv15 undifferentiated ESC,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 17;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: ZMYM2/FGFR1;	biological replicate: 3,pert
Intestine_KO_biological rep2,pert
sex: Female;	family: 1;	age: 69;	disease status: Asymptomatic;	tissue: Muscle: Biceps,pert
RORasg/sg liver_HFD_rep2,pert
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: control; biological replicate: 3,ctrl
1056-05-A,pert
Gender:F;	Age:44;	Tissue: Mucosa,pert
"p400 KD, replicate A",pert
microdissected breast cancer cells from case 843,pert
GIST Pre Treatment Biopsy 19,ctrl
"non-SS control gland, patient 19, batch 2",ctrl
"Vehicle treated, DAY 6, biological rep.3, MOLM-13 cells",ctrl
12P-M4,pert
muscle Smad4KO 3 control,pert
age: 29;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
tissue: white blood cells;	age: 14.94;	Sex: male,pert
FW_5a_BV8411,pert
braak stage: BR12;	rin: 58;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
ICM pool 4 (n=4),pert
B4 395 wild-type untreated,ctrl
B-CLL PB P143,pert
mES cells TR71 KD rep3,pert
UnInfected-2,ctrl
PGA-HMO-NonObese-5aUA-s2,ctrl
mouse cerebellar granule cells wild type 5,ctrl
A673 cell line that has been treated with DMSO vehicle control for 24 hours.,ctrl
tissue: leukemia;	genotype: Sh2b3 wild type ΔE-NOTCH1;	strain: C57BL6,ctrl
"Wild type epithelials cells, biological rep4",ctrl
Patient: O;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 74;	age-at-onset: 73;	geographical origin: Mirandela;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
"TH cells from LC, wild type control, young time point, biological replicate 1",ctrl
PsOEt-22-Week 1,pert
"Uninvolved Skin, NS-18",pert
patient: 257;	current medication: 6MP 50mg;	birth date: 5/16/64;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/2/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/2/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 2/1/05;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Syracuse Low Avoidance (SLA) learning rats 2,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (34),pert
BCells_WildType_day2_REP2,ctrl
Untreated CHOP-/- D,pert
ILD Study Number S036,ctrl
LNCaP + ELK1-shRNA rep 2,pert
colon_CRC_1293,pert
Wild type naïve T cells stimulated for 3 hours with medium alone 2,ctrl
Patient 1 skin baseline,ctrl
01LN1_PolyRF-,pert
BM_preTherapy_I,pert
"Patient R, uninvolved skin",ctrl
Normal-ERα-positive breast cancer 12,ctrl
BP patient 50_biological replicate 1,pert
"YAP-overexpressing cells, biological rep1",pert
treatment: AMN107 (Nilotinib);	cell line: K562,pert
Mouse No Cldn16 B9 443,pert
Control 120 days sample 2,ctrl
Macro-dissected renal epithelial tissue from wild-type littermate controls,ctrl
Extract:LOX-1:113501;	Extract Description:GFP_Untreated_24hr:113501;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.09;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.38;	Quality: Absent (%):56.87;	Quality: Absent (%) Dev.:1.07;	Quality: Scaling Factor:0.52;	Quality: Scaling Factor Dev.:0.75;	Pretreatment [C]:GFP;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113501;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_24hr;	RNA extraction source key [A]:282295833,ctrl
tissue: Frontal cortex;	age: 87;	Sex: F,ctrl
"alveolar macrophages, smoker 002",pert
BAL_47a_A0B0,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 50.28767,pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 10",pert
HEK001_pLKO_R1,ctrl
Bone-Marrow_SMM_S1329,pert
Normal-ERα-positive breast cancer 4,ctrl
ePuro,ctrl
"NF-YA KD ES cells 96hr, replicate 2",pert
CEPI_IIIc_528,pert
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 59;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 16101647,ctrl
G93A 120 days sample 2,pert
Run8.aUa.010615d.SkMInS1080D.CEL-IS basal,ctrl
Hippocampus 1982 15 month Old,pert
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: exogenous SNF5 overexpression,pert
"vector d2, rep 3",ctrl
Dengue Hemorrhagic Fever Patient 38,pert
Thyroid_ unaffected_paired with PTC26T,ctrl
KU_14T,pert
Y VIS _B065,ctrl
strain: BALB/c;	genotype/variation: Rag1-deficient;	treatment: WT nTreg + WT iTreg;	cell type (sorted): ex-iTreg,pert
c_B51,ctrl
Knockout liver_saline-injected 12weeks repl2,pert
Mouse fetal liver_E14.5_WT_rep3,ctrl
HCC1954 Cell Control 1,ctrl
"NTera-2 cells SOX2 siRNA, biological replicate 1",pert
Tendon_lesional_rep6,pert
s9129_1,pert
"NF-YB KD ES cells 96hr, replicate 2",pert
strain: C57BL/6J;	day: 18;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 2,ctrl
"Liver from control mice, biological replicate 7",ctrl
liver knock out replicate2,ctrl
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-WT;	overexpression induced with doxycline: No,ctrl
Mut+/+ rep1,ctrl
Vector control 2,ctrl
siHic5_2_2h_3,pert
duration of untreated disease in month:30.6;	age at onset:1.0,pert
Bone-Marrow_MM_M758,pert
3978-1 E2F1 Null,ctrl
"non-AD_FC, biological rep2",ctrl
Pten cKO rep1,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_16,ctrl
Gender: Male;	Age: 38;	Ethnicity: Black,pert
liver_female ko_rep1,pert
tissue: lesional skin;	urticaria status: affected;	patient: 1,pert
E10_otic_vesicle_mut_replicate2,pert
strain: C57BL/6;	genotype: Cmah knockout;	tissue: kidney;	age: 12 weeks,pert
Scd1-/- on very low fat diet (TD03045 from Harlan Teklad) replicate 1,pert
phenotype: alcoholic;	gender: male;	case_id: 252;	age: 59;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.57;	labeling_batch: 1,pert
Bone-Marrow_MM_M956,pert
"control, BA46-83",ctrl
Floxed_Mstn_3,pert
P0 - nudelcko/ko 1,pert
2065N,ctrl
695_EV_0hr_repeat,ctrl
"fibroblast, MFS subject FB1234 rep 4",pert
PBMCs_Control_13 [IS],ctrl
Cardiac Progenitor MUT3,pert
patient: 51104;	disease state: LGSC;	component: Invasive,pert
D_LS_Wk12,pert
"Vehicle treated, no doxycycline; biological replicate 3",pert
"CRT knockout mouse embryonic stem cell, biological rep1",pert
ILD_7,pert
"211, ADIPOOSE TISSUE, Before",ctrl
Muscle PCOS control 11,ctrl
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep2,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 41 yr;	population: white;	dsm-iv: 295.9;	age of onset: 20 yr,pert
H31 Ctrl 12h 1,ctrl
NPC6,pert
"Normal T-cells, CD3+, donor 1",ctrl
mutant_ANT_PDE_10-1,pert
HLA risk: High;	Height: 157.7 cm;	Weight: 54.5 kg;	BMI: 21.9;	Age: 57.96 years;	Gender: Female;	Race: White;	Glucose: 83 mg/dl;	HbA1c: NA,ctrl
condition: Discoid Lupus;	patient: L1;	tissue: LS skin biopsy;	kit: Ovation,pert
prostate tumor 3,pert
Trim28CKO TCR-stimulated CD4 positve T cell rep3,pert
Mouse hypothalamus,pert
Array Type: HG-U133A_2;	Ratio: 2.02;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
patient id: T142;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 56;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
Hippocampus_NaiveControl_rep3,ctrl
Carbo Day4 (379R),pert
MCF-7 cell_tRA_12hr_biological rep1,pert
KO (Rnh1-/-) -3,pert
Knock-out postnatal day 10 rep 1,pert
MPM tumor 11,pert
Gastrocnemius Muscle_Cmah KO_mdx_rep3,pert
"breast, post AFI treatment (H10_1594)",pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case6,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,ctrl
"DBA/2J ACU, Rep1",pert
chronic lymphocytic leukemia (CLL 34297),pert
ID4+/+TCL1-tg spleen CD19+ B cells collected from 3 mice 1,ctrl
ME180 6 hours rep 1,pert
IM29_control,ctrl
control AU1165305,ctrl
T57 Non failing heart biopsy,ctrl
"3mg/kg/day PFOA, Rep 2, Block 1, lung (low dose)",pert
strain: C57BL/6;	tissue: heart;	genotype/variation: KO;	age: 6-weeks old,pert
siCtrlE24h_2655,pert
"S1P2-KO-neocortex, biological rep1 (male)",pert
SLE myeloid cells 6,pert
untreated AML 6B blasts,ctrl
VillinCreERT2-_Rep2,ctrl
IFN_Gamma_24hr_rep3,pert
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: SNF5 shRNA infenction,pert
Patient 1 a,pert
9A;pretreatment;female;breast tumor,ctrl
VMM-WT_MyoD12h-1MP-s2,ctrl
"p38alpha knock out fetal liver E13.5, biological rep2",pert
NM4 healthy control,ctrl
"Liver from STZ-treated mice, biological replicate 1",pert
"Acute Myeloid Leukemia, sample 56",pert
cell line: MOLM-14;	replicate: Replicate1;	treatment: shLuciferase,ctrl
female_control_460,ctrl
Bronchial Epithelial Cells MMA biological 2079X,pert
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl;	tissue: Primary palate mesenchyme;	age: E13.5  + P2,ctrl
Wild type CD4+ CD3-stimulated 2,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 26;	maternal age: 23,ctrl
"miR-148b-D (miR-148b-3, biological replicate 4)",pert
8 hour tunicamycin wild type B,ctrl
IRF8 KO 1,pert
GM19238_Kd_NS3_21A,ctrl
MBD1 WT #3,ctrl
N/A,pert
Control spleen - Biological Replicate 3 - Technical Replicate 2,ctrl
SGK1-IL23 rep2,pert
06R049 RA,pert
PKBa-/- MEF time 24 replicate 2,pert
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Male;	Age of onset (years): 31;	Duration of illness (years): 17;	Brain pH: 6.90;	Post mortem interval (hours): 23;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
wildtype HUES6 1,ctrl
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14439;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
embryonic stage: E14;	cell type: embryonic stem cells;	genotype/variation: Trip12 mut/mut,pert
"3mg/kg/day PFOA, Rep 2, Block 1, liver (low dose)",pert
Lymphedema Tail Skin 2,pert
cDNA scc 11,pert
CH2126,ctrl
Calu3-GemR_Veh_1,pert
phenotype: no or early glaucoma;	gender: female;	strain: DBA/2J;	tissue: retina;	age: 10.5 months,pert
RNA-DHL6-R406-48H-2,pert
Phan_007_KO.saline rep1,ctrl
A2008-(1),ctrl
"Crohn's Disease subject (22 year old caucasian female, SAK_1316756241)",pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: NLGN1 shRNA,pert
gender: Female;	age: 75;	post-mortem delay: 3h;	ph: 6,pert
Control LM2 Cell on HMVEC-L Replicate 3,ctrl
Control male 2,ctrl
Pias1 null IFN-gamma 2 h,pert
"Epidydimal white adipose tissue from Casp1-/- after 16 weeks of high fat diet feeding, replicate 3",pert
"strain: C57BL/6;	tissue: heart, left ventricle;	gender: male;	genotype/variation: Hsp22 KO;	stress: control",pert
15_0005C_Day1_43,ctrl
patient: 18;	disease state: hypertension;	tissue: Atheroma plaque,pert
"Subject 6, Family 2, Control",ctrl
HL60-shGSK3B-Construct2-rep1,pert
Patient no. 2: control,ctrl
Mut1_2,pert
"Mutant in the presence of tetracycline, rep1",ctrl
"transgene: none;	treatment: treated with scrambled siRNA, after 48h",ctrl
tissue: liver;	treatment: CCl4;	strain: A/J,ctrl
Normal-ERα-positive breast cancer 27,ctrl
TMRI E2 48hr,pert
chip number: 14;	transfection plate: 5;	target gene: ZHX2;	kd level: 0.51;	rin: 9.2;	transfection date: 2011-10-17,pert
control siRNA rep1,ctrl
ATM_siRNA_0c,pert
MLL_00129,pert
Run8.aUa.010615d.SkMInS1074D.CEL-IS basal,ctrl
cell line: PC3;	treatment: none,ctrl
"CCALD patient fibroblast, biological rep3",pert
Gastric Cancer PBMC Sample 1,pert
"A673 treated with Puromycin for 3 days with concentration of 0.18 uM (2 x EC50), biological rep1",pert
SUM149_siTIG1_rep3,pert
patient: 238;	current medication: Enalapril Zantac;	birth date: 9/27/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 9/25/03;	diagnosis date: 1/14/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: NEW;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: Hypertension Diverticular disease;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
HF0120_U133P2,ctrl
IkkβΔ_replicate1,pert
disease state:DM;,pert
coc-57_A,pert
PsOEt-12-Week 2,pert
PND28 Rat Testis_Rat230-2_12hr Corn Oil_Animal#60_04005,ctrl
Het-pDC1,pert
Cancer 1,pert
2944-lcm,pert
47A,pert
MCL_IGHV_MUT (R1941),pert
cerebellum_wild type_6 weeks_replicate 1,ctrl
"vestibualr organ at E18.5 of Igf1 -/-, biological rep 3",pert
"SFM control cells (24hr), biological rep_2",ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 74,pert
sample type: fvb control;	strain: fvb/nj;	gender: Male;	age: 8 weeks;	tissue: glomerulus;	disease state: Nondiabetic,ctrl
"Liver from Nrf2 k.o. mice, biological replicate 1",ctrl
Fibroid_2192,pert
BP3,pert
"Gender: Female, Age: 28, BMI: 17, Tissue: luteinized cumulus cells",ctrl
cMetKO CSC Technical Rep.2,pert
"cochlea at P7, ko, biological rep 2",pert
autism with dup(15q) 01-19,pert
Jejunum_POR-null_3,pert
10uM H2O2 rep 3,pert
Frontal_cerebrocortex_Deltamethrin_3mg/kg_6hr_rep6,pert
PGA-RMM-7h-2aA-s2,pert
Patient: B;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
cell line: H295R adrenocortical carcinoma cells;	tissue: Cells derived from Adrenal gland;	agent: angiotensin II;	dose: 100 nM;	time: 3 hr,pert
PND28 Rat Testis_Rat230-2_2hr Corn Oil_Animal#47_04005,ctrl
neuron_rep2,pert
healthy chondrocytes,ctrl
Patient: C;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
"Healthy volunteer, Control_11819",ctrl
Healthy control c4,ctrl
HeLa_TP082505-28_HG-U133A_2_IMFGN0023,ctrl
cell line: SKMEL28;	time point: 0h;	mutation: BRAFV600E;	treatment: untreated,ctrl
Discoid Lupus-L1,pert
status: Control;	gender: Male;	age: 47;	tissue: Blood,ctrl
Arid3a KD replicate 1,pert
colon_C57mouse_6weeks_rep3,ctrl
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 6hr.",ctrl
T8F-LU,pert
Aged 2,pert
Day: 15; Drug: Heroin; Phase: Withdrawal; Replicate: 3,pert
cerebellum_Pink1 knockout_18 month_replicate 2,pert
Peripheral blood mononuclear cells;	ttf: 120min;	race: White;	sex: Male,pert
HUVEC_control experiment 3,ctrl
BalbC_6h_DMSO,ctrl
gender: Female;	tissue: Tendon;Subscapularis;	age: 63;	donor: 20;	disease state: Non-lesional,ctrl
"Cell culture. A549 treated by MK886, control 2",ctrl
01LP7_PolyRF-,pert
DBA_24h_DMSO,ctrl
"human failing LV myocardium, Ischemic106",pert
A520 MI 7 day,pert
sirna: control;	plate: collagen coated;	cell line: MCF10A,pert
KU_07T,pert
Sham 9,ctrl
"RISC-free control transfected, biological rep 4",ctrl
"G42 cells from Cerebellum, Mecp2 null, biological replicate 2",pert
Bone-Marrow_SMM_S1360,pert
Control bone marrow - Biological Replicate 5 - Technical Replicate 1,ctrl
Pancreatic Sample 1-Tumor,pert
tissue: Frontal cortex;	age: 84;	Sex: M,ctrl
Leg 14 Day mdx rep 3,pert
V5-P251,pert
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro Technologies;	Cause of Death: Hypoxia;	Tobacco Use: No,ctrl
Individual_5815_NN_sample,ctrl
E9_Embryo_Heterozygous_3,pert
"Gender: female, Age: 33 years, Tissue: normal vulva,",ctrl
Mouse WT mandibular molar [ABH_11A],ctrl
WTGFP QSC Biological Rep.1 Technical Rep.2,ctrl
P55 Non failing heart biopsy,ctrl
"gender: male;	batch: 1;	age (years): 32;	patient id: Severe_3;	fev1 (% predicted): 98;	fvc (% predicted): 113;	medication: prednisolone 15mg od,Seretide 500mcg 2pbd,Montelukast 10mg nocte,Ventolin prn,Phyllocontin 450mg bd,Flixonase od;	cell type: CD8+ T-cells",pert
control IgG_rep5,ctrl
Yolk sac tumor 2110,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous endotoxin challenge""",pert
"A549, -TNFα, Claudin 1 siRNA, rep1",pert
scan batch: Batch 1;	group: control;	subject age: 10;	paternal age: 30;	maternal age: 29,ctrl
"Strain: Sprague-Dawley, Gender: male, Weight: 350 g",ctrl
diagnosis: HP;	fvc-group: FVC2;	tissue: lung,pert
PGA-MPF-C57-saline-24h-2bAv2-s1,ctrl
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: SRF Silencing;	agent (treatment): EtOH vehicle,ctrl
wild-type mouse kidney - 1,ctrl
"control, subject 2",ctrl
Skinbiopsy_48hoursnickel_nickel_allergic_subject_P1,pert
ID4+/-TCL1-tg spleen CD19+ B cells collected from 3 mice 1,pert
35A;pretreatment;female;breast tumor; nonresponder,ctrl
wt 13.5d replicate 5,ctrl
Csbm/m Mouse_cerebellum_Old_saline treatment_Replicate-1,ctrl
"Empty vector control, 2 hrs, Rosiglitazone (ROS_2_2)",pert
pSUPER-scramble replicate 2,ctrl
Md02h026,pert
A_AN08166_F,pert
F-IIP(NSIP)3_Cy3,pert
Epididymal adipose GPR120KO ND #719,pert
"DMD skeletal muscle, technical rep1",pert
E.8 DBA-C57BL/6 whole embryo,ctrl
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 5;	gender: male,pert
adenocarcinoma (ADC2),pert
PGK12.1_Kdm6a RNAi-2,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 7;	gender: male,pert
A537 MI 1 day,pert
CD4IncTp1-4,pert
T40656,pert
Strain: C57BL/6; Tissue: quadricpes muscle,ctrl
shCON3,ctrl
UTX knockout (KO) cell line 1,pert
GEIM176-NORM,ctrl
tissue: rectal mucosal epithelia;	genotype: CFTR D508,pert
colon cancer cells,pert
MEF Wild Type 3-rep4,ctrl
FACS-purified B cells_129SV/EV_influenza-infected_rep2,pert
P0 - WT129s6 3,ctrl
Genotype: FGF23 TG on C57Bl strain;	Age: 8 weeks,pert
"WT, PR03M002v0",ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: sh53BP1-1,pert
PsOEt-21-Week 2,pert
tissue: Biceps muscle;	patient: P.b.9;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 1m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 90,ctrl
glaucoma: glaucoma;	phenotype: no or early glaucoma;	radiation: No radiation treatment;	strain: DBA/2J;	gender: Female;	age (mos): 10.5,pert
N/SM2,ctrl
EP66_adipose_pcos,pert
"Subject 4, Family 2, Affected",pert
3950M patient’s mucosa,pert
estrogen treated ipsilateral to stroke,pert
Wild type Mice-M125,ctrl
Grid2 deleted mouse 3,pert
age: 14dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 7.8;	colon weight (mg): 172;	colon ratio (mg/mm): 2.21;	myeloperoxidase activity (u/mg): 0.076;	tissue: colon;	treatment: 5% DSS,ctrl
"PIO, subject 14",pert
MCF10A cells,ctrl
"Testes, 20 hours after cadmium treatment, biological rep 1",pert
Control  VZ12,ctrl
Heart-Base_WT-2,ctrl
Moderate rep7 (OHN),pert
hur status: WT;	rna subtype: nuclear RNA after HnRNPA1 Immunoprecipitation,ctrl
"PBMC, healthy control, biological rep13",ctrl
6 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24721,pert
"Acute Myeloid Leukemia, sample 14",pert
266D6,pert
cell type: Primary hepatocytes;	strain: BalbC;	agent: Wy14643;	time: 24h;	gender: Male;	age: 6 months,pert
3P-M4-ND,pert
"Benign, Pooled, prostate tissue",ctrl
Control Replicate 1,ctrl
"bcatGOF  mouse kidney E12.5, biological rep 3",pert
12h PTD-DRBD GAPDH siRNA (SAMPLE 4),pert
"experiment 1, ethanol-treated 2",pert
"9B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Scd1-/- on chow diet replicate 2,pert
"BOEC, normal 13",ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 4,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 19d ID155,pert
miR122-WT,ctrl
Expression data from liver of the KRAP deficient mice (KO2),pert
"seminoma specimen, pT2, pN2, pM1, patient age: 37y",pert
L1 062502 Pio2,pert
tissue: rectal mucosal epithelia;	genotype: non-CF,ctrl
B-CLL PB P254,pert
Recent-onset T1D_sample11,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M1;	flt3 status: internal tandem duplication (ITD),pert
Individual_4216_PN_sample,pert
"GSL30, PR04M010v0",pert
Placenta_nl1,ctrl
"0mg/kg/day PFOA, Rep 4, Block 4, lung (high dose)",ctrl
9L,pert
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.34 uM (2 x EC50), biological rep2",pert
"PBMC, patient. Mtx rep2",pert
SA_257,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 16.848;	Ratio: 2.11,pert
WildType_1,ctrl
"A673 treated with Doxorubicin for 24 hours with concentration of 119.76 nM (2 x EC50), biological rep1",pert
MGd_3,pert
U937_luc_Replicate2,ctrl
RKO_rep_4,pert
41A;pretreatment;female;breast tumor; responder,ctrl
THRB bN mutant + vehicle replicate 3,ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 59;	donor: 34;	disease state: Lesional,pert
No or early 2 rep1 (OHN),pert
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 6,pert
"non-AD_FC, biological rep18",ctrl
FMR1_2,pert
whole blood_101094,pert
"MAT1A knockout at 15 month age, peritumoral tissues, biological replicate 5",pert
"Normal cervix, commercial_Stratagene",ctrl
Mening UNSTIM WB SW 3a,ctrl
WT-Fibr1 8,ctrl
control participant P338,ctrl
LKR13_Control-1,ctrl
MOLM14-shGSK3A-Construct6-rep1,pert
37A;pretreatment;female;breast tumor,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 1,pert
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: control (none);	timepoint: 2 hours,ctrl
WT CFTR unexposed replicate 1,ctrl
e_2m51,pert
brain_DLPFC_bipolar C_mr682,ctrl
Reh_shCBFA2T3_1,pert
patient: 232;	current medication: Pentaza 2g BD;	birth date: 1/9/63;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/95;	diagnosis date: 1/1/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/31/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
LCCS sample 23 weeks,pert
strain: C57BL/6 (B6);	genotype: WT;	cell type: leukemia stem cells (LSCs);	age: 8 weeks,ctrl
"Control, biological rep1 (E17.5)",ctrl
LPS 3hr 2,pert
"P210 HCT-116, DNMT3B knockout, U0126-treated",pert
Ulk1/2+/+ (untreated) 1,ctrl
"granulocyte, patient. Mtx rep3",pert
NHE3+/+ replicate 1,ctrl
IRS-2 KO (jos0952),pert
"seminoma specimen, pT2, patient age: 34y; W03 037",pert
AQA B,pert
N7,ctrl
"Cervical cancer cell line, C-33A",pert
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC;	Vehicle Treated 0.1N KOH (equivalent volume to treated) in cell culture media,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 44;	sex: M,ctrl
control-control rep 4,ctrl
ctrl_512,ctrl
strain: C57BL6/J;	age: 12 weeks;	gender: female,pert
whole blood_100240,pert
Subject #8009-8hr Postinfection,ctrl
TAp63 alpha Q540L 24h without induction s1,pert
"Acute Myeloid Leukemia, sample 77",ctrl
liver_Wt_8wk_rep2,ctrl
Erythroblast_SOD2+/+_repWT29,ctrl
01LN4_Oligo,pert
SIN3A_siRNA_LIF1h_rep1,pert
Normal bladder 61-99,ctrl
cell line: U373;	cell type: glioma;	vector: MAML1 dominant-negative,pert
cell line: Raji;	cell type: human Burkitt's lymphoma;	gender: male;	treatment: expression of miR-142-3p mimic;	treatment duration: 24 hrs,pert
"Normal subject (45 year old caucasian male, SAK_1290589154)",ctrl
"Rb null fetal liver 1, embryo at 12.5 days of development",pert
sample =XCGD5 treatment=Stimulated time=360 (min),pert
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/8,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 12h",pert
"SPC-c-raf transgenic mice, 12 month old, female, tumor",pert
3007-ls,pert
"SFM control cells (3hr), biological rep2",ctrl
"Hif1a-/- LSC, biological rep2",pert
"Patient 26, Atheroma plaque",pert
WFS1 KO USHT_18_330_wt,pert
42A,pert
N29,ctrl
Mening UNSTIM WB NP 1a,ctrl
Subject #8002-Preinfection,ctrl
Patient: N;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-tu2,pert
Strain: B6SJL;	Age: 75 days,ctrl
"Patient H-661-N, normal colonic mucosa",ctrl
Cell line established from CA1 HESC using pClip vector,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 43, stage IIB, HPV 16",pert
H16_P_B2,pert
MCF-10A shATM-1 replicate 3 [set 5],pert
Treg cells WT replicate 3,ctrl
heart MHC-Plin5 2,pert
"fibroblast, MFS subject GDO21 rep 2",pert
MDA-MB-231_siZMPSTE24_rep.2,pert
Tendon_lesional_rep2,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 47.31781,pert
tissue: Biceps muscle;	patient: C.b.1;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 1y 2m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
HIF-1-/- control 2,pert
"age at diagnosis: 75;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 28;	dfs-event: 1;	distant metastasis: 1",pert
PTC BRAF wt 3,pert
A4_LEF1,pert
TA-n7-2; normal tibialis anterior 7 month,ctrl
C15-7,pert
"Fourth ventricular choroid plexus from Otx2ko mice at E13, biological replicate 3",pert
Spleen_ko_4m_rep3,pert
ubb_d7_ko_1,pert
"vehicle, biological rep6",ctrl
female JAK2 KO liver sample 131,pert
PGA-MAH-C3H_PBS6h-2aA-s2,ctrl
tissue: brain;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
PC3 Control Rep2 (weak signal),ctrl
HD12,pert
Spleen_wt_4m_rep1,ctrl
23 weeks male,pert
chondrocyte_5azatreated_rep2,pert
TF1_controlsiRNA_3,ctrl
VMM-MUT_MyoD24h-2MP-s2,pert
major HCC5,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 55 days;	subject: Mouse4;	genetic background: BALB/c,ctrl
KO_MEF_un.1,pert
"Dumbo retina, biological rep2",pert
MS patient 10,pert
MCF7/c p.2,ctrl
SARRC-1021-01-A,pert
Muscle WT Adult 07273,ctrl
SA_259,pert
cell line: KU-812;	tissue: Myeloid leukemia cells;	agent: Imatinib,pert
F9 RA sample #3,pert
wild-type replicate 2,ctrl
unaffectd brother,ctrl
"BN strain, male, age 21 weeks, treated with the synthetic estrogen diethylstilbestrol (DES) for 12 weeks",pert
KN-smoke-low-5 month-R1,pert
06R033 Control,ctrl
cell type: hepatoma cells;	cell line: Huh7,ctrl
"expression at 0hr, bio rep3",ctrl
control to Sample 15,ctrl
01_0053A_Day1_15,pert
patient id: T79;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 59;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 4;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
"208, MUSCLE, Before",ctrl
"strain background: C57BL/6;	genotype/variation: wild type; Cdh1+, P53+;	age: 2 months;	gender: female;	tissue: uterus",ctrl
"Rat liver, treated with ANIT, 125 mg/kg in corn oil per orally, extrated 48 hours after treatment, biological rep2",pert
0820-01-A,pert
NTG replicate 2,ctrl
Cnah KO_heart_2,pert
"fibroblast, MFS subject GDO21 rep 4",pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days.",ctrl
01UNR_ERA,pert
Patient: C;	Time: 1 week;	Group: responder;	Condition: lesional,pert
tissue: lung adenocarcinoma;	cell line: A549;	transfection: pcDNA-MYC (control),ctrl
Native-0-4,ctrl
genotype: PIK3CA.H1047R;	agent: DMSO,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 8",ctrl
HC-WT-20A,ctrl
umbilical cord_nobpd: 6D,ctrl
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.59;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
Patient identifyier: F;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 28 years;	Body surface area: 15 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
HCC014T,pert
Diseased individual (ulcerative colitis) of twinpair #1,pert
cell type: granulocytes;	group: Healthy control;	patient treatment: not applicable,ctrl
HB1.F5-Nurr1,pert
HeLa_TP082505-27_HG-U133A_2_IMFGN0023,ctrl
"MCF-10A cells, overexpression ΔNp63α, biological rep2",pert
PE_D_587,pert
"Empty vector, plastic plate, rep2",ctrl
Wt Mouse_cerebellum_Standard diet Ad Lib_Replicate-1,ctrl
NOMO-1_LEN-GFP,ctrl
Wild type Mice-M128,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: fresh air, treatment over 5 month, 4x1h exposure per day",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 52.78082,pert
"Male, 25 years old, HIV infection of ~2 months",pert
LT 341 +/T untreated,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 6,pert
"Retina from control mouse at ZT20, biological rep 2",ctrl
Control MEF 3,ctrl
brain_DLPFC_bipolar B_mr446,pert
sample type: Primary culture of type II cells collected from SPC KO lung adult;	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C KO;	genetic background: 129S6/SvEvTac,pert
"breast, post AF treatment (H8_1389)",pert
LKO_102412,pert
ILD Study Number S014,ctrl
L1 062502 Pio1,pert
strain: C57BL/6;	genotype: wildtype;	tissue: heart;	age: 12 weeks,ctrl
"Transgenic, snap frozen, diaphragm muscle, 10 month age animal",pert
wild-type_TCPOBOP_rep2,ctrl
"seminoma specimen, pT2, pN2, pM1, patient age: 37y; W00 111",pert
U937_ROS_untreated_4h_rep3,ctrl
FHCRCAML7209,pert
ACI DES-treated replicate 4,pert
Individual_3822_PP_sample,pert
30A;pretreatment;female;breast tumor; nonresponder,ctrl
"Hdh knock-in embryonic stem cells, Q91 line, biological replicate 2",pert
"seminoma specimen, pT1, patient age: 56y",pert
Bronchial Epithelial Cells MMA biological 0154V,pert
"brain, hippocampus: wildtype 2_e1_le1",ctrl
Rat fatty liver19,ctrl
"DSS colon tissue, biological rep3",pert
wt_P2_rep2,ctrl
High weight gainer Kozak1_ABI_ING_H2,pert
Mening UNSTIM WB NP 3b,ctrl
"brain, cerebellum: RNA#3S_le1",pert
PBMCs from normal control subject K (KPBMC),ctrl
HEK001_A08_R2,pert
"209, MUSCLE, Before",ctrl
"GFPMYC negative GC B cells, Biological replicate 2",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.242;	OD280: 1.132;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 50;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Individual_5414_PP_sample,pert
pMX-jhdm1b vitamin C Jhdm1BVc+_1,pert
B7hi mTEC B6/129 aire-/- 1,pert
KU_15N,ctrl
"38B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
colon_epithelium_IL10mouse_6weeks_rep6,pert
"Spinal cord, acrylamide treated, biological rep1",pert
AP-2 gamma targetting siRNA 2: GCGGCCCAGCAACUGUGUAAA Technical Replicate 1,pert
patient: 10;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 1,pert
Series 1; older; 3 days,pert
liver_Pink1 knockout_12 weeks_replicate_1,pert
treatment: progesterone;	genotype: progesterone receptor knockout;	treatement time: 4 hours,pert
231_GATA3_rep1,pert
Mannitol_1,ctrl
105B,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.03;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Cancer 18,pert
DU145_VprBPsh_rep2,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case2,ctrl
Wildtype 3 (jos0951),ctrl
tissue: Pancreas;	strain: C57BL/6;	genotype: Mist1Cre-ER/Cre-ER;	age: 8 weeks,pert
"Trained diabetic mice, time point 5 week",pert
2 hr vehicle repl 1,ctrl
"Nrl-ko, purified Gfp+ photoreceptor cell",pert
"HSCs from female mice treated with oil, replicate 1",ctrl
Eed KO J1 ESCs on day 7 #1,pert
agent: untreated;	time point: 0 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 74 years,ctrl
"Acute Myeloid Leukemia, sample 19",pert
Normal-ERα-positive breast cancer 41,ctrl
GhrhKO_005,pert
Testis_WT_rep2,ctrl
"Tg brain, biological rep3",pert
Jejunum_Wild Type+Quercetin_1,pert
"DMSO-treated, 24h after UV, Replicate B",ctrl
PBMC_C5,ctrl
Cardian muscle Trained diabetic 1 week DT1,pert
RAW_0.35mM_HOCl_#1,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: REBIF;	time: 24 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
Gastric_cancer_patient_9_dye_swap,ctrl
Donor6_24h_DMSO,ctrl
16SAGEA,pert
H5med,ctrl
wild type MEF time 6 replicate 3,ctrl
Cerebellum_nontransgenic control A39_4 months_replicate 4,ctrl
"Patient 6, control tissue",ctrl
HCV_Control_3,ctrl
Sample 5,pert
BRCA1_2,pert
MCF7_siRNA_GCMedControl_24h_AM0011_97.1,ctrl
Severe rep4 (OHN),pert
FmrWT5_brain,ctrl
Hippocampus_Soman_72h_rep1,pert
Scd1-/- on very low fat diet (TD03045 from Harlan Teklad) replicate 2,pert
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 12",pert
Usp22 depleted replicate 1,pert
subject: 2826 TG;	type: transgenic;	tissue: Mouse skeletal muscle,pert
genotype/variation: Usp2-KO;	strain: C57BL6/N,pert
siControl_4,ctrl
"SKO-transduced MEFs, Vc+, D6",pert
RNA from HCC_5N,ctrl
striatum SNCA knockout 21 month replicate 1,pert
Mouse old brain w/ a-tocopherol aT-Br-2,pert
Raji_mi-Ctrl_2,ctrl
"Runx1KO, biological replicate 1",pert
KO_TER119+_rep1,pert
"human failing LV myocardium, Ischemic90",pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Paraventricular nucleus,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 33;	maternal age: 32,pert
GFP Untreated 6hr 282295613,ctrl
"brain, brainstem: CB6_e1_le1",ctrl
strain: C57BL/6;	tissue: small intestine;	genotype: wild type;	treatment: lubiprostone,pert
Mening UNSTIM WB NP 12a,ctrl
liver wild type replicate2,ctrl
"Male, Wistar, 6hrs/day access to cocaine, nucleus accumbens",pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M2;	flt3 status: WT,ctrl
AFFS084-4-291004,pert
tissue: normal skin;	urticaria status: non-afffected;	patient: 14,ctrl
healthy CD4 T cells 1,ctrl
age: 31;	gender: female;	ejection fraction: 56;	left ventricular end diastolic diameter: 71;	inflammation/PVB19: positive,pert
Chondrogenic progenitor cells from OA male 1,pert
gastrocnemius-30 months of age-resveratrol diet-biological replicate3,pert
Control d10 (2),ctrl
HLA risk: High;	Height: 171.8 cm;	Weight: 82.4 kg;	BMI: 28;	Age: 57.67 years;	Gender: Female;	Race: White;	Glucose: 78 mg/dl;	HbA1c: NA,ctrl
disease state: sarcoidosis;	biopsy type: transbronchial;	tissue: lung,pert
Healthy control 8,ctrl
P77 dilated cardiomyopathy heart biopsy,pert
chip number: 4;	transfection plate: 1;	target gene: CLOCK;	kd level: 0.84;	rin: 9.1;	transfection date: 2011-03-29,pert
F_Ctrl_3,ctrl
"breast tumor epithelium,8",pert
New 3 hr 1,pert
"Rat_Tracheal_Control_2hr, rep6",ctrl
age: 6 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
IR-WT_Rep2,ctrl
Thyroid_ papillary carcinoma 50,pert
"Wild type used for MAT1A 15 month, replicate 2",ctrl
21day 4OHT-treated-sample3,pert
"E-FABP knockout GM-BMMs, biological rep1",pert
colonic_mucosa_non_inflamed_94,pert
"Peripheral blood, patient without recurrent events [N36]",pert
"Muscle from DS, biological rep3",pert
RAW_0.7mM_HOCl#3,pert
A61 WT3	F24/2	A61	wild type	Mouse	8 months	Cerebellum	Male,ctrl
subject: 10;	disease: TD;	muscle: GR;	gender: M;	age: 14.9;	gmfcs: N/A;	popliteal angle: N/A,ctrl
CLL 377-01 Control,ctrl
"Aorta, Ang II 7d, #4",pert
Mening SWB WB SW 6a,pert
MKK7D control female replicate 2 early timepoint,pert
midbrain_wild type_12 weeks_replicate 2,ctrl
mESCs_Tip60KD_rep3,pert
KD control replicate 2,ctrl
P1 mouse eyeball extracted total RNA_wt3_GSM618317,ctrl
female_control_410,ctrl
"Skin removed from back region of embryonic day 16.5 mouse, Tcfap2c mutation",pert
"Patient 32, Atheroma plaque",pert
G_LS_Wk2,pert
B_lymphoma_1,pert
AA_Control1_CD8,ctrl
Wild-type rep1,ctrl
3895-2 E2F1 Null,ctrl
"D425-shOTX2_3, t=48",pert
strain background: C57BL/6J;129S5/Brd mixed hybrid;	genotype/variation: wild type control;	tissue: uterine;	age: 15 days,ctrl
mutant_ANT_PDE_A4,pert
"control endometrium, patient 24",ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day0,ctrl
gender: male;	age: 2-3 months;	tissue: kidney;	genotype: ERRa KO,pert
WTT 160 bleomycin treated.,ctrl
21A;pretreatment;female;breast tumor,ctrl
OSCE-2N,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 48.13151,pert
B6_Male_Control_rep1,ctrl
17-0001A_Day1_44,pert
RNA-DHL6-DMSO-1,ctrl
LCCS sample 18 weeks,pert
A375 Wnt1-3,pert
cell type: Dorsal skin Basal IFE epidermal stem cells;	genotype: wild type,ctrl
Run4.aUa.010110d.SkMDbt1150D.CEL-DB basal,ctrl
protocol: control;	cells: Neural Neural Stem Cell Line F3,ctrl
b78+,pert
LSK cells from wild type mouse rep3,ctrl
RT4D6_wild type Sox10 siRNA_rep2,pert
monocytes_Q10H2_2,pert
KN-smoke-med-5 month+1d-R4,pert
"ATP7B -/- Ko mice, 6 weeks old",pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: Vemurafenib 1000 nM for 48h,pert
"patient 036b, normal, homogenized",ctrl
HL60-shGSK3A-Construct6-rep2,pert
Heart dissected from wildtype E12.5 fetus.,ctrl
gender: Male;	age: 74;	post-mortem delay: 4.5h;	ph: 6,pert
MDS patient 111,pert
24SMOKEH,ctrl
WT-smoke-med-5 month+13d-R3,ctrl
Ex1_cells_rep3,ctrl
race: caucasian;	age (years): 66;	stage: IB;	grade: 1;	histology: endometrioid,pert
"Peripheral blood, normal control [N57]",ctrl
"Whole ovary from 8 Month Old FORKO mice_02, biological rep2",pert
"array 27, xenograft, DBP 500 mg/kg/d",pert
"CFU-PreB colonies Hspa9+/-, biological replicate 4",pert
major HCC6,ctrl
mouse cerebellum at P30 wild type 2,pert
BxPC3-KO4 rep 4,pert
"Patient I-1031-N, normal colonic mucosa",ctrl
GM19238_Kd_NS4_22,ctrl
"human failing LV myocardium, Ischemic3",pert
"BMMs, untreated control, wt, Replicate 3",ctrl
cumulus_nonPCOS_Obese_rep3,ctrl
Patient 4 after folic acid,pert
10A,pert
H4-II-E-C3_untreated_rep1,ctrl
race: caucasian;	age (years): 62;	stage: IB;	grade: 1;	histology: endometrioid,pert
subject id: 38;	infection: DENV;	status: DHF;	tissue: whole blood,pert
WT - Cre Control - 5 mo - repeat 4 - Cy5 - mAdbID:74103,ctrl
"nasopharyngeal carcinoma, specimen T27",pert
Muscle PCOS after pioglitazone 122,pert
race: african american;	age (years): 73;	stage: IB;	grade: 3;	histology: papillary serous,pert
"testis, Repro9 mutant, 17dpp, Rep2",pert
"brain, hippocampus: KA240-I_e1_le1",pert
tissue: skin;	cell line: NZM15;	tumour stage: metastatic melanoma;	tumour site: neck nodule;	treatment: media-only control,ctrl
Kidney_400 mg/kg VCM ip_mouse #104,pert
S3star_Sham_wildtype_8,ctrl
Extract:LOX-1:113403;	Extract Description:GFP_Untreated_12hr:113403;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0.04;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.7;	Quality: Background Mean Dev.:1.04;	Quality: Absent (%):57.99;	Quality: Absent (%) Dev.:0.2;	Quality: Scaling Factor:0.48;	Quality: Scaling Factor Dev.:1.14;	Pretreatment [C]:GFP;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113403;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_12hr;	RNA extraction source key [A]:282295733,ctrl
MCF10A cells,pert
gender: female;	batch: 1;	age (years): 31;	patient id: Control_7;	fev1 (% predicted): 85;	fvc (% predicted): 96;	medication: None;	cell type: CD4+ T-cells,ctrl
KO-Nrf2-Male-2,pert
"Sh2b3 WT, biological rep2",ctrl
Testis_KO_rep5,pert
PTC BRAF wt 11,pert
HDAC2 siRNA_4_Huh7 [HDAC2 siRNA subset],pert
"1833 control, biological replicate 2",ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, FLX treated, biological rep1",pert
cell line: OV90;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
"Wild-type-hippocampus, biological rep4 (male)",ctrl
SCC-40_siScramble_rep.2,ctrl
"ES cell line, RNA 70",pert
OCI-Ly10_ctrloverexpression,ctrl
"TCF-1 KO CD8 memory T cells, biological rep2",pert
Sample 4 Posterior  -/-,pert
MDS patient 69,pert
"SKI-DLCL cells, not treated and cultured for 24h. Total RNA was isolated using RNeasy kit",ctrl
Muscle-AMPKgamma3-wt-2,ctrl
3P-ER-ND,pert
"testis with regular spermatogenesis from orchiectomy cases due to prostate carcinoma, patient age: 67y; W03 002",ctrl
cell line: MDA-MB231;	treatment: G9a knockdown;	cell type: less metastatic breast cancer cells,pert
Dicer WT CD4 T cells 2,ctrl
Donor3_24h_Wy,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 4,pert
AVIC sample#3 treated with DAPT,pert
11404 Normal Uninflamed ascending colon,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: normal,pert
"genotype: Ring1B mutant generated by gene targeting (Leeb et al., 2007);	cell line: ES",pert
Epithelial prostate primary cells from fresh tumor explant.,pert
SLE CD19 B cells 7,pert
Parkinson's disease sample x178,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 64, stage IIB, HPV 18",pert
M24met_control_2,ctrl
strain: SW129/C57BL/6J  cells;	genotype/variation: c-jun knock out;	cell type: B-lymphoid,pert
10.5 Months Heart MDX rep 2,pert
"brain, adrenal medulla: Sample#A2 (Exp pt 2)_e1_le1",pert
wild-type Jurkat cells,ctrl
SA1,ctrl
s3t3c,ctrl
Normal mucosa 22,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 104min;	race: White;	sex: Female,ctrl
gender: male;	batch: 1;	age (years): 46;	patient id: Control_4;	fev1 (% predicted): 92;	fvc (% predicted): 105;	medication: None;	cell type: CD8+ T-cells,ctrl
"brain, Entorhinal Cortex: 00 28 normal_e1_le1",ctrl
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, bone marrow;;	disease: (severe) aplastic anemia (SAA) post therapy / in hematological remission",pert
Mutated-ERα-positive breast cancer 17,pert
ctrl_MPH,pert
PFC S control 3,pert
disease state: healthy control;	tissue: epidermis;	age: 74;	gender: female;	treatment: untreated;	time: control,ctrl
V5-P061,pert
A673_CloneAsp14_Dox_96h_2,pert
transgene: FTO;	treatment: noninduced,ctrl
MCF10A_SFN_rep3,pert
Cell line established from CA2 HESC using pClip vector,pert
5247 UC Uninflamed sigmoid colon,pert
gender: Male;	tissue: Tendon;Subscapularis;	age: 59;	donor: 17;	disease state: Non-lesional,ctrl
Cbx2_KO_XX_3,pert
"Ada3FL/FL MEF, control, biological replicate 1",ctrl
tissue: white blood cells;	age: 14.51;	Sex: female,pert
"Peripheral blood, normal control [N65]",ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 45;	age-at-onset: n/a;	geographical origin: Mirandela,ctrl
control participant P336,ctrl
C57/BL6 murine Liver RNA- 6 hours post-injection with PBS,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.549;	OD280: 0.803;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 63;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"sebocytes cultured from M, 55, normal preauricular sebaceous glands and SV-40 immortalized",pert
Parkinson's disease sample x175,pert
sample =XCGD2 treatment=Stimulated time=360 (min),pert
Control 1 a,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 5,ctrl
MCF-7 +scrambled siRNA + vehicle rep2 (MD40),ctrl
cell line: TOV112D;	cell type: epithelial ovarian cancer cell;	treatment: Untreated,ctrl
tissue: freshly isolated human monocyte;	gender:female; age: 19 yr; weight: 65 kg,pert
Fibroblasts_DBApatient_2,pert
control to Sample 21,ctrl
"ERbKO mouse aorta with placebo, biological rep1",pert
Nerve_Diabetic_Rosi_716,pert
12491 UC Inflamed sigmoid colon,pert
"granulocyte, patient. Mtx rep4",pert
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: resistant,pert
Control Colon 1 17 days old,ctrl
CA99-43B,ctrl
n3_hi_11,pert
CD4DecTp2-9,pert
Extract:LOX-1:113202;	Extract Description:GFP_Untreated_2hr:113202;	Quality: Classification:Medium;	Quality: Gradient Severity:0.06;	Quality: Distortion Severity:0.07;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.75;	Quality: Background Mean Dev.:2.27;	Quality: Absent (%):59.11;	Quality: Absent (%) Dev.:0.67;	Quality: Scaling Factor:0.55;	Quality: Scaling Factor Dev.:0.5;	Pretreatment [C]:GFP;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113202;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_2hr;	RNA extraction source key [A]:282295483,ctrl
strain background: Mixed; mostly C57BL/6 with some 129S/SvImJ (from CJ7 ES cells).;	genotype/variation: Eed KO;	age: 9-day old;	tissue: bone marrow;	cell type: long-term hematopoietic stem cells (LT-HSC);	cell type: Lin-Sca1+CD48-CD150+,pert
"brain, cerebellum: WCb4w#3_e1_le1",ctrl
209/4,ctrl
53_129_KO,pert
Liver-5 month-Myc heterozygous-technical replicate 1,pert
Extract:LOX-1:113503;	Extract Description:GFP_Untreated_24hr:113503;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0.04;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.36;	Quality: Absent (%):58.28;	Quality: Absent (%) Dev.:0.02;	Quality: Scaling Factor:0.65;	Quality: Scaling Factor Dev.:0.34;	Pretreatment [C]:GFP;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113503;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_24hr;	RNA extraction source key [A]:282295853,ctrl
Dengue Hemorrhagic Fever Patient 39,pert
HF0312_U133P2,ctrl
06_NOR,ctrl
RNA from HCC_20N,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 2,pert
Run4.aUa.010110d.SkMDbt1149D.CEL-DB stimulate,pert
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-3,ctrl
WT littermate1,ctrl
Normal myocardium sold commercially (F),ctrl
S5_S5010928,pert
"PBMC, healthy control, biological rep7",ctrl
LacZ control_0c,ctrl
Pancreatic Sample 5-Tumor,pert
"seminoma specimen, pT1, patient age: 55y",pert
sampleID: SAM630147;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
"SHR adrenals, replicate 1",pert
Wild-type Rep2,ctrl
strain: mixed 129/Ola-C57BL/6 background;	genotype/variation: Jun delta mu,pert
"rat hippocampus (CA1 region), sham, 18 months old, subject 6",ctrl
whole tissue section from case 1279,ctrl
Control 1a,ctrl
Raji_mi-142-3p_1,pert
LT-HSC Zbtb7a F/F Mx1-Cre+ #1,pert
tissue: T cells;	genotype: CTLA-4 KO 5C.C7;	background mouse strain: B10.A,pert
5199 Normal Uninflamed sigmoid colon,ctrl
"shCDK19, low glucose, replicate 2",pert
CLL1-CD8,pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 50;	donor: 27;	disease state: Lesional,pert
Phan_012_KO.bleomycin rep3,pert
gender: Male;	age: 60;	post-mortem delay: 16h;	ph: 6.9,ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case6,pert
tissue: Breast adenocarcinoma,ctrl
Fat FC3,ctrl
"cells treated with Scrambled siRNA, biological replicate 2",ctrl
No or early 2 rep7 (OHN),pert
51104.LMP,ctrl
strain: Wistar;	gender: male;	tissue: spinal cord;	treatment: saline,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 5d ID60,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 42.93699,pert
cell line: HeyC2;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
Sample ID: TP13;	Twin Pair ID: CCN1.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.1R** ,ctrl
chip number: 20;	transfection plate: 3B;	target gene: E2F6;	kd level: 0.65;	rin: 9.5;	transfection date: 2012-03-26,pert
cell type: Primary hepatocytes;	strain: BalbC;	agent: control;	time: 6h;	gender: Male;	age: 6 months,ctrl
fibroblast_Slow_D69_Media_7,pert
COV434 Mutant [RR1019],pert
lung_control_1,ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 4",pert
colon_C57mouse_6weeks_rep6,ctrl
129_Sv_3_WT_d6_4302,ctrl
PsOEt-24-Week 1,pert
BAL_15a_A0B1,ctrl
7021.31PBMC,ctrl
"shControl clone 2, rep 2",ctrl
Itk knockout CD4+ CD3-stimulated 1,pert
"PDK1 null CTL, biological replicate 3",pert
Day: 6; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 1,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 6",pert
HepG2_100uM_Trovafloxacin_24hr_prep1,pert
BV2_Curcumin_rep3,pert
Day: 18; Drug: Heroin; Phase: Withdrawal; Replicate: 3,pert
humanMBC_FOXP1 overexpression_2,pert
cell line: NOMO-1,pert
Contralateral 4,ctrl
"patient 11, baseline",ctrl
FBooth-CON-2Av2-s2,ctrl
B2KO; No Treatment #2,pert
ApoD KO rep_1 (CKO1),pert
HUVEC_TSA_rep1,pert
01LMB_Oligo,pert
No or early 1 rep3 (retina),pert
KO Soleus at 4 weeks biological rep2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.898;	OD280: 0.49;	Ratio: 1.84;	Dilution: 1:5;	RNA Integrity Number: 7.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 209;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
VIN_B090,pert
OVCAR-8+(1),pert
Wild type fully-grown GV oocyte from transgenic mice,ctrl
Sle1a R2,pert
Severe rep5 (OHN),pert
"Wild-type-hippocampus, biological rep9 (female)",ctrl
genotype: C57BL/6 WT,ctrl
AA_Case6_CD8,pert
PGA-RMM-5h-2aA-s2,pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep1,pert
Tissue:tumor; Gender:male; Age:36; Tumor stage:T4aN1aM1,pert
LNCaP + ELK1-shRNA + R1881 rep 2,pert
RatLung_H24h_2,pert
Carbo Day4 (71L),pert
"Untreated TG2 knockout NB4, biological rep1",ctrl
background strain: B6/129;	genotype/variation: wild type;	age: 11 Month;	tissue type: Liver,ctrl
JoMa1_3,ctrl
X_p8_rep4,pert
normal scar treated with hydrocortisone-2,pert
HMEC X Senescent HMEC-2,ctrl
Treatment 4,pert
48 hrs TAC-5,pert
rtTA-Dmrt5_d7_-Dox_rep_1,ctrl
Gastric_cancer_patient_3_dye_swap,ctrl
"Patient 2, Macroscopically intact tissue",ctrl
Pancreatic Sample 14-Tumor,pert
"Kinin B1 receptor knockout, biological rep1",pert
phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject J,ctrl
Endometrial stromal cell - Jag1 retrovirus infected 1,pert
"KSR1 Alone, Replicate 3",ctrl
liver_Akt1+/-_35wk_rep3,pert
con-11_A,ctrl
"HUVEC treated with Non-sense SiRNA , biological rep1",pert
Muscle-AMPKgamma3-wt-7,ctrl
CD19_selected_B-cells_after_R_rep3,pert
Subject #8032-2d Postinfection,pert
"endometrioma, patient 6",pert
Genotype: wildtype MEFs;	Primary mouse embryonic fibroblasts (MEFs) generated from embryos at E13.5,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 4,pert
A39 NES 142Q TG6	F1/4	A39	NES Htt exon 1 142Q	Mouse	10.5 months	Cerebellum	Female,pert
patient: 7;	disease state: hypertension;	tissue: Atheroma plaque,pert
PGA-lv_4h_507,ctrl
cell line: HCT 116;	treatment: control,ctrl
"sebocytes cultured from M, 55, normal preauricular sebaceous glands and SV-40 immortalized",ctrl
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14504;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
51104.INV,pert
Disease_status: Healthy control;	Age (years): 50;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.75;	Post mortem interval (hours): 49;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
A549 DAC 1 uM (3221),pert
cerebellum_wild type_6 weeks_replicate 2,ctrl
Subject #8009-2d Postinfection,ctrl
ko 13.5d replicate 4,pert
"schizophrenia, BA46-3",pert
age: 20;	sex: M;	disease status: Marfan subject;	Filter number: 89;	Usage number: 4;	Exposures: 3,pert
Gnmt_KO_1,pert
"iPSC derived from healthy control fibroblast WT1, biological rep2",ctrl
"schizophrenia, BA46-93",pert
"Wild-type-neocortex, biological rep6 (female)",ctrl
BP21,pert
"DMD skeletal muscle, biological rep2",pert
"BMMs, untreated control, db, Replicate 2",pert
8 week old leg MDX rep 3,pert
tetO-Satb2 #1 +DOX,pert
"Heart, MAT1 CKO, 4 wk, sample 3",pert
AEP-first,ctrl
"TAMs sorted from imatinib treated tumors, biological replicate#1",pert
Ppif-/- heart 3,pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Atypical antipsychotic Clozapine, Dose: 12mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking water, Period of treatment: 4 weeks, Method of sacrificing: cervical dislocation.",pert
F-IIP(UIP)6_Cy3,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 15b;	treatment: with vehicle for 6h,pert
CLC5 ko rep 2,pert
"BOEC, normal 2",ctrl
"IN1472 siNT treated, Biological replicate1",ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 6h ID207,pert
gender: female;	age (years): 60;	evolution time (years): 22;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
Psoriatic arthritis PsA 8,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 58, stage IIA, HPV 16",pert
"Control siRNA - 5 days adipocyte differentiation, rep1",ctrl
mdx diaphragm sample 1,pert
"non-SS control gland, patient 17, batch 2",ctrl
cell line: mda-mb-231;	transfectant: siRNA for LacZ,ctrl
WT HPC PDE10i 11,pert
ColonTum_022HAFC9_cta.txt,pert
Bone-Marrow_MM_M1028,pert
gfp control sample 3,ctrl
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Post mortem interval (hours): 29;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
skin.KO.replicate26,pert
129/BSw het1 heart,pert
liver control diet rep1,ctrl
"Strain: Polg+/+ mice;	Gender: male;	Age: 9 month-old ;	Tissue: cochlea;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",ctrl
2_WT_1,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 2x1h exposure per day",ctrl
Bronchial Epithelial Cells SA biological 2047K,pert
"Luc control esiRNA, biological rep2",ctrl
Bronchial Epithelial Cells MMA biological 2003Q,pert
Pancreatic Cancer PBMC Sample 2,pert
microdissected breast cancer cells from case 68,pert
Donor (Sample 22),ctrl
RNA-DHL6-DMSO-2,ctrl
"89 y/o female. 46,XX",pert
48 hrs TAC-2,pert
01LQK: normal control,ctrl
HNF4 Control_1193,ctrl
CUTLL1 MigR1 GSI-rep2,ctrl
GC13_skin_5dpn_1,pert
"immortalized cells derived from brown fat tissue of PGC-1alpha KO mouse (mixed background), expressing a control siRNA.",pert
control participant P329,ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/16;	hybridization date: 09/06/30;	colon length (mm): 6.6;	colon weight (mg): 160;	colon ratio (mg/mm): 2.42;	myeloperoxidase activity (u/mg): 0.423;	tissue: colon;	treatment: 5% DSS,pert
Gene expression of murine fibroblast-like synoviocytes Grp2_C57BL6_3_FLS_TNFtg,ctrl
CLL16-CD8,pert
genotype: Wild type;	strain: C57BL6,pert
A4_C4_nasal_stem_cell_rep1,ctrl
ko 13.5d replicate 12,pert
MBD2_3,pert
cell type: primary human monocyte-derived macrophages;	differentiation factor: MCSF,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 10.008;	Ratio: 2.11,pert
gender: Female;	age: 65;	post-mortem delay: 3h;	ph: 6.1,pert
01LMR,pert
cell type: embryonic stem cells;	genetic modification: WT,ctrl
"ALL_NDS, K54 011509",ctrl
"T-cell prolymphocytic leukemia, no inv(14)(q11q32), case 8",pert
"alveolar macrophages, non-smoker 006",ctrl
"eye, retina: Control 2_e1_le1",ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 35 yr;	population: white;	dsm-iv: 295.3;	age of onset: 14 yr,pert
"A549, +TNFα, control siRNA, rep2",ctrl
Age (mean +- SE),ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 68 years,ctrl
YFP+Foxp3delta r1,pert
RV83.09_CHF_day10_Slide76,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 90,pert
gender: Male;	age: 41;	post-mortem delay: 8h;	ph: 6.3,pert
Gata3_Cdx2_null_3,pert
"Spi-60, biological rep 8",pert
infection: GFP protein (control),ctrl
DN4 cells sorted from mouse n°129 (Cre+),pert
db/db 12-3,ctrl
64A;pretreatment;female;breast tumor; responder,ctrl
tissue: kidney;	protocol: intravenous;	agent: saline;	dose: 0 mg/kg,ctrl
Ishikawa_VeryLowDose_BPA_8h_rep3,pert
11101 UC Uninflamed descending colon,pert
Normal Pleura 2,ctrl
sample: #24;	subject: PD case #6;	brain: T-227;	age: 76;	sex: Female;	region: Inferior olivary nucleus,pert
strain: C57BL/6;	genotype/variation: wild type;	gender: male;	age: 5 Month old;	tissue: Liver;	diet: 35% Fat Diet (High Fat Diet; HFD),ctrl
MOLT4_GSI_A,pert
Wild_type_control,ctrl
"mouse, mutant, liver, RNA B8877",pert
V5-P241,ctrl
Sham 50d replicate 2,ctrl
Braak α-synuclein 3-4 BR34_7SN,pert
3798M patient’s mucosa,pert
Severe rep8 (OHN),pert
EA_Control5_CD8,ctrl
diagnosis: UIP/IPF;	fvc-group: FVC1;	tissue: lung,pert
Psoriatic arthritis PsA 16,pert
"AALE-KRAS uninfected, biological rep1",pert
fibroblast cultured from normal esophageal tissue_HEF_2111,ctrl
No or early 1 rep7 (OHN),pert
MCAD + LPS 1,pert
tetO-Satb1 #1 +DOX,pert
"KARPAS-231, non-targeting siRNA, REP1",ctrl
"Normal T-cells, CD3+, donor 5",ctrl
3458-scrape,pert
fibroblast_Slow_D72_Media_8,pert
Cells:U-33 cells stably transfected with a PPARg2 expression construct (U-33/g2 cells);	Time: 2 hrs;	Drug: No Rosiglitazone present,pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: siRNA targeting FOXP1;	genotype/variation: siRNA-mediated FOXP1 knockdown,pert
Mutated-ERα-positive breast cancer 46,pert
brain wild type replicate2,pert
SLE CD19 B cells 6,pert
21day 4OHT-treated-sample1,pert
U937-shGSK3A-Construct6-rep1,pert
Gastrocnemius Muscle_WT_rep2,ctrl
host strain: nude mice;	injected with: iNRAS-475 mouse melanoma cells;	tissue: Melanoma allograft;	treated with: AZD6244 MEK inhibitor 100mg/kg for 4 days,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 50;	sex: F,ctrl
R7E 8,pert
siCtrlVeh4h_2657,ctrl
HeLa cells control 2 (Luciferase siRNA transfection),ctrl
RNA from HCC_14T,pert
BP19,pert
db/m 8wk 1,ctrl
wt_rep1,ctrl
"breast tumor epithelium,45",pert
Pooled PBMC sample enriched for CD8+ cells from normal control subjects (140CD8),ctrl
LY2 SRC1-siRNA untreated rep2,pert
Klf9KO_jejunum_PND30_2,pert
"P16 mutant OC base, biological rep 2",pert
A YOKE_B061,pert
01N6Z_CTRL,ctrl
sample =XCGD2 treatment=Stimulated time=90 (min),pert
jzo023-rp1-v5-u74av2-met,ctrl
"age at diagnosis: 38;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 60;	dfs-event: 0;	distant metastasis: 0",pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID325,ctrl
strain: C57BL/6J;	day: 18;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
ctrl_506,ctrl
IRAK2 KO_macrophages_2h,pert
KN-smoke-low-5 month+1d-R2,pert
subject: 21A;	cohort: 21;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 82;	Sex: F;	batch: Batch_5,pert
5796 KSR2-/- Mouse White Adipose Tissue,pert
esophageal squamous cell carcinoma from patient E1796,pert
"wt total RNA LSK, rep 2",ctrl
Healthy control_sample11,ctrl
WT HPC Veh 5,ctrl
E2 4hr,pert
"SIRT3KO, standard diet, rep3",pert
XBP1s B cells 5,pert
Pancreatic Sample 25-Normal,ctrl
PBMC from T cell LGL leukemia patient #108 (TLGL108),pert
231-Empty_rep3,ctrl
cell line: Normal bone cell line 695;	phenotype: Parental;	cell type: human osteoblast (hOB),ctrl
"vestibualr organ at P90 of Igf1 +/+, biological rep 3",ctrl
11399 Normal Uninflamed terminal ileum,ctrl
3D-cultured chondrocytes from OA donor 1,pert
RNA from HCC_17N,ctrl
SUP-B15 Imatinib-treated,pert
"siRNA, plastic plate, rep1",ctrl
pre-iPSC- siRNA to Cbx3- biological replicate2,pert
"Male, Wistar, 0 access to cocaine, lateral hypothalamus",ctrl
cell type: HeLa cells,pert
Dicer KO CD4 T cells 3,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_10 months_replicate 1,pert
V5-P127,ctrl
Subject #8023-8hr Postinfection,ctrl
"breast tumor epithelium,14",pert
sample O term wt,ctrl
Rybp#15 (OHT+)_12d_rep2,pert
"healthy control fibroblast, biological rep5",ctrl
normal 1546,ctrl
"nasopharyngeal carcinoma, specimen T31",pert
216/0,pert
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14503;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
"shZBP-89, biological rep1",pert
"NPTX1 shRNA Day 0, biological rep1",pert
"RWPE-PCAT1 cMyc siRNA #4, replicate 2",pert
Cav3KO 1504,pert
Untreated CHOP-/- B,pert
CD8_T_cell_pool_healthy_H07+H08,ctrl
"mouse aorta cross strain comparison, C3H_T40_NC_02",ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 6h ID127,pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Aldosterone;	genotype: CTNNB1 mutation (T41A),pert
Experimental 2,pert
"brain, Entorhinal Cortex: 95-08 tangle_e1_le1",pert
"KO+Empty, biological rep1",pert
gender: male;	strain: CBA/C57BL/6;	genotype/variation: IL8 transgenic;	tissue: colon cancer tumor,pert
"MDA-MB-231/shNS, biological rep1",ctrl
Ctrl siRNA 4d 2,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 5 months;	genotype: Myc heterozygous,pert
4421-1 E2F3 Heterozygous,pert
Strain: a mixed C57BL6/129 genetic background,ctrl
"strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 15 months;	tissue: liver, tumoral tissue;	disease status: hepatocellular carcinoma",pert
"siThoc5-1, biological rep1",pert
tissue: liver;	genotype: WT;	genetic background: C57BL/6,pert
OSCE-14T,pert
5248 UC Uninflamed sigmoid colon,pert
"Lens epithelium, SPARC KO, #1R",pert
E12.5 heart_Sp3 knockout_sample a,pert
healthy CD19 B cells 5,ctrl
Sample 15 Kidney Normal Mouse - Control Diet,ctrl
"IKK2 -/- tumor, biological replicate 1",pert
PGA-MAH-C3H_OVA24h-5aA-s2,pert
"Strain: Wistar, Sex: male",pert
10SC-pbo,ctrl
U937_shSYK_2_Replicate1,pert
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug.  At four hours prior to RNA isolation, 1.25uM sapphyrin PCI-2050 (1.25uM final concentration) was added to the culture.  After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",pert
AIRE-ko-CD80hi-mTEC-sample1,pert
Donor2_6h_Wy,pert
brain_DLPFC_bipolar C_mr423,ctrl
HN_64,ctrl
individual: patient15;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
heart female CVD3 10 dpi rep1,pert
MIY_day_5-4,ctrl
race: caucasian;	age (years): unknown;	stage: IA;	grade: 3;	histology: endometrioid,pert
Human prostate cancer primary culture C41sx,pert
tissue: Cop1-null embryos,pert
"MGSKO, PR02M006v0",pert
ATCC CRL-2868,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 165min;	race: Caucasian/White;	sex: Female;	group: A;	prototype: Y,pert
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	1st technical replicate,pert
"control mouse cerebral microvascular fragments, biological rep3",ctrl
01_C57_KO,pert
human_hepatocyte_vehicle_donorB_24hr_prep2,ctrl
IRAK4-KD-MEFs_unstimulated_4hours_rep2,pert
GIST_PDGFRA_3,pert
Mutant biological rep2,pert
INCB18424 Acute 3,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 54.90137,pert
CD11b+Gr1- cell sample_4 (derived from wild type mouse),ctrl
23d wt4,ctrl
P0 - nudelcko/ko 3,pert
5IDC_normal_ductal,ctrl
age: adult;	gender: female;	tissue: lung,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-tu3,pert
strain: FVB/N;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Fibroblasts;	genotype: Fsp-cre; PtenloxP/loxP,pert
"vector d10, rep 1",ctrl
Sample ID:TP9;	Twin Pair ID:DCBD3.1;	Clinical Status:BD1 with psychotic features ;	Age of Onset:18 ;	Age at interview & blood sampling:35 ;	Current Age (2007):38 ;	Sex: Female ;	Medication at interview (duration) :sodium valproate (5 years),pert
RNA from HCC_34N,ctrl
Mammary cell line,pert
NuLi cell line treated at DMNQ biological rep3,pert
siRNA LMG4 treated HeLa cells 2,pert
cell type: embryonic stem cells;	genotype/variation: Satb1 overexpression,pert
"fibroblast, MFS subject FB1627 rep 3",pert
KU_40T,pert
1_CD34+_12h_TCDD-,ctrl
brain_DLPFC_bipolar C_mr539,pert
"CFU-PreB colonies Hspa9+/-, biological replicate 1",pert
"WT mouse heart at 6-weeks old, biological rep3",ctrl
GM19238_Kd_IRF5_1_rep,pert
GSK3B shRNA replicate 2,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: OE-NANOG,pert
S46 WT7	F5/55	S46	wild type	Mouse	10 months	Cerebellum	Female,ctrl
"FOXP3, mut, REP3, 0h",pert
"AALE-Vector + shTBK1, biological rep1",pert
Mut+/+ rep4,ctrl
Subject #8015-Preinfection,ctrl
A8_C8_nasal_stem_cell_rep1,ctrl
"72 hour-treated wild-type NB4, biological rep2",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 85min;	race: White;	sex: Female,pert
Subject 5 Pre allergen challenge,ctrl
Liver_normal_no.3,ctrl
lesion_preUV_patient8,pert
phenotype: control;	gender: male;	case_id: 257;	age: 58;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 12;	brain ph at time of freezing: 6.46;	labeling_batch: 2,ctrl
Liver_nash_no.4,ctrl
Cont G2,ctrl
"brain, cochlea: [3] Sample #3_le1",pert
Mening Unstim WB SW 24a,ctrl
HT29siRNAc.833,pert
ubb_d21_wt_1,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.131;	Ratio: 2.11,pert
GhrhKO_006,pert
Snell 6 month Dwarf Liver 83dw,pert
PPAR KO_ctr_116,pert
PGA-HMO-NonObese-1aUA-s2,ctrl
S46 NLS 142Q TG7	F4/3	S46	NLS Htt exon 1 142Q	Mouse	10 months	Cerebellum	Female,pert
HLA risk: Low;	Height: 160 cm;	Weight: 53.4 kg;	BMI: 20.7;	Age: 22.84 years;	Gender: Female;	Race: White;	Glucose: 88 mg/dl;	HbA1c: NA,ctrl
MSE_N_626,ctrl
Bone Marrow Mononuclear Cells;	26y Female,ctrl
Mouse No Cldn16 B9 439,ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle cell;	matched/unmatched: unmatched,pert
Trib1 #1 Wild-type macrophage LPS,ctrl
patient: 19;	disease state: hypertension;	tissue: Atheroma plaque,pert
treatment: BCL-3 vector;	cell line: HaCaT;	tissue: Immortalized keratinocytes;	cell type: Immortalized cell line,pert
skeletal muscle Crhr2-/- replicate1,pert
subjectid: 5269;	imatinib: IM;	lbh589: NoLBH,pert
LNCaP prostate cancer epithelial cell line,pert
Control_24h_rep2,ctrl
Nonspecific siRNA2,ctrl
Cardiac Muscle_WT_rep1,ctrl
T6C-LU,pert
race: caucasian;	age (years): 85-90;	stage: n/a;	grade: n/a;	histology: cystic atrophy with sessile polyp,ctrl
H9_d15_hepatic differentiated_3,ctrl
No or early 2 rep11 (OHN),pert
EA_Case4_CD8,pert
E_Kin_3,pert
4033-1 E2F WT,ctrl
Muscle control 2,ctrl
"Wild type used for MAT1A 15 month, replicate 1",ctrl
prefrontal cortex (BA46);	control,ctrl
"Cerebral Palsy, Gracilis, Patient Replicate 3",pert
Individual_4208_PN_sample,pert
Subtype: RAEB1;	Karyotype: del(5q),pert
Strain: NMRI mouse;	Age: 14 day embryo;	Tissue: molar tooth germ,pert
TTP_KO_0ActD_BioRep4,pert
CLL24-CD4,pert
lean control-2,ctrl
"breast tumor epithelium,39",pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: fresh air, treatment over 5 month + 1 day recovery, 4x1h exposure per day",pert
"human failing LV myocardium, Ischemic1",pert
homozygot FH P262,pert
control siRNA (siCon) tranfected into C2C12 myoblasts rep1,ctrl
484MM,pert
WT / Reference_13425477,ctrl
Individual_5177_PP_sample,pert
453MM,pert
M229_R5_B_DMSO,ctrl
V5-P582,pert
mTert 2,pert
Bmpr1a-/- ESC media sample 2,pert
cell line: AINV15;	strain background: 129P2/OlaHsd;	genotype/variation: Control;	condition: -Dox,ctrl
Biceps_Pompe_1,pert
MDS patient 143,pert
whole tissue section from case 1389,ctrl
"Peripheral blood, patient without recurrent events [N45]",pert
M465 Wt,pert
PE_D_26A,pert
Cell line expressing inducible wt-GFP-lamin A. Induction: day 0. Replicate B,ctrl
heterozygot FH P278,pert
NTB_heart 1,ctrl
baseline control 04,ctrl
"disease group: Nonatopic Control;	Sex: m;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 90;	ige (kiu/l): normal (0-48.5 kIU/L): 70.8;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 19;	maternal age: 19,pert
01MJ9_Oligo,pert
"C57BL/10-SJL.Dysf TA, replicate 1",pert
U937-shControl-rep1,ctrl
cell type: Oct4-GiP ES cells,pert
"36B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 65;	Sex: male;	region: CB (cerebellum);	genotype: Y/Mecp2-;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,pert
age: 6 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 knockout,pert
neocortex-30 months of age-resveratrol diet-biological replicate4,pert
CD11b+Gr1- cell sample_5 (derived from IL17RC Knock out mouse),pert
CD8_T_cell_pool_melanoma_M09+M10,pert
"Grape extract group, 12 months, patient number 32",ctrl
"fibroblast, control subject NF5 rep 2",ctrl
DOV13-(3),ctrl
uterus_veh_PRKO_4hrs_rep1,pert
colon_IBD_1802,pert
Hippocampus_Soman_168h_rep1,pert
St6gal1-/- tumor #3376,pert
Diagnosis: MDS/AML;	Age: 51y ;	Gender: Female;	Blast %: 72;	Source: PB;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
WT-smoke-low-5 month+1d-R2,ctrl
Wild-type Rep1,ctrl
29_C57_WT,ctrl
WT1 naive CD8 T cells,ctrl
RAW CstF-64 3,pert
MA_301,pert
"Peripheral blood, patient without recurrent events [N39]",pert
"4105_CD133+, laminin treated",pert
GIST Pre Treatment Biopsy 12,ctrl
Scd1-/- on very low fat diet (TD03045 from Harlan Teklad) replicate 3,pert
RORasg/sg liver_HFD_rep3,pert
"PBMC, patient. Mtx rep6",pert
GM19238_Kd_NFE2L1_1,pert
treatment: Mepenzolate;	time: 7,pert
major non-tumor2,pert
Pfeiffer NTshRNA 2,ctrl
liver wild type replicate3,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: tumor;	sample name: 6-tu2,pert
db/db mice (stock 000642 Jackson lab),ctrl
"2B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
GATA3KO_3,pert
Control Day7 (313R),ctrl
Bone Marrow Mononuclear Cells;	31y Male,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 27.56164,ctrl
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 102;	Usage number: 4;	Exposures: 3,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 35 yr;	population: white;	dsm-iv: 296.54;	age of onset: 19 yr,pert
Cochlea_D257A_9mo_2,pert
condition: Discoid Lupus;	patient: L9;	tissue: LS skin biopsy;	kit: Ovation,pert
PC3 Wee1 Rep2,pert
strain background: CD1;	genotype/variation: Raldh2 null mutant; Raldh2 -/-;	tissue: embryonic brain;	tissue region: Rostral/Anterior;	developmental stage: 14 somite stage,pert
"Ulcerative Colitis (29 year old caucasian female, SAK_1305780306)",pert
CLL14-CD8,pert
P5 Patient None,pert
sMPNST_shBrd4.552_3day_rep3,pert
patient: TLW18;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
EUR12_T6_PP_day14_048,pert
CPU R control 1,pert
3896-1 E2F1 Null,ctrl
"Wild-type Liver, replicate1",ctrl
FACS-purified B cells_129SV/EV_influenza-infected_rep4,pert
Run4.aUa.010110d.SkMDbt1147D.CEL-DB stimulate,pert
Pediatric_GBM_45,ctrl
Strain: 129Sv/C57BL/6,ctrl
PGA-HMO-NonObese-3aUA-s2,ctrl
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 71,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: LOW;	genome/variation: no mutation detected,ctrl
"FOXP3, WT, REP4, 0h",ctrl
CLDN18_KnockOut_3,pert
cerebellum_WT_20d_rep2,ctrl
GB 8 63B NO LPA,ctrl
"wdNHBE with KY/180 at 36hpi, biological rep2",pert
G93A-SOD1 mouse spinal cord 75 day,pert
Severe rep2 (OHN),pert
Cervical cancer_CC214,pert
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 1hr,ctrl
H295R_Group_A_Dose_NA_TIMEPT1_003,ctrl
DMSO4_24H,ctrl
GB 12 NTB NO LPA,ctrl
Disease_status: Bipolar disorder;	Age (years): 35;	Gender: Male;	Age of onset (years): 19;	Duration of illness (years): 16;	Brain pH: 6.30;	Post mortem interval (hours): 35;	Side of brain: Right;	Fluphenazine mg. Equivalents: 30000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Run7.aUa.001206d.SkMInS1079D.CEL-IS stimulate,pert
"Cervical cancer cell line, MS751",pert
"DSS + L-Arg colon tissue, biological rep1",pert
FVB_8W_3_3,ctrl
mouse: 4;	strain: C57Bl/6;	genotype/variation: STAT6 KO;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,pert
age_years: 57;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
Neuroblastoma SH-SY5Y cells_cloneH_scramble control_replicate2,ctrl
Evi1-3,pert
"WI-38 cells, at 24 h after exposure to 1 uM BPDE, biological rep1",pert
Etoh 2,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 45, stage IIIB, HPV 16",pert
wt #6. 466,ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_L112,ctrl
695-383_24hr,pert
siOGT 12 hours_2,pert
liver_Pink1 knockout_24 weeks_replicate_3,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 43;	gender: female;	tumor grade: IV,pert
PBMC from T cell Large granular lymphocyte leukemia patient#114,pert
antimicroRNA-449_rep3,ctrl
Itk knockout CD4+ unstimulated 1,pert
Eed KO E14 ESCs on day 0 #1,pert
A549 cells Stretch 1hr Oct 20 2002,pert
Subject #8031-Preinfection,ctrl
Argyrin A treated 24h_2,pert
tissue: mouse lung upper left lobe;	strain: C57BL/6;	genotype/variation: wildtype;	age: 6-10 weeks old mouse,ctrl
coc-53_A,pert
WT-smoke-low-5 month-R3,ctrl
"All mice (C57BL/6) were free of Helicobacter species, housed in a specific pathogen free facility with 12-h light/dark cycles with free access to standard food and water.",ctrl
major HCC3,ctrl
SEB-1 vehicle control biological replicate 2,ctrl
Young 6,ctrl
T2E-LU,pert
strain: C57BL/6J;	genotype: APOE-deficient;	tissue: aorta;	treatment: captopril;	treatment time: 7 months;	age: 32-34 weeks,pert
LOX1 0hr 282295443,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 8d ID300,pert
"human failing LV myocardium, Idiopathic6",pert
WTT 161 bleomycin treated,pert
"CD8 DC wild type, biological replicate 1",ctrl
"MS patient 12, technical replicate 1",pert
disease state: wild type;	strain: BALB/c AJ,ctrl
Individual_4981_NN_sample,ctrl
HSF1+/+ T cells at 37oC replicate #1,ctrl
"Patient 7, Macroscopically intact tissue",ctrl
13A;pretreatment;female;breast tumor,ctrl
RAW_2.8mM_HOCl_#1,pert
HCC014N,ctrl
patient code: 104;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 1;	ajcc classif. (2002): 2b,ctrl
control AU0943303,ctrl
wildtype strong 3,pert
KO - knock-out Treated - 0.5 hrs - repeat 1 - Cy5 - mAdbID:62538,pert
AVIC sample#1 treated with DMSO,ctrl
LICR_HN2_PBS2,ctrl
3N,ctrl
BACH2-/- ALL (Sample1),pert
age: 54;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
CD8 KLF13 WT 2,ctrl
RelA_siRNA_0c,pert
strain: C57BL/6J;	genotype: HDC-EGFP/HDC-KO;	age: 3-4 months;	tissue: bone marrow;	cell type: bone marrow CD11b+Gr-1+ myeloid cells,pert
CON13,ctrl
"Control shRNA cells passage 7, rep 3",ctrl
12465 UC Inflamed ascending colon,pert
"AD_TC, biological rep7",pert
rd1_P2_rep2,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: healthy;	Sex: M;	age: 58,ctrl
"Lesional skin from K5-Stat3c mouse, biological replicate 2",pert
LJMJDW14,pert
chip number: 15;	transfection plate: 4;	target gene: GTF2B;	kd level: 0.55;	rin: 9.5;	transfection date: 2011-10-17,pert
061HZ_CTRL,ctrl
Strain: 129SV/EV;	Gender: Female;	Age: 8-12weeks;	Tissue: Mediastinal lymph node B cell;	Influenza A/Mem71 48h;		,pert
"Strain: mixed genetic background, predominantly (>87.5%) C57BL/6 with some CD1. Genotype: PTEN mutant = Mx1-Cre positive: PTENfx/fx. Sex: Male. Age: Eight and a half weeks (at tissue isolation). Tissue: Intestinal Polyp (from jejunun/ileum).",pert
"C57BL/10 control TA, replicate 3",ctrl
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: 10μM ATRA;	treatment time: 3 hours",pert
"human failing LV myocardium, Ischemic35",pert
MDS32,pert
01N3M: new onset sJIA,pert
biopsy specimen,ctrl
"non-AD_TC, biological rep11",ctrl
MCF-10A sh53BP1-1 replicate 2 [set 5],pert
Bcl6 KO 1 sample A,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 25;	gender: male,ctrl
tissue: testis;	gender: male;	age: 2-3 months;	genotype: wild-type,ctrl
RV16;	Age = 22;	Sex = F,pert
Huh7 cells_Mock Infected 24 hours_ rep2,ctrl
Lung-normal-rep5,ctrl
CD70Tg biological rep 3,pert
DMSO2_6H,ctrl
"Wild type mouse embryonic stem cell, biological rep1",ctrl
Dicer KO replicate 1,pert
"p400 KD, replicate B",pert
Mouse old heart C30-Ht-2,ctrl
Lmna H222P homozygous male 4,pert
H295R adrenocortical carcinoma cell line,ctrl
SR-A mutant olfactory epithlium 0 h replicate3,pert
pt. HCL C treated with DMSO for 72h,ctrl
Rex-1 KO_minus LIF_rep3,pert
ATF6-MER TG mouse_tamoxifen1,pert
"Acute Myeloid Leukemia, sample 1",pert
Adipose-24 month-wild type-technical replicate 1,ctrl
"SS gland, early, patient 6, batch 1",pert
chip number: 13;	transfection plate: 4;	target gene: NR3C1;	kd level: 0.67;	rin: 9.5;	transfection date: 2011-10-17,pert
treatment: DMSO;	time: Day8;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,ctrl
CAR.AH_corn oil_rep2,pert
HMEC X BC17,pert
WT-Fibr1 9,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-KO;	tissue: Skeletal muscle (quadriceps),pert
Corl51 SCLC cell line,pert
"vastus lateralis biopsy, 76 year-old healthy trained male (#71)",pert
Control bone marrow - Biological Replicate 3 - Technical Replicate 1,ctrl
11409 UC Inflamed ascending colon,pert
Liver sample from Alcoholic hepatitis group (CA28),pert
MDS patient 118,pert
HF1235_U133P2,pert
S011_Scz_M_82,pert
Kidney_Biopsy_Liver_Disease_5,pert
"mortality: alive;	ethnicity: Hispanic;	gender: M;	age (yrs): 48;	ld: ETOH;	creatnine: 1.9;	mdrd: 38;	gfr: 63;	protein: 1.2;	hematuria: 1;	c3: 1;	c4: 1;	rf: 52;	hcv: NEG;	htn: 0;	dm: NEG;	hba1c: 5.1;	meld: 19;	ana: POS;	gp: Mesangial Immune complex deposit, lupus class II;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 0;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 2;	igm: 1;	c: 2;	empe: NA;	bmwid: NA;	bmd: NA;	edd: P;	no of glomeruli: 7;	glomerulosclerosis: 0;	intact t: 0.95;	arteries: intimal fibrosis, thickening;	if: IGM+IGG+IGA++C3++C1Q+mesangial;	mesangium ig: ACMG;	tissue: Kidney_Biopsy_Liver_disease",pert
WT_P14_Naive_rep1,ctrl
gender: female;	age (years): 62;	evolution time (years): 4;	disease extension: Pancolitis;	treatment: Azathioprine,pert
"mortality: alive;	ethnicity: Hispanic;	gender: F;	age (yrs): 52;	ld: HCV;	creatnine: 1.5;	mdrd: 39;	gfr: UN;	protein: 0;	hematuria: 0;	c3: 0;	c4: 0;	rf: neg;	hcv: NEG;	htn: 0;	dm: POS;	hba1c: 7;	meld: 23;	ana: NEG;	gp: arterisclerosis, mild mesangial expansion;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 1;	if (interstital fibrosis): 1;	as (arteiosclerosis): 0;	igg: NA;	iga: NA;	igm: NA;	c: NA;	empe: NA;	bmwid: NA;	bmd: P;	edd: P;	no of glomeruli: 1;	glomerulosclerosis: 0;	intact t: 0.7;	arteries: intimal duplication/fibrosis;	if: not submitted;	tissue: Kidney_Biopsy_Liver_disease",pert
CRC_nodrug_F4872,ctrl
Huntington's disease 820F,pert
pt. HCL D treated with DMSO for 72h,ctrl
siGL3Veh 1,ctrl
age: 57;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
gender: female;	batch: 1;	age (years): 31;	patient id: Control_7;	fev1 (% predicted): 85;	fvc (% predicted): 96;	medication: None;	cell type: CD8+ T-cells,ctrl
strain: C57BL6;	genotype: WT;	tissue: hippocampus;	treatment: PDE10i,pert
Control #1,ctrl
Dilated cardiomyopathy_G8,pert
tissue: LNCaP-LM NSG xenografts;	expression: Hes6 overexpression,pert
AQA C,pert
"strain: C57BL6/10J;	genotype: Cmah KO, mdx;	gender: male;	age: 2 months;	tissue: cardiac muscle",pert
Healthy individual of twinpair #1,ctrl
"3T3-L1 siLSD1 24h, biological rep 2",ctrl
"Retina from NeuroD1 cKO mouse at ZT20, biological rep 3",pert
15A;pretreatment;female;breast tumor; responder,ctrl
34GOBMUC2H,ctrl
disease: Down syndrome;	gender: male;	age: 1 year and 2 months;	tissue: thymus,pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates taken 7 hours after nickel exposure",pert
Substantia nigra normal rep3,ctrl
Normal testis 9013,ctrl
subject: 35;	disease: CP;	muscle: GR;	gender: M;	age: 5.9;	gmfcs: 5;	popliteal angle: 130,pert
"hepatic gene expression at ""1 hr"", rep1",pert
background strain: B6/129;	genotype/variation: WT;	tissue: Liver;	age: 2 Month,ctrl
tissue: peripheral blood;	subject: sickle-cell patient;	rna prep: PBMC;	molecule: RNA extracted from PBMC,pert
patient: 24;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Control subject 117_biological replicate 2,ctrl
Vector control 3,ctrl
NPC5,pert
colon_epithelium_C57 mouse_12weeks_rep3,ctrl
subject id: 574328;	infection: DENV;	status: DHF;	tissue: whole blood,pert
Liver_WildType_2,ctrl
CEPI_Ic_317,pert
jzo024-rp1-v5-u74av2-met,pert
VehLPS1,pert
Subject 5_t=30days_resveratrol,pert
"ESCs overexpressed Foxd3, biological rep2",pert
NIH3T3_0h_exp2,ctrl
32GOBMUC2H,ctrl
age: 12 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
"cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: 100 nM 1,25(OH)2D;	time point: 24 hours",pert
Cell line expressing inducible wt-GFP-lamin A. Induction: day 10. Replicate A,ctrl
12mo Control #2,ctrl
LC1003ni,pert
"Patient C-c145T, MSI colorectal tumor",pert
"BOEC, normal 7",ctrl
normal control_CTL2,pert
BL6_24h_DMSO,ctrl
RTX9 T12,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 64 years,ctrl
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/45;	differentiation status: undifferentiated;	cell line: Q50,pert
umbilical cord_nobpd: 3I,ctrl
40SAGEA,pert
phenotype: control;	gender: male;	case_id: 329;	age: 48;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.73;	labeling_batch: 1,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:64;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
2059N,ctrl
"MGSKO, PR01M006v0",pert
Brain_Adult_Salineip_4hr_mouse2 (YP2_#59),ctrl
strain: C57B6;	genotype: Tgfbr2fl/fl;	tissue: Secondary palate;	age: E14.5;	gender: Not determined,ctrl
Nerve_Control_Vehicle_704,pert
tissue: Hippocampus;	age: 55;	Sex: M,ctrl
TAp63 alpha Q540L 24h without induction s2,pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 62;	donor: 13;	disease state: Lesional,pert
"brain, cerebellum: RNA#4*_le1",ctrl
A549_NS siRNA_biological rep1,ctrl
Normal cortex of patient T158,ctrl
"Patient 25, Macroscopically intact tissue",ctrl
WT vehicle (7991003040_A),ctrl
diet_LIVER_2,ctrl
Cutaneous psoriasis without arthritis PsC 16,pert
GM19238_Kd_IRF3_2,pert
Zfx fl MA9 cells + 4-OHT [10949],pert
tissue: blood;	control: 3;	gender: female;	age: 38,ctrl
Nerve_Diabetic_Rosi_719,pert
"breast, post AFI treatment (H5_1332)",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 55,pert
Cavin-1/PTRF KO #238,pert
P4B Progranulin-cerebellum,pert
3451-1 E2F WT,ctrl
"47, XY, +21",pert
"Infected with H37Rv, replicate 3",ctrl
Lung myd88 mock repB,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 30,pert
strain: C57BL/6J;	day: 1;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 2,ctrl
"patient: 106;	current medication: None;	birth date: 5/29/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: Abdominal pain, upper GI symptoms.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
cell line: Hep3B;	treatment: transfection with nonsense siRNA,ctrl
"BMDC, wt, replicate 2",ctrl
cell line: SV589;	knockdown (days): 0;	treatment: no treatment,ctrl
C5bt5,pert
"Wild type fetal liver 2, embryo at 12.5 days of development",ctrl
D890_WBS,pert
Knock-out postnatal day 10 rep 2,pert
HVS-CD4-control_unstim_rep3,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: PR;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 87;	baseline tumor size (cm): 5x3;	patient id (to identify the 2 chips from the same patient): 19301950,pert
sample =XCGD2 treatment=Control time=0 (min),pert
Genotype: wild type;	not differentiated,ctrl
Pancreatic Sample 15-Normal,ctrl
non-malignant FTEn_patient 4,ctrl
PKBa-/- MEF time 0 replicate 2,pert
Jurkat T-cells transfected with siRNA #2 for Sp3 for 48 hours,pert
Control (C56),ctrl
4_Hr_+MGd_1,pert
OVCAR3_rep2/CD157_DS,ctrl
"Infected with H37Rv and treated with 1,25D, replicate 1",pert
TP06-727-993,ctrl
"RISC-free control transfected, biological rep 2",ctrl
MCL_IGHV_UNMUT (R1595),ctrl
"medulloblastoma, M2_cMYC_silenced, rep2",pert
ILD Study Number 1319,pert
tissue: white blood cells;	age: 4;	Sex: male,ctrl
"villin-creERT2:beta-catenin+/lox, induced by tamoxifen for 2days",ctrl
WT1(-KTS) expression induced for 8 hrs 01-14-03_Lee_U133A_8_2,pert
age: 68;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Pancreatic Sample 35-Normal,ctrl
"human failing LV myocardium, Ischemic67",pert
cell type: MCF-7;	sirna: control non-targeting pool,ctrl
"A673 treated with Doxorubicin for 5 days with concentration of 119.76 nM (2 x EC50), biological rep3",pert
U2OS_control_shRNA_pLenti_2,ctrl
H1_SS11_01Nov07,pert
Day: 18; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 1,pert
"Epidydimal white adipose tissue from ASC-/- after 16 weeks of high fat diet feeding, replicate 2",pert
strain: C57BL/6;	cell type: MEFs;	genotype/variation: Cebpg-/-,pert
LCL Unaffected MZ twin pair 1 (CCN1.2R)(TP16),ctrl
"human failing LV myocardium, Idiopathic12",pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 74,ctrl
lymphocytes_ctl_M_38y,ctrl
gender: Female;	age: 28;	post-mortem delay: 11h;	ph: 6.3,pert
knockdown: siRNA-scrambled;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 6.1;	colon weight (mg): 180;	colon ratio (mg/mm): 2.95;	myeloperoxidase activity (u/mg): 0.27;	tissue: colon;	treatment: 5% DSS,ctrl
Tissue:tumor; Gender: male; Age:43; Tumor stage:T2NxMx,pert
"Peripheral blood, patient without recurrent events [N49]",pert
"proband g, past exhaustive exercise",pert
"TNFa-OMe-P siRNA-C, replicate 1",pert
HF0377_U133P2,ctrl
Normal_Kidney_Biopsy_7,ctrl
normal adjacent esophageal tissue from patient E1584,ctrl
LJMJDW11,pert
"72 hour-treated wild-type NB4, biological rep3",ctrl
"129 Mouse P0 Pineal Tissue, Sample 3, 05-31-06",ctrl
06R017 Control,ctrl
cell line: prostate cancer cell line LNCaP;	genotype/variation: MYB siRNA,pert
Expression data from liver of the KRAP deficient mice (WT2),ctrl
mdx Biological Replicate 3,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M4;	flt3 status: internal tandem duplication (ITD),pert
23A;pretreatment;female;breast tumor; responder,ctrl
sex: Male;	family: 4;	age: 54;	disease status: Asymptomatic;	tissue: Muscle: Biceps,pert
01N71: normal control,ctrl
"Pten null epithelials cells, biological rep2",pert
NS4-040331-SA,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-KO;	tissue: Skeletal muscle (quadriceps),ctrl
"213, MUSCLE, After",pert
Ishikawa_LowDose_BPA_8h_rep4,pert
N5,ctrl
Gata3_H4,ctrl
"Placebo treated, HIV-1 positive male, day 14 (1)",ctrl
Tissue: lung;	Genetics: Sporadic IIP;	Histology: Usual Interstitial Pneumonia,pert
FmrKO1_brain,pert
"breast tumor epithelium,49",pert
"Cerebral Palsy, Gracilis, Patient Replicate 5",pert
WT 3,ctrl
Colon_POR-null_2,ctrl
Cerebellum_nontransgenic control A39_4 months_replicate 3,ctrl
Control spleen - Biological Replicate 5 - Technical Replicate 2,ctrl
24h WT Cel.39,ctrl
THRA 6a mutant + vehicle replicate 1,ctrl
T2-FP_spleen_wt_rep3,ctrl
"5mg/kg/day PFOA, Rep 5, Block 4, lung (high dose)",pert
AAA neck (Sample 5),pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,pert
Disease_status: Healthy control;	Age (years): 58;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.0;	Post mortem interval (hours): 27;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
ZNF395 knock-down (shZNF395-2),pert
Liver_PXR KO_Vehicle_Rep3,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 25.945;	Ratio: 2.12,pert
strain/background: C57BL/6;	genotype/variation: Zbtb7a Flox/+ Mx1-Cre+ (LRF heterozygous);	age: 4 weeks;	cell type: FACS-sorted LT-HSCs (LSK IL7Ra-Flt3-CD150+CD48-);	time point: 9 days after 1st pIpC injection,ctrl
"U373-DTX1-myc, rep 3",pert
tissue: Temporal cortex;	age: 72;	Sex: F,ctrl
male_control_257,ctrl
sidroshaB-transfected sample,pert
NTB_skeletal 2,ctrl
microdissected breast cancer cells from case 295,pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. vehicle (ethanol) + 1 uM vehicle (ethanol) for 24hr;	batch: 2,ctrl
knockdown: siRNA-scrambled;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.1;	colon weight (mg): 183;	colon ratio (mg/mm): 3;	myeloperoxidase activity (u/mg): 0.298;	tissue: colon;	treatment: 5% DSS,ctrl
3 wks sham-4,ctrl
H_LS_Wk12,pert
0968-01-C,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: LPA,pert
Run1.a10a.000609jd.2.SkMNor909.CEL-IS basal,ctrl
5213 UC Inflamed sigmoid colon,pert
Individual_4136_PN_sample,pert
MA_302,pert
"Primary, Prostate cancer, localized",pert
cell line: V6.5;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 3,ctrl
EA_Case9_CD20,pert
SHR20-2,pert
"Uninvolved Skin, NS-30",pert
thyroid sample containing normal cells,ctrl
"seminoma specimen, pT1, patient age: 39y; W02 102",pert
pt. HCL F treated with DMSO for 72h,ctrl
status: Control;	gender: Male;	age: 66;	tissue: Blood,ctrl
PGA-MLS-Dil-1bAv2-s1,ctrl
SC-RbKO 3,pert
Subject 6_t=30days_resveratrol,pert
PGA_MI_nilv_24h_362,pert
HF0151_U133P2,ctrl
"Wild-type-hippocampus, biological rep1 (male)",ctrl
TTP_KO_0ActD_BioRep1,pert
WT_liver_vehicle 0 mg/kg_96 hr_4,ctrl
Aldosterone-producing adenoma (APA15),pert
"Wild type fibroblasts, biological rep2",ctrl
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-2,pert
08_PAH,pert
Oct4GipES_Panct1_esiRNA_72h_rep1,pert
RNA A549 cells Static Control 4hr Replicate 1,ctrl
treated with TGF-beta,ctrl
patient: 135;	current medication: none;	birth date: 8/14/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/28/05;	indictation for procedure: bloody diahorrea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
age_years: 70;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
53A;pretreatment;female;breast tumor,ctrl
Endometrium/Ovary-Disease 1,pert
020109-4,pert
"Acute Myeloid Leukemia, sample 73",ctrl
CHB PBMC_sample 5,pert
"treatment: diclofenac;	batch: 3;	donor: 29;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
shNANOG_6,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 73,ctrl
chip number: 20;	transfection plate: 5;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-10-17,ctrl
01J46: new onset sJIA,pert
Squamous cell carcinoma 035,pert
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 35week,pert
subject id: c9;	infection: control;	status: control;	tissue: whole blood,ctrl
patient: 261;	current medication: Asacol 800mg BD;	birth date: 1/7/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/98;	diagnosis date: 1/1/98;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
microdissected breast cancer cells from case 1218,pert
"eye, cornea: TRizol Extraction_le1 2",pert
04_NOR,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: normal,pert
liver_STZ treated diabetic_rep1,ctrl
tissue: skin;	individual: Patient P13;	condition: ANL;	eczema severity: SCORAD: 0,pert
agent: ConA;	time point: 6 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
platelet_sickle_3,pert
cell line: J1;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 0,pert
Bronchial Epithelial Cells MMA biological 2143G,pert
ethanol_ethanol_31,ctrl
ESE_D_599,pert
15KD_SerumStarved->1hrEGF_rep2,pert
untreated WT MEFs-1,ctrl
KO - 5 mo - repeat 4 - Cy5 - mAdbID:74138,pert
brain_control_sampleid_mr951,ctrl
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep2,pert
SON siRNA rep1,pert
Parkinson's disease sample x012,pert
KN-smoke-high-5 month-R3,pert
CF_lubiprostone,pert
1214-3C,pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case4,pert
Jejunum_POR-null+quercetin_1,pert
"mouse liver sample, WT strain, biological replicate 3",ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 68;	gender: male;	tumor grade: IV,pert
U-87MG-V17 set 1,ctrl
Healthy controls; individual=MB; time=2; beverage=alcohol,pert
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
SKBR3 PR 2,pert
tissue: Frontal cortex;	age: 89;	Sex: M,ctrl
HMEC X Confluent HMEC,ctrl
WT - Cre Control - 3 mo - repeat 5 - Cy5 - mAdbID:74668,ctrl
22A;pretreatment;female;breast tumor,ctrl
neuron_rep7,pert
AKT_PLACEBO_12hours_1,pert
subject id: 37;	infection: DENV;	status: DF;	tissue: whole blood,pert
WT_BoneMarrowMacrophages_unstimulated_4hours_rep2,ctrl
SCC1,pert
"E18.5 ERRg -/- heart, biological rep 1",pert
"human failing LV myocardium, Idiopathic66",pert
mES cells TR71 KD rep2,pert
e_M45B,pert
"GNMT knockout at 3 month age, biological replicate 1",pert
EOM 28 Day Control rep 2,ctrl
healthy control sample x121,ctrl
cell: MCF-7;	treatment: FoxA1 siRNA and vehicle (control),pert
tissue: pancreatic ductal adenocarcinoma tumor;	genotype: Pdx1-Cre; Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 10 weeks-old,pert
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: No;	1st technical replicate,pert
Barrett's esophagus (B6),pert
"control, BA46-30",ctrl
male JAK2 KO liver sample 207,pert
H4_SS11_01Nov07,pert
"Mutant in the presence of tetracycline, rep2",ctrl
129S1/SvImJ Vehicle liver sample batch 5,ctrl
"SKO-transduced MEFs, Vc-, D10",ctrl
5200 Normal Uninflamed sigmoid colon,ctrl
strain: C57BL/6J;	age: 4 months;	gender: male;	tissue: lung;	genotype/variation: control,ctrl
"U373-MAML1-dn, rep 2",pert
HCaRG-9 HG-U133 Plus 2.0,pert
MCL_IGHV_UNMUT (R1762),ctrl
Pax3 WT E14.5 palatal shelves 8,ctrl
FACS-purified B cells_IFNAR1-/-_influenza-infected_rep3,pert
"cochlea at P60, ko, biological rep 2",pert
Dilated cardiomyopathy_G2,pert
wildtype_normoxia,ctrl
braak stage: BR34;	rin: 77;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
Bronchial Epithelial Cells SA biological 2184U,pert
EA_Case19_CD4,pert
HNF1b_2b-,ctrl
Human skeletal muscle biopsy sample;	Patient #197 with PM,pert
MEF_TFAMhet_rep2,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 6,pert
background strain: B6/129;	genotype/variation: wild type;	age: 14 Month;	tissue type: Liver,ctrl
Wild-type anterior prostate 1,ctrl
"Gata4-KO heart, CRE, biological rep3",pert
FACS-purified B cells_129SV/EV_non-infected_rep3,ctrl
control replicate 2,ctrl
C33KD2_without doxycycline_2,ctrl
H6PDH WT,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L014,ctrl
RPE65_KO_4months_retina33,pert
BCell_resting_sample5,ctrl
"Control shRNA cells passage 11, rep 3",ctrl
SeroTest-8,pert
subject: 13B;	cohort: 13;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 16kb;	age (y): 42;	Sex: F;	batch: Batch_3,pert
siSPDEF_2,pert
gender: male;	genetic background: C57BL/6x129;	age: 6.5 months;	tissue: Crhr2-/-;	genotype: Gastrocnemius and Soleus muscles,pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,ctrl
Carbo Day1 (332L),pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 21.753;	Ratio: 2.10,pert
cell type: Human melanoma cell line;	cell line: M238_R1;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
phenotype: alcoholic;	gender: male;	case_id: 212;	age: 50;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.59;	labeling_batch: 2,pert
strain: FVB;	genotype: wild-type;	tissue: mammary gland tumor,ctrl
batch: A;	knock-in: VEC;	cell line: MycCap prostate cancer cells,pert
Normal-ERα-positive breast cancer 3,ctrl
C57BL/6 BMDM infected with WA(pYV),pert
colon_epithelium_C57mouse_6weeks_rep6,ctrl
Colo205 parental cell line,ctrl
strain: BALB/C;	age: 8-10 weeks;	treatment: CVB3;	gender: Female;	time: 10 dpi;	tissue: heart,pert
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14535;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
coc-8_B,pert
s8,ctrl
Individual_5919_NN_sample,ctrl
HeyC2+(1),pert
age: 6 month postnatal;	tissue: striatum;	genotype: wild type (129S6/SvEvTac),pert
Psoriatic arthritis PsA 15,pert
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14503;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
umbilical cord_nobpd: 6A,ctrl
1087CTRPBMC,ctrl
cell line: CL1-0;	gender: male,ctrl
01UN9_ERA,pert
F9 TSA sample #1,pert
PGA_MI_nilv_8w_326,pert
tissue: glomeruli of human kidney;	disease state: nephrosclerosis,pert
Normal Biological Replicate 4,ctrl
EA_Case15_CD4,pert
Bronchial Epithelial Cells MMA biological 0828C,pert
"Control siRNA - Undifferentiated, rep3",ctrl
"Patient I-840-N, normal colonic mucosa",ctrl
Diaphragm 7 Day control  rep 2,ctrl
WT LSK rep2,ctrl
TscHet3_brain,pert
Liver_normoglycima_no.4,ctrl
Tretinoin3,pert
genotype/variation: Vax2-/-;	age: E10.5;	tissue: whole eye,pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 80;	Usage number: 5;	Exposures: 3,pert
Benign prostate tissue NX2,ctrl
tetO-Satb2 #2,ctrl
Bone-Marrow_MGUS_G588,pert
Mouse old brain w/ a-tocopherol aT-Br-4,pert
H1bt5,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.811;	OD280: 0.9;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 372;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Tissue: peripheral blood, Subject:Sickle cell patient",pert
liver_STZ 0.5% quercetin diet_rep2,pert
06R052 Control,ctrl
THRB wt + T3 replicate 4,pert
B137+,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 27;	sex: F,ctrl
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 41;	maternal age: 32,pert
Sex: male;	Age at operation: 70 years;	Site: thigh;	Size in cm: 9x3x6;	Histological Subtype: atypical lipoma;	Responder type: medium;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
Setleis Syndrome patient 2,pert
liver_STZ treated diabetic_rep1,pert
striatum_wild type_24 weeks_replicate 1,ctrl
normal adjacent esophageal tissue from patient E1520,ctrl
fluorescent activated cell sorter (FACS)-selected cells,ctrl
tissue: skin;	individual: Patient P2;	condition: ANL;	eczema severity: SCORAD: 0,pert
Strain:J1 Cell type: mouse embryonic stem cell,ctrl
"BCL-3 vector, biological rep2",pert
C3_transgenic but unaltered,pert
LNCaP + vehicle rep1,ctrl
GM19238_Kd_KLF13_1,pert
Dilated cardiomyopathy_G28,pert
WT MEFs at passage 3_biological replicate 3,ctrl
Emd KO male 1,pert
KN-sham-1 day-R3,pert
midbrain_Pink1 knockout_18 month_replicate 2,pert
mouse strain: C57BL/6J;	genotype/variation: normal control,ctrl
cell line: MH1C1,pert
0966-01-C,ctrl
KN-sham-5 month+1d-R1,pert
"Ifitm1-deficient lung tissue, biological replicate 5",pert
01LN7_Systemic,pert
HepG2-control-2,ctrl
12492 UC Inflamed descending colon,pert
U2OS shControl replicate 1 [set 4],ctrl
b36-,pert
H01_S_B2,pert
3 wks TAC-3,pert
Liver_Female_WT_rep2,ctrl
"Amoxicillin treated Proximal, Small Intestine 3 17 days old",pert
"CBFb-SMMHCd179-221 animal 2, replicate 3",pert
HeLa cells were transfected with siRNA specific for optineurin mRNA,ctrl
THP1-shGSK3B-Construct2-rep2,pert
"brain, hippocampus: CH2_e1_le1",ctrl
Kidney_400 mg/kg VCM iv_mouse #046,pert
treatment: control;	time: 0 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,ctrl
Diaphragm 14 Day control rep 1,ctrl
jzo022-rp1-v5-u74av2-met,pert
Mammary gland R1 8 hr rep1,pert
reference: whole mouse total RNA,ctrl
"vector d4, rep 5",ctrl
Adrenal WT 0h batch 3 [AdWTh00.23],ctrl
WildType_4,ctrl
A_AN01570_F,pert
"Control, biological rep1 (with calcium)",ctrl
patient: 226;	current medication: Azathioprine 150mg Asacol 1.6g Ca Vit D B12;	birth date: 6/15/74;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 1/11/05;	indictation for procedure: ;	ucss: 8;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/11/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 145min;	race: White;	sex: Female,ctrl
gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6,pert
tissue: Temporal cortex;	age: 83;	Sex: M,ctrl
mESCs_EGFPcontrol_rep1,ctrl
KO-517,pert
strain: BALB/c;	cell type: CD8 T;	genotype/variation: KLF13 KO,pert
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: Regular chow diet,ctrl
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 44;	donor: 33;	disease state: Lesional,pert
Strain: C57BL;	Gender: male;	Age: 9-10 weeks;	Tissue: liver;	Developmental stage: adult;	Cell type: Primary hepatocytes,pert
T50 U133p2,pert
"NPTX1 shRNA Day 2, biological rep2",pert
.SAL_II_2,ctrl
wild-type rep_1 (CWT1),ctrl
Normal-N_LJ_1,ctrl
"ALL_NDS, K38 011409",ctrl
IRF4-mut_Th17_cells_42hr_rep2,pert
clone type: AtT20 clone types treated with control siRNA rep 3,ctrl
"Rb KO, biological rep2",pert
"brain, hippocampus: C24-III_e1_le1",ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 67;	gender: male;	years of disease: < 1 y;	treatment: phototherapy;	time: post-UV,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 4;	biological rep: 1,ctrl
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure.",pert
116A,ctrl
n6t7d,pert
CON25,ctrl
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/22,ctrl
"ERaKO mouse aorta with placebo, biological rep2",pert
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug.  At four hours prior to RNA isolation, actinomycin D (5 ug/mL final concentration) was added to the culture.  After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",pert
"Age: 40;	Sex: M;	Ancestry: African;	Smoking status: smoker, 24 pack-years",pert
"Heart, MAT1 control, 2 wk, sample 1",ctrl
"human failing LV myocardium, Idiopathic86",pert
B3_saline_overexpressor_48,pert
liver_QH2_6M_rep3,pert
colon_Runx1-WT_Cy3_15479,ctrl
cerebellum wild type 21 month replicate 4,ctrl
lymphoma_4936_nt,ctrl
mouse B6xCF-1  Non-transgenic (control-1),ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 82 days;	subject: Mouse1;	genetic background: BALB/c,pert
Moderate rep8 (OHN),pert
V5-P104,pert
"genotype: wild-type;	strain: C57BL/6;	gender: male;	age: 8 weeks, 3 days;	tissue: colon",ctrl
IP RNA_KO_rep3,pert
KU_15T,pert
BP patient 75_biological replicate 2,pert
"ALL_DS, K1 011409",pert
Moderate rep3 (OHN),pert
T144 U133p2,pert
NLGN1_2,pert
platelet_sickle_12,pert
Gender: Male; Tissue: Prostate.,ctrl
ic20 -- APF on membrane B,ctrl
MDA-MB-231-pcDNA6 cell culture 2,pert
batch: A;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 105min;	race: White;	sex: Female,ctrl
wt_TGFb_24hr_1,ctrl
cell line: IGROV-1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 28.81096,ctrl
CLL23-CD4,pert
cerebellum_WT_4w_rep1,ctrl
E10_otic_vesicle_wt_replicate2,ctrl
DC-5LA,pert
"Acute Myeloid Leukemia, sample 37",ctrl
BALB/c d3 (190msn),pert
Melanoma cells,pert
intestine_wildtype_control_rep2,ctrl
Hippocampus 1989 15 month Old,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 61 years,ctrl
"U-87 glioma cell line with shcontrol, biological rep3",ctrl
Insig1 ∆/∆ /Insig2 -/- InsigKO_E3,pert
"BMMCs from NTAL WT, pLKO.1 infected, 2 h activated, biological rep2",ctrl
Bronchial Epithelial Cells MMA biological 2073L,pert
CD4_T_cell_pool_melanoma_M01+M02,pert
Normal-ERα-positive breast cancer 37,ctrl
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep4,pert
sepsis patient #15,ctrl
U2OS shCHK1-4 replicate 3 [set 4],pert
Trabecular meshwork tissue from POAG donor A. 59y/male/caucasian. Cause of death: Renal failure. Othe ocular diseases: cataracts. IOP: 17-28. Drug therapy: Xalatan,pert
knockdown: Control;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 7.5;	colon weight (mg): 166;	colon ratio (mg/mm): 2.21;	myeloperoxidase activity (u/mg): 0.009;	tissue: colon;	treatment: 5% DSS,ctrl
"Strain: C57BL/6; PGC1beta mutant mopuse, Tissue: quadriceps muscle",pert
Liver_normal_no.2,ctrl
SW480_control RNAi_luciferase_rep1,ctrl
DS-Fibr 2,pert
strain: C57BL/6J;	day: 12;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 2,pert
MEF Wild Type 2-rep1,ctrl
A/J Vehicle liver sample batch 2,ctrl
non-malignant FTEn_patient 7,ctrl
P14 - nudelkoMix/+ 1,pert
A2058 CT16 siRNA Rep1,pert
SLE CD4 T cells 12,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.606;	OD280: 0.744;	Ratio: 2.12;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 145;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
CONTROL;	Age = 19;	Sex = M,ctrl
266C6,ctrl
liver knock out replicate3,ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 63;	gender: male;	tumor grade: AIII,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case3,pert
Hunk Knock-Out rep 1,pert
memory HD-/- P14 T cells #1,pert
"male,17,Caucasian",ctrl
2B1_Dlx5_replicate2,pert
34208.LMP,ctrl
0205-01-C,ctrl
Pooled normal myocardium sold commercially (B),ctrl
"Rat liver, treated with DMN, 15 mg/kg in water per orally, extrated 48 hours after treatment, biological rep1",pert
"human failing LV myocardium, Ischemic51",pert
Braak α-synuclein 3-4 BR34_5SN,pert
Spleen_infected_6weeks_rep1,pert
"Lens epithelium, SPARC KO, #4L",pert
TL3 LAMC2 KO 3,pert
mn cells sample 2,pert
cell type: mouse embryonic fibroblasts (MEF);	phase: cycling,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 30 min after intravenous endotoxin challenge""",pert
"RWPE-PCAT1 NT siRNA, replicate 1",ctrl
type_of_rx: AF;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 68;	baseline tumor size (cm): 8x8;	patient id (to identify the 2 chips from the same patient): 12781328,pert
Ad infected murine liver-MO30k-(230)-6hpi,ctrl
Tet1-kd_ES_rep1,pert
V5-P069,pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 3,ctrl
01LKY_PolyRF-,pert
wt-Gfp P10 replicate 1,ctrl
"breast tumor epithelium,36",pert
strain: 129SV;	gender: male;	age: 6 months;	tissue: right ventricle;	genotype: wt,ctrl
Subject #8009-Preinfection,ctrl
"3mg/kg/day PFOA, Rep 1, Block 3, liver (low dose)",pert
chip number: 23;	transfection plate: 3B;	target gene: KLF13;	kd level: 0.84;	rin: 9.7;	transfection date: 2012-03-26,pert
sample =Healthy4 treatment=Control time=180 (min),ctrl
GEIM164-PM,pert
Jurkat-KD1,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: B;	genotype/variation: NET1 present;	agent: LPA,pert
IP RNA_KO_rep2,pert
B_LS_Wk4,pert
A549 AZA 3 uM (3215),pert
tissue: white blood cells;	age: 10.6;	Sex: male,pert
wild-type_corn oil_rep1,ctrl
Prostate Cancer_MS 36C3,pert
individual: patient6;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
platelet_Ctrl_6,ctrl
"SiRNA-scrambled, replicate 7",ctrl
Skinbiopsy_7hoursnickel_controlsubject_k4,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.848;	OD280: 0.434;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 207;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
A2008+(3),pert
HEK293 F18_doxycycline untreated,pert
genotype/variation: Tpl2 deficient;	treatment: unstimulated,pert
H6_SS11_01Nov07,pert
affected brother,pert
Disease_status: Healthy control;	Age (years): 40;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 38;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
C1_CLP_wildtype_8,ctrl
Normal mucosa 8,ctrl
subject: 22A;	cohort: 22;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 27kb;	age (y): 71;	Sex: F;	batch: Batch_5,pert
"TMD_EHL, T1",pert
MDS patient 115,pert
I_LS_Time0,ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 30;	maternal age: 28,ctrl
Strain: C57BL/6; Tissue: quadriceps muscle,ctrl
Diagnosis: AML M5;	Age: 68y ;	Gender: Male;	Blast %: 69;	Source: BM;	Cyto: tris8;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
Integrin alpha7 transgenic mouse rep1,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 6h",pert
mouse cerebellum at P30 knockout 2,pert
"HA-Fbxl10 cell, Replicate 3",pert
Trim28CKO unstimulated CD4 positve T cell rep3,pert
genotype: E-mu-BRD2;	cell-type: lymphoma_marginal;	splenomegaly: marginal;	Ig clonality: oligoclonal,pert
strain: C57BL/6J;	day: 18;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
R6/2 (untreated) 5227,pert
cell type: mouse embryonic fibroblasts (MEFs);	genotype: KSR1 -/-;	expression: GFP;	background strain: DBA,pert
Bone-Marrow_MM_M1142,pert
"Vehicle treated, no doxycycline; biological replicate 2",pert
"Heart, MAT1 control, 4 wk, sample 3",ctrl
HNF4a2_1+,pert
5871841165_A,pert
C_LS_Wk12,pert
Bmpr1a-/- N2B27 sample 3,pert
"56B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
"GFPMYC negative GC B cells, Biological replicate 4",ctrl
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep1,pert
knockdown Tcof1 [A],pert
231_GATA3_rep3,pert
"4105_CD133-, untreated",ctrl
CD46+ hippo - Untreated-C,ctrl
MKK3bE transgenic female replicate 3 late timepoint,pert
Bronchial Epithelial Cells MMA biological 1821T,pert
genotype: Villin-Cre - / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 88,ctrl
CA1,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 30;	maternal age: 29,pert
OSCE-5T,pert
NFIA P16KO1,pert
1_WT_2,ctrl
"non-AD_FC, biological rep10",ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 8",ctrl
"20 days old normal mice, cerebellum",ctrl
C57BL10 quadriceps sample 2,ctrl
TN1,pert
OSCE-18N,ctrl
"D425-shOTX2_1, t=48",pert
LNCaP.FoxA1.6,pert
Liver_nash_no.1,ctrl
"129P3/J CHR, Rep2",pert
F191G B,pert
"HME-CC, 12h, 0.2uM DOX B",pert
"Vehicle treated, no doxycycline; biological replicate 3",ctrl
MF_II_2,pert
"S1P2-KO-neocortex, biological rep6 (female)",pert
"control triceps, biological rep1",ctrl
Nr2_pre221,pert
"Normal subject (47 year old caucasian male, SAK_1274874502)",ctrl
XmO7,pert
56A;pretreatment;female;breast tumor,ctrl
"Organism: Homo sapiens (human) Morphology: lymphoblast;	Source: Organ: bone marrow;	Disease: chronic myelogenous leukemia (CML) ;	Age: 53 years ;	Gender: female ;	Cytogenetic Analysis: The stemline chromosome number is triploid with the 2S component occurring at 4.2%. Fifteen markers (M1 and M(15)) occurred in nearly all S metaphases. Spontaneous non-specific dicentrics occurred, but rarely. Unstable markers were also rarely seen. The X was disomic, and N9 was nullisomic.",ctrl
Globin_S6,pert
R1 ES cells expressing human Gata3 T2ER fusion,ctrl
MO32_15,pert
WT HPC PDE10i 15,pert
E17.5 preB cells_Smchd1 wildtype_Rep 2,ctrl
Monocyte-RCC-untreated-5,pert
49A;pretreatment;female;breast tumor; responder,ctrl
Pt25_Post,pert
"p38alpha wild type fetal liver E15.5, biological rep2",ctrl
ILD_5,pert
C4bt5,pert
Individual_511_PN_sample,pert
Wildtype liver_saline-injected 12weeks repl3,ctrl
V5-P187,pert
age: 44;	gender: female,pert
H25 HA 24h 1,pert
umbilical cord_nobpd: 3C,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 pM;	treatment time: 24 hours,pert
Saline treated mouse gallbladder 1,ctrl
"Ulcerative Colitis (40 year old caucasian female, SAK_1285156893)",pert
Tendon_lesional_rep18,pert
"10mg/kg/day PFOA, Rep 3, Block 3, liver (high dose)",pert
LT 339 +/T untreated,ctrl
Muscle 50 eccentric contractions 12 hours KO Adult 01031,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: spleen;	sample name: 5-sp3,pert
siIPMK + MMC experiment 2,pert
SC263_PBS2,ctrl
"22B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
NM Spinal cord 75 day,ctrl
NE-rep5,ctrl
Subject #8040-8hr Postinfection,pert
L428+MAT_rep3,pert
"human nonfailing LV myocardium, NonFailing11",ctrl
SHR20-3,pert
HCC1937_3,ctrl
patient: CLS14;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
CD4+_Tcells_non_severe_asthmatic_1,pert
HCC PBMC Sample 3,pert
"Patient 4, Macroscopically intact tissue",ctrl
brain_DLPFC_bipolar C_mr801,pert
Muscle JDM (YJD-JDM-14UA-s2),pert
"SiRNA-scrambled, replicate 5",ctrl
"Acute Myeloid Leukemia, sample 50",pert
patient: 135;	current medication: none;	birth date: 8/14/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/28/05;	indictation for procedure: bloody diahorrea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
2002T,pert
subject: 21B;	cohort: 21;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 59;	Sex: F;	batch: Batch_5,pert
strain: FVB/N;	genotype/variation: wildtype;	age: embryonic day 9.5;	cell type: erythroid cells,ctrl
strain: C57BL/6;	tissue: Lung;	agent: saline;	genotype/variation: FIZZ2 knockout,ctrl
OVCAR-8+(3),pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: ATF6aKO;	treatment: DSS for 3 days,pert
JIA PBMC Pre treatment A235_L010,ctrl
Braak α-synuclein stages 5-6  BR56_5SN,pert
"fibroblast, MFS subject FB1234 rep 2",pert
Psoriatic arthritis PsA 10,pert
age_years: 45;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
"Exp A, Animal #270, 5mg/kg D-Serine",pert
WT-pDC2,ctrl
"Control Distal, Small Intestine 1 17 days old",ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 24h,ctrl
tissue: blood;	patient: 6;	gender: male;	age: 46,pert
Human skeletal muscle biopsy sample;	Patient #17 with PM,pert
Control siRNA 1,ctrl
"Control, biological replicate 1",ctrl
"WI-38 cells, at 24 h after exposure to 0.5 uM BPDE, biological rep3",pert
Cisplatin_2h_rep2,pert
Mouse old brain w/ a-tocopherol aT-Br-1,pert
8 week old EOM MDX rep 1,pert
S6-041001-SA,pert
non-malignant FTEn_patient 10,ctrl
PND28 Rat Testis_Rat230-2_1hr MEHP_Animal#39_04005,pert
4m3,pert
0972-01-C,ctrl
SKM WT1,ctrl
tissue: large intestine;	genotype: HDAC3FF;	strain: C57BL/6,ctrl
s5t4c,ctrl
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: NO,ctrl
Disease_status: Healthy control;	Age (years): 34;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.48;	Post mortem interval (hours): 22;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Mouse RSK2 mutant mandibular molar [ABH_14A],pert
APBMNC.LPS-.2,ctrl
"human failing LV myocardium, Idiopathic53",pert
"P206 HCT-116, DNMT1 knockout, DMSO-treated",pert
cell line: HEK293 cells WTX inducible clone F18;	agent: control,ctrl
SKBR3_1uM_Lapatinib_1,ctrl
Patient 2 skin baseline,ctrl
Tissue: striatum;	Age: 6 months;	Gender: F,pert
"Patient #1, Untreated",pert
Disease_status: Bipolar disorder;	Age (years): 54;	Gender: Male;	Age of onset (years): 45;	Duration of illness (years): 9;	Brain pH: 6.50;	Post mortem interval (hours): 44;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-sp2,pert
unstimulated sparse HUVECs,ctrl
Fiona Biological Replicate3,pert
mammary stoma-4w-KO-rep1,pert
age_years: 63;	sex: F;	ethnicity: Latino;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
Fetal heart control 1,ctrl
MDS patient 164,pert
RNA from HCC_37T,pert
jzo015-rp1-v5-u74av2-met,ctrl
Peripheral blood mononuclear cells;	TTF=65min;	Race=White;	Sex=Female,pert
Sample 04 Kidney Mouse Hyp - Low Phosphate Diet,pert
"Testes, 8 hours after cadmium treatment, biological rep 1",pert
pediatric AML PP5,pert
"KARPAS-231, non-targeting siRNA, REP2",ctrl
Disease_status: Healthy control;	Age (years): 51;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
"WI-38 cells, at 24 h after exposure to 0.5 uM BPDE, biological rep1",pert
HP-1,pert
quiescent ulcerative colitis_UCN4,ctrl
HEK293 cells siRNA BAHD1 biological rep3,pert
cell type: Primary hepatocytes;	strain: DBA;	agent: control;	time: 6h;	gender: Female;	age: 3 months,ctrl
GEIM63-NORM,ctrl
"strain: C57BL6/J;	pooled: Yes;	amplification batch: 07/15/05;	# cells: 11+16=27;	Sex: male;	region: M1;	age: 37,40;	genotype: Y/Mecp2-;G42/-",pert
"H69 tumor post-PDT, biological rep1",pert
Sox9egfp_p23-2,pert
"Wildtype, biological rep1",ctrl
B2KO; No Treatment #6,pert
Male C57Bl/6  Mice were 10.5 weeks old at time of sacrifice.,ctrl
patient: 51628;	sample: normal,ctrl
BP patient 49_biological replicate 1,pert
ic patient 5,pert
SeroNeg-1,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 8 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
background strain: C57BL/6J;	cell type: Lin- hematopoietic progenitors,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day14,ctrl
"HERVH shRNA, rep3",pert
"DCIS 8, biological rep. 8",pert
patient: 211;	current medication: Predfoam Adcal D3 Alendronate;	birth date: 11/10/44;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 6/7/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/5/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/5/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Coeliac disease 1991;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
MDS patient 29,pert
Cebpg-/- MEFs at passage 3_biological replicate 2,pert
"mouse aorta cross strain comparison, C3H_T04_NC_01",ctrl
Tumor-WT-rep4,ctrl
Control_4,ctrl
brain_OFC_control C_mr350,ctrl
4015-1 E2F2 Null,pert
"ALL_DS, K28 011409",pert
5192 Normal Uninflamed sigmoid colon,ctrl
MCF10A-Vector-rep3,ctrl
diet_LIVER_4,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: spleen;	sample name: 2-sp1,pert
cell line: MOLM-14;	shRNA construct: GSK3B Construct 1,pert
MyD88_ZYM_B,pert
Subject 9_t=30days_resveratrol,pert
Diagnosis: MDS/AML;	Age: 76y ;	Gender: Female;	Blast %: 96;	Source: PB;	Cyto: No Data;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
whole blood_101794,ctrl
KOT 80 bleomycin treated,pert
Fetal heart 3 ug/kg TCDD rep2,pert
"650nM MLN4924 after 1hr, replicate 3",pert
"Wild type used for MAT1A 3 month, replicate 3",ctrl
RPE65_KO_4months_retina25,pert
colonic_mucosa_non_inflamed_123,pert
Scrambled 12 hours_2,ctrl
6171 Wild Type Mouse White Adipose Tissue,ctrl
HMEC X HMEC + TGFbeta 24hrs,ctrl
Backskin_Get1_e18_KO2,pert
PGA-MAH-OuJO3-1bAv2-s1,ctrl
"HEK293 cells siRNA control, biological rep3",ctrl
Large cell neuroendocrine carcinoma 001,pert
CF (D508) subject1,pert
"schizophrenia, BA46-97",pert
1-ONS76_a,pert
Pax_S4,pert
liver_co_14M_rep3,ctrl
Bronchial Epithelial Cells MMA biological 2119J,pert
strain background: F2 of C57BL/6J and DBA;	gender: female;	genotype/variation: wild type;	age: 3 months;	tissue: hippocampus,ctrl
MDS patient 87,pert
Series 3; old; 6 weeks after fracture,pert
chip number: 22;	transfection plate: 4;	target gene: NFKB2;	kd level: 0.82;	rin: 9.3;	transfection date: 2011-10-17,pert
H02_P_B2,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 55;	sex: M,ctrl
FR-si222-3,pert
patient: 30364;	sample: tumor,pert
nebivolol treated muscle cells,pert
RKO_liver_fasted_refed_3hr_rep3,pert
tissue: normal adjacent esophageal tissue,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.03;	RNA Integrity Number: 8.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Large cell carcinoma 010,pert
non-malignant FTEn_patient 6,ctrl
Strain: Fischer 344;	Gender: Male ;	Age: 6 ;	Tissue: Liver of D3T treated rat,pert
"14B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"Lesion Skin, LS-16",pert
HT29siRNAc.E,pert
FVB 129 mice were used as bone marrow donors,pert
cell line: HEK293 cells WTX inducible clone F18;	agent: doxycycline,ctrl
PBMC_S4,pert
CuFi cell line treated at DMNQ biological rep1,pert
NINDS-RHS-Ctr_240h-3aUA-s2,ctrl
scrambled siRNA biological rep 2,ctrl
P4_Ovary_NT3_biological rep2,pert
age: 71;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"brain, hippocampus: C72-II_e1_le1",ctrl
"DCIS 6, biological rep. 6",pert
ASC_lean_biological rep2,ctrl
"normal breast epithelium,2",ctrl
GM19238_Kd_RAD21_2,pert
MCL_IGHV_MUT (R1970),pert
Diaphragm 14 Day control rep 2,ctrl
Glioblastoma_4,pert
cell line: HT144;	transfection: negative control non-targeting siRNA,ctrl
WT_P14_D3_Effector_rep4,ctrl
"gender: Female;	age: 90;	post-mortem delay: 12.5h;	ph: 5.7;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Patient 3 a,pert
KO - 3 mo - repeat 4 - Cy3 - mAdbID:74675,pert
Knockout liver DEN-injected 12weeks repl2,pert
5238 UC Uninflamed sigmoid colon,pert
Against CDK8-2 rep2,pert
C10-4,pert
VillinCreERT2+_Brg1fl/fl_Rep3,pert
microdissected breast cancer cells from case 605,ctrl
CML-BM 3,pert
striatum wild type 6 month replicate 1,pert
strain: C57BL/6;	genotype/variation: Smchd1 wildtype;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: E,ctrl
sex: Male;	family: 1;	age: 49;	disease status: Affected;	tissue: Muscle: Biceps,pert
Cdh1_cKO_3,pert
CAB10_T3_PP_day1_033,pert
U133A_B0_dv,pert
"Ctrl OBCs, post doxycyclin withdrawal, rep3",ctrl
"healthy breast 2, biological rep. 2",ctrl
COP control replicate 1,ctrl
NFIA P16KO2,pert
condition: Psoriasis;	patient: PS-G;	tissue: LS skin biopsy;	kit: Affy,pert
"acutely admitted, severely psychotic schizophrenia patient  A25",pert
ILD Study Number 1107,pert
treatment: siCFIm68;	cell line: HeLa,pert
siGFP-transfected sample 2,ctrl
"Peripheral blood, normal control [N58]",ctrl
PKBa-/- MEF time 0 replicate 4,pert
Tet1-kd_ES_rep2,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.86;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"Alk shRNA, biological rep3",pert
AA_Case18_CD8,pert
"brain, hippocampus: Aldh5a1-/- #3363 Cort_e1_le1",pert
SU8686 rep-3,ctrl
06R014 Control,ctrl
"Nod2-UN2,experimental replicate 2",pert
Patient 4,pert
whole tissue section from case 607,ctrl
"brain, cerebellum: RNA#42a_le1",pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 1,ctrl
race: caucasian;	age (years): 67;	stage: IC;	grade: 1;	histology: endometrioid,pert
muscle_Wt_8wk_rep2,ctrl
5241 UC Uninflamed sigmoid colon,pert
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: BETAFERON;	time: 3 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
S-IIP(UIP)12_Cy3,pert
Individual_4618_NN_sample,ctrl
"new born prosaposin knockout mice, cerebrum",pert
"tissue sample from Bellevue Hospital, NY",pert
MLL_00123,pert
"gender: Male;	age: 77;	post-mortem delay: 3h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"DBA/2J SAL, Rep2",ctrl
3x Ez f/wt,ctrl
I_LS_Wk4,pert
MDS46,pert
"proband g, before exhaustive exercise",ctrl
Disease_status: Healthy control;	Age (years): 37;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 13;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
MO32_17,ctrl
GC resistant clone C7H2-R10E7 treated for 6 hours with GC,pert
P60 wt1,ctrl
cell line: Panc0504;	cell type: dasatinib-sensitive pancreatic cancer cell line,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 3;	psoriasis duration: 16.9158110882957;	age of psoriasis onset: 18,pert
HCT116-Neo124 PTEN +/+,ctrl
HEL_Control shRNA (Luc)_3,ctrl
race: caucasian;	age (years): 58;	stage: IB;	grade: 1;	histology: endometrioid,pert
Normal cervix_05-4602,ctrl
disease state: paediatric glioblastoma;	age: NA;	gender: NA;	h3.3_status: wt,ctrl
"shCDK8, normal growth, replicate 2",pert
age	31;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	8.3;	hemoglobin (g/dl)	14.9;	platelet count (/nl)	269,ctrl
"Normal subject (42 year old caucasian male, SAK_1276036865)",ctrl
cell line: H1299 lung cancer cell line;	genotype/variation: RBP2 depletion;	shRNA: RBP2 KD1,pert
HCC1954 Cell Treated 1,pert
patient: CEM11;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
T30617,pert
CH1+(1),pert
b38+,pert
Adipose-24 month-Myc heterozygous-technical replicate 2,pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Untreated-Control, Period of treatment: 4 weeks, Method of sacrificing: cervical dislocation.",ctrl
MA_67,pert
Patient no. 15: control,ctrl
"DMSO-treated NRK-52E cells at 6h, biological rep 1",ctrl
Carboplatin;	Carboplatin 30 hours set 1,pert
48SAGEA2,pert
genotype/variation: Vax2-/-;	age: P60;	tissue: Whole eye,pert
Wild-type standard cage Rep1,ctrl
3880-1 E2F WT,ctrl
brain_DLPFC_bipolar C_mr677,pert
KN-sham-5 month+13d-R3,pert
MIC3,ctrl
Run5.aUa.010110d.SkmDbt2448D.CEL-DB stimulate,pert
Isoflurane 5 exposures-2,pert
N51176,ctrl
"Femal C57BL/6, ovariectomized",ctrl
Disease_status: Bipolar disorder;	Age (years): 44;	Gender: Female;	Age of onset (years): 26;	Duration of illness (years): 18;	Brain pH: 6.37;	Post mortem interval (hours): 37;	Side of brain: Right;	Fluphenazine mg. Equivalents: 30000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
4041-1 E2F3 Heterozygous,pert
MacularDegen-healthy-4cAv2-s2,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#123,pert
strain: C57BL/6;	genotype/variation: wild type;	gender: male;	age: 5 Month old;	tissue: White adipose tissue (WAT);	diet: 35% Fat Diet (High Fat Diet; HFD),ctrl
GB 9 65A NO LPA,ctrl
"MCF-7 cells-40mM g-T3, biological rep 3",pert
PTEN+/- ep_A,ctrl
"Control Day 5, biological rep2",ctrl
wt_off_rep3,ctrl
fibroblast_Normal_D207_Media_6,ctrl
Wild type IFN-gamma 2 h,ctrl
MZ1774 YAPshRNA rep 4,pert
HUVEC_control experiment 4,ctrl
Wild type day 3 Air replicate 2,ctrl
IEC_GF-HDAC3FF -1,ctrl
P0 - WTMixA 2,ctrl
db/db 14-1,ctrl
RL_siRNA_LIF1h_rep2,pert
Peripheral blood mononuclear cells (PBMC)-Patient SE T1,pert
colonic_mucosa_inflamation_119,pert
U937-shControl-rep3,ctrl
"nasopharyngeal carcinoma, specimen T5",pert
C_AN00142_T,ctrl
"Liver from STZ-treated mice, biological replicate 6",pert
Seltzer 21d replicate 2,pert
n16,ctrl
CD8_T_cell_pool_healthy_H11+H12,ctrl
WT 1 cerebellum 3 month,ctrl
D2-Gpnmb+ control rep1 (retina),ctrl
CON_D,ctrl
Sample 4,pert
"SFM control cells (24hr), biological rep1",ctrl
"breast tumor epithelium,33",pert
Muscle PCOS control 8,ctrl
Liver_Control _Rep4,ctrl
MS patient 1,pert
STV_E,pert
"ARD291, CAIS, F, GOF, 6 x 100nM DHT, 14d",pert
DC-7LA,pert
age: 71;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
01LNH_CTRL,ctrl
Healthy3-CD8,ctrl
Muscle-AMPKgamma3-wt-1,ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 4,pert
RNA from HCC_13T,pert
P0 - nudelko/+ 3,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_10 months_replicate 3,pert
tissue: Liver;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 687,ctrl
kontrolli_DC_D,ctrl
iPSC control triplicate 3,ctrl
Spleen_ko_1m_rep1,pert
Postnatal 12 weeks control heart biological rep3,ctrl
C57/BL6 murine Liver RNA- 6 hours post-injection with a 1st generation (E1-E3-CMVLacZ) vector.,pert
1067-03-A,pert
erStress_twins_AA_1720twin1_DMSO_4h,ctrl
01MLB: new onset sJIA,pert
in situ 2,pert
tissue: blood;	control: 1;	gender: male;	age: 41,ctrl
511MM,pert
BAT_KO_4,pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: ATF6bKO;	treatment: untreated,pert
NOMO-1 control 2,ctrl
Untransduced Wild Type DAOY Cells;	,ctrl
db/m 5-4,pert
B6-rep1,ctrl
sample type: ove26 mice;	strain: fvb(cg)-tg(ins2-calm1)26ove tg(cryaa-tag)1ove/pnej;	gender: Male;	age: 8 weeks;	tissue: glomerulus;	disease state: Diabetic,pert
Wild-type standard cage Rep3,ctrl
MDS patient 96,pert
13: NORMAL #99-0583,ctrl
INS-1 cell line (FLP-In T-REx clone #5-3.14),ctrl
H1299_shGFP,ctrl
high grade serous carcinoma_patient 7,pert
9m5,ctrl
BL Day 2 siSC transfected biological rep4,ctrl
Uninfected control_0b,ctrl
SCC-2_siZMPSTE24_rep.2,pert
Psoriatic arthritis PsA 20,pert
MDS26,pert
PGA-HMO-MObese-6aUA-s2,pert
Ngn3 EB10 OFF replicate 2,ctrl
Trib1 #2 Wild-type macrophage LPS,ctrl
age: 77;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 60,ctrl
59A;pretreatment;female;breast tumor; nonresponder,ctrl
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate 3,pert
HLA risk: Low;	Height: 178.5 cm;	Weight: 71.2 kg;	BMI: 22.4;	Age: 25.25 years;	Gender: Female;	Race: White;	Glucose: 80 mg/dl;	HbA1c: NA,ctrl
patient: 116;	current medication: Clomiprimine;	birth date: 1/19/56;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: FH Colon cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
sample =XCGD5 treatment=Control time=90 (min),pert
BAL_41_A1B0,ctrl
cell line: A549;	agent: decitabine;	dose: 0.3 uM,pert
MH1C1_untreated_rep2,ctrl
AZ-521_doxycycline_18h_rep1,pert
SCHT control 2,ctrl
"Endometrium, postmenopausal, control, 2",ctrl
Subject #8046-2d Postinfection,ctrl
BAL_19_A0B0,ctrl
"shEGFP T47D cell line, replicate 1",ctrl
sample =XCGD3 treatment=Stimulated time=90 (min),pert
"Normal subject (53 year old caucasian male, SAK_1287347487)",ctrl
L_LS_Time0,ctrl
cerebellum_WT_18w_rep1,ctrl
Mtb infected-42d-1,ctrl
224 Day 1 siMut12 transfected biological rep1,pert
Satb1-/- clone 1-2,pert
Pool Eu_P0_hyb2,ctrl
Jurkat Biological Replicate 1,ctrl
PB_DON056,ctrl
Huh7 cells_JFH-1 Infected 24 hours_ rep1,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 25.208;	Ratio: 2.10,pert
disease affected colon of an adult with Crohn's disease (CD).,pert
GLIP2,pert
gender: M;	age at blood draw: 58;	tissue: whole blood,ctrl
KPW13_T5_PP_day7_053,pert
Actinomycin D treated A549 human lung cancer cell cultures replicate A,pert
disease status: CML chronic phase (CP);	cell source: bone marrow (BM);	cell type: CD34+ mononuclear cells,pert
10 week mutant OMN rep 1,pert
Control subject 106_biological replicate 1,ctrl
MeCP2_1,pert
cKO 24h V1::1,pert
SC-RbKO 1,pert
"N-58, NORM, M, GSF, 6 x 100nM DHT, 14d",ctrl
Pool Eu_P0_hyb1,ctrl
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,ctrl
Wild type_kidney_3,ctrl
multiple myeloma (MM 158),pert
cell type: Melanoma cell line;	cell line: A375,pert
Y SIT_B070,ctrl
"205, ADIPOOSE TISSUE, After",pert
gender: male;	age: 8 weeks;	strain: Sprague Dawley rats;	tissue: lumbar dorsal root ganglia,pert
Insm1 mutant #3,pert
"Acute Myeloid Leukemia, sample 34",ctrl
"650nM MLN4924 after 8hr, replicate 3",pert
cell type: MEFs;	genotype/variation: p27KO,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 314;	age-at-biopsy-years: 49,ctrl
CLL14-CD4,pert
strain/background: C57B6SJL;	genotype/variation: wild type;	age: 15 months;	tissue: liver;	disease status: healthy,ctrl
p53_siRNA_0a,pert
B10.H2g7 Idd3_S1,ctrl
H157 siDJ-1 #1,pert
cell type: Normal Human Epidermal Keratinocytes (NHEK);	transfected with: MLL2 siRNA,pert
Liver Tro3,pert
Skinbiopsy_0h_controlsubject_k4,ctrl
Kidney_WT_baseline_rep1,ctrl
"patient: 101;	current medication: Paracetamol;	birth date: 10/5/63;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: Weight loss, altered bowel habbit.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
"69B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"Global gene expression of NASH patient, P59",pert
HepG2_Ni rep3,pert
"brain, hippocampus: Ctr-72h-P15-II_e1_le1",ctrl
"fibroblast, MFS subject FB1040 rep 2",pert
esophageal squamous cell carcinoma from patient E1532,pert
2h WT Cel.37,ctrl
"brain, hippocampus: KA24-II_e1_le1",pert
11434 UC Inflamed descending colon,pert
PGA-RMM-18h-3aA-s2b,pert
Subject #8031-8hr Postinfection,ctrl
RNA-DHL4-R406-48H-2,pert
Jurkat T-cells non-transfected,ctrl
5922012008_D,pert
agent: EphB2-Fc conjugate;	time: 4h,pert
Caco2-siRNA-control2-rep3,ctrl
"4B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
PPARg KO macrophages rep 2,pert
cell line: A549;	agent: azacitidine;	dose: 3 uM,pert
ILD Study Number 558,pert
Recent-onset T1D_sample3,pert
treatment: Vehicle;	time: 25,ctrl
individual: patient11;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"fibroblast, control subject NF10 rep 2",ctrl
"GTF2iTrap line, biological rep 2",pert
"2102Ep cells SOX2 siRNA, biological replicate 2",pert
EA_Case4_CD20,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.76164,ctrl
"human failing LV myocardium, Ischemic4",pert
73 year old male,pert
Tslc1 +/+ mice_rep1,ctrl
Strain:  B6.V-Lep ob;	Gender: female;	Age:  12 weeks;	Tissue:  gallbladder,pert
"CL1-0 mock control, biological rep1",ctrl
sex: female;	tissue: liver,pert
heart_Q10_6M_rep2,pert
"brain, cochlea: [11] Sample #11_le1",ctrl
cell line: E14;	treatment: control,ctrl
"age at diagnosis: 55;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1b;	er: EV;	pgr: EV;	dfs-month: 22;	dfs-event: 0;	distant metastasis: 0",pert
V5-P276,pert
Whisker pad WT biological rep2,ctrl
SA_253,pert
Clozapine treated 4weeks AffyGC RMA rep3,pert
NPC_wt_rep4,ctrl
duration of untreated disease in month: 63.5;	age at onset: 5.1,pert
HCC PBMC Sample 2,pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_287,pert
patient: 224;	current medication: Salazopyrin BFZ Losartan Thyroxine Doxazosin;	birth date: 2/21/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 1/1/77;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 12;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Hypertension Hashimoto's Thyroditis;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
wild type stria vascularis replicate 3,ctrl
cerebellum SNCA knockout 6 month replicate 1,pert
KO STR Veh 26,pert
HEK293_HNF1a_#1_uninduced,ctrl
background mouse strain: C57BL/6;	source: mouse embryonic fibroblast;	genotype: wildtype,ctrl
LY2 SRC1-siRNA untreated rep3,pert
cKO 24h V1::3,pert
tissue: white blood cells;	age: 15.59;	Sex: male,pert
C57BL/10-SJL.Dysf QF replicate 1,pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 8",ctrl
10SAGEA,pert
NICM pool 3 (n=4),pert
4-HPR_LUNG_4,pert
34A,pert
Control subject 40_biological replicate 1,ctrl
WT3-iPS 1,ctrl
strain: C57BL/6J;	tissue: WAT;	genotype/variation: wild-type;	gender: male;	age: 3 month,ctrl
Sox2-ShRNA-1,pert
age_years: 63;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
mortality: alive;	ethnicity: Asian;	gender: M;	age (yrs): 33;	tissue: Normal_Kidney_Biopsy,ctrl
"MCF7/BUS, 60 pM E2, 48 hours, biological replication 3",pert
16: NORMAL #99-1053,ctrl
"ERbKO mouse aorta with placebo, biological rep2",pert
020112-5,ctrl
Biceps_Control_1,ctrl
Hippocampus_Soman_6h_rep3,pert
"Gata6-KO heart, CRE, biological rep3",pert
BP27,pert
"Endometrium, postmenopausal, control, 37",ctrl
"E18.5 brain, Meg3 knock-out, rep 5",pert
HEL_Control shRNA (Luc)_2,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient B;	treatment: Vemurafenib 1000 nM for 48h,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 44;	gender: male;	tumor grade: IV,pert
cDNA no 17,ctrl
Wild-type standard cage Rep2,ctrl
RKO_NEGsiRNA_6hDMSO_REP2,ctrl
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 72;	Usage number: 1;	Exposures: 4,pert
"The Identification of gene expression changes in human embryonic fibroblast cells, background. Sample B",ctrl
Sex: female;	Age at operation: 57 years;	Site: thorax;	Size in cm: 4.9x4x3;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,pert
"Acute Myeloid Leukemia, sample 66",pert
heart female pbs 10 dpi rep1,ctrl
remitted schizophrenia patient  S08,pert
Testis WT 0h batch 4 [TeWTh00.25],ctrl
11439 UC Uninflamed descending colon,pert
"age at diagnosis: 60;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIC;	t (extent of primary tumor): T2;	n (lymph node metastasis): N3a;	er: 0;	pgr: 0;	dfs-month: 19;	dfs-event: 1;	distant metastasis: 1",pert
LT489 wild-type after nicotine-induced seizures,pert
"Testosterone treated, HIV-1 positive male, day 14 (10)",pert
22SMOKEH,ctrl
NPC_p5ko_rep2,pert
Pancreatic Sample 11-Normal,ctrl
ACC Xenograft X4,pert
"normal skeletal muscle, biological rep7",ctrl
3879-1 E2F WT,pert
Nerve_Diabetic_Rosi_720,pert
1P-M4-ND,pert
"Normal subject (57 year old caucasian male, SAK_1290276212)",ctrl
A HID B_B046,pert
Subject 6 / lung subsegment instillated by Saline,ctrl
TAC 4,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 18.378;	Ratio: 2.09,ctrl
PND28 Rat Testis_Rat230-2_6hr MEHP_Animal#33_04005,pert
Large cell carcinoma 011,pert
Zucker rats,pert
HaCaT_ZNF750i_ biological rep3,ctrl
"Normal skin from Tgfbeta_control mouse, biological replicate 3",ctrl
AKT_PLACEBO_48hours_3,pert
hNHEPS_0.1 μM_6 h_rep2,pert
genetic background: hybrid C57BL/6J and 129S5/SvEvBrd;	genotype: Alk2 cKO,pert
CH2128,ctrl
PTC BRAF mut 8,pert
Retina wildtype 30 days 1,ctrl
cell line: H1;	cell type: embryonic stem cells;	shRNA: HERVH,pert
strain background: C57Bl/6;	genotype/variation: P14 TCR transgenic C57Bl/6;	cell state: Day 0 Naïve CD8+ T cells,ctrl
01LKS,pert
MDS patient 173,pert
"Uninvolved Skin, NS-2",pert
"patient 041b, cancer, homogenized",pert
age_years: 62;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
batch: A;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,pert
"8 wk old BALB/c (or BALB-RAG) mice were sensitized to ovalbumin (or PBS)]on days 1 and 7, and challenged with aerosolized ovalbumin (or PBS) on days 15-21, and samples harvested on day 22",pert
"gender: female;	age: juvenile, 8 weeks (P59);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/+;	tissue type: renal tissue",ctrl
"experiment IV, hTERT, replicate 2",pert
SKBR3_1uM_Lapatinib_1,pert
db/db 11-4,pert
blood_day6_patient1,pert
NSC_FOXO_WT-3,ctrl
Luciferase shRNA_3 Days knockdown_rep2,ctrl
Normal mucosa 1,ctrl
Keratinocytes treated with EFNA4 for 24h,pert
S46 WT1	F5/3	S46	wild type	Mouse	3.5 months	Cerebellum	Male,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 6;	gender: male,ctrl
tissue: primary brain tumor;	cell type: oligodendrioglioma;	age: 45;	gender: male;	tumor grade: OGIII,pert
"liver_LDLr-KO, biological replicate 3",ctrl
"Lens epithelium, WT, #2L",ctrl
RNA from HCC_2N,ctrl
"Normal subject (40 year old caucasian male, SAK_1265998952)",ctrl
HD 2,ctrl
sampleID: SAM630142;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
MCL_IGHV_MUT (R1333),pert
"schizophrenia, BA10-29",pert
tissue: liver;	gender: male;	disease status: type 2 diabetes,pert
Psoriasis-Patient-C,pert
RNA from HCC_20T,pert
U2-OS-ERa E2 4 hrs 1,pert
11420 UC Uninflamed ascending colon,pert
Cre_day_3-3,pert
"breast tumor epithelium,25",pert
No or early 1 rep8 (OHN),pert
"A673 treated with Puromycin for 3 days with concentration of 0.18 uM (2 x EC50), biological rep3",pert
WT V6.5 ESCs on day 0 #1,ctrl
Gsk-3b-/- ESCs Rep1,pert
14 saline,ctrl
Mature mice skeletal muscle sample from the forelimb,ctrl
P8 Vax2-/- 1,pert
cell type: mammary epithelial cells;	gender: female;	age: 8 weeks;	myc: WT;	p53: KO;	rb: WT,pert
normal main pancreatic duct 7,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 21.40548,pert
subject id: c6;	infection: control;	status: control;	tissue: whole blood,ctrl
brain_DLPFC_bipolar C_mr276,ctrl
Subject #8017-Preinfection,ctrl
Luciferase control 1,ctrl
Tendon_non-lesional_rep11,ctrl
Patient 9 after folic acid,pert
LNT-1,ctrl
"AALE-Vector uninfected, biological rep2",ctrl
ATP-treated AML 13 blasts,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 220,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: Vemurafenib 1000 nM for 48h,pert
strain: Wistar;	gender: male;	tissue: sciatic nerve;	treatment: acrylamide,pert
phenotype: alcoholic;	gender: female;	case_id: 443;	age: 49;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 56;	brain ph at time of freezing: 6.11;	labeling_batch: 1,pert
GM19238_Kd_CLOCK_3,pert
215/0,pert
ko 13.5d replicate 9,pert
tissue: Hippocampus;	age: 2-3 months;	genotype/variation: IκBαfl/-;Nestin-Cre,pert
A549_Cisplatin_rep2,pert
"Control, sample 1",ctrl
age: 40;	sex: F;	disease status: control subject;	Filter number: 90;	Usage number: 1;	Exposures: 2,ctrl
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1+/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: liver,ctrl
"lymphoblastoid cell line from F6.01, one out of seven of sensitive group, 50*10e6 cells",pert
"wild-type P9 hair follicle, biological rep2",ctrl
AZ-521_uninduced_12h_rep1,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 6",pert
Peripheral blood mononuclear cells;	TTF=125min;	Race=White;	Sex=Male,pert
3_month_old_Prnp_knockout_mouse_rep3,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-sp2,pert
cell line: HEK001,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: G;	transfectant type: stably transfected with RNAi against DJ-1,ctrl
"Uninfected TG at 5 d.p.i., rep2",pert
Muscle PCOS pioglitazone 161,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 1;	psoriasis duration: 17.7488021902806;	age of psoriasis onset: 21,pert
age: 49;	sex: M;	disease status: control subject;	Filter number: 84;	Usage number: 5;	Exposures: 3,ctrl
age: 36;	sex: M;	disease status: control subject;	Filter number: 98;	Usage number: 5;	Exposures: 3,ctrl
"human peripheral blood derived monocytes, no stimulation, biological rep2",ctrl
SKM KO7,pert
BE-rep7,pert
Normal Biological Replicate 2,ctrl
452MM,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 24h ID292,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 25.57808,pert
KU_03N,ctrl
Substantia nigra normal rep9,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 36;	maternal age: 27,pert
cell line: NAS2;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: wild-type,ctrl
"pancreas, ethanol diet, male Wistar rat",pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_L027,pert
scrambled biological rep1,ctrl
erlot2_CT41,pert
cell type: Primary hepatocytes;	strain: BL6;	agent: control;	time: 6h;	gender: Male;	age: 2 months,ctrl
Mening UNSTIM WB SW 0b,ctrl
CH2119,pert
Run4.aUa.010110d.SkMDbt1146D.CEL-DB basal,ctrl
CA4,pert
"wildtype liver, biological rep 1",ctrl
cDNA no 18,ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 6,ctrl
6-ONS76 Mock_c,ctrl
cell line: PC-3;	transfection: control miR,ctrl
Brain area 8/9_8yp_RTT,pert
Strain: C57BL/6;	Gender: female;	Age: 110 days;	Tissue: mammary tumor;	Days after tumor onset: 14 days,ctrl
cell line: PA-1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
Day3 Genistein treatment replicate 1,pert
"control triceps, biological rep4",ctrl
Bone-Marrow_SMM_S1216,pert
"wild type saline, biological rep2",ctrl
Run8.aUa.010615d.SkMInS1086D.CEL-IS basal,ctrl
Sex: female;	Age: 12;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
MCL_IGHV_MUT (R1589),pert
"mouse liver, RNA B9216",pert
"Creatine-treated, biological rep1",pert
WTGFP QSC Biological Rep.2 Technical Rep.2,ctrl
Fetal heart 3.0 ug/kg TCDD rep4,pert
"schizophrenia, BA10-12(3)",pert
T14,pert
colonic_mucosa_non_inflamed_743,ctrl
"Liver from MON exposed rats, biological rep 4",pert
Mening SWB WB NP 12a,pert
BACH2-/- ALL (Sample2),pert
"testis, Repro9 mutant, 14dpp, Rep1",pert
"control mice, whole uterine tissues, replicate 3",ctrl
V5-P107,pert
DC2,ctrl
"anN1 P9 hair follicle, biological rep1",pert
G93A 120 days sample 1,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 8d ID298,pert
MIY_day_5-1,ctrl
HF0088_U133P2,ctrl
"gender: female;	batch: 1;	age (years): 45;	patient id: Severe_7;	fev1 (% predicted): 71;	fvc (% predicted): 105;	medication: Prednisolone 10mg od, Insulin S/C,Seretide 500mcg 2pbd, Metformin,Nexium, Flixonase,Tramacet,Calcium,Valsartan,Amitriptyline;	cell type: CD8+ T-cells",pert
Gastrocnemius Muscle WT rep1,ctrl
B4 436 b4-/- after nicotine-induced seizures,pert
patient: 30617;	sample: tumor,pert
strain: C57BL6;	genotype: PDE10A KO;	tissue: hippocampus;	treatment: vehicle control,pert
THRB 15b mutant + vehicle replicate 2,ctrl
"sirna: Sense Control siRNA (Ambion);	cell line: Human epithelial colonic adenocarcinoma, Caco-2",ctrl
b2.2,pert
"age at diagnosis: 46;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIA;	t (extent of primary tumor): TX;	n (lymph node metastasis): N2;	er: 1;	pgr: 1;	dfs-month: 60;	dfs-event: 0;	distant metastasis: 0",pert
Leg 112 Day mdx rep 1,pert
SeroTest-7,pert
KU_17T,pert
SNB19 PARK2 siRNA#1 replicate 2,pert
695-383_16hr,pert
antimicroRNA-449_rep1,ctrl
"Ulcerative Colitis (25 year old caucasian female, SAK_1286453367)",pert
BL Day 1 siMut10 transfected biological rep4,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 28;	gender: male,ctrl
tissue: kidney;	protocol: intraperitoneal;	agent: vancomycin;	dose: 200 mg/kg,pert
MCF-10A shATR-4 replicate 1 [set 5],pert
NFIA P16WT2,ctrl
"brain, cerebellum: RNA#17_le1",ctrl
Cutaneous psoriasis without arthritis PsC 3,pert
pediatric AML S20,pert
Quercetin day 05 sample 1,pert
PBMCs_IS_10 [IS],pert
"Patient S-316-N, normal colonic mucosa",ctrl
Mouse old heart C30-Ht-5,ctrl
4 hour tunicamycin CHOP-/- A,pert
Wild Type 650,ctrl
Psoriatic arthritis PsA 11,pert
Series 3; young; 2 weeks after fracture,pert
KU_31N,ctrl
age: 62;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
HSC cells from MSI2-inducible mouse rep2,pert
3461,pert
patient: 261;	current medication: Asacol 800mg BD;	birth date: 1/7/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/98;	diagnosis date: 1/1/98;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
heart_WT_rep1,ctrl
Control_AF_2,ctrl
Cmah KO_kidney_1,pert
Untreated Myd88 knockout - repeat 1 - mAdbID:102771,pert
N2A Normal-frontal,ctrl
0975-01-C,ctrl
SP-WT-Nrf2-Female-1,ctrl
"Estradiol, rep 1",pert
Braak α-synuclein 3-4 BR34_6SN,pert
BS2011051062,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 24 hrs;	time course: 3,pert
10uM H2O2 rep 2,pert
condition: Normal;	patient: N_LJ_4;	tissue: Normal skin biopsy;	kit: Affy,ctrl
Eed KO E14 ESCs on day 3 #2,pert
M24met_control_4,ctrl
FmrKO5_brain,pert
3269-lcm,pert
knockdown: siRNA-scrambled;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 155;	colon ratio (mg/mm): 2.58;	myeloperoxidase activity (u/mg): 1.35;	tissue: colon;	treatment: 5% DSS,ctrl
tissue: Epididymal adipose;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 719,pert
source tissue: lung;	strain: Insig1 flox/flox /Insig2 -/- ( AT2 cells obtained from 2 months old SpC-rTTA / Otet-CRE / Insig1 flox/flox / Insig2-/- mice treated with doxycycline from E6.5 to E12.5. Control animals lacked either SpC-rtTA or Otet-CRE);	cell type: Alveolar Type II,ctrl
Bronchial Epithelial Cells MMA biological 2134F,pert
"schizophrenia, BA46-37",pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK1-4,pert
chip number: 4;	transfection plate: 1;	target gene: E2F1;	kd level: 0.77;	rin: 9.8;	transfection date: 2011-03-29,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 8.5;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 45;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
A549_Control_rep3,ctrl
male_alcoholic_313,pert
"VPA 1, 16hrs",pert
GM19238_Kd_SREBF2_2,pert
"PPARg2 expression construct, 72 hrs, No Rosiglitazone (PPAR_72_1)",pert
18GOBMUC2A,pert
"immortalized cells derived from brown fat tissue of PGC-1alpha KO mouse (mixed background), expressing a siRNA specific for PGC-1beta knockdown.",pert
Dengue Fever Patient 33,pert
MDS patient 25,pert
cell line: MLL-AF9 AML cell line 10949 (Zfx fl);	treatment protocol: vehicle;	genotype/variation: fl,ctrl
tissue: white blood cells;	age: 5;	Sex: male,ctrl
PBMCs_IS_17 [IS],pert
"Patient I-c396T, MSI colorectal tumor",pert
Tendon_non-lesional_rep9,ctrl
type_of_rx: AF;	pre_or_post_treatment: pre;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 76;	baseline tumor size (cm): 7x8;	patient id (to identify the 2 chips from the same patient): 13491389,ctrl
MOLM14_luc_Replicate1,ctrl
Parkinson's disease sample x102,pert
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC,pert
S003_Scz_F_89,pert
control4,ctrl
strain background: 129/B6 hybrid;	cell type: embryonic stem cells;	genotype/variation: Rybp-KO,pert
"Gender: female, Age: 43 years, Tissue: normal vulva,",ctrl
EA_Case12_CD8,pert
Control d10 (4),ctrl
WT-SB-2,ctrl
Mnk_3176-R-7,pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 4,ctrl
MNR 5-2 KO 2,pert
Cancer 12,pert
70 year old male,pert
01N0R_PolyRF-,pert
CD11b+Gr1+ cell sample_4 (derived from IL17RC Knock out mouse),pert
"ESCs overexpressed Foxd3, biological rep1",pert
ROS4,pert
"DMD skeletal muscle, biological rep15",pert
C6star_CLP_wildtype_8,ctrl
156B,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 5,ctrl
phenotype: moderate glaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 10.5 months,pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: corn oil vehicle,pert
Liver_untreated_wild type_rep3,ctrl
"human failing LV myocardium, Idiopathic20",pert
"Biceps, FSHD, cohort 21, subject 21A",pert
pt. HCL A treated with DMSO for 48h,ctrl
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14481;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
heart tissue,pert
cell line: NG4;	cell type: embryonic stem cells;	transfection: siUbr5,pert
"prdm-Rosi, biological rep2",pert
KOC 55 PBS treated,pert
10.5 months Heart Control rep 1,ctrl
FmrWT2_brain,ctrl
92.1 - siBAP1 - replicate1,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 6h ID284,pert
15d control_Pool 11,ctrl
F9 TSA sample #3,pert
P0 Quadriceps Klhl40 KO 1,pert
Knockdown Cell Replicate 3,pert
T137 U133p2,pert
01 Con,ctrl
WT2 PBS,ctrl
adenosquamous carcinoma 003,pert
"endometrioma, patient M1",pert
original diagnosis: Psoriatic;	cell type: Peripheral blood mononuclear cells,pert
aa.4,pert
agent: Control,ctrl
Teratozoospermic individual: Sample T4,pert
2 hr KLF4 Time Course Control,ctrl
NPC Brain 59d Mouse1,pert
Snell 6 month Wild Type Liver 86c,ctrl
ab144 IM,pert
HDAC6_1,pert
Control_Castrated OWJ59,ctrl
gender: Male;	tissue: Tendon;ECRB;	age: 48;	donor: 9;	disease state: Lesional,pert
mT5,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 140min;	race: White;	sex: Female,ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 145;	time: 0;	batch: 4,ctrl
ILD Study Number S027,ctrl
"129 Mouse P0 Pineal Tissue, Sample 2, 05-23-06",ctrl
PGA-RMM-12h-1aA-s2,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 50.55616,pert
"KARPAS-231, LITAF-specific siRNA, REP2",pert
GSK-3 inhibitor effect on MLL leukemia cells - 3,pert
NPC_VUB01_2,ctrl
"Untreated ES cells, Rep 3",ctrl
SHR20-1,pert
4 hour tunicamycin wild type B,ctrl
disease state: healthy (non EBS);	cell type: Keratinocytes;	tissue origin: skin biopsies with no stimulation,ctrl
"Carcinoma in situ_2 (CIS, double transgene)",pert
"breast, pre AF treatment (H1_1278)",ctrl
"brain, hippocampus: Ctr-240h-P15-II_e1_le1",ctrl
e_M43B,pert
WT-sham-2 month-R2,ctrl
HF1380_U133P2,pert
Patient identifyier: P;	Sex: male;	Age of patient: 76 years;	Duration of psoriasis: 56 years;	Body surface area: 15 percent;	Overall erythema: mild;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: minimal (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
age: 62;	gender: male;	ejection fraction: 51;	left ventricular end diastolic diameter: 73;	inflammation/PVB19: positive,pert
Oga_WT_MEF_E8_rep3,ctrl
sample 1:;	age: 58;	gender: male;	sample 2;	age: 64;	gender: male,ctrl
PB_DON058,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#110,pert
Control with WY14643 replicate 6,pert
"RES-enriched Grape extract group, 12 months, patient number 28",pert
8SC-pbo,ctrl
15SAGEA,pert
subject id: 6;	infection: DENV;	status: DF;	tissue: whole blood,pert
10-0029A_Day1_20,pert
AL Chip#37,pert
Lmna H222P heterozygous male 4,pert
Skin_ K5IKKb_2,pert
con-56_B,ctrl
181D6,pert
Wtc-Met_2,ctrl
mESCs_Tip60KD_rep4,pert
CON16,ctrl
male JAK2 WT liver sample 112,ctrl
Wild Type 10,ctrl
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep5",ctrl
"Age: 44;	Sex: M;	Ancestry: European;	Smoking status: smoker, 45 pack-years",pert
background mouse strain: C57BL/6;	source: mouse embryonic fibroblast;	genotype: Rap1 knockout,pert
"Wild-type-neocortex, biological rep8 (female)",ctrl
"Retina from control mouse at ZT6, biological rep 1",ctrl
WT tumor DNA,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A08",pert
tissue: kidney;	protocol: intravenous;	agent: vancomycin;	dose: 400 mg/kg,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P60,ctrl
A3243G-MELAS subject 3,pert
siHic5 VC 1,pert
lesion_midUV_patient1,pert
M238_B_PLX,pert
cell line: Reh;	transfection: control shRNA;	malignancy: non-Hodgkin lymphoma,ctrl
age: 91;	post-mortem delay: 4.5h;	ph: 6.3,ctrl
sex: Male;	Age: 6 months;	additional patient information found in Series supplementary file,pert
IOSE80pc shARID1A at 72h,pert
"Alk2 cKO mice, whole uterine tissues, replicate 1",pert
sample =Healthy3 treatment=Stimulated time=90 (min),ctrl
Blood_Control 5,ctrl
Second shYY1,pert
cell line: Lung Epithelial Cell Line MLE15;	genotype/variation: Grhl2 knockdown,pert
"Normal 12, control tissue",ctrl
E12.5 wt1,ctrl
ARF1 siRNA knockdown MDA-MB-231 sample 5,pert
tissue: Biceps muscle;	patient: P.b.4;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 10m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
brain_DLPFC_bipolar C_mr283,ctrl
knockdown: Control;	cell line: 92.1,ctrl
Gender: Female;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: poor;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 68;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension,ctrl
affection: unaffected;	treatment: untreated;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 6 unaffected controls,ctrl
"shBAP1 #1 cells, rep1",pert
Retina homozygous KO 30 days 4,pert
"fibroblast, control subject NM9 rep 2",ctrl
strain: FVB;	genotype: E2F2 null;	tissue: mammary gland tumor,pert
Cervical Cancer C567,pert
Tk6 untreated controls for arsenic exposure rep2,ctrl
cell line: SKBR3 resistant;	treatment: 1uM Lapatinib,pert
strain: C57BL6/J;	genotype/variation: Sfrp5 KO (Q27Stop);	gender: male;	age: 12 weeks;	diet: 8 wks of high-fat diet;	tissue: gonadal white adipose tissue (WAT),pert
"metastatic, prostate cancer",pert
"Pou4f1-/- cells, transduced with control virus_KO_MSCV_84",pert
12466 UC Inflamed descending colon,pert
"Patient C-c215T, MSI colorectal tumor",pert
Insig1 flox/flox /Insig2 -/- InsigKO_C3,ctrl
mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 24;	tissue: Normal_Kidney_Biopsy,ctrl
sepsis patient #9,ctrl
Rybp#15 (OHT+)_4d_rep2,pert
PsOEt-14-Week 1,pert
control siRNA (siCon) tranfected into C2C12 myoblasts rep2,ctrl
normal 1037,ctrl
FVB_MMTV_Wnt1_2543-4L_Rosen,ctrl
A549 DAC 3 uM (3223),pert
quiescent p27KO MEFs 1,pert
"BPH adrenals, replicate 1",pert
126OE 20A n,pert
B6C3F1/JTCE liver sample batch 4,pert
minor HCC1,pert
GM19238_Kd_TCF12_1,pert
tissue: breast;	normal/tumor: tumor,pert
tissue: Hodgkin lymphoma;	cell line: KM-H2,pert
"Mel18 shRNA, biological rep2",pert
E9C,ctrl
cell line: SUM149,pert
neuron_rep10,pert
Liver Pio3,pert
CLDN18_KnockOut_1,pert
RAW Untreated 3,ctrl
tissue: Frontal cortex;	age: 80;	Sex: M,ctrl
"Control siRNA - Undifferentiated, rep2",ctrl
HeLa_06_21_04 TP-6,pert
age: 48;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"MCF7/BUS, 100 pM E2, 48 hours, biological replication 3",pert
"G42 cells from M1, wild type control, biological replicate 3",ctrl
cerebellum wild type 21 month replicate 1,ctrl
WT-smoke-high-5 month+1d-R1,ctrl
blank_7,ctrl
ARF1 siRNA knockdown MDA-MB-231 sample 1,pert
Gender: Male;	AJCC Stage: I;	Pathological T: 2;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
Healthy-10 baseline,ctrl
DUSP1+/+ control replicate 3,ctrl
"SFM control cells (24hr), biological rep3",pert
wild type MEF time 0 replicate 3,ctrl
"PCB77 treated HepG2 cells at T24, biological replicate 2",pert
strain: C57BL/6;	Sex: Female;	age: 3-weeks old;	genotype: CF,pert
HEK293_A263insGG_#6_induced,pert
NT2,pert
tissue: Liver;	genotype/variation: Hmgn1-/-;	treatment: injection of 10 µg/g body weight of N-nitrosodiethylamine,pert
MOLT4_ctrl_B,ctrl
Liver phenobarbital pool2 Affy,pert
"brain, Entorhinal Cortex: 01-22 tangle_e1_le1",pert
"Control 2, biological rep1",ctrl
ccRCC tumor of patient 75,pert
At Risk: +;	Age: 18;	Sex: M,pert
Scrambled 12 hours_3,ctrl
brain_DLPFC_bipolar C_mr521,pert
Liver KO5,pert
Muscle control 6,ctrl
E14.5 Tgfbr2 Wildtype Mouse Model Tongue 1,ctrl
CKO Wild Type V1,ctrl
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: STAG2 knockout clone 21 (STAG2 deficient),pert
"Female (age range 33-49), skin biopsy taken from upper nates no nickel exposure",ctrl
major non-tumor2,ctrl
strain: C57BL/6J;	day: 24;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
CME-Emerin4d-2MA-S2,pert
PGA-lv_1h_514,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M5a;	flt3 status: internal tandem duplication (ITD),ctrl
GIST_WT_2,ctrl
cell type: peripheral blood mononuclear cells;	disease state: healthy control,ctrl
MPM tumor 37,pert
renal_vesicle_Lim1_mutant_3,pert
Grhl2 downregulation in MLE 15 cells 3,pert
phenotype: alcoholic;	gender: male;	case_id: 322;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 30;	brain ph at time of freezing: 6.13;	labeling_batch: 1,pert
Gender: Female;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 2;	Pathological M: 1;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: NO,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 2 days osteoblast differentiation,pert
"Deltoid, FSHD, cohort 19, subject 19A",pert
A_AN08873_F,pert
GM19238_Kd_RAD21_1,pert
HF0383_U133P2,ctrl
Strain: C57BL/6J;	Gender: female;	Age: 7 weeks;	Tissue: whole brain,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 63;	sex: F,ctrl
patient: 25;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
NCCIT siTET2 rep2,pert
patient: 30277;	sample: tumor,pert
HCC PBMC_sample 1,pert
subject id: 43;	infection: DENV;	status: DF;	tissue: whole blood,pert
whole tissue section from case 180,ctrl
KO - 5 mo - repeat 4 - Cy3 - mAdbID:74139,pert
control IgG_rep3,ctrl
HMEC X BC2-2,pert
Disease_status: Healthy control;	Age (years): 49;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.72;	Post mortem interval (hours): 45;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Flp-InTMT-RExTM-293 (Invitrogen) cell line derived from the human embryonic kidney cell line HEK293 carrying tetracycline inducible transgene,pert
Pt_3 Acne Lesion,pert
braak stage: BR34;	rin: 75;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
3_KO_2,pert
"shControl cells, rep3",ctrl
"patient: 111;	current medication: Paracetamol;	birth date: 9/5/82;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: FH of CD, Path Increased lymphiod in TI Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
Control day 10 sample 1,ctrl
Kidney_400 mg/kg VCM ip_mouse #107,pert
BALB-RAG_PBS Replicate 2,pert
A263insGG_mut3b-,ctrl
"cochlea at P13, wt, biological rep 1",ctrl
cerebellum SNCA knockout 6 month replicate 3,pert
strain background: C57BL/6;	genotype/variation: WT;	cell type: sorted Ter119+CD71+ bone marrow cells,ctrl
5922012047_B,ctrl
"NTera-2 cells SOX2 siRNA, biological replicate 2",pert
M24met_Wnt1_1,pert
"Atm+/+ 120 min post IR, B",pert
E1 clone infected with control retrovirus.,ctrl
Patient no. 11: treated,pert
7113.3PBMC,ctrl
Peripheral blood mononuclear cells;	TTF=105min;	Race=White;	Sex=Female,pert
Tendon_non-lesional_rep10,ctrl
Src-overexpression - replicate 3,pert
sample 1;	age: 58;	gender: male;	sample 2;	age: 58;	gender: male,ctrl
"gender: female;	age: juvenile, 8 weeks (P58);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/+;	tissue type: renal tissue",ctrl
4T1.2-BV-3,ctrl
"44B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Control_4months_retina17,ctrl
Mening SWB WB SW 3b,pert
cell type: E14 murine embryonic stem cells;	genotype: Zfp322a Knock-down cells,pert
Control peripheral blood leukocytes - Biological Replicate 2 - Technical Replicate 1,ctrl
BS2011051061,ctrl
control-control rep 1,ctrl
HUH-nonsense-#1,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: Treg;	treatment: unstimulated;	genotype: WT,ctrl
Endometrium-Normal 10,ctrl
"P116 ZAP70 negative  0 hours, #2",pert
NESG1-overexpressed 2F4-5-8F NPC cells rep1,pert
"control, rep1",ctrl
Third shYY2,pert
"PBMC, patient. Mtx rep12",pert
Bc_WAP_1,pert
S2,pert
"disease group: Nonatopic Control;	Sex: f;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 50;	ige (kiu/l): normal (0-48.5 kIU/L): 2.5;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
CLC5 ko rep 3,pert
"PPARg d0, rep 3",pert
status: Control;	gender: Male;	age: 67;	tissue: Blood,ctrl
HEK293_pLKO_R1,ctrl
RNA-DHL6-R406-24H-2,pert
"2 months, contralateral group, biological replicate 1",pert
CD4+_Tcells_severe_asthmatic_1,pert
Kidney_400 mg/kg VCM ip_mouse #108,pert
C_AN03217_C,ctrl
sepsis patient #1,ctrl
"Index, patient1",pert
FVB; No Treatment #8,ctrl
No or early 2 rep2 (retina),pert
"alveolar macrophages, smoker 069",pert
CA2 Cre Sox17D,pert
NE-rep2,ctrl
tissue: Frontal cortex;	age: 100;	Sex: F,pert
ARF1 siRNA knockdown MDA-MB-231 sample 2,pert
"DMSO Control after 4hr, replicate 3",ctrl
"P40_wt cones, replicate 2 [array]",ctrl
"Deltoid, control, cohort 18, subject 18U",ctrl
status: Control;	gender: Female;	age: 55;	tissue: Blood,ctrl
early HCC,pert
strain background: C57BL/6N;	genotype/variation: Stat1 delta alpha (da);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),pert
Wild type,ctrl
nt S. aureus 11,ctrl
shRNA control R11 T5,ctrl
"brain, Entorhinal Cortex: 99-21 normal_e1_le1",ctrl
PC3 Control Rep1,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: DMSO for 48h,ctrl
"DMD skeletal muscle, biological rep21",pert
gender: male;	strain: BL6/C57;	genotype/variation: A2BAR-/-;	age: 12 weeks,pert
WT J1 ESCs on day 0 #2,ctrl
SW1736_t48h_rep3,pert
strain: C57Bl6;	age: 4 weeks;	cell type: BCR-ABL1 transformed pre-B cells;	disease state: BCR-ABL1-driven ALL;	genotype/variation: Bach2 knockout,pert
11084 Normal Uninflamed descending colon,ctrl
HLA risk: High;	Height: 147 cm;	Weight: 58.9 kg;	BMI: 27.3;	Age: 9.9 years;	Gender: Male;	Race: White;	Glucose: 94 mg/dl;	HbA1c: NA,ctrl
"Control, biological rep2 (E17.5)",ctrl
"A673 treated with Doxorubicin for 3 days with concentration of 119.76 nM (2 x EC50), biological rep3",pert
8DKD_SerumStarved_rep1,pert
"shControl, low glucose, replicate 1",ctrl
"Immortalized MEFs WA, empty retroviral vector infected, rep2",ctrl
tissue: Frontal cortex;	age: 55;	Sex: M,ctrl
RV63.10_CHF_day19_Slide44,pert
B4 365 b4-/- untraeted,ctrl
tissue: white blood cells;	age: 10.58;	Sex: female,pert
"brain, frontal cortex: Sample48_e1_le1",pert
"Wild type, snap frozen, diaphragm muscle, 7month age animal",ctrl
Mnk_3142-T-7,pert
S028_Scz_F_28,pert
"ESCs overexpressed CA-NFATc3, biological rep1",pert
brain_Q10_14M_rep3,pert
Normal Biological Replicate 1,ctrl
441MM,pert
NEO-1_HG-U133 Plus 2_Rep,ctrl
Recent-onset T1D_sample7,pert
LOX1 Untreated 24hr 282295903,pert
cell line: RT112;	transduced: FGFR3 shRNA 6-16;	doxycycline treatment: no,pert
"vehicle treatment, 24 hour time point, biological replicate 1",ctrl
cell type: Human melanoma cell line;	cell line: M229;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case3,ctrl
colon_IL10mouse_6weeks_rep2,pert
Advanced IPF_explant_upper lobe_rep160,pert
"RET-PTC, 6 months",pert
Hippocampus_WildType_rep1,ctrl
mouse cerebellar granule cells wild type 7,ctrl
batch: B;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,ctrl
brain_DLPFC_bipolar B_mr426,pert
Ainv15 ES0 replicate 2,ctrl
n12,ctrl
CD11b+Gr1- cell sample_2 (derived from wild type mouse),ctrl
35A;pretreatment;female;breast tumor,ctrl
con-52_B,ctrl
Normal-BM 7,ctrl
HCC012T,pert
"C57BL/6J female number 1, 2 months old , whole ear tissue, untreated control ear",ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 43;	maternal age: 36,pert
amygdala long access to cocaine replicate 2,pert
CLL 11-18 LMP-420,pert
"P50_wt cones, replicate 1 [array]",ctrl
Strain: J1 Cell type: mouse embryonis stem cell,ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,pert
treatment: EtOH + cycloheximide;	genotype: RARaKO;	cell line: F9,pert
Normal PBMC Sample 7,ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 143;	time: 0;	batch: 2,pert
KOPT-K control 1,ctrl
Etoh 4,ctrl
BJ-iPSC replicate 2,ctrl
B10.H2g7_T1,ctrl
timepoint: 2h;	drug: Saline;	group no.: 16;	large batch: X;	plate: 1957998115;	hybridization batch: I,ctrl
n7t6h,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 6h ID209,pert
"MelJuSo, 48h treatment with 5 AzadC",pert
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
"Acute Myeloid Leukemia, sample 25",pert
thyroid_tumor_3,pert
"Gender: female, Age: 16 years, Tissue: normal vulva,",ctrl
"Patient #2, Untreated",pert
"AD_FC, biological rep10",pert
Characteristics:;	Organism: Rattus norvegicus;	Strain: Brown Norway;	Weight: 150-170 grams;	Tissue: liver;	Gender: male;	Sacrifice Time: 6 hours,ctrl
tissue: inner ear;	genotype/variation: Wild-type;	age: E10.5,ctrl
Normal bladder 277-99,ctrl
Patient: N;	Time: 1 week;	Group: responder;	Condition: lesional,pert
"Strain: D3, mouse embryonic stem cell",pert
M833,pert
AGS cells - Celecoxib treated biological rep 3,pert
braak stage: CTRL;	rin: 72;	tissue: substantia nigra;	disease state: control,ctrl
NeuroD1 transgenic animals die very shortly after birth.,pert
PBMC;	Age: day 3,pert
GEIM57-U133A-Norm,ctrl
Rosi-treated diabetic-3,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 77;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
OVCA433-(2),ctrl
Normal_Kidney_Biopsy_2,ctrl
"36B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
agent: untreated;	time point: 0 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,ctrl
"proband f, past exhaustive exercise",pert
PS-first,ctrl
NPC Brain 82d Mouse1,pert
11378 Normal Uninflamed ascending colon,ctrl
KM_019N,ctrl
del337TR replicate 3,pert
MA_294,pert
GM19238_Kd_NS_P1_21B,ctrl
K14deltaNB-cateninER Time 0 replicate 2,pert
braak stage: BR12;	rin: 51;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
"vehicle treatment, 72 hour time point, biological replicate 3",ctrl
T5_pitM,pert
"T-cell prolymphocytic leukemia, inv(14)(q11q32), case 2",pert
"patient: 213;	current medication: PRED 7MG, ATENOLOL 100MG, ASPRIN 75MG, SIMVASTATI;	birth date: 11/1/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/82;	diagnosis date: 2/2/83;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/12/04;	followup rectum: COLONOSCOPIC;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/74;	smoking amount: unknown;	other illnesses: ISCHEAMIC HEART DISEASE;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",pert
disease: cardiopathy;	gender: male;	age: 2 years;	tissue: thymus,ctrl
GM19238_Kd_NS_P2_24,ctrl
CT1 vs PBS 4 hr pooled,ctrl
Tendon_lesional_rep19,pert
FoxM1 C,pert
patient: 128;	current medication: Pentaza;	birth date: 3/19/81;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
C1 clone infected with control retrovirus.,ctrl
"HIV-1 positive male, 18-60 years old, weight loss of 5-15% in preceding 6 months, stable anti-retroviral therapy. CD4+ T-cells >50/ml, HIV copies =< 10,000/ml, free testosterone <50pg/ml.",ctrl
patient: 25;	disease state: hypertension;	tissue: Atheroma plaque,pert
Diaphragm 56 Day control rep 3,ctrl
lucif_1,ctrl
32m4,ctrl
Muscle PCOS control 17,ctrl
Bronchial Epithelial Cells MMA biological 2001M,pert
A549_control_rep1,ctrl
age	34;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	6.3;	hemoglobin (g/dl)	14.5;	platelet count (/nl)	293,ctrl
Liver_POR-null_2,pert
N51308,ctrl
PND28 Rat Testis_Rat230-2_1hr Corn Oil_Animal#42_04005,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: A;	genotype/variation: NET1 present;	agent: LPA,ctrl
WAT from Ahnak knockout fed high fat diet Replicate 1,pert
"ZR-75-1, 12h, 0.4uM DOX",pert
Dengue Fever Patient 47,pert
PC-3_basalhTERT_ShortTelomeres_mockcre_3,ctrl
NonIR-WT_Rep1,ctrl
PND28 Rat Testis_Rat230-2_3hr Corn Oil_Animal#52_04005,ctrl
"age at diagnosis: 63;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1b;	n (lymph node metastasis): N2a;	er: 0;	pgr: 0;	dfs-month: 52;	dfs-event: 0;	distant metastasis: 0",pert
"breast, pre AF treatment (H7_1349)",ctrl
Kidney_50 mg/kg VCM ip_mouse #072,pert
cell type: lineage depleted cord blood cells;	culture: liquid culture day 11;	transduction 1: BCR-ABL1;	transduction 2: control,pert
healthy control C4,ctrl
"Control KD, rep2",ctrl
PGA-MAH-AJ_PBS24h-4aA-s2,ctrl
cell line: MLL-AF9 AML cell line 10980 (Zfx wt);	treatment protocol: vehicle;	genotype/variation: wt,ctrl
"schizophrenia, BA46-85",pert
HNF1b_1a-,ctrl
Braak α-synuclein stage 1-2 BR12_2SN,pert
ATP-treated AML 8 blasts,pert
"ALL_NDS, K42 011509",ctrl
patient: 40892;	sample: tumor,pert
miR122-KO-03,pert
No_abuse_7,ctrl
WT osteoclasts untreated 1,ctrl
14-week-old Trim24-/- liver_411M,pert
age: adult;	gender: female;	tissue: lung,pert
Age: 36;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
Wildtype_Sham_Rep3,ctrl
Disease_status: Healthy control;	Age (years): 39;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.46;	Post mortem interval (hours): 58;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
0705-01-A,pert
CD4+_Tcells_non_severe_asthmatic_3,pert
Patient 1 after folic acid,pert
#1,ctrl
control participant P302,ctrl
"PCB153 treated HepG2 cells at T6, biological replicate 2",pert
"spleen follicular B in IRF8 conditional KO, biological rep6",pert
cell line: RWPE-1-PCAT-1 (CRL-11609);	age: < 20 cell passages from derivation,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 119;	genotype/variation: WT;	age: 8 weeks,ctrl
tissue: neonatal foreskin;	cell type: primary dermal fibroblasts;	shRNA transfection: shKDM4C construct 2,pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 32; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.,pert
"patient: 113;	current medication: OCP;	birth date: 8/17/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Recurrant abcess, ?IBD;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 29.04384,pert
MLL_PTD01,pert
WT / Reference_13425675,ctrl
WKY12-3,ctrl
age: 24 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep4,pert
genotype: wildtype;	cell-type: resting;	splenomegaly: none;	Ig clonality: polyclonal,ctrl
2.5uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate C,pert
Normal urothelium_2 (Wild-type),ctrl
"wdNHBE with BN/59 at 36hpi, biological rep3",pert
KO-control-4,pert
Oct4GipES_Panct1_esiRNA_72h_rep2,pert
S-IIP(UIP)13_Cy3,pert
LCL Unaffected MZ twin pair 5 (CCN5.1)(TP27),ctrl
Trim28CKO TCR-stimulated CD4 positve T cell rep2,pert
No or early 2 rep5 (OHN),pert
RNA mix 1 of nomarl lungs,ctrl
hNHEPS_0.1 μM_6 h_rep1,pert
219/4,pert
MKK3bE transgenic female replicate 2 early timepoint,pert
WSD-final,pert
Healthy3-CD4,ctrl
cell line: shEGFP T47D;	sherbb3: -;	sample type: control,ctrl
cell line: THP-1;	shRNA construct: GSK3A Construct 6,pert
PGA-MAA-IL4-1cAv2-s2,pert
CME-Ctr_LaminA0d-2MA-S2,ctrl
Transgenic ATF6-MER mouse;	Strain: C57 BL/6;	Gender: male;	Age: ~30wk;	Tissue: heart LV;	treatment: tamoxifen,pert
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 6h;	donor: 2,pert
CD4_T_cell_pool_melanoma_M05+M06,pert
A39 NES 142Q TG4	F7/5	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Male,pert
strain: C57BL/6J;	day: 24;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
T140 U133p2,pert
"Scarmbled control knockdown, replicate 2",pert
RAW_0.7mM_HOCl_#2,pert
"E18.5 brain, wild-type, rep 3",ctrl
"Female (age range 33-49), skin biopsy from upper nates taken 7 hours after nickel exposure",ctrl
SiTIF- rep1,pert
KO (Rnh1-/-) -1,pert
2h WT Cel.17,ctrl
clone type: AtT20 clone types overexpressing NSBP1SE protein rep3,pert
"cochlea at P13, ko, biological rep 3",pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p29;	strain: E14,ctrl
Muscle 50 eccentric contractions 12 hours WT Aged 0106,ctrl
N/SM3,ctrl
LNCaP + AR-shRNA rep1,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID50,ctrl
TAC 1,pert
UV-SeV 3663,ctrl
No or early 1 rep2 (retina),pert
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
"126 (221), ADIPOOSE TISSUE, Before",ctrl
"Mouse bone marrow-derived mast cells treated with IL3, rep 1",ctrl
Pax_C3,ctrl
E_Kin_2,pert
chip number: 18;	transfection plate: 4;	target gene: NFKB2;	kd level: 0.9;	rin: 9.4;	transfection date: 2011-10-17,pert
SeroNeg-4,ctrl
HF0434_U133P2,pert
Wildtype_XX_1,ctrl
NOD/LtJTCE liver sample batch 2,pert
24h Kin- Cel.43,pert
V5-P501,pert
KO_0525-3,pert
Jak2VF vehicle (7991003028_B),pert
race: caucasian;	age (years): unknown;	stage: IB;	grade: 3;	histology: papillary serous,pert
disease status: autism;	tissue (brain region): Cerebellum,pert
Raji_mi-Ctrl_3,ctrl
ZMYM2/FGFR1 biological replicate 3,pert
Mouse RSK2 mutant mandibular molar [AZN_MolairesMutant],pert
HET Brain 40d Mouse1,ctrl
Tumor_Ker24,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.93;	Post mortem interval (hours): 23;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Adrenocortical adenoma with CTNNB1 mutation_(S37C),pert
cell line: A549;	agent: azacitidine;	dose: 1 uM,pert
Bmi1 embryonic stem cells sample_2 (Bmi1_ESC_2),pert
Cervical cancer_2035T,pert
"female Spargue-Dawley rats, diet only for 7 days,  tissue: lung",ctrl
"DMD skeletal muscle, biological rep5",pert
Ishikawa_Control_24h_rep1,ctrl
Bone-Marrow_MM_M1094,pert
CN1,ctrl
"WT, PR01M002v0",ctrl
E81-/-SRFdM-VP16-1,pert
patient: 41027;	sample: normal,ctrl
remitted schizophrenia patient  S19,pert
treatment: DMSO;	time: Day3;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,ctrl
"C57BL/6, CD-1",ctrl
WKY16-4,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 3",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 221,pert
H1299 DAC 3 uM (3240),pert
"gender: female;	age: juvenile, 8 weeks (P58);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/-;	tissue type: renal tissue",pert
PB_DON102,ctrl
strain background: 129/SvEv;	genotype/variation: wild type;	cell type: bone marrow derived dendritic cells (BMDCs);	stimulated with: purified tumor-cell derived DNA,ctrl
A_AN19511_C,pert
"shEGFP T47D cell line, replicate 2",ctrl
"Patient GM, stable renal transplant recipients, female, 53 years old, T0 (time of enrollment)",ctrl
Laser Capture Microdissection (LCM) to isolate tissue sections of the hippocampus area of Rasgrf1 knockout mice brains,pert
brain_DLPFC_bipolar C_mr284,ctrl
"Normal cervix epithelium, microdissected, Age 43",ctrl
GNMT-KO mouse hepatocytes (sample 2),pert
Postnatal 3 weeks mutant heart biological rep3,pert
BTBR+tf/JTCE liver sample batch 5,pert
Neocortex_Eomes_WT.7,ctrl
Brain CD8 T cells that are IL-10- rep1,pert
homozygot FH P261,pert
agent: pristane;	time: 18 days;	strain: BALB/c;	tissue: mesentery,pert
Ileum_POR-null_1,ctrl
background strain: C57Bl6;	genotype/variation: Gata4_S105A_homozygous mutant;	age: 9 weeks old;	tissue: whole heart ventricle,pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 4",pert
Retina homozygous KO 30 days 2,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 69;	gender: female;	tumor grade: IV,pert
Bmpr2-Delx4 2,pert
32054.LMP,ctrl
WT-EtOH-3 (DFW),pert
14.5_KO_540G,pert
"Patient J, uninvolved skin",ctrl
sample =XCGD5 treatment=Control time=360 (min),pert
BTBR+tf/JTCE liver sample batch 4,pert
Actinomycin D treated A549 human lung cancer cell cultures replicate C,pert
"male,15,Caucasian",ctrl
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Atypical antipsychotic Clozapine, Dose: 12mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking water, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation.",pert
patient: 225;	current medication: Asacol;	birth date: 5/30/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/2/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/99;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
cell line: WM-266;	pir knock-down: yes,pert
R3_saline_wildtype_48,ctrl
MOLF/EiJ Vehicle liver sample batch 5,ctrl
CUTLL1 MigR1 GSIwash4h-rep1,pert
"PIO, subject 11",pert
NOD Aire KO MEC rep3,pert
N51084,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 5",pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep3,pert
Control bone marrow - Biological Replicate 4 - Technical Replicate 1,ctrl
CA99-43A,ctrl
OVCAR-8-(1),ctrl
MPA 3,pert
LNCaP-abl_siControl_1,ctrl
Panc1005 rep-2,pert
db/db 13-1,ctrl
"Autoimmune pancreatic islets, day 1 cyclophosphamide treatment, rep 2",pert
Seguin_IDR_BrownNorway_Liver_treated7,pert
5255 UC Uninflamed terminal ileum,pert
MDA-MB-231 - MTDH-WT-KD-1,pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 64;	donor: 23;	disease state: Lesional,pert
KU_22N,ctrl
GIST_KIT_2,pert
T51783,pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 1,pert
gender: M;	age at blood draw: 32;	tissue: whole blood,ctrl
HF0137_U133P2,ctrl
LNCaP R1881 rep 1,ctrl
strain: 129-Sv;	cell line: J1;	cell type: embryonic stem;	time: 6 days;	differentiation: differentiated Flk1+ WT ES cells,ctrl
colon_adenoma_1141,pert
"125, ADIPOOSE TISSUE, After",pert
"ERaKO mouse aorta with placebo, biological rep1",pert
Individual_5063_NN_sample,ctrl
"WT CLP LY6D-, biological rep2",ctrl
esophageal squamous cell carcinoma from patient E1610,pert
PTEN+/-IKK2ca/ca ep_B,pert
H28 HA 24h 4,pert
LICR_HN1_CETU2,pert
"granulocyte, healthy control, biological rep3",ctrl
CD47 null Endothelial cells 2,pert
Ishikawa_HighDose_BPA_24h_rep1,pert
E18.5_Control_Kidney_array2,ctrl
No or early 1 rep10 (OHN),pert
ALI patient #6,pert
cell line: AINV15;	strain background: 129P2/OlaHsd;	genotype/variation: Aurka;	condition: -Dox,ctrl
Day: 12; Drug: Saline; Phase: Drug treatment; Replicate: 1,ctrl
normal adjacent esophageal tissue from patient E1546,ctrl
tissue: kidney;	protocol: intraperitoneal;	agent: vancomycin;	dose: 400 mg/kg,pert
"Strain: SPARC-null, C57Bl/6 background;	Gender: female;	Age: 28 days;	Eye: Left",pert
EOM 56 Day Control rep 1,ctrl
"HUVEC treated with ERG SiRNA , biological rep2",ctrl
NPC_VUB01_3,ctrl
FHCRCAML169020,pert
24h_c2,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_2h_Con_HG-U133A_2_YCHSUP501,ctrl
MRL/MpJ heart left ventrical (LAD ligation 30 day),pert
MCF7_CHX_EtOH_24h_rep2,pert
Caco2-siRNA1-rep3,pert
THRA aI mutant + T3 replicate 3,pert
infection status: stably expressing shRNA directed against YAP;	cell type: human ccRCC cell line,pert
SKNSH MECP2_e1 3,pert
Skin_WT_2,ctrl
NOD2wt_0h_MDP_biological replicate 2,ctrl
endothelial_rep3,pert
"105, MUSCLE, After",pert
Patient no. 18: treated,pert
MLL1-KO MEF CT30-1,pert
Disease_status: Healthy control;	Age (years): 37;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 13;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
liver 1.0% quercetin diet rep3,pert
KN-sham-5 month-R2,pert
PGA-MAH-OuJAir-1bAv2-s1,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_1_1_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
healthy control sample x058,ctrl
Liver of pup from control group rep5,ctrl
Wild-type_macrophages_8h,ctrl
APOE_KO_NODM_9W_5,ctrl
"brain, hippocampus: Ctr-1h-P15-I_e1_le1",ctrl
subject: 09U;	cohort: 9;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 47kb;	age (y): 57;	Sex: F;	batch: Batch_2,ctrl
01MHW_Oligo,pert
A549 DAC 3 uM (3222),pert
adenocarcinoma (ADC8),pert
Run5.aUa.010110d.SkmDbt1960D.CEL-DB stimulate,pert
jzo027-rp1-v5_u74av2-met,ctrl
disease state: healthy control;	tissue: epidermis;	age: 26;	gender: male;	treatment: untreated;	time: control,ctrl
"control endometrium, patient 1",ctrl
Csbm/m Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-3,pert
erStress_twins_AA_1727twin2_500nM_thapsigargin_4h,pert
"Healthy volunteer, Control_11696",ctrl
"human failing LV myocardium, Idiopathic73",pert
0153-01-C,ctrl
Male 8week AJ sham rep1,ctrl
Diaphragm 112 Day control rep 1,ctrl
Control_R_-Dox_rep1,ctrl
V5-P102,ctrl
Wild type CD4+ unstimulated 1,ctrl
"ALL_DS, K19 011409",pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_1_21_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
M833 / Reference_13425519,pert
overexpressed Tcof1 [C],pert
SGK1-IL23 rep1,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 2;	psoriasis duration: 18.0;	age of psoriasis onset: 29,pert
HDAC2_B10-rep3,pert
"patient 045b, normal, homogenized",ctrl
lung_E18_sftpc-nmyc_rep2,pert
Control Replicate 3,ctrl
Dominant negative cJun  VZ18,pert
Subject #8024-8hr Postinfection,pert
3894M patient’s mucosa,pert
RTX2 T12,pert
Nrf2 KO rep3,pert
KO - knock-out Treated - 2 hrs - repeat 1 - Cy5 - mAdbID:62608,pert
gender: Male;	age: 54;	post-mortem delay: 12h;	ph: 6.6,ctrl
expression array - AO2,pert
cell line: T47D;	sherbb3: -;	sample type: control,ctrl
strain: ICR;	agent: saline/distilled water;	time point (week end): 2;	disease state: normal,ctrl
major non-tumor6,pert
wild-type rep_3 (CWT3),ctrl
Donor3_6h_DMSO,ctrl
mdx Biological Replicate 5,ctrl
phenotype: control;	gender: male;	case_id: 277;	age: 50;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 19;	brain ph at time of freezing: 6.26;	labeling_batch: 2,ctrl
duration of untreated disease in month:2.6;	age at onset:8.8,pert
patient: 30308;	sample: tumor,pert
74_129_WT,ctrl
strain: C57BL/6;	genotype/variation: KLF5 KO;	cell type: LSK BM cells,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 13 days;	treatment: fresh air, treatment over 5 month + 15 days recovery, 4x1h exposure per day",ctrl
disease status: CML chronic phase (CP);	cell source: leukapheresis products (LP);	cell type: CD34+ mononuclear cells,ctrl
type_of_rx: AF;	pre_or_post_treatment: post;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 76;	baseline tumor size (cm): 7x8;	patient id (to identify the 2 chips from the same patient): 13491389,pert
"Normal Skin, Normal-3",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 35;	gender: male,pert
Bone-Marrow_MM_M1134,pert
VCaP/MYB siRNA #1,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 45 yr;	population: white;	dsm-iv: 296.44;	age of onset: 35 yr,pert
Pancreatic Sample 9-Normal,ctrl
V5-P478,pert
Halothane 10 exposure-1,pert
"treatment with BZP, replicate 1",pert
non-malignant FTEb_patient 1,ctrl
Klf9WT_jejunum_PND30_3,ctrl
Normal Cervix N14,ctrl
Healthy8-CD8,ctrl
ab047 IM,pert
2975,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M2;	flt3 status: WT,pert
@52055800697862121408403718160344,ctrl
HEK293 F5_doxycycline untreated,pert
WT-IL23 rep1,ctrl
HeLa cells control 1 (Luciferase siRNA transfection),ctrl
"Normal subject (42 year old caucasian male, SAK_1274829796)",ctrl
32SAGEA2,pert
Pediatric_GBM_26,ctrl
sex: Male;	Age: 12 months;	additional patient information found in Series supplementary file,pert
strain: C57BL/6;	tissue: liver;	gender: female;	age: 35week,pert
Luciferase-rep1,ctrl
"Macrophage cultures were prepared from C57BL/6J, male, mouse peripheral blood by Optiprep (Accurate Chemical and Scientific, Westbury, NY) gradient centrifugation.",ctrl
strain: CD1;	tissue type: back skin,pert
"genotype/variation: wildtype;	strain: mixed background (Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med. 2003 Dec 15;198(12):1937-49.);	age: P1",ctrl
"Patient S242, MSI colorectal tumor",pert
Patient identifyier: G;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 19 years;	Body surface area: 12 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
K562 cells CREB Knock-out replicate 9,pert
"Typically Developing Control, Semitendinosus, Patient Replicate 3",ctrl
01LPP_PolyRF-,pert
DDR-1-KO mouse (KO_Tal2),pert
"Normal cervix, age 27 years, micordissected squamous epitheilium",ctrl
Proximal hindlimb bud tissue (~500um from base of limb bud) pooled from 3 embryos (6 limbs total).,ctrl
patient: 32;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
microdissected breast cancer cells from case 607,ctrl
batch: B;	knock-in: VEC;	cell line: MycCap prostate cancer cells,ctrl
"WT VSV infected, biological replicate 3",ctrl
Treatment 5,pert
patient: 18;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
MPM tumor 25,pert
"MLD, biallelic AML MLL_00252",pert
HSC cells from MSI2-inducible mouse rep1,pert
MDS patient 113,pert
liver_STZ 0.1% quercetin diet_rep6,pert
Cisplatin-treated Rb-/- MEFs-b,pert
strain: C57BL/6J;	day: 12;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 1,ctrl
Human myeloid leukemia cell line,ctrl
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: well;	Tumor Site: Ascending;	Drug Treatment: NO,ctrl
Wild type 618,ctrl
ILD Study Number 897,pert
3210-lcm,pert
WT.DMSO_4,ctrl
V5-P415,ctrl
IPMA 4,pert
Huh7_TGFbeta_plus_1,ctrl
0671-01-C,ctrl
SR-A mutant olfactory epithlium 0 h replicate2,pert
"Acute Myeloid Leukemia, sample 21",pert
MKK7D transgenic female replicate 7 early timepoint,pert
Septic shock;	gender: Female;	Survivor;	organism: None;	update,pert
BCell_lymphoma_marginal_sample4,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 28;	gender: female;	years of disease: > 10y;	treatment: phototherapy;	time: post-UV,pert
"S1P2-KO-neocortex, biological rep5 (male)",pert
"ALL_NDS, K60 011409",ctrl
MDS patient 108,pert
"Global gene expression of NASH patients, normal control A107",ctrl
disease: Down syndrome;	gender: female;	age: 1 year and 2 months;	tissue: thymus,pert
"WT, PR01M003v0",ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 211,ctrl
5194 Normal Uninflamed sigmoid colon,ctrl
KU_05N,ctrl
strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: phenobarbitol,ctrl
V5-P480,pert
individual: Control2;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
"human failing LV myocardium, Ischemic18",pert
treatment: Arid3a overexpression pool;	cell line: J1 ES cells;	sample type: pool,pert
8 wt,ctrl
"29B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
LKR13_Wt1 sh-1,pert
KM-first,ctrl
Sox9egfp_p23-1,pert
"PBMC, healthy control, biological rep9",ctrl
Control_liver_1,ctrl
BxPC3_JMJD3KD_rep2,pert
MKK3bE transgenic female replicate 2 late timepoint,pert
Cont G1,ctrl
0159-01-C,ctrl
age: 36;	sex: M;	disease status: control subject;	Filter number: 99;	Usage number: 5;	Exposures: 3,ctrl
Treatment 3,pert
cell line: SCC-2;	cell line origin: Oral cancer;	genotype/variation: ZMPSTE24 silencing,pert
Liver WT HFD #547,ctrl
BACH2+/+ ALL + Imatinib (Sample2),pert
05_NML,ctrl
HUVEC_4h_rep2_1107,ctrl
erStress_twins_AA_1736twin1_500nM_thapsigargin_4h,pert
C57BL/6J_Islet_rep2,ctrl
cell line: non-small cell lung carcinoma cell line H1299;	protocol: Lipofection-mediated siRNA delivery;	time: 12hr,pert
WAT from wild-type control fed regular chow diet Replicate 3,ctrl
Wild type no tumor 2,ctrl
Control subject 116_biological replicate 2,ctrl
"1mg/kg/day PFOA, Rep 1, Block 5, liver (low dose)",pert
"E2f8 KO, biological rep3",pert
Sex: female;	Age at operation: 78 years;	Site: thigh;	Size in cm: 13x10x6;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: high;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
strain: BALB/cByJ;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: infected,pert
Mannitol control treated A549 human lung cancer cell cultures replicate C,ctrl
"205, MUSCLE, After",pert
sex: Male;	Age: 28 months;	additional patient information found in Series supplementary file,pert
sex: Female;	family: 5;	age: 57;	disease status: Asymptomatic;	tissue: Muscle: Biceps,pert
"cell line: HeTH-4;	genotype/variation: THOC1-depletion;	comments: HeLa cell line with inducible THOC1-depletion, induced",pert
mouse jejunum_hnf1alphamutant_rep1,pert
Tissue: normal thyroid; Gender:male; Age:56,ctrl
"sirna: siRNA1 (Ambion);	cell line: Human epithelial colonic adenocarcinoma, Caco-2",pert
"CD14+ after 2 wk quercetin supplementation, biological replicate 3",pert
"SIN3A siRNA, biological replicate 3",pert
striatum wild type 21 month replicate 2,ctrl
WT 570 R2,ctrl
"MCF7/BUS, 10 pM E2, 48 hours, biological replication 2",pert
"201, MUSCLE, Before",ctrl
Trasnsformed Lymphocytes Unaffected Twin Pair 3 (DCBD3.2)(TP10),ctrl
Ramos pRTS-CA-IKK2 H+,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous saline challenge""",ctrl
E1-GemKD,pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: control GFP;	rep: 3,ctrl
48 hrs sham-4,ctrl
HIF-1-/- S. aureus 6,pert
umbilical cord_nobpd: 3F,ctrl
colon_IBD_1156,pert
chip number: 17;	transfection plate: 3B;	target gene: CREBBP;	kd level: 0.74;	rin: 9.2;	transfection date: 2012-03-26,pert
KO - 5 mo - repeat 1 - Cy3 - mAdbID:74108,pert
Bl6_p60_2,pert
Strain: C57BL/6;	Genotype: wild type;	Generation: F5;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
Individual_4609_PN_sample,pert
age_years: 63;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
"Inclusion body myositis, biological rep1",pert
Retina ko/ko rep2,pert
Huh7 cells_Mock Infected 12 hours_ rep2,ctrl
erStress_twins_AA_1712twin1_DMSO_4h,ctrl
"siRNA, collagen plate, rep3",pert
"HeLa treated with Cas-II-gly, biological rep3",pert
SKI-DLCL cells were treated with Aplidin at concentration 3nM for 24h. Total RNA was extracted.,pert
gender: Males;	strain: C57/B6;	age: 3 months old;	tissue: Brain,pert
"MAT1A knockout at 15 month age, peritumoral tissues, biological replicate 3",pert
E10.5 wt1,ctrl
gender: female;	age (years): 40;	evolution time (years): 13;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
male;	42 yr old;	Black,pert
E12.5 Lim1 mutant renal vesicles isolated by laser capture microdissection.,pert
patient10,pert
CHF - R14,pert
HepG2_5-aza_rep3,pert
E17.5 preB cells_Smchd1 null_Rep 1,pert
age: 69;	gender: male;	ejection fraction: 35;	left ventricular end diastolic diameter: 60;	inflammation/PVB19: positive,pert
MEFs-3,ctrl
gender: male;	batch: 1;	age (years): 39;	patient id: Control_1;	fev1 (% predicted): 78;	fvc (% predicted): 76;	medication: None;	cell type: CD8+ T-cells,ctrl
Y YOKE_B024,ctrl
Sample M558,pert
Clock_mutant Circadian_Time_02,pert
CXCR4 knockout 2,pert
SKM-1 control 1,ctrl
"Line A39 transgenic cerebellum, mouse, male, 10 months",pert
RNA from HCC_25T,pert
"DSS + L-Arg colon tissue, biological rep3",pert
Control subject 44_biological replicate 1,ctrl
Ago2-IP RNA Wildtype-2,ctrl
"Female (age range 33-49), skin biopsy taken from upper nates 7 hours after nickel exposure",ctrl
MEF E2F4 KO 2-rep2,pert
Liver WT4,ctrl
Diseased individual (ulcerative colitis) of twinpair #12,pert
"Vehicle treated, DAY 4, biological rep.2, MV4-11 cells",ctrl
"ZR-75-1, 12h, 0.4uM DOX B",pert
New 3 hr 3,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: spleen;	sample name: 5-sp2,pert
cell line: Y79;	passage: 29;	cell type: Retinoblastoma,pert
D2-Gpnmb+ control rep3 (retina),ctrl
V5-P556,pert
Strain:  B6.V-Lep ob;	Gender:  Female;	Age: 12 weeks;	Tissue:  Gallbladder,pert
"83 y/o male 46,XY",pert
patient: 105;	current medication: None;	birth date: 7/29/84;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
subjectid: 5278;	imatinib: NoIM;	lbh589: NoLBH,ctrl
disease state: paediatric glioblastoma;	age: 8;	gender: F;	h3.3_status: K27M,pert
chip number: 1;	transfection plate: 1;	target gene: CEBPG;	kd level: 0.78;	rin: 9.8;	transfection date: 2011-03-29,pert
MCF10A-HER2(+) 3days,pert
PBMC_S3,pert
AA_Case11_CD8,pert
scan batch: Batch 2;	group: autism;	subject age: n/a;	paternal age: 36;	maternal age: 38,pert
strain: C57BL/6;	genotype: Cmah knockout;	tissue: heart;	age: 12 weeks,pert
"Patient CV, stable renal transplant recipients, male, 58 years old, T0 (time of enrollment)",ctrl
Cav1 knockout,pert
cerebellum SNCA knockout 21 month replicate 3,ctrl
Normal cervix_05-1352,ctrl
shGFP-rep-1,pert
Csbm/m Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-3,pert
normal adjacent esophageal tissue from patient E1610,ctrl
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 6h,pert
"non-AD_TC, biological rep12",ctrl
Insm1 control #4,ctrl
lymphoma_4936_ADR,pert
Teratozoospermic individual: Sample T2,pert
chip number: 16;	transfection plate: 3A;	target gene: IKZF3;	kd level: 0.66;	rin: 9.5;	transfection date: 2012-03-26,pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 51;	gender: f;	treatment: NSAIDs,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 1,ctrl
C1 clone infected with Deaf-1-expressing retrovirus.,pert
Disease_status: Healthy control;	Age (years): 53;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.2;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 2;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,ctrl
Normal cervix epithelium_CaCx4,ctrl
Disease_status: Bipolar disorder;	Age (years): 29;	Gender: Female;	Age of onset (years): 18;	Duration of illness (years): 11;	Brain pH: 6.74;	Post mortem interval (hours): 62;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
HEK293_A263insGG_#6_uninduced,ctrl
FACS-purified B cells_129SV/EV_influenza-infected_rep3,ctrl
Wild_Type Circadian_Time_02,ctrl
siFOXM1Veh24h rep1,pert
"Nickel 400 µM, biologcial rep2",pert
cerebellum_PSNA_ 18w_rep2,pert
Mouse No Cldn16 B9 441,pert
Wild-type E11.5 proximal hindlimb pool 1,ctrl
Individual_5258_PN_sample,pert
"A pool of two pure subsets of peripheral blood CD4+ T cells (CD19- CD3+ CD4+ CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
Gastrin Knockout parietal cell replicate 3,pert
control virus-infected replicate 2 (MCF7),ctrl
strain: C57BL/6;	cell type: MACS-purified mature B cells;	genotype: irf4+/+,ctrl
CTRL_4_GMP,ctrl
"Mouse heart, IDH2 R140Q mutant, replicate 4",pert
3 wks TAC-5,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: scrambled;	transfection time: 24h,pert
Sample Group: control; Gender: female; Age: 39; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
Hippocampus_Soman_1h_rep3,pert
MEF_WT_rep1,ctrl
Plate vs. Nail:  3 Day Sham,ctrl
tissue: resected non-tumor liver tissue;	genotype: major [rs8099917 TT],pert
Patient no. 13: control,ctrl
NuLi cell line biological rep1,ctrl
Liver_Female_CF_rep4,pert
DC-5,ctrl
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 13",pert
"EtOH, RARaKO, set 2",ctrl
Ileum_POR-null_3,pert
C_LS_Wk2,pert
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 3,pert
P3A Progranulin-frontal,pert
Moderate rep10 (retina),pert
Tumor from MYF-5 CRE/SSM2 mouse CC23,pert
day 30 5-FU HSC 2,pert
age_years: 57;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
healthy control C3,ctrl
KO_cycling_rep2,pert
patient: 223;	current medication: Prednisolone 20mg Asacol 2.4g;	birth date: 1/18/44;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/04;	diagnosis date: 3/15/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/16/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/16/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: unknown;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
CH2120,ctrl
race: caucasian;	age (years): 60;	stage: IA;	grade: 3;	histology: endometrioid,pert
"AALE-Vector + shGFP, biological rep3",ctrl
strain: C57BL/6;	tissue: cerebral microvascular fragments;	genotype/variation: wildtype;	age: 2 months,ctrl
BM_healthyControl_III,ctrl
"PIO, subject 16",pert
CD8+_Tcells_severe_asthmatic_1,pert
CON2,ctrl
colon_epithelium_C57mouse_6weeks_rep5,ctrl
liver cells from wildtype 8wk male mouse 8 challenged with vehicle (saline)_8,ctrl
OE-SOX2_1,pert
E8.5 wt.1,ctrl
"brain, cerebellum: RNA#2_le1",pert
healthy control C6,ctrl
wt 13.5d replicate 8,ctrl
cell line: H1299;	agent: azacitidine;	dose: 0.3 uM,pert
diseased_media 1,ctrl
Testis_Taf7l knockout_rep1,pert
EOM 28 Day Control rep 1,ctrl
Cont subject 09,ctrl
tissue: dorsal skin;	genotype/variation: GR+/+;	strain: B6D2/F1;	age: E18.5,ctrl
9ILC_normal_ductal,ctrl
patient: 240;	current medication: Asacol 800mg BD;	birth date: 1/10/59;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 8/2/04;	diagnosis date: 12/14/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/3/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
disease status: controls;	tissue (brain region): Temporal cortex,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: internal tandem duplication (ITD),pert
KM_015N,ctrl
"Vehicle treated, DAY 6, biological rep.1, MV4-11 cells",ctrl
Plate vs. Nail:  4 Week Plate,pert
PBMC from T cell LGL leukemia patient #131 (TLGL131),pert
"brain, cerebellum: RNA#40_le1",ctrl
"brain, cerebellum: WCx12w#1_e1_le1",ctrl
Bone-Marrow_SMM_S1215,pert
"13B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"PPARg2 expression construct, 24 hrs, No Rosiglitazone (PPAR_24_1)",pert
WT15,pert
Leptin treated mouse gallbladder 5,pert
sex: Female;	family: 3;	age: 35;	disease status: Control;	tissue: Muscle: Deltoid,ctrl
CON18,ctrl
Liver_Nrf2 Control_rep2.,ctrl
Mening UNSTIM WB NP 1b,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.708;	OD280: 0.892;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 298;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
HEK293_A08_R2,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 2",pert
RTX8 T12,pert
HP-45,ctrl
HepG2_Hg rep3,pert
control participant P331,ctrl
whole blood_100603,pert
WKY12-1,ctrl
"SS gland, early, patient 21, batch 2",pert
tissue: temporal lobe;	strain: C57;	genotype: WFS1 KO,pert
patient: 40728;	sample: normal,ctrl
IRS-1 KO (jos1534),pert
gender: Male;	tissue: Tendon;Biceps;	age: 41;	donor: 28;	disease state: Non-lesional,ctrl
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Stromal Cell,ctrl
age: 18 month postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
Vehicle-Control 30 hours set 2,ctrl
cerebellum wild type 21 month replicate 3,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: spleen;	sample name: 5-sp1,pert
Cardian muscle Trained diabetic 3 week DT3,pert
"hepatic gene expression at ""0 hr"", rep1",ctrl
cell line: LNCaP-abl (abl) prostate cancer cells;	genotype/variation: depleted of EZH2;	treatment protocol: under hormone depleted conditions,pert
"human failing LV myocardium, Ischemic105",pert
MCF10A-HER2(+) 1.5days,pert
Control_Castrated OWJ52,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Supraoptic nucleus,pert
"SiRNA-scrambled, replicate 2",ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 52;	gender: male,ctrl
strain: C57BL/6;	genotype: Wild Type;	replicate: 2,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5a;	flt3 status: internal tandem duplication (ITD),pert
"PCB77 treated HepG2 cells at T6, biological replicate 2",pert
WT HPC PDE10i 14,pert
Human Chronic HIV Sample C062-CD8+ T cells,pert
heart of mouse subjected 4 week to chronic constant hypoxia (4B),pert
T51308,pert
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 24 months;	genotype: Myc heterozygous,pert
V5-P124,pert
Mutated-ERα-positive breast cancer 28,pert
NCCIT-Mock-rep2,ctrl
CD19_selected_B-cells_before_R_rep5,ctrl
Parent 2,ctrl
E14wt-vector-1,ctrl
An XDP Filipino (aged 52 yr),pert
695-383_8hr,pert
"MAT1A knockout at 3 month age, biological replicate 5",pert
colon_IBD_1606,pert
duration of untreated disease in month:13.6;	age at onset:2.5,pert
CF (D508) subject8,pert
esophageal squamous cell carcinoma from patient E1542,pert
"Healthy volunteer, Control_11692",ctrl
U-87MG-PK7 set 2,pert
strain: C57Bl/6;	genotype/variation: Notch2 KO;	cell type: cDC;	cell type subset: CD11b+,pert
"HUVEC treated with ERG SiRNA , biological rep2",pert
E12 distal retina progenitors_control_rep 3,ctrl
MCF7 - Control_1,ctrl
"twin pair: #4;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
SW480 Vector (1),ctrl
Cerebellum_nontransgenic control S46_10 months_replicate 3,ctrl
race: caucasian;	age (years): 53;	stage: IC;	grade: 3;	histology: endometrioid,pert
H1299_shPTK7-1,pert
Low Glucose Transcriptome Profiling {rpt},ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 30;	maternal age: 29,ctrl
"nasopharyngeal carcinoma, specimen T1",pert
"PBMC, healthy control, biological rep11",ctrl
cell type: Primary human epidermal melanocytes (neonatal),ctrl
Liver phenobarbital pool4 Affy,pert
"human failing LV myocardium, Idiopathic68",pert
DMN-NF1Hippo15d-2cAv2-s2,pert
"E2-treated cells (24hr), biological rep_3",pert
"Patient 11, Atheroma plaque",pert
"Control shRNA, rep2",ctrl
Brain_Adult_LPSip_4hr_mouse2 (YL2_#65),pert
C_AN07176_T,ctrl
race: caucasian;	age (years): 57;	stage: IC;	grade: 2;	histology: endometrioid,pert
MDS patient 100,pert
Hippocampus_Soman_48h_rep2,pert
12458 Normal Uninflamed ascending colon,ctrl
"41B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
OBF-1 overexpression BCS-1 (Large PreB),pert
C2F-LU,ctrl
Adrenal CREMKO 0h batch 1 [AdKOh00.8],pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 4,pert
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep2,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
r04,pert
Bone-Marrow_MM_M786,pert
"disease state: Nasopharyngeal carcinoma;	stage: IVA, T4, N2b, M0, G4",pert
"Normal Skin, Normal-1",ctrl
"treatment with TFMPP, replicate 1",pert
Strain: 129Sv (PPARalpha knockout);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,pert
Bl6_p60_1,pert
"Human hepatoma cell line (HepG2), grown for 6 or 12 hours, and then total RNA harvested with Trizol and Qiagen Rneasy kit.",pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 5d ID140,pert
dental pulp cell from control 5,ctrl
CO_3,ctrl
"normal skeletal muscle, biological rep12",ctrl
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: mild stress + saline vehicle,pert
WT_03,ctrl
"MCF-7 cells-40mM g-T3, biological rep 2",pert
HCC PBMC Sample 6,pert
NALT_infected_24h_90-226_rep4,pert
PBMCs_Control_15 [IS],ctrl
9m3,ctrl
MCL_IGHV_MUT (R1339),pert
Postmenopausal female. Untreated control. nr 12.,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: tumor;	sample name: 3-tu2,pert
MDS patient 102,pert
"Control, replicate 9",ctrl
"age: 41;	sex: M;	ancestry: African;	smoking status: smoker, 20 pack-years",pert
strain: Hnf4LoxP/+AlfpCre;	age: E18.5;	tissue: Fetal Liver,ctrl
Age: 39;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
15A;pretreatment;female;breast tumor,ctrl
liver 1.0% quercetin diet rep6,pert
tissue: testis;	gestational age: 22 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: 0.3% Tween-20 vehicle,pert
"CBP, p300, CH1, TAZ1, hypoxia, MEF",ctrl
NS1_NS010112,ctrl
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug TAK1 siRNA,pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection - NTAL knock down;	vector: pLKO.1/TRCN0000127243;	activation: none,pert
Tendon_lesional_rep15,pert
"wild type CTL, biological replicate 2",ctrl
wildtype 6,ctrl
treatment: control,ctrl
fibroblast_Rapid_D26_Media_15,pert
Muscle PCOS case 251,pert
695-EV_2hr,ctrl
batch: B;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,pert
cell line: HT1080;	clone: 8;	genotype: Knockout,pert
normal skin sample,pert
Ad infected murine liver-MO30k-(229)-6hpi,pert
BACH2+/+ ALL (Sample2),ctrl
"p63shRNA_B2, p63-depleted",pert
HRas-v12 transgenic male replicate 2 early timepoint,pert
N41027_rep,ctrl
Md02h029,ctrl
RBP2-/- MEF(2),pert
rapamycin treated_3 3h,pert
strain: ICR;	agent: AOM/DSS;	time point (week end): 20;	disease state: colorectal adenocarcinoma,pert
"72 hour-treated TG2 knockout NB4, biological rep2",pert
BP20,pert
HMEC_control experiment 2,ctrl
tissue: kidney;	protocol: intraperitoneal;	agent: saline;	dose: 0 mg/kg,ctrl
CD-58-un,pert
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 33;	Usage number: 1;	Exposures: 4,pert
Cerebellum_nontransgenic control S25_3 months_replicate 1,ctrl
"PC-3 Ctrl, biological rep2 [mRNA]",ctrl
heterozygot FH P273,pert
"EBF1 d4, rep 2",pert
KM_032T,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 220,pert
12h control (2);HT-29;colon:carcinoma;NONE;42995,ctrl
0h Kin Cel.14,pert
autism with dup(15q) 98-19,pert
Ero1-C104A/C131A induced biological repB,pert
Capan2_siLLGL1-2 biological rep2,pert
passage: 10;	cell type: fibroblast;	treatment: overexpressing prelamin A treated with FTI;	cell line: GM00038,pert
Endometrium-Normal 5,ctrl
"P116 ZAP70 negative  0 hours, #1",pert
pt. HCL C treated with Vemurafenib 1000 nM for 48h,pert
KN-sham-5 month+13d-R1,pert
myoblast_untreated_rep1,ctrl
No or early 2 rep6 (OHN),pert
Neocortex_Eomes_WT.5,ctrl
sample =XCGD1 treatment=Control time=180 (min),pert
Stratagene Human Universal Reference Pool,pert
treatment: 1 ug/ml doxycyline;	time: 72 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
cell type: embryonic stem cells;	genotype/variation: Satb2 overexpression,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous saline challenge""",ctrl
parental HeLa cells rep 2,ctrl
age	42;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	5.4;	leukocyte count (/nl)	180;	hemoglobin (g/dl)	12.1;	platelet count (/nl)	476,pert
Cav3KO 1506,pert
CAR.AH_phenobarbitol_rep2,pert
CTRL_siRNA_rep1,ctrl
r7,pert
tissue: Liver;	genotype: GPR120 KO;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 427,pert
cell line: MOLM-14;	shRNA construct: GSK3B Construct 2,pert
Snell 22 month Wild Type Liver 24c,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_6h_1mM_HG-U133A_2_YCHSUP501,pert
TAC 2,pert
Muscle PCOS after pioglitazone 42,pert
"alveolar macrophages, smoker 040",pert
"mortality: alive;	ethnicity: Hispanic;	gender: F;	age (yrs): 58;	ld: HCV;	creatnine: 1.4;	mdrd: 41;	gfr: 39;	protein: 0;	hematuria: 0;	c3: 1;	c4: 1;	rf: 102;	hcv: POS;	htn: 1;	dm: POS;	hba1c: 7;	meld: 15;	ana: NEG;	gp: MESANGAIL PROLIFEATION,Ig A nephropathy;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 0;	podocyte: 1;	bm (basement membrane thickening): 1;	ta (tubular atrophy): 2;	if (interstital fibrosis): 2;	as (arteiosclerosis): 2;	igg: 1;	iga: 3;	igm: 2;	c: 0;	empe: 2;	bmwid: 1;	bmd: 0;	edd: 0;	no of glomeruli: 31;	glomerulosclerosis: 0.13;	intact t: 0.5;	arteries: intimal fibrosis,duplication n widening;	if: IGG+IGM+IGA+++C1Q+ mesangial only IgG and focal capillary walls;	mesangium ig: A;	tissue: Kidney_Biopsy_Liver_disease",pert
"non-transgenic mice, 7 month old, male",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 33.34247,pert
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 3",pert
MCF7 cells treated with 2uM ARC for 24 hours Array 1,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 124;	Sex: male;	region: LC;	age: 39;	genotype: Y/Mecp2-;TH/-,pert
IM12_case,pert
patient: 259;	current medication: pentaza 2g D;	birth date: 9/20/78;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 8/1/03;	diagnosis date: 1/13/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/7/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/7/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
KU_34T,pert
3 wks sham-2,ctrl
MCL_IGHV_UNMUT (R1329),ctrl
"GSL30, PR04M007v0",pert
Gene expression of murine fibroblast-like synoviocytes Grp1_C57BL6_2_FLS_TNFtg_plus_RSK2-KO,pert
"human failing LV myocardium, Ischemic73",pert
"human failing LV myocardium, Ischemic5",pert
Dengue Fever Patient 6,pert
Injured 30 day Rat Retina 2,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 95min;	race: Asian;	sex: Female,pert
Untreated CLL2,ctrl
atopic eczema P6,pert
ApoD transgenic mouse+PQ rep_1 (PQTG1),pert
58A;pretreatment;female;breast tumor,ctrl
"Lesional skin from K5-Tgfbeta mouse, biological replicate 2",pert
"human failing LV myocardium, Ischemic34",pert
AQA B,ctrl
Akt1 double transgenic mice on a high fat diet (DH 2),pert
S46 NLS 142Q TG4	F5/12	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Female,pert
APBMNC.LPS+.2,pert
ctrl_515,ctrl
lineage: colorectal;	cell line: SW480;	treatment: none,ctrl
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 98;	Usage number: 4;	Exposures: 3,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 51 yr;	population: white;	dsm-iv: 296.44;	age of onset: 23 yr,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 15.0;	age of psoriasis onset: 32,pert
Normal cervix epithelium_03-4986,ctrl
C_AN07176_F,ctrl
Normal_MS 36D3,ctrl
"alveolar macrophages, non-smoker 008",ctrl
"Sv129/C57B6 hybrid strain, 12 week old male",ctrl
Pancreatic Sample 13-Tumor,pert
CTR 2,ctrl
whole blood_100309,pert
01MCY: new onset sJIA,pert
IRS-3 KO (jos1528),pert
Frontal_Cerebrocortex_Vehicle_6hr_rep2,ctrl
MSC_VUB03_DM1_2,pert
MOLM14-shControl-rep3,ctrl
NM18 healthy control,ctrl
pediatric AML S18,pert
patient: KPW13;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
Gender:male,ctrl
parental cell line: WC;	vector: pBabe-human v-src (v-src vector);	replicate: 3,pert
mouse cerebellum at P30 wild type 2,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 9 weeks;	Tissue: whole brain,ctrl
human_LIMA_artery_patient2_paclitaxel-eluting_stent,pert
MDS29,pert
HWC7,ctrl
coronary smooth muscle cells metoprolol replicate 2,pert
cumulus_nonPCOS_Lean_rep6,ctrl
"HepG2 cells at T18 Control, biological replicate 1",ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 3",pert
colon_C57mouse_6weeks_rep4,ctrl
genotype/variation: Pou4f1-/-;	agent: control virus;	tissue type: fetal liver,pert
wild-type 3,ctrl
siGL3E2 1,pert
DBA control (201msn),ctrl
Normal,ctrl
TYK-nu-(2),ctrl
42_C57_WT,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 13 days;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 15 days recovery, 3x1h exposure per day",pert
"brain, hippocampus: KA72-III_e1_le1",pert
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep5,pert
"Uninvolved Skin, NS-8",pert
A375 cells 24h Control rep2,ctrl
Pt_4 Acne Lesion,pert
A_AN17254_F,pert
myoblast_treated_rep1,pert
PB_postTherapy_IIb,pert
female_control_270,ctrl
Kidney_50 mg/kg VCM iv_mouse #009,pert
siERK1Veh4h_2665,ctrl
"DBA/2J CHR, Rep1",pert
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shSOX11.1,pert
"C57BL/6N, adult, male",ctrl
cell line: Reh;	transfection: CBFA2T3 shRNA;	malignancy: non-Hodgkin lymphoma,pert
hNHEPS_control_0 h_rep1,ctrl
"nTreg Foxo1 KO, rep2",pert
"YPFH cells from M1, wild type control, biological replicate 1",ctrl
"peripheral ganglion, unknown: control 24 hr_2",ctrl
heart of mouse subjected 4 week to chronic constant hypoxia (4A),pert
K562 AMN107 sample 1,pert
"patient: 115;	current medication: Frusemide, Codine Phosphate;	birth date: 9/14/28;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: Diarrhoea, Also has Prostate Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
whole blood_101584,pert
58A;pretreatment;female;breast tumor; responder,ctrl
Estrogen [H1],ctrl
Control 2 at age 35-day,ctrl
first-episode BP patient 120_biological replicate 2,pert
CD4+_Tcells_non_severe_asthmatic_2,pert
SUP-B15 non-treated,ctrl
Tg77,pert
"ZR-75-1, 12h, sham",ctrl
genotype: wildtype;	strain: C57Bl/6;	cell type: HSC,ctrl
strain: C57BL/6;	gender: male;	genotype/variation: CCRPKO;	treatment: phenobarbital;	tissue: liver,pert
Myoblast-GATA4-KO-day3-3,pert
Nrl ko P10 replicate 4,pert
SC-RbKO 2,pert
206_DMSO,ctrl
01SAGEA,pert
MPM tumor 6,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339032,ctrl
"proband a, past exhaustive exercise",pert
SKBR3-R_0.1uM_Lapatinib_3,pert
WT_M_1,ctrl
treatment: Untreated,ctrl
Young 7,ctrl
non-malignant FTEn_patient 8,ctrl
hNHEPS_10 μM_6 h_rep2,pert
control to Sample 5,ctrl
Ad infected murine liver-MO30k-(231)-6hpi,pert
wild type stria vascularis replicate 2,ctrl
Amniocytes_euploid_1561,ctrl
HCT116 human colon cancer cells with intact PTEN,pert
age: 69;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Adolescent mouse tumor sample,pert
sample =XCGD3 treatment=Stimulated time=360 (min),pert
Squamous cell carcinoma 033,pert
striatum SNCA knockout 21 month replicate 3,pert
Pool Ts1Cje_P30_hyb1,pert
V5-P335,ctrl
Cervical Cancer C495,pert
KM_012T,pert
Old Control;	male,ctrl
subject: 18A;	cohort: 18;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 21kb;	age (y): 36;	Sex: F;	batch: Batch_4,pert
coronary smooth muscle cells metoprolol replicate 3,pert
MRF CKO Oligodendrocyte Replicate 2,pert
M303 C,ctrl
IRF4_1,pert
"HSCs from female mice treated with oil, replicate 3",ctrl
Patient: K;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
MPM tumor 1,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 2,ctrl
"Primary, localized, prostate cancer",pert
"Normal 15, control tissue",ctrl
patient: 217;	current medication: Asacol 1.2g daily;	birth date: 2/9/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/10/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/26/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/26/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
tissue: skin;	individual: Patient P13;	condition: AL;	eczema severity: SCORAD: 51,pert
Haloperidol treated 4weeks AffyGC RMA rep2,pert
46A;pretreatment;female;breast tumor,ctrl
tissue: Biceps muscle;	patient: C.b.10.MELAS;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 2y 9m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
"brain, Entorhinal Cortex: 99-28 tangle_e1_le1",pert
"BOEC, at_risk 11",pert
treatment: Oct4 knockdown;	cell line: J1 ES cells,pert
57_129_KO,pert
SCC12,pert
WT-MAC-SEV-2,pert
"breast tumor epithelium,41",pert
pMX-jhdm1b no vitamin C Jhdm1BVc-_1,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 40;	maternal age: 38,ctrl
Normal cortex of patient 83,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: Vemurafenib 1000 nM for 48h,pert
BAL_40_A0B0,ctrl
sirna: Syk siRNA knockdown;	plate: plastic;	cell line: MCF10A,pert
01N15: new onset sJIA,pert
mouse liver A3,pert
RTX2 T0,ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 24h,pert
DMSO1_24H,ctrl
HCC013N,ctrl
>95% CD3+ T cells negatively isolated with Dynal kit,pert
Control biological rep4,ctrl
4040-2 E2F3 Heterozygous,pert
"Wild type used for GNMT 3 month, replicate 3",ctrl
H69_Ctr_1,ctrl
control_08hr_rep1,ctrl
"Uninvolved Skin, NS-26",pert
"testis wt, 17dpp, Rep1",ctrl
1L,pert
BV2_rep2,ctrl
human_hepatocyte_400uM_grepafloxacin_donorA_24hr_prep1,pert
Wild type caerulein rep2,pert
strain: C57BL/6;	cell type: mononuclear bone marrow cells;	treatment protocol: Evi1 retroviral transduction,pert
HeyA8-(3),ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5a;	flt3 status: WT,pert
UTX conditional knockout (cKO) cell line 1,ctrl
"Acute Myeloid Leukemia, sample 23",pert
OSCE-16T,pert
Subject #8010-8hr Postinfection,ctrl
breast cancer patient 359,pert
0-KO,pert
"gender: female;	batch: 1;	age (years): 42;	patient id: Severe_8;	fev1 (% predicted): 33;	fvc (% predicted): 94;	medication: Prednisolone 5mg od, Aminophylline 225mg bd,Seretide 500 2pbd,doxycycline, Tiotropium;	cell type: CD4+ T-cells",pert
ctrl_519,ctrl
T5+6,pert
"Autoimmune pancreatic islets, day 1 cyclophosphamide treatment, rep 1",pert
"array type: Affymetrix Mouse 430_2,;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7",ctrl
"ALL_NDS, K63 011409",ctrl
"WT, PR03M005v0",ctrl
Liver control pool1 Affy,ctrl
Nasal Epithelium Instilation Formaldehyde 400mM 6h ID372,pert
"KO VSV infected, biological replicate 1",pert
Primary neonatal keratinocytes_control_rep1,ctrl
"Normal ear skin from control mouse, biological replicate 3",ctrl
Lmna H222P heterozygous male 6,pert
M465 Wt,ctrl
"IDC 3, biological rep. 3",pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 5 - Technical Replicate 1,pert
strain: C57BL/6;	cell type: cytotoxic T-lymphocytes (CTL);	genotype/variation: PDK1 null,pert
1a_c,ctrl
A673 cell line that has been treated with Puromycin for 3 days with concentration of 0.09 uM (EC50).,pert
U2-OS-ERb E2 4 hours 2,pert
SKI-DLCL cells_Aplidin 3.0nM_24h_rpt2,pert
Male BALB/c deficient in Il1rn,pert
uterus_veh_WT_4hrs_rep1,ctrl
1164-03-A,pert
Skinbiopsy_0h_controlsubject_k2,ctrl
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 wild type mouse, chow diet, liver",ctrl
Tslc1 +/+ mice_rep2,ctrl
"MCF7 cells stably transfected with pCDNA3.1, passage 2",ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:60;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 47 yr;	population: white,ctrl
15 saline,ctrl
gastrocnemius-30 months of age-resveratrol diet-biological replicate2,pert
"infected primary RPE, biological replicate 1",pert
"Patient 8, control tissue",ctrl
strain: 129/Sv,ctrl
duration of untreated disease in month:1.1;	age at onset:6.8,pert
ALS gray matter 1 Familial,pert
"brain, hippocampus: C6-III_e1_le1",ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 6",ctrl
Normal-ERα-positive breast cancer 51,ctrl
Rybp#15 (OHT-)_12d_rep1,ctrl
tissue: breast cancer;	cell line: MDA-MB-231,pert
strain: C57BL/6;	genotype: WT;	gender: male;	age: 10-12 weeks;	tissue: liver;	resection_percent: 85%;	time_after_resection: 2 hours,ctrl
strain: C57BL/6;	cell type: MEFs;	genotype/variation: wild type,ctrl
rat heart ventricle,pert
HT29 PLX Day8 rep1,pert
HEL_Control shRNA (GFP)_3,ctrl
KU_09N,ctrl
jzo008-rp1-v5-u74av2-met,pert
"normal colorectal mucosa, biological rep1",ctrl
"STZ pancreas, biological rep3",pert
5 Ko,pert
strain background: 129/SvEv;	genotype/variation: STING knockout;	cell type: bone marrow derived dendritic cells (BMDCs);	stimulated with: purified tumor-cell derived DNA,pert
patient: 40975;	sample: tumor,pert
tissue type: normal thyroid;	matched/unmatched: unmatched,ctrl
WFS1 WT USHT_20_331_wt,ctrl
Lung wt mock repC,ctrl
PTEN deletion Replicate1,pert
normal with no hydrocortisone treatment-3,ctrl
Control subject 107_biological replicate 1,ctrl
colonic_mucosa_non_inflamed_75,pert
tissue: brain;	genotype: mutant Lis1 ko/cko;	age: P0,pert
patient: 51176;	sample: normal,ctrl
Cell line expressing inducible GFP-progerin. Induction: day 10. Replicate A,pert
LRRK2 (G2019S) heterozygous iPSC sample 2,pert
Disease_status: Healthy control;	Age (years): 51;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
patient: 241;	current medication: Asacol 800mg bd Azathioprine 100mg;	birth date: 6/25/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/90;	diagnosis date: 11/11/91;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 22;	igr2198: 22;	igr2230: 22;	octn1: 22;	octn2: 22;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/10/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Cmah KO_liver _3,pert
disease state: Normal,ctrl
PGA-RMM-1h-1aA-s2,pert
pSUPER-mir-210 replicate 1,pert
"array 14, xenograft, abiraterone 75 mg/kg/d",pert
HMEC_50 vs T47D,pert
GM19238_Kd_NS_P1_22,ctrl
HCC PBMC_sample 3,pert
"SIN3A siRNA, biological replicate 2",pert
chip number: 16;	transfection plate: 6;	target gene: USF1;	kd level: 0.79;	rin: 9.4;	transfection date: 2012-03-26,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 53;	sex: F,ctrl
"hepatic gene expression at ""1 hr"", rep3",pert
"mouse aorta cross strain comparison, C3H_T40_NC_01",ctrl
age: 72;	sex: M;	disease status: control subject;	Filter number: 103;	Usage number: 4;	Exposures: 3,ctrl
CON12,ctrl
brain_co_6M_rep3,ctrl
"Control, biological rep2",ctrl
pMX-Oct4 vitamin C Oct4Vc+_2,pert
Liver vehicle rep2,ctrl
Sample 07 Kidney Hyp Mouse - Control Diet,pert
dex4hr_2,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: Vemurafenib 1000 nM for 48h,pert
patient: 224;	current medication: Salazopyrin BFZ Losartan Thyroxine Doxazosin;	birth date: 2/21/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 1/1/77;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 12;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Hypertension Hashimoto's Thyroditis;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
cell line: KYSE70;	cell type: squamous cell carcinoma,pert
SKM-1 control 2,ctrl
cell type: granulosa cells;	disease: Polycystic ovary Syndrome,pert
potilas_DC_A,pert
SLE CD4 T cells 5,pert
colon_epithelium_IL10mouse_6weeks_rep4,pert
WFS1 WT USHT_19_320_ko,ctrl
source: JAX stock # 000664;	strain: C57BL/6J;	tissue: retina;	age: P8;	genotype: wild type,ctrl
"Patient L, lesional skin",pert
+7hr Wnt (dye swap),ctrl
GFP-kd_ES_rep3,ctrl
DNGM-12,pert
10A;pretreatment;female;breast tumor,ctrl
"human failing LV myocardium, Idiopathic1",pert
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep7,pert
KO - knock-out Treated - 0.5 hrs - repeat 3 - Cy3 - mAdbID:62537,pert
"10mg/kg/day PFOA, Rep 4, Block 4, liver (high dose)",pert
mortality: alive;	ethnicity: Asian;	gender: F;	age (yrs): 26;	tissue: Normal_Kidney_Biopsy,ctrl
cell line: non-small cell lung carcinoma cell line H1299;	protocol: control;	time: 24hr,ctrl
C57BL/6J_Muscle_rep1,ctrl
"Cadmium 0.55 µM, biological rep4",pert
normal plasma cells (NPC 625),ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 75 years,pert
ns DHT 3,ctrl
"DCIS 4, biological rep. 4",pert
ab035 IM,pert
cell type: Primary hepatocytes;	strain: NMRI;	agent: control;	time: 6h;	gender: Male;	age: 4 months,ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle/squamoid cell;	matched/unmatched: unmatched,pert
GIST Pre Treatment Biopsy 37,ctrl
"control endometrium, patient 18",ctrl
E12.5 wt2,ctrl
"fibroblast, control subject NF9 rep 1",ctrl
"PMA treated, doxycycline treated; biological replicate 1",ctrl
Recent-onset T1D_sample6,pert
Heart_WT_2,ctrl
Peripheral blood mononuclear cells;	TTF=85min;	Race=White;	Sex=Male,pert
AO C2,ctrl
"Peripheral blood, patient with recurrent events [N21]",pert
"brain, frontal cortex: Sample54_e1_le1",pert
01N70: normal control,ctrl
tissue: liver tissue;	disease state: hepatocellular carcinoma tumor,pert
A HID B_B090,pert
"alveolar macrophages, smoker 027",pert
"NASP Overexpression, sample #3",pert
"brain, lateral and medial ganglionic eminences: Arx+/Y #2_le1",ctrl
Tissue: lung,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 720,pert
HF0171_U133P2,ctrl
Strain: C57BL/6; Tissue: liver;,ctrl
tissue: brain;	genotype: mutant Lis1 ko/cko;	age: P14,pert
LDLR_LF_3,pert
HepG2 cells quercetin 2h,pert
FVB; No Treatment #10,ctrl
WT_uninf_1,ctrl
day 3 5-FU HSC 1,pert
07-0006A_Day1_18,pert
agent: ConA;	time point: 1 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
Cerebellum_nontransgenic control A39_10 months_replicate 2,ctrl
Klf9KO_jejunum_PND30_1,pert
MCF10A_Vehicle_rep1,ctrl
condition: Psoriasis;	patient: PS-J;	tissue: LS skin biopsy;	kit: Affy,pert
iA50clone9-,pert
"5mg/kg/day PFOA, Rep 4, Block 3, lung (high dose)",pert
MLL_PTD05,pert
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: hypertensive cardiomyopathy,ctrl
CA1 Cre Sox7H,pert
Sample Group: control; Gender: female; Age: 68; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 6h;	donor: 1,ctrl
Subject #8007-2d Postinfection,pert
fibroblast_Normal_D160_Media_5,ctrl
"human failing LV myocardium, Ischemic99",pert
brain_DLPFC_bipolar B_mr777,pert
"gender: female;	batch: 1;	age (years): 45;	patient id: Severe_7;	fev1 (% predicted): 71;	fvc (% predicted): 105;	medication: Prednisolone 10mg od, Insulin S/C,Seretide 500mcg 2pbd, Metformin,Nexium, Flixonase,Tramacet,Calcium,Valsartan,Amitriptyline;	cell type: CD4+ T-cells",pert
cell type: Embryonic Stem Cells;	genotype/variation: Suz12KO,pert
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 1.5,pert
"4 weeks old PS-NA mice, cerebellum",pert
Wild type Mice-M23,ctrl
GEIM110-NORM,ctrl
Tendon_lesional_rep22,pert
Normal-N_LJ_4,ctrl
"Kidney from control rats, biological rep 4",ctrl
myoblasts-expt1_untransduced-rep4,ctrl
"brain, hippocampus: LH7_e1_le1",pert
5244 UC Uninflamed sigmoid colon,pert
"IN1760 siPD treated, Biological replicate3",pert
"Primary aortic endothelial cells, transgenic_PPARG_V290M_1",pert
cell type: myoblast;	transduction: lentiDUX4short,pert
Cardiac Muscle_mdx_rep3,pert
"WT brain, biological rep1",ctrl
"Acute Myeloid Leukemia, sample 78",ctrl
sex: Male;	Age: 7 months;	additional patient information found in Series supplementary file,ctrl
C3H/HeJTCE liver sample batch 3,pert
PGA-RMM-45m-2aA-s2,pert
siRNA Stau1 Duplicate 1,pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: BETAFERON;	time: 12 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
MCF-7 control rep 2,ctrl
Braf 2,pert
nt control 9,ctrl
WT Uterus_saline_24h_rep3,ctrl
Run1.a10a.000608jd.2.SkMNor925.CEL-IS basal,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 67;	gender: male;	years of disease: < 1 y;	treatment: phototherapy;	time: mid-UV,pert
MCF7 cells treated with 2uM Sangivamycin for 24 hours Array 2,pert
CTRL_2_GMP,ctrl
"patient: 126;	current medication: None;	birth date: 4/4/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: FH of Crohn's disease, Symtom free at procedure;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
07R054 RA,pert
B7hi mTEC B6/129 wt2,ctrl
phenotype: no glaucoma;	gender: female;	strain: D2-Gpnmb+;	tissue: retina;	age: 10.5 months,ctrl
MCF-7 +scrambled siRNA + 100 nM 4-hydroxytamoxifen rep2 (MD34),pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Supraoptic nucleus,ctrl
ctrl_502,ctrl
"C57BL/6J ACU, Rep3",pert
WT-2 (EPLM),ctrl
"schizophrenia, BA46-22",pert
0178-01-C,ctrl
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.17 uM (EC50), biological rep1",pert
"TNFa-OMe-P siRNA-C, replicate 7",pert
Normal-ERα-positive breast cancer 45,ctrl
4_CD34+_12h_TCDD-,ctrl
race: caucasian;	age (years): 61;	stage: IC;	grade: 2;	histology: endometrioid,pert
Individual_5883_NN_sample,ctrl
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.17 uM (EC50), biological rep1",pert
Myh11-CreERT2.Tgfbr2f/f Knockout 1,pert
db/m 1-1,pert
Empty vector CCE embryonic stem cells (CCE_ESC_Vector),ctrl
"infected primary RPE, biological replicate 2",pert
OVCAR-8-(3),ctrl
blood_day6_patient4,pert
2000N_2,ctrl
B-CLL PB P86,pert
BT474-J4_DMSO_24-2,ctrl
CHF - R12,pert
MOLT4_ctrl_C,ctrl
KN-sham-2 month-R1,pert
GM19238_Kd_EP300_1,pert
cell line: D3;	treatment: siPRMT8,pert
Day: 6; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 3,pert
"human failing LV myocardium, Idiopathic52",pert
tissue: Frontal cortex;	age: 78;	Sex: F,ctrl
CF (D508) subject3,pert
RNA from HCC_31N,ctrl
SW1736_t6h_rep3,pert
"seminoma specimen, pT1, patient age: 36y; W00 223",pert
Mouse_ATF6aKO_colon_DSS_rep2,pert
5272 UC Uninflamed sigmoid colon,pert
DRG_DMSO_0.1%_Rep1,ctrl
wt_TGFb_4hr_1,ctrl
protocol: AP-2 gamma targetting siRNA 2;	cell line: MCF7,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 3,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M5b;	flt3 status: D835 mutation,pert
sample 1:;	age: 45;	gender: female;	sample 2;	age: 46;	gender: female;	sample 3:;	age: 64;	gender: male,pert
Donor5_24h_DMSO,ctrl
control to Sample 9,ctrl
Transgenic male mouse 120 day old,pert
Mouse E10.5 urogenital epithelium +/+ #2,ctrl
strain: C57BL/6J;	genotype: APOE-deficient;	tissue: aorta;	treatment: none;	disease: atherosclerosis;	age: 32-34 weeks,pert
CML_5_MEP,pert
C3H/HeJ Vehicle liver sample batch 5,ctrl
"Whole ovary from 8 Month Old Wild Type mice_03, biological rep3",ctrl
RA_F,pert
"Cell type: neuronal, age:52, gender:male, diagnostic group: schizophrenia, PMI:16h",pert
"BOEC, at_risk 4",pert
"adenocarcinoma at 20wk, biological rep 2",pert
shRNA6-16-noDox-rep1,ctrl
"fibroblast, control subject NM6 rep 2",ctrl
patient15,pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Cortisol;	genotype: CTNNB1 mutation (S37C),pert
sex: Female;	family: 3;	age: 14;	disease status: Affected;	tissue: Muscle: Deltoid,pert
normal muscle replicate 2,ctrl
PKBa-/- MEF time 6 replicate 1,pert
"Global gene expression of NASH patients, P40",pert
parental cell line: WB;	vector: pBabe-puro (empty vector);	replicate: 1,ctrl
OCI-Ly10_FOXP1 overexpression,pert
"human failing LV myocardium, Ischemic33",pert
MDS patient 36,pert
patient: 30617;	sample: normal,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 44;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
M454 SKM-Tg,pert
MZ1774 mock rep 1,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: spleen;	sample name: 6-sp3,pert
PGA-MAH-C3H_PBS24h-1aA-s2,ctrl
"Colitis 02, UC02",pert
Leg 112 day mdx rep 3,pert
MPZ-Tfam Knockout - rep2,pert
4 Ctrl 4,ctrl
BS2011051063,pert
Diseased individual (ulcerative colitis) of twinpair #8,pert
"107, MUSCLE, Before",ctrl
erStress_twins_AA_1727twin1_DMSO_4h,ctrl
WT-VILI replicate 2,ctrl
"brain, Entorhinal Cortex: 96-18 tangle_e1_le1",pert
H295R_Group_C_Dose_100_TIMEPT1_032,pert
normal plasma cells (NPC 642),ctrl
APOE_KO_DM_9W_4,ctrl
CML Patient 4 before therapy,ctrl
HP-27,pert
"brain, Entorhinal Cortex: 95-08 normal_e1_le1",ctrl
"Male, 44 years old, HIV infection of 12 years",pert
Array Type: HG-U133A_2;	Ratio: 2.03;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Recent-onset T1D_sample10,pert
N51091,ctrl
high grade serous carcinoma_patient 5,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 80min;	race: White;	sex: Female,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 19d ID232,pert
SZ10,pert
LM2 cells cultured with HMVEC-L and then purified by FACS,ctrl
cell type: Erythroid progenitors on day 6 of differentiation;	genotype/variation: transduced with lentivirus expressing short hairpins against ZBP-89,pert
3883-2 E2F WT,ctrl
blood_day0_patient2,pert
Day: 24; Drug: Heroin; Phase: Withdrawal; Replicate: 3,pert
Bronchial Epithelial Cells MMA biological 1790I,pert
Array Type: HG-U133A_2;	Ratio: 2.01;	RNA Integrity Number: 9.4;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Cancer 17,pert
race: caucasian;	age (years): 47;	stage: IC;	grade: 2;	histology: endometrioid,pert
MDS patient 139,pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 66;	donor: 31;	disease state: Lesional,pert
CTRL_4_CMP,ctrl
"Endometrium, postmenopausal, control, 17",ctrl
FACS-purified B cells_129SV/EV_influenza-infected_rep2,ctrl
WT-sham-5 month+13d-R4,ctrl
"PIO, subject 13",pert
Genotype: FGF23 TG on C57Bl strain;	Age: 8 weeks,ctrl
WAT from Ahnak knockout fed regular chow diet Replicate 3,pert
EA_Control1_CD8,ctrl
HaCaT_ZNF750i_ biological rep1,pert
CH1-(2),ctrl
brain_DLPFC_bipolar C_mr869,pert
MEKi 4h biological replicate 2,pert
COV434 Control [RR1023],ctrl
"Patient 112, 24 month of REBIF",pert
SNB19 PARK2 siRNA#2 replicate 1,pert
cbp+/- standard cage Rep5,pert
cell line: COLO829 melanoma cell line;	genotype/variation: MITF knockdown;	agent: control,ctrl
CEM NBD 1,pert
01LLR_CTRL,ctrl
Skin_Control E16.5_rep3,ctrl
Patient identifyier: J;	Sex: female;	Age of patient: 54 years;	Duration of psoriasis: 48 years;	Body surface area: 9 percent;	Overall erythema: mild;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
Monocyte FCH rep 3,pert
Buffy Coat blood of healthy donors,pert
"4105_CD133+, untreated",ctrl
"Embryonic cerebral cortex, Trnp1 knockdown, biological replicate 3",pert
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: control siRNA,ctrl
"Control, replicate 2",ctrl
osteoblast_control_rep2,ctrl
Wildtype fibroblast sample 2,ctrl
E9.5 FVB/N erythroid cells-10,ctrl
BCell_lymphoma_aggressive_sample7,pert
tissue: Brain;	genotype: Npc1+/-;	age: 20 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
Patient: N;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
MLL_PTD13,pert
tissue type: brown adipose;	gender: male;	genotype/variation: ob/ob;	harvest time: 4 day post injection;	age: 3 months,ctrl
sampleID: SAM630132;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
Wild Type B cells Spleen 4,ctrl
NSC miR-Control 1,ctrl
siERK1E24h_2664,pert
F191G C,ctrl
subject: 32;	disease: CP;	muscle: GR;	gender: F;	age: 7.9;	gmfcs: 2;	popliteal angle: 95,pert
11_0011C_Day1_23,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L009,pert
WT_R6_rep1,ctrl
"Exp A, Animal #258, 50mg/kg D-Serine",pert
05 MINUS OHT 3,ctrl
224 Day 0 Untransfected biological rep3,ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: healthy control;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,ctrl
H16 Ctrl 12h 2,ctrl
Prostate Cancer_NUGEN TEST05,pert
01LM6_Systemic,pert
disease state: allergic asthmatic;	cell type: Keratinocytes;	tissue origin: skin biopsies with no stimulation,pert
cell line: J1;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 0,ctrl
3416M patient's mucosa,pert
BL Day 1 siMut12 transfected biological rep1,pert
01LM2_ERA,pert
Lung-sarcoidosis-rep3,pert
MPM tumor 28,pert
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/22,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 26;	gender: male;	years of disease: 1 y;	treatment: phototherapy;	time: pre-UV,pert
age: 66;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
neuron_rep15,ctrl
BV-173 non-treated,ctrl
PTEN_mutant_3_intestinal_polyp_30_days,pert
BAL_45b_A2B0,pert
Targretin_LIVER_3,pert
"expression at 0hr, bio rep1",ctrl
genotype/variation: wt;	age: E16.5;	tissue: Whole eye,ctrl
"wdNHBE with KY/136 at 36hpi, biological rep1",pert
CTL2 E2 1hr,pert
Genotype: non-transgenic;	In the non-transgenic control animals no abnormalities in lung tissue was detected with the exception of a single animal which showed a slight focal interstitial mononuclear cell infiltration.,ctrl
Mouse testicular Sertoli cell line TTE3,ctrl
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: scrambled;	transfection time: 24h,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.245;	OD280: 1.679;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 321;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
PGA-HMO-Obese-4bUA-s2,pert
KO - 3 mo - repeat 1 - Cy5 - mAdbID:74593,pert
Elf4 KO2 activated CD8 T cells,pert
transfection: Rif1 shRNA;	cell line: J1 ES Cells;	background strain: 129S4/SvJae,pert
Lean Rosiglitazone 1,pert
"ARD842, CAIS, F, GOF, 6 x ETOH, 14d",pert
"iPSC derived from healthy control fibroblast WT2, biological rep5",ctrl
"NC1, biological replicate 2",ctrl
hippocampus: Sample #5_e1_le1,ctrl
Subject #8042-Preinfection,ctrl
Control (C85),ctrl
colon_IBD_1533,pert
N14,ctrl
clone type: AtT20 clone types treated with control siRNA rep 2,ctrl
Cervical cancer_CC163,pert
Vehicle-Control;	Vehicle-Control 36 hours set 2,ctrl
"DMSO-treated NRK-52E cells at 72h, biological rep 2",ctrl
"Monuron-treated NRK-52E cells at 72h, biological rep 2",pert
18A;pretreatment;female;breast tumor; responder,ctrl
phytohemagglutinin-activated PBMCs from normal control subject C,ctrl
Disease_status: Bipolar disorder;	Age (years): 41;	Gender: Male;	Age of onset (years): 22;	Duration of illness (years): 19;	Brain pH: 6.71;	Post mortem interval (hours): 70;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: Yes;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 33;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
Luciferase-rep2,ctrl
OVE26_8W_3_6,pert
ND_6,ctrl
ANL Chip#23,pert
"Monuron-treated NRK-52E cells at 6h, biological rep 3",pert
"Control, sample 3",ctrl
No or early 2 rep9 (OHN),pert
"WI-38 cells, at 24 h after exposure to 1 uM BPDE, biological rep4",pert
NFIA E18WT3,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 53 yr;	population: white;	dsm-iv: 295.9;	age of onset: 29 yr,pert
mdx5cv EDL sample 2,pert
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: standard AIN-93G diet (SD; carbohydrate:protein:fat ratio of 64:19:17 percent of kcal) ad libitum for 8 months,ctrl
gender: Male;	age: 87;	post-mortem delay: 3.5h;	ph: 6,pert
"WT, PR04M004v0",ctrl
"brain, hippocampus: KA-6h-P15-II_e1_le1",pert
cell line: HM1 embryonic stem cell line;	genotype/variation: Prmt6 overexpression,pert
X66-,pert
"Fibroblasts, formoterol, time 6h, patient 1, rep 1",pert
"SIRT7 Knockout Liver, replicate1",pert
cerebellum_PSNA_ 0d_rep2,pert
"Cervical cancer, squamous cell carcinoma, microdissected, stage IIB1, HPV 18, HPV 45",pert
DMN-CtrHippo15d-2dAv2-s2,ctrl
Control peripheral blood leukocytes - Biological Replicate 1 - Technical Replicate 2,ctrl
Healthy11-CD8,ctrl
"Patient 14, Atheroma plaque",pert
sMPNST_shCONTROL_3day_rep3,ctrl
"DMSO-treated, 24h after UV, Replicate E",ctrl
"MCF-10A cells, shRNA targetting p63 TA, biological rep2",pert
Double_positive_thymocytes_Dexamethasone (1E-07 M) _3h_rep1,pert
"Vldlr knockout saline, biological rep3",pert
0120-01-C,ctrl
siRNA mediated WTAP knockdown in HUVEC,ctrl
H441 transfected with ETS2-specific siRNA 2,pert
genotype/variation: Fmr1 wildtype;	tissue: blood;	gender: Female,ctrl
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: myocardium,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: control; biological replicate: 3,ctrl
proband-MS,pert
Severe rep10 (OHN),pert
sex: Male;	Age: 20 months;	additional patient information found in Series supplementary file,pert
MCF10A_SFN_rep1,pert
jzo028-rp1-v5-u74av2-met,pert
B6-WT2 melanocytes,ctrl
Floxed_Mstn_1,pert
cell line: U937;	replicate: Replicate1;	treatment: shLuciferase,ctrl
"AALE-KRAS uninfected, biological rep3",pert
age: 8 weeks;	genetic background: SV 129/C57BL/6;	genotype: PPAR-beta deletion;	cell type: pancreatic beta-cell,pert
c_B53,ctrl
HaCaT_ZNF750i_ biological rep1,ctrl
15_0003C_Day1_42,ctrl
db/db 10-5,pert
M238_R1_B_PLX,pert
tissue: primary brain tumor;	cell type: astrocytoma;	age: 39;	gender: male;	tumor grade: AII,pert
"Murine 3T3-L1 progenitor adipocytes cell cultures, T2 (treated with resveratrol)",pert
PsOEt-22-Week 12,pert
WT-1,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.72;	OD280: 0.901;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 206;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"strain:BALB/c SCID, gender:male, age:8wks, tissue: whole lung, condition: uninfected control",pert
BALB/c control (bmsnmix7),ctrl
cell line: JCRB0086 [TALL-1];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
10.5 Months Heart MDX rep 3,pert
IkkβΔ_replicate2,pert
Cardian muscle Healthy 1 week C1,ctrl
shNANOG_3,pert
5206 Normal Uninflamed sigmoid colon,ctrl
Trained diabetic 3 weeks DT3,pert
G392E_on_rep3,pert
Gata-1 Knock Down A,pert
tissue: Gastrocnemius muscle;	genotype: WT;	age: OLD,ctrl
strain background: CD1;	genotype/variation: wild type; Raldh2 +/+;	tissue: embryonic brain;	tissue region: posterior;	developmental stage: 4 somite stage,ctrl
Individual_4505_PP_sample,pert
Sedentary-23,ctrl
RPE65_KO_2months_retina3,pert
"Wild-type retina, biological rep3",ctrl
"fibroblast, TSG6-knockout, untreated, biological replicate 8",pert
HCC003T,pert
P4_TR_1,pert
age_years: 40;	sex: M;	ethnicity: Asian;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
BP patient 110_biological replicate 1,pert
cerebrum_PSNA_ 12w_rep1,pert
BP patient 53_biological replicate 1,pert
age: 24 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 knockout,pert
"Keratinocytes untreated control, 48h",ctrl
strain/background: C57B6SJL;	genotype/variation: GNMT knockout;	age: 3 months;	tissue: liver;	disease status: non-alcoholic steatohepatitis,pert
RatLung_H6h_2,pert
KU_49T,pert
MCF7 control siRNA Vehicle Rep2,ctrl
H9 Ctrl 6h 3,ctrl
Ero1-C104A/C131A non-induced biological repC,ctrl
LECs from cirrhotic rats 1,pert
"depression, BA10-22(4)",pert
Telencephalon cKO 1,pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates taken 96 hours after nickel exposure",pert
01LSC_Oligo,pert
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: JQ1 treated,pert
Intestine_KO_biological rep3,pert
129_Sv_2_WT_d6_4302,ctrl
0193-01-C,ctrl
IRS-4 KO (jos0954),pert
genetic background: C57Bl/6;	genotype: wildtype;	cell type: Osteoclasts;	treatment: Calcitonin,pert
OVCA420-(1),ctrl
tissue: adipose tissue;	sample group: calorie restrictive;	treatment: before;	gender: Female,ctrl
chip number: 17;	transfection plate: 5;	target gene: STAT2;	kd level: 0.7;	rin: 9.7;	transfection date: 2011-10-17,pert
Early IPF_surgical biopsy_upper lobe_rep144,pert
"hepatic gene expression at ""3 hr"" (rep3)",pert
status: Control;	gender: Female;	age: 54;	tissue: Blood,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 57;	tissue: Blood,pert
db/db 7-5,ctrl
braak stage: BR56;	rin: 78;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
NM9 healthy control,ctrl
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-GFP retrovirus,ctrl
BAL_4_A0B0,ctrl
11_0019C_Day1_28,ctrl
Postnatal 3 weeks control heart biological rep1,ctrl
P1 mouse eyeball extracted total RNA_wildtype3,ctrl
"human failing LV myocardium, Idiopathic39",pert
GIST Pre Treatment Biopsy 32,ctrl
C2C12 myotubes 100uM H2O2 rep 1,pert
Donor (Sample 18),ctrl
OE33 siRNA rep2,pert
Genotype: Mdr2-KO heterozygous mouse;	Age: 3 month,ctrl
age: 71;	sex: M;	disease status: control subject;	Filter number: 87;	Usage number: 1;	Exposures: 3,ctrl
12h_c1,ctrl
C57BL/6J-ob/ob;	Soleus muscle;	Age: 14 weeks;	Gender: Male,ctrl
ME180 DMSO rep 1,ctrl
5207 Normal Uninflamed sigmoid colon,ctrl
01UN4_PolyRF-,pert
Ishikawa_Control_8h_rep2,ctrl
Diaphragm 28 Day mdx rep 2,pert
Allo-4-5,pert
Txnip deficient tumor 27 months sample 1,pert
wild-type macrophages stimulated with MALP-2 for 8 h,ctrl
10 weeks old,ctrl
parental Ainv15 ESC differentiated as EB for 3 days,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 59;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 16101647,pert
"Normal subject (40 year old caucasian male, SAK_1254688334)",ctrl
30A,pert
"Normal 13, control tissue",ctrl
cMetKO QSC Technical Rep.2,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 68,pert
non-CF subject 40,ctrl
Individual_4079_PP_sample,pert
HCC004T,pert
WT / Reference_13425478,ctrl
atopic eczema P5,pert
strain: C57BL/6;	genotype/variation: Smchd1 wildtype;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: C,ctrl
Barrett's esophagus (B8),pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5;	flt3 status: internal tandem duplication (ITD),pert
HT29 resistant cells replicate 1,pert
OCI-Ly7 NTsiRNA 3,ctrl
"human failing LV myocardium, Ischemic30",pert
"Deltoid, FSHD, cohort 03, subject 03A",pert
37A;pretreatment;female;breast tumor; not assessable,ctrl
"SPC-c-raf transgenic mice, 5 month old, female, unaltered",pert
"human failing LV myocardium, Ischemic98",pert
Patient: L;	Time: 1 week;	Group: responder;	Condition: lesional,pert
Normal control 3,ctrl
LNCaP.GFP.6,ctrl
"Normal skin from Tgfbeta_control mouse, biological replicate 1",ctrl
02SAGEA,pert
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/lacZ; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 14.5; Tissue: whole kidneys from 17 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",pert
Wild Type Time 7 replicate 2,ctrl
C4_pitM,ctrl
Postmenopausal female. Tibolone treated. Patient 1.,pert
NCCIT-SNF5sh-rep2,pert
t21,pert
Liver sample from Alcoholic hepatitis group (CA51),pert
01LPL_ERA,pert
460A.LMP,ctrl
strain: C57BL/6;	gender: male;	cell type: ESCs;	genotype/variation: No genetic modification;	culture conditions: 2i,ctrl
01_0049A_Day1_12,pert
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 72 hrs;	Drug: No Rosiglitazone present,ctrl
"Lesion Skin, LS-14",pert
gender: Male;	tissue: Tendon;Brachialis;	age: 45;	donor: 5;	disease state: Non-lesional,ctrl
Native-0-3,ctrl
H3f3b WT 3974,ctrl
WT STR PDE10i 11,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-tu1,pert
E9.5 FVB/N erythroid cells-12,ctrl
siHic5_2_24h_2,pert
"2 months, contralateral group, biological replicate 3",pert
age: 56;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 24hr.",ctrl
tissue: T cells;	genotype: wild type 5C.C7;	background mouse strain: B10.A,ctrl
"Typically Developing Control, Gracilis, Patient Replicate 10",ctrl
GM19238_Kd_CLOCK_2,pert
HF0975_U133P2,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
SLE4-TC,pert
Kidney_400 mg/kg VCM ip_mouse #105,pert
Healthy2-CD8,ctrl
CD4IncDec-test-1,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
WT.DMSO.2,ctrl
"Control, untreated",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 07/15/05;	# cells: 38;	Sex: male;	region: M1;	age: 45;	genotype: Y/X;G42/-,ctrl
PC-3_basalhTERT_ShortTelomeres_mock_3,ctrl
CD8+_Tcells_healthy_donor_2,ctrl
Control PB C105,ctrl
Weight:Low;	CFstatus:knockout;	Sex:Female,pert
E81-/-vector-2,pert
LOX1 Untreated 24hr 282295913,pert
01LM3_Oligo,pert
Striatum of 8-10 week old 129P3/J mice,ctrl
Sex: male;	Age: 15;	SL: 4.01;	House: 7;	Severity: M;	Ashworth: 2;	Zancolli: 2B;	PEFF: 80;	PESF: 80;	AEFF: -50,pert
IDTC 3,pert
"2102Ep cells SOX2 siRNA, biological replicate 3",pert
genetic background: hybrid C57BL/6J and 129S5/SvEvBrd;	genotype: control,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
m1-carcinoma2,pert
"Wistar Han;	Crl:Wi(Han), Male, tissue: Heart",pert
Globin_S3,pert
NSC miR-128 2,pert
E14 - DCXko/Y 3,pert
"wild type, sample 2",ctrl
Advanced IPF_explant_lower lobe_rep157,pert
type 2 diabetes subject 01,pert
ATM_siRNA_4b,pert
ZNF395 knock-down (shZNF395-3),pert
VGP2,pert
"depression, BA10-38",pert
P1A Progranulin-frontal,pert
HT29 DMSO Day1 rep1,ctrl
"PIO, subject 9",pert
subject: 6;	disease: TD;	muscle: GR;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
WT1-iPS 6,ctrl
"metastasis: none;	Stage: 3b;	tissue: cancer, homogenized",pert
MCF-7-Pit-1 rep 2,pert
WT J1 ESCs on day 3 #2,ctrl
autism with dup(15q) 03-43,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 219,pert
CD positive WT T cell TCR-stimulated rep2,ctrl
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L009,ctrl
15: NORMAL #99-0693,ctrl
"Wildtype luminal mammary epithelial cells, MD892",ctrl
imanitib2,pert
ColTum_022GAFD8_g8.txt,pert
"Wildtype, biological rep2",ctrl
BL Day 0 Untransfected biological rep2,ctrl
day 6 5-FU HSC 1,pert
01LNS_PolyRF-,pert
Non-transgenic mouse rep 2,ctrl
del337TR replicate 4,pert
SHR12-3,pert
"IκBα-deficient animal, biological repeat 1",pert
SNB19 scramble siRNA replicate 2,ctrl
Esophagus CTR replicate 3,ctrl
N6A Normal-frontal,ctrl
ILD_6,pert
genotype: WT;	cell type: Th17,ctrl
colonic_mucosa_non_inflamed_76,pert
Liver_hyperglycima_no.7,pert
Contusion - 35 Day Epicenter Rep3,pert
human esophageal squamous cell carcinoma cell line_KYSE140,pert
FR-si222-1,pert
cell line: MCF-7;	cell line: breast cancer cells;	transfected with: Empty vector,ctrl
"P16 control OC apex, biological rep 1",ctrl
"Untreated TG2 knockout NB4, biological rep3",pert
H19 siRNA (simH19) tranfected into C2C12 myoblasts rep2,pert
Csbm/m Mouse_cerebellum_Young_saline treatment_Replicate-3,ctrl
race: caucasian;	age (years): 60;	stage: IB;	grade: 2;	histology: endometrioid,pert
E14 - nudelko/+ 2,pert
Control + LPS 2,ctrl
cKO_P67,pert
HSC_Zfx-cko_Replicate2,pert
minor non-tumor2,pert
MCI-001,ctrl
GM19238_Kd_ESRRA_3,pert
"P60_wt cones, replicate 1 [array]",ctrl
WT_3,ctrl
"50B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
FVB_8W_1_1,ctrl
A/OVX/P4/6h/UTX 129/SvImJ WT,pert
5215 UC Uninflamed ascending colon,pert
Kidney_WT_baseline_rep3,ctrl
"Series 3, young, no fracture",ctrl
"cell line: 1104, control, skin fibroblasts;	gender: female;	age at biopsy: 3 years",ctrl
patient code: 91;	gender: Female;	age: 51;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,ctrl
HeLa_01-04-05 TP10_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
patient id: 131;	tissue: Normal cortex;	gender: Male;	age: 51;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
CDK9 Knock Down1,pert
"MTDH control, biological replicate 2",ctrl
HN_125,ctrl
mouselung_scid_control_rep02,pert
SKBR3_0.1uM_Lapatinib_1,pert
GM19238_Kd_HCST_3,pert
"DMSO Control after 1hr, replicate 3",ctrl
strain: C57BL/6;	treatment: control;	cell type: lineage-negative marrow progenitors,ctrl
"G9a knockdown cells, rep1",pert
Normal mucosa 12,ctrl
4_DMSO-4,ctrl
NTB_skeletal 3,ctrl
IOSE80pc shGFP Ctr at 72h,ctrl
patient: 262;	current medication: Asacol 2.4g co-codamol;	birth date: 7/17/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/87;	diagnosis date: 1/1/87;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 7/5/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/5/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
cell line: TYK-nu;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
tissue: skeletal muscle;	strain: mixed background (C57Bl/6 and 129);	genotype: Yin Yang 1 (YY1) knockout;	age: 6 months,pert
"N-58, NORM, M, GSF, 1 x ETOH, 24h",ctrl
Muscle-5 month-wild type-technical replicate 1,ctrl
Leg 112 Day control rep 2,ctrl
asthma_OVA24h_2,pert
Subject 7_t=30days_resveratrol,pert
minor HCC7,pert
C6 Control None,ctrl
"seminoma specimen, pT1, patient age: 38y; W99 063",pert
colon_IL10mouse_12weeks_rep3,pert
cerebrum_WT_4w_rep1,ctrl
"Dermatomyositis, biological rep3",pert
AtT20 cells treated with control siRNA rep 1,ctrl
PND28 Rat Testis_Rat230-2_2hr MEHP_Animal#45_04005,pert
WT MEF CT18-3,ctrl
hBSMC_control_rep3,ctrl
patient: 229;	current medication: Naproxen;	birth date: 11/27/61;	gender: unknown;	ethnicity: CAUCASIAN;	symptoms onset date: 1/14/05;	diagnosis date: 1/18/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/18/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/26/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: NEW;	smoking status: unknown;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT wildtype, U0126-treated",ctrl
ab117 N,ctrl
antimicroRNA-449_rep2,ctrl
chip number: 15;	transfection plate: 5;	target gene: RXRA;	kd level: 0.78;	rin: 9.6;	transfection date: 2011-10-17,pert
Patient identifyier: F;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 28 years;	Body surface area: 15 percent;	Overall erythema: moderate;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
Carboplatin 24 hours set 1,pert
"gender: female;	batch: 1;	age (years): 21;	patient id: Severe_2;	fev1 (% predicted): 105;	fvc (% predicted): 101;	medication: Prednisolone 8mg - 1mg for 5wks(stopped 30/5/08),seretide 500mcg 1pbd,Singular 10mg bd,Phyllocontin 225mg am 450mg pm,Ventolin prn;	cell type: CD8+ T-cells",pert
gender: female;	strain: C3H/HeN;	genotype/variation: WT;	tissue: liver;	age: Five-weeks-old;	agent: EtOH,pert
Muscle-24 month-Myc heterozygous-technical replicate 3,pert
renal_vesicle_Lim1_mutant_4,pert
NOD/LtJTCE liver sample batch 6,pert
Diaphragm 56 Day mdx rep 3,pert
3_CD34+_12h_TCDD+,pert
Muscle PCOS case 271,pert
Ileum_Wild Type_3,ctrl
Psoriasis-Patient-D,pert
11382 Normal Uninflamed ascending colon,ctrl
Wild-type postnatal day 10 rep 2,ctrl
Extract:LOX-1:213101;	Extract Description:LOX1_0hr:213101;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0.02;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.53;	Quality: Background Mean Dev.:1.12;	Quality: Absent (%):58.17;	Quality: Absent (%) Dev.:0.07;	Quality: Scaling Factor:0.51;	Quality: Scaling Factor Dev.:0.89;	Pretreatment [C]:LOX1;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213101;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_0hr;	RNA extraction source key [A]:282295443,pert
"fibroblast, control subject NM2 rep 1",ctrl
knockdown: TNFa siRNA-A;	amplification date: 09/06/16;	hybridization date: 09/06/30;	colon length (mm): 5.8;	colon weight (mg): 159;	colon ratio (mg/mm): 2.741;	myeloperoxidase activity (u/mg): 0.442;	tissue: colon;	treatment: 5% DSS,pert
HSF1-/- T cells at 37oC replicate #2,pert
24h Control (SAMPLE 7),ctrl
scan batch: Batch 1;	group: control;	subject age: 5;	paternal age: 29;	maternal age: 29,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.93;	choa: 330;	fata: 22;	eea: 1930;	wtkg: 84.5;	perfat: 35.2;	lbm: 54;	fat_mass: 2974.4,ctrl
MIC1,ctrl
HLA risk: High;	Height: 147.8 cm;	Weight: 52.9 kg;	BMI: 24.1;	Age: 12.2 years;	Gender: Female;	Race: White;	Glucose: 83 mg/dl;	HbA1c: 8.1%,pert
OBF-1 overexpression BCS-2 (EPLM),pert
MCF7_E2_24h_rep4,pert
microdissected breast cancer cells from case 180,ctrl
Normal mucosa 17,ctrl
strain: 116;	Disorder: normal scar;	Condition: +hydrocortisone,pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T2N1,pert
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: ApoD knock-out,pert
MacularDegen-injured-15aAv2-s2,pert
D4_non-transgenic,ctrl
Young 3,ctrl
"Exp A, Animal #249, 500mg/kg D-Serine",pert
64SmokeH,ctrl
IM14_case,pert
SHP-/-_rep2,pert
GM19238_Kd_EP300_2,pert
"liver sample of Wistar rat fed for 12 weeks with standard chow diet, after overnight fast",ctrl
"Genotype: B6.Alb/cre,Pdss2loxP/loxP(Liver-conditional knock-out);	Age: 224-day-old male;	40 mg liver used for RNA extraction",pert
01ML9_PolyRF-,pert
strain: 129-Sv;	cell line: J1;	cell type: embryonic stem;	time: 6 days;	differentiation: differentiated Flk1+ Tal-1-/-  ES cells,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_4 months_replicate 3,pert
Donor1_24h_DMSO,ctrl
cDNA scc 01,pert
control MLL_00107,ctrl
wild-type replicate 3,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 6h ID131,pert
V5-P260,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 43 yr;	population: white;	dsm-iv: 295.9;	age of onset: 25 yr,pert
Waldenström’s macroglobulinemia (WM-PC 32395),pert
Cont subject 05,ctrl
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/+; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 18.5; Tissue: whole kidneys from 14 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",ctrl
6h_c1,ctrl
MEKi 16h biological replicate 2,pert
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 26;	maternal age: n/a,pert
Control subject 39_biological replicate 2,ctrl
Rybp#10 (OHT+)_4d_rep2,pert
"ARD842, CAIS, F, GOF, 1 x 1000nM DHT, 24h",pert
iA50clone9+,ctrl
siNEG replicate 3,ctrl
"WT2_ileum, 5 days post-infection with T. gondii",ctrl
Peripheral blood mononuclear cells (PBMC)-Patient SE T0,ctrl
wild-type naïve CD4 T cells KAI270,ctrl
GIST_PDGFRA_11,pert
normal 1345,ctrl
MDS patient 84,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.572;	OD280: 1.326;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 369;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"WT4_ileum, 5 days post-infection with T. gondii",ctrl
Bronchial Epithelial Cells MMA biological 2012R,pert
PGA-MAH-C3H_OVA24h-1aA-s2,pert
BAL_44a_A0B0,ctrl
sample =Healthy1 treatment=Control time=90 (min),ctrl
C6_CLP_wildtype_12,ctrl
Human.AQ.CP.ECRB,pert
Tetracycline-inducible glioma cells no dox 3,ctrl
baseline control 09,ctrl
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
Rb-/-PrE serum 1,pert
"Rad21 esiRNA, biological rep3",pert
Msgn1_12hMinDox-biological rep2,ctrl
mdx5cv diaphragm sample 2,pert
C2C12 myotubes 1uM H2O2 rep 3,pert
27A;pretreatment;female;breast tumor,ctrl
strain: C57BL6/J;	genotype/variation: txnrd1 null;	age: 8wks;	developmental stage: adult;	gender: male;	agent: acetaminophen (APAP);	tissue: liver,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 64;	tissue: Blood,pert
WT_ANT_PDE_B2,ctrl
Muscle Control 2,ctrl
MDS patient 40,pert
Kidney_200 mg/kg VCM ip_mouse #087,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 133min;	race: White;	sex: Male,pert
treatment: vehicle;	genotype: progesterone receptor knockout;	treatement time: 40 hours,pert
"GSL30, PR04M006v0",pert
4_Hr_+MGd_3,pert
LJMJDW21,ctrl
healthy control_1,ctrl
PND28 Rat Testis_Rat230-2_2hr MEHP_Animal#44_04005,pert
"brain, hippocampus: KA240-II_e1_le1",pert
Plate vs. Nail:  4 Week Nail,pert
Tumor_18w_vechicle_DEN_123,ctrl
RNA from HCC_40T,pert
CyP 3hr 2,pert
XX1_Paf,ctrl
"Typically Developing Control, Gracilis, Patient Replicate 9",ctrl
gender: male;	batch: 1;	age (years): 33;	patient id: Control_5;	fev1 (% predicted): 78;	fvc (% predicted): 77;	medication: None;	cell type: CD4+ T-cells,ctrl
5195 Normal Uninflamed sigmoid colon,ctrl
Carbo Day1 (73R),pert
4321-1 E2F2 Null,pert
healthy myeloid cells 5,ctrl
S3_S010809,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 57.34247,ctrl
V5-P025,ctrl
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep6",ctrl
KD control 17A n,ctrl
sample =XCGD1 treatment=Control time=90 (min),pert
"Male, 34 years old",ctrl
3446M patient’s mucosa,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 1;	psoriasis duration: 2.8104038329911;	age of psoriasis onset: 26,pert
multiple sclerosis_4,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_4,ctrl
Fetal heart 1.5 ug/kg TCDD rep4,pert
EUR12_T2_PP_day0_044,ctrl
BxPC3-KO111 rep 1,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 19d ID154,pert
"202, ADIPOOSE TISSUE, After",pert
CH2121,ctrl
"ShamC-60, biological rep 1",ctrl
"E18.5 brain, Meg3 knock-out, rep 6",pert
chip number: 8;	transfection plate: 1;	target gene: NS;	kd level: NA;	rin: 9.8;	transfection date: 2011-03-29,ctrl
genotype: E-mu-BRD2;	cell-type: lymphoma_transitional;	splenomegaly: mild;	Ig clonality: oligoclonal,pert
6h_RA3,pert
5922012047_F,pert
EOM 112 Day mdx rep 2,pert
Integrin alpha7 transgenic mouse rep2,pert
TG KLS 1,pert
PBMCs enriched for CD8+ cells from normal control subject K,ctrl
brain_DLPFC_bipolar C_mr404,pert
RAW_0.14mM_HOCl_#1,pert
"KO total RNA LSK, rep 1",pert
MDS patient 34,pert
"Patient L, uninvolved skin",ctrl
"patient 12, baseline",ctrl
"twin pair: #7;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
tumor tissue from mastectomy specimen from postmenopausal patient with invasive ductal carcinoma (IDC),pert
11386 Normal Uninflamed ascending colon,ctrl
"205, ADIPOOSE TISSUE, Before",ctrl
"wt muscle 3, biological rep 3",ctrl
tissue: temporal lobe;	strain: C57;	genotype: WT,ctrl
cell line: L8057;	cell type: megakaryocytic cells;	genotype/variation: shRNA-mediated Ring1b knockdown,pert
erStress_twins_AA_1744twin2_500nM_thapsigargin_4h,pert
Control subject 45_biological replicate 1,ctrl
"brain, frontal cortex: Sample47_e1_le1",pert
Heart_KO_4,pert
siControl_rep_3,ctrl
gender: male;	strain: C57BL/6;	developmental stage: day 13.5 embryo;	genotype/variation: DUSP5 knockout (KO),pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 2,ctrl
Treated with 25uM Zinc for 4 hrs -- replicate #1,pert
"brain, cerebellum: KCx4w#2_e1_le1",pert
condition: Psoriasis;	patient: PS-D;	tissue: LS skin biopsy;	kit: Affy,pert
tissue: skin;	individual: Patient P7;	condition: AL;	eczema severity: SCORAD: 56,pert
Cervical cancer_841T,pert
patient: 6;	disease state: hypertension;	tissue: Atheroma plaque,pert
race: caucasian;	age (years): 63;	stage: IA;	grade: 3;	histology: endometrioid,pert
ILD Study Number 1115,pert
H441 transfected with ETS2-specific siRNA 1,pert
"AG825-treated, 6h after UV, Replicate B",pert
5283 UC Inflamed ascending colon,pert
strain: mixed 129/Ola-C57BL/6 background;	genotype/variation: Junf/f,ctrl
Normal Gingiva replicate2,ctrl
Subject 3_t=30days_resveratrol,pert
461MM,pert
"Normal cervical epithelium, microdissected, Age 30",ctrl
MCF10A-HER2(+) 9days,pert
"Control animal, biological repeat 2",ctrl
IMR-32_pCMV-SQSTM1_48hr_rep 1,pert
No_abuse_3,ctrl
P2,pert
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 29;	maternal age: 27,pert
subject: 07U;	cohort: 7;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 34kb;	age (y): 49;	Sex: F;	batch: Batch_2,ctrl
ab139 N,ctrl
ab057 IM,pert
"A673 treated with Doxorubicin for 5 days with concentration of 59.88 nM (EC50), biological rep1",pert
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b retrovirus,ctrl
"Peripheral blood was obtained by venipuncture from healthy adult volunteers. Blood samples from umbilical cords of the placentas of healthy, full-term infants after scheduled caesarean section or vaginal delivery were obtained by puncture of the cord immediately after delivery",ctrl
patient: 136;	current medication: metranidazole 400mg TDS Prednisolone;	birth date: 5/21/51;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/20/05;	indictation for procedure: Diarrhoea PR bleeding;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,ctrl
MH1C1_untreated_rep1,ctrl
14.5_WT_522B,ctrl
WT littermate2,ctrl
Huh-7/Fluc rep2,ctrl
"Normal Skin, Normal-4",ctrl
MDS patient 41,pert
multiple sclerosis_2,pert
siCITED1#1 replicate2,pert
Parkinson's disease sample x115,pert
Healthy control 11,ctrl
"Patient B, lesional skin",pert
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Endothelial Cell,pert
strain: C57BL/6;	genotype/variation: Zmpste24+/+;	cell type: mouse embryonic fibroblasts,ctrl
lineage: colorectal;	cell line: SW480;	treatment: treated with MEK inhibitor for 4h,pert
E9.5 FVB/N erythroid cells-11,ctrl
cell type: monocytes;	disease state: healthy,ctrl
91 year old male,pert
"TNFa-OMe siRNA-B, replicate 2",pert
NTB_skeletal 1,ctrl
WT CMP rep2,ctrl
Gastric_cancer_patient_2,pert
Neuroblastoma SH-SY5Y cells_cloneM_scramble control_replicate1,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q plus other,pert
Strain: C57BL/6J;	Gender: M;	Age: 6 weeks;	Treatment: untreated,ctrl
GM19238_Kd_NFKB2_2,pert
Liver CTR replicate 3,ctrl
GIST Pre Treatment Biopsy 08,ctrl
strain: 21;	Disorder: normal scar;	Condition: +hydrocortisone,pert
"Acute Myeloid Leukemia, sample 32",ctrl
129_Sv_3_Tal1_Ko_d6_4302,pert
"Vehicle treated, DAY 6, biological rep.3, MV4-11 cells",ctrl
chip number: 6;	transfection plate: 1;	target gene: CLOCK;	kd level: 0.83;	rin: 9.1;	transfection date: 2011-03-29,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.83;	choa: 148;	fata: 78;	eea: 1590;	wtkg: 84.3;	perfat: 20.7;	lbm: 62.7;	fat_mass: 1745.01,ctrl
CLL9-CD8,pert
sex: female;	tissue: liver,ctrl
"ALL_DS, K25 011509",pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of SUZ12. Sample B,pert
PGA-MAH-C3H_PBS6h-4aA-s2,ctrl
HCT116-Neo124 human colon cancer cells with intact PTEN,ctrl
PsOEt-21-Week 1,pert
Control 2,ctrl
"25B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"Peripheral blood, patient without recurrent events [N23]",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-tu3,ctrl
EVI_GFP positive Lin- cells replicate 2,pert
minor non-tumor4,pert
Braak α-synuclein stages 5-6  BR56_4SN,pert
cell line: HuT-102;	cell type: human cutaneous T cell lymphoma cells;	transfection vector: shRNA expression vector against Luc,ctrl
tissue: Biceps muscle;	patient: C.b.3;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 2y 1m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
strain: C57Bl6;	gender: female;	age: 6 months;	tissue: white adipose tissue;	genotype: WT,ctrl
healthy control H20,ctrl
disease status: allergic asthmatic subjects;	tissue: bronchial biopsies,pert
Tendon_non-lesional_rep14,ctrl
KU_44N,ctrl
scan batch: Batch 2;	group: autism;	subject age: 10;	paternal age: 26;	maternal age: 24,pert
WT-EtOH-4 (DFW),pert
Heregulin 979-CLA-36,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 40.17808,pert
"PCB153 treated HepG2 cells at T6, biological replicate 1",pert
colon_IBD_939,pert
RNA from HCC_9N,ctrl
MDS patient 127,pert
PND28 Rat Testis_Rat230-2_1hr MEHP_Animal#38_04005,pert
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14476;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
strain: C57BL/6;	genotype/variation: B6.Sle1a.1;	gender: female;	sample type: experimental,pert
"344SQ with control shRNA, replicate 2",ctrl
cell line: MLL-AF9 AML cell line 10949 (Zfx fl);	treatment protocol: +OHT;	genotype/variation: cko,pert
AKR/J Vehicle liver sample batch 6,ctrl
cell line: ACC483 [HPB-ALL];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
"strain: C57BL/6;	genotype variation: Il10+/+;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 24 hours;	agent: air;	exposure dose: 0 ppm O3",ctrl
"Typically Developing Control, Gracilis, Patient Replicate 7",ctrl
Allo-4-1,pert
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14477;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 2 hrs;	Drug: Rosiglitazone present,pert
Kidney_400 mg/kg VCM iv_mouse #043,pert
B6_Female_Control_rep3,ctrl
Cell line HeLa_control_expt1,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 1;	time: 0;	batch: 1,pert
control siRNA rep3,ctrl
"Mut, biological rep2",pert
Cell bank no: RCB1648;	Cell name: Hep G2 ;	Sex: male ;	Age of sampling: 15 years ;	Tissue derived: liver ;	Case history: hepatocyte carcinoma ;	Life span: infinite ;	Classification: Transformed,ctrl
patient: 51681;	sample: normal,ctrl
Normal cortex of patient 1524,ctrl
0950-01-A,pert
siERK2Veh24h_3500,pert
MPM tumor 10,pert
TTP_WT_60ActD_BioRep5,pert
chip number: 20;	transfection plate: 3A;	target gene: IKZF3;	kd level: 0.59;	rin: 9.8;	transfection date: 2012-03-26,pert
CD8+_Tcells_severe_asthmatic_5,pert
WT_IL-6_400_rep3,ctrl
lesion_preUV_patient11,pert
db/db 8-3,ctrl
CEPI_III_183,pert
CPU S control 1,pert
Patient: E;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
976PBMC,pert
tissue: primary skin cells;	genotype/variation: Adam10 knockout,pert
b6.2,pert
subject: 03A;	cohort: 3;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 40;	Sex: F;	batch: Batch_1,pert
cell line: A549;	cell line origin: Lung cancer;	genotype/variation: control,ctrl
microdissected breast cancer cells from case 342,pert
"PBMC, healthy control, biological rep4",ctrl
"48 hour-treated wild-type NB4, biological rep3",ctrl
Kidney_200 mg/kg VCM iv_mouse #027,pert
WT3 SPLEEN,ctrl
cerebellum_Pink1 knockout_12 weeks_replicate 2,pert
NPC17,pert
diet_mammary_3,ctrl
PLT-t7; transgenic plantaris 7 month,pert
FR-si221-1,pert
JIA PBMC Pre treatment A235_L009,ctrl
Retina wildtype 30 days 4,ctrl
Diaphragm 23 Day mdx rep 1,pert
Disease_status: Bipolar disorder;	Age (years): 45;	Gender: Male;	Age of onset (years): 35;	Duration of illness (years): 10;	Brain pH: 6.35;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: 10000;	Lithium treatment: Yes;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): Unknown,pert
Carbo Day7 (416L),pert
Mut_M_2,pert
Day: 15; Drug: Saline; Phase: Withdrawal; Replicate: 1,ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 scrambled;	treatment: untreated,ctrl
cell type: hRPE;	disease state: uninfected;	gender: male,ctrl
cell line: THP-1;	shRNA construct: Scrambled Control,ctrl
MDS44,pert
Nod2-/- 2,pert
treatment: baseline;	gender: M;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,ctrl
B_lymphoma_3,pert
genotype: C57BL/6 Ptenfl/flFoxp3-Cre,pert
M454 SKM-Tg,ctrl
Patient no. 9: treated,pert
"Mouse ex-iTreg cells, replicate pool 1",pert
Weight:High;	CFstatus:control;	Sex:Male,ctrl
Human Uninfected Sample N050-CD8+ T cells,ctrl
Ulk1/2-/- (untreated) 2,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 79 years,pert
treatment protocol: depleted BRCA1,pert
Control [G3],ctrl
patient id: 131;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 51;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
Huh-7/Fluc rep1,ctrl
"Mouse heart, IDH2 R140Q mutant, replicate 3",pert
"BPL adrenals, replicate 1",ctrl
SLE CD19 B cells 14,pert
SZ24,pert
Human prostate cancer primary culture C39sx,pert
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P55;	clone: C18,pert
"Hdh knock-in embryonic stem cells, Q91 line, biological replicate 1",pert
C5med,ctrl
"Control subject, biopsy taken from the colon, no macroscopic signs of inflammation.",ctrl
EA_Control1_CD20,ctrl
p300_2,pert
TNKSi 4h biological replicate 1,pert
CTL2 AO 4hr,ctrl
"brain, hippocampus: C24-II_e1_le1",ctrl
Bone-Marrow_SMM_S1377,pert
"rat hippocampus (CA1 region), sham, 18 months old, subject 9",ctrl
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 43;	gender: f;	treatment: -,ctrl
"35B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
cell line: HepG2;	cell type: Human hepatocellular liver carcinoma cells;	genotype/variation: HIF-1α knockdown;	cell subtype: 10 days old tumor spheroids,pert
platelet_sickle_7,pert
"Mdr2-KO heterozygous mouse, 12 month old mouse 3",ctrl
Squamous cell carcinoma 032,pert
"endometrioma, patient 2",pert
"human failing LV myocardium, Idiopathic50",pert
L1 062502 Tro1,pert
BalbC_24h-DMSO,ctrl
FmrWT5_blood,ctrl
T133 U133p2,pert
Subject #8030-Preinfection,pert
tissue: blood;	patient: 3;	gender: male;	age: 59,pert
48 hrs TAC-1,pert
1015-01-A,pert
long-Con rep2,ctrl
SZ20,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 2;	gender: male,pert
"AALE-Vector + shTBK1, biological rep2",pert
"RPMI8226_shKLF2#2, replicate2",pert
01LR6_ERA,pert
MCF-7 +scrambled siRNA + vehicle rep1 (MD39),ctrl
NPC_SA01_2,ctrl
HMEC_50 vs HMEC_41,ctrl
jzo016-rp1-v5-u74av2-met,pert
strain: Fisher 344;	gender: male;	age: 18 months;	tissue: hippocampal CA1 brain;	treament group: sham,ctrl
P0 - WT129s6 2,ctrl
CLL15-CD4,pert
"Lesion Skin, LS-20",pert
strain background: Mixed; mostly C57BL/6 with some 129S/SvImJ (from CJ7 ES cells).;	genotype/variation: wild type;	age: 9-day old;	tissue: bone marrow;	cell type: long-term hematopoietic stem cells (LT-HSC);	cell type: Lin-Sca1+Kit+CD48-CD150+,ctrl
BALB_Female_Control_rep2,ctrl
HC-WT-15B,ctrl
Day: 15; Drug: Saline; Phase: Withdrawal; Replicate: 3,ctrl
RNA from HCC_9T,pert
Jejunum_POR-null+quercetin_2,pert
HGPS-iPSC replicate 2,pert
Wt_ liver_fasted_refed_3hr_ rep1,ctrl
"BMMs, untreated control, db, Replicate 3",pert
"SLE patient, 1001V1",pert
Lung-sarcoidosis-rep4,pert
"Lesion Skin, LS-7",pert
lesion_postUV_patient2,pert
control participant P312,ctrl
GB 10 65B NO LPA,ctrl
RatLung_H16h_3,pert
"patient 15, baseline",ctrl
KU_39T,pert
"Control siRNA - Undifferentiated, rep1",ctrl
CTL2 E2 24hr,pert
"Diagnosis:AML M2;	Age: 66y ;	Gender: Male;	Blast %: 87;	Source: PB;	Cyto: INV9, INV14;	FLT3 ITD: No Data;	FLT3 TKD: No Data",pert
"CCM3 shRNA cells passage 7, rep 1",pert
F/F.ES. rep1,ctrl
05_C57_KO,pert
A2008-(2),ctrl
C57/BL6 C3KO murine Liver RNA- 6 hours post-injection with a 1st generation (E1-E3-CMVLacZ) vector.,pert
Cre_day_7-2,pert
S25 NLS 142Q TG2	F4/26	S25	NLS Htt exon 1 142Q	Mouse	3 months	Cerebellum	Male,pert
RatLung_H24h_3,pert
Seguin_IDR_BrownNorway_Liver_treated6,pert
RTX6 T0,ctrl
strain: C57BL/6;	genotype/variation: KLF5 WT;	cell type: LSK BM cells,ctrl
genotype: wild-type;	cell type: naive CD8 T cells;	genetic background: C57BL\6,ctrl
SKI-DLCL cells cultured for 24h,ctrl
PBMC from T cell LGL leukemia patient #132 (TLGL132),pert
SALL4 shRNA biological rep1,pert
"Uninvolved Skin, NS-16",pert
25SAGEA,pert
Patient identifyier: C;	Sex: male;	Age of patient: 32 years;	Duration of psoriasis: 17 years;	Body surface area: 8 percent;	Overall erythema: moderate;	Induration: severe (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 41 yr;	population: white,ctrl
cell type: PBMCs;	disease state: healthy control;	gender: male,ctrl
Moderate rep3 (retina),pert
Z6_TA,ctrl
K562 cells control replicate 4,ctrl
CTRL_3_MEP,ctrl
WT-sham-2 month-R1,ctrl
Bl6_WAP_3,pert
TTE3 cells treated with BPA for 0 h-1,ctrl
patient: 40843;	sample: tumor,pert
tissue: brain;	genotype: mutant Dcx ko/Y;	age: E14,pert
GIST Pre Treatment Biopsy 03,ctrl
Wild-type E11.5 proximal hindlimb pool 3,ctrl
"Gender: Female, Age: 29, BMI: 22, Tissue: luteinized cumulus cells",ctrl
embryons of mice at 14.5 days.,pert
CME-LaminA3d-1MA-S2,pert
Stratagene Human Universal Reference Pool,ctrl
age: 11;	sex: F;	disease status: control subject;	Filter number: 94;	Usage number: 1;	Exposures: 3,ctrl
Gender: male;	Age: 31;	Ethnicity: White,ctrl
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 1.5,ctrl
Sample 3 Posterior  +/+,ctrl
subject id: 3;	infection: DENV;	status: DF;	tissue: whole blood,pert
Adult 7d SNI; Biological replicate 5,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.681;	OD280: 0.848;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 219;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell line: HCT116;	clone: 20;	genotype: Wild type,ctrl
B5_Pseudomonas_overexpressor_48,pert
agent: ConA;	time point: 3 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
"46B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
ccRCC tumor of patient T163,pert
Backskin_Get1_e18_KO3,pert
Pancreatic Sample 31-Tumor,pert
3030,pert
HTB58_antiEvi1siRNA_1,pert
siNS_4h_4,ctrl
Pertuzumab treated after 4 days (P1_2),pert
treatment: control knockdown;	cell line: J1 ES cells,ctrl
host strain: nude mice;	injected with: iNRAS-475 mouse melanoma cells;	tissue: Melanoma allograft;	treated with: vehicle,ctrl
tissue: minor salivary gland;	disease status: early SS,pert
Muscle PCOS control 6,ctrl
Parkinson's disease sample x045,pert
"Wild type used for GNMT 8 month, replicate 1",ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day0,ctrl
"seminoma specimen, pT2, patient age: 37y",pert
erStress_twins_AA_1734twin2_DMSO_4h,ctrl
Human skeletal muscle biopsy sample;	Patient #128 with NORM,ctrl
Cervical Cancer C517,pert
multiple myeloma (MM 370),pert
patient: 206;	current medication: Asacol 800mg BD;	birth date: 9/10/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/80;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"Heart, MAT1 CKO, 4 wk, sample 1",pert
control participant P317,ctrl
"0mg/kg/day PFOA, Rep 5, Block 3, lung (low dose)",ctrl
WT osteoclasts untreated 2,ctrl
"proband i, before exhaustive exercise",ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 114;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 258;	age-at-biopsy-years: 65,pert
normal main pancreatic duct 6,ctrl
KU-812 non-treated,ctrl
WT P2 replicate 3,ctrl
4010-3 E2F2 Null,pert
"DBA/2J ACU, Rep2",pert
Patient no. 18: control,ctrl
R6/1 22 week transgenic_BD1Bv1,pert
CD4IncTp2-2,pert
BCR/ABL1 biological replicate 2,pert
WT1 activated CD8 T cells,ctrl
ESE_D_517,pert
knockout mouse kidney - 2,pert
CTRL_4_HSC,ctrl
E9.5 FVB/N erythroid cells-9,ctrl
EP34_adipose_pcos,pert
COV434 Wildtype [RR1020],pert
tissue: testis;	genotype: WT;	genetic background: C57BL/6,ctrl
NALT_infected_24h_90-226_rep3,pert
LCL Unaffected MZ twin pair 1 (CCN1.1)(TP13),ctrl
WT-sham-5 month+1d-R4,ctrl
MCF10A-Myc-rep1,pert
strain/background: C57BL/6;	genotype/variation: wild type;	tissue: lung;	treatment: PBS control,ctrl
"IRF6 knockout, biological rep3",pert
HVS-CD4-control_unstim_rep1,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 53 yr;	population: white,ctrl
chip number: 21;	transfection plate: 4;	target gene: IRF9;	kd level: 0.7;	rin: 9.5;	transfection date: 2011-10-17,pert
"genetic background: B6;	genotype/variation: Xbp1 knockout;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",pert
No or early 1 rep4 (retina),pert
10_b,pert
AMWT_Ker42,ctrl
3975-1 E2F1 Null,ctrl
SIRT4 WT liver_7587,ctrl
pB  is a clonal control (puromycin resitant) stably-expressing stem cell line,ctrl
Replicate 1 - Vehicle,ctrl
AFFS084-6-291004,pert
14-week-old Trim24-/- liver_463M,pert
KO (Rnh1-/-) -2,pert
gender: F;	age at blood draw: 37;	tissue: whole blood,ctrl
BP patient 60_biological replicate 1,pert
patient: 220;	current medication: Asacol 800mg BFZ 2.5mg Metformin Simvastatin;	birth date: 6/28/48;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/10/95;	diagnosis date: 3/25/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/10/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/10/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/90;	smoking amount: 5-14;	other illnesses: Type 2 DM.;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
Cell line expressing inducible GFP-progerin. Induction: day 0. Replicate B,pert
Gender: Male;	Age: 25;	Ethnicity: White,pert
"human nonfailing LV myocardium, NonFailing15",ctrl
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep2,pert
H3med,ctrl
"Heart, MAT1 control, 2 wk, sample 3",ctrl
"Other: Equal quantities of total RNA from each cell line (brain, breast, B-lymphocyte, cervix, liver, liposarcoma, macrophages, skin, testis, Y-lymphocyte) were pooled together.",ctrl
"Uninfected, replicate 2",ctrl
A HID B_B041,pert
01LNJ: normal control,ctrl
"WT, PR04M001v0",ctrl
scan batch: Batch 1;	group: control;	subject age: 5;	paternal age: 32;	maternal age: n/a,ctrl
patient: 220;	current medication: Asacol 800mg BFZ 2.5mg Metformin Simvastatin;	birth date: 6/28/48;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/10/95;	diagnosis date: 3/25/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/10/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/10/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/90;	smoking amount: 5-14;	other illnesses: Type 2 DM.;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"human nonfailing LV myocardium, NonFailing16",ctrl
Akt1-deficient 2,pert
ASO T00278947,pert
sample =XCGD6 treatment=Stimulated time=180 (min),pert
0577-01-A,pert
cerebrum_PSNA_ 0d_rep2,pert
tissue: Brain;	genotype: Npc1+/-;	age: 67 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
s2t0c,ctrl
HepG2_Phenol rep2,pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,pert
Placenta_PE(LO)1,pert
strain: C57BL/6;	tissue: Lung;	agent: bleomycin;	genotype/variation: FIZZ2 knockout,pert
MCF-10A shCHK1-4 replicate 3 [set 5],pert
NSC_ DMSO_24h_biological rep2,ctrl
ccRCC tumor of patient T26,pert
"ESCs overexpressed vector control, biological rep3",ctrl
EBS_5,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.732;	OD280: 0.907;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 138;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
subject id: c7;	infection: control;	status: control;	tissue: whole blood,ctrl
"Normal cervix epithelium, Age 41",ctrl
11391 Normal Uninflamed ascending colon,ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype squamoid/giant cell;	matched/unmatched: unmatched,pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 74;	Usage number: 1;	Exposures: 4,pert
Wild type_heart_3,ctrl
CHB PBMC_sample 8,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 29;	sex: F,ctrl
"human failing LV myocardium, Ischemic46",pert
MDS patient 159,pert
"RES-enriched Grape extract group, 12 months, patient number 13",pert
IPMA 6,pert
OVCAR-10+(1),pert
NSCLC cell line H157. Transfected with Oligofectamine (Invitrogen) without RNA,ctrl
T1008ni,pert
BN DES-treated replicate 2,pert
HEK293 transiently EWS-FLI1-transfected 2,pert
"Mdr2-KO heterozygous mouse, 12 month old mouse 1",ctrl
"SLE patient, 1004V1",pert
NTG 1,ctrl
RKO_HSF1siRNA_6hDMSO_REP2,pert
IPMC 3,pert
HT29 resistant cells replicate 3,ctrl
KL2_muscle_control,ctrl
Muscle Control 3,ctrl
"Lesional tail skin from K14-Areg mouse, biological replicate 3",pert
n4t30m,pert
WT_POST_PDE_059,ctrl
GATA3KO_2,pert
A_AN11989_C,pert
"PCB77 treated HepG2 cells at T0.5, biological replicate 3",pert
P0 - lis1cko/ko Mix 3,pert
"Retina from NeuroD1 cKO mouse at ZT20, biological rep 2",pert
DMN-CtrHippo28d-1aAv2-s2,ctrl
0967-01-C,ctrl
"bipolar disorder, BA10-18",pert
"p38alpha knock out fetal liver E13.5, biological rep1",pert
breast cancer patient 232,pert
liver western diet 0.05% quercetin rep1,pert
U2OS_control_shRNA_pLenti_1,ctrl
"Biceps, FSHD, cohort 07, subject 07A",pert
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 40;	Usage number: 4;	Exposures: 2,pert
PBMC from T cell Large granular lymphocyte leukemia patient#132,pert
ic6 -- mock APF#1 on cell line 1,ctrl
"Patient 16, Macroscopically intact tissue",ctrl
erStress_twins_AA_1717twin1_500nM_thapsigargin_4h,pert
Wild type MEFs from 13.5 day embryos,ctrl
tissue: heart;	genotype: Gata4_KO;	age: 8 week adult mice,pert
Normal-ERα-positive breast cancer 66,ctrl
E9.5 embryo_wild-type_rep2,ctrl
tissue: tumor tissue from cancer patients;	genotype: p53 wild type;	disease state: Microsatellite Stable Stage III Colorectal adenocarcinoma,ctrl
tissue: testis;	gestational age: 16 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: DBP,pert
PC-3M/MYB siRNA #3,pert
MCE301 cells treated with SB for 0 h-1,ctrl
striatum_Pink1 knockout_24 weeks_replicate 3,pert
NE-rep6,ctrl
RPE65_KO_6months_retina4,pert
Targretin_Lung_1,pert
umbilical cord_nobpd: 9D,ctrl
T123,pert
Substantia nigra PD rep1,pert
Cdx2_H2,ctrl
1705-EV_24hr,pert
Ishikawa_VeryHighDose_BPA_24h_rep3,pert
chip number: 18;	transfection plate: 4;	target gene: GTF2B;	kd level: 0.55;	rin: 9.3;	transfection date: 2011-10-17,pert
"gender: Male;	age: 72;	post-mortem delay: 12h;	ph: 6.8;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
cell line: OV90;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
patient: 107;	current medication: None;	birth date: 07/28/1060;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
db/db 11-3,pert
"control, BA10-42",ctrl
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: LOW;	genome/variation: PDGFRA mutation detected,pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: STZ,ctrl
Kidney_saline iv_mouse #001,ctrl
Colon_Wild Type+Quercetin_3,pert
Cervical Cancer C405,pert
liver-AHRKO-cornoil-rep3,pert
Subject #8042-2d Postinfection,ctrl
"Peripheral blood, patient without recurrent events [N41]",pert
Nrl ko P10 replicate 1,pert
Empty Vector Control for transient transfection replicate 2,ctrl
"Crohn's Disease subject (41 year old caucasian female, SAK_1277825109)",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 22.31507,pert
Shn2_Wildtype_2,ctrl
"PBMC, healthy control, biological rep8",ctrl
"RWPE1 cells, vehicle, 6h, biological rep4",ctrl
strain background: C57Bl/6;	genotype/variation: BATF-/- P14 TCR transgenic C57Bl/6;	cell state: Day 0 Naïve CD8+ T cells,pert
MCI-017,pert
osteoblast_control_rep3,ctrl
"NASP siRNA treatment, sample #2",ctrl
genotype: wild type;	cell type: colon epithelial cells;	gender: male;	treatment: water,ctrl
Bl6_WAP_1,pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3WT;	age: 12 weeks;	nutrient state: 24h fasted;	diet: Standard diet,ctrl
Txnip deficient normal 24 months sample 2,ctrl
ab180 N,ctrl
Individual_4503_PP_sample,pert
"human failing LV myocardium, Ischemic81",pert
"knockout white adipose tissue, biological rep 1",pert
"Patient 7, Atheroma plaque",pert
NCCIT siTET3 rep1,pert
cell line: HEK293T;	transfection: si-control;	induction agent: CM;	induction time: 4 hours,ctrl
24 hr KLF4 Time Course Induced,pert
Osteoblasts_Lrp5_Knockout_Day7_rep4,pert
"normal skeletal muscle, biological rep2",ctrl
WT4-iPS 1,ctrl
lymphocytes_HD_F_36y,pert
Tgfbr2 Wildtype Mouse Model MEPM 3,ctrl
cbp+/- standard cage Rep2,pert
22B,pert
PBMC from T cell Large granular lymphocyte leukemia patient#124,pert
"brain, hippocampus: Ctr-72h-P15-I_e1_le1",ctrl
WAT from wild-type control fed regular chow diet Replicate 2,ctrl
"Pten null fibroblasts, biological rep3",pert
Seltzer 21d replicate 3,pert
"Retina from NeuroD1 cKO mouse at ZT6, biological rep 2",pert
"Deltoid, control, cohort 03, subject 03U",ctrl
6 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24724,pert
cell line: ACC525 [DND41];	cell type: human T-ALL cell line;	agent: control,ctrl
"patient 036b, cancer, homogenized",pert
"treatment: control;	batch: 5;	donor: 5;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
MO32_18,ctrl
Human Acute HIV Sample A051-CD4+ T cells,pert
patient: 242;	current medication: Salazopyrin Folic acid;	birth date: 10/18/39;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/75;	diagnosis date: 1/1/75;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/22/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/22/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
92.1 - siBAP1 - replicate2,pert
pediatric AML PP8,pert
DS2-iPS 3,pert
3wks sham-1,ctrl
HC MB 2 alcohol,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 225min;	race: White;	sex: Male,pert
untreated AML 7C blasts,ctrl
gender: male;	tissue: gastrocnemius muscle;	age: 7.5 months;	genotype: Mstn ko,pert
"210, MUSCLE, After",pert
431MM,ctrl
3783-lcm,pert
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 7;	gender: male,ctrl
phenotype: alcoholic;	gender: male;	case_id: 351;	age: 42;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 41;	brain ph at time of freezing: 6.5;	labeling_batch: 2,pert
Ribavirin Treated Cells 2,pert
HEK293_ControlsiRNAConfluent_rep1,ctrl
E2 8hr,pert
Control 60 days sample 2,ctrl
"heart of mouse, 1 week control (1A)",ctrl
"Uninvolved Skin, NS-13",pert
intestine_PPARa_kockout_24hfasted_rep3,pert
HepG2_Cd rep1,pert
CPU R control 2,pert
"male, 275-300g",pert
"age at diagnosis: 76;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIIB;	t (extent of primary tumor): T4;	n (lymph node metastasis): N1a;	er: NA;	pgr: NA;	dfs-month: 48;	dfs-event: 0;	distant metastasis: 0",pert
genotype/variation: Tsc2 +/- mouse;	tissue: cerebellum;	gender: Female,pert
ACC Xenograft X1,pert
strain: FVB/NCrIBR;	tissue type: tail skin,ctrl
TYK-nu+(2),pert
AVIC sample#1 treated with DAPT,pert
"human failing LV myocardium, Idiopathic75",pert
F4,ctrl
LCL Unaffected MZ twin pair 2 (CCN2.2)(TP18),ctrl
LNCaP R1881 rep 3,pert
HF0251_U133P2,pert
"Kidney from MON exposed rats, biological rep 4",pert
strain: CD-1;	age: 20 week;	tissue: heart left ventricle;	genotype: dominant negative CREB1 driven by cardiomyocyte-specific myosin heavy chain-? promoter,pert
LNCaP.GFP.5,ctrl
"knockout liver, biological rep 3",pert
DBA d3 (185msn),pert
HCV_Core_1,pert
H2_SS12_01Nov07,ctrl
Infergen_24hr,pert
11437 UC Inflamed sigmoid colon,pert
"ATP7B -/- KO mice, 6 weeks old",pert
Strain CD-1,ctrl
"human peripheral blood derived monocytes, 2 hour LPS stimulation, biological rep2",pert
A_AN19511_T,pert
"Rat liver, treated with DMN, 15 mg/kg in water per orally, extrated 48 hours after treatment, biological rep3",pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_24_10_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes;	1st technical replicate,pert
"brain, lateral and medial ganglionic eminences: Arx+/Y #1_le1",ctrl
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: REBIF;	time: 12 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
DMSO2,ctrl
"Ulcerative Colitis (37 year old caucasian female, SAK_1286609838)",pert
"Peripheral blood, patient without recurrent events [N27]",pert
C13-(1),ctrl
SKNSH MECP2_e1 1,pert
"non-AD_HI, biological rep7",ctrl
"A549, -TNFα, control siRNA, rep1",ctrl
cell line: HCT116;	shRNA: CDK19;	treatment: untreated,pert
disease state: healthy control;	tissue: epidermis;	age: 59;	gender: male;	treatment: untreated;	time: control,ctrl
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-2;	Primary Site:Floor of Mouth;	Age:58;	Sex:F;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",ctrl
K562 cells control replicate 7,ctrl
subject: 2825 WT;	type: wild type;	tissue: Mouse skeletal muscle,ctrl
"Lesion Skin, LS-12",pert
Early IPF_surgical biopsy_upper lobe_rep149,pert
ApoD KO rep_3 (CKO3),pert
MCF-7 +scrambled siRNA + 100 nM 4-hydroxytamoxifen rep1 (MD33),pert
control mice colon rep 3,ctrl
clone 42 replicate 1,ctrl
3 weeks TAC-2,pert
06 PLUS OHT 3,pert
MIY_day_3-4,ctrl
"Peripheral blood, patient without recurrent events [N46]",pert
PND28 Rat Testis_Rat230-2_2hr MEHP_Animal#43_04005,pert
0970-01-C,ctrl
20A;pretreatment;female;breast tumor,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 13.0;	age of psoriasis onset: 30,pert
Patient: D;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
"Ulcerative Colitis (45 year old caucasian male, SAK_1286475720)",pert
"B10 sham kidney, biological rep3",ctrl
"MCF7 cells stably transfected with XBP1, passage 2",pert
brain_DLPFC_bipolar C_mr645,pert
hdh genotype: Q111/Q111;	tissue: cerebellum;	age: 3~10 weeks,pert
New El-Ashry 001.CEL,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day7,pert
MOLM14_shSYK_1_Replicate1,pert
Cerebellum_nontransgenic control A39_10 months_replicate 3,ctrl
lymphoma_5783_nt,ctrl
"103, MUSCLE, Before",ctrl
PBMCs_Control_3 [IS],ctrl
LCL Unaffected MZ twin pair 5 (CCN5.2)(TP28),ctrl
B_LS_Wk1,pert
D_LS_Wk1,pert
1197-03-A,pert
cell type: monocytes;	disease state: renal cell carcinoma (RCC),pert
High weight gainer KOZAK2_ABI_HYP_H1,pert
nucleus accumbens ctrl replicate 2,ctrl
sample type: HeLa-LAMP3siRNA-3d;	cell line: HeLa;	knockdown: LAMP-3 siRNA;	time: 3d interferon alpha;	treatment: interferon alpha,pert
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 1h;	donor: 3,ctrl
16L,pert
"120, ADIPOOSE TISSUE, After",pert
"Epithelial prostate primary cells from fresh explant of controlateral normal tissue characterized by the presence of few areas of ""PIN"" (Prostatic In Situ Neoplasia)",ctrl
esophageal squamous cell carcinoma from patient E2644,pert
SLE myeloid cells 4,pert
HF0966_U133P2,pert
ANL Chip#31,pert
PGA_MI_nilv_8w_311,pert
RO38,ctrl
Lmna H222P homozygous male 6,pert
5264 UC Uninflamed sigmoid colon,pert
"Global gene expression of NASH patients, normal control A99",ctrl
whole tissue section from case 1125,ctrl
Adrenocortical adenoma with wild-type CTNNB1-3,ctrl
Normal-BM 3,ctrl
"Rat liver, treated with ANIT, 125 mg/kg in corn oil per orally, extrated 48 hours after treatment, biological rep3",pert
"Patient 17, Atheroma plaque",pert
HP-65,pert
"age at diagnosis: 69;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N2a;	er: 1;	pgr: 0;	dfs-month: 31;	dfs-event: 1;	distant metastasis: 1",pert
JoMa1_1,ctrl
Retina wildtype 30 days 3,ctrl
"BMMCs from NTAL KO, noninfected, 2 h activated, biological rep3",pert
"HL-60 + 100 µM curcumin, biological replicate 2",pert
subject id: 4;	infection: DENV;	status: DF;	tissue: whole blood,pert
Postmenopausal female. Untreated control. nr 12.;	Replicate,ctrl
cumulus_PCOS_Lean_rep4,pert
P 27 Control,ctrl
brain_Down_syndrome_sampleid_jg1740,pert
WM-266 cells transfected with CONTROL siRNA - Replica 2,ctrl
tissue: white blood cells;	age: 16.61;	Sex: female,pert
"Gender: female;	Age: 51;	Source: skin, neck",pert
normal 1502,ctrl
HeLa Cells,ctrl
Lymphedema Tail Skin 1,pert
Sex: female;	Age at operation: 67 years;	Site: thigh;	Size in cm: 35x15x12;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
Dengue Fever Patient 37,pert
Plate vs. Nail:  3 Day Nail,pert
strain: C57BL/6;	genotype/variation: wild type;	gender: female;	sample type: control,ctrl
whole blood_100961,pert
WT vehicle (7991003028_E),ctrl
Allo-25-2,pert
Etoh 6,ctrl
thoracic mammary glands were collected from three virgin F1 CF-1/FVB LH-overexpressing (transgenic) mice at 16 weeks of age and pooled before synthesis of cDNA,pert
MV 3,pert
ns VC 1,ctrl
ND_5,ctrl
GM19238_Kd_ESRRA_2,pert
Gene expression of murine fibroblast-like synoviocytes Grp2_C57BL6_2_FLS_TNFtg,ctrl
V5-P077,pert
SLE CD19 B cells 13,pert
Mouse RSK2 mutant mandibular molar [ABH_16A],pert
"Gender: Female, Age: 33, BMI: 33, Tissue: luteinized cumulus cells",ctrl
100uM H2O2 rep 4,pert
Recent-onset T1D_sample9,pert
"Wild type used for GNMT 3 month, replicate 4",ctrl
12472 UC Uninflamed ascending colon,pert
strain: C57BL/6J;	day: 24;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
Psoriatic arthritis PsA 2,pert
"GFPMYC positive GC B cells, Biological replicate 5",pert
Parkinson's disease sample x032,pert
"MCF-7, 12h, 0.3mM 5FU",pert
tissue: liver;	gender: female;	disease status: normal glucose tolerance,ctrl
Mouse_ESC_Pcl2_mismatch_control_sample 3,ctrl
Dengue Fever Patient 80,pert
"EAE, 1,25(OH)2D3-treated #8",pert
C3_CLP_overexpressor_12,pert
"DMSO-treated NRK-52E cells at 24h, biological rep 3",ctrl
Y HID_B002,ctrl
3 wks sham-3,ctrl
cell line: MCF-7;	expression: Control,ctrl
control participant P332wh,ctrl
Seltzer 50d replicate 1,pert
"Index, patient2",pert
wild-type mouse kidney - 2,ctrl
sample =XCGD4 treatment=Stimulated time=180 (min),pert
Normal Puerto Rican control 3,ctrl
Liver_POR-null_3,ctrl
Mening SWB WB NP 12b,pert
"4302_CD133-, untreated",ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 274;	age-at-biopsy-years: 49,pert
vacht KD 3,pert
HepG2 cells quercetin 24h,pert
Ad-rep1,pert
Disease_status: Bipolar disorder;	Age (years): 43;	Gender: Female;	Age of onset (years): 29;	Duration of illness (years): 14;	Brain pH: 5.92;	Post mortem interval (hours): 57;	Side of brain: Left;	Fluphenazine mg. Equivalents: 10000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 33, stage IIB, HPV 16",pert
"WT Heart with no treatment, biological rep3",ctrl
"uninfected primary RPE, biological replicate 4",ctrl
7d-Sham-81,ctrl
S-IIP(UIP)4_Cy3,pert
cell line: FU-OV-1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
N/LV4,ctrl
MCL_IGHV_UNMUT (R1328),ctrl
16C-M4-D,ctrl
Control 26,ctrl
PB_healthyControl_III,ctrl
P4_Ovary_Control_biological rep1,ctrl
"cell line: prostate cancer, PPC1",ctrl
"Lesional tail skin from K14-Areg mouse, biological replicate 1",pert
CLL19-CD4,pert
BALB/c control (bmsnmix9),ctrl
Postmenopausal female. Untreated control. nr 38.,ctrl
cell line: SNB19;	transfection: Scramble siRNA,ctrl
PTC BRAF wt 7,pert
cell type: human peripheral blood memory B cells (MBCs);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
WT 541 L5,ctrl
age: 5;	sex: F;	disease status: control subject;	Filter number: 105;	Usage number: 1;	Exposures: 3,ctrl
C_AN04479_F,ctrl
"Global gene expression of NASH patients, P55",pert
clone 48 replicate 1,ctrl
SKBR3-R_1uM_Lapatinib_3,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339032,ctrl
cell type: epithelial cells,ctrl
"PMA treated, doxycycline treated; biological replicate 3",ctrl
"DMD skeletal muscle, biological rep20",pert
06R041 RA,pert
PGA-lv_1w_672,ctrl
liver_co_6M_rep1,ctrl
sepsis patient #17,ctrl
"57B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 80;	time: 0;	batch: 3,ctrl
gender: female;	batch: 1;	age (years): 33;	patient id: Control_6;	fev1 (% predicted): 116;	fvc (% predicted): 115;	medication: None;	cell type: CD4+ T-cells,ctrl
11432 UC Uninflamed sigmoid colon,pert
"affected status (disease state): control;	gender: female;	age-at-examination: 73;	age-at-onset: n/a;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia",ctrl
chip number: 15;	transfection plate: 4;	target gene: IRF8;	kd level: 0.65;	rin: 9.3;	transfection date: 2011-10-17,pert
"RWPE1 cells, vehicle, 6h, biological rep2",ctrl
NFIA P16WT3,ctrl
tissue: bone marrow;	cell type: macrophage;	genotype/variation: WT;	infection: uninfected,ctrl
lung_silica_1,pert
14.5_WT_522C,ctrl
Saline treated mouse gallbladder 3,pert
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b(jmjc) retrovirus,ctrl
cerebrum_WT_10d_rep1,ctrl
B4 392 b4-/- after nicotine-induced seizures,pert
MGd_1,pert
H13 HA 6h 3,pert
"control, BA46-24",ctrl
Y HID_B038,ctrl
Oct4GipES_Luc_esiRNA_72h_rep2,ctrl
Nrl ko 2 mon replicate 2,pert
normal adjacent esophageal tissue from patient E1507,ctrl
lesion_preUV_patient10,pert
"Empty vector, collagen plate, rep1",pert
Normal_MS 36A5,ctrl
Liver sample of p14 KO mouse 1,pert
Control (C60),ctrl
CF (D508) subject9,pert
brain_DLPFC_bipolar B_mr409,pert
T-REx293-NPAP1-induced-3,pert
WFS1 WT USHT_11_326_wt,ctrl
GEIM39-U133A-DM,pert
"WT cells, replicate 4",ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: LPA,pert
"acutely admitted, severely psychotic schizophrenia patient  A06",pert
-DOX/-E2_2,ctrl
Subject #8040-Preinfection,pert
status: Control;	gender: Female;	age: 47;	tissue: Blood,ctrl
ic9 -- Cell line 2 treated with APF#1,ctrl
WT1 PBS,ctrl
BN DES-treated replicate 3,pert
"BOEC, not_at_risk 6",pert
patient id: T144;	tissue: Normal cortex;	gender: Male;	age: 74;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
sample type: Negative control;	cell line: H1;	cell type: embryonic stem cell;	protocol: control;	time: 3 Days,ctrl
5249 UC Uninflamed sigmoid colon,pert
RORasg/sg WAT_HFD_rep2,pert
cerebellum_wild type_12 weeks_replicate 3,ctrl
PsOEt-15-LS,ctrl
SRF Wt. IgM+IgD+ (GBF0551),ctrl
APP_R6_rep2,pert
Kidney_200 mg/kg VCM iv_mouse #030,pert
cell type: embryonic fibroblasts (MEFs);	genotype: FIH null,pert
Substantia nigra PD rep10,pert
strain: C57B6;	genotype: Tgfbr2fl/fl;Wnt1-Cre;	tissue: Secondary palate;	age: E14.5;	gender: Not determined,pert
"siRNA, plastic plate, rep3",ctrl
PWD/PhJTCE liver sample batch 1,pert
"MCF-10A cells, overexpression TAp63γ, biological rep2",pert
GM19238_Kd_POU2F1_3,pert
LY2 control-siRNA tamoxifen treated rep2,pert
siTNIK+4hr Wnt,pert
KGN Knockdown [RR1008],pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 36;	gender: male,ctrl
No or early 1 rep5 (OHN),pert
Wildtype_XY_1,ctrl
brain_DLPFC_bipolar B_mr678,pert
WT-pDC1,ctrl
"breast tumor epithelium,24",pert
Patient: I;	Time: 0;	Group: responder;	Condition: lesional,ctrl
12490 UC Inflamed descending colon,pert
DBA/2JTCE liver sample batch 4,pert
"ALL_DS, K24 011609",pert
Bone Marrow Mononuclear Cells;	24y Male,ctrl
cKO_P69,pert
"Wild-type-neocortex, biological rep9 (female)",ctrl
pRb+/+.2,ctrl
4_day_old_Prnp_knockout_mouse_rep2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.242;	OD280: 1.1;	Ratio: 1.97;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 288;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"SS gland, early, patient 5, batch 1",pert
LCL Unaffected MZ twin pair 4 (CCN4.1)(TP25),ctrl
A375 Wnt1-2,pert
Calu3-GemR_Veh_3,pert
"in vivo,2 cell stage, embryo",pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. E2 + 1 uM vehicle (ethanol) for 24hr;	batch: 3,pert
tissue: skin;	individual: Patient P14;	condition: AL;	eczema severity: SCORAD: 33,pert
Control Day14 (329L),ctrl
NPC_wt_rep1,ctrl
"AD_FC, biological rep5",pert
F191G C,pert
130A,ctrl
4040-1 E2F3 Heterozygous,pert
GIST Pre Treatment Biopsy 39,pert
GFP A,ctrl
CD4+_Tcells_severe_asthmatic_4,pert
Mut-/- rep4,pert
umbilical cord_nobpd: 1A,ctrl
tissue: Temporal cortex;	age: 84;	Sex: F,ctrl
HeyC2+(2),pert
V5-P482,pert
"control, BA46-19",ctrl
Non-silencing control siRNA: AAUUCUCCGAACGUGUCACGU Technical Replicate 1,ctrl
Bone-Marrow_MM_M1155,pert
brain_DLPFC_bipolar C_mr701,pert
cell line: SBC-5 cells;	treatment: siEGR4 (target);	time: 24 hr,pert
"Exp A, Animal #262, 20mg/kg D-Serine",pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 232;	age-at-biopsy-years: 59,pert
"brain, cochlea: [1] Sample #1_le1",pert
"11B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Normal-ERα-positive breast cancer 2,ctrl
110B,ctrl
PGA-RMM-7h-3aA-s2,pert
diseased_media,ctrl
CD4+ CD25+ Foxp3- T cells,ctrl
E_LS_Time0,ctrl
age_years: 37;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
"Strain: C57BL/10J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle Treated with AAV carrying Galgt2, Deficient in Dystrophin",pert
T64 dilated cardiomyopathy heart biopsy,pert
HCT 116  siChe-1 rep3,pert
chip number: 14;	transfection plate: 4;	target gene: IRF8;	kd level: 0.66;	rin: 9.3;	transfection date: 2011-10-17,pert
Cisplatin_24h_rep3,pert
EosKOCD25+#2,pert
"breast tumor epithelium,11",pert
tissue: Frontal cortex;	age: 89;	Sex: M,pert
strain: FVB/NCrIBR;	tissue type: ear skin,ctrl
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep2",ctrl
major HCC8,ctrl
BAL_42_A0B0,ctrl
"46B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
patient id: T166;	tissue: Normal cortex;	gender: Male;	age: 56;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: oral cavity;	donor sex: male,pert
NSC4,pert
"Tet1 KD, rep3",pert
V5-P157,ctrl
tissue: lesional skin;	urticaria status: affected;	patient: 2,pert
tissue: tumor;	cell line: SK-BR-3;	origin: luminal-like;	transfector: TFPI alpha,pert
"scr-Rosi, biological rep1",pert
siControl_rep_2,ctrl
Wild-type CS_2_16_WT_3,ctrl
PFR3K650E_replicate_4,pert
"heart of mouse, 2 week control (1A)",ctrl
miR122-KO-94,pert
P0 - lis1cko/ko Mix 2,pert
SALL4 shRNA biological rep3,pert
Empty vector control (RNAi 1B)_3of3,ctrl
wild-type 1,ctrl
HSC-3_vector_48hr culture_rep2,ctrl
Control (C275),ctrl
WT A,pert
"Patient W, uninvolved skin",ctrl
MLL_00111,ctrl
"Ifitm1-deficient lung tissue, biological replicate 3",pert
Patient no. 1: control,ctrl
s4t0c,ctrl
WT_P14_D3_Effector_rep1,ctrl
HCC PBMC Sample 4,pert
LM2 cells,ctrl
DW298_Tg_M,pert
"Crohn's Disease subject (61 year old caucasian male, SAK_1316018592)",pert
MCI-004,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 5d ID138,pert
M479 Wt,pert
cell type: T cell;	disease state: heterozygote FH,pert
erStress_twins_AA_1727twin1_500nM_thapsigargin_4h,pert
WKY16-2,ctrl
BC6 TC,ctrl
"Pineal gland from control mouse at ZT6, biological rep 1",ctrl
H295R_Group_A_Dose_NA_TIMEPT1_002,ctrl
WT C,pert
V5-P256,pert
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle cell;	matched/unmatched: matched to N14,pert
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: retina;	time: ZT6,ctrl
Normal B cell 1,ctrl
WFS1 WT USHT_07_314_ko,ctrl
"HepG2 cells, control, rep1",ctrl
221/4,pert
HCC PBMC Sample 1,pert
brain_DLPFC_bipolar C_mr951,ctrl
KU_07N,ctrl
CON 3,ctrl
Cell line BT-474_c-myc KD_expt1,pert
sMPNST_shCONTROL_3day_rep2,ctrl
"Testosterone treated, HIV-1 positive male, day 14 (3)",pert
21: NORMAL #99-0636,ctrl
Pt_4 Normal Skin,ctrl
"3 uM EPZ004777 treated, DAY 6, biological rep.2, MV4-11 cells",pert
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 27;	maternal age: 27,ctrl
"Gender: Female, Age: 35, BMI: 27, Tissue: luteinized cumulus cells",ctrl
Control peripheral blood leukocytes - Biological Replicate 4 - Technical Replicate 2,ctrl
"Biceps, FSHD, cohort 09, subject 09A",pert
scan batch: Batch 2;	group: autism;	subject age: 5;	paternal age: 38;	maternal age: 31,pert
newborn (P0) Krt1+/+ skin_replicate 3,ctrl
PsOEt-11-Week 1,pert
patient id: 265;	tissue: Normal cortex;	gender: Female;	age: 43;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
"34B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 95min;	race: White;	sex: Male,pert
chip number: 23;	transfection plate: 6;	target gene: RAD21;	kd level: 0.87;	rin: 9.6;	transfection date: 2012-03-26,pert
MCF-7 +scrambled siRNA + 500 nM 4-hydroxytamoxifen rep1 (MD35),pert
midbrain_Pink1 knockout_12 weeks_replicate 2,pert
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 31;	maternal age: 30,ctrl
Tetracycline-inducible glioma cells no dox 2,ctrl
"Strain: C57BL/6J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle",ctrl
Tia-1 122972 cerebellum 3 month,pert
cell line: BV2;	treatment: untreated,ctrl
cell line: GIST882;	agent: DMSO (control);	replicate: Rep2,ctrl
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep3",ctrl
Prostate Cancer_MS 36D7,pert
CLS14_T2_PP_day0_056,ctrl
"WT, rep2",ctrl
266D3,pert
KN-sham-5 month+1d-R3,pert
atopic eczema P3,pert
chip number: 14;	transfection plate: 6;	target gene: JUND;	kd level: 0.71;	rin: 9.6;	transfection date: 2012-03-26,pert
"A pool of RNA from lung from three male mice with SM22-rtTA transgene on an FVB/N background, raised at Denver altitude (nearly normoxic), fed doxycycline for 8 weeks and sac'd at 12 weeks of age.",ctrl
Dilated cardiomyopathy_G68,pert
Scrambled 24 hours_2,ctrl
Ad infected murine liver-MO30k-(6697)-6 hpi,pert
ME180 3 hours rep 1,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-sp2,pert
normal control 2,ctrl
human_LIMA_artery_patient4_control,ctrl
RNA mix 3 of nomarl lungs,ctrl
tissue: skeletal muscle (gastrocnemius);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Troglitazone,pert
cell line: JoMa1;	cell type: neural crest precursor cells,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 11.938;	Ratio: 2.09,ctrl
Pt23_Pre,ctrl
siHic5 DHT 2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.434;	OD280: 1.353;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 7.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 140;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Fog2flox/delta; alpha MHC Cre biological replicate 1,pert
MacularDegen-healthy-8aAv2-s2,ctrl
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6;	colon weight (mg): 172;	colon ratio (mg/mm): 2.87;	myeloperoxidase activity (u/mg): 0.384;	tissue: colon;	treatment: 5% DSS,pert
ATCC CRL-2868,ctrl
tissue: normal skin;	urticaria status: non-afffected;	patient: 11,ctrl
HT29 DMSO Day3 rep1,ctrl
coc-8_C,pert
knockdown: siRNA-scrambled;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 5.8;	colon weight (mg): 150;	colon ratio (mg/mm): 2.76;	myeloperoxidase activity (u/mg): 0.393;	tissue: colon;	treatment: 5% DSS,ctrl
female JAK2 WT liver sample 132,ctrl
Mutant_liver_2,pert
CD19_selected_B-cells_before_R_rep8,ctrl
cell line: LN229;	expression: Cyr61,pert
GEIM218-NORM,ctrl
control12,ctrl
DEX4_6H,pert
siCtrl.exp2,ctrl
Insm1 mutant #5,pert
non-malignant FTEb_patient 10,ctrl
siHic5 DHT 3,pert
NB83 U133p2,ctrl
Phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject K (KAcCD8),ctrl
HeLa_06_21_04 TP-1,pert
CCRPKO-PB_rep-2,pert
BL6_6h_DMSO,ctrl
Heart-Base_KO-1,pert
scan batch: Batch 2;	group: autism;	subject age: 7;	paternal age: 19;	maternal age: n/a,pert
midbrain_Pink1 knockout_24 weeks_replicate 3,pert
Individual_582_PN_sample,pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: control GFP;	rep: 2,ctrl
DW83_WT_M,ctrl
"Control 1, 16hrs",ctrl
Control subject 42_biological replicate 2,ctrl
PLT-t7-2; transgenic plantaris 7 month,pert
Replicate 2 - R5020,pert
Strain: C57BL/6;	Genotype: wild type;	Generation: F5;	Gender: male;	Tissue: white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
GIST Pre Treatment Biopsy 13,pert
control 2,ctrl
colon_1h_rep1,pert
Gender:F;	Age:41;	Tissue: Mucosa,ctrl
"seminoma specimen, pT1, patient age: 33y",pert
pediatric AML S26,pert
CTRL_5_HSC,ctrl
KM_050N,ctrl
Muscle-AMPKgamma3-mutant(R225Q)transgenic-3,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_8_18_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
01LRF_ERA,pert
Infergen_6hr_rep2,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.11;	RNA Integrity Number: 9.2;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
PGA-RMM-18h-1aA-s2,pert
microdissected breast cancer cells from case 317,pert
strain: B6EiC3SnF1/J (mix of B6 and C3H background);	genotype: wild-type;	tissue: skeletal muscle;	Sex: male;	age: 5 months,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 304B;	age-at-biopsy-years: 49,pert
"seminoma specimen, pT1, patient age: 37y; W03 023",pert
cell line: HepG2;	genotype/variation: HNF4a knockdown,pert
"Biological Material: Cell line, grown invitro; Tissue derivation: Adenoid cystic carinoma of the parotid gland",ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 24h ID213,pert
Heart_caAkt_02,pert
Bone-Marrow_MGUS_G721,pert
V5-P465,pert
normal main pancreatic duct 3,ctrl
HUVEC/NmenMC58_WT_4h_rep2_1108,pert
CD4IncTp2-3,pert
Exercised-4,pert
RE550_KPL4_un2,ctrl
Sample Group: HD patient; Gender: male; Age: 62; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/47,pert
Liver WT ND #687,ctrl
Control 60 days sample 1,ctrl
"expression at 16hr, bio rep2",pert
control7,ctrl
"A549, -TNFα, control siRNA, rep3",ctrl
"Wild type used for MAT1A 15 month, replicate 4",ctrl
Normal esophageal epithelium (N7),ctrl
NFIA E18WT2,ctrl
colon_0h_rep1,ctrl
vMyb virus-infected replicate 1 (MCF7),pert
Caco2-siRNA-control1-rep3,ctrl
Sex: male;	genotype: sst +/+;	tissue: liver;	genetic background: C57BL/6,ctrl
1204-03-A-b,pert
Ischemic cardiomyopathy_G30,pert
shRNA6-16-noDox-rep1,pert
Muscle-AMPKgamma3-ko-2,pert
"SKO-transduced MEFs, Vc+, D4",pert
Hunk Knock-Out rep 5,pert
FoxO deficient LSK (6),pert
"Uninvolved Skin, NS-14",pert
strain background: BALB/c;	cell line: 4T1.2;	stably transfected with: pMSCV retroviral expression vector system with IRF7;	expressing: IRF7;	tissue: Mammary Tumour,pert
Hippocampus 1997 15 month Old,pert
"cell type: myeloid monocytic cells;	protocol: 24h Q10H2 preincubation, 4h LPS stimulation",pert
Invasive cancer originating in IPMN 2,pert
mdx soleus sample 2,pert
strain: C57BL6/10J;	genotype: mdx;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle,pert
"C57BL/6N, adult, female",ctrl
"control, BA10-30",ctrl
MEF E2F4 KO 5-rep1,pert
"Atm+/+ 120 min post IR, A",pert
Mutated-ERα-positive breast cancer 7,pert
B_cell_pool_melanoma_M01+M02,pert
WT differentiated brown fat cells (rep1),ctrl
Individual_5839_NN_sample,ctrl
A39 NES 142Q TG3	F7/4	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Male,pert
CD8+_Tcells_healthy_donor_7,ctrl
9-cis-retinoic-acid_mammary_4,pert
40_C57_WT,ctrl
Shn2_Mutant_2,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 24h,pert
control to Sample 13,ctrl
strain: C57BL/6J;	genotype/variation: wild type;	cell type: bone marrow derived dendritic cells,ctrl
LY2 control-siRNA untreated rep4,ctrl
PGA-RMM-7h-1aA-s2,pert
abl siEZH2 at VEH rep 0,pert
Liver_POR-null+quercetin_1,pert
FC 02,ctrl
strain background: C57BL/6;	gender: female;	genotype/variation: MMA heterozygote;	tissue: kidney;	diet: high protein diet for 2 months,pert
No or early 2 rep5 (retina),pert
A6_LEF1,pert
"TNFa-OMe-P siRNA-C, replicate 4",pert
RL_siRNA_NS_rep3,ctrl
Plate vs. Nail:  2 Week Plate,pert
Knockout CS_MA_5_11_KO_3,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 251;	age-at-biopsy-years: 45,pert
Leg 7 Day mdx rep 2,pert
2-WT,ctrl
fat_Wt_8wk_rep3,ctrl
IFN_Gamma_24hr,pert
cell type: CD4+ T;	strain: C57BL/6J;	genotype/variation: wild type;	treatment: stimulated for 3 hours with medium alone,ctrl
"Macrophage cultures were prepared from C57BL/6J, male, mouse peripheral blood by Optiprep (Accurate Chemical and Scientific, Westbury, NY) gradient centrifugation.",pert
Sample Group: control; Gender: female; Age: 30; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: insulin,pert
"Biceps, control, cohort 21, subject 21U",ctrl
Control subject 47_biological replicate 1,ctrl
Skinbiopsy_7hoursnickel_controlsubject_k5,ctrl
untreated_24hr_rep2,ctrl
"human failing LV myocardium, Idiopathic19",pert
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 6h;	donor: 3,ctrl
cerebellum_Pink1 knockout_6 weeks_replicate 1,pert
WT648,ctrl
"Strain: C57BL/6 Ly5.1+, tissue: CD45.2+ transplanted bone marrow",ctrl
IRS-4 KO (jos1529),pert
CKO V5,pert
abl siEZH2 at VEH rep 1,pert
Normal cortex of patient T142,ctrl
human_hepatocyte_vehicle_donorA_24hr_prep1,ctrl
cell type: mammary epithelial cells;	cell line: MCF10A Cells;	genotype/variation: Cas,pert
striatum_ctip2_KO_3,pert
Individual_5177_PN_sample,pert
P14 - WTMixA 2,ctrl
CUTLL1 MigR1 GSIwash2h-rep1,pert
WT replicate 1,ctrl
"fibroblast, wild-type, untreated, biological replicate 5",ctrl
THRB wt + T3 replicate 3,pert
M464 Wt,ctrl
V5-P043,pert
Rb-/-PrE serumfree 1,pert
"brain, hippocampus: C240-I_e1_le1",ctrl
Phan_006_WT.bleomycin rep3,pert
cell line: U-87 MG;	cell type: glioma,pert
AA_Case13_CD8,pert
Mouse colonic epithelial cell line MCE301,ctrl
Nrl-ko-Gfp 4 weeks retina replicate 1,pert
Jurkat T-cells 48 hour transfection,ctrl
"fibroblast, MFS subject FB836 rep 1",pert
Postmenopausal female. Tibolone treated. Patient 11.;	Replicate,pert
"Normal subject (31 year old caucasian female, SAK_1265864834)",ctrl
"non-AD_TC, biological rep18",ctrl
Seltzer 14d replicate 1,pert
colonic_mucosa_inflamation_94,pert
"Rat_Tracheal_Dex_2hr, rep6",pert
Superior Frontal Gyrus_2-4y_RTT,pert
Huh-7/IRF1 rep3,pert
Control PB C103,ctrl
CML Patient 6 before therapy,ctrl
WT #182,ctrl
tissue: thymus;	genotype: wild-type cd4-cre+;	age: 8 weeks,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 165min;	race: White;	sex: Female,pert
DN4 cells sorted from mouse n°137 (Cre-),ctrl
A_AN01570_C,pert
H1P_2,ctrl
C1A-LU,ctrl
Mnk_3201-R-7,pert
PHM-DM-4aUA-s2,pert
type 2 diabetes subject 03,pert
minor non-tumor3,pert
Wt Mouse_cerebellum_Young_saline treatment_Replicate-4,ctrl
cell line: MCF7 breast cancer;	treatment: SIN3A silenced and LIF-stimulated,pert
GAS-t10-2; transgenic gastrocnemus 10 month,pert
"disease state: Nasopharyngeal carcinoma;	stage: III, T1, N2, M0, G4",pert
Gata1KO25+#1,pert
Endometrium-Normal 9,ctrl
Sample Group: HD patient; Gender: male; Age: 55; Tissue: lymphocytes (blood); IT15 CAG repeats: 25/43,pert
"brain, brainstem: PB2_e1_le1",pert
"brain, forebrain: WCx4w#3_e1_le1",ctrl
striatum_wild type_12 weeks_replicate 1,ctrl
SW1736_t48h_rep2,pert
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 1,pert
K562 cells control replicate 6,ctrl
Klf9WT_jejunum_PND30_2,ctrl
siHic5_2_24h_1,pert
Ishikawa_VeryHighDose_BPA_8h_rep2,pert
"Male, 39 years old, HIV infection of 11 years",pert
Control Day0 (306R),ctrl
SRF silenced EtOH rep 3,pert
gender: female;	agent: control;	cell type: Hematopoietic stem cells,ctrl
cell line: MCF10A;	transduction: HER2,pert
"Control Day 2, biological rep2",ctrl
Control Endometrium Mesenchymal Cell_031.UC208++,ctrl
2_CD34+_12h_TCDD+,pert
Bronchial Epithelial Cells control biological 2129M,ctrl
genetic background: 129SV;	genotype: WFS1 KO;	tissue: hypothalamus,ctrl
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 7x6x4;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
affection: ADHD;	treatment: MPH;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 7 ADHD patients,pert
AZ-521_uninduced_18h_rep3,ctrl
"brain, cerebellum: RNA#2S_le1",ctrl
Silberg3 ( S4) 191102-1NE,ctrl
"age: 8 month;	strain: FVB/N;	genotype: H-ras+/-, p53-/-;	tissue: carcinoma in situ",pert
cell line: MCF7;	treatment: velcade stimulated,pert
Msgn1_12hPlusDox-biological rep1,pert
F9 RA sample #2,pert
"mouse aorta cross strain comparison, C3H_T08_HF_01",pert
tissue: normal esopahgus,ctrl
WAT from wild-type control fed high fat diet Replicate 1,ctrl
Ker,ctrl
Mature mice skeletal muscle sample from the hind limb 2,ctrl
72_129_WT,ctrl
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.34 uM (2 x EC50), biological rep1",pert
B6_Male_CF_rep1,pert
BAT_WT_1,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 59,pert
GM19238_Kd_CEBPG_2,pert
SV129_6h_DMSO,ctrl
SKNSH eGFP1,ctrl
Wildtype_Sham_Rep4,ctrl
B4 391 b4-/- after nicotine-induced seizures,pert
22SAGEA,pert
"Cadmium 0.55 µM, biological rep1",pert
Saline treated mouse gallbladder 2,ctrl
cell line: HCT116;	cell type: colon cancer;	sirna: control,ctrl
Bronchial Epithelial Cells MMA biological 2122Y,pert
H1299 vehicle control (3225),ctrl
123A,ctrl
siRNA Med12 + Estrogen [L3],pert
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: Control shRNA infection,ctrl
Muscle PCOS pioglitazone 121,ctrl
WT-Nrf2-Male-1,ctrl
patient: 51292;	sample: normal,ctrl
JGB-Post-3UP_Run2-S2,ctrl
MB231 PIAS1 shRNA-SCM,ctrl
condition: Normal;	patient: N_LJ_3;	tissue: Normal skin biopsy;	kit: Affy,ctrl
cell type: embryonic stem cells;	cell line: CGR8;	treatment: overexpressed CA-NFATc3,pert
"human failing LV myocardium, Ischemic10",pert
BALB_Female_CF_rep2,pert
CD34+ cells without fenretinide treatment from CML34,pert
"strain: FVB/C57B6 mixed backgroud;	cell type: primary KrasG12D Pten L/+ pancreatic ductal epithelial cells, P4;	genotype/variation: Pdx1-Cre;LSL-KrasG12D L/+;Pten L/+",pert
H19 siRNA (simH19) tranfected into C2C12 myoblasts rep3,pert
Genotype: FORKO (FSH Recptor Knock Out). FORKO mice was generated by deleting all variants of FSH-Receptor,pert
8DKD_SerumStarved->1hrEGF_rep1,pert
XDP nucleus accumbens,pert
Bone-Marrow_MM_M1117,pert
SIN3A_siRNA_NS_rep2,pert
TA-n10-2; normal tibialis anterior 10 month,ctrl
HaCaT_ZNF750i_ biological rep2,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G48,pert
patient: 201;	current medication: None;	birth date: 4/12/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/19/03;	diagnosis date: 7/4/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: BOTH;	followup recto sigmoid: HISTOLOGICAL;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/7/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/70;	smoking stop date: 1/1/99;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
liver_STZ treated diabetic_rep5,pert
Cardiac Muscle_Cmah KO_mdx_rep3,pert
"NF-YA KD ES cells 96hr, replicate 1",pert
patient: 32023;	disease state: LGSC;	component: Invasive,pert
"Creatine-treated, biological rep2",pert
ALS gray matter 2 Familial,pert
Placebo treated ipsilateral to stroke P6IC-1a,ctrl
KM_032N,ctrl
strain background: C57BL/6N;	genotype/variation: Stat1 delta beta (db);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),pert
GLIP4,pert
esophageal squamous cell carcinoma from patient E1507,pert
strain: BALB/c;	gender: female;	type: Wild-type;	treatment: none,ctrl
"seminoma specimen, pT1, patient age: 33y; W03 015",pert
Gadd45a-/-_MEF_rep2,pert
Wild type naïve T cells stimulated for 3 hours with medium alone 1,ctrl
"H69 tumor post-PDT, biological rep2",pert
heart-30 months of age-control diet-biological replicate3,ctrl
02-0002A_Day1_16,pert
patient: 224;	current medication: Salazopyrin BFZ Losartan Thyroxine Doxazosin;	birth date: 2/21/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 1/1/77;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 12;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Hypertension Hashimoto's Thyroditis;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 71;	gender: f;	treatment: NSAIDs,ctrl
siCtrlE24h_2661,pert
"Patient I-c451T, MSI colorectal tumor",pert
"PC-3 Ctrl, biological rep1 [mRNA]",ctrl
"D425-control, t=8",ctrl
MCL_IGHV_MUT (R1304),pert
"MN1VP16, 1",pert
Healthy7-CD8,ctrl
Amniocytes_euploid_1565,ctrl
thoracic mammary glands were collected from three virgin F1 CF-1/FVB LH-overexpressing (transgenic) mice at 16 weeks of age; RNA was pooled before synthesis of cDNA,pert
WT Tibialis Anterior at 4 weeks biological rep3,ctrl
"BOEC, normal 9",ctrl
umbilical cord_nobpd: 1E,ctrl
S-IIP(UIP)14_Cy3,pert
mammary stoma-4w-wt-rep2,ctrl
HSL-null 1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.139;	OD280: 0.58;	Ratio: 1.95;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 154;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.1,pert
ubb_d14_ko_1,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 6,pert
Caco2-siRNA1-rep1,pert
"KM-H2 cells, Non-silencing control, replicate 2",ctrl
Eed KO E14 ESCs on day 3 #1,pert
cell type: HeLa;	genotype/variation: nucleofacted with CABIN1 siRNA,pert
LCL Unaffected MZ twin pair 2 (CCN2.1)(TP17),ctrl
AAA neck (Sample 8),pert
Liver Rosi2,pert
MPM tumor 31,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 52;	tissue: Blood,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 85min;	race: White;	sex: Female,pert
"Strain: Bl6, Tissue: Bone marrow, Age: 7 weeks",ctrl
Healthy control 1,ctrl
Patient 3 c,pert
C3H/HeJ Vehicle liver sample batch 1,ctrl
memory P14 T cells #2,ctrl
RAW_3.5mM_HOCl_#1,pert
Obese Control-1,ctrl
"granulocyte, healthy control, biological rep7",ctrl
KO_TER119+_rep2,pert
LC1008ni,pert
"RPMI8226_shLuc, replicate2",ctrl
PGA-MAA-IL4-1bAv2-s2,pert
"patient 16, arm treated with pimecrolimus",pert
Wild type LSK (1),ctrl
Gender:F;	Age:45;	Tissue: Mucosa,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L010,ctrl
Trim33-KD-ac-2,pert
ATF2 KO-2,pert
Csbm/m Mouse_cerebellum_Old_saline treatment_Replicate-2,ctrl
F_LS_Wk4,pert
brain_control_sampleid_mr275,ctrl
10 mg/kg MPH tr1003,pert
WT A,ctrl
18C-M4,ctrl
sirna: NT control;	cell line: ES2;	cell type: Ovarian cancer cell line,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
GBM_stem_4 days_2,ctrl
C_Kin_2,pert
"Control 2, biological rep4",ctrl
VMM-MUT_MyoD24h-1MP-s2,pert
optineurin expression-b02,ctrl
Empty vector control embryoid body sample_2 (Vector_EB_2),ctrl
genetic background: 129/SVE;	genotype: wild type;	tissue: tibialis anterior;	age: 12-14 mo;	strain: 129/SVE;	treatment: 50 eccentric contractions 12 hours,ctrl
MCL_IGHV_UNMUT (043-01-4TR),ctrl
Sample 1 Posterior  +/+,ctrl
Control with WY14643 replicate 2,pert
6ILC_normal_ductal,ctrl
6h_c2,ctrl
control3,ctrl
MCL_IGHV_MUT (R1400),pert
Cervical cancer_20-04T,pert
2a_c,ctrl
strain: C57BL/6 (B6);	genotype: Hif1a-/-;	cell type: leukemia stem cells (LSCs);	age: 8 weeks,pert
patient: 24;	disease state: hypertension;	tissue: Atheroma plaque,pert
gender: Male;	tissue: Tendon;Subscapularis;	age: 50;	donor: 27;	disease state: Non-lesional,ctrl
"Patient GM, stable renal transplant recipients, female, 53 years old, T1 (3 months after the switching of the therapy)",pert
Normal-ERα-positive breast cancer 68,ctrl
"expression at 4hr, bio rep1",pert
BTBR_Islet_rep1,pert
"genotype: Gata6-KO;	cell: Peritoneal resident (CD11b-high, MHCII-low/negative) macrophages",pert
Pediatric_GBM_14,pert
t16,pert
"metastasis: none;	Stage: 3c;	tissue: normal, homogenized",ctrl
heart_WT_rep3,ctrl
control shRNA replicate 4,ctrl
b38-,pert
tissue: skin;	individual: Patient P9;	condition: AL;	eczema severity: SCORAD: 55,pert
3880-3 E2F WT,ctrl
Chondrogenic progenitor cells from OA female 1,pert
Healthy4-CD4,ctrl
siRNA-96_rep1,ctrl
5922012038_E,pert
"7B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
KU_10T,pert
gender: Male;	tissue: Tendon;ECRB;	age: 55;	donor: 26;	disease state: Non-lesional,ctrl
"depression, BA10-48",pert
"non-AD_TC, biological rep3",ctrl
ASO T00278951,pert
KU_18T,pert
R1_control,ctrl
patient: 267;	current medication: Mesalazine 800mg TDS;	birth date: 8/16/74;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/05;	diagnosis date: 5/10/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 8/15/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/20/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 9/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 5/1/03;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
normal adult rat testis,ctrl
RNA-DHL4-R406-24H-3,pert
MDS patient 63,pert
5178-scrape,pert
Preglaucoma control rep7 (OHN),ctrl
Control (C267),ctrl
RNA-DHL6-R406-2H-2,pert
N40875,ctrl
n5t0h,pert
Sham 8,ctrl
LOX1 Untreated 6hr 282295673,pert
b106,ctrl
PWD/PhJ Vehicle liver sample batch 1,ctrl
X6752318096 E MYC positive#3394,pert
Pertuzumab treated after 4 days (P3_2),pert
"C57BL/6N, adult, male",pert
sample M 18.5 wt,ctrl
"SDC1-silenced group, replicate 2",pert
strain background: C57Bl/6;	genotype/variation: BATF-/- P14 TCR transgenic C57Bl/6;	cell state: Day 3 in vitro effector CD8+ T cells,pert
chip number: 21;	transfection plate: 3B;	target gene: WHSC1;	kd level: 0.8;	rin: 9.7;	transfection date: 2012-03-26,pert
Carbo Day4 (336R),pert
M229_R5_A_DMSO,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 218,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Male,pert
"Cell type: endothelial, age:45, gender:male, diagnostic group: schizophrenia, PMI:35h",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Male,ctrl
myoblasts-expt1_untransduced-rep1,ctrl
Bronchial Epithelial Cells MMA biological 2139P,pert
hES_VUB03_DM1_2,pert
Cerebellum_nontransgenic control A39_8 months_replicate 2,ctrl
LY2 control-siRNA untreated rep3,ctrl
E9.0 ko.1,pert
63A;pretreatment;female;breast tumor; responder,ctrl
gender: female;	age (years): 36;	evolution time (years): 0;	disease extension: Left-sided colitis;	treatment: No treatment,pert
s5t0c,ctrl
Mut_M_1,pert
astrocytes normoxia batch 3,ctrl
Spleen_wt_1m_rep2,ctrl
"HME-CC, 12h, sham",ctrl
Negative Control 3,ctrl
lesion_midUV_patient2,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
Control (C54),ctrl
"Immortalized MEFs WC, v-src expression retroviral vector infected, rep1",pert
sepsis patient #11,ctrl
Cavin-1/PTRF KO #192,pert
breast tumor 1,pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: ATF6aKO;	treatment: untreated,pert
colon_epithelium_C57mouse_6weeks_rep3,ctrl
"Mice_c-myc trans, biological rep4",pert
Macro-dissected renal cystic epithelial tissue from Fh1 knockout mouse,pert
IDCM1,pert
shOCT4_1,pert
tissue: Lung Epithelium,pert
age_years: 55;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
untreated with TGF-beta,pert
MSE_D_543,pert
"Peripheral blood, patient without recurrent events [N35]",pert
Ulk1/2+/+ (untreated) 2,ctrl
"control embryonic stem cells, biological replicate 2",ctrl
siHic5 VC 3,pert
3894-2 E2F WT,pert
4_day_old_Prnp_knockout_mouse_rep3,pert
DNGM-13,pert
"Patient M030-258N, normal colonic mucosa",ctrl
Human hepatocellular carcinoma cell line infected with MIR517A and GFP protein 2,pert
IRS-3 KO (jos0699),pert
"control, BA46-91",ctrl
Control peripheral blood leukocytes - Biological Replicate 3 - Technical Replicate 1,ctrl
REH_shG1_rep2,pert
Cervical cancer_1434T,pert
strain: C57BL6/J;	age: 12 weeks;	gender: female,ctrl
"Please refer to Lilly et al., Am J Respir Crit Care Med. 2005 Mar 15;171(6):579-86",ctrl
overexpressed Tcof1 [A],pert
Human Non-progressor HIV Sample L004-CD4+ T cells,pert
Common Reference 2 round amplification 2 ug,pert
WT13,pert
VEC B,ctrl
S25 NLS 142Q TG3	F4/34	S25	NLS Htt exon 1 142Q	Mouse	3 months	Cerebellum	Male,pert
HCC PBMC Sample 9,pert
Sample Group: HD patient; Gender: male; Age: 59; Tissue: lymphocytes (blood); IT15 CAG repeats: 21/45,pert
patient: 51292;	sample: tumor,pert
First shYY1,pert
status: Slow;	age: 54;	gender: female;	tissue: cultured human fibroblasts,pert
gender: female;	batch: 1;	age (years): 25;	patient id: Control_2;	fev1 (% predicted): 103;	fvc (% predicted): 107;	medication: None;	cell type: CD8+ T-cells,ctrl
Sex: male;	Age: adult (11-12 weeks),ctrl
phenotype: control;	gender: male;	case_id: 225;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.53;	labeling_batch: 1,ctrl
Leg 14 Day mdx rep 1,pert
GFP Replicate B,ctrl
female JAK2 KO liver sample 141,pert
"BMDC, Asc-/-, replicate 3",pert
striatum_wild type_18 month_replicate 2,ctrl
healthy control H03,ctrl
THRA 6a mutant + T3 replicate 2,pert
Ishikawa_VeryHighDose_BPA_8h_rep3,pert
Waldenström’s macroglobulinemia (WM-BL 30381),pert
PB_DON097,ctrl
AL Chip#43,pert
Pt_1 Acne Lesion,pert
Tissue: normal thyroid; Gender: female; Age:31,ctrl
KO1 CD11b,pert
Waldenström’s macroglobulinemia (WM-BL 31098),pert
patient: 133;	current medication: Omeprazole 20mg;	birth date: 4/23/65;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/13/05;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: BETAFERON;	time: 24 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
strain: C57Bl/6;	genotype/variation: : ARR2PB-Cre;ROSA(N1IC) model (a.k.a. PB-NICD) that expresses the Notch1 intracellular domain (NICD or N1IC) in the prostate and develops prostatic intraepithelial neoplasia (PIN lesions).,pert
"Amoxicillin treated Proximal, Small Intestine 2 17 days old",pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: spleen;	sample name: 6-sp2,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 4,pert
HEK293_ControlsiRNASparse_rep1,ctrl
GM19238_Kd_NS4_12,ctrl
cell type: glioma stem cells;	treatment: DMSO,ctrl
liver_Wt_35wk_rep3,ctrl
T63 dilated cardiomyopathy heart biopsy,pert
"Control Distal, Small Intestine 2 21 days old",ctrl
Bronchial Epithelial Cells SA biological 2102S,pert
WT-Fibr1 3,ctrl
knockdown: shControl;	cell line: MDA-MB-231,ctrl
CXCR4 knockout 7,pert
A_Kin_1,pert
"LacZ, #2 repeat",ctrl
ccRCC tumor of patient T144,ctrl
SW1736_t6h_rep1,pert
"CD11b DC Xbp1 KO (DC conditional KO), biological replicate 3",pert
DK-final,pert
WT78,ctrl
"0mg/kg/day PFOA, Rep 5, Block 5, liver (high dose)",ctrl
PWD/PhJ Vehicle liver sample batch 3,ctrl
78_129_WT,ctrl
"Control, rep 3",ctrl
THP1-shGSK3A-Construct6-rep1,pert
"Strain: MRL/MpJ;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 140min;	race: White;	sex: Male,ctrl
healthy control H21,ctrl
hESC H1 wt rep1 (H1A),ctrl
GFP Untreated 12hr 282295723,ctrl
strain: Balb/C;	Sex: female;	tissue: pancreas;	age: 30 days old;	maternal diet: Control diet;	treatment: streptozotocin,pert
"PBMC, patient. Mtx rep1",pert
WT-2 (Large PreB),ctrl
CLL 141-08 Control,ctrl
Bronchial Epithelial Cells SA biological 2111T,pert
treatment: Arid3a knockdown;	cell line: J1 ES cells,pert
"SNCA triplication iPSCs, AST13",pert
LC1022ni,pert
Mutant biological rep4,pert
"Testosterone treated, HIV-1 positive male, day 14 (6)",pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 172;	fata: 63;	eea: 1500;	wtkg: 70;	perfat: 21.2;	lbm: 51.4;	fat_mass: 1484,ctrl
NSC miR-128 3,pert
cell type: brown preadipocyte;	genotype: Ezh2 -/-,pert
WT-VILI replicate 3,ctrl
sirna: control;	plate: collagen coated;	cell line: MCF10A,ctrl
female JAK2 WT liver sample 119,ctrl
HepG2_5-aza_rep1,pert
29A,pert
WT25+_rep1,ctrl
NTG 3,ctrl
OVCA433-(3),ctrl
MDS patient 122,pert
FRD440 1,pert
"Dumbo retina, biological rep1",pert
RTX8 T0,ctrl
genotype/variation: Cyp27b1 flox/flox;Cre+;	tissue: breast tumor;	genetic background: FVB,pert
ILD_1,pert
genotype/variation: TRPV4 knockdown,pert
"peripheral ganglion, unknown: nicotine 1hr_3",pert
cell type: Neuronal Stem Cells;	developmental stage: E14.5;	strain: CD-1 albino,ctrl
Cbfb-deficient Treg_rep1,ctrl
KO-control-5,pert
Human Uninfected Sample N071-CD8+ T cells,ctrl
Series 1; older; no fracture,ctrl
"Male, 59 years old, HIV infection of 15 years",pert
tissue: brain;	genotype: mutant Dcx ko/Y;	age: P0,pert
uterus_P4_WT_4hrs_rep3,ctrl
SEB-1 vehicle control biological replicate 1,ctrl
Keratinocytes treated with EphB2 for 24h,pert
GFP Zfx wt 2,ctrl
WT2-iPS 1,ctrl
patient id: 324;	tissue: Normal cortex;	gender: Male;	age: 60;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
strain: Sprague-Dawley;	tissue: Dorsal root ganglia;	postnatal age: 2 months;	surgery type: Sham;	experimetal group: Adult Sham,ctrl
CLL 145-04 Control,ctrl
High weight gainer KOZAK2_ABI_HYP_H3,pert
020112-1,ctrl
TREx_Flp_Scrambled_siRNA_2,ctrl
Ls174T-pTER-β-catenin con2,ctrl
A_AN16641_F,pert
"63B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M1;	flt3 status: WT,ctrl
tissue type: Bone Marrow;	cell type: Normal Plama Cells (NPC),ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: tibialis anterior;	age at biopsy: 52;	Sex: male,pert
"Deltoid, FSHD, cohort 21, subject 21B",pert
strain: C57BL/6;	tissue: liver;	gender: female;	age: 8week,pert
Eed KO J1 ESCs on day 3 #1,pert
parental cell line: WA;	vector: pBabe-human v-src (v-src vector);	replicate: 3,pert
chip number: 18;	transfection plate: 5;	target gene: SREBF2;	kd level: 0.82;	rin: 9;	transfection date: 2011-10-17,pert
01UP3_Oligo,pert
Subject 7 / lung subsegment instillated by Saline,ctrl
"Control KD, rep3",ctrl
0h WT Sample 01,ctrl
"72 hour-treated TG2 knockout NB4, biological rep1",pert
cont_OO11,ctrl
PC-3M/MYB siRNA #2,pert
HEK293_HNF1a_#4_induced,pert
Strain: Mix 129X1/SvJ and C57BL/6J and Sjl;	Gender: Mix;	Age: 4Wks;	Tissue: retina,pert
H441 transfected with ETS2-specific siRNA 2,ctrl
"shKDM4C 1, clone 2, rep 2",pert
MOLF/EiJTCE liver sample batch 1,pert
G93A 120 days sample 3,pert
knockout mouse kidney - 3,pert
normal with no hydrocortisone treatment-5,ctrl
agent: resveratrol_250mM;	tissue: mammary epithelium adenocarcinoma;	cell line: MCF7,pert
4-HPR_LIVER_4,pert
background strain: C57Bl6;	genotype: Rsk2 knockout,pert
cerebellum SNCA knockout 21 month replicate 2,pert
Scd1+/+ on very low fat diet (TD03045 from Harlan Teklad) replicate 2,ctrl
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l -/-;	days after transduction: 3,pert
"Fibroblasts, baseline, time 0, patient 2, rep 2",ctrl
RA_E,pert
ILD Study Number 1245,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 205min;	race: White;	sex: Male,pert
24: NORMAL #99-0739,ctrl
53SageA,pert
NCCIT-SNF5oe-rep2,pert
020112-6,pert
renal_vesicle_Lim1_mutant_1,pert
MPM tumor 36,pert
"Subject 7, Family 3, Affected",pert
"PPARg d4, rep 6",pert
KO Tibialis Anterior at 4 weeks biological rep3,pert
Glioblastoma_2,pert
"SPC-c-raf transgenic mice, 5 month old, male, unaltered",pert
tumor cell line HepG2 rep2,ctrl
strain: Wistar;	agent (mother exposed to): TCDD;	gender (pup): male;	age (pup): PND70;	tissue (pup): pituitary,pert
L-540_CTRL_24hrs_1C,ctrl
+4hr Wnt,ctrl
MGd_2,pert
"spleen follicular B in WT, biological rep2",ctrl
"genotype: mutation in the NOTCH 1 gene (Weng et al., 2004, Science, 306, 269-271)",pert
Healthy donor_biological replicate4,ctrl
Liver phenobarbital pool3 Affy,pert
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"2 months, sham group, biological replicate 3",ctrl
heart_co_6M_rep1,ctrl
ApoD KO+PQ rep_3 (PQKO3),pert
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug Control siRNA;	treated with: 100nM PD173074 for 48 hrs,pert
Control ESC media sample 1,ctrl
"EBF1 d10, rep 1",pert
Donor2_24h_Wy,pert
LOXL2 1,pert
transfection: Control siRNA;	cell line: HeLa S3,ctrl
MH1C1_high_rep4,pert
BAL_26_A2B0,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: tumor;	sample name: 2-tu2,pert
Lamp3 KD 3d 2,pert
"DCIS 7, biological rep. 7",pert
strain/background: C57/B6x129 mixed background;	genotype/variation: Bptf KO;	age: 12.5 dpc;	cell type: mouse embryonic fibroblasts,pert
background mouse strain: C57BL/6;	source: white adipose tissue;	genotype: wildtype,ctrl
Rybp#15 (OHT-)_4d_rep1,ctrl
colon_IL10mouse_6weeks_rep3,pert
59_129_KO,pert
Cutaneous psoriasis without arthritis PsC 4,pert
MDS patient 31,pert
MKO_rep_1,pert
C33KD2_with doxycycline_2,pert
ab045 N,ctrl
"brain, hippocampus: C24-I_e1_le1",ctrl
tissue: brain;	genotype: WT mix background A;	age: E14,ctrl
Day 3 (T21),pert
CD46+/STAT1-KO hippo - Untreated-D,pert
69A;pretreatment;female;breast tumor,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: D835 mutation,pert
Patient no. 9: control,ctrl
"colonic tissue from macrophage-specific PPARgamma-deficient mouse, biological rep1",pert
Knockout liver_saline-injected 12weeks repl1,pert
cell line: WM-266;	pir knock-down: no,ctrl
genotype: ß-catenin gain-of-function mutant (ß-catGOF-UB);	tissue: kidney (uteric bud);	developmental stage: embryo;	age: 12.5 days,pert
high grade serous carcinoma_patient 9,pert
HF1381_U133P2,pert
26_C57_WT,ctrl
Control sample 19 weeks,ctrl
"65B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
HP-64,pert
cell line: PA-1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
lateral hypothalamus no access to cocaine replicate 4,ctrl
PC3 Wee1 Rep1,pert
dental pulp cell from control 6,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 57,pert
"C57BL/6, Male, Contol",ctrl
C57/BL6 murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock).,ctrl
healthy CD19 B cells 3,ctrl
Patient: N;	Time: 0;	Group: responder;	Condition: lesional,ctrl
Mock_cells_rep1,ctrl
"HME-CC, 12h, 0.01mM 5FU B",pert
90 year old male,pert
ns VC 2,ctrl
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l flox/flox;	days after transduction: 3,ctrl
695_EV_16hr_repeat,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 28.0;	age of psoriasis onset: 13,pert
untreated or induced,pert
3386-scrape,pert
"sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta, aneurysm;	agent: Ang II;	time: 14d",pert
Braak α-synuclein 3-4 BR34_2SN,pert
anti-FGFR1_rep4,pert
cell type: CD4+CD25+;	strain: C57BL6;	genotype/variation: Wild type,ctrl
disease state: healthy donor;	tissue: PBMC,ctrl
"BMMs, untreated control, da, Replicate 3",pert
Cervical cancer_CC222,pert
Carbo Day4 (358L),pert
WT-sham-1 day-R2,ctrl
strain background: C57/129S;	genotype/variation: Fra-1-/-: Fra-1 KO;	gender: female;	age: 2 months;	treated with: 30 µl of PBS containing bleomycin (0.075U/mouse) for 5 days;	tissue: lung,pert
Sex: male;	Age at operation: 38 years;	Site: knee;	Size in cm: 8.3x4x7;	Histological Subtype: myxoid liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: yes;	Previous chemotherapy: no,pert
Telencephalon WT 2,ctrl
Normal bladder 18-99,ctrl
11405 Normal Uninflamed descending colon,ctrl
IR-KO_Rep2,pert
A2 corrected_C2_transgenic but unaltered,pert
"Exp A, Animal #261, 50mg/kg D-Serine",pert
N/LV3,ctrl
genetic modification: no modification;	tissue:  spleen: FACS sorted IgM+IgD+ cells,ctrl
diet_LIVER_3,ctrl
Control #3,ctrl
C7bt5,pert
MDS patient 154,pert
"schizophrenia, BA10-7(2)",pert
F-IIP(UIP)8_Cy3,pert
Erythroblast_SOD2+/+_repWT17,ctrl
BT474_DMSO_24-1,ctrl
PGA_Ras_2-m5,pert
"brain, forebrain: WCx4w#2_e1_le1",ctrl
V5-P212,ctrl
"Prospectively purified bone marrow hematopoietic stem cells (LSK, defined as Lineage- Sca-1+ c-Kit+) and myeloid progenitors (defined as Lineage- Sca-1- c-Kit+) from Mx-Cre-; FoxO1/O3/O4LoxP/LoxP and Mx-Cre+; FoxO1/O3/O4LoxP/LoxP mice 4 weeks after induction of excision with polyinosine-polycyticylic acid (pIpC, 300ug)",pert
"gender: female;	age: juvenile, 8 weeks (P59);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/-;	tissue type: renal tissue",pert
IGROV-1-(1),ctrl
"human failing LV myocardium, Idiopathic67",pert
Carbo Day14 (351L),pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 0 hrs;	time course: 2,pert
TN1b-control,ctrl
patient id: T164;	tissue: Normal cortex;	gender: Male;	age: 75;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
Male mice from fiona transgenic line (dystrophin-deficient with a transgene expressing high level of full length utrophin) were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,pert
SCLC cell line MS-1,pert
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-18;	Primary Site:Floor of Mouth;	Age:52;	Sex:M;	TNM:T4N2M0;	;	Abbreviation:TNM,Tumor-node-metastasis",ctrl
Psoriasis-Patient-G,pert
Patient: G;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
GM19238_Kd_NS3_23,ctrl
Knockout liver_saline-injected 12weeks repl3,pert
Braak α-synuclein stages 5-6  BR56_6SN,pert
microdissected breast cancer cells from case 648,ctrl
RV64.11_CHF_day25_Slide46,pert
NCCIT-SNF5sh-rep1,pert
scram_hi_8,ctrl
"Acute Myeloid Leukemia, sample 47",pert
Myh11-CreERT2.Tgfbr2f/f Control 1,ctrl
siERK2Veh4h_2660,ctrl
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/8,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT3B knockout, non-treated",pert
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 45;	donor: 19;	disease state: Non-lesional,ctrl
PBMC from T cell LGL leukemia patient #1352 (TLGL1352),pert
T74 U133p2,pert
"experiment I, hTERT, replicate 1",pert
cell line: MLL-AF9 AML cell line 10977 (Zfx wt);	treatment protocol: +OHT;	genotype/variation: wt,pert
tissue: testis;	genotype: WT;	genetic background: C57BL/6,pert
C_LS_Wk4,pert
"wt-Gfp, Gfp+ photoreceptor cells",ctrl
Cell line expressing inducible GFP-progerin. Induction: day 5. Replicate B,pert
patient id: 1393;	tissue: Normal cortex;	gender: Male;	age: 83;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/flox, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_2h_Con_HG-U133A_2_YCHSUP501,ctrl
P4_Ovary_Control_biological rep2,ctrl
cell line: HEK293 cells WTX inducible clone F5;	agent: control,ctrl
"array 29, xenograft, corn oil vehicle",pert
disease status: autism;	tissue (brain region): Frontal cortex,pert
uterus_P4_PRKO_4hrs_rep2,pert
Day: 6; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 2,pert
Heart left ventricle dnCREB-PBS replicate 3,pert
T105,pert
Basal IFE epidermal stem cells from WT mice 1,ctrl
p300_1,pert
cell line: SKBR3 parental;	treatment: 1uM Lapatinib,ctrl
R6/2 (untreated) 5270,pert
patient: 225;	current medication: Asacol;	birth date: 5/30/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/2/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/99;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 28;	gender: f;	treatment: -,ctrl
01-0066A_Day1_9,pert
H16_P_B1,ctrl
4_Hr_+MGd_2,pert
HCC PBMC_sample 4,pert
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: littermate control, Atoh1-Cre;Dicer1(flox/wt);	tissue: organ of Corti from cochlea, apical half;	age: postnatal day 16",ctrl
umbilical cord_nobpd: 4C,ctrl
duration of untreated disease in month:4.9;	age at onset:8.3,pert
GFPRhoGDI2 Replicate B,pert
LNCaP.GFP.4,ctrl
PND28 Rat Testis_Rat230-2_12hr MEHP_Animal#58_04005,pert
Nerve_Control_Rosi_715,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 58,pert
Usp22 depleted replicate 2,pert
Disease_status: Bipolar disorder;	Age (years): 59;	Gender: Male;	Age of onset (years): 25;	Duration of illness (years): 34;	Brain pH: 6.65;	Post mortem interval (hours): 84;	Side of brain: Right;	Fluphenazine mg. Equivalents: 500;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: Yes;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 42.64384,pert
KO_TER119-_rep2,pert
KU_49N,ctrl
atopic eczema P10,pert
Tissue: brain (frontal cortex);	Disease State: HIVE-control,ctrl
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 3,pert
RORasg/sg liver_HFD_rep5,pert
Squamous cell carcinoma 016,pert
Cells: HCT116 colon cancer cell line,ctrl
muscle_Wt_35wk_rep1,ctrl
genotype: WT;	sample type: DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma);	genetic background: WT C57/BLACK6;	cell type: DP (CD4+/8+) cells,ctrl
scan batch: Batch 2;	group: control;	subject age: 3;	paternal age: 22;	maternal age: 22,ctrl
MacularDegen-injured-6aAv2-s2,pert
20: FCHL patient #99-1225,pert
HCT116-Neo124 human colon cancer cells with intact PTEN,pert
RatLung_H6h_5,pert
"RNF40 siRNA - 5 days adipocyte differentiation, rep3",pert
Raji_mi-142-3p_4,pert
"MCF7 cells stably transfected with XBP1, passage 3",pert
DBA_24h_Wy,pert
BCell_lymphoma_aggressive_sample1,pert
cell line: SKBR3 parental;	treatment: 0.1uM Lapatinib,ctrl
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 14.5x7.5x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
"Normal Skin, Normal-5",ctrl
"HepG2 cells, HNF4a RNAi treated,  rep1",pert
P 29 Control,ctrl
695_383_0hr,pert
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 21;	maternal age: 21,pert
"schizophrenia, BA10-46",pert
HL60-shGSK3A-Construct5-rep1,ctrl
Hes6_Castrated OWJ64,pert
SA_101,pert
"PCB153 treated HepG2 cells at T0, biological replicate 3",ctrl
FmrKO2_blood,pert
TNKSi 16h biological replicate 2,pert
2826,pert
"shCDK8, normal growth, replicate 1",pert
Tslc1-/- mice_rep1,pert
NOD Aire KO MEC rep2,pert
P8 Patient None,pert
Mouse old brain C30-Br-3,ctrl
Insm1 mutant #1,pert
BALB_Male_CF_rep1,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 5,ctrl
siUbr5 replicate1,pert
batch: B;	knock-in: VEC;	cell line: MycCap prostate cancer cells,pert
CUTLL1 DNMAML1 GSI-rep3,ctrl
EA_Case7_CD8,pert
Vehicle-Control;	Vehicle-Control 30 hours set 1,ctrl
patient id: T127;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 35;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/wt, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",pert
DNGL-4,pert
"Distal and Proximal Large Intestine, 8week old Wild-type mouse 2",ctrl
BALB/c control (bmsnmix8),ctrl
BASC-Control-2 [mRNA],ctrl
Human.AN.CP.ECRB,pert
Dengue Fever Patient 3,pert
H295R_Group_B_Dose_100_TIMEPT1_007,pert
0562-01-A,pert
1030-03-A-b,pert
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 1",pert
"Prkaca+/- caudal vertebral bone, rep4",pert
"Patient 4, 24 month of BETAFERON",pert
DNGM-4,pert
HCC017N,ctrl
S031_Scz_M_79,pert
induction of AICD,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.674;	OD280: 0.969;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 293;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.03;	OD280: 1.028;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 7.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 218;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
SZ18,pert
WT-control-4 (DFW),ctrl
"Prospectively purified bone marrow hematopoietic stem cells (LSK, defined as Lineage- Sca-1+ c-Kit+) and myeloid progenitors (defined as Lineage- Sca-1- c-Kit+) from Mx-Cre-; FoxO1/O3/O4LoxP/LoxP and Mx-Cre+; FoxO1/O3/O4LoxP/LoxP mice 4 weeks after induction of excision with polyinosine-polycyticylic acid (pIpC, 300ug)",ctrl
"brain, cerebellum: WCb12w#2_e1_le1",ctrl
pediatric AML S25,pert
"0mg/kg/day PFOA, Rep 5, Block 3, liver (low dose)",ctrl
"Crohn's Disease subject (39 year old caucasian male, SAK_1275567445)",pert
Sham3,ctrl
MIY_day_7-3,ctrl
Placenta Adra2bKO 3,pert
STHdhQ7/Q7-B,ctrl
Papilloma_tumour_epithelial_cells_CTRL_rep2,ctrl
MSE_D_G72A,pert
"C57BL/6, Male, CF",pert
Human_macrophages_hypoxia_repB,pert
Grid2 deleted mouse 1,pert
WT_PLACEBO_48hours_3,ctrl
iPSC idiopathic autistic patient triplicate 1,pert
ESE_D_575,pert
"D425-shOTX2_1, t=8",pert
Mnk_3220-S-7,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: ZXDC1 knockdown;	agent: vehicle,pert
LJMJDW20,pert
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Female;	Age of onset (years): 16;	Duration of illness (years): 32;	Brain pH: 5.8;	Post mortem interval (hours): 22;	Side of brain: Left;	Fluphenazine mg. Equivalents: 32000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
normal tissue from mastectomy specimen from postmenopausal patient with invasive ductal carcinoma (IDC),ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: extensor digitorum longus;	age at biopsy: 53;	Sex: male,pert
T152 U133p2,pert
TMRI E2 8hr,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_10 months_replicate 2,pert
MacularDegen-healthy-12aAv2-s2,ctrl
HW_476,ctrl
PC-3_overexpresshTERT_LongTelomeres_LhTERTL_1,pert
gender: male;	age (years): 50;	evolution time (years): 6;	disease extension: Pancolitis;	treatment: Azathioprine,pert
sex: Male;	Age: 61 months;	additional patient information found in Series supplementary file,pert
"FACS-sorted Lin-, c-kit+, Sca-1+ HSC from the bone marrow of PU.1 knockdown mice with targeted disruption of the distal enhancer (URE) –14kb upstream of the PU.1 gene.",ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 10 nM;	treatment time: 8 hours,pert
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	treatment: Pyrazinamide;	time: 63 dpi,pert
cell line: TOM-1;	tissue: Human B cell precursor leukemia,pert
5258-lcm,pert
Sample 7,pert
cell line: HCT116;	shRNA: non-target;	treatment: low glucose,ctrl
24 weeks female,pert
MCF-10A sh53BP1-2 replicate 3 [set 5],pert
48h_RA1,pert
B6-rep2,ctrl
"AD_TC, biological rep5",pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 8 hrs;	time course: 2,pert
U2-OS-ERb E2 4 hours,pert
Mouse No Cldn16 B9 452,pert
C_AN10833_F,ctrl
"214, MUSCLE, Before",ctrl
NM14 healthy control,ctrl
MEF E2F4 KO 3-rep2,pert
tissue: LNCaP-LM NSG xenografts;	expression: vector control,ctrl
Wt Mouse_cerebellum_Standard diet Ad Lib_Replicate-3,ctrl
ME180 6 hours rep 2,pert
478MM,pert
IRAK4-KD-MEFs_unstimulated_4hours_rep1,pert
"Colitis 05, UC05",pert
heart/muscle-specific MnSOD-deficient mouse (f/f)(control),ctrl
1295-2C,pert
VMM-WT_MyoD12h-3MP-s2,ctrl
age: 40;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Expression data from BAT of the KRAP deficient mice (KO3),pert
"Nickel 140 µM, biological rep1",pert
"wdNHBE with KY/180 at 36hpi, biological rep3",pert
age: 60;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Moderate rep5 (OHN),pert
PTC BRAF wt 2,pert
MacularDegen-healthy-6bAv2-s2,ctrl
LacZ control_4a,ctrl
mouse colon_hnf4mutant_rep2,pert
EA_Case11_CD8,pert
"colonic tissue from floxed mouse, biological rep1",ctrl
strain: mixed background;	age: 4 months;	genotype: hnf1alpha KO;	tissue: jejunum;	sample type: mutant,pert
Glioblastoma_7,pert
Rb F19/F19;	age: newborn;	strain: FVB;	tissue: skin,ctrl
Pt_2 Normal Skin,ctrl
normal embryonic day 18 lungs,ctrl
sample =Healthy4 treatment=Stimulated time=90 (min),ctrl
healthy control H17,ctrl
Healthy control 7,ctrl
age: 34;	sex: F;	disease status: control subject;	Filter number: 96;	Usage number: 5;	Exposures: 3,ctrl
568.B6,ctrl
HF0828_U133P2,pert
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 39;	gender: f;	treatment: -,ctrl
strain: 129-Sv;	cell line: J1;	cell type: embryonic stem;	time: 6 days;	differentiation: differentiated Flk1+ Runx1-/- ES cells,pert
06R022 RA,pert
M833 / Reference_13431199,pert
BP patient 104_biological replicate 1,pert
BALB/c control (bmsnmix6),ctrl
"brain, cerebellum: RNA#8S_le1",ctrl
Bronchial Epithelial Cells MMA biological 2163M,pert
chip number: 23;	transfection plate: 3B;	target gene: CREBBP;	kd level: 0.81;	rin: 9.7;	transfection date: 2012-03-26,pert
P52 Non failing heart biopsy,ctrl
APBMNC.LPS-.1,ctrl
Moderate rep9 (retina),pert
"Control Proximal, Small Intestine 2 17 days old",ctrl
A_AN00493_F,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 27.651;	Ratio: 2.11,ctrl
Mening UNSTIM WB NP 6a,ctrl
Huh7 cells_Mock Infected 48 hours_ rep2,ctrl
CLL 161-04 LMP-420,pert
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 4 hours,ctrl
"SW480, stable line of treatment of ezrin RNAi. Incubate in L15 medium, 37.0°C, air 100%",pert
Injured 1 day Rat Retina 1,pert
SENS 4 4hr,pert
liver_Wt_35wk_rep1,ctrl
"mouse liver sample, KO strain, biological replicate 3",pert
Cre_day_5-2,pert
type 2 diabetes subject 07,pert
Pediatric_GBM_17,ctrl
colon_IBD_1110,pert
470MM,pert
blood_day0_patient7,pert
cell line: SCC-2;	cell line origin: Oral cancer;	genotype/variation: control,ctrl
uterus_veh_WT_40hrs_rep3,ctrl
RatLung_H1h_3,pert
WT - Cre Treated - 24 hrs - repeat 3 - Cy5 - mAdbID:54724,ctrl
Ad infected murine liver-MO30k-(232)-6hpi,pert
Ifng-/- biological rep 2,pert
Pcgf6_4_shRNA2-dox,ctrl
1044-03-A,pert
Leg 7 Day Control rep 2,ctrl
Tgfbr2 fl/fl Control Posterior Palate 5,ctrl
liver-AHRWT-cornoil-rep3,ctrl
Clozapine treated 4weeks AffyGC RMA rep2,pert
"Immortalized MEFs WB, empty retroviral vector infected, rep1",ctrl
Methoxychlor (50uM) rep 1,pert
NSCLC cell line H157. Transfected with siRNA oligomers targeting DJ-1 - #2,pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 44;	maternal age: 40,pert
race: caucasian;	age (years): 49;	stage: IC;	grade: 3;	histology: endometrioid,pert
whole tissue section from case 295,pert
cell type: Endothelial cell;	agent: estradiol;	dose: 1 nM;	time: 24 h,pert
156A,ctrl
P63 Non failing heart biopsy,ctrl
Mesenchymal derived mouse cell line,pert
Male mouse 120 day old,ctrl
"BOEC, normal 10",ctrl
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug Control siRNA,ctrl
Fibroblasts_HealthyControl_4,ctrl
"Ulcerative colitis patient, biopsy taken from the sigmoideum, no macroscopic signs of inflammation.",pert
Aldosterone-producing adenoma (APA6),pert
monocytes_-LPS_2,ctrl
"SLE patient, 1014V1",pert
NS3_NS010823,ctrl
"ShamC-21, biological rep 4",ctrl
Normal male wistar rat,ctrl
initial tumor increase/(-)decrease: n/a;	kit mutation: exon 11;	tissue: GIST Tumor,pert
Control Day1 (394L),ctrl
scan batch: Batch 1;	group: autism;	subject age: 7;	paternal age: n/a;	maternal age: n/a,pert
H157 siCTL2,ctrl
"WT1_ileum, 5 days post-infection with T. gondii",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.57534,pert
TP02-402,ctrl
"imr-32,t=0,3",ctrl
mouse liver A2,pert
"Normal diaphragm 4, 8 week",ctrl
Control (C64),ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 5d ID296,pert
AMWT_Ker41,ctrl
cerebellum SNCA knockout 21 month replicate 1,ctrl
T84 U133p2,pert
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 5,ctrl
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: None,pert
"GM8923, proband-MS",pert
CAST/EiJTCE liver sample batch 2,pert
"seminoma specimen, pT3, pN1, pM1, patient age: 23y; W00 011",pert
RO35,pert
race: caucasian;	age (years): 49;	stage: IA;	grade: 2;	histology: endometrioid,pert
Patient: D;	Time: 1 week;	Group: responder;	Condition: lesional,pert
NIXKO10 SPLEEN,pert
LC1024ni,pert
"Control skin, rep2",ctrl
BP24,pert
Replication 1 control,ctrl
INSENS 4 4hr,pert
CD8+_Tcells_healthy_donor_3,ctrl
48 year old female,ctrl
tissue: dental pulp cells;	genotype: control;	passages: 7,ctrl
"xenograft: Panc-1 human pancreatic carcinoma cell line, grown in mice;	treatment: control shRNA",ctrl
S014_Scz_M_74,pert
ApoD transgenic mouse+PQ rep_2 (PQTG2),pert
KO STR Veh 25,pert
"Wild type, pancreas",pert
"strain: C57BL/Ka-CD45.2:Thy-1.1;	genotype: Lkb1 knockout;	tissue: bone marrow from femoral and tibial bones;	cell type: LSK (Lin-, Sca-1+, c-Kit+) cells",pert
AKR/JTCE liver sample batch 2,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 50,pert
"non-AD_TC, biological rep2",ctrl
ploidy: euploid;	tissue: cerebellum;	developmental stage: P30 postnatal stage,ctrl
Normal-ERα-positive breast cancer 74,ctrl
ANL Chip#29,pert
"strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: CITCO; 6-(4-chlorophenyl)imidazo[2-1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime",pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: BETAFERON;	time: 3 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
striatum wild type 6 month replicate 3,pert
TYK-nu-(3),ctrl
chip number: 20;	transfection plate: 3B;	target gene: STAT6;	kd level: 0.74;	rin: 9.6;	transfection date: 2012-03-26,pert
FmrWT2_blood,ctrl
"imr-32,gfp siRNA, t=48, 4",ctrl
"human failing LV myocardium, Idiopathic64",pert
Human prostate cancer primary culture C43dx,pert
Day: 1; Drug: Heroin; Phase: Drug treatment; Replicate: 1,pert
Healthy5-CD8,ctrl
race: caucasian;	age (years): 48;	stage: IB;	grade: 2;	histology: endometrioid,pert
8DKD_SerumStarved->1hrEGF_rep4,pert
breast cancer patient 304B,pert
"BOEC, at_risk 5",pert
breast cancer patient 351,pert
"Liver, Normoxia 1",ctrl
"S1P3-KO-neocortex, biological rep1 (male)",pert
"210, MUSCLE, Before",ctrl
"wild type CTL+AktI, biological replicate 1",pert
TTF=115min;	Race=Caucasian/White;	Sex=Male;	Group=C;	Prototype_N,pert
"ALL_NDS, K37 011609",ctrl
HC CM 2 alcohol,pert
"Peripheral blood, normal control [N64]",ctrl
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P6,pert
HEL_JAK2 knockdown (Jak2-9 shRNA)_1,pert
A501 Sham 7 day,ctrl
brownfat_KO2_day3,pert
sex: Male;	Age: 6 months;	additional patient information found in Series supplementary file,ctrl
"Mdr2-KO heterozygous mouse, 3 month old mouse 3",ctrl
liver_Pink1 knockout_24 weeks_replicate_1,pert
B_lymphoma_2,pert
GB 7 63A NO LPA,pert
Substantia nigra PD rep8,pert
Csbm/m Mouse_cerebellum_Young_saline treatment_Replicate-2,ctrl
BCR/ABL1 biological replicate 1,pert
age: 46;	gender: female;	ejection fraction: 61;	left ventricular end diastolic diameter: 49;	inflammation/PVB19: negative,ctrl
WT_PLACEBO_12hours_1,ctrl
M7KOepi_infect_0h_rep2,pert
"Peripheral blood, normal control [N69]",ctrl
GFP_2,ctrl
SLE CD19 B cells 10,pert
Wild-type mice rep4,ctrl
C006_Control_F_71,ctrl
tissue: non-lesional skin;	urticaria status: affected;	patient: 1,ctrl
Karyotype: inv(14)(q11q32);	Age: 49 years;	Gender: male,pert
astrocytes hypoxia batch 2,pert
A549 NSCLC cell line,pert
EA_Case13_CD20,pert
HP-13C,ctrl
Cervical Cancer C366,pert
7 Etoh 3,pert
PBMC from T cell LGL leukemia patient #120 (TLGL120),pert
"vector d4, rep 6",ctrl
L_LS_Wk1,pert
A YOKE_B062,pert
heterozygot FH P279,pert
DS2-iPS 4,pert
Bronchial Epithelial Cells SA biological 2147O,pert
microdissected breast cancer cells from case 356,pert
44n,ctrl
B_Kin_1,pert
breast normal 4,ctrl
C3_HypM,ctrl
MPM tumor 17,pert
"BMMCs from NTAL WT, NTAL shRNA infected, nonactivated, biological rep1",pert
Obese 2,pert
db/db 7-4,pert
e_B7,pert
"gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Hippocampus 1992 15 month Old,pert
"Empty vector, plastic plate, rep1",pert
01MJT_PolyRF+,pert
Monocyte control rep 2,ctrl
endothelial_rep9,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5b;	flt3 status: internal tandem duplication (ITD),pert
patient: 124;	current medication: OCP;	birth date: 6/25/77;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
Disease_status: Bipolar disorder;	Age (years): 42;	Gender: Female;	Age of onset (years): 20;	Duration of illness (years): 22;	Brain pH: 6.65;	Post mortem interval (hours): 49;	Side of brain: Left;	Fluphenazine mg. Equivalents: 15000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
tissue: Hippocampus;	age: 72;	Sex: F,ctrl
Mouse_E14 ES cell_Undifferentialted,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 3;	psoriasis duration: 13;	age of psoriasis onset: 25,pert
A514 Sham 7 day,ctrl
3024-lcm,pert
Subject #8039-Preinfection,ctrl
BALB_Female_Control_rep3,ctrl
"Normal subject (40 year old caucasian male, SAK_1265820128)",ctrl
"WT, PR04M003v0",ctrl
sMPNST_JQ1_2day_rep1,pert
Advanced IPF_explant_lower lobe_rep146,pert
condition: Discoid Lupus;	patient: L4;	tissue: LS skin biopsy;	kit: Ovation,pert
Msgn1_24hPlusDox-biological rep2,pert
"0mg/kg/day PFOA, Rep 2, Block 1 lung (low dose)",ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: WT,ctrl
healthy control H30,ctrl
ApoD KO+PQ rep_1 (PQKO1),pert
VehLPS2,pert
"Gata4_S105Amut, PE treated whole heart, individual 8",pert
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 29;	maternal age: 29,ctrl
cell line: U87;	tumor tissue source: Cell line established;	tumor organ site: Brain;	pathological diagonosis: Glioma,ctrl
cell line: FU-OV-1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
Disease_status: Healthy control;	Age (years): 35;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.6;	Post mortem interval (hours): 23;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"Wild type epithelials cells, biological rep2",ctrl
"Strain: C57BL/6, NOD-SCID;	Gender: Male;	Age: 8 weeks;	Tissue: Large Intestine (Distal and Proximal);	C57BL/6, NOD-SCID Eeyore T2996C",pert
BV2_rep1,ctrl
coc-12_A,pert
db/m 16 wk 3,ctrl
C_AN12240_F,ctrl
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 32;	maternal age: 33,pert
cell type: LSK;	tissue: hematopoietic stem cell enriched fraction from bone marrow,ctrl
12481 UC Uninflamed sigmoid colon,pert
Expression data from BAT of the KRAP deficient mice (WT1),ctrl
ic5 -- cell line 1 treated with APF#1,ctrl
Clock_mutant Circadian_Time_14,pert
At Risk: -;	Age: 15;	Sex: M,pert
Subject #8031-2d Postinfection,ctrl
Mtb infected-42d-2,pert
FO_spleen_KO_rep2,pert
WT J1 ESCs on day 7 #1,ctrl
MF-46,pert
"MCF7 silenced Estrogen receptor, biological rep2",pert
Retina ko/ko rep1,pert
Testis_WT_rep3,ctrl
tissue: arterial;	status: unruptured aneurysm,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 111min;	race: White;	sex: Male,pert
Keratinocytes treated with EFNA4 for 1h,pert
48h_c4,ctrl
siNS_0h_4,ctrl
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 2 - Technical Replicate 2,pert
brain_DLPFC_bipolar C_mr275,ctrl
coc-14_A,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 54,ctrl
Quercetin day 05 sample 2,pert
wt 13.5d replicate 4,ctrl
Nerve_Control_Rosi_712,ctrl
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: Human-ApoD transgenic gain of function mutant,pert
"Patient 2, control tissue",ctrl
BACH2+/+ ALL + Imatinib (Sample3),pert
Gene expression profiling of Phgdh knockout embryo wild2,ctrl
Subject #8045-2d Postinfection,ctrl
strain: C57BL/6;	genotype/variation: Smchd1 null;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: F,pert
Bronchial Epithelial Cells MMA biological 0168R,pert
tissue: dental pulp cells;	genotype: control;	passages: 5,ctrl
"septic CD4+ splenocytes at 6h, biological replicate 4",pert
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep8,pert
wt PBS3,pert
IP RNA_WT_rep1,ctrl
disease state: normal;	specimen: Ovarian Surface Epithelia,ctrl
"wildtype pancreas, biological rep3",ctrl
genetic background: 129/SVE;	genotype: wild type;	tissue: tibialis anterior;	age: 7-9 wk;	strain: 129/SVE;	treatment: 50 eccentric contractions 12 hours,ctrl
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: untreated;	treatment time: 4 hours,ctrl
Myoblast-GATA4-Wt-day0-2,ctrl
O_LS_Time0,ctrl
EmptyVector 2,ctrl
PBMC,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: maxilla;	donor sex: female,pert
"Human healthy male subjects, peripheral blood monocytes",ctrl
liver_co_6M_rep2,ctrl
"gender: Male;	age: 76;	post-mortem delay: 6h;	ph: 6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 6hr",ctrl
control AU016703,ctrl
Blood_Control 2,ctrl
FTO1_C1_ni,ctrl
OVCA429+(3),pert
treatment: empty vector;	cell line: HaCaT;	tissue: Immortalized keratinocytes;	cell type: Immortalized cell line,ctrl
B6 Control R1,ctrl
"59B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Large cell carcinoma 005,pert
age_years: 66;	sex: F;	ethnicity: Latino;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
Array Type: HG-U133A_2;	RNA Integrity Number: 9.6;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Native ko biological replicate 1,pert
MDA-MB-231 RRP1B over-expressing clone #9,pert
male_alcoholic_256,pert
Mouse No Cldn16 B9 449,pert
Hunk Knock-Out rep 4,pert
HEK293_MIF siRNA 1#_24h_Illumina,pert
strain: c57/bl6;	age: 4 month;	gender: n/a;	weight: 25-30g;	tissue: whole trachea,ctrl
AA_Case3_CD8,pert
Nrl-ko-Gfp E16 replicate 1,pert
scan batch: Batch 2;	group: autism;	subject age: 5;	paternal age: 31;	maternal age: 26,pert
Tendon_non-lesional_rep12,ctrl
GEIM128-NORM,ctrl
Human Uninfected Sample N110-CD4+ T cells,ctrl
colon_IL10mouse_6weeks_rep6,pert
"Hdh knock-out embryonic stem cells, biological replicate 2",pert
breast tumor 2,pert
CD4_T_cell_pool_melanoma_M09+M10,pert
"Control shRNA cells passage 11, rep 2",ctrl
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Epithelial Cell,pert
Leg 112 Day mdx rep 2,pert
Aldosterone-producing adenoma (APA1),pert
male;	34 yr old;	Black,ctrl
PGA-RMM-5h-3aA-s2,pert
Heart left ventricle dnCREB-PBS replicate 2,pert
"Dermatomyositis, biological rep1",pert
E10C,ctrl
Patient: M;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
14-week-old Trim24-/- liver_648M,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 73;	gender: female;	years of disease: Unknown;	treatment: phototherapy;	time: mid-UV,pert
Healthy control 4,ctrl
PGA-HMO-Obese-5aUA-s2,pert
"MAT1A knockout at 15 month age, tumoral tissue, biological replicate 1",pert
"Atm+/+ 30 min post IR, A",pert
Mic26_muscle_control,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 1",ctrl
"Wild type, snap frozen, plantaris muscle, 7 month age animal",ctrl
T51294,pert
tissue: white blood cells;	age: 15.6;	Sex: male,pert
"C57BL/6J-Il10tm1Cgn, sample 2",pert
wt-Gfp P10 replicate 3,ctrl
"Normal subject (54 year old caucasian male, SAK_1289963270)",ctrl
n6t6h,pert
breast cancer patient 297B,pert
Obese rosiglitazone-1,pert
24A,pert
erStress_twins_AA_1744twin1_DMSO_4h,ctrl
cell line: REH E/R positive leukemia;	treatment: treated with non targeting lacZ shRNA,ctrl
"gender: Female;	age: 68;	post-mortem delay: 6h;	ph: 6.4;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Normal-3 - mAdbID:91658,ctrl
"Deltoid, FSHD, cohort 12, subject 12A",pert
genotype: ILKR211A Tg;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Female,pert
NT3,pert
"BMDC, wt, replicate 3",ctrl
WT2R1,pert
"HeJ, air, biological rep 2",pert
"Typically Developing Control, Semitendinosus, Patient Replicate 2",ctrl
gender: Female;	age (y): 52;	tissue: prolactinoma,pert
A YOKE_B063,pert
Control Endometrium Epithelial Cell_034.UC209_EpCAM,ctrl
ubb_d21_ko_2,pert
"schizophrenia, BA46-94",pert
WT-smoke-high-5 month-R2,ctrl
Control 1,ctrl
BCells_Transgenic_day2_REP2,pert
cell: ES cells;	genotype/variation: UTX conditional knockout,ctrl
agent: ConA;	time point: 6 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3KO;	age: 12 weeks;	nutrient state: 24h fasted;	diet: High-fat diet,pert
"iPSC derived from healthy control fibroblast WT2, biological rep6",ctrl
KN-smoke-high-5 month-R2,pert
Bronchial Epithelial Cells MMA biological 1958U,pert
Muscle JDM (YJD-JDM-25UA-s2),pert
"A673 treated with DMSO vehicle control for 24 hours, biological rep5",ctrl
"DSS colon tissue, biological rep1",pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 3",ctrl
"experiment 1, control 2",ctrl
Peripheral blood mononuclear cells;	TTF=105min;	Race=White;	Sex=Male,pert
Age: 38;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 A1959T;	Family History: Yes,ctrl
1218-4C,pert
RV16;	Age = 19;	Sex = M,pert
Jurkat-KD2,pert
Allo-14-5,pert
"treatment with BZP, replicate 3",pert
mT4,pert
NM Spinal cord 110 day,ctrl
tissue: Temporal cortex;	age: 71;	Sex: F,ctrl
cell line: COV434;	transfection: pFOXL2m,pert
"WT brain, biological rep2",ctrl
"Vehicle, biological rep3",ctrl
CT-receptor-KO osteoclasts untreated 3,pert
PBMC from T cell Large granular lymphocyte leukemia patient#133,pert
gender: male;	age: 8 weeks;	strain: Sprague Dawley rats;	tissue: lumbar dorsal root ganglia,ctrl
tissue: breast;	normal/tumor: normal,ctrl
Ls174T-pTER-β-catenin con3,pert
Tumor-WT-rep3,ctrl
Pancreatic Sample 53-Tumor,pert
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14509;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
type_of_rx: AF;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 50;	baseline tumor size (cm): missing;	patient id (to identify the 2 chips from the same patient): 22332259,pert
Strain: mixed;	Tissue: liver;	Age: 28 days,ctrl
"Wild type epithelials cells, biological rep3",ctrl
control participant P316,ctrl
PND28 Rat Testis_Rat230-2_6hr Corn Oil_Animal#35_04005,ctrl
Msgn1_24hMinDox-biological rep2,ctrl
"wildtype mouse embryonic fibroblast, biological rep 1",ctrl
age: 49;	sex: M;	disease status: control subject;	Filter number: 100;	Usage number: 5;	Exposures: 3,ctrl
gender: male;	individual: patient 4;	treatment: paclitaxel-eluting stent,pert
C028_Control_F_54,ctrl
"human failing LV myocardium, Idiopathic49",pert
"Immortalized MEFs WB, empty retroviral vector infected, rep3",ctrl
0536-01-C,ctrl
MDS18,pert
"3T3-L1 siControl 48h, biological rep 3",pert
Y HID_B040,ctrl
"heart, beta1-Gly389 transgenic mice at 90 days of age",pert
293TsiLL-3,pert
pediatric AML GP6,pert
age	26;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	9.3;	leukocyte count (/nl)	25.7;	hemoglobin (g/dl)	13.9;	platelet count (/nl)	915,pert
14L,pert
L425-PAX5+MAT_rep3,pert
MDS patient 109,pert
E10.5 wt.3,ctrl
chip number: 21;	transfection plate: 3B;	target gene: BCL3;	kd level: 0.62;	rin: 9.2;	transfection date: 2012-03-26,pert
protocol: NGN1 overexpression;	cells: Neural Neural Stem Cell Line F3,pert
cell line: SCOV3,pert
adult HSC 1 (untreated),ctrl
"fibroblast, MFS subject FB1627 rep 1",pert
P3 Patient None,pert
Muscle-AMPKgamma3-wt-5,ctrl
T178 U133p2,pert
P1 mouse eyeball extracted total RNA_Snf2h_cKO3,pert
pediatric AML PP6,pert
2d-IR-73,pert
blood_day6_patient3,pert
gender: Male;	cell type: hESC H1 cells;	genotype/variation: wt,ctrl
Bl6_p60_3,pert
HB1.F5,ctrl
"C2C12 Myotubes treated with Palmitate, rep3",pert
"control, BA46-54",ctrl
MLL_00118,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-sp1,pert
MDS patient 4,pert
"Ring1B deficient ES cells, biological replicate 2",pert
"breast, pre AF treatment (H15_1682)",ctrl
"2 months, ipsilateral group, biological replicate 1",pert
age	55;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	25.8;	leukocyte count (/nl)	206;	hemoglobin (g/dl)	10.1;	platelet count (/nl)	331,pert
Male 8week AJ CBDLrep2,pert
Healthy donor_biological replicate1,ctrl
Series 2; Older; no fracture,ctrl
CyP 1hr 1,pert
T1,pert
Expression data from liver of the KRAP deficient mice (WT1),ctrl
PB_DON046,ctrl
"human failing LV myocardium, Ischemic75",pert
DS1-iPS 1,pert
KO kidney pool 1,pert
Healthy control_sample3,ctrl
C008_Control_F_94,ctrl
13_PAH,pert
"lymphoblastoid cell line from F6.06, one out of seven of sensitive group, 50*10e6 cells",ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day4,pert
P14 - Lis1ko/+ 3,pert
Control Braak α- synuclein Stage 0 C3SN,ctrl
KN-smoke-med-5 month+1d-R2,pert
genotype/variation: Cbx2_KO_XX;	tissue: gonads;	age: E11.5,pert
transfected with pSuper-shMTDH,pert
normal 1144,ctrl
mutant_POST_PDE_053,pert
H1299 AZA 0.3 uM (3229),pert
TN4b-control,ctrl
HD 5,ctrl
condition: Non-syndromic cleft lip/palate (NSCL/P);	tissue: decidous teeth dental pulp;	gender: male,pert
1 h (2),pert
BxPC3-KO111 rep 2,pert
TTP_KO_0ActD_BioRep2,ctrl
"knockout mouse embryonic fibroblast, biological rep 3",pert
Neocortex_Eomes_WT.3,ctrl
"8 weeks old sex age matched littermates, lung typeII cells",ctrl
WT P2 replicate 1,ctrl
Control10,ctrl
"brain, cerebellum: WCx12w#2_e1_le1",ctrl
HaCaT_ZNF750i_ biological rep2,ctrl
"PBMC, healthy control, biological rep2",ctrl
BP patient 110_biological replicate 2,pert
tissue: Biceps muscle;	patient: C.b.6;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 59.3726,pert
Ishikawa_VeryHighDose_BPA_48h_rep1,pert
K562 DMSO sample 10,ctrl
Postmenopausal female. Estradiol treated. Patient 13.,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 39;	maternal age: 33,ctrl
25uM_Zn_1,pert
KM_075N,ctrl
chip number: 16;	transfection plate: 3B;	target gene: ZBTB38;	kd level: 0.57;	rin: 9.5;	transfection date: 2012-03-26,pert
normal with no hydrocortisone treatment-2,ctrl
CHB PBMC_sample 11,pert
cell line: RT112;	transduced: EGFP shRNA;	doxycycline treatment: yes,ctrl
"Retina from control mouse at ZT20, biological rep 1",ctrl
"Control #5, Untreated",ctrl
OVCA429+(1),pert
SKBR3_Control_2,ctrl
111A,ctrl
Kidney_colistin_4,pert
4T1.2-IRF7-3,pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 44;	Usage number: 1;	Exposures: 3,pert
"human failing LV myocardium, Idiopathic56",pert
Cutaneous psoriasis without arthritis PsC 6,pert
cell line: A2058;	treatment: CT16 siRNA,pert
GM19238_Kd_TAF1_3,pert
"new born PS-NA mice, cerebellum",pert
FRD440 4,pert
Pancreatic Sample 26-Tumor,pert
"control, BA46-95",ctrl
MLL_00122,pert
NOD RIP-Aire27 islet rep1,pert
Control 3 c,ctrl
IFN_Gamma_6hr_rep1,pert
Mouse_ESC_Pcl2_mismatch_control_sample 2,ctrl
SEB-1 treated biological replicate 1,pert
colon_epithelium_C57mouse_6weeks_rep1,ctrl
"nasopharyngeal carcinoma, specimen T9",pert
No or early 1 rep9 (retina),pert
braak stage: BR12;	rin: 71;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
CEM-C1 cells treated with 10 nM rapmycin for 3 hours,pert
"Lesion Skin, LS-11",pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. vehicle (ethanol) + 1 uM vehicle (ethanol) for 24hr;	batch: 3,ctrl
ic patient 1,pert
17C-M4,ctrl
LCL Concordant for Epilepsy twin pair 1 (CCE1.2)(TP22),pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 80min;	race: White;	sex: Female,ctrl
"fibroblast, control subject NF3 rep 2",ctrl
"genotype/variation: Pten-null (Ptenloxp/loxp), with doxycycline-inducible PTEN transgene;	cell type: embryonic fibroblasts;	transgene: tet-inducible Pten transgene;	time: 0 h;	genetic background: C57BL\6",pert
wtPrE serum 1,ctrl
"patient 030b, normal, homogenized",ctrl
HA01-149A,pert
NB64 U133p2,ctrl
microdissected breast cancer cells from case 1260,ctrl
Substantia nigra PD rep5,pert
MPM tumor 34,pert
MEF_TFAMhet_rep1,pert
Dengue Hemorrhagic Fever Patient 48,pert
"twin pair: #12;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
Liver_D3T _Rep2,pert
BM_01000,ctrl
Nod2-/- 1,pert
MDS patient 124,pert
"breast tumor epithelium,17",pert
strain: C57Bl/6;	genotype: AIRE ko;	treatment: Freshly isolated cells,pert
Gene expression profiling of Phgdh knockout embryo KO4,pert
LCL Unaffected MZ twin pair 3 (CCN3.2)(TP24),ctrl
"C57BL/6 male sick, 100",pert
MOLF/EiJ Vehicle liver sample batch 6,ctrl
ILD Study Number 1000,pert
U937-shGSK3B-Construct1-rep2,pert
A375 cells 24h Control rep3,ctrl
Ad infected murine liver-MO30k-(467)-6 hpi,pert
Eed KO E14 ESCs on day 7 #2,pert
MA_290,pert
GFP-KD-1 (total RNA),ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 5,ctrl
WFS1 WT USHT_17_315_ko,ctrl
"Empty vector, collagen plate, rep3",ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#115,pert
CUTLL1 DNMAML1 GSI-rep1,ctrl
sampleID: SAM630137;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
"Wild type used for GNMT 8 month, replicate 3",ctrl
S1A Sporadic-frontal,ctrl
MCL_IGHV_MUT (R1585),pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: sh53BP1-2,pert
cell line: J1;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 3,pert
Array Type: HG-U133A_2;	Ratio: 1.99;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
striatum SNCA knockout 6 month replicate 2,ctrl
E10.5 wt2,ctrl
CML Patient 2 before therapy,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 6h ID206,pert
chip number: 9;	transfection plate: 1;	target gene: ARNTL2;	kd level: 0.84;	rin: 9.2;	transfection date: 2011-03-29,pert
Diagnosis: AML M5;	Age: 69y ;	Gender: Male;	Blast %: 93;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
pMX-GFP vitamin C GFPVc+_1,pert
Ero1-C104A/C131A induced biological repC,pert
timepoint: 2h;	drug: Saline;	group no.: 37;	large batch: Y;	plate: 4164379004;	hybridization batch: V,ctrl
BC3 TC,ctrl
"seminoma specimen, pT2, pN1, patient age: 43y; W00 120",pert
"Alk shRNA, biological rep2",pert
Akt1 wild type 2,ctrl
"Fibroblasts from normal histology lung tissue, NL-7",ctrl
"HSCs from female mice treated with E2, replicate 1",pert
YFP-pos GMP Dicer wt rep1,ctrl
"IL22KO1_ileum, 5 days post-infection with T. gondii",pert
5281 UC Inflamed ascending colon,pert
neocortex-30 months of age-control diet-biological replicate5,ctrl
SBVGA1 2,pert
"PCB153 treated HepG2 cells at T0, biological replicate 2",ctrl
Patient 7 skin baseline,ctrl
"EtOH, RARaKO, set 3",pert
18B,pert
3883-1 E2F WT,pert
tissue: adipose tissue;	sample group: resveratrol;	treatment: before;	gender: Female,ctrl
Fetal heart 1.5 ug/kg TCDD rep1,pert
Osteoblasts_Lrp5_Knockout_Day7_rep1,pert
3_month_old_wildtype_mouse_rep1,ctrl
No or early 1 rep8 (retina),pert
coc-10_A,pert
"Male, 42 years old",ctrl
multiple myeloma (MM 409),pert
COP DES-treated replicate 3,pert
s9129_3,pert
siHic5 DHT 1,pert
"brain, brainstem: LB4_e1_le1",pert
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: control,pert
"patient: 213;	current medication: PRED 7MG, ATENOLOL 100MG, ASPRIN 75MG, SIMVASTATI;	birth date: 11/1/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/82;	diagnosis date: 2/2/83;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/12/04;	followup rectum: COLONOSCOPIC;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/74;	smoking amount: unknown;	other illnesses: ISCHEAMIC HEART DISEASE;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
PsOEt-14-LS,ctrl
age: 14dpp;	genotype/variation: wild type;	tissue: testis,ctrl
Series 1; young; no fracture,ctrl
5203 Normal Uninflamed sigmoid colon,ctrl
lymphocytes_HD_F_43y_1,pert
cell type: IMR90 (Normal human diploid lung fibroblast);	gender: Female;	overexpression: H-RasV12;	treatment: Vehicle,ctrl
GM19238_Kd_RDBP_2,pert
ILD_23,pert
Age: 49;	Sex: F;	Ancestry: European;	Smoking status: non-smoker,ctrl
THP1-shControl-rep1,ctrl
"HUVEC, atorvastatin",pert
"20B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"129P3/J ACU, Rep3",pert
"51B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Squamous cell carcinoma 029,pert
GEIM50-NORM,ctrl
tissue: lesional skin;	urticaria status: affected;	patient: 3,pert
A SIT_B098,pert
"MCF7/BUS, 100 pM E2, 48 hours, biological replication 4",pert
Diabetic Rat Retinal Müller Cells (technical replicate 2),pert
agent: EFNA4-Fc conjugate;	time: 24h,pert
condition: Psoriasis;	patient: PS-K;	tissue: LS skin biopsy;	kit: Affy,pert
liver_Pink1 knockout_12 weeks_replicate_2,pert
jejunum_1h_rep1,pert
SLE myeloid cells 14,pert
P0 - nudel129s6 3,pert
V5-P577,pert
cell line: U87MG;	treatment: siRNA against CASP2,pert
gender: Female;	tissue: Tendon;Teres minor;	age: 46;	donor: 32;	disease state: Non-lesional,ctrl
SKBR3 WT 2,ctrl
1051-03-A-b,pert
cumulus_PCOS_Lean_rep2,pert
"1mg/kg/day PFOA, Rep 1, Block 2, lung (low dose)",pert
tissue: freshly isolated human monocyte;	gender:male; age: 41 yr; weight: 92 kg,pert
ET 1,pert
35A,pert
C1D-LU,ctrl
"Ctrl OBCs, post doxycyclin withdrawal, rep2",ctrl
"Uninvolved Skin, NS-22",pert
MDS patient 116,pert
Nonlesional Epithelium Atopic Dermatitis rep2,pert
Mouse embryonic stem cell line E14,pert
Gender: Male;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: moderate;	Tumor Site: Rectosigmoid;	Drug Treatment: NO,ctrl
"Liver from control mice, biological replicate 6",ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: tamoxifen for 120 mins,pert
strain: B6/129;	gender: male;	age: 6 months;	tissue: dorsal prostate;	genotype: Klf5+/+; Pten-/-;PB-Cre4,ctrl
background strain: Derived from blastcysts from a 129 female crossed to a (129 X PGK)F1 male.;	cell line: PGK12.1;	cell type: ES cell;	passage: 14-18,ctrl
E14 molar TCDD 1,pert
tissue: skin;	individual: Patient P5;	condition: AL;	eczema severity: SCORAD: 57,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 102;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
"SiRNA-scrambled, replicate 3",ctrl
m1-carcinoma1,pert
X50 NLS 18Q TG1	F2/34	X50	NLS Htt exon 1 18Q	Mouse	16 months	Cerebellum	Male,pert
"MAT1A knockout at 15 month age, tumoral tissue, biological replicate 4",pert
3885-1 E2F WT,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 6",pert
Surgical Sham Control Tail Skin 2,ctrl
aa_NY79,pert
Anti-scramble replicate 1,ctrl
ILD Study Number 1299,pert
cell line: HEK293 cells WTX inducible clone F5;	agent: control,pert
"patient 13, arm treated with pimecrolimus",pert
tissue: Liver;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 690,ctrl
GIST882 Imatinib Rep2,pert
AA_Case10_CD8,pert
THRB bN mutant + T3 replicate 3,pert
MDA-MB-231-ZNF217 cell culture 1,pert
"A pool of RNA from lung from three male mice, raised at Denver altitude (nearly normoxic), with SM22-rtTA x tetO7-BMPR2delx4+ transgene activated for 8 weeks; mice are 12 weeks old when sac'd.",pert
PBMC from T cell Large granular lymphocyte leukemia patient#116,pert
CON22,ctrl
con-9_B,ctrl
baseline control 01,ctrl
"wild type, sample 1",ctrl
5113-scrape,pert
Rybp#10 (OHT+)_12d_rep1,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	target lesion score (peasi): 5;	peasi reduction [%]: 0,pert
S4_S010926,pert
MCF-7ADR_multi-step_doxorubicin_selected_subline_rep_2,pert
E99-/+SRFdM-VP16-1,pert
age: 13.5 day;	strain: 129;	genotype/variation: wild type,ctrl
patient: 40656;	sample: tumor,pert
N5B Normal-cerebelum,ctrl
"control, subject 5",ctrl
gender: Male;	tissue: Tendon;ECRL;	age: 52;	donor: 30;	disease state: Non-lesional,ctrl
NM24 healthy control,ctrl
Benign prostate tissue N4,ctrl
colon_normal_1440,ctrl
Healthy11-CD4,ctrl
"Sciatic nerve, saline control, biological rep2",ctrl
normal control_CTL1,pert
brain wild type replicate3,pert
GM19238_Kd_RELA_1,pert
Kidney HEK293 cells,pert
Age: 43;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
"HERVH shRNA, rep1",pert
age: 18 month postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
Donor4_24h_Wy,pert
12470 UC Inflamed descending colon,pert
"Patient 31, Macroscopically intact tissue",ctrl
ZNF395 knock-down (shZNF395-4),pert
MV 5,pert
Healthy control_sample6,ctrl
"Mouse heart, IDH2 R140Q mutant, replicate 1",pert
Ad infected murine liver-MO30k-(340)-6 hpi,pert
Cisplatin_24h_rep2,pert
D2-Gpnmb+ control rep8 (retina),ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 59;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
"E2f8 KO, biological rep1",pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 48 hrs;	time course: 2,pert
"human failing LV myocardium, Idiopathic61",pert
WT Soleus at 4 weeks biological rep2,ctrl
"HepG2 cells, HNF4a RNAi treated,  rep1",ctrl
liver_STZ 0.5% quercetin diet_rep5,pert
"fetal sex: female;	karyotype: 45,X",pert
HUH-YAP-#1,pert
WT_PLACEBO_48hours_1,ctrl
"WT in the presence of tetracycline, rep3",ctrl
breast cancer patient 248,pert
infection: 2009 pandemic H1N1 Influenza virus;	cell type: cultured primary human lung epithelial cells,pert
"DMSO treated HL60 cells, biological replicate 2",ctrl
"S1P2-KO-hippocampus, biological rep7 (female)",pert
"MCF7/BUS, 60 pM E2, 48 hours, biological replication 5",pert
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Female;	Age of onset (years): 25;	Duration of illness (years): 25;	Brain pH: 6.51;	Post mortem interval (hours): 62;	Side of brain: Left;	Fluphenazine mg. Equivalents: 15000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Affymetrix chip HG-U133A,ctrl
control AU016804,ctrl
male_control_282,ctrl
background mouse strain: C57BL/6;	source: mouse embryonic fibroblast;	genotype: Rap1 I312R mutant,pert
"Pten WT/null epithelials cells, biological rep4",pert
"Crohn's Disease subject (33 year old caucasian female, SAK_1316622123)",pert
T40892,pert
LIVER_diclofenac_repl2,pert
"non-AD_HI, biological rep10",ctrl
"RPMI8226_shKLF2#2, replicate1",pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.98;	RNA Integrity Number: 8.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 48;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Liver KO7,pert
Akt1 double transgenic mice on a high fat diet (DH 4),pert
gender: Female;	age: 67;	post-mortem delay: 3.5h;	ph: 6.1,pert
"Donor 2, Ebola infected 6hr",pert
695-383_4hr,pert
Fog2flox/delta; alpha MHC Cre biological replicate 2,pert
"Acute Myeloid Leukemia, sample 65",pert
siCtrlVeh24h rep1,ctrl
jzo018-rp1-v5-u74av2-met,pert
6h WT Cel.18,ctrl
"prdm-control, biological rep2",pert
cell line: HL-60;	replicate: Replicate2;	treatment: shSYK_2,pert
Wild type Retina Rep3,ctrl
Age: 38;	Sex: M;	Ancestry: Hispanic;	Smoking status: non-smoker,ctrl
OSE_434,ctrl
"Normal subject (39 year old caucasian female, SAK_1265797775)",ctrl
No or early 1 rep6 (retina),pert
"seminoma specimen, pT1, patient age: 38y; W97 082",pert
age	29;	gender	female;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	7.3;	hemoglobin (g/dl)	12.9;	platelet count (/nl)	257,ctrl
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 7 hours,ctrl
Strain: CBA,ctrl
MKO_rep_4,pert
"P202 HCT-116, DNMT wildtype, U0126-treated",ctrl
cerebrum_WT_10d_rep2,ctrl
"PMA treated, no doxycycline; biological replicate 2",ctrl
parental HeLa cells rep 3,ctrl
"ALL_DS, K57 011509",pert
E18.5 Top2b+/+ brain,ctrl
KM_012N,ctrl
S2A Sporadic-frontal,ctrl
EGF 4h replicate 3,pert
"WT, LPS 0hr",pert
retina_DBA_552R_8mo_rep3,pert
si FoxA1 and vehicle replicate 2,pert
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P5,ctrl
SARRC-0146-01-C,ctrl
PGA_Ras_1-m5,pert
Subject #8027-8hr Postinfection,ctrl
Biceps_Control_9,ctrl
"human failing LV myocardium, Ischemic91",pert
Run5.aUa.010110d.SkmDbt1962D.CEL-DB stimulate,pert
LNCaP/NC siRNA #2,ctrl
Sample M535,ctrl
N7B Normal-cerebellum,ctrl
"lymphoblastoid cell line from T21.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
strain background: C57BL/6;	gender: female;	genotype/variation: Mut -/- ;TgINS-Alb-Mut (MMA mutant);	tissue: kidney;	diet: high protein diet for 2 months,pert
T54 Non failing heart biopsy,ctrl
strain: C57BL/6J;	genotype: wild type;	gender: male;	age: 2 months;	tissue: cardiac muscle,ctrl
chip number: 19;	transfection plate: 5;	target gene: SREBF2;	kd level: 0.87;	rin: 9.2;	transfection date: 2011-10-17,pert
LJMJDW4,pert
strain background: C57BL/6J;	genotype/variation: WT;	age: 8 weeks;	tissue: small intestine;	cell type: laser captured Paneth cells,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 5 days adipocyte differentiation,pert
12479 UC Uninflamed sigmoid colon,pert
T30068,pert
patient: 117;	current medication: Loperamide;	birth date: 3/31/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.04;	OD280: 1.071;	Ratio: 1.88;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 131;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Control_EHL, C2",ctrl
Argyrin A treated 12h_2,pert
cortex_HtrA2_KO_rep1,pert
Gastric Cancer PBMC Sample 3,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 24.450;	Ratio: 2.11,ctrl
Tumor_Ker22,pert
WT HSC 2,ctrl
strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: phenobarbitol,pert
HCT116_shN91_rep1,pert
EA_Case14_CD20,pert
"Patient C-c691T, MSI colorectal tumor",pert
6SC-PBO,ctrl
cell line: SK-N-SH;	lentivirus isoform: e1;	lentivirus: WT,pert
"Transgenic mice with water, replicate 2",pert
"knockout white adipose tissue, biological rep 3",pert
Mutated-ERα-positive breast cancer 14,pert
Healthy-1 baseline,ctrl
HLA risk: Medium;	Height: 167 cm;	Weight: 65 kg;	BMI: 23.3;	Age: 33.7 years;	Gender: Male;	Race: Asian;	Glucose: 85 mg/dl;	HbA1c: NA,ctrl
Turner_AF_3,pert
KOPT-K NBD 2,pert
C5_CLP_overexpressor_12,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: spleen;	sample name: 2-sp3,pert
Emd KO male 4,pert
CuFi cell line biological rep3,ctrl
CD4IncDec-test-2,pert
07R055 RA,pert
"seminoma specimen, pT1, patient age: 38y",pert
Teratozoospermic individual: Sample T7,pert
race: american indian;	age (years): 60;	stage: IC;	grade: 2;	histology: endometrioid,pert
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: severe stress + morphine,pert
HCV_Core_2,pert
r13,pert
Gene expression profiles of Lkb1 WT #7 HSCs,ctrl
midbrain_Pink1 knockout_24 weeks_replicate 2,pert
P0 - WTMixA 3,ctrl
224 Day 2 siSC transfected biological rep3,ctrl
HL60_luc_Replicate1,ctrl
Mening SWB WB SW 1b,pert
Early IPF_surgical biopsy_lower lobe_rep159,pert
RatLung_H72h_3,pert
cell line: Mc3T3-E1;	cell type: osteoblastic cells;	treated with: 50µg of Ascorbic Acid (AA) for 5 days,pert
"E18.5 ERRg +/- heart, biological rep 3",pert
Human prostate cancer primary culture C13dx,pert
Strain: C57BL/6; PGC1beta mutant; Tissue: liver,pert
"WI-38 cells, at 24 h after exposure to 1 uM BPDE, biological rep2",pert
strain: C57BL/6;	cell type: Lineagelow Sca1+cKit high Cells;	genotype/variation: Wild type,ctrl
Pax_C4,ctrl
"RNF40 siRNA - 2 days osteoblast differentiation, rep3",pert
colon,ctrl
01UNK_PolyRF-,pert
Injured 7 day Rat Retina 1,pert
"Adult mouse, C57black background, left ventricle of heart",pert
Carbo Day7 (368L),pert
"Transgenic, snap frozen, extensor digitorum longus muscle, 7 month age animal",pert
"brain, hippocampus: Aldh5a1-/- #3363 Cereb_e1_le1",pert
"Lesion Skin, LS-18",pert
Control Day1 (393L),ctrl
strain: 2nd Gen. FVB/N from 129Sv/Ev and Black Swiss mix;	age: 13.5 days;	tissue: whole body;	cell type: Fibroblasts;	genotype: Ptenloxp/loxp,pert
gender: M;	age at blood draw: 48;	tissue: whole blood,pert
HCC008T,pert
K562_ICL670_10uM_dup2,pert
Untreated wild type D,ctrl
"WT, PR02M004v0",ctrl
"non-AD_HI, biological rep5",ctrl
Kidney_Aqp11+/+_P7_1-1,ctrl
wt_P4_rep3,ctrl
patient: 234;	current medication: Aza 150mg Atenolol Atorvastatin BFZ Clopidogril;	birth date: 9/29/46;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/1/88;	diagnosis date: 9/29/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 2/3/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Angina;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
MCI-009,pert
G206-lcm,pert
Control_4months_retina14,ctrl
"EAE, 1,25(OH)2D2 treated #6",pert
OCI-Ly7 BCL6siRNA 1,pert
Intestine_Ctrl_biological rep2,ctrl
patient: 117;	current medication: Loperamide;	birth date: 3/31/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
ctrl_511,ctrl
"Wild-type-neocortex, biological rep2 (male)",ctrl
Age: 46;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
"brain, hippocampus: Wt #3396 Cereb_e1_le1",ctrl
Monocyte FCH rep 3,ctrl
Individual_4778_NN_sample,ctrl
HeLa_01-04-05 TP2_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
WT Soleus at 4 weeks biological rep3,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 08/23/05;	# cells: 38;	Sex: male;	region: M1;	age: 47;	genotype: Y/X;G42/-,ctrl
Cardiac Muscle_Cmah KO_mdx_rep1,pert
Md02h036,pert
"Mouse LV, akt2-/- 3",pert
"gender: Female;	age: 54;	post-mortem delay: 4h;	ph: 6.5;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 38;	gender: f;	treatment: -,pert
VMH of KO1 mice,pert
"Notch3 knockout mouse cerebral microvascular fragments, biological rep2",pert
Disease_status: Bipolar disorder;	Age (years): 30;	Gender: Male;	Age of onset (years): 7;	Duration of illness (years): 23;	Brain pH: 5.8;	Post mortem interval (hours): 56;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
H27 HA 24h 3,pert
"Hdh knock-in embryonic stem cells, Q91 line, biological replicate 3",pert
S/SM1,pert
WT3R1,pert
"119, MUSCLE, Before",ctrl
Vit A deficient 1b,pert
"IRF6 knockout, biological rep2",pert
KU_39N,ctrl
n5t30m,pert
TB 7,pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 1 - Technical Replicate 1,pert
"A pool of two pure subsets of peripheral blood CD56dim natural killer cells (CD19- CD3- CD56dim Cd16+), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M2;	flt3 status: internal tandem duplication (ITD),pert
whole tissue section from case 469,ctrl
Bmi1 embryonic stem cells sample_1 (Bmi1_ESC_1),pert
Tendon_lesional_rep16,pert
"Subject 1, Family 1, Affected",pert
A_AN09730_T,pert
PBMC from T cell LGL leukemia patient #107 (TLGL107),pert
high grade serous carcinoma_patient 2_sample 2,pert
strain: C57BL/6;	genotype/variation: Zmpste24-/-;	cell type: mouse embryonic fibroblasts,pert
"Patient 12, Macroscopically intact tissue",ctrl
181D3,pert
brain_DLPFC_bipolar C_mr418,pert
HEK293 F18_doxycycline treated,ctrl
"Human lung carcinoma H1299 cells (p53 null, no p63 expression) Tet-on",ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.999;	Ratio: 2.12,pert
"HeJ, air, biological rep 1",pert
cell line: A2008;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
Subconfluent RBP2-/- primary mouse embryonic fibroblasts at passage 3.,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339033,pert
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: Tip60,pert
Large cell carcinoma 001,pert
EOM 112 Day mdx rep 3,pert
"GFP Alone, Replicate 3",pert
Ishikawa_HighDose_BPA_48h_rep1,pert
MCF7_Sangivamycin_Array_1,pert
8 week old leg control rep 1,ctrl
KN-smoke-med-5 month+13d-R2,pert
"Alk2 cKO mice, whole uterine tissues, replicate 3",pert
MDA_Parental_3,ctrl
"Cell type: endothelial, age:32, gender:male, diagnostic group: control, PMI:13h",ctrl
"Wild-type-neocortex, biological rep1 (male)",ctrl
liver_NEMO_KO_replicate2,pert
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.3;	Post mortem interval (hours): 25;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
"Age: 44;	Sex: F;	Ancestry: European;	Smoking status: smoker, 30 pack-years",pert
TOV112D cells_treated with NSC319726_biological rep1,pert
"BA OBCs, post doxycyclin withdrawal, rep3",pert
jejunum_0h_rep1,ctrl
12h_RA3,pert
scan batch: Batch 1;	group: autism;	subject age: 7;	paternal age: 32;	maternal age: 33,pert
N40836,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_4_32_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
intestine_PPARa-knockout_control_rep2,pert
SCC13,pert
cerebrum_PSNA_ 12w_rep2,pert
LY2 control-siRNA tamoxifen treated rep1,ctrl
Treg WT rep4,ctrl
age: 67;	gender: male;	ejection fraction: 43;	left ventricular end diastolic diameter: 59;	inflammation/PVB19: positive,pert
Wildtype_XX_3,ctrl
"Healthy volunteer, Control_11691",ctrl
con-15_C,ctrl
MCF7 cell line_resveratrol_150mM_biological replicate 2,pert
"Diabetic mice, time point 3 week",pert
uterus_P4_PRKO_4hrs_rep1,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 59 yr;	population: white;	dsm-iv: 296.53;	age of onset: 25 yr,pert
No or early 1 rep2 (OHN),pert
ILD Study Number 1196,pert
"P90_wt cones, replicate 1 [array]",ctrl
Striatum of 8-10 week old SWR/J mice,ctrl
Post Transduction:24 hr; treatment:Mut;,pert
Bronchial Epithelial Cells SA biological 1986Z,pert
OV90-(3),ctrl
4031-3 E2F3 Heterozygous,pert
KO PGC rep2,pert
"Rad21 esiRNA, biological rep4",pert
BC1 TC_NOC,pert
PTEN+/- ep_B,ctrl
iPSC idiopathic autistic patient triplicate 3,pert
race: african american;	age (years): 72;	stage: IC;	grade: 2;	histology: endometrioid,pert
ubb_d21_ko_1,pert
Human skeletal muscle biopsy sample;	Patient #176 with NORM,ctrl
cumulus_nonPCOS_Obese_rep2,ctrl
PGA-RMM-48h-3aA-s2,pert
"GTF2iTrap line, biological rep 1",pert
"fibroblast, control subject NF11 rep 2",ctrl
m1-WT2,ctrl
Nrl-ko-Gfp P10 replicate 4,pert
"iPSC derived from healthy control fibroblast WT1, biological rep1",ctrl
CML_5_GMP,pert
"human failing LV myocardium, Ischemic42",pert
Cell line HeLa_c-myc KD_expt3,pert
"TH cells from LC, Mecp2 null, young time point, biological replicate 2",pert
"twin pair: #3;	individual: healthy individual, non-inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
"Typically Developing Control, Semitendinosus, Patient Replicate 7",ctrl
wild type CBA (sample2),ctrl
Bmpr2-R899X 2,pert
WT-smoke-med-5 month+13d-R1,ctrl
Parkinson's disease sample x124,pert
"normal skeletal muscle, biological rep8",ctrl
"human failing LV myocardium, Idiopathic32",pert
Diaphragm 28 Day control rep 1,ctrl
"SLE patient, 1014V2",pert
H17_S_B1,ctrl
gender: male;	batch: 1;	age (years): 39;	patient id: Control_1;	fev1 (% predicted): 78;	fvc (% predicted): 76;	medication: None;	cell type: CD4+ T-cells,ctrl
cell line: MCF-7;	expression: BP1-overexpressor,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 165min;	race: Asian;	sex: Male,pert
MDA-MB-231 - Control-1,ctrl
siGL3E2 1,ctrl
MDS12,pert
Pool Eu_P30_hyb1,ctrl
NINDS-RHS-Kainate_240h-2aUA-s2,pert
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p30;	strain: E14,pert
AA_88,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5b;	flt3 status: WT,pert
Kidney_saline ip_mouse #063,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case4,pert
"Du145-PCAT1 cMyc siRNA #4, replicate 1",pert
Liver_Nrf1 CKO_rep1.,pert
aa_NY74,pert
Tgfbr2 Wildtype Mouse Model MEPM 2,ctrl
V5-P280,pert
"fibroblast, control subject NM10 rep 1",ctrl
KO3 CD11b,pert
cell line: Normal bone cell line 1705;	phenotype: RB1 knockdown;	cell type: human osteoblast (hOB),pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,ctrl
Donor1_24h_Wy,pert
brain_OFC_control C_mr217,ctrl
4-Vinylcyclohexene Diepoxide (50uM) rep 3,pert
sampleID: SAM630138;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
liver western diet rep6,ctrl
gender: Female;	age: 94;	post-mortem delay: 9.5h;	ph: 6.3,ctrl
db/db 12-1,pert
"48 hour-treated wild-type NB4, biological rep1",pert
control participant P300,ctrl
LKR13_Kras sh-1,pert
"C57BL/10-SJL.Dysf TA, replicate 3",pert
multiple myeloma (MM 412),pert
"experiment XI, hTERT",pert
sMPNST_JQ1_2day_rep3,pert
C_AN19442_F,ctrl
"control, BA10-50(2)",ctrl
Muscle PCOS case 101,pert
CD4+_Tcells_severe_asthmatic_5,pert
transfection: CDK19-1;	cell line: HeLa S3,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 78;	time: 0;	batch: 1,ctrl
Testis_wild type_rep2,ctrl
HEL_JAK2 knockdown (Jak2-9 shRNA)_2,pert
transfection: CDK19-2;	cell line: HeLa S3,pert
chip number: 19;	transfection plate: 3A;	target gene: NFYC;	kd level: 0.59;	rin: 9.6;	transfection date: 2012-03-26,pert
condition: Psoriasis;	patient: PS-I;	tissue: LS skin biopsy;	kit: Affy,pert
A/JTCE liver sample batch 6,pert
Nerve_Diabetic_Vehicle_707,ctrl
cell line: COLO829 melanoma cell line;	genotype/variation: control;	agent: BRAF inhibitor PLX4032 (Vemurafenib),pert
T3B-LU,pert
wt-Gfp P2 replicate 3,ctrl
Cont G3,ctrl
Squamous cell carcinoma 013,pert
"Global gene expression of NASH patients, normal control A154",ctrl
GFP-progerin Induction: day 5 Replicate B (5b_progerin_5d_B),pert
"113, ADIPOOSE TISSUE, Before",ctrl
Control;	Survivor;	gender: Female,ctrl
fasted liver standard chow diet 1,ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 7",ctrl
NOD/LtJ Vehicle liver sample batch 3,ctrl
male JAK2 WT liver sample 116,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_8_8_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
cell line: BxPC3;	cell type: pancreatic cancer;	transfected vector: shJMJD3-expressing,pert
02_ADL,pert
PlagL2KO4,pert
ME180 DMSO rep 4,ctrl
PsOEt-11-LS,ctrl
Untreated after 4 days (C3_2),ctrl
normal main pancreatic duct 2,ctrl
U937_luc_Replicate1,ctrl
"metastasis: none;	Stage: 2b;	tissue: normal, homogenized",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 28;	gender: male,pert
cell type: LSK;	tissue: hematopoietic stem cell enriched fraction from bone marrow,pert
CD4IncTp1-3,pert
14.5_KO_615B,pert
RTX12 T0,ctrl
N40656,ctrl
wild type MEF time 48 replicate 3,ctrl
Severe rep1 (OHN),pert
Ischemic cardiomyopathy_G43,pert
AKO-rep1,pert
"N-58, NORM, M, GSF, 1 x 100nM DHT, 24h",ctrl
CD34+ cells with fenretinide treatment from CML34,pert
"vector d4, rep 2",ctrl
Disease_status: Healthy control;	Age (years): 42;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.6;	Post mortem interval (hours): 27;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
RORasg/sg liver_HFD_rep4,pert
Series 2; young; no fracture,ctrl
GM19238_Kd_STAT6_2,pert
Sham2,ctrl
race: caucasian;	age (years): 62;	stage: IB;	grade: 2;	histology: endometrioid,pert
P32_exPKO_pancreas,pert
strain: Des(-/-)/129/SVE;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 7-9 wk,pert
"A673 treated with DMSO vehicle control for 3 days, biological rep5",ctrl
RV16;	Age = 21;	Sex = M,pert
1193-03-A-b,pert
"Immortalized MEFs WA, empty retroviral vector infected, rep1",ctrl
"breast tumor epithelium,7",pert
t22,pert
KO_TER119-_rep1,pert
51A;pretreatment;female;breast tumor; responder,ctrl
brain_DLPFC_bipolar C_mr275,pert
cell line: Calu-3;	cell type: airway epithelia cells,ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 8",ctrl
patient: 26;	disease state: hypertension;	tissue: Atheroma plaque,pert
newborn (P0) Krt1-/- skin_replicate 3,pert
OE control 2,ctrl
Strain: C57BL/6;	Genotype: AMPK gamma3 knock-out;	Generation: F7;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,pert
Gender: Male;	Age: 25;	Ethnicity: Black,ctrl
tissue: cardiac biventricle;	genotype/variation: PGC-1a KO (PGC-1b expression is unaffected),ctrl
LJMJDW2,pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Untreated-Control, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation.",ctrl
At Risk: +;	Age: 9;	Sex: F,pert
"CD8 DC Xbp1 KO (DC conditional KO), biological replicate 3",pert
race: unknown;	age (years): 64;	stage: IB;	grade: 2;	histology: endometrioid,pert
disease state: paediatric glioblastoma;	age: 14;	gender: M;	h3.3_status: wt,ctrl
"203, ADIPOOSE TISSUE, Before",ctrl
Wt Mouse_cerebellum_Young_saline treatment_Replicate-1,ctrl
wild type 2 cell embryo rep1,ctrl
tissue: Peripheral blood;	disease status: normal control,ctrl
LNCaP R1881 rep 2,pert
Control_9,ctrl
Gender:F;	Age:42;	Tissue: Mucosa,ctrl
"Normal T-cells, CD3+, donor 3",ctrl
Scrambled 12 hours_1,ctrl
Mtb infected-42d-4,ctrl
ESC_Zfx-null_Replicate2,pert
genotype/variation: WT;	cell type: pancreatic cells,ctrl
Monocyte derived dendritic cells were generated by culturing human monocytes isolated from buffy coats using CD14 microbeads (Miltenyi),pert
"MCF-10A cells, overexpression ΔNp63α, biological rep1",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 70 years,ctrl
db/db 11-5,pert
11418 UC Uninflamed ascending colon,pert
Liver_hyperglycima_no.6,pert
CEM Control 2,ctrl
Bronchial Epithelial Cells MMA biological 2048M,pert
Backskin_Get1_e18_WT3,ctrl
Md02h023,ctrl
Muscle Experiment 3,pert
Muscle PCOS control 2,ctrl
"NPTX1 shRNA Day 3, biological rep3",pert
Control 120 days sample 1,ctrl
baseline control 05,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 217,pert
Carbo Day2 (376R),pert
Strain: C57BL/6J;	Gender: F;	Age: 8 weeks;	Treatment: untreated,ctrl
Patient identifyier: D;	Sex: male;	Age of patient: 61 years;	Duration of psoriasis: 21 years;	Body surface area: 12 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
liver control diet rep3,ctrl
18A;pretreatment;female;breast tumor,ctrl
Gender:M;	Age:22;	Tissue: Mucosa,pert
tissue: adipose tissue;	sample group: placebo;	treatment: before;	gender: Female,ctrl
microdissected breast cancer cells from case 1437,ctrl
strain: C57BL/6;	tissue: liver;	gender: female;	age: 35week,ctrl
Untreated after 4 days (C3_1),ctrl
brain_DLPFC_bipolar B_mr425,pert
A VIS _B067,pert
MDA-MB-231 - Control-2,ctrl
Nonlesional Epithelium Nonatopic Control rep5,ctrl
0537-01-C,ctrl
phenotype: control;	gender: male;	case_id: 282;	age: 82;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 36;	brain ph at time of freezing: 6.24;	labeling_batch: 1,ctrl
short-Con rep2,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 9.8;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 50;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: HepG2;	cell type: Human hepatocellular liver carcinoma cells;	genotype/variation: HIF-2α knockdown;	cell subtype: 10 days old tumor spheroids,pert
181D1,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 6 months,pert
non-malignant FTEb_patient 4,ctrl
disease state: control;	patient: 25,ctrl
Normal Chip#8,ctrl
CONTROL;	Age = 21;	Sex = M,ctrl
LSK SRF-null 2,pert
IM24_control,ctrl
0952-01-A,pert
strain background: C57Bl/6;	genotype/variation: P14 TCR transgenic C57Bl/6;	cell state: Day 3 in vitro effector CD8+ T cells,ctrl
PBMCs_IS_9 [IS],pert
Peripheral blood mononuclear cells;	TTF=90min;	Race=White;	Sex=Male,pert
tissue: Temporal cortex;	age: 77;	Sex: F,ctrl
siControl_2,ctrl
MF-16,ctrl
CD4IncTp2-1,pert
01L4M_CTRL,ctrl
"G42 cells from M1, Mecp2 null, biological replicate 4",pert
patient: 6;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
normal muscle replicate 3,ctrl
WT - Cre Treated - 0.5 hrs - repeat 3 - Cy5 - mAdbID:62546,ctrl
"human failing LV myocardium, Ischemic22",pert
RNA from HCC_13N,ctrl
"KO total RNA LSK, rep 5",pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 47;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
PGA-lv_4h_506,ctrl
NS1-030915-SA,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-tu1,pert
jzo019-rp1-v5-u74av2-met.TXT,ctrl
Amniocytes_trisomy 21_1573,pert
Fiona Biological Replicate 5,pert
LT346 wilt-type untreated,ctrl
Myoblast-GATA4-Wt-day3-3,ctrl
E5C,ctrl
443MM,pert
Hippocampus_Soman_6h_rep1,pert
3_month_old_wildtype_mouse_rep4,ctrl
"Neuroretina 8-week diabetic, Biological replica_1",pert
6 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24720,ctrl
lung_silica_3,pert
WD44_control RNAi-2,ctrl
Control 2_Huh7 [HDAC2 siRNA subset],ctrl
ColonTumor022RAFBU_cta.txt,pert
sex: Female;	family: 1;	age: 41;	disease status: Control;	tissue: Muscle: Biceps,ctrl
"PBMC, patient. Mtx rep7",pert
Tet1-kd_ES_rep3,pert
Pool Ts1Cje_P0_hyb1,pert
genotype variation: Nrf-/-;	treatment: air;	developmental stage: neonate,pert
Gene expression profiling of Phgdh knockout embryo wild1,ctrl
GM19238_Kd_NS3_12,ctrl
"Patient N, uninvolved skin",ctrl
a_NY70,pert
CML_6_HSC,pert
"septic CD4+ splenocytes at 6h, biological replicate 5",pert
PPC1_CBFbeta shRNA replicate 1,pert
"Acute Myeloid Leukemia, sample 43",pert
age: 7 weeks old;	strain: C57Bl/6;	phenotype markers: CD4+ Foxp3+ CD25+;	separation method: FACSAria;	Sex: Female,ctrl
Genotype: HDAC1 knock out;	not differentiated,pert
ref,ctrl
Leg 56 Day mdx rep 1,pert
Liver Control 3,ctrl
MOLT4_GSI_B,pert
"C57BL/10 QF, replicate 3",ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 4",ctrl
cRNA;	postnatal day 16;	WT,ctrl
short-hairpin rna: shControl;	cell line: HCT116,ctrl
Bone-Marrow_MM_M995,pert
SHR-vehicle pool sample3,pert
Yolk sac tumor 0216,pert
Myoblast-GATA4-OE-day3-1,pert
strain: Myd88 KO;	age: 4 month;	gender: N/A;	weight: 25-30g;	tissue: whole trachea,pert
db/db 14-3,ctrl
FW_7a_BV8479,pert
mouse: 1;	strain: C57Bl/6;	genotype/variation: Wild-type;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,ctrl
CCl4_CT19,ctrl
EP31_adipose_control_rep1,ctrl
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 2;	time: 3h,pert
"A673 treated with Doxorubicin for 3 days with concentration of 119.76 nM (2 x EC50), biological rep2",pert
104B,ctrl
eNOS Knockout Mice-M10,pert
RL_siRNA_NS_rep1,ctrl
HDAC6_2,pert
"control, BA46-65",ctrl
"Fibroblasts from normal histology lung tissue, NL-5",ctrl
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-4,pert
cell line: HT29RC PLX4720 resistant cell line;	cell type: colon cancer,pert
WT-GFP-lamin A Induction: day 0 Replicate B (1b_WT_0d_B),ctrl
Liver_WT_Vehicle_Rep1,ctrl
shScr replicate 1,ctrl
platelet_Ctrl_10,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.15;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Diaphragm 14 Day mdx rep 1,pert
Strain: a mixed C57BL6/129 genetic background,pert
Subject #8008-Preinfection,ctrl
11a_c,ctrl
TOV112D cells_treated with NSC319726_biological rep2,pert
"Wild-type myeloid-derived suppressor cell from bone marrow, rep1",ctrl
MDA-MB-231 RRP1B over-expressing clone #7,pert
genotype: Tsc1-deficient;	cell type: CD4 naive cells;	genetic background: C57BL\6,pert
normal main pancreatic duct 4,ctrl
"Wild type, snap frozen, extensor digitorum longus muscle, 7month age animal",ctrl
MKK3bE transgenic female replicate 1 early timepoint,pert
"ESCs overexpressed CA-NFATc3, biological rep2",pert
CRC_celecoxib_F4859,pert
"Distal and Proximal Large Intestine, 8week old Wild-type mouse 3",ctrl
WT Brain 25d Mouse1,ctrl
C2C12 myotubes 100uM H2O2 rep 4,pert
"Mkl2-/-, sample 1",pert
HLA risk: Low;	Height: 147.2 cm;	Weight: 35.2 kg;	BMI: 16.2;	Age: 11.45 years;	Gender: Female;	Race: White;	Glucose: 247 mg/dl;	HbA1c: 6.7%,pert
race: caucasian;	age (years): 45;	stage: IA;	grade: 1;	histology: endometrioid,pert
Series 2; adult; 3 days,pert
"Cell culture. A549 treated by MK886, control 3",ctrl
"Strain: C57BL/6J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle, Galgt2 Transgenic",pert
KU_19T,pert
esr1 genotype: WT;	agent: saline control;	time point: 24h;	strain: C57bl6/Jx129;	age: adult (10+ weeks);	gender: ovariectomized female;	tissue: uterus,ctrl
"Wild type,pancreas",pert
"Male, Wistar, 0 access to cocaine, nucleus accumbens",ctrl
tetracycline inducible Ngn3 ESC differentiated for 10 days as EB with doxycycline for 3 days,pert
"tissue: lung, upper lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 67",pert
patient id: 209;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 63;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 2;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
Hippocampus_Soman_72h_rep2,pert
695_EV_0hr,ctrl
vehicle treated rep 1,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 30.4411,pert
cell line: MDA-LM2-shTARBP2;	transfection: shZNF395,pert
Normal-ERα-positive breast cancer 50,ctrl
WT - Cre Treated - 0.5 hrs - repeat 1 - Cy5 - mAdbID:62544,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_4_7_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
F_Kin_1,pert
Human squamous cell lung cancer cells,pert
nucleus accumbens ctrl replicate 4,ctrl
pediatric AML S11,pert
OBF-1 overexpression BCS-4 (Large PreB),pert
tissue: skin;	individual: Patient N-4;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
695_383_16hr_repeat,pert
01LNM: normal control,ctrl
KU_28N,ctrl
Sham 3,ctrl
"RPMI8226_shLuc2, replicate1",ctrl
tissue: liver;	genotype: IR flox/flox albumin:CRE +,pert
Muscle JDM (YJD-JDM-23UA-s2),pert
"siYAP RNA #1 transfected, biological rep 2",pert
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 2",pert
Dendritic cells generated from blood of donor 1,ctrl
"Patient 1, Macroscopically intact tissue",ctrl
treatment: RISC-free control transfected;	cell type: Primary cell line,ctrl
P4_WT_2,ctrl
FcgKO Non stim 2,pert
WT-smoke-med-1 day-R1,ctrl
Plate vs. Nail:  1 Week Nail,pert
Tendon_lesional_rep5,pert
Tumor-KO-rep1,pert
3451-1 E2F WT,pert
Normal cervix epithelium_03-4216,ctrl
Individual_4356_PN_sample,pert
Insm1 control #9,ctrl
HMEC_50 vs MCF7,pert
rd1_P8_rep2,pert
Sex: female;	Age at operation: 69 years;	Site: lower arm;	Size in cm: 4.5x3.5x2.2;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,ctrl
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 40,ctrl
chip number: 20;	transfection plate: 4;	target gene: IRF3;	kd level: 0.91;	rin: 9.1;	transfection date: 2011-10-17,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: vehicle control;	treatment time: 24 hours,ctrl
01MKV: new onset sJIA,pert
"breast tumor epithelium,53",pert
"siRNA, plastic plate, rep2",ctrl
hBSMC_vitamin D_rep3,pert
strain: C57BL/6;	tissue: Lung;	agent: saline;	genotype/variation: FIZZ2 knockout,pert
Normal cervix_05-4615,ctrl
patient: 253;	current medication: Asacol 800mg BD;	birth date: 3/14/58;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 8/24/97;	diagnosis date: 9/4/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/24/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/24/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/3/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"fibroblast, control subject NM3 rep 2",ctrl
SBVGA3 3,ctrl
Liver phenobarbital pool1 Affy,pert
C16-4,pert
source: Breast adenocarcinoma;	cell line: MCF-7;	treatment: ethanol;	knockdown: control,ctrl
"colonic tissue from floxed mouse, biological rep3",ctrl
CD4+_Tcells_severe_asthmatic_7,pert
Huh-7/Fluc rep3,ctrl
S/LV1,pert
SC-RbKO 4,pert
chip number: 5;	transfection plate: 2;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2011-03-29,ctrl
age: 35;	sex: M;	disease status: control subject;	Filter number: 84;	Usage number: 1;	Exposures: 3,ctrl
Wild Type Time 0 replicate 1,ctrl
healthy CD4 T cells 8,ctrl
Cancer 6,pert
Liver_Female_WT_rep3,ctrl
Individual_5844_NN_sample,ctrl
MKK3bE transgenic male replicate 3 late timepoint,pert
"human failing LV myocardium, Idiopathic11",pert
retina_DBA_1025L_3mo_rep2,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 95;	Sex: male;	region: LC;	age: 41;	genotype: Y/Mecp2-;TH/-,pert
C57/BL6 C3KO murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock).;	,ctrl
siERK2Veh4h_2654,pert
Knockdown Cell on HMVEC-L Replicate 2,pert
8 week old EOM MDX rep 2,pert
mouse adipose tissue,pert
siOGT 24 hours_2,pert
TTE3 cells treated with BPA for 3 h-2,pert
"Cnr1-/-/Cnr2-/- female number 1, 2 months old, whole ear tissue, untreated control ear",pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_6h_0.4mM_HG-U133A_2_YCHSUP501,pert
Age: 45;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.163;	OD280: 0.612;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 60;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 112;	genotype/variation: WT;	age: 8 weeks,ctrl
Normal Pleura 1,ctrl
Prostate Cancer_MS 36D6,pert
ALI patient #10,pert
Sample 01 Kidney Normal mouse - Control diet,ctrl
Wild type pancreas,ctrl
6 hr KLF4 Time Course Control,ctrl
"strain: FVB/C57B6 mixed backgroud;	cell type: primary KrasG12D pancreatic ductal epithelial cells, P7;	genotype/variation: Pdx1-Cre;LSL-KrasG12D L/+",ctrl
E2A-deficient DN2 replicate 2,pert
"Embryonic cerebral cortex, control, biological replicate 2",ctrl
Mouse_Retina_P7_Rs1h_KO 2,pert
A513 Sham 7 day,ctrl
disease state: Diamond-Blackfan anaemia;	gender: Male,pert
KU_11N,ctrl
age: 53;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
AVC_control_rep2,ctrl
U937_ROS_curcumin_4h_rep1,pert
age: 77;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
rd1_P2_rep3,pert
b146,ctrl
healthy control C9,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 19d ID75,ctrl
Bone-Marrow_MM_M1081,pert
patient: 21;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
HL60_luc_Replicate3,ctrl
"brain, hippocampus: KA1-I_e1_le1",pert
tissue: Brain;	genotype: Npc1-/-;	age: 59 days;	subject: Mouse1;	genetic background: BALB/c,pert
WFS1 WT USHT_17_315_ko,pert
Strain: B6SJL-G93A-SOD1;	Age: 75 day,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 55 yr;	population: white,ctrl
HRas-v12 transgenic male replicate 3 early timepoint,pert
HeyC2-(2),ctrl
Control Braak α- synuclein Stage 0 C1SN,ctrl
microdissected breast cancer cells from case 319,pert
disease state: cocaine addiction;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: cocaine related,pert
11387 Normal Uninflamed descending colon,ctrl
"human failing LV myocardium, Ischemic11",pert
"Mutant, biological rep1",pert
cadmium_32hr_rep2,pert
11395 Normal Uninflamed sigmoid colon,ctrl
U2OS_PRC_shRNA4_pLenti_1,pert
Experimental 3,pert
Kidney_saline ip_mouse #065,ctrl
KU_41T,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 11,pert
N_LS_Time0,ctrl
"BALB/c, Male, CF",pert
cell line: E14;	treatment: Usp22 depletion,pert
Nerve_Control_Rosi_712,pert
clone 3-2,pert
0180-01-C,ctrl
"age at diagnosis: 76;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 1;	dfs-month: 48;	dfs-event: 0;	distant metastasis: 0",pert
striatum wild type 21 month replicate 3,ctrl
40SAGEA2,pert
AA_Case20_CD8,pert
Against CDK8-2 rep3,pert
"Liver from Nrf2 k.o. mice, biological replicate 2",pert
3T3 Vector Control Vehicle 3,ctrl
CAR.KO_corn oil_rep2,pert
Muscle_control_1,ctrl
2x' Ez f/wt,ctrl
"Eed KO BM LT-HSC, biological rep3",pert
mES cells rep1,ctrl
patient: 30364;	sample: normal,ctrl
"SFM control cells (24hr), biological rep2",ctrl
patient: 51572;	sample: normal,ctrl
heart of mouse subjected 2 week to chronic constant hypoxia,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep12,ctrl
cell line: IOSE80pc;	knockdown: control;	cell type: ovarian surface epithelial cells,ctrl
CD19_selected_B-cells_after_R_rep2,pert
GM19238_Kd_NS1_11,ctrl
3975-1 E2F1 Null,pert
pB  is a clonal control (puromycin resitant) stably-expressing stem cell line,pert
224 Day 2 siMut10 transfected biological rep2,pert
coc-10_B,pert
3T3 Vector Control A-928605 1,pert
KO1,pert
Wild-type Type II 1_8_9_04,ctrl
01MKC_PolyRF-,pert
cell line: RWPE-1-PCAT-1 (CRL-11609);	age: < 20 cell passages from derivation,ctrl
"human failing LV myocardium, Ischemic17",pert
rtTA-Dmrt5_d7_+Dox_rep_2,pert
MCL_IGHV_MUT (R1940),pert
"Crohn's Disease subject (28 year old caucasian female, SAK_1316711535)",pert
"siYAP RNA #1 transfected, biological rep 3",pert
3507-scrape,pert
"control endometrium, patient 12",ctrl
Velcade I1,pert
SCARKO d10 (2),pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 64,pert
CML_7_MEP,pert
P117,ctrl
WT liver_HFD_rep1,ctrl
WFS1 KO USHT_04_319_ko,pert
Pool 1 Convalescent stage,pert
Parkinson's disease sample x205,pert
STHdhQ111/Q111-B,pert
tissue: dental pulp cells;	genotype: control;	passages: 6,ctrl
"E2F-1, #2 repeat",pert
GLY replicate 5,pert
Time 0 mins rep 2,ctrl
DMSO1,ctrl
FHCRCAML723,pert
"58B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"patient 042b, normal, homogenized",ctrl
PsOEt-10-Week 1,pert
F9 RA sample #1,pert
"brain, lateral and medial ganglionic eminences: Arx-/Y #3_le1",pert
MCL_IGHV_UNMUT (268-01-5TR),ctrl
Endometrium-Normal 7,pert
CBMNC.LPS+.1,pert
GM19238_Kd_SP3_2,pert
3216M patient's mucosa,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: DMSO for 72h,ctrl
Sham 6,ctrl
NSC_FBS_V2,ctrl
"BA OBCs, post doxycyclin withdrawal, rep2",pert
gender: male;	age (years): 53;	evolution time (years): 8;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
"IDC 2, biological rep. 2",pert
PGA-MAH-C3H_OVA6h-5aA-s2,pert
Monocyte FCH rep 2,pert
Panc-1 TGFβ Treated 1 48 hr,pert
oocyte_wildtype_rep2,ctrl
FBooth-CON-5Av2-s2,ctrl
DUSP1-/- control replicate 1,pert
BCR/ABL1 biological replicate 3,pert
BP18,pert
patient: 250;	current medication: Asacol 2.4g/d;	birth date: 1/27/58;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 1/1/94;	diagnosis date: 5/30/94;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/29/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 4/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
age: 63;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"Wild type, biological rep 2",ctrl
Gastrocnemius Muscle_Cmah KO_rep2,pert
Strain: Inbred C57BL/6J;;	 Gender: male;;	 Age: day of life 3;;	 Tissue: liver,pert
RNA: whole lung;	strain: C57BL/6;	genotyp: myd88 -/-;	infected: no;	replicate: A,pert
Muscle PCOS pioglitazone 81,ctrl
RTX10 T0,ctrl
"Embryonic cerebral cortex, control, biological replicate 3",ctrl
fibroblast_Normal_D139_Media_4,ctrl
quiescent p27WT MEFs 1,ctrl
cell line: KYSE30;	cell type: squamous cell carcinoma,pert
HUVEC_control_rep1,ctrl
cell line: KYSE50;	cell type: squamous cell carcinoma,pert
cell line: HCT116;	shRNA: CDK8;	treatment: low glucose,pert
siCITED1#1 replicate4,pert
"shCDK19, normal growth, replicate 1",pert
UM30_Wt_rep3,ctrl
testis knock out replicate1,pert
p300_3,pert
6h Kin- Cel.42,pert
3987-1 E2F1 Null,ctrl
lymphoma_1032_ADR,pert
"proband i, past exhaustive exercise",pert
Patient 4 skin treated,pert
CEM-C1 cells treated with DMSO,ctrl
Common Myeloid Progenitors,pert
sMPNST_JQ1_2day_rep2,pert
cell type: Primary hepatocytes;	donor: 6;	agent: Wy14643;	time: 24h;	gender: Male;	age: 73 years old,pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep7,pert
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: mir126 knockdown,pert
RAW_1.4mM_HOCl_#2,pert
IM69_control,ctrl
440MM,pert
iPSC control triplicate 2,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Neurointermediate lobe of the Pituitary,pert
brain_DLPFC_bipolar B_mr950,pert
PGA-MAH-C3H_PBS6h-5aA-s2,ctrl
"29B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
brain_DLPFC_bipolar C_mr540,ctrl
OVCAR-10-(2),ctrl
"Global gene expression of NASH patients, normal control A643",ctrl
T143 U133p2,pert
XBP1s Tumor 2,pert
"Cnr1-/-/Cnr2-/- female number 3, untreated control ear (#9_Ko-C-7)",pert
Donor (Sample 20),ctrl
E9.5 FVB/N erythroid cells-3,ctrl
"Uninfected NT at 5 d.p.i., rep3",ctrl
heart_KO_rep3,pert
"GFPMYC positive GC B cells, Biological replicate 6",pert
ROSI-4--71602,pert
6: FCHL patient #98-1174,pert
"foxp3 expression: YES;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 wild type;	gender: female;	treatment: anti-CD3, anti-CD28 for 72 h",ctrl
cell type: umbilical cord endothelial cells (HUVEC);	passage: 4,ctrl
Skin_SKO_Rep1,pert
kidney_QH2_6M_rep2,pert
"DMSO Control after 4hr, replicate 2",ctrl
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 42 dpi,ctrl
DES D3,pert
NCI-H716_Control.1,ctrl
Bronchial Epithelial Cells SA biological 1578K,pert
DNGM-9,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 18.18082,ctrl
TB 1,pert
"Liver from Nrf2 wt mice, biological replicate 2",ctrl
"Knockout Heart with no treatment, biological rep3",pert
rd1_P2_rep1,pert
CF_control,ctrl
"Gender: Female, Age: 31, BMI: 21, Tissue: luteinized cumulus cells",ctrl
strain: HNF4LoxP/+AlfpCre;	age: E18.5;	tissue: Fetal Liver,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#102,pert
PCOS Endometrium Stromal Cell_118.PC11-+,pert
XBP1s_B_cells_spleen_20weeks,pert
Muscle PCOS case 161,pert
tissue: muscle;	sample group: placebo;	treatment: before;	gender: Female,ctrl
"Pineal gland from NeuroD1 cKO mouse at ZT6, biological rep 3",pert
condition: Discoid Lupus;	patient: L3;	tissue: LS skin biopsy;	kit: Ovation,pert
GM19238_Kd_JUND_3,pert
"shCDK19, low glucose, replicate 3",pert
status: control,ctrl
TGFb1 treated experiment B (10ng/ml 24 hours),pert
lymphocytes_ctl_F_60y,ctrl
brownfat_KO1_day3,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Colon",pert
Tissue: Spleen;	Type: CLP;	Strain: C57BL/6;	Batch: 8/1/03,ctrl
batch: A;	knock-in: Twist-DQD;	cell line: MycCap prostate cancer cells,pert
RNA from HCC_23T,pert
"WT VSV infected, biological replicate 2",ctrl
Gastric_cancer_patient_2_dye_swap,ctrl
AKR/JTCE liver sample batch 1,pert
Subtype: RAEB1;	Karyotype: normal,pert
normal scar treated with hydrocortisone-4,pert
Osteoblasts_Lrp5_Control_Day7_rep1,ctrl
"5 x 10^4 Zfx-flox LSK (Lin-, Sca1+, c-Kit+) cells were sorted directly into Trizol Reagent (Invitrogen) form pooled bone marrow cells from Zfx-flox mice.",ctrl
KU_17N,ctrl
Cancer 7,pert
CD4IncTp1-1,pert
Patient identifyier: P;	Sex: male;	Age of patient: 76 years;	Duration of psoriasis: 56 years;	Body surface area: 15 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
cell type: HeLa;	genotype/variation: nucleofacted with HIRA siRNA,pert
HEK293_A263insGG_#5_induced,pert
cell line: MDA-MB-231 breast cancer cell line;	genotype/variation: scramble,ctrl
SKBR3_Control_1,ctrl
WT-3 (EPLM),ctrl
Mouse fetal liver_E14.5_WT_rep5,ctrl
D2-Gpnmb+ control rep6 (retina),ctrl
Tsc1-deficient CD8 naïve cells KAI286,pert
Insm1 mutant #2,pert
Psoriasis-Patient-O,pert
31A;pretreatment;female;breast tumor; responder,ctrl
"Wild type, snap frozen, diaphragm muscle, 10 month age animal",ctrl
KU_16N,ctrl
WT P2 replicate 2,ctrl
P3B Progranulin-cerebellum,pert
"Aorta, saline 14d, #2",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 48h",pert
"VPA 2, 4hrs",pert
DU145/NC siRNA #3,ctrl
"human failing LV myocardium, Ischemic70",pert
4-Vinylcyclohexene Diepoxide (50uM) rep 2,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 93min;	race: White;	sex: Female,pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 32;	maternal age: 27,ctrl
Paclitaxel-resistant,pert
CD4+ CD25hi Foxp3+ T cells,pert
"MIST1-null pancreas, biological rep4",pert
"Cnr1-/-/Cnr2-/- female number 2, 2 months old, whole ear tissue, untreated control ear",pert
chip number: 11;	transfection plate: 3B;	target gene: EP300;	kd level: 0.62;	rin: 9.4;	transfection date: 2012-03-26,pert
tissue: bone marrow;	genotype: HEB-KO;	strain: C57bl/6;	age: 10-13 weeks old;	cell type: FACS sorted LY6D- CLP cells (LIN-FLT3+CD127+),pert
Fiona Biological Replicate 4,pert
scpk/WT/17,ctrl
Control male 4,ctrl
"Trip12 mut/mut, biological rep3",pert
"twin pair: #6;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
JIA PBMC Post treatment A235_L009(2),pert
MCF-10A shATR-4 replicate 2 [set 5],pert
"Wild type used for MAT1A 3 month, replicate 4",ctrl
"patient: 203;	current medication: Asacol 800mg BD, Simvastatin;	birth date: 1/10/35;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/92;	diagnosis date: 3/23/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/1/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 14;	crp: 0;	hb: 147;	wcc: 6;	neutrophils: 4;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: HISTOLOGICAL;	diagnosis recto sigmoid: HISTOLOGICAL;	diagnosis splen flex: HISTOLOGICAL;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/50;	smoking stop date: 1/1/57;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
"A673 treated with Doxorubicin for 3 days with concentration of 59.88 nM (EC50), biological rep1",pert
MiaPaCa2 pCEP4 clone 1,ctrl
Jejunum_POR-null_2,pert
Sedentary-24,ctrl
WT-smoke-low-5 month+1d-R3,ctrl
"metastasis: metastatic recurrence;	Stage: 2b;	tissue: normal, homogenized",ctrl
Muscle WT Adult 0629,ctrl
parental cell line: WC;	vector: pBabe-puro (empty vector);	replicate: 1,ctrl
"N-BMSCs, biological rep1",ctrl
Cutaneous psoriasis without arthritis PsC 1,pert
"male;	CABG patient, atrial tissue;	propofol anesthesia, after CABG surgery",pert
MDS patient 26,pert
4194-1 E2F3 Heterozygous,pert
"Setd2 knockout mESCs, biological rep3",pert
cell type: peripheral blood mononuclear cell (PBMC);	disease status: hepatocellular carcinoma (HCC),pert
FACS-purified B cells_wildtype_influenza-infected_rep1,ctrl
muscle_Wt_35wk_rep3,ctrl
platelet_sickle_10,pert
patient: 51091;	sample: normal,ctrl
status: Control;	gender: Female;	age: 49;	tissue: Blood,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-14;	Primary Site:Floor of Mouth;	Age:60;	Sex:F;	TNM:T4N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
HES2_Mir122WT_rep2,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: LSD1;	transfection time: 24h,ctrl
"Kinin B1 receptor knockout, biological rep4",pert
HEK293_HNF1b_#1_uninduced,ctrl
Control  VZ13,ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 2 - Technical Replicate 1,pert
MV 6,pert
"CCALD patient fibroblast, biological rep5",pert
Isoflurane 5 exposures-1,pert
Skin_SKO_Rep2,pert
day 2 5-FU HSC 2,pert
liver western diet rep4,ctrl
"brain, cerebellum: RNA#21*_le1",ctrl
01LS6_Oligo,pert
AJ3251_muscle_mutation,pert
HD9,pert
cell line: J1;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 7,ctrl
FC 03,ctrl
Muscle Tro1,pert
R1 control ES cells,ctrl
XBP1s Tumor 3,pert
batch: A;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,pert
con_B130,ctrl
ADHC4,pert
BAT_WT_4,ctrl
"Histopathological diagnostic: oligodendroglioma, grade 2",pert
nodex_3,ctrl
"Control, biological rep10",ctrl
siEGFP (48 hr) _2,ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 5,ctrl
"runx1-null luminal mammary epithelial cells, MD643",pert
"CRT knockout mouse embryonic stem cell, biological rep4",pert
"strain background: C57BL/6;	genotype/variation: Cdh1 knock-out; Cdh1-, P53+;	age: 2 months;	gender: female;	tissue: uterus",pert
mortality: alive;	ethnicity: White;	gender: M;	age (yrs): 28;	tissue: Normal_Kidney_Biopsy,ctrl
sirna: control (siSTABLE V2 non-targeting siRNA#1);	treated with tnfα: NO,ctrl
CAR.KO_TCPOBOP_rep2,pert
non-malignant FTEb_patient 8,ctrl
"Infected with H37Rv and treated with 1,25D, replicate 2",pert
"12 weeks old PS-NA mice, cerebrum",pert
Bone-Marrow_MGUS_G1694,pert
Parkinson's Disease;	male,pert
ILD_3,pert
disease: cardiopathy;	gender: female;	age: 200 days;	tissue: thymus,ctrl
T2_HypM,pert
"210, ADIPOOSE TISSUE, Before",ctrl
ab060 IM,pert
P7B Progranulin-cerebellum,pert
"Strain: MRL/MpJ;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",ctrl
pediatric AML S08,pert
"HEB CLP LY6D-, biological rep1",pert
strain: C57/Bl6;	gender: male;	genotype: Egr-1 wildtype;	age: 42 days;	tissue: retina,ctrl
V5-P063,pert
LKR13_Control-3,ctrl
"sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta, non-dissected aneurysm;	agent: Ang II;	time: 7d",pert
Cervical Cancer_1981T,pert
DOV13+(1),pert
Mouse fetal liver_E14.5_KO_rep3,pert
age: 65;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 221,pert
P0 - nudelko/+ 2,pert
ILKS343D3,pert
"G42 cells from M1, wild type control, biological replicate 1",ctrl
strain: FVB;	transduction: none;	tissue: Primary prostate epithelial cell culture,ctrl
31SAGEA2,pert
"218, ADIPOOSE TISSUE, After",pert
T3A-LU,pert
erStress_twins_AA_1743twin1_500nM_thapsigargin_4h,pert
CD4+_Tcells_healthy_donor_7,ctrl
Muscle WT Adult 0701,ctrl
cell line: Breast carcinoma cell line Cal51;	genotype/variation: IPMK depletion;	agent: untreated,pert
"human failing LV myocardium, Idiopathic18",pert
MDS patient 123,pert
MDA-MB-231 - MTDH-WT-KD-3,pert
con-56_A,ctrl
WAT from Ahnak knockout fed high fat diet Replicate 2,pert
"Gender: Female, Age: 31, BMI: 37, Tissue: luteinized cumulus cells",pert
Proximal hindlimb bud tissue (~500um from base of limb bud) pooled from 3 embryos (6 limbs total).,pert
DMN-CtrHippo15d-1aAv2-s2,ctrl
cell line: MCF-7;	agent: gamma tocotrienol,pert
A_Kin_2,pert
10.5 Months Heart MDX rep 1,pert
26 year old male,ctrl
"BOEC, at_risk 3",pert
AVC_mutant_rep3,pert
Mutated-ERα-positive breast cancer 11,pert
liver_STZ 0.5% quercetin diet_rep4,pert
Ishikawa_Control_48h_rep1,ctrl
"WI-38 cells, at 24 h after exposure to DMSO vehicle control, biological rep3",ctrl
nt S. aureus 10,ctrl
Het-pDC2,pert
treatment: baseline;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,ctrl
Sex: male;	Age at operation: 37 years;	Site: thigh;	Size in cm: 7x14x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: yes,ctrl
Wildtype 2 (jos0950),ctrl
astrocytes hypoxia batch 1,pert
cell line: KOPT-K;	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
HepG2_Ni rep2,pert
T2-FP_spleen_KO_rep2,pert
Bone-Marrow_SMM_S1398,pert
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 1h;	donor: 2,ctrl
MS patient 2,pert
disease state: endometrioma;	patient: 19,pert
genotype: SRC-2 null;	tissue: Liver;	genetic background: C57;	Sex: Female,pert
WT-IL23 rep2,ctrl
Jurkat 1,pert
Nrf2 KO rep1,pert
Adrenal CREMKO 0h batch 2 [AdKOh00.15],pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 170min;	race: White;	sex: Female,pert
"empty vector, biological rep3",ctrl
"Wild type, biological rep1",ctrl
"uninfected primary RPE, biological replicate 1",ctrl
WT31,ctrl
CPU FVB/N control 2,ctrl
C3H/HeJTCE liver sample batch 1,pert
patient: 30582;	sample: normal,ctrl
El-Ashry 004.CEL,pert
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 73;	Usage number: 1;	Exposures: 4,pert
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 6 h;	dose: 10 μM;	agent: VX (O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothiolate),pert
"vector d4, rep 1",ctrl
in situ 1,pert
strain: 129/Sv;	group: knock-out;	genotype (hdh cag repeat length): null;	differentiation status: undifferentiated,pert
patient: TLW18;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
3T3 Vector Control Vehicle 1,ctrl
Bronchial Epithelial Cells SA biological 1969Z,pert
Liver_hyperglycima_no.10,pert
EA_Case1_CD20,pert
Lung dnCREB-PBS replicate 1,pert
colon_adenoma_1187,pert
"P30_wt cones, replicate 2 [array]",ctrl
V5-P562,pert
"strain background: mixed 129S6/SvEvTac, C57BL/6J, Balb/c;	genotype/variation: CLDN18_KnockOut;	age: 3-4 months;	gender: Male;	tissue: whole lung tissue",pert
XX3_Paf,ctrl
Treg Trim28 conditional KO rep1,pert
Series 2; young; 3 day,pert
HP-28,ctrl
"126 (221), MUSCLE, Before",ctrl
"siYAP RNA #1 transfected, biological rep 1",pert
scpk/ikLL/192,ctrl
FmrWT3_blood,ctrl
C1_pitM,ctrl
"testis with regular spermatogenesis from orchiectomy cases due to prostate carcinoma, patient age: 58y; W03 003",ctrl
3497-1 E2F2 Null,pert
TFEB_Overexpression(S3),pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate 2,pert
48B,pert
subject id: 44;	infection: DENV;	status: DF;	tissue: whole blood,pert
transgene: none;	treatment: siRNA trasfected - 48h of depletion from FTO,pert
MDS patient 126,pert
Vit A deficient 3a,pert
Treated with 50uM Zinc for 4 hrs -- replicate #2,pert
heart_KO_rep2,pert
CLL 149-05 Control,ctrl
Large cell carcinoma 012,pert
P1 mouse eyeball extracted total RNA_Snf2h_cKO4,pert
P73 dilated cardiomyopathy heart biopsy,pert
strain: Sprague-Dawley;	cell type: aortic valve interstitial cells,pert
Cancer 16,pert
P0 Quadriceps Klhl40 KO 2,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A61_8 months_replicate 3,pert
Nerve_Control_Vehicle_702,ctrl
"Patient 4, lesion tissue",pert
"experiment 1, ethanol-treated 1",pert
"non-AD_FC, biological rep16",ctrl
3871-1 E2F WT,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 26.8,pert
pMX-GFP no vitamin C GFPVc-_1,ctrl
cell type: Primary hepatocytes;	donor: 6;	agent: Wy14643;	time: 6h;	gender: Male;	age: 73 years old,pert
"MaF pre-iPSC9P2, Vc-, D6",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 210min;	race: White;	sex: Female,pert
"breast, pre AFI treatment (H3_1296)",ctrl
BxPC3-KO4 rep 6,pert
NSC_FOXO_WT-2,ctrl
"human peripheral blood derived monocytes, no stimulation, biological rep1",ctrl
testis wild type replicate2,pert
ctrl_501,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: metastasis to lung;	organ site at which tumor arose: parotid salivary gland;	donor sex: male,pert
"Peripheral blood, normal control [N59]",ctrl
HP-13,ctrl
TAC 5,pert
strain: Gata4tm1.1Sad/J;	infection: Mouse GATA4;	culture: Differentiation medium for 3 days,pert
07R062 Control,ctrl
cultured LNCaP cells;	refer to ATTC,pert
P0 Quadriceps Klhl40 KO 3,pert
Tumor from MYF-5 CRE/SSM2 mouse SSM5,pert
"IL22KO5_ileum, 5 days post-infection with T. gondii",pert
coc-53_B,pert
Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model MEPM 4,pert
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: T,pert
"genetic modification: cells stably expressing the oncogenes c-myc and Ha-ras under the control of the Tet-off regulatable promoter, konstitutive expression of the estradiol activatabel IRF-1hER fusion protein;	tissue: fibroblast",ctrl
ACC 3 cell line Sox4-RNAi replicate 2,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.69;	Ratio: 2.13,pert
Liver Experiment 1,pert
Post Transduction:12 hr; treatment:WT;,ctrl
Mutated-ERα-positive breast cancer 10,pert
EUR12_T5_PP_day7_047,pert
PPAR KO_ctr_117,pert
cell line: U2OS;	treatment: shBAP1 #1,pert
"shCDK8, normal growth, replicate 3",pert
day 2 5-FU HSC 1,pert
U138MG shcontrol 2,ctrl
mouse cerebellum at P30 knockout 3,ctrl
"age at diagnosis: 67;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i+);	er: 1;	pgr: 1;	dfs-month: 17;	dfs-event: 0;	distant metastasis: 0",pert
PBMC from T cell LGL leukemia patient #1233 (TLGL1233),pert
Endometrium/Ovary-Disease 10,pert
T116 U133p2,pert
Vehicle 24 hours_1,ctrl
"Normal subject (48 year old caucasian female, SAK_1289292737)",ctrl
A549 NSCLC cell line,ctrl
SKM KO5,pert
V5-P121,ctrl
"WT3_ileum, 5 days post-infection with T. gondii",ctrl
RTX11 T12,pert
gender: male;	strain: C57/BL6;	tissue: heart;	genotype/variation: wild type,ctrl
Treated with 25uM Zinc for 4 hrs -- replicate #3,pert
126OE 24A n,pert
monocytes_-LPS_3,ctrl
Cutaneous psoriasis without arthritis PsC 17,pert
CH2112,pert
cell line: LKR13,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-17;	Primary Site:Tongue;	Age:47;	Sex:M;	TNM:T4N3M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
tissue: Epididymal adipose;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 718,pert
Strain: C57BL/6J;	Gender: female;	Age: 7 weeks;	Tissue: whole brain,pert
"Acute Myeloid Leukemia, sample 5",pert
SA_271,pert
Day: 1; Drug: Saline; Phase: Drug treatment; Replicate: 1,ctrl
strain: C57/Bl6;	genotype/variation: wild-type;	gender: male;	tissue: epididymal white adipose tissue,ctrl
brain_DLPFC_bipolar B_mr430,pert
GIST 1,pert
healthy CD4 T cells 5,ctrl
L1 062502 Con2,ctrl
Nr3_ctrl,ctrl
MA_15,pert
long-Con rep1,ctrl
B2_saline_overexpressor_422,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT3B knockout, DMSO-treated",pert
D2_non-transgenic,ctrl
"BPL adrenals, replicate 3",ctrl
"fibroblast, control subject NF10 rep 3",ctrl
"Kidney from MON exposed rats, biological rep 3",pert
genotype: Male;	age: 15 years adolescent male,pert
cell type: embryonic stem cells;	cell line: CGR8;	treatment: overexpressed Foxd3,pert
"patient: 102;	current medication: Movicol 1 sachet daily;	birth date: 9/5/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: RIF pain, persistent anaemia.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
"seminoma specimen, pT3, pN1, pM1, patient age: 23y",pert
"lymphoblastoid cell line from T9.01, one out of seven of insensitive group, 50*10e6 cells",pert
Dominant negative cJun  VZ17,pert
HCT116_rep2,ctrl
Dendritic cells generated from blood of donor 1 + A. fumigatus germ tubes,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 248;	age-at-biopsy-years: 49,pert
"PBMC, patient. Mtx rep5",pert
HeLa_06_21_04 TP-2,pert
TscHet2_brain,pert
266C3,ctrl
Mening UNSTIM WB SW 12a,ctrl
WT.DMSO_1,ctrl
"E18.5 brain, wild-type, rep 4",ctrl
tissue: PBMCs;	treatment: after IFNb-1a in-vivo treatment,pert
N2,ctrl
JIA PBMC Pre treatment A235_287,ctrl
01UNP_Systemic,pert
SLE CD4 T cells 9,pert
Postnatal 12 weeks mutant heart biological rep3,pert
Strain: C3HeB/FeJ;	Age: 10-12 weeks at the beginning of the feeding regimen,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: TCPOBOP; 1,4-bis[2-(3, 5-dichloropyridyloxy)]benzene",ctrl
"PBMC, healthy control, biological rep3",ctrl
LY2 SRC1-siRNA untreated rep4,ctrl
B6_Female_CF_rep2,pert
MF-41,pert
"Empty vector control, 2 hrs, Rosiglitazone (ROS_2_1)",pert
heterozygot FH P283,pert
TARBP2 over-expression (pCMV-TARBP2-1)_MDA-231,pert
"sodium arsenite added to food: 10 ppb, 5wk;	diet: LRD-5001",pert
chip number: 22;	transfection plate: 3B;	target gene: STAT6;	kd level: 0.77;	rin: 9.4;	transfection date: 2012-03-26,pert
treatment: transfected with Ambion Silencer Select SOX2 siRNA;	cell type: embryonal carcinoma;	cell line: 2102Ep;	passage: 35-50,pert
KN-sham-1 day-R1,pert
"Fourth ventricular choroid plexus from wildtype mice at E13, biological replicate 1",ctrl
Knockout 3,pert
wtPrE serumfree 2,ctrl
"PPARg d2, rep 4",pert
clone type: AtT20 clone types overexpressing NSBP1WT protein rep2,pert
lymphoma_9250_nt,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 16 weeks;	Tissue: testis;	;	,ctrl
Cervical Cancer C579,pert
13GOBMUC2A,pert
cell type: embryonic stem cells;	cell line: CGR8;	treatment: overexpressed vector control,ctrl
Cancer 8,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 8d ID146,pert
MDA-MB-231 cells siRhoGDIbeta transfected rep3 HG-U133A,pert
shSOX2_5,pert
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-5,ctrl
gender: Male;	age (y): 39;	tissue: prolactinoma,pert
Wild type (untreated) 5296,ctrl
HeLa cells transiently transfected with a nonspecific control siRNA,ctrl
Zfx fl MA9 cells + Vehicle [10949],ctrl
A/OVX/no inj/0h/UTX 129/SvImJ WT,ctrl
MIG control biological replicate 1,ctrl
"Wild-type MEFs, biological rep1",ctrl
Healthy control_sample5,ctrl
Tk6 untreated controls for arsenic exposure rep1,ctrl
nodex_2,ctrl
GM19238_Kd_HCST_1,pert
tissue: lymph node;	genotype: Dicer WT;	cell type: CD4+CD62L- resting T cells,ctrl
strain: C57BL6/J;	Sex: female;	genotype: Pdpn-/-;	cell type: mouse embryonic fibroblasts,pert
cell line: JCRB0033 [CEM];	cell type: human T-ALL cell line;	agent: control,ctrl
B4 437 b4-/- untreated,ctrl
"57B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Dental pulp cells control sample triplicate 3,ctrl
Liver sample from Alcoholic hepatitis group (CA80),pert
microdissected breast cancer cells from case 1085,pert
WT-Fibr1 4,ctrl
autism with dup(15q) AU010603,pert
RatLung_H72h_2,pert
"lymphoblastoid cell line from T3.02, one out of seven of insensitive group, 50*10e6 cells",ctrl
Liver WT1,ctrl
P14 - WTMixA 1,ctrl
"Mepenzolate treatment, 7 hours (replication 2)",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 60,pert
PGA-lv_24h_510,ctrl
Low Glucose Transcriptome Profiling {rpt 2},ctrl
"U-87 glioma cell line with shcontrol, biological rep2",ctrl
01UNG_Oligo,pert
"WT, PR01M004v0",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.675;	OD280: 0.838;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 234;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Control bone marrow - Biological Replicate 2 - Technical Replicate 2,ctrl
patient: 28;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Mouse hypothalamus,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 30.42192,pert
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 2,pert
3094-lcm,pert
"FA6 transiently transfected with non-targeting siRNA, transfection A",ctrl
23d wt12,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: LOW;	genome/variation: KIT mutation detected,pert
Normospermic individual: Sample N3,ctrl
C_LS_Wk1,pert
"PCOS, biological rep 2",pert
cell line: MCF10A;	gender: female;	tissue: breast;	expression: Her2 and Myc over-expression,pert
T38 U133p2,pert
patient: 117;	current medication: Loperamide;	birth date: 3/31/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"Hdh knock-in embryonic stem cells, Q111 line, biological replicate 2",pert
patient id: 325;	tissue: Normal cortex;	gender: Female;	age: 80;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
CF (D508) subject5,pert
LICR_HN2_CETU3,pert
Early IPF_surgical biopsy_upper lobe_rep140,pert
Setdb1 2lox/1lox/Cre minus tamoxifen 3,ctrl
cell culture: grade VI GBM short term cultures,pert
P14 - nudelkoMix/+ 3,pert
"spleen marginal zone B in WT, biological rep2",ctrl
UM23_Wt_rep2,ctrl
dex4hr_4,pert
"Patient #5, Untreated",pert
"SKO-transduced MEFs, Vc+, D3",pert
Leg 112 Day control rep 3,ctrl
SeroTest-5,pert
Parkinson's disease sample x076,pert
coc-10_C,pert
cell line: HL-60 promyelocytic leukemia cell line;	leukemia type by fab: M2;	agent: curcumin,pert
chip number: 19;	transfection plate: 3B;	target gene: YY1;	kd level: 0.63;	rin: 9.3;	transfection date: 2012-03-26,pert
BalbC_24h_Wy,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 3,ctrl
background strain: C57Bl/6;	developmental stage: E11.5;	tissue: fore-limb;	genotype/variation: Sost-/-; Sostdc1-/-,pert
WT_TER119-_rep1,ctrl
DS-Fibr 3,pert
"Du145-PCAT1 cMyc siRNA #3, replicate 1",pert
"seminoma specimen, pT1, patient age: 51y; W02 116",pert
FHCRCAML1970,pert
NALT_infected_24h_90-226_rep1,pert
tissue: secondary brain tumor;	cell type: glioblastoma;	age: 13;	gender: male;	tumor grade: IV,pert
Gender: Male;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 1;	Pathological M: 1;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: YES,pert
sirna: Syk siRNA knockdown;	plate: collagen coated;	cell line: MCF10A,pert
"mouse aorta cross strain comparison, C3H_T40_HF_01",pert
"Gender: Female, Age: 25, BMI: 23, Tissue: luteinized cumulus cells",pert
LCH3ani,pert
Postnatal 3 weeks mutant heart biological rep2,pert
LY2 control-siRNA tamoxifen treated rep4,pert
diabetic muscle replicate 3,pert
"ALL_DS, K3 012109",pert
Cutaneous psoriasis without arthritis PsC 7,pert
"Crohn's Disease subject (46 year old black female, SAK_1259829456)",pert
imanitib5,pert
"array 18, xenograft, abiraterone 75 mg/kg/d",pert
Muscle_Rpt3 null_3,pert
"array 28, unimplanted",ctrl
WT-smoke-med-5 month-R3,ctrl
"Gender: female, Age: 35 years, Tissue: VIN 3",pert
70_129_WT,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 2;	psoriasis duration: 31.0;	age of psoriasis onset: 23,pert
TLW18_T4_PP_day3_016,pert
Panc1005 rep-3,pert
FoxO3null_2_1,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 50;	sex: F,ctrl
"Exp A, Animal #271, 5mg/kg D-Serine",pert
Hippocampus 1988 15 month Old,pert
Zfx-null TC1 ESC;	Cultured in 15% KO + LIF without feeders,pert
"NASP Overexpression, sample #1",pert
11L,pert
41B,pert
siPin1.exp2,pert
ESE_D_496,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_12_24_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
R6/1 18 week transgenic_BC91,pert
Knockout cre_ppar_beta_floxed_rep1,pert
treatment: siRNA against ETS2;	cell line: H441,pert
Subject #8024-2d Postinfection,pert
"Normal ear skin from control mouse, biological replicate 2",ctrl
PlagL2WT4,ctrl
tissue: brain;	genotype: WT mix background B;	age: E14,ctrl
"HeJ, air, biological rep 3",pert
siTNIK+7hr Wnt (Experiment 2),pert
Etoh 3,ctrl
brain_co_14M_rep1,ctrl
tissue: lung;	strain: Balb/c;	genotype: wild-type;	treatment: cecal ligation and puncture surgery;	age: 8-10 weeks,ctrl
129S1/SvImJ Vehicle liver sample batch 6,ctrl
"Placebo treated, HIV-1 positive male, day 14 (6)",ctrl
Control 120 days sample 3,ctrl
01MJU_PolyRF-,pert
WTC 158 PBS treated,ctrl
SCC3,pert
Bone-Marrow_MM_M724,pert
umbilical cord_nobpd: 6E/2F,ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 2h,pert
214/0,pert
brain_Q10_14M_rep1,pert
normal 1074,ctrl
Spleen_wt_4m_rep2,ctrl
strain background: C57BL;	genotype/variation: wild-type;	tissue: liver,ctrl
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: DMSO,ctrl
Infergen_24hr_rep4,pert
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; Pten+/+,ctrl
Control siRNA rep2,ctrl
agent: Cadmium 1.2 µM,pert
"Cell type: endothelial, age:47, gender:male, diagnostic group: control, PMI:11h",ctrl
multiple myeloma (MM 410),pert
female_alcoholic_285,pert
Huh7 cells_Mock Infected 48 hours_ rep1,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 3,pert
male_control_507,ctrl
PTEN_4,pert
Wild type_lung_3,ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 78;	time: 0;	batch: 3,ctrl
"vestibualr organ at P90 of Igf1 +/+, biological rep 2",ctrl
subject id: 47;	infection: DENV;	status: DF;	tissue: whole blood,pert
4T1.2-IRF7-2,pert
"spleen marginal zone B in IRF8 conditional KO, biological rep5",pert
E17.5 preB cells_Smchd1 null_Rep 2,pert
"N-58, NORM, M, GSF, 6 x ETOH, 14d",ctrl
WT V6.5 ESCs on day 0 #2,ctrl
WT mouse 2_heart_basal,ctrl
B4 528 b4-/- after nicotine-induced seizures,pert
healthy CD19 B cells 6,ctrl
MDS patient 8,pert
Rat fatty liver7,ctrl
126KD 22A n,pert
Pooled PBMC sample from normal control subjects,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 40;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: mid-UV,pert
C_AN10833_T,ctrl
NTac_liver_vehicle 0 mg/kg_96 hr_2,pert
cell line: Panc-1;	transfected with: pCIG (empty vector),ctrl
Tg35,pert
scan batch: Batch 2;	group: autism;	subject age: 5;	paternal age: 22;	maternal age: 20,pert
M229_R5_B_PLX,pert
whole blood_100676,pert
"Amoxicillin treated Distal, Small Intestine 3 17 days old",pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days. The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
siCONTROL + MMC experiment 2,ctrl
KU_27N,ctrl
IRF4_3,pert
Control 8,ctrl
cell line: A549;	cell line origin: Lung cancer;	genotype/variation: ZMPSTE24 silencing,pert
Nrl-ko-Gfp P6 replicate 4,pert
cell type: breast cancer cells;	agent: 200 uM Lacciac Acid A,pert
HeTH-4 +DOX rep-1,pert
DR AA4+ replicate 1,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.229;	OD280: 1.143;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 297;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
CD8_T_cell_pool_melanoma_M05+M06,pert
m1-carcinoma3,pert
"GM8921A, unaffected brother",ctrl
cell type: F442A cultured adipocyte;	cell line: 3T3L1;	back ground strain: Swiss,pert
Wild type Mice-M158,ctrl
"Strain:Wistar, Gender: male, Tissue: cirrhotic liver, Induction of cirrhosis: CCl4",ctrl
Ishikawa_Control_48h_rep4,ctrl
"Normal, biological rep 3",ctrl
treatment: STAT3 siRNA;	cell line: Esophagus cell line OE33;	array id: 5617835005,pert
tissue: skin;	individual: Patient P4;	condition: ANL;	eczema severity: SCORAD: 0,pert
Pediatric_GBM_39,ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 340;	age-at-biopsy-years: 41,ctrl
Gata3_Cdx2_null_9,pert
patient: 263;	current medication: Azathioprine 75mg Fosomax 70mg;	birth date: 11/9/58;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/00;	diagnosis date: 6/1/00;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 7/8/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
mouse jejunum_hnf1alphamutant_rep3,pert
V5-P154,pert
H295R adrenocortical carcinoma cell line,pert
Disease_status: Healthy control;	Age (years): 53;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.40;	Post mortem interval (hours): 9;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
CH1801,pert
Human.AO.CP.FCU,pert
NSC14,pert
Parkinson's disease sample x007,pert
"patient 035b, normal, homogenized",ctrl
"Vehicle treated, no doxycycline; biological replicate 1",ctrl
RAW_0mM_HOCl_#2,ctrl
PBMCs_Control_18 [IS],ctrl
Wildtype_TAC_Rep6,pert
breast normal 3,ctrl
Bronchial Epithelial Cells SA biological 2136J,pert
WT Brain 20d Mouse1,ctrl
7d-sham-82,ctrl
MCL_IGHV_UNMUT (R1587),ctrl
Bronchial Epithelial Cells control biological 1701J,ctrl
M24met_Wnt1_3,pert
sip53mut.exp1,pert
mortality: alive;	ethnicity: White;	gender: F;	age (yrs): 65;	tissue: Normal_Kidney_Biopsy,ctrl
cell type: preadipocytes;	tissue: white adipose tissue,ctrl
N_LS_Wk1,pert
race: caucasian;	age (years): 56;	stage: IA;	grade: 2;	histology: endometrioid,pert
cell line: THP-1;	shRNA construct: GSK3B Construct 1,pert
r22,pert
Cerebellum_nontransgenic control S46_10 months_replicate 1,ctrl
t02,pert
"Grape extract group, 6 months, patient number 15",ctrl
Liver_Nrf2 Control_rep3.,ctrl
Placental tissue from early onset Preeclampsia,pert
GM19238_Kd_TAF1_1,pert
brain_DLPFC_bipolar C_mr523,pert
Healthy control_sample4,ctrl
"control, BA46-99",ctrl
Control_6months_retina3,ctrl
XmO2,pert
pt. HCL C treated with DMSO for 48h,ctrl
0165-01-C,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: TCPOBOP; 1,4-bis[2-(3, 5-dichloropyridyloxy)]benzene",pert
GC resistant clone C7H2-R9C10 treated for 6 hours with GC,pert
"Mdr2-KO homozygous mouse, 3 month old mouse 2",pert
Retina homozygous KO 30 days 3,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 58.44932,ctrl
CLP3,pert
Control (0.1% DMSO) rep 2,ctrl
WT-MEFs_unstimulated_4hours_rep2,ctrl
BC3 TC_NOC,pert
"male, healthy, no medicamentation",pert
MV 2,pert
0943-01-A,pert
Tissue: normal thyroid; Gender:female; Age:48,ctrl
"129 Mouse P0 Pineal Tissue, Sample 1, 05-16-06",ctrl
18C-ER,ctrl
Scd1+/+ on chow diet replicate 1,ctrl
liver_Q10_6M_rep1,pert
gender: mixed;	genotype: Homozygous for the Q119X mutation in the TWIST2 gene;	ethnicity: Puerto Rican,pert
Sex: male;	Age: 14;	SL: 3.57;	House: 0;	Severity: SS;	Ashworth: 3;	Zancolli: 3;	PEFF: 45;	PESF: 40;	AEFF:,pert
age	54;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	5.7;	leukocyte count (/nl)	52.2;	hemoglobin (g/dl)	9.3;	platelet count (/nl)	388,pert
genotype: Sox3 positive;	cell line: R1;	cell type: Embryonic stem cells differentiated into neural progenitor cells,ctrl
"normal colorectal mucosa, biological rep 3",ctrl
"E18.5 brain, Meg3 knock-out, rep 3",pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 2,ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6.1;	colon weight (mg): 170;	colon ratio (mg/mm): 2.62;	myeloperoxidase activity (u/mg): 0.463;	tissue: colon;	treatment: 5% DSS,pert
Control_24h_rep1,ctrl
BL Day 1 siMut12 transfected biological rep4,pert
wild-type naïve CD4 T cells KAI267,ctrl
8: NORMAL #00-0074,ctrl
P53_cKO_2,pert
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: undifferentiated,pert
baseline control 03,ctrl
TNKSi 16h biological replicate 1,pert
Phytohemagglutinin-activated PBMCs from normal control subject C (CAcPBMC),ctrl
subject: 15V;	cohort: 15;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 107kb;	age (y): 60;	Sex: F;	batch: Batch_5,ctrl
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 13;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 41;	donor: 28;	disease state: Lesional,pert
Bone-Marrow_NPC_N1588,ctrl
"control, rep3",ctrl
tissue: Temporal cortex;	age: 65;	Sex: F,ctrl
"gender: female;	batch: 1;	age (years): 21;	patient id: Severe_2;	fev1 (% predicted): 105;	fvc (% predicted): 101;	medication: Prednisolone 8mg - 1mg for 5wks(stopped 30/5/08),seretide 500mcg 1pbd,Singular 10mg bd,Phyllocontin 225mg am 450mg pm,Ventolin prn;	cell type: CD4+ T-cells",pert
Hippocampus_WildType_rep2,ctrl
Seltzer 50d replicate 2,pert
age: 31;	gender: male;	ejection fraction: 52;	left ventricular end diastolic diameter: 57;	inflammation/PVB19: positive,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-tu2,ctrl
"TGCT cell line 2102Ep/clone 2A6, treated 7 days with retinoic acid",pert
siLRH-1_#3_rep_3,pert
"shKDM4C 2, clone 1, rep 1",pert
Human.AO.CP.ECRB,pert
Bone-Marrow_MGUS_G800,pert
b72,ctrl
TMRI AO 4hr,ctrl
RKO_liver_fasted_refed_3hr_rep1,pert
TB 5,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 3,pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_L015,ctrl
sample D 18.5 homo,pert
"brain, hippocampus: LH4_e1_le1",pert
TMRI E2 24hr,pert
Allo-14-1,pert
"Age: 8 months, Sex: Female, Retina: right, Final IOP (mm Hg): 30.4, Strain:DBA/2J",pert
cell line: A549;	agent: decitabine;	dose: 1 uM,pert
"human failing LV myocardium, Ischemic97",pert
HeLa_01-04-05 TP9_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
ASC_morbidly-obese_biological rep1,pert
agent: pristane;	time: 18 days;	strain: DBA;	tissue: mesentery,pert
strain: C57BL/6J;	genotype: K14-Cre;Tgfbr2 fl/fl;	tissue: Posterior Palate;	age: E15.5;	gender: Not determined,pert
T-ALL1 Control 1,ctrl
CLL 119-09 LMP-420,pert
HepG2_Ni rep1,pert
"Normal subject (36 year old caucasian male, SAK_1782763706)",ctrl
H295R_Group_B_Dose_100_TIMEPT1_009,pert
age: 71;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
cell line: Hep G2;	genotype: HCC-THRA mutant al;	treatment: with 100 nM T3 for 6h,pert
strain: CD-1;	genotype/variation: wild-type;	developmental stage: embryo;	age: E14.5;	tissue: kidney,ctrl
Recent-onset T1D_sample1,pert
V5-P426,pert
erStress_twins_AA_1724twin1_DMSO_4h,ctrl
Carboplatin;	Carboplatin 24 hours set 2,pert
strain: FVB;	genotype: E2F1 null;	tissue: mammary gland tumor,pert
Control subject 41_biological replicate 1,ctrl
Dengue Fever Patient 43,pert
"IN1760 siNT treated, Biological replicate2",ctrl
"BMMCs from NTAL WT, pLKO.1 infected, 2 h activated, biological rep1",ctrl
rtTA-Dmrt5_d9_-Dox_rep_2,ctrl
HeLa_01-04-05 TP8_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
control participant P319,ctrl
muscle knock out replicate3,pert
GM19238_Kd_NR3C1_2,pert
Double_positive_thymocytes_medium _3h_rep1,ctrl
wt PBS5,pert
Rex KO_minus LIF_rep3r,pert
Double_positive_thymocytes_medium _3h_rep2,ctrl
Aorta_APOE-deficient with atherosclerosis_2,pert
Dengue Fever Patient 55,pert
Control subject 42_biological replicate 1,ctrl
48A;pretreatment;female;breast tumor; responder,ctrl
N1,ctrl
Normal bladder,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: C;	tissue: Skeletal muscle (quadriceps),pert
Patient: H;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/ABL1;	biological replicate: 3,pert
lateral hypothalamus long access to cocaine replicate 1,pert
Teratozoospermic individual: Sample T1,pert
Untreated diabetic-5,ctrl
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: FRAG.cRNA-4A,pert
strain: C57BL/6J;	day: 24;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
MiaPaCa2 pCEP4 - AGR2 clone 15,pert
"Patient H-615-N, normal colonic mucosa",ctrl
Active ITP chip B,pert
5922012047_A,pert
tissue: lung;	genotype: PPTA knockout;	treatment: cecal ligation and puncture surgery;	age: 8-10 weeks,pert
Rb-/-PrE serum 2,pert
RptorKO CSC Technical Rep.1,pert
Postmenopausal female. Untreated control. nr 33.,ctrl
strain: C57BL/6;	tissue: small intestine;	genotype: wild type;	treatment: none,ctrl
Postmenopausal female. Tibolone treated. Patient 26.,pert
APP_R6_rep3,pert
H1299 AZA 3 uM (3232),pert
Ainv15 EB10 replicate 2,ctrl
Knockout 2,pert
Individual_3690_PP_sample,pert
N12A Normal-frontal,ctrl
A_Ctrl_2,ctrl
AKT_PLACEBO_48hours_5,pert
Healthy individual of twinpair #9,ctrl
lean control-3,ctrl
cell line: BL2;	transfection: scrb siRNA;	batch: 1,ctrl
COP control replicate 3,ctrl
T58 Non failing heart biopsy,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.054;	OD280: 1.504;	Ratio: 1.99;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 365;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
D3_non-transgenic,ctrl
10 week mutant OMN rep 2,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: tumor;	sample name: 5-tu1,pert
5278-lcm,pert
CD4DecTp1-9,pert
K562 STI sample 7,pert
Kidney_200 mg/kg VCM iv_mouse #025,pert
MCF-7 control rep 1,ctrl
C_AN10028_T,ctrl
PBMCs_Control_4 [IS],ctrl
Genotype: wildtype MEFs;	Primary mouse embryonic fibroblasts (MEFs) generated from embryos at E13.5,pert
nucleus accumbens long access to cocaine replicate 2,pert
WT liver_HFD_rep5,ctrl
Mock infected murine liver-MO30k-(C)-6 hpi,ctrl
PGA-lv_48h_518,ctrl
BP patient 96_biological replicate 1,pert
PsOEt-12-Week 1,pert
Healthy individual of twinpair #12,ctrl
HCC001N,ctrl
"cell type: Primary chondrocytes;	genotype: Wt;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant",ctrl
GM19238_Kd_BATF_2,pert
MCK-PPARa rep 1,pert
C011_Control_F_89,ctrl
normal brain_1,ctrl
Control 7,ctrl
pre-iPSC- siRNA to luciferase- biological replicate1,ctrl
treatment: DMSO (control);	cell line: K562,ctrl
tissue: Gastrocnemius muscle;	genotype: WT;	age: YOUNG,ctrl
"liver, wt mouse, sample WT5",ctrl
"human failing LV myocardium, Idiopathic24",pert
HUVEC_TNF-stimulated experiment 2,pert
"PBMC, patient. Mtx rep14",pert
"EBF1 d4, rep 6",pert
"DMSO-treated, 6h after UV, Replicate G",ctrl
"depression, BA10-9",pert
treatment: Sirt1 siRNA Knockdown Control;	cell line: Caco-2,ctrl
"Control, biological rep7",ctrl
LNCaP-abl_siMED19_2,pert
liver cells from wildtype 8wk male mouse 8 challenged with vehicle (saline)_9,ctrl
PTEN-22 (-/-),ctrl
"Mdr2-KO homozygous mouse, 12 month old mouse 2",pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 45 yr;	population: white,ctrl
"FA6 transiently transfected with non-targeting siRNA, transfection B",ctrl
Moderate rep1 (retina),pert
"WI-38 cells, at 24 h after exposure to 0.1 uM BPDE, biological rep1",pert
"WT+Empty, biological rep2",ctrl
Mammary gland R1 NT rep4,ctrl
ethnicity: Hispanic;	Gender: Male;	Age: 31;	Tissue: primary human bronchial smooth muscle cells,ctrl
Mouse WT mandibular molar [AZN_MolairesWT1],ctrl
08SE1179,ctrl
MDA_Parental_2,ctrl
Sex: female;	Age at operation: 70 years;	Site: thorax;	Size in cm: 1.9x1.3x1;	Histological Subtype: pleomorphic liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: residual tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
genotype: HDAC6 knock out,pert
tissue: inner ear;	genotype/variation: Dlx5-null;	age: E10.5,pert
lymphocytes_HD_M_59y,pert
"2102Ep cells negative control, biological replicate 1",ctrl
fibroblast_5azacontrol_rep2,ctrl
erStress_twins_AA_1724twin1_500nM_thapsigargin_4h,pert
age_years: 62;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
"brain, brainstem: LB2_e1_le1",pert
Akt1-deficient 3,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: female;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,ctrl
pediatric AML S32,pert
NCCIT siNTC rep1,ctrl
tetracycline inducible Ngn3 ESC differentiated for 10 days as EB without doxycycline,ctrl
HMEC X BC4 : 0088-5k,pert
H3_SS9_01Nov07,pert
V5-P175,pert
"Distal and Proximal Large Intestine, 8week old Wild-type mouse 1",ctrl
"10 days normal mice, cerebrum",ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: E;	experimental sample name: PC3-R,ctrl
"schizophrenia, BA46-101",pert
IGROV-1+(2),pert
mouse cerebellum at P7 wild type 4,ctrl
GEIM168-U133A-DM,pert
BCR-ABL1-control rep 1,pert
siNS_24h_4,ctrl
"spleen marginal zone B in WT, biological rep4",ctrl
Ulk1/2-/- + IFNβ 1,pert
01UN1_PolyRF-,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: spleen;	sample name: 1-sp3,ctrl
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 47;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,pert
C57BL/10-SJL.Dysf QF replicate 3,pert
"Autoimmune pancreatic islets, no cyclophosphamide treatment, rep 5",ctrl
"schizophrenia, BA10-45",pert
MKK3bE transgenic male replicate 4 late timepoint,pert
Cbx2_KO_XX_1,pert
DMN-NF1Hippo10d-1bAv2-s2,pert
Liver vehicle rep3,ctrl
genotype/variation: AhR knockout;	strain: AhRtm1Bra;	gender: female;	cell type: skin melanocytes,pert
"A pool of two pure subsets of peripheral blood CD8+ T cells (CD19- CD3+ CD4- CD8+ CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
Diagnosis: AML M1;	Age: 68y;	Gender: Female;	Blast %: 81;	Source: BM;	Cyto: Normal;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
6N,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_6h_4mM_HG-U133A_2_YCHSUP501,pert
Genotype: Homo sapiens,pert
"Normal Skin, Normal-21",ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: tumor;	sample name: 4-tu3,pert
FBooth-MDX-2Av2-s2,pert
expression array - BRAIN 1,ctrl
P8 Vax2-/- 2,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 77min;	race: White;	sex: Female,ctrl
5-KO_RD3a,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-16;	Primary Site:Mandible;	Age:50;	Sex:F;	TNM:T4N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
0510-01-C,ctrl
clone 2-2,pert
H18_P_B1,ctrl
12463 UC Inflamed descending colon,pert
HMEC_TNF-stimulated experiment 2,pert
V5-P474,pert
KO SPC Type II 2_8_9_04,pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 48h, biological rep3",pert
shCypB1,pert
Liver sample from Control group (C12),ctrl
..SAL_II_2,ctrl
liver_QH2_14M_rep3,pert
PKBa-/- MEF time 48 replicate 2,pert
tissue: GV oocyte;	strain: mixed 129/Sv and C57BL/6J;	genotype/variation: Ring1-/-Rnf2F/F (Ring1 mutant),pert
TOM-1 Imatinib-treated,pert
"Liver, Intermittent Hypoxia 5",pert
treatment: no DOX,ctrl
"shControl clone 1, rep1",ctrl
Huntington's disease 820C,pert
A HID U_B081,pert
clone type: AtT20 clone types overexpressing NSBP1WT protein rep1,pert
Mock infected murine liver-MO30k-(D)-6 hpi,ctrl
thyroid_tumor_4,pert
5239 UC Uninflamed sigmoid colon,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 69;	gender: male;	tumor grade: IV,pert
umbilical cord_nobpd: 4F,ctrl
PsOEt-13-Week 2,pert
U2OS_PRC_shRNA1_pLenti_2_2007,pert
ctrl_508,ctrl
THRA 6a mutant + T3 replicate 3,pert
ATL-3 - mAdbID:91660,pert
Age: 45;	Sex: M;	Ancestry: European;	Smoking status: non-smoker,ctrl
"Liver from control exposed rats, biological rep 1",ctrl
GFP3_1578I,ctrl
Strain: J1 Cell type: mouse embryonic stem cell,ctrl
APPsa_R6_rep1,pert
cell line: Hep G2;	genotype: HCC-THRA mutant al;	treatment: with vehicle for 6h,pert
wild type MEF time 6 replicate 4,ctrl
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure",pert
Mock infected murine liver-MO30k-(788)-6 hpi,ctrl
C57BL/10 QF replicate 2,ctrl
hNHEPS_10 μM_6 h_rep1,pert
CON4,ctrl
G_Kin_2,pert
"eye, cornea: TRizol Extraction_le1 3",pert
age	28;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	11.2;	leukocyte count (/nl)	164;	hemoglobin (g/dl)	9.5;	platelet count (/nl)	842,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 73 years,ctrl
"DMSO treated THP-1 cells, biological replicate 2",ctrl
FRD1 4,pert
gender: Female;	age: 52;	cell type: PBMC;	individual: Patient 13;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
"spinal cord, ventral spinal cord: EP133/L - hSOD1(Chan)/e14-wildtype hSOD1_le2",ctrl
Nerve_Control_Vehicle_703,pert
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14480;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
HF0960_U133P2,pert
Human skeletal muscle biopsy sample;	Patient #186 with NORM,ctrl
TscHet1_brain,pert
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 4 - Technical Replicate 1,pert
"Patient 14, Macroscopically intact tissue",ctrl
FU-OV-1-(1),ctrl
tissue: large intestine;	genotype: HDAC3ΔIEC;	strain: C57BL/6,pert
07R059 RA,pert
Dental pulp cells idipopathic autistic patient triplicate 1,pert
BALB_Female_CF_rep1,pert
cell type: IMR90 (Normal human diploid lung fibroblast);	gender: Female;	overexpression: H-RasV12;	treatment: Metformin,pert
MCF10A-Her2Myc-rep1,pert
Sham1,ctrl
tissue: Hippocampus;	age: 83;	Sex: M,pert
remitted schizophrenia patient  S05,pert
5252 UC Inflamed sigmoid colon,pert
01UN8_Oligo,pert
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119+;	genotype/variation: Klf3 KO,pert
Sex: male;	Age at operation: 53 years;	Site: thigh;	Size in cm: 10x3x5;	Histological Subtype: atypical liposarcoma;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
CH2115,pert
446MM,pert
S012_Scz_M_63,pert
mammary_16wkLH_ker72,pert
strain background: C57BL/6;	gender: female;	genotype/variation: MMA wild type;	tissue: kidney;	diet: high protein diet for 2 months,ctrl
THRA wt + T3 replicate 1,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 41;	gender: male,pert
Strain: C57BL/6;	Age: 2 months;	Tissue: retina,ctrl
3217-lcm,pert
parental cell line: WC;	vector: pBabe-puro (empty vector);	replicate: 2,ctrl
Human skeletal muscle biopsy sample;	Patient #63 with NORM,ctrl
HUVEC/NmenMC58_frpC/frpA_4h_rep3_1117,pert
"siRNA, collagen plate, rep1",ctrl
brain_Q10_14M_rep2,pert
MCL_IGHV_UNMUT (R1388),ctrl
Liver sample from Alcoholic hepatitis group (CA62),pert
phenotype: preglaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 4.5 months,ctrl
"age at diagnosis: 47;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0 (i-);	er: 0;	pgr: 0;	dfs-month: 35;	dfs-event: 0;	distant metastasis: 0",pert
Ad+TOT replicate3,pert
brain_OFC_bipolar B_mr421,pert
strain: C57BL/6J;	day: 15;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
Genotype: B6.Pdss2loxP/loxP;	Age: 140-day-old male;	40 mg liver used for RNA extraction,ctrl
cell line: J1;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 7,pert
Tissue: Primary Human Hepatocyte;	Gender: female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use: Yes,pert
"Patient 999, 3 month of BETAFERON",pert
"non-AD_FC, biological rep3",ctrl
MF_II_1,pert
Skinbiopsy_7hoursnickel_nickel_allergic_subject_P6,pert
"A549, +TNFα, Claudin 1 siRNA, rep1",pert
jejunum_GATA4mutant_3,pert
"iPSC derived from CCALD patient fibroblast CCALD1, biological rep1",pert
RORasg/sg WAT_HFD_rep1,pert
BTBR+tf/J Vehicle liver sample batch 3,ctrl
age: 40;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
TOV112D NT-4,ctrl
Non-silencing control siRNA: AAUUCUCCGAACGUGUCACGU Technical Replicate 3,ctrl
Skinbiopsy_48hoursnickel_nickel_allergic_subject_P7,pert
HT29 PLX Day1 rep2,pert
PGA-RMM-6h-3aA-s2,pert
"10 week, control;	SOD1(G93A);	Male",ctrl
C57 72 ozone 2,ctrl
Bronchial Epithelial Cells control biological 1325H,ctrl
HT29 DMSO Day8 rep2,ctrl
01LSM_Oligo,pert
HF1136_U133P2,pert
STING tumor DNA III,pert
"Wild type, pancreas",ctrl
KM_008T,pert
Placenta_PE(LO)5,pert
"Hdh knock-in embryonic stem cells, Q20 line, biological replicate 1",pert
WT_2,ctrl
"brain, hippocampus: Wt #3405 Cereb_e1_le1",ctrl
ic patient 4,pert
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 1,pert
P0 - DCXko/Y 1,pert
KL4_muscle_control,ctrl
01LQK_CTRL,ctrl
GC resistant clone C7H2-R19F2 treated for 6 hours with EtOH,ctrl
whole blood_100812,pert
"Typically Developing Control, Semitendinosus, Patient Replicate 9",ctrl
age: 11;	sex: F;	disease status: control subject;	Filter number: 81;	Usage number: 1;	Exposures: 3,ctrl
MDS patient 121,pert
"Endometrium, postmenopausal, tibolone, 30",pert
"Patient M030-827N, normal colonic mucosa",ctrl
Control3,ctrl
"50B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
WAT from wild-type control fed regular chow diet Replicate 1,ctrl
control_32hr_rep1,ctrl
Control (0.1% DMSO) rep 3,ctrl
Muscle PCOS pioglitazone 41,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, VEH treated, biological rep1",ctrl
DW292_Tg_M,pert
LKR13_Wt1 sh-2,pert
ColonDistal0220AFAR_071.txt,ctrl
V5-P254,pert
MLL_PTD15,pert
cell line: Normal bone cell line 1705;	phenotype: Parental;	cell type: human osteoblast (hOB),pert
SKM KO6,pert
"age at diagnosis: 80;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T3;	n (lymph node metastasis): NX;	er: 1;	pgr: 1;	dfs-month: 45;	dfs-event: 0;	distant metastasis: 0",pert
age: 3 wk;	tissue: whole heart;	genotype: MCKcre Pitx2 Flox/Flox,pert
MiaPaCa2 pCEP4 - AGR2 clone 16,pert
11100 UC Uninflamed descending colon,pert
HeLa cells transiently transfected with a Stau1 siRNA,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
"Normal cervix epiethelium, microdissected, Age 48",ctrl
HF0593_U133P2,ctrl
ILD Study Number S038,ctrl
"FIH null MEFs, biological rep2",pert
Control4,ctrl
"Biceps, control, cohort 13, subject 13U",ctrl
"Control 1, biological rep1",ctrl
LT 339 +/T untreated,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (16),pert
HCC PBMC_sample 2,pert
strain: E14Tg2A;	cell type: mouse ES cells;	knockdown: Tet1;	overexpression: none,pert
PC-3M/MYB siRNA #1,pert
strain: C57BL6/10J;	genotype: mdx;	gender: male;	age: 2 months;	tissue: cardiac muscle,pert
"MCF7/BUS, 10 pM E2, 48 hours, biological replication 3",pert
"Normal skin from Stat3c_control mouse, biological replicate 1",ctrl
pSUPER-mir-210 replicate 2,pert
WT heart 3,ctrl
Subject 3 Pre allergen challenge,ctrl
siERK1E24h_2651,pert
Muscle 50 eccentric contractions 12 hours KO Adult 01271,pert
control MLL_00109,ctrl
genotype: E-mu-BRD2;	cell-type: lymphoma_aggressive;	splenomegaly: severe;	Ig clonality: monoclonal,pert
tissue: Pancreas;	strain: C57BL/6;	genotype: Mist1Cre-ER/Cre-ER; LSL-MIST1myc;	age: 8 weeks,pert
Patient: J;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
Human Chronic HIV Sample C138-CD4+ T cells,pert
Subject #8019-Preinfection,pert
"Data 1, Valpha2",pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 84,ctrl
m1-adenoma1,pert
"siRNA, collagen plate, rep2",ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: pineal gland;	time: ZT6,pert
Pooled total RNAs from lymphoblastoid cells of 14 individuals,pert
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs cultured for another 48h,ctrl
"patient: 208;	current medication: Prednisolone 25mg/d, Pentaza 1g BD, Fosomax weekly;	birth date: 8/16/85;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 6/1/04;	diagnosis date: 6/25/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/14/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 17;	crp: 3;	hb: 121;	wcc: 8;	neutrophils: 5;	albumin: 39;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/14/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
Spleen_ko_4m_rep1,pert
STHdhQ7/Q7-C,ctrl
01L4G: normal control,ctrl
new onset sJIA,pert
colon_epithelium_IL10mouse_6weeks_rep1,pert
Day: 24; Drug: Heroin; Phase: Withdrawal; Replicate: 1,pert
Tk6 treated with arsenic rep2,pert
Septic shock;	gender: Female;	Survivor;	organism: Group A Strep,pert
siRNA Smc3 + Estrogen [N1],pert
Patient: L;	Time: 0;	Group: responder;	Condition: lesional,ctrl
Wt Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-5,pert
miR122-WT-258,ctrl
"17B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
wt-Gfp P10 replicate 2,ctrl
"ShamC-60, biological rep 2",ctrl
11092 Normal Uninflamed descending colon,ctrl
01 MINUS OHT 1A,ctrl
2880,pert
strain background: C57BL/6;	genotype/variation: control mice (Runx1floxed/floxedMxCre-/-);	tissue: bone marrow;	cell type: sorted c-Kit+/Sca-1+/Lin-/IL7Ra- (KSL) cells;	experimental procedure: 3 months after poly IC treatment,ctrl
non-CF subject 39,ctrl
array 1 plus E,ctrl
hNHEPS_0.1 μM_6 h_rep4,pert
diseasedl_IL-13,pert
The control subjects had normal glucose tolerance and no family history of diabetes.,ctrl
"Immortalized MEFs WB, v-src expression retroviral vector infected, rep2",pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EZH2. Sample C,pert
Cebpg-/- MEFs at passage 3_biological replicate 1,pert
T6D-LU,pert
50SageA2,pert
tissue: resected non-tumor liver tissue;	genotype: major [rs8099917 TT],ctrl
"RNF40 siRNA - Undifferentiated, rep2",pert
"NASP siRNA treatment, sample #1",ctrl
NZW/LacJTCE liver sample batch 1,pert
disease state: paediatric glioblastoma;	age: 7.3;	gender: M;	h3.3_status: wt,ctrl
"Patient 15, Atheroma plaque",pert
MF-44,pert
Gender: Male; Tissue: Prostate.,pert
colon_IL10mouse_6weeks_rep4,pert
"patient: 114;	current medication: None;	birth date: 6/27/36;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Altered bowel habit, Alcohol excess;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 74,pert
PPC1_CBFbeta shRNA replicate 3,pert
minor HCC10,pert
HaCaT_Control_ biological rep3,pert
Leg 14 Day Control rep 3,ctrl
cell line: L428;	treatment: Mifepristone (M);	duration of treatment: 5 days,ctrl
LNCaP + R1881 rep 2,ctrl
MCF7_CHX_EtOH_24h_rep1,pert
Nrl-ko-Gfp 4 weeks replicate 3,ctrl
3979-1 E2F1 Null,pert
normal 1090,ctrl
"patient 12, arm treated with pimecrolimus",pert
transfection: control siRNA (siCon);	cell: C2C12,ctrl
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P13,ctrl
Fibroid_2540A,pert
HEK293_Control RNA_24h_Illumina,ctrl
APPsa_R6_rep2,pert
SUM149_siControl_rep2,ctrl
"brain, hippocampus: Ctr-6h-P15-I_e1_le1",ctrl
Gender: male;	Source tissue: lymph node of the scalp/neck,pert
pt. HCL B treated with Vemurafenib 1000 nM for 48h,pert
GEIM186-NORM,ctrl
tetO-Satb1 #3 +DOX,pert
"PPARg2 expression construct, 24 hrs, No Rosiglitazone (PPAR_24_2)",pert
Age: 58;	Cycle: NA;	BRCA1/2 mutation: BRCA1;	Family History: Yes,pert
PPC1_non-target shRNA_replicate 3,ctrl
tissue: Cop1 control embryos,ctrl
mouse cerebellum at P30 knockout 1,pert
"ALL_DS, K26 011609",pert
F191G A,pert
"DMSO-treated, Sham UV, Replicate B",ctrl
RT4D6_mutant Sox10 siRNA_rep2,ctrl
"heart of mouse, 4 week control (4A)",ctrl
Severe rep9 (OHN),pert
OVE26_8W_2_5,pert
cell type: glioma stem cells;	treatment: SIO,pert
2_c,ctrl
sepsis patient #13,ctrl
neocortex-30 months of age-resveratrol diet-biological replicate1,pert
KO_IL-6_400_rep2,pert
S7C Sporadic-hippocampus,ctrl
Cell line established from CA1 HESC using pClip vector,pert
Bone-Marrow_SMM_S1485,pert
cerebellum wild type 21 month replicate 2,pert
gender: F;	age at blood draw: 62;	tissue: whole blood,pert
EP23_adipose_control,ctrl
"brain, hippocampus: KA1-II_e1_le1",pert
E35,pert
24h_RA3,pert
Subject #8046-8hr Postinfection,ctrl
"TNFa siRNA-A, replicate 1",pert
FO_spleen_KO_rep3,pert
33A;pretreatment;female;breast tumor,ctrl
"Patient H-c870T, MSI colorectal tumor",pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.02;	RNA Integrity Number: 9.9;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
treatment: TRPM2-AS siRNA;	cell line: PC3,pert
Muscle 50 eccentric contractions 12 hours WT Aged 12172,ctrl
cell type: mouse embryonic fibroblasts (MEF);	phase: cycling,ctrl
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 19",pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 77;	time: 0;	batch: 4,pert
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: Wild type,ctrl
MDA-MB-231 cells siRhoGDIbeta transfected rep2 HG-U133A,pert
"patient 8, arm treated with pimecrolimus",pert
"MIST1-null pancreas, biological rep2",pert
Allo-25-4,pert
Severe rep10 (retina),pert
strain: BALB/c;	genotype/variation: Rag1-deficient;	treatment: WT nTreg + WT iTreg;	cell type (sorted): iTreg,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-8;	Primary Site:Tongue;	Age:77;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
Psoriasis-252,pert
"WI-38 cells, at 24 h after exposure to DMSO vehicle control, biological rep4",ctrl
liver 0.1% quercetin diet rep5,pert
siCITED1#3 replicate3,pert
phenotype: alcoholic;	gender: male;	case_id: 417;	age: 58;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 20;	brain ph at time of freezing: 6.64;	labeling_batch: 2,pert
cell line: BV2;	treatment: Curcimun,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 43.23288,pert
tissue: microsatellite instability (MSI) colorectal tumor,pert
43SAGEA2,pert
"strain background: mixed C57BL/6, FVB, 129 background;	genotype/variation: BrafV600E::Pten-/-::Pdk+/+, Pdk1 wild-type;	tissue: tumor",ctrl
CDKI-73 CLL2,pert
Vit A sufficient 4a,ctrl
CD8+_Tcells_non_severe_asthmatic_3,pert
CXCR4 knockout 6,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (8),pert
New 3 hr 2,pert
diabetic muscle replicate 2,pert
"NeuroD1 knockout mouse, P0 Pineal Tissue, Sample 1, 05-16-06",pert
BT474-J4_GSK089_24-2,pert
V5-P066,pert
10uM H2O2,pert
"E12.5 wild-type embryonic kidney, biological rep1",ctrl
"Spinal cord, acrylamide treated, biological rep2",pert
"Control, biological rep8",ctrl
umbilical cord_nobpd: 8B,ctrl
mouse cerebellum at P7 wild type 3,ctrl
"Liver, Intermittent Hypoxia 3",pert
"Healthy volunteer, Control_11699",ctrl
GM19238_Kd_NS_P3_11,ctrl
cell line: MLL-AF9 AML cell line 10986 (Zfx fl);	treatment protocol: +OHT;	genotype/variation: cko,pert
"ShamC-60, biological rep 5",ctrl
Strain:  C57BL/6,ctrl
NALT_infected_24h_90-226att_rep2,pert
36A;pretreatment;female;breast tumor; nonresponder,ctrl
tissue: heart;	genotype: Gata6_KO;	age: 8 week adult mice,pert
Cell line: human ES cell HES2,ctrl
Adult Sham; Biological replicate 5,ctrl
Muscle-5 month-wild type-technical replicate 3,ctrl
whole blood_101291,pert
A549_siScramble_rep.1,ctrl
Liver_TAK1KO_Rep2,pert
CML Patient 3 7 days therapy,pert
tissue: testis;	genotype: repro9/repro9;	age: 14dpp,pert
H1P_3,ctrl
CD-49-un1,pert
gender: male;	dietary group: resveratrol-enriched grape extract (C);	time point: 12 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),pert
"Patient 998, 24 month of BETAFERON",pert
Phan_007_KO.saline rep1,pert
H2009_shPTK7-2,pert
"normal nasopharyngeal tissue, specimen N7",ctrl
"Deltoid, FSHD, cohort 07, subject 07A",pert
HRas-v12 transgenic male replicate 4 late timepoint,pert
Diaphragm 23 Day control rep 3,ctrl
E10.5_otic_vesicle_wt_replicate1,ctrl
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14440;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Ad+veh replicate1 b,ctrl
Patient identifyier: L;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 22 years;	Body surface area: 10 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
55A;pretreatment;female;breast tumor,ctrl
Normal cortex of patient 324,ctrl
NSCLC cell line H157. Transfected with scrambeled control non-targetting oligomer siRNA - #2,ctrl
"Gender: female, Age: 36 years, Tissue: VIN 3",pert
sample: #12;	subject: PD case #1;	brain: T-243;	age: 77;	sex: Female;	region: Inferior olivary nucleus,pert
"Mouse bone marrow-derived mast cells treated with IL3, rep 6",ctrl
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 1h;	donor: 2,pert
"experiment 2, ethanol-treated 2",pert
Control Endometrium Mesenchymal Cell_035.UC209++),ctrl
1 PC3 0hr,ctrl
sex: Female;	Age: 8 months;	additional patient information found in Series supplementary file,ctrl
knockdown: siRNA-scrambled;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 5.8;	colon weight (mg): 174;	colon ratio (mg/mm): 3;	myeloperoxidase activity (u/mg): 0.238;	tissue: colon;	treatment: 5% DSS,ctrl
tissue: Whole pancreas;	genotype: WT;	background: C57BL/6;	age: 8 weeks,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/ABL1;	biological replicate: 2,pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Tongue 3,pert
Gender: Male;	Age: 57;	Ethnicity: White,ctrl
strain: FVB/N;	genotype/variation: KLF1-/-;	age: embryonic day 9.5;	cell type: erythroid cells,pert
THRB 15b mutant + vehicle replicate 1,ctrl
"Cell line:  Fibroblast TTP WT cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",ctrl
KM_103N,ctrl
KO HPC Veh 25,pert
Series 2; adult; no fracture,ctrl
TTE3 cells treated with BPA for 6 h-2,pert
"brain, Entorhinal Cortex: 98-18 tangle_e1_le1",pert
HepG2_As rep2,pert
expression array - BRAIN 4,ctrl
"age at diagnosis: 54;	diagnosis: Adenocarcinoma of breast, ductal, recurrent;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 13;	dfs-event: 0;	distant metastasis: 0",pert
Disease_status: Healthy control;	Age (years): 49;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 46;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"Endometrium, postmenopausal, estradiol, 3",pert
PBMC from T cell Large granular lymphocyte leukemia patient#121,pert
Gender:F;	Age:48;	Tissue: Mucosa,ctrl
C_AN01125_F,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: DMSO for 72h,ctrl
AA_Case19_CD8,pert
Ischemia-reperfusion #1,pert
"Liver from Nrf2 k.o. mice, biological replicate 2",ctrl
ST045849 12 hours_2,pert
PGA-RMM-30h-2aA-s2,pert
Strain: top2b-/- in 129SvEv (minor 129SvJ) background;;	Age: E18.5 embryo;;	Gender: male;;	Tissue: whole brain,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 140min;	race: White;	sex: Female,pert
gender: Female;	age: 81;	post-mortem delay: 22h,pert
Balb/c WT_2,ctrl
"HL-60 + 0.5 % DMSO, biological replicate 1",ctrl
11408 UC Inflamed sigmoid colon,pert
RAW_1.4mM_HOCl_#1,pert
IRAK2 KO macrophages stimulated with MALP-2 for 8 h,pert
MPM tumor 14,pert
"FOXP3, WT, REP5, 0h",ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 19d ID312,pert
Patient: I;	Time: 1 week;	Group: responder;	Condition: lesional,pert
HeLa_TP082505-19_HG-U133A_2_IMFGN0023,ctrl
100uM H2O2 rep 3,pert
Parkinson's disease sample x149,pert
CD8-IGF1R 3T3 A-928605 2,pert
Testis_KO_rep4,pert
CEM11_T3_PP_day1_039,pert
tissue: colon;	cell line: HT29,ctrl
tissue: Hippocampus;	age: 78;	Sex: F,ctrl
agent: control;	strain: BALB/DBA F1 hybrid;	tissue: mesentery,ctrl
agent: control (untreated);	time: 4h,ctrl
patient: 40730;	sample: normal,ctrl
ME180 1 hour rep 3,pert
PGA-RMM-45m-3aA-s2,pert
Nonlesional Epithelium Nonatopic Control rep3,ctrl
KO9-1,pert
H441 transfected with scrambled siRNA 3,pert
Colon_POR-null_1,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 19.67397,pert
Liver WT HFD #546,ctrl
"PPARg d2, rep 3",pert
esophageal squamous cell carcinoma from patient E1520,pert
Adrenocortical adenoma with CTNNB1 mutation (T41A),pert
Substantia nigra PD rep2,pert
FHCRCAML72,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 105min;	race: White;	sex: Female,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 112min;	race: White;	sex: Male,pert
Cultured HTM cells-B,ctrl
RptorKO QSC Technical Rep.2,pert
CCI 14d replicate 3,pert
"WT liver, biological rep2",ctrl
brain_QH2_6M_rep2,pert
"human failing LV myocardium, Ischemic36",pert
K562 cells CREB Knock-out replicate 10,pert
"Vitamin C treated ES cells, Rep 1",pert
p300+/- Rep2,pert
Sex: male;	Age at operation: 70 years;	Site: thigh;	Size in cm: 9x3x6;	Histological Subtype: atypical lipoma;	Responder type: medium;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
"endometrioma, patient M4",pert
Diaphragm 14 Day mdx rep 2,pert
Donor (Sample 21),ctrl
siCABIN1 2,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 38 yr;	population: Hispanic;	dsm-iv: 295.9;	age of onset: 17 yr,pert
129_Sv_1_Tal1_Ko_d6_4302,pert
N/SM1,ctrl
ET 3,pert
"Immortalized MEFs WA, empty retroviral vector infected, rep3",ctrl
B6_Female_Control_rep1,ctrl
HeLa_01-04-05 TP5_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
"male;	CABG patient, atrial tissue;	sevoflurane anesthesia, after CABG surgery",pert
"Lesion Skin, LS-33",pert
agent: control (untreated);	time: 24h,ctrl
normal plasma cells (NPC 389),ctrl
cell line: KYSE150;	cell type: squamous cell carcinoma,pert
"EAE, placebo treated #5",pert
tissue: Brain;	genotype: Npc1+/+;	age: 67 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
CLL12-CD8,pert
TTF=122min;	Race=Black or African American;	Sex=Female;	Group=A;	Prototype_N,pert
GIST Pre Treatment Biopsy 22,ctrl
"ICL670 50uM 16hrs, K562 cells",pert
HeLa cells transfected with UPF1 siRNA 1 (experiment),pert
"Overexpress TFPIalpha, biological rep. 1",pert
N1A Normal-frontal,ctrl
"Untreated TG2 knockout NB4, biological rep2",ctrl
MCF-7 +scrambled siRNA + 500 nM 4-hydroxytamoxifen rep2 (MD36),pert
tissue: Lung Epithelium,ctrl
Control ppar_beta_floxed_rep3,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: del5q,pert
Cerebellum_nontransgenic control A39_8 months_replicate 4,ctrl
agent: EphB2-Fc conjugate;	time: 48h,pert
subject: 2827 TG;	type: transgenic;	tissue: Mouse skeletal muscle,pert
No or early 1 rep1 (retina),pert
gender: F;	age at blood draw: 63;	tissue: whole blood,pert
"brain, hippocampus: KA-1h-P15-I_e1_le1",pert
"Crohn 02, CD02",pert
"Strain: mixed genetic background, predominantly (>87.5%) C57BL/6 with some CD1. Genotype: Mx1-Cre negative: PTENfx/+. Sex: Female. Age:;	Eight and a half weeks (at tissue isolation). Tissue: small intestine (jejunum/ileum).",ctrl
phenotype: alcoholic;	gender: female;	case_id: 337;	age: 62;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 22;	brain ph at time of freezing: 6.74;	labeling_batch: 1,pert
overexpressed Tcof1 [B],pert
56SageA2,pert
B2KO; No Treatment #9,pert
CAR.AH_TCPOBOP_rep1,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P15;	genotype: Igf1 -/-,pert
"Typically Developing Control, Gracilis, Patient Replicate 3",ctrl
Wild-type Type II 9_27_04,ctrl
M7KOepi_infect_0h_rep3,pert
"control endometrium, patient 25",ctrl
GEIM4-U133A-DM,pert
FRD440 2,pert
expression array - AO1,pert
GC resistant clone C7H2-R19E5 treated for 6 hours with EtOH,ctrl
whole tissue section from case 638,ctrl
"fibroblast, MFS subject GDO21 rep 1",pert
db/db 10-1,ctrl
"lymphoblastoid cell line from F23.05, one out of seven of insensitive group, 50*10e6 cells",ctrl
BDC2.5/NOD.scid,pert
Subject 1 / lung subsegment instillated by Saline,ctrl
"knockout mouse embryonic fibroblast, biological rep 1",pert
db/db 16 wk 3,pert
DMN-NF1Hippo18d-1aAv2-s2,pert
Gsk-3a-/- ESCs Rep1,pert
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep9",ctrl
RI39,pert
12464 UC Inflamed sigmoid colon,pert
U-87MG-V17 set 2,ctrl
A HID B_B088,pert
strain:C57BL/6; VillinCRE-HNF4loxp; male; tissue colon; mutant,pert
"seminoma specimen, pT1, patient age: 35y; W03 030",pert
siNS_24h_1,ctrl
Normal-BM 5,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 6 months,pert
WT STR Veh 2,ctrl
P14 - nudelko/+ 3,pert
CA2,pert
"Lesional ear skin from K14-Areg mouse, biological replicate 1",pert
platelet_sickle_18,pert
FRD1 2,pert
cell line: U937;	shRNA construct: GSK3B Construct 2,pert
"10 days old prosaposin knockout mice, cerebellum",pert
G609-lcm,pert
Wt Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-2,pert
FBooth-MDX-3Av2-s2,pert
61 year old female,pert
MLL_00113,ctrl
"cochlea at P60, wt, biological rep 3",ctrl
"1833 shHMGA2, biological replicate 3",pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 88;	Usage number: 4;	Exposures: 3,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day14,ctrl
"Normal Skin, Normal-8",ctrl
Extract:LOX-1:213502;	Extract Description:LOX1_Untreated_24hr:213502;	Quality: Classification:Good;	Quality: Gradient Severity:0.07;	Quality: Distortion Severity:0.03;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.58;	Quality: Background Mean Dev.:1.06;	Quality: Absent (%):57.27;	Quality: Absent (%) Dev.:0.76;	Quality: Scaling Factor:0.47;	Quality: Scaling Factor Dev.:1.26;	Pretreatment [C]:LOX1;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213502;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_24hr;	RNA extraction source key [A]:282295903,pert
38SAGEA,pert
microdissected breast cancer cells from case 547,pert
Calu3-Parental_4,ctrl
WT_POST_PDE_042,ctrl
C57BL10 EDL sample 1,ctrl
MPM tumor 7,pert
"Patient 7, control tissue",ctrl
A549 Stretch 4hr Nov 21 2002,pert
4-HPR_LIVER_1,pert
Kidney_Biopsy_Liver_Disease_4,pert
BT474_Lap_24-1,pert
race: caucasian;	age (years): unknown;	stage: IC;	grade: 1;	histology: endometrioid,pert
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 67;	baseline tumor size (cm): 9x7;	patient id (to identify the 2 chips from the same patient): 12791332,ctrl
Healthy-8 baseline,ctrl
cell type: DN4,pert
"granulocyte, healthy control, biological rep13",ctrl
BS2011051060,ctrl
strain: C57BL/6J;	day: 1;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 1,ctrl
gender: male;	age: 2-3 months;	tissue: kidney;	genotype: WT,ctrl
patient: 109;	current medication: None;	birth date: 10/10/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: FH of Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
NALT_sham_24h_rep1,ctrl
GFP2_1578H,ctrl
"BMMs, untreated control, da, Replicate 1",pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 2",ctrl
c_M101,ctrl
Bulun 1-3h-,ctrl
MCI-015,pert
IMR-32_pCMV-DPP3_48hr_rep 1,pert
11A,pert
tDEA003.CEL,pert
"Acute Myeloid Leukemia, sample 35",ctrl
"Notch3 knockout mouse cerebral microvascular fragments, biological rep1",pert
Itk knockout CD8+ unstimulated 2,pert
PGA-RMM-6h-2aA-s2,pert
V5-P492-2,pert
GFP Untreated 2hr 282295493,ctrl
WT osteoclasts treated 3,pert
Control bone marrow - Biological Replicate 1 - Technical Replicate 2,ctrl
DMN-CtrHippo10d-2aAv2-s2,ctrl
control (day 0) replicate 2,ctrl
patient id: 233;	tissue: Normal cortex;	gender: Female;	age: 79;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
Healthy4-CD8,ctrl
"liver_ABCA1-TG, biological replicate 1",pert
"treatment with TFMPP, replicate 2",pert
"HepG2 cells, HNF4a RNAi treated, rep2",pert
MEF.WT.F,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells prior to 30 min intravenous saline challenge""",ctrl
At Risk: -;	Age: 8;	Sex: M,pert
"P30_wt cones, replicate 1 [array]",ctrl
cell line: MCF7 breast cancer cells;	genotype/variation: control,ctrl
NTac_liver_vehicle 0 mg/kg_96 hr_5,pert
genotype: Wild type,ctrl
N/LV5,ctrl
strain: C57BL/6;	genotype: wildtype,ctrl
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep3,pert
KU_19N,ctrl
BC-920079,ctrl
b148,ctrl
UnInfected-4,ctrl
MacularDegen-injured-13aAv2-s2,pert
"1833 expressing Tet1, biological replicate 2",pert
SFM,ctrl
Cdx2 null ES cells expressing human Gata3 T2ER fusion,pert
liver wild type replicate3,pert
OC1-WT embryo 1,ctrl
Diabetic 3 weeks D3,pert
A_AN00764_T,pert
genotype/variation: C56B/6 and CD-1 mixed;	strain background: Shh mutant;	age: E9.5;	tissue: E9.5 embryos;	microdissection: posterior second heart field,pert
H12_P_B2,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 30.888;	Ratio: 2.10,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 2,ctrl
"brain, hippocampus: KA6-III_e1_le1",pert
UIP lung explant,pert
"Hdh knock-in embryonic stem cells, Q50 line, biological replicate 1",pert
FHCRCAML169018,pert
gender: Female;	age: 85;	post-mortem delay: 3.5h;	ph: 5.9,pert
cumulus_nonPCOS_Lean_rep2,ctrl
OCI-Ly7_FOXP1 overexpression,ctrl
Amoxicillin treated Colon 3 21 days old,pert
erStress_twins_AA_1717twin2_DMSO_4h,ctrl
146_SIO,pert
ndf control1,ctrl
Monocyte FCH rep 1,ctrl
sample 1:;	age: 58;	gender: male;	sample 2;	age: 69;	gender: female,ctrl
Left ventricular myocardium in patients with Dilated cardiomyopathty (30),pert
0238-01-A,pert
E9.0 ko.2,pert
microdissected breast cancer cells from case 871,pert
"experiment VIII, hTERT",pert
Run3.aUa.010110d.SkMDbt1139D.CEL-DB stimulate,pert
"age at diagnosis: 51;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T3;	n (lymph node metastasis): N0;	er: 0;	pgr: NA;	dfs-month: 21;	dfs-event: 1;	distant metastasis: 1",pert
MDS patient 149,pert
bladder cell with APF,ctrl
R5_Pseudomonas_wildtype_48,ctrl
Individual_4089_PP_sample,pert
HVS-CD4-ITK-R335W_unstim_rep1,pert
cell type: Bladder cancer;	treatment: mock,ctrl
cell line: AST13;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: SNCA triplication,pert
Keratinocytes treated with EphB2 for 1h,pert
New El-Ashry 004.CEL,pert
"wildtype liver, biological rep 3",ctrl
ES cells_OE_rep3,pert
BP patient 83_biological replicate 1,pert
"RPMI8226_shKDM3A#2, replicate1",pert
"KO mouse heart at 6-weeks old, biological rep4",pert
whole blood_101339,ctrl
Postmenopausal female. Untreated control. nr 21.,ctrl
scan batch: Batch 2;	group: control;	subject age: 4;	paternal age: 36;	maternal age: n/a,ctrl
mock-1,ctrl
Control (C284),ctrl
"Empty vector, plastic plate, rep3",pert
12A,pert
Normal cortex of patient 209,ctrl
Diaphragm 112 Day mdx rep 3,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 3",pert
Melanoma,pert
MCF7 cells treated with 2uM ARC for 24 hours Array 2,pert
Muscle PCOS 5,pert
"genotype: mutation in the NOTCH 1 gene (Weng et al., 2004, Science, 306, 269-271)",ctrl
Txnip deficient tumor 24 months sample 3,pert
"alveolar macrophages, smoker 057",pert
"Chromium 1 µM, biological rep2",pert
"3T3-L1 siLSD1 48h, biological rep 1",ctrl
BSKO 3,pert
17GOBMUC2H,ctrl
"ID: MLL_00268;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
CON15,ctrl
HaCaT_Control_ biological rep3,ctrl
strain: FVB;	genotype: E2F1 null;	tissue: mammary gland tumor,ctrl
CD34-003,ctrl
PGA-HMO-Obese-7aUA-s2,pert
C_AN15566_C,ctrl
MDA_PR_2,ctrl
LDLR_HF_2,pert
MDS patient 169,pert
"Hif1a-/- LSC, biological rep1",pert
"PC from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE,CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
"wildtype mouse embryonic fibroblast, biological rep 2",ctrl
Hdh mutant (111/111-polyQ) 1,pert
tissue: heart;	gender: male;	genotype: WT;	age: 3 months;	strain: C57BL/6,ctrl
Patient: J;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
BIO586221,ctrl
"strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 15 months;	tissue: liver, peritumoral tissue;	disease status: hepatocellular carcinoma",pert
NPC10,pert
NPC7,pert
"Normal 14, control tissue",ctrl
Hippocampus_Soman_3h_rep1,pert
Genotype: Mdr2-KO homozygous mouse;	Age: 3 month,pert
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"Liver from control mice, biological replicate 2",ctrl
T4E-LU,pert
MSE_N_M163,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 24h ID134,pert
GM19238_Kd_TAF1_2,pert
CLL 38-11 Control,ctrl
"breast tumor epithelium,20",pert
Hippocampus Fluoxetine Group 1,pert
Morbidly obese control subject,ctrl
"PCOS, biological rep 3",pert
A YOKE_B025,pert
BJ-fib_2,ctrl
"126 (221), ADIPOOSE TISSUE, After",pert
1 hr KLF4 Time Course Induced,pert
Tendon_non-lesional_rep6,ctrl
HUVEC/NmenMC58_pilD_4h_rep1_1103,pert
Mut-/- rep3,pert
"strain background: C57BL/6;	genotype/variation: P53 knock-out; Cdh1+, P53-;	age: 2 months;	gender: female;	tissue: uterus",pert
B6_Male_Control_rep2,ctrl
MLL_00126,pert
AO 2hr,ctrl
cell line: rtTA-Dmrt5;	differentiation: 7 days;	treatment: -Dox,ctrl
cell line: KOPT-K;	cell type: human T-ALL cell line;	agent: control,ctrl
GLY replicate 4,pert
1006-03-A,pert
Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model MEPM 3,pert
WT MEP 1,ctrl
KO 541 L1,pert
tissue: tumor tissue from cancer patients;	genotype: p53 mutant;	disease state: Microsatellite Stable Stage III Colorectal adenocarcinoma,pert
"Cell type: endothelial, age:54, gender:male, diagnostic group: schizophrenia, PMI:38h",pert
Patient: M;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
PGA-lv_1w_651,ctrl
HeLa_01-04-05 TP7_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
genotype: wildtype;	cell-type: activated;	splenomegaly: none;	Ig clonality: polyclonal,ctrl
L_LS_Wk12,pert
SeV 3479,pert
Nrl ko P10 replicate 2,pert
SIN3A_siRNA_NS_rep3,pert
cell line: Y79;	passage: 29;	cell type: Retinoblastoma,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 29 yr;	population: white;	dsm-iv: 296.54;	age of onset: 22 yr,pert
IRF4-control_Th17_cells_42hr_rep2,ctrl
3872-1 E2F WT,ctrl
Strain:B6.V-Lepob;	gender: female;	age: 12 weeks;	tissue: gallbladder,pert
whole blood_100801,ctrl
Native wt biological replicate 2,ctrl
PGA-MAH-C3H_OVA24h-3aA-s2,pert
U87 untreated rep2,ctrl
GM19238_Kd_ZHX2_3,pert
PGA_MI_nilv_1h_395,pert
WT-CD80hi-mTEC-sample2,ctrl
brain_DLPFC_bipolar C_mr801,ctrl
"HSCs from male mice treated with E2, replicate 1",pert
"ALL_DS, K4 011509",pert
CH1813,ctrl
15KD_rep2,ctrl
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.94;	Post mortem interval (hours): 29;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
duration of untreated disease in month: 20.6;	age at onset: 6.0,pert
RI57,pert
"Crohn's Disease subject (32 year old caucasian male, SAK_1287459252)",pert
wt-Gfp 4 weeks replicate 4,ctrl
P60_PMP22TG_1,pert
cerebellum_PSNA_ 4w_rep1,pert
strain: 129;	cell type: EBs;	genotype/variation: WT,ctrl
GBM_differentiation_4 days_1,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P7,pert
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: sensitive,pert
ANL Chip#38,pert
"Pten null fibroblasts, biological rep2",pert
ovaries dissected from 0-day old Sprague-Dawley rats and cleaned of ovarian bursa.,ctrl
EA_Case18_CD20,pert
colon_adenoma_1419,pert
LICR_HN2_CETU1,pert
1212-2heart_OTT1KO,pert
HNF4 Control_8,ctrl
14-week-old WT liver_393WT,ctrl
RE550_DU145_8-Medi5117,pert
KO - knock-out Treated - 24 hrs - repeat 3 - Cy5 - mAdbID:54820,pert
cell line: MDA-MB231;	treatment: control shRNA;	media: SCM,pert
brain_co_14M_rep2,ctrl
Glioblastoma_10,pert
14.5_KO_615A,pert
V5-P565,pert
"treated with Roziglitazone, 1000 mg/kg in Methylcellulose soln per orally, extracted 48h after treatment, biol. rep5",pert
platelet_sickle_5,pert
MDA-MB-231 cells siLuc (control) transfected rep3 HG-U133A,ctrl
H7 HA 2h 3,pert
"Patient 13, Atheroma plaque",pert
Teratozoospermic individual: Sample T6,pert
Atopic eczema,pert
"Rb null fetal liver 3, embryo at 12.5 days of development",pert
"Vehicle treated, DAY 6, biological rep.2, MV4-11 cells",ctrl
MCF10A_Empty vector_1,ctrl
"3T3-L1 siLSD1 24h, biological rep 2",pert
Individual_4935_NN_sample,ctrl
cerebellum_Pink1 knockout_24 weeks_replicate 1,pert
CON3,ctrl
DBTRG untreated rep1,ctrl
control AU1038304,ctrl
Disease_status: Bipolar disorder;	Age (years): 30;	Gender: Male;	Age of onset (years): 22;	Duration of illness (years): 8;	Brain pH: 6.1;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: 60000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
age_years: 56;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
GM19238_Kd_ZBTB38_2,pert
IRF4_4,pert
Osteoblasts_Lrp5_Knockout_Day7_rep2,pert
RNA from HCC_21N,ctrl
"healthy breast 5, biological rep. 5",ctrl
"SKO-transduced MEFs, Vc+, D8",pert
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14536;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 2;	psoriasis duration: 12.6235455167693;	age of psoriasis onset: 37,pert
KU_33T,pert
saline ctr002,ctrl
T81 U133p2,pert
"shKDM4C 2, clone 2, rep 2",pert
CTRL_2_HSC,ctrl
RNA from HCC_38T,pert
"Mammary gland, control, biological repl 2",ctrl
V5-P387,ctrl
Adipose-5 month-wild type-technical replicate 3,ctrl
ovary_cultured_control_rep1,ctrl
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-C104A/C131A;	overexpression induced with doxycline: No,ctrl
t11,pert
MDA_PR_Paclitaxel_3,pert
Z4_Cont_TA,pert
strain: SW129/C57BL/6J  cells;	genotype/variation: wild type;	cell type: B-lymphoid,ctrl
"Foxd3 conditional knockout cells treated with Tamoxifen, biological rep3",pert
cell line: MOLM-14;	shRNA construct: Scrambled Control,ctrl
"A673 treated with DMSO vehicle control for 24 hours, biological rep3",ctrl
Z138-shControl.2,ctrl
CML_1_HSC,pert
Run3.aUa.010110d.SkMDbt1134D.CEL-DB basal,ctrl
"T47D cell line, replicate 1",ctrl
"breast, pre AFI treatment (H17_1910)",ctrl
T41027,pert
E10.5_otic_vesicle_mut_replicate2,pert
Pancreatic Sample 36-Normal,ctrl
GFPRhoGDI2 Replicate A,pert
strain/background: A/J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: cholestatic intestinal injury,pert
MDS patient 172,pert
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 14.5x7.5x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
Gata-1 Wild Type B,ctrl
cerebellum SNCA knockout 6 month replicate 1,ctrl
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 3,ctrl
Sample ID:DCBD2.1;	Twin Pair ID:TP8 ;	Clinical Status:Control;	Age of Onset:-;	Age at interview & blood sampling:20 ;	Current Age (2007):24;	Sex: Male ;	Medication at interview (duration) :none,ctrl
"Quercetin, sample 4",pert
V5-P056,pert
gender: female;	age (years): 36;	evolution time (years): 3;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
3T3 Vector Control Vehicle 2,ctrl
wild-type macrophages unstimulated,ctrl
tissue: peripheral blood;	subject: sickle-cell patient;	rna prep: PAXgene;	molecule: total RNA,pert
"septic CD4+ splenocytes at 6h, biological replicate 2",pert
217/4,pert
scan batch: Batch 1;	group: autism;	subject age: 2;	paternal age: n/a;	maternal age: n/a,pert
Cell line BT-474_control_expt2,ctrl
brain_OFC_control C_mr169,ctrl
Amniocytes_trisomy 21_1549,pert
AA_98,pert
"D425-shOTX2_2, t=16",pert
MLL_PTD10,pert
Huh7 cells_Mock Infected 12 hours_ rep1,ctrl
"Patient CCa, stable renal transplant recipients, female, 70 years old, T0 (time of enrollment)",ctrl
464MM,pert
strain: C57BL/6J;129S5/SvEvBrd;	genome/variation: wild type;	cell type: granulosa cell;	treatment group: 44-46hr PMSG,ctrl
MV 1,pert
scan batch: Batch 1;	group: control;	subject age: n/a;	paternal age: 32;	maternal age: n/a,ctrl
"tissue: heart;	strain: mixed background of C57BL/6, 129/sv, and Balb/c",ctrl
437MM,ctrl
Muscle PCOS case 201,pert
db/db 9-1,pert
CD34+ cells without fenretinide treatment from CML32,ctrl
"217, MUSCLE, Before",ctrl
Ezh2-Cre1,pert
Run5.aUa.010110d.SkMDbt1151D.CEL-DB stimulate,pert
V5-P103,pert
Rat fatty liver12,pert
race: caucasian;	age (years): 54;	stage: IB;	grade: 1;	histology: endometrioid,pert
"28B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
>95% CD3+ T cells negatively isolated with Dynal kit from SLE patient,pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 56;	gender: m;	treatment: -,ctrl
"AG825-treated, Sham UV, Replicate D",pert
COV434 Mutant [RR1024],pert
Liver_KnockOut_2,pert
"MCF-10A cells, overexpression vector control, biological rep3",ctrl
GEIM9-U133A-DM,pert
Male 8week AJ sham rep3,ctrl
siWTAP 2,pert
11403 Normal Uninflamed terminal ileum,ctrl
11415 UC Uninflamed ascending colon,pert
source tissue: lymphoid;	cell type: Splenic CD11b+Gr-1 cells;	disease state: no tumor;	genotype: IRF8 KO;	genetic background: H-2b,pert
Series 1; young; 3 days,pert
Transfection Reagent Only Technical Replicate 3,ctrl
Sample: alpha-TM180;	Replicate: 4;	Pool: P,pert
lateral hypothalamus no access to cocaine replicate 3,ctrl
cell type: Human melanoma cell line;	cell line: M249_R4;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
whole blood_101467,ctrl
Osteoblasts_Lrp5_Knockout_Day7_rep3,pert
IRF4-control_Th17_cells_42hr_rep1,ctrl
genotype: WT;	gender: Female;	cell type: MEF,ctrl
tissue: Frontal cortex;	age: 88;	Sex: M,pert
SCD1 +/+ liver rep2,ctrl
K562 cells CREB Knock-out replicate 7,pert
siRNA-140_rep1,pert
NSC miR-128 1,pert
"RKO colon carcinoma cells (ATCC #CRL-2577), cultured in DMEM (Invitrogen Catalog#10569) containing 10% FBS (Atlas Biologicals)",ctrl
Whisker pad mutant biological rep3,pert
asthma_OVA24h_1,pert
15d control_Pool 7,ctrl
V5-P054,pert
Diabetic Rat Retinal Müller Cells,pert
cell line: SKBR3 resistant;	treatment: 0.1uM Lapatinib,pert
siControl_rep_1,ctrl
Adrenal WT 0h batch 3 [AdWTh00.19],ctrl
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 3,pert
HUVEC/NmenMC58_pilD_4h_rep3_1114,pert
MCF7 cell line_resveratrol_150mM_biological replicate 1,pert
Time:0 day; condition:Emerin ko;,pert
WT - Cre Control - 5 mo - repeat 3 - Cy3 - mAdbID:74102,ctrl
Neuroblastoma SH-SY5Y cells_cloneH_scramble control_replicate2,pert
del337TR replicate 1,pert
"TNFa siRNA-A, replicate 6",pert
gender: Male;	age: 79;	post-mortem delay: 4h;	ph: 6.2,pert
tissue: Gastrocnemius muscle;	genotype: KO;	age: YOUNG,pert
11426 UC Uninflamed ascending colon,pert
ILD Study Number 942,pert
Paclitaxel-resistant,ctrl
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T1N1,pert
age: 53;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Untreated native HeLa cells 1,ctrl
healthy myeloid cells 3,ctrl
68A;pretreatment;female;breast tumor; nonresponder,ctrl
"metastatic, pooled, prostate cancer",pert
NoKD,ctrl
"Cadmium 0.2 µM, biological rep2",pert
HSC_Zfx-flox_Replicate2,ctrl
cell line: L428-PAX5;	treatment: Mifepristone + 5-aza-2′-deoxycytidine + Trichostatin A (MAT);	duration of treatment: 5 days,pert
striatum_Pink1 knockout_6 weeks_replicate 3,pert
Pancreatic Sample 34-Tumor,pert
WT - Cre Treated - 24 hrs - repeat 2 - Cy3 - mAdbID:54726,ctrl
Pool 3 Convalescent stage,pert
cells: CD8+ cells;	tissue: spleen;	strain: Elf4-/- KO,pert
"WT mouse skin treated once with acetone and collected 24 hr later, replicate 3",pert
Subtype: RA;	Karyotype: del(5q),pert
Halothane 5 exposures-2,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 5",ctrl
remitted schizophrenia patient  S13,pert
"Kdm2b KD E14, rep1",pert
age: 61;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
HF1489_U133P2,pert
tissue: brain;	genotype: mutant Ndel ko/+ mix background;	age: P14,pert
"Control_SOL, C5",ctrl
Bone-Marrow_MM_M1041,pert
Braak α-synuclein stage 1-2 BR12_1SN,pert
HepG2_As rep3,pert
strain background: C57Bl/6J;	gender: male;	strain background: Glo1 overexpression;	age: adult;	tissue: whole brain,pert
ic 19 -- with mock APF,ctrl
N7_Cy3,ctrl
Bone Marrow Mononuclear Cells;	44y Female,ctrl
MPM tumor 4,pert
Male 8weekBL6 shamrep3,ctrl
"PPARg2 expression construct, 2 hrs, No Rosiglitazone (PPAR_2_2)",pert
foxp3 expression: YES;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 wild type;	gender: female;	treatment: none,ctrl
eNOS Knockout Mice-M4,pert
Substantia nigra PD rep12,pert
strain: C57BL/6J;	cell type: MEP;	genotype/varation: ∆Hmga2,pert
tissue: Whole pancreas;	genotype: Rkip-1 KO;	background: C57BL/6;	age: 8 weeks,ctrl
C57_LF_1,ctrl
Bronchial Epithelial Cells SA biological 1841Z,pert
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 5,pert
Erythroblast_SOD2+/+_repWT37,ctrl
"Patient S-414-N, normal colonic mucosa",ctrl
Bone-Marrow_MM_M813,pert
"breast, post AFI treatment (H20_1950)",pert
Rex KO_plus LIF_rep4r,pert
MCF-10A sh53BP1-1 replicate 1 [set 5],pert
4IDC_normal_ductal,ctrl
GM19238_Kd_IKZF3_2,pert
prefrontal cortex (BA10);	schizophrenia,pert
WT_cells_rep1,pert
Carbo Day14 (455R),pert
uterus_veh_WT_4hrs_rep3,ctrl
Bronchial Epithelial Cells MMA biological 2128K,pert
Ulk1/2-/- (untreated) 3,pert
cell line: MCF-7 breast cancer cell line;	agent: estradiol (E2);	time: 24hr,pert
Strain: 129SV/EV IFNAR1-/-;	Gender: Female;	Age: 8-12weeks;	Tissue: Mediastinal lymph node B cell;	Influenza A/Mem71 48h;		,pert
hsa-mir-30a/30d inhibitor_24-8,pert
C2_2,ctrl
01LMN_Systemic,pert
m1-WT5,ctrl
Treatment 2,pert
"Typically Developing Control, Gracilis, Patient Replicate 1",ctrl
rheumatoid arthritis 1152,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 24h,ctrl
BCR/FGFR1 biological replicate 2,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: B;	genotype/variation: NET1 present;	agent: LPA,ctrl
MDS patient 22,pert
CLL22-CD4,pert
"brain, cerebellum: RNA #5_le1",pert
"U373-EGFP, rep 1",ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: REBIF;	time: 24 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 309;	age-at-biopsy-years: 49,ctrl
CLDN18_KnockOut_2,pert
subject: 8;	disease: CP;	muscle: ST;	gender: M;	age: 16.7;	gmfcs: 5;	popliteal angle: 90,pert
"control embryonic stem cells, biological replicate 1",ctrl
22A;pretreatment;female;breast tumor; responder,ctrl
brain_DLPFC_bipolar B_mr282,pert
WT - Cre Control - 3 mo - repeat 5 - Cy3 - mAdbID:74673,ctrl
"Female (age range 33-49), skin biopsy upper nates. No nickel exposure",ctrl
gender: female;	batch: 1;	age (years): 25;	patient id: Control_2;	fev1 (% predicted): 103;	fvc (% predicted): 107;	medication: None;	cell type: CD4+ T-cells,ctrl
INSENS 4 0hr,ctrl
treatment: baseline;	gender: F;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,ctrl
A5_C5_nasal_stem_cell_rep1,pert
Normal subject 3,ctrl
cerebellum_WT_20d_rep1,ctrl
"HepG2 cells, HNF4a RNAi treated, rep2",ctrl
"knockout mouse embryonic fibroblast, biological rep 2",pert
Wild-type ESCs Rep1,ctrl
SLE myeloid cells 10,pert
Clint-Dhh-2-011411,pert
High weight gainer KOZAK2_ABI_HYP_H2,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.32603,pert
"Strain: C57BL/6 Ly5.1+, tissue: CD45.2+ transplanted bone marrow",pert
tissue: blood;	patient: 5;	gender: male;	age: 38,pert
CD8+_Tcells_healthy_donor_1,ctrl
"GNMT knockout at 8 month age, biological replicate 1",pert
Disease_status: Healthy control;	Age (years): 35;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 52;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Muscle 50 eccentric contractions 12 hours KO Aged 1027,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 0,pert
Recent-onset T1D_sample5,pert
control sample 2,ctrl
duration of untreated disease in month:6.5;	age at onset:7.7,pert
KO Ang3,pert
Array Type: HG-U133A_2;	Ratio: 2.01;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
"Neurons overexpressing GFP, biological rep2",ctrl
BL Day 2 siMut10 transfected biological rep2,pert
Aurka_R_+Dox_rep2,pert
Disease_status: Healthy control;	Age (years): 34;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.87;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
DS2-iPS 6,pert
strain: Swiss;	tissue: Ovary;	agent: Control (0.1% DMSO);	replicate: 3;	age: Post natal day 3-6,ctrl
OE control 1,ctrl
brain_OFC_control C_mr231,ctrl
DBA control (122msn),ctrl
"DMSO Control after 2hr, replicate 1",ctrl
"RWPE1 cells, vehicle, 48h, biological rep3",ctrl
Trained 1 week T1,ctrl
Pancreatic Sample 21-Tumor,pert
GC resistant clone C7H2-R9C10 treated for 6 hours with EtOH,ctrl
Silberg2 (S3) 23100BE,pert
BL305,pert
DRG_DMSO_0.1%_Rep4,ctrl
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 72;	gender: m;	treatment: -,ctrl
tissue: Frontal cortex;	age: 88;	Sex: F,pert
"IN1472 siNT treated, Biological replicate3",ctrl
Wildtype_Sham_Rep1,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 185min;	race: Asian;	sex: Female,pert
"Metformin, biological rep3",pert
Liver_Wildtype_Rep3,ctrl
E14 - nudelcko/ko 2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.542;	OD280: 0.787;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 62;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
scan batch: Batch 1;	group: control;	subject age: 4;	paternal age: 28;	maternal age: 27,ctrl
genetic background: 129SV;	genotype: WFS1 WT;	tissue: hypothalamus,pert
Human prostate cancer primary culture C19dx,pert
Bmpr1a-/- N2B27 sample 2,pert
Karyotype: inv(14)(q11q32);	Age: 74 years;	Gender: female,pert
DN2 replicate 2,ctrl
"Normal subject (27 year old caucasian female, SAK_1276081571)",ctrl
"Normal subject (31 year old indian male, SAK_1274852149)",ctrl
14.5_KO_540C,pert
Day: 15; Drug: Heroin; Phase: Withdrawal; Replicate: 1,pert
strain: FVB;	genotype: wild-type;	tissue: mammary gland tumor,pert
44SMOKEH,ctrl
Healthy controls; individual=JR; time=2; beverage=water,ctrl
ccRCC tumor of patient T142,pert
NSCL/P sample 3,pert
"human failing LV myocardium, Ischemic61",pert
Colon_POR-null+quercetin_1,pert
Patient 5 after folic acid,pert
age: 49;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
B_cell_pool_melanoma_M03+M04,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK1;	agent: E2;	time: 4h,pert
H1_SS12_01Nov07,ctrl
A673_CloneAsp14_Dox_36h_3,pert
"Global gene expression of NASH patients, P62",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.793;	OD280: 0.877;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 143;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: littermate control, Atoh1-Cre;Dicer1(flox/wt);	tissue: organ of Corti from cochlea, basal half;	age: postnatal day 16",ctrl
NOD RIP-Aire27 islet rep2,pert
KO624,pert
"Liver from control mice, biological replicate 4",ctrl
sparse HUVECs stimulated with Angiopoietin for 1 hour after overnight starvation,pert
Proliferative Phase Endometriosis,pert
H720 MK886 1 micromole 24h serum free Sample 3,pert
WT_IL-6_400_rep2,ctrl
Control 1 b,ctrl
PsOEt-20-Week 1,pert
"PPARg d4, rep 2",pert
ACC Xenograft X5M1,pert
Bronchial Epithelial Cells SA biological 1743Z,pert
HUVEC exposure no colchicine 12 hr_1,ctrl
Day2 Estrogen treatment replicate 1,pert
ACC Xenograft X2,pert
Pancreatic Sample 23-Tumor,pert
CF CFTR unexposed replicate 4,pert
Strain:  B6.V-Lep ob;	Gender: female;	Age:  12 weeks;	Tissue:  gallbladder,ctrl
"A673 treated with DMSO vehicle control for 5 days, biological rep4",ctrl
Bronchial Epithelial Cells control biological 1656E,ctrl
Normal_Kidney_Biopsy_5,ctrl
CML-BM 1,pert
Skin_Tcfap2c Mutant E16.5_rep3,pert
R6/1 22 week wildtype_OAD3,ctrl
CUTLL1 GSI-rep3,ctrl
VIN_B105,pert
"seminoma specimen, pT1, patient age: 39y",pert
Patient 9,pert
treatment: shcontrol;	cell line: U138MG,ctrl
"genetic background: B6;	genotype/variation: Eos (Ikzf4) knockout;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",pert
"MCF-7, 12h, sham",ctrl
"HSCs from male mice treated with oil, replicate 1",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.167;	OD280: 1.069;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 134;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
gender: male;	strain: BALB/c;	tissue: liver,pert
"control mouse cerebral microvascular fragments, biological rep1",ctrl
32m1,pert
Rybp#15 (OHT+)_4d_rep1,pert
B4 424 b4-/- untreated,pert
Tobacco_abuse_6,pert
injury stage: Spinal 60 days;	gender: male;	strain: Wistar,pert
BCells_Transgenic_day0_REP1,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 27.167;	Ratio: 2.13,pert
Cell line: human ES cell HES2,pert
wt_P8_rep2,ctrl
Globin_C3,ctrl
"cell type: MYC positive B-cell;	transgene: MycEGFP (a Myc reporter allele, in which a MYC-EGFP fusion protein (MYCEGFP) is expressed from the endogenous Myc locus);	genetic background: C57/Bl6",pert
BALB/cByJTCE liver sample batch 3,pert
Sham 21 replicate 3,ctrl
KU_30N,ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 350;	age-at-biopsy-years: 47,ctrl
"Rat liver, treated with Caerulein, 50 µg/kg in saline i.p., extrated 48 hours after treatment, biological rep2",pert
"40B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"Acute Myeloid Leukemia, sample 67",pert
RKO_HSF1siRNA_6hDMSO_REP3,pert
"Genotype: c-Myc transgenic;	c-Myc transgenic female mice displayed morphological alterations with varying degree of nuclear atypia, such as bronchiolo-adenomas and bronchiolo-adenocarcinomas. Thus, different stages of malignant transformation of alveolar epithelium were observed.",pert
harmane 1uM batch 3,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 30 minutes after intravenous saline challenge""",ctrl
"Liver from MON exposed rats, biological rep 3",pert
tissue: heart;	genotype: WT;	genetic background: C57BL/6,pert
28B,pert
"dy3K/dy3K, mouse model for congenital muscular dystrophy type 1 A",pert
Series 3; old; 1 week after fracture,pert
SHR20-4,pert
"PCB77 treated HepG2 cells at T24, biological replicate 1",pert
MPM tumor 20,pert
BS2011051058,pert
"Strain: C57BL/6, Gender: female, Age: 6-10 weeks;	Tissue: nasal-associated lymphoid tissue (NALT)",pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: SRF Silencing;	agent (treatment): R1881,pert
OVCA420-(2),ctrl
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 5 months;	genotype: Wild type,ctrl
Control subject 23_biological replicate 2,ctrl
0833-01-C,ctrl
Day 4 (T34),pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 67;	gender: male;	years of disease: < 1 y;	treatment: phototherapy;	time: pre-UV,pert
OCT4 shRNA_3 Days knockdown_rep1,pert
"disease state: Nasopharyngeal carcinoma;	stage: IVA, T4, N2, M0, G4",pert
Severe rep3 (retina),pert
51_129_KO,pert
"Cells transfected with sirtuin 6, biological rep1",pert
Striatum of 8-10 week old C57BL/6J mice,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: healthy;	Sex: F;	age: 50,ctrl
prostate normal 2,ctrl
CEPI_IIIc_229,pert
strain: C57BL/6J;	genotype: Cmah KO;	gender: male;	age: 2 months;	tissue: cardiac muscle,pert
strain: C57BL/6;	genotype: Cmah knockout;	tissue: liver;	age: 12 weeks,pert
"mouse aorta cross strain comparison, C3H_T24_NC_03",ctrl
NB4 INFECTED 1,pert
SC263_CETU1,pert
tissue: testis;	gestational age: 22 weeks;	xenografted into host: control (unimplanted samples were snap-frozen immediately);	host treatment: N/A,ctrl
Methoxychlor (50uM) rep 2,pert
ILD Study Number S019,ctrl
Kidney_WT_baseline_rep2,ctrl
gender: Female;	age: 87;	post-mortem delay: 14.5h;	ph: 6.5,ctrl
Neuroblastoma cell line,ctrl
36SAGEA,pert
liver_Wt_8wk_rep1,ctrl
mouse B6xCF-1  Non-transgenic (control-2),ctrl
"Peripheral blood, normal control [N56]",ctrl
WT replicate 2,ctrl
wild type MEF time 2 replicate 1,ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 47;	gender: male;	tumor grade: AIII,pert
HF0616_U133P2,ctrl
microdissected breast cancer cells from case 59,pert
genetic background: 129SV;	genotype: WFS1 WT;	tissue: hypothalamus,ctrl
"Microdissected normal cervical epithelium, Age 38",ctrl
db/db 13-2,ctrl
uterus_veh_PRKO_40hrs_rep1,pert
hsa-mir-30a/30d inhibitor_24-6,pert
IPMC 5,pert
Parent 1,ctrl
TTP_KO_60ActD_BioRep1,pert
"D425-shOTX2_2, t=48",pert
tissue type: Lesional skin;	time: Week2_etanercept,pert
WFS1 WT USHT_07_314_ko,pert
"HepG2 cells, control, rep1",pert
U937_shSYK_1_Replicate2,pert
brain_DLPFC_bipolar C_mr951,pert
Crx-Nr2e3-Nrl-ko-Gfp4W-2,pert
umbilical cord_nobpd: 3A,ctrl
HepG2 cells control 12h,ctrl
"spleen follicular B in IRF8 conditional KO, biological rep3",pert
immortalized cells derived from brown fat tissue of mouse of mixed background. passage number: 4.,ctrl
"Control Distal, Small Intestine 1 21 days old",ctrl
"Normal subject (51 year old caucasian female, SAK_1276014509)",ctrl
Time 180 mins rep 2,pert
Msgn1_24hMinDox-biological rep1,ctrl
CD4DecTp1-5,pert
Donor5_6h_DMSO,ctrl
Individual_4356_PP_sample,pert
4m2,ctrl
"AG825-treated, Sham UV, Replicate C",pert
WD44_control RNAi-1,ctrl
PGA-RMM-72h-1aA-s2,pert
SCD1 -/- liver rep3,pert
"Rat_Tracheal_Dex_2hr, rep5",pert
CD8+_Tcells_severe_asthmatic_4,pert
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 4;	gender: male,ctrl
Placenta Adra2bWT 3,ctrl
LT 435 +/T after nicotine-induced seizures,pert
HUH-YAP-#2,pert
age: 15;	sex: M;	disease status: control subject;	Filter number: 98;	Usage number: 1;	Exposures: 3,ctrl
KU_20T,pert
clone type: AtT20 clone types overexpressing NSBP1WT protein rep3,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 20;	age of psoriasis onset: 33,pert
29A;pretreatment;female;breast tumor; responder,ctrl
C_Kin_3,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 6h ID129,pert
VehLPS,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 6 months,pert
colonic_mucosa_non_inflamed_721,ctrl
Human hepatocellular carcinoma cell line infected with MIR517A and GFP protein 1,pert
RNA from HCC_24N,ctrl
db/db 9-2,pert
TRPM2-AS siRNA rep2,pert
"Prdm14(+/+): 2i, rep1",ctrl
FmrKO2_brain,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-tu1,pert
"PCB153 treated HepG2 cells at T0.5, biological replicate 2",pert
Subject #8037-2d Postinfection,pert
sex: Male;	Age: 47 months;	additional patient information found in Series supplementary file,pert
F348_WBS,pert
3765-2 E2F1 Null,pert
CLL 379-01 LMP-420,pert
FU-OV-1+(1),pert
GSK-3 inhibitor effect on MLL leukemia cells - 2,pert
CT-receptor-KO osteoclasts treated 1,pert
Hippocampus_WildType_rep3,ctrl
control mice colon rep 2,ctrl
Caco2-siRNA1-rep2,pert
homozygous_2,pert
lung_CLP_wildtype_rep3,ctrl
RNA from HCC_31T,pert
KO - 3 mo - repeat 3 - Cy5 - mAdbID:74669,pert
8 week old EOM control rep 3,ctrl
cell type: endometrial stromal cells;	growth phase: early passage,ctrl
2861-scrape,pert
Non-Transgenic replicate 1,ctrl
Primary neonatal keratinocytes_control_rep2,ctrl
Male Sprague-Dawley (Crl:CD(SD)IGS Br;	Age: between 5 and 6 weeks old,ctrl
Sham 21 replicate 1,ctrl
cerebrum_WT_4w_rep2,ctrl
"non-AD_TC, biological rep5",ctrl
saline ctr001,ctrl
"Peripheral blood, patient without recurrent events [N74]",pert
disease group: osteoarthritis;	cell type: chondrocytes;	cell culture: 3-D,pert
cell line: neuro 2A (N2A);	cell type: neuroblastoma cell line;	genotype/variation: transiently transfected with non-targeting vector,ctrl
"Lesional skin from K5-Tie2 mouse, biological replicate 3",pert
Syracuse High Avoidance (SHA) learning rats 1,ctrl
A_Ctrl_3,ctrl
coc-8_A,pert
ES cells_control_rep3,ctrl
"Patient 11, Macroscopically intact tissue",ctrl
G4D_Sham_Rep4,pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 31;	maternal age: 28,pert
02_PAH,pert
"breast tumor epithelium,28",pert
WT HPC PDE10i 12,pert
TscWT2_brain,ctrl
subject: 32;	disease: CP;	muscle: ST;	gender: F;	age: 7.9;	gmfcs: 2;	popliteal angle: 95,pert
PBMCs enriched for CD8+ cells from normal control subject C (CCD8),ctrl
"fibroblast, control subject NF7 rep 2",ctrl
NTac_liver_vehicle 0 mg/kg_96 hr_3,pert
"C57BL/6 female, fasted 18h (overnight), age 4-5 months",ctrl
"tissue: liver;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: monuron 72 hr",pert
EosWTCD25+#1,ctrl
Jejunum_POR-null_1,ctrl
WT-smoke-med-5 month+13d-R2,ctrl
Heart dissected from E12.5 fetus with a null mutation for the Sp3 transcription factor.,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 72 years,pert
V5-P270,ctrl
H20_S_B1,ctrl
APOE_KO_DM_9W_3,ctrl
Tendon_lesional_rep10,pert
"Atm-/- 120 min post IR, A",ctrl
"wdNHBE uninfected at 36hpi, biological rep2",ctrl
clone 3-1,pert
disease state: healthy control;	tissue: epidermis;	age: 47;	gender: female;	treatment: untreated;	time: control,ctrl
CME-LaminA4d-3MA-S2,pert
treatment: transfected with Ambion Silencer Select Negative Control #1;	cell type: embryonal carcinoma;	cell line: NTera-2;	passage: 40-50,ctrl
146_DMSO,ctrl
P14 - Lis1cko/ko 1,pert
Neuroblastoma SH-SY5Y cells_cloneG_stably transfected with RNAi against DJ-1_replicate1,pert
"3T3-L1 siLSD1 24h, biological rep 1",ctrl
WT liver_HFD_rep4,ctrl
"Normal subject (35 year old caucasian female, SAK_1265842481)",ctrl
Human Acute HIV Sample A044-CD4 T cells,pert
8 hour tunicamycin wild type D,ctrl
A_AN16641_T,pert
sampleID: SAM630143;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
"Male, 32 years old",ctrl
timepoint: 2h;	drug: Saline;	group no.: 16;	large batch: X;	plate: 4051964034;	hybridization batch: II,ctrl
U133A_G3,ctrl
cell line: U87;	treatment: 10 uM Y15;	cell type: glioblastoma cancer cell line,pert
muscle wild type replicate3,ctrl
S4_Sham_wildtype_8,ctrl
mammary_16wkWT_ker71,ctrl
Disease_status: Bipolar disorder;	Age (years): 58;	Gender: Female;	Age of onset (years): 27;	Duration of illness (years): 31;	Brain pH: 6.50;	Post mortem interval (hours): 35;	Side of brain: Left;	Fluphenazine mg. Equivalents: 12000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Fetal heart 1.5 ug/kg TCDD rep2,pert
"Crohn's Disease subject (47 year old caucasian male, SAK_1263137700)",pert
CML Patient 6 7 days therapy,pert
B_LS_Time0,ctrl
MIY_day_5-2,ctrl
Kidney_50 mg/kg VCM iv_mouse #0078,pert
GFP_1,ctrl
HCC1954 Cell Control 2,ctrl
Wt Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-1,pert
"E18.5 lung KO1, biological rep1",pert
strain: 129SV;	gender: male;	genotype/variation: SIRT4 WT;	tissue: liver,ctrl
"Patient Z, uninvolved skin",ctrl
PKBa-/- MEF time 6 replicate 3,pert
"Autoimmune pancreatic islets, day 1 cyclophosphamide treatment, rep 4",pert
Human.AI.CP.ECRB,pert
HSF1-/- T cells at 37oC replicate #1,pert
"Normal Skin, Normal-17",ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 16 hr AP20187,pert
"tissue: Cardiac, ventricular tissue;	genotype: wild-type;	age: 8 weeks-old",ctrl
EmptyVector 1,ctrl
race: caucasian;	age (years): 65;	stage: IA;	grade: 2;	histology: endometrioid,pert
293T cells stably transfected with 1 scramble shRNA construct. Control cell line for 293TsiLL cell line (LEDGF transcript knockdown - PSIP1 gene).;	,ctrl
"Normal subject (54 year old caucasian male, SAK_1287392193)",ctrl
ES_WT_rep2,ctrl
5192-scrape,pert
OE Sirt1 1,pert
siUbr5 replicate2,pert
"Gender: Female, Age: 358, BMI: 30, Tissue: luteinized cumulus cells",pert
brain_OFC_control C_mr170,ctrl
siCONTROL no DNA Damage experiment 3,ctrl
G668-lcm,pert
NOD2wt_0h_MDP_biological replicate 1,ctrl
01UP6_PolyRF-,pert
"S1P2-KO-neocortex, biological rep7 (female)",pert
"Male, 32 years old, HIV infection of ~4 months",pert
"control, BA46-84",ctrl
wild-type replicate 1,ctrl
Time:3 day; condition:Emerin ko;,pert
PFC FVB/N control 3,ctrl
M833 / Reference_13425521,pert
"medulloblastoma, wt, rep2",ctrl
H05_S_B2,pert
"SNCA triplication iPSCs, AST18",pert
platelet_sickle_1,pert
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 95;	Sex: male;	region: LC (locus coeruleus);	age: P23;	genotype: Y/X;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,ctrl
RORasg/sg WAT_HFD_rep4,pert
KO MEF 3,pert
WT10,pert
"Donor 1, mock infected 6hr",ctrl
Setleis Syndrome patient 1,pert
cell line: LNCaP,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.881;	OD280: 0.457;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 310;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 24h",pert
normal bone marrow NBM4,ctrl
KN-sham-2 month-R4,pert
siLMO3_oligo1_0_rep1,pert
Muscle PCOS case 81,pert
kidney_QH2_14M_rep3,pert
"Wild-type HFD 8 weeks, biological rep2",ctrl
"Wild type, 6 weeks old",ctrl
Control treated cells Rep1,ctrl
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P6,ctrl
"age at diagnosis: 34;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 61;	dfs-event: 1;	distant metastasis: 0",pert
cell line: SKMEL28;	time point: 48h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 48 h,pert
normal muscle replicate 4,ctrl
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 2hr,pert
strain background: C57BL/6;	genotype/variation: IL-22-/-;	infected with: ME49 strain of T. gondii;	time point: at day 5 post-infection;	tissue: ileum,pert
HF0726_U133P2,pert
HCC1954 Cell Treated 3,pert
Stratagene reference,pert
patient: 232;	current medication: Pentaza 2g BD;	birth date: 1/9/63;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/95;	diagnosis date: 1/1/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/31/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.17 uM (EC50), biological rep3",pert
"Control, biological rep2 (with calcium)",ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 26;	maternal age: 24,pert
FHCRCAML169014,pert
Control 1_Huh7 [HDAC2 siRNA subset],ctrl
2A;pretreatment;female;breast tumor; responder,ctrl
primary cell culture,ctrl
"Patient M030-827T, MSI colorectal tumor",pert
Muscle KO Aged 1217,pert
WT-SB replicate 3,ctrl
Patient no. 8: control,ctrl
Untreated diabetic-1,ctrl
Individual_5243_NN_sample,ctrl
Trim28CKO unstimulated CD4 positve T cell rep2,pert
"Rb KO, biological rep1",pert
Ishikawa_LowDose_BPA_24h_rep4,pert
sip53mut.exp3,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 145;	time: 0;	batch: 3,ctrl
ID: MLL_00114;	cell type: PBMC;	disease state: control,ctrl
Csbm/m Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-2,pert
"Typically Developing Control, Gracilis, Patient Replicate 2",ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case3,pert
cell type: Immortalized AR positive myofibroblast,ctrl
"PCOS, biological rep 5",pert
"Empty vector control, 2 hrs, No Rosiglitazone (NONE_2_2)",ctrl
adenocarcinoma (ADC3),pert
ST045849 24 hours_1,pert
"SFM control cells (3hr), biological rep_1",ctrl
"Patient H-c1027T, MSI colorectal tumor",pert
P19_exPKO_pancreas,pert
"pt. HCL A treated with Vemurafenib 1000 nM for 72h, replicate2",pert
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:wildtype,Treatment:cornoil,Batch:Batch2",ctrl
Wild type Retina Rep1,ctrl
THRA 6a mutant + T3 replicate 1,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep4,ctrl
"Uninfected TG at 5 d.p.i., rep1",pert
"brain, hippocampus: CH5_e1_le1",ctrl
ILD_18,pert
Gsk-3a-/- ESCs Rep3,pert
Fibroblasts_DBApatient_4,pert
patient: 251;	current medication: Bumetanide Asprin Lisinopril Colifoam;	birth date: 5/22/21;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/05;	diagnosis date: 6/6/05;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/6/05;	indictation for procedure: ;	ucss: 9;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Vaginal Prolapse-Angina;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
sex: Female;	family: 3;	age: 32;	disease status: Asymptomatic;	tissue: Muscle: Deltoid,pert
tissue: Hippocampus;	age: 84;	Sex: F,ctrl
C2C12 myotubes 100uM H2O2 rep 2,pert
"affected status (disease state): control;	gender: male;	age-at-examination: 50;	age-at-onset: n/a;	geographical origin: Lisboa;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 23.33973,ctrl
9264PBMC,pert
Postmenopausal female. Untreated control. nr 17.,ctrl
"Deltoid, FSHD, cohort 21, subject 21A",pert
Human prostate cancer primary culture C35sx,pert
Targretin_LIVER_1,pert
27SAGEA2,pert
normal 3208,ctrl
P19_WT_pancreas,ctrl
heart-ko-1,pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 37;	gender: f;	treatment: NSAIDs,ctrl
"granulocyte, patient. Mtx rep9",pert
EA_Case3_CD20,pert
strain: C57BL/6;	diet: MCD + HF diet mixed with 0.1% metformin (nash metformin);	tissue: liver,pert
mouse strain: C57BL/6J;	genotype/variation: AhR null,pert
CML Patient 5 7 days therapy,pert
SNB19 PARK2 siRNA#2 replicate 2,pert
brain_OFC_bipolar B_mr89,pert
01N3C: new onset sJIA,pert
CLL8-CD4,pert
HEK293 F5_doxycycline treated,pert
umbilical cord_bpd: 9I,pert
HSC cells from control rtTA mouse rep2,ctrl
"C57BL6J-backcrossed, male",pert
WT Brain 60d Mouse2,ctrl
normal 1050,ctrl
lymphocytes_HD_F_44y,pert
Gender:F;	Age:45;	Tissue:Mucosa,pert
"Endometrium, postmenopausal, estradiol, 24",pert
U937-shGSK3A-Construct5-rep1,pert
Pediatric_GBM_9,pert
Ex1_cells_rep1,ctrl
Dominant negative cJun  VZ20,pert
No or early 1 rep5 (retina),pert
"Vehicle treated, DAY 4, biological rep.3, MV4-11 cells",ctrl
M10KOepi_infect_0h_rep1,pert
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
"BN strain, male, age 21 weeks",ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 65;	donor: 21;	disease state: Lesional,pert
H2_SS8_01Nov07,pert
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of saline for one week,ctrl
Cre_day_3-2,pert
Time:3 day; condition:ctr;,ctrl
SUM149_siControl_rep1,ctrl
FVB; No Treatment #4,ctrl
tissue: skin;	individual: Patient P1;	condition: ANL;	eczema severity: SCORAD: 0,pert
Parkinson's disease sample x114,pert
iPSC idiopathic autistic patient triplicate 2,pert
n5t24h,pert
Bronchial Epithelial Cells MMA biological 2065M,pert
PGA-RMM-8h-2aA-s2,pert
wild_type_embryonic_stem cells_biological_rep1,ctrl
"mutant mouse embryonic fibroblast, biological rep 3",pert
mouse: 5;	strain: C57Bl/6;	genotype/variation: STAT6 KO;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,pert
Lmna H222P homozygous male 1,pert
Lima1A_case,pert
Hippocampus_Soman_48h_rep3,pert
Human.BP.CTRL.ECRB,ctrl
"21B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Individual_582_PP_sample,pert
"endometrioma, patient 14",pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: parotid salivary gland;	donor sex: male,pert
Patient no. 16: control,ctrl
SKI-DLCL cells_Aplidin 3nM_24h_rpt1,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: H;	transfectant type: stably transfected with scramble control,pert
EA_Case5_CD8,pert
9A;pretreatment;female;breast tumor; responder,ctrl
age: 35;	sex: F;	disease status: Marfan subject;	Filter number: 32;	Usage number: 4;	Exposures: 3,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P13,pert
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: REBIF;	time: 24 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
OBF-1 overexpression BCS-2 (Large PreB),pert
Neuroblastoma SH-SY5Y cells_cloneB_stably transfected with RNAi against DJ-1_replicate2,pert
endothelial_rep8,ctrl
"KO total RNA LSK, rep 3",pert
"TH cells from LC, wild type control, young time point, biological replicate 3",ctrl
Muscle-24 month-Myc heterozygous-technical replicate 2,pert
"age at diagnosis: 51;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IV;	t (extent of primary tumor): T3;	n (lymph node metastasis): N1biii;	er: 0;	pgr: 1;	dfs-month: 16;	dfs-event: 1;	distant metastasis: 1",pert
"treatment: diclofenac;	batch: 5;	donor: 5;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
1 Ctrl 1,ctrl
"Normal cervix, microdissected, Age 42",ctrl
5A,pert
siNS_2h_3,ctrl
tissue type: Primary lung tumor;	histology: AS,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 70min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 176,pert
"Patient 13, Macroscopically intact tissue",ctrl
FVB_skin_5dpn_3,ctrl
cell type: embryonic stem cells;	cell line: CGR8;	treatment: Foxd3 conditional knockout cells treated with DMSO,ctrl
Phan_002_WT.saline rep2,ctrl
01N3C_Systemic,pert
tissue: Temporal cortex;	age: 86;	Sex: F,ctrl
cell line: HL-60 promyelocytic leukemia cell line;	leukemia type by fab: M2;	agent: TCDD,pert
3880-2 E2F WT,pert
"12 weeks normal mice, cerebrum",ctrl
"brain, cochlea: [7] Sample #7_le1",pert
MLL1-KO MEF CT30-3,pert
patient: 8;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
colonic_mucosa_non_inflamed_741,ctrl
Gender: male;	Age: 34;	Ethnicity: white,ctrl
A YOKE_B095,pert
Liver sample from Alcoholic hepatitis group (CA39),pert
N_LS_Wk12,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 33, stage IV, HPV 16",pert
"SFM control cells (3hr), biological rep1",ctrl
"array 13, xenograft, 0.3% Tween-20 vehicle",pert
"pancreas, control diet, replicate 2",ctrl
B6 wild type;	Age: 4-8 wks,ctrl
[OBF-1]-1,pert
umbilical cord_bpd: 7H,pert
NOMO-1 STK33-2077,pert
HepG2_100uM_Trovafloxacin_24hr_prep3,pert
miR122-KO-265-T,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: REBIF;	time: 12 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
Colon_Wild Type_1,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 42 yr;	population: white;	dsm-iv: 296.64;	age of onset: 20 yr,pert
PBMC from T cell Large granular lymphocyte leukemia patient#128,pert
"cell line: HeTH-4;	genotype/variation: control;	comments: HeLa cell line with inducible THOC1-depletion, non induced",ctrl
"Neo6, 48h treatment with 5 AzadC",pert
79_129_WT,ctrl
patient: 40645;	sample: normal,ctrl
cell line: RT112;	transduced: EGFP shRNA;	doxycycline treatment: no,ctrl
"Deltoid, FSHD, cohort 09, subject 09A",pert
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 116;	genotype/variation: WT;	age: 8 weeks,ctrl
Age: 50;	Cycle: NA;	BRCA1/2 mutation: BRCA1 917delTT;	Family History: Yes,pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: Treg;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
"RWPE1 cells, vehicle, 24h, biological rep2",ctrl
PC3 Control Rep3,ctrl
P53_cKO_1,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day7,ctrl
whole tissue section from case 518,ctrl
Patient: H;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
cell type: Endothelial cells,pert
"A673 treated with DMSO vehicle control for 5 days, biological rep5",ctrl
13SC-nbc,pert
LY2 control-siRNA tamoxifen treated rep3,ctrl
HepG2-PARP2 depleted-1,pert
Liver_normoglycima_no.1,ctrl
Ngn3 EB3 OFF replicate 2,ctrl
cell type: brown preadipocyte;	genotype: Ezh2 +/+,ctrl
Liver_Female_CF_rep2,pert
wild-type_CITCO_rep1,ctrl
MDS patient 119,pert
DP (CD4+/8+) cells from Normal Thymus Replicate 2,ctrl
"G42 cells from Cerebellum, wild type control, biological replicate 2",ctrl
T44 U133p2,pert
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 retrovirus,ctrl
"female Spargue-Dawley rats, 4-hydroxyphenylretinamide, 782 mg/kg diet for 7 days, tissue: mammary gland",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 82min;	race: White;	sex: Female,pert
Trim28CKO TCR-stimulated CD4 positve T cell rep4,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 1",pert
microdissected breast cancer cells from case 518,ctrl
cell line: MCF7;	condition: control,ctrl
normal;	Adjacent pair of T18,ctrl
HUVEC/NmenMC58_pilD_6h_rep2_1107,pert
EOM 56 Day mdx rep 2,pert
ApoE-/- mouse infected wtih a control adenovirus expressing GFP,ctrl
Mannitol control treated A549 human lung cancer cell cultures replicate A,ctrl
Cre_day_3-5,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 43;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
SKI-DLCL cells_untreated_24h_rpt3,ctrl
disease: cardiopathy;	gender: male;	age: 9 years and 10 months;	tissue: thymus,ctrl
JIA PBMC Post treatment A235_L027(2),pert
"nasopharyngeal carcinoma, specimen T8",pert
erStress_twins_AA_1734twin1_500nM_thapsigargin_4h,pert
P14 - nudelcko/ko 1,pert
strain background: C57BL/6J;129S5/Brd mixed hybrid;	genotype/variation: Cre knockout of Dicer;	tissue: uterine;	age: 15 days,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Female,pert
age: 54;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
tissue: Temporal cortex;	age: 88;	Sex: M,pert
3514-lcm,pert
tissue: colon biopsie,ctrl
RNA from HCC_41T,pert
heart/muscle-specific MnSOD-deficient mouse (d/d),pert
Day 3 (T12),pert
"testis, Repro9 mutant, 17dpp, Rep4",pert
"Transgenic, brain hemisphere",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.814;	OD280: 0.932;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 137;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Tissue:tumor; Gender:female; Age:43; Tumor stage:T1N1aMx,pert
"CL1-0 mock control, biological rep2",ctrl
lymphocytes_HD_F_50y,pert
"iPSC derived from CCALD patient fibroblast CCALD1, biological rep2",pert
tetracycline inducible Ngn3 ESC differentiated for 3 days as EB with doxycycline,pert
"granulocyte, healthy control, biological rep12",ctrl
48 hrs sham-2,ctrl
202/4,ctrl
Dengue Fever Patient 7,pert
KO mouse 3_heart_basal,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 50;	gender: male,pert
tissue: Biceps muscle;	patient: P.b.5;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 4m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
Phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject J (JAcCD8),ctrl
siHic5_2_4h_4,pert
OV90+(1),pert
healthy CD4 T cells 7,ctrl
06R021 RA,pert
H6 HA 2h 2,pert
38m1,ctrl
"seminoma specimen, pT2, patient age: 27y; W03 021",pert
strain: GNMT KO;	developmental stage: Post natal day 90,ctrl
strain: F1 (C57BL6 X 129/SvEv);	genotype: wild type mice;	tissue: kidney;	gender: male;	treatment: NS diet,ctrl
ESE_N_629,ctrl
"Rat liver, treated with NMF, 1000 mg/kg in saline i.p., extrated 48 hours after treatment, biological rep4",pert
strain: Ola129;	cell type: Embryonic Stem Cells;	genotype/variation: Ogt silencing,pert
21day 4OHT-treated-sample2,pert
5208 Normal Uninflamed sigmoid colon,ctrl
"cochlea at P7, ko, biological rep 3",pert
"Transgenic, snap frozen, gastrocnemus muscle, 10 month age animal",pert
Vit A deficient 4b,pert
"gender: male;	batch: 2;	age (years): 23;	patient id: Non_severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 98;	medication: Becotide, Ventolin;	cell type: CD8+ T-cells",pert
MCF7 - MTDH_WT_KD_3,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 146;	time: 0;	batch: 2,ctrl
subject: 12U;	cohort: 12;	tissue: Biceps;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 24;	Sex: F;	batch: Batch_3,ctrl
C005_Control_M_91,ctrl
Cerebellum_nontransgenic control S46_3.5 months_replicate 1,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: TCPOBOP; 1,4-bis[2-(3, 5-dichloropyridyloxy)]benzene",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-sp1,pert
WT-sham-1 day-R4,ctrl
"S1P2-KO-neocortex, biological rep4 (male)",pert
"experiment I, passage 9, replicate 2",ctrl
"AD_FC, biological rep4",pert
cell line: SBC-5 cells;	treatment: siEGFP (control);	time: 48 hr,ctrl
4013-1 E2F2 Null,pert
rtTA-Dmrt5_d9_+Dox_rep_1,pert
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P55;	clone: C11,pert
CLL 38-11 LMP-420,pert
HF0962_U133P2,pert
strain: C57BL/6;	diet: methionine- and choline-deficient diet+ high fat diet (NASH);	tissue: liver,ctrl
Cardiac Muscle_Cmah KO_rep1,pert
normal;	Adjacent pair of T10,ctrl
MEF Wild Type 3-rep3,ctrl
patient id: T165;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 40;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
GIST Pre Treatment Biopsy 30,ctrl
Gastric_cancer_patient_9,pert
01N1B_ERA,pert
"brain, frontal cortex: Sample57_e1_le1",ctrl
"age at diagnosis: 70;	diagnosis: Adenocarcinoma of breast, ductal, mucinous;	tumor grade: G1;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 1;	pgr: 1;	dfs-month: 37;	dfs-event: 0;	distant metastasis: 0",pert
"Spinal cord, saline control, biological rep1",ctrl
Ainv15 EB3 replicate 1,ctrl
3898-1 E2F1 Null,ctrl
Postmenopausal female. Estradiol treated. Patient 36.,pert
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: untreated;	treatment time: 16 hours,ctrl
Control peripheral blood leukocytes - Biological Replicate 1 - Technical Replicate 1,ctrl
hnf4KD_H9_d20_hepatic differentiated_1,pert
BAL_1_A0B0,ctrl
Subject #8035-2d Postinfection,pert
"CD11b DC wild type, biological replicate 1",ctrl
Subject 2_t=30days_resveratrol,pert
patient: 244;	current medication: Seratide Bricanyl BFZ;	birth date: 1/29/55;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/16/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 15-24;	other illnesses: Asthma Hypertension;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
0702-01-C-b,ctrl
P82 dilated cardiomyopathy heart biopsy,pert
KOC 53 PBS treated,ctrl
OE33 Control rep1,ctrl
shSOX2_4,pert
heart_QH2_14M_rep2,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day4,pert
HL60-shControl-rep1,pert
JIA PBMC Post treatment A235_L016(2),pert
disease state: healthy control;	tissue: epidermis;	age: 17;	gender: male;	treatment: untreated;	time: control,ctrl
12482 UC Inflamed ascending colon,pert
HeLa_01-04-05 TP11_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
Testis_wild type_rep1,ctrl
DP (CD4+/8+) cells from Normal Thymus Replicate 1,ctrl
B-CLL PB P136,pert
Neuroblastoma SH-SY5Y cells_cloneH_scramble control_replicate1,pert
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T2, N3, M0, G4",pert
condition: Non-syndromic cleft lip/palate (NSCL/P);	tissue: decidous teeth dental pulp;	gender: female,pert
"control triceps, biological rep3",ctrl
CT2 vs PBS 4 hr pooled,ctrl
BV2_Curcumin_rep1,pert
3550-1 E2F WT,pert
short-Con rep1,ctrl
PGA-RMM-48h-1aA-s2,pert
H_Ctrl_2,ctrl
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 2h,pert
patient: 32;	disease state: hypertension;	tissue: Atheroma plaque,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with acetaminophen (APAP)_3,pert
C2_CLP_overexpressor_12,pert
B1_saline_overexpressor_422,pert
whole blood_100416,pert
Telencephalon WT 3,ctrl
kidney_co_6M_rep2,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: LOW;	genome/variation: PDGFRA mutation detected,pert
MKK7D transgenic female replicate 6 early timepoint,pert
subject id: 80;	infection: DENV;	status: DF;	tissue: whole blood,pert
genotype: MLL translocation,ctrl
Liver sample of p14 KO mouse 3,pert
5_CD34+_12h_TCDD-,ctrl
TB 9,pert
PGK12.1_Kdm6a RNAi-3,pert
strain: Gata4tm1.1Sad/J;	infection: Mouse GATA4;	culture: Growth medium,pert
"Crohn's Disease subject (65 year old caucasian female, SAK_1280909823)",pert
siERK2E224h_3493,pert
"MCF-10A cells, overexpression TAp63γ, biological rep1",pert
"shControl clone 1, rep2",ctrl
Age: 47;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
b10.2,pert
Liver control pool4 Affy,ctrl
fibroblast cultured from normal esophageal tissue_HEF_1173,ctrl
chip number: 13;	transfection plate: 4;	target gene: IRF5;	kd level: 0.79;	rin: 9.3;	transfection date: 2011-10-17,pert
WT_P58,ctrl
cell line: CAL27;	treatment: PBS,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: F;	experimental sample name: PC11-R,pert
disease state: paediatric glioblastoma;	age: 9;	gender: M;	h3.3_status: wt,ctrl
Parkinson's disease sample x103,pert
MDS patient 148,pert
lesion_postUV_patient4,pert
Day: 15; Drug: Saline; Phase: Withdrawal; Replicate: 2,ctrl
RatLung_H1h_2,pert
"NF-YC KD ES cells 96hr, replicate 3",pert
MDA-MB-231 control clone #3,ctrl
EOM 14 Day COntrol rep 3,ctrl
striatum_Pink1 knockout_6 weeks_replicate 1,pert
chip number: 22;	transfection plate: 4;	target gene: IRF5;	kd level: 0.65;	rin: 9.1;	transfection date: 2011-10-17,pert
patient: 51783;	sample: normal,ctrl
Treatment 6,pert
brain_DLPFC_bipolar C_mr540,pert
Carrier-inj_C57_rep2,ctrl
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P90;	genotype: Igf1 -/-,pert
Healthy control_sample12,ctrl
3DKD_SerumStarved->1hrEGF_rep2,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 23.54521,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
age_years: 67;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
fibroblast_Rapid_D200_Media_14,pert
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 2,pert
BP patient 104_biological replicate 2,pert
CD-53-un,pert
"cell line: MCF7;	disease state: Breast adenocarcinoma, estrogen receptor-positive;	genotype/variation: Control",ctrl
Sex: male;	Age at operation: 53 years;	Site: thigh;	Size in cm: 10x3x5;	Histological Subtype: atypical liposarcoma;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
Phan_001_WT.saline rep1,ctrl
DNGM-1,pert
A517 Sham 7 day,ctrl
GBM_differentiation_4 days_3,pert
12457 Normal Inflamed sigmoid colon,ctrl
"control, subject 3",ctrl
control-plusDox-rep2,ctrl
158A,ctrl
Control_5,ctrl
Waldenström’s macroglobulinemia (WM-PC 33325),pert
healthy control sample x191,ctrl
KM_053N,ctrl
Ileum_POR-null+quercetin_3,pert
disease unaffected colon of a adult with Crohn's disease (CD),pert
"disease state: Nasopharyngeal carcinoma;	stage: IVC, T4, N3, M1, G4",pert
Substantia nigra PD rep4,pert
Individual_5008_NN_sample,ctrl
minor non-tumor5,pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 34;	Usage number: 1;	Exposures: 4,pert
age: 24 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
"tissue: neurectoderm derived from embryonic stem cells;	treatment: Geminin knockdown, shRNAmir #11;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",pert
oocyte_wildtype_rep1,ctrl
RE550_KPL4_8-Medi5117,pert
Nerve_Control_Vehicle_702,pert
Animal 5,pert
cell type: neuron progenitor cells (NPC);	disease group: schizophrenia,pert
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P3,pert
AZ-521_uninduced_8h_rep2,ctrl
3978-1 E2F1 Null,pert
lucif_2,ctrl
"Wild Type, 2",ctrl
major HCC9,ctrl
"P60_wt cones, replicate 2 [array]",ctrl
unstimulated(confluent)-2,ctrl
"Patient 113, 3 month of REBIF",pert
"vestibualr organ at P15 of Igf1 -/-, biological rep 2",pert
V5-P171,pert
A512 MI 1 day,pert
control female replicate 1,ctrl
disease state: paediatric glioblastoma;	age: 16;	gender: F;	h3.3_status: wt,ctrl
CHB PBMC_sample 2,pert
"LckCre Dicer lox/lox KO, biological rep2",pert
CON-4--71602,ctrl
12493 UC Inflamed sigmoid colon,pert
cell type: iPSC;	genotype: healthy control,ctrl
"wild type, control, biological rep1",ctrl
KO Soleus at 4 weeks biological rep1,pert
strain: GNMT WT;	developmental stage: Post natal day 90,pert
cells: CD8+ cells;	tissue: spleen;	strain: C57BL/6,ctrl
WT HPC Veh 4,ctrl
"31B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
PWD/PhJTCE liver sample batch 5,pert
Wild Type Mice fed Low fat diet 2,ctrl
"Neurons overexpressing GFP, biological rep1",ctrl
3976-3 E2F1 Null,pert
WT619,ctrl
GEIM86-U133A-DM,pert
Carbo Day1 (370L),pert
CD11b+Gr1- cell sample_3 (derived from wild type mouse),ctrl
PsOEt-17-Week 12,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 53 years,ctrl
cell line: RPMI8226;	cell type: Myeloma cells;	transduced with: shRNAs targeting KLF2,pert
Normal cortex of patient T144,ctrl
Strain: C57BL/6JNIA;	Age: 2 months;	Gender: Male;	Tissue: Whole hippocampus,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 3,ctrl
01J46_Systemic,pert
Contusion - 35 Day Epicenter Rep2,pert
KO.ES. rep1,pert
strain: FVB;	developmental stage: adult (3-month-old);	tissue: hippocampus;	genotype/variation: Prnp+/+,ctrl
USF1 replicate 1,pert
"MCF7, biological rep2",ctrl
"human failing LV myocardium, Ischemic2",pert
01LN8_Systemic,pert
2d-sham-71,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: extensor digitorum longus;	age at biopsy: 65;	Sex: male,pert
Mouse_WT_colon_UT_rep1,ctrl
cell type: Human melanoma cell line;	cell line: M229_R5;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
Wild type CD4+ unstimulated 2,ctrl
CML_3_GMP,pert
fibroblast_Rapid_D56_Media_16,pert
tissue: resected non-tumor liver tissue;	genotype: minor [rs8099917 TG/GG],pert
01N1R,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 51;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 19d ID310,pert
"PPARg d4, rep 5",pert
CON6,ctrl
UnInfected-3,ctrl
Hippocampus 1995 15 month Old,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 2;	psoriasis duration: 43.0;	age of psoriasis onset: 15,pert
MS patient 7,pert
CML Patient 3 before therapy,ctrl
wild_type_embryonic_stem cells_biological_rep2,ctrl
T-ALL1 NBD 2,pert
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 58",pert
"Exp A, Animal #267, 5mg/kg D-Serine",pert
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep7",ctrl
HCT116 PTEN +/+,pert
ID: MLL_00111;	cell type: PBMC;	disease state: control,ctrl
Tissue: Spleen;	Type: CLP;	Strain: C57BL/6;	Batch: 12/1/03,pert
IM18_control,ctrl
patient: 40656;	sample: normal,ctrl
Scd1-/- on chow diet replicate 3,ctrl
"Wild-type-neocortex, biological rep10 (female)",ctrl
K562_ICL670_untreated_dup1,ctrl
HCC013T,pert
"Peripheral blood, normal control [N68]",ctrl
No or early 2 rep9 (retina),pert
157A,ctrl
nucleus accumbens long access to cocaine replicate 3,pert
Waldenström’s macroglobulinemia (WM-BL 33325),pert
Subject #8037-Preinfection,pert
genotype/variation: ApoE-/-;	strain: C57BL/6;	mouse provider: Jackson labs (backcrossed >10 generations against C57BL/6 background).;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: non-diabetic,ctrl
"Muscle from WT, biological rep1",ctrl
"SUDHL-1, control repl 3",ctrl
KO - knock-out Treated - 0.5 hrs - repeat 2 - Cy3 - mAdbID:62530,pert
Jurkat-J2,ctrl
major non-tumor7,pert
disease state: skin squamous cell carcinoma,pert
Control (C276),ctrl
hdh genotype: Q7/Q7;	tissue: cerebellum;	age: 3~10 weeks,ctrl
Muscle FC3,ctrl
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep1,pert
Untreated Control 12weeks AffyGC RMA rep9,ctrl
umbilical cord_bpd: 8A,pert
HN_119,ctrl
"Gender: Female, Age: 25, BMI: 16, Tissue: luteinized cumulus cells",ctrl
Spleen_ko_1m_rep3,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 100min;	race: White;	sex: Male,ctrl
genotype/variation: Cavin-1 deficiency;	age: newborn 0-6 h;	tissue: Lung,pert
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 31;	maternal age: 31,pert
"treatment with BZP, replicate 2",pert
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14583;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
NB69 U133p2,ctrl
HET Brain 54d Mouse1,ctrl
Control replicate 7,ctrl
liver_STZ treated diabetic_rep2,pert
Nerve_Control_Rosi_713,pert
4145M patient’s mucosa,pert
Cell culture. A549 treated by MK886 3,pert
cell line: L8057;	cell type: megakaryocytic cells;	genotype/variation: empty vector control,ctrl
"brain, hippocampus: C72-I_e1_le1",ctrl
Normal_Kidney_Biopsy_4,ctrl
healthy control C1,ctrl
C57BL10 TA sample 1,ctrl
AAA neck (Sample 9),pert
Btk KO primary splenic B-cells (sample2),pert
Nerve_Control_Rosi_714,pert
CD19_selected_B-cells_after_R_rep10,pert
01UND_PolyRF+,pert
Carbo Day4 (66L),pert
C_LS_Time0,ctrl
MS25_3A_LV_220307,ctrl
TL3 SCR 2,ctrl
"CFU-PreB colonies Wildtype littermate, biological replicate 3",ctrl
CD8_T_cell_pool_melanoma_M03+M04,pert
Carbo Day7 (419L),pert
cell line: MLL-AF9 AML cell line 10950 (Zfx fl);	treatment protocol: +OHT;	genotype/variation: cko,pert
Human.BF.CP.ECRB,pert
"WT VSV infected, biological replicate 1",ctrl
Time 240 mins rep 1,pert
EGF 4h replicate 2,pert
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 49days;	genotype/variation: WT,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 38;	Sex: male;	region: M1;	age: 38;	genotype: Y/Mecp2-;YFPH/-,pert
lesion_postUV_patient12,pert
MA_307,pert
A673_CloneAsp14_Dox_53h_1,pert
"testis, Repro9 mutant, 14dpp, Rep2",pert
tissue: Spleen;	cell type: B lymphocytes;	gfpmyc status: negative,ctrl
cell line: prostate cancer cell line PC-3M;	genotype/variation: MYB siRNA,pert
EA_Case14_CD8,pert
"ESCs overexpressed vector control, biological rep1",ctrl
ccRCC tumor of patient 265,pert
"cells treated with Vamp7 siRNA, biological replicate 1",pert
"Age: 48;	Sex: M;	Ancestry: European;	Smoking status: smoker, 20 pack-years",pert
LPS + CyP 3hr 2,pert
colonic_mucosa_non_inflamed_728,ctrl
cell line: Panc-1;	transfected with: pCIG-Gli3T (expressing Gli3T),pert
5922012008_A,ctrl
liver-AHRWT-cornoil-rep4,ctrl
6_c,ctrl
MDS patient 178,pert
Patient: O;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
cell line: Normal bone cell line 695;	phenotype: RB1 knockdown;	cell type: human osteoblast (hOB),pert
"SWR/J ACU, Rep1",pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 5,pert
BL Day 2 siMut12 transfected biological rep3,pert
patient: 124;	current medication: OCP;	birth date: 6/25/77;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
GIST Pre Treatment Biopsy 31,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M4;	flt3 status: internal tandem duplication (ITD),ctrl
01MKV_Systemic,pert
E18.5_Mutant_Kidney_array1,pert
11102 UC Uninflamed descending colon,pert
"E2f8 KO, biological rep2",pert
erStress_twins_AA_1712twin2_DMSO_4h,ctrl
01LKT: normal control,ctrl
1083-03-A,pert
"control, BA10-58",ctrl
Sample 12 Kidney Normal Mouse - Low Phosphate Diet,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 29.459;	Ratio: 2.10,pert
"HepG2 cells, control, rep2",ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID49,ctrl
"RWPE-PCAT1 cMyc siRNA #3, replicate 1",pert
subject id: 48;	infection: DENV;	status: DHF;	tissue: whole blood,pert
Control male replicate1,ctrl
Moderate rep2 (OHN),pert
WFS1 WT USHT_09_332_wt,ctrl
Normospermic individual: Sample N13,ctrl
subject: 39;	disease: CP;	muscle: ST;	gender: M;	age: 15.3;	gmfcs: 2;	popliteal angle: 120,pert
Mature mice skeletal intercostal muscle sample,ctrl
E14 cells_Zfp322a RNAi-rep1,pert
Control rep 2,ctrl
9 olanzapine,pert
HSC cells from control rtTA mouse rep3,ctrl
0156-01-C,ctrl
whole blood_100981,ctrl
"D425-control, t=96",ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 10",pert
Sample Group: HD patient; Gender: female; Age: 56; Tissue: lymphocytes (blood); IT15 CAG repeats: 18/43,pert
G501,pert
"SKO-transduced MEFs, Vc-, D8",ctrl
Normal-2 - mAdbID:91659,ctrl
"non-AD_TC, biological rep7",ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 26 weeks;	genotype/variation: VhlhKO",pert
GFP-kd_ES_rep1,ctrl
"breast tumor epithelium,56",pert
BALB/cByJ Vehicle liver sample batch 4,ctrl
"metastasis: none;	Stage: 2b;	tissue: cancer, homogenized",pert
DMN-NF1Hippo10d-2bAv2-s2,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 48.09041,pert
"Control, biological rep. 3",ctrl
25 uM chlorpyrifos batch 3,pert
human_hepatocyte_400uM_Ciprofloxacin_donorA_24hr_prep2,pert
Pool Ts1Cje_P30_hyb2,pert
GM19238_Kd_JUND_1,pert
ethnicity: Hispanic;	Gender: Male;	Age: 31;	Tissue: primary human bronchial smooth muscle cells,pert
"Inclusion body myositis, biological rep4",pert
HMEC X BC24,pert
"Lesion Skin, LS-32",pert
H01_S_B1,ctrl
BxPC3-KO4 rep 2,pert
01UMW_ERA,pert
WD44_Kdm6a RNAi-2,pert
ColTum_022NAFD9_g8.txt,pert
patient: 245;	current medication: Pentaza 1g BD;	birth date: 11/4/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/4/04;	diagnosis date: 3/16/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/16/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/16/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 6/3/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Asthma;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
wt_P6_rep3,ctrl
"fibroblast, MFS subject FB1286 rep 1",pert
"Control 02, NC02",ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 351;	age-at-biopsy-years: 35,pert
transfection: scrambled transfected,ctrl
G_Kin_1,pert
RNA-DHL4-R406-24H-2,pert
Human prolactinoma 131,pert
age_years: 60;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
"Liver from control exposed rats, biological rep 4",ctrl
Gastrin Knockout parietal cell replicate 1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.509;	OD280: 0.793;	Ratio: 1.84;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 58;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
R6/2 (untreated) 5197,pert
34208.INV,pert
"Aorta, Ang II 7d, #3",pert
age: 21dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
PGA-RMM-330m-2aA-s2,pert
"SIRT7 Knockout Liver, replicate2",pert
"Control group, replicate 2 [GY_Con2]",ctrl
WT #188,ctrl
CEPI_Ic_336,pert
tissue: skin;	cell line: NZM12;	tumour stage: metastatic melanoma;	tumour site: small intestine;	treatment: PAX3 siRNA,pert
"Primary aortic endothelial cells, transgenic_PPARG_V290M_2",pert
Normal PBMC_sample 5,ctrl
"disease group: Atopic Dermatitis;	Sex: m;	age: 50s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 34.6;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 510;	ige (kiu/l): normal (0-48.5 kIU/L): 710;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
ctrl_503,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_6h_0.4mM_HG-U133A_2_YCHSUP501,pert
"Kidney from MON exposed rats, biological rep 1",pert
age: 38;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
day: d00;	strain: C57BL/6;	genotype: WT;	experimental run: eX,ctrl
FVB_MMTV_Wnt1_iFGFR2_3068_2L_ROSEN,pert
Kidney_Aqp11-/-_P7_5-2,pert
"TNFa-OMe siRNA-B, replicate 6",pert
remitted schizophrenia patient  S07,pert
B_Ctrl_1,ctrl
0993-01-C,ctrl
BE-rep5,pert
CHB PBMC_sample 3,pert
White adipose tissue in Fsp27 knockout mice (rep1),pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.539;	OD280: 1.303;	Ratio: 1.91;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 221;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Vehicle-Control;	Vehicle-Control 36 hours set 1,ctrl
Normal bladder 16-99,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 24 months;	genotype: Wild type,ctrl
"PTEN inducible MEFs at T1 = 24hr, biological rep2",pert
"Peripheral blood, normal control [N62]",ctrl
"eye, cornea: TRizol Extraction_le1 4",pert
HDAC2 siRNA_2_Huh7 [HDAC2 siRNA subset],pert
"SIRT3KO, standard diet, rep2",pert
Human hepatocellular carcinoma cell line infected with MIR517A and GFP protein 3,pert
Embryonic day 14.5 and 16.5 pancreas,ctrl
lesion_preUV_patient7,pert
genetic background: 129/SVE;	genotype: Des(-/-);	tissue: tibialis anterior;	age: 12-14 mo;	strain: Des(-/-)/129/SVE;	treatment: 50 eccentric contractions 12 hours,pert
Strain: C57BL/6J;	Gender: male;	Age: 9 weeks;	Tissue: whole brain,pert
KOC 67 PBS treated,pert
"126 (221), MUSCLE, After",pert
4_day_old_Prnp_knockout_mouse_rep1,pert
5196 Normal Uninflamed sigmoid colon,ctrl
03_ADL,pert
treatment: PLX4720;	time: Day1;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,pert
Gender:M;	Age:27;	Tissue: Mucosa,ctrl
Individual_4124_NN_sample,ctrl
Liver of pup from control group rep4,ctrl
S46 WT4	F5/13	S46	wild type	Mouse	3.5 months	Cerebellum	Female,ctrl
"WI-38 cells, at 24 h after exposure to 0.5 uM BPDE, biological rep2",pert
"Biceps, FSHD, cohort 20, subject 20A",pert
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 103;	Usage number: 5;	Exposures: 3,pert
cell line: ONS76;	cell type: medulloblastoma;	treatment: mock control;	transfectant: ONS76_si_mock,ctrl
4 STAT6KO control macrophage,pert
MDA-MB-231 control clone #5,ctrl
J1_minus LIF_rep1r,ctrl
"cell line: 10590, WBS, skin fibroblasts;	microdeletion: del(7q11.23);	gender: female;	age at biopsy: 3 years",pert
5278 UC Inflamed descending colon,pert
Bicalutamide_2,pert
colon_1h_rep2,pert
age in weeks: 8-10wk;	gender: Male;	strain: C57BL/6,pert
Embryonic age 14.5 mutant rep2 (PKD1_35),pert
sMPNST_Vehicle_2day_rep3,ctrl
LOX1 Untreated 12hr 282295783,pert
cell line: OVCA420;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
"eye, retina: Myoc 2_e1_le1",pert
Bone-Marrow_SMM_S1412,pert
"breast tumor epithelium,46",pert
"IGF-treated cells (24hr), biological rep3",pert
2000N_1,ctrl
"216, ADIPOOSE TISSUE, Before",ctrl
"brain, frontal cortex: Sample55_e1_le1",pert
CUTLL1 wash4h-CHX_rep3,pert
CON - R17,ctrl
ns VC 3,ctrl
MPM tumor 3,pert
Tet2 KO CFU 5th rep2,pert
strain: C57BL/6;	Sex: Female;	age: 3-weeks old;	genotype: WT,ctrl
Subject #8032-8hr Postinfection,pert
"GATA6 knockout, biological rep 2",pert
Primary neonatal keratinocytes_ACTL6a_i_rep1,pert
HMEC-I control,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case2,pert
"Lens epithelium, SPARC KO, #1L",pert
AMWT_Ker40,ctrl
Hippocampus_Soman_72h_rep4,pert
disease state: endometrioma;	patient: M3,pert
race: african american;	age (years): 59;	stage: IC;	grade: 2;	histology: endometrioid,pert
5021-lcm,pert
Pancreatic Sample 30-Tumor,pert
U87 10 uM Y15 rep2,pert
tissue: GV oocyte;	strain: mixed 129/Sv and C57BL/6J;	genotype/variation: Ring1+/+Rnf2F/FZp3-cre (Rnf2 mutant),pert
tissue type: Primary lung tumor;	histology: LCNEC,pert
JGB-Post-1UP_Run2-S2,ctrl
01-0061A_Day1_7,pert
potilas_DC_D,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.221;	OD280: 0.621;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 152;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
strain: C57BL/6;	genotype: Cmah knockout;	tissue: lung;	age: 12 weeks,pert
Control ESC media sample 2,ctrl
Array Type: HG-U133A_2;	Ratio: 2.02;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
dex24hr_1,pert
systolic heart failure due to idiopathic dilated cardiomyopathy,pert
Wild_type_lubiprostone,pert
"E2-treated cells (3hr), biological rep_1",pert
knockdown: shLOXL2;	cell line: MDA-MB-231,pert
control participant P310,ctrl
0h WT Sample 36,ctrl
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 42;	gender: m;	treatment: colchicine,ctrl
cell type: mouse embryonic stem cells 3x passaged without feeder cells;	genotype: WT;	genetic background: C57BL/6,ctrl
liver_Q10_14M_rep1,pert
"control, BA46-96",ctrl
CUTLL1 DNMAML1 GSIwash2h-rep1,pert
monolayer chondrocytes from normal donor 2,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 48.72877,ctrl
BTBR_Muscle_rep2,pert
PBMCs_IS_6 [IS],pert
whole blood_101446,pert
"Strain: SPARC-null, C57Bl/6 background;	Gender: female;	Age: 28 days;	Eye: Right",pert
"Control KD, rep4",ctrl
muscle Smad4KO 1 control,pert
"non-AD_FC, biological rep11",ctrl
L428+M_rep3,ctrl
10N,ctrl
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 67",pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 6,ctrl
cell line: rtTA-Dmrt5;	differentiation: 9 days;	treatment: +Dox,pert
Testis_KO_rep1,pert
"Normal Skin, Normal-6",ctrl
Panc1 rep-1,ctrl
NoKD_SerumStarved->1hrEGF_rep3,pert
Biceps_Control_6,ctrl
Embryonic age 17.5 wild-type rep3 (PKD1_2),ctrl
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 28;	maternal age: 28,pert
"Mouse ex-iTreg cells, replicate pool 2",pert
ACC 3 cell line lacZ-RNAi replicate 1,ctrl
NALT_infected_24h_90-226att_rep4,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 36 yr;	population: white;	dsm-iv: 295.9;	age of onset: 33 yr,pert
MDS patient 158,pert
11SAGEA,pert
patient: 125;	current medication: OCP;	birth date: 3/17/78;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: Diarrhoea predominant IBS;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
C1 patient,ctrl
Hippocampus_Rasgrf1KO_rep1,pert
"STZ pancreas, biological rep1",pert
SLE CD4 T cells 1,pert
strain: mixed background of C57BL/6;	genotype: Ezh2f/f;Mef2cAHF::Cre;	tissue: heart;	developmental stage: adult,pert
platelet_Ctrl_1,ctrl
kontrolli_DC_C,ctrl
strain: C57BL/6J;	day: 24;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 2,ctrl
heart control 4,ctrl
D_LS_Wk2,pert
MacularDegen-injured-12aAv2-s2,pert
patient id: T84;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 52;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T4N1M1;	Stage: IV;	fuhrman grade: 4;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
major non-tumor3,pert
PsOEt-24-LS,ctrl
Zfx wt MA9 cells + Vehicle [10977],ctrl
patient: 260;	current medication: asacol 800mg TDS Asprin coproxamol;	birth date: 1/1/54;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/79;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/9/05;	indictation for procedure: ;	ucss: 12;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/9/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Arthritis Depression Alcohol excess;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Normal mucosa 4,ctrl
Bone-Marrow_MGUS_G1386,pert
IFN_Gamma_6hr_rep4,pert
Carbo Day14 (378R),pert
TA-t7; transgenic tibialis anterior 7 month,pert
E31,pert
individual: Control5;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
"Ulcerative Colitis (30 year old black female, SAK_1286498073)",pert
breast cancer patient 251,pert
B4 363 b4-/- untreated,pert
mouse_islets_VhlhKO_02,pert
patient: 216;	current medication: NONE;	birth date: 5/10/36;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/19/66;	diagnosis date: 8/20/66;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/18/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: NONE;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
cell line: PC3;	treatment: Wee1 inhibitor II,pert
high grade serous carcinoma_patient 4,pert
male_alcoholic_417,pert
129_Sv_2_Tal1_Ko_d6_4302,pert
Strain: C57BL/6J;	Gender: Male;	Tissue: primary culture tracheal epithelial cells,ctrl
Diabetic untreated rats 3,pert
MLL_PTD04,pert
Bronchial Epithelial Cells MMA biological 1784N,pert
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Post mortem interval (hours): 24;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
Normal cervix epithelium_03-5419,ctrl
gender: female;	genotype: Homozygous for the Q65X mutation in the TWIST2 gene,pert
cell line: OVCAR-8;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
Liver_Wildtype_Rep2,ctrl
sepsis patient #19,ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 24h ID289,pert
KM_065T,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: OE-OCT4,pert
gender: male;	strain: BALB/c;	tissue: liver;	diet: AIN93G with 0.1% quercetin diet for 14 days,pert
Hunk Knock-Out rep 3,pert
"WT-UN3,experimental replicate 3",ctrl
15KD_SerumStarved_rep2,pert
tissue: white blood cells;	age: 12.35;	Sex: female,pert
"Ptenloxp/loxp + pBP-Cre, biological rep 3",pert
"seminoma specimen, pT2, patient age: 27y",pert
Extract:LOX-1:113203;	Extract Description:GFP_Untreated_2hr:113203;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:2.09;	Quality: Background Mean Dev.:0.23;	Quality: Absent (%):59.1;	Quality: Absent (%) Dev.:0.66;	Quality: Scaling Factor:0.68;	Quality: Scaling Factor Dev.:0.6;	Pretreatment [C]:GFP;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113203;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_2hr;	RNA extraction source key [A]:282295493,ctrl
"Uninfected NT at 5 d.p.i., rep1",ctrl
Untreated 979-CLA-27,ctrl
age: 46;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
kidney_QH2_14M_rep1,pert
lung_CLP_PPTA knockout_rep2,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 74,ctrl
"MGSKO, PR02M007v0",pert
optineurin expression-a03,pert
"human failing LV myocardium, Idiopathic9",pert
INS-1 cell line (FLP-In T-REx clone #1-1.2),ctrl
mouse liver D3,pert
9m1,ctrl
cell line: MCF10A;	transduction: Empty vector,ctrl
Pancreatic Sample 17-Tumor,pert
Strain: C57BL/6J;	Gender: M;	Age: 8 weeks;	Treatment: untreated,pert
MOLM14_shSYK_1_Replicate2,pert
48h_RA3,pert
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: control; biological replicate: 1,ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6.4;	colon weight (mg): 162;	colon ratio (mg/mm): 2.53;	myeloperoxidase activity (u/mg): 0.815;	tissue: colon;	treatment: 5% DSS,pert
none provided,ctrl
tissue: retina;	age: postnatal day 4;	genotype: wild type,ctrl
treatment: 12 weeks of RTX therapy;	gender: M;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,pert
17beta estradiol: 0 pM,ctrl
BP10,pert
428B.INV,pert
4 hr KLF4 Time Course Induced,pert
"Uninvolved Skin, NS-4",pert
CTL2 E2 2hr,pert
gender: male;	agent: control;	cell type: Hematopoietic stem cells,ctrl
Sox9egfpneg_p23-2,ctrl
"C57BL/10 Control QF, replicate 1",ctrl
P83 dilated cardiomyopathy heart biopsy,pert
RAW LPS 3,pert
"Liver, Intermittent Hypoxia 1",pert
"strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
BIO586223,pert
Extract:LOX-1:113301;	Extract Description:GFP_Untreated_6hr:113301;	Quality: Classification:Medium;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.09;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.52;	Quality: Background Mean Dev.:1.13;	Quality: Absent (%):61.55;	Quality: Absent (%) Dev.:2.56;	Quality: Scaling Factor:0.77;	Quality: Scaling Factor Dev.:1.36;	Pretreatment [C]:GFP;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113301;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_6hr;	RNA extraction source key [A]:282295593,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 0,pert
N26,ctrl
"mouse control, liver, RNA B6477A",ctrl
KN-smoke-med-1 day-R1,pert
"human failing LV myocardium, Idiopathic43",pert
cell line: DBTRG;	treatment: 10 uM Y15;	cell type: glioblastoma cancer cell line,pert
cell line: HCT 116;	treatment: siChe-1,pert
"heterozygous, control, biological rep1",pert
Invasive cancer originating in IPMN 1,pert
Mouse E10.5 urogenital epithelium +/+ #3,ctrl
strain: C57BL/6;	tissue: heart;	genotype/variation: WT;	age: 6-weeks old,ctrl
condition: Normal;	patient: N_LJ_10;	tissue: Normal skin biopsy;	kit: Affy,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 6 weeks;	Treatment: untreated,pert
SLE myeloid cells 8,pert
23d tg6,pert
HUVEC/NmenMC58_WT_1h_rep1_1102,pert
"control, BA10-59",ctrl
"48B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Large cell carcinoma 017,pert
16A,pert
Patient no. 11: control,ctrl
MLL_PTD02,pert
11_MLN8237-2,pert
TTE3 cells treated with BPA for 3 h-1,pert
"seminoma specimen, pT1, patient age: 43y",pert
strain: 129/Sv,pert
duration of untreated disease in month:0.6;	age at onset:5.5,pert
mouse cerebellum at P30 knockout 2,ctrl
Gender:F;	Age:44;	Tissue: Mucosa,ctrl
HMEC X Hs578t,pert
WT STR PDE10i 10,pert
D_Ctrl_2,ctrl
Cell culture. A549 treated by MK886 2,pert
CH2116,pert
non-CF subject 36,ctrl
EA_Case18_CD8,pert
Renal vesicles from Lim1 mutant E12.5 embryos isolated by laser capture microdissection.,pert
Gender: Male;	Age: 37;	Ethnicity: White,pert
"iPSC derived from CCALD patient fibroblast CCALD1, biological rep4",pert
Insm1 control #8,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 8 hrs AP20187,pert
Mening UNSTIM WB SW 1a,ctrl
Cyclophosphamide-treated spleen 1 day - Biological Replicate 1 - Technical Replicate 2,pert
cell line: mda-mb-231;	transfectant: siRNA for p53,pert
S9C Sporadic-hippocampus,ctrl
Testis WT 0h batch 2 [TeWTh00.9],ctrl
strain background: (BALB/c x C57BL/6J) F1 obtained by breeding heterozygote mice(+/-) with a C57BL/6J and BALB/cA background;	genotype/variation: wild type;	age: adult;	gender: male;	tissue: hippocampus,ctrl
SIRT4 WT liver_7583,ctrl
Normal mucosa 2,ctrl
Intima media,ctrl
HCT116 non-recombinant clone 24 (STAG2 wild-type),ctrl
cell line: NOMO-1;	genotype: ZFX knock-down,pert
CD4DecTp2-2,pert
BP patient 81_biological replicate 1,pert
"JAG1 overexpressed CL1-0, biological rep1",pert
renal_vesicle_Lim1_mutant_2,pert
Normal Rat Retina,ctrl
NSC2,pert
Mouse_ESC_Pcl2_shRNA_sample 1,pert
T40728,pert
Individual_4874_NN_sample,ctrl
"human failing LV myocardium, Idiopathic23",pert
EA_Case1_CD8,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: unknown;	tissue: GIST Tumor,ctrl
WT White adipose tissue (WAT)_HFD_rep3,ctrl
pcdh12-deficient mice rep1,pert
"BOEC, normal 12",ctrl
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 7,ctrl
Gender: Male;	AJCC Stage: II;	Pathological T: 4;	Pathological N: 0;	Pathological M: 0;	Grade: poor;	Tumor Site: Hepatic Flexure;	Drug Treatment: NO,ctrl
gender: male;	strain: C57/BL6;	tissue: heart;	genotype/variation: KLF15-null,pert
IMR-32_pCMV_48hr_rep 1,ctrl
SON siRNA rep2,pert
sample: #18;	subject: PD case #3;	brain: T-3321;	age: 77;	sex: Female;	region: Inferior olivary nucleus,pert
strain: C57BL/6J;	Sex: male;	expression: sh-PRDM16;	agent: none,ctrl
blood_day6_patient7,pert
Strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue:  gallbladder,pert
patient: 221;	current medication: Prednisolone 7mg Asacol Adcal Seretide Fe SO4;	birth date: 1/29/86;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 12/10/01;	diagnosis date: 12/10/01;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/14/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Asthma Eczema;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"alveolar macrophages, non-smoker 035",ctrl
WT_cells_rep3,ctrl
Liver WT ND #686,ctrl
PGA_MI_nilv_8w_332,pert
patient id: T26;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 73;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM1;	Stage: IV;	fuhrman grade: 4;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
MB231 con-SCM,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: EF1a-control,ctrl
"Acute Myeloid Leukemia, sample 4",pert
Cervical cancer_1907T,pert
"gender: Female;	age: 97;	post-mortem delay: 3.5h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 6",ctrl
Genotype: Taf7l knockout;	Strain: C57BL/6J;	Age: 8-weeks,pert
"wild type ES cells, biological replicate 2",ctrl
"treatment with MDBP, replicate 2",pert
E14 - DCXko/Y 2,pert
gender: male;	strain: CBA/C57BL/6;	genotype/variation: wild type;	tissue: colon cancer tumor,ctrl
V5-P584,ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 2,ctrl
Ishikawa_Control_8h_rep4,ctrl
NOD_S1,pert
Rosi-treated diabetic-5,pert
"granulocyte, patient. Mtx rep5",pert
"Rescue pancreas, biological rep3",pert
201/4,ctrl
34SAGEA,pert
strain: CB6F1;	tissue: Skin;	gender: female;	age: E17.5;	genotype/variation: Control,ctrl
"human failing LV myocardium, Ischemic74",pert
Healthy control 3,ctrl
Raji_mi-Ctrl_1,ctrl
"Amoxicillin treated Proximal, Small Intestine 1 17 days old",pert
Individual_4257_PN_sample,pert
strain background: C57Bl/6;	genotype/variation: Lrp5-/-;	cell type: primary calvarial osteoblasts;	time point: day 7 of differentiation,pert
tissue: temporal lobe;	strain: 129SV;	genotype: WT,ctrl
NME2 induced A549 cell Replicate3,pert
3881-1 E2F WT,ctrl
tissue: Mouse heart;	genotype: akt2-/-;	strain: C57BL/6,pert
Naive (control) #2,ctrl
A1_C1_nasal_stem_cell_rep1,pert
Skinbiopsy_7hoursnickel_nickel_allergic_subject_P2,pert
Cervical cancer_CC140,pert
"G42 cells from Cerebellum, Mecp2 null, biological replicate 1",pert
Kidney_50 mg/kg VCM iv_mouse #010,pert
parental cell line: WB;	vector: pBabe-puro (empty vector);	replicate: 3,ctrl
20A;pretreatment;female;breast tumor; responder,ctrl
NK_cell_pool_melanoma_M03+M04,pert
GIST_PDGFRA_10,pert
RV16;	Age = 21;	Sex = F,pert
E14.5 Tgfbr2 Wildtype Mouse Model Palate 1,ctrl
NTB_heart 2,ctrl
"TG mouse lung, biological rep2",pert
BP16,pert
CD4_T_cell_pool_healthy_H11+H12,ctrl
disease state: paediatric glioblastoma;	age: 7;	gender: M;	h3.3_status: wt,ctrl
WT-Fibr2 3,ctrl
WT2 naive CD8 T cells,ctrl
11441 UC Uninflamed ascending colon,pert
HMEC X BC23 : 0090-5k,pert
PGK12.1_Kdm6a RNAi-1,pert
Gastric_cancer_patient_5,pert
Mnk_3137-T-B,ctrl
IRF4-control_Th17_cells_42hr_rep3,ctrl
"shControl, low glucose, replicate 3",ctrl
T3+4,pert
4h 4OHT-treated-sample3,pert
Liver sample from Alcoholic hepatitis group (CA77),pert
control-2,ctrl
non-malignant FTEb_patient 5,ctrl
Normal bladder 283-99,ctrl
Liver_WT_Vehicle_Rep4,ctrl
CUTLL1 wash2h-CHX_rep2,pert
background strain: B6/129;	genotype/variation: mir-122 knockout;	age: 11 Month;	tissue type: Tumor,pert
"cervical cancer cell line, MS751",pert
strain: C57BL/6;	cell type: mononuclear bone marrow cells;	treatment protocol: mock retroviral transduction,ctrl
Adult 7d SNI; Biological replicate 1,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day2,pert
strain: F1 littermate of TCL1 (C3H/B6) and ID4+/- (CD1) mice;	genotype/variation: ID4+/-TCL1-tg;	tissue type: spleen;	cell type: CD19+ B;	age of the mice: 1 month old,pert
"gender: male;	batch: 2;	age (years): 35;	patient id: Non_severe_3;	fev1 (% predicted): 77;	fvc (% predicted): 89;	medication: Becotide, Ventolin;	cell type: CD8+ T-cells",pert
"cell line: hgps-ipsc_2: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository and reprogrammed using the protocol below.",pert
striatum_wild type_6 weeks_replicate 3,ctrl
Pfeiffer BCL6siRNA 1,pert
age: 48;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
A504 MI 7 day,pert
MDS patient 74,pert
MDS13,pert
RNAi -Transgenic replicate 13,pert
PIK3CA.DMSO.1,pert
cell line: CL-0;	transfection: YWHAZ vector,pert
age: 28dpp;	genotype/variation: wild type;	tissue: testis,ctrl
sample =XCGD1 treatment=Stimulated time=360 (min),pert
"patient 6, arm treated with pimecrolimus",pert
Diaphragm 7 Day mdx rep 2,pert
PGA-HMO-NonObese-4aUA-s2,ctrl
cell line: BT474;	cell type: breast cancer;	lapatinib sensitivity: lapatinib-sensitive;	her2 status: HER2-positive;	treatment: DMSO,ctrl
Control biological rep2,ctrl
"MCF-7 cells-control, biological rep 3",ctrl
Patient 3 after folic acid,pert
Tendon_non-lesional_rep19,ctrl
CA97-14A,ctrl
Individual_511_PP_sample,pert
"schizophrenia, BA46-7",pert
patient: 40875;	sample: normal,ctrl
Tmod3 WT-1,ctrl
heterozygot FH P282,pert
Genotype: Rb null MEFs;	Primary mouse embryonic fibroblasts (MEFs) generated from embryos at E13.5,pert
5251 UC Uninflamed sigmoid colon,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 46 years,pert
"disease state: Nasopharyngeal carcinoma;	stage: IIB, T1, N0, M0, G4",pert
"control, BA46-105",ctrl
Gene expression profiling of Phgdh knockout embryo wild4,ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 1",ctrl
"fibroblast, wild-type, untreated, biological replicate 3",ctrl
Individual_4977_NN_sample,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 9.883;	Ratio: 2.1,pert
E12.5 heart_Sp3 knockout_sample c,pert
Diagnosis: AML M4;	Age: 53y ;	Gender: Male;	Blast %: 65;	Source: BM;	Cyto: No Data;	FLT3 ITD: No Data;	FLT3 TKD: No Data,pert
brain_OFC_control C_mr206,ctrl
subject: 35;	disease: CP;	muscle: ST;	gender: M;	age: 5.9;	gmfcs: 5;	popliteal angle: 130,pert
WT 0h TPA rep2,ctrl
Parkinson's disease sample x118,pert
EBS_6,pert
"BMMCs from NTAL WT, noninfected, 2 h activated, biological rep3",ctrl
Msgn1_12hPlusDox-biological rep2,pert
03_NOR,ctrl
THRA aI mutant + vehicle replicate 1,ctrl
SA_291,pert
Sarc_2,pert
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 100;	Usage number: 4;	Exposures: 3,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: E18.5;	genotype: Igf1 +/+,ctrl
KN-smoke-high-5 month+1d-R1,pert
HepG2-control-3,ctrl
155A,ctrl
P14 - Lis1cko/ko 3,pert
"acutely admitted, severely psychotic schizophrenia patient  A03",pert
Haloperidol treated 12weeks AffyGC RMA rep7,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.27123,pert
liver_QH2_6M_rep1,pert
Sex: female;	Age: 14;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
3 Ctrl 3,ctrl
array 3 plus E,ctrl
KO_IL-6_400_rep1,pert
Untreated CLL1,ctrl
MCF10A 7days,ctrl
WFS1 KO USHT_18_330_wt,ctrl
AhR-KO1 melanocytes,pert
220/4,pert
age_years: 31;	sex: F;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
Control Day1 (328R),ctrl
"Gender: Female, Age: 28, BMI: 30, Tissue: luteinized cumulus cells",ctrl
brain_healthy_control_sampleid_jg1745,ctrl
MDA-MB-231-ZNF217 cell culture 1,ctrl
"0mg/kg/day PFOA, Rep 2, Block 1 liver (high dose)",ctrl
"ALL_NDS, K40 012109",ctrl
KU_26N,ctrl
cell line: RT112;	transduced: FGFR3 shRNA 6-16;	doxycycline treatment: yes,pert
non-CF subject 35,ctrl
A673_CloneAsp14_Dox_96h_1,pert
whole tissue section from case 140,pert
Individual_3140_PN_sample,pert
CME-LaminA0d-1MA-S2,pert
age: 40;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"Healthy control, biological rep4",ctrl
H20_S_B2,pert
V5-P596,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 67 years,pert
Sex: female;	Age at operation: 85 years;	Site: lower arm;	Size in cm: 11x8x4;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
Prostate Cancer_MS 36D8,pert
strain: C57BL/6J;	genotype/variation: wild type,ctrl
wt Ang4,ctrl
INSENS 6 4hr,pert
"human failing LV myocardium, Ischemic84",pert
MCL_IGHV_MUT (R1629),pert
NIH3T3_0h_exp1_rep2,ctrl
"patient 14, baseline",ctrl
E12.5 heart_wildtype_sample b,ctrl
Subject #8012-8hr Postinfection,pert
BM_030065,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 62;	gender: male,ctrl
DS1-iPS 5,pert
IkkβF/F_replicate2,ctrl
PFC S control 4,pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. E2 + 1 uM vehicle (ethanol) for 24hr;	batch: 2,pert
ApoD KO+PQ rep_2 (PQKO2),pert
Retina homozygous KO 42 days 3,pert
8 Week Heart Control rep 1,ctrl
NOMO-1_ZFX-SH3,pert
cell type: prostate cancer cell;	cell line: LNCaP;	transfection: MED1 expression vector,pert
PND28 Rat Testis_Rat230-2_3hr MEHP_Animal#49_04005,pert
MDS patient 16,pert
HepG2-control-1,ctrl
Parkinson's disease sample x186,pert
"Peripheral blood, patient without recurrent events [N30]",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-sp2,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 26;	gender: male;	years of disease: 1 y;	treatment: phototherapy;	time: mid-UV,pert
LIVER_CONTROL_repl5,ctrl
Hepatic reductase null N8,pert
"wild-type DP cells, biological rep 2",ctrl
7ILC_normal_ductal,ctrl
SENS 7 4hr,pert
Strain: C57BL/6; PGC1beta mutant mouse; Tissue: quadriceps muscle,pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 71;	age-at-onset: 65;	geographical origin: Porto,pert
Cdx2_E1,ctrl
APOE_KO_RAGE_KO_DM_9W_10,pert
Normal cortex of patient 233,ctrl
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: BETAFERON;	time: 12 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
cell type: Human melanoma cell line;	cell line: M229_R5;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
Normal Adrenal Gland (AN18),ctrl
patient: 51084;	sample: normal,ctrl
"Cadmium 0.2 µM, biological rep4",pert
"UACC903, 48h treatment with 5 AzadC",pert
NOMO-1 STK33-2081,pert
Cavin-1/PTRF KO #157,pert
"Primary aortic endothelial cells, Non_transgenic_control_2",ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 8 hrs;	time course: 3,pert
siERK2E24h_2652,pert
unaffected brother,ctrl
Myoblast-GATA4-Wt-day3-1,ctrl
MDS22,pert
Panc0504 rep-1,pert
MLL_00127,pert
"wdNHBE with BN/59 at 36hpi, biological rep2",pert
SKM WT3,ctrl
background strain: C57Bl6;	genotype: Polgtm1Lrsn+/+;	tissue: Mouse bone marrow;	age: 32 weeks;	gender: female,ctrl
strain: C57BL/6;	genotype: RORalpha1delDE;	replicate: 1,pert
"siNC-BMSCs , biological rep1",ctrl
Preglaucoma control rep10 (OHN),ctrl
"Gender: female, Age: 39 years, Tissue: VIN 3",pert
H1299_shPTK7-2,pert
Healthy-3 baseline,ctrl
Lung from SM22-dnBMPR2 inducible transgenic females activated 8 weeks,pert
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep5,pert
BN DES-treated replicate 1,pert
A549_siZMPSTE24_rep.1,pert
"wildtype pancreas, biological rep4",ctrl
IGF,pert
M238_A_PLX,pert
1083PBMC,ctrl
"Patient M030-161C, MSI colorectal tumor",pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.93;	choa: 184;	fata: 14;	eea: 1070;	wtkg: 62.6;	perfat: 33.6;	lbm: 38.9;	fat_mass: 2103.36,ctrl
PBMC from T cell LGL leukemia patient #115 (TLGL115),pert
SeroNeg-8,ctrl
Postmenopausal female. Tibolone treated. Patient 32.,pert
cell type: CD4+CD25+;	strain: C57BL6;	genotype/variation: fl-DNMT1/Foxp3cre,pert
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 24 months;	genotype: Wild type,ctrl
non-CF subject 37,ctrl
colon_adenoma_1115,pert
"Lesional ear skin from K14-Areg mouse, biological replicate 3",pert
"Liver from control mice, biological replicate 3",ctrl
patient: 428;	disease state: LGSC;	component: Invasive,pert
Wild-type ESCs Rep2,ctrl
Aorta-APOE-deficient and vitamin E treatment-rep1,pert
cell type: Transcriptional 2 Follicular Progenitor (T2-FP) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: WT,ctrl
WT2-iPS 3,ctrl
mouse cerebellar granule cells knockout 3,pert
"patient 11, arm treated with pimecrolimus",pert
BP patient 96_biological replicate 2,pert
gender: female;	age (years): 54;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
strain: SW129/C57BL/6J  cells;	genotype/variation: c-jun knock out;	cell type: B-lymphoid,ctrl
Patient: K;	Time: 1 week;	Group: responder;	Condition: lesional,pert
"Wild-type HFD 8 weeks, biological rep6",ctrl
H441 transfected with scrambled siRNA 2,ctrl
monolayer chondrocytes from normal donor 1,ctrl
MF-25,pert
blood-derived macrophages,ctrl
Cont subject 10,ctrl
57A;pretreatment;female;breast tumor; responder,ctrl
11103 UC Uninflamed descending colon,pert
wild type MEF time 48 replicate 1,ctrl
cumulus_PCOS_Obese_rep7,pert
Silberg2 (S10) 25091NE,ctrl
Normal cortex of patient 111,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-sp3,pert
PBMC_C2,ctrl
b76,ctrl
"S1P3-KO-neocortex, biological rep3 (female)",pert
Hippocampus 1986 15 month Old,pert
"p38alpha knock out fetal liver E15.5, biological rep3",pert
WT #179,ctrl
Liver sample from Alcoholic hepatitis group (CA45),pert
CON20,ctrl
nt control 8,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 48h",pert
cell type: AML blasts;	fab classification: M4,pert
cell line: HEK293T;	transfection: si-TNIK;	induction agent: Wnt3A;	induction time: 4 hours,pert
cell line: MLL-AF9 AML cell line 10980 (Zfx wt);	treatment protocol: +OHT;	genotype/variation: wt,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.701;	OD280: 1.82;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 354;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 49;	maternal age: 36,pert
Brain_Adult_LPSip_4hr_mouse3 (YL3_#66),pert
WT White adipose tissue (WAT)_HFD_rep1,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: Vemurafenib 1000 nM for 72h,pert
chip number: 18;	transfection plate: 3B;	target gene: ESRRA;	kd level: 0.83;	rin: 9.3;	transfection date: 2012-03-26,pert
Sex: female;	Age at operation: 85 years;	Site: lower arm;	Size in cm: 11x8x4;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
gender: Male;	tissue: Tendon;Patellar;	age: 32;	donor: 15;	disease state: Lesional,pert
patient: 51677;	sample: tumor,pert
"strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
H_Ctrl_3,ctrl
EOM 28 Day mdx rep 3,pert
umbilical cord_nobpd: 2C,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 5 days osteoblast differentiation,ctrl
WT_MEF_rep2,ctrl
siHic5_2_0h_2,pert
S-IIP(UIP)8_Cy3,pert
G_Ctrl_2,ctrl
31SAGEA,pert
"Age: 3 months, Sex: Female, Retina: left, Final IOP (mm Hg): 18.2, Strain:DBA/2J",ctrl
mouse B6xCF-1  RNAi transgenic,ctrl
tissue: prostate tumor;	genotype: Pten null;	age: older than 20 weeks,pert
TTE3 cells treated with BPA for 12 h-2,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 pM;	treatment time: 48 hours,pert
Wildtype (untreated) 5176,ctrl
PBMCs_Control_11 [IS],ctrl
Bone-Marrow_MM_M1111,pert
3381-scrape,pert
Diaphragm 112 Day mdx rep 2,pert
cell type: embryonic stem cells;	genotype/variation: control,ctrl
Squamous cell carcinoma 007,pert
E12 ko.2,pert
microdissected breast cancer cells from case 1368,ctrl
Placenta_PE(EO)4,pert
PKBa-/- MEF time 6 replicate 2,pert
"Rad21 esiRNA, biological rep1",pert
brain_DLPFC_bipolar B_mr867,pert
"Patient 116, 24 month of REBIF",pert
BL150,ctrl
"Vehicle treated,  doxycycline treated; biological replicate 3",pert
02_NOR,ctrl
Run1.a10a.000607jd.2.SkMNor918.CEL-IS stimulate,pert
R6/1 18 week wildtype_F272,ctrl
"Crohn's Disease subject (41 year old caucasian female, SAK_1304662648)",pert
nmMLCK-/- -SB replicate 3,pert
OCI-Ly1_sictrl,ctrl
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 32;	maternal age: n/a,pert
umbilical cord_nobpd: 7D,ctrl
Normal-N_LJ_5,ctrl
Muscle Tro3,pert
695_383_0hr,ctrl
"Scd1 knock out mouse, Harlan Teklad TD03045 diet, liver",pert
HC-WT-23B,ctrl
RNA from HCC_39T,pert
"spinal cord, ventral spinal cord: EP144/L - G93R(Roth)/e14-mutant hSOD1_le2",pert
Empty Vector Control for transient transfection replicate 1,ctrl
GFP Zfx ko 3,pert
Leg 23 Day mdx rep 3,pert
3433-lcm,pert
"human failing LV myocardium, Idiopathic51",pert
04SAGEA2,pert
"8 weeks old sex age matched littermates, lung typeII cells",pert
"Mdr2-KO homozygous mouse, 12 month old mouse 3",pert
tissue: white blood cells;	age: 11.58;	Sex: female,pert
0-WT,ctrl
Healthy Donors 3,ctrl
3264-lcm,pert
BL Day 2 siMut12 transfected biological rep1,pert
"106, ADIPOOSE TISSUE, Before",ctrl
siCtrl_FM_rep2,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L017,ctrl
WT B,ctrl
"schizophrenia, BA46-44",pert
"brain, hippocampus: KA-6h-P15-III_e1_le1",pert
"20 days old prosaposin knockout mice, cerebrum",pert
Disease_status: Healthy control;	Age (years): 31;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.13;	Post mortem interval (hours): 11;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
"Deltoid, control, cohort 20, subject 20U",ctrl
Papilloma_tumour_epithelial_cells_Sox2cKO_rep2,pert
liver_co_14M_rep1,ctrl
Untreated Jurkat cells (replicate 3),ctrl
NL E,ctrl
c_NY102,ctrl
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.34 uM (2 x EC50), biological rep3",pert
MDS patient 91,pert
strain: MBT/Pas;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: non-infected,ctrl
JGB-Pre-1UP_Run2-S2,pert
MCF10A_HER2_1,pert
BE-rep10,pert
Control_Time_0_1,ctrl
231_Empty_rep2,ctrl
"testis wt, 14dpp, Rep2",ctrl
GV oocyte_Rnf2 mut_rep1,pert
brain_DLPFC_bipolar C_mr418,ctrl
"Human lung carcinoma H1299 cells (p53 null, no p63 expression) Tet-on",pert
HUVEC_1h_rep2_1107,ctrl
tissue: retina;	age: postnatal day 6;	genotype: wild type,ctrl
"human failing LV myocardium, Idiopathic42",pert
"CD4+ splenocytes at 6h, biological replicate 1 sham-5",ctrl
"DMD skeletal muscle, biological rep1",pert
"siTERC-BMSCs, biological rep3",pert
DC2 AM,pert
S259A-2,pert
WT Hippocampus - 2,ctrl
patient id: 209;	tissue: Normal cortex;	gender: Male;	age: 63;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
Disease_status: Bipolar disorder;	Age (years): 19;	Gender: Male;	Age of onset (years): 17;	Duration of illness (years): 2;	Brain pH: 5.97;	Post mortem interval (hours): 12;	Side of brain: Right;	Fluphenazine mg. Equivalents: 2000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
"Age: 45;	Sex: M;	Ancestry: African;	Smoking status: smoker, 24 pack-years",pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: none;	time: 24hr,ctrl
batch: A;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,ctrl
Rybp#15 (OHT-)_4d_rep2,ctrl
"DMD skeletal muscle, biological rep14",pert
LT-HSC Zbtb7a F/F Mx1-Cre+ #2,pert
strain: C57BL/6N;	genotype: wildtype;	tissue: liver;	age: 5-6 months;	gender: male;	treatment: mock,ctrl
SKMEL28_t6h_rep3,pert
strain: C57BL6J;	genotype: H3f3b WT/WT;	age: E12.5;	tissue: 1 of 2 mouse testes,ctrl
lesion_midUV_patient8,pert
KM_009N,ctrl
"MGSKO, PR03M007v0",pert
E8.5 ko.1,pert
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: none,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case4,ctrl
"seminoma specimen, pT2, patient age: 45y",pert
strain/background: C57BL/6;	genotype: wild-type;	tissue: anterior prostate;	age: 12 weeks,ctrl
24h PTD-DRBD GAPDH siRNA (SAMPLE 9),pert
siSPDEF_3,pert
"Cell type: neuronal, age:47, gender:female, diagnostic group: schizophrenia, PMI:35h",pert
gender: Male;	age: 72;	post-mortem delay: 12h;	ph: 6.8,ctrl
P1 mouse eyeball extracted total RNA_wt2_GSM618316,ctrl
condition: Psoriasis;	patient: PS-M;	tissue: LS skin biopsy;	kit: Affy,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 46.70685,pert
microdissected breast cancer cells from case 1419,ctrl
Individual_4607_NN_sample,ctrl
brain knock out replicate2,ctrl
strain: C57BL/6;	genotype: Nrf2 KO;	gender: Male;	age: 9 weeks;	tissue: kidney;	treatment: intraperitoneally injected with a single dose of vehicle (saline),pert
tissue: neonatal foreskin;	cell type: primary dermal fibroblasts;	shRNA transfection: shKDM4C construct 1,pert
23: FCHL patient #99-0562,pert
Prostate Cancer_MS 36C9,pert
monocytes_Q10H2_3,pert
Control male 8,ctrl
healthy control sample x117,ctrl
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep3,pert
OVCA433+(1),pert
strain: 129SV;	gender: male;	genotype/variation: SIRT4 KO;	tissue: liver,pert
"strain: B6.129P2-Il10tmlCgn/J;	genotype variation: Il10-/-;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 72 hours;	agent: ozone;	exposure dose: 0.3 ppm O3;	test article cas no: 10028-15-6",pert
Individual_3059_PP_sample,pert
Mtb infected-42d-5,pert
Individual_3937_PN_sample,pert
pMX-jhdm1b no vitamin C Jhdm1BVc-_2,ctrl
db/m 8wk 3,ctrl
neuron_rep16,ctrl
"shKDM4C 2, clone 2, rep 1",pert
Tet2 KO CFU 5th rep1,pert
"age at diagnosis: 39;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: 0;	pgr: 0;	dfs-month: 15;	dfs-event: 1;	distant metastasis: 0",pert
CD-45-un2,pert
C7 Control None,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#131,pert
patient: 40977;	sample: normal,ctrl
prostate normal 6,ctrl
V5-P391,pert
STAT3-deficient naïve T cells stimulated for 3 hours with medium alone 1,pert
KGN Control  [RR1009],ctrl
PGA-MAH-AJ_OVA6h-1aA-s2,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 21.8274,pert
INSENS 1 0hr,ctrl
phenotype: alcoholic;	gender: female;	case_id: 327;	age: 59;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 19.5;	brain ph at time of freezing: 6.63;	labeling_batch: 1,pert
SR-A mutant olfactory epithelium 0 h replicate1,pert
whole tissue section from case 25,pert
PPC1_CBFbeta shRNA replicate 2,pert
"fibroblast, MFS subject 60FR rep 3",pert
Control Day14 (457L),ctrl
Cadherin-11 siRNA (RNAi 4A)_1of2,pert
01MLF_PolyRF+,pert
"RNF40 siRNA - Undifferentiated, rep3",pert
GM19238_Kd_IRF9_2,pert
cell type: Primary hepatocytes;	strain: SV129;	agent: Wy14643;	time: 24h;	gender: Male;	age: 4 months,pert
Human Uninfected Sample N001-CD8+ T cells,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 8d ID222,pert
tissue: brain;	genotype: mutant Ndel ko/+ inbred;	age: P0,pert
Cutaneous psoriasis without arthritis PsC 15,pert
Individual_4288_NN_sample,ctrl
cerebellum wild type 21 month replicate 3,ctrl
"control, BA46-35",ctrl
cerebellum_WT_18w_rep2,ctrl
condition: Psoriasis;	patient: PS-E;	tissue: LS skin biopsy;	kit: Affy,pert
"patient: 209;	current medication: AZA 150mg/d, Mesalazine 800mg TDS;	birth date: 3/27/80;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 10/15/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/15/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
DMN-CtrHippo20d-2aAv2-s2,ctrl
BM CD34+ Pool II,ctrl
7N,ctrl
S9,pert
CTL2 E2 8hr,pert
"A673 treated with Doxorubicin for 3 days with concentration of 59.88 nM (EC50), biological rep3",pert
TF_1_shTRAF6_d2.5_rep2,pert
AVC_control_rep4,ctrl
pt. HCL F treated with Vemurafenib 1000 nM for 48h,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M2;	flt3 status: WT,pert
wild-type tumor #3152,ctrl
01LSD_ERA,pert
pool of thyroids from 10 months old RET-PTC transgenic mice,pert
brain_DLPFC_bipolar B_mr943,pert
strain: C57BL/6;	genotype/variation: Smchd1 wildtype;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: A,ctrl
race: caucasian;	age (years): 75;	stage: IB;	grade: 2;	histology: endometrioid,pert
Normal-ERα-positive breast cancer 5,ctrl
"proband a, before exhaustive exercise",ctrl
HA01-57B,pert
cerebellum_PS-/-_ 20d_rep2,pert
25 weeks male,pert
parental Ainv15 ESC differentiated as EB for 10 days,ctrl
"lymphoblastoid cell line from T9.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
N40728_rep,ctrl
09_C57_KO,pert
V5-P296,pert
ns DHT 2,ctrl
BC-036,pert
AL Chip#47,pert
IM CD34+ Pool I,pert
Mening SWB WB NP 1b,pert
Normal-ERα-positive breast cancer 25,ctrl
WTGFP QSC Biological Rep.3 Technical Rep.1,ctrl
"Patient H-c661T, MSI colorectal tumor",pert
"human failing LV myocardium, Idiopathic76",pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_10 months_replicate 1,pert
Bronchial Epithelial Cells MMA biological 0667E,pert
cell type: CD43+/41+/235+ progenitors generated from euploid iPSCs,ctrl
SON siRNA rep3,ctrl
chip number: 13;	transfection plate: 3B;	target gene: E2F6;	kd level: 0.64;	rin: 9.4;	transfection date: 2012-03-26,pert
cell line: THP-1;	disease state: monocytic leukemia,pert
sample: #10;	subject: Control case #4;	brain: T-779;	age: 76;	sex: Female;	region: Inferior Olivary Nucleus,ctrl
Clinically localized primary prostate cancer P1,pert
tissue: skin;	individual: Patient P6;	condition: ANL;	eczema severity: SCORAD: 0,pert
AA_Control4_CD8,ctrl
GIST Pre Treatment Biopsy 28,pert
Rejecting allografts 7 days No.1,pert
PTEN25+_rep1,pert
Mid Secretory Phase Normal,ctrl
"seminoma specimen, pT1, pN1, patient age: 42y",pert
FVB_6h_Wy,pert
liver-AHRKO-cornoil-rep2,pert
HK12B5,ctrl
"siSCR neuron, biological rep1",ctrl
"Empty vector control, 24 hrs, No Rosiglitazone (NONE_24_2)",ctrl
THRB bN mutant + vehicle replicate 2,ctrl
Human Acute HIV Sample A064-CD4+ T cells,pert
TTP_KO_0ActD_BioRep3,pert
patient: 23;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
wtPrE serum 3,ctrl
HTH83 LAMC2 KO 3,pert
"E18.5 brain, wild-type, rep 1",ctrl
LCL Concordant for Epilepsy twin pair 3 (CCE3.1)(TP35),pert
"Strain: C57BL/6 X SV129, Age: Embryonic Day 14.5, Tissue: Palatal Shelves",pert
"Hdh knock-in embryonic stem cells, Q50 line, biological replicate 2",pert
"WT, PR03M004v0",ctrl
2IDC_normal_ductal,ctrl
EBS_4,pert
Aorta_non-transgenic C57BL/6J control_2,ctrl
MCF-10A shATM-1 replicate 1 [set 5],pert
Control (C286),ctrl
ALI patient #4,pert
whole tissue section from case 868,ctrl
prostate_Klf5 wt_rep2,ctrl
Liver_Control _Rep2,ctrl
T41027_rep,pert
Hippocampus_NaiveControl_rep2,ctrl
HW_453,ctrl
E2A-deficient DN2 replicate 1,pert
shRNA2-4-noDox-rep3,pert
med2d_3,pert
Human prostate cancer primary culture C45,pert
MDS patient 46,pert
NonIR-KO_Rep3,pert
Control subject 102_biological replicate 2,ctrl
"human failing LV myocardium, Ischemic64",pert
WKY20-3,ctrl
Mouse RSK2 mutant mandibular molar [ABH_26A],pert
Nod2-/- 3,pert
MDS patient 97,pert
Diseased individual (ulcerative colitis) of twinpair #6,pert
Testis CREMKO 0h batch 2 [TeKOh00.12],pert
Hippocampus_Soman_3h_rep2,pert
MDS patient 166,pert
colonic_mucosa_non_inflamed_881,pert
FHCRCAML_2762,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_6h_Con_HG-U133A_2_YCHSUP501,ctrl
Liver Pio1,pert
HN_122,ctrl
tissue: normal skin;	urticaria status: non-afffected;	patient: 12,ctrl
MDS patient 153,pert
"Patient 25, Atheroma plaque",pert
Wild Type 612,ctrl
RPE65_KO_2months_retina1,pert
Carbo Day1 (408R),pert
Ero1-WT induced biological repC,pert
"Wild type, 2 month old male mice parietal cell",ctrl
Muscle PCOS control 3,ctrl
jzo004-v5-u74av2-met,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 334;	age-at-biopsy-years: 42,ctrl
ILD Study Number S012,ctrl
PBMCs enriched for CD8+ cells from normal control subject J,ctrl
Normal Caucasian control 4,ctrl
SLE CD19 B cells 12,pert
BCell_lymphoma_marginal_sample5,pert
"Normal cervix epithelium, microdissected, Age 42",ctrl
WT_TER119+_rep3,ctrl
T21_2,pert
Cutaneous psoriasis without arthritis PsC 18,pert
MDS patient 179,pert
"breast, post AF treatment (H24_2259)",pert
shRNA4-1-noDox-rep1,pert
"Patient CCo, stable renal transplant recipients, male, 38 years old, T1 (3 months after the switching of the therapy)",pert
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 5 months;	genotype: Myc heterozygous,pert
Healthy control_sample9,ctrl
Bronchial Epithelial Cells MMA biological 1765J,pert
"0mg/kg/day PFOA, Rep 1, Block 5 lung (low dose)",ctrl
LT 436 +/T untreated,pert
DRG_Capsaicin_10microM_Rep1,pert
E12.5 heart_Sp3 knockout_sample b,pert
"Control cells, rep2",ctrl
KU_38N,ctrl
strain background: 129SvJ;	genotype/variation: wild type;	gender: female;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,ctrl
CA95-198A,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 201,ctrl
day: d00;	strain: C57BL/6;	genotype: KO;	experimental run: e0,pert
LSK cells from heterozygous JAK2V617F mouse rep2,pert
"RWPE-PCAT1 NT siRNA, replicate 2",ctrl
Cyclophosphamide-treated spleen 1 day - Biological Replicate 2 - Technical Replicate 1,pert
11105 UC Uninflamed descending colon,pert
BM_postTherapy_IIb,pert
CH1802,pert
human_hepatocyte_400uM_grepafloxacin_donorA_24hr_prep2,pert
genotype: E-mu-BRD2;	cell-type: lymphoma_transitional;	splenomegaly: severe;	Ig clonality: oligoclonal,pert
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 18 weeks;	genotype/variation: control",ctrl
0175-01-C,ctrl
466MM,pert
fully differentiated (day 6) myotubes,ctrl
RatLung_H3h_3,pert
EA_Case19_CD8,pert
03_C57_KO,pert
6_DMSO-6,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 72,pert
male;	48 yr old;	White,pert
B137+,ctrl
"12 weeks old PS-NA mice, cerebellum",pert
Normal_MS 36D5,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 5;	gender: male,ctrl
prostate normal 4,ctrl
Monocyte control rep 1,ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 4",ctrl
NoKD_rep2,ctrl
chip number: 19;	transfection plate: 5;	target gene: RELA;	kd level: 0.68;	rin: 8.9;	transfection date: 2011-10-17,pert
JIA PBMC Post treatment A235_L015(2),pert
"Normal Skin, Normal-19",ctrl
Kidney_saline iv_mouse #006,ctrl
Tolerizing allografts 7 days No.2,ctrl
Preglaucoma control rep2 (OHN),ctrl
strain/background: C57B6SJL;	genotype/variation: wild type;	age: 8 months;	tissue: liver;	disease status: healthy,ctrl
LY2 SRC1-siRNA tamoxifen treated rep1,pert
"ARD531, CAIS, F, GOF, 6 x 100nM DHT, 14d",pert
Control + LPS 4,ctrl
PGA-MPF-C57-bleo-24h-3bAv2-s2,pert
sample type: normal breast cell line with stably transfected full-length chimeric human HER2 receptor with FKBP and HA tags;	cell line: MCF10A;	treatment: TGF-alpha,pert
"Mouse stable invitro iTreg cells, replicate pool 1",pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 46;	gender: male;	tumor grade: IV,pert
OSCE-8T,pert
MDS patient 177,pert
Psoriasis-5 baseline,pert
Embryonic age 17.5 wild-type rep3 (PKD1_41),ctrl
4-HPR_LUNG_3,pert
genotype/variation: MBD1 KO;	tissue type: thymus;	cell type: medullary thymic epithelial cell (mTECs),pert
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 7,pert
individual: patient16;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
CRC_nodrug_M4870,ctrl
53 year old male,ctrl
"breast tumor epithelium,1",pert
"Pou4f1+/+ cells, transduced with control virus_Wt-MSCV_81",ctrl
C018_Control_F_67,ctrl
H10_P_B2,pert
MPA 5,pert
224 Day 3 siMut10 transfected biological rep1,pert
CON 2,ctrl
"Retina from NeuroD1 cKO mouse at ZT6, biological rep 3",pert
Subject #8042-8hr Postinfection,ctrl
age: 35;	sex: M;	disease status: control subject;	Filter number: 92;	Usage number: 1;	Exposures: 3,ctrl
OTT1 null/wt mouse;	sacrificed at gestational age,ctrl
WT4,ctrl
Testicular seminoma 1113,pert
"nTreg Foxo1 KO, rep1",pert
"cochlea at P60, ko, biological rep 3",pert
E9.5 FVB/N erythroid cells-2,ctrl
Wild type olfactory epithlium 0 h replicate1,ctrl
"heart of mouse, 4 week control (4B)",ctrl
fibroblast_Slow_D223_Media_12,pert
sample F term homo,pert
anti-FGFR1_rep2,pert
Pax_C2,ctrl
BxPC3_JMJD3KD_rep1,pert
FHCRCAML2852,pert
patient id: 265;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 43;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
control mouse WT8,ctrl
Pancreatic Sample 25-Tumor,pert
1705-383_16hr,pert
EO1389_muscle_mutation,pert
A673 cell line that has been treated with Doxorubicin for 5 days with concentration of 59.88 nM (EC50).,pert
genotype: wild type;	cell type: FoxP3+ Treg,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Paraventricular nucleus,pert
maternal diet: Control;	genotype/variation: Cited2 -/-;	strain: C57BL6/J;	developmental stage: Embryonic (8.5 days post coitum),pert
01-0033A_Day1_10,pert
Lrp5 Retina Rep1,pert
Tissue: HepG2 Cells;	Gender: male;	Source: ATCC,ctrl
disease state: healthy control;	tissue: epidermis;	age: 67;	gender: male;	treatment: untreated;	time: control,ctrl
"Wild Type, 3",ctrl
Tendon_lesional_rep23,pert
"human failing LV myocardium, Idiopathic8",pert
"2 months, ipsilateral group, biological replicate 3",pert
gender: female;	age (years): 43;	evolution time (years): 7;	disease extension: Pancolitis;	treatment: Azathioprine,pert
chip number: 19;	transfection plate: 3B;	target gene: POU2F1;	kd level: 0.79;	rin: 9.4;	transfection date: 2012-03-26,pert
CCRPKO-PB_rep-3,pert
cell line: MCF7 breast cancer;	treatment: RL silenced,ctrl
V5-P592,pert
PML Knockout Mice fed Low Fat Diet 2,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M5b;	flt3 status: WT,pert
CD8_T_cell_pool_healthy_H09+H10,ctrl
"brain, hippocampus: KA-72h-P15-I_e1_le1",pert
PGA-MPF-C57-bleo-24h-2aAv2-s2,pert
"WT, rep3",ctrl
07R069 Control,ctrl
A549_siRNA_STAT3_rep1,pert
sample A 18.5 homo,pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Post mortem interval (hours): 28;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
HF0453_U133P2,pert
"Acute Myeloid Leukemia, sample 42",pert
diagnosis: systemic lupus erythematosus (SLE);	tissue: blood,pert
RE550_DU145_Un2,ctrl
"GNMT knockout at 3 month age, biological replicate 5",pert
Substantia nigra PD rep9,pert
strain/background: C57BL/6;	genotype: Pb-Cre4;PtenLoxP/LoxP;	tissue: anterior prostate;	age: 12 weeks,pert
SLE1-TC,pert
07R065 RA,pert
miR122-KO-90,pert
db/db 16 wk 1,pert
E10.5 wt.1,ctrl
gender: male;	disease state: healthy;	tissue: peripheral blood;	cell type: white blood cells;	sample type: matched control,ctrl
siRNA Smc3 + Estrogen [N2],pert
cell line: Hep3B;	treatment: transfected with YAP-specific siRNA,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 8d ID66,ctrl
"P60_C-DGCR8 KO cones, replicate 1 [array]",pert
"Control Day 3, biological rep3",ctrl
Liver sample from Alcoholic hepatitis group (CA47),pert
Wild type no tumor 1,ctrl
erStress_twins_AA_1744twin1_500nM_thapsigargin_4h,pert
control_32hr_rep2,ctrl
strain: FVB/N;	tissue: Skin;	gender: female;	age: E17.5;	genotype/variation: Ovol2 overexpression (Ovol2 BT),pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Typical antipsychotic Haloperidol, Dose: 1.6mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking Water, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation. At the end of the treatment, drug level in the plasma was assessed by Tandem mass Spectrometry LC- MS/MS.",pert
"gender: Male;	age: 41;	post-mortem delay: 8h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
clone type: AtT20 clone types infected with empty vector rep3,ctrl
GIST_KIT_10,pert
Normal-ERα-positive breast cancer 64,ctrl
695-EV_4hr,ctrl
PEC control - replicate 2,ctrl
subject: 18;	disease: TD;	muscle: ST;	gender: F;	age: 17.4;	gmfcs: N/A;	popliteal angle: N/A,ctrl
SLE3-TC,pert
NOD2-L1007fsinsC_0h_MDP_biological replicate 2,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 27,ctrl
UC-33-un,pert
RI45,pert
"P116 ZAP70 negative  0 hours, #3",pert
mouse cerebellum at P7 knockout 2,pert
cell line: HCT116;	clone: 15;	genotype: Wild type,ctrl
race: caucasian;	age (years): unknown;	stage: IA;	grade: 3;	histology: papillary serous,pert
PGA-RMM-30m-2aA-s2,pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep4,pert
umbilical cord_bpd: 5C,pert
shNANOG_8,pert
tissue: Liver;	genotype/variation: Hmgn1+/+;	treatment: injection of 10 µg/g body weight of N-nitrosodiethylamine,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 47;	gender: male;	tumor grade: IV,pert
gender: male;	strain: BALB/c;	tissue: liver;	diet: AIN93G diet for 14 days,ctrl
Individual_4992_NN_sample,ctrl
T30 U133p2,pert
"Atria, Mutant, biological replicate 1",pert
PCOS Endometrium Epithelial Cell_119.PC11_EpCAM,pert
patient id: 42;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 45;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N0M0;	Stage: II;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
FRD1 3,pert
ALI patient #3,pert
Healthy CD4+T cells 5-PS,ctrl
whole blood_100476,pert
"Control_EHL, C4",ctrl
Normospermic individual: Sample N11,ctrl
"ACI strain, male, age 21 weeks, treated with the synthetic estrogen diethylstilbestrol (DES) for 12 weeks",pert
affected status (disease state): control;	gender: male;	age-at-examination: 45;	age-at-onset: n/a;	geographical origin: Vila-Real,ctrl
HMEC X HB2 (0164),pert
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
"Ulcerative Colitis (27 year old caucasian female, SAK_1286587485)",pert
MiaPaCa2 pCEP4 - AGR2 clone 2,pert
myoblast_treated_rep3,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 8d ID143,pert
C5_pitM,ctrl
heart female CVD3 10 dpi rep3,pert
NL B,ctrl
NHE3-/- replicate 1,pert
Control Day0 (451R),ctrl
affected status (disease state): IS patient;	gender: male;	age-at-examination: 46;	age-at-onset: 45;	geographical origin: Mirandela;	clinical characteristics: Hypertension;	lifestyle characteristics: ever drinker,pert
platelet_Ctrl_12,ctrl
"Patient 30, Atheroma plaque",pert
"Strain: C57BL/10J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle Treated with Phosphate-Buffered Saline, Deficient in Dystrophin",ctrl
patient id: 26;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 77;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N0Mx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
H69_TGX221_3,pert
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Post mortem interval (hours): 18;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
MCF-7_parental_cell_rep_2,ctrl
THP1-shGSK3A-Construct6-rep2,pert
cell type: myeloid monocytic cells;	protocol: 28h medium,ctrl
Disease_status: Healthy control;	Age (years): 68;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.3;	Post mortem interval (hours): 13;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
3416-lcm,pert
WT STR PDE10i 12,pert
Mouse E10.5 urogenital epithelium -/- #2,pert
liver_QH2_14M_rep2,pert
HCC016N,ctrl
strain: C57BL/6J;	day: 15;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
2965M patient's mucosa,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: tumor;	sample name: 2-tu3,pert
genotype/variation: Pou4f1+/+;	agent: control virus;	tissue type: fetal liver,ctrl
MDS patient 48,pert
"Muscle from DS, biological rep1",pert
"Human male subjects with familial combined hyperlipidemia (FCH), peripheral blood monocytes",ctrl
"Placebo treated, HIV-1 positive male, day 14 (8)",ctrl
adult male,ctrl
"brain, cerebellum: RNA#36_le1",pert
ILD Study Number 1098,pert
tissue: pancreas;	cell type: epithelial cells;	disease status: normal,ctrl
Patient: O;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
cell line: SC263;	treatment: PBS,ctrl
A3_scrb,ctrl
sirna: NT control;	cell line: TOV112D;	cell type: Ovarian cancer cell line,ctrl
"210, ADIPOOSE TISSUE, After",pert
F9 con sample #2,ctrl
strain: C57BL/6J;	day: 24;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 1,ctrl
CD4_T_cell_pool_melanoma_M03+M04,pert
U-87MG-PK7 set 1,pert
4 hr KLF4 Time Course Control,ctrl
48h_c3,ctrl
Muscle PCOS 25,pert
"Rat liver, treated with NMF, 1000 mg/kg in saline i.p., extrated 48 hours after treatment, biological rep1",pert
"KO total RNA LSK, rep 2",pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 75;	Usage number: 1;	Exposures: 4,pert
HeyA8+(1),pert
BALB/c_PBS Replicate 3,ctrl
S-IIP(UIP)9_Cy3,pert
WT_4,ctrl
HCC018T,pert
CF knockout HMCF CHN310,pert
Patient: I;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
CEM11_T2_PP_day0_038,ctrl
Braf 3,pert
Control Endometrium Endothelial Cell_036.UC209+-,ctrl
8 Weeks  Heart MDX rep 1,pert
Hematopoietic Stem Cells,ctrl
KU_03T,pert
BTBR-ob/ob;	Soleus muscle;	Age: 14 weeks;	Gender: Male,pert
MDS patient 44,pert
CDF1-p3 (179msn),pert
T40899,pert
patient: 4;	disease state: hypertension;	tissue: Atheroma plaque,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.89;	choa: 197;	fata: 43;	eea: 1380;	wtkg: 61.8;	perfat: 26.9;	lbm: 43;	fat_mass: 1662.42,ctrl
CML_7_GMP,pert
Mouse RSK2 mutant mandibular molar [AZN_MolairesMutant4],pert
"Chromium 1 µM, biological rep1",pert
PsOEt-16-Week 12,pert
patient code: 91;	gender: Female;	age: 51;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,pert
2933-ls,pert
tissue: minor salivary gland;	disease status: moderate SS,pert
age: 48;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 69, stage IIB, HPV 16",pert
autism with FMR1-FM AU039304,pert
"human failing LV myocardium, Ischemic79",pert
MDA-MB-231_TR6194: transfected with a vector containing a shRNAs against CD146,pert
NB4 INFECTED 3,pert
Mouse_Retina_P7_Control 2,ctrl
Empty vector control (RNAi 1B)_2of3,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#120,pert
MCF-7 +scrambled siRNA + vehicle rep1 (MD31),ctrl
SKI-DLCL cells_AraC 20nM_24h_rpt3,pert
"Cell culture. A549 treated by MK886, control 1",ctrl
Gender: female;	Age: 10 weeks,pert
Individual_5258_PP_sample,pert
TOV112D cells_untreated_biological rep1,ctrl
cell line: HCT116;	shRNA: CDK19;	treatment: low glucose,pert
con-11_C,ctrl
"Cerebral Palsy, Gracilis, Patient Replicate 10",pert
B6 Control R2,ctrl
wild-type mouse 1,ctrl
Cochlea_WT_9mo_2,ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 4;	biological rep: 2,ctrl
MCAD + LPS 3,pert
Liver_WT_Vehicle_Rep2,ctrl
NIXKO6 SPLEEN,pert
Infected Jurkat cells (replicate 3),pert
nucleus accumbens ctrl replicate 1,ctrl
striatum_wild type_6 weeks_replicate 2,ctrl
Chronic plaque 1 (CP1),pert
reduction mammoplasty patient 368,ctrl
WT1(-KTS) expression induced for 4 hrs 01-14-03_Lee_U133A_4_2,ctrl
Gnmt_WT_1,ctrl
wt_P8_rep3,ctrl
Knockdown Cell Replicate 1,pert
Against CDK19-2 rep2,pert
"MCF7/BUS, 100 pM E2, 48 hours, biological replication 1",pert
Mtb infected-42d-6,ctrl
IFN_Gamma_24hr_rep4,pert
"ALL_NDS, K61 011509",ctrl
"expression at 16hr, bio rep1",pert
"Deltoid, FSHD, cohort 12, subject 12B",pert
ES2 COUP-TFII-5 25nM,pert
E12.5 Vax2-/- 1,pert
17: NORMAL #99-0160,ctrl
duration of untreated disease in month:6.1;	age at onset:1.8,pert
1065-03-C,ctrl
817PBMC,pert
"Wild type, biological rep 3",ctrl
mutant_POST_PDE_046,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.15;	OD280: 0.539;	Ratio: 2.03;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 217;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
V5-P522,pert
NOD/LtJTCE liver sample batch 4,pert
tissue: normal skin;	urticaria status: non-afffected;	patient: 13,ctrl
CDKI-73 CLL3,pert
cell line: OVCA420;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
Endometrial stromal cell - control/vector 1,ctrl
Muscle JDM (YJD-JDM-6UA-s2),pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M1;	flt3 status: WT,ctrl
Wild-type CS_12_29_1_WT_1,ctrl
Basal IFE epidermal stem cells from WT mice 3,ctrl
"BMMs, untreated control, ko, Replicate 2",pert
"twin pair: #12;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 5d ID215,pert
"0mg/kg/day PFOA, Rep 4, Block 4, liver (high dose)",ctrl
Ishikawa_Control_24h_rep4,ctrl
Normal esophageal epithelium (N5),ctrl
Native-0-5,ctrl
COP DES-treated replicate 2,pert
"strain background: mixed C57BL/6, FVB, 129 background;	genotype/variation: BrafV600E::Pten-/-::Pdk1-/-, Pdk1 knock out;	tissue: tumor",pert
LT 342 +/T untreated,pert
Day: 18; Drug: Saline; Phase: Withdrawal; Replicate: 3,ctrl
WT #1,ctrl
Conditional Sample 3,ctrl
12_MLN8237-3,pert
293TsiScram-1,ctrl
01N0Y: new onset sJIA,pert
NB4 CONTROL 2,ctrl
TP06-987,ctrl
db/m 1-2,pert
"Transgenic, snap frozen, tibialis anterior muscle, 7month age animal",pert
C4 patient,ctrl
KM_025N,ctrl
"vestibualr organ at P90 of Igf1 -/-, biological rep 3",pert
Normal PBMC Sample 2,ctrl
"brain, hippocampus: C240-II_e1_le1",ctrl
INHA1,pert
"brain, hippocampus: KA-240h-P15-II_e1_le1",pert
"Cervical cancer cell line, ME-180, Human, squamous cell cancer",pert
V5-P092,pert
"female Spargue-Dawley rats, 9-cis-retinoic-acid, 100 mg/kg diet for 7 days,  tissue: lung",pert
control replicate 1,ctrl
disease state: endometrioma;	patient: 6,pert
Mannitol_2,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 48 yr;	population: white;	dsm-iv: 296.7;	age of onset: 33 yr,pert
"Cerebral Palsy, Gracilis, Patient Replicate 8",pert
DS1-iPS 3,pert
WT Littermate2,ctrl
sex: Male;	family: 5;	age: 38;	disease status: Affected;	tissue: Muscle: Biceps,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 14 months,ctrl
Cardiac Muscle_WT_rep3,ctrl
Skinbiopsy_7hoursnickel_controlsubject_k3,ctrl
Healthy donor_biological replicate5,ctrl
Injured 30 day Rat Retina 1,pert
"human failing LV myocardium, Ischemic8",pert
211/0,ctrl
control MLL_00106,ctrl
"twin pair: #1;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
"DMD skeletal muscle, biological rep8",pert
MSE_N_M153,ctrl
02 PLUS OHT 1,pert
"ES cell control, RNA 298",ctrl
cell line: KYSE180;	cell type: squamous cell carcinoma,pert
Series 3; old; no fracture,ctrl
Subject 10_t=30days_resveratrol,pert
jos1983,pert
9P-M4-ND,pert
"Primary aortic endothelial cells, transgenic_PPARG_V290M_3",pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 47;	age-at-onset: 43;	geographical origin: Vila-Real;	clinical characteristics: Hypercholesterolemia,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 46;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
09SAGEA,pert
MDS patient 83,pert
"U373-DTX1-myc, rep 1",pert
"strain: C57BL6/J;	pooled: Yes;	amplification batch: 07/15/05;	# cells: 25+29=54;	Sex: male;	region: M1;	age: 38,41;	genotype: Y/X;G42/-",ctrl
SCC2,pert
WT_M_2,ctrl
"treatment: control;	batch: 4;	donor: 30;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
A549 AZA 1 uM (3212),pert
C57/BL,ctrl
del337TR replicate 6,pert
Normal mucosa 13,ctrl
n03,ctrl
Muscle PCOS 24,pert
BxPC3-WT rep 1,ctrl
T5A-LU,pert
PGA-MAH-HeJO3-1aAv2-s1,pert
Huh7 cells_Mock Infected 24 hours_ rep1,ctrl
age: 20;	sex: M;	disease status: Marfan subject;	Filter number: 85;	Usage number: 4;	Exposures: 3,pert
Healthy control c9,ctrl
age_years: 73;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14465;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
C57Bl6N Mouse;	gd17.5 fetal heart,pert
fluorescent activated cell sorter (FACS)-selected cells,pert
"brain, cerebellum: RNA#31_le1",pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 8",pert
genotype: C57BL/6;	gender: male;	age: 10 weeks;	tissue: Liver;	diet: chow diet,pert
TP02-478,ctrl
BL Day 1 siSC transfected biological rep2,ctrl
siCITED1#3 replicate2,pert
SF539 PARK2 siRNA#2 replicate 1,pert
"A673 treated with DMSO vehicle control for 24 hours, biological rep4",ctrl
shScr replicate 2,ctrl
A HID B_B091,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
Individual_4616_PN_sample,pert
mRNA from A549 Static Control 1hr Jan 31 2003,ctrl
MEF.FHL2mutH,pert
NLGN1_4,pert
"BOEC, not_at_risk 8",pert
RA5,ctrl
"human failing LV myocardium, Idiopathic38",pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M0;	flt3 status: internal tandem duplication (ITD),ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 96 hrs;	time course: 2,pert
strain: Swiss;	tissue: Ovary;	agent: 4-Vinylcyclohexene Diepoxide (50uM);	replicate: 2;	age: Post natal day 3-8,pert
siCtrl_FM_rep1,ctrl
469MM,pert
Cavin-1/PTRF KO #235,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous saline challenge""",ctrl
scram_hi_9,ctrl
129 mouse pineal gland tissues taken at postnatal day zero.,ctrl
GB 3 65A +LPA,pert
non-malignant FTEn_patient 5,ctrl
PGA-lv_48h_519,ctrl
tissue: heart;	genotype: CRE;	age: 8 week adult mice,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 25;	gender: male,pert
sampleID: SAM630131;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
"Cell type: endothelial, age:44, gender:male, diagnostic group: schizophrenia, PMI:9h",pert
Papilloma_tumour_epithelial_cells_CTRL_rep3,ctrl
50uM_Zn_2,pert
PGA-HMO-NonObese-7aUA-s2,ctrl
CD19_selected_B-cells_before_R_rep1,ctrl
cell line: Hep G2;	genotype: HCC-THRA mutant al;	treatment: with vehicle for 6h,ctrl
cell type: Anaplastic thyroid carcinoma;	expression: HTH83 LAMC2 shRNA;	cell line: HTH83,pert
Strain: J1 Cell type: mouse embryonic stem cell,pert
"Uninvolved Skin, NS-20",pert
"Mouse heart, control, replicate 1",ctrl
Sedentary-21,ctrl
"Rat liver, treated with DMN, 15 mg/kg in water per orally, extrated 48 hours after treatment, biological rep4",pert
"Monuron-treated NRK-52E cells at 72h, biological rep 1",pert
monocytes_T0_rep2,ctrl
AKT_PLACEBO_12hours_5,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day7,ctrl
2-WT_RD1b,ctrl
patient: 40977;	sample: tumor,pert
4-ONS76 Mock_a,ctrl
A YOKE_B093,pert
Esophagus TG replicate 3,pert
11392 Normal Uninflamed descending colon,ctrl
0982-01-c,ctrl
"IKK2 -/- cell line, biological replicate 2",pert
"Amoxicillin treated Proximal, Small Intestine 1 21 days old",pert
disease state: tibial muscular dystrophy (TMD);	tissue: soleus;	age at biopsy: 52;	Sex: male,pert
H30 Ctrl 6h 4,ctrl
11093 Normal Uninflamed descending colon,ctrl
Cancer 4,pert
Mononcyte-healthy-untreated-2,ctrl
strain: C57BL/6;	tissue type: back skin,pert
V5-P392,pert
affected status (disease state): IS patient;	gender: male;	age-at-examination: 68;	age-at-onset: 66;	geographical origin: Mirandela;	lifestyle characteristics: ever drinker,pert
strain: C57BL6/J;	genotype/variation: txnrd1 null;	age: 8wks;	developmental stage: adult;	gender: male;	agent: vehicle (saline);	tissue: liver,pert
chip number: 17;	transfection plate: 3A;	target gene: NFYC;	kd level: 0.54;	rin: 9.6;	transfection date: 2012-03-26,pert
ic7 -- cell line 1 treated with APF#2,ctrl
sample =XCGD5 treatment=Stimulated time=90 (min),pert
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: siRNA against TET2 transcript,pert
disease state: paediatric glioblastoma;	age: 6;	gender: M;	h3.3_status: wt,ctrl
embryons of mice at 14.5 days.,ctrl
Itk knockout CD8+ unstimulated 1,pert
tissue: Embrionic stem cell line;	genotype/variation: Δexon2/+,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.03;	RNA Integrity Number: 10;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
Severe rep7 (retina),pert
first-episode BP patient 120_biological replicate 1,pert
"hepatic gene expression at ""6 hr"" (rep2)",pert
ic patient3,pert
MPA 2,pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: DMSO,ctrl
genotype: Emu-myc;Suv39h1-/-;	transduction: Bcl2;	cell type: primary lymphoma cells from lymph nodes;	treatment: none,ctrl
CAST/EiJ Vehicle liver sample batch 5,ctrl
sample =Healthy2 treatment=Stimulated time=180 (min),ctrl
cell type: B-cell;	cell line: Pfeiffer DLBCL,pert
"S1P2-KO-neocortex, biological rep2 (male)",pert
Peripheral blood mononuclear cells;	TTF=101min;	Race=White;	Sex=Male,pert
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: mild stress + morphine,pert
con-7_C,ctrl
5240 UC Inflamed sigmoid colon,pert
Subtype: RA;	Karyotype: other,pert
Oct4GipES_Panct1_esiRNA_72h_rep3,pert
control-noDox-rep1,ctrl
Tetracycline-inducible glioma cells no dox 1,ctrl
"Male, 29 years old, HIV infection of 3.5 years",pert
KO Ang3,ctrl
E2_ethanol_96,pert
"p38alpha wild type fetal liver E15.5, biological rep1",ctrl
13 wt E11.5 heart,ctrl
HD1,pert
cell line: HEK-293;	genotype: NOD2 L1007fsinsC;	stimulation: Muramyl-dipeptide (MDP) 10 µg/ml;	time point: 0 h,pert
age: 51;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
parental cell line: WC;	vector: pBabe-puro (empty vector);	replicate: 3,ctrl
A VIS _B032,pert
"Wild type, biological rep 1",ctrl
E9_Embryo_Heterozygous_2,pert
Control_R_-Dox_rep2,ctrl
Sample ID: TP22;	Twin Pair ID: CCE1.2;	Clinical Status:  Childhood Absence Epilepsy + Febrile Seizures;	Age of Onset:-5;	Age at interview & blood sampling: 22;	Current Age (2007):25;	Sex: FEMALE;	Medication at blood sampling : None,pert
M833 / Reference_13431198,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_2h_4mM_HG-U133A_2_YCHSUP501,pert
NonIR-WT_Rep2,ctrl
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.20;	Post mortem interval (hours): 10;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
SALINE 4 HOURS,ctrl
gender: F;	age at blood draw: 58;	tissue: whole blood,pert
colon_C57mouse_6weeks_rep5,ctrl
"BOEC, at_risk 6",pert
Dilated cardiomyopathy_G62,pert
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 2 hrs;	Drug: No Rosiglitazone present,ctrl
HLA risk: Medium;	Height: 151.2 cm;	Weight: 42.9 kg;	BMI: 18.4;	Age: 11.22 years;	Gender: Female;	Race: White;	Glucose: 230 mg/dl;	HbA1c: 6.8%,pert
MDS patient 147,pert
rtTA-Dmrt5_d7_-Dox_rep_2,ctrl
CDK9 Knock Down4,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 150min;	race: White;	sex: Female,pert
KM_069T,pert
patient: 109;	current medication: None;	birth date: 10/10/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: FH of Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
Patient 7 after folic acid,pert
"control, BA46-52",ctrl
cell line: HUVEC,ctrl
Control replicate 3,ctrl
SKI-DLCL cells_Aplidin treated 3nM_24h_rpt3,pert
H4-II-E-C3_low_rep2,pert
01LLR: normal control,ctrl
HUH-nonsense-#2,ctrl
GATA6 KO lung E18.5 mixed strain,pert
normal gingiva tissue from volunteers,ctrl
GEIM16-PM,pert
Spleen_infected_6weeks_rep2,pert
Embryonic day 14.5 and 16.5 pancreas,pert
lateral hypothalamus no access to cocaine replicate 2,ctrl
3285-lcm,pert
"Cadmium 0.2 µM, biological rep1",pert
E10.5 wt.2,ctrl
WT biological rep 3,ctrl
Z138-shControl.1,ctrl
Sample from retroviral MSCV-D1a infected cyclin D1 knockout 3T3 cells (line 12).,ctrl
A YOKE_B094,pert
cell line: KYSE170;	cell type: squamous cell carcinoma,pert
CD8+_Tcells_healthy_donor_5,ctrl
"Ulcerative colitis patient, biopsy taken from the colon, no macroscopic signs of inflammation.",pert
"EBF1 d0, rep 1",pert
strain: C57BL/6J;	day: 15;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
Array Type: HG-U133A_2;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Wildtype H9 hESC derived NSC 3,ctrl
Experimental 4,pert
PGA-MAH-AJ_PBS24h-3aA-s2,ctrl
3025-lcm,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 132min;	race: White;	sex: Female,pert
"G42 cells from Cerebellum, Mecp2 null, biological replicate 3",pert
age	24;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	4.7;	hemoglobin (g/dl)	14.2;	platelet count (/nl)	192,ctrl
"Tg brain, biological rep2",pert
"Wild type sham, biological rep1",ctrl
1023-01-A-b,pert
PB_preTherapy_I,pert
brain wild type replicate1,ctrl
DNGH-4,pert
patient: 256;	current medication: None;	birth date: 10/16/44;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 4/1/05;	diagnosis date: 6/2/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/2/05;	indictation for procedure: ;	ucss: 10;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 6/2/05;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
lung_CLP_wildtype_rep2,ctrl
patient: 32023;	disease state: LGSC;	component: Borderline,ctrl
cell type: CD47 null Endothelial cells;	strain: C57Bl/6;	genotype/variation: CD47 null,pert
RNA: whole lung;	strain: C57BL/6;	genotyp: wt;	infected: no;	replicate: B,ctrl
Strain: C57BL/6J;	Gender: female;	Age: 7 days;	Tissue: kidney,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 428,pert
Disease_status: Healthy control;	Age (years): 59;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.80;	Post mortem interval (hours): 47;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
strain: C57BL6/J;	genotype/variation: txnrd1 null;	age: 8wks;	developmental stage: adult;	gender: male;	agent: vehicle (saline);	tissue: liver,ctrl
Array Type: HG-U133A_2;	Ratio: 2.03;	RNA Integrity Number: 9.7;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.4;	colon weight (mg): 180;	colon ratio (mg/mm): 2.81;	myeloperoxidase activity (u/mg): 0.031;	tissue: colon;	treatment: 5% DSS,pert
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
RTX6 T12,pert
"3mg/kg/day PFOA, Rep 3, Block 5, lung (low dose)",pert
plasma;	patient with sepsis only,ctrl
BCR-ABL1-control rep 3,pert
Mid Secretory Phase Endometriosis,pert
cell type: R1 mouse embryonic stem cells stably transfected with shRNA mismatch control sequence,ctrl
Sample Group: HD patient; Gender: female; Age: 43; Tissue: lymphocytes (blood); IT15 CAG repeats: 15/50,pert
SZ2,pert
BAT_KO_3,pert
"46, XX",ctrl
PGC-1alpha -/- differentiated brown fat cells expressing a siRNA specific for PGC-1beta knockdown (rep2),pert
diet: LRD-5001,ctrl
midbrain_wild type_6 weeks_replicate 3,ctrl
cell line: MCF-7 breast cancer cell line;	agent: estradiol (E2);	time: 3hr,pert
minor HCC2,pert
"seminoma specimen, pT2, patient age: 46y; W03 017",pert
Substantia nigra normal rep7,ctrl
tissue: skin;	individual: Patient P11;	condition: AL;	eczema severity: SCORAD: 64,pert
"Male, 26 years old, HIV infection of ~5 months",pert
ctrl_517,ctrl
P57 Non failing heart biopsy,ctrl
MCF7 cell line _vehicle (control)_biological replicate 3,ctrl
healthy control sample x097,ctrl
cell type: Oct4-Gip ES;	RNAi: Luciferase;	treatment time: 72h,ctrl
gender: male;	genotype: TAK1 flox;	strain: C57BL/6;	tissue: liver;	age: 4 wk,ctrl
MOLM14-shGSK3A-Construct5-rep1,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 51 yr;	population: white;	dsm-iv: 295.9;	age of onset: 23 yr,pert
PDAC_2,pert
strain: C57BL/6;	genotype/variation: Ret Deficient;	tissue: whole embryonic kidney;	age: gestational day 12.5 (E12.5),pert
siERK1Veh4h_2653,ctrl
OVCAR3_rep1/CD157_norm,pert
tissue: Hippocampus;	age: 2-3 months;	genotype/variation: IκBαfl/-,ctrl
chip number: 18;	transfection plate: 4;	target gene: IRF7;	kd level: 0.71;	rin: 9;	transfection date: 2011-10-17,pert
WD44_Kdm6a RNAi-1,pert
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.20;	Post mortem interval (hours): 10;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"GFPMYC negative GC B cells, Biological replicate 1",ctrl
CF (D508) subject11,pert
"BMMs, untreated control, wt, Replicate 1",ctrl
tMLL03,ctrl
"Ulcerative Colitis (42 year old caucasian male, SAK_1285268658)",pert
strain: C57BL/6;	genotype: PTEN+/- IKK2ca/ca (epithelium);	age: 12 months;	tissue: lateral prostate,pert
PBMCs from normal control subject K,ctrl
Individual_4334_PN_sample,pert
Muscle-5 month-wild type-technical replicate 2,ctrl
Sarcoma cell line  - Dicer Heterozygote -rep2,ctrl
ILD Study Number S024,ctrl
H04_P_B1,ctrl
"breast tumor epithelium,12",pert
"SLE patient, 1024V1",pert
age: 6 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
P0 - nudel129s6 1,pert
neocortex-30 months of age-control diet-biological replicate1,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 50;	gender: male;	tumor grade: IV,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: H;	transfectant type: stably transfected with scramble control,ctrl
Strain: FVB/N;	Genotype: mCftr+|+,ctrl
cell type: Primary hepatocytes;	donor: 3;	agent: control;	time: 24h;	gender: Female;	age: 70 years old,ctrl
CD8-IGF1R 3T3 A-928605 3,pert
patient: 259;	current medication: pentaza 2g D;	birth date: 9/20/78;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 8/1/03;	diagnosis date: 1/13/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/7/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/7/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
CAR.KO_TCPOBOP_rep1,pert
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep4",ctrl
"Normal diaphragm 2, 8 week",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 82min;	race: White;	sex: Male,ctrl
male_alcoholic_351,pert
"Metformin, biological rep1",pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L010,pert
patient: 122;	current medication: Venlafaxine;	birth date: 7/10/61;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
wild type parietal cell replicate 2,ctrl
WT_POST_PDE_050,ctrl
F-IIP(UIP)4_Cy3,pert
"VHL null MEFs, biological rep2",pert
liver_wild type_24 weeks_replicate_2,ctrl
knockdown: BAP1;	cell line: 92.1,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 100min;	race: Black/African American;	sex: Male,pert
GIST_PDGFRA_1,pert
subject: 20A;	cohort: 20;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 28;	Sex: M;	batch: Batch_5,pert
Run3.aUa.010110d.SkMDbt1137D.CEL-DB stimulate,pert
sex: Male;	Age: 11 months;	additional patient information found in Series supplementary file,ctrl
Jurkat 2,pert
HW_447,pert
10L,pert
WT HPC Veh 1,ctrl
n7t24h,pert
KO HPC Veh 28,pert
Tissue: endothelial cells,ctrl
cell line: MCF-7 breast cancer cell line;	sirna: ER siRNA;	agent: control (vehicle);	dose: n/a,pert
erStress_twins_AA_1717twin2_500nM_thapsigargin_4h,pert
Total RNA Wildtype-1,ctrl
Exercised-8,pert
Asthmatic after Placebo,pert
S/LV2,pert
BAL_3_A1B0,ctrl
tissue: white blood cells;	age: 11.16;	Sex: female,pert
Control bone marrow - Biological Replicate 1 - Technical Replicate 1,ctrl
TN2,pert
THRB bN mutant + T3 replicate 1,pert
Amoxicillin treated Colon 1 21 days old,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 44 yr;	population: white,ctrl
CD-33-Aff,pert
COLO829_shMITF_DMSO_A,ctrl
"Control Proximal, Small Intestine 1 17 days old",ctrl
MDS patient 114,pert
Kidney_Aqp11-/-_P7_3-4,pert
Subject 3 Post allergen challenge,pert
CD4DecTp1-3,pert
Human Non-progressor HIV Sample L115-CD4+ T cells,pert
"PCB153 treated HepG2 cells at T0.5, biological replicate 1",pert
KN-sham-1 day-R2,pert
Empty control #2,ctrl
"Nickel 140 µM, biological rep3",pert
C_AN10028_F,ctrl
CA1 NoCre Sox7I,ctrl
Mc3T3 AA_ 5day_rep2,pert
MSE_D_540,pert
WT1(-KTS) expression induced for 12 hrs 01-14-03_Lee_U133A_12_2,pert
striatum_Pink1 knockout_24 weeks_replicate 2,pert
Ngn3 EB3 OFF replicate 2,pert
strain background: mixed;	tissue: retina;	Stage: E14;	onecut genotype: OC1-KO,pert
cardiomyocyte SRF-null 1,pert
T141 U133p2,pert
dental pulp cell from control 1,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 7 days;	Tissue: kidney,ctrl
cell line: HEK293 cells WTX inducible clone F5;	agent: doxycycline,ctrl
"5mg/kg/day PFOA, Rep 3, Block 2, liver (high dose)",pert
PTC BRAF wt 8,pert
12h control (1);HT-29;colon:carcinoma;NONE;42994,ctrl
A2_LEF1,pert
PFR3_replicate_2,ctrl
"septic CD4+ splenocytes at 6h, biological replicate 3",pert
shRNA6-16-noDox-rep2,pert
N/SM5,ctrl
whole tissue section from case 1368,ctrl
Muscle PCOS 22,pert
"E18.5 brain, Meg3 knock-out, rep 4",pert
"age at diagnosis: 60;	diagnosis: Adenocarcinoma of breast, lobular;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: 1;	pgr: NA;	dfs-month: 16;	dfs-event: 0;	distant metastasis: 0",pert
strain: mixed background of 129/SV and C57BL/6;	cell type: macrophage;	genotype/variation: PPARg WT,ctrl
Nerve_Diabetic_Vehicle_710,pert
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 0h,ctrl
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep8,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 43;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
WT-CD80hi-mTEC-sample1,ctrl
WT - Cre Treated - 2 hrs - repeat 3 - Cy5 - mAdbID:62604,ctrl
BAL_39_A0B1,ctrl
DW307_WT_M,ctrl
29SAGEA2,pert
PGA-HMO-MObese-3aUA-s2,pert
14-week-old WT liver_611WT,ctrl
CTRL_3_GMP,ctrl
Donor5_24h_Wy,pert
N5_Cy3,ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 4",pert
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 4,pert
Retina wt/wt rep3,ctrl
cell line: LNCaP;	overexpression vector: GFP,ctrl
Healthy untreated rats 3,ctrl
Time 180 mins rep 1,pert
PEC control - replicate 3,ctrl
Gastrocnemius Muscle mdx AAV-Galgt2-Treated rep2,pert
"Liver, Normoxia 2",ctrl
"112, ADIPOOSE TISSUE, Before",ctrl
liver_STZ 0.1% quercetin diet_rep3,pert
brain_OFC_bipolar B_mr233,pert
Tolerizing allografts 7 days No.3,ctrl
age: 45;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"DMSO-treated NRK-52E cells at 72h, biological rep 3",ctrl
Squamous cell carcinoma 018,pert
"cell line: SW480-Vector, vector control treated stable line",ctrl
Panc-1 Ctrl 1,ctrl
"Cell type: endothelial, age:34, gender:male, diagnostic group: control, PMI:22h",ctrl
ND_2,ctrl
agent: control;	strain: BALB/c;	tissue: mesentery,ctrl
"seminoma specimen, pT2, patient age: 46y",pert
35/1-22 - Dox +48h E2_1,pert
agent: EFNA4-Fc conjugate;	time: 4h,pert
THP1-shGSK3A-Construct5-rep1,pert
cell type: embryonic stem cell;	genetic background: C57BL/6;	genotype: wild-type control,ctrl
AL Chip#32,pert
platelet_sickle_11,pert
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 69;	Usage number: 1;	Exposures: 4,pert
tissue: blood;	patient: 1;	gender: male;	age: 54,pert
tissue: Hippocampus;	age: 83;	Sex: M,ctrl
strain: C57BL/6;	cell type: cytotoxic T-lymphocytes (CTL);	genotype/variation: wild type;	agent: Akt inhibitor AktI-1/2,pert
Gender:M;	Age:28;	Tissue: Mucosa,ctrl
Actinomycin D treated A549 human lung cancer cell cultures replicate B,pert
control IgG_rep1,ctrl
AA_126,pert
whole tissue section from case 68,pert
"Tet1 KD, rep4",pert
PTC BRAF wt 9,pert
"medulloblastoma, M2_scrambled, rep3",ctrl
LOX1 Untreated 12hr 282295773,pert
midbrain_Pink1 knockout_6 weeks_replicate 1,pert
genotype/variation: Tpl2 wild type;	treatment: unstimulated,ctrl
IDCM3,pert
brain_Down_syndrome_sampleid_jg1738,pert
T40645,pert
Normoxic Control N1,pert
Individual_4284_PN_sample,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 pM;	treatment time: 8 hours,pert
CML-BM 4,pert
HSC-3_TAT-2_48hr culture_ rep3,pert
"HUVEC infected with Control Vector , biological rep1",ctrl
"SW480, stable line of treatment of luciferase RNAi. Incubate in L15 medium, 37.0°C, air 100%",ctrl
"General population, Female",ctrl
Nerve_Diabetic_Vehicle_706,ctrl
"Female (age range 33-49), skin biopsy taken from upper nates 48 hours after nickel exposure",ctrl
5201 Normal Uninflamed sigmoid colon,ctrl
"Lesion Skin, LS-26",pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 5",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-sp3,pert
female;	37 yr old;	Black,pert
4140-3 E2F3 Heterozygous,pert
cerebellum_WT_12w_rep1,ctrl
Human Non-progressor HIV Sample L115-CD8+ T cells,pert
LICR_HN1_CETU1,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 28;	maternal age: 27,pert
38m4,ctrl
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 2,pert
tissue: skin;	individual: Patient N-7;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 8d ID223,pert
tissue: skin;	individual: Patient P6;	condition: AL;	eczema severity: SCORAD: 70,pert
coc-38_A,pert
GM19238_Kd_NFYC_2,pert
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: Brd4 shRNA,pert
IRF4-mut_Th17_cells_42hr_rep1,pert
"fibroblast, control subject NM8 rep 1",ctrl
Control (C83),ctrl
Healthy control c8,ctrl
35B,pert
CD4DecTp1-7,pert
healthy control H10,ctrl
NPC_SA01_3,ctrl
Ex1_cells_rep2,ctrl
PC-3_basalhTERT_ShortTelomeres_mock_4,ctrl
strain/background: mixed B6/129;	tissue: thymus;	cell type: CD4+CD8+ thymocytes;	genotype/variation: Dicer lox/lox control,ctrl
GC resistant clone C7H2-R3B5 treated for 6 hours with GC,pert
BALB/cByJTCE liver sample batch 2,pert
untreated control,ctrl
CD-45-un,pert
"DMSO-treated, 6h after UV, Replicate F",ctrl
brain_DLPFC_bipolar B_mr676,pert
wt-Gfp P10 replicate 4,ctrl
Subject #8039-2d Postinfection,ctrl
LNCaP-abl_siControl_2,ctrl
colon_epithelium_IL10mouse_12weeks_rep4,pert
PsOEt-23-Week 1,pert
Heart_caAkt_01,pert
Gene expression profiling of Phgdh knockout embryo KO3,pert
"Pten WT/null epithelials cells, biological rep3",pert
siIPMK + MMC experiment 3,pert
MKK7D control female replicate 8 late timepoint,pert
"alveolar macrophages, non-smoker 019",ctrl
Asthmatic at baseline,pert
"MaF pre-iPSC9P2, Vc+, D4",pert
UM15_Mtu_rep2,pert
TG MEP 1,pert
MCF7_siRNA_GCMedControl_24h_AM0004_14.1,ctrl
"IGF-treated cells (3hr), biological rep1",pert
carcinoma,ctrl
S46 NLS 142Q TG1	F5/2	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Male,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 41.5589,pert
"BALB/c, Female, CF",pert
Patient identifyier: W;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 27 years;	Body surface area: 6 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
non-malignant FTEn_patient 3,ctrl
HIF-1-/- S. aureus 4,pert
Oga_WT_MEF_E8_rep1,ctrl
A549 DAC 0.3 uM (3219),pert
Cell line: MDA-MB-231,ctrl
"twin pair: #7;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
subject: 22U;	cohort: 22;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 60kb;	age (y): 43;	Sex: F;	batch: Batch_5,ctrl
"Control shRNA cells passage 7, rep 4",ctrl
metoprolol treated muscle cells,pert
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
WT-smoke-med-1 day-R2,ctrl
CD34+ cells with fenretinide treatment from CML33,pert
EUR12_T4_PP_day3_046,pert
MS patient 4,pert
"female Spargue-Dawley rats, 9-cis-retinoic-acid, 100 mg/kg diet for 7 days,  tissue: mammary gland",pert
"TGCT cell line 2102Ep/clone 2A6, untreated, undifferentiated",pert
neuron_rep5,pert
BP8,pert
Human Non-progressor HIV Sample L134-CD4+ T cells,pert
Cervical cancer_CC218,pert
LRRK2 (G2019S) heterozygous fibroblast sample 1,pert
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 24 months;	genotype: Myc heterozygous,pert
T41 U133p2,pert
"Crohn's Disease subject (34 year old caucasian female, SAK_1288197141)",pert
"Peripheral blood, patient without recurrent events [N24]",pert
Mouse WT mandibular molar [AZN_MolairesWT3],ctrl
midbrain_Pink1 knockout_18 month_replicate 3,pert
H15 Ctrl 12h 1,ctrl
cumulus_PCOS_Obese_rep5,pert
RNA from HCC_3T,pert
cell type: Embrionic stem cell line;	genotype: HPRT -/-,pert
cell line: U20S;	tissue type: osteosarcoma,ctrl
tMLL08,ctrl
cell type: Primary hepatocytes;	donor: 2;	agent: control;	time: 6h;	gender: Male;	age: 44 years old,ctrl
DMSO treated CEM-C1 cells_1,ctrl
06R016 Control,ctrl
"Pancreas from adult WT mice, biological replicate 3",ctrl
CBMNC.LPS-.2,ctrl
Sample: alpha-TM180;	Replicate: 3;	Pool: NP,pert
RNA-DHL4-R406-2H-3,pert
tissue: skeletal muscle;	strain: mixed background (C57Bl/6 and 129);	genotype: wild type;	age: 6 months,ctrl
S1_sham_overexpressor_12,pert
Strain: C57BL/6J;	Gender: M;	Age: 7 weeks;	Treatment: untreated,ctrl
"Wild-type myeloid-derived suppressor cell from bone marrow, rep2",ctrl
Liver_WT_Rep3,ctrl
5279 UC Inflamed ascending colon,pert
"MGSKO, PR01M007v0",pert
Turner_AF_4,pert
B7m5,pert
Liver sample from Control group (N52),ctrl
Cardiac Muscle_mdx_rep1,ctrl
CLP2,pert
sample type: Primary culture of typeII cells collected from SPC WT lung (adult);	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C WT;	genetic background: 129S6/SvEvTac,ctrl
cell type: Primary hepatocytes;	donor: 5;	agent: Wy14643;	time: 24h;	gender: Male;	age: 73 years old,pert
CD19_selected_B-cells_before_R_rep3,ctrl
"age at diagnosis: 51;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 48;	dfs-event: 0;	distant metastasis: 0",pert
P79 dilated cardiomyopathy heart biopsy,pert
tissue: lesional skin;	urticaria status: affected;	patient: 4,pert
Diagnosis: MDS/AML;	Age: 53y ;	Gender: Male;	Blast %: 77;	Source: PB;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
NeuoD1 transgenic animals die very shortly after birth.,pert
wild-type_TCPOBOP_rep1,ctrl
MCF10A_SFN_rep4,pert
"Dicer lox/lox control, biological rep2",ctrl
Rejecting allografts 7 days No.3,pert
Telencephalon WT 1,ctrl
"human failing LV myocardium, Ischemic6",pert
cell line: HL-60;	shRNA construct: Scrambled Control,pert
CON - LV21,ctrl
Normal skin 2,ctrl
mutant_ANT_PDE_21,pert
"human failing LV myocardium, Idiopathic41",pert
YFP-pos GMP Dicer het rep2,pert
RL_siRNA_LIF1h_rep2,ctrl
Kidney_200 mg/kg VCM iv_mouse #029,pert
Time 0 mins rep 1,ctrl
microdissected breast cancer cells from case 1047,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 35;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Pt_1 Normal Skin,ctrl
cell type: pre-iPSCs;	sirna mediated knockdown: control,ctrl
Disease_status: Bipolar disorder;	Age (years): 56;	Gender: Male;	Age of onset (years): 28;	Duration of illness (years): 28;	Brain pH: 6.07;	Post mortem interval (hours): 23;	Side of brain: Right;	Fluphenazine mg. Equivalents: Unknown;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: Yes (60 treatments);	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
"fibroblast, control subject NF6 rep 3",ctrl
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 80;	tissue: Blood,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 75,ctrl
RNA from HCC_24T,pert
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of saline for one week,ctrl
"Retina from control mouse at ZT6, biological rep 3",ctrl
XpO18,pert
atopic eczema P9,pert
HepG2_Sb rep2,pert
liver_Wt_8wk_rep3,ctrl
OVE26_8W_1_4,pert
77 year old male,pert
NIXKO3 SPLEEN,pert
U87 20 uM Temozolomide rep2,pert
diagnosis: NSIP;	fvc-group: FVC2;	tissue: lung,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P90;	genotype: Igf1 +/+,ctrl
RTX7 T0,ctrl
Y VIS _B029,ctrl
transfection: H19 siRNA (simH19);	cell: C2C12,pert
52_129_KO,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: other,pert
S2_sham_overexpressor_12,pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 4 - Technical Replicate 2,pert
CRC_celecoxib_M4875,pert
"Cadmium 0.55 µM, biological rep2, repeated microarray",pert
"HEB CLP LY6D-, biological rep2",pert
Bone-Marrow_MM_M1037,pert
AZ-521_uninduced_24h_rep2,ctrl
"experiment I, passage 9, replicate 1",ctrl
MCF10A-Her2Myc-rep2,pert
CEPI_II_367,pert
A9_C9_nasal_stem_cell_rep1,pert
clone type: AtT20 clone types treated with NSBP1 siRNA rep 2,pert
MCF7 DMSO+E2,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_1_31_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
KU_35T,pert
Dengue Hemorrhagic Fever Patient 81,pert
MPM tumor 13,pert
cell type: primary p53-null neural stem cells;	retroviral expression: vector,ctrl
pediatric AML S22,pert
V5-P250,pert
EP3_adipose_control,ctrl
"pancreas, ethanol diet, replicate 2",pert
MCF7 cell line_resveratrol_250mM_biological replicate 3,pert
Kidney_200 mg/kg VCM ip_mouse #086,pert
"Rb KO, biological rep3",pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T1N1,pert
Array Type: HG-U133A_2;	Ratio: 2.03;	RNA Integrity Number: 9.4;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
MCL_IGHV_UNMUT (R1332),ctrl
strain: 170;	Disorder: normal scar;	Condition: +hydrocortisone,pert
"spleen marginal zone B in WT, biological rep5",ctrl
ko 13.5d replicate 7,pert
Expression data from liver of the KRAP deficient mice (KO3),pert
tissue: Temporal cortex;	age: 78;	Sex: F,ctrl
KO STR Veh 30,pert
Waldenström’s macroglobulinemia (WM-BL 30866),pert
Mut+/- rep4,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 173;	Sex: male;	region: LC;	age: 38;	genotype: Y/X;TH/-,ctrl
Wt Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-3,pert
"WM35, 48h treatment with 5 AzadC",pert
tissue: Breast adenocarcinoma,pert
SOCS3 Cre minus A,ctrl
MacularDegen-injured-9aAv2-s2,pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 65;	age-at-onset: 65;	geographical origin: Vila-Real;	clinical characteristics: Hypertension,pert
P32_WT_pancreas,ctrl
Control ESC media sample 3,ctrl
Trasnsformed Lymphocytes Bipolar Disorder Affected Twin Pair 3 (DCBD3.1)(TP9),pert
CD-51-un,pert
strain: C57Bl/6;	cell type: Regulatory T-cells CD4+CD25+;	genotype/variation: fl-p300/Foxp3cre,pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
genotype/variation: wt;	age: P60;	tissue: Whole eye,ctrl
EP37_adipose_control,ctrl
sepsis patient #6,ctrl
ab104 IM,pert
"patient 028b, cancer, homogenized",pert
tissue type: Benign prostate tissue,ctrl
cell line: HepG2,pert
BN DES-treated replicate 4,pert
MCF7_EtOH_24h_rep3,ctrl
"104, ADIPOOSE TISSUE, Before",ctrl
WT-smoke-med-5 month-R4,ctrl
Wild type mice on a high fat diet (CH 1),ctrl
217/0,pert
"A pool of two pure subsets of peripheral blood CD56dim natural killer cells (CD19- CD3- CD56dim Cd16+), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
"control, BA46-79",ctrl
RatLung_H16h_1,pert
Treg cells Ptenfl/flFoxp3-Cre replicate 2,pert
tetO-Satb1 #2 +DOX,pert
3799-lcm,pert
"seminoma specimen, pT1, pN1, patient age: 34y; W99 113",pert
genetic background: C57BL/6-129Sv hybrid background;	genotype: Setdb1 2lox/1lox/Cre;	cell type: embryonic stem cell,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: tumor;	sample name: 6-tu1,pert
"Crohn's Disease subject (31 year old caucasian male, SAK_1315951533)",pert
whole blood_101621,pert
Extract:LOX-1:213402;	Extract Description:LOX1_Untreated_12hr:213402;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.55;	Quality: Background Mean Dev.:0.39;	Quality: Absent (%):57.62;	Quality: Absent (%) Dev.:0.49;	Quality: Scaling Factor:0.55;	Quality: Scaling Factor Dev.:0.52;	Pretreatment [C]:LOX1;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213402;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_12hr;	RNA extraction source key [A]:282295783,pert
microdissected breast cancer cells from case 655,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 58;	gender: male,pert
"control, BA46-56",ctrl
GhrhKO_004,pert
01MJ2_ERA,pert
ILD_4,pert
4124-1 E2F2 Null,pert
"cell type: Human mammary epithelial cells infected with retrovirus carrying hTERT and the oncogenic allele of H-Ras, H-RasV12 described in (Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, and Weinberg RA (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50-65)",pert
Wild type saline replicate3,ctrl
"control, BA46-38",ctrl
GM19238_Kd_ARNTL2_3,pert
cell type: embryonic fibroblasts (MEFs);	genotype: wild type,ctrl
MCF7 cells treated with 2uM Doxorubicin for 24 hours Array 1,pert
S008_Scz_F_81,pert
"atRA RARaKO, set 2",pert
C_AN14757_T,ctrl
HUVEC/NmenMC58_frpC/frpA_4h_rep1_1108,pert
Fetal heart control 3,ctrl
Tet2 KO CMP rep1,pert
11423 UC Uninflamed ascending colon,pert
Control mouse 3,ctrl
cell line: AST18;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: SNCA triplication,pert
RNAi -Transgenic replicate 4,pert
Gastric_cancer_patient_8,pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 94;	Usage number: 5;	Exposures: 3,pert
Cancer 5,pert
AAA neck (Sample 13),pert
5922012008_E,pert
Normal donor Lung,ctrl
MacularDegen-healthy-13aAv2-s2,ctrl
genotype: WT;	time (h): 0;	cell type: primary hippocampal neuron;	treatment: untreated;	genetic background: C57BL/6,ctrl
WT MEP 2,ctrl
BRCA1_3,pert
NK_cell_pool_healthy_H09+H10,ctrl
2A;pretreatment;female;breast tumor,ctrl
Map3k7 (TAK1) knockout replicate 1,pert
HUVEC exposure no colchicine 12 hr_2,ctrl
"non-AD_HI, biological rep4",ctrl
cell line: SUP-B15;	tissue: Human B cell precursor leukemia,pert
Substantia nigra PD rep15,pert
Heregulin 979-CLA-34,pert
"Patient 2, lesion tissue",pert
GFP Untreated 12hr 282295713,ctrl
Neuroblastoma SH-SY5Y cells_cloneM_scramble control_replicate2,ctrl
WT - Cre Control - 5 mo - repeat 1 - Cy3 - mAdbID:74098,ctrl
"Patient 1, lesion tissue",pert
"VPA 1, 4hrs",pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 72h",pert
platelet_sickle_2,pert
Mtb infected-42d-2,ctrl
GAS-n10-2; normal gastrocnemus 10 month,ctrl
U-87MG-V22 set 6,ctrl
ALI patient #8,pert
"YWHAZ overexpressed CL1-0, biological rep1",pert
CRC_nodrug_F4862,ctrl
CLL17-CD8,pert
M833 / Reference_13425673,pert
5276 UC Uninflamed descending colon,pert
male_control_510,ctrl
CLL 378-01 Control,ctrl
normal muscle replicate 5,ctrl
"siCFIm68-2, biological rep2",pert
Array Type: HG-U133A_2;	Ratio: 1.96;	RNA Integrity Number: 9.8;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
mouse_islets_ctrl_02,ctrl
Age: 42;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
striatum_wildtype_2,ctrl
erStress_twins_AA_1736twin1_DMSO_4h,ctrl
Lmna H222P heterozygous male 5,pert
"Colitis 04, UC04",pert
3492-ls,pert
NOD1,ctrl
"genotype/variation: Pten-null (Ptenloxp/loxp), with doxycycline-inducible PTEN transgene;	cell type: embryonic fibroblasts;	transgene: tet-inducible Pten transgene;	time: 24 h;	genetic background: C57BL\6",pert
Sirt1 siRNA control 1,ctrl
H6PDH knockout,pert
cell line: MCF-7;	sirna knockdown: siLRH-1_#2,pert
KU_46T,pert
cell line: SV589;	knockdown (days): 3;	treatment: no treatment,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 2,pert
age: 50;	sex: M;	disease status: control subject;	Filter number: 101;	Usage number: 1;	Exposures: 3,ctrl
HP-50,ctrl
cell line,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 6 months,pert
Control Treg_rep3,ctrl
Embryonic age 14.5 mutant rep2 (PKD1_65),pert
INSENS 3 4hr,pert
OE-OCT4_2,pert
strain: C57BL6,pert
Empty vector replicate 2,ctrl
SimvaVeh2,pert
"human failing LV myocardium, Ischemic62",pert
LECs from control rats 3,ctrl
"shControl, normal growth, replicate 1",ctrl
LPS 3hr 1,pert
striatum_Pink1 knockout_18 month_replicate 3,pert
U133A_B2,pert
Liver TG replicate 1,pert
"human failing LV myocardium, Ischemic56",pert
"Mouse LV, akt2-/- 2",pert
cell line: SNB19;	transfection: PARK2 siRNA#1,pert
CAR.AH_phenobarbitol_rep1,pert
157_DMSO,ctrl
"BioBreeding DRlyp/lyp rat, day65, mast cells derived form pancreatic lymph node",pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: DBP,pert
cell line: HEK293 human embryonic kidney cell line;	protocol: control (control RNA),ctrl
Muscle-5 month-Myc heterozygous-technical replicate 3,pert
WT - Cre Untreated - 0 hrs - repeat 1 - Cy3 - mAdbID:61715,ctrl
"A549, -TNFα, Claudin 1 siRNA, rep2",pert
LT-HSC Zbtb7a F/+ Mx1-Cre+ #2,ctrl
patient id: 75;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 48;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N0M0;	Stage: II;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
"WT5_ileum, 5 days post-infection with T. gondii",ctrl
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.60;	Post mortem interval (hours): 11;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
IPMC 4,pert
"16B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
EA_Control5_CD20,ctrl
Tumor-WT-rep1,ctrl
PGA-MLS-RA-1aAv2-s1,pert
Experiment TOX3 transient transfection replicate 1,pert
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14455;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
6 hr KLF4 Time Course Induced,pert
Healthy CD4+T cells 13-UD,ctrl
PGA-RMM-15m-3aA-s2,pert
Colo205RC PLX4720 resistant cell line,pert
midbrain_Pink1 knockout_6 weeks_replicate 2,pert
"RORalpha1delDE, 3",pert
patient: 239;	current medication: Asacol Fybogel Amitriptiline;	birth date: 4/10/41;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 12/1/63;	diagnosis date: 12/12/64;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/3/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 1;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
miR122-KO-157-T,pert
73_129_WT,ctrl
STAT3-deficient naïve T cells stimulated for 3 hours with medium alone 3,pert
cell line: SV589;	knockdown (days): 8;	treatment: Serum Starved; 3h EGF,pert
mouse model: 3xTG-AD;	gender: female;	age: 14 months old,pert
tissue: lesional skin;	urticaria status: affected;	patient: 6,pert
treatment: naïve;	transgenic variant: FVB/N;	tissue: Caudate-Putamen;	genetic background: FVB/N,ctrl
C1_CLP_overexpressor_12,pert
CAST/EiJ Vehicle liver sample batch 6,ctrl
shRNA-PGC1a #65 rep-2,pert
chip number: 18;	transfection plate: 3B;	target gene: ZBTB38;	kd level: 0.67;	rin: 9.5;	transfection date: 2012-03-26,pert
"cochlea at P3, ko, biological rep 3",pert
strain: Wistar;	agent (mother exposed to): vehicle;	gender (pup): male;	age (pup): PND70;	tissue (pup): pituitary,ctrl
Patient: B;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
SHR12-4,pert
genetic background: C57Bl/6;	genotype: Calcr-/-;	cell type: Osteoclasts;	treatment: untreated,pert
"gastrocnemius-30 months of age, resveratrol diet-biological replicate5",pert
Sample ID:TP6;	Twin Pair ID:DCBD1.2;	Clinical Status:Control ;	Age of Onset:-;	Age at interview & blood sampling:55 ;	Current Age (2007):58 ;	Sex: Female ;	Medication at interview (duration) :None,ctrl
AA_Case12_CD8,pert
Muscle Pio3,pert
HD 1,ctrl
tissue: non-lesional skin;	urticaria status: affected;	patient: 4,ctrl
Control_liver_3,ctrl
pediatric AML S10,pert
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: DMSO 6 hr,ctrl
gender: male;	strain: BALB/c;	tissue: liver,ctrl
Postmenopausal female. Tibolone treated. Patient 6.,pert
MA_306,pert
WT_Mstn_2,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 237;	age-at-biopsy-years: 55,pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep5,pert
"brain, cerebellum: KCb4w#1_e1_le1",pert
cell line: 344SQ lung cancer cell line;	genotype.variation: control,ctrl
NHE3+/+ replicate 2,ctrl
cell line: HEK293 cells WTX inducible clone F5;	agent: doxycycline,pert
3497-3 E2F2 Null,pert
HDAC2 KO mice colon rep 2,pert
cell type: Primary hepatocytes;	strain: NMRI;	agent: Wy14643;	time: 6h;	gender: Male;	age: 4 months,pert
cell line: PC-3;	treatment: none;	treatment duration: 0h,ctrl
Day 14 (T1+2),pert
Normal Chip#2,ctrl
SZ3,pert
"ALL_DS, K21 011509",pert
Control MEF 1,ctrl
8A;pretreatment;female;breast tumor; nonresponder,ctrl
cerebrum_WT_20d_rep1,ctrl
WT-sham-5 month-R1,ctrl
FMR1_4,pert
BCell_lymphoma_marginal_sample2,pert
KO SPC Type II 9_27_04,pert
HTB58_antiEvi1siRNA_3,pert
genotype/variation: Fmr1 wildtype;	tissue: cerebellum;	gender: Female,ctrl
Mononcyte-healthy-untreated-3,ctrl
GFP_3,ctrl
PKBa-/- MEF time 24 replicate 1,pert
healthy control sample x062,ctrl
Rat fatty liver10,pert
NPC Brain 62d Mouse1,pert
Testis CREMKO 0h batch 1 [TeKOh00.6],pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.894;	OD280: 0.979;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 61;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
V5-P324,pert
T5B-LU,pert
Jak2VF vehicle (7991003028_F),pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 2",pert
"wild type saline, biological rep3",ctrl
Severe rep5 (retina),pert
"human failing LV myocardium, Idiopathic65",pert
Individual_953_PN_sample,pert
Control_pancreas_2,ctrl
GIST Pre Treatment Biopsy 36,pert
LCL Concordant for Epilepsy twin pair 2 (CCE2.1)(TP31),pert
tissue: brain;	genotype: WT mix background A;	age: P0,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 110min;	race: White;	sex: Female,pert
liver western diet 0.05% quercetin rep3,pert
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:56;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
Skin_Lox_Control_Rep3,ctrl
LY2 control-siRNA untreated rep2,ctrl
TTP_WT_0ActD_BioRep2,ctrl
cell line: MDA-MB-231,ctrl
individual: Control8;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 86;	Usage number: 5;	Exposures: 3,pert
Mtb infected-42d-5,ctrl
strain/background: A/J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: sham surgery,ctrl
EDL-t7-2; transgenic extensor digitorum longus 7 month,pert
PsOEt-10-Week 2,pert
27A;pretreatment;female;breast tumor; nonresponder,ctrl
LNCaP.FoxA1.4,pert
race: caucasian;	age (years): 59;	stage: IB;	grade: 2;	histology: endometrioid,pert
36B,pert
age: 54;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
patient: 218;	current medication: Sulphasalazine Asprin Metoprolol Atorvastatin;	birth date: 9/27/24;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/58;	diagnosis date: 1/1/58;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/3/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Breast cancer;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"genetic background: B6/129;	genotype: Tet2 KO;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor High CD34 positive expressing bone marrow progenitors GMP",pert
fasted liver lard diet 1,pert
215/4,pert
Elf4 KO1 naive CD8 T cells,pert
lesion_postUV_patient11,pert
MCF10A-Vector-rep1,ctrl
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: LSD1;	transfection time: 24h,pert
cell type: hepatoma cells;	cell line: Huh-7;	transfection: luciferase,ctrl
E9.5 embryo_wild-type_rep1,ctrl
Trib1 #2 KO macrophage LPS,pert
BP patient 111_biological replicate 2,pert
BTBR-ob/ob;	Pancreatic islets;	Age: 14 weeks;	Gender: Male,pert
scan batch: Batch 2;	group: autism;	subject age: 7;	paternal age: 27;	maternal age: 39,pert
Dendritic cells generated from blood of donor 2 + A. fumigatus germ tubes,pert
microdissected breast cancer cells from case 772,pert
GM19238_Kd_BCL3_1,pert
"WT-UN2,experimental replicate 2",ctrl
"Resveratrol treatment exp 3T3-L1 cells, CT1",ctrl
"The Identification of gene expression changes in human embryonic fibroblast cells, background. Sample C",ctrl
subject: 40;	disease: CP;	muscle: ST;	gender: M;	age: 10.1;	gmfcs: 2;	popliteal angle: 120,pert
"Patient 20, Atheroma plaque",pert
DC1 AM,pert
tissue: Lung;	strain: Lewis;	treatment: control,ctrl
"patient: 227;	current medication: Asacol Prednisolone 5 Omeprazole Warfarin Cal VitD;	birth date: 4/17/28;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/90;	diagnosis date: 1/1/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/72;	smoking amount: 5-14;	other illnesses: Prostate cancer 1985, Previous DVT's on warfarin;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
@52055800697862121408403718160371,pert
"age at diagnosis: 54;	diagnosis: Adenocarcinoma of breast, ductal, lobular features;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N2a;	er: 1;	pgr: 1;	dfs-month: 15;	dfs-event: 0;	distant metastasis: 0",pert
brain_DLPFC_bipolar C_mr546,ctrl
Psoriatic arthritis PsA 1,pert
BRCA1-KD-2 (total RNA),pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 28;	gender: female;	years of disease: > 10y;	treatment: phototherapy;	time: mid-UV,pert
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-6,ctrl
Cell line MDA-MB-231_control_expt2,ctrl
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 1,pert
HCC009T,pert
SKI-DLCL cells were treated with AraC alone at concentration 20nM for 24h. Total RNA was isolated.,pert
gender: female;	batch: 1;	age (years): 26;	patient id: Control_3;	fev1 (% predicted): 105;	fvc (% predicted): 115;	medication: None;	cell type: CD8+ T-cells,ctrl
HepG2_Vehicle_24hr_prep3,ctrl
HPB-ALL Control 2,ctrl
Bronchial Epithelial Cells SA biological 1870G,pert
"5mg/kg/day PFOA, Rep 1, Block 5, liver (high dose)",pert
Chronic active plaque 2 (CAP2),pert
patient: 16;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
DBA/2J Vehicle liver sample batch 1,ctrl
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 42;	Usage number: 1;	Exposures: 3,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
KM_049N,ctrl
clone type: AtT20 clone types treated with NSBP1 siRNA rep 3,pert
"216, MUSCLE, Before",ctrl
BM_02496,ctrl
Fibronectin 1,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 1,pert
colon_normal_1122,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 8 weeks;	Treatment: untreated,pert
KOT 72 bleomycin treated,pert
"MLD, biallelic AML MLL_00230",pert
"fibroblast, MFS subject FB773 rep 1",pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: sigenome non-targeting siRNA;	genotype/variation: negative control,ctrl
passage: 10;	cell type: fibroblast;	treatment: overexpressing progerin treated with FTI;	cell line: GM00038,pert
strain: C57BL/6;	genotype: Wild Type;	replicate: 1,ctrl
"Normal subject (54 year old caucasian female, SAK_1289203312)",ctrl
liver_Pink1 knockout_6 weeks_replicate_1,pert
OV90-(2),ctrl
db/db 8wk 3,pert
race: african american;	age (years): 69;	stage: IB;	grade: 2;	histology: endometrioid,pert
Normospermic individual: Sample N10,ctrl
TscWT1_brain,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.5;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 49;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
"Control 01, NC01",ctrl
platelet_sickle_14,pert
"5mg/kg/day PFOA, Rep 2, Block 1, lung (high dose)",pert
strain: C57BL/6;	genotype: RORalpha1delDE;	replicate: 2,pert
Human Uninfected Sample N001-CD4+ T cells,ctrl
GM19238_Kd_NS2_24,ctrl
MDS patient 134,pert
major non-tumor4,pert
181C1,ctrl
MeCP2_4,pert
"MCF7/BUS, 60 pM E2, 48 hours, biological replication 2",pert
"control, BA46-70",ctrl
WT-ac-2,ctrl
220C3,ctrl
status: Slow;	age: 68;	gender: female;	tissue: cultured human fibroblasts,pert
A HID I_B087,pert
Cervical Cancer C496,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 5 days with concentration of 0.17 uM (EC50).,pert
Control bone marrow - Biological Replicate 3 - Technical Replicate 2,ctrl
"HUVEC treated with ERG SiRNA , biological rep1",ctrl
mouse cerebellum at P7 wild type 2,ctrl
APP_R6_rep1,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: LPA,pert
subject id: 39;	infection: DENV;	status: DHF;	tissue: whole blood,pert
Kidney_400 mg/kg VCM iv_mouse #044,pert
ACC 3 cell line lacZ-RNAi replicate 2,ctrl
CF (D508) subject6,pert
OSE_452,ctrl
"Primary aortic endothelial cells, Non_transgenic_control_1",ctrl
Psoriasis-3 baseline,pert
Carbo Day2 (352L),pert
lymphoma_7890_ADR,pert
cell type: Primary hepatocytes;	strain: SV129;	agent: control;	time: 6h;	gender: Male;	age: 4 months,ctrl
"brain, lateral and medial ganglionic eminences: Arx+/Y #4_le1",ctrl
Individual_5292_NN_sample,ctrl
NSC_ X5050_24h_biological rep3,pert
strain: Swiss;	tissue: Ovary;	agent: Control (0.1% DMSO);	replicate: 1;	age: Post natal day 3-4,ctrl
chip number: 3;	transfection plate: 1;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-03-29,ctrl
M17 - infected MBT/Pas fibroblasts (9 h post inf),pert
HCC PBMC_sample 8,pert
KU_10N,ctrl
R26Pax3/Pax3 E14.5 palatal shelves 3,pert
multiple myeloma (MM 513),pert
chronic lymphocytic leukemia (CLL 532),pert
tissue: Biceps muscle;	patient: P.b.2;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 4m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
"Wild type mouse aorta with placebo, biological rep3",ctrl
N7A Normal-frontal,ctrl
BP patient 56_biological replicate 1,pert
G392E_off_rep1,pert
sex: male;	tissue: liver,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G63,ctrl
"Pancreatic tumor cells, replicate 6",pert
scan batch: Batch 1;	group: autism;	subject age: 11;	paternal age: 24;	maternal age: 24,ctrl
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep4,pert
V5-P371,ctrl
01UNN,pert
treatment: before Rituximab (control),ctrl
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_4;	fev1 (% predicted): 65;	fvc (% predicted): 81;	medication: Prednisolone 10mg od,Spiriva 18mcg od,Methotrexate 12.5mg wkly, Seretode 500 1pbd,Fosamax 70mg once/wk,Folic acid 5mg od,Calchichew,Cocodamol prn;	cell type: CD4+ T-cells",pert
201/0,ctrl
EOM 56 Day mdx rep 1,pert
construct: HDAC2 B10 shRNA;	cell type: Primary human erythroid progenitor cells,pert
E14 cells_control RNAi-rep1,ctrl
3838M patient’s mucosa,pert
MCF7 - MTDH_WT_KD_2,pert
DEX1_24H,pert
"GM9018, unaffected brother",ctrl
"Patient S-855-N, normal colonic mucosa",ctrl
Donor1_6h_Wy,pert
Cochlea_D257A_9mo_4,pert
braf status: BRAF wild type;	tissue: PTC without a BRAF mutation,pert
Liver_nash metformin_no.2,pert
H10_P_B1,ctrl
status: Control;	gender: Female;	age: 61;	tissue: Blood,ctrl
disease state: control;	patient: 4,ctrl
"Nickel 40 µM, biological rep2",pert
A673_CloneAsp14_Dox_36h_2,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M4e;	flt3 status: WT,ctrl
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 7x6x4;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
genetic background: 129SV;	genotype: WFS1 KO;	tissue: hypothalamus,pert
DC-8LA,pert
Muscle control 7,ctrl
ARF1 siRNA knockdown MDA-MB-231 sample 6,pert
renal_vesicle_wild_type_5,ctrl
MO32_8,pert
"fibroblast, MFS subject FB881 rep 4",pert
control_0530-1,ctrl
H9_d15_hepatic differentiated_1,ctrl
MDS25,pert
"AD_TC, biological rep8",pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: 0.3% Tween-20 vehicle,pert
race: caucasian;	age (years): 66;	stage: IB;	grade: 2;	histology: endometrioid,pert
NE-rep3,ctrl
KO 569 R4,pert
"strain background: F2 of C57BL/6J and DBA;	gender: female;	genotype/variation: cbp+/-  (CBP deficient, heterozygous);	age: 3 months;	tissue: hippocampus",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 69 years,ctrl
subject id: 66;	infection: DENV;	status: DF;	tissue: whole blood,pert
H4bt5,pert
MPM tumor 29,pert
92.1 - control #1 - replicate3,ctrl
patient: 241;	current medication: Asacol 800mg bd Azathioprine 100mg;	birth date: 6/25/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/90;	diagnosis date: 11/11/91;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 22;	igr2198: 22;	igr2230: 22;	octn1: 22;	octn2: 22;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/10/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
Strain: B6SJL-G93A-SOD1H;	Age: 110 days,pert
"spleen marginal zone B in WT, biological rep3",ctrl
MCF-10A shControl replicate 3 [set 5],ctrl
11094 Normal Uninflamed descending colon,ctrl
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 39;	maternal age: 36,pert
erStress_twins_AA_1720twin1_500nM_thapsigargin_4h,pert
"AALE-Vector + shGFP, biological rep1",ctrl
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 1,pert
human promyelocytic leukemia cells,pert
TP07-152,ctrl
remitted schizophrenia patient  S03,pert
Oga_KO_MEF_E7_rep3,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.04;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 36;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
LCH4ani,pert
"twin pair: #9;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
"47B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
mT3,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 24h",pert
ID: MLL_00106;	cell type: PBMC;	disease state: control,ctrl
"TLR4 null sham kidney, biological rep2",pert
female_alcoholic_327,pert
Sample ID:TP10;	Twin Pair ID:DCBD3.2 ;	Clinical Status:Control;	Age of Onset:-;	Age at interview & blood sampling:35 ;	Current Age (2007):38 ;	Sex: Female ;	Medication at interview (duration) :None,ctrl
control MLL_00112,ctrl
"SHR adrenals, replicate 2",pert
Embryonic age 17.5 wild-type rep3 (PKD1_38),ctrl
HepG2_control_rep4,ctrl
Bone-Marrow_SMM_S1313,pert
"patient: 207;	current medication: Asacol 800mg BD, Colifoam Enemas Daily;	birth date: 4/29/47;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/88;	diagnosis date: 8/18/88;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/14/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 10/14/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/10/62;	smoking stop date: 3/15/75;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
wild type 2 cell embryo rep2,ctrl
Normal Rat Retinal Müller Cells,ctrl
8DKD_SerumStarved_rep2,pert
"MEKi 4 days, biological rep2",pert
Panc-1 Untreated Control 1,ctrl
EA_Case6_CD8,pert
T2A-LU,pert
cell line: OSE4;	knockdown: control;	cell type: ovarian surface epithelial cells,ctrl
MCL_IGHV_UNMUT (R1897),ctrl
E12.5 Vax2-/- 2,pert
Control_2h_rep3,ctrl
CON28,ctrl
U937-shGSK3A-Construct5-rep2,pert
pediatric AML S21,pert
disease state: sarcoidosis;	biopsy type: surgical;	tissue: lung,pert
224 Day 3 siSC transfected biological rep2,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.8;	choa: 88;	fata: 71;	eea: 1480;	wtkg: 67.1;	perfat: 21.8;	lbm: 50.8;	fat_mass: 1462.78,ctrl
3112-lcm,pert
Wt_cycling_rep3,ctrl
Leg 14 Day Control rep 2,ctrl
Dicer KO replicate 3,pert
tissue: Gastrocnemius muscle;	genotype: KO;	age: OLD,pert
"ShamC-60, biological rep 4",ctrl
Day3 Estrogen treatment replicate 2,pert
FmrWT1_blood,ctrl
"CCALD patient fibroblast, biological rep2",pert
"treatment with MeOPP, replicate 1",pert
01LLE: normal control,ctrl
25 uM cyfluthrin batch 1,pert
wt_P4_rep2,ctrl
wild type 2 cell embryo rep3,ctrl
Control LM2 Cell Replicate 2,ctrl
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep7,pert
GM19238_Kd_CLOCK_1,pert
Brain_Aged_Salineip_4hr_mouse2 (OP2_#62),ctrl
K562 cells control replicate 8,ctrl
GIST_PDGFRA_9,pert
5205 Normal Uninflamed sigmoid colon,ctrl
MCF-10A shCHK1-3 replicate 1 [set 5],pert
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: Mbd3,pert
EA_Control3_CD20,ctrl
MF_43,pert
L-540_Perifosine 10µM_24hrs_2A,pert
Zucker rats,ctrl
LT-HSC Zbtb7a F/F Mx1-Cre+ #3,pert
Kidney_saline_4,ctrl
"Rat liver, treated with DMN, 15 mg/kg in water per orally, extrated 48 hours after treatment, biological rep2",pert
P4_WT_3,ctrl
HTH83 LAMC2 KO 2,pert
healthy myeloid cells 10,ctrl
PTC BRAF mut 3,pert
Mel,ctrl
SOCS3 Cre minus B,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 137min;	race: White;	sex: Female,pert
B9_102412,ctrl
158B,ctrl
"WT, PR03M001v0",ctrl
FHCRCAML4500,pert
WT 0h TPA rep1,ctrl
age: 63;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Muscle PCOS 12,pert
control_16hr_rep1,ctrl
"breast tumor epithelium,47",pert
Mammary gland R1 24 hr rep3,pert
12mo APPSw #2,pert
subject: 21B;	cohort: 21;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 59;	Sex: F;	batch: Batch_5,pert
lean rosiglitazone-3,pert
genotype: E-mu-BRD2;	cell-type: lymphoma_marginal;	splenomegaly: mild;	Ig clonality: oligoclonal,pert
LNCaP + R1881 rep 1,ctrl
CH1800,pert
D_Kin_3,pert
"DOCK8 knockout, thymic, NK1.1+ NKT cells replicate1",pert
healthy CD19 B cells 8,ctrl
ST045849 24 hours_2,pert
HMEC control X HMEC+Interferon gamma 24hrs,ctrl
Normal mucosa 3,ctrl
Halothane 5 exposures-3,pert
Colo-205 DMSO Day 3,ctrl
wildtype Tcof1 [C],ctrl
"GM9017, unaffectd brother",ctrl
pcdh12-deficient mice rep4,pert
Control male 7,ctrl
SKM KO8,pert
pediatric AML S36,pert
cell line: MDA-MB-231;	cell type: Breast cancer cells;	group: SDC1-silenced group,pert
MEF E2F4 KO 2-rep1,pert
V5-P564,pert
ASC_morbidly-obese_biological rep2,pert
myoblasts-expt1_lentiDUX4short-rep2,pert
4A;pretreatment;female;breast tumor; not assessable,ctrl
11401 Normal Uninflamed ascending colon,ctrl
muscle knock out replicate1,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 24;	gender: male,pert
sampleID: SAM630136;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
HES2_Mir122Mut_rep1,ctrl
"gender: Male;	age: 91;	post-mortem delay: 13h;	ph: 6.3;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
8 week old EOM MDX rep 5,pert
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 28;	maternal age: 28,pert
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 3,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 97min;	race: White;	sex: Female,ctrl
pMX-Oct4 and pMX-jhdm1b no vitamin C O+Jhdm1BVc-_1,ctrl
N4_Cy5,ctrl
cell: ES cells;	genotype/variation: UTX knockout,pert
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of saline for one week,ctrl
status: Rapid;	age: 49;	gender: male;	tissue: cultured human fibroblasts,pert
High weight gainer KOZAK2_ABI_HYP_H4,pert
TTF=180min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
H11_S_B1,ctrl
V5-P301,ctrl
Aged 3,pert
CD8 KLF13 KO 1,pert
Individual_3171_PP_sample,pert
"Untreated wild-type NB4, biological rep3",ctrl
At Risk: -;	Age: 14;	Sex: F,pert
Syracuse Low Avoidance (SLA) learning rats 1,pert
Thyroid_ papillary carcinoma 69,pert
patient code: 104;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 1;	ajcc classif. (2002): 2b,pert
SIRT4 KO liver_7232,pert
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-GFP retrovirus,pert
wt 13.5d replicate 2,ctrl
cell type: primary human monocyte-derived macrophages;	differentiation factor: CXCL4,pert
status: Slow;	age: 71;	gender: male;	tissue: cultured human fibroblasts,pert
"human failing LV myocardium, Ischemic57",pert
genotype: Wild Type;	treatment: Low fat diet;	gender: male;	tissue: liver,ctrl
ILD Study Number 1040,pert
breast tumor,pert
"CCM3 shRNA cells passage 7, rep 4",pert
patient2,pert
chip number: 14;	transfection plate: 4;	target gene: NS;	kd level: NA;	rin: 9.1;	transfection date: 2011-10-17,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 7 days;	Tissue: kidney,pert
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 79;	Usage number: 5;	Exposures: 3,pert
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l flox/flox;	days after transduction: 5,ctrl
"1mg/kg/day PFOA, Rep 4, Block 1, lung (low dose)",pert
WFS1 KO USHT_15_329_wt,ctrl
ColonTumor022KAFBT_cta.txt,pert
"Pten WT/null epithelials cells, biological rep2",pert
genotype/variation: Cyp27b1 flox/flox;Cre-;	tissue: breast tumor;	genetic background: FVB,ctrl
CLL20-CD4,pert
MCF7_ARC_Array_1,pert
Run8.aUa.010615d.SkMInS1078D.CEL-IS basal,ctrl
"DMSO Control after 2hr, replicate 3",ctrl
strain background: C57BL/6;	genotype/variation: WT;	infected with: ME49 strain of T. gondii;	time point: at day 5 post-infection;	tissue: ileum,ctrl
CAR.KO_phenobarbitol_rep2,pert
age_years: 39;	sex: F;	ethnicity: Latino;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 56 yr;	population: white;	dsm-iv: 296.54;	age of onset: 28 yr,pert
ancestral background: African-American (AA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,pert
PPAR KO_ctr_115,pert
genotype/variation: Gfi1b KO,pert
"PCB77 treated HepG2 cells at T0, biological replicate 3",ctrl
Normal Puerto Rican control 2,ctrl
"IκBα-deficient animal, biological repeat 2",pert
Control_7,ctrl
fibroblast_Rapid_D10_Media_13,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 16.0;	age of psoriasis onset: 25,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 15b;	treatment: with 100 nM T3 for 6h,pert
parental cell line: WC;	vector: pBabe-human v-src (v-src vector);	replicate: 1,pert
Reh_IKK_1,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: C;	experimental sample name: PC2-R,ctrl
SLE CD19 B cells 5,pert
"SKO-transduced MEFs, Vc+, D10",pert
tissue: Hippocampus;	age: 87;	Sex: F,ctrl
"atRA WT, set 3",pert
WT - Cre Control - 3 mo - repeat 4 - Cy5 - mAdbID:74667,ctrl
"brain, hippocampus: LH6_e1_le1",pert
control siRNA rep2,ctrl
male_control_225,ctrl
T-REx293-NPAP1-induced-2,pert
BxPC3_Ctrl_rep2,ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: RNAi-6A,pert
12475 UC Inflamed descending colon,pert
V5-P463,pert
APOE_KO_RAGE_KO_DM_9W_9,pert
Control 25,ctrl
cerebellum_Pink1 knockout_24 weeks_replicate 3,pert
Donor (Sample 17),ctrl
PBMCs_IS_2 [IS],pert
developmental stage: E14.5;	genotype: Prmt5F/F;	genetic background: mixed C57BL/6 X 129S1/SvlmJ;	cell type: NPC;	treatment: control,ctrl
Cre_day_7-1,pert
Pediatric_GBM_8,pert
sample: #20;	subject: PD case #1;	brain: T-9;	age: 74;	sex: Male;	region: Inferior olivary nucleus,pert
"Lesion Skin, LS-25",pert
"human failing LV myocardium, Ischemic78",pert
Carbo Day1 (75L),pert
"granulocyte, healthy control, biological rep5",ctrl
Individual_999027_NN_sample,ctrl
"brain, cerebellum: RNA#6S_le1",ctrl
Kidney_saline_3,ctrl
fat_Akt1+/-_8wk_rep2,pert
major non-tumor10,pert
"PCB153 treated HepG2 cells at T0.5, biological replicate 3",pert
P4_TR_3,pert
"HEK293 stably EWS-FLI1-transfected, clone",pert
wild-type MEF 3,ctrl
Cadmium_00hr_rep2,pert
ploidy: euploid;	tissue: cerebellum;	developmental stage: P15 postnatal stage,ctrl
control2,ctrl
SKBR3-R_Control_1,ctrl
117B,ctrl
J_LS_Wk2,pert
female_control_393,ctrl
NSC miR-Control 2,ctrl
nmMLCK-/- -SB replicate 2,pert
"Hdh knock-out embryonic stem cells, biological replicate 4",pert
tumor cell line HepG2 with knockdown of HIF-1α rep2,pert
Nrl ko P10 replicate 3,pert
PPARg WT macrophages rep 2,ctrl
CLL,pert
non-treated WT_rep-3,ctrl
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: U,pert
Liver-24 month-wild type-technical replicate 3,ctrl
MCL_IGHV_MUT (R1628),pert
colon_IL10mouse_12weeks_rep5,pert
LICR_HN2_PBS1,ctrl
"Pten null, biological rep1",pert
Hippocampus_Soman_1h_rep2,pert
"GATA6 knockout, biological rep 1",pert
clone type: AtT20 clone types treated with NSBP1 siRNA rep 1,pert
"EtOH, RARaKO, set 2",pert
WT_liver_vehicle 0 mg/kg_96 hr_2,ctrl
MCF7 cell line_resveratrol_250mM_biological replicate 2,pert
"RWPE1 cells, vehicle, 6h, biological rep3",ctrl
"disease group: Nonatopic Control;	Sex: m;	age: 40s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 140;	ige (kiu/l): normal (0-48.5 kIU/L): 2;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
A6_C6_nasal_stem_cell_rep1,ctrl
01L4N_CTRL,ctrl
"Tet1 KD, rep2",pert
cell type: Primary hepatocytes;	strain: SV129;	agent: Wy14643;	time: 6h;	gender: Male;	age: 4 months,pert
"Embryonic cerebral cortex, Trnp1 knockdown, biological replicate 2",pert
MDA_PR_2,pert
"Patient 90N, normal colonic mucosa",ctrl
NME2 induced A549 cell Replicate1,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 12h",pert
Wild-type_macrophages_2h,ctrl
Csbm/m Mouse_cerebellum_Young_saline treatment_Replicate-1,ctrl
e4 Ez f/wt,ctrl
CD8+_Tcells_healthy_donor_6,ctrl
rd1_P8_rep3,pert
"Toral RNA, commercial",ctrl
tissue: adipose tissue (epididymal);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: normal chow,ctrl
BALB-RAG_PBS Replicate 4,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 14 months,pert
"brain, cochlea: [14] Sample #14_le1",ctrl
"222, MUSCLE, Before",ctrl
brain_DLPFC_bipolar B_mr427,pert
Gene expression profiles of Lkb1 WT #6 HSCs,ctrl
age: 38;	sex: F;	disease status: control subject;	Filter number: 85;	Usage number: 5;	Exposures: 3,ctrl
"brain, brainstem: PB7_e1_le1",pert
cell line: MDA-MB-231,pert
Fetal heart 6 ug/kg TCDD rep2,pert
Kidney_Biopsy_Liver_Disease_8,pert
PKBa-/- MEF time 6 replicate 4,pert
36SAGEA2,pert
"Mice_c-myc trans, biological rep3",pert
Substantia nigra normal rep5,ctrl
age: 21dpp;	genotype/variation: wild type;	tissue: testis,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-sp1,pert
Placenta_PE(EO)5,pert
KO - 3 mo - repeat 2 - Cy3 - mAdbID:74594,pert
liver control diet rep6,ctrl
OBF-1 overexpression BCS-3 (Large PreB),pert
Control_4months_retina24,ctrl
SeroNeg-7,ctrl
"Grape extract group, 12 months, patient number 56",ctrl
"Control Day 3, biological rep1",ctrl
"Atm+/+ 30 min post IR, B",pert
"HeLa control, biological rep1",ctrl
race: caucasian;	age (years): 67;	stage: IB;	grade: 1;	histology: endometrioid,pert
Normal-ERα-positive breast cancer 59,ctrl
"Control lung tissue, biological replicate 5",ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 40 yr;	population: white;	dsm-iv: 295.9;	age of onset: 21 yr,pert
S46 WT5	F5/53	S46	wild type	Mouse	10 months	Cerebellum	Female,ctrl
C57BL/6 heart left ventrical,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-tu2,pert
KU_46N,ctrl
Epithelial prostate primary cells from fresh tumor explant,pert
"Normal Skin, Normal-11",ctrl
cell line: Embryonic kidney cell line HEK;	genotype/variation: WT channel;	agent: untreated,pert
Caco2-siRNA-control1-rep2,ctrl
"Ring1B deficient ES cells, biological replicate 3",pert
cell line: A2008;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
"114, MUSCLE, Before",ctrl
status: Slow;	age: 72;	gender: female;	tissue: cultured human fibroblasts,pert
chronic lymphocytic leukemia (CLL 529),pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_2h_1mM_HG-U133A_2_YCHSUP501,pert
Cont subject 04,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 37;	gender: male,ctrl
Placenta_PE(EO)3,pert
"brain, cerebellum: RNA#11S_le1",pert
SCLC cell line DMS53,pert
"EBF1 d0, rep 2",pert
stomach_0h_rep2,ctrl
WT MEF CT30-2,ctrl
Healthy control_sample2,ctrl
"BMMCs from NTAL WT, pLKO.1 infected, nonactivated, biological rep3",ctrl
CEM-C1 cells treated with rapamycin for 3 hours,pert
MDS patient 136,pert
01MLR_PolyRF+,pert
untreated_6hr_rep3,ctrl
Emd KO male 6,pert
knockdown Tcof1 [B],pert
33/OVX/oil/6h/UTX 129 Hoxa-10+/+,ctrl
RE550_KPL4_6-Medi5117,pert
8P-ER-ND,pert
"human failing LV myocardium, Idiopathic34",pert
V5-P052,pert
strain: C57BL6;	genotype: WT;	tissue: hippocampus;	treatment: vehicle control,ctrl
Mock infected murine liver-MO30k-(272)-6hpi,ctrl
4mo wt10,ctrl
Low weight gainer Kozak1_ABI_ING_L3,ctrl
A VIS _B097,pert
condition: Psoriasis;	patient: PS-F;	tissue: LS skin biopsy;	kit: Affy,pert
"Wild type used for GNMT 8 month, replicate 4",ctrl
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep6,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 57;	sex: F,ctrl
chip number: 22;	transfection plate: 3B;	target gene: YY1;	kd level: 0.65;	rin: 9.5;	transfection date: 2012-03-26,pert
Rybp#10 (OHT-)_4d_rep1,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 54 days;	subject: Mouse3;	genetic background: BALB/c,ctrl
IRF4-mut_Th17_cells_42hr_rep3,pert
cell type: fibroblast;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P9;	clone: 0,ctrl
"breast, post AFI treatment (H19_1935)",pert
MCF7 - Control_2,ctrl
ILD Study Number 901,pert
male JAK2 KO liver sample 114,pert
LDLR_LF_1,pert
KPW13_T6_PP_day14_054,pert
subject: 1;	disease: TD;	muscle: GR;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
GM19238_Kd_NFYC_3,pert
"vehicle treatment, 24 hour time point, biological replicate 2",ctrl
"mouse aorta cross strain comparison, C3H_T08_NC_03",ctrl
strain: Swiss;	tissue: Ovary;	agent: Menadione (5uM);	replicate: 2;	age: Post natal day 3-14,pert
subject: 22U;	cohort: 22;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 60kb;	age (y): 43;	Sex: F;	batch: Batch_5,ctrl
NEO-1_HG-U133_Plus_2_Rep2,ctrl
coc-42_C,pert
G4D_Sham_Rep3,pert
strain: 129/Sv;	genotype/variation: wild type;	tissue: madibular condyle cartilage,ctrl
KU_50N,ctrl
hNHEPS_0.1 μM_6 h_rep3,pert
tissue: glioblastoma xenografts,ctrl
age: 31;	sex: F;	disease status: Marfan subject;	Filter number: 38;	Usage number: 1;	Exposures: 4,pert
deletion in 337TR,pert
HVS-CD4-ITK-R335W_unstim_rep3,pert
Pit-1 mutant (Snell) resulting in long lived dwarf pheontype,pert
tissue: skeletal muscle (gastrocnemius);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: normal chow,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.435;	OD280: 0.745;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 287;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"4 weeks old normal mice, cerebellum",ctrl
Bronchial Epithelial Cells control biological 1878H,ctrl
SUM149_siControl_rep3,ctrl
Gastric Cancer PBMC Sample 2,pert
13P-ER-ND,pert
tissue: Embryonic lung E18.5;	genotype: C57BL/6 WT;	age: Embryonic Day 18.5,ctrl
"Diclofenac treated HL-60 cells, biological replicate 1",pert
WT9,pert
BL005,ctrl
"Control Day 2, biological rep1",ctrl
3986-lcm,pert
diagnosis: Normal;	fvc-group: Normal;	tissue: lung,ctrl
"experiment 2, control 2",ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 8 hrs AP20187,pert
"S1P2-KO-neocortex, biological rep9 (female)",pert
"spleen follicular B in IRF8 conditional KO, biological rep2",pert
MDS patient 11,pert
"WT in the absence of tetracycline, rep1",pert
"HCT116 cells with empty vector, technical replicate 1",ctrl
HNF4 Null_61,pert
"NPCxhIPSC CON, replicate 1",ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 19.758;	Ratio: 2.11,pert
"human failing LV myocardium, Ischemic26",pert
cell line: U2OS;	treatment: shControl,ctrl
26 weeks male,pert
U2OS_PRC_shRNA4_pLenti_3,pert
"37B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
cerebrum_WT_12w_rep2,ctrl
genotype/variation: C56B/6 and CD-1 mixed;	strain background: wild type;	age: E9.5;	tissue: E9.5 embryos;	microdissection: posterior second heart field,ctrl
A508 Sham 1 day,ctrl
H3 Ctrl 2h 3,ctrl
Skinbiopsy_96hoursnickel_controlsubject_k3,ctrl
"Pou4f1+/+ cells, transduced with MSCV-Pou4f1 virus_WT-POU_82",pert
E14.5 Tgfbr2 Wildtype Mouse Model Tongue 2,ctrl
sample: #2;	subject: Control case #1;	brain: T-199;	age: 82;	sex: Female;	region: Inferior olivary nucleus,ctrl
whole blood_100760,pert
TA-n7; normal tibialis anterior 7 month,ctrl
s4t1c,ctrl
"eye, retina: Control 2_le1",ctrl
"strain background: C57BL/6J;	genotype/variation: IRF4 -/-;	tissue: spleen;	cell type: Naïve CD4+, CD62L hi, CD25 - T cells;	differentiation condition: Th17;	timepoint: 42 hrs",pert
BAL_21_A0B0,ctrl
Low weight gainer KOZAK2_ABI_HYP_L1,ctrl
11379 Normal Uninflamed ascending colon,ctrl
LKR13_Kras sh-3,pert
Teratoma 0691,pert
MDS patient 129,pert
"MTDH knockdown, biological replicate 3",pert
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 3;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
sample type: HeLa-Ctrl-siRNA-4d;	cell line: HeLa;	knockdown: Ctrl-siRNA;	time: 4d interferon alpha;	treatment: interferon alpha,ctrl
age: 12 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
DR AA4+ replicate 2,ctrl
ANL Chip#36,pert
Bronchial Epithelial Cells MMA biological 2230B,pert
non-malignant FTEn_patient 12,ctrl
siCONTROL + MMC experiment 1,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day14,pert
"Typically Developing Control, Semitendinosus, Patient Replicate 8",ctrl
WT tumor DNA II,ctrl
duration of untreated disease in month:16.1;	age at onset:3.9,pert
OSCE-4T,pert
"Gtf2i Mutant line, biological rep 1",pert
phenotype: control;	gender: female;	case_id: 299;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 23;	brain ph at time of freezing: 6.65;	labeling_batch: 2,ctrl
"disease group: Atopic Dermatitis;	Sex: m;	age: 20s;	race: Native American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 11.6;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 990;	ige (kiu/l): normal (0-48.5 kIU/L): 4136;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: pos",pert
minor HCC4,pert
4-HPR_mammary_2,pert
"Wild type mouse aorta with placebo, biological rep4",ctrl
MDS patient 103,pert
KU_50T,pert
Control_6,ctrl
WT-sham-5 month-R2,ctrl
genotype/variation: Snf2h lens-conditional knockout;	strain: C57BL/6;	age: newborn,pert
UC-32-Aff,pert
tissue: adipose tissue (epididymal);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Troglitazone,pert
"human failing LV myocardium, Ischemic71",pert
Control Day0 (356L),ctrl
cell line: Abelson B cell line,ctrl
CH1810,ctrl
Liver_TAK1KO_Rep5,pert
umbilical cord_bpd: 8I,pert
normal B lymphocytes (NBL 005),ctrl
RatLung_H3h_2,pert
t05,pert
LICR_HN1_PBS1,ctrl
H1299 AZA 0.3 uM (3228),pert
WT mouse (WT_Tal6),ctrl
MLL_PTD06,pert
Diseased individual (ulcerative colitis) of twinpair #7,pert
Aldosterone-producing adenoma (APA11),pert
brain_DLPFC_bipolar B_mr403,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 2,ctrl
B6_Female_CF_rep1,pert
G016,pert
N66s1,ctrl
224 Day 1 siMut12 transfected biological rep3,pert
FVB; No Treatment #5,ctrl
GM19238_Kd_RDBP_1,pert
RAW_0mM_HOCl_#1,ctrl
U2-OS-ERa vehicle control 1,ctrl
"WT, untreated whole heart, individual 1",ctrl
wild type Jurkat cells,ctrl
NPC_VUB03_DM1_2,pert
Control subject 39_biological replicate 1,ctrl
OA1,ctrl
B6_pseudomonas_overexpressor_422,pert
CCI 14d replicate 1,pert
Peripheral blood mononuclear cells (PBMC)-Patient GM T0,ctrl
Plate vs. Nail:  No Fracture,ctrl
lung_control_3,ctrl
Barrett's esophagus (B3),pert
Knockdown Cell Replicate 2,pert
"E18.5 brain, Meg3 knock-out, rep 7",pert
50_129_KO,pert
strain: 129SV;	gender: female;	age: 10 months;	tissue: right ventricle;	genotype: plakoglobin (+/-),pert
MIG control biological replicate 2,ctrl
"Healthy volunteer, Control_11693",ctrl
PB_DON005,ctrl
"U87MG - control siRNA, biological rep1",ctrl
"Trabecular meshwork tissue from POAG donor B. 77y/female/africanamerican. Cause of death: renal failure. Other ocular diseases: cataracts. IOP: 15-25. Drug therapy: Xalatan, cosopt.",pert
"Wild-type Liver, replicate2",ctrl
Skinbiopsy_48hoursnickel_controlsubject_k4,ctrl
"brain, hippocampus: Wt #3406 Cereb_e1_le1",ctrl
"WT in the absence of tetracycline, rep3",pert
"Atm-/- 30 min post IR, A",ctrl
cell type: B-cell;	cell line: OCI-Ly7 DLBCL,pert
Disease_status: Bipolar disorder;	Age (years): 43;	Gender: Female;	Age of onset (years): 25;	Duration of illness (years): 18;	Brain pH: 6.74;	Post mortem interval (hours): 39;	Side of brain: Left;	Fluphenazine mg. Equivalents: 4500;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
"Wild type sham, biological rep2",ctrl
"strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
disease state: healthy;	tissue: extensor digitorum longus;	age at biopsy: 80;	Sex: male;	individual identifier: 2,ctrl
MacularDegen-healthy-3cAv2-s2b,ctrl
Cebpg-/- MEFs at passage 3_biological replicate 4,pert
SimvaVeh3,pert
Control PB C104,ctrl
SP-WT-Nrf2-Female-2,ctrl
BALB/c control (199msn),ctrl
pMX-Oct4 no vitamin C Oct4Vc-_1,ctrl
SLE2-TC,pert
platelet_sickle_16,pert
"human failing LV myocardium, Idiopathic22",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 71,pert
Strain: CBA/N (mutation R28C),pert
HDAC2_B10-rep2,pert
"A673 treated with Doxorubicin for 24 hours with concentration of 119.76 nM (2 x EC50), biological rep3",pert
FBooth-MDX-5Av2-s2,pert
"Control 2, 4hrs",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 106;	Sex: male;	region: LC (locus coeruleus);	age: P23;	genotype: Y/X;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,ctrl
HCC006N,ctrl
Parkinson's disease sample x174,pert
Liver_SRC-2 Knockout_Rep2,pert
BN control replicate 3,ctrl
cell type: Bladder cancer;	treatment: VprBP-depleted,pert
MEFs-5,ctrl
G039-lcm,pert
small intestine,ctrl
V5-P029,ctrl
"Embryonic cerebral cortex, control, biological replicate 1",ctrl
CD8_T_cell_pool_healthy_H05+H06,ctrl
Preglaucoma control rep4 (OHN),ctrl
Dicer KO CD4 T cells 1,pert
Weight:High;	CFstatus:knockout;	Sex:Female,pert
"S1P2-KO-hippocampus, biological rep4 (male)",pert
Kidney_Aqp11+/+_P7_5-1,ctrl
whole tissue section from case 356,pert
"47B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
brain_DLPFC_bipolar C_mr700,pert
cell line: mOS482;	cell type: osteosarcoma,ctrl
G425,pert
Muscle KO Adult 01032,pert
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep4,pert
"12B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
WT_POST_PDE_049,ctrl
RelA_siRNA_0b,pert
C016_Control_M_60,ctrl
control-3,ctrl
MCF10A-HER2(+) 7days,pert
healthy control sample x201,ctrl
Monocyte FCH rep 1,pert
Donor5_6h_Wy,pert
F191G A,ctrl
"This allele contains a deletion of the second coding exon of Gata4, including the start codon and the Nterminal 46% of the coding region. The mice used in this study were all male and on a uniform F1 genetic background resulting from the cross of Gata4WT/Δex2 (abbreviated;	G4D) mice, backcrossed for greater than 8 generations into C57BL6/J, to wild-type FVB/N mice. G4D progeny from this cross were present at weaning at the expected Mendelian ratio (104/218, 48%), survived normally to 18 months of age, and had no evidence of structural heart disease (0 out of 15 embryos examined histologically at E15.5-E18.5). Gata4WT/WT littermates (WT) from these crosses were used as controls.",ctrl
HCC1954 Cell Treated 2,pert
siERK2E224h_3496,pert
Healthy control c6,ctrl
1 hr KLF4 Time Course Control,ctrl
ILD_13,pert
cKO_P68,pert
HeyC2+(3),pert
breast normal 5,ctrl
INSENS 7 0hr,ctrl
PGC-1a KO 3,pert
"patient: 233;	current medication: Asacol 1.2g Asprin 75mg Amilodipine 10mg;	birth date: 2/2/29;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/92;	diagnosis date: 1/1/92;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/1/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/86;	smoking amount: 15-24;	other illnesses: MI 1986, Prostate cancer 1994;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",pert
Normal-BM 2,ctrl
KO 541 L2,pert
Disease_status: Healthy control;	Age (years): 46;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
Patient: E;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
HepG2 cells control 24h,ctrl
ctrl_505,ctrl
"Mut, biological rep1",pert
Control Endometrium Mesenchymal Cell_015.UC182++new,ctrl
ME180 1 hour rep 1,pert
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 5,pert
"age at diagnosis: 68;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: NA;	dfs-month: 9;	dfs-event: 0;	distant metastasis: 0",pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_4_22_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
C3_CLP_wildtype_8,ctrl
"Cbfb-/-, technical replicate 3",pert
"Crohn's Disease subject (21 year old caucasian male, SAK_1260634232)",pert
Liver antiangiogenic-treatment rep1,pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 6,ctrl
E12 distal retina progenitors_mutant_rep 3,pert
strain: C57BL/6J;	day: 6;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 3,pert
"schizophrenia, BA10-56",pert
"650nM MLN4924 after 4hr, replicate 1",pert
"PCB153 treated HepG2 cells at T18, biological replicate 1",pert
age_years: 42;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
Gender: Female;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 0;	Pathological M: 1;	Grade: well;	Tumor Site: Hepatic Flexure;	Drug Treatment: YES,pert
GB 10 65B NO LPA,pert
Nrl-ko-Gfp P2 replicate 3,pert
cerebellum_wild type_24 weeks_replicate 2,ctrl
KU_47N,ctrl
Age: 42;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
"18B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 320;	age-at-biopsy-years: 34,pert
M238_B_DMSO,ctrl
cell line: NOMO-1,ctrl
PGC-1a-/- rep5,ctrl
GM19238_Kd_RDBP_3,pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. E2 + 1 uM vehicle (ethanol) for 24hr;	batch: 1,pert
RNA-DHL6-R406-48H-1,pert
A/J Vehicle liver sample batch 1,ctrl
A549_NS siRNA_biological rep2,ctrl
sample =XCGD2 treatment=Control time=180 (min),pert
"brain, lateral and medial ganglionic eminences: Arx-/Y#1_le1",pert
"gender: Female;	age: 53;	post-mortem delay: 11h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
KO3,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: parotid salivary gland;	donor sex: female,pert
"ESCs overexpressed CA-NFATc3, biological rep3",pert
4117-1 E2F1 Null,ctrl
GB 11 NTA NO LPA,ctrl
Pancreatic Sample 38-Tumor,pert
TN2b-control,ctrl
Obese rosiglitazone-2,pert
TOV112D COUP-TFII-4,pert
genotype/variation: K5-IKKbeta transgenic;	tissue: skin;	age: 32 days;	sex: male;	strain: C57BL6 X DBA2,pert
Tetracycline-inducible glioma cells dox 3,pert
Male 8weekBL6 shamrep1,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 29,ctrl
Phan_005_WT.bleomycin rep2,pert
strain: C57BL/6;	genotype: WT;	gender: Male;	age: 9 weeks;	tissue: kidney;	treatment: intraperitoneally injected with a single dose of vehicle (saline),ctrl
A HID U_B045,pert
"Sciatic nerve, saline control, biological rep1",ctrl
adenosquamous carcinoma 004,pert
SON siRNA rep3,pert
braak stage: BR12;	rin: 72;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
Argyrin A treated 12h_1,pert
Heart left ventricle WT-PBS replicate 3,ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 2",ctrl
Control 4,ctrl
MZ1774 YAPshRNA rep 1,pert
KO-021,pert
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 24 hrs;	Drug: No Rosiglitazone present,ctrl
genotype/variation: Fmr1 knockout;	tissue: blood;	gender: Female,pert
"seminoma specimen, pT2, patient age: 45y; W99 037",pert
V5-P083,pert
01B Con,ctrl
PsOEt-24-Week 2,pert
E14 - nudelko/+ 3,pert
MKK7D transgenic female replicate 5 early timepoint,pert
CML-BM 8,pert
Thyroid_ papillary carcinoma 11,pert
Md02h025,pert
Diaphragm 56 Day control rep 1,ctrl
OSE_470,ctrl
WT_02,ctrl
PsOEt-24-Week 12,pert
Subtype: normal;	Karyotype: normal,ctrl
CKO V3,pert
IM66_control,ctrl
Heart-Base_KO-2,pert
"Acute Myeloid Leukemia, sample 54",pert
day 1 5-FU HSC 2,pert
"DMSO-treated NRK-52E cells at 6h, biological rep 2",ctrl
LJMJDW12,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 19d ID309,pert
siERK5E2 2,pert
"Autoimmune pancreatic islets, no cyclophosphamide treatment, rep 1",ctrl
strain: 4th Gen. FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; Pten+/+,ctrl
IFN_Gamma_6hr_rep2,pert
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14474;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 24h ID211,pert
MDS patient 120,pert
Spleen_ko_1m_rep2,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 24.116;	Ratio: 2.13,pert
D6,pert
Msgn1_48hPlusDox-biological rep1,pert
01LNL: normal control,ctrl
whole tissue section from case 1085,pert
SF539 scramble siRNA replicate 2,ctrl
HUVEC/NmenMC58_WT_1h_rep2_1108,pert
WT C,ctrl
SF539 scramble siRNA replicate 1,ctrl
NCCIT-Consh-rep1,ctrl
"treated with Roziglitazone, 1000 mg/kg in Methylcellulose soln per orally, extracted 48h after treatment, biol. rep4",pert
KU_06N,ctrl
Postmenopausal female. Estradiol treated. Patient 24.,pert
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T2N1,pert
Array Type: HG-U133A_2;	Ratio: 2.04;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
SKBR3_0.1uM_Lapatinib_3,ctrl
M833 / Reference_13431197,pert
brain_DLPFC_bipolar B_mr648,pert
Cell line HeLa_c-myc KD_expt2,pert
HET Brain 59d Mouse1,ctrl
Multiple Myeloma Patient 3,pert
"LckCre Dicer lox/lox KO, biological rep1",pert
MF-34,pert
WT-470,ctrl
cell line: TOM-1;	tissue: Human B cell precursor leukemia,ctrl
"seminoma specimen, pT2, patient age: 40y; W03 025",pert
Mammary gland R1 24 hr rep4,pert
GM19238_Kd_BATF_3,pert
3379-scrape,pert
heart of mouse subjected 2 week to chronic constant hypoxia (2B),pert
AZ-521_uninduced_24h_rep1,ctrl
"breast, post AFI treatment (H6_1346)",pert
D final PC3 AA 2hr,pert
estrogen treated ipsilateral to stroke replicate,pert
WFS1 WT USHT_14_317_ko,ctrl
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 5,pert
01L4G_CTRL,ctrl
KN-smoke-low-5 month-R4,pert
Amoxicillin treated Colon 2 17 days old,pert
695-EV_24hr,ctrl
Normal Puerto Rican control 1,ctrl
"schizophrenia, BA46-81",pert
Lmx1b -/- E11.5 proximal hindlimb pool 1,pert
sirna: Claudin 1;	treated with tnfα: NO,pert
cell type: peripheral blood mononuclear cell (PBMC);	disease status: gastric cancer,pert
11086 Normal Uninflamed descending colon,ctrl
"Setd2 wild type mESCs, biological rep2",ctrl
Brain_nAChRbeta4SubunitDeficent_MiceNob4424,pert
ab077 IM,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q,pert
Carrier-inj_C57_rep1,ctrl
"Biceps, FSHD, cohort 22, subject 22A",pert
"Lesional skin from imiquimod-treated mouse, biological replicate 3",pert
"p38alpha knock out fetal liver E15.5, biological rep2",pert
SP-KO-Nrf2-Female-1,pert
WT-sham-5 month+13d-R2,ctrl
Leg 28 Day control rep 1,ctrl
ku86(wt)_Terc(wt)_2,ctrl
sMPNST_Vehicle_2day_rep1,ctrl
HUVEC_1h_rep1_1103b,ctrl
astrocytes hypoxia batch 3,pert
"Normal skin from Tie2_control mouse, biological replicate 2",ctrl
"39B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
N40975,ctrl
HeTH-4 rep-2,ctrl
shCON1,ctrl
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep1,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: oral cavity;	donor sex: female,pert
C57Bl6N Mouse;	gd17.5 fetal heart,ctrl
6P-ER-ND,pert
Mutated-ERα-positive breast cancer 52,pert
"Control, sample 2",ctrl
CA3,pert
Knockout CS_2_9_KO_1,pert
tissue: Lung;	strain: Lewis;	treatment: exposed to silica,pert
"Patient H-c1095T, MSI colorectal tumor",pert
RNA from HCC_7N,ctrl
Tendon_lesional_rep1,pert
Rat fatty liver11,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A61_8 months_replicate 2,pert
pt. HCL E treated with Vemurafenib 1000 nM for 72h,pert
Patient: H;	Time: 1 week;	Group: responder;	Condition: lesional,pert
del337TR replicate 5,pert
striatum_ctip2_KO_2,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 3 days with concentration of 0.34 uM (2 x EC50).,pert
"Ptenloxp/loxp + pBP-Cre, biological rep 4",pert
GM19238_Kd_BCL3_2,pert
PsOEt-15-Week 2,pert
sample: #22;	subject: PD case #5;	brain: T-72;	age: 81;	sex: Male;	region: Inferior olivary nucleus,pert
tissue: Hippocampus;	age: 74;	Sex: M,ctrl
HP-45c,ctrl
06R044 Control,ctrl
MRL/MpJ heart left ventrical,ctrl
"brain, cerebellum: RNA#41_le1",pert
Day: 12; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 2,pert
Cre_day_5-3,pert
lymphoma_1032_nt,ctrl
umbilical cord_bpd: 3E,pert
condition: Normal;	patient: N_LJ_5;	tissue: Normal skin biopsy;	kit: Affy,ctrl
AA_Control5_CD8,ctrl
healthy myeloid cells 8,ctrl
"Patient 116, baseline",ctrl
"Brg1 KD, replicate A",pert
WT B,pert
subjectid: 5269;	imatinib: NoIM;	lbh589: NoLBH,ctrl
Gata4Loxp/-VillinCre adult male jejunum (6-8wk). GATA4 conditional knockout (mutant) sample.,pert
"Wistar Han;	Crl:Wi(Han), Male, tissue: Heart",ctrl
MiaPaCa2 rep-2,ctrl
tissue: tumor;	disease state: IDC,pert
Individual_4626_NN_sample,ctrl
Cell line BT-474_control_expt1,ctrl
Sample M537,pert
HPB-ALL NBD 2,pert
mn cells sample 1,pert
Muscle PCOS 27,pert
"MAT1A knockout at 15 month age, peritumoral tissues, biological replicate 1",pert
MO_DH3c_SON_NCBI,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 368;	age-at-biopsy-years: 49,ctrl
"Rat liver, treated with Caerulein, 50 µg/kg in saline i.p., extrated 48 hours after treatment, biological rep4",pert
ERRa KO biological replicate 3,pert
"brain, cochlea: [9] Sample #9_le1",pert
2946-scrape,pert
DQD B,pert
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 76;	Usage number: 1;	Exposures: 4,pert
3_month_old_Prnp_knockout_mouse_rep1,pert
erStress_twins_AA_1712twin2_500nM_thapsigargin_4h,pert
Undifferentiated Dicer +/- (D4) ES cell line replicate_1,ctrl
Individual_3983_PN_sample,pert
020109-3,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 43.41918,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 5.2;	colon weight (mg): 156;	colon ratio (mg/mm): 3;	myeloperoxidase activity (u/mg): 0.057;	tissue: colon;	treatment: 5% DSS,pert
healthy myeloid cells 6,ctrl
"3mg/kg/day PFOA, Rep 5, Block 2, lung (low dose)",pert
Pancreatic Sample 33-Tumor,pert
agent: Control;	selection protocol: negatively selected cells,ctrl
cerebellum wild type 6 month replicate 1,ctrl
disease state: paediatric glioblastoma;	age: 17;	gender: M;	h3.3_status: wt,ctrl
Parent 3,ctrl
55_129_KO,pert
RAW_0mM_HOCl_#4,ctrl
HepG2_Phenol rep3,pert
"650nM MLN4924 after 24hr, replicate 3",pert
SLE myeloid cells 12,pert
CML_1_MEP,pert
tissue: peripheral blood;	subject: Control;	rna prep: PBMC;	molecule: RNA extracted from PBMC,ctrl
Treated with 50uM Zinc for 4 hrs -- replicate #3,pert
ILD_8,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: spleen;	sample name: 1-sp2,ctrl
cell line: SKBR3 parental;	treatment: 1uM Lapatinib,pert
17beta estradiol: 10 pM,pert
E12 distal retina progenitors_control_rep 2,ctrl
n7t30m,pert
MDS patient 99,pert
Vehicle-Control;	Vehicle-Control 30 hours set 2,ctrl
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 90;	Usage number: 4;	Exposures: 3,pert
strain: Wistar;	agent (mother exposed to): TCDD;	gender (pup): male;	age (pup): PND70;	tissue (pup): hypothalamus,pert
695_EV_2hr_repeat,ctrl
n23,ctrl
Psoriatic arthritis PsA 18,pert
"TNFa-OMe-P siRNA-C, replicate 2",pert
KN-sham-2 month-R2,pert
microdissected breast cancer cells from case 856,ctrl
THRB 15b mutant + T3 replicate 1,pert
HCT116_shN91_rep3,pert
mutant_ANT_PDE_A6,pert
Kidney_saline iv_mouse #004,ctrl
"Pten WT/null epithelials cells, biological rep1",pert
HeLa cells control 3 (Luciferase siRNA transfection),ctrl
disease state: paediatric glioblastoma;	age: 15;	gender: M;	h3.3_status: wt,ctrl
umbilical cord_bpd: 2B,pert
ic23 -- mock APF on membrane B,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 25.920;	Ratio: 2.12,pert
Mc3T3 control_ 5day_rep2,ctrl
Cell line HeLa_c-myc KD_expt1,pert
Day: 24; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 3,pert
strain background: Mixed background;	genotype/variation: Wildtype;	developmental stage: E13;	gender: not determined,ctrl
"Histidine decarboxylase null myeloid-derived suppressor cell from colon tumor, rep2",pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: lung bronchus;	donor sex: female,pert
PBMC_S1,pert
Hippocampus Control group 2,ctrl
NSC7,pert
Tumor_setB_Ker81,pert
SA3,ctrl
Bl6 - Control - rep1,ctrl
ILD_16,pert
Non-Transgenic replicate 2,ctrl
"E-FABP knockout GM-BMMs, biological rep2",pert
disease state: paediatric glioblastoma;	age: 6;	gender: F;	h3.3_status: K27M,pert
normal bone marrow NBM2,ctrl
3527-lcm,pert
HEK293_Normal_24h_Illumina,ctrl
Heregulin 979-CLA-35,pert
striatum_Pink1 knockout_18 month_replicate 2,pert
Hes6_Castrated OWJ40,pert
2079N,ctrl
Mouse old heart C30-Ht-1,ctrl
L1 062502 Tro2,pert
T1B-LU,pert
Muscle PCOS 19,pert
P14 - Lis1cko/ko 2,pert
Parkinson's disease sample x199,pert
"alveolar macrophages, non-smoker 014",ctrl
"TH cells from LC, Mecp2 null, young time point, biological replicate 1",pert
"age at diagnosis: 70;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: NA;	pgr: NA;	dfs-month: 58;	dfs-event: 0;	distant metastasis: 0",pert
Untreated after 4 days (C1_2),ctrl
Cmah KO_liver _1,pert
"MGSKO, PR02M001v0",pert
s5t3c,ctrl
Control_24h_rep3,ctrl
Myoblast-GATA4-Wt-day3-2,ctrl
FO_spleen_wt_rep2,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.08;	RNA Integrity Number: 9.1;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: tumor;	sample name: 1-tu3,ctrl
"3T3-L1 siControl 24h, biological rep 1",ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#136,pert
Scd1-/- on chow diet replicate 2,ctrl
OVCA429+(2),pert
"ALL_DS, K6 011509",pert
UM17_Mtu_rep3,pert
Bone Marrow Mononuclear Cells;	Unknown Age/Unknown Gender,ctrl
Panc0504 rep-2,pert
"vestibualr organ at E18.5 of Igf1 -/-, biological rep 1",pert
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 15days;	genotype/variation: NSun2 KO,pert
"P40_wt cones, replicate 1 [array]",ctrl
HepG2_Cr rep1,pert
"Cerebral Palsy, Gracilis, Patient Replicate 7",pert
esophageal squamous cell carcinoma from patient E1566,pert
K_LS_Wk12,pert
Donor (Sample 19),ctrl
mef2a_3,pert
MBD1 KO #2,pert
Wild-type E11.5 proximal hindlimb pool 2,ctrl
lung_E18_wildtype_rep2,ctrl
5267 UC Inflamed sigmoid colon,pert
RNA from HCC_7T,pert
Fourth shYY2,pert
"wildtype mouse embryonic fibroblast, biological rep 3",ctrl
Carbo Day2 (409L),pert
Mnk_3226-T-B,ctrl
"human failing LV myocardium, Ischemic20",pert
"Fibroblasts, formoterol, time 3h, patient 1, rep 1",pert
PFC S control 1,pert
non-treated CCRPKO_rep-2,pert
gender: Female;	tissue: Tendon;Biceps;	age: 59;	donor: 34;	disease state: Non-lesional,ctrl
tissue: full-thickness skin;	age: newborn (P0);	genotype/variation: Krt1-/-;	strain: C57BL/6,pert
whole tissue section from case 1343,pert
cell type: primary mouse microglia;	genotype: TLR4 knockout,pert
"brain, hippocampus: LH2_e1_le1",pert
cell line: RT112;	transduced: FGFR3 shRNA 2-4;	doxycycline treatment: yes,pert
"3T3-L1 siControl 24h, biological rep 2",pert
liver_STZ 0.5% quercetin diet_rep3,pert
race: caucasian;	age (years): 58;	stage: IA;	grade: 1;	histology: endometrioid,pert
Waldenström’s macroglobulinemia (WM-BL 31489),pert
gender: Male;	age: 77;	post-mortem delay: 3h;	ph: 6.2,pert
"WildType mice with water, replicate 2",ctrl
"RORalpha1delDE, 2",pert
brain_DLPFC_bipolar C_mr945,pert
Run5.aUa.010110d.SkmDbt1961D.CEL-DB basal,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IB;	age:66;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=advanced gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=poorly differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=not determined",pert
lucif_3,ctrl
KU_16T,pert
CH2118,pert
"FOXP3, mut, REP5, 0h",pert
Non -Transgenic replicate 7,ctrl
431: control mouse 2,ctrl
RNA-DHL6-R406-6H-1,pert
sMPNST_shCONTROL_3day_rep1,ctrl
Rybp#10 (OHT+)_12d_rep2,pert
cell line: MDA-231;	transfection: pCMV-GFP,ctrl
"cell line: D890, WBS, skin fibroblasts;	microdeletion: del(7q11.23);	gender: female;	age at biopsy: 3 years",pert
ILKR211A2,pert
Individual_4362_PN_sample,pert
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 13;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
9-cis-retinoic-acid_Lung_2,pert
CLL20-CD8,pert
MRF control Oligodendrocyte Replicate 2,ctrl
Fetal heart control 8,ctrl
Bronchial Epithelial Cells SA biological 1661X,pert
tissue: brain;	genotype: mutant Lis1 ko/+;	age: P14,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 2;	psoriasis duration: 30.2026009582478;	age of psoriasis onset: 30,pert
"Peripheral blood, patient without recurrent events [N42]",pert
41SAGEA2,pert
A2008+(2),pert
450MM,pert
No_DHT_control_2,ctrl
Control for EGF 12h replicate 1,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.371;	OD280: 0.727;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 283;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
MDS patient 45,pert
Ls174T-pTER-β-catenin con1,ctrl
PGA_MI_nilv_24h_361,pert
U937_ROS_untreated_4h_rep2,ctrl
Total RNA Wildtype-2,ctrl
KO - 3 mo - repeat 5 - Cy3 - mAdbID:74676,pert
major non-tumor6,ctrl
Strain: FVB/N;	Genotype: SP-C-hCFTR+|-/mCftr+|+,pert
NS2_NS010119,ctrl
male_alcoholic_466,pert
strain: C57BL/6J;	day: 18;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 3,ctrl
genotype: E-mu-BRD2;	cell-type: lymphoma_transitional;	splenomegaly: moderately severe;	Ig clonality: oligoclonal,pert
control mouse WT7,ctrl
patient: 201;	current medication: None;	birth date: 4/12/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/19/03;	diagnosis date: 7/4/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: BOTH;	followup recto sigmoid: HISTOLOGICAL;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/7/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/70;	smoking stop date: 1/1/99;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
race: african american;	age (years): 73;	stage: IB;	grade: 3;	histology: endometrioid,pert
background mouse strain: C57BL/6;	source: liver;	genotype: Rap1 knockout,pert
Subtype: RAEB2;	Karyotype: other,pert
WT STR PDE10i 14,pert
HUVEC_4h_rep1_1103,ctrl
gender: F;	age at blood draw: 50;	tissue: whole blood,pert
"Typically Developing Control, Semitendinosus, Patient Replicate 5",ctrl
patient: 5;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
25 uM cyfluthrin batch 3,pert
HUVEC/NmenMC58_frpC/frpA_4h_rep2_1112,pert
lineage: colorectal;	cell line: SW480;	treatment: treated with TNKS inhibitor for 4h,pert
Transgenic ATF6-MER mouse;	Strain: C57BL6;	Gender: male;	Age: ~30 weeks;	Tissue: heart LV;	Treatment: tamoxifen,pert
N22,ctrl
Fetal heart control 2,ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: MIG control;	biological replicate: 1,ctrl
HUVEC treated with Non-sense SiRNA  biological rep2,pert
"cochlea at P7, wt, biological rep 2",ctrl
Bone-Marrow_MM_M942,pert
wt PBS5,ctrl
Heart_WT_3,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: C;	tissue: Skeletal muscle (quadriceps),ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_L015,pert
"Knockout sham, biological rep2",pert
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC;	2nd technical replicate,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	sex: Male,pert
treatment: naïve;	transgenic variant: AChE-R;	tissue: Pre-Frontal Cortex;	genetic background: FVB/N,pert
EP10_adipose_pcos,pert
MSE_D_G73A,pert
ESC_Zfx-flox_Replicate2,ctrl
"Patient 12, Atheroma plaque",pert
"non-AD_TC, biological rep6",ctrl
GNMT-KO mouse hepatocytes (sample 1),pert
histology: control;	disease state: healthy control;	tissue: brain white matter,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#1233,pert
adenocarcinoma (ADC1),pert
gender: Male;	age: 91;	post-mortem delay: 13h;	ph: 6.3,ctrl
Normal esophageal epithelium (N6),ctrl
R6/1 22 week transgenic_BBB4,pert
race: african american;	age (years): 65;	stage: IA;	grade: 2;	histology: endometrioid,pert
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 40;	gender: f;	treatment: NSAIDs,pert
batch: A;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,ctrl
HDAC1_knock_out_embryonic_stem_cells_biological_rep2,pert
n09,ctrl
colon_C57mouse_6weeks_rep2,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-6;	Primary Site:Vestibule;	Age:72;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis",pert
Lmna H222P homozygous male 3,pert
Aorta_APOE-deficient with atherosclerosis_1,pert
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: gastrocnemius,pert
"TNFa siRNA-A, replicate 3",pert
Sox3 null Sample 4,pert
Strain: RPE65-/-;	Age: 6 months;	Tissue: retina,pert
sample J 18.5 wt,ctrl
"knockout liver, biological rep 2",pert
liver-AHRWT-cornoil-rep5,ctrl
Bone-Marrow_SMM_S1403,pert
"nasopharyngeal carcinoma, specimen T19",pert
"Cell line SLM2, mutant status WT, condition Treated with Sorafenib 2",pert
"SIRT3KO, high-fat diet, rep1",pert
WT4,pert
"patient 14, arm treated with pimecrolimus",pert
9-cis-retinoic-acid_LIVER_2,pert
Fat Tro1,pert
Subject #8019-2d Postinfection,pert
WT_P59,ctrl
"mutant triceps, biological rep2",pert
db/m 3-3,pert
A549_EGFplus_rep1,ctrl
"MAT1A knockout at 8 month age, biological replicate 4",pert
PsOEt-16-Week 2,pert
WT / Reference_13425560,ctrl
PPC1_non-target shRNA_replicate 1,ctrl
individual: Control6;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
Cervical cancer_1898T,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous endotoxin challenge""",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
status: Slow;	age: 64;	gender: female;	tissue: cultured human fibroblasts,pert
DMSO4_6H,ctrl
"20 days old prosaposin knockout mice, cerebellum",pert
brain_healthy_control_sampleid_jg1744,ctrl
P53 Non failing heart biopsy,ctrl
Control PB C107,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: monosomy7/del(7q),pert
Extract:LOX-1:213303;	Extract Description:LOX1_Untreated_6hr:213303;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.1;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.96;	Quality: Background Mean Dev.:0.14;	Quality: Absent (%):57.57;	Quality: Absent (%) Dev.:0.53;	Quality: Scaling Factor:0.44;	Quality: Scaling Factor Dev.:1.44;	Pretreatment [C]:LOX1;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213303;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_6hr;	RNA extraction source key [A]:282295673,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep3,ctrl
Aorta_APOE-deficient and captopril treated_1,pert
Extract:LOX-1:213301;	Extract Description:LOX1_Untreated_6hr:213301;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.09;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.02;	Quality: 3'/5' Mean:1.62;	Quality: Background Mean Dev.:0.52;	Quality: Absent (%):57.11;	Quality: Absent (%) Dev.:0.88;	Quality: Scaling Factor:0.53;	Quality: Scaling Factor Dev.:0.69;	Pretreatment [C]:LOX1;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213301;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_6hr;	RNA extraction source key [A]:282295653,pert
strain/background: C57BL/6;	genotype/variation: hsp70 transgenic;	tissue: brain (right cerebral hemisphere);	age: 7 days;	treatment: PBS control;	time post-infection: 5,pert
No or early 2 rep8 (retina),pert
Lung-sarcoidosis-rep2,pert
Brain_Adult_Salineip_4hr_mouse1 (YP1_#58),ctrl
ILD_20,pert
muscle wild type replicate2,ctrl
"fibroblast, control subject NF8 rep 1",ctrl
NSC_FBS_L2,pert
PGA-RMM-15m-1aA-s2,pert
heart MHC-Plin5 4,pert
Age: 39;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 1293del40;	Family History: Yes,ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 5,pert
Pax_S1,pert
braak stage: BR34;	rin: 63;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
"lymphoblastoid cell line from F6.01, one out of seven of sensitive group, 50*10e6 cells",ctrl
ab010 IM,pert
strain/background: mixed B6/129;	tissue: thymus;	cell type: CD4+CD8+ thymocytes;	genotype/variation: LckCre Dicer lox/lox knockout,pert
cell type: HeLa cells,ctrl
"brain, adrenal medulla: Sample#A4 (Exp pt 4)_e1_le1",pert
2907-lcm,pert
061J3: normal control,ctrl
patient: 128;	current medication: Pentaza;	birth date: 3/19/81;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
1_DMSO-1,ctrl
"Acute Myeloid Leukemia, sample 68",ctrl
Transgenic nr 614,pert
age_years: 66;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
1218-6C,ctrl
11106 UC Uninflamed descending colon,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 2,pert
"Placebo treated, HIV-1 positive male, day 14 (4)",ctrl
gender: female;	age (years): 47;	evolution time (years): 1;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
Ad infected murine liver-MO30k-(665)-6 hpi,pert
L428+MAT_rep2,pert
RKO_rep_6,pert
HEK293_pLKO_R3,ctrl
umbilical cord_nobpd: 7I,ctrl
EF1a-control_2,ctrl
patient code: 123;	gender: Male;	age: 74;	tumor grade: 3;	t-stage: 1;	n-stage: 1;	ajcc classif. (2002): 2b,pert
"male,15,Caucasian",pert
OVCAR-10-(3),ctrl
"Aorta, saline 7d, #2",ctrl
"Male, Wistar, 0 access to cocaine, amygdala",ctrl
strain: Wistar;	gender: male;	tissue: spinal cord;	treatment: acrylamide,pert
disease state: tuberculosis;	tissue: PBMC,pert
CML_7_CMP,pert
HT29 sensitive cells replicate 1,pert
BAL_31_A0B1,ctrl
"MAT1A knockout at 3 month age, biological replicate 4",pert
striatum_wild type_18 month_replicate 3,ctrl
Bronchial Epithelial Cells control biological 1734Y,ctrl
gender: Male;	age: 90;	post-mortem delay: 6.75h;	ph: 6.2,ctrl
first-episode BP patient 77_biological replicate 2,pert
WT3,ctrl
PGA-RMM-2h-2aA-s2,pert
LT 407 +/T after nicotine-induced seizures,pert
age: 49;	sex: F;	disease status: control subject;	Filter number: 88;	Usage number: 1;	Exposures: 3,ctrl
cell type: primary mouse microglia;	genotype: wild-type,ctrl
Capan2_NC-2 biological rep2,ctrl
status: Slow;	age: 73;	gender: male;	tissue: cultured human fibroblasts,pert
siLMO3_oligo1_0_rep2,pert
tissue: skin;	individual: Patient N-5;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
"Trip12 mut/mut, biological rep2",pert
cell type: mouse embryonic fibroblasts (MEFs);	genotype: KSR1 -/-;	expression: KSR1 and GFP;	background strain: DBA,ctrl
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/lacZ; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 18.5; Tissue: whole kidneys from 9 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",pert
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/flox, Foxp3-ires-Cre;	gender: male;	age: 16 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",pert
BM_02417,ctrl
Untreated WT - repeat 3 - mAdbID:102767,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: CITCO; 6-(4-chlorophenyl)imidazo[2-1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime",ctrl
R5_Pseudomonas_wildtype_422,ctrl
"Biceps, FSHD, cohort 13, subject 13B",pert
high grade serous carcinoma_patient 8,pert
Granulocyte-Macrophage Progenitors,ctrl
"fibroblast, control subject NM4 rep 1",ctrl
"S1P3-KO-hippocampus, biological rep5 (female)",pert
pt. HCL E treated with DMSO for 72h,ctrl
major non-tumor8,pert
tissue: brain;	genotype: WT;	genetic background: C57BL/6,pert
"Pten null, biological rep2",pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: MEF2D shRNA,pert
ErbB2 1,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 8h,pert
colon_epithelium_IL10mouse_12weeks_rep5,pert
sepsis patient #3,ctrl
YFP+Foxp3+ r1,ctrl
GEIM63-U133A-Norm,ctrl
A375 control-3,ctrl
OCI-Ly7 NTsiRNA 2,ctrl
Diaphragm 14 Day control rep 3,ctrl
S259A-4,pert
CLL 149-05 LMP-420,pert
3 h-apra-2 nM,pert
healthy control_3,ctrl
KU_37T,pert
"COP strain, male, age 21 weeks, treated with the synthetic estrogen diethylstilbestrol (DES) for 12 weeks",pert
Pancreatic Sample 20-Tumor,pert
AtT20 cells treated with control siRNA rep 2,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 31.41096,ctrl
Healthy control c3,ctrl
normal;	Biopsy Negative Control,ctrl
"Mel18 shRNA, biological rep1",pert
cell type: Anaplastic thyroid carcinoma;	expression: TL3 SCR shRNA;	cell line: TL3,ctrl
lesion_preUV_patient1,pert
ab149 N,ctrl
"WT caudal vertebral bone, rep4",ctrl
CD4+_Tcells_healthy_donor_3,ctrl
age: 40;	sex: F;	disease status: control subject;	Filter number: 99;	Usage number: 1;	Exposures: 2,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 44 yr;	population: white;	dsm-iv: 295.9;	age of onset: 16 yr,pert
strain: c57/bl6;	weight: 25-30g;	age: 4 month;	gender: n/a;	tissue: whole trachea,ctrl
"U-87 glioma cell line with shp105, biological rep1",pert
cell line: prostate cancer cell line LNCaP;	genotype/variation: negative control siRNA,ctrl
U-87MG-PK19 set 3,pert
EDL-t7; transgenic extensor digitorum longus 7 month,pert
PND28 Rat Testis_Rat230-2_12hr Corn Oil_Animal#61_04005,ctrl
TP06-872-lcm,ctrl
tissue: Lung;	strain: B6D2F1;	infection: uninfected;	time: control,ctrl
Sample isolated from wild type Foxp3 CD4+YFP+Ly5.2+ T cells following treatment with HR-MMPCreGFP and six week adoptive transfer.,ctrl
"brain, hippocampus: CH4_e1_le1",ctrl
CH2127,ctrl
STHdhQ111/Q111-C,pert
clone 2-1,pert
"Overexpress TFPIbeta, biological rep. 1",pert
E16.5 Top2b+/+ brain,ctrl
ES2 NT-3 25nM,ctrl
"MAT1A knockout at 15 month age, tumoral tissue, biological replicate 5",pert
parental biological replicate 1,ctrl
cell line: MCF10A;	treatment protocol: SFN,pert
normal B lymphocytes (NBL 533),ctrl
Muscle PCOS after pioglitazone 202,pert
Nonlesional Epithelium Psoriasis rep4,pert
Saline T00278942,ctrl
CD8 KLF13 KO 2,pert
platelet_sickle_17,pert
BT474-J4_GSK089_24-3,pert
MacularDegen-injured-5aAv2-s2,pert
"DMSO-treated NRK-52E cells at 6h, biological rep 3",ctrl
Muscle JDM (YJD-JDM-10UA-S2),pert
tumor cell line HepG2 with knockdown of HIF-2α rep1,pert
Kidney_Biopsy_Liver_Disease_7,pert
"ID: MLL_00235;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
Muscle JDM (YJD-JDM-12UA-s2),pert
"lymphoblastoid cell line from T5.02, one out of seven of sensitive group, 50*10e6 cells",ctrl
jzo020-rp1-v5-u74av2-met.TXT,pert
VGLL4 HUES6 1,pert
MCF7_siRNA_ESR1_24h_AM0003_8.1,pert
strain: backcrossed 3-5 generations on C57BL/6 from FVB;	rna: TRAP;	driver: S100a10;	line: ES691/p11 KO;	tissue: cortex;	treatment: vehicle,ctrl
genotype:Rb null;	Age: e12.5,pert
MacularDegen-injured-4cAv2-s2,pert
WT_P14_D3_Effector_rep3,ctrl
Sle1a R1,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 3 days with concentration of 0.17 uM (EC50).,pert
EA_Case5_CD4,pert
Wild Type Time 0 replicate 2,ctrl
strain: BALB/c;	cell type: CD8 T;	genotype/variation: wild type,ctrl
"33B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
A2AR_KO_saline_24h_rep4,pert
tissue: Hippocampus;	age: 90;	Sex: M,pert
disease state: control;	patient: 20,ctrl
cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: Vehicle (0.1% ethanol);	time point: 24 hours,ctrl
"Global gene expression of NASH patient, P34",pert
muscle_Akt1+/-_8wk_rep1,pert
Brg1 mutant 2 cell embryo rep2,pert
EP47_adipose_pcos,pert
CME-Emerin3d-2MA-S2,pert
"MCF7 cells stably transfected with pCDNA3.1, passage 6",ctrl
WT,ctrl
Nasal Epithelium Instilation Formaldehyde 400mM 6h ID365,pert
expression array - BRAIN 3,ctrl
colon_IL10mouse_12weeks_rep1,pert
KU_32N,ctrl
Cisplatin-treated Rb-/- MEFs-a,pert
FVB_6h_DMSO,ctrl
"siDsRed-2, biological rep2",ctrl
neuron_rep8,ctrl
TRPM2-AS siRNA rep1,pert
"breast tumor epithelium,5",pert
Peripheral blood mononuclear cells (PBMC)-Patient CV T1,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 1 day;	treatment: 2R4F whole mainstream smoke 125 µg/ml, treatment over 1 day, 3x1h exposure per day",pert
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 7.8;	colon weight (mg): 158;	colon ratio (mg/mm): 2.03;	myeloperoxidase activity (u/mg): 0.043;	tissue: colon;	treatment: 5% DSS,ctrl
ID: MLL_00109;	cell type: PBMC;	disease state: control,ctrl
"P16 control OC base, biological rep 1",ctrl
"Patient 23, Atheroma plaque",pert
MF-35,pert
Muscle control (YJD-JDM-54UA-s2),ctrl
Testis CREMKO 0h batch 4 [TeKOh00.28],pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: del5q plus other,pert
Tolerizing allografts 70 days No.2,ctrl
H5bt5,pert
Thoracic mammary glands were collected from three virgin wild type F1 CF-1/FVB mice at 16 weeks of age; RNA was pooled before synthesis of cDNA.,ctrl
A2008+(1),pert
SRF Mut. IgM+IgD+ (GBF0611),pert
tissue: peripheral blood from 8-10 E12.5 embryos;	genotype: Cbfb-/-;	progeny from cross: Cbfb+/- x Cbfb+/-,pert
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: cisplatin;	timepoint: 24 hours,pert
"Hdh knock-in embryonic stem cells, Q111 line, biological replicate 1",pert
PBMCs_Control_12 [IS],ctrl
cell type: Human melanoma cell line;	cell line: M238;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
Mut2,pert
Bronchial Epithelial Cells SA biological 2040W,pert
220D0,pert
whole tissue section from case 260,pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
VPA Treated Rep 4,pert
disease state: Mantle Cell Lymphoma;	cell type: B cell lymphocyte;	ighv status: MUT,pert
SLE CD19 B cells 1,pert
pediatric AML S30,pert
colon_epithelium_IL10mouse_12weeks_rep3,pert
NPC Brain 37d Mouse1,pert
3 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24717,pert
HeyA8-(1),ctrl
Seguin_IDR_BrownNorway_Liver_control1,ctrl
developmental stage: E14.5;	genotype: PtenloxP/+ and PtenloxP/loxP,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-18;	Primary Site:Floor of Mouth;	Age:52;	Sex:M;	TNM:T4N2M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	;	",pert
05_PAH,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 27.08767,pert
agent: control;	strain: DBA;	tissue: mesentery,ctrl
BL6_6h_Wy,pert
mef2a_1,pert
Control_6months_retina1,ctrl
cortex_HtrA2_KO_rep2,pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: control (unimplanted samples were snap-frozen immediately);	host treatment: N/A,ctrl
09SAGEA2,pert
HEK293_A08_R1,pert
"patient 038b, normal, homogenized",ctrl
esophageal squamous cell carcinoma from patient E1535,pert
"WT mouse lung, biological rep2",ctrl
chip number: 1;	transfection plate: 1;	target gene: NS;	kd level: NA;	rin: 9.8;	transfection date: 2011-03-29,ctrl
Cervical Cancer C437,pert
SF539 PARK2 siRNA#1 replicate 1,pert
mouse cerebellum at P7 knockout 5,pert
platelet_Ctrl_11,ctrl
Mening SWB WB NP 3a,pert
strain: C57BL/6;	gender: male;	genotype/variation: WT;	treatment: non-treated;	tissue: liver,ctrl
mouse cerebellum at P30 knockout 3,pert
NZW/LacJ Vehicle liver sample batch 5,ctrl
n3_lo_5,pert
Cisplatin-treated Rb-/- MEFs-c,pert
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: ZNF750 gene silencing,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 82, HPV 16",pert
whole tissue section from case 1437,ctrl
DN4 cells sorted from mouse n°135 (Cre+),pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: NLGN3 shRNA,pert
MPA 1,pert
"peripheral ganglion, unknown: control 24 hr _3",ctrl
skin.wt.replicate6,ctrl
432MM,ctrl
5922012047_D,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_6h_Con_HG-U133A_2_YCHSUP501,ctrl
IPMA 1,pert
MRF control Oligodendrocyte Replicate 4,ctrl
Individual_4394_NN_sample,ctrl
S4,pert
Disease_status: Healthy control;	Age (years): 34;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.87;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"Acute Myeloid Leukemia, sample 51",pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 316;	age-at-biopsy-years: 39,pert
subject: 19A;	cohort: 19;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 22kb;	age (y): 65;	Sex: M;	batch: Batch_4,pert
COLO829_shSCR_DMSO_A,ctrl
strain: FVB;	developmental stage: newborn (4-day-old);	tissue: hippocampus;	genotype/variation: Prnp+/+,ctrl
CHB PBMC_sample 4,pert
"depression, BA10-35",pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 5d ID137,pert
Fat FC1,ctrl
Ischemic cardiomyopathy_G53,pert
P1 mouse eyeball extracted total RNA_wt1_GSM618315,ctrl
tissue: peripheral blood;	subject: Control;	rna prep: PAXgene;	molecule: total RNA,ctrl
"SHR adrenals, replicate 3",pert
HF0285_U133P2,pert
X50 WT1	F2/8	X50	wild type	Mouse	16 months	Cerebellum	Male,ctrl
healthy control sample x005,ctrl
Adrenocortical adenoma with CTNNB1 mutation (S45P),pert
"cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: 100 nM 1,25(OH)2D;	time point: 6 hours",pert
CyP 1hr 2,pert
"IL22KO3_ileum, 5 days post-infection with T. gondii",pert
"cell type: Normal human diploid WI-38 lung fibroblasts, CCL-75(TM), passage 7-12.",ctrl
D5_non-transgenic,ctrl
CLL 379-01 Control,ctrl
293T cells stably transfected with 1 scramble shRNA construct. Control cell line for 293TsiLL cell line (LEDGF transcript knockdown - PSIP1 gene).,ctrl
Huh7_TGFbeta_minus_1,pert
"MLD, biallelic AML MLL_00259",pert
P0 - epsilon129s6 2,pert
ATCC CRL-1555,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 24h ID136,pert
"Control Day 0, biological rep2",ctrl
Hunk WT rep6,ctrl
WT12,pert
6 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24723,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M0;	flt3 status: WT,ctrl
"GNMT knockout at 3 month age, biological replicate 3",pert
"Mice_non trans, biological rep1",ctrl
BP patient 91_biological replicate 1,pert
"GM8830, MS-proband",pert
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep5,pert
"Nickel 140 µM, biological rep4, repeated microarray",pert
IFNb-treated MEF 3,pert
"ARD842, CAIS, F, GOF, 1 x ETOH, 24h",pert
Caco2-siRNA2-rep1,pert
pMX-Oct4 and pMX-jhdm1b vitamin C O+Jhdm1BVc+_1,pert
cell line: Breast carcinoma cell line Cal51;	genotype/variation: control;	agent: MMC,ctrl
H18 HA 12h 1,pert
Seguin_IDR_BrownNorway_Liver_control3,ctrl
Thyroid_papillary carcinoma 67,pert
"CD14+ at baseline, biological replicate 3",ctrl
Normal cortex of patient 131,ctrl
Patient: J;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT1 knockout, non-treated",pert
Ls174T-L8 dox3,pert
CD25+Xbp1WT#2,ctrl
MDS patient 88,pert
Dgcr8 KO replicate 3,pert
"Cell line:  Fibroblast TTP KO cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",pert
Huh7 cells_JFH-1 Infected 18 hours_ rep1,pert
Wild type caerulein rep1,pert
K562 DMSO sample 12,ctrl
4_b,pert
Biceps_Control_4,ctrl
"Ctrl OBCs, post doxycyclin withdrawal, rep4",ctrl
DBA_6h_DMSO,ctrl
cell line: SV589;	knockdown (days): 0;	treatment: Serum Starved; no EGF,pert
COLO829_shSCR_DMSO_B,ctrl
12483 UC Inflamed descending colon,pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.5;	Post mortem interval (hours): 8;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
MCF7_E2_24h_rep1,pert
ILKR211A1,pert
Tissue: tumor; Gender:male; Age:33  Tumor stage:T1N0MX,pert
cell line: KU-812;	tissue: Myeloid leukemia cells;	agent: untreated,ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_L112,pert
cell type: myoblast;	transduction: lentiDUX4fl,pert
CME-Emerin3d-3MA-S2,pert
control (day 0) replicate 1,ctrl
JIA PBMC Pre treatment A235_L015,ctrl
"breast tumor epithelium,32",pert
"Empty vector, collagen plate, rep1",ctrl
patient: 4;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Gender:F;	Age:49;	Tissue:Mucosa,pert
genotype: Sgk1-/-;	cell type: Th17,pert
COV434 Mutant [RR1017],pert
Normal myocardium sold commercially (A),ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 35 yr;	population: white;	dsm-iv: 296.74;	age of onset: 14 yr,pert
Ing1-/-_MEF_rep1,pert
8 hour tunicamycin CHOP-/- C,pert
PGA-RMM-330m-1aA-s2,pert
"Ulcerative Colitis (27 year old caucasian female, SAK_1286520426)",pert
tissue: Frontal cortex;	age: 82;	Sex: M,ctrl
C_AN14757_F,ctrl
N9,ctrl
untreated_1,ctrl
"PPARg d2, rep 1",pert
GM19238_Kd_STAT6_3,pert
siHIRA 1,pert
"Patient S196, MSI colorectal tumor",pert
OSCE-18T,pert
H4-II-E-C3_high_rep1,pert
Muscle-AMPKgamma3-ko-5,pert
KM_056T,pert
"S1P2-KO-hippocampus, biological rep2 (male)",pert
Nr4_ctrl,ctrl
"brain, hippocampus: PH4_e1_le1",pert
The nucleus accumbens from a neurologically normal Jpanese male (aged 60 yr).,ctrl
"wild type ES cells, biological replicate 1",ctrl
"fibroblast, control subject NF12 rep 1",ctrl
"Control Proximal, Small Intestine 2 21 days old",ctrl
Parkinson's disease sample x204,pert
V5-P597,pert
"Rat liver, treated with ANIT, 125 mg/kg in corn oil per orally, extrated 48 hours after treatment, biological rep4",pert
OCI-Ly1_ctrloverexpression,ctrl
Cervical Cancer C484,pert
UC-38-Aff,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 2x1h exposure per day",pert
"Patient 2, Atheroma plaque",pert
A375 cells 24h Control rep1,ctrl
5271 UC Inflamed sigmoid colon,pert
Whisker pad mutant biological rep1,pert
CD4IncTp2-4,pert
sampleID: SAM630129;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
Ulk1/2-/- + IFNβ 2,pert
Scd1+/+ on chow diet replicate 5,ctrl
Mutated-ERα-positive breast cancer 9,pert
subject: 19U;	cohort: 19;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 79kb;	age (y): 41;	Sex: F;	batch: Batch_4,ctrl
Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model MEPM 2,pert
colon_CRC_1739,pert
n4t24h,pert
"MCF-10A cells, overexpression ΔNp63α, biological rep3",pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.60;	Post mortem interval (hours): 11;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Peripheral blood mononuclear cells;	TTF=70min;	Race=White;	Sex=Female,pert
Psoriasis-Patient-F,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.413;	OD280: 1.719;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 7.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 323;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Msgn1_48hMinDox-biological rep3,ctrl
"A673 treated with DMSO vehicle control for 3 days, biological rep1",ctrl
ILD Study Number 1074,pert
uterus_P4_PRKO_4hrs_rep3,pert
Ishikawa_VeryLowDose_BPA_48h_rep3,pert
liver control diet rep4,ctrl
PTEN+/-IKK2ca/ca ep_A,pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 62;	gender: m;	treatment: NSAIDs,ctrl
clone type: AtT20 clone types infected with empty vector rep2,ctrl
whole blood_100683,pert
BL Day 1 siMut10 transfected biological rep3,pert
WT vehicle (7991003040_E),ctrl
46A;pretreatment;female;breast tumor; not assessable,ctrl
"RES-enriched Grape extract group, 6 months, patient number 22",pert
testis wild type replicate3,pert
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 8.1;	colon weight (mg): 200;	colon ratio (mg/mm): 2.47;	myeloperoxidase activity (u/mg): 0.016;	tissue: colon;	treatment: 5% DSS,ctrl
brain_DLPFC_bipolar B_mr613,pert
CML_3_HSC,pert
266C0,ctrl
Heart RNA,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 40, stage IIIB, HPV 16",pert
MOLF/EiJ Vehicle liver sample batch 4,ctrl
LNT-4,pert
MCI-020,ctrl
"non-AD_TC, biological rep16",ctrl
Normal Tail Skin 2,ctrl
parental cell line: WA;	vector: pBabe-human v-src (v-src vector);	replicate: 1,pert
9N,ctrl
H2med,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 73,pert
Gender:M;	Age:36;	Tissue: Mucosa,pert
genotype/variation: ApoE-/-;	strain: C57BL/6;	mouse provider: Jackson labs (backcrossed >10 generations against C57BL/6 background).;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: diabetic,ctrl
5720 Wild Type Mouse White Adipose Tissue,ctrl
ic24 -- APF on membrane B,ctrl
"age at diagnosis: 44;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 16;	dfs-event: 0;	distant metastasis: 0",pert
"Retina from control mouse at ZT20, biological rep 3",ctrl
muscle WT 1 control,ctrl
"129P3/J ACU, Rep1",pert
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P1,pert
Strain:  B6.V-Lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,ctrl
Cerebellum_nontransgenic control X50_16 months_replicate 3,ctrl
"Normal subject (42 year old caucasian male, SAK_1782808510)",ctrl
S2_Sham_wildtype_8,ctrl
"brain, hippocampus: Ctr-6h-P15-II_e1_le1",ctrl
age_years: 48;	sex: M;	ethnicity: Black;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
Advanced IPF_explant_lower lobe_rep152,pert
LCL Concordant for Epilepsy twin pair 2 (CCE2.2)(TP32),pert
control participant P303,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 201,ctrl
"Brg1 KD, replicate B",pert
siRNA Med12 [K3],pert
"non-AD_TC, biological rep14",ctrl
healthy control sample x112,ctrl
liver western diet rep2,ctrl
"Heart, MAT1 CKO, 2 wk, sample 2",pert
CD19_selected_B-cells_before_R_rep2,ctrl
phenotype: alcoholic;	gender: female;	case_id: 402;	age: 75;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 9;	brain ph at time of freezing: 6;	labeling_batch: 1,pert
RNA from HCC_6T,pert
"Normal cervix epithelium, Age 49",ctrl
Control Endometrium Endothelial Cell_032.UC208+-,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 75 years,ctrl
"Strain: C57BL/6;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",ctrl
whole tissue section from case 856,ctrl
"heart, non-transgenic mice at 90 days of age",ctrl
TB 2,pert
N10A Normal-frontal,ctrl
Sox2-shRNA-3,pert
"fibroblast, control subject NF4 rep 2",ctrl
Strain: 129S2/SvPasCrlf;	Sex: male;	Genotype: L1CAM knockout (-/Y),pert
"NPTX1 shRNA Day 2, biological rep3",pert
Mnk_3149-R-7,pert
tissue: left lung;	genotype: Gata5 KO;	age: 8-week-old,pert
cell type: Primary hepatocytes;	strain: BL6;	agent: Wy14643;	time: 6h;	gender: Male;	age: 2 months,pert
E14 - 14-3-3Epsilon 1,pert
TN 1,ctrl
Nonlesional Epithelium Nonatopic Control rep4a,ctrl
45A;pretreatment;female;breast tumor; responder,ctrl
"BL6/C57 mouse heart, control, rep1",ctrl
"pancreas, ethanol diet, replicate 1",pert
"PC-3 Gefitinib, biological rep1 [mRNA]",pert
Tsc1-deficient CD4 naïve cells KAI279,pert
GFP Untreated 2hr 282295483,ctrl
"P50_C-DGCR8 KO cones, replicate 2 [array]",pert
BxPC3-WT rep 4,ctrl
MPA 4,pert
A263insGG_mut4a-,ctrl
chondrocyte_control_rep1,ctrl
Frontal_Cerebrocortex_Vehicle_6hr_rep1,ctrl
061J0: normal control,ctrl
Genotype: p38alpha wt;	Age: E15.5,ctrl
Substantia nigra normal rep6,ctrl
Morbidly obese PCOS patient,pert
Septic shock;	gender: Male;	Survivor;	organism: None,pert
HP-23,ctrl
Ctr MCF10A.B2 2,ctrl
BL308,pert
"Lesional skin from imiquimod-treated mouse, biological replicate 1",pert
10 days TAC-3,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 28;	gender: female;	years of disease: > 10y;	treatment: phototherapy;	time: pre-UV,pert
Liver-5 month-wild type-technical replicate 1,ctrl
gender: male;	dietary group: resveratrol-enriched grape extract (C);	time point: 6 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),pert
VEC B,pert
phenotype: alcoholic;	gender: male;	case_id: 326;	age: 61;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 21;	brain ph at time of freezing: 6.93;	labeling_batch: 2,pert
RNA from HCC_39N,ctrl
"Neo6, no treatment",ctrl
"Ulcerative Colitis (49 year old caucasian female, SAK_1286431014)",pert
braak stage: BR34;	rin: 65;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
human esophageal squamous cell carcinoma cell line_KYSE50,pert
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, peripheral blood;;	disease: (severe) aplastic anemia (SAA) post therapy / in hematological remission",pert
A_Kin_3,pert
SRF silenced EtOH rep 2,ctrl
WT HPC PDE10i 10,pert
clone type: AtT20 clone types overexpressing NSBP1SE protein rep1,pert
WT5 SPLEEN,ctrl
Wild type mice on a high fat diet (CH 3),ctrl
Squamous cell lung cancer X33nml,ctrl
nucleus accumbens ctrl replicate 3,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 46 yr;	population: white,ctrl
Control (shControl-4),ctrl
control MLL_00110,ctrl
Tissue: HepG2 cells;	Gender: Male;	Source: ATCC;	1st technical replicate,pert
UTX knockout (KO) cell line 2,pert
WT_d00_eX_vs_WT_d21_eX,ctrl
cells: spleen marginal zone B cells;	genotype: WT;	genetic background: C57BL/6J,ctrl
Parkinson's disease sample x015,pert
C2C12 myotubes 10uM H2O2,pert
Ischemic cardiomyopathy_G12,pert
Ishikawa_HighDose_BPA_8h_rep3,pert
cDNA ak 12,pert
strain: 129;	cell type: EBs;	genotype/variation: Trim33-KD,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_2h_4mM_HG-U133A_2_YCHSUP501,pert
phenotype: control;	gender: male;	case_id: 367;	age: 57;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 18;	brain ph at time of freezing: 6.6;	labeling_batch: 1,ctrl
10_C57_KO,pert
Human Chronic HIV Sample C101-CD8+ T cells,pert
+4hr Wnt (dye swap),ctrl
CD-48-un,pert
9-cis-retinoic-acid_mammary_3,pert
16B,pert
Strain: In-house BALB/c mice; Gender: Male; Age: 4 months old; Tissue: Brain; Treatment: 4 hours post Saline ip.,ctrl
TF1_controlsiRNA_1,ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 18 weeks;	genotype/variation: VhlhKO",pert
"vastus lateralis biopsy, 56 year-old healthy sedentary male (#3)",ctrl
liver_wild type_12 weeks_replicate_1,ctrl
Adult 7d SNI; Biological replicate 4,pert
"Healthy control mice, time point 3 week",ctrl
"FOXP3, mut, REP4, 72h",pert
Pancreatic Sample 31-Normal,ctrl
tissue: lung;	genotype/variation: Tmem1002loxP/2loxP;ROSA26+/CreER,pert
"Wild type used for GNMT 3 month, replicate 5",ctrl
117A,ctrl
62SmokeH,ctrl
treatment: EtOH + cycloheximide;	genotype: RARaKO;	cell line: F9,ctrl
KU_06T,pert
LJMJDW9,ctrl
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.94;	Post mortem interval (hours): 29;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: A;	experimental sample name: PC4-R,ctrl
Liver-24 month-wild type-technical replicate 2,ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs cultured for another 24h,ctrl
Thyroid_ unaffected_paired with PTC77T,ctrl
shCDK8_Time_0_1,pert
"Peripheral blood, normal control [N55]",ctrl
"Fourth ventricular choroid plexus from Otx2ko mice at E13, biological replicate 2",pert
genotype/variation: Wild-type (E14K);	cell type: embryonic stem cells,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.692;	OD280: 1.387;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 49;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
gender: Female;	age: 88;	post-mortem delay: 7h;	ph: 5.7,pert
11089 Normal Uninflamed descending colon,ctrl
cerebellum_Pink1 knockout_18 month_replicate 3,pert
HL60-shGSK3A-Construct6-rep1,ctrl
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 2;	time: 6h,pert
Control replicate 6,ctrl
DMN-CtrHippo10d-2bAv2-s2,ctrl
control-noDox-rep3,ctrl
Control (C277),ctrl
t01,pert
Patient 4 b,pert
Wild Type Time 1 replicate 1,ctrl
"Crohn's Disease subject (31 year old caucasian female, SAK_1313134987)",pert
"Mut, biological rep3",pert
Untreated WT - repeat 4 - mAdbID:102768,ctrl
BS2011051053,ctrl
"Aorta, saline 14d, #4",ctrl
CH1+(3),pert
Vehicle 12 hours_3,ctrl
R1_saline_wildtype_422,ctrl
UC-35-Aff,pert
V5-P313,pert
Liver_hyperglycima_no.9,pert
cell line: HL-60;	replicate: Replicate1;	treatment: shLuciferase,ctrl
Mc3T3 AA_ 5day_rep3,pert
R6/2 (untreated) 5213,pert
85 year old male,pert
WT-CD80lo-mTEC-sample1,ctrl
BAT_KO_5,pert
GV oocyte_control_rep1,ctrl
Normal cortex of patient T163,ctrl
HeLa control knock down 3,ctrl
cell type: bone marrow cells;	strain: DBA/2,pert
KN-sham-5 month+13d-R4,pert
age: 58;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"experiment 2, control 3",ctrl
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P3,ctrl
GV oocyte_Rnf2 mut_rep2,pert
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 19;	gender: f;	treatment: NSAIDs,pert
chronic lymphocytic leukemia (CLL 32489),pert
LY2 control-siRNA tamoxifen treated rep1,pert
"NASP siRNA treatment, sample #4",ctrl
MIY_day_7-1,ctrl
SENS 1 4hr,pert
"age at diagnosis: 50;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIC;	t (extent of primary tumor): T3;	n (lymph node metastasis): N3a;	er: NA;	pgr: NA;	dfs-month: 17;	dfs-event: 1;	distant metastasis: 1",pert
"208, MUSCLE, After",pert
RO38,pert
THRA wt + T3 replicate 3,pert
"C57BL/6J ACU, Rep2",pert
"Cell culture. A549 treated by MK886, control 4",ctrl
CON_C,ctrl
Male 8week AJ CBDLrep1,pert
Treatment 1,pert
HepG2_Hg rep2,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.02;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
"Grape extract group, 6 months, patient number 56",ctrl
CML_3_MEP,pert
WT1R1,pert
Cell line expressing inducible GFP-progerin. Induction: day 10. Replicate B,pert
DK-first,ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 41;	gender: male;	tumor grade: AII,pert
483MM,pert
Normal-ERα-positive breast cancer 49,ctrl
23 wt E11.5 heart,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 47;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siCtrl;	agent: EtOH;	time: 4h,ctrl
sample: #15;	subject: Control case #5;	brain: T-2017;	age: 74;	sex: Male;	region: Dorsal motor nucleus of the vagus,ctrl
[OBF-1]-2,pert
5 STAT6KO control macrophage,pert
chip number: 15;	transfection plate: 3B;	target gene: STAT6;	kd level: 0.74;	rin: 9.5;	transfection date: 2012-03-26,pert
MDS patient 163,pert
e2 Ez f/f Mef2c-cre,pert
cell type: Primary hepatocytes;	donor: 1;	agent: Wy14643;	time: 24h;	gender: Male;	age: 63 years old,pert
Liver_normoglycima_no.6,ctrl
Subject #8017-2d Postinfection,ctrl
"Data 1, overnight control",ctrl
WM-266 cells transfected with CONTROL siRNA - Replica 1,ctrl
A549 AZA 3 uM (3214),pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 69;	tissue: Blood,pert
genotype/variation: MBD1 WT;	tissue type: thymus;	cell type: medullary thymic epithelial cell (mTECs),ctrl
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 11,pert
13a_b,pert
12459 Normal Uninflamed descending colon,ctrl
HCV_Control_1,ctrl
V5-P079,ctrl
CD8+_Tcells_non_severe_asthmatic_4,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 347;	age-at-biopsy-years: 43,ctrl
A673 cell line that has been treated with Puromycin for 24 hours with concentration of 0.18 uM (2 x EC50).,pert
cell type: embryonic stem cells [E14];	transfected with: pooled non-specific siRNAs (control),ctrl
02-P CF,pert
HMEC X BC14 : 0096-5k,pert
WT 3 1782,ctrl
status: Normal;	age: 59;	gender: female;	tissue: cultured human fibroblasts,ctrl
M24met_control_5,ctrl
PGC-1alpha -/- differentiated brown fat cells expressing a control siRNA (rep1),pert
Scd1-/- on very low fat diet (TD03045 from Harlan Teklad) replicate 5,pert
genotype: Wild-type;	replicate: 3;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,ctrl
PTC BRAF mut 13,pert
1099-03-A,pert
HT-WT-9B,ctrl
wt_P6_rep2,ctrl
C2C12 myotubes 0uM H2O2 rep 3,ctrl
U937_naive_untreated_4h_rep2,ctrl
Muscle PCOS case 231,pert
A549 DAC 1 uM (3220),pert
Tendon_non-lesional_rep1,ctrl
jzo011-rp1-v5-u74av2-met,ctrl
P 25 Si RNA,pert
MEFs-2,ctrl
MO_DH1c_SON_NCBI,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 4",pert
Rat fatty liver6,pert
"Deltoid, control, cohort 07, subject 07U",ctrl
PBMC_C4,ctrl
"fibroblast, MFS subject GDO1051 rep 4",pert
APOE_KO_RAGE_KO_DM_9W_11,pert
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ scramble;	treatment: Ca 0.09mM, 72 h",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 87;	Sex: male;	region: CB (cerebellum);	genotype: Y/X;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,ctrl
FmrKO3_brain,pert
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 2",pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
tissue: white blood cells;	age: 16.94;	Sex: female,pert
"Liver from STZ-treated mice, biological replicate 4",pert
Txnip deficient tumor 24 months sample 1,pert
Muscle PCOS control 15,ctrl
con-9_C,ctrl
Series 3; young; 6 weeks after fracture,pert
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 1,pert
HEK293 cells siRNA BAHD1 biological rep1,pert
"WT in the absence of tetracycline, rep2",pert
8x  Ez f/fMef2c-cre,pert
"Benign, pooled tissue, prostate",ctrl
gender: female;	batch: 2;	age (years): 44;	patient id: Non_severe_2;	fev1 (% predicted): 87;	fvc (% predicted): 92;	medication: flixotide;	cell type: CD4+ T-cells,pert
treatment: control scrambled siRNA;	cell line: H441,ctrl
HPB-ALL Control 1,ctrl
Cell bank no: RCB1648;	Cell name: Hep G2 ;	Sex: male ;	Age of sampling: 15 years ;	Tissue derived: liver ;	Case history: hepatocyte carcinoma ;	Life span: infinite ;	Classification: Transformed ,pert
HEK293_MIF siRNA 2#_24h_Illumina,pert
Strain: C57BL/6J;	Gender: male;	Age: 8 weeks;	Tissue: whole brain,ctrl
"4B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
MacularDegen-healthy-7bAv2-s2,ctrl
lymphocytes_HD_F_43y_2,pert
Clozapine treated 12weeks AffyGC RMA rep1,pert
siCABIN1 3,pert
Wt1-null MEFs-2,pert
WT25+_rep3,ctrl
Individual_4164_PN_sample,pert
pediatric AML S16,pert
CD34-005,ctrl
Individual_5325_PP_sample,pert
"Patient 1, control tissue",ctrl
cell type: dental pulp cells,pert
Male mice from mdx (C57BL/10ScSn-Dmdmdx/J) line were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 1,pert
human esophageal squamous cell carcinoma cell line_KYSE180,pert
Subject #8010-2d Postinfection,ctrl
BCell_lymphoma_transitional_sample2,pert
brain knock out replicate2,pert
genotype/variation: c-Myb sufficient;	age: 4-5weeks,ctrl
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
6h_RA2,pert
"Cbfb+/+, technical replicate 1",ctrl
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 24 hrs,ctrl
subject id: c2;	infection: control;	status: control;	tissue: whole blood,ctrl
EA_Control2_CD20,ctrl
Pax3 WT E14.5 palatal shelves 11,ctrl
"Normal Skin, Normal-7",ctrl
PBMC from T cell LGL leukemia patient #121 (TLGL121),pert
11A;pretreatment;female;breast tumor,ctrl
MDA-MB-231_siZMPSTE24_rep.1,pert
5260 UC Uninflamed descending colon,pert
1212-3heart_OTT1KO,pert
CEM Control 1,ctrl
0152-01-C,ctrl
MCAD + LPS 2,pert
S021_Scz_M_71,pert
CEM11_T5_PP_day7_041,pert
mdx5cv TA sample 1,pert
cell line: Y79;	passage: 25;	cell type: Retinoblastoma,ctrl
TOV112D cells_treated with NSC319726_biological rep3,pert
"brain, brainstem: PB6_e1_le1",pert
Adipose-5 month-Myc heterozygous-technical replicate 2,pert
"Transgenic, snap frozen, gastrocnemus muscle, 7month age animal",pert
Empty vector replicate 1,ctrl
monocytes_T14_rep3,pert
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep8",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.621;	OD280: 0.822;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 130;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Sex: female;	Age at operation: 70 years;	Site: upper arm;	Size in cm: 3x5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
Control 3_Huh7 [HDAC2 siRNA subset],ctrl
Heart_WT_02,ctrl
Wild type_kidney_1,ctrl
ic12 -- cell line 2 treated with mock APF#2,ctrl
Lmx1b -/- E11.5 proximal hindlimb pool 2,pert
RNA from HCC_2T,pert
Age: 59;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: No,pert
Mening UNSTIM WB SW 1b,ctrl
T2-FP_spleen_wt_rep2,ctrl
3D-cultured chondrocytes from normal donor 1,ctrl
TAp63 alpha Q540L 24h without induction s3,pert
genotype: Wild Type;	stimulation: non stimulated;	cell type: B cells,ctrl
"E2A CLP LY6D-, biological rep2",pert
Genotype: Wild Type,ctrl
cell line: Du145-PCAT1 (HTB-81);	age: < 20 cell passages from derivation,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: fresh air, treatment over 5 month, 4x1h exposure per day",pert
Peripheral blood mononuclear cells;	TTF=140min;	Race=White;	Sex=Male,pert
"brain, hippocampus: KA24-III_e1_le1",pert
r19,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.7726,pert
A515 MI 7 day,pert
"MLD, biallelic AML MLL_00266",pert
Etoh 1,ctrl
agent: LMP-420;	selection protocol: negatively selected cells,pert
tissue: Epididymal adipose;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 690,ctrl
Normospermic individual: Sample N5,ctrl
A2058 Ctrl siRNA Rep1,ctrl
"Cervical cancer cell line, HT-3",pert
RAW_0.35mM_HOCl_#3,pert
race: african american;	age (years): 51;	stage: IB;	grade: 3;	histology: papillary serous,pert
T2C-LU,pert
H4-II-E-C3_untreated_rep3,ctrl
cell line: HeLa cervical carcinoma,ctrl
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: monuron 24 hr,pert
SRF silenced EtOH rep 3,ctrl
E14 - Lis1cko/ko 3,pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 24h, biological rep3",pert
BCells_WildType_day2_REP3,ctrl
Leg 56 Day control rep 2,ctrl
intestine_PPARa-knockout_control_rep1,pert
Liver sample from Control group (N53),ctrl
"IN1472 siPD treated, Biological replicate1",pert
Tendon_lesional_rep14,pert
NOD RIP-Aire27 islet rep3,pert
RNA from HCC_16N,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EZH2. Sample A,pert
"Crohn's Disease subject (46 year old black female, SAK_1307657998)",pert
WT-smoke-med-5 month+1d-R4,ctrl
ET 5,pert
microdissected breast cancer cells from case 662,pert
"adenocarcinoma at 20wk, biological rep 1",pert
25 uM chlorpyrifos batch 1,pert
"Biceps, FSHD, cohort 19, subject 19A",pert
Heterozygous mouse pDCs,pert
normal scar treated with hydrocortisone-1,pert
chip number: 14;	transfection plate: 5;	target gene: RXRA;	kd level: 0.88;	rin: 8.9;	transfection date: 2011-10-17,pert
age: 40;	sex: F;	disease status: control subject;	Filter number: 85;	Usage number: 1;	Exposures: 3,ctrl
Control subject 23_biological replicate 1,ctrl
Skin_Lox_Control_Rep1,ctrl
KN-smoke-med-5 month-R1,pert
age: 35;	sex: F;	disease status: control subject;	Filter number: 87;	Usage number: 4;	Exposures: 3,ctrl
Liver KO8,pert
"C57BL/6 female sick, 125",pert
Muscle KO Aged 1106,pert
At Risk: +;	Age: 13;	Sex: F,pert
RT4D6_mutant Sox10 siRNA_rep1,ctrl
N69s,ctrl
CD4DecTp2-8,pert
"Mel18 shRNA, biological rep3",pert
PU.1 KD HSC 2,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 23;	sex: F,ctrl
"Epidydimal white adipose tissue from WT after 16 weeks of high fat diet feeding, replicate 1",ctrl
LY2 control-siRNA tamoxifen treated rep3,pert
HRas-v12 transgenic female replicate 4 late timepoint,pert
P81 dilated cardiomyopathy heart biopsy,pert
Wild type CD4+ CD3-stimulated 1,ctrl
FU-OV-1-(3),ctrl
"Rat liver, treated with DMN, 15 mg/kg in water per orally, extrated 48 hours after treatment, biological rep5",pert
patient id: 14;	tissue: Normal cortex;	gender: Female;	age: 64;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
cell type: preadipocytes;	tissue: white adipose tissue,pert
MLL_00112,ctrl
Dengue Hemorrhagic Fever Patient 60,pert
ILD Study Number 1039,pert
"10mg/kg/day PFOA, Rep 1, Block 2, lung (high dose)",pert
cerebrum_PSNA_ 4w_rep2,pert
"BL from CLL patient, isolated using CD19-PE and CD5-APC.",pert
tissue: spleen Ter19+CD71high sorted cells;	genotype: WT;	age: 3-month,ctrl
11B,pert
HNF4 Null_190,pert
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 80;	Sex: male;	region: LC (locus coeruleus);	age: P24;	genotype: Y/Mecp2-;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,pert
Plate vs. Nail:  6 Week Plate,pert
N5+6,ctrl
DMN-CtrHippo18d-1cAv2-s2,ctrl
"0mg/kg/day PFOA, Rep 1, Block 2 liver (high dose)",ctrl
"ES cell control, RNA 297",ctrl
whole tissue section from case 59,pert
Parkinson's disease sample x109,pert
Tsc1-deficient CD8 naïve cells KAI288,pert
"human peripheral blood derived monocytes, 4 hour LPS stimulation, biological rep1",pert
Treg cells WT replicate 1,ctrl
cell type: PGC;	genotype/variation: Tcfap2c KO,pert
control mice colon rep 1,ctrl
patient: 30;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Spleen_ko_4m_rep2,pert
"vestibualr organ at P90 of Igf1 +/+, biological rep 1",ctrl
"Histidine decarboxylase null myeloid-derived suppressor cell from colon tumor, rep1",pert
Carbo Day7 (417L),pert
Control  VZ15,ctrl
scrambled biological rep3,ctrl
PBMC from T cell LGL leukemia patient #114 (TLGL114),pert
sample =XCGD2 treatment=Control time=90 (min),pert
"E18.5 brain, Meg3 knock-out, rep 1",pert
3335M patient’s mucosa,pert
"human failing LV myocardium, Idiopathic17",pert
"Untreated Testes, biological rep 3",ctrl
S022_Scz_M_44,pert
N1_Cy3,ctrl
Hunk WT rep1,ctrl
KO-control-2,pert
WT-080,ctrl
chronic lymphocytic leukemia (CLL 35513),pert
negative control inhibitor (NTC1)_24-9,ctrl
Day: 15; Drug: Heroin; Phase: Withdrawal; Replicate: 2,pert
gastrocnemius-30 months of age-control diet-biological replicate2,ctrl
FVB; No Treatment #9,ctrl
"brain, hippocampus: C240-III_e1_le1",ctrl
Disease_status: Healthy control;	Age (years): 61;	Gender: Female;	Post mortem interval (hours): 30;	Braak stage: 0;	Cause of death: Lung cancer,ctrl
KO_IL-6_400_rep3,pert
Individual_4208_PP_sample,pert
APOE_KO_NODM_9W_7,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 5d ID139,pert
Tendon_non-lesional_rep22,ctrl
139A,ctrl
HF1493_U133P2,pert
BJ-iPSC replicate 1,ctrl
colon_adenoma_980,pert
V5-P524,pert
WT-sham-1 day-R1,ctrl
"ALL_NDS, K36 011609",ctrl
New El-Ashry 006.CEL,pert
"patient: 204;	current medication: AZA 200mg, Insulin, Asprin, Atenolol, Simvastatin;	birth date: 8/15/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 7/1/02;	diagnosis date: 8/1/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 11/1/04;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 0;	nod 702: 0;	nod 908: 0;	dlg5 133a: 0;	nod 1007 fs: 0;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/58;	smoking stop date: 1/1/01;	smoking amount: 25+;	other illnesses: Type 2 DM 02/2004.-Gout.;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
"WT, LPS 1hr",pert
shRNA4-1-plusDox-rep2,pert
PGA-lv_1h_512,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: DMSO for 48h,ctrl
shScr replicate 4,ctrl
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ shNotch3;	treatment: Ca 0.6mM, 72 h",pert
Wildtype 2,ctrl
Donor (Sample 16),ctrl
AKT_PLACEBO_12hours_2,pert
BAL_47b_A0B1,ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 1 - Technical Replicate 2,pert
"PCB77 treated HepG2 cells at T6, biological replicate 1",pert
NM22 healthy control,ctrl
gender: male;	strain: BALB/c;	tissue: liver;	diet: Western diet for 20 weeks,ctrl
chip number: 15;	transfection plate: 6;	target gene: NS;	kd level: NA;	rin: 9.6;	transfection date: 2012-03-26,ctrl
chip number: 13;	transfection plate: 3B;	target gene: BCL3;	kd level: 0.62;	rin: 9.7;	transfection date: 2012-03-26,pert
10 weeks old,pert
Panc-1 Ctrl 2,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 85min;	race: White;	sex: Female,ctrl
Ishikawa_Control_24h_rep2,ctrl
Carbo Day7 (311R),pert
09EXPLANTH,ctrl
tissue: cervical cancer cell line HeLa,ctrl
Male 6-8 week BALB/c grafts in Male 6-8 week C57Bl/6 host,pert
strain/background: C57BL/6;	genotype/variation: AhR-deficient knockout (AhR-/-);	tissue: lung;	treatment: PBS control,pert
C_AN04479_T,ctrl
CH1-(1),ctrl
atopic eczema P8,pert
"TNFa-OMe-P siRNA-C, replicate 8",pert
"non-AD_FC, biological rep12",ctrl
condition: Normal;	patient: N_LJ_1;	tissue: Normal skin biopsy;	kit: Affy,ctrl
Against CDK19-1 rep3,pert
Psoriatic arthritis PsA 7,pert
"cell line: 9837, control, skin fibroblasts;	gender: female;	age at biopsy: 3 years",ctrl
Huh7 cells_JFH-1 Infected 18 hours_ rep3,pert
Liver_Nrf2 Control_rep1.,ctrl
Rat fatty liver15,ctrl
sepsis patient #4,ctrl
HUVEC_6h_rep1_1103,ctrl
tissue: liver;	treatment: vehicle;	strain: A/J,ctrl
Bronchial Epithelial Cells MMA biological 2130X,pert
Young 4,ctrl
"human failing LV myocardium, Idiopathic54",pert
Parkinson's disease sample x123,pert
Gender: Male;	Age: 34;	Ethnicity: White,pert
PE_D_647,pert
IPMA 2,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 4x1h exposure per day",pert
Manca 1,pert
Recent-onset T1D_sample4,pert
coronary smooth muscle cells metoprolol replicate 1,pert
cell type: Primary hepatocytes;	donor: 4;	agent: Wy14643;	time: 24h;	gender: Female;	age: 54 years old,pert
"patient: 111;	current medication: Paracetamol;	birth date: 9/5/82;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: FH of CD, Path Increased lymphiod in TI Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
treatment: Arid3a overexpression high;	cell line: J1 ES cells;	sample type: single colony,pert
WT - Cre Treated - 12 hrs - repeat 2 - Cy5 - mAdbID:61754,ctrl
HeLa_01-04-05 TP3_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
db/db 10-4,ctrl
Control Braak α- synuclein Stage 0 C4SN,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M1;	flt3 status: WT,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 13 days;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 15 days recovery, 3x1h exposure per day",ctrl
01LMN: new onset sJIA,pert
cell line: HT1080;	clone: 9;	genotype: Wild type,ctrl
Glioblastoma_3,pert
genetic background: C57BL/6;	tissue: liver;	genotype: LmnaG609G/G609G knock-in;	gender: female;	age: 3 mo,pert
lean control-1,ctrl
PGA-RMM-4h-2aA-s2,pert
CD4DecTp2-12,pert
cerebellum_KO_2,pert
At Risk: +;	Age: 12;	Sex: M,pert
mES cells rep2,ctrl
PGA-MAH-AJ_PBS24h-1aA-s2,ctrl
Adult Sham; Biological replicate 6,ctrl
MCF7 DMSO+EtOH,ctrl
sample: #4;	subject: Control case #2;	brain: T-346;	age: 84;	sex: Male;	region: Inferior olivary nucleus,ctrl
WT - Cre Untreated - 0 hrs - repeat 3 - Cy5 - mAdbID:54710,ctrl
0h Kin Cel.05,pert
myoblasts-expt1_untransduced-rep2,ctrl
2073N,ctrl
passage: 10;	cell type: fibroblast;	treatment: overexpressing prelamin A and ZMPSTE24;	cell line: GM00038,pert
"cell line: Hec50co endometrial cancer cell line;	cell line traits: Loss of p53, loss of hormone receptors ER and PR;	disease state: Grade 3 endometrioid adenocarcinoma;	genotype/variation: control",ctrl
control participant P351,ctrl
patient: 51308;	sample: normal,ctrl
patient7,pert
SCD1 -/- liver rep5,pert
HeLa cells;	(cervical cancer cells),ctrl
R7E 9,pert
sample =Healthy2 treatment=Control time=360 (min),ctrl
01-0007A_Day1_0,pert
blank_5,ctrl
PGA-HMO-Obese-2aUA-s2,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 08/23/05;	# cells: 48;	Sex: male;	region: M1;	age: 48;	genotype: Y/Mecp2-;G42/-,pert
"EBF1 d4, rep 3",pert
MCF10A-Her2-rep2,pert
Healthy controls; individual=CJ; time=2; beverage=water,ctrl
"TAMs sorted from vehicle control tumors, biological replicate#2",ctrl
cell line: U251;	transduction: stably expressing non-target control shRNA,ctrl
Bronchial Epithelial Cells MMA biological 1781H,pert
lymphocytes_HD_F_41y,pert
age: 35;	sex: M;	disease status: control subject;	Filter number: 102;	Usage number: 5;	Exposures: 3,ctrl
Astrocytoma_3,pert
"Acute Myeloid Leukemia, sample 71",ctrl
Sex: male;	Age at operation: 60 years;	Site: upper arm;	Size in cm: 9.9x7x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
RNA from HCC_10N,ctrl
Ero1-WT induced biological repA,pert
strain: 129/Ola;	cell type: embryonic stem cells,ctrl
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p28;	strain: E14,pert
GSK-3 inhibitor effect on MLL leukemia cells - 1,pert
LOX1 0hr 282295453,pert
R7E 6,pert
8 week old EOM control rep 4,ctrl
BSKO 2,pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: siRNA targeting FOXP1;	genotype/variation: siRNA-mediated FOXP1 knockdown,pert
tissue: retina;	age: postnatal day 2;	genotype: rd1,pert
"array 20, unimplanted",ctrl
2112-01-A,pert
Control spleen - Biological Replicate 4 - Technical Replicate 1,ctrl
"Endometrium, postmenopausal, control, 12",ctrl
K562 STI sample 5,pert
GB 5 NTA +LPA,pert
Y SIT_B076,ctrl
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep8,pert
"A673 treated with Puromycin for 24 hours with concentration of 0.18 uM (2 x EC50), biological rep1",pert
Menadione (5uM) rep 2,pert
Esophagus TG replicate 1,pert
Control subject 46_biological replicate 1,ctrl
Braak α-synuclein stages 5-6  BR56_1SN,pert
A39 NES 142Q TG2	F5/52	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Female,pert
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 36;	maternal age: 34,ctrl
B6C3F1/J Vehicle liver sample batch 3,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 42 yr;	population: white,ctrl
Cebpg-/- MEFs at passage 3_biological replicate 3,pert
01L4M: normal control,ctrl
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14532;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
ES cells_control_rep1,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 uM;	treatment time: 8 hours,pert
disease: type 1 diabetes;	gender: female;	cell type: endothelial progenitor cell,pert
prostate tumor 4,pert
52A;pretreatment;female;breast tumor,ctrl
Untreated Myd88 knockout - repeat 5 - mAdbID:102775,pert
H1P_7,ctrl
WT-Fibr1 6,ctrl
Tissue: normal thyroid; Gender:male; Age:33,ctrl
Diagnosis: MDS/AML;	Age: 51y;	Gender: Female;	Blast %: 71;	Source: PB;	Cyto: t(15:17);	FLT3 ITD: 1;	FLT3 TKD: No Data,pert
Parkinson's disease sample x006,pert
2P-M4,pert
jos1987,ctrl
PGA-HMO-NonObese-2aUA-s2,ctrl
mdx Biological Replicate 6,pert
Errb mutant stria vascularis replicate 1,pert
genetic background: c57/bl;	gender: male;	tissue: heart;	genotype: MHC-Plin5,pert
220D3,pert
tissue: Liver;	genotype: wild-type;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 547,ctrl
ploidy: Ts1Cje (segmental trisomy of chromosome 16);	tissue: cerebellum;	developmental stage: P0 postnatal stage,pert
"Control lung tissue, biological replicate 2",ctrl
genotype/variation: Rpt3 null;	strain: mlc1f-Cre/ Rpt3-floxed;	gender: female;	age: 6weeks;	tissue: tibialis anterior,pert
tissue: xenograft tumor,pert
B_cell_pool_healthy_H07+H08,ctrl
Pediatric_GBM_47,ctrl
HT29 resistant cells replicate 2,pert
Multiple sclerosis CD4+T cells 3-TE,pert
34B,pert
BALB_Female_CF_rep3,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 58;	tissue: Blood,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: M;	transfectant type: stably transfected with scramble control,pert
11385 Normal Uninflamed ascending colon,ctrl
10_PAH,pert
GAS-t7-2; transgenic gastrocnemus 7 month,pert
EVI_GFP positive Lin- cells replicate 3,pert
OE control 23A n,ctrl
patient: 230;	current medication: Asacol 1.6g/ day;	birth date: 12/27/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/12/02;	diagnosis date: 12/3/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/25/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/25/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: ? MS never proven;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
LNCaP-abl_siHIPK2_1,pert
CD4+ CD25- Foxp3- T cells,ctrl
BALB_Female_Control_rep1,ctrl
GFP Untreated 6hr 282295603,ctrl
3 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24713,ctrl
"TH cells from LC, wild type control, young time point, biological replicate 2",ctrl
BP patient 92_biological replicate 2,pert
"MN1, 2",ctrl
E14 - Lis1ko/+ 3,pert
3 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24716,pert
a_NY34,pert
Run7.aUa.001206d.SkMInS1085D.CEL-IS stimulate,pert
"Liver from STZ-treated mice, biological replicate 2",pert
LJMJDW19,pert
"siYAP RNA #2 transfected, biological rep 1",pert
Heart_KO_1,pert
GATA6 KO #3,pert
"Mice_c-myc trans, biological rep1",pert
"Normal subject (46 year old caucasian female, SAK_1280015703)",ctrl
cell line: RPMI8226;	cell type: Myeloma cells;	transduced with: shRNAs targeting luciferase (control),ctrl
Healthy individual of twinpair #3,ctrl
KO_d00_eX_vs_WT_d00_eX,pert
Genotype: p38alpha KO;	Age: E15.5,pert
RPEshp,ctrl
pediatric AML S14,pert
tissue: Biceps muscle;	patient: P.b.7;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 7m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
121-01-C,ctrl
8 week old dy/dy dystrophic mouse diaphragm,pert
LNCaP.FoxA1.3,pert
40SMOKEH,ctrl
strain: C57BL/6;	tissue: liver;	genotype/variation: wild type;	diet: high-fat diet fed starting at 3 months of age for eight weeks.,ctrl
RO35,ctrl
S10,pert
control_crypt_day2_sample2,ctrl
strain: C57BL/6J;	genotype: HDC-EGFP;	age: 3-4 months;	tissue: bone marrow;	cell type: bone marrow CD11b+Gr-1+ myeloid cells,ctrl
strain: C57BL/6J;	day: 15;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
"Retina from NeuroD1 cKO mouse at ZT20, biological rep 1",pert
XBP1s_B_cells_spleen_20 weeks,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
heart wild type replicate2,pert
Mouse_WT_colon_DSS_rep1,ctrl
AA_Case7_CD8,pert
Dilated cardiomyopathy_G6,pert
diseased_IL-13 1,pert
CD46+ hippo - Untreated-A,ctrl
SLE CD19 B cells 2,pert
age: 8 weeks;	genetic background: SV 129/C57BL/6;	genotype: control;	cell type: pancreatic beta-cell,ctrl
WT-3 (Large PreB),ctrl
Subject #8013-Preinfection,ctrl
"mutant mouse embryonic fibroblast, biological rep 2",pert
Vit A sufficient 2a,ctrl
KU_13T,pert
01LQJ_CTRL,ctrl
tissue: whole whisker pad;	genotype: wild-type;	age: E12.5,ctrl
Disease_status: Down syndrome;	Age (years): 55;	Gender: Male;	Post mortem interval (hours): Unknown;	Braak stage: Unknown;	Cause of death: Unknown,pert
SKM-1 STK33-2077,pert
RAW_2.8mM_HOCl_#2,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 67,pert
E99-/+SRFdM-VP16-2,pert
Kidney_saline iv_mouse #005,ctrl
Normal mucosa 10,ctrl
non-treated CCRPKO_rep-1,pert
Run8.aUa.010615d.SkMInS1082D.CEL-IS basal,ctrl
ALI patient #9,pert
AA_135,pert
esophageal squamous cell carcinoma from patient E1635,pert
gender: male;	age (years): 30;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
condition: Discoid Lupus;	patient: L8;	tissue: LS skin biopsy;	kit: Ovation,pert
Age: 32;	Cycle: NA;	BRCA1/2 mutation: BRCA1;	Family History: Yes,pert
PGA-MAA-IL4-1aAv2-s2,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 74;	gender: female;	years of disease: 2 y;	treatment: phototherapy;	time: pre-UV,pert
Trasnsformed Lymphocytes Bipolar Disorder Affected Twin Pair 2 (DCBD2.1)(TP7),pert
LNCaP-abl_siMED19_1,pert
"gender: female;	age: juvenile, 8 weeks (P58);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 -/-;	tissue type: renal tissue",pert
Age: 46;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
5046-lcm,pert
NuLi cell line treated at DMNQ biological rep2,pert
MPM tumor 22,pert
"AD_FC, biological rep1",pert
SCD1 +/+ liver rep4,ctrl
"siRNA, plastic plate, rep3",pert
GATA6 KO #1,pert
patient: 112;	current medication: None;	birth date: 7/5/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"prdm-control, biological rep1",pert
56SageA,pert
AKT_PLACEBO_48hours_4,pert
NoKD_SerumStarved->1hrEGF_rep2,pert
"Aorta, Ang II 14d, #5",pert
ES cells_OE_rep2,pert
Muscle 50 eccentric contractions 12 hours KO Adult 01032,pert
SZ9,pert
"Cell type: neuronal, age:41, gender:female, diagnostic group: bipolar disorder, PMI:28h",pert
Ad-rep2,pert
Control subject 117_biological replicate 1,ctrl
24A;pretreatment;female;breast tumor; not assessable,ctrl
hES_SA01_1,ctrl
RBP2-/- MEF(1),pert
AtT20 cells treated with NSBP1 siRNA rep 2,pert
Disease_status: Bipolar disorder;	Age (years): 29;	Gender: Male;	Age of onset (years): 22;	Duration of illness (years): 7;	Brain pH: 6.39;	Post mortem interval (hours): 48;	Side of brain: Left;	Fluphenazine mg. Equivalents: 9000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
Astrocytoma_5,pert
BP29,pert
duration of untreated disease in month:105.6;	age at onset:2.6,pert
P0 - DCXko/Y 2,pert
Silberg2 (8) 021301BE,pert
PBMCs_IS_4 [IS],pert
"EBF1 d0, rep 4",pert
PGC-1alpha -/- differentiated brown fat cells (rep1),pert
coc-57_B,pert
Healthy control 2,ctrl
MDS patient 64,pert
cell line: T47D;	treatment: contol,ctrl
hES_SA01_2,ctrl
Osteoblasts_Lrp5_Control_Day7_rep4,ctrl
SZ17,pert
H14 HA 6h 4,pert
tissue: pancreas;	cell type: epithelial cells;	disease status: intraductal papillary-mucinous adenoma (IPMA),pert
Individual_4397_PP_sample,pert
HF1325_U133P2,pert
age: 31;	sex: F;	disease status: Marfan subject;	Filter number: 36;	Usage number: 1;	Exposures: 4,pert
EBS_3,pert
01LPH,pert
B13 - non-infected BALB/cByJ fibroblasts,ctrl
sample 1:;	age: 58;	gender: male;	sample 2;	age: unknown;	gender: unknown,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M5a;	flt3 status: internal tandem duplication (ITD),ctrl
"Ulcerative Colitis (63 year old caucasian female, SAK_1318991541)",pert
"brain, frontal cortex: Sample61_e1_le1",ctrl
CML-BM 7,pert
TTP_WT_0ActD_BioRep1,ctrl
Transgenic nr 661,pert
"human failing LV myocardium, Ischemic86",pert
MCF10A_HER3_1,pert
Obese rosiglitazone-3,pert
C014_Control_M91,ctrl
pMX-GFP no vitamin C GFPVc-_2,ctrl
"testis wt, 14dpp, Rep3",ctrl
"p38alpha wild type fetal liver E13.5, biological rep2",ctrl
RA4,ctrl
miR122-KO-69-T,pert
cRNA;	embryonic day 18;	NFIA deficient,pert
"disease group: Atopic Dermatitis;	Sex: f;	age: 40s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 11.3;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 430;	ige (kiu/l): normal (0-48.5 kIU/L): 319;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: pos",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: del5q plus other,pert
FmrWT4_brain,ctrl
"Male F344 rats, sacrificed at the age 18 weeks",ctrl
G392E_on_rep1,pert
genotype: T-ALL;	sample type: DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma);	genetic background: WT C57/BLACK6;	cell type: DP (CD4+/8+) cells,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 38;	gender: male,pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 6,ctrl
MA_282,pert
5_b,pert
HeLa cells transfected with UPF1 siRNA 2 (experiment),pert
Waldenström’s macroglobulinemia (WM-BL 33161),pert
postmortem brain,ctrl
"patient: 102;	current medication: Movicol 1 sachet daily;	birth date: 9/5/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: RIF pain, persistent anaemia.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
WT HPC Veh 6,ctrl
BL Day 0 Untransfected biological rep3,ctrl
phenotype: control;	gender: male;	case_id: 507;	age: 52;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 32;	brain ph at time of freezing: 6.76;	labeling_batch: 2,ctrl
"human failing LV myocardium, Idiopathic16",pert
H441 transfected with scrambled siRNA 1,pert
FC 05,ctrl
N11,ctrl
3871-1 E2F WT,ctrl
normal sigmoid colon of adult,ctrl
Normal cervix_05-4959,ctrl
Ishikawa_VeryHighDose_BPA_48h_rep3,pert
WT - Cre Treated - 24 hrs - repeat 1 - Cy5 - mAdbID:61765,ctrl
colon_IBD_1537,pert
HEL_Control shRNA (Luc)_1,ctrl
HT29 DMSO Day1 rep2,ctrl
Individual_4649_NN_sample,ctrl
S-IIP(UIP)7_Cy3,pert
shNANOG_5,pert
RPE65_KO_6months_retina6,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 25;	maternal age: 24,pert
Testis WT 0h batch 3 [TeWTh00.20],ctrl
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 24h,pert
GM19238_Kd_CREBBP_1,pert
"Bmi1 shRNA, biological rep2",pert
Hippocampus_NaiveControl_rep1,ctrl
Cardiac Muscle_Cmah KO_rep2,pert
MCF7_E2_24h_rep3,pert
cell line: mOS482;	cell type: osteosarcoma,pert
Muscle JDM (YJD-JDM-15UA-s2),pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 2;	bead chip array sentrix code: 4421339046,ctrl
age: 10-week old;	sex: male;	strain: C57BL6;	tissue: liver,ctrl
"RPMI8226_shKLF2#1, replicate1",pert
heart_co_14M_rep2,ctrl
"patient 044b, cancer, homogenized",pert
B2KO; No Treatment #5,pert
race: caucasian;	age (years): 68;	stage: IA;	grade: 3;	histology: endometrioid,pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 54;	age-at-onset: 50;	geographical origin: Vila-Real;	clinical characteristics: Hypertension,pert
brain knock out replicate3,ctrl
NALT_infected_24h_90-226_rep2,pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 41;	maternal age: n/a,ctrl
mESCs_Tip60KD_rep2,pert
"Gtf2i Mutant line, biological rep 2",pert
b44+,pert
Errb mutant stria vascularis replicate 2,pert
SIN3A_siRNA_LIF1h_rep2,pert
"WT caudal vertebral bone, rep1",ctrl
"control endometrium, patient 20",ctrl
MCF7_EtOH_24h_rep4,ctrl
"Patient 21, Atheroma plaque",pert
Bone-Marrow_MGUS_G693,pert
HMEC_50 vs BT474,pert
"control endometrium, patient 32",ctrl
0199-01-C,ctrl
pD  is a clonal control (puromycin resitant) stably-expressing stem cell line,ctrl
52 year old male,ctrl
tissue: liver;	gender: female;	disease status: type 2 diabetes,pert
Vitamin A,pert
PBMC_C3,ctrl
"KO+Empty, biological rep2",pert
DS2-iPS 2,pert
"ES cell line, RNA 73",pert
5_c,ctrl
cell type: Anaplastic thyroid carcinoma;	expression: HTH83 SCR shRNA;	cell line: HTH83,ctrl
asthma_saline_2,ctrl
NS4_NS010827,ctrl
Nasal Epithelium Inhalation Formaldehyde 15ppm 6h ID337,pert
minor HCC3,pert
IRF8 KO 2,pert
disease state: normal (control);	tissue: liver,ctrl
race: caucasian;	age (years): 80;	stage: IC;	grade: 2;	histology: endometrioid,pert
Tissue: endothelial cells,pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 8",pert
LRRK2 (G2019S) homozygous fibroblast sample 2,pert
PA-1-(2),ctrl
2h Kin- Cel.41,pert
tissue: Brain;	genotype: Npc1-/-;	age: 20 days;	subject: Mouse1;	genetic background: BALB/c,pert
"Pancreas from adult Rkip-1 KO mice, biological replicate 3",ctrl
patient: 29;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
ME180 6 hours rep 3,pert
"array 19, unimplanted",ctrl
PE_D_594,pert
KU_02N,ctrl
Colon_POR-null_1,ctrl
midbrain_wild type_24 weeks_replicate 2,ctrl
Brain_Adult_LPSip_4hr_mouse1 (YL1_#64),pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,ctrl
BDC2.5/NOD.scid_1,pert
mouse cerebellum at P30 wild type 3,pert
Nuclear RNA_KO_rep2,pert
strain: C57BL/6J;	day: 6;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 1,pert
tetO-Satb2 #2 +DOX,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 151;	time: 0;	batch: 1,pert
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.124;	OD280: 0.574;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 212;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
B10.H2g7 Idd3_T1,ctrl
DEX treated rep 2,pert
"16B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
HL60-shGSK3A-Construct5-rep2,ctrl
"Lesional skin from K5-Tgfbeta mouse, biological replicate 3",pert
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 35week,ctrl
Array Type: HG-U133A_2;	Ratio: 2.04;	RNA Integrity Number: 9.6;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Age: 55;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: Yes,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: A;	genotype/variation: NET1 present;	agent: no LPA (control),ctrl
Huh7_TGFbeta_minus_2,pert
"63B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
disease: AML;	bcor mutation: BCOR mutation;	karyotype: normal karyotype,pert
race: caucasian;	age (years): 55-60;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
5262 UC Inflamed sigmoid colon,pert
Wt Mouse_cerebellum_Standard diet Ad Lib_Replicate-2,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339032,ctrl
cell line: Y79;	passage: 27;	cell type: Retinoblastoma,pert
Bc_Mock_1,ctrl
Bronchial Epithelial Cells MMA biological 1973Q,pert
F2,ctrl
chip number: 15;	transfection plate: 3B;	target gene: ZBTB38;	kd level: 0.65;	rin: 9.6;	transfection date: 2012-03-26,pert
2d-IR-76,pert
Liver_Nrf2 KO_rep3.,pert
MCE301 cells treated with SB for 6 h-1,pert
RNA from HCC_15T,pert
HTH83 LAMC2 KO 1,pert
Muscle PCOS control 18,ctrl
mouselung_wt_control_rep02,ctrl
type 2 diabetes subject 02,pert
HCC PBMC_sample 7,pert
cell line: MCF-7 breast cancer cell line;	agent: SFM (control);	time: 24hr,ctrl
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1tetO-Nanog/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: liver,pert
CTL2 AO 1hr,ctrl
U-87MG-PK25 set 1,pert
P16_WT_pancreas_rep2,ctrl
"10 days old normal mice, cerebellum",ctrl
H295R_Group_B_Dose_100_TIMEPT1_008,pert
dental pulp cell from control 4,ctrl
CyP 3hr 1,pert
"Liver from control exposed rats, biological rep 3",ctrl
"seminoma specimen, pT2, patient age: 40y",pert
Parkinson's Disease;	female,pert
"DMSO-treated, sham UV exposed",ctrl
Bronchial Epithelial Cells control biological 2052D,ctrl
HepG2_control_rep3,ctrl
chip number: 16;	transfection plate: 4;	target gene: IRF5;	kd level: 0.63;	rin: 9.3;	transfection date: 2011-10-17,pert
Cancer 19,pert
Nrl-ko-Gfp P10 replicate 3,pert
duration of untreated disease in month:1.1;	age at onset:4.7,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 29.72329,pert
"N-BMSCs, biological rep2",ctrl
Ex1_cells_rep1,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_12_4_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
"brain, cerebellum: KCx4w#3_e1_le1",pert
Yy1_siRNA_rep2,pert
Mist1KO saline rep3,ctrl
"KO mouse heart at 6-weeks old, biological rep1",pert
Control (C66),ctrl
SRF Wt. IgM+IgD+ (GBF0610),ctrl
Individual_5023_NN_sample,ctrl
NOD non-transgenic islet rep2,ctrl
Patient: B;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
ILD_22,pert
subject: 2828 WT;	type: wild type;	tissue: Mouse skeletal muscle,ctrl
V5-P357,pert
"Rb null fetal liver 2, embryo at 12.5 days of development",pert
SCC-2_siScramble_rep.2,ctrl
BALB/c d18 (bmsnmix2),pert
"shControl cells, rep2",ctrl
Tolerizing allografts 70 days No.3,ctrl
liver_STZ 0.1% quercetin diet_rep1,pert
cell line: HeyA8;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
"treated with Roziglitazone, 1000 mg/kg in Methylcellulose soln per orally, extracted 48h after treatment, biol. rep2",pert
tissue: oropharyngeal carcinoma KB,ctrl
"breast, post AF treatment (H4_1328)",pert
KO - knock-out Treated - 24 hrs - repeat 1 - Cy5 - mAdbID:61772,pert
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 24;	maternal age: n/a,ctrl
5025-scrape,pert
sampleID: SAM630141;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
BT474-J4_GSK089_24-1,pert
CLC5 ko rep 1,pert
control AU1165303,ctrl
"Mouse invivo nTreg cells, replicate pool 2",ctrl
Diaphragm 23 Day mdx rep 2,pert
"BMMCs from NTAL WT, NTAL shRNA infected, 2 h activated, biological rep2",pert
H23 Ctrl 24h 3,ctrl
antimicroRNA-140_rep2,pert
"E18.5 ERRg +/+ heart, biological rep 2",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 73;	Sex: male;	region: CB (cerebellum);	genotype: Y/X;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,ctrl
NHE3-/- replicate 2,pert
HT-KO-21B,pert
GFP-KD-2 (total RNA),ctrl
FcgKO Non stim 1,pert
"BMMCs from NTAL WT, noninfected, 2 h activated, biological rep1",ctrl
IM19_case,pert
Patient identifyier: C;	Sex: male;	Age of patient: 32 years;	Duration of psoriasis: 17 years;	Body surface area: 8 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
PKBa-/- MEF time 0 replicate 1,pert
RNA-DHL4-R406-2H-2,pert
E2 24hr,pert
MPM tumor 33,pert
WT_3,pert
02 CF,pert
BL Day 1 siMut10 transfected biological rep2,pert
neuron_rep12,pert
Wild Type Skeletal Muscle Sample (Intercostal),ctrl
BM CD34+ Pool III,ctrl
SeroTest-3,pert
Patient 10 after folic acid,pert
AKR/JTCE liver sample batch 3,pert
Saline treated mouse gallbladder 1,pert
NPC_wt_rep3,ctrl
GV oocyte_Rnf2 mut_rep3,pert
219/0,pert
"SUDHL-1, Treated by ALK inhibitor repl 3",pert
T55 Non failing heart biopsy,ctrl
tissue: brain;	genotype: mutant 14-3-3 ko/ko inbred;	age: P0,pert
N40843,ctrl
"Uninvolved Skin, NS-5",pert
NK_cell_pool_healthy_H11+H12,ctrl
CLL 69-04 LMP-420,pert
fibroblast cultured from normal esophageal tissue_HEF_75,ctrl
train: C57BL/6;	Genotype: wild type;	Generation: F5;	Gender: male;	Tissue: white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: control shRNA,ctrl
Ainv15 ES0 replicate 1,ctrl
Nrl ko 2 mon replicate 4,pert
"diet: AIN-76A;	sodium arsenite added to drinking water: 100 ppb, 5wk",pert
"Gender: Female, Age: 25, BMI: 32, Tissue: luteinized cumulus cells",pert
MCF7 control siRNA Estradiol Rep1,ctrl
"Heart, MAT1 CKO, 4 wk, sample 5",pert
"PCOS, biological rep 1",pert
"acutely admitted, severely psychotic schizophrenia patient  A24",pert
"gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6.4;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"68B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Clinically localized primary prostate cancer P3,pert
microdissected breast cancer cells from case 633,pert
n6t24h,pert
male_alcoholic_303,pert
Wild-type anterior prostate 2,ctrl
01N41_ERA,pert
2008-Ets1 cells_rep2,pert
sample =Healthy4 treatment=Stimulated time=360 (min),ctrl
"lymphoblastoid cell line from T21.01, one out of seven of insensitive group, 50*10e6 cells",pert
Ad infected murine liver-MO30k-(228)-6hpi,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 19.666;	Ratio: 2.14,pert
"AG825-treated, 24h after UV, Replicate A",pert
P0 - WTMixB 3,ctrl
wt_TGFb_24hr_2,ctrl
"34B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
01UNB_PolyRF-,pert
HW_1089,ctrl
L_LS_Wk4,pert
1082-01-C,ctrl
"schizophrenia, BA46-25",pert
"age at diagnosis: 68;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIC;	t (extent of primary tumor): T2;	n (lymph node metastasis): N3;	er: 0;	pgr: NA;	dfs-month: 5;	dfs-event: 1;	distant metastasis: 1",pert
sample 1:;	age: 41;	gender: male;	sample 2;	age: 66;	gender: female,pert
H08_P_B2,pert
PGA-RMM-30m-3aA-s2,pert
23d tg7,pert
V5-P057,pert
ab164 IM,pert
E12 distal retina progenitors_mutant_rep 1,pert
"brain, cerebellum: WCb4w#1_e1_le1",ctrl
HE_3,pert
cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: Vehicle (0.1% ethanol);	time point: 48 hours,ctrl
Zfx fl MA9 cells + Vehicle [10986],ctrl
11_0027C_Day1_30,ctrl
KO - 3 mo - repeat 5 - Cy5 - mAdbID:74671,pert
"fibroblast, control subject NM4 rep 2",ctrl
WT P10 replicate 1,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.03;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
PFC R control 2,pert
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 62;	donor: 12;	disease state: Lesional,pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 63;	donor: 20;	disease state: Lesional,pert
LNCaP R1881 rep 3,ctrl
"Du145-PCAT1 NT siRNA, replicate 2",ctrl
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl;	tissue: Tongue;	age: E14.5;	gender: Not determined,ctrl
"21B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P5,pert
"Cell type: neuronal, age:34, gender:male, diagnostic group: control, PMI:22h",ctrl
C3 Control None,ctrl
patient: 30068;	sample: normal,ctrl
ab050 IM,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 2,ctrl
MDS patient 51,pert
H13_S_B1,ctrl
SNB19 PARK2 siRNA#1 replicate 1,pert
C57BL6,pert
Male wild-type (C57BL/10SnJ) mice were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,ctrl
MDS patient 128,pert
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 8hr,ctrl
age: 50;	sex: M;	disease status: control subject;	Filter number: 89;	Usage number: 1;	Exposures: 3,ctrl
CD4IncTp2-6,pert
PsOEt-20-LS,ctrl
Lamp3 KD 4d 2,pert
"brain, cerebellum: RNA#34*_le1",ctrl
Subject 1_t=30days_placebo,ctrl
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: Regular chow diet,pert
LJMJDW23,pert
cell type: Primary hepatocytes;	donor: 1;	agent: Wy14643;	time: 6h;	gender: Male;	age: 63 years old,pert
DBTRG 10 uM Y15 rep2,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.11;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: wildtype;	tissue: GIST Tumor,ctrl
Tumor_18w_vechicle_DEN_134,ctrl
control to Sample 11,ctrl
human_hepatocyte_400uM_Trovafloxacin_donorA_24hr_prep1,pert
hES_VUB03_DM1_1,pert
cell line: CUTLL1 (T lymphoblastic leukemia / lymphoma),ctrl
HDAC1_knock_out_embryonic_stem_cells_biological_rep1,pert
OBF-1 overexpression BCS-1 (EPLM),pert
REH_control_rep1,ctrl
Run5.aUa.010110d.SkmDbt2447D.CEL-DB basal,ctrl
4_day_old_wildtype_mouse_rep2,ctrl
siOGT 24 hours_1,pert
Disease_status: Down syndrome;	Age (years): 56;	Gender: Female;	Post mortem interval (hours): 6;	Braak stage: VI;	Cause of death: Unknown,pert
N41027,ctrl
Keratinocytes_siANCR_rep2,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M4;	flt3 status: WT,pert
Muscle-24 month-wild type-technical replicate 3,ctrl
liver cells from wildtype 8wk male mouse 8 challenged with acetaminophen (APAP)_13,pert
control-plusDox-rep3,ctrl
"brain, hippocampus: C6-I_e1_le1",ctrl
HT29 resistant cells replicate 1,ctrl
remitted schizophrenia patient  S20,pert
Eed KO J1 ESCs on day 7 #2,pert
E99-/+SRFVP16-2,pert
KU_01N,ctrl
"fibroblast, MFS subject FB969 rep 3",pert
disease: Down syndrome;	gender: female;	age: 1 year and 6 months;	tissue: thymus,pert
45 year old male,ctrl
"human failing LV myocardium, Ischemic27",pert
MPM tumor 2,pert
RE550_KPL4_5-Medi5117,pert
SOCS3 Cre minus C,ctrl
KU_11T,pert
BP4,pert
Melanoma cells,ctrl
OVCA429-(3),ctrl
At Risk: +;	Age: 4;	Sex: F,pert
status: Normal;	age: 58;	gender: female;	tissue: cultured human fibroblasts,ctrl
early to medium response after cadmium treatment,pert
brain_DLPFC_bipolar C_mr545,ctrl
"Strain: Polg+/+ mice;	Gender: male;	Age: 9 months old;	Tissue: cochlea;	For additional details about the strain used please refer to the following r;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",ctrl
mouselung_wt_control_rep01,ctrl
Human skeletal muscle biopsy sample;	Patient #80 with PM,pert
lrrk2 genotype: GS / GS,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
cell line: MDA-MB231;	treatment: control shRNA;	media: DMEM,ctrl
HWS22,pert
Tsc1-deficient CD4 naïve cells KAI276,pert
"endometrioma, patient 9",pert
lrrk2 genotype: GS / WT,pert
cell type: Pancreatic ductal adenocarcinoma;	cell line: CAPAN2;	transfection: lentivirus carrying shRNAs targeting LLGL1 transcript,pert
1064-03-A,pert
Individual_4344_PP_sample,pert
wild type; 10 months,ctrl
"p53-, rep2",pert
0167-01-C,ctrl
esophageal squamous cell carcinoma from patient E1709,pert
Human Uninfected Sample N071-CD4+ T cells,ctrl
cell type: Human melanoma cell line;	cell line: M229;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
Run2.aUa.001206d.SkMInS1087D.CEL-IS stimulate,pert
oocyte_Brwd1_mutant_rep3,pert
cerebellum_WT_10d_rep2,ctrl
5211 Normal Uninflamed terminal ileum,ctrl
"schizophrenia, BA46-55",pert
control male replicate 5,ctrl
TRPM2-AS siRNA rep4,pert
cell line: Normal bone cell line 695;	phenotype: RB1 knockdown;	cell type: human osteoblast (hOB),ctrl
MLL_00124,pert
sXBP1_1578Q,pert
1132-03-A,pert
06R009 Control,ctrl
"iPSC derived from healthy control fibroblast WT3, biological rep8",ctrl
age: 49;	sex: F;	disease status: control subject;	Filter number: 96;	Usage number: 1;	Exposures: 3,ctrl
PBMC from T cell LGL leukemia patient #133 (TLGL133),pert
E99-/+SRFVP16-1,pert
ALI patient #7,pert
KPW13_T2_PP_day0_050,ctrl
"Control Proximal, Small Intestine 3 21 days old",ctrl
patient: 51315;	sample: tumor,pert
"Peripheral blood, normal control [N67]",ctrl
erStress_twins_AA_1725twin2_DMSO_4h,ctrl
DNGM-8,pert
GB 4 65B +LPA,pert
13-0002A_Day1_35,pert
CON19,ctrl
n7t7d,pert
PB_DON088,ctrl
IRAK2 KO macrophages stimulated with MALP-2 for 2 h,pert
strain: Swiss;	tissue: Ovary;	agent: 4-Vinylcyclohexene Diepoxide (50uM);	replicate: 1;	age: Post natal day 3-7,pert
Diagnosis: AML M2;	Age: 44y ;	Gender: Female;	Blast %: 75;	Source: BM;	Cyto: Normal;	FLT3 ITD: 1;	FLT3 TKD: No data,pert
"MDA-MB-231/shNS, biological rep2",ctrl
0653-01-C,ctrl
CRC_nodrug_F4881,ctrl
Total RNA from cervix,ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 55 days;	subject: Mouse1;	genetic background: BALB/c,pert
Waldenström’s macroglobulinemia (WM-PC 31098),pert
INCB18424 Persistent 2,pert
prostate tumor 1,pert
Preglaucoma control rep3 (OHN),ctrl
"Data 1, Vbeta5",pert
WT30,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 48.50137,pert
128B,ctrl
"D425-control, t=0",ctrl
Control subject 116_biological replicate 1,ctrl
"nasopharyngeal carcinoma, specimen T22",pert
HCT116_shBgal-rep2,ctrl
T4 U133p2,pert
PFR3_replicate_3,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 6h",pert
PGA-FVB_3m_3f-m5,ctrl
Healthy9-CD4,ctrl
"Uninfected TG at 5 d.p.i., rep4",pert
brain_DLPFC_bipolar B_mr646,pert
HMEC_50 vs BT549,pert
"Peripheral blood, patient without recurrent events [N32]",pert
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 35;	maternal age: 24,ctrl
status: Control;	gender: Female;	age: 53;	tissue: Blood,ctrl
"Acute Myeloid Leukemia, sample 48",pert
5250 UC Uninflamed sigmoid colon,pert
Pooled_3,pert
cell type: Transcriptional 2 Follicular Progenitor (T2-FP) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: KAP1 KO,pert
06R019 RA,pert
NSC_ X5050_24h_biological rep1,pert
control rep 3,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 28, stage IIIB, HPV 45",pert
DNGM-6,pert
Septic shock;	gender: Female;	Survivor;	organism: Neisseria,pert
3449-1 E2F WT,ctrl
t17,pert
NSCL/P sample 1,pert
NPC Brain 67d Mouse1,pert
G205,pert
Kidney_saline ip_mouse #066,ctrl
A549 siRNA FAM60A CNTRL 1,ctrl
short-Rif1 KD rep2,pert
mouse: 2;	strain: C57Bl/6;	genotype/variation: Wild-type;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,ctrl
cerebellum_PSNA_ 4w_rep2,pert
NMRI_24h_DMSO,ctrl
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: none;	time: 72hr,ctrl
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug.  At four hours prior to RNA isolation, mannitol (5% final concentration) was added to the culture.  After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",ctrl
Leg 56 Day control rep 1,ctrl
Subject 3 / lung subsegment instillated by Saline,ctrl
liver western diet rep1,ctrl
WT_TER119+_rep4,ctrl
A263insGG_mut3b+,pert
Cervical cancer_CC126,pert
A/J Vehicle liver sample batch 3,ctrl
Muscle PCOS pioglitazone 201,ctrl
NTG replicate 1,ctrl
tissue: blood;	patient: 7;	gender: male;	age: 25,pert
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P2,ctrl
gender: female;	genotype: Wild type for TWIST2;	ethnicity: Caucasian,ctrl
"control triceps, biological rep2",ctrl
"WT, LPS 5hr",pert
Severe rep6 (OHN),pert
Sarcoma cell line  - Dicer Heterozygote -rep1,ctrl
hippocampus: Sample #2_e1_le2,pert
genotype/variation: c-Myb deficient;	age: 4-5weeks,pert
cell line: A549;	cell type: Lung adenocarcinoma,pert
WT-628,ctrl
N15,ctrl
PFR3K650E_replicate_2,pert
disease affected colon of an adult with Crohn's disease (CD). Replicate-2,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.9;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
HT29 sensitive cells replicate 3,pert
061J4: normal control,ctrl
1106-03-A,pert
5275 UC Uninflamed descending colon,pert
remitted schizophrenia patient  S15,pert
"AD_TC, biological rep9",pert
Z138-shSOX11.1,pert
sample =Healthy2 treatment=Control time=0 (min),ctrl
Human skeletal muscle biopsy sample;	Patient #133 with NORM,ctrl
MDS patient 53,pert
D_Ctrl_3,ctrl
Bronchial Epithelial Cells MMA biological 1815Y,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: trachea;	donor sex: female,pert
KO - knock-out Untreated - 0 hrs - repeat 1 - Cy3 - mAdbID:61726,pert
Biceps_Pompe_5,pert
Normal Pleura 3,ctrl
"seminoma specimen, pT1, patient age: 31y; W98 100",pert
CD-48-un2,pert
Strain: C57BL/6;	Genotype: AMPK gamma3 mutant (R225Q) transgenic;	Generation: F5;	Gender: male;	Tissue: white portion of the gastrocnemius muscle;	Feeding condition: fasted,pert
Individual_4609_PP_sample,pert
4-HPR_LIVER_2,pert
homozygot FH P253,pert
"Hdh knock-in embryonic stem cells, Q111 line, biological replicate 3",pert
source tissue: lung;	strain: Insig1 ∆/∆ /Insig2 -/- (AT2 cells obtained from 2 months old SpC-rTTA / Otet-CRE / Insig1 flox/flox / Insig2-/- mice treated with doxycycline from E6.5 to E12.5. Control animals lacked either SpC-rtTA or Otet-CRE);	cell type: Alveolar Type II,pert
whole tissue section from case 1093,ctrl
CML_5_CMP,pert
AR-CO-24-1-541,ctrl
GLY replicate 2,pert
BL Day 2 siMut10 transfected biological rep1,pert
"Control, biological rep5",ctrl
2095-03-A,pert
Brain_Wild-type_MiceNoLT346,ctrl
Brain_Adult_Salineip_4hr_mouse3(YP3_#60),ctrl
"Chromium 10 µM, biological rep4",pert
BxPC3-KO111 rep 6,pert
NPC9,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: Schistosoma japonicum;	time point: 6 weeks post infection 20 cercariae,pert
Control 11,ctrl
sirt7 allele: knock-out,pert
S027_Scz_M_77,pert
19 olanzapine,pert
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: Brg1,pert
"Uninvolved Skin, NS-27",pert
Postnatal 12 weeks mutant heart biological rep1,pert
WT-control-1,ctrl
genotype/variation: control;	tissue: skin;	age: 32 days;	sex: male;	strain: C57BL6 X DBA2,ctrl
"Wild-type retina, biological rep2",ctrl
disease state: hepatocellular carcinoma;	cell type: Peripheral blood mononuclear cells,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 8d ID220,pert
AtT20 cells infected with empty vector rep1,ctrl
Organism: Rattus norvegicus;	Strain: Brown Norway;	Weight: 150-170 grams;	Tissue: liver;	Gender: male;	Sacrifice Time: 6 hours;	Treatment: D-penicillamine 150 mg/kg by oral gavage,pert
strain: C57BL6;	genotype: PDE10A KO;	tissue: striatum;	treatment: vehicle control,pert
mdx5cv TA sample 2,pert
S026_Scz_M_72,pert
normal skin sample,ctrl
"BMMs, untreated control, wt, Replicate 2",ctrl
ADH4,ctrl
Cervical cancer_1900T,pert
HF1219_U133P2,pert
Day: 15; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 1,pert
Shn2_Wildtype_4,ctrl
lesion_preUV_patient6,pert
"Age: 3 months, Sex: Female, Retina: left, Final IOP (mm Hg): 19.1, Strain:DBA/2J",ctrl
siEGFP (48 hr) _1,ctrl
PGA-MAH-AJ_OVA6h-2aA-s2,pert
Replicate 2 - CDB4124,pert
HLA risk: Medium;	Height: 124.8 cm;	Weight: 26 kg;	BMI: 16.9;	Age: 7.21 years;	Gender: Female;	Race: White;	Glucose: 180 mg/dl;	HbA1c: 7.5%,pert
E10.5 wt3,ctrl
Sox9egfpneg_p23-3,ctrl
WT - Cre Control - 5 mo - repeat 4 - Cy3 - mAdbID:74104,ctrl
Colon_POR-null+quercetin_3,pert
Cadherin-11 siRNA (RNAi 4A)_2of2,pert
No or early 1 rep3 (OHN),pert
Sample 10 Kidney Hyp Mouse - Low Phosphate Diet,pert
Huh7 cells_JFH-1 Infected 12 hours_ rep2,pert
APLP2_R1_rep2,pert
472MM,pert
"gender: Female;	age: 87;	post-mortem delay: 5.5h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Normal_MS 36C6,ctrl
"PC-3 Gefitinib, biological rep2 [mRNA]",pert
sMPNST_Vehicle_2day_rep2,ctrl
appendix sample removed from patient who went to the operating room with the diagnosis of acute appendicitis,pert
genotype: HDAC6 knock out,ctrl
Sex: female;	Age at operation: 70 years;	Site: thorax;	Size in cm: 1.9x1.3x1;	Histological Subtype: pleomorphic liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: residual tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
Carboplatin 30 hours set 1,pert
"10 week, mutant;	SOD1(G93A)",pert
R6_Pseudomonas_wildtype_48,ctrl
"cervical cancer, SiHa, squamous cell cancer",pert
strain: C57BL/6;	cell type: cytotoxic T-lymphocytes (CTL);	genotype/variation: wild type;	agent: control,ctrl
A HID B_B010,pert
con-7_B,ctrl
cell line: THP-1;	disease state: monocytic leukemia,ctrl
RNA-DHL4-R406-6H-1,pert
n11t6h,pert
"non-AD_TC, biological rep4",ctrl
strain: C57BL/6J;	day: 15;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
CML_2_HSC,pert
Parkinson's disease sample x193,pert
whole tissue section from case 547,pert
"Tg brain, biological rep1",pert
PND28 Rat Testis_Rat230-2_1hr Corn Oil_Animal#41_04005,ctrl
Liver GPR120KO HFD #427,pert
GM19238_Kd_IRF7_1,pert
Mist1KO saline rep1,pert
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.34 uM (2 x EC50), biological rep2",pert
"disease group: Psoriasis;	Sex: m;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 3;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 110;	ige (kiu/l): normal (0-48.5 kIU/L): 31.2;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg / positive to Strep. Viridans",pert
Ppif-/- heart 2,pert
CDKI-73 CLL1,pert
MPM tumor 16,pert
"medulloblastoma, wt, rep3",ctrl
SA2117_muscle_mutation,pert
A2780+(2),pert
cerebellum_Pink1 knockout_18 month_replicate 1,pert
9-cis-retinoic-acid_LIVER_3,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 19.96712,pert
A673 cell line that has been treated with Doxorubicin for 3 days with concentration of 59.88 nM (EC50).,pert
Carbo Day2 (410L),pert
D_Kin_1,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Ileum",pert
Mock infected murine liver-MO30k-(790)-6 hpi,ctrl
Surgical Sham Control Tail Skin 1,ctrl
"A pool of two pure subsets of peripheral blood B cells (CD19+ CD3- CD4- CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
striatum_wild type_12 weeks_replicate 2,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 718,pert
cell line: COLO829 melanoma cell line;	genotype/variation: MITF knockdown;	agent: BRAF inhibitor PLX4032 (Vemurafenib),pert
407MM,pert
strain: C57BL/6J;	day: 6;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 3,ctrl
"wt muscle 1, biological rep 1",ctrl
"fibroblast, MFS subject FB969 rep 1",pert
"BioBreeding DR+/+ rat, day 65, mast cells derived from pancreatic lymph node.",ctrl
cell line: HUVEC,pert
atopic eczema P4,pert
Seguin_IDR_BrownNorway_Liver_treated3,pert
"Atm-/- untreated, A",ctrl
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: monuron 72 hr,pert
Pooled normal myocardium sold commercially (E),ctrl
wt-Gfp 4 weeks replicate 3,ctrl
1214-5C,ctrl
"human failing LV myocardium, Ischemic31",pert
"Patient CCo, stable renal transplant recipients, male, 38 years old, T0 (time of enrollment)",ctrl
lungs were over expressing nmyc-gfp fusion protein using the lung surfactant  c promoter.,pert
RTX1 T0,ctrl
sample: #15;	subject: Control case #5;	brain: T-2017;	age: 74;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
CUTLL1 DNMAML1 GSIwash2h-rep2,pert
"Nickel 400 µM, biologcial rep3",pert
12 h-apra-10 nM,pert
coronary smooth muscle cells control replicate 3,ctrl
CH2114,pert
"650nM MLN4924 after 2hr, replicate 3",pert
HF1334_U133P2,pert
INF-156,pert
"tissue: whole brain;	strain: C57BL/6J;	genotype/variation: Sarm1-/-;	age: 8 weeks, 5 days;	infection: 107 pfu of VSV-Indiana strain",pert
0515-01-C,ctrl
CT-receptor-KO osteoclasts treated 3,pert
Run1.a10a.000607jd.2.SkMNor917.CEL-IS basal,ctrl
MRF control Oligodendrocyte Replicate 1,ctrl
KM_076T,pert
Dicer KO CD4 T cells 2,pert
07R084 Control,ctrl
"Pineal gland from control mouse at ZT20, biological rep 2",ctrl
Huh7_TGFbeta_plus_2,ctrl
Skinbiopsy_96hoursnickel_controlsubject_k4,ctrl
"G9a knockdown cells, rep2",pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EED. Sample C,pert
PBMC from T cell LGL leukemia patient #1375 (TLGL1375),pert
"ES cells: E14 (129P2/OlaHsd background), Genotype: Knockout (Phgdh-/-), C57BL/6J background, Gestation: 13.5 days, Tissue: head",pert
wild-type 2,ctrl
KL6_muscle_control,ctrl
"granulocyte, patient. Mtx rep1",pert
Run1.a10a.000607jd.2.SkMNor922.CEL-IS stimulate,pert
cell line: RT112;	transduced: FGFR3 shRNA 6-16;	doxycycline treatment: no,ctrl
Control peripheral blood leukocytes - Biological Replicate 4 - Technical Replicate 1,ctrl
Animal 4,ctrl
erStress_twins_AA_1743twin1_DMSO_4h,ctrl
Retina homozygous KO 42 days 4,pert
"Mdr2-KO heterozygous mouse, 12 month old mouse 2",ctrl
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His plasmid,ctrl
"fibroblast, MFS subject GDO1051 rep 2",pert
chip number: 15;	transfection plate: 3A;	target gene: SP3;	kd level: 0.62;	rin: 9.6;	transfection date: 2012-03-26,pert
Normal cervix epithelium_CaCX3,ctrl
colon_normal_1081,ctrl
Tgfbr2 fl/fl Control Posterior Palate 3,ctrl
MCF10A 1.5days,ctrl
"seminoma specimen, pT1, patient age: 39y; W03 035",pert
135B,ctrl
V5-P390,ctrl
"Strain : 75% C57BL/6, 25% CBAJ;	Gender: Female;	Age: 9 weeks (Moderate stage);	WILD TYPE",ctrl
cell line: LKR13,pert
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro Technologies;	Cause of Death: Anoxia;	Tobacco Use: No;	2nd technical replicate,pert
"lymphoblastoid cell line from F1.02, one out of seven of sensitive group, 50*10e6 cells",ctrl
NZM12_siPAX3_30hrs_rep1,pert
0466-01-C,ctrl
Haloperidol treated 12weeks AffyGC RMA rep1,pert
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 62;	donor: 12;	disease state: Non-lesional,ctrl
"Vehicle treated, no doxycycline; biological replicate 1",pert
"10mg/kg/day PFOA, Rep 4, Block 4, lung (high dose)",pert
"BOEC, normal 1",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 35.43014,pert
MDS patient 76,pert
SIRT1 LKO liver_4 pm_rep3,pert
PE_D_508,pert
Emd KO male 5,pert
"Age: 3 months, Sex: Female, Retina: left, Final IOP (mm Hg): 15.3, Strain:DBA/2J",ctrl
Atm+/+ untreated B,ctrl
"medulloblastoma, M2_scrambled, rep2",ctrl
Individual_3822_PN_sample,pert
S-IIP(UIP)11_Cy3,pert
Myoblast-GATA4-OE-day0-2,pert
remitted schizophrenia patient  S18,pert
MCE301 cells treated with SB for 12 h-1,pert
wildtype 2,ctrl
Age: 42;	Cycle: NA;	BRCA1/2 mutation: BRCA1 3875delGTCT;	Family History: No,pert
"Rat liver, treated with ANIT, 125 mg/kg in corn oil per orally, extrated 48 hours after treatment, biological rep5",pert
MGHU3 Cells_TAK1 siRNA + PD173074_Biological Replicate 2,pert
cells: spleen marginal zone B cells;	genotype: IRF8 KO;	genetic background: C57BL/6J-lrf8-/- x CD19-Cre,pert
"Du145-PCAT1 cMyc siRNA #4, replicate 2",pert
E2 72hr,pert
Mouse: strain C57,pert
"650nM MLN4924 after 1hr, replicate 2",pert
Muscle control 11,ctrl
strain: FVB/N;	genotype/variation: Bmpr2-delx4+ mutation;	cell type: pulmonary vascular microendothelial cells (PMVEC),pert
RatLung_Con_2,ctrl
whole tissue section from case 605,ctrl
"SUDHL-1, control repl 1",ctrl
RatLung_H1h_1,pert
colon_epithelium_C57mouse_6weeks_rep4,ctrl
wild type; 2 months,ctrl
ILD Study Number S030,ctrl
Pt32_Pre,ctrl
Muscle JDM (YJD-JDM-13UA-s2),pert
LDLR_HF_1,pert
Patient identifyier: B;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 15 years;	Body surface area: 6 percent;	Overall erythema: severe;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
"BOEC, not_at_risk 9",pert
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:58;	Sex: female, male:female;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=poorly differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=diffuse type",pert
33SMOKEH,ctrl
"human peripheral blood derived monocytes, 8 hour LPS stimulation, biological rep1",pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, mock",ctrl
BALB/c d18 (bmsnmix1),pert
gender: Male;	tissue: Tendon;ECRB;	age: 55;	donor: 26;	disease state: Lesional,pert
"ALL_NDS, K35 011409",ctrl
strain: 129SV;	gender: female;	age: 6 months;	tissue: right ventricle;	genotype: wt,ctrl
"HepG2 cells at T18 Control, biological replicate 2",ctrl
3x'  Ez f/wt,ctrl
"vehicle, biological rep1",ctrl
T104,pert
"genotype: Gata6-WT;	cell: Peritoneal resident (CD11b-high, MHCII-low/negative) macrophages",ctrl
Mammary Gland_Cav-3KO_rep2,pert
RNA from HCC_12N,ctrl
colonic_mucosa_non_inflamed_125,pert
H69_TGX221_2,pert
remitted schizophrenia patient  S21,pert
Human Neural Stem Cell Line F3 Overexpressing NGN1 (replicate),pert
fibroblast_5azatreated_rep3,pert
Untreated Melan-Ink4a #3,ctrl
Arid3a OE-High replicate 1,pert
"postnatal 3~5 days, mixed gender, C57BL6/129 mixed background",ctrl
initial tumor increase/(-)decrease: n/a;	kit mutation: unknown;	tissue: GIST Tumor,pert
Subconfluent wild type primary mouse embryonic fibroblasts at passage 3.,ctrl
"brain, cerebellum: RNA#7S_le1",pert
colon_epithelium_C57 mouse_12weeks_rep2,ctrl
age: 29;	sex: F;	disease status: Marfan subject;	Filter number: 93;	Usage number: 5;	Exposures: 3,pert
5265 UC Inflamed sigmoid colon,pert
Early IPF_surgical biopsy_upper lobe_rep145,pert
Mouse fetal liver_E14.5_KO_rep2,pert
COV434 Control [RR1021],ctrl
A_AN08792_T,pert
ARF1 siRNA knockdown MDA-MB-231 sample 7,pert
37 year old male,ctrl
M474 SKM-Tg,pert
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 36;	maternal age: 36,pert
age_years: 51;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
"Global gene expression of NASH patients, P35",pert
"fibroblast, MFS subject FB1627 rep 4",pert
e_NY16,pert
Vit A deficient 4a,pert
"GFP Alone, Replicate 2",pert
MDS9,pert
patient: 241;	current medication: Asacol 800mg bd Azathioprine 100mg;	birth date: 6/25/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/90;	diagnosis date: 11/11/91;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 22;	igr2198: 22;	igr2230: 22;	octn1: 22;	octn2: 22;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/10/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
"Normal cervix epithelium, Age 50",ctrl
IPMA 5,pert
Nasal Epithelium Instilation Formaldehyde 400mM 6h ID369,pert
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-6,pert
Cultured human trabecular meshwork cells (passage 3) obtained from a donor with no known history of glaucoma. 58y/male/caucasian. Cause of death: cancer,ctrl
FR-control-3,ctrl
MLL_PTD07,pert
genetic background strain: C57BLKS/J;	tissue: Neuroretina;	age: 8-week old;	genotype: db/+;	phenotype: lean non-diabetic,ctrl
10.5 Months Heart Control rep 3,ctrl
healthy control H14,ctrl
M13 - non-infected MBT/Pas fibroblasts,ctrl
brain_DLPFC_bipolar C_mr538,ctrl
wild-type control 1,ctrl
Sarcoma cell line  - Dicer Null -rep2,pert
erlot5_CT36,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
IP RNA_WT_rep2,ctrl
neuron_rep4,ctrl
Bone-Marrow_SMM_S1220,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 72,pert
ATF6-MER TG mouse_tamoxifen2,pert
HT-WT-2A,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT1 knockout, DMSO-treated",pert
AVIC sample#2 treated with DAPT,pert
MGHU3 Cells_TAK1 siRNA_Biological Replicate 2,pert
heart of mouse subjected 1 week to chronic intermittent hypoxia (1B),pert
"DMD skeletal muscle, biological rep17",pert
genotype: Tsc1-deficient;	cell type: CD8 naive cells;	genetic background: C57BL\6,pert
Age: 54;	Cycle: NA;	BRCA1/2 mutation: BRCA1;	Family History: Yes,pert
"seminoma specimen, pT2, patient age: 34y; W03 031",pert
Patient: M;	Time: 1 week;	Group: responder;	Condition: lesional,pert
"Strain: C57BL/6, ADNP+/- Gender: mixed Age:E9 Tissue: whole embryonic body;	Please refer to: Activity-dependent neuroprotective protein: a novel gene essential for brain formation.;	Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90. PMID: 12888219 [PubMed - indexed for MEDLINE]",pert
Diaphragm 112 Day mdx rep 1,pert
Disease_status: Healthy control;	Age (years): 55;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
wt 13.5d replicate 1,ctrl
strain: Gata4tm1.1Sad/J;	infection: Nuclear β-galactosidase;	culture: Growth medium,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 59;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: post-UV,pert
cell line: JoMa1;	cell type: neural crest precursor cells;	transfectant: GFP control,ctrl
SZ25,pert
human promyelocytic leukemia cells,ctrl
"shKDM4C 1, clone 1, rep 1",pert
Series 3; adult; 6 weeks after fracture,pert
17beta estradiol: 30 pM,pert
cell type: Primary hepatocytes;	strain: FVB;	agent: Wy14643;	time: 6h;	gender: Female;	age: 5 months,pert
Individual_4298_PP_sample,pert
PsOEt-18-Week 2,pert
TTP_WT_60ActD_BioRep1,pert
BSKO 4,pert
tissue: testis;	genotype: ClpP KO;	genetic background: C57BL/6,pert
age: 71;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
c48 is a clonal Nurr1 stably-expressing stem cell line,pert
HWC16,ctrl
Squamous cell carcinoma 011,pert
normal adjacent esophageal tissue from patient E1535,ctrl
"Pten F341V epithelials cells, biological rep1",pert
race: caucasian;	age (years): unknown;	stage: IC;	grade: 2;	histology: endometrioid,pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: BETAFERON;	time: 24 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
LN-T-3,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 19d ID234,pert
neocortex-30 months of age-control diet-biological replicate2,ctrl
"non-AD_TC, biological rep1",ctrl
Kidney_Biopsy_Liver_Disease_2,pert
tissue: white blood cells;	age: 15;	Sex: male,ctrl
age: 55;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
multiple sclerosis_3,pert
M229_B_PLX,pert
CHF - LV15,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 24h ID214,pert
"DEX-treated embryonic primary chondrocyte cultures, incubated for 24hr",pert
cell line: HL60;	disease state: promyelocytic leukemia,ctrl
genotype: PML Knockout;	treatment: Low Fat Diet;	gender: male;	tissue: liver,pert
Sample 2 Posterior  -/-,pert
Transgenic 1,pert
Tmod3 KO-1,pert
age: 60;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
CF CFTR unexposed replicate 1,pert
P0 - epsilon129s6 1,pert
12 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxi;24728,pert
"Crohn's Disease subject (28 year old black male, SAK_1313738586)",pert
A2058 Ctrl siRNA Rep2,ctrl
Karyotype: inv(14)(q11q32);	Age: 72 years;	Gender: male,pert
umbilical cord_nobpd: 2D,ctrl
Dilated cardiomyopathy_G9,pert
Control gray matter 1,ctrl
timepoint: Post-Cediranib treatment,pert
Thyroid_ unaffected_paired with PTC50T,ctrl
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: none;	time: 72hr,pert
"Cervical cancer cell line, CaSki",pert
WT-smoke-med-5 month+1d-R3,ctrl
"Crohn's Disease subject (52 year old caucasian female, SAK_1307747342)",pert
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14533;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
cell line: MDA-MB231;	treatment: none;	cell type: metastatic breast cancer cells,ctrl
"ALL_DS, K17 011409",pert
LNCaP + ELK1-shRNA + R1881 rep 1,pert
Liver_WT_Rep1,ctrl
HA96-61A,pert
C2C-LU,ctrl
"endometrioma, patient 7",pert
Liver vehicle rep4,ctrl
6h_c3,ctrl
GV oocyte_Ring1 mut_rep1,pert
prostate_Klf5 wt_rep4,ctrl
KO Soleus at 4 weeks biological rep3,pert
CH2122,ctrl
strain: C57BL/6;	genotype: Wild Type;	replicate: 3,ctrl
VillinCreERT2+_Brg1fl/fl_Rep4,pert
RatLung_H3h_1,pert
MCF-7_parental_cell_rep_1,ctrl
Healthy7-CD4,ctrl
CF knockout LFCF CHN309,pert
Control_pancreas_1,ctrl
"transfection: pRTS-GFP;	cell type: human Burkitt lymphoma;	dsmz no.: ACC 603;	origin: established from the ascitic fluid of a 3-year-old boy with American-type Burkitt lymphoma in 1972; cells were described to be EBV-negative but EBV infectible, to carry the (8;14) translocation and p53 mutations",ctrl
A39 WT2	F5/53	A39	wild type	Mouse	4 months	Cerebellum	Female,ctrl
"MEKi 4 days, biological rep6",pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 48 hrs;	time course: 1,pert
APLP2_R6_rep2,pert
"Wild-type Liver, replicate3",ctrl
cell type: T cell;	treatment: 37C;	genotype: HSF1-/-;	genetic background: mixed 129Sv.BALB/c background,pert
genotype/variation: control mice treated with tamoxifen for 1 week;	tumour stage: Benign tumour,ctrl
aa.3,pert
"CL1-0, biological rep2",ctrl
OCI-Ly7 NTsiRNA 1,ctrl
Methoxychlor (50uM) rep 3,pert
WFS1 WT USHT_19_320_ko,pert
wild-type+PQ rep_1 (PQWT1),ctrl
"Wildtype, thymic, NK1.1+ NKT cells replicate1",ctrl
cell line: OVCAR-10;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
gender: female;	batch: 1;	age (years): 33;	patient id: Control_6;	fev1 (% predicted): 116;	fvc (% predicted): 115;	medication: None;	cell type: CD8+ T-cells,ctrl
"Neuroretina 8-week lean non-diabetic, Biological replica_3",ctrl
"female Spargue-Dawley rats, diet only for 7 days,  tissue: mammary gland",ctrl
Preglaucoma control rep8 (OHN),ctrl
strain: Myd88 KO;	gender: n/a;	age: 4 month;	weight: 25-30g;	tissue: trachea,pert
5217 UC Inflamed sigmoid colon,pert
"U373-EGFP, rep 3",ctrl
V5-P119,ctrl
Patient: F;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
MacularDegen-injured-7dAv2-s2,pert
LUC 20 KD #1,ctrl
WT4-iPS 2,ctrl
"BALB/c, Female, Control",ctrl
S4B Sporadic-cerebellum,ctrl
Cervical cancer_CC207,pert
Btk KO2,pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: Rosiglitazone,ctrl
scan batch: Batch 2;	group: autism;	subject age: 7;	paternal age: 33;	maternal age: 27,pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 97;	Usage number: 5;	Exposures: 3,pert
B6C3F1 male,pert
A HID U_B015,pert
patient code: 117;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,pert
"control colon tissue, biological rep3",ctrl
C57 72 ozone 3,ctrl
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: PMA,pert
CD34+ cells of CML patient before therapy,ctrl
pcDNA3(CT3),ctrl
Normal cortex of patient 42,ctrl
Control_2months_retina11,ctrl
B6 Control R3,ctrl
Embryonic age 14.5 wild-type rep1 (PKD1_34),ctrl
THRB bN mutant + T3 replicate 2,pert
Pool 5 Convalescent stage,pert
Ishikawa_HighDose_BPA_24h_rep3,pert
PGA-HMO-Obese-6aUA-s2,pert
"spleen marginal zone B in WT, biological rep6",ctrl
control_08hr_rep2,ctrl
HP-81c,pert
Individual_4165_PN_sample,pert
3DKD_rep2,ctrl
HeLa_06_21_04 TP-12,pert
CLL13-CD4,pert
control AU055103,ctrl
LSK cells from heterozygous JAK2V617F mouse rep1,pert
"DOX, rep2",pert
RNA from A549 Cells - Static Control 1hr Replicate 1,ctrl
pRb+/+;p107-/-.1,pert
IFNAR_uninf_2,pert
HF0897_U133P2,pert
Age: 48;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
cell type: Embrionic stem cell line;	genotype: HPRT -/-: GTF2I +/-,pert
B-CLL PB P155,pert
c57BL/6J Vehicle liver sample batch 3,ctrl
NALT_infected_24h_90-226-dM_rep3,pert
cerebrum_PS-/-_ 10d_rep2,pert
phenotype: alcoholic;	gender: male;	case_id: 210;	age: 51;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 27;	brain ph at time of freezing: 5.58;	labeling_batch: 1,pert
SeroNeg-5,ctrl
C57BL/6J_Liver_rep2,ctrl
CD-33-un,pert
A263insGG_mut4a+,pert
Braak α-synuclein 3-4 BR34_1SN,pert
"Mutator, biological rep2",pert
heart_Q10_14M_rep1,pert
KO STR Veh 29,pert
KOPT-K NBD 1,pert
genotype: mcad -/-;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: LPS;	tissue: liver,pert
Individual_3992_PN_sample,pert
uterus_P4_WT_40hrs_rep3,ctrl
lesion_midUV_patient12,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_12_9_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
FACS-purified B cells_IFNAR1-/-_influenza-infected_rep2,pert
HEK293 F18_doxycycline treated,pert
braak stage: CTRL;	rin: 74;	tissue: substantia nigra;	disease state: control,ctrl
gender: female;	age (years): 34;	evolution time (years): 14;	disease extension: Pancolitis;	treatment: Azathioprine,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 20.57534,pert
CON 1,ctrl
WFS1 KO USHT_08_316_ko,pert
wild-type naïve CD4 T cells KAI264,ctrl
266D0,pert
diseased cells stimulated,pert
"IkB, LPS 1hr",ctrl
PGA-RMM-8h-1aA-s2,pert
CD11b+Gr1+ cell sample_2 (derived from IL17RC Knock out mouse),pert
Aorta_APOE-deficient with atherosclerosis_1,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 46.68219,pert
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: gastrocnemius,ctrl
cell line: SU8686;	cell type: dasatinib-resistant pancreatic cancer cell line,ctrl
A549_Cisplatin_rep1,pert
A_AN17254_C,pert
"Acute Myeloid Leukemia, sample 13",pert
Strain : 100% C57BL/6;	Gender: Female;	Age: 9 weeks (Moderate stage);	Transgene: Mutant ataxin-7,pert
cell line: HEK293;	sirna: hCdc73;	condition: sparse,pert
Kyoto rat liver tissue following animal exposure to orotic acid for 1 day,ctrl
BM_02680,ctrl
Muscle PCOS after pioglitazone 232,pert
minor HCC8,pert
SW480 Snail (2),pert
cell line: non-clonal BMSC cultures;	transfection: siTERC-RNA (siTERC) construct,pert
V5-P487,pert
Subject #8040-2d Postinfection,pert
Sex: male;	Age at operation: 76 years;	Site: thigh;	Size in cm: 3.5x3x3;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
C57BL10 TA sample 2,ctrl
ab161 N,ctrl
tissue: Frontal cortex;	age: 77;	Sex: M,ctrl
Prostate Cancer_MS 36C2,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.2;	colon weight (mg): 159;	colon ratio (mg/mm): 2.56;	myeloperoxidase activity (u/mg): 0.391;	tissue: colon;	treatment: 5% DSS,pert
C57BL/6 heart left ventrical (LAD ligation 60 day),pert
Diabetes 2,pert
Raji_mi-142-3p_3,pert
Replicate 3 - R5020,pert
Subtype: RA;	Karyotype: normal,pert
sample =XCGD1 treatment=Control time=360 (min),pert
Blood_Control 3,ctrl
Wild type_lung_2,ctrl
Ishikawa_Control_48h_rep2,ctrl
cDNA no 19,ctrl
Control Colon 2 17 days old,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 57;	baseline tumor size (cm): 5x5;	patient id (to identify the 2 chips from the same patient): 19101935,pert
astrocytes normoxia batch 2,ctrl
mdx Biological Replicate 6,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#1375,pert
normal 2266,ctrl
SA4,ctrl
tissue: oropharyngeal carcinoma KB,pert
206_SIO,pert
vacht KD 2,pert
PGA-MLS-Dex-1aAv2-s1,pert
MDS30,pert
"Affymetrix chip HG-U133A, siPTHrP 2",pert
KO2 CD11b,pert
jzo026-rp1-v5-u74av2-met,pert
FVB 129 mice used as bone marrow donors,pert
Human prostate cancer primary culture C14sx,pert
SKM-1 STK33-2081,pert
"Peripheral blood, normal control [N54]",ctrl
CTRL_2_CMP,ctrl
Tissue:tumor; Gender:male; Age:56; Tumor stage:T4N0M1,pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 5,ctrl
Sample 20 Kidney Normal Mouse - Low Phosphate Diet,ctrl
"expression at 16hr, bio rep3",pert
A HID U_B054,pert
MDS40,pert
heart-30 months of age-resveratrol diet-biological replicate2,pert
HLA risk: Medium;	Height: 162.5 cm;	Weight: 53.4 kg;	BMI: 20.2;	Age: 13.03 years;	Gender: Female;	Race: White;	Glucose: 81 mg/dl;	HbA1c: 7.8%,pert
Male 8week AJ sham rep2,ctrl
Wild type rep 3,ctrl
Calu3-GemR_Veh_4,pert
potilas_DC_E,pert
Liver sample from Alcoholic hepatitis group (CA82),pert
WT-GFP-lamin A Induction: Day 0 Replicate A (CBGE_Hsapiens_WG_progerin1),ctrl
ko 13.5d replicate 10,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 184;	fata: 69;	eea: 2080;	wtkg: 109.2;	perfat: 30.1;	lbm: 68.9;	fat_mass: 3286.92,ctrl
Muscle PCOS 3,pert
Ishikawa_HighDose_BPA_24h_rep4,pert
coc-51_B,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 42 yr;	population: white;	dsm-iv: 295.3;	age of onset: 18 yr,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 12h",pert
VIN_B060,pert
kidney_co_14M_rep2,ctrl
Wildtype 2 (jos1524),ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,pert
3898-1 E2F1 Null,pert
Insm1 control #2,ctrl
DNGH-1,pert
"Murine 3T3-L1 progenitor adipocytes cell cultures, T1 (treated with resveratrol)",pert
Hippocampus 2005 2 month Old,ctrl
Bc_Mock_2,ctrl
CA95-198B,ctrl
K562 cells control replicate 3,ctrl
SCD1 +/+ liver rep3,ctrl
"NC1, biological replicate 4",ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 35, stage IB1, HPV 18, HPV 45",pert
"vestibualr organ at P90 of Igf1 -/-, biological rep 2",pert
cortex_HtrA2_KO_rep3,pert
"granulocyte, patient. Mtx rep8",pert
erStress_twins_AA_1733twin2_DMSO_4h,ctrl
H18_P_B2,pert
chronic lymphocytic leukemia (CLL 525),pert
11a_b,pert
FHCRCAML16907,pert
skin.KO.replicate25,pert
NOD_S2,pert
subject: 37;	disease: CP;	muscle: GR;	gender: M;	age: 8.7;	gmfcs: 2;	popliteal angle: 95,pert
knockdown: Control;	amplification date: 09/06/16;	hybridization date: 09/06/30;	colon length (mm): 7.7;	colon weight (mg): 169;	colon ratio (mg/mm): 2.19;	myeloperoxidase activity (u/mg): 0.039;	tissue: colon;	treatment: 5% DSS,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 62 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
strain background: Sprague Dawley;	gender: male;	diet: Lieber-DeCarlie diet containg EtOH for 6 wk;	sample group: Alcohol ingestion;	cell type: Alveolar type 2 cells,pert
individual: Control3;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
Pfeiffer NTshRNA 3,ctrl
Amniocytes_euploid_1567,ctrl
CH1-(3),ctrl
DMSO treated CEM-C1 cells_3,ctrl
567.KO,pert
"non-AD_FC, biological rep7",ctrl
"D425-shOTX2_3, t=8",pert
WT kidney pool 1,ctrl
"human failing LV myocardium, Ischemic100",pert
3883-2 E2F WT,pert
"E-FABP knockout GM-BMMs, biological rep3",pert
Endometrium-Normal 8,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_6h_1mM_HG-U133A_2_YCHSUP501,pert
treatment: baseline;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
"Control, biological rep1",ctrl
HepG2_Cd rep2,pert
NICM pool 2 (n=2),pert
age_years: 43;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
"E12.5 wild-type embryonic kidney, biological rep3",ctrl
AZ-521_doxycycline_12h_rep2,pert
wt Ang2,ctrl
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 2 - Technical Replicate 1,pert
"Grape extract group, 6 months, patient number 14",ctrl
Sham 7,ctrl
RNA from HCC_8T,pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of BMI-1. Sample C,pert
tissue: temporal lobe;	strain: 129SV;	genotype: WFS1 KO,pert
"BOEC, normal 20",ctrl
cortex_WT_rep2,ctrl
Cerebellum_nontransgenic control S46_3.5 months_replicate 2,ctrl
WT-smoke-med-1 day-R4,ctrl
Large cell carcinoma 006,pert
Trim28CKO TCR-stimulated CD4 positve T cell rep1,pert
strain: C57BL6/10J;	genotype: mdx;	gender: male;	age: 2 months;	tissue: cardiac muscle,ctrl
Dengue Hemorrhagic Fever Patient 40,pert
"S1P2-KO-neocortex, biological rep10 (female)",pert
cell line: U87;	treatment: 20 uM Temozolomide;	cell type: glioblastoma cancer cell line,pert
Ileum_POR-null_2,pert
0137-01-C,ctrl
MDS patient 175,pert
"MN1, 1",ctrl
gender: female;	age (years): 41;	evolution time (years): 7;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
Contralateral 1,ctrl
WT - Cre Control - 3 mo - repeat 4 - Cy3 - mAdbID:74672,ctrl
Carbo Day14 (439R),pert
strain background: C57/129S;	genotype/variation: Fra-1-/-: Fra-1 KO;	gender: female;	age: 2 months;	treated with: 30 µl of PBS for 5 days;	tissue: lung,pert
CME-Ctr_LaminA3d-2MA-S2,ctrl
Jejunum_Wild Type_1,ctrl
"Dumbo retina, biological rep3",pert
"Untreated ES cells, Rep 2",ctrl
HEK001_pLKO_R3,ctrl
AA_Control2_CD8,ctrl
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 6 h;	dose: 0.1 μM;	agent: VX (O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothiolate),pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 43;	gender: male,ctrl
"wildtype white adipose tissue, biological rep 1",ctrl
HCC007N,ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
3560-3 E2F2 Null,pert
PBMCs_IS_13 [IS],pert
"CRT knockout mouse embryonic stem cell, biological rep2",pert
"G42 cells from M1, Mecp2 null, biological replicate 3",pert
KU_29T,pert
"NF-YB KD ES cells 96hr, replicate 1",pert
Muscle-AMPKgamma3-wt-3,ctrl
High Glucose Transcriptome Profiling {rpt},pert
N40728,ctrl
PHM-DM-3aUA-s2,pert
Msgn1_48hMinDox-biological rep1,ctrl
male_control_190,ctrl
siSPDEF_5,pert
phenotype: alcoholic;	gender: male;	case_id: 290;	age: 51;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 46;	brain ph at time of freezing: 6.35;	labeling_batch: 1,pert
Human prostate cancer primary culture C29dx,pert
cerebellum_PS-/-_ 10d_rep2,pert
L1 062502 Con1,ctrl
"brain, hippocampus: Wt #3405 Hippo_e1_le1",ctrl
NSC11,pert
cell type: mammary epithelial cells;	gender: female;	age: 8 weeks;	myc: WT;	p53: WT;	rb: WT,ctrl
patient: 206;	current medication: Asacol 800mg BD;	birth date: 9/10/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/80;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
M249_R4_A_DMSO,ctrl
Scd1-/- on chow diet replicate 1,pert
Run5.aUa.010110d.SkMDbt1153D.CEL-DB stimulate,pert
miR122-WT-163,ctrl
Strain: B6129;	Gender: male;	Age: 12 weeks;	Tissue: liver;	Developmental stage: adult,pert
cell line: U937;	replicate: Replicate1;	treatment: shSYK_2,pert
RNA from HCC_36T,pert
colon_IL10mouse_6weeks_rep5,pert
control5,ctrl
NSC5,pert
C26_heart 1,pert
Individual_5579_NN_sample,ctrl
Control bone marrow - Biological Replicate 4 - Technical Replicate 2,ctrl
Mutated-ERα-positive breast cancer 71,pert
"Wild-type-hippocampus, biological rep3 (male)",ctrl
"Mouse bone marrow-derived mast cells treated with IL3, rep 4",ctrl
control MLL_00111,ctrl
quiescent ulcerative colitis_UCN2,ctrl
8h 4OHT-treated-sample2,pert
Skin_WT_1,ctrl
HT29RC PLX4720 resistant cell line,pert
KO Ang4,pert
Estrogen [H3],ctrl
T62 dilated cardiomyopathy heart biopsy,pert
race: caucasian;	age (years): 55;	stage: IB;	grade: 1;	histology: endometrioid,pert
4mo tg2,pert
"Normal skin from lmq_control mouse, biological replicate 1",ctrl
patient id: T166;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 56;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3N1M0;	Stage: III;	fuhrman grade: 4;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
Day: 6; Drug: Saline; Phase: Drug treatment; Replicate: 3,ctrl
Normal control 2,ctrl
background strain: C57Bl6;	genotype: wildtype,ctrl
multiple myeloma (MM 500),pert
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 5,ctrl
genotype/variation: Ghrh-KO;	tissue: liver;	gender: male;	strain: mixed C57BL6 and 129SV,pert
"control embryonic stem cells, biological replicate 3",ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 67;	baseline tumor size (cm): 9x7;	patient id (to identify the 2 chips from the same patient): 12791332,pert
Cutaneous psoriasis without arthritis PsC 19,pert
P91,ctrl
A673_CloneAsp14_Dox_72h_2,pert
HCV_Control_2,ctrl
miR122-KO-T2,pert
Muscle-AMPKgamma3-mutant(R225Q)transgenic-2,pert
DU145_VprBPsh_rep1,pert
"PBMC, healthy control, biological rep12",ctrl
prostate_Klf5 wt_rep1,ctrl
cell line: A549;	agent: decitabine;	dose: 3 uM,pert
Individual_4160_PN_sample,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.977;	OD280: 0.478;	Ratio: 1.99;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 300;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
RA_C,pert
NLGN1_3,pert
autism with dup(15q) 02-07,pert
condition: Normal;	patient: N_AJ1;	tissue: Normal skin biopsy;	kit: Ovation,ctrl
"SIRT3KO, standard diet, rep1",pert
Sex: male;	Age: adult (11-12 weeks),pert
colon cancer cells,ctrl
B9_092612,ctrl
Subject 1 Pre allergen challenge,ctrl
Muscle PCOS control 9,ctrl
"Rat_Tracheal_Control_2hr, rep5",ctrl
01UP8_ERA,pert
MO_DH3b_SON_NCBI,pert
Squamous cell carcinoma 015,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 29.01644,ctrl
pediatric AML PP2,pert
MBD1 WT #1,ctrl
MCF-7ADR_multi-step_doxorubicin_selected_subline_rep_1,pert
whole tissue section from case 1260,ctrl
C2A-LU,ctrl
DNGH-2,pert
0514-01-C,ctrl
"human failing LV myocardium, Idiopathic47",pert
"Normal 11, control tissue",ctrl
healthy control sample x302,ctrl
Diaphragm 23 Day control rep 1,ctrl
PGA-lv_8w_340,ctrl
FmrWT1_brain,ctrl
Mutant_liver_1,pert
Against CDK19-2 rep3,pert
NPC Brain 54d MOuse1,pert
Control replicate 4,ctrl
liver_STZ 0.5% quercetin diet_rep1,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 2,pert
"treatment with TFMPP, replicate 3",pert
WT3-iPS 3,ctrl
Control (pCMV-GFP-2)_MDA-231,ctrl
IRS-4 KO (jos0931),pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 230min;	race: White;	sex: Female,pert
H_Kin_1,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	sex: Female,pert
shNANOG_7,pert
Cnah KO_heart_1,pert
control9,ctrl
"Patient 19, Macroscopically intact tissue",ctrl
GM19238_Kd_NS4_21B,ctrl
NSC8,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep7,ctrl
chip number: 23;	transfection plate: 3A;	target gene: SP3;	kd level: 0.59;	rin: 9.4;	transfection date: 2012-03-26,pert
sepsis patient #16,ctrl
MOLF/EiJTCE liver sample batch 3,pert
HMEC_50 vs BT20,pert
Control,ctrl
ApoE-/- mouse infected wtih an adenovirus expressing dominant negative cJun,pert
"Liver from control mice, biological replicate 5",ctrl
"Epidydimal white adipose tissue from ASC-/- after 16 weeks of high fat diet feeding, replicate 3",pert
Bone-Marrow_MGUS_G991,pert
Strain: C57BL/6J;	Gender: F;	Age: 7 weeks;	Treatment: untreated,ctrl
"fibroblast, MFS subject GDO1051 rep 1",pert
Injured 3 day Rat Retina 1,pert
Wildtype_TAC_Rep1,pert
"cell line: F348, WBS, skin fibroblasts;	microdeletion: del(7q11.23);	gender: female;	age at biopsy: 3 years",pert
24 weeks male,pert
Against CDK19-2 rep1,pert
"Deltoid, FSHD, cohort 15, subject 15A",pert
male_control_366,ctrl
cell type: HUVEC;	treatment: RAF1 S259A,pert
Age: 57;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: No,pert
mammary_16wkLH_ker73,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 4;	biological rep: 3,ctrl
WT osteoclasts untreated 3,ctrl
CTL2 AO 2hr,ctrl
WT_MEF_un.2,ctrl
"Empty vector control, 24 hrs, No Rosiglitazone (NONE_24_1)",ctrl
P0 - WTMixA 1,ctrl
Extract:LOX-1:113402;	Extract Description:GFP_Untreated_12hr:113402;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.48;	Quality: Background Mean Dev.:0.18;	Quality: Absent (%):59.48;	Quality: Absent (%) Dev.:0.95;	Quality: Scaling Factor:0.7;	Quality: Scaling Factor Dev.:0.72;	Pretreatment [C]:GFP;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113402;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_12hr;	RNA extraction source key [A]:282295723,ctrl
cell type: Primary hepatocytes;	donor: 2;	agent: Wy14643;	time: 24h;	gender: Male;	age: 44 years old,pert
EA_Case5_CD20,pert
chip number: 14;	transfection plate: 3B;	target gene: POU2F1;	kd level: 0.84;	rin: 9.6;	transfection date: 2012-03-26,pert
RNA-DHL6-DMSO-3,ctrl
LSK SRF-null 3,pert
DBTRG untreated rep2,ctrl
Cbfb-deficient Treg_rep2,pert
Aged 6,pert
01MHR_PolyRF+,pert
Liver_Nrf1 CKO_rep2.,pert
cell type: dental pulp cells,ctrl
AKR/J Vehicle liver sample batch 3,ctrl
M_LS_Wk12,pert
histology: chronice active plaque;	disease state: multiple sclerosis following demyelination-active inflammation;	tissue: multiple sclerosis brain lesion,pert
K562 AMN107 sample 3,pert
T1D-LU,pert
KJD+doxorubicin_rep1,pert
"brain, hippocampus: Aldh5a1-/- #3403 Hippo_e1_le1",pert
cells_ATCC 16 Lu _human lung fibroblasts_JCB_0_12_19_Lung_Fibroblast_Rcontrol_HG-U133A_2_IMFRT0014,ctrl
patient id: 111;	tissue: Normal cortex;	gender: Female;	age: 72;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
BALB/c_PBS Replicate 2,ctrl
C_AN19760_C,ctrl
healthy control H23,ctrl
Pancreatic Sample 27-Tumor,pert
HD2,pert
"B10 sham kidney, biological rep1",ctrl
hippocampus: Sample #1_e1_le1,pert
WT_liver_vehicle 0 mg/kg_96 hr_5,ctrl
WT differentiated brown fat cells (rep2),ctrl
Bone-Marrow_MM_M906,pert
potilas_DC_B,pert
38SMOKEH,ctrl
Contralateral 5,ctrl
SV129_24h_DMSO,ctrl
U-87MG-PK7 set 3,pert
Muscle JDM (YJD-JDM-3UA-s2),pert
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 81;	Usage number: 4;	Exposures: 3,pert
Mouse old brain C30-Br-4,ctrl
genotype/variation: GATA3 KO;	cell type: Tregs,pert
Bone-Marrow_MM_M1049,pert
"Mutatn in the absence of tetracycline, rep3",pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 70;	age-at-onset: 69;	geographical origin: Vila-Real;	clinical characteristics: Hypertension, hypercholesterolemia",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339033,pert
"116, MUSCLE, Before",ctrl
Fetal heart control 5,ctrl
AtT20 cells treated with NSBP1 siRNA rep 1,pert
disease state: paediatric glioblastoma;	age: 13;	gender: M;	h3.3_status: G34R,pert
"EtOH, WT, set 4",ctrl
Subject #8024-Preinfection,pert
FU-OV-1-(2),ctrl
"Wild-type myeloid-derived suppressor cell from colon tumor, rep2",ctrl
siHic5_2_24h_4,pert
MDS patient 66,pert
"Atria, Control, biological replicate 2",ctrl
Klf9WT_jejunum_PND30_1,ctrl
GSK3B shRNA replicate 3,pert
7118.3PBMC,ctrl
CH2110,pert
day 6 5-FU HSC 2,pert
Patient: M;	Time: 0;	Group: responder;	Condition: lesional,ctrl
MCI-003,ctrl
"Wild type mouse embryonic stem cell, biological rep2",ctrl
SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2),pert
"JCAM1 Lck negative 0 hours, #3",pert
01JE9_ERA,pert
patient6,pert
genotype: Oga knockout;	gender: Female;	cell type: MEF,pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep6,pert
brain_DLPFC_bipolar C_mr448,pert
strain: wt;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 12-14 mo,ctrl
1009-03-A,pert
MCAD 5,pert
"vector control cells, biological rep1",ctrl
B-CLL PB P137,pert
A_AN06420_C,pert
TTP_KO_0ActD_BioRep1,ctrl
HF1150_U133P2,pert
Adrenocortical adenoma with wild-type CTNNB1-1,ctrl
"CD11b DC Xbp1 KO (DC conditional KO), biological replicate 1",pert
A_AN06420_T,pert
MLL1-KO MEF CT30-2,pert
18A,pert
"nasopharyngeal carcinoma, specimen T23",pert
patient code: 138;	gender: Male;	age: 50;	tumor grade: 2;	t-stage: 2;	n-stage: 1;	ajcc classif. (2002): 2b,ctrl
HL60-shControl-rep1,ctrl
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14454;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
B4 422 wild-type after nicotine-induced seizures,pert
Second shYY2,pert
2 Wild-type control macrophage,ctrl
"AD_FC, biological rep12",pert
Bc_p60_2,pert
Hippocampus 1980 15 month Old,pert
ALI patient #5,pert
PBMC from T cell Large granular lymphocyte leukemia patient#112,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 uM;	treatment time: 24 hours,pert
WT rep1,ctrl
"nasopharyngeal carcinoma, specimen T4",pert
HCC1937_1,ctrl
age_years: 41;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: Vemurafenib 1000 nM for 72h,pert
HeLa_TP082505_20_HG-U133A_2_IMFGN0023,ctrl
MZ1774 YAPshRNA rep 3,pert
"PC from MM patient, isolated using CD38-APC.",pert
DMN-CtrHippo15d-1bAv2-s2,ctrl
control-plusDox-rep1,ctrl
HEK293 F18_doxycycline untreated,ctrl
EA_Case20_CD8,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: metastasis to lung;	organ site at which tumor arose: oral cavity;	donor sex: male,pert
YFP-pos GMP Dicer het rep3,pert
"cochlea at P13, ko, biological rep 2",pert
PBMCs from normal control subject J,ctrl
H4 Ctrl 2h 4,ctrl
NZM12_media_control_30hrs_rep1,ctrl
Ishikawa_VeryHighDose_BPA_24h_rep1,pert
Bone-Marrow_MM_M1051,pert
race: caucasian;	age (years): 83;	stage: IB;	grade: 3;	histology: endometrioid,pert
"Distal and Proximal Large Intestine, 8week old Winnie mouse 3",pert
"seminoma specimen, pT1, patient age: 36y; W01 145",pert
affected status (disease state): control;	gender: female;	age-at-examination: 73;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension,ctrl
cell line: MCF-7;	sirna knockdown: siLRH-1_#3,pert
Tissue: Primary human hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use:  Yes,ctrl
"brain, hippocampus: KA-240h-P15-III_e1_le1",pert
01UMZ_PolyRF-,pert
0652-01-C,ctrl
"E2A-deficient (E2AKO) DP cells, biological rep 1",pert
muscle_Akt1+/-_35wk_rep3,pert
Oct4GipES_Luc_esiRNA_72h_rep1,ctrl
"lymphoblastoid cell line from P910, one out of seven of sensitive group, 50*10e6 cells",ctrl
THRB wt + T3 replicate 5,pert
"non-AD_HI, biological rep6",ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 5d ID216,pert
"HPRTKO, biological rep1",pert
whole blood_100374,ctrl
ATM_siRNA_4a,pert
Septic shock;	gender: Male;	Survivor;	organism: Adenovirus;	organism class: Viral,pert
DOV13-(2)b,ctrl
WT1-iPS 5,ctrl
cell line: HeLa;	cell type: human Cervical Carcinoma;	genotype/variation: parental,ctrl
cell line: MDA-MB-231;	cell type: Breast cancer cells;	group: Control group,ctrl
CA97-14B,ctrl
"Strain: C57BL/6J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle. Galgt2 Transgenic",pert
"Hdh knock-in embryonic stem cells, Q50 line, biological replicate 3",pert
Skinbiopsy_0h_controlsubject_k5,ctrl
"Immortalized MEFs WC, empty retroviral vector infected, rep1",ctrl
WildType_2_2,ctrl
BAL_12_A1B0,ctrl
"Age: 37;	Sex: F;	Ancestry: African;	Smoking status: smoker, 23 pack-years",pert
CON24,ctrl
cell type: WAO9 human embryonic stem cells;	genotype/variation: shRNA-mediated HNF4a knockdown;	growth protocol: subjected to a hepatic differentiation protocol;	time: d20,pert
tissue: Brain;	genotype: Npc1-/-;	age: 37 days;	subject: Mouse1;	genetic background: BALB/c,pert
sample =Healthy2 treatment=Stimulated time=90 (min),ctrl
sample K 18.5 wt,ctrl
"A673 treated with Doxorubicin for 3 days with concentration of 119.76 nM (2 x EC50), biological rep1",pert
KU_40N,ctrl
MC3T3 cell line,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-tu1,pert
s4t2c,ctrl
SKBR3_0.1uM_Lapatinib_2,ctrl
Patient identifyier: L;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 22 years;	Body surface area: 10 percent;	Overall erythema: moderate;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
BP patient 81_biological replicate 2,pert
MGHU3 Cells_TAK1 siRNA_Biological Replicate 1,pert
"Mouse stable invitro iTreg cells, replicate pool 2",pert
BCell_activated_sample3,ctrl
patient: EUR12;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
Jurkat with Nef Biological Replicate 1,pert
"sh2608 (to target ERBB3) T47D cell line, replicate 1",pert
subject: 12U;	cohort: 12;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 24;	Sex: F;	batch: Batch_3,ctrl
"BOEC, normal 18",ctrl
"breast tumor epithelium,21",pert
patient: 17;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
PGA-MAH-C3H_OVA6h-4aA-s2,pert
JGB-Post-2UP_Run2-S2,ctrl
strain: C57BL/6J;	tissue: E13.5 embryonic fibroblasts;	genotype/variation: wild type,ctrl
RI46,pert
healthy control H26,ctrl
cell line: KARPAS-231;	cell type: diffuse large B-cell lymphoma (DLBCL) cells;	treatment: non-targeting siRNA,ctrl
OCI-Ly1_siFOXP1,pert
"patient 035b, cancer, homogenized",pert
gender: male;	age: adult;	tissue: liver;	genotype: Rictor floxed;	treatment: fasted 16hr then given ad libitum access to food for 3 hr,pert
GC resistant clone C7H2-R10E7 treated for 6 hours with EtOH,ctrl
Embryonic age 17.5 mutant rep4 (PKD1_40),pert
Mouse_Klf5 KO_ES_clone 1,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 49 yr;	population: white;	dsm-iv: 296.54;	age of onset: 20 yr,pert
cell line: D3;	genotype/variation: PRMT1 knockdown (siPRMT);	cell type: undifferentiated embryonic stem cells,pert
Transgenic nr 652,pert
26 weeks female,pert
WT_P_1,ctrl
Huh7 cells_Mock Infected 6 hours_ rep2,ctrl
"NPCxhIPSC SCZP, replicate 1",pert
"Pancreas from adult Rkip-1 KO mice, biological replicate 3",pert
E_Ctrl_2,ctrl
MLL2 siRNA biological rep 2,pert
M323 C,ctrl
B2KO; No Treatment #8,pert
Monocyte derived dendritic cells were generated by culturing human monocytes isolated from buffy coats using CD14 microbeads (Miltenyi),ctrl
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,pert
"bcatGOF  mouse kidney E12.5, biological rep 2",pert
Normal cervix_05-5007,ctrl
patient: 250;	current medication: Asacol 2.4g/d;	birth date: 1/27/58;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 1/1/94;	diagnosis date: 5/30/94;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/29/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 4/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
treatment: baseline;	gender: F;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,ctrl
Cutaneous psoriasis without arthritis PsC 2,pert
Muscle PCOS case 41,pert
PFC R control 4,pert
01MJD_Oligo,pert
"0mg/kg/day PFOA, Rep 3, Block 3, liver (high dose)",ctrl
wild-type tumor #3375,ctrl
Patient 1 skin treated,pert
"Mice_c-myc trans, biological rep2",pert
56 y/o male,ctrl
control MLL_00114,ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 3",pert
AR-CO-24-1-542,pert
"non-AD_HI, biological rep1",ctrl
Spleen_infected_4weeks_rep2,pert
CUTLL1 MigR1 GSIwash4h-rep2,pert
GIST882 Imatinib Rep1,pert
"control E14, rep1",ctrl
BP15,pert
RNAi -Transgenic replicate 5,pert
"CRT knockout mouse embryonic stem cell, biological rep3",pert
prefrontal cortex (BA10);	depression,pert
C593,ctrl
S035_Scz_F_87,pert
3976-3 E2F1 Null,ctrl
"brain, frontal cortex: Sample46_e1_le1",pert
tissue: Temporal cortex;	age: 89;	Sex: M,ctrl
scan batch: Batch 1;	group: autism;	subject age: 9;	paternal age: 27;	maternal age: 28,pert
Manca 2,pert
cell line: MCF7;	treatment: Control,ctrl
umbilical cord_nobpd: 5D,ctrl
pediatric AML S27,pert
cell line: COV434;	transfection: empty vector,ctrl
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 24hr",ctrl
E11_WT3,ctrl
04 PLUS OHT 2A,pert
brain_OFC_control C_mr96,ctrl
ILD Study Number S013,ctrl
patient: 31;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"5mg/kg/day PFOA, Rep 5, Block 4, liver (high dose)",pert
Nrl-ko-Gfp 4 weeks replicate 2,ctrl
HNF4a2_1-,ctrl
"Ptenloxp/loxp + pBP-Cre, biological rep 2",pert
PBMC;	Age: day 4,pert
platelet_Ctrl_2,ctrl
"OuJ, air, biological rep 2",ctrl
cell line: U87;	tumor tissue source: Cell line established;	tumor organ site: Brain;	pathological diagonosis: Glioma,pert
"A549, +TNFα, Claudin 1 siRNA, rep2",pert
Multiple sclerosis CD4+T cells 7-PM,pert
genotype/variation: mutant ThPOK,pert
NALM-1 non-treated,ctrl
11419 UC Uninflamed ascending colon,pert
pediatric AML PP7,pert
Cancer 11,pert
"35B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
GATA3KO_1,pert
Strain:  B6.V-Lep ob;	Gender:  Female;	Age: 12 weeks;	Tissue:  Gallbladder,ctrl
"Foxd3 conditional knockout cells treated with DMSO, biological rep3",ctrl
HeLa cells were transfected with siRNA specific for optineurin mRNA,pert
microdissected breast cancer cells from case 749,ctrl
lymphocytes_ctl_M_46y,ctrl
BCell_resting_sample1,ctrl
KO2 PBS,pert
"brain, Entorhinal Cortex: 01-22 normal_e1_le1",ctrl
ASC_morbidly-obese_bilogical rep3,pert
tissue: full-thickness skin;	age: newborn (P0);	genotype/variation: Krt1+/+;	strain: C57BL/6,ctrl
"human failing LV myocardium, Ischemic93",pert
Cerebellum_nontransgenic control A39_4 months_replicate 2,ctrl
Squamous cell lung cancer X36nml,ctrl
MO32_7,pert
MCF-10A shATM-3 replicate 3 [set 5],pert
"Endometrium, postmenopausal, estradiol, 36",pert
strain: B6/C3H F1 hybrid;	gender: male;	age: 30-month-old,ctrl
cell line: FOXO WT,ctrl
"650nM MLN4924 after 8hr, replicate 2",pert
T134 U133p2,pert
strain: C57BL/6J;	cell type: KLS;	genotype/varation: ∆Hmga2,pert
E11_SostKOSostLKO_2,pert
Sample 11 Kidney Normal Mouse - Control Diet,ctrl
HB1.F3-Nurr1,pert
scrambled siRNA biological rep 1,ctrl
treatment: shRNA against DBC1 (shDBC1);	cell line: MDA-MB-231,pert
wild-type #2,ctrl
Bone-Marrow_MGUS_G736,pert
EOM 14 Day mdx rep 3,pert
LT 411 +/T after nicotine-induced seizures,pert
MDS patient 168,pert
muscle_Wt_8wk_rep3,ctrl
E.8 DBA-C57BL/6 whole embryo,pert
ME180 1 hour rep 2,pert
cell line: SK-N-SH;	lentivirus: eGFP,ctrl
sample: #13;	subject: PD case #1;	brain: T-1982;	age: 79;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
U2OS_control_shRNA_pLenti_3,ctrl
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIa;	Sex: F;	age: 47,pert
siLRH-1_#3_rep_1,pert
"normal nasopharyngeal tissue, specimen N5",ctrl
"650nM MLN4924 after 24hr, replicate 1",pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 24 hrs Solvent,pert
"Subject 15, Family 5, Control",ctrl
"Lesion Skin, LS-27",pert
subject id: c3;	infection: control;	status: control;	tissue: whole blood,ctrl
"alveolar macrophages, non-smoker 005",ctrl
MCF7/XBP1 p.6,pert
patient: EUR12;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
LICR_HN1_CETU3,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: tumor;	sample name: 4-tu1,pert
HeTH-4 rep-3,ctrl
"schizophrenia, BA10-15",pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M1;	flt3 status: internal tandem duplication (ITD),ctrl
IM71_case,pert
"Strain: D3, mouse embryonic stem cell",ctrl
gender: female;	age (years): 30;	evolution time (years): 3;	disease extension: Pancolitis;	treatment: Systemic steroids,pert
shRNA-PGC1a #66 rep-1,pert
lesion_postUV_patient3,pert
adult HSC 2 (untreated),ctrl
cell type: embryonic stem cells;	genotype/variation: transfected with yy1-specific siRNA,pert
RAW_0mM_HOCl_#3,ctrl
"Crohn's Disease subject (46 year old caucasian female, SAK_1316845653)",pert
"Lesion Skin, LS-6",pert
Carbo Day2 (65R),pert
brain_DLPFC_bipolar C_mr645,ctrl
"Lesion Skin, LS-5",pert
Muscle 50 eccentric contractions 12 hours WT Adult 0701,ctrl
colon_epithelium_IL10mouse_6weeks_rep2,pert
Normal Rat Retinal Müller Cells (biological replicate 2),ctrl
patient4,pert
cell line: CH1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: WT,ctrl
K562 cells CREB Knock-out replicate 6,pert
MeCP2_2,pert
medium to late response after cadmium treatment,pert
12489 UC Uninflamed ascending colon,pert
HDAC6_2,ctrl
AL Chip#35,pert
ic25 -- mock APF on membrane A,ctrl
DBA control (202msn),ctrl
Mening SWB WB NP 6b,pert
cell line: KYSE220;	cell type: squamous cell carcinoma,pert
Liver_normoglycima_no.7,ctrl
strain background: B6/C3H;	genotype/variation: Brwd1 mutant;	developmental stage: germinal vesicle (GV) stage;	tissue: oocytes (100 cells),pert
Waldenström’s macroglobulinemia (WM-PC 30866),pert
BC2 TC_NOC,pert
SRF silenced R1881 rep 1,pert
knockout rep-1,pert
Liver_WT_Rep2,ctrl
PS-final,pert
strain: C57BL/6;	tissue: cerebellum;	genotype/variation: wildtype,ctrl
Liver sample from Alcoholic hepatitis group (CA79),pert
"Control, standard diet, rep1",ctrl
"YPFH cells from M1, Mecp2 null, biological replicate 3",pert
40A;pretreatment;female;breast tumor; responder,ctrl
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep2,pert
HVS-CD4-ITK-R335W_unstim_rep2,pert
Map3k7 (TAK1) knockout replicate 2,pert
mdx Biological Replicate 1,pert
Multiple Myeloma Patient 2,pert
"Grape extract group, 6 months, patient number 29",ctrl
NICM pool 4 (n=4),pert
"T47D cell line, replicate 2",ctrl
CD4+ CD25lo Foxp3+ T cells,pert
"Normal subject (25 year old caucasian male, SAK_1280038056)",ctrl
Striatum of 8-10 week old DBA/2J mice,pert
Control (C278),ctrl
SHR12-1,pert
Run4.aUa.010110d.SkMDbt1148D.CEL-DB basal,ctrl
DEX2_24H,pert
5008-scrape,pert
kidney_co_14M_rep3,ctrl
MyD88_ZYM_A,pert
cell line: AT2 E/R positive leukemia;	treatment: treated with specific E/R targeting shRNA,pert
"Ulcerative Colitis (41 year old caucasian female, SAK_1285223952)",pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_3 months_replicate 4,pert
B_cell_pool_healthy_H09+H10,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: gastrocnemius medialis;	age at biopsy: 62;	Sex: male,pert
224 Day 0 Untransfected biological rep2,ctrl
"gender: female;	age: juvenile, 8 weeks (P59);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 -/-;	tissue type: renal tissue",pert
colon_C57 mouse_12weeks_rep3,ctrl
OSCE-13T,pert
Extract:LOX-1:213102;	Extract Description:LOX1_0hr:213102;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.07;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.58;	Quality: Background Mean Dev.:1.4;	Quality: Absent (%):59.09;	Quality: Absent (%) Dev.:0.65;	Quality: Scaling Factor:0.6;	Quality: Scaling Factor Dev.:0.13;	Pretreatment [C]:LOX1;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213102;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_0hr;	RNA extraction source key [A]:282295453,pert
Knockout liver DEN-injected 12weeks repl1,pert
K562 cells CREB Knock-out replicate 2,pert
"BOEC, at_risk 9",pert
genotype: control;	strain: inbred 129;	cell line: E14;	cell type: embryonbic stem cells,ctrl
WT-sham-2 month-R3,ctrl
"BOEC, not_at_risk 5",pert
cell type: Mouse embryonic fibroblasts;	genotype: MLL1 KO;	time: CT30,pert
RAW_0.14mM_HOCl_#2,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-sp3,ctrl
V5-P568,pert
cell line: mNB-A1;	strain/background: mixed C57BL/6 x 129X1/SvJ;	cell type: MYCN-driven neuroblastoma;	treatment: MLN8237,pert
NZW/LacJ Vehicle liver sample batch 2,ctrl
Muscle JDM (YJD-JDM-9UA-S2),pert
MDS patient 156,pert
genotype/variation: WT;	cell type: Tregs,ctrl
E14wt-SRFVP16-2,ctrl
mouse jejunum_hnf1alphacontrol_rep3,ctrl
Lymphedema Tail Skin 3,pert
T-ALL cell line treated with DMSO,ctrl
WT biological replicate 3,ctrl
"Eed KO BM LT-HSC, biological rep2",pert
"Peripheral blood, normal control [N63]",ctrl
Wildtype liver DEN-injected 12weeks repl3,ctrl
S8,pert
cell line: HepG2,ctrl
L428+M_rep2,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.315;	OD280: 0.668;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 312;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
WT biological rep 2,ctrl
"Pineal gland from control mouse at ZT6, biological rep 3",ctrl
WT - Cre Treated - 2 hrs - repeat 2 - Cy3 - mAdbID:62606,ctrl
SENS 3 0hr,ctrl
P50 Non failing heart biopsy,ctrl
Bronchial Epithelial Cells control biological 1705R,ctrl
"WT, PR02M002v0",ctrl
"Acute Myeloid Leukemia, sample 45",pert
"G42 cells from Cerebellum, wild type control, biological replicate 3",ctrl
Replicate 3 - CDB4124,pert
Liver sample from Alcoholic hepatitis group (CA92),pert
"Patient J, lesional skin",pert
Brain CD8 T cells that are IL-10+ rep3,ctrl
BirA control replicate 2,ctrl
CLL18-CD8,pert
colon_CRC_1761,pert
"WT, PR01M001v0",ctrl
Control N2B27 sample 1,ctrl
H157 siMOCK,ctrl
liver_wild type_12 weeks_replicate_2,ctrl
H19 siRNA (simH19) tranfected into C2C12 myoblasts rep1,pert
"JurkatNegative (Mock stim)  0 hours, #3",ctrl
affected status (disease state): control;	gender: male;	age-at-examination: 48;	age-at-onset: n/a;	geographical origin: Lisboa;	lifestyle characteristics: ever smoker,ctrl
"12-week-old spontaneously hypertensive rats (SHR), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump.",pert
tissue: skin;	individual: Patient P3;	condition: AL;	eczema severity: SCORAD: 81,pert
"72 hour-treated wild-type NB4, biological rep1",pert
"Patient 27, Macroscopically intact tissue",ctrl
DMN-CtrHippo10d-1bAv2-s2,ctrl
E11_WT1,ctrl
SZ15,pert
patient: 40741;	sample: tumor,pert
Control1,ctrl
CC1 21d replicate 2,pert
"brain, hippocampus: PH3_e1_le1",pert
cell line: SC263;	treatment: Cetuximab 15 nm Cetuximab for 13 hours,pert
lesion_preUV_patient3,pert
Nasal Epithelium Inhalation Formaldehyde 15ppm 6h ID341,pert
SeroNeg-10,ctrl
Rat fatty liver13,pert
Snell 22 month Wild Type Liver 2c,ctrl
WT659,ctrl
E12 ko.1,pert
Prostate-specific Pten deletion anterior prostate tumor 1,pert
PBMC from T cell LGL leukemia patient #110 (TLGL110),pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 1",pert
age_years: 56;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
patient: 263;	current medication: Azathioprine 75mg Fosomax 70mg;	birth date: 11/9/58;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/00;	diagnosis date: 6/1/00;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 7/8/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Adrenal CREMKO 0h batch 1 [AdKOh00.1],pert
tissue: liver;	strain: C57BL/6JBomTac;	genotype/variation: ACBP-/- (KO),pert
PBMCs_Control_10 [IS],ctrl
"Uninfected NT at 5 d.p.i., rep4",ctrl
WT - Cre Treated - 2 hrs - repeat 2 - Cy5 - mAdbID:62603,ctrl
A_AN17138_T,pert
"ARD842, CAIS, F, GOF, 1 x 100nM DHT, 24h",pert
mouse liver B1,ctrl
Huntington's disease 874H,pert
"A673 treated with DMSO vehicle control for 24 hours, biological rep1",ctrl
Sox9egfp_p23-3,pert
liver_control_diet_rep4,ctrl
S/LV4,pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 3,pert
HF0639_U133P2,pert
AL Chip#26,pert
cell line: HEK293 cells;	transgene: NPAP1/C15orf2;	treatment: uninduced,ctrl
PGA_MI_nilv_1w_662,pert
wild type stria vascularis replicate 1,ctrl
cell type: placental trophoblast;	developmental stage: E12.5;	genotype/variation: c-Met KO,pert
MPM tumor 5,pert
lung_silica_2,pert
4IDC_tumor ductal,pert
age: 24 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
WT-control-1 (DFW),ctrl
injection: IP 8hr 1 mg/kg Dexamethasone in saline;	diet: AIN-76A,pert
Wildtype_TAC_Rep5,pert
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 17",pert
"spleen follicular B in WT, biological rep6",ctrl
3976-1 E2F1 Null,pert
patient: 217;	current medication: Asacol 1.2g daily;	birth date: 2/9/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/10/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/26/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/26/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
A2780-(3),ctrl
ko 13.5d replicate 6,pert
106 year old female,pert
RNA from HCC_37N,ctrl
PGA-MAH-C3H_PBS6h-1aA-s2,ctrl
ubb_d7_ko_2,pert
uterus_P4_WT_4hrs_rep2,ctrl
"IMR-32 ,T=0, 1",ctrl
patient: 238;	current medication: Enalapril Zantac;	birth date: 9/27/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 9/25/03;	diagnosis date: 1/14/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: NEW;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: Hypertension Diverticular disease;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
ILD Study Number 1021,pert
race: caucasian;	age (years): 60-65;	stage: n/a;	grade: n/a;	histology: atrophic endometrium,ctrl
whole blood_101007,pert
24h kin- Cel.08,pert
rd1_P4_rep2,pert
clone type: AtT20 clone types treated with control siRNA rep 1,ctrl
strain: C57BL/6;	genotype/variation: WT;	cell type: Peritoneal MF,ctrl
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: R,pert
HDAC6_3,ctrl
IM67_case,pert
Jurkat T-cells non transfected,ctrl
"ERRa ko baseline heart, sample 1",ctrl
Mock infected murine liver-MO30k-(211)-6hpi,ctrl
"Patient 116, 12 month of REBIF",pert
Individual_649_PN_sample,pert
"Male, Wistar, 6hrs/day access to cocaine, lateral hypothalamus",pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 2;	psoriasis duration: 37.0;	age of psoriasis onset: 24,pert
A_AN11989_T,pert
mdx5cv diaphragm sample 1,pert
RNA-DHL4-R406-6H-3,pert
Low weight gainer Kozak1_ABI_ING_L2,ctrl
RNA-DHL4-R406-48H-1,pert
control_0412-7,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:45;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=poorly differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=diffuse type",pert
cell line: RUES2;	cell type: human embryonic stem cells;	transduced with: shRNA targeting TMEM88;	time point: Day 5 of cardiac differentiation; cardiovascular progenitor cell stage,pert
BATF_KO_P14_D3_Effector_rep1,pert
Male 8week BL6 CBDLrep3,pert
Rosiglitazone treated cells Rep1,pert
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 35;	maternal age: n/a,pert
tissue: prefrontal cortex from adult APP knock-out mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,pert
knockdown: siRNA-scrambled;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.7;	colon weight (mg): 168;	colon ratio (mg/mm): 2.51;	myeloperoxidase activity (u/mg): 0.474;	tissue: colon;	treatment: 5% DSS,ctrl
"fibroblast, MFS subject FB890 rep 5",pert
Clint-Cont-2-011411,ctrl
KOPT-K control 2,ctrl
agent: EFNA4-Fc conjugate;	time: 1h,pert
"diet: LRD-5001;	sodium arsenite added to drinking water: 10 ppb, 5wk",pert
DBA d3 (183msn),pert
Rat fatty liver8,ctrl
"Endometrium, postmenopausal, estradiol, 23",pert
P14 - nudelcko/ko 3,pert
erStress_twins_AA_1736twin2_DMSO_4h,ctrl
7149.3PBMC,ctrl
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: Treg;	treatment: unstimulated;	genotype: WT,ctrl
normal adjacent esophageal tissue from patient E1532,ctrl
Cerebellum_nontransgenic control X50_16 months_replicate 1,ctrl
"Crohn's Disease subject (34 year old caucasian female, SAK_1307702704)",pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 35;	maternal age: 32,ctrl
WT MEFs at passage 3_biological replicate 1,ctrl
cell line: Colo205 parental cell line;	cell type: colon cancer,ctrl
WT_Mstn_4,ctrl
age: 6 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 wild type,ctrl
AZ-521_uninduced_24h_rep3,ctrl
"344SQ with PIK3CA shRNA, replicate 2",pert
"Colitis 01, UC01",pert
CTRL_1_MEP,ctrl
Pancreatic Sample 14-Normal,ctrl
A673 cell line that has been treated with DMSO vehicle control for 3 days.,ctrl
3T3 Vector Control A-928605 3,pert
"Ulcerative Colitis (33 year old hispanic female, SAK_1285179246)",pert
Human skeletal muscle biopsy sample;	Patient #164 with PM,pert
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 49;	age-at-onset: 47;	geographical origin: Mirandela;	lifestyle characteristics: ever smoker, ever drinker",pert
"49B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
cell type: primary p53-null neural stem cells;	retroviral expression: PlagL2,pert
EBS_2,pert
"Aorta, saline 7d, #3",ctrl
01N4B_PolyRF-,pert
"3 uM EPZ004777 treated, DAY 4, biological rep.3, MV4-11 cells",pert
tetracycline inducible Ngn3 ESC differentiated for 3 days without feeder cells or LIF and with doxycycline,pert
GEIM193-NORM,ctrl
MLL_00110,ctrl
"BMDC, Asc-/-, replicate 1",pert
0989-01-C,ctrl
cell type: PBMC;	disease state: Convalescence,pert
HeLa_TP082505_22_HG-U133A_2_IMFGN0023,ctrl
GFP-progerin Induction: day 0 Replicate B (4b_progerin_0d_B),pert
"metastasis: metastatic recurrence;	Stage: 3c;	tissue: cancer, homogenized",pert
cell line: H1299;	agent: azacitidine;	dose: 3 uM,pert
cell type: ESC;	genotype/variation: Snai1 knockout,pert
"lymphoblastoid cell line from F6.04, one out of seven of sensitive group",ctrl
disease state: Mantle Cell Lymphoma;	cell type: B cell lymphocyte;	ighv status: UNMUT,ctrl
parental cell line: WB;	vector: pBabe-human v-src (v-src vector);	replicate: 3,pert
WT.DMSO_3,ctrl
Esophagus TG replicate 2,pert
PsOEt-18-LS,ctrl
genotype/variation: wildtype;	strain: C57Bl/6;	gender: female;	cell type: skin melanocytes,ctrl
"Spi-21, biological rep 2",pert
VIN_B077,pert
Diaphragm 28 Day mdx rep 1,pert
MCF7 cyclin D1 siRNA Vehicle Rep2,pert
b66+,pert
Gene expression of murine fibroblast-like synoviocytes Grp1_C57BL6_3_FLS_TNFtg_plus_RSK2-KO,pert
"testis wt, 14dpp, Rep1",ctrl
CON - R20,ctrl
chip number: 15;	transfection plate: 3B;	target gene: CREBBP;	kd level: 0.72;	rin: 9.7;	transfection date: 2012-03-26,pert
AAA neck (Sample 12),pert
PFC R control 3,pert
Adipose-5 month-Myc heterozygous-technical replicate 1,pert
21A;pretreatment;female;breast tumor; responder,ctrl
patient: 255;	current medication: Asacol 800mg BD;	birth date: 3/14/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/01;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
"human nonfailing LV myocardium, NonFailing3",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.809;	OD280: 0.918;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 156;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Pediatric_GBM_43,ctrl
HaCaT_Control_ biological rep1,pert
ATM_siRNA_4c,pert
cell line: ARPE-19;	clone: 23;	genotype: Wild type,ctrl
pre-iPSC- siRNA to luciferase- biological replicate2,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 43 yr;	population: white;	dsm-iv: 295.9;	age of onset: 18 yr,pert
Cardian muscle Diabetic 5 week D5,pert
PFC R control 1,pert
"BMMCs from NTAL WT, NTAL shRNA infected, nonactivated, biological rep2",pert
Psoriasis-Patient-J,pert
"Infected with H37Rv, replicate 1",ctrl
"patient 13, baseline",ctrl
"nasopharyngeal carcinoma, specimen T16",pert
cell line: HL-60;	shRNA construct: GSK3A Construct 6,pert
tissue: atria;	genotype: Myh6-cre; COUP-TFIIflox/flox;	age: 2 months;	genetic background: C57BL/6,pert
age: 6 month postnatal;	tissue: striatum;	genotype: wild type (129S6/SvEvTac),ctrl
Patient 10,pert
K562 cells control replicate 10,ctrl
testis knock out replicate3,pert
tissue: PBMCs;	treatment: before IFNb-1a in-vivo treatment,ctrl
"neocortex-30 months of age, resveratrol diet-biological replicate5",pert
liver sample group: : Control,ctrl
siEGR4 (24 hr) _1,pert
"RWPE1 cells, vehicle, 24h, biological rep3",ctrl
tissue: prostate;	normal/tumor: normal,ctrl
HC-KO-10B,pert
VMH of KO3 mice,pert
WT - Cre Treated - 24 hrs - repeat 2 - Cy5 - mAdbID:61766,ctrl
UTX conditional knockout (cKO) cell line 2,ctrl
Rat fatty liver2,pert
"Gata6-KO heart, CRE, biological rep1",pert
Vit A sufficient 3a,ctrl
Ls174T-L8 dox1,pert
midbrain_wild type_24 weeks_replicate 3,ctrl
"Wild type, brain hemisphere",ctrl
tissue: glomeruli of human kidney;	disease state: control,ctrl
brownfat_wt3_day3,ctrl
t10,pert
Cell culture. A549 treated by MK886 4,pert
Rapamycin treated_2 3h,pert
PTEN+/-IKK2ca/ca ep_C,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_6h_4mM_HG-U133A_2_YCHSUP501,pert
GM19238_Kd_BCL3_3,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 25.68219,ctrl
FoxO deficient LSK (5),pert
tissue: Biceps muscle;	patient: C.b.4;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 2m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
RV63.09_CHF_day19_Slide45,pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: control GFP;	rep: 1,ctrl
Backskin_Get1_e18_WT1,ctrl
YFP-pos GMP Dicer wt rep3,ctrl
"Colitis 08, UC08",pert
"56B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
MS patient 9,pert
NPC20,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 54.32329,pert
GV oocyte_control_rep2,ctrl
Ishikawa_VeryLowDose_BPA_24h_rep3,pert
strain: C57BL6;	genotype: WT;	tissue: striatum;	treatment: vehicle control,ctrl
"strain: FVB;	transduction: transformed by v-src gene;	tissue: Primary prostate epithelial cell culture, oncogene-transduced",pert
Erythroblast_SOD2-/-_repKO31,pert
HMEC_50 vs SKBR3,pert
P2 Patient None,pert
4 hr unpooled 1 vs PBS 4hrpooled,pert
liver_Akt1+/-_8wk_rep3,pert
tissue: retina;	disease state: Diabetes,pert
CA1 NoCre Sox7H,ctrl
non-treated WT_rep-2,ctrl
PTC BRAF mut 11,pert
GM19238_Kd_DIP2B_2,pert
MacularDegen-healthy-10aAv2-s2,ctrl
"Cadmium 0.2 µM, biological rep3",pert
OSCE-2T,pert
"129P3/J SAL, Rep2",ctrl
Prostate Cancer_MS 36A6,pert
"wild type 5C.C7 T cells, biological rep1",ctrl
OBF-1 overexpression BCS-3 (EPLM),pert
Rsk2-KO Hippocampus - 3,pert
GFP Untreated 2hr 282295473,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 297B;	age-at-biopsy-years: 46,pert
gender: Male;	age (y): N/A;	tissue: normal pituitary,ctrl
E14 - Lis1cko/ko 2,pert
Bronchial Epithelial Cells MMA biological 1863J,pert
CN2,ctrl
Undifferentiated Dicer -/- (27H) ES cell line replicate_1,pert
"C57BL/6J SAL, Rep3",ctrl
MED1 overexpression #2,pert
"cell line: MCF7;	disease state: Breast adenocarcinoma, estrogen receptor-positive;	genotype/variation: MTDH WT KD",pert
KO_d00_eX_vs_KO_d21_eX,pert
CRC_nodrug_F4879,ctrl
BAL_45a_A1B0,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: spleen;	sample name: 4-sp2,pert
EA_Case12_CD20,pert
race: caucasian;	age (years): 64;	stage: IC;	grade: 1;	histology: endometrioid,pert
Spleen_uninfected_control_rep1,ctrl
patient: 216;	current medication: NONE;	birth date: 5/10/36;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/19/66;	diagnosis date: 8/20/66;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/18/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: NONE;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
"Normal cervix epithelium, microdissected, Age 44",ctrl
A536 Sham 1 day,ctrl
cell line: KCL-22;	tissue: Myeloid leukemia cells;	agent: untreated,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 33.0;	age of psoriasis onset: 26,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 47 yr;	population: white,pert
Oligodendrioglioma_5,pert
Strain: C57BL/6;	Gender:male;	Tissue:liver,ctrl
"Acute Myeloid Leukemia, sample 31",ctrl
C024_Control_F_78,ctrl
"Mouse Embryonice Stem Cells, control si RNA, Rep1",ctrl
JGB-Pre-2UP_Run2-S2,pert
"Undifferentiated C2C12 myoblasts, passage #11;	",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 90min;	race: White;	sex: Male,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 41.25205,pert
"106, MUSCLE, Before",ctrl
Prostate Cancer_MS 36C8,pert
C_AN15566_T,ctrl
experiment I hTERT replicate 2,pert
N51721,ctrl
"TNFa-OMe siRNA-B, replicate 5",pert
"IN1472 siPD treated, Biological replicate3",pert
T4_pitM,pert
patient: 128;	current medication: Pentaza;	birth date: 3/19/81;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.417;	OD280: 1.217;	Ratio: 1.98;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 337;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
mef2a_4,pert
"FVB/N genetic background. 4-month old;	virgin female mice were used, mice were kept on a 12-hour;	light/dark cycle with ad libitum access to chow and water",ctrl
MDS patient 79,pert
"Patient 116, 3 month of REBIF",pert
"P90_wt cones, replicate 2 [array]",ctrl
"gender: male;	batch: 1;	age (years): 32;	patient id: Severe_3;	fev1 (% predicted): 98;	fvc (% predicted): 113;	medication: prednisolone 15mg od,Seretide 500mcg 2pbd,Montelukast 10mg nocte,Ventolin prn,Phyllocontin 450mg bd,Flixonase od;	cell type: CD4+ T-cells",pert
MSE_D_33A,pert
"Tfrc-/- (GFP-positive) kidney cells, biological rep1",pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 1,pert
Carboplatin treated cells Rep1,pert
scrambled control-2,ctrl
AT2_shG1_rep2,pert
LCL Concordant for Epilepsy twin pair 4 (CCE4.1)(TP39),pert
sample =XCGD6 treatment=Control time=360 (min),pert
brain_OFC_control C_mr216,ctrl
CLL11-CD4,pert
KU_45N,ctrl
human esophageal squamous cell carcinoma cell line_KYSE30,pert
IFC 01,pert
V5-P084,ctrl
S033_Scz_M_83,pert
N11B Normal-cerebellum,ctrl
"mouse aorta cross strain comparison, C3H_T40_HF_03",pert
Gene expression of murine fibroblast-like synoviocytes Grp1_C57BL6_1_FLS_TNFtg_plus_RSK2-KO,pert
"8B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
genotype: Wild Type;	stimulation: stimulated with LPS and mouse recombinant IL-4 (day 2);	cell type: B cells,ctrl
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 8week,ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD20-APC;	cell type: CD20 positive B cells,pert
MDS patient 125,pert
"IN1472 siNT treated, Biological replicate2",ctrl
"spleen follicular B in IRF8 conditional KO, biological rep4",pert
genotype: Emu-myc;Suv39h1-/-;	transduction: Bcl2;	cell type: primary lymphoma cells from lymph nodes;	treatment: Adriamycin (ADR),pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 51,ctrl
transfected with control siRNA_4,ctrl
XBP1s_B_cells_spleen_20_weeks,pert
Extract:LOX-1:113102;	Extract Description:GFP_0hr:113102;	Quality: Classification:Medium;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.62;	Quality: Background Mean Dev.:0.83;	Quality: Absent (%):60.38;	Quality: Absent (%) Dev.:1.65;	Quality: Scaling Factor:0.75;	Quality: Scaling Factor Dev.:1.2;	Pretreatment [C]:GFP;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113102;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_0hr;	RNA extraction source key [A]:282295423,ctrl
Kidney_saline iv_mouse #003,ctrl
"shCDK8, low glucose, replicate 3",pert
MacularDegen-healthy-5bAv2-s2,ctrl
tissue: skin;	individual: Patient P4;	condition: AL;	eczema severity: SCORAD: 97.5,pert
parental cell line: WA;	vector: pBabe-puro (empty vector);	replicate: 1,ctrl
WKY12-4,ctrl
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14439;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 31;	sex: F,ctrl
SW1736_t0h_rep3,ctrl
tissue: white blood cells;	age: 7.88;	Sex: male,pert
MSC_VUB03_DM1_3,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 20;	maternal age: 19,ctrl
tri_CH1_normoxia,ctrl
Muscle 50 eccentric contractions 12 hours KO Aged 1217,pert
lesion_preUV_patient12,pert
"brain, hippocampus: KA72-II_e1_le1",pert
"Chromium 10 µM, biological rep2",pert
kidney_co_6M_rep3,ctrl
DS-Fibr 6,pert
Individual_4389_PP_sample,pert
cell line: non-small cell lung carcinoma cell line H1299;	protocol: PTD-DRBD-mediated siRNA delivery;	time: 12hr,pert
"Rat_Tracheal_Dex_2hr, rep2",pert
expression array - O5,pert
"MGSKO, PR01M008v0",pert
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: spleen;	sample name: 3-sp3,pert
genetic background: 129/SVE;	genotype: Des(-/-);	tissue: tibialis anterior;	age: 7-9 wk;	strain: Des(-/-)/129/SVE;	treatment: 50 eccentric contractions 12 hours,pert
age: 6 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
CME-Emerin0d-1MA-S2,pert
tissue: white blood cells;	age: 13;	Sex: female,ctrl
cell line: MCF-7;	cell type: Breast tumor cell line;	transfected with: pcDNA3 (control vector),ctrl
Bc_WAP_3,pert
umbilical cord_nobpd: 8C,ctrl
Septic shock;	gender: Male;	Non survivor;	organism: None;	organism class: None,pert
C023_Control_M_38,ctrl
"male,17,Caucasian",pert
Heart-Base_WT-1,ctrl
NTac_liver_vehicle 0 mg/kg_96 hr_1,pert
CML_1_GMP,pert
T138,pert
"metastasis: metastatic recurrence;	Stage: 3c;	tissue: normal, homogenized",ctrl
wild-type mouse 3,ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_287,ctrl
patient: 236;	current medication: None;	birth date: 11/20/53;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/05;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/18/05;	indictation for procedure: ;	ucss: 15;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 2/18/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: 1/1/71;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,pert
37/OVX/oil/6h/UTX 129 Hoxa-10+/+,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID53,ctrl
db/m 16 wk1,ctrl
Mouse_ATF6aKO_colon_UT_rep1,pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 5 - Technical Replicate 2,pert
strain: HNF4LoxP/- no Cre;	age: 1 month;	tissue: small intestine;	sex: male,ctrl
RAW_2.1mM_HOCl_#2,pert
"206, MUSCLE, Before",ctrl
ES cells_control_rep2,ctrl
Nrl-ko-Gfp P6 replicate 1,pert
cell type: Human melanoma cell line;	cell line: M238_R1;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
tissue: prefrontal cortex from adult wild-type mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,ctrl
healthy myeloid cells 9,ctrl
"Luc control esiRNA, biological rep1",ctrl
microdissected breast cancer cells from case 140,pert
coc-14_C,pert
2L,pert
Postmenopausal female. Estradiol treated. Patient 8.,pert
MLL_00125,pert
"gene expression of wild type oocyte, replicate 2",ctrl
"affected status (disease state): control;	gender: male;	age-at-examination: 52;	age-at-onset: n/a;	geographical origin: Vila-Real;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever drinker",ctrl
MCF7_siRNA_ESR1_24h_AM0006_7.1,pert
MGHU3 Cells_Control siRNA_Biological Replicate 2,ctrl
"Acute Myeloid Leukemia, sample 63",pert
cRNA;	postnatal day 16;	NFIA deficient,pert
Control_6months_retina2,ctrl
MCI-021,pert
Healthy untreated rats 1,ctrl
DIA-t10; transgenic diaphragm 10 month,pert
KGN Control  [RR1006],ctrl
cell line: SV589;	knockdown (days): 3;	treatment: Serum Starved; no EGF,pert
MGHU3 Cells_TAK1 siRNA_Biological Replicate 3,pert
AT2_control_rep2,ctrl
siLMO3_oligo2_0_rep2,pert
"metastasis: metastatic recurrence;	Stage: 3b;	tissue: cancer, homogenized",pert
"Nickel 400 µM, biologcial rep1",pert
U138MG shVEGFR-2 3,pert
Wt Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-3,pert
Disease_status: Healthy control;	Age (years): 40;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 38;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
disease state: healthy;	tissue: soleus;	age at biopsy: 76;	Sex: male;	individual identifier: 1,ctrl
erStress_twins_AA_1734twin1_DMSO_4h,ctrl
NZW/LacJTCE liver sample batch 3,pert
M249_A_PLX,pert
01-P,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 33;	sex: M,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_24_20_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
MCF-10A shCHK2-1 replicate 3 [set 5],pert
Mouse testicular Sertoli cell line TTE3,pert
Psoriasis-4 baseline,pert
microdissected breast cancer cells from case 469,ctrl
WT - Thymus - biological repeat 2,ctrl
Setdb1 2lox/1lox/Cre plus tamoxifen 1,pert
SCC25_rep2,ctrl
Akt1 double transgenic mice on a high fat diet (DH 1),pert
PsOEt-13-Week 1,pert
GB 6 NTB +LPA,ctrl
Diaphragm 7 Day control rep 1,ctrl
"RPMI8226_shKDM3A#1, replicate2",pert
SHR-vehicle pool sample2,pert
Bronchial Epithelial Cells control biological 1902T,ctrl
H720 MK886 1 micromole 24h serum free Sample 4,pert
RS-first,ctrl
Nrl-ko-Gfp P2 replicate 4,pert
Wild type unstimulated 3,ctrl
Healthy9-CD8,ctrl
27GOBMUC2H,ctrl
Rybp#15 (OHT-)_12d_rep2,ctrl
HMEC X NB1,pert
subject id: 41;	infection: DENV;	status: DF;	tissue: whole blood,pert
"GNMT knockout at 3 month age, biological replicate 4",pert
Uninfected_control_0a,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 11.442;	Ratio: 2.08,pert
cerebellum_Pink1 knockout_6 weeks_replicate 2,pert
20C-ER-D,ctrl
N12,ctrl
PPC1_non-target shRNA_replicate 2,ctrl
tissue: brain;	genotype: mutant Ndel ko/cko;	age: P0,pert
35/1-22 - Dox_1,ctrl
KO 0h TPA rep3,pert
MCF-10A shATR-3 replicate 2 [set 5],pert
Liver-Cpr-null_pool 2,pert
GM19238_Kd_IRF8_2,pert
KU_44T,pert
cell line: SUDHL-1 Cells derived from the a patient with Anaplastic Large Cell Lymphoma;	agent: ALK inhibitor CEP-14083,pert
midbrain_wild type_6 weeks_replicate 1,ctrl
T40730,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.899;	OD280: 1.476;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 56;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
healthy control H22,ctrl
VCaP/MYB siRNA #2,pert
Liver Tro1,pert
CF knockout LFCF CHN532,pert
CML-BM 9,pert
Untreated CHOP-/- C,pert
agent: ConA;	time point: 3 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 19d ID152,pert
cerebellum SNCA knockout 21 month replicate 3,pert
Endometrium/Ovary-Disease 9,pert
"Uninfected, replicate 3",ctrl
224 Day 0 Untransfected biological rep1,ctrl
gender: male;	strain: C57B/6Jx129Sv;	genotype/variation: SRC-2 knockout (KO);	tissue: heart;	age: 10-12 weeks old,pert
"PPARg d10, rep 3",pert
Normal_1801,ctrl
shRNA-TAK1-1 (HuT-102 cells + shRNA-TAK1),pert
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 knock out mouse, chow diet, liver",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 214,pert
TYK-nu+(3),pert
liver western diet 0.05% quercetin rep2,pert
Mutated-ERα-positive breast cancer 73,pert
WT-Fibr2 4,ctrl
ccRCC tumor of patient 1524,pert
subject: 5;	disease: TD;	muscle: GR;	gender: F;	age: 12.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Normal Tail Skin 1,ctrl
"WT mouse lung, biological rep3",ctrl
"PCB77 treated HepG2 cells at T6, biological replicate 3",pert
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14481;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of BMI-1. Sample B,pert
KPW13_T3_PP_day1_051,pert
Wild Type Time 1 replicate 3,ctrl
AO 24hr,ctrl
ALI patient #1,pert
Gender:male,pert
ATCC HTB-30,ctrl
E12.5 heart_wildtype_sample c,ctrl
Array Type: HG-U133A_2;	Ratio: 1.96;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.2;	Post mortem interval (hours): 22;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,ctrl
"Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications.",pert
13L,pert
"fetal sex: female;	karyotype: 46,XX",ctrl
"atRA RARaKO, set 4",pert
4 hr unpooled 3 vs PBS 4hrpooled,pert
RPE65_KO_4months_retina31,pert
shNANOG_4,pert
Preglaucoma control rep6 (OHN),ctrl
"Subject 5, Family 2, Asymptomatic",pert
mESC_undifferentiated_Alkb1-/-_rep2,pert
patient: 231;	current medication: prednisolone 40mg heparin clarithromycin;	birth date: 10/29/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/00;	diagnosis date: 11/19/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/28/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
Control subject 97_biological replicate 1,ctrl
cell line: HT144;	transfection: siRNA targeting CITED1,pert
A5_tumor,pert
Liver WT2,ctrl
KO - knock-out Treated - 12 hrs - repeat 1 - Cy3 - mAdbID:61762,pert
BP17,pert
"Endometrium, postmenopausal, tibolone, 6-2",pert
CON - R18,ctrl
"cells treated with Scrambled siRNA, biological replicate 1",ctrl
Blood_Control 4,ctrl
BATF_KO_P14_Naive_rep2,pert
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14440;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
esophageal squamous cell carcinoma from patient E1584,pert
"vastus lateralis biopsy, 76 year-old healthy sedentary male (#47)",pert
fibroblast_Slow_D76_Media_9,pert
CHB PBMC_sample 10,pert
cell line: PC-3;	treatment: siAgo1,pert
Carboplatin 36 hours set 1,pert
"PCB77 treated HepG2 cells at T24, biological replicate 3",pert
strain: C57BL6  X 129sv mixed;	tissue: liver;	genotype: sphingosine-1-phosphate (S1P) lyase knock-out,pert
J1_plus LIF_rep2r,ctrl
"5B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
HL60-shGSK3A-Construct5-rep2,pert
A549 vehicle control (3207),ctrl
hippocampus: Sample #3_e1_le1,pert
diet_Lung_2,ctrl
Control LM2 Cell Replicate 3,ctrl
IkkβF/F_replicate1,ctrl
"GM9013, proband-MS",pert
M238_R1_A_DMSO,ctrl
Bronchial Epithelial Cells SA biological 1566D,pert
Hippocampus_Soman_24h_rep1,pert
HW_449,ctrl
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 33;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
OVE26_8W_4_7,pert
CUTLL1 MigR1 GSIwash4h-rep3,pert
397MM,pert
EA_Case21_CD4,pert
Human normal prostate primary culture N1,ctrl
MPM tumor 21,pert
FO_spleen_KO_rep1,pert
"strain background: 129/B6 mixed;	cell type: Ada3FL/FL MEF, immortalized;	infected with: Cre adenovirus",pert
B15 - infected BALB/cByJ fibroblasts (9 h post inf),pert
strain: C57BL/6;	cell type: hepatocytes;	genotype/variation: GNMT-WT;	agent: aflatoxin B1 (AFB1),ctrl
ERRa KO biological replicate 1,pert
E12 distal retina progenitors_mutant_rep 2,pert
NALT_infected_24h_90-226att_rep1,pert
"DMD skeletal muscle, biological rep7",pert
brownfat_KO3_day3,pert
Control Day14 (441L),ctrl
"Whole ovary from 8 Month Old Wild Type mice_02, biological rep2",ctrl
"CD44 siRNA, 2",pert
P1 mouse eyeball extracted total RNA_wildtype2,ctrl
strain CD-1 mouse. RV was isolated by laser capture microdissection.,ctrl
RNA from HCC_3N,ctrl
jzo010-rp1-v5-u74av2-met,pert
c.3,ctrl
"Wildtype, thymic, NK1.1+ NKT cells replicate2",ctrl
"Wildtype luminal mammary epithelial cells, MD638",ctrl
KU_47T,pert
SCC-2_siZMPSTE24_rep.1,pert
HWC14,ctrl
25A;pretreatment;female;breast tumor; responder,ctrl
"gender: Female;	age: 67;	post-mortem delay: 3.5h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 48 yr;	population: white;	dsm-iv: 296.53;	age of onset: 31 yr,pert
cell type: Mouse embryonic fibroblasts;	genotype: wild type;	time: CT18,ctrl
MF-32,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 39;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
ZMYM2/FGFR1 biological replicate 2,pert
Strain: Inbred C57BL/6J;;	 Gender: male;;	 Age: day of life 3;;	 Tissue: liver,ctrl
Muscle-AMPKgamma3-ko-6,pert
ccRCC tumor of patient 42,pert
CD4+_Tcells_healthy_donor_8,ctrl
NCCIT siTET1 rep1,pert
"schizophrenia, BA46-66",pert
kidney_Q10_6M_rep1,pert
NEO-6_HG-U133 Plus 2,ctrl
cerebellum_PS-/-_ 10d_rep1,pert
myoblast_untreated_rep3,ctrl
control participant P328wh,ctrl
1122-03-A,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 71;	tissue: Blood,pert
C017_Control_M_72,ctrl
Tet2 KO GMP rep2,pert
A673_CloneAsp14_Dox_0h_3,ctrl
"MCF-7, 12h, 0.3mM 5FU B",pert
LIVER_CONTROL_repl4,ctrl
"3 uM EPZ004777 treated, DAY 6, biological rep.2, MOLM-13 cells",pert
WildType_2_1,ctrl
"Vehicle treatment, 25 hours (replication 1)",ctrl
"PMA treated, no doxycycline; biological replicate 3",ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 46 yr;	population: white;	dsm-iv: 295.9;	age of onset: 22 yr,pert
muscle Smad4KO 2 control,pert
H720 cell line control 4,ctrl
jzo007-rp1-v5-u74av2-met,ctrl
MCF7 cyclin D1 siRNA Estradiol Rep1,pert
"mortality: alive;	ethnicity: White;	gender: M;	age (yrs): 38;	ld: ETOH;	creatnine: 1.4;	mdrd: 60;	gfr: 57;	protein: 0;	hematuria: 0;	c3: 1;	c4: 0;	rf: 30;	hcv: NEG;	htn: 0;	dm: NEG;	hba1c: 5.2;	meld: 11;	ana: NEG;	gp: normal parenchyma by LM and IF, limited sample;	mm (mesangial matrix expansion): 0;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 0;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 0;	if (interstital fibrosis): 0;	as (arteiosclerosis): 0;	igg: 0;	iga: 0;	igm: 1;	c: 1;	empe: 1;	bmwid: 1;	bmd: 0;	edd: P;	no of glomeruli: 3;	glomerulosclerosis: 0;	intact t: 1;	arteries: normal;	if: IGM+ mesangial;	mesangium ig: M;	tissue: Kidney_Biopsy_Liver_disease",pert
A518 Sham 7 day,ctrl
shRNA2-4-plusDox-rep1,pert
strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: corn oil,ctrl
Subject #8037-8hr Postinfection,pert
20SMOKEH,ctrl
treatment: 1 ug/ml doxycyline;	time: 53 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
8 Etoh 4,pert
Normal-ERα-positive breast cancer 24,ctrl
PE_N_M182,ctrl
gastrocnemius-30 months of age-control diet-biological replicate4,ctrl
Reh_IKK_2,pert
intestine_wildtype_24hfasted_rep3,ctrl
HET Brain 62d Mouse1,ctrl
PGC-1a-/- rep1,ctrl
H295R _2OHBDE85_rep2,pert
cell type: Sarcoma cell line;	strain: C57BL6/J;	genotype/variation: Dicer Heterozygote,ctrl
AVC_mutant_rep1,pert
agent: Cadmium 0.2 µM,pert
WT_PLACEBO_12hours_2,ctrl
WT-sham-2 month-R4,ctrl
control to Sample 1,ctrl
Glioblastoma_9,pert
"Fibroblasts from UIP histology lung tissue, IPF-20",pert
ZNF395 knock-down (shZNF395-1),pert
cell line: HeLa cervical carcinoma,pert
prefrontal cortex (BA10);	control,ctrl
Tissue: primary human hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes,pert
Normal myocardium sold commercially (C),ctrl
WT CMP rep1,ctrl
NPC_wt_rep2,ctrl
patient: 223;	current medication: Prednisolone 20mg Asacol 2.4g;	birth date: 1/18/44;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/04;	diagnosis date: 3/15/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/16/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/16/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: unknown;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
RatLung_H48h_1,pert
Day6 Genistein treatment replicate 1,pert
gender: Male;	tissue: Tendon;Patellar;	age: 41;	donor: 10;	disease state: Lesional,pert
"Normal subject (42 year old caucasian female, SAK_1289918632)",ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-sp3,pert
KU_23N,ctrl
LacZ control_0a,ctrl
liver cells from wildtype 8wk male mouse 8 challenged with acetaminophen (APAP)_12,pert
neuron_rep6,pert
"DMSO Control after 8hr, replicate 3",ctrl
MPM tumor 38,pert
DNGL-3,pert
Huh7 cells_JFH-1 Infected 48 hours_ rep1,pert
skin: normal,ctrl
CME-Ctr_LaminA0d-1MA-S2,ctrl
E100-/-SRFVP16-1,pert
wild-type naïve CD8 T cells KAI282,ctrl
Placenta Adra2bKO 1,pert
MCF7 Control cells Array 2,ctrl
patient: 253;	current medication: Asacol 800mg BD;	birth date: 3/14/58;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 8/24/97;	diagnosis date: 9/4/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/24/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/24/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/3/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"Cervical cancer, squamous cell carcinoma, microdissected, stage IIIA, HPV 16",pert
Squamous cell carcinoma 019,pert
Myh11-CreERT2.Tgfbr2f/f Knockout 2,pert
TTF=90min;	Race=Caucasian/White;	Sex=Female;	Group=Con;	Prototype_N,pert
T123 U133p2,pert
B4 437 b4-/- untreated,pert
Array Type: HG-U133A_2;	Ratio: 1.97;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
GM19238_Kd_IRF5_2_rep,pert
"Morphology: epithelial, Organ: lung, Disease: adenocarcinoma (pleural effusion), Gender: male, Ethnicity: caucasian",ctrl
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 2,pert
U937_ROS_curcumin_18h_rep3,pert
cell type: pre-iPSCs;	sirna mediated knockdown: Cbx3 (HP1gamma),pert
cell line: prostate cancer cell line VCaP;	genotype/variation: negative control siRNA,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: HIGH;	genome/variation: KIT mutation detected,pert
2119-03-A,pert
"ALL_NDS, K52 011609",ctrl
"A2BAR -/- mouse heart, control, rep3",pert
Pediatric_GBM_35,ctrl
01LQD: normal control,ctrl
"DMSO-treated NRK-52E cells at 72h, biological rep 1",ctrl
SA_258,pert
siCABIN1 1,pert
coc-57_C,pert
erStress_twins_AA_1724twin2_DMSO_4h,ctrl
"GM9016, affected brother",pert
C57BL/6J-ob/ob;	Pancreatic islets;	Age: 14 weeks;	Gender: Male,ctrl
cell line: PC-3;	treatment: siControl,ctrl
"Normal skin from Tie2_control mouse, biological replicate 1",ctrl
colon_epithelium_IL10mouse_6weeks_rep5,pert
CD11b+Gr1+ cell sample_5 (derived from IL17RC Knock out mouse),pert
Psoriatic arthritis PsA 5,pert
CLL3-CD8,pert
"vestibualr organ at E18.5 of Igf1 +/+, biological rep 2",ctrl
lymphocytes_HD_M_55y,pert
healthy control sample x027,ctrl
TMRI E2 72hr,pert
"control mice, whole uterine tissues, replicate 2",ctrl
"brain, hippocampus: Wt #3406 Cort_e1_le1",ctrl
"healthy breast 3, biological rep. 3",ctrl
16A;pretreatment;female;breast tumor; not assessable,ctrl
A431 WT 2,ctrl
AA_78,pert
22C-M4-D,ctrl
48 hrs TAC-3,pert
age: 72;	sex: M;	disease status: control subject;	Filter number: 94;	Usage number: 4;	Exposures: 3,ctrl
subject: 19A;	cohort: 19;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 22kb;	age (y): 65;	Sex: M;	batch: Batch_4,pert
"TNFa-OMe siRNA-B, replicate 1",pert
WT_d00_e0_vs_KO_d00_e0,ctrl
a10a.000606jd.2.SkMNor908.CEL-IS stimulate,pert
569.KO,pert
batch: B;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 3",ctrl
MDS patient 62,pert
Emx2 KO mouse,pert
"brain, cerebellum: WCb12w#1_e1_le1",ctrl
"human failing LV myocardium, Ischemic69",pert
"Acute Myeloid Leukemia, sample 10",pert
"CD4+ splenocytes at 6h, biological replicate 1 sham-2",ctrl
"HL-60 + 0.5 % DMSO, biological replicate 2",ctrl
11431 UC Uninflamed terminal ileum,pert
"Exp A, Animal #265, 20mg/kg D-Serine",pert
12 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratox;24729,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.386;	OD280: 0.669;	Ratio: 2.01;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 308;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
405MM,pert
"brain, brainstem: LB7_e1_le1",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-tu3,pert
Skinbiopsy_7hoursnickel_controlsubject_k2,ctrl
Y VIS _B030,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-sp1,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 8d ID67,ctrl
BASC-Myc-depletion-1 [mRNA],pert
Sample ID: TP25;	Twin Pair ID: CCN4.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 29;	Current Age (2007): 32;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
NSCL/P sample 7,pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3WT;	age: 12 weeks;	nutrient state: 24h fasted;	diet: High-fat diet,ctrl
AAA neck (Sample 14),pert
patient id: 1524;	tissue: Normal cortex;	gender: Male;	age: 70;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
PsOEt-12-LS,ctrl
Healthy control 6,ctrl
Healthy6-CD8,ctrl
87 year old female,pert
hnf4KD_H9_d20_hepatic differentiated_2,pert
"Crohn's Disease subject (65 year old caucasian female, SAK_1280798058)",pert
KO - knock-out Treated - 2 hrs - repeat 3 - Cy3 - mAdbID:51964,pert
patient: 40726;	sample: normal,ctrl
infection: seasaonal H1N1 Influenza virus;	cell type: cultured primary human lung epithelial cells,pert
Carbo Day2 (355R),pert
CLL 119-09 Control,ctrl
diagnosis: COP;	fvc-group: FVC3;	tissue: lung,pert
GM19238_Kd_DIP2B_3,pert
monocytes_-LPS_1,ctrl
Testis_WT_rep1,ctrl
liver_WT_replicate3,ctrl
cell line: SCOV3,ctrl
"ZR-75-1, 12h, 3.0mM 5FU",pert
"metastasis: none;	Stage: 2a;	tissue: normal, homogenized",ctrl
shRNA-TAK1-2 (HuT-102 cells + shRNA-TAK1),pert
s1,ctrl
FoxO3null_1_2,pert
Extract:LOX-1:213203;	Extract Description:LOX1_Untreated_2hr:213203;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0.04;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.76;	Quality: Background Mean Dev.:0.44;	Quality: Absent (%):57.87;	Quality: Absent (%) Dev.:0.3;	Quality: Scaling Factor:0.58;	Quality: Scaling Factor Dev.:0.29;	Pretreatment [C]:LOX1;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213203;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_2hr;	RNA extraction source key [A]:282295553,pert
"genotype: wild type (Wutz et al., 2000);	cell line: ES",ctrl
Mouse old heart w/ a-tocopherol aT-Ht-5,pert
Tendon_lesional_rep7,pert
SKBR3_1uM_Lapatinib_3,pert
CRC_nodrug_F4882,ctrl
gender: Female;	age: 89;	post-mortem delay: 5h;	ph: 6.5,ctrl
tissue: arterial;	status: normal,ctrl
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: BETAFERON;	time: 24 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Day6 Genistein treatment replicate 2,pert
Mnk_3204-T-B,ctrl
secondary glioblastoma_3,pert
PGA-lv_24h_515,ctrl
Itk knockout CD8+ CD3-stimulated,pert
"Patient N, lesional skin",pert
No_abuse_9,ctrl
multiple sclerosis_8,pert
"patient 038b, cancer, homogenized",pert
Against CDK19-1 rep1,pert
Tetracycline-inducible glioma cells dox 1,pert
KU_24N,ctrl
midbrain_Pink1 knockout_18 month_replicate 1,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 41;	maternal age: 39,pert
cell line: NCI-H2009;	cell type: lung cancer cells;	transfected with: shPTK7 (PTK7 knockdown),pert
race: caucasian;	age (years): 58;	stage: IC;	grade: 3;	histology: endometrioid,pert
cell type: hepatocytes,pert
remitted schizophrenia patient  S17,pert
patient: 7;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
normal arterial tissue: sample #1,ctrl
platelet_Ctrl_5,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.749;	OD280: 0.86;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 220;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
chip number: 13;	transfection plate: 5;	target gene: RELA;	kd level: 0.62;	rin: 9.3;	transfection date: 2011-10-17,pert
C5_transgenic but unaltered,pert
"Spi-60, biological rep 1",pert
Leg 28 Day control rep 3,ctrl
3DKD_rep3,ctrl
V5-P096,pert
"Distal and Proximal Large Intestine, 8week old Eeyore mouse 1",pert
CD4IncTp1-7,pert
cerebrum_PS-/-_ 10d_rep1,pert
rtTA-Dmrt5_d7_+Dox_rep_1,pert
Fat Tro3,pert
muscle wild type replicate1,ctrl
Healthy Pulp 1,ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: pineal gland;	time: ZT6,ctrl
cell line: BT474-J4;	cell type: breast cancer;	lapatinib sensitivity: acquired lapatinib-resistant;	her2 status: HER2-positive;	treatment: lapatinib,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: Schistosoma japonicum;	time point: 7 weeks post infection 20 cercariae,pert
asthma_saline_1,ctrl
Superior Frontal Gyrus from a 5 year-old girl not suffering from Rett Syndrome and therefore considered as a normal subject.,ctrl
cell line: NOMO-1;	genotype: ZFX wild type,ctrl
uterus_veh_WT_40hrs_rep2,ctrl
KN-smoke-low-5 month-R3,pert
B4 527 wild-type after nicotine-induced seizures,pert
WT1-iPS 4,ctrl
P1 mouse eyeball extracted total RNA_Brg1_cKO1_GSM618318,pert
EA_Case10_CD4,pert
566.B6,ctrl
Treg Trim28 conditional KO rep2,pert
H1299 RBP2 KD1_rep 2,pert
Msgn1_12hMinDox-biological rep1,ctrl
Parkinson's disease sample x187,pert
"Crohn's Disease subject (56 year old caucasian male, SAK_1263271818)",pert
TYK-nu-(1),ctrl
Ileum_POR-null_1,pert
"cell type: PBMCs;	disease state: acutely admitted, severely psychotic schizophrenia patient;	gender: male",pert
HC-KO-10A,pert
Hepatic Reductase null N7,pert
WT_liver_vehicle 0 mg/kg_96 hr_3,ctrl
shOCT4_3,pert
scan batch: Batch 2;	group: control;	subject age: 8;	paternal age: 31;	maternal age: 30,ctrl
"Lesion Skin, LS-19",pert
C022_Control_F_68,ctrl
"Control 2, biological rep3",ctrl
Colon_Wild Type+Quercetin_2,pert
control shRNA replicate 2,ctrl
CLP1,pert
cell line: THP-1,ctrl
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 15days;	genotype/variation: WT,ctrl
liver-AHRWT-cornoil-rep2,ctrl
Ishikawa_VeryHighDose_BPA_48h_rep4,pert
cell line: H1993;	tissue: Lung adenocarcinoma,ctrl
Hippocampus_Soman_1h_rep1,pert
MDS patient 181,pert
Control pool 1 (n=2),ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 24.21096,ctrl
Huntington's disease 874B,pert
human esophageal squamous cell carcinoma cell line_KYSE170,pert
Biceps_Control_7,ctrl
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 4,ctrl
"human failing LV myocardium, Ischemic7",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 58,pert
GM19238_Kd_DIP2B_1,pert
cell line: U20S;	tissue type: osteosarcoma,pert
IM32_control,ctrl
MDS patient 72,pert
32/OVX/oil/6h/UTX 129 Hoxa-10-/-,pert
siEGR4 (72 hr) _2,pert
disease state: healthy control;	tissue: epidermis;	age: 33;	gender: female;	treatment: untreated;	time: control,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.442;	OD280: 1.248;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 205;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
S023_Scz_F_97,pert
mir-26b overexpression 1,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: Vemurafenib 1000 nM for 72h,pert
CCRPKO-PBS_rep-1,pert
gender: female;	agent: E2;	cell type: Hematopoietic stem cells,pert
TTP_KO_60ActD_BioRep2,pert
"IDC 4, biological rep. 4",pert
strain: C57BL/6;	gender: male;	cell type: ESC-like cells;	genotype/variation: Prdm14 Knockout;	culture conditions: 2i,pert
strain: Wistar;	gender: male;	tissue: sciatic nerve;	treatment: saline,ctrl
endothelial_rep1,pert
WM-266 knock-down of Pirin by siRNA - Replica 1,pert
"P40_C-DGCR8 KO cones, replicate 1 [array]",pert
Nerve_Diabetic_Vehicle_709,ctrl
subject: 34;	disease: CP;	muscle: GR;	gender: M;	age: 15.2;	gmfcs: 2;	popliteal angle: 120,pert
"Runx1KO, biological replicate 3",pert
strain: C57BL/6;	genotype: Myd88 null;	gender: male;	age: 10-12 weeks;	tissue: liver;	resection_percent: 85%;	time_after_resection: 2 hours,pert
Native-0-2,ctrl
Human Acute HIV Sample A044-CD8+ T cells,pert
S10B Sporadic-cerebellum,ctrl
G643-lcm,pert
"BOEC, normal 15",ctrl
HeLa_06_21_04 TP-8,pert
P4_WT_1,ctrl
H295R _Control_rep2,ctrl
brain_DLPFC_bipolar B_mr667,pert
monolayer chondrocytes from OA donor 3,pert
"control, BA46-67",ctrl
Leg 56 Day mdx rep 3,pert
"45B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
APOE_KO_NODM_9W_8,ctrl
WTT 164 bleomycin treated,pert
"Pou4f1+/+ cells, transduced with control virus_Wt-MSCV_85",ctrl
AL Chip#34,pert
Experimental 5,pert
Lung wt mock repB,ctrl
Dengue Hemorrhagic Fever Patient 34,pert
Pediatric_GBM_29,ctrl
HL60-shGSK3B-Construct2-rep2,pert
agent: EphB2-Fc conjugate;	time: 1h,pert
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 63 dpi,pert
tissue: white blood cells;	age: 16.02;	Sex: male,pert
tissue: Frontal cortex;	age: 92;	Sex: F,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 5.3;	colon weight (mg): 149;	colon ratio (mg/mm): 2.811;	myeloperoxidase activity (u/mg): 0.208;	tissue: colon;	treatment: 5% DSS,pert
Ulk1/2+/+ (untreated) 3,ctrl
renal_vesicle_wild_type_4,ctrl
Day: 18; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 3,pert
Substantia nigra normal rep1,ctrl
B16 - infected BALB/cByJ fibroblasts (9 h post inf),pert
CLL12-CD4,pert
Md02h032,ctrl
cell line: BL2;	transfection: scrb siRNA;	batch: 3,ctrl
patient id: 26;	tissue: Normal cortex;	gender: Female;	age: 77;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 310;	age-at-biopsy-years: 60,ctrl
patient9,pert
aa_NY216,pert
MEFs_unstimulated_4hours_rep1,ctrl
"Hdh knock-out embryonic stem cells, biological replicate 3",pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 51;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,pert
LICR_HN2_CETU2,pert
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Male;	Age of onset (years): 27;	Duration of illness (years): 21;	Brain pH: 6.1;	Post mortem interval (hours): 13;	Side of brain: Right;	Fluphenazine mg. Equivalents: 200;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
rd1_P6_rep2,pert
Bronchial Epithelial Cells control biological 1733W,ctrl
HEK293_HNF1b_#2_uninduced,ctrl
treatment group: inorganic arsenic 0.1 uM;	cell line: TK6 cells,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 23.6137,pert
TA-t7-2; transgenic tibialis anterior 7 month,pert
UM13_Wt_rep1,ctrl
Bone-Marrow_MM_M832,pert
"human failing LV myocardium, Ischemic16",pert
Lamp3 KD 4d 1,pert
TL3 SCR 1,ctrl
db/m 16 wk 2,ctrl
TTF=135min;	Race=Black or African American;	Sex=Female;	Group=B;	Prototype_N,pert
knockdown: control;	cell line: MCF7,ctrl
Extract:LOX-1:213403;	Extract Description:LOX1_Untreated_12hr:213403;	Quality: Classification:Good;	Quality: Gradient Severity:0.1;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0.08;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.79;	Quality: Background Mean Dev.:0.74;	Quality: Absent (%):59.36;	Quality: Absent (%) Dev.:0.86;	Quality: Scaling Factor:0.66;	Quality: Scaling Factor Dev.:0.42;	Pretreatment [C]:LOX1;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213403;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_12hr;	RNA extraction source key [A]:282295793,pert
JoMa1_GFP,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 40;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: pre-UV,pert
tissue: skin;	cell line: NZM15;	tumour stage: metastatic melanoma;	tumour site: neck nodule;	treatment: PAX3 siRNA,pert
MLL_PTD12,pert
timepoint: 2h;	drug: Saline;	group no.: 16;	large batch: X;	plate: 1953348007;	hybridization batch: III,ctrl
HWC17,ctrl
con-41_C,ctrl
genotype/variation: C57BL/KLS-leprdb/leprdb (db/db),pert
chip number: 3;	transfection plate: 1;	target gene: ARNTL2;	kd level: 0.84;	rin: 9.4;	transfection date: 2011-03-29,pert
Cre_day_5-1,pert
Mening UNSTIM WB NP 0b,ctrl
Disease_status: Healthy control;	Age (years): 46;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
"Monuron-treated NRK-52E cells at 24h, biological rep 1",pert
"BMDM, Tpl2 KO, unstimulated, biological replicate 2",pert
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Male;	Age of onset (years): 17;	Duration of illness (years): 23;	Brain pH: 6.2;	Post mortem interval (hours): 19;	Side of brain: Left;	Fluphenazine mg. Equivalents: 60000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
cell type: Dorsal skin Basal IFE epidermal stem cells;	genotype: Bmal1 KO,pert
"Kidney from MON exposed rats, biological rep 2",pert
"RPMI8226_shKDM3A#1, replicate1",pert
model: Fischer 344;	gender: Male;	age: 21 to 22 months old,pert
shScr replicate 3,ctrl
"MCF-7, 12h, sham B",ctrl
liver_QH2_6M_rep2,pert
microdissected breast cancer cells from case 878,ctrl
Snell 22 month Wild Type Liver 1c,ctrl
GM19238_Kd_TCF12_2,pert
patient: 30162;	sample: normal,ctrl
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep3,pert
CT3 vs PBS 4 hr pooled,ctrl
n9t7d,pert
Gata3_D3,ctrl
RPE65_KO_6months_retina5,pert
Dengue Fever Patient 4,pert
F9 con sample #3,ctrl
3409-lcm,pert
"male;	CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery",pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 46;	maternal age: 42,pert
strain: FVB/N;	tissue: forebrain,ctrl
tissue: brain;	genotype: ClpP KO;	genetic background: C57BL/6,pert
"tissue: kidney;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: monuron 72 hr",pert
uterus_P4_PRKO_40hrs_rep3,pert
NPC4,pert
chip number: 14;	transfection plate: 4;	target gene: HCST;	kd level: 0.87;	rin: 9.6;	transfection date: 2011-10-17,pert
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep1",ctrl
Mtb infected-63d-2,pert
Biceps_Pompe_2,pert
H1_SS8_01Nov07,pert
C13-(2),ctrl
"fibroblast, control subject NM2 rep 2",ctrl
b147,ctrl
"B10 sham kidney, biological rep2",ctrl
microdissected breast cancer cells from case 289,pert
Teratozoospermic individual: Sample T5,pert
p53r2 siRNA 1,pert
Wild-type standard cage Rep4,ctrl
"Cells: U2OS, Treatment: infected with PRC shRNA4_pLenti, blasticidin selection",pert
Human Non-progressor HIV Sample L015-CD4+ T cells,pert
TLW18_T5_PP_day7_017,pert
"Patient R, lesional skin",pert
OC1-WT embryo 3,ctrl
ILKS343D,pert
Ovalbumin-induced inflammation 1 hour,pert
01SAGEA2,pert
"Patient D, lesional skin",pert
erStress_twins_AA_1757twin2_DMSO_4h,ctrl
A673 cell line that has been treated with Doxorubicin for 5 days with concentration of 119.76 nM (2 x EC50).,pert
ID: MLL_00117;	cell type: PBMC;	disease state: control,ctrl
"Gastrin Knockout, 2 month old male mice parietal cell",pert
TTP_WT_60ActD_BioRep3,pert
rat heart ventricle,ctrl
genotype/variation: wt;	age: E12.5;	tissue: whole eye,ctrl
01MHM_PolyRF-,pert
"A2BAR -/- mouse heart, control, rep1",pert
06R024 RA,pert
Sample 19 Kidney Normal Mouse - Control Diet,ctrl
"ID: MLL_00248;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
Tendon_non-lesional_rep20,ctrl
normal donors TA1,ctrl
Hdh mutant (111/111-polyQ) 3,pert
VillinCreERT2+_Brg1fl/fl_Rep2,pert
Trim28CKO unstimulated CD4 positve T cell rep4,pert
COLO829_shMITF_PLX4032_A,pert
newborn (P0) Krt1-/- skin_replicate 2,pert
Ishikawa_LowDose_BPA_8h_rep2,pert
Strain: B6SJL;	Age: 110 days;	,ctrl
subject: 12B;	cohort: 12;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 49;	Sex: M;	batch: Batch_3,pert
Substantia nigra PD rep16,pert
Subject 7_t=30days_placebo,ctrl
"HEK293E cells, TDP-43 siRNA, replicate 3",pert
"breast tumor epithelium,34",pert
siERK5E2 1,pert
Y SIT_B074,ctrl
MCI-016,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 146;	time: 0;	batch: 3,ctrl
JoMa1_2,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 83;	Sex: male;	region: M1;	age: 38;	genotype: Y/X;YFPH/-,ctrl
subject: 09U;	cohort: 9;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 47kb;	age (y): 57;	Sex: F;	batch: Batch_2,ctrl
"brain, cerebellum: RNA#12_le1",ctrl
sex: male;	tissue: liver,ctrl
38 year old female,ctrl
Pediatric_GBM_49,ctrl
FmrKO1_blood,pert
"HSCs from male mice treated with oil, replicate 2",ctrl
"Patient 1, Atheroma plaque",pert
Normal Tail Skin 3,ctrl
"D425-shOTX2_1, t=96",pert
15KD_SerumStarved->1hrEGF_rep1,pert
tMLL10,ctrl
"brain, brainstem: PB1_e1_le1",pert
BE-rep6,pert
12h_c2,ctrl
P1 Patient None,pert
cell line: prostate cancer cell line VCaP;	genotype/variation: MYB siRNA,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 2;	psoriasis duration: 38.0;	age of psoriasis onset: 7,pert
cell line: CUTLL1 (T lymphoblastic leukemia / lymphoma),pert
"Strain: C57BL/6, ADNP+/- Gender: mixed Age:E9 Tissue: whole embryonic body;	Please refer to: Activity-dependent neuroprotective protein: a novel gene essential for brain formation.;	Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90. ;	PMID: 12888219 [PubMed - indexed for MEDLINE]",pert
38GOBMUC2H,ctrl
Muscle 50 eccentric contractions 12 hours KO Aged 1106,pert
"brain, hippocampus: KA72-I_e1_le1",pert
"siSCR neuron, biological rep2",ctrl
DS2-iPS 1,pert
LSK SRF-null 1,pert
Severe rep9 (retina),pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 352;	age-at-biopsy-years: 41,ctrl
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
PGA-MLS-Dil-1aAv2-s1,ctrl
sample =XCGD3 treatment=Control time=360 (min),pert
"A673 treated with DMSO vehicle control for 3 days, biological rep4",ctrl
cell type: induced pluripotent stem cells,pert
CRC_celecoxib_F4874,pert
SKBR3_0.1uM_Lapatinib_3,pert
b7.2,pert
MCAD + LPS 4,pert
E14wt-SRFVP16-1,ctrl
A549_Nrf2 siRNA_biological rep2,pert
mdx quadriceps sample 1,pert
Scd1-/- on chow diet replicate 4,ctrl
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 29;	maternal age: 37,pert
Early IPF_surgical biopsy_upper lobe_rep159,pert
GIST Pre Treatment Biopsy 16,ctrl
"new born normal mice, cerebellum",ctrl
CLL4-CD8,pert
"Patient 3, Atheroma plaque",pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep3,pert
Angiopoietin-1(sparse)-1,pert
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2-/-;	agent: untreated,pert
"3 uM EPZ004777 treated, DAY 6, biological rep.1, MV4-11 cells",pert
DEX2_6H,pert
Muscle Pio2,pert
Tissue: Spleen;	Type: Sham;	Strain: C57BL/6;	Batch: 12/1/03,ctrl
HET Brain 82d Mouse1,ctrl
HMEC X BC1498,pert
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His plasmid,pert
OCI-Ly7_siFOXP1,pert
cell line: MCF-7 breast cancer cells,ctrl
pt. HCL B treated with DMSO for 48h,ctrl
2096-03-A,pert
5N,ctrl
Exon3_T2,pert
heart-30 months of age-control diet-biological replicate1,ctrl
Healthy12-CD4,ctrl
OA4,ctrl
tissue: inner ear;	genotype/variation: Wild-type;	age: E10,ctrl
H14_P_B2,pert
MDS47,pert
striatum_Pink1 knockout_6 weeks_replicate 2,pert
"Crohn 09, CD09",pert
MA_305,pert
"patient 16, baseline",ctrl
Treg WT rep2,ctrl
ctrl_513,ctrl
colonoc_mucosa_non_inflamed_30,pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 73;	gender: f;	treatment: -,ctrl
breast tumor 4,pert
"experiment II, hTERT, replicate 1",pert
sampleID: SAM630130;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
NoKD_SerumStarved->3hrEGF_rep2,pert
Sample Group: HD patient; Gender: female; Age: 61; Tissue: lymphocytes (blood); IT15 CAG repeats: 19/44,pert
061K3: normal control,ctrl
"age at diagnosis: 25;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 25;	dfs-event: 1;	distant metastasis: 1",pert
"MCF7, biological rep3",ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 59.49589,pert
"hepatic gene expression at ""1 hr"", rep2",pert
race: african american;	age (years): 55-60;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
Mc3T3 control_ 5day_rep3,ctrl
"peripheral ganglion, unknown: nicotine 1hr_2",pert
135A,ctrl
GIST Pre Treatment Biopsy 04,ctrl
MDS patient 52,pert
LUC KD #2,ctrl
N40892,ctrl
treatment: progesterone;	genotype: wild type;	treatement time: 4 hours,ctrl
"Crohn's Disease subject (64 year old caucasian female, SAK_1260745997)",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 81,pert
PBMC from T cell LGL leukemia patient #100 (TLGL100),pert
Bronchial Epithelial Cells SA biological 1683H,pert
KJD_rep1,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 33;	gender: male,ctrl
"E18.5 lung WT1, biological rep1",ctrl
12 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratox;24730,pert
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 9,ctrl
"Patient #6, Untreated",pert
age: 21 month postnatal;	tissue: striatum;	genotype: wild type (129S6/SvEvTac),ctrl
strain: FVB/NCrIBR;	tissue type: ear skin,pert
Wild type CD8+ CD3-stimulated,ctrl
KU_04N,ctrl
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: ZNF750 gene silencing,ctrl
GB 5 NTA +LPA,ctrl
Bronchial Epithelial Cells SA biological 0658D,pert
"EBF1 d4, rep 4",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.929;	OD280: 1.018;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 233;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
wild-type macrophages stimulated with MALP-2 for 2 h,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.607;	OD280: 0.846;	Ratio: 1.83;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 213;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Lung myd88 mock repC,pert
hBSMC_control_rep1,ctrl
PE_N_M165,ctrl
147B,ctrl
Isoflurane 5 exposures-3,pert
Estrogen [H2],ctrl
01L4J_CTRL,ctrl
Nfix_depleted_rep3,pert
"Strain: Sprague-Dawley, Gender: male, Weight: 350 g",pert
Disease_status: Healthy control;	Age (years): 50;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.75;	Post mortem interval (hours): 49;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
V5-P393,ctrl
"gender: Male;	age: 60;	post-mortem delay: 16h;	ph: 6.9;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
strain background: mixed;	tissue: retina;	Stage: E14;	onecut genotype: WT,ctrl
Sedentary-13,ctrl
Diagnosis: MDS/AML;	Age: 79y ;	Gender: Male;	Blast %: 87;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 3,pert
CD4+_Tcells_healthy_donor_1,ctrl
EP55_adipose_pcos,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
tissue: gastrointestinal stromal tumor (GIST);	cell type: freshly sorted tumor associated macrophages (TAMs),pert
0947-01-A-b,pert
"ShamC-60, biological rep 3",ctrl
"MLD, biallelic AML MLL_00248",pert
MEF Wild Type 3-rep1,ctrl
MPM tumor 12,pert
P4_PMP22TG_3,pert
Barrett's esophagus (B7),pert
EA_Case10_CD20,pert
"CD4+ splenocytes at 6h, biological replicate 1 sham-4",ctrl
"DCIS 5, biological rep. 5",pert
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
HLA risk: Low;	Height: 157.3 cm;	Weight: 54.4 kg;	BMI: 21.9;	Age: 24.43 years;	Gender: Female;	Race: White;	Glucose: 95 mg/dl;	HbA1c: NA,ctrl
CHB PBMC_sample 9,pert
Series 3; Young; 1 Week after fracture,pert
E100-/-SRFdM-VP16-2,pert
"scr-control, biological rep1",ctrl
FACS-purified B cells_129SV/EV_influenza-infected_rep3,pert
infection: Un-infected control;	cell type: cultured primary human lung epithelial cells,ctrl
reduction mammoplasty patient 361,ctrl
shRNA2-4-noDox-rep1,ctrl
heterozygot FH P387,pert
chip number: 12;	transfection plate: 5;	target gene: SREBF2;	kd level: 0.8;	rin: 9.2;	transfection date: 2011-10-17,pert
OVCA429-(1),ctrl
MacularDegen-healthy-1cAv2-s2,ctrl
MCAD 4,pert
dex4hr_3,pert
M479 Wt,ctrl
Normal mucosa 9,ctrl
D2-Gpnmb+ control rep4 (retina),ctrl
A HID I_B047,pert
subject id: 49;	infection: DENV;	status: DHF;	tissue: whole blood,pert
Treg Trim28 conditional KO rep4,pert
Bc_Mock_4,ctrl
Huh-7/IRF1 rep1,pert
cell type: hRPE;	disease state: 24h post-infection with WNV;	gender: male,pert
CD4+_Tcells_healthy_donor_5,ctrl
WT-2,ctrl
Muscle PCOS after pioglitazone 82,pert
GIST882 DMSO Rep3,ctrl
IM17_control,ctrl
Seltzer 14d replicate 2,pert
CRC_nodrug_F4860,ctrl
Brg1 mutant 2 cell embryo rep3,pert
cell type: sorted LSK cells;	strain: C57BL/6;	genotype/variation: SRF wt,ctrl
Scd1-/- on chow diet replicate 4,pert
H295R _2OHBDE85_rep3,pert
THRA wt + T3 replicate 2,pert
Ramos pRTS-CA-IKK2 E+,pert
A39 WT1	F5/50	A39	wild type	Mouse	4 months	Cerebellum	Female,ctrl
Pancreatic Sample 19-Tumor,pert
liver_Q10_6M_rep3,pert
Psoriatic arthritis PsA 4,pert
Mannitol control treated A549 human lung cancer cell cultures replicate B,ctrl
"Strain: C57BL/6 X SV129, Age: Embryonic Day 17.5, Tissue: Heart Venticle",ctrl
Strain: C3H/HeN;	Gender: female;	Age: 4 weeks;	Tissue: thymus,ctrl
wt-Gfp P6 replicate 3,ctrl
CLL9-CD4,pert
"testis wt, 17dpp, Rep2",ctrl
strain: C57BL/6;	gender: male;	develpmental stage: embryonic day E15.5;	genotype/variation: Ing1-/-;	cell type: mouse embryonic fibroblasts (MEF cells),pert
01UPD_ERA,pert
I_LS_Wk2,pert
Control caudate,ctrl
Src-overexpression - replicate 1,pert
Run2.aUa.001206d.SkMInS1089D.CEL-IS stimulate,pert
HMEC X BC21,pert
"Wild type GM-BMMs, biological rep1",ctrl
"Age: 8 months, Sex: Female, Retina: left, Final IOP (mm Hg): 25.3, Strain:DBA/2J",pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 1,ctrl
skeletal muscle Crhr2+/+ replicate2,ctrl
Healthy control_sample8,ctrl
"patient: 115;	current medication: Frusemide, Codine Phosphate;	birth date: 9/14/28;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: Diarrhoea, Also has Prostate Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
"control, BA10-40",ctrl
CsA,pert
Ctrl siRNA 3d 1,ctrl
cell line: MDA-MB-231;	cell line origin: Breast cancer;	genotype/variation: ZMPSTE24 silencing,pert
siSox2 replicate2,pert
Cont subject 06,ctrl
"Control shRNA cells passage 11, rep 4",ctrl
subject: 07A;	cohort: 7;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 29kb;	age (y): 18;	Sex: F;	batch: Batch_2,pert
CON_A,ctrl
PND28 Rat Testis_Rat230-2_3hr MEHP_Animal#50_04005,pert
0523-01-C,ctrl
myoblasts-expt1_untransduced-rep3,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.9;	choa: 195;	fata: 28;	eea: 1310;	wtkg: 64.5;	perfat: 27;	lbm: 44.9;	fat_mass: 1741.5,ctrl
shRNA-control-rep-2,ctrl
adenocarcinoma (ADC7),pert
Sample 10,ctrl
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-2,ctrl
Tobacco_abuse_5,pert
cell line: M24met melanoma cell-line;	genotype/variation: wild type;	treatment: control,ctrl
"Mdr2-KO heterozygous mouse, 3 month old mouse 2",ctrl
tissue: Hippocampus;	age: 80;	Sex: M,ctrl
cell type: embryonic stem cells;	genotype/variation: wild-type,ctrl
Gata3_F2,ctrl
5209 Normal Uninflamed sigmoid colon,ctrl
cell line: NCI-H1299;	cell type: lung cancer cells;	transfected with: shPTK7 (PTK7 knockdown),pert
tissue: Epididymal adipose;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 687,ctrl
age: 40;	sex: F;	disease status: control subject;	Filter number: 93;	Usage number: 4;	Exposures: 1,ctrl
nt control 7,ctrl
del337TR replicate 2,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 4;	biological rep: 1,pert
HD3,pert
NPC14,pert
Control Treg_rep1,pert
"KO total RNA LSK, rep 4",pert
subject: 30;	disease: CP;	muscle: ST;	gender: M;	age: 4.1;	gmfcs: 2;	popliteal angle: 125,pert
Control Endometrium Endothelial Cell_016.UC182+-new,ctrl
B6_Female_CF_rep3,pert
tissue: Brain;	genotype: Npc1+/+;	age: 20 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
HD8,pert
tissue: skin;	individual: Patient P12;	condition: AL;	eczema severity: SCORAD: 91.1,pert
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14465;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
P0 - WT129s6 1,ctrl
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 17;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
heterozygot FH P250,pert
Injured 3 day Rat Retina 2,pert
BP patient 78_biological replicate 1,pert
Normal PBMC Sample 3,ctrl
Bronchial Epithelial Cells MMA biological 2198F,pert
c 1-2,pert
cell line: HL-60;	replicate: Replicate1;	treatment: shSYK_1,pert
"SS gland, moderate, patient 22, batch 2",pert
NM16 healthy control,ctrl
Dengue Hemorrhagic Fever Patient 45,pert
control sample 3,ctrl
Run4.aUa.010110d.SkMDbt1144D.CEL-DB basal,ctrl
Tendon_non-lesional_rep16,ctrl
OV90-(1),ctrl
HCC PBMC Sample 7,pert
A2AR_WT_saline_24h_rep4,ctrl
healthy control H28_2,ctrl
Subject #8011-Preinfection,ctrl
treatment: baseline;	gender: M;	age (y): 44;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
Male 8week BL6 CBDLrep2,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 42;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: DMSO for 72h,ctrl
Hdh mutant (111/111-polyQ) 2,pert
HC-KO-28B,pert
cell type: Primary hepatocytes;	strain: FVB;	agent: Wy14643;	time: 24h;	gender: Female;	age: 5 months,pert
"PMA treated, doxycycline treated; biological replicate 2",ctrl
SA_71,pert
Pooled_2,pert
imanitib3,pert
"lymphoblastoid cell line from T6.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
EVI_GFP negative Lin- cells replicate 1,ctrl
"Neuroretina 8-week diabetic, Biological replica_2",pert
"11B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
"age at diagnosis: 48;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N2a;	er: 1;	pgr: 1;	dfs-month: 34;	dfs-event: 0;	distant metastasis: 0",pert
siRNA scramble_control  MDA-MB-231 sample 3,ctrl
Ad infected murine liver-MO30k-(233)-6hpi,pert
E2_ethanol_21,pert
AO C3,ctrl
Jurkat-J1d,ctrl
14_PAH,pert
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 0,pert
"human failing LV myocardium, Idiopathic26",pert
CF knockout HMCF CHN537,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 34.13425,pert
cell line: H4-II-E-C3,ctrl
ab106 IM,pert
"Strain: C57BL/6;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",pert
Bronchial Epithelial Cells control biological 1624R,ctrl
"U373-EGFP, rep 2",ctrl
Panc-1 Gli3T 1,pert
PGK12.1_control RNAi-3,ctrl
control participant P318,ctrl
MLL_00114,ctrl
multiple myeloma (MM 48),pert
"Strain: SPARC-null, C57Bl/6 background;	Gender: male;	Age: 28 days;	Eye: Left",pert
"Healthy volunteer, Control_11816",ctrl
"Acute Myeloid Leukemia, sample 15",pert
Strain: C57BL/6J;	Gender: M;	Age: 6 weeks;	Treatment: untreated,pert
V5-P510,ctrl
CTRL_5_MEP,ctrl
0170-01-C,ctrl
Individual_4382_NN_sample,ctrl
Strain: Fischer 344;	Gender: Male ;	Age: 6 ;	Tissue: Liver of vehicle treated rat,ctrl
Barretts esophagus (B1),pert
"medulloblastoma, M2_scrambled, rep1",ctrl
tissue: skeletal muscle (gastrocnemius);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Pioglitazone,pert
"Human mononuclear cells were isolated by Ficoll-Paque centrifugation in a discontinuous gradient from buffy coats from healthy blood donors. Cells were differentiated in macrophage-SFM medium supplemented with 70 U/ml human granulocyte macrophage colony-stimulating factor. After 3 days, the medium was changed to macrophage-SFM without GM-CSF and cells were cultured up to 8 days",pert
cell line: HCT116;	cell type: colon cancer;	sirna: CD44,pert
liver_female ko_rep2,pert
Pancreatic Sample 37-Tumor,pert
"kn muscle 1, biological rep 1",pert
chip number: 16;	transfection plate: 4;	target gene: NS;	kd level: NA;	rin: 9.3;	transfection date: 2011-10-17,ctrl
MCF7 cyclin D1 siRNA Vehicle Rep1,pert
Insm1 mutant #4,pert
FoxO3null_2_2,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 4h,ctrl
r04,ctrl
"seminoma specimen, pT2, patient age: 37y; W00 025",pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: B;	transfectant type: stably transfected with RNAi against DJ-1,ctrl
HUVEC_control experiment 2,ctrl
"brain, cerebellum: KCx4w#1_e1_le1",pert
cerebellum wild type 6 month replicate 2,ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: E2;	time: 4h,pert
"Rescue pancreas, biological rep1",pert
"Chromium 1 µM, biological rep3",pert
microdissected breast cancer cells from case 1304,pert
LNT-5,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 45 yr;	population: white;	dsm-iv: 295.9;	age of onset: 15 yr,pert
array 7 minus E,pert
ALS gray matter 4 Sporadic,pert
SRF silenced EtOH rep 2,pert
CLL7-CD4,pert
RNA from HCC_33T,pert
imanitib6,pert
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Mammary gland R1 NT rep2,ctrl
disease status: controls;	tissue (brain region): Frontal cortex,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: III, T2, N2, M0, G4",pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 60,pert
Teratoma 2201,pert
tissue: peripheral blood;	subject: sickle-cell patient;	rna prep: PAXgene Globin reduced;	molecule: Globin-depleted RNA,pert
siERK2E24h_2648,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 41 yr;	population: Native American;	dsm-iv: 296.53;	age of onset: 22 yr,pert
cell line: MOLM-14;	replicate: Replicate1;	treatment: shSYK_2,pert
tissue: Temporal cortex;	age: 80;	Sex: M,ctrl
PGA_MI_nilv_48h_354,pert
a_B35B,pert
tissue: breast cancer;	cell line: MDA-MB-231,ctrl
Cell line HeLa_control_expt3,ctrl
0977-01-C,ctrl
01N3E_Oligo,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.232;	OD280: 0.618;	Ratio: 1.95;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 230;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Postmenopausal female. Untreated control. nr 37.,ctrl
CD46+/STAT1-KO hippo - Untreated-C,pert
"Control ES cells 96hr, replicate 2",ctrl
myoblasts-expt1_lentiDUX4fl-rep1,pert
C_AN10028_C,ctrl
SC263_PBS3,ctrl
hNHEPS_control_6 h_rep1,ctrl
strain/background: C57BL/6;	genotype/variation: Zbtb7a Flox/Flox Mx1-Cre+ (LRF homozygous knockout);	age: 4 weeks;	cell type: FACS-sorted LT-HSCs (LSK IL7Ra-Flt3-CD150+CD48-);	time point: 9 days after 1st pIpC injection,pert
"65 y/o male 46,XY",pert
CRC_celecoxib_M4877,pert
ME180 3 hours rep 3,pert
IRAK2 KO macrophages unstimulated,pert
Xid primary splenic B-cells (sample2),pert
wildtype 4,ctrl
Mut2_2,pert
tissue: brain;	genotype: WT mix background B;	age: P0,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_6h_Con_HG-U133A_2_YCHSUP501,ctrl
chip number: 20;	transfection plate: 3B;	target gene: NFE2L1;	kd level: 0.71;	rin: 9.8;	transfection date: 2012-03-26,pert
DIA-t7; transgenic diaphragm 7 month,pert
Human.AQ.CP.FCU,pert
disease state: paediatric glioblastoma;	age: 10;	gender: M;	h3.3_status: K27M,pert
IPMC 2,pert
Mouse_WT_colon_UT_rep2,ctrl
Arid3a OE-High replicate 2,pert
DUSP1-/- control replicate 3,pert
strain: 170;	Disorder: normal;	Condition: no hydrocortisone,ctrl
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P55;	clone: C11,ctrl
4013-2 E2F2 Null,pert
PBS Treated Cells 3,ctrl
Adipose-24 month-wild type-technical replicate 3,ctrl
Mening UNSTIM WB NP 24b,ctrl
"Patient 113, 12 month of REBIF",pert
Muscle WT Aged 0106,ctrl
Ecad_Con_2,ctrl
"Mutant, biological rep3",pert
PTC BRAF wt 1,pert
LY2 control-siRNA tamoxifen treated rep4,ctrl
"brain, hippocampus: KA-24h-P15-I_e1_le1",pert
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD4-FITC;	cell type: CD4 positive T cells,ctrl
strain: C57BL/6J;	day: 12;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 1,pert
Patient 1,ctrl
S029_Scz_F_53,pert
17beta estradiol: 100 pM,pert
"P16 control OC apex, biological rep 2",ctrl
disease state: normal;	biopsy type: surgical;	tissue: lung,ctrl
Patient: D;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
"Pten null fibroblasts, biological rep1",pert
Subject 2 Pre allergen challenge,ctrl
"Pten null epithelials cells, biological rep1",pert
healthy control sample x072,ctrl
"Amoxicillin treated Distal, Small Intestine 3 21 days old",pert
passage: 10;	cell type: fibroblast;	cell line: GM00038,ctrl
chip number: 22;	transfection plate: 3A;	target gene: BATF;	kd level: 0.64;	rin: 9.8;	transfection date: 2012-03-26,pert
"Lens epithelium, SPARC KO, #7L",pert
"normal skeletal muscle, biological rep14",ctrl
female,pert
siNS_0h_3,ctrl
T149 U133p2,pert
"Biceps, control, cohort 19, subject 19U",ctrl
"SiRNA-scrambled, replicate 1",ctrl
PBMCs_IS_12 [IS],pert
NOD/LtJ Vehicle liver sample batch 1,ctrl
Adipose-24 month-Myc heterozygous-technical replicate 3,pert
normal main pancreatic duct 5,ctrl
A HID I_B008,pert
"Patient I-c1034T, MSI colorectal tumor",pert
"conditional Keap1 knockout Alb-Cre:Keap1(flox/-), gender- male, age- 9 weeks, n = 1, # of tissue = 1 tissue: Liver",pert
"human failing LV myocardium, Ischemic96",pert
P0 - lis1ko/+ Mix 2,pert
siNS_24h_2,ctrl
Thyroid_ unaffected_paired with PTC11T,ctrl
BV-173 Imatinib-treated,pert
"0mg/kg/day PFOA, Rep 3, Block 3 lung (high dose)",ctrl
b89,ctrl
osteoblast_5azatreated_rep3,pert
strain CD-1,ctrl
"Mbd3 KD, replicate A",pert
NK_cell_pool_melanoma_M05+M06,pert
"Patient S238, MSI colorectal tumor",pert
subject: 2824 TG;	type: transgenic;	tissue: Mouse skeletal muscle,pert
"Normal, biological rep 2",ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 71 years,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 135min;	race: White;	sex: Female,pert
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119-;	genotype/variation: Klf3 KO,pert
"vector d10, rep 2",ctrl
SeroNeg-9,ctrl
Control (shControl-3),ctrl
C_AN00142_F,ctrl
adenocarcinoma (ADC4),pert
H295R_Group_C_Dose_100_TIMEPT1_033,pert
cell type: late passage (LP50) LNCaP,ctrl
Treated with 5% mannitol for 4 hrs -- replicate #3,ctrl
Normal cervix_05-446,ctrl
KO - 5 mo - repeat 1 - Cy5 - mAdbID:74107,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-tu3,pert
NM19 healthy control,ctrl
Amoxicillin treated Colon 1 17 days old,pert
EOM 28 Day Control rep 3,ctrl
Knockout day 3 Air replicate 2,pert
HL60_shSYK_1_Replicate2,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 79,ctrl
L-540_CTRL_24hrs_1A,ctrl
4_day_old_wildtype_mouse_rep1,ctrl
M24met_control_3,ctrl
"shKDM4C 2, clone 1, rep 2",pert
"Subject 9, Family 3, Control",ctrl
5-ONS76 Mock_b,ctrl
HT-WT-2B,ctrl
"Endometrium, postmenopausal, control, 21",ctrl
Extract:LOX-1:213201;	Extract Description:LOX1_Untreated_2hr:213201;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.07;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.67;	Quality: Background Mean Dev.:0.2;	Quality: Absent (%):57.28;	Quality: Absent (%) Dev.:0.75;	Quality: Scaling Factor:0.54;	Quality: Scaling Factor Dev.:0.59;	Pretreatment [C]:LOX1;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213201;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_2hr;	RNA extraction source key [A]:282295533,pert
Control_AF_3,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.88;	choa: 240;	fata: 58;	eea: 1750;	wtkg: 85.6;	perfat: 23.1;	lbm: 58.3;	fat_mass: 1977.36,ctrl
130B,ctrl
erStress_twins_AA_1712twin1_500nM_thapsigargin_4h,pert
KO Tibialis Anterior at 4 weeks biological rep2,pert
PsOEt-19-Week 12,pert
Mammary gland R1 24 hr rep2,pert
"HepG2 cells, control, rep2",pert
Normal Biological Replicate 3,ctrl
lateral hypothalamus long access to cocaine replicate 3,pert
coc-16_C,pert
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14475;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"Acute Myeloid Leukemia, sample 28",pert
"WT caudal vertebral bone, rep2",ctrl
Fetal heart 6 ug/kg TCDD rep1,pert
pMX-GFP vitamin C GFPVc+_2,pert
scan batch: Batch 2;	group: control;	subject age: 8;	paternal age: 29;	maternal age: 24,ctrl
FVB_MMTV_Wnt1_3065_Rosen,ctrl
patient: 15;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
15_0002C_Day1_41,ctrl
3979-2 E2F1 Null,ctrl
FW_2a_BV8343,pert
INSENS 5 0hr,ctrl
RI47,pert
Glioblastoma_5,pert
r18,pert
Brain_Aged_LPSip_4hr_mouse1 (OL1_#67),pert
10_c,ctrl
S25 WT1	F4/27	S25	wild type	Mouse	3 months	Cerebellum	Male,ctrl
Diagnosis: MDS/AML;	Age: 45y ;	Gender: Male;	Blast %: 85;	Source: PB;	Cyto: Complex;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
colonic_mucosa_inflammation_30,pert
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: PR;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 87;	baseline tumor size (cm): 5x3;	patient id (to identify the 2 chips from the same patient): 19301950,ctrl
"C57BL/6 female, fasted 18h (overnight), age 4-5 months",pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 18h,pert
cell line: PC-3;	treatment: luteolin;	treatment duration: 24h,pert
MDS patient 146,pert
V5-P239,ctrl
S46 NLS 142Q TG3	F5/10	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Female,pert
"control, subject 7",ctrl
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 57;	baseline tumor size (cm): 5x5;	patient id (to identify the 2 chips from the same patient): 19101935,ctrl
lean rosiglitazone 2,pert
M452 SKM-Tg,ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD4-FITC;	cell type: CD4 positive T cells,pert
cell line: um-uc-3 (atcc# crl-1749);	cell type: bladder cancer cells;	genotype/variation: transfected with gfp,ctrl
Individual_4216_PP_sample,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 2,pert
treatment: 12 weeks of RTX therapy;	gender: M;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
"Wild type, snap frozen, gastrocnemus muscle, 7month age animal",ctrl
"Acute Myeloid Leukemia, sample 69",ctrl
con_B149,ctrl
Strain: J1 Cell type: mouse embryonic stem culture,ctrl
sepsis patient #21,ctrl
"Acute Myeloid Leukemia, sample 3",pert
C57BL10 gastroc sample 1,ctrl
NCCIT-Consh-rep2,ctrl
"23B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Age: 66 yrs Gender: Female  Ethnicity: Caucasian,ctrl
tissue: Primary human lung fibroblasts;	treatment: None;	patient: 1;	time: Baseline,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 33 yr;	population: white;	dsm-iv: 295.9;	age of onset: 19 yr,pert
AA_87,pert
"Transgenic, snap frozen, plantaris muscle, 7month age animal",pert
Patient identifyier: N;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 20 years;	Body surface area: 25 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
3491-2 E2F2 Null,pert
patient: 107;	current medication: None;	birth date: 07/28/1060;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
A_AN11989_F,pert
"Wild type used for MAT1A 3 month, replicate 2",ctrl
Endometrium-Normal 1,pert
age: 49;	gender: female,pert
Insig1 flox/flox /Insig2 -/- InsigKO_C2,ctrl
Sample Group: control; Gender: female; Age: 51; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
Ileum_Wild Type+Quercetin_1,pert
"HEK293E cells, scrambled siRNA, replicate 3",ctrl
non-CF subject 29,ctrl
LRRK2 (G2019S) homozygous iPSC sample 1,pert
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P4,ctrl
brain wild type replicate3,ctrl
Kidney HEK293 cells,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 16 hrs;	time course: 1,pert
healthy control H15,ctrl
12N,ctrl
Day: 24; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 2,pert
Control Endometrium Mesenchymal Cell_ETB65 ++,ctrl
P0 - DCXko/Y 3,pert
WT CFTR unexposed replicate 2,ctrl
s5t2c,ctrl
chip number: 13;	transfection plate: 6;	target gene: USF1;	kd level: 0.79;	rin: 9.5;	transfection date: 2012-03-26,pert
D1 patient,pert
cells: spleen follicular B cells;	genotype: WT;	genetic background: C57BL/6J,ctrl
strain: SW129/C57BL/6J  cells;	genotype/variation: wild type;	cell type: B-lymphoid,pert
developmental stage: E14.5;	genotype: Pax2Cre/+;PtenloxP/loxP,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 3",ctrl
EGF 4h replicate 1,pert
CD34+ cells without fenretinide treatment from CML33,ctrl
01N15_Systemic,pert
MCAD 3,pert
coc-16_B,pert
ND_9,ctrl
WT_IL-6_100_rep2,ctrl
25uM_Zn_2,pert
array 10 minus E,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 6 months,ctrl
Normal_002,ctrl
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 3,pert
subject: 9;	disease: CP;	muscle: GR;	gender: M;	age: 11.2;	gmfcs: 2;	popliteal angle: 110,pert
Control #2,ctrl
r07,pert
Control;	Survivor;	gender: Male,ctrl
Individual_4968_NN_sample,ctrl
Hippocampus_Soman_168h_rep3,pert
brain_QH2_14M_rep2,pert
tissue: Frontal cortex;	age: 77;	Sex: F,ctrl
si Control and vehicle replicate 1,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: spleen;	sample name: 3-sp2,pert
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 24h,pert
shOCT4_5,pert
"Healthy control mice, time point 1 week",ctrl
AA_Case5_CD8,pert
synovial fluid macrophages,pert
background strain: CD1;	age: p23;	tissue: pancreas;	genotype/variation: Sox9-EGFP;	facs: GFP+,pert
Leg 28 Day control rep 2,ctrl
Skin_Lox_Control_Rep2,ctrl
"CD4+ splenocytes at 6h, biological replicate 1 sham-3",ctrl
GEIM12-U133A-DM,pert
CON31,ctrl
"3 uM EPZ004777 treated, DAY 6, biological rep.3, MOLM-13 cells",pert
Luciferase shRNA_3 Days knockdown_rep3,ctrl
lung_CLP_PPTA knockout_rep3,pert
"TMD_TA, T3",pert
EOM 56 Day Control rep 3,ctrl
PBMCs_IS_14 [IS],pert
"104, MUSCLE, Before",ctrl
Kidney_50 mg/kg VCM ip_mouse #068,pert
MDS16,pert
"MAT1A knockout at 8 month age, biological replicate 1",pert
EA_Case2_CD20,pert
"1mg/kg/day PFOA, Rep 4, Block 1, liver (low dose)",pert
"patient: 210;	current medication: Mesalazine 800mg B, Prednisolone Supps;	birth date: 6/28/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/73;	diagnosis date: 1/10/74;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/19/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/14/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Scarlet Fever 1964;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
"human failing LV myocardium, Idiopathic40",pert
tissue: atria;	genotype: COUP-TFIIflox/flox;	age: 2 months;	genetic background: C57BL/6,ctrl
patient: 40892;	sample: normal,ctrl
"MCF-7 transfected with pcDNA3.2-BP1, rep.2",pert
embryonic stage: E14;	cell type: embryonic stem cells;	genotype/variation: wild-type,ctrl
48SAGEA,pert
"RNF40 siRNA - 2 days adipocyte differentiation, rep3",pert
Patient 22,pert
"Gata4_S105Amut, PE treated whole heart, individual 7",pert
Ls174T-L8 dox2,pert
Tumor_Ker50,pert
endothelial_rep15,ctrl
Healthy controls; individual=JR; time=2; beverage=alcohol,pert
CA01-103B,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 39 yr;	population: white;	dsm-iv: 295.3;	age of onset: 17 yr,pert
"Exp A, Animal #245, control (0mg/kg) D-Serine",ctrl
"Patient I-c671T, MSI colorectal tumor",pert
Angiopoietin-1(sparse)-2,pert
Normal mucosa 11,ctrl
WT-smoke-med-5 month+13d-R4,ctrl
"brain, hippocampus: KA6-I_e1_le1",pert
Ero1-C104A/C131A induced biological repA,pert
Snell 6 month Dwarf Liver 87dw,pert
tissue: dorsal skin;	genotype/variation: GR-/-;	strain: B6D2/F1;	age: E18.5,pert
WT_PMΦ_rep1,ctrl
Array Type; Affymetrix Mouse 430_2;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7,pert
fibroblast_Slow_D98_Media_11,pert
Subject #8023-2d Postinfection,ctrl
parental cell line: WB;	vector: pBabe-puro (empty vector);	replicate: 2,ctrl
Subject 3 / lung subsegment instillated by LPS,pert
"28B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
normal control 6,ctrl
Cervical cancer_88-04T,pert
PHM-DM-5aUA-s2,pert
"Patient 9, Macroscopically intact tissue",ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 24h,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: del5q plus monosomy7/del7q plus other,pert
mESCs_EGFPcontrol_rep3,ctrl
PGA-RMM-18h-2aA-s2,pert
B7hi mTEC B6/129 aire-/- 2,pert
major non-tumor1,ctrl
Peripheral blood mononuclear cells (PBMC)-Patient CV T0,ctrl
"Crohn's Disease subject (23 year old caucasian male, SAK_1316577485)",pert
liver_female wt_rep3,ctrl
remitted schizophrenia patient  S11,pert
tissue: isolated from spleen;	cell type: memory CD8 T cells;	strain: C57/BL6;	genome/variation: wild type;	age: over 80 days after infection,ctrl
"Global gene expression of NASH patients, P53",pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Cortisol;	genotype: WT CTNNB1,ctrl
T59 dilated cardiomyopathy heart biopsy,pert
Allo-4-4,pert
WT-PBS_rep-1,ctrl
muscle_Akt1+/-_8wk_rep3,pert
Diseased individual (ulcerative colitis) of twinpair #2,pert
race: african american;	age (years): 50;	stage: IA;	grade: 1;	histology: endometrioid,pert
Kidney_200 mg/kg VCM ip_mouse #085,pert
"patient 024b, normal, homogenized",ctrl
"eye, cornea: TRizol Extraction_le1 5",ctrl
"Colitis 03, UC03",pert
8ILC_normal_ductal,ctrl
"Mammary gland, IGF1R-overexpressed, biological rep1",pert
Wt Mouse_cerebellum_Old_saline treatment_Replicate-3,ctrl
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 42;	gender: m;	treatment: -,ctrl
"RWPE1 cells, vehicle, 48h, biological rep1",ctrl
Human Non-progressor HIV Sample L128-CD8+ T cells,pert
66 mt E11.5 heart,pert
Nonlesional Epithelium Atopic Dermatitis rep1,pert
patient: 34208;	disease state: LGSC;	component: Borderline,ctrl
Donor1_6h_DMSO,ctrl
"male;	CABG patient, atrial tissue, propofol anesthesia, after CABG surgery",pert
LNCaP.GFP.1,ctrl
Leg 28 Day mdx rep 1,pert
LPS 4 HOURS,pert
uterus_P4_PRKO_40hrs_rep1,pert
Sox3 null Sample 3,pert
WT_rep_3,ctrl
Control [G2],ctrl
tissue: skeletal muscle;	disease status: inclusion body myositis,pert
"C57BL/6 female 6 weeks, 125",pert
H1P_6,ctrl
"MAT1A knockout at 8 month age, biological replicate 3",pert
cell line: cervical cancer (HeLa) cells;	agent: Cas II-gly,pert
"Crohn's Disease subject (21 year old caucasian female, SAK_1261327175)",pert
"Rat_Tracheal_Control_2hr, rep1",ctrl
shRNA4-1-noDox-rep3,ctrl
"Donor 3, mock infected 1hr",ctrl
KN-smoke-high-5 month-R1,pert
AAA neck (Sample 3),pert
T2-FP_spleen_wt_rep1,ctrl
P2A Progranulin-frontal,pert
Day2 Estrogen treatment replicate 2,pert
RV16;	Age = 20;	Sex = M,pert
Donor4_6h_Wy,pert
HF0303_U133P2,ctrl
jos1985,pert
4140-4 E2F3 Heterozygous,pert
C8 Control None,ctrl
V5-P594,pert
MEF Wild Type 2-rep2,ctrl
WT-sham-5 month+1d-R1,ctrl
LCL Concordant for Epilepsy twin pair 3 (CCE3.2)(TP36),pert
endothelial_rep4,ctrl
4mo wt9,ctrl
MCF10A 9days,ctrl
CLL 164-02 LMP-420,pert
PND28 Rat Testis_Rat230-2_3hr Corn Oil_Animal#54_04005,ctrl
Colo-205 DMSO Day 10,ctrl
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Mesenchymal Cell,pert
Md02h030,ctrl
striatum_wild type_18 month_replicate 1,ctrl
"IκBα-deficient animal, biological repeat 3",pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 36;	maternal age: 36,pert
KO_d00_e0_vs_WT_d00_e0,pert
E12 wt.2,ctrl
CXCR4 knockout 5,pert
"Patient H-c587T, MSI colorectal tumor",pert
Subject #8001-8hr Postinfection,pert
"Control, replicate 6",ctrl
2_DMSO-2,ctrl
brain_Down_syndrome_sampleid_jg1739,pert
Non failing,ctrl
patient: CLS14;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
cell type: embryonic stem cells;	genotype/variation: transfected with scrampled-control siRNA,ctrl
Sex: female;	genotype: sst -/-;	tissue: liver;	genetic background: C57BL/6,pert
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14475;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
tissue: Biceps muscle;	patient: C.b.8;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 1y 9m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
Strain: 129S2/SvPasCrlf;	Genotype: Wildtype,ctrl
HP-49,pert
CBMNC.LPS-.1,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 85min;	race: White;	sex: Male,pert
major HCC10,ctrl
subject: 13U;	cohort: 13;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 63;	Sex: F;	batch: Batch_3,ctrl
SLE CD4 T cells 11,pert
siHic5_2_0h_1,pert
disease state: heterozygous Nxnl1 null;	strain: BALB/c AJ,pert
PBMC_C1,ctrl
8 week old Nix null mice (Nix-/-) spleen,pert
36 year old female,ctrl
"AALE-Vector + shGFP, biological rep2",ctrl
Nerve_Control_Rosi_711,ctrl
Astrocytoma_2,pert
HDAC6_3,pert
Day: 18; Drug: Saline; Phase: Withdrawal; Replicate: 1,ctrl
Strain: C57BL/6J;	Gender: female;	Age: 7 days;	Tissue: kidney,pert
Tissue: lung;;	Genetics: Sporadic IIP;;	Histology: Usual Interstitial Pneumonia,pert
ACC 3 cell line lacZ-RNAi replicate 3,ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 1,pert
B6C3F1/J Vehicle liver sample batch 2,ctrl
Lung-normal-rep6,ctrl
c57/BL,ctrl
WT - Cre Control - 3 mo - repeat 1 - Cy5 - mAdbID:74586,ctrl
1095PBMC,ctrl
"wt total RNA LSK, rep 5",ctrl
S46 WT6	F5/54	S46	wild type	Mouse	10 months	Cerebellum	Female,ctrl
Gender:M;	Age:35;	Tissue: Mucosa,ctrl
cell line: THP-1;	shRNA construct: GSK3A Construct 5,pert
"alveolar macrophages, non-smoker 002",ctrl
"Grape extract group, 12 months, patient number 29",ctrl
"EtOH, RARaKO, set 3",ctrl
patient: 244;	current medication: Seratide Bricanyl BFZ;	birth date: 1/29/55;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/16/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 15-24;	other illnesses: Asthma Hypertension;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
scan batch: Batch 2;	group: control;	subject age: 5;	paternal age: 30;	maternal age: 27,ctrl
"Aorta, saline 7d, #6",ctrl
"Colitis 10, UC10",pert
KO - 5 mo - repeat 3 - Cy5 - mAdbID:74137,pert
cell type: Oct4-GiP ES cells,ctrl
IFNAR_uninf_1,pert
DMN-CtrHippo20d-2bAv2-s2,ctrl
sampleID: SAM630140;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 211,ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 68;	age-at-onset: n/a;	geographical origin: Mirandela,ctrl
wild-type E18.5,ctrl
52A;pretreatment;female;breast tumor; nonresponder,ctrl
Wild type olfactory epithlium 0 h replicate2,ctrl
genotype: TAF4b knockout,pert
healthy control C2,ctrl
HLA risk: Medium;	Height: 166.3 cm;	Weight: 64.5 kg;	BMI: 23.2;	Age: 18.16 years;	Gender: Female;	Race: Other;	Glucose: 114 mg/dl;	HbA1c: 7.4%,pert
Liver-5 month-Myc heterozygous-technical replicate 2,pert
WT - Cre Treated - 24 hrs - repeat 1 - Cy3 - mAdbID:61769,ctrl
IRAK2 KO macrophages stimulated with MALP-2 for 4 h,pert
"Acute Myeloid Leukemia, sample 75",ctrl
P75 dilated cardiomyopathy heart biopsy,pert
wildtype strong 2,pert
"HEK293 cells siRNA control, biological rep2",ctrl
FmrKO5_blood,pert
Klf9KO_jejunum_PND30_5,pert
WT623,ctrl
Wild type_lung_1,ctrl
C_AN01125_C,ctrl
EA_Case15_CD8,pert
Dicer WT CD4 T cells 1,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 55.27671,pert
NOD,ctrl
short-hairpin rna: shCDK8;	cell line: HCT116,pert
"3mg/kg/day PFOA, Rep 1, Block 3, lung (low dose)",pert
Aged 7,pert
Liver sample from Control group (C9),ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 35.01096,pert
BV2_rep3,ctrl
lateral hypothalamus long access to cocaine replicate 2,pert
M304 SKM-KO,pert
Pancreatic Sample 4-Tumor,pert
KO-control-1,pert
whole tissue section from case 871,pert
cerebellum_KO_3,pert
116B,ctrl
anti-FGFR1_rep3,pert
human_hepatocyte_400uM_levofloxacin_donorA_24hr_prep1,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.783;	Ratio: 2.13,ctrl
sex: Male;	Age: 8 months;	additional patient information found in Series supplementary file,pert
PGA-MAH-AJ_PBS24h-5aA-s2,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 18.308;	Ratio: 2.12,pert
FASSc2 medium only,pert
patient: 120;	current medication: Minicycline;	birth date: 5/6/54;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/18/05;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
Extract:LOX-1:213103;	Extract Description:LOX1_0hr:213103;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.03;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.53;	Quality: Background Mean Dev.:1.32;	Quality: Absent (%):58.85;	Quality: Absent (%) Dev.:0.46;	Quality: Scaling Factor:0.54;	Quality: Scaling Factor Dev.:0.6;	Pretreatment [C]:LOX1;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213103;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_0hr;	RNA extraction source key [A]:282295463,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 100min;	race: White;	sex: Female,pert
"human failing LV myocardium, Ischemic82",pert
major non-tumor10,ctrl
male_control_367,ctrl
"fibroblast, control subject NM7 rep 2",ctrl
tissue: leukemia;	genotype: Sh2b3-/- ΔE-NOTCH1,pert
"E18.5 ERRg -/- heart, biological rep 3",pert
heart of mouse subjected 1 week to chronic constant hypoxia,pert
healthy control C7,ctrl
siHic5_2_4h_1,pert
Nasal Epithelium Instilation Formaldehyde 400mM 6h ID374,pert
"3T3-L1 siControl 48h, biological rep 2",ctrl
695-383_2hr,pert
HEL_JAK2 knockdown (Jak2-10 shRNA)_1,pert
healthy control H04,ctrl
Saline T00278945,ctrl
SCARKO d10 (1),pert
1_CD34+_12h_TCDD+,pert
NSC_FBS_L1,pert
embryonic fibroblasts from female wild type Balb/c mice,ctrl
"breast tumor epithelium,44",pert
FVB_24h_Wy,pert
Nonlesional Epithelium Psoriasis rep3,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_8_23_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
midbrain_wild type_18 month_replicate 2,ctrl
"seminoma specimen, pT2, patient age: 31y",pert
HD6,pert
tissue: testis;	gestational age: 22 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: abiraterone,pert
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 scrambled;	treatment: tamoxifen for 120 min,pert
V5-P237,pert
BIO586225,pert
"P208 HCT-116, DNMT3B knockout, non-treated",pert
t12,pert
si Control and vehicle replicate 2,ctrl
"brain, cerebellum: KCb4w#3_e1_le1",pert
A_AN17777_F,pert
Pancreatic Sample 30-Normal,ctrl
RNA from HCC_18N,ctrl
colon_CRC_1651,pert
"Ulcerative colitis patient, biopsy taken from the descending colon, no macroscopic signs of inflammation.",pert
"Control, replicate 7",ctrl
LmnaG609G/G609G KI #5. 465,pert
WT P2 replicate 4,ctrl
age: 42;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Aorta_APOE-deficient with atherosclerosis_2,ctrl
"Lesional skin from K5-Tie2 mouse, biological replicate 1",pert
ploidy: euploid;	tissue: cerebellum;	developmental stage: P0 postnatal stage,ctrl
Mening SWB WB NP 24b,pert
age: 67;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"Lesion Skin, LS-4",pert
siNS_24h_3,ctrl
0155-01-c,ctrl
H441 transfected with ETS2-specific siRNA 3,ctrl
liver western diet 0.05% quercetin rep6,pert
GM19238_Kd_NFKB2_1,pert
C_AN19760_F,ctrl
"Atm-/- untreated, A",pert
HeLa_TP082505_21_HG-U133A_2_IMFGN0023,ctrl
"Normal T-cells, CD3+, donor 7",ctrl
3765-ls,pert
brain_DLPFC_bipolar C_mr871,pert
"nasopharyngeal carcinoma, specimen T18",pert
patient id: T142;	tissue: Normal cortex;	gender: Female;	age: 56;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
Patient no. 4: control,ctrl
8 week old leg MDX rep 1,pert
patient id: 83;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 85;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: loss;	vhl status: mutant,pert
strain: Sprague-Dawley;	tissue: spinal cord (ipsilateral dorsal horn);	developmental stage: Adult (8-12wks);	treatment group: sham,ctrl
51n,ctrl
cell line: V6.5;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 0,ctrl
Kidney_Aqp11-/-_P7_2-3,pert
NPC Brain 20d Mouse1,pert
Untreated 979-CLA-25,ctrl
RAW_0.14mM_HOCl_#3,pert
control-1,pert
5268 UC Inflamed sigmoid colon,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: WT,ctrl
"10B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
tissue: Biceps muscle;	patient: C.b.9;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y 11m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
condition: Normal;	patient: N_LJ_6;	tissue: Normal skin biopsy;	kit: Affy,ctrl
colon_C57 mouse_12weeks_rep1,ctrl
n2a-Pou3f3-kd-1,pert
P64 Non failing heart biopsy,ctrl
mdx EDL sample 1,pert
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 4hr,pert
"Crohn's Disease subject (33 year old caucasian female, SAK_1275455680)",pert
Leptin treated mouse gallbladder 6,pert
"Mouse LV, WT 1",ctrl
Array Type: HG-U133A_2;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.2;	Bioanalyzer Results: excellent;	Sample Preservation: -70C,ctrl
Brain_Aged_LPSip_4hr_mouse2 (OL2_#68),pert
treatment: untreated;	cell type: CLL B-cells,ctrl
Pool Ts1Cje_P15_hyb1,pert
Tslc1 -/- mice_rep2,pert
TP06-855,ctrl
Cisplatin_2h_rep1,pert
T3_HypM,pert
Heart_KO_2,pert
"vehicle, biological rep2",ctrl
Knockdown Cell on HMVEC-L Replicate 3,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 202,ctrl
cell line: MCF-10A,ctrl
"tissue sample from Bellevue Hospital, NY",ctrl
MDS45,pert
..SAL_II_3,ctrl
WT_Mstn_3,ctrl
cell type: E14 murine embryonic stem cells;	genotype: Mock knock-down cells,ctrl
patient: 124;	current medication: OCP;	birth date: 6/25/77;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
"bipolar disorder, BA10-13(2)",pert
Tumor-KO-rep4,pert
S1-030626-SA,pert
12474 UC Inflamed sigmoid colon,pert
tissue: testis;	genotype: wt;	age: 14dpp,ctrl
WT_1,pert
129B,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 8d ID68,ctrl
Diagnosis: AML M1;	Age: 52y ;	Gender: Female;	Blast %: 88;	Source: BM;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.34 uM (2 x EC50), biological rep3",pert
ctrl.1,ctrl
CAR.AH_CITCO_rep1,pert
"BPH adrenals, replicate 2",pert
T30277,pert
jos1984,pert
mutant_crypt_day2_sample2,pert
U937_ROS_curcumin_4h_rep3,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 4;	psoriasis duration: 18.009582477755;	age of psoriasis onset: 20,pert
sirna: NR2F2 knockdown;	cell line: TOV112D;	cell type: Ovarian cancer cell line,pert
AP-2 gamma targetting siRNA 2: GCGGCCCAGCAACUGUGUAAA Technical Replicate 3,pert
V5-P511,pert
knockout rep-3,pert
Mc3T3 AA_ 5day_rep1,pert
strain: C57BL/6;	tissue: mouse bone marrow;	genotype: wild type;	treatment: 1x10^6 cells in a 12-well plate co-cultured overnight with 1x10^6 E0771 tumor cells in an sterile insert,ctrl
con-15_B,ctrl
b138,ctrl
"HeLa control, biological rep2",ctrl
IM70_control,ctrl
"tissue: whole lung;	strain: SPC(+)Cre(-), Dox E6.5-12.5, PN15;	genotype/variation: wildtype, control",ctrl
"gender: Male;	age: 82;	post-mortem delay: 5h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"DCIS 2, biological rep. 2",pert
2008-Ets1 cells_rep3,pert
TTP_WT_0ActD_BioRep5,ctrl
cell line: BxPC3;	cell type: pancreatic cancer;	transfected vector: control,ctrl
tissue: GV oocyte;	strain: mixed 129/Sv and C57BL/6J;	genotype/variation: Ring1+/+Rnf2F/F (control),ctrl
"Mutant in the presence of tetracycline, rep3",ctrl
C26_skeletal 1,pert
DU145/MYB siRNA #3,pert
WT 569 R3,ctrl
Hippocampus_Soman_96h_rep1,pert
Cmah KO_lung_2,pert
hNHEPS_control_6 h_rep2,ctrl
Tendon_non-lesional_rep18,ctrl
3551-1 E2F WT,ctrl
Disease_status: Bipolar disorder;	Age (years): 44;	Gender: Male;	Age of onset (years): 33;	Duration of illness (years): 11;	Brain pH: 6.74;	Post mortem interval (hours): 19;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous saline challenge""",ctrl
HepG2_Cd rep3,pert
wt 13.5d replicate 3,ctrl
cell line: SNU-398;	cell type: Hepatocellular carcinoma (HCC);	genotype/variation: SALL4 knockdown,pert
SKI-DLCL cells_AraC 20nM_24h_rpt2,pert
"Autoimmune pancreatic islets, day 2 cyclophosphamide treatment, Rep 1",pert
KN-sham-5 month-R3,pert
BIO586226,pert
Healthy controls; individual=IF; time=2; beverage=alcohol,pert
Gastrocnemius Muscle mdx AAV-Galgt2-Treated rep1,pert
Nerve_Diabetic_Rosi_718,pert
cell type: Embryonic Stem Cells;	genotype/variation: WT,ctrl
condition: Normal;	patient: N_LJ_2;	tissue: Normal skin biopsy;	kit: Affy,ctrl
WM-266 knock-down of Pirin by siRNA - Replica 2,pert
Muscle-24 month-wild type-technical replicate 1,ctrl
SeV 3660,pert
Bronchial Epithelial Cells MMA biological 1691G,pert
Kidney_saline iv_mouse #002,ctrl
Pancreatic Sample 24-Tumor,pert
CD4+ cells IL1RN knockout 1 month rep2,pert
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: HIGH;	genome/variation: PDGFRA mutation detected,pert
scpk/ikLLtumor/21,pert
"PPARg d0, rep 4",pert
Huh7 cells_Mock Infected 18 hours_ rep3,ctrl
Bronchial Epithelial Cells control biological 1579M,ctrl
genotype: tg/g;	treatment: CaNrf2;	gender: female;	background strain: FVB/N/C57BL/6 mixed,ctrl
"human failing LV myocardium, Idiopathic5",pert
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 54;	age-at-onset: 53;	geographical origin: Mirandela;	clinical characteristics: Diabetes, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
"female Spargue-Dawley rats, 4-hydroxyphenylretinamide, 782 mg/kg diet for 7 days, tissue: liver",pert
S-IIP(UIP)6_Cy3,pert
treatment: PLX4720;	time: Day10;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,pert
Bronchial Epithelial Cells SA biological 1568H,pert
NALT_infected_24h_90-226-dM_rep1,pert
"brain, hippocampus: C1-II_e1_le1",ctrl
PGA-MAH-C3H_OVA24h-4aA-s2,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 42;	gender: male,ctrl
EDL-n10; normal extensor digitorum longus 10 month,ctrl
3496-lcm,pert
Muscle 50 eccentric contractions 12 hours WT Aged 12171,ctrl
PGA_MI_nilv_24h_360,pert
BCells_WildType_day0_REP1,ctrl
"seminoma specimen, pT2, patient age: 28y; W03 012",pert
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14477;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
Ishikawa_Control_8h_rep3,ctrl
"mouse aorta cross strain comparison, C3H_T24_HF_01",pert
Pertuzumab treated after 4 days (P1_1),pert
Aire KO,pert
heart of mouse subjected 4 week to chronic intermittent hypoxia (4A),pert
S5_sham_overexpressor_12,pert
Bone-Marrow_SMM_S1365,pert
"NF-YA KD ES cells 96hr, replicate 3",pert
strain: C57BL/6J;	genotype: non-transgenic;	tissue: aorta;	age: 32-34 weeks,ctrl
CD4DecTp1-2,pert
6h Kin- Cel.46,pert
cell line: LNCaP-abl;	transfection: siHIPK2,pert
strain: C57BL/6J;	day: 1;	drug: Heroin;	phase: Drug treatment;	tissue: striatum;	replicate: 1,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 44.0274,pert
4B,pert
"miR-148b-B (miR-148b-1+, biological replicate 2)",pert
Subject #8028-2d Postinfection,pert
DIA-t7-2; transgenic diaphragm 7 month,pert
colon_adenoma_1830,pert
HF1677_U133P2,pert
NS2,ctrl
MDS21,pert
patient8,pert
X50 WT2	F2/9	X50	wild type	Mouse	16 months	Cerebellum	Male,ctrl
WT_ANT_PDE_B1,ctrl
AVIC sample#2 treated with DMSO,ctrl
"WT mouse lung, biological rep4",ctrl
"wild type 5C.C7 T cells, biological rep2",ctrl
NIH3T3_4h_FGF_exp2,pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure",ctrl
homozygous_1,pert
90 year old female,pert
mouse liver C2,pert
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14508;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
"control, BA46-77",ctrl
cell line: U373;	cell type: glioma;	vector: Deltex1 (Myc-tagged),pert
disease state: Control;	gender: Female,ctrl
"Control subject, biopsy taken from the sigmoideum, no macroscopic signs of inflammation.",ctrl
Non_Target_3,ctrl
"gender: Female;	age: 75;	post-mortem delay: 3h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"NeuroD1 knockout mouse, P0 Pineal Tissue, Sample 3, 05-31-06",pert
Strain: C57BL/6;	Age: E14;	Retrovirus: MSCV-GFP,pert
"BOEC, normal 25",ctrl
tissue: Biceps muscle;	patient: P.b.6;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 4m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
fibroblast_5azatreated_rep1,pert
"fibroblast, MFS subject FB890 rep 3",pert
WT Uterus_saline_24h_rep2,ctrl
tissue: tumor;	disease state: DCIS,pert
4140-1 E2F3 Heterozygous,pert
OSCE-9N,ctrl
IRAK4-KD_BoneMarrowMacrophages_unstimulated_4hours_rep1,pert
"Hdh knock-out embryonic stem cells, biological replicate 1",pert
"P16 mutant OC apex, biological rep 1",pert
HF0087_U133P2,pert
"Retina from control mouse at ZT6, biological rep 2",ctrl
"Lesion Skin, LS-30",pert
SLE CD4 T cells 3,pert
phenotype: control;	gender: male;	case_id: 510;	age: 60;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 21.5;	brain ph at time of freezing: 6.66;	labeling_batch: 1,ctrl
Mut+/- rep3,pert
Retina homozygous KO 42 days 2,pert
SRF silenced R1881 rep 3,pert
gender: Male;	age: 83;	post-mortem delay: 11.5h;	ph: 6.1,pert
Fog2flox/delta; no Cre biological replicate 3,ctrl
TTP_WT_60ActD_BioRep2,pert
SA2,ctrl
P 27 Si RNA,pert
AO 4hr,ctrl
"tissue: neurectoderm derived from embryonic stem cells;	treatment: control, shRNAmir #11;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",ctrl
cerebellum_PSNA_ 12w_rep2,pert
cell line: MOLM-14;	shRNA construct: GSK3A Construct 5,pert
Exon3_T1,pert
c42 is aclonal Nurr1 stably-expressing stem cell line,ctrl
Retina homozygous KO 30 days 1,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 24h ID56,ctrl
Normal_1975,ctrl
cardiomyocyte SRF-null 3,pert
"Healthy control mice, time point 5 week",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 33;	gender: male,pert
"alveolar macrophages, non-smoker 013",ctrl
cell type: fibroblast;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: 0;	clone: 0,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 70;	gender: male,pert
"WT cells, replicate 5",ctrl
array 5 plus E,ctrl
129_Sv_1_Runx1_Ko_d6_4302,pert
GM19238_Kd_STAT2_1,pert
Diaphragm 28 Day control rep 2,ctrl
Transgenic nr 619,pert
gender: female;	cell type: peritoneal macrophages;	strain: Nfkbiz-/-,pert
23B,pert
NB4 CONTROL 1,ctrl
siCtrlVeh4h_2663,ctrl
Bone-Marrow_MM_M1018,pert
10 days sham-1,ctrl
patient: 216;	current medication: NONE;	birth date: 5/10/36;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/19/66;	diagnosis date: 8/20/66;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/18/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: NONE;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
tissue: lesional skin;	urticaria status: affected;	patient: 7,pert
E9.0 wt.3,ctrl
Control siRNA rep1,ctrl
Colon_POR-null_2,pert
gender: male;	age (years): 40;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
REH_shG1_rep1,pert
sample: #17;	subject: PD case #3;	brain: T-3321;	age: 77;	sex: Female;	region: Dorsal motor nucleus of the vagus,pert
Cont subject 01,ctrl
ccRCC tumor of patient 131,ctrl
Healthy,ctrl
BAT_KO_2,pert
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: Mock,ctrl
"female,20,Caucasian",ctrl
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14464;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Extract:LOX-1:113302;	Extract Description:GFP_Untreated_6hr:113302;	Quality: Classification:Medium;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.43;	Quality: Background Mean Dev.:1.03;	Quality: Absent (%):59.24;	Quality: Absent (%) Dev.:0.77;	Quality: Scaling Factor:0.87;	Quality: Scaling Factor Dev.:2.23;	Pretreatment [C]:GFP;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113302;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_6hr;	RNA extraction source key [A]:282295603,ctrl
M303 C,pert
RV64.02_CONTROL_day25_Slide41,ctrl
U937_ROS_untreated_18h_rep2,ctrl
"shCDK8, low glucose, replicate 2",pert
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/111;	differentiation status: undifferentiated;	cell line: Q111,pert
437_CreER: mutant mouse 3,pert
25A;pretreatment;female;breast tumor,ctrl
Sample ID:TP5;	Twin Pair ID:DCBD1.1;	Clinical Status:BD1 with psychotic features;	Age of Onset:19;	Age at interview & blood sampling:55;	Current Age (2007):58;	Sex: Female;	Medication at interview (duration) :lithium & citalopram (22.5 years),pert
"seminoma specimen, pT1, patient age: 35y",pert
"Normal Skin, Normal-20",ctrl
MCF-7 cell_DMSO_12hr_biological rep1,ctrl
major HCC2,ctrl
U2OS shCHK1-3 replicate 3 [set 4],pert
cell line: HL-60;	shRNA construct: GSK3A Construct 5,pert
Normal myocardium sold commercially (H),ctrl
control AU1086301,ctrl
MKK7D transgenic female replicate 14 late timepoint,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 41;	sex: M,ctrl
non-CF subject 30,ctrl
Uninfected control_4b,pert
HC CM 2 water,ctrl
cell type: NPC 5-8F cells;	genotype/variation: NESG1 overexpression,pert
"MDA-MB-231 (human, Caucasian, breast, adenocarcinoma)",pert
Aorta_APOE-deficient and captopril treated_2,pert
H3f3b KO 3967,pert
NCI-H69 human small cell lung cancer,ctrl
MDS patient 35,pert
sex: Male;	Age: 11 months;	additional patient information found in Series supplementary file,pert
race: african american;	age (years): 79;	stage: IA;	grade: 2;	histology: endometrioid,pert
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep3,pert
COLO829_shSCR_PLX4032_B,pert
"vehicle treatment, 24 hour time point, biological replicate 3",ctrl
Cardiac Muscle_Cmah KO_rep3,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 2;	bead chip array sentrix code: 4421339032,ctrl
subject: 13U;	cohort: 13;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 63;	Sex: F;	batch: Batch_3,ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 4",pert
patient code: 105;	gender: Male;	age: 68;	tumor grade: 3;	t-stage: 2;	n-stage: 0;	ajcc classif. (2002): 1b,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-sp2,pert
Trastuzumab treated after 4 days (T1_2),pert
Patient no. 8: treated,pert
"Pten null epithelials cells, biological rep3",pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 22.0;	age of psoriasis onset: 23,pert
Individual_777_PN_sample,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 217,pert
HP-24,ctrl
SKMEL28_t1h_rep3,pert
Aorta-APOE-deficient and vitamin E treatment-rep2,pert
P105,ctrl
liver_STZ treated diabetic_rep4,ctrl
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 101;	Usage number: 4;	Exposures: 3,pert
HSC_Zfx-cko_Replicate1,pert
SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2),ctrl
"5mg/kg/day PFOA, Rep 2, Block 1, liver (high dose)",pert
PGA-RMM-330m-3aA-s2,pert
Control replicate 1,ctrl
WT 2 mon replicate 3,ctrl
10 week control OMN rep 3,ctrl
SLE2,pert
Kidney_Biopsy_Liver_Disease_6,pert
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 33;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 3,pert
TMRI E2 2hr,pert
"DMSO Control after 4hr, replicate 1",ctrl
strain: Balb/C;	Sex: female;	tissue: pancreas;	age: 30 days old;	maternal diet: Control diet;	treatment: sham,ctrl
cell line: NAS9;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: wild-type,ctrl
strain: 129/Sv;	genotype/variation: DDR-1-KO;	tissue: madibular condyle cartilage,pert
"brain, hippocampus: inhibitor-1 KO 1_e1_le1",pert
Nerve_Control_Rosi_711,pert
Csbm/m Mouse_cerebellum_Old_saline treatment_Replicate-3,ctrl
PTEN_mutant_1_intestinal_polyp_30days,pert
"cell line: HEK293 human embryonic kidney cell line;	protocol: MIF depletion, siRNA-mediated;	siRNA concentration = 50pmol/ml",pert
"DMSO Control after 24hr, replicate 3",ctrl
Adrenal WT 0h batch 3 [AdWTh00.22],ctrl
intestine_wildtype_control_rep3,ctrl
cell line: derived from JoMa1-MYCN-induced tumor,pert
cell line: HEK293,pert
"Acute Myeloid Leukemia, sample 58",pert
Nonlesional Epithelium Nonatopic Control rep4b,ctrl
"Atria, Control, biological replicate 3",ctrl
gender: male;	age: 7.5 mo +/-2.5 weeks;	genotype/variation: PPAR KO;	treatment: control,pert
gender: Male;	strain: C57BL/6;	genotype/variation: B1-/-;	tissue: Epididymal fat;	age: 3 month-old,pert
treatment group: air;	tissue: left lung lobe;	gender: Male;	strain: C3H/HeJ,pert
"RPMI8226_shLuc2, replicate2",ctrl
3769,pert
gender: male;	age (years): 51;	evolution time (years): 2;	disease extension: Pancolitis;	treatment: Azathioprine,pert
"strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
"Cells: U2OS, Treatment: infected with PRC shRNA1_pLenti, blasticidin selection",pert
"siYAP RNA #2 transfected, biological rep 4",pert
M10KOepi_infect_0h_rep3,pert
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 4hr,ctrl
aa_NY226,pert
normal 2911,ctrl
R6/1 18 week transgenic_C627,pert
8 week old leg MDX rep 4,pert
Diabetic 5 weeks D5,pert
S/SM3,pert
Strain: In-house BALB/c mice; Gender: Male; Age: 22 months old; Tissue: Brain; Treatment: 4 hours post saline ip.,ctrl
lesion_midUV_patient7,pert
cell type: Heptaocellular carcinoma cell line with HIF-1alpha knockdown,pert
"DCIS 9, biological rep. 9",pert
Low weight gainer KOZAK2_ABI_HYP_L2,ctrl
human_hepatocyte_400uM_clinafloxacin_donorA_24hr_prep1,pert
Strain: C57BL/6 Rs1h knockout P7,pert
phenotype: control;	gender: female;	case_id: 270;	age: 60;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: ?;	post-mortem-interval (hrs): 21;	brain ph at time of freezing: 6.8;	labeling_batch: 1,ctrl
liver_male ko_rep1,pert
Subject 2 Post allergen challenge,pert
Patient 4 c,pert
coc-12_C,pert
Diseased individual (ulcerative colitis) of twinpair #9,pert
subject: 20U;	cohort: 20;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 39kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
treatment: EtOH + cycloheximide;	genotype: WT;	cell line: F9,ctrl
cell: Cultured oligodendrocytes;	genotype: Myelin-gene Regulatory Factor control littermate,ctrl
KO - knock-out Untreated - 0 hrs - repeat 2 - Cy5 - mAdbID:61725,pert
Parkinson's disease sample x092,pert
P65 Non failing heart biopsy,ctrl
3557-ls,pert
MCL_IGHV_MUT (R1640),pert
scpk/ikLL/57,pert
"ACI strain, male, age 21 weeks",ctrl
T161 U133p2,pert
pediatric AML PP3,pert
IFC 03,pert
"Uninvolved Skin, NS-25",pert
prostate_Klf5 ko_rep2,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 61,pert
strain: HNF4LoxP/+  Villin Cre;	age: 1 month;	tissue: small intestine;	sex: female,ctrl
CLL 378-01 LMP-420,pert
Normal-ERα-positive breast cancer 72,ctrl
"human failing LV myocardium, Ischemic94",pert
MDS patient 170,pert
"Spi-60, biological rep 4",pert
Control PB C106,ctrl
S024_Scz_M_75,pert
"Exp A, Animal #266, 20mg/kg D-Serine",pert
fasted liver lard diet 2,pert
liver knock out replicate1,ctrl
agent: ConA;	time point: 1 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
Choriocarcinoma 0915,pert
SBVGA1 1,pert
MCF-10A shATM-1 replicate 2 [set 5],pert
tissue: blood;	patient: 4;	gender: female;	age: 28,pert
"JCAM1 Lck negative 0 hours, #2",pert
Liver_Nrf1 Control_rep1.,ctrl
Ad infected murine liver-MO30k-(468)-6 hpi,pert
"Mammary gland, control, biological repl 1",ctrl
healthy donor,ctrl
cell line: SCC-40;	cell line origin: Oral cancer;	genotype/variation: ZMPSTE24 silencing,pert
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.34 uM (2 x EC50), biological rep1",pert
patient: 20;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
APOE_KO_NODM_9W_6,ctrl
DMSO Treated Control 2,ctrl
protocol: Non-silencing control siRNA;	cell line: MCF7,ctrl
VPA Treated Rep 1,pert
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 58;	tissue: Blood,pert
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep4,pert
"Gender: female, Age: 44 years, Tissue: VIN 3",pert
control virus-infected replicate 1 (MCF7),ctrl
cell line: A2058;	treatment: Control siRNA,ctrl
control siRNA rep1,pert
01LQQ_PolyRF-,pert
"fibroblast, control subject NM7 rep 1",ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-4;	Primary Site:Floor of the mouth;	Age:60;	Sex:M;	TNM:T4N1M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
coc-53_C,pert
HDAC1_G10-rep3,pert
ATP-treated AML 14 blasts,pert
A10_C10_nasal_stem_cell_rep1,ctrl
heart knock out replicate3,ctrl
MCL_IGHV_MUT (R1305),pert
Bronchial Epithelial Cells control biological 2096X,ctrl
TOV112D cells_untreated_biological rep3,ctrl
Cal27_CETU1,pert
No or early 2 rep10 (retina),pert
NS5_NS010926,ctrl
Liver_hyperglycima_no.8,pert
HSC_Zfx-flox_Replicate1,ctrl
MS25_4B_MEK5_220307,pert
"BMMCs from NTAL WT, pLKO.1 infected, 2 h activated, biological rep3",ctrl
cell type: Primary hepatocytes;	strain: DBA;	agent: control;	time: 24h;	gender: Female;	age: 3 months,ctrl
PDAC_1,pert
Ishikawa_VeryLowDose_BPA_24h_rep2,pert
A503 MI 7 day,pert
microdissected breast cancer cells from case 1037,ctrl
HCT116_rep1,ctrl
"PDK1 null CTL, biological replicate 2",pert
Control with WY14643 replicate 7,pert
timepoint: 2h;	drug: Saline;	group no.: 37;	large batch: Y;	plate: 4164379020;	hybridization batch: IV,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous endotoxin challenge""",pert
cell line: KJD;	transformation: SV40 virus transformed;	cell type: epidermal keratinocyte;	treatment: doxorubicin,pert
Mouse No Cldn16 B9 458,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-Tg;	tissue: Skeletal muscle (quadriceps),pert
F_Kin_3,pert
Exercised-5,pert
"testis wt, 17dpp, Rep5",ctrl
lymphocytes_ctl_F_51y,ctrl
GM19238_Kd_IRF7_2,pert
"PTEN inducible MEFs at T1 = 24hr, biological rep1",pert
"MAT1A knockout at 8 month age, biological replicate 2",pert
Ctrl siRNA 4d 1,ctrl
Fibroblasts_HealthyControl_2,ctrl
"HERVH shRNA, rep2",pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 7,ctrl
WFS1 KO USHT_01_337_wt,ctrl
Extract:LOX-1:113101;	Extract Description:GFP_0hr:113101;	Quality: Classification:Bad;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.12;	Quality: Defective Area (%):0.08;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.61;	Quality: Background Mean Dev.:6.14;	Quality: Absent (%):61.21;	Quality: Absent (%) Dev.:2.29;	Quality: Scaling Factor:0.45;	Quality: Scaling Factor Dev.:1.4;	Pretreatment [C]:GFP;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113101;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_0hr;	RNA extraction source key [A]:282295413,ctrl
Postmenopausal female. Estradiol treated. Patient 3.,pert
MF-24,pert
SA_252,pert
strain: C57BL/6J;	cell type: KLS;	genotype/varation: wildtype,ctrl
Cervical Cancer C524,pert
Native-0-1,ctrl
Postmenopausal female. Untreated control. nr 22.,ctrl
Normal testis 0140,ctrl
SLE5-TC,pert
CLS14_T6_PP_day14_060,pert
cell line: NCI-H2009;	cell type: lung cancer cells;	transfected with: control hairpins targeting GFP,ctrl
Disease_status: Bipolar disorder;	Age (years): 45;	Gender: Male;	Age of onset (years): 16;	Duration of illness (years): 29;	Brain pH: 6.03;	Post mortem interval (hours): 35;	Side of brain: Left;	Fluphenazine mg. Equivalents: 20000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
Haloperidol treated 12weeks AffyGC RMA rep3,pert
Control subject 25_biological replicate 1,ctrl
BCell_lymphoma_transitional_sample4,pert
lymphocytes_HD_F_61y,pert
high grade serous carcinoma_patient 3_sample 1,pert
"depression, BA10-57",pert
Skinbiopsy_7hoursnickel_nickel_allergic_subject_P4,pert
kidney_QH2_6M_rep1,pert
wild-type rep_2 (CWT2),ctrl
"human failing LV myocardium, Idiopathic69",pert
n3_hi_10,pert
Cardiac Progenitor MUT2,pert
tg-1,pert
03 MINUS OHT 2,ctrl
ROS2,pert
dental pulp cell from control 2,ctrl
RKO_rep_2,pert
ARF1 siRNA knockdown MDA-MB-231 sample 8,pert
P14 - nudelko/+ 1,pert
cell line: NCI-H716;	treatment: YAP mutant vector,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (6),pert
jejunum_GATA4mutant_2,pert
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,pert
AKT_PLACEBO_48hours_1,pert
Strain: Long-Evans;	Gender: Male;	Age: Adult (PND62-PND64);	Tissue:  Cerebrocortex,ctrl
Scd1-/- on chow diet replicate 5,ctrl
sample =XCGD4 treatment=Control time=360 (min),pert
age (days old): 10;	genotype: SC-RbKO,pert
CRC_celecoxib_F4880,pert
"control, BA46-90",ctrl
Mammary cell line,ctrl
CONTROL;	Age = 21;	Sex = F,ctrl
H1299 DAC 1 uM (3239),pert
Globin_C1,ctrl
THRA aI mutant + T3 replicate 1,pert
FVB_skin_5dpn_2,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: trisomy8,pert
liver_control_diet_rep3,ctrl
"4105_CD133-, laminin treated",pert
"patient 10, baseline",ctrl
0979-01-C,ctrl
"NPTX1 shRNA Day 5, biological rep1",pert
subject: 09A;	cohort: 9;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 25kb;	age (y): 31;	Sex: F;	batch: Batch_2,pert
treatment: PLX4720;	time: Day8;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,pert
"Fourth ventricular choroid plexus from Otx2ko mice at E13, biological replicate 1",pert
"Crohn's Disease subject (39 year old caucasian female, SAK_1261237763)",pert
"normal skeletal muscle, biological rep11",ctrl
injury stage: Spinal 21 days;	gender: male;	strain: Wistar,pert
gender: male;	age (years): 33;	evolution time (years): 8;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
"P16 control OC base, biological rep 2",ctrl
female_alcoholic_304,pert
patient: 21;	disease state: hypertension;	tissue: Atheroma plaque,pert
cell type: Primary hepatocytes;	strain: NMRI;	agent: control;	time: 24h;	gender: Male;	age: 4 months,ctrl
Normal skin 1,ctrl
"EBF1 d0, rep 3",pert
t20,pert
NCCIT siTET1 rep2,pert
"C57BL/6J female number 3, untreated control ear (#3_Wt-C-7)",ctrl
PGA-HMO-MObese-7aUA-s2,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 60 years,ctrl
"2 month old, double transgenic (InsMycER+,RIP-BclXL+)",pert
normal 1103,ctrl
"ARD531, CAIS, F, GOF, 6 x ETOH, 14d",pert
SKBR3_0.1uM_Lapatinib_2,pert
striatum wild type 6 month replicate 2,ctrl
NPC_VUB03_DM1_1,pert
S2_S010403,pert
WT - Cre Control - 3 mo - repeat 3 - Cy3 - mAdbID:74591,ctrl
cell line: Calu-3;	cell type: airway epithelia cells;	treated with: SIN3A siRNA,pert
GM19238_Kd_GTF2B_2,pert
WT 1 1508,ctrl
Individual_5749_NN_sample,ctrl
LC1025ni,pert
Wild type LSK (2),ctrl
Nonlesional Epithelium Psoriasis rep1,pert
COP DES-treated replicate 1,pert
PGA-MAH-AJ_PBS6h-2aA-s2,ctrl
normal arterial tissue: sample #2,ctrl
"shControl, low glucose, replicate 2",ctrl
strain: C57BL/6;	cell type: Lineagelow Sca1+cKit high Cells;	genotype/variation: mutant JAK2V617F (heterozygous),pert
"MCF7/BUS, 30 pM E2, 48 hours, biological replication 2",pert
39SAGEA2,pert
cell type: Sarcoma cell line;	strain: C57BL6/J;	genotype/variation: Dicer Null,pert
cell line: U937;	replicate: Replicate2;	treatment: shSYK_2,pert
A673 cell line that has been treated with DMSO vehicle control for 5 days.,ctrl
"Pancreatic tumor cells, replicate 4",pert
"human nonfailing LV myocardium, NonFailing10",ctrl
KN-smoke-med-1 day-R2,pert
condition: Psoriasis;	patient: PS-O;	tissue: LS skin biopsy;	kit: Affy,pert
"brain, hippocampus: Ctr-1h-P15-II_e1_le1",ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 76;	time: 0;	batch: 4,pert
WT_P14_Naive_rep2,ctrl
siRNA scramble_control  MDA-MB-231 sample 1,ctrl
Human.BF.CP.FCU,pert
55SageA,pert
Infergen_6hr_rep1,pert
GIST_KIT_14,pert
"wildtype pancreas, biological rep2",ctrl
"gender: Male;	age: 87;	post-mortem delay: 3.5h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
KN-smoke-med-5 month+13d-R1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 4.08;	OD280: 2.003;	Ratio: 2.01;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 325;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
ab129 IM,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: MIG control;	biological replicate: 2,ctrl
MacularDegen-injured-16aAv2-s2,pert
Control Braak α- synuclein Stage 0 C8SN,ctrl
BACH2+/+ ALL (Sample3),ctrl
iPSC control triplicate 1,ctrl
age: 21 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,pert
KO_0424-2,pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 8 hrs,ctrl
MCF-10A shControl replicate 1 [set 5],ctrl
"Human mononuclear cells were isolated by Ficoll-Paque centrifugation in a discontinuous gradient from buffy coats from healthy blood donors. Cells were differentiated in macrophage-SFM medium supplemented with 70 U/ml human granulocyte macrophage colony-stimulating factor. After 3 days, the medium was changed to macrophage-SFM without GM-CSF and cells were cultured up to 8 days",ctrl
BT474-J4_DMSO_24-1,ctrl
brain_DLPFC_bipolar B_mr281,pert
D1_non-transgenic,ctrl
53A;pretreatment;female;breast tumor; nonresponder,ctrl
Wild type olfactory epithlium 0 h replicate3,ctrl
cerebellum_Pink1 knockout_12 weeks_replicate 1,pert
GM19238_Kd_ZHX2_1,pert
5B,pert
S46 NLS 142Q TG6	F4/2	S46	NLS Htt exon 1 142Q	Mouse	10 months	Cerebellum	Female,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 58,ctrl
KM_050T,pert
570.B6,ctrl
224 Day 2 siSC transfected biological rep1,ctrl
B_cell_pool_melanoma_M07+M08,pert
ME180 DMSO rep 3,ctrl
Floxed_Mstn_4,pert
"RNF40 siRNA - 2 days adipocyte differentiation, rep1",pert
"BOEC, normal 23",ctrl
Disease_status: Healthy control;	Age (years): 59;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.80;	Post mortem interval (hours): 47;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.37534,pert
Control 2 a,ctrl
cell line: HT29 parental cell line;	cell type: colon cancer,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	sex: Female,pert
"fibroblast, MFS subject FB969 rep 4",pert
uterus_P4_WT_40hrs_rep1,ctrl
pMX-jhdm1b vitamin C Jhdm1BVc+_2,pert
race: african american;	age (years): 71;	stage: IA;	grade: 1;	histology: endometrioid,pert
U937_naive_untreated_4h_rep1,ctrl
Individual_5242_PN_sample,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A61_8 months_replicate 1,pert
strain background: C57/129S;	genotype/variation: Fra-1+/+; wild type;	gender: female;	age: 2 months;	treated with: 30 µl of PBS for 5 days;	tissue: lung,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.468;	OD280: 1.278;	Ratio: 1.88;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 57;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
tissue: Biceps muscle;	patient: P.b.3;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 7m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
EA_Case15_CD20,pert
age: 63;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
aneurysmal tissue: sample #3,pert
DIA-n7; normal diaphragm 7 month,ctrl
mdx Biological Replicate 2,ctrl
Bone-Marrow_MM_M988,pert
Bronchial Epithelial Cells SA biological 2254P,pert
"patient 011b, normal, homogenized",ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_2h_1mM_HG-U133A_2_YCHSUP501,pert
whole blood_101832,pert
type_of_rx: AFG;	pre_or_post_treatment: post;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 12961346,pert
Wildtype 1 (jos0668),ctrl
"Amoxicillin treated Proximal, Small Intestine 3 21 days old",pert
FVB_MMTV_Wnt1_2406.4R_Rosen,ctrl
"hepatic gene expression at ""0 hr"", rep3",ctrl
A673 cell line that has been treated with Doxorubicin for 3 days with concentration of 119.76 nM (2 x EC50).,pert
Teratozoospermic individual: Sample T8,pert
G630,pert
HT-KO-8A,pert
strain: C57BL/6;	genotype: Ager null;	gender: male;	age: 10-12 weeks;	tissue: liver;	resection_percent: 85%;	time_after_resection: 2 hours,pert
mdx5cv soleus sample 2,pert
"metastasis: none;	Stage: 2a;	tissue: cancer, homogenized",pert
Jejunum_POR-null+quercetin_3,pert
The placenta (E 10.5) of a congenic adra2B-/- mouse embryo (maternal genotype Adra2b+/-) was rapidly dissected and flash frozen.,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 360;	age-at-biopsy-years: 36,ctrl
rd1_P6_rep4,pert
"DMD skeletal muscle, biological rep6",pert
DQD C,pert
tissue: Brain;	genotype: Npc1-/-;	age: 62 days;	subject: Mouse1;	genetic background: BALB/c,pert
siERK1E24h_2659,pert
Age: 41;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
Diagnosis: AML M5;	Age: 62y ;	Gender: Male;	Blast %: 96;	Sourc: PB;	Cyto: No Data;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
db/m 8wk 2,ctrl
MDS patient 86,pert
Sex: male;	genotype: sst -/-;	tissue: liver;	genetic background: C57BL/6,pert
"seminoma specimen, pT2, pN1, patient age: 43y",pert
"WT, PE treated whole heart, individual 3",ctrl
testis wild type replicate1,ctrl
disease: type 1 diabetes;	gender: male;	cell type: endothelial progenitor cell,pert
Snell 6 month Dwarf Liver 85dw,pert
Fibronectin 2,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 21;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
5922012008_F,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Jejunum",pert
"Wild type used for GNMT 8 month, replicate 2",ctrl
male_alcoholic_290,pert
"testis, Repro9 mutant, 14dpp, Rep3",pert
"fibroblast, MFS subject FB881 rep 3",pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: GATA3 and GFP;	rep: 2,pert
"C57BL/6J, sample 1",ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 6h ID287,pert
Ishikawa_VeryLowDose_BPA_48h_rep1,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 31 yr;	population: white,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Ileum",ctrl
phenotype: control;	gender: female;	case_id: 460;	age: 49;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: ?;	post-mortem-interval (hrs): 15;	brain ph at time of freezing: 6.93;	labeling_batch: 2,ctrl
cell type: embryonic stem cells;	genotype/variation: Trim71 KD,pert
sampleID: SAM630134;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
"PPARg d0, rep 1",pert
cell line: GIST882;	agent: Imatinib;	dose: 1μM;	replicate: Rep2,pert
06R031 Control,ctrl
Normal_Kidney_Biopsy_6,ctrl
RAW CstF-64 1,pert
Psoriasis-287,pert
"YWHAZ overexpressed CL1-0, biological rep3",pert
Strain: RPE65-/-;	Age: 2 months;	Tissue: retina,pert
"ALL_NDS, K39 011509",ctrl
Wt Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-5,pert
WKY-vehicle pool sample1,ctrl
shRNA2-4-plusDox-rep2,pert
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 41;	Usage number: 1;	Exposures: 3,pert
BT474_DMSO_24-2,ctrl
normal tissue from mastectomy specimen from postmenopausal patient with invasive lobular carcinoma (ILC),ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 4;	psoriasis duration: 4;	age of psoriasis onset: 24,pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 1,pert
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14584;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
strain: C57BL/6J;	day: 24;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
genotype: wild-type;	cell type: naive CD4 T cells;	genetic background: C57BL\6,ctrl
"CBFb-SMMHCd179-221 animal 1, replicate 1",pert
Hippocampus_Soman_48h_rep1,pert
Kidney_Aqp11-/-_P7_4-3,pert
Bronchial Epithelial Cells MMA biological 2131Z,pert
0983-01-C,ctrl
MCF-10A sh53BP1-2 replicate 1 [set 5],pert
cell line: ARPE-19;	clone: 30;	genotype: Knockout,pert
Polyamide1_3,ctrl
"cell line: hgps-ipsc_1: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository and reprogrammed using the protocol below",pert
Anti-mir-210 replicate 2,pert
PA-1-(3),ctrl
siLMO3_oligo1_FM_rep2,pert
"Wild-type-neocortex, biological rep5 (male)",ctrl
4-KO,pert
Preglaucoma control rep1 (OHN),ctrl
"fibroblast, MFS subject FB783 rep 4",pert
HCC016T,pert
Kidney_50 mg/kg VCM iv_mouse #012,pert
Monocyte ATV rep 2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.023;	OD280: 1.564;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 322;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
tissue: Epididymal adipose;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 686,ctrl
Healthy1-CD8,ctrl
Control MEF 2,ctrl
"Typically Developing Control, Semitendinosus, Patient Replicate 6",ctrl
Pt_3 Normal Skin,ctrl
C57/BL6 murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock),ctrl
GC resistant clone C7H2-R19E5 treated for 6 hours with GC,pert
Subject #8022-8hr Postinfection,ctrl
siOGT 12 hours_1,pert
"RES-enriched Grape extract group, 6 months, patient number 13",pert
APLP2_R6_rep3,pert
Untreated Control 4weeks AffyGC RMA rep1,ctrl
OSE_463,ctrl
"Control siRNA - 5 days osteoblast differentiation, rep2",ctrl
"BOEC, normal 16",ctrl
Ctrl PGC rep1,ctrl
strain: Gata4tm1.1Sad/J;	infection: Cre recombinase;	culture: Differentiation medium for 3 days,pert
38SAGEA2,pert
Healthy8-CD4,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 216,pert
FVB 129 mice were used as bone marrow donors,ctrl
"118, ADIPOOSE TISSUE, Before",ctrl
"eye, retina: Control 1_e1_le1",ctrl
Spleen_infected_7weeks_rep2,pert
mdx5cv soleus sample 1,pert
patient: 219;	current medication: Sulphasalazine 1.2g Colifoam;	birth date: 1/5/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/81;	diagnosis date: 1/1/81;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/7/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 48 hrs;	time course: 3,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 2;	time: 0;	batch: 2,pert
gender: Male;	age: 91;	post-mortem delay: 9.5h;	ph: 6.3,ctrl
Cerebellum_nontransgenic control A39_8 months_replicate 3,ctrl
"human failing LV myocardium, Idiopathic82",pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 57;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
WT Soleus at 4 weeks biological rep1,ctrl
Cas 2,pert
M_LS_Time0,ctrl
"AD_TC, biological rep2",pert
Transfection Reagent Only Technical Replicate 2,ctrl
C33KD2_without doxycycline_1,ctrl
Young 5,ctrl
"seminoma specimen, pT2, patient age: 28y",pert
patient: 201;	current medication: None;	birth date: 4/12/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/19/03;	diagnosis date: 7/4/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: BOTH;	followup recto sigmoid: HISTOLOGICAL;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/7/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/70;	smoking stop date: 1/1/99;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
Individual_4934_PP_sample,pert
HL60-shGSK3B-Construct1-rep2,pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Tongue 2,pert
"C57BL/6N, adult, female",pert
BTBR_Muscle_rep1,pert
HeLa_01-04-05 TP4_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
abl control at VEH rep 1,ctrl
sample type: no history of asthma;	tissue: smooth muscle cells;	treatment: none,ctrl
SKI-DLCL cells treated with Aplidin 3.0nM for 24h. Total RNA was isolated using RNeasy kit.,pert
ndf + progerin + FTI,pert
A673_CloneAsp14_Dox_0h_4,ctrl
Control8,ctrl
NK_cell_pool_melanoma_M07+M08,pert
ILD Study Number 1222,pert
MDS patient 151,pert
M249_B_DMSO,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#117,pert
Wild type 2,ctrl
HL60-shGSK3A-Construct6-rep1,pert
01MJG_Oligo,pert
"MS patient 11, technical replicate 1",pert
Muscle PCOS 11,pert
sample 1:;	age: 69;	gender: female;	sample 2: ;	age: 64;	gender: male;	sample 3:;	age: 75;	gender: male;	sample 4:;	age: 58;	gender: male,ctrl
"Data 2, Valpha2",pert
breast tumor 3,pert
tissue: murine embryonic stem cells;	genotype: knockout;	strain: 129SV/C57BL/6,pert
Control_AF_1,ctrl
cell line: Y79;	passage: 27;	cell type: Retinoblastoma,ctrl
"gender: Male;	age: 25;	post-mortem delay: 12h;	ph: 6.6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
MCSF_A,ctrl
Ishikawa_VeryHighDose_BPA_48h_rep2,pert
Endothelial cells 1,ctrl
Array Type: HG-U133A_2;	Ratio: 2.03;	RNA Integrity Number: 9.3;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
LNCaP R1881 rep 2,ctrl
Sample ID: TP36;	Twin Pair ID: CCE3.2;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-7;	Age at interview & blood sampling: 57;	Current Age (2007): 60;	Sex: MALE;	Medication at blood sampling : None,pert
"disease state: Nasopharyngeal carcinoma;	stage: IIB, T1, N1, M0, G4",pert
"seminoma specimen, pT1, patient age: 55y; W03 011",pert
"Neurons overexpressing GFP, biological rep3",ctrl
WT Littermate1,ctrl
"human failing LV myocardium, Idiopathic28",pert
age: 47;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"DMSO-treated, 6h after UV, Replicate C",ctrl
"wild type 5C.C7 T cells, biological rep3",ctrl
WT osteoclasts treated 2,pert
SeroTest-6,pert
WFS1 KO USHT_02_323_ko,pert
"ALL_NDS, K43 012109",ctrl
untreated_24hr,ctrl
AIRE-ko-CD80lo-mTEC-sample2,pert
first-episode BP patient 74_biological replicate 1,pert
strain: C57BL/6J;	genotype/variation: Rsk2-KO,pert
Individual_4362_PP_sample,pert
control 1,ctrl
CML_4_GMP,pert
"brain, frontal cortex: Sample50_e1_le1",pert
8 week old leg MDX rep 2,pert
patient: 234;	current medication: Aza 150mg Atenolol Atorvastatin BFZ Clopidogril;	birth date: 9/29/46;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/1/88;	diagnosis date: 9/29/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 2/3/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Angina;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
S/SM5,pert
HF1167_U133P2,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case5,pert
cKO 24h V1::2,pert
strain: mixed background of C57BL/6;	genotype: Ezh2f/f;	tissue: heart;	developmental stage: adult,ctrl
brain_DLPFC_bipolar C_mr544,ctrl
WildType_1_1,ctrl
PGC-1alpha -/- differentiated brown fat cells expressing a control siRNA (rep2),pert
Muscle control 10,ctrl
PGA-MAH-AJ_PBS24h-2aA-s2,ctrl
"wild-type control (littermates) of ""P19_exPKO_pancreas""; mixed genetic background; postnatal day 19; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.",ctrl
Turner_AF_5,pert
Bone-Marrow_SMM_S1519,pert
Rex KO_plus LIF_rep4,pert
Array Type: HG-U133A_2;	RNA Integrity Number: 9.2;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
GFP B,ctrl
whole tissue section from case 655,ctrl
Bone Marrow Mononuclear Cells;	35y Male,ctrl
cell line: SKBR3 parental;	treatment: 0.1uM Lapatinib,pert
endothelial_rep12,pert
LCL Unaffected MZ twin pair 1 (CCN1.1R)(TP15),ctrl
Msgn1_24hMinDox-biological rep3,ctrl
n2a-Pou3f3-kd-2,pert
Disease_status: Healthy control;	Age (years): 49;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 46;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
S2-041129-SA,pert
"Empty vector, collagen plate, rep2",pert
tissue: Whole Brain;	developemental stage: E 18.5;	genotype/variation: Wild-type,ctrl
shRNA2-4-plusDox-rep3,pert
patient: KPW13;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
1000uM H2O2 rep 4,pert
HD4,pert
WT 1 sample A,ctrl
UV-SeV 3478,ctrl
PND28 Rat Testis_Rat230-2_3hr Corn Oil_Animal#53_04005,ctrl
non-malignant FTEb_patient 11,ctrl
Cadherin-11 siRNA (RNAi 6A)_2of2,pert
jzo017-rp1-v5-u74av2-met,ctrl
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl;	tissue: Posterior Palate;	age: E15.5;	gender: Not determined,ctrl
ID4+/-TCL1-tg spleen CD19+ B cells collected from 3 mice 2,pert
147A,ctrl
transgene: FTO;	treatment: 48h after induced espression of integrated copy of the FTO gene,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 4,ctrl
BAL_44b_A0B0,ctrl
8DKD_SerumStarved->3hrEGF_rep2,pert
chip number: 14;	transfection plate: 3B;	target gene: WHSC1;	kd level: 0.7;	rin: 9.7;	transfection date: 2012-03-26,pert
cell type: tumor-derived cell line;	ikk2 status: IKK2 -/-,pert
strain background: FVB;	genotype/variation: wild type;	tissue: whole skin,pert
5202 Normal Uninflamed sigmoid colon,ctrl
5-KO,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 278;	age-at-biopsy-years: 44,ctrl
"DMD skeletal muscle, biological rep3",pert
n2a-Pou3f3-cont-1,ctrl
Wild type rep 1,ctrl
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 5.7;	colon weight (mg): 172;	colon ratio (mg/mm): 3.02;	myeloperoxidase activity (u/mg): 0.932;	tissue: colon;	treatment: 5% DSS,pert
ADHC2,pert
71 year old female,pert
CD4_T_cell_pool_healthy_H09+H10,ctrl
wild type 2 cell embryo rep4,ctrl
tissue: Brain;	genotype: Npc1+/+;	age: 25 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
ILD Study Number 660,pert
"Normal subject (31 year old asian male, SAK_1265931893)",ctrl
Wildtype H9 hESC derived NSC 1,ctrl
age	40;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	9.5;	leukocyte count (/nl)	129;	hemoglobin (g/dl)	9.4;	platelet count (/nl)	261,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 32;	maternal age: 27,ctrl
"U-87 glioma cell line with shp105, biological rep3",pert
Normal Rat Retina 3,ctrl
siRNA LMG2 treated HeLa cells 1,pert
"brain, hippocampus: PH2_e1_le1",pert
Cerebellum_nontransgenic control A61_8 months_replicate 1,ctrl
PGA-HMO-Obese-8aUA-s2,pert
cMyb virus-infected replicate 1	(monocytes),pert
E14 - WTMixB 2,ctrl
cell line: L-540;	cell type: Human Hodgkin Lymphoma;	treatment: 10 µM Perifosine for 24hrs,pert
thyroid_tumor_2,pert
"Ovol1 KO, biological rep1 (with calcium)",pert
NB42 U133p2,ctrl
"113, MUSCLE, Before",ctrl
11410 UC Inflamed descending colon,pert
CML_6_CMP,pert
chip number: 21;	transfection plate: 3A;	target gene: BATF;	kd level: 0.5;	rin: 9.8;	transfection date: 2012-03-26,pert
Gender:F;	Age:33;	Tissue:Mucosa,pert
Run3.aUa.010110d.SkMDbt1135D.CEL-DB stimulate,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 50 yr;	population: white;	dsm-iv: 296.54;	age of onset: 25 yr,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: SAMPLE-6A,pert
Thyroid_ unaffected_paired with PTC86T,ctrl
Scd1+/+ on chow diet replicate 2,ctrl
healthy control H01,ctrl
A510 MI 1 day,pert
A HID B_B021,pert
"Amoxicillin treated Distal, Small Intestine 2 17 days old",pert
"Normal skin from Stat3c_control mouse, biological replicate 2",ctrl
"BCL-3 vector, biological rep1",pert
BALB/c d18 (bmsnmix3),pert
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.17 uM (EC50), biological rep2",pert
Placenta_PE(LO)3,pert
M322 SKM-KO,pert
HEK293 F5_doxycycline untreated,ctrl
C590,pert
IR-KO_Rep1,pert
Plate vs. Nail:  1 Day Nail,pert
"Lesional tail skin from K14-Areg mouse, biological replicate 2",pert
R26Pax3/Pax3 E14.5 palatal shelves 7,pert
M15 - infected MBT/Pas fibroblasts (9 h post inf),pert
non-malignant FTEb_patient 3,ctrl
PBMCs_IS_3 [IS],pert
"treatment with MeOPP, replicate 2",pert
X6752318096 F MYC negative#3394,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 43;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
background strain: Derived from blastcysts from a 129 female crossed to a (129 X PGK)F1 male.;	cell line: PGK12.1;	cell type: ES cell;	passage: 14-18,pert
R6/1 22 week wildtype_O7A2,ctrl
E_LS_Wk2,pert
Untreated Jurkat cells (replicate 2),ctrl
"disease state: Nasopharyngeal carcinoma;	stage: II, T2, N0, M0, G4",pert
Healthy control 5,ctrl
C57BL/6 male control,ctrl
"gender: male;	batch: 2;	age (years): 23;	patient id: Non_severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 98;	medication: Becotide, Ventolin;	cell type: CD4+ T-cells",pert
"Pten F341V epithelials cells, biological rep4",pert
CDF1-p3 (178msn),pert
major non-tumor1,pert
cell line: U937;	replicate: Replicate2;	treatment: shLuciferase,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: spleen;	sample name: 3-sp1,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M4;	flt3 status: WT,ctrl
PE_N_598,ctrl
WT-CD80lo-mTEC-sample2,ctrl
liver_female wt_rep2,ctrl
ATL-2 - mAdbID:91502,pert
treatment: baseline;	gender: F;	age (y): 21;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
Nfix_depleted_rep2,pert
Injured 30 day Rat Retina 3,pert
"bipolar disorder, BA10-47",pert
"Crohn's Disease subject (46 year old caucasian female, SAK_1313783292)",pert
"schizophrenia, BA46-75",pert
cell line: U937;	replicate: Replicate1;	treatment: shSYK_1,pert
T-ALL1 NBD 1,pert
Individual_5414_PN_sample,pert
"schizophrenia, BA10-25",pert
KN-smoke-low-5 month-R2,pert
esophageal squamous cell carcinoma from patient E1546,pert
C019_Control_F_46,ctrl
cell line: MLL-AF9 AML cell line 10950 (Zfx fl);	treatment protocol: vehicle;	genotype/variation: fl,ctrl
affection: unaffected;	treatment: MPH;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 6 unaffected controls,pert
Strain: C57BL6;	Transgenic ATF6-MER;	Gender: male;	Age: 40 weeks;	Tissue: left ventricle;	Treatment: tamoxifen,pert
"DBA/2J SAL, Rep3",ctrl
"Strain : 75% C57BL/6, 25% CBAJ;	Gender: Male;	Age: 9 weeks (Moderate stage);	WILD TYPE",ctrl
gender: female;	age (years): 22;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
tissue: liver;	genotype: p14 WT;	genetic background: C57BL/6,ctrl
A_AN19511_F,pert
Normal_Kidney_Biopsy_3,ctrl
RNA from HCC_21T,pert
pool of wild type thyroids from 2 months old wild type mice,ctrl
Pt_6 Normal Skin,ctrl
WT14,pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 3,ctrl
WT_POST_PDE_041,ctrl
construct: HDAC1 G10 shRNA;	cell type: Primary human erythroid progenitor cells,pert
"AALE-KRAS uninfected, biological rep2",pert
Muscle JDM (YJD-JDM-5UA-s2),pert
"ID: MLL_00259;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
sample type: Sample;	cell line: H1;	cell type: embryonic stem cell;	protocol: OCT4 knockdown;	time: 2 Days,pert
cell type: R1/E ESC;	RNAi: Rad21,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: wildtype;	tissue: GIST Tumor,pert
cell line: CH1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
CD70Tg biological rep 1,pert
b23.2,pert
KN-smoke-high-5 month+1d-R4,pert
OSE_440,ctrl
WT-sham-5 month+1d-R2,ctrl
"human peripheral blood derived monocytes, 4 hour LPS stimulation, biological rep2",pert
subject id: 54;	infection: DENV;	status: DF;	tissue: whole blood,pert
Normal Cervix N13,ctrl
"SPC-c-raf transgenic mice, 6 month old, male, unaltered",pert
mixed reference (FR + CRG),ctrl
scan batch: Batch 1;	group: control;	subject age: n/a;	paternal age: n/a;	maternal age: n/a,ctrl
01N1E_Systemic,pert
RNA from HCC_19N,ctrl
10 mg/kg MPH tr1001,pert
HB1.A4-Nurr1,pert
"EtOH, WT, set 3",ctrl
WT Littermate3,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 8,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 24h,ctrl
Control treated with WY14643,pert
Human skeletal muscle biopsy sample;	Patient #193 with NORM,ctrl
mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 44;	ld: HCV;	creatnine: 2.8;	mdrd: 26;	gfr: 30;	protein: 0.3;	hematuria: 1;	c3: 0;	c4: 0;	rf: 29;	hcv: POS;	htn: 1;	dm: POS;	hba1c: 5.9;	meld: 16;	ana: NEG;	gp: Mesangial GN+ 2nd FSGS;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 1;	ii (interstitial inflammation): 1;	podocyte: 1;	bm (basement membrane thickening): 1;	ta (tubular atrophy): 1;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 2;	igm: 1;	c: 1;	empe: 1;	bmwid: 1;	bmd: 0;	edd: 1;	no of glomeruli: 16;	glomerulosclerosis: 0;	intact t: 0.7;	arteries: normal;	if: IGG+IGM+IGA++C3+ mesangial;	mesangium ig: AMC;	tissue: Kidney_Biopsy_Liver_disease,pert
Floxed_Mstn_5,pert
23 weeks female,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/18/05;	# cells: 55;	Sex: male;	region: M1;	age: 40;	genotype: Y/X;YFPH/-,ctrl
disease state: non-alcoholic steatohepatitis (NASH);	tissue: liver,pert
cell type: Primary hepatocytes;	donor: 3;	agent: Wy14643;	time: 6h;	gender: Female;	age: 70 years old,pert
MacularDegen-injured-11aAv2-s2,pert
"PCB153 treated HepG2 cells at T1.5, biological replicate 1",pert
MDS patient 30,pert
Normal-N_LJ_3,ctrl
FASSc3 medium only,pert
FHCRCAML2429,pert
"69B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"Diabetic mice, time point 5 week",pert
male_alcoholic_210,pert
strain: C57BL/6;	age: 1 year old;	tissue: liver,pert
WT3-iPS 2,ctrl
wild-type naïve CD8 T cells KAI284,ctrl
ANL Chip#25,pert
Normal cortex of patient T79,ctrl
Estrogen treated ipsilateral to stroke replicate E6IC-2a,pert
cumulus_PCOS_Obese_rep1,pert
MDA-MB-231 control clone #6,ctrl
gender: Male;	age: 63;	post-mortem delay: 30h;	ph: 6.5,pert
cell type: embryonic stem cells;	cell line: CGR8;	treatment: Foxd3 conditional knockout cells treated with Tamoxifen,pert
Low Glucose Transcriptome Profiling {rpt 3},ctrl
age: 65;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 12.21;	Ratio: 2.08,pert
PND28 Rat Testis_Rat230-2_12hr Corn Oil_Animal#62_04005,ctrl
LIVER_diclofenac_repl3,pert
Testis WT 0h batch 2 [TeWTh00.11],ctrl
CTL2 AO 72hr,ctrl
"colonic tissue from macrophage-specific PPARgamma-deficient mouse, biological rep3",pert
"SWR/J SAL, Rep2",ctrl
BMM_C3H/ARC_time0h,ctrl
HDAC2 KO mice colon rep 3,pert
Liver_nash metformin_no.1,pert
"Peripheral blood, normal control [N73]",ctrl
CD8-IGF1R 3T3 A-928605 1,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 180min;	race: White;	sex: Female,pert
"alveolar macrophages, non-smoker 001",ctrl
"Gender: female, Age: 38 years, Tissue: normal vulva,",ctrl
Argyrin A treated 24h_1,pert
Hippocampus_Soman_24h_rep3,pert
male,ctrl
strain: C57BL/6;	gender: male;	genotype/variation: WT;	treatment: phenobarbital;	tissue: liver,ctrl
Carboplatin;	Carboplatin 36 hours set 1,pert
Sample ID: TP14;	Twin Pair ID: CCN1.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.2R** ,ctrl
CAR.KO_CITCO_rep1,pert
patient: 134;	current medication: None;	birth date: 12/21/50;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/12/05;	indictation for procedure: Abdominal pain;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,ctrl
3_month_old_wildtype_mouse_rep3,ctrl
Run3.aUa.010110d.SkMDbt1133D.CEL-DB stimulate,pert
S46 NLS 142Q TG2	F5/9	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Female,pert
Crx-Nr2e3-Nrl-ko-Gfp4W-4,pert
"Acute Myeloid Leukemia, sample 76",ctrl
subject: 39;	disease: CP;	muscle: GR;	gender: M;	age: 15.3;	gmfcs: 2;	popliteal angle: 120,pert
Bone-Marrow_SMM_S1410,pert
Sample from retroviral MSCV-D1a infected cyclin D1 knockout 3T3 cells (line 1).,ctrl
A549 non-small cell lung cancer (NSCLC) cell line,ctrl
cell type: Bone marrow cells;	genotype: MSI2-inducible mice;	strain: C57BL/6,pert
Cisplatin_24h_rep1,pert
control to Sample 23,ctrl
age: 15;	sex: F;	disease status: control subject;	Filter number: 102;	Usage number: 1;	Exposures: 3,ctrl
Control male 1,ctrl
tissue: Hippocampus;	age: 100;	Sex: F,pert
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: severe stress + saline vehicle,pert
cell type: Pancreatic ductal adenocarcinoma;	cell line: CAPAN2;	transfection: control lentivirus,ctrl
WAT from Ahnak knockout fed regular chow diet Replicate 2,pert
scan batch: Batch 2;	group: control;	subject age: 4;	paternal age: 32;	maternal age: 38,ctrl
K562 AMN107 sample 2,pert
cell line: non-small cell lung carcinoma cell line H1299;	protocol: Lipofection-mediated siRNA delivery;	time: 24hr,pert
Subject #8039-8hr Postinfection,ctrl
NPC24,pert
Human prostate cancer primary culture C1dx,pert
"patient: 210;	current medication: Mesalazine 800mg B, Prednisolone Supps;	birth date: 6/28/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/73;	diagnosis date: 1/10/74;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/19/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/14/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Scarlet Fever 1964;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",pert
cell line: U-87MG;	treatment: vector,ctrl
"DOX, rep1",pert
HCC827 WT 1,ctrl
"Normal subject (49 year old caucasian male, SAK_1254531863)",ctrl
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: wild-type,ctrl
FK2,ctrl
disease state: paediatric glioblastoma;	age: 11;	gender: M;	h3.3_status: K27M,pert
10590_WBS,pert
Pool Ts1Cje_P15_hyb2,pert
cell type: hepatoma cells;	cell line: Huh-7;	transfection: IRF1,pert
Cancer 20,pert
Tissue: lung;;	Genetics: Familial IIP;;	Histology: Usual Interstitial Pneumonia,pert
Gender:M;	Age:33;	Tissue: Mucosa,pert
Globin_C5,ctrl
ST045849 12 hours_3,pert
Aged 1,pert
"72 hour-treated wild-type NB4, biological rep2",ctrl
EGF 12h replicate 2,pert
colon_normal_1114,ctrl
tissue: esophageal squamous cell carcinoma,pert
CTRL_5_GMP,ctrl
"Typically Developing Control, Gracilis, Patient Replicate 5",ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: retina;	time: ZT20,pert
"control, BA10-54",ctrl
"brain, hippocampus: CH7_e1_le1",ctrl
Carbo Day7 (320R),pert
H1P_5,ctrl
WT-smoke-high-5 month-R4,ctrl
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-9;	Primary Site:Tongue;	Age:66;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",ctrl
Anti-mir-210 replicate 3,pert
"pt. HCL A treated with Vemurafenib 1000 nM for 48h, replicate1",pert
AZ-521_uninduced_8h_rep1,ctrl
BP patient 55_biological replicate 2,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day7,pert
X50 NLS 18Q TG3	F2/49	X50	NLS Htt exon 1 18Q	Mouse	16 months	Cerebellum	Male,pert
Cre_day_3-1,pert
Nerve_Control_Vehicle_704,ctrl
U937-shControl-rep2,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L221,ctrl
AA_Case16_CD8,pert
"control, BA10-44",ctrl
cell line: MiaPaCa2;	cell type: dasatinib-resistant pancreatic cancer cell line,ctrl
subject: 10;	disease: TD;	muscle: ST;	gender: M;	age: 14.9;	gmfcs: N/A;	popliteal angle: N/A,ctrl
CME-LaminA3d-2MA-S2,pert
H3_SS12_01Nov07,ctrl
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep6,pert
"testis wt, 17dpp, Rep3",ctrl
EA_Case2_CD4,pert
01LQT_Oligo,pert
MDS patient 49,pert
"Vehicle, biological rep2",ctrl
Patient no. 10: control,ctrl
mouse liver C3,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 5d ID294,pert
treatment: baseline;	gender: F;	age (y): 51;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,ctrl
U2-OS-ERb vehicle 2,ctrl
"vehicle, biological rep3",ctrl
GM19238_Kd_ARNTL2_1,pert
strain: C57BL/6J;	day: 12;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 2,ctrl
"control, BA10-1",ctrl
NSC_FOXO_NULL-2,pert
8 hour tunicamycin wild type A,ctrl
Patient identifyier: J;	Sex: female;	Age of patient: 54 years;	Duration of psoriasis: 48 years;	Body surface area: 9 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
Cervical Cancer C477,pert
Disease_status: Healthy control;	Age (years): 29;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.2;	Post mortem interval (hours): 42;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
UC-38-un,pert
"Spi-60, biological rep 7",pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (32),pert
Pool Eu_P15_hyb2,ctrl
"brain, hippocampus: Wt #3396 Hippo_e1_le1",ctrl
strain: C57BL/6J;	day: 6;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 2,pert
SHR16-3,pert
uterus_P4_WT_40hrs_rep2,ctrl
Liver_SRC-2 Knockout_Rep3,pert
genetic background: C57Bl/6;	genotype: Calcr-/-;	cell type: Osteoclasts;	treatment: untreated,ctrl
"DCIS 1, biological rep. 1",pert
Patient 4 skin baseline,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 8d ID144,pert
diagnosis: RB-ILD;	fvc-group: FVC3;	tissue: lung,pert
nodex_1,ctrl
"gene expression of wild type oocyte, replicate 5",ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: FMR1 shRNA,pert
sampleID: SAM630145;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
genotype: SIRT3 KO;	tissue: brown adipose;	genetic background: 129,pert
"scr-Rosi, biological rep2",pert
Tendon_lesional_rep9,pert
"wdNHBE with BN/59 at 36hpi, biological rep1",pert
Mouse old brain C30-Br-1,ctrl
"TAMs sorted from imatinib treated tumors, biological replicate#2",pert
Wild type rep 2,ctrl
B6-rep3,ctrl
Prdm14 knockout 3,pert
Lmna H222P heterozygous male 3,pert
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: JAK2 knockdown (Jak2-9 shRNA),pert
Ishikawa_LowDose_BPA_24h_rep3,pert
"LSD2 knockdown, replicate 1",ctrl
CD19_selected_B-cells_after_R_rep4,pert
Muscle PCOS after pioglitazone 162,pert
B6C3F1/JTCE liver sample batch 6,pert
XBP1s B cells 4,pert
Pancreatic Sample 12-Tumor,pert
"Wild-type iPSCs, NAS9",ctrl
Individual_4426_PP_sample,pert
AP-920039,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK1;	agent: EtOH;	time: 4h,ctrl
tissue: mouse lung upper left lobe;	strain: C57BL/6;	genotype/variation: CC10-rtTA-IL13 transgenic (TG);	age: 6-10 weeks old mouse,pert
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l -/-;	days after transduction: 7,pert
MDS patient 160,pert
MDS patient 59,pert
434_CreER: mutant mouse 1,pert
subject: 28;	disease: TD;	muscle: GR;	gender: M;	age: 14.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes,pert
"MaF pre-iPSC9P2, Vc-, D4",ctrl
C_C7,ctrl
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 4 - Technical Replicate 1,pert
PGA-MAH-AJ_PBS6h-1aA-s2,ctrl
cell type: R1 mouse embryonic stem cells stably transfected with Pcl2 shRNA sequence,pert
RV16;	Age = 20;	Sex = F,pert
"AG825-treated, 6h after UV, Replicate A",pert
Untreated native HeLa cells 2,ctrl
MCF7 cell line _vehicle (control)_biological replicate 1,ctrl
tissue: muscle;	sample group: resveratrol;	treatment: after;	gender: Female,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 70min;	race: White;	sex: Male,ctrl
01LN0_PolyRF-,pert
Basal IFE epidermal stem cells from KO mice 1,pert
MIY_day_7-2,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 48.36986,pert
Emx2 KO mouse,ctrl
Patient no. 19: treated,pert
patient: 28;	disease state: hypertension;	tissue: Atheroma plaque,pert
T51721,pert
Intima media,pert
WT Brain 60d Mouse1,ctrl
day 1 5-FU HSC 1,pert
cell line: OVCAR3;	transfection: eukaryotic expression vector pcDNA3.1 containing the full-length cDNA for CD157,pert
treatment: Vehicle;	time: 7,ctrl
siPsmd14 replicate2,pert
C4 Control None,ctrl
"Biceps, control, cohort 20, subject 20U",ctrl
"Strain: C57BL/6 X SV129, Age: Embryonic Day 17.5, Tissue: Heart Venticlee",pert
whole tissue section from case 749,ctrl
TOV112D COUP-TFII-2,pert
cell line: BL2;	transfection: LEF siRNA;	batch: 2,pert
"H69 tumor untreated, biological rep2",ctrl
"Prdm14(-/-): 2i, rep1",pert
cell line: SBC-5 cells;	treatment: siEGFP (control);	time: 72 hr,ctrl
0147-01-C,ctrl
"PTEN inducible MEFs at T0, biological rep1",pert
HaCaT_ZNF750i_ biological rep3,pert
WT3-1,ctrl
"EBF1 d2, rep 1",pert
Gene expression profiles of Lkb1 KO #6 HSCs,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.092;	OD280: 0.567;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 284;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Snell 6 month Wild Type Liver 84c,ctrl
"Typically Developing Control, Gracilis, Patient Replicate 4",ctrl
"gender: female;	batch: 1;	age (years): 42;	patient id: Severe_8;	fev1 (% predicted): 33;	fvc (% predicted): 94;	medication: Prednisolone 5mg od, Aminophylline 225mg bd,Seretide 500 2pbd,doxycycline, Tiotropium;	cell type: CD8+ T-cells",pert
Phan_009_KO.saline rep3,pert
GEIM87-U133A-DM,pert
Healthy control c2,ctrl
ve_B5,pert
healthy control H08,ctrl
"PBMC, patient. Mtx rep4",pert
subject: 20A;	cohort: 20;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 28;	Sex: M;	batch: Batch_5,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
204/4,ctrl
M323 C,pert
NOMO-1_ZFX-SH1,pert
"schizophrenia, BA46-82",pert
11SC-nbc,pert
OSE_437,ctrl
A HID B_B009,pert
Subject #8035-Preinfection,pert
control participant P309,ctrl
normal donors XH1,ctrl
Infergen_24hr_rep1,pert
HUVEC_TNF-stimulated experiment 1,pert
Mouse_ESC_Pcl2_shRNA_sample 3,pert
12_PAH,pert
"BOEC, normal 21",ctrl
"1833 control, biological replicate 1",ctrl
"Uninvolved Skin, NS-23",pert
NLGN3_1,pert
ethnic background: Caucasian;	gender: male;	age: 45-65 years;	tissue: vastus lateralis muscle,pert
C57/BL,pert
"Uninvolved Skin, NS-1",pert
"SLE patient, 1001V2",pert
mouse liver B3,ctrl
Carbo Day2 (72L),pert
LOXL2 2,pert
DND41 NBD 2,pert
CLL10-CD8,pert
BC4 TC,ctrl
RE550_KPL4_un3,ctrl
Trastuzumab treated after 4 days (T2_1),pert
cell line: T47D;	treatment: Telpristone [1µM],pert
EA_Control3_CD4,ctrl
24h 4OHT-treated-sample3,pert
Patient: F;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
U937_naive_curcumin_18h_rep3,pert
wildtype HUES6 4,ctrl
"human failing LV myocardium, Ischemic60",pert
cell line: U87MG;	treatment: control siRNA,ctrl
HCT116 human colon cancer cells with PTEN -/-,ctrl
Liver Pio2,pert
TNKSi 4h biological replicate 2,pert
TF1_antiEvi1siRNA_3,pert
patient: 265;	current medication: Pentaza 500mg TDS;	birth date: 8/17/71;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/5/04;	diagnosis date: 3/22/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/19/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/19/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"SWR/J CHR, Rep3",pert
"TH cells from LC, Mecp2 null, biological replicate 1",pert
"twin pair: #10;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
tissue: skin;	individual: Patient N-2;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
24h_RA4,pert
"human failing LV myocardium, Ischemic25",pert
non-CF subject 38,ctrl
hur status: WT;	rna subtype: nuclear RNA,ctrl
cell line: NG4;	cell type: embryonic stem cells;	transfection: siPsmd14,pert
pediatric AML S28,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siCtrl;	agent: EtOH;	time: 24h,ctrl
"Control 2, 16hrs",ctrl
BxPC3-KO4 rep 5,pert
A549_siRNA_STAT3_rep2,pert
shRNA6-16-plusDox-rep3,pert
cell line: MOLM-14;	replicate: Replicate2;	treatment: shLuciferase,ctrl
"cell type: HVS-transformed T cells;	genotype/variation: ITK R335W mutant , homozygous",pert
patient: 11;	disease state: hypertension;	tissue: Atheroma plaque,pert
HTH83 SCR 2,ctrl
"Patient 29, Macroscopically intact tissue",ctrl
LRRK2 (G2019S) homozygous iPSC sample 2,pert
"Neuroretina 8-week diabetic, Biological replica_3",pert
strain background: FVB;	genotype/variation: wild type;	tissue: whole skin,ctrl
CEPI_IIIc_369,pert
L428-PAX5+M_rep3,ctrl
"HUVEC treated with ERG SiRNA , biological rep1",pert
CF (D508) subject16,pert
MLL_00133,pert
cell line: THP-1,pert
SCD1 +/+ liver rep1,ctrl
TN 2,ctrl
H_Ctrl_1,ctrl
agent: resveratrol_150mM;	tissue: mammary epithelium adenocarcinoma;	cell line: MCF7,pert
Human_macrophages_normoxia_repB,ctrl
cell line: MCF-7 breast cancer cell line;	sirna: control (scrambled siRNA);	agent: 4-hydroxytamoxifen;	dose: 500 nM,pert
LRRK2 mutant knockin H9 hESC derived NSC 1,pert
cell line: Panc0403;	cell type: dasatinib-sensitive pancreatic cancer cell line,pert
Peripheral blood mononuclear cells;	TTF=95min;	Race=White;	Sex=Male,pert
SCC8,pert
PBMCs_IS_11 [IS],pert
-DOX/+E2 48h_2,pert
CCRPKO-PBS_rep-3,pert
E_Ctrl_3,ctrl
WT - Cre Treated - 12 hrs - repeat 3 - Cy5 - mAdbID:61755,ctrl
MDS patient 152,pert
"N-33, NORM, M, GSF, 6 x 100nM DHT, 14d",ctrl
striatum_Pink1 knockout_18 month_replicate 1,pert
Ramos pRTS-GFP D+,ctrl
"Control, high-fat diet, rep3",ctrl
"68B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T4, N3, M0, G4",pert
isoflurane 03,pert
H295R _Control_rep1,ctrl
CEM NBD 2,pert
MDS patient 47,pert
D6,ctrl
CPU S control 2,pert
first-episode BP patient 77_biological replicate 1,pert
S/LV3,pert
GM19238_Kd_USF1_3,pert
Carbo Day1 (396L),pert
tissue: freshly isolated human monocyte;	gender:male; age: 47 yr; weight: 80 kg,pert
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Rectosigmoid;	Drug Treatment: NO,ctrl
cell line: BT474;	cell type: breast cancer;	lapatinib sensitivity: lapatinib-sensitive;	her2 status: HER2-positive;	treatment: lapatinib,pert
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: multiple gunshot wounds,ctrl
Postmenopausal female. Tibolone treated. Patient 11.,pert
68A;pretreatment;female;breast tumor,ctrl
siERK2Veh4h_2660,pert
"strain: C57BL6/J;	pooled: Yes;	amplification batch: 07/15/05;	# cells: 32+26=58;	Sex: male;	region: M1;	age: 47,48;	genotype: Y/Mecp2-;G42/-",pert
HF1606_U133P2,pert
"Control, biological rep 3",ctrl
Liver sample of WT mouse 3,ctrl
"G42 cells from M1, Mecp2 null, biological replicate 1",pert
Bone-Marrow_SMM_S1535,pert
PKBa-/- MEF time 2 replicate 2,pert
Bone Marrow Mononuclear Cells;	22y Male,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 120min;	race: UK;	sex: Female,ctrl
Control-1 (HuT-102 cells + vector only),ctrl
Rosi-treated diabetic-4,pert
uterus_P4_PRKO_40hrs_rep2,pert
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 2hr,ctrl
cell line: LNCaP;	overexpression vector: FOXA1,pert
genetic background: C57BL/6-129Sv hybrid background;	genotype: Setdb1 2lox/1lox/Cre;	treatment: tamoxifen;	cell type: embryonic stem cell,pert
strain: C57BL/6J;	day: 6;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 1,ctrl
PsOEt-22-Week 2,pert
"age at diagnosis: 56;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1biii;	er: 0;	pgr: 0;	dfs-month: 13;	dfs-event: 0;	distant metastasis: 0",pert
tissue: white blood cells;	age: 16.28;	Sex: male,pert
468MM,pert
cell line: GIST882;	agent: DMSO (control);	replicate: Rep3,ctrl
endothelial_rep13,pert
WT-SB replicate 1,ctrl
High Glucose Transcriptome Profiling,pert
heart knock out replicate1,pert
MEF E2F4 KO 5-rep2,pert
NB87 U133p2,ctrl
Strain: C57BL/6 Gender: mixed Age:E9 Tissue: whole embryonic body;	,ctrl
Tumor_Ker26,pert
Peripheral blood mononuclear cells;	TTF=92min;	Race=White;	Sex=Female,pert
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2+/+;	agent: untreated,ctrl
MDA-MB-231 breast cancer cell line,ctrl
MDS patient 141,pert
"Ovol2 BT, biological rep1 (E17.5)",pert
strain: FVB;	cell type: 6 DIV cultured hippocampal neurons;	transfected with: Sindbis virus expressing myc-tagged Hes1 and GFP,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 33.53973,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 50;	sex: M,ctrl
RNA-DHL6-R406-6H-2,pert
mixed background e18.5 male cardiac ventricle,pert
Tgfbr2 fl/fl Control Posterior Palate 4,ctrl
HSC-wildtype-2,ctrl
Ishikawa_LowDose_BPA_24h_rep2,pert
"CTLA-4 KO 5C.C7 T cells, biological rep1",pert
cell type: Human melanoma cell line;	cell line: M249;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
"Control, standard diet, rep2",ctrl
age	26;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	6.1;	hemoglobin (g/dl)	14.6;	platelet count (/nl)	217,ctrl
individual: patient5;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
4T1.2-IRF7-1,pert
"Wild-type HFD 8 weeks, biological rep1",ctrl
BalbC_6h_Wy,pert
strain background: C57BL;	genotype/variation: SHP knockout; SHP-/-;	tissue: liver,pert
CON8,ctrl
0h WT Sample 13,ctrl
cPuro,ctrl
Strain: C57BL/6;	Age: 6 months;	Tissue: retina,ctrl
V5-P165,ctrl
LSK control 3,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 5 months;	genotype: Wild type,ctrl
Bronchial Epithelial Cells control biological 1546X,ctrl
Squamous cell lung cancer X31nml,ctrl
Mening SWB WB SW 12b,pert
Leg 7 Day mdx rep 1,pert
"brain, hippocampus: CH6_e1_le1",ctrl
"BOEC, at_risk 10",pert
Multiple sclerosis CD4+T cells 9-RS,pert
BE-rep4,pert
"array 23, xenograft, corn oil vehicle",pert
Trained 3 weeks T3,ctrl
"PBMC, patient. Mtx rep8",pert
Patient: N;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
tissue: Temporal cortex;	age: 95;	Sex: F,pert
db/db 7-3,pert
Tendon_lesional_rep20,pert
Dengue Fever Patient 36,pert
BL306,pert
BACH2+/+ ALL + Imatinib (Sample1),pert
CD8+_Tcells_healthy_donor_4,ctrl
"2102Ep cells negative control, biological replicate 3",ctrl
Endometrium-Normal 3,pert
erlot2_CT42,pert
scram_lo_2,ctrl
"SLE patient, 1019V1",pert
CME-Emerin3d-1MA-S2,pert
tissue: Frontal cortex;	age: 90;	Sex: M,pert
cell type: Primary neonatal keratinocytes,ctrl
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days.  The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
Liver_WildType_3,ctrl
"Female (age range 33-49), skin biopsy taken from upper nates 96 hours after nickel exposure",ctrl
"Acute Myeloid Leukemia, sample 53",pert
race: african american;	age (years): unknown;	stage: IA;	grade: 2;	histology: papillary serous,pert
amygdala no access to cocaine replicate 4,ctrl
cell line: Hep G2;	genotype: HCC-THRA mutant bN;	treatment: with vehicle for 6h,ctrl
Carbo Day2 (409R),pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 8",pert
mammary_16wkWT_ker70,ctrl
LSK cells from heterozygous JAK2V617F mouse rep4,pert
Bmpr2-R899X 1,pert
gender: male;	genotype: Alb-Cre/ TAK1 flox;	strain: C57BL/6;	tissue: liver;	age: 4 wk,pert
subject: 33;	disease: TD;	muscle: GR;	gender: M;	age: 13;	gmfcs: N/A;	popliteal angle: N/A,ctrl
IRS-2 KO (jos1527),pert
"age: Embryonic day 14.5;	genotype: Zfp36l2 knockout (KO);	tissue type: fetal liver;	strain: b6, 129 mixed background strain",pert
"experiment 2, control 1",ctrl
142A,ctrl
"Biceps, FSHD, cohort 12, subject 12A",pert
tissue: white blood cells;	age: 14.5;	Sex: male,pert
Cochlea_D257A_9mo_3,pert
111B,ctrl
cell type: Human melanoma cell line;	cell line: M238;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
08SE1182,pert
Immortilised monocyte cell line,ctrl
Subject #8018-2d Postinfection,pert
striatum_ctip2_KO_4,pert
"MCF7/BUS, 60 pM E2, 48 hours, biological replication 1",pert
12A;pretreatment;female;breast tumor,ctrl
Wt Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-4,pert
25uM_Zn_3,pert
"Human male subjects with familial combined hyperlipidemia (FCH), peripheral blood monocytes",pert
WT_cells_rep1,ctrl
"Fourth ventricular choroid plexus from Otx2ko mice at E13, biological replicate 4",pert
1 mt E11.5 heart,pert
Replication 1 Aldosterone,pert
human_hepatocyte_400uM_gatifloxacin_donorA_24hr_prep2,pert
SKM WT2,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 1,pert
1% dmso batch 3,ctrl
Amniocytes_euploid_1569,ctrl
BxPC3-WT rep 3,ctrl
Normal bladder 7-99,ctrl
chip number: 14;	transfection plate: 3B;	target gene: PAX5;	kd level: 0.65;	rin: 9.8;	transfection date: 2012-03-26,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-tu1,ctrl
Young 8,ctrl
disease state: Healthy;	cell type: CD4+T;	twin: R,ctrl
ID4+/-TCL1-tg spleen CD19+ B cells collected from 3 mice 3,pert
mdx soleus sample 1,pert
"spleen follicular B in IRF8 conditional KO, biological rep1",pert
"Gender: Female, Age: 32, BMI: 25, Tissue: luteinized cumulus cells",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5b;	flt3 status: internal tandem duplication (ITD)/D835 mutation,pert
"brain, hippocampus: KA6-II_e1_le1",pert
Control-2 (HuT-102 cells + vector only),ctrl
MDS33,pert
Transgenic 4,pert
Normal-BM 8,ctrl
gender: male;	individual: patient 5;	treatment: paclitaxel-eluting stent,pert
strain: Des(-/-)/129/SVE;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 12-14 mo,pert
AL Chip#39,pert
Cardiac Muscle_mdx_rep1,pert
B17 - infected BALB/cByJ fibroblasts (9 h post inf),pert
E14.5 Tgfbr2 Wildtype Mouse Model Palate 3,ctrl
c 1-1,pert
5-C_1,ctrl
P4A Progranulin-frontal,pert
gender: male;	strain: C57B/6Jx129Sv;	genotype/variation: wild type;	tissue: heart;	age: 10-12 weeks old,ctrl
Background: mixed genetic backgroud of C57Bl/6 and 129/SvJ;	Genotype: IRF6 wt;	Age: Embryonic day 17.5,ctrl
"patient: 121;	current medication: Cp-tenedone, Enalapril, Loperamide.;	birth date: 4/8/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: Diarrhoea, Blastocytitis on stool cultures.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",ctrl
patient: 29;	disease state: hypertension;	tissue: Atheroma plaque,pert
C13+(2),pert
mouse B6xCF-1  Non-transgenic (control-3),ctrl
lymphocytes_ctl_M_60y,ctrl
"T-cell prolymphocytic leukemia, inv(14)(q11q32), case 5",pert
Nerve_Control_Rosi_713,ctrl
liver_STZ treated diabetic_rep2,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, FLX treated, biological rep3",pert
cell type: AML blasts;	fab classification: M2,ctrl
CD4+_Tcells_severe_asthmatic_2,pert
N16,ctrl
"Acute Myeloid Leukemia, sample 74",ctrl
Liver_POR-null+quercetin_2,pert
"breast tumor epithelium,27",pert
background strain: mixed (C57BL6/6J and 129);	genotype: Dmrt1 flox/flox with Dhh-cre;	gender: male;	tissue: testis;	age: postnatal day 28 (P28),pert
cerebrum_PSNA_ 4w_rep1,pert
Jurkat Biological Replicate 2,ctrl
healthy control H29,ctrl
RNA-DHL6-R406-2H-1,pert
disease state: paediatric glioblastoma;	age: 14;	gender: F;	h3.3_status: wt,ctrl
Oligodendrioglioma_6,pert
DEX treated rep 1,pert
AKT_PLACEBO_48hours_2,pert
"38B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
Mouse old heart w/ a-tocopherol aT-Ht-2,pert
61SMOKEH,ctrl
Mouse old heart w/ a-tocopherol aT-Ht-1,pert
S001_Scz_F_75,pert
tissue: Brain;	genotype: Npc1-/-;	age: 40 days;	subject: Mouse2;	genetic background: BALB/c,pert
"Resveratrol treatment exp 3T3-L1 cells, T2",pert
"IKK2 WT tumor, biological replicate 4",ctrl
EA_Case11_CD20,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-tu3,pert
Male C57Bl/6  Mice were 10.5 weeks old at time of sacrifice.,pert
Endometrium/Ovary-Disease 8,pert
N8C Normal-hippocampus,ctrl
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 23;	maternal age: n/a,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 73;	gender: female;	years of disease: Unknown;	treatment: phototherapy;	time: pre-UV,pert
"liver_LDLr-KO, biological replicate 4",ctrl
"Control cells unstimulated, biological rep1",ctrl
KU_27T,pert
"Cell type: neuronal, age:46, gender:male, diagnostic group: control, PMI:31h",ctrl
"Endometrium, postmenopausal, tibolone, 16",pert
agent: pristane;	time: 3 days;	strain: BALB/DBA F1 hybrid;	tissue: mesentery,pert
WT-GFP-lamin A Induction: day 10 Replicate A (3a_WT_10d_A),ctrl
"MGSKO, PR01M005v0",pert
NALT_infected_24h_90-226-dM_rep2,pert
Mening SWB WB SW 6b,pert
lesion_midUV_patient9,pert
PTEN deletion Replicate3,pert
treatment: PLX4720;	time: Day3;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,pert
Time 120 mins rep 2,pert
"P90_C-DGCR8 KO cones, replicate 2 [array]",pert
"RET-PTC, 2 months",pert
"Tet1 KD, rep1",pert
PFC S control 2,pert
2B1_empty_vector_replicate2,ctrl
18.5 dpc mouse small intestine pLagl2 knockout,pert
wild-type_rep1,ctrl
34/OVX/oil/6h/UTX 129 Hoxa-10-/-,pert
patient: 226;	current medication: Azathioprine 150mg Asacol 1.6g Ca Vit D B12;	birth date: 6/15/74;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 1/11/05;	indictation for procedure: ;	ucss: 8;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/11/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
CHARACTERISTICS;	Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Paraventricular nucleus,pert
"HPRTKO, biological rep2",pert
scpk/ikLLtumor/163,pert
LNCaP + ELK1-shRNA rep 1,pert
Day: 24; Drug: Saline; Phase: Withdrawal; Replicate: 1,ctrl
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep3,pert
HD7,pert
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 70",pert
strain: C57BL/6;	tissue: cerebral microvascular fragments;	genotype/variation: Notch3 knockout;	age: 2 months,pert
patient: 232;	current medication: Pentaza 2g BD;	birth date: 1/9/63;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/95;	diagnosis date: 1/1/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/31/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Gender: Female;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: YES,pert
colonic_mucosa_non_inflamed_122,pert
5072-scrape,pert
"human failing LV myocardium, Ischemic80",pert
Tetracycline-inducible glioma cells dox 2,pert
control_00hr_rep1,ctrl
WT MEFs at passage 3_biological replicate 2,ctrl
normal bone marrow NBM1,ctrl
Muscle 50 eccentric contractions 12 hours WT Aged 0123,ctrl
multiple myeloma (MM 517),pert
Heart left ventricle dnCREB-PBS replicate 1,pert
Control for EGF 4h replicate 3,ctrl
"fibroblast, control subject NF3 rep 1",ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 45 yr;	population: white;	dsm-iv: 295.3;	age of onset: 34 yr,pert
E14 - WTMixA 1,ctrl
oocyte_wildtype_rep3,ctrl
8DKD_SerumStarved->3hrEGF_rep1,pert
"BL from CLL patient, isolated using CD19-PE and CD5-APC",pert
braak stage: BR34;	rin: 62;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
hur status: KO;	rna subtype: nuclear RNA,pert
Control 874C,ctrl
Bmi1 embryoid body sample_2 (Bmi1_EB_2),pert
FmrKO4_brain,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 51,pert
IM13_control,ctrl
+7hr Wnt,ctrl
44m2,ctrl
MDA-MB-231 RRP1B over-expressing clone #8,pert
1049-03-A,pert
mTert 1,pert
phenotype: moderate glaucoma;	gender: female;	strain: DBA/2J;	tissue: retina;	age: 10.5 months,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 36.00274,pert
siRNA Stau1,pert
"metastasis: none;	Stage: 1;	tissue: cancer, homogenized",pert
Mammary gland R1 NT rep1,ctrl
MSE_N_610,ctrl
Subject #8010-Preinfection,ctrl
"Control, rep 1",ctrl
EA_Case9_CD4,pert
"Ada3FL/FL MEF, control, biological replicate 2",ctrl
"nasopharyngeal carcinoma, specimen T30",pert
"SS gland, moderate, patient 7, batch 1",pert
OE33 siRNA rep3,pert
Myoblast-GATA4-OE-day0-3,pert
age: 36;	gender: male;	ejection fraction: 64;	left ventricular end diastolic diameter: 50;	inflammation/PVB19: negative,ctrl
NM20 healthy control,ctrl
5256 UC Uninflamed terminal ileum,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_2h_0.4mM_HG-U133A_2_YCHSUP501,pert
"MEKi 4 days, biological rep5",pert
kidney_Q10_6M_rep3,pert
Emd KO male 3,pert
TOM-1 non-treated,ctrl
U2OS shCHK1-4 replicate 2 [set 4],pert
BM CD34+ Pool I,ctrl
liver_control_diet_rep6,ctrl
N30582,ctrl
braak stage: CTRL;	rin: 65;	tissue: substantia nigra;	disease state: control,ctrl
"Normal diaphragm 3, 8 week",ctrl
SCARKO d 10 (3),pert
tissue: Spleen;	cell type: B lymphocytes;	gfpmyc status: positive,pert
Untransfected Jurkat cell line,ctrl
GIST Pre Treatment Biopsy 23,ctrl
Muscle FC1,ctrl
Muscle control (YJD-JDM-51UA-s2),ctrl
testis knock out replicate3,ctrl
Subject #8034-2d Postinfection,pert
12-0002A_Day1_34,pert
cell line: JURL-MK1;	tissue: Myeloid leukemia cells;	agent: untreated,ctrl
MCF-10A shCHK1-4 replicate 1 [set 5],pert
siCITED1#3 replicate1,pert
NIH3T3_4h_FGF_exp1,pert
cell type: Osteoblastic lineage cell;	strain: C57BL/6;	phenotype: Control;	time point: 5-6 weeks post doxycylcin withdrawal,ctrl
"BALB/c, Male, Contol",ctrl
Bone-Marrow_MGUS_G850,pert
genotype/variation: Zfx wt/y CreER;	treatment: infected with control retrovirus with GFP selectable marker,ctrl
Strain: B6.V-lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,pert
Muscle 50 eccentric contractions 12 hours WT Adult 07272,ctrl
11422 UC Uninflamed ascending colon,pert
T40977,pert
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 50,ctrl
patient id: T158;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 82;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM1;	Stage: IV;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
untreated,ctrl
"Wild Type, biological rep2",ctrl
NLGN3_4,pert
HepG2_Phenol rep1,pert
PGC-1alpha -/- differentiated brown fat cells expressing a siRNA specific for PGC-1beta knockdown (rep1),pert
pRb+/+;p107-/-.2,pert
T30582,pert
MDS patient 13,pert
PGA_MI_nilv_4h_391,pert
"Colitis 07, UC07",pert
cell line: SKMEL28;	time point: 1h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 1 h,pert
"Control lung tissue, biological replicate 3",ctrl
disease state: healthy control;	tissue: epidermis;	age: 28;	gender: female;	treatment: untreated;	time: control,ctrl
"Peripheral blood, patient without recurrent events [N44]",pert
background strain: C57Bl/6;	genotype/variation: Notch1 wild type,ctrl
MO_CTb_SON_NCBI,ctrl
"gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
THRA aI mutant + vehicle replicate 1,pert
strain background: C57BL/6;	gender: male;	tissue: thymus;	cell type: CD4 single-positive thymocytes;	genotype/variation: Ly5.1+,ctrl
WTC 76 PBS treated,ctrl
PTEN-22 (-/-),pert
WT_TER119-_rep4,ctrl
P0 - nudelko/+ 1,pert
Individual_4257_PP_sample,pert
cell line: IEC-6;	tissue: colon epithelium,pert
EA_Case17_CD4,pert
HeLa SCY1-like 1 knock down 3,pert
Brain_Wild-type_MiceNob4367,ctrl
"3 uM EPZ004777 treated, DAY 4, biological rep.2, MV4-11 cells",pert
"siRNA, plastic plate, rep1",pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: ZMYM2/FGFR1;	biological replicate: 1,pert
MF-22,pert
Control Day7 (388L),ctrl
Txnip deficient tumor 22 months sample 2,pert
MCF10A-Her2Myc-rep3,pert
GM19238_Kd_RELA_3,pert
01J43: new onset sJIA,pert
Untreated diabetic-2,ctrl
Braak α-synuclein stage 1-2 BR12_4SN,pert
cell line: mda-mb-231;	transfectant: siRNA for Pin1,pert
gender: Male;	age: 25;	post-mortem delay: 17h;	ph: 6.9,ctrl
tissue: embryonic fibroblasts,pert
"normal nasopharyngeal tissue, specimen N6",ctrl
G_LS_Wk12,pert
COP control replicate 2,ctrl
11087 Normal Uninflamed descending colon,ctrl
0990-01-C,ctrl
8 week old leg control rep 3,ctrl
"DMD skeletal muscle, biological rep19",pert
imanitib4,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.448;	OD280: 0.781;	Ratio: 1.85;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 309;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell type: Oct4-Gip ES;	RNAi: Panct1;	treatment time: 72h,pert
B7m2,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 165;	Sex: male;	region: LC;	age: 40;	genotype: Y/X;TH/-,ctrl
healthy control_2,ctrl
Nuclear RNA_KO_rep1,pert
Patient 13,pert
"Prkaca+/- caudal vertebral bone, rep1",pert
"bipolar disorder, BA10-19",pert
C025_Control_F_88,ctrl
IP RNA_WT_rep3,ctrl
19C-ER,ctrl
patient: 40836;	sample: tumor,pert
liver western diet 0.05% quercetin rep5,pert
Ecad_Mut_2,pert
E8.5 wt.2,ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: REBIF;	time: 3 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
224 Day 1 siMut12 transfected biological rep2,pert
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 4",pert
"PPARg d4, rep 3",pert
transfection: Rif1 shRNA;	cell line: Stable F1 Rif1 knockdown ES cells at passage 16;	background strain: C57BL/6xC3H,pert
"foxp3 expression: NO;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 2T>C(mut);	gender: female;	treatment: anti-CD3, anti-CD28 for 72 h",pert
HGPS iPSC replicate 1,pert
T117 U133p2,pert
1186-03-A-b,pert
Patient no. 14: control,ctrl
isoflurane 04,pert
H1299 SC_rep 1,ctrl
KO PBS2,ctrl
siHIRA 3,pert
Healthy 3 weeks C3,ctrl
cell line: Hep G2;	genotype: wild-type THRA and;	treatment: with vehicle for 6h,ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 6h, biological rep1",pert
"CCALD patient fibroblast, biological rep1",pert
43SMOKEH,ctrl
siRNA Smc3 + Estrogen [N3],pert
Individual_5248_NN_sample,ctrl
"Acute Myeloid Leukemia, sample 46",pert
"Knockout sham, biological rep1",pert
Superior Frontal Gyrus_10y_normal,ctrl
Ishikawa_VeryLowDose_BPA_48h_rep4,pert
patient: 262;	current medication: Asacol 2.4g co-codamol;	birth date: 7/17/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/87;	diagnosis date: 1/1/87;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 7/5/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/5/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Advanced IPF_explant_lower lobe_rep158,pert
"brain, hippocampus: Wt #3406 Hippo_e1_le1",ctrl
n6t0h,pert
"Untreated TG2 knockout NB4, biological rep1",pert
"ZR-75-1, 12h, 3.0mM 5FU C",pert
MCF7_EtOH_24h_rep1,ctrl
"gender: Male;	age: 44;	post-mortem delay: 4h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
P80 dilated cardiomyopathy heart biopsy,pert
wt Ang2,pert
MDS patient 85,pert
TTP_WT_0ActD_BioRep3,ctrl
07R057 RA,pert
PBMCs_IS_16 [IS],pert
Cisplatin_2h_rep3,pert
"U87MG - CASP2siRNA, biological rep2",pert
209/0,ctrl
Sample Group: control; Gender: female; Age: 60; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
"siPRMT8 neuron, biological rep3",pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 36;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
MDA_PR_Paclitaxel_2,pert
AP-2 gamma targetting siRNA 1: AAUGAGAUGGCAGCUAGGAAG Technical Replicate 3,pert
CD4_T_cell_pool_healthy_H03+H04,ctrl
BATF_KO_P14_D3_Effector_rep3,pert
ICL670 treated K562 cells (10uM for 16hrs),pert
gender: male;	strain: BALB/c;	tissue: liver;	diet: AIN93G with 1.0% quercetin diet for 14 days,pert
gender: female;	age (years): 38;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
"Peripheral blood, patient with recurrent events [N47]",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-tu1,pert
V5-P517,pert
Cervical Cancer C555,pert
"CCM3 shRNA cells passage 11, rep 2",pert
RKO_rep_1,pert
Patient no. 7: control,ctrl
A_LS_Wk2,pert
0959-01-A,pert
NRG Melan-Ink4a #1,pert
mir-26b overexpression 3,pert
"Rat_Tracheal_Dex_2hr, rep4",pert
chip number: 12;	transfection plate: 6;	target gene: RAD21;	kd level: 0.89;	rin: 9.3;	transfection date: 2012-03-26,pert
B6-WT1 melanocytes,ctrl
02B CF,pert
autism with FMR1-FM AU046708,pert
CD positive WT T cell TCR-stimulated rep1,ctrl
patient: 20;	disease state: hypertension;	tissue: Atheroma plaque,pert
Bronchial Epithelial Cells MMA biological 2014V,pert
FGF21KO.DMSO_3,pert
Brain (Inferior Olivary Nucleus)_Control_case4,ctrl
"Fibroblasts from normal histology lung tissue, NL-6",ctrl
Non-Transgenic replicate 8,ctrl
HUVEC_control experiment 1,ctrl
Normal Pleura 5,ctrl
HWS26,pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 93;	Usage number: 4;	Exposures: 2,pert
WT-Nrf2-Male-2,ctrl
Liver control pool2 Affy,ctrl
SHANK3_1,pert
AtT20 cells overexpressing NSBP1SE protein rep3,pert
A549_siZMPSTE24_rep.2,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 4;	psoriasis duration: 20.0;	age of psoriasis onset: 19,pert
Patient 2 after folic acid,pert
"Cell type: neuronal, age:48, gender:male, diagnostic group: bipolar disorder, PMI:23h",pert
e_NY44,pert
BL Day 2 siSC transfected biological rep3,ctrl
age: 31;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
muscle_Akt1+/-_8wk_rep2,pert
1076-03-A,pert
RNA from HCC_22N,ctrl
"Wild type, biological rep2",ctrl
Patient no. 6: control,ctrl
fibroblast_5azacontrol_rep1,ctrl
lymphocytes_ctl_F_39y,ctrl
TMRI AO 1hr,ctrl
H09_S_B2,pert
V5-P457,ctrl
01MK9_PolyRF-,pert
NALT_sham_24h_rep4,ctrl
myoblasts-expt1_lentiDUX4short-rep1,pert
"genotype: wild-type;	strain: C57BL/6;	gender: male;	age: 8 weeks, 3 days;	tissue: colon",pert
RL_siRNA_LIF1h_rep1,ctrl
chip number: 15;	transfection plate: 3B;	target gene: TCF12;	kd level: 0.85;	rin: 9.4;	transfection date: 2012-03-26,pert
Liver_Wild Type_2,ctrl
Normal heart_G66,ctrl
"A673 treated with DMSO vehicle control for 5 days, biological rep6",ctrl
P4C Progranulin-hippocampus,pert
FGF21KO.DMSO_1,pert
"Patient H-c883T, MSI colorectal tumor",pert
cumulus_PCOS_Obese_rep6,pert
Gastrocnemius muscle wild-type mouse - control mouse for PPARalpha overexpressing,ctrl
cell line: Colo205RC PLX4720 resistant cell line;	cell type: colon cancer,pert
Individual_4284_PP_sample,pert
Control (C280),ctrl
cell line: H69;	treatment: none,ctrl
KU_24T,pert
"U87MG - control siRNA, biological rep2",ctrl
cell line: SW1736;	time point: 1h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 1 h,pert
MDS1,pert
race: caucasian;	age (years): unknown;	stage: IA;	grade: 2;	histology: endometrioid,pert
patient: 228;	current medication: None;	birth date: 11/22/48;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/80;	diagnosis date: 1/1/82;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Migraines;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
Carbo Day7 (374L),pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,pert
gender: Male;	age: 72;	post-mortem delay: 20h;	ph: 6.6,pert
V5-P249,pert
"DMD skeletal muscle, biological rep22",pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L017,pert
Male wild-type BALB/c,ctrl
MPM tumor 27,pert
MDS patient 90,pert
Early Secretory Phase Endometriosis,pert
"cochlea at P7, ko, biological rep 1",pert
Run2.aUa.001206d.SkMInS1088D.CEL-IS basal,ctrl
MEF Wild Type 1-rep2,ctrl
B-CLL PB P250,pert
DS-Fibr 5,pert
M_LS_Wk2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.782;	OD280: 1.422;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 54;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
cell type: granulosa cells;	disease: normal,ctrl
WT_2,pert
"Control, high-fat diet, rep2",ctrl
Advanced IPF_explant_lower lobe_rep160,pert
Disease_status: Bipolar disorder;	Age (years): 61;	Gender: Female;	Age of onset (years): 18;	Duration of illness (years): 43;	Brain pH: 6.5;	Post mortem interval (hours): 60;	Side of brain: Left;	Fluphenazine mg. Equivalents: 40000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: Yes (5 treatments);	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
tissue: Frontal cortex;	age: 99;	Sex: M,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.01;	RNA Integrity Number: 10;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
ATF6-MER TG mouse_tamoxifen3,pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 2,ctrl
kidney_QH2_14M_rep2,pert
age: 24 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
pSUPER-mir-210 replicate 3,pert
Turner_AF_2,pert
PBMCs_IS_19 [IS],pert
"cell line: SW480-Snail, Snail expressing stable line",pert
cell line: M24met melanoma cell-line;	genotype/variation: Wnt-1 overexpressing;	treatment: control,pert
"Peripheral blood, normal control [N66]",ctrl
Human prostate cancer primary culture  sample C2dx,pert
SZ16,pert
EA_Case11_CD4,pert
MB231 PIAS1 shRNA-DMEM,pert
Thyroid_ unaffected_paired with PTC67T,ctrl
heterozygot FH P276,pert
"genetic modification: cells stably expressing the oncogenes c-myc and Ha-ras under the control of the Tet-off regulatable promoter, konstitutive expression of the estradiol activatabel IRF-1hER fusion protein;	tissue: fibroblast",pert
BATF_KO_P14_Naive_rep3,pert
esophageal squamous cell carcinoma from patient E1589,pert
IM27_case,pert
Wildtype 2 (jos0533),ctrl
"ALL_DS, K29 011509",pert
Pool 4 Acute stage,ctrl
ALI patient #12,pert
tissue: neonatal foreskin;	cell type: primary dermal fibroblasts;	shRNA transfection: Control construct,ctrl
GB 2 63B +LPA,pert
OE control 15A,ctrl
Mammary gland R1 8 hr rep3,pert
Liver GPR120KO HFD #429,pert
E9.5 embryo_Cop1KO_rep2,pert
AtT20 cells overexpressing NSBP1SE protein rep2,pert
A375 control-1,ctrl
neuron_rep11,ctrl
PsOEt-23-Week 2,pert
3500-1 E2F2 Null,pert
myoblast_treated_rep2,pert
AVIC sample#3 treated with DMSO,ctrl
strain/background: C57BL6J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: cholestatic intestinal injury,pert
DMN-NF1Hippo20d-1aAv2-s2,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 44.58082,pert
"MS patient 12, technical replicate 2",pert
NCI-H716_YAP1.2,pert
PBMCs from normal control subject C (CPBMC),ctrl
"siPRMT1 ES, biological rep3",pert
"Ott1 knock out, biological rep 3",pert
tDEA002.CEL,pert
Allo-4-3,pert
4112-1 E2F WT,ctrl
Day: 1; Drug: Saline; Phase: Drug treatment; Replicate: 2,ctrl
"control colon tissue, biological rep1",ctrl
AKO-rep2,pert
cell line: LNCap;	sirna transfection: siRNA Control1,ctrl
strain: HNF4 loxP/- villin cre;	age: 1 month;	tissue: small intestine;	sex: male,pert
U133A_G0,ctrl
Huntington's disease 874A,pert
"brain, cochlea: [4] Sample #4_le1",pert
LZ11,ctrl
strain: v6.5;	cell_type: ES cells;	transfection protocol: Tet1 shRNA transfected;	culture media: ES,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: del5q plus monosomy7/del7q plus other,pert
V5-P283,pert
TMRI E2 4hr,pert
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-5,pert
PBMCs_IS_5 [IS],pert
FRD440 3,pert
chip number: 17;	transfection plate: 3B;	target gene: WHSC1;	kd level: 0.73;	rin: 9.7;	transfection date: 2012-03-26,pert
tissue: prefrontal cortex from adult APLP2 knock-out mouse with mixed genetic background;	genetic background: back-crossed to C57BL/6 for 1 generation;	gender: male,pert
AQA A,pert
injury stage: Sham 21 days;	gender: male;	strain: Wistar,ctrl
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:knockout,Treatment:cornoil,Batch:Batch2",pert
cell line: KCL-22;	tissue: Myeloid leukemia cells;	agent: Imatinib,pert
"fibroblast, MFS subject FB773 rep 4",pert
striatum wild type 6 month replicate 2,pert
06-0009A_Day1_17,pert
"brain, adrenal medulla: Sample#B3 (Ctrl Pt3)_e1_le1",ctrl
Control + LPS 3,ctrl
Control_1,ctrl
8 hr KLF4 Time Course Induced,pert
BS2011051064,pert
"Spinal cord, saline control, biological rep2",ctrl
224 Day 1 siSC transfected biological rep3,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/15/07;	# cells: 60;	Sex: male;	region: CB (cerebellum);	genotype: Y/X;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,ctrl
"Control group, replicate 1 [GY_Con1]",ctrl
Untreated WT - repeat 5 - mAdbID:102769,ctrl
GIST_KIT_9,pert
Normal cervix_05-15,ctrl
Plate vs. Nail:  2 Week Nail,pert
Healthy controls; individual=IF; time=2; beverage=water,ctrl
Evi1-4,pert
"Untreated, biological rep4",ctrl
HLA risk: High;	Height: 184.1 cm;	Weight: 77 kg;	BMI: 22.7;	Age: 17.16 years;	Gender: Male;	Race: White;	Glucose: 260 mg/dl;	HbA1c: 6.3%,pert
siHic5_2_24h_3,pert
OCT4 shRNA_3 Days knockdown_rep3,pert
N/LV1,ctrl
IFNb-treated MEF 1,pert
Hunk WT rep5,ctrl
Human Acute HIV Sample A051-CD8+ T cells,pert
WT6 SPLEEN,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 8d ID145,pert
Liver_Female_CF_rep1,pert
TLW18_T2_PP_day0_013,ctrl
Day: 24; Drug: Saline; Phase: Withdrawal; Replicate: 3,ctrl
HLA risk: Low;	Height: 157 cm;	Weight: 52 kg;	BMI: 21.1;	Age: 27.24 years;	Gender: Female;	Race: White;	Glucose: 79 mg/dl;	HbA1c: NA,ctrl
CF CFTR unexposed replicate 3,pert
control participant P333,ctrl
cell type: Follicular (FO) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: KAP1 KO,pert
H441 transfected with scrambled siRNA 1,ctrl
esiOgt_rep1,pert
S5,pert
"Patient 999, 12 month of BETAFERON",pert
subject: 12A;	cohort: 12;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 22;	Sex: F;	batch: Batch_3,pert
"spleen marginal zone B in IRF8 conditional KO, biological rep2",pert
Ero1-WT non-induced biological repC,ctrl
tissue: Murine small intestine (jejunum);	genotype/variation: VillinCreERT2-,ctrl
subject: 07A;	cohort: 7;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 29kb;	age (y): 18;	Sex: F;	batch: Batch_2,pert
Gender: Female;	AJCC Stage: I;	Pathological T: 2;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_6h_0.4mM_HG-U133A_2_YCHSUP501,pert
"NPCxhIPSC SCZP, replicate 3",pert
"IKK2 WT tumor, biological replicate 3",ctrl
WT STR Veh 1,ctrl
Kidney_Aqp11-/-_P7_4-4,pert
"Subject 11, Family 4, Asymptomatic",pert
CD4DecTp2-5,pert
"wdNHBE uninfected at 36hpi, biological rep3",ctrl
Md02h024,ctrl
LOX1 Untreated 12hr 282295793,pert
Gastrocnemius Muscle mdx PBS-Treated rep1,ctrl
"human failing LV myocardium, Ischemic15",pert
Normal myocardium sold commercially (D),ctrl
tissue: Frontal cortex;	age: 86;	Sex: F,ctrl
"seminoma specimen, pT1, patient age: 33y; W01 231",pert
age: 10-week old;	sex: male;	strain: C57BL6;	tissue: liver,pert
VPA Treated Rep 2,pert
10 week control OMN rep 2,ctrl
Individual_4598_NN_sample,ctrl
Transgenic male mouse 60 day old,pert
"Global gene expression of NASH patients, P51",pert
cell type: lineage depleted cord blood cells;	culture: liquid culture day 11;	transduction 1: control;	transduction 2: control,ctrl
1uM H2O2 rep2,pert
BC2 TC,ctrl
CD-51-Aff,pert
Subject 2 / lung subsegment instillated by LPS,pert
Pt38_Pre,ctrl
Lmna H222P heterozygous male 7,pert
Treated with 10uM Motexafin gadolinium for 4 hrs -- replicate #1,pert
"PCB153 treated HepG2 cells at T18, biological replicate 2",pert
"control, BA10-60",ctrl
"IDC 1, biological rep. 1",pert
Normospermic individual: Sample N8,ctrl
3880-3 E2F WT,pert
Undifferentiated Dicer +/- (D4) ES cell line replicate_3,ctrl
HET Brain 20d Mouse1,ctrl
MCI-007,ctrl
sample N term wt,ctrl
4L,pert
Nerve_Diabetic_Vehicle_710,ctrl
liver_Q10_6M_rep2,pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: SRF Silencing;	agent (treatment): EtOH vehicle,pert
disease state: Healthy;	cell type: CD4+T;	twin: P,ctrl
"atRA WT, set 2",pert
tissue: white blood cells;	age: 17.45;	Sex: female,pert
"30B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
Subject #8018-8hr Postinfection,pert
SUBSTANCE P 1 HOUR,pert
Jejunum_Wild Type+Quercetin_2,pert
DNGM-3,pert
"IN1760 siNT treated, Biological replicate3",ctrl
day: d00;	strain: C57BL/6;	genotype: WT;	experimental run: e0,ctrl
non-treated WT_rep-1,ctrl
"seminoma specimen, pT1, patient age: 35y; W00 222",pert
healthy CD19 B cells 4,ctrl
3491-1 E2F2 Null,pert
HEL_JAK2 knockdown (Jak2-10 shRNA)_3,pert
CT-receptor-KO osteoclasts treated 2,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 19 yr;	population: white;	dsm-iv: 295.9;	age of onset: 18 yr,pert
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 45;	donor: 19;	disease state: Lesional,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G52,pert
cDNA no 21,ctrl
Subject 1_t=30days_resveratrol,pert
ct-2,ctrl
"Resveratrol treatment exp 3T3-L1 cells, CT3",ctrl
Parkinson's disease sample x100,pert
MEKi 4h biological replicate 1,pert
Subject #8012-2d Postinfection,pert
treatment: atRA + cycloheximide;	genotype: RARaKO;	cell line: F9,pert
cell line: U87;	treatment: untreated;	cell type: glioblastoma cancer cell line,ctrl
"Autoimmune pancreatic islets, day 2 cyclophosphamide treatment, rep 2",pert
Human hepatocellular carcinoma cell line infected with GFP protein (control) 2,ctrl
"Peripheral blood, patient without recurrent events [N25]",pert
No_DHT_control_1,ctrl
"wild type CTL+AktI, biological replicate 2",pert
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 54",pert
"WT CLP LY6D-, biological rep1",ctrl
sMPNST_shBrd4.552_3day_rep2,pert
RTX4 T12,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 49,pert
25 weeks male,ctrl
"heart-30 months of age, resveratrol diet-biological replicate5",pert
Wildtype_XY_2,ctrl
"Wild-type HFD 8 weeks, biological rep3",ctrl
subject: 12;	disease: TD;	muscle: ST;	gender: M;	age: 15.6;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Brain (Inferior Olivary Nucleus)_Control_case3,ctrl
brain_DLPFC_bipolar C_mr537,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Liver",ctrl
"cell line: MDA-MB-231;	disease state: Breast adenocarcinoma, estrogen receptor-negative;	genotype/variation: Control",ctrl
Liver_Wild Type_1,ctrl
Endometrial stromal cell - control/vector 3,ctrl
CTL2 E2 4hr,pert
cell line: U937;	replicate: Replicate3;	treatment: shLuciferase,ctrl
PGA_Ras_3-m5,pert
"control embryonic stem cells, biological replicate 5",ctrl
"Creatine-treated, biological rep6",pert
"ALL_DS, K23 011409",pert
Gastric_cancer_patient_3,pert
Klf9 mutant (Klf9KO) mice jejunum; Age: PND 30,pert
HLA risk: Low;	Height: 170 cm;	Weight: 61.2 kg;	BMI: 21.1;	Age: 14.9 years;	Gender: Female;	Race: White;	Glucose: 86 mg/dl;	HbA1c: NA,ctrl
Muscle PCOS after pioglitazone 32,pert
genetic background: C57Bl/6;	genotype: wildtype;	cell type: Osteoclasts;	treatment: untreated,ctrl
strain: C57BL/6;	genotype/variation: Smchd1 null;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: D,pert
HT29 parental cell line,ctrl
Liver_Nrf2 KO_rep2.,pert
V5-P447,pert
NPC19,pert
wt_on_rep3,ctrl
"breast tumor epithelium,6",pert
liver_female ko_rep3,pert
P328L329_del5a+,pert
10 mg/kg MPH tr1002,pert
strain: C57BL/6;	tissue: mouse bone marrow;	genotype: E-FABP knockout;	treatment: 1x10^6 cells in a 12-well plate co-cultured overnight with 1x10^6 E0771 tumor cells in an sterile insert,pert
Extract:LOX-1:113303;	Extract Description:GFP_Untreated_6hr:113303;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.13;	Quality: Absent (%):58.09;	Quality: Absent (%) Dev.:0.13;	Quality: Scaling Factor:0.63;	Quality: Scaling Factor Dev.:0.14;	Pretreatment [C]:GFP;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113303;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_6hr;	RNA extraction source key [A]:282295613,ctrl
status: Control;	gender: Female;	age: 48;	tissue: Blood,ctrl
"HEK293 cells siRNA control, biological rep1",ctrl
Nerve_Control_Rosi_715,pert
"Crohn 06, CD06",pert
"Empty vector, collagen plate, rep3",pert
MCF10A_Vehicle_rep4,ctrl
mdx gastroc sample 1,pert
Pax_S2,pert
tetO-Satb1 #1,ctrl
DMSO Treated Control 1,ctrl
ID: MLL_00107;	cell type: PBMC;	disease state: control,ctrl
MCF7 control siRNA Vehicle Rep1,ctrl
"seminoma specimen, pT1, patient age: 43y; W02 003",pert
"WildType mice with water, replicate 3",ctrl
AtT20 cells overexpressing NSBP1WT protein rep2,pert
07R058 RA,pert
KU_33N,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Neurointermediate lobe of the Pituitary,ctrl
XBP1s_B_cells_spleen,pert
Bone-Marrow_MM_M1137,pert
Patient: G;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
Kidney_400 mg/kg VCM ip_mouse #103,pert
PGA-RMM-15m-2aA-s2,pert
ccRCC tumor of patient 83,pert
ccRCC tumor of patient T127,ctrl
MOLM14_shSYK_2_Replicate1,pert
WT / Reference_13425561,ctrl
tissue: peripheral blood;	subject: Control;	rna prep: PAXgene Globin reduced;	molecule: Globin-depleted RNA,ctrl
"Control 10, NC10",ctrl
10ILC_normal_ductal,ctrl
strain: Swiss Webster;	treatment: 10mg/kg MPH;	tissue: substantia nigra,pert
"seminoma specimen, pT2, patient age: 35y; W03 032",pert
"Patient C, uninvolved skin",ctrl
VGP1,pert
BCell_lymphoma_aggressive_sample2,pert
REST shRNA KD 2,pert
Normal Biological Replicate 5,ctrl
180C6,ctrl
strain: Swiss;	tissue: Ovary;	agent: Control (0.1% DMSO);	replicate: 2;	age: Post natal day 3-5,ctrl
Control bone marrow - Biological Replicate 5 - Technical Replicate 2,ctrl
Leg 23 Day mdx rep 2,pert
Liver sample from Alcoholic hepatitis group (CA5),pert
224 Day 3 siSC transfected biological rep1,ctrl
heart knock out replicate3,pert
G518,pert
CH1812,ctrl
M24met_control_1,ctrl
ZMYM2/FGFR1 biological replicate 1,pert
Individual_3591_PP_sample,pert
Normoxic Control N2,pert
phenotype: severe glaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 10.5 months,pert
cell line: MCF10A;	transduction: HER3,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 33;	maternal age: 36,ctrl
CON1,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_1_16_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
HMEC_50 vs HMEC_21,ctrl
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 7.03;	Post mortem interval (hours): 24;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,ctrl
background strain: B6/129;	genotype/variation: mir-122 knockout;	tissue: Liver;	age: 2 Month,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	target lesion score (peasi): 6;	peasi reduction [%]: 0,ctrl
tissue: Frontal cortex;	age: 80;	Sex: F,ctrl
5221 UC Uninflamed sigmoid colon,pert
3886-1 E2F1 Null,ctrl
cell type: Melanoma cell line;	cell line name: A375P;	expression: Control shGFP,ctrl
"fibroblast, MFS subject FB881 rep 1",pert
HB1.A4,ctrl
age: 26;	gender: female;	ejection fraction: 74;	left ventricular end diastolic diameter: 47;	inflammation/PVB19: negative,ctrl
KO HPC Veh 29,pert
MDS patient 61,pert
Squamous cell carcinoma 024,pert
strain: C57BL/6J;	gender: male,ctrl
3339-lcm,pert
male_alcoholic_252,pert
"C57Bl/6, CD-1",ctrl
"Healthy control, biological rep5",ctrl
"Heart, MAT1 control, 4 wk, sample 2",ctrl
XpO15,pert
HCT116 human colon cancer cells with PTEn -/-,ctrl
tissue: freshly isolated human monocyte;	gender:male; age: 47 yr; weight: 80 kg,ctrl
KO_0525-2,pert
cell type: mammary epithelial cells;	cell line: MCF10A Cells;	genotype/variation: ErbB2,pert
"Muscle from DS, biological rep2",pert
Bronchial Epithelial Cells SA biological 2166S,pert
mouse colon_hnf4mutant_rep1,pert
"1mg/kg/day PFOA, Rep 3, Block 4, liver (low dose)",pert
"human failing LV myocardium, Ischemic104",pert
"Cbfb+/+, technical replicate 3",ctrl
"human failing LV myocardium, Ischemic77",pert
monocytes_T0_rep1,ctrl
COLO829_shMITF_PLX4032_B,pert
"Control 1, biological rep2",ctrl
cell line: HL-60;	shRNA construct: Scrambled Control,ctrl
CD19_selected_B-cells_after_R_rep9,pert
CRC_celecoxib_M4867,pert
5242 UC Uninflamed sigmoid colon,pert
"3T3-L1 siLSD1 48h, biological rep 2",ctrl
Phan_008_KO.saline rep2,ctrl
ctrl.3,ctrl
MDS patient 162,pert
"CCM3 shRNA cells passage 7, rep 2",pert
"Acute Myeloid Leukemia, sample 27",pert
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14464;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
Bronchial Epithelial Cells MMA biological 0114X,pert
Mouse No Cldn16 B9 461,pert
whole lungs overexpressing an nmyc-gfp fusion protein via the lung surfactant c promoter,pert
control AU0995302,ctrl
Individual_5144_NN_sample,ctrl
MDS patient 60,pert
MKO_rep_2,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 2",pert
liver_wild type_24 weeks_replicate_1,ctrl
PGK12.1_control RNAi-4,ctrl
DMN-NF1Hippo15d-1cAv2-s2,pert
"acutely admitted, severely psychotic schizophrenia patient  A18",pert
"Aorta, saline 14d, #1",ctrl
HCT116 human colon cancer cells with intact PTEN,ctrl
patient: 13;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
tissue: skin;	individual: Patient P5;	condition: ANL;	eczema severity: SCORAD: 0,pert
Sample 05 Kidney Normal Mouse - Control Diet,ctrl
Diaphragm 28 Day control rep 3,ctrl
"hepatic gene expression at ""3 hr"" (rep1)",pert
cbp+/- standard cage Rep1,pert
cell type: hepatocytes,ctrl
204/0,ctrl
8 week old leg control rep 2,ctrl
"Testosterone treated, HIV-1 positive male, day 14 (5)",pert
"A pool of two pure subsets of peripheral blood B cells (CD19+ CD3- CD4- CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
Ischemia-reperfusion #3,pert
gemcitabine resistant Calu3 derivative generated from the parental Calu3 line by consecutive treatments with 50 nM gemcitabine over a period of 3 months,pert
Bone-Marrow_SMM_S1449,pert
tMLL02,ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 26 weeks;	genotype/variation: control",ctrl
MDS patient 56,pert
HepG2_control_rep2,ctrl
FoxO3null_1_1,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 80min;	race: White;	sex: Female,ctrl
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 82;	Usage number: 5;	Exposures: 3,pert
"proband f, before exhaustive exercise",ctrl
"normal mouse kidney E12.5, biological rep 3",ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
tissue: white blood cells;	age: 13.07;	Sex: male,pert
liver knock out replicate3,pert
SHR16-4,pert
Discoid Lupus-L5,pert
"brain, cerebellum: RNA #1_le1",pert
gender: Male;	age: 38;	post-mortem delay: 6h;	ph: 6.9,ctrl
FW_1a_BN1544,pert
GIST_KIT_15,pert
Zfx wt MA9 cells + 4-OHT [10980],pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 71,pert
cell line: BT474-J4;	cell type: breast cancer;	lapatinib sensitivity: acquired lapatinib-resistant;	her2 status: HER2-positive;	treatment: DMSO,ctrl
whole blood_100346,pert
15DKD_rep1,ctrl
9-cis-retinoic-acid_mammary_1,pert
"Liver, Normoxia 5",ctrl
IM CD34+ Pool III,pert
Pcgf6_1_shRNA1+dox,pert
sepsis patient #8,ctrl
"testis, Repro9 mutant, 17dpp, Rep1",pert
N14B Normal-cerebellum,ctrl
T175 U133p2,pert
miR122-KO-105-T,pert
"ShamC-21, biological rep 2",ctrl
timepoint: 2h;	drug: Morphine;	group no.: 4;	large batch: X;	plate: 4051964045;	hybridization batch: II,pert
"CTR-D (CTR-3, biological replicate 4)",ctrl
Control 3 medium only,ctrl
"Genotype: B6.Alb/cre,Pdss2loxP/loxP(Liver-conditional knock-out);	Age: 176-day-old male;	70 mg liver used for RNA extraction",pert
gender: Male;	tissue: Tendon;Patellar;	age: 32;	donor: 15;	disease state: Non-lesional,ctrl
Isoflurane 10 exposures-1,pert
braak stage: BR56;	rin: 72;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
"iPSC derived from healthy control fibroblast WT2, biological rep4",ctrl
tissue: brain;	genotype: mutant Ndel ko/+;	age: P0,pert
MDS55,pert
1156-03-A,pert
7-Mut_1,pert
cell line: MDA-MB-231 1833;	cell type: breast cancer cells,ctrl
patient: CAB10;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
HC-WT-20B,ctrl
control siRNA rep3,pert
2098-03-A,pert
OCI-Ly1_FOXP1 overexpression,pert
CF knockout HMCF CHN538,pert
HF0533_U133P2,ctrl
"48 hour-treated wild-type NB4, biological rep1",ctrl
WT - Cre Control - 5 mo - repeat 1 - Cy5 - mAdbID:74097,ctrl
cell line: OVCA429;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
A61 WT1	F6/20	A61	wild type	Mouse	8 months	Cerebellum	Male,ctrl
The Caco-2 cell line is derived from a male Caucasian with a colon tumor,ctrl
tissue: prostate tumor;	genotype: Pb-Cre+;PtenL/W;K-rasG12D/W;	age: older than 20 weeks,ctrl
strain: FVB;	cell type: 6 DIV cultured hippocampal neurons;	transfected with: Sindbis virus expressing GFP alone,ctrl
"Control skin, rep1",ctrl
ic8 -- cell line 1treated with mock APF #2,ctrl
HF1502_U133P2,pert
whole tissue section from case 1304,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 35;	maternal age: 30,pert
Biceps_Control_2,ctrl
Left ventricular myocardium in patients with Dilated cardiomyopathty (13),pert
Mnk_3206-R-7,pert
Mnk_3204-T-7,pert
Untreated diabetic-3,ctrl
siERK2Veh4h_2654,ctrl
Male mice from fiona transgenic line (dystrophin-deficient with a transgene expressing high level of full length utrophin) were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction. Biological Replicate 1.,pert
mouse adipose tissue,ctrl
H19_P_B1,ctrl
monocytes_T0_rep3,ctrl
patient id: T163;	tissue: Normal cortex;	gender: Male;	age: 52;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
PGC-1a-/- rep4,ctrl
BP patient 48_biological replicate 2,pert
diagnosis: FU;	fvc-group: FVC1;	tissue: lung,pert
G026-lcm,pert
"nasopharyngeal carcinoma, specimen T14",pert
umbilical cord_bpd: 7C,pert
LJMJDW24,pert
Wild type_liver _3,ctrl
WT_liver_vehicle 0 mg/kg_96 hr_1,ctrl
GM19238_Kd_NS2_11,ctrl
genetic background: C57BL/6;	gender: male;	cell type: primary murine fibroblast-like synoviocytes (FLS);	genotype: human TNF transgenic without knockout (Rsk2+/y FLS);	flow cytometric cell sorting: CD90.2pos/VCAM1pos/CD11bneg,ctrl
Untreated CCE embryonic stem cells (CCE_ESC_Control),ctrl
CA5,pert
CD34-001,ctrl
GIST_KIT_1,pert
age: 8 month;	strain: FVB/N;	genotype: wide type;	tissue: normal urothelium,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 33;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
Patient 6,ctrl
sex: Male;	Age: 36 months;	additional patient information found in Series supplementary file,ctrl
BCell_lymphoma_transitional_sample5,pert
NOD.scid1,ctrl
AAA neck (Sample 10),pert
WT_P_2,ctrl
tissue: Adrenocortical adenoma;	tumor secretion profile: Aldosterone;	genotype: WT CTNNB1,ctrl
10B,pert
shSOX2_3,pert
patient: 8;	disease state: hypertension;	tissue: Atheroma plaque,pert
CDF1-c (197msn),ctrl
Yolk sac tumor 0738,pert
"CFU-PreB colonies Wildtype littermate, biological replicate 4",ctrl
Ad infected murine liver-MO30k-(464)-6 hpi,pert
Snell 22 month Dwarf Liver 4dw,pert
M464 Wt,pert
Carrier-inj_Mip-1a-KO_rep2,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: none,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 63;	gender: male,pert
neuron_rep9,pert
01-0045A_Day1_11,pert
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: normal chow,ctrl
AAA neck (Sample 2),pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_6h_4mM_HG-U133A_2_YCHSUP501,pert
cell type: fibroblast;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P7;	clone: 0,pert
"Patient I-c226T, MSI colorectal tumor",pert
mock A,ctrl
WT-sham-5 month+13d-R1,ctrl
colon_C57 mouse_12weeks_rep4,ctrl
Control peripheral blood leukocytes - Biological Replicate 2 - Technical Replicate 2,ctrl
CA96-116A,ctrl
Astrocytoma_1,pert
brownfat_WT1_day3,ctrl
Individual_4163_PP_sample,pert
Normal_001,ctrl
MEF Wild Type 3-rep2,ctrl
AQA A,ctrl
jzo031-rp1-v5_u74av2-met,ctrl
K14deltaNB-cateninER  Time 7 replicate 3,pert
HCC005N,ctrl
CD4+_Tcells_severe_asthmatic_6,pert
Jurkat with Nef Biological Replicate 3,pert
sample H term homo,pert
SRF silenced EtOH rep 1,pert
01N3S_Oligo,pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: not treated,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 5d ID63,ctrl
NPC15,pert
C4_CLP_overexpressor_12,pert
Treg WT rep1,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.87;	choa: 154;	fata: 45;	eea: 1280;	wtkg: 79.3;	perfat: 44.9;	lbm: 40.9;	fat_mass: 3560.57,ctrl
sex: Male;	Age: 14 months;	additional patient information found in Series supplementary file,pert
29A;pretreatment;female;breast tumor,ctrl
c.1,ctrl
cell line: MDA-MB-231 breast cancer cells;	protocol: control;	other: SAMPLE-1B,ctrl
"human failing LV myocardium, Ischemic40",pert
R6/1 18 week wildtype_DFFC,ctrl
Control N2B27 sample 2,ctrl
"CTR-A (CTR-1, biological replicate 1)",ctrl
MDS34,pert
another 26 year old male,ctrl
"brain, hippocampus: LH3_e1_le1",pert
wild type MEF time 2 replicate 2,ctrl
"male;	CABG patient, atrial tissue, ;	baseline before CABG surgery",ctrl
EOM 14 Day Control rep 2,ctrl
Trasnsformed Lymphocytes Unaffected Twin Pair 2 (DCBD2.2)(TP8),ctrl
cell line: TF-1;	gender: male;	age: 35 years;	disease: erythroleukemia (AML M6);	sirna: anti-Evi1,pert
miR122-WT-349,ctrl
Keratinocytes_siANCR_rep1,pert
WT_Mstn_5,ctrl
H4med,ctrl
36A,pert
"BOEC, normal 3",ctrl
E9.0 ko.3,pert
siNS_2h_4,ctrl
DNGM-11,pert
Ecad_Mut_1,pert
A2AR_WT_saline_24h_rep3,ctrl
Cochlea_WT_9mo_4,ctrl
siRNA Control,ctrl
Pcgf6_3_shRNA2+dox,pert
siCtrl_0_rep2,ctrl
Cancer 14,pert
RA_A,pert
DND41 Control 1,ctrl
Mouse fetal liver_E14.5_KO_rep4,pert
patient id: 1524;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 70;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
"CBFb-SMMHC animal 1, replicate 1",ctrl
"Control Distal, Small Intestine 3 17 days old",ctrl
IRS-3 KO (jos0930),pert
"cochlea at P13, wt, biological rep 3",ctrl
lesion_midUV_patient4,pert
"patient 030b, cancer, homogenized",pert
THRA 6a mutant + vehicle replicate 3,pert
Targretin_mammary_1,pert
HUVEC_TNF-stimulated experiment 3,pert
cell line: MCF-7;	cell type: Breast tumor cell line;	transfected with: pcDNA3-Pit-1 overexpression vector,pert
PGA-RMM-1h-2aA-s2,pert
"schizophrenia, BA46-26",pert
KM_079N,ctrl
HepG2_DMNQ rep2,pert
skin.KO.replicate17,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 74 years,pert
"schizophrenia, BA10-37(3)",pert
MS patient 6,pert
B2_saline_overexpressor_48,pert
4472-2 E2F3 Heterozygous,pert
Ezh2-Vec2,ctrl
"Uninfected NT at 5 d.p.i., rep2",ctrl
Metastatic prostate cancer tissue pool WX1,pert
216/4,pert
"A673 treated with Puromycin for 5 days with concentration of 0.09 uM (EC50), biological rep1",pert
KOC 55 PBS treated,ctrl
KO1 PBS,pert
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep7,pert
061J5_CTRL,ctrl
fasted liver standard chow diet 2,ctrl
P60_WT_2,ctrl
"eye, cornea: TRizol Extraction_le1 8",ctrl
cerebrum_WT_0d_rep2,ctrl
cell line: SF539;	transfection: PARK2 siRNA#2,pert
GFP-progerin Induction: day 10 Replicate A (6a_progerin_10d_A),pert
H1299 DAC 0.3 uM (3237),pert
No abuse,ctrl
tissue type: Bone Marrow;	cell type: Monoclonal Gammopathy of Undetermined Significance (MGUS) plasma cells,pert
"breast tumor epithelium,55",pert
Brain (Inferior Olivary Nucleus)_Control_case5,ctrl
Early IPF_surgical biopsy_lower lobe_rep149,pert
MDA_Parental_1,ctrl
MCK-PPARa rep 2,pert
RL_siRNA_NS_rep2,ctrl
"Grape extract group, 12 months, patient number 11",ctrl
Adrenocortical adenoma with wild-type CTNNB1-2,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 6h ID130,pert
"24B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
strain: C57BL/6J;	day: 18;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
age: 43;	sex: M;	disease status: control subject;	Filter number: 95;	Usage number: 4;	Exposures: 3,ctrl
"female Spargue-Dawley rats, diet only for 7 days,  tissue: liver",ctrl
"Liver from STZ-treated mice, biological replicate 3",pert
Trastuzumab treated after 4 days (T2_2),pert
race: caucasian;	age (years): 77;	stage: IA;	grade: 2;	histology: endometrioid,pert
cell line: LICR HN2;	treatment: Cetuximab 15 nm Cetuximab for 13 hours,pert
PTEN_1,pert
HepG2_100uM_Trovafloxacin_24hr_Prep2,pert
4 hour tunicamycin wild type C,ctrl
puroB replicate 1,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 74;	gender: female;	years of disease: 2 y;	treatment: phototherapy;	time: mid-UV,pert
DMN-CtrHippo28d-1bAv2-s2,ctrl
TN3,pert
tissue: cardiac biventricle;	genotype/variation: PGC-1a KO/PGC-1b KO,pert
C010_Control_F_90,ctrl
"Transgenic, snap frozen, diaphragm muscle, 7 month age animal",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 31 yr;	population: white;	dsm-iv: 295.3;	age of onset: 22 yr,pert
HepG2 cells treated with 5-aza-dC,pert
"human failing LV myocardium, Idiopathic13",pert
brain_DLPFC_bipolar C_mr780,pert
DC2 RSG,pert
8DKD_rep2,ctrl
K_LS_Wk2,pert
LPS 24 HOURS,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-tu3,pert
MPM tumor 9,pert
HCT116 STAG2 knockout clone 21 (STAG2 deficient),pert
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 45;	gender: m;	treatment: NSAIDs,ctrl
Control Day1 (357R),ctrl
WT_1,ctrl
kidney_Q10_6M_rep2,pert
lineage: colorectal;	cell line: SW480;	treatment: treated with TNKS inhibitor for 16h,pert
"hepatic gene expression at ""3 hr"" (rep2)",pert
Mononcyte-healthy-untreated-1,ctrl
cell line: DAOY M2.1;	cell type: medulloblastoma;	genetic modification: siRNA cMYC silenced,pert
N1B Normal-cerebellum,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 59, stage IIB, HPV 18",pert
RV16;	Age = 19;	Sex = F,pert
siLMO3_oligo2_0_rep1,pert
Control with WY14643 replicate 3,pert
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 1hr,pert
Strain: C57BL/6J;	Gender: M;	Age: 7 weeks;	Treatment: untreated,pert
cell line: HeLa;	cell type: human Cervical Carcinoma;	transfected with: siRNA directed against Sp1 mRNA (siSp1),pert
3_month_old_Prnp_knockout_mouse_rep4,pert
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l flox/flox;	days after transduction: 7,ctrl
"44B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
"patient: 121;	current medication: Cp-tenedone, Enalapril, Loperamide.;	birth date: 4/8/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: Diarrhoea, Blastocytitis on stool cultures.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
KU_14N,ctrl
gender: female;	age (years): 41;	evolution time (years): 15;	disease extension: Pancolitis;	treatment: 5-ASA,pert
Expression data from BAT of the KRAP deficient mice (WT3),ctrl
P0 - lis1ko/+ Mix 1,pert
MPM tumor 15,pert
"breast, pre AFI treatment (H18_1930)",ctrl
Bronchial Epithelial Cells MMA biological 2063I,pert
SIRT1 LKO liver_4 pm_rep2,pert
cerebrum_PS-/-_ 20d_rep1,pert
24h_RA2,pert
skeletal muscle Crhr2-/- replicate2,pert
"SLE patient, 1005V1",pert
SKBR3 PR 1,pert
Asthmatic after Flovent,pert
rd1_P4_rep3,pert
brain_DLPFC_bipolar B_mr781,pert
ATCC HTB-30,pert
Normal Rat Retinal Müller Cells (biological replicate 3),ctrl
BIO586222,pert
0511-01-c,ctrl
cell type: BMDM;	strain: C57BL/6;	genotype: wild-type;	infection status: uninfected,ctrl
01LMX_Oligo,pert
sampleID: SAM630148;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
wt #2. 462,ctrl
11443 UC Uninflamed sigmoid colon,pert
Cre_day_7-3,pert
MBD2_1,pert
Normal-N_LJ_8,ctrl
NPC11,pert
ND_8,ctrl
tissue: Biceps muscle;	patient: P.b.8;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 1y 5m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
Mouse_ATF6aKO_colon_DSS_rep1,pert
B6C3F1 male,ctrl
Wt Mouse_cerebellum_Young_saline treatment_Replicate-3,ctrl
Ishikawa_LowDose_BPA_48h_rep1,pert
Individual_4339_PP_sample,pert
"52B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Control (C70),ctrl
S007_Scz_F_67,pert
intestine_wildtype_24hfasted_rep1,ctrl
disease group: osteoarthritis;	cell type: chondrocytes;	cell culture: monolayer,pert
testis knock out replicate2,pert
5320-scrape,pert
Cutaneous psoriasis without arthritis PsC 11,pert
"MCF-7 transfected with pcDNA3.2, rep.1",ctrl
N51722,ctrl
Carbo Day14 (453R),pert
R7E 11,pert
DBA/2JTCE liver sample batch 5,pert
HUH-YAP-#3,pert
"Atria, Mutant, biological replicate 2",pert
"CFU-PreB colonies Hspa9+/-, biological replicate 5",pert
77_129_WT,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 204,ctrl
SKBR3-R_1uM_Lapatinib_1,pert
C57 72 ozone 1,ctrl
tissue: Liver;	strain: C57BL/6;	genotype/variation: PXR+/+;	treatment group: vehicle 0 mg/kg,ctrl
strain: CD-1;	genotype/variation: wild-type;	developmental stage: embryo;	age: E17.5;	tissue: kidney,ctrl
A673 cell line that has been treated with Doxorubicin for 24 hours with concentration of 59.88 nM (EC50).,pert
HEK293 stably pIRES2-EGFP-transfected,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 96 hrs;	time course: 1,pert
NK_cell_pool_healthy_H01+H02,ctrl
OE Sirt1 2,pert
P14 - Lis1ko/+ 2,pert
B-CLL PB P138,pert
pediatric AML GP1,pert
"amnion mesenchymal cells, no treatment, biological rep3",ctrl
NSC_ DMSO_24h_biological rep3,ctrl
jos1986,ctrl
E16.5 Vax2-/- 2,pert
"Colitis 09, UC09",pert
tissue: blood;	control: 6;	gender: female;	age: 40,ctrl
subject: 21A;	cohort: 21;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 82;	Sex: F;	batch: Batch_5,pert
"HEK293E cells, TDP-43 siRNA, replicate 1",pert
Untreated Control 12weeks AffyGC RMA rep6,ctrl
"Colitis 06, UC06",pert
"ES cell mutant, RNA 308",pert
5871841165_B,ctrl
GM19238_Kd_USF1_2,pert
Pediatric_GBM_42,ctrl
"Control 07, NC07",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.326;	OD280: 0.691;	Ratio: 1.83;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 292;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
17B,pert
braak stage: BR56;	rin: 69;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
MDS patient 14,pert
erStress_twins_AA_1757twin1_500nM_thapsigargin_4h,pert
liver 1.0% quercetin diet rep1,pert
NTG mouse_tamoxifen1,ctrl
4010-1 E2F2 Null,pert
tissue: white blood cells;	age: 10.88;	Sex: male,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 2;	bead chip array sentrix code: 4421339033,pert
Control Day14 (360L),ctrl
Strain: C3H/HeN;	Gender: female;	Age: 4 weeks,ctrl
MPM tumor 30,pert
Wt Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-4,pert
Subject #8022-2d Postinfection,ctrl
Vit A deficient 2a,pert
umbilical cord_bpd: 7F,pert
BL Day 2 siMut10 transfected biological rep3,pert
"Tfrc-/- (GFP-positive) kidney cells, biological rep2",pert
strain: Mixed;	genotype/variation: Nrf1 CKO;	gender: Female;	tissue: Liver;	age: 6weeks,pert
MDS patient 42,pert
control sample 6,ctrl
BRCA1 KD #1,pert
WT_PLACEBO_48hours_4,ctrl
mouse jejunum_hnf1alphacontrol_rep2,ctrl
C_AN17425_T,ctrl
MO32_17,pert
AA_124,pert
"PBMC, patient. Mtx rep13",pert
Jejunum_POR-null_3,ctrl
S259A-3,pert
ILD Study Number 1035,pert
Leg 14 Day Control rep 1,ctrl
Waldenström’s macroglobulinemia (WM-PC 30639),pert
"bipolar disorder, BA10-16",pert
IDCM4,pert
race: caucasian;	age (years): 63;	stage: IC;	grade: 1;	histology: endometrioid,pert
genotype: p300+/-;	replicate: 2;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,pert
Skin_Tcfap2c Mutant E16.5_rep1,pert
PND28 Rat Testis_Rat230-2_2hr Corn Oil_Animal#48_04005,ctrl
tissue: Temporal cortex;	age: 75;	Sex: F,ctrl
Normal mucosa 21,ctrl
cerebellum_wild type_12 weeks_replicate 2,ctrl
29 year old male,ctrl
major non-tumor5,ctrl
"schizophrenia, BA10-41",pert
Muscle PCOS 9,pert
VCaP/NC siRNA #2,ctrl
Myoblast-GATA4-KO-day3-2,pert
PWD/PhJTCE liver sample batch 4,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 70;	gender: male;	tumor grade: IV,pert
M322 SKM-KO,ctrl
Diaphragm 7 Day mdx rep 3,pert
disease state: tibial muscular dystrophy (TMD);	tissue: tibialis posterior;	age at biopsy: 52;	Sex: male,pert
Huh7 cells_Mock Infected 48 hours_ rep3,ctrl
Substantia nigra normal rep2,ctrl
normal control_CTL5,pert
KO HPC Veh 26,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 31;	sex: M,ctrl
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P7;	clone: C11,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 27.0;	age of psoriasis onset: 24,pert
parental cell line: WB;	vector: pBabe-human v-src (v-src vector);	replicate: 2,pert
TFEB_Overexpression(S2),pert
Ngn3 EB3 OFF replicate 1,pert
"ME16C, 12h, 0.06mM 5FU B",pert
8 Weeks Heart Control rep 3,ctrl
chip number: 22;	transfection plate: 4;	target gene: NR3C1;	kd level: 0.63;	rin: 9.1;	transfection date: 2011-10-17,pert
Healthy controls; individual=JL; time=2; beverage=water,ctrl
cell type: epithelial cells,pert
T51315,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 60.6137,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: tumor;	sample name: 4-tu2,pert
HEK293 F5_doxycycline treated,ctrl
01LM6: new onset sJIA,pert
Subject #8045-8hr Postinfection,ctrl
Genotype: HtrA2 wild type,ctrl
major non-tumor9,ctrl
Substantia nigra PD rep7,pert
"NPCxhIPSC CON, replicate 2",ctrl
Prdm14 knockout 1,pert
siControl_1,ctrl
Embryonic age 17.5 mutant rep4 (PKD1_12),pert
"amnion mesenchymal cells, 1h interleukin-1-beta, biological rep1",pert
cell line: CL1-0;	gender: male,pert
"Patient SE, stable renal transplant recipients, male, 31 years old, T0 (time of enrollment)",ctrl
strain background: C57Bl/6J;	gender: male;	strain background: wild type;	age: adult;	tissue: whole brain,ctrl
PGA-RMM-2h-3aA-s2,pert
imanitib7,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 145min;	race: White;	sex: Female,pert
Erythroblast_SOD2-/-_repKO39,pert
A673 cell line that has been treated with Puromycin for 24 hours with concentration of 0.09 uM (EC50).,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 167;	colon ratio (mg/mm): 2.783;	myeloperoxidase activity (u/mg): 0.199;	tissue: colon;	treatment: 5% DSS,pert
Human Neural Stem Cell Line F3 Overexpressing NGN1,pert
AKT_PLACEBO_12hours_4,pert
Individual_777_PP_sample,pert
Human skeletal muscle biopsy sample;	Patient #45 with NORM,ctrl
"D425-shOTX2_3, t=24",pert
"healthy control fibroblast, biological rep3",ctrl
C3H/HeJ Vehicle liver sample batch 6,ctrl
S3A Sporadic-frontal,ctrl
HeLa cells transfected with UPF1 siRNA 3 (experiment),pert
Age: 40;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
MH1C1_untreated_rep3,ctrl
E14 - nudelko/+ 1,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 84,pert
E81-/-SRFVP16-1,pert
"non-AD_FC, biological rep6",ctrl
wild type MEF(2),ctrl
"endometrioma, patient 19",pert
BP patient 111_biological replicate 1,pert
3471-1 E2F3 Heterozygous,pert
P1 mouse eyeball extracted total RNA_wildtype4,ctrl
CME-LaminA0d-3MA-S2,pert
Control 874G,ctrl
Y HID_B003,ctrl
gender: male;	tissue: heart;	tissue: Transmural sample taken from near the apex of the left ventricle,pert
siControl,ctrl
"ALL_NDS, K41 011509",ctrl
01LNM_CTRL,ctrl
"fibroblast, MFS subject FB1286 rep 4",pert
"human failing LV myocardium, Idiopathic2",pert
Subject #8030-8hr Postinfection,pert
HCC018N,ctrl
P60_PMP22KO_2,pert
5871841165_D,ctrl
patient: 30277;	sample: normal,ctrl
"SFM control cells (24hr), biological rep2",pert
Liver sample from Alcoholic hepatitis group (CA64),pert
"control embryonic stem cells, biological replicate 4",ctrl
"mortality: dead;	ethnicity: Hispanic;	gender: F;	age (yrs): 59;	ld: HCV;	creatnine: 1.4;	mdrd: 41;	gfr: 38;	protein: 0;	hematuria: 1;	c3: 1;	c4: 1;	rf: 96;	hcv: POS;	htn: 0;	dm: POS;	hba1c: 6.4;	meld: 14;	ana: POS;	gp: Nodular glomerulosclerosis, Diabetic Nephropathy;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 1;	bm (basement membrane thickening): 1;	ta (tubular atrophy): 0;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 1;	igm: 2;	c: 1;	empe: P;	bmwid: P;	bmd: P;	edd: P;	no of glomeruli: 6;	glomerulosclerosis: 0;	intact t: 0.9;	arteries: duplication;	if: IGG+IGM++IGA+C3+C1q+ capillary wall linear;	mesangium ig: O;	tissue: Kidney_Biopsy_Liver_disease",pert
12471 UC Inflamed sigmoid colon,pert
Telencephalon cKO 2,pert
Mammary Gland_WT_rep3,ctrl
mouse cerebellar granule cells wild type 8,ctrl
FC 04,ctrl
tissue: non-lesional skin;	urticaria status: affected;	patient: 8,ctrl
Strain: In-house BALB/c mice; Gender: Male; Age: 22 months old; Tissue: Brain; Treatment: 4 hours post LPS 0.33mg/kg BW ip.,pert
subject: 12A;	cohort: 12;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 22;	Sex: F;	batch: Batch_3,pert
"Gender: female, Age: 41 years, Tissue: normal vulva,",ctrl
uterus_veh_PRKO_40hrs_rep3,pert
"breast, pre AFI treatment (H11_1610)",ctrl
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug. At four hours prior to RNA isolation, 2.5uM sapphyrin PCI-2050 (final concentration) was added to the culture. After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",pert
Injured 1 day Rat Retina 2,pert
2-ONS76_b,pert
breast adenocarcinoma from 69yr old female caucasian,pert
Strain: C57BL/6J;	Gender: female;	Age: 6 weeks;	Tissue: whole brain,ctrl
HCT 116  siChe-1 rep2,pert
Large cell carcinoma 008,pert
"1mg/kg/day PFOA, Rep 2, Block 3, liver (low dose)",pert
"imr-32,ccnd1siRNA, t=48, 4",pert
Ago2-IP RNA Wildtype-1,ctrl
n4t6h,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 5,pert
MKK7D control female replicate 3 early timepoint,pert
MDS patient 3,pert
striatum_wild type_24 weeks_replicate 3,ctrl
cell line: U-87 MG;	cell type: glioma,ctrl
"schizophrenia, BA46-45",pert
strain: Top2b+/+ in 129SvEv (minor 129SvJ) background;;	Age: E18.5 embryo;;	Gender: male;;	Tissue: whole brain,ctrl
cell type: Lin- Sca-1+ c-Kit+ (LSK);	age: six weeks old;	genotype/variation: Ott1 flox/null Tg-Mx1cre,pert
none provided,pert
11095 Normal Uninflamed descending colon,ctrl
AGS control biological rep 3,ctrl
"Strain:Wistar, Gender: male, Tissue: cirrhotic liver, Induction of cirrhosis: CCl4",pert
gender: male;	age (years): 41;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
"PBMC, healthy control, biological rep14",ctrl
Huh7 cells_JFH-1 Infected 24 hours_ rep2,pert
e1 Ez f/fMef2c-cre,pert
patient: 221;	current medication: Prednisolone 7mg Asacol Adcal Seretide Fe SO4;	birth date: 1/29/86;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 12/10/01;	diagnosis date: 12/10/01;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/14/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Asthma Eczema;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"HUVEC infected with Control Vector,  biological rep2",ctrl
Pre-frontal cortex from male C57Bl/6 mice 31 d after i.d. injection of Complete Freunds adjuvant,ctrl
MZ1774 mock rep 4,ctrl
01LN7: new onset sJIA,pert
GM19238_Kd_ARNTL2_2,pert
"granulocyte, healthy control, biological rep6",ctrl
CLL 161-04 Control,ctrl
"granulocyte, healthy control, biological rep2",ctrl
cell line: CL-0;	transfection: vector control,ctrl
"TG mouse lung, biological rep1",pert
Leg 14 day mdx rep 2,pert
Tissue: whole retina,ctrl
Gata-1 Wild Type A,ctrl
"DMSO Control after 1hr, replicate 2",ctrl
"Cervical cancer cell line, ME-180",pert
homozygot FH P251,pert
tissue: testis;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
HCC015N,ctrl
Halothane 5 exposures-1,pert
"Control, replicate 5",ctrl
Leg 23 Day Control rep 1,ctrl
Cyclophosphamide-treated spleen 1 day - Biological Replicate 2 - Technical Replicate 2,pert
wt_on_rep1,ctrl
41A,pert
Sample ID: TP16;	Twin Pair ID: CCN1.2R;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.2**,ctrl
OCI-Ly7 BCL6siRNA 3,pert
PGC-1a-/-bf/f/MerCre rep2,pert
SW480_control RNAi_luciferase_rep2,ctrl
colon_epithelium_C57 mouse_12weeks_rep4,ctrl
"breast, post AFI treatment (H13_1647)",pert
"3T3-L1 siLSD1 48h, biological rep 1",pert
Pias1 null IFN-beta 4 h,pert
H1299_shLUC,ctrl
c 4-1,pert
"fibroblast, control subject NM3 rep 1",ctrl
"TMD_TP, T6",pert
"Exp A, Animal #256, 200mg/kg D-Serine",pert
Oligodendrioglioma_1,pert
pediatric AML S06,pert
NT1,pert
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: valproic acid (VPA);	treatment time: 16 hours,pert
strain: C57BL/6J;129S5/SvEvBrd;	genome/variation: Inha-/-;	cell type: granulosa cell;	treatment group: 44-46hr PMSG,pert
Non-silencing control siRNA: AAUUCUCCGAACGUGUCACGU Technical Replicate 2,ctrl
MCL_IGHV_MUT (R1399_M),pert
MCL_IGHV_MUT (R1942),pert
"twin pair: #9;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
"A673 treated with Doxorubicin for 24 hours with concentration of 59.88 nM (EC50), biological rep2",pert
Normoxic Adeno Treated Control N2,ctrl
REST shRNA KD 1,pert
PGA-RMM-4h-3aA-s2,pert
"Notch3 knockout mouse cerebral microvascular fragments, biological rep3",pert
"ES cells: E14 (129P2/OlaHsd background), Genotype: Wild (Phgdh+/+), C57BL/6J background, Gestation: 13.5 days, Tissue: head",ctrl
6-KO_RD3b,pert
NK_cell_pool_healthy_H03+H04,ctrl
"Patient 4, baseline",ctrl
GIST_WT_1,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 19d ID230,pert
"Atria, Control, biological replicate 1",ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: n/a;	maternal age: n/a,pert
A538 MI 1 day,pert
Tobacco_abuse_1,pert
Jurkat 3,pert
gender: female;	mean age: 41.3;	mean bmi: 28.9;	depot: abdomen;	type: white adipose tissue;	ethnicity: Caucasian,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Male,pert
Healthy controls; individual=JL; time=2; beverage=alcohol,pert
patient: 30582;	sample: tumor,pert
RNA from HCC_4N,ctrl
Individual_3777_PN_sample,pert
"S1P3-KO-hippocampus, biological rep2 (male)",pert
PGC-1a-/-bf/f/MerCre rep3,pert
NE-rep8,ctrl
12h Control (SAMPLE 1),ctrl
Trim33-KD-SB-2,pert
GM19238_Kd_GTF2B_3,pert
28A;pretreatment;female;breast tumor; responder,ctrl
Sh-control-3,ctrl
Age: 41;	Cycle: NA;	BRCA1/2 mutation: Negative;	Family History: No,pert
PA-1+(1),pert
N/SM4,ctrl
age: adult;	gender: male;	tissue: lung,ctrl
Tk6 treated with cadmium rep2,pert
4 PC3 2hr,pert
14-0004A_Day1_37,pert
DNGH-3,pert
01N1J_PolyRF-,pert
Leg 112 Day control rep 1,ctrl
Stratagene reference,ctrl
"Pb-Cre+;PtenL/W;K-rasG12D/W, biological rep3",ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 35;	gender: female;	tumor grade: IV,pert
HTH83 SCR 1,ctrl
"gender: Female;	age: 78;	post-mortem delay: 8h;	ph: 6.7;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
genotype: Wild type;	strain: C57BL6,ctrl
"gender: Male;	age: 79;	post-mortem delay: 4h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Peripheral blood mononuclear cells;	TTF=125min;	Race=Black/African American;	Sex=Male,pert
Sample M539,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 4,pert
SeroTest-4,pert
Mammary Gland_WT_rep1,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 2,pert
"CFU-PreB colonies Hspa9+/-, biological replicate 2",pert
"KARPAS-231, LITAF-specific siRNA, REP3",pert
"KO mouse heart at 6-weeks old, biological rep2",pert
OSE_552,ctrl
heart_KO_rep1,pert
Superior Frontal Gyrus from a 10 year-old girl not suffering from Rett Syndrome and therefore considered as a normal subject.,ctrl
"Gender: female;	Age: 25;	Source: skin, left thigh",ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day1,pert
PND28 Rat Testis_Rat230-2_12hr MEHP_Animal#57_04005,pert
con-37_A,ctrl
CD8+_Tcells_severe_asthmatic_3,pert
CD positive WT T cell unstimulated rep2,ctrl
KN-smoke-med-5 month-R4,pert
"CBFb-SMMHCd179-221 animal 2, replicate 2",pert
FW_16c_BV7565,ctrl
Benign prostate tissue NX1,ctrl
KO_PMΦ_rep1,pert
HF0131_U133P2,ctrl
Control_Time_0_2,ctrl
"Vitamin C treated ES cells, Rep 3",pert
platelet_Ctrl_3,ctrl
EA_Case10_CD8,pert
11421 UC Uninflamed ascending colon,pert
"Eed KO BM LT-HSC, biological rep1",pert
cells origin: subcutaneous white adipose tissue;	individual characteristics: Non-obese individual,ctrl
BRCA1-KD-3 (mRNA),pert
JIA PBMC Pre treatment A235_L014,ctrl
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: Control shRNA (Luc),ctrl
"U2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression.",pert
"123, ADIPOOSE TISSUE, Before",ctrl
placebo treated ipsilateral to stroke,ctrl
Gastrocnemius muscle from transgenic mouse overexpressing PPARalpha,pert
"DMD skeletal muscle, biological rep4",pert
Saline_3,ctrl
Normal PBMC_sample 1,ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 3,ctrl
Sirt1 siRNA KD1 1,pert
H720 MK886 1 micromole 24h serum free Sample 2,pert
Mnk_3213-S-7,pert
"Rescue pancreas, biological rep4",pert
Recent-onset T1D_sample2,pert
24h Kin Cel.47,pert
"Vitamin C treated ES cells, Rep 2",pert
RNA from HCC_19T,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/ABL1;	biological replicate: 1,pert
protocol: AP-2 gamma targetting siRNA 3;	cell line: MCF7,pert
cumulus_nonPCOS_Lean_rep4,ctrl
Age: 37;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Unknown,ctrl
Patient: K;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
RTX9 T0,ctrl
22: NORMAL #99-0694,ctrl
INSENS 2 0hr,ctrl
"Atm-/- untreated, B",ctrl
siIPMK + MMC experiment 1,pert
cell line: BV-173;	tissue: Human B cell precursor leukemia,ctrl
"genetic background: Cebpa-Cre;R26-LSL-Eyfp;Dicer1wt/fl/Dicer1fl/fl (donror), C57BL/6 (recipient);	genotype: Dicer wild type;	cell type: YFP-positive  granulocyte-macrophage progenitor",ctrl
Mouse_ATF6bKO_colon_UT_rep1,pert
patient: 14;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
mouse cerebellum at P7 wild type 1,ctrl
T60 dilated cardiomyopathy heart biopsy,pert
01-0060A_Day1_6,pert
"HeLa treated with Cas-II-gly, biological rep1",pert
Wild type 4,ctrl
IFN-KO,pert
Sh-control-2,ctrl
brain_DLPFC_bipolar C_mr780,ctrl
5254 UC Uninflamed sigmoid colon,pert
"shRNA-PGC1a #66, rep-2",pert
"CBFb-SMMHCd179-221 animal 2, replicate 1",pert
"Heart, MAT1 CKO, 4wk, sample 2",pert
MCF-7 +ER siRNA + vehicle rep1 (MD37),pert
prostate tumor 5,pert
gender: male;	strain: C57BL/6;	developmental stage: day 13.5 embryo;	genotype/variation: wild type (WT),ctrl
"Crohn's Disease subject (44 year old hispanic female, SAK_1307613224)",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 180min;	race: Black/African American;	sex: Female,pert
"Rat liver, treated with Caerulein, 50 µg/kg in saline i.p., extrated 48 hours after treatment, biological rep3",pert
ab199 IM,pert
IDCM5,pert
"SLE patient, 1025V1",pert
DUSP1-/- control replicate 2,pert
age: 66;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 135min;	race: Black/African American;	Sex: Male;	fstl-1 (ng/ml): 176,pert
SA_260,pert
RNA from HCC_27N,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 100 pM;	treatment time: 24 hours,pert
OA2,ctrl
Patient 2,ctrl
Dengue Hemorrhagic Fever Patient 49,pert
Cavin-1/PTRF KO #186,pert
siOGT 24 hours_3,pert
CT-receptor-KO osteoclasts untreated 1,pert
SZ13,pert
GM19238_Kd_KLF13_3,pert
Against CDK8-1 rep2,pert
"Prdm14(-/-): 2i, rep2",pert
"YPFH cells from M1, wild type control, biological replicate 2",ctrl
diagnosis: UIP/IPF;	fvc-group: FVC2;	tissue: lung,pert
status: Rapid;	age: 68;	gender: male;	tissue: cultured human fibroblasts,pert
Cardian muscle Trained 3 week T3,ctrl
Human prostate cancer primary culture C24sx,pert
KM_001N,ctrl
Human prostate cancer primary culture C38dx,pert
"Normal subject (50 year old caucasian male, SAK_1276059218)",ctrl
cDNA scc 06,pert
brain_DLPFC_bipolar C_mr677,ctrl
B6.IL10 24 air 2,pert
Embryonic age 14.5 mutant rep2 (PKD1_59),pert
LNCaP/MYB siRNA #2,pert
Carboplatin;	Carboplatin 36 hours set 2,pert
brain_OFC_bipolar B_mr93,pert
Total RNA was extracted from omental adipose tissue from a control subject,ctrl
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: 26;	maternal age: 23,ctrl
Wildtype liver_saline-injected 12weeks repl2,ctrl
"patient: 114;	current medication: None;	birth date: 6/27/36;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Altered bowel habit, Alcohol excess;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: trisomy8,pert
"SKO-transduced MEFs, Vc+, D5",pert
C7med,ctrl
"IRF6 knockout, biological rep1",pert
shRNA 94 R7 T5,pert
455MM,pert
HepG2 cells quercetin 4h,pert
695_383_4hr_repeat,pert
ShKdm2b replicate 3,pert
Normal-ERα-positive breast cancer 34,ctrl
HCC010N,ctrl
Rosiglitazone treated cells Rep2,pert
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype N/A;	matched/unmatched: unmatched,pert
strain: C57BL/6J;	day: 24;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 3,ctrl
GFP 0hr 282295433,ctrl
tissue: whole Gastrocnemius;	gender: adult male;	strain: CD1,ctrl
coc-51_C,pert
tissue: Liver;	genotype: GPR120 KO;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 429,pert
Cell bank no: RCB1648;	Cell name: Hep G2 ;	Sex: male ;	Age of sampling: 15 years ;	Tissue derived: liver ;	Case history: hepatocyte carcinoma ;	Life span: infinite ;	Classification: Transformed,pert
GC13_skin_5dpn_2,pert
cell type: DN4,ctrl
"BMMCs from NTAL WT, NTAL shRNA infected, 2 h activated, biological rep1",pert
"normal mouse kidney E12.5, biological rep 2",ctrl
"ALL_NDS, K62 011409",ctrl
tissue: liver;	genotype: WT;	genetic background: C57BL/6,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 76 years,pert
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14536;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"PMA treated, no doxycycline; biological replicate 2",pert
affected status (disease state): control;	gender: female;	age-at-examination: 48;	age-at-onset: n/a;	geographical origin: Lisboa;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever drinker,ctrl
advanced HCC,pert
MSE_D_645,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.536;	OD280: 0.766;	Ratio: 1.98;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 299;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"cochlea at P60, wt, biological rep 2",ctrl
Squamous cell lung cancer X35nml,ctrl
pool of 3 normal E12.5 kidneys,ctrl
HET Brain 67d Mouse1,ctrl
SZ27,pert
Colo-205 PLX Day 1,pert
H295R _2OHBDE85_rep1,pert
age: E14.5;	gender: male;	tissue: dorsal telencephalon;	genotype: histone methyltransferase ESET KO;	genetic background: C57BL\6,pert
"ALL_DS, K5 012109",pert
cell type: leukemic spleen cells;	genotype: CBFb-SMMHCd179-221 chimera,pert
tissue: Fallopian tube;	cell type: epithelium;	cell line: OE-E6/E7,ctrl
disease state: endometrioma;	patient: M1,pert
P4_Ovary_Control_biological rep3,ctrl
control to Sample 19,ctrl
MDS patient 6,pert
"ALL_NDS, K32 011609",ctrl
PA-1-(1),ctrl
RAW_2.8mM_HOCl_#3,pert
Ishikawa_LowDose_BPA_24h_rep1,pert
Cardiac Muscle_mdx_rep2,ctrl
BT474-J4_Lap_24-3,pert
The caudate nucleus from a neurologically normal Jpanese male (aged 60 yr).,ctrl
V5-P117,pert
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 0h,pert
81 year old female,pert
p53_siRNA_0b,pert
HC JL 2 water,ctrl
WT MEF CT30-3,ctrl
"breast tumor epithelium,16",pert
AFFS084-1-291004,ctrl
chip number: 18;	transfection plate: 3B;	target gene: PAX5;	kd level: 0.82;	rin: 9.5;	transfection date: 2012-03-26,pert
"patient: 119;	current medication: Salubtamol, Bricanyl;	birth date: 9/30/70;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/27/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
KO - knock-out Treated - 0.5 hrs - repeat 3 - Cy5 - mAdbID:62540,pert
"RKO colon carcinoma cells (ATCC #CRL-2577), cultured in DMEM (Invitrogen Catalog#10569) containing 10% FBS (Atlas Biologicals)",pert
A VIS _B068,pert
Sex: male;	Age at operation: 60 years;	Site: upper arm;	Size in cm: 9.9x7x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
strain: 129/Ola;	cell type: embryonic stem cells,pert
"N-56, NORM, M, GSF, 6 x ETOH, 14d",ctrl
Heart-Base_WT-3,ctrl
Diagnosis: AML M2;	Age: 41y ;	Gender: Male;	Blast %: 70;	Source: PB;	Cyto: Normal;	FLT3 ITD: No Data;	FLT3 TKD: No Data,pert
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/wt, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 37;	gender: male,pert
CML_6_GMP,pert
"Ifitm1-deficient lung tissue, biological replicate 2",pert
Diabetic 1 week D1,pert
"Testosterone treated, HIV-1 positive male, day 14 (8)",pert
"AD_FC, biological rep14",pert
"NPTX1 shRNA Day 3, biological rep1",pert
Strain: C57BL/6;	Age: E14;	Retrovirus: MSCV-D1a,ctrl
DOV13-(2),ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs induced with doxycycline and cultured for another 24h,pert
"S100a10 cells, p11 KO, cortex, TRAP RNA, FLX treated, biological rep2",pert
Monocytes from buffy coat preparation,pert
"control, untreated muscle cells",ctrl
HCT 116 control rep1,ctrl
"vehicle, biological rep5",ctrl
"MIST1-null pancreas, biological rep1",pert
.SAL_II_3,ctrl
multiple myeloma (MM 199),pert
NCCIT siNTC rep2,ctrl
strain: C57BL/6J;	genotype: Cmah KO;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle,pert
"seminoma specimen, pT1, patient age: 40y",pert
Individual_4344_PN_sample,pert
hNHEPS_10 μM_6 h_rep3,pert
"Patient 10, Macroscopically intact tissue",ctrl
2: FCHL patient #98-1103,pert
KN-sham-5 month+13d-R2,pert
WT-Fibr1 5,ctrl
Individual_5079_NN_sample,ctrl
race: caucasian;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: secretory endometrium,ctrl
B4 363 b4-/- untreated,ctrl
RNA from HCC_6N,ctrl
cell line: E14;	treatment: REST knockdown,pert
"OuJ, air, biological rep 1",ctrl
"lymphoblastoid cell line from F16.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
FVB_MMTV_Wnt1_iFGFR1_4013_3L_ROSEN,pert
strain: C57BL/6J;	age: 4 months;	gender: male;	tissue: lung;	genotype/variation: Ifitm1 k.o.,pert
cell line: KM-H2;	treatment: CIITA-BX648577 knockdown,pert
10P-M4,pert
38A;pretreatment;female;breast tumor; nonresponder,ctrl
CD4DecTp2-6,pert
Human prostate cancer primary culture C27dx,pert
NuLi cell line biological rep2,ctrl
"AG825-treated, 24h after UV, Replicate B",pert
"Transgenic mice with water, replicate 3",pert
GFP,ctrl
S1C Sporadic-hippocampus,ctrl
Control Day7 (418L),ctrl
"gene expression of wild type oocyte, replicate 3",ctrl
PBMC from T cell LGL leukemia patient #101 (TLGL101),pert
Mouse No Cldn16 B9 457,pert
"Control Distal, Small Intestine 3 21 days old",ctrl
"Normal cervix, Age 56",ctrl
SKI-DLCL cells were treated with AraC alone in concentration 20nM for 24h. Total RNA was extracted,pert
DuodTumor0225AFBW_dtb.txt,pert
A375 cells 24h Vemurafenib rep2,pert
"PPARg d4, rep 7",pert
"twin pair: #1;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; Pten+/loxP,pert
H2009_shLUC,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_2h_0.4mM_HG-U133A_2_YCHSUP501,pert
AA_Case15_CD8,pert
Patient: M;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
Subject #8013-8hr Postinfection,ctrl
chip number: 20;	transfection plate: 5;	target gene: RELA;	kd level: 0.79;	rin: 7.9;	transfection date: 2011-10-17,pert
cell type: AML blasts;	fab classification: M4,ctrl
MCI-013,ctrl
"TGCT cell line NTera2/clone D1, untreated, undifferentiated and pluripotent",pert
Mening UNSTIM WB NP 12b,ctrl
"breast tumor epithelium,35",pert
aa_NY82,pert
CBA2,ctrl
liver_STZ treated diabetic_rep3,ctrl
BT474-J4_Lap_24-1,pert
"ES cell mutant, RNA 307",pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 59,ctrl
U138MG shcontrol 1,ctrl
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 5,pert
"human failing LV myocardium, Idiopathic44",pert
tissue: whole Gastrocnemius;	gender: adult male;	strain: CD1,pert
218/4,pert
100uM H2O2 rep 2,pert
"acutely admitted, severely psychotic schizophrenia patient  A21",pert
very early HCC,pert
H441 transfected with scrambled siRNA 3,ctrl
BMM_C3H/HeJ_time21h,pert
PlagL2KO1,pert
Bronchial Epithelial Cells MMA biological 1753C,pert
K562 cells control replicate 1,ctrl
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 1h;	donor: 3,pert
WT - Cre Control - 3 mo - repeat 2 - Cy3 - mAdbID:74589,ctrl
Pias1 null IFN-gamma 4 h,pert
"shCDK19, low glucose, replicate 1",pert
day 30 5-FU HSC 1,pert
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 34;	Usage number: 4;	Exposures: 2,pert
cell line: RT112;	transduced: FGFR3 shRNA 4-1;	doxycycline treatment: no,pert
PGA-RMM-4h-1aA-s2,pert
strain: Swiss;	tissue: Ovary;	agent: 4-Vinylcyclohexene Diepoxide (50uM);	replicate: 3;	age: Post natal day 3-9,pert
Control Braak α- synuclein Stage 0 C6SN,ctrl
siCtrl_0_rep1,ctrl
"experiment 2, ethanol-treated 1",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.77534,pert
"HUVEC, untreated 2",ctrl
E100-/-SRFVP16-2,pert
"WT cells, replicate 3",ctrl
"brain, frontal cortex: Sample52_e1_le1",pert
nmMLCK-/- -VILI replicate 2,pert
CRC_celecoxib_M4858,pert
"IGF-treated cells (3hr), biological rep2",pert
gfp control sample 2,ctrl
Control A549 cell Replicate2,ctrl
Sham 21 replicate 2,ctrl
Thyroid_papillary carcinoma 71,pert
genotype/variation: GSK-3b-/-;	cell type: embryonic stem cells,pert
Mammary gland R1 16 hr rep2,pert
10uM H2O2 rep 4,pert
HC IF 2 alcohol,pert
CF control DFW CHN312,ctrl
V5-P495,pert
Nrl-ko-Gfp 4 weeks replicate 2,pert
genetic background: CD1;	genotype: A2AR KO;	Sex: male;	age: 14 weeks;	tissue: ventricular myocardium;	treatment: saline,pert
"Control #7, Untreated",ctrl
REST shRNA KD 3,pert
"D425-control, t=16",ctrl
tissue: ankle joint;	genotype/variation: MMP-8 KO;	strain: C57BL/6,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 32;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: Hep G2;	genotype: wild-type THRA and;	treatment: with 100 nM T3 for 6h,pert
wild type MEF time 24 replicate 2,ctrl
Mnk_3149-R-B,ctrl
AP-920050,pert
PGA-RMM-45m-1aA-s2,pert
A2008-(3),ctrl
Psoriatic arthritis PsA 17,pert
Lung WT-PBS replicate 1,ctrl
Liver_nash metformin_no.4,pert
WT3-3,ctrl
BL Day 1 siMut12 transfected biological rep3,pert
RAW_00.35mM_HOCl_#2,pert
A549_EGFplus_rep2,ctrl
treatment: 1 ug/ml doxycyline;	time: 36 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
"wt muscle 2, biological rep 2",ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 2;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
cultured MGP melanoma cells,pert
A_LS_Time0,ctrl
LY2 SRC1-siRNA untreated rep2,ctrl
01N4L_Oligo,pert
"7B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Bach2 KO - Thymus - biological repeat 2,pert
3275-1 E2F WT,ctrl
a_NY18,pert
fat_Wt_8wk_rep1,ctrl
MEF.FHL2mutE,pert
PB_DON040,ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 4;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.683;	OD280: 0.839;	Ratio: 1.98;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 294;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
sepsis patient #5,ctrl
IRS-1 KO (jos0678),pert
OVCAR-8+(2),pert
LNCaP.FoxA1.2,pert
gender: Male;	age (y): 48;	tissue: prolactinoma,pert
"Amoxicillin treated Proximal, Small Intestine 2 21 days old",pert
EA_Case21_CD20,pert
lymphocytes_ctl_M_42y,ctrl
"AALE-Vector uninfected, biological rep1",ctrl
siLMO3_oligo2_FM_rep1,pert
T15,pert
wild type MEF time 6 replicate 2,ctrl
HaCaT_Control_ biological rep1,ctrl
HCC010T,pert
HepG2_5-aza_rep2,pert
Cutaneous psoriasis without arthritis PsC 10,pert
SCLC cell line Lu-130,pert
sample: #9;	subject: Control case #4;	brain: T-779;	age: 76;	sex: Female;	region: Dorsal motor nucleus of the vagus,ctrl
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 32;	maternal age: 38,ctrl
pediatric AML S04,pert
tissue: Frontal cortex;	age: 83;	Sex: M,ctrl
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 77;	Usage number: 1;	Exposures: 4,pert
strain: C57BL/6;	cell type: hepatocytes;	genotype/variation: GNMT-KO;	agent: aflatoxin B1 (AFB1),pert
Sham 5,ctrl
Patient 8,ctrl
strain background: C57Bl/6;	genotype/variation: Lrp5+/+;	cell type: primary calvarial osteoblasts;	time point: day 7 of differentiation,ctrl
P0 - WTMixB 1,ctrl
WT Uterus_saline_24h_rep1,ctrl
WTT 164 bleomycin treated,ctrl
Ero1-WT induced biological repB,pert
Patient: E;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
"P16 mutant OC base, biological rep 1",pert
age: 42;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Akt1 wild type 3,ctrl
db/m 6-2,pert
11389 Normal Uninflamed sigmoid colon,ctrl
mouse B6xCF-1 RNAi transgenic,pert
brain_Down_syndrome_sampleid_jg1741,pert
"brain, brainstem: PB3_e1_le1",pert
"gene expression of CTCF-depleted oocyte, replicate 4",pert
cumulus_nonPCOS_Lean_rep1,ctrl
Retina wildtype 30 days 2,ctrl
Cervical cancer_1798T,pert
cell line: Reh;	transfection: IKKb(EE);	malignancy: non-Hodgkin lymphoma,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.7;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 53;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
05SAGEA,pert
Liver_hyperglycima_no.5,pert
stomach,ctrl
healthy control_4,ctrl
PGA-HMO-MObese-4aUA-s2,pert
Infected Jurkat cells (replicate 2),pert
Silberg2 (S11) 25091BE,pert
striatum SNCA knockout 21 month replicate 2,pert
cell type: Lin- Sca-1+ c-Kit+ (LSK);	age: six weeks old;	genotype/variation: Ott1 wild type,ctrl
db/m 6-4,pert
"Patient 27, Atheroma plaque",pert
E100-/-vector-2,pert
A HID I_B083,pert
4117-1 E2F1 Null,pert
GIST Pre Treatment Biopsy 56,ctrl
liver_STZ 0.1% quercetin diet_rep4,pert
DMSO treated CEM-C1 cells_2,ctrl
"treated with Roziglitazone, 1000 mg/kg in Methylcellulose soln per orally, extracted 48h after treatment, biol. rep1",pert
SA_114,pert
Control subject 33_biological replicate 2,ctrl
"Acute Myeloid Leukemia, sample 9",pert
Day: 1; Drug: Heroin; Phase: Drug treatment; Replicate: 3,pert
"lymphoblastoid cell line from F6.04, one out of seven of sensitive group, 50*10e6 cells",pert
"non-AD_FC, biological rep17",ctrl
STHdhQ111/Q111-A,pert
"Global gene expression of NASH patients, Normal control A486",ctrl
TN 5,ctrl
"TGCT cell line NTera2/clone D1, treated 7 days with retinoic acid, differentiated",pert
NonIR-WT_Rep3,ctrl
cell line: HL-60;	shRNA construct: GSK3A Construct 5,ctrl
695_383_8hr_repeat,pert
1089PBMC,ctrl
MOLM14-shGSK3B-Construct2-rep2,pert
P4_PMP22KO_2,pert
8 week old EOM control rep 5,ctrl
EA_Case13_CD8,pert
GIST_KIT_7,pert
siPin1.exp1,pert
"patient: 126;	current medication: None;	birth date: 4/4/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: FH of Crohn's disease, Symtom free at procedure;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
"fibroblast, MFS subject FB1286 rep 3",pert
A HID B_B011,pert
"20 days normal mice, cerebrum",ctrl
GM19238_Kd_NR3C1_3,pert
condition: control;	tissue: decidous teeth dental pulp;	gender: female,ctrl
PCOS Endometrium Epithelial Cell_105.PC07_EpCAM,pert
subject id: c1;	infection: control;	status: control;	tissue: whole blood,ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: E2;	time: 24h,pert
V5-P122,pert
brain_DLPFC_bipolar C_mr521,ctrl
disease state: paediatric glioblastoma;	age: 15;	gender: M;	h3.3_status: G34R,pert
NINDS-RHS-Ctr_240h-1aUA-s2,ctrl
A_AN16115_F,pert
condition: Psoriasis;	patient: PS-C;	tissue: LS skin biopsy;	kit: Affy,pert
"brain, hippocampus: inhibitor-1 KO 3_e1_le1",pert
"SKO-transduced MEFs, Vc-, D3",ctrl
Brain_Wild-type_MiceNoLT340,ctrl
CH1+(2),pert
scan batch: Batch 1;	group: control;	subject age: 4;	paternal age: 35;	maternal age: 33,ctrl
strain: C57/Bl6;	gender: N/A;	age: 4 months;	weight: 25-30g;	tissue: whole trachea,ctrl
strain: C57BL/6;	genotype: PTEN+/- (epithelium);	age: 12 months;	tissue: lateral prostate,ctrl
No_abuse_4,ctrl
age: 6 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
Liver_untreated_wild type_rep1,ctrl
colon_CRC_1556,pert
PGA-MAH-AJ_OVA24h-1aA-s2,pert
Young 10,ctrl
"Patient E, lesional skin",pert
subject id: 60;	infection: DENV;	status: DHF;	tissue: whole blood,pert
genotype: Bcl6 knock-out;	cell type: FoxP3+ Treg,pert
CRC_nodrug_M4865,ctrl
cell line: KGN;	transfection: FOXL2 stealth RNAi,pert
"Patient 32, Macroscopically intact tissue",ctrl
LDLR_LF_2,pert
"MCF7 cells stably transfected with XBP1, passage 6",pert
n10t24h,pert
DBA/2J Vehicle liver sample batch 3,ctrl
"SPC-c-raf transgenic mice, 10 month old, female, tumor",pert
"fibroblast, MFS subject FB992 rep 1",pert
Intestine_KO_biological rep1,pert
Huh7 cells_Mock Infected 18 hours_ rep2,ctrl
CBMNC.LPS-.3,ctrl
"human failing LV myocardium, Idiopathic83",pert
Septic shock;	gender: Male;	Non survivor;	organism: None,pert
subject: 03A;	cohort: 3;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 40;	Sex: F;	batch: Batch_1,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 7.1;	colon weight (mg): 151;	colon ratio (mg/mm): 2.127;	myeloperoxidase activity (u/mg): 0.082;	tissue: colon;	treatment: 5% DSS,pert
"dy/dy dystrophic diaphragm 2, 8 week",pert
LJMJDW1,ctrl
Pediatric_GBM_24,ctrl
cell type: Osteoblastic lineage cell;	strain: C57BL/6;	phenotype: Scl-tTA::TRE-BCR/ABL;	time point: 5-6 weeks post doxycylcin withdrawal,pert
460MM,pert
RA7,ctrl
Mock infected murine liver-MO30k-(B)-6 hpi,ctrl
treatment: naïve;	transgenic variant: AChE-S;	tissue: Caudate-Putamen;	genetic background: FVB/N,pert
CD8_T_cell_pool_melanoma_M11+M12,pert
cell type: monocyte;	disease state: homozygote FH,pert
CTRL_4_MEP,ctrl
tissue: prostate;	normal/tumor: tumor,pert
MCL_IGHV_MUT (R1610),pert
Animal 9,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 70min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 248,pert
race: caucasian;	age (years): 43;	stage: IB;	grade: 3;	histology: endometrioid,pert
hNHEPS_control_0 h_rep2,ctrl
THRB wt + vehicle replicate 2,ctrl
"WT mouse skin treated once with TPA and collected 24 hr later, replicate 1",ctrl
8 Weeks Heart Control rep 2,ctrl
control to Sample 3,ctrl
"Pancreas from adult Rkip-1 KO mice, biological replicate 1",ctrl
treatment: baseline;	gender: F;	age (y): 77;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
knockdown: TNFa siRNA-A;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.4;	colon weight (mg): 171;	colon ratio (mg/mm): 2.672;	myeloperoxidase activity (u/mg): 0.204;	tissue: colon;	treatment: 5% DSS,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 40;	maternal age: 40,pert
PGA-lv_48h_520,ctrl
BCells_WildType_day0_REP3,ctrl
H19_P_B2,pert
"RWPE1 cells, vehicle, 6h, biological rep1",ctrl
"Acute Myeloid Leukemia, sample 40",pert
"ERbKO mouse aorta with placebo, biological rep3",pert
P53_cKO_3,pert
Tet2 KO LSK rep1,pert
tissue: Hippocampus;	age: 95;	Sex: F,pert
RTX5 T0,ctrl
age: 35;	sex: M;	disease status: control subject;	Filter number: 79;	Usage number: 1;	Exposures: 3,ctrl
cell type: MEFs;	genotype/variation: wild type,ctrl
"Control Proximal, Small Intestine 1 21 days old",ctrl
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro Technologies;	Cause of Death: Anoxia;	Tobacco Use: No;	1st technical replicate,pert
"T-cell prolymphocytic leukemia, inv(14)(q11q32), case 3",pert
SCC-40_siZMPSTE24_rep.1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.918;	OD280: 0.454;	Ratio: 1.99;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 301;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
n4t0h,pert
HUH-nonsense-#3,ctrl
disease state: endometrioma;	patient: 2,pert
11_0008C_Day1_21,ctrl
wild-type #1,ctrl
Gsk-3b-/- ESCs Rep2,pert
ILKR211A3,pert
subject: 13B;	cohort: 13;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 16kb;	age (y): 42;	Sex: F;	batch: Batch_3,pert
Peripheral blood mononuclear cells (PBMC)-Patient CCa T1,pert
12467 UC Inflamed sigmoid colon,pert
E9.5 KLF1-/- erythroid-6,pert
"Empty vector control, 72 hrs, No Rosiglitazone (NONE_72_1)",ctrl
patient: 266;	current medication: Prednisolone ciproxin mesalazine fosomax Fe SO4;	birth date: 8/12/40;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/22/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 700;	esr: 0;	crp: 20;	hb: 93;	wcc: 17;	neutrophils: 16;	albumin: 23;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 0;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/22/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: COPD-Previous severe pneumonia;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
cell line: MCF10A;	treatment protocol: Vehicle,ctrl
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 68",pert
"HUVEC, atorvastatin 2",pert
db/db 13-5,ctrl
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 24hr,pert
106A,ctrl
cell type: Primary hepatocytes;	strain: FVB;	agent: control;	time: 24h;	gender: Female;	age: 5 months,ctrl
SENS 1 0hr,ctrl
Patient: C;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
"acutely admitted, severely psychotic schizophrenia patient  A04",pert
GM19238_Kd_NFYC_1,pert
Muscle PCOS 13,pert
"Metformin, biological rep2",pert
E9.5 KLF1-/- erythroid-5,pert
D2 patient,pert
4160M patient’s mucosa,pert
3DKD_SerumStarved_rep3,pert
Brain_Wild-type_MiceNoLT345,ctrl
EF1a-control_1,ctrl
LNCaP-abl_siHIPK2_2,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_2h_0.4mM_HG-U133A_2_YCHSUP501,pert
Targretin_mammary_3,pert
gender: female;	batch: 2;	age (years): 23;	patient id: Non_severe_4;	fev1 (% predicted): 84;	fvc (% predicted): 81;	medication: Salbutamol;	cell type: CD4+ T-cells,pert
"array 16, unimplanted",ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 57 years,ctrl
Pax_S6,pert
WFS1 KO USHT_15_329_wt,pert
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p27;	strain: E14,pert
PZA treated-42d-1,pert
11377 Normal Uninflamed ascending colon,ctrl
brain_DLPFC_bipolar C_mr404,ctrl
minor HCC9,pert
231_Empty_rep1,ctrl
"brain, hippocampus: C72-III_e1_le1",ctrl
1 h,pert
strain: mixed C57BL6;	genotype/variation: Rptrflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,pert
age	43;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	6.8;	hemoglobin (g/dl)	14;	platelet count (/nl)	311,ctrl
KO HPC Veh 30,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: B;	genotype/variation: NET1 present;	agent: no LPA (control),ctrl
"gender: Male;	age: 38;	post-mortem delay: 6h;	ph: 6.9;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 2 - Technical Replicate 2,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 2;	bead chip array sentrix code: 4421339046,ctrl
whole tissue section from case 1206,pert
cell line: HEK293T,pert
"BOEC, normal 4",ctrl
LCH5ani,pert
colon_adenoma_1312,pert
stomach_1h_rep1,pert
THRA aI mutant + T3 replicate 2,pert
"219, MUSCLE, Before",ctrl
healthy control H24,ctrl
Wt_cycling_rep1,ctrl
OCI-Ly1_FOXP1 overexpression,ctrl
strain: C57BL/6;	tissue: cerebellum;	genotype/variation: Cxcr4 null,pert
HF0526_U133P2,ctrl
180D0,pert
"Rat liver, treated with Caerulein, 50 µg/kg in saline i.p., extrated 48 hours after treatment, biological rep1",pert
cell type: HeLa;	genotype/variation: Transfected with wild type Neuroserpin,ctrl
06_ADL,pert
118A,ctrl
Sex: female;	Age at operation: 58 years;	Site: pelvis retroperitoneal;	Size in cm: 4x7x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: metastasis;	Previous radiation: no;	Previous chemotherapy: no,ctrl
2.5uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate A,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 31;	maternal age: 28,pert
tissue: skin;	individual: Patient P8;	condition: ANL;	eczema severity: SCORAD: 0,pert
day: d00;	strain: C57BL/6;	genotype: KO;	experimental run: eX,pert
BALB/c d18 (bmsnmix4),pert
"Vehicle treated, DAY 4, biological rep.1, MV4-11 cells",ctrl
A549_siScramble_rep.2,ctrl
sample =Healthy1 treatment=Stimulated time=180 (min),ctrl
C13+(3),pert
Extract:LOX-1:113502;	Extract Description:GFP_Untreated_24hr:113502;	Quality: Classification:Medium;	Quality: Gradient Severity:0.12;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.46;	Quality: Background Mean Dev.:0.06;	Quality: Absent (%):60.04;	Quality: Absent (%) Dev.:1.38;	Quality: Scaling Factor:0.87;	Quality: Scaling Factor Dev.:2.22;	Pretreatment [C]:GFP;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113502;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_24hr;	RNA extraction source key [A]:282295843,ctrl
UV-SeV 3482,ctrl
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/22,ctrl
MCAD 1,pert
BxPC3-KO111 rep 3,pert
"G42 cells from M1, wild type control, biological replicate 4",ctrl
"strain: C57BL/6J;	genotype: Tmod3-/-;	phenotype: small fetal liver, anemia",pert
tissue: Hippocampus;	age: 99;	Sex: M,pert
5245 UC Uninflamed sigmoid colon,pert
"WT mouse skin treated once with acetone and collected 24 hr later, replicate 2",pert
17A;pretreatment;female;breast tumor,ctrl
tissue: white blood cells;	age: 10.37;	Sex: male,pert
Ishikawa_HighDose_BPA_48h_rep2,pert
endothelial_rep16,ctrl
Skinbiopsy_7hoursnickel_nickel_allergic_subject_P5,pert
ACC Xenograft X6,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: Vemurafenib 1000 nM for 48h,pert
3885-1 E2F WT,ctrl
A673_CloneAsp14_Dox_0h_1,ctrl
Bulun 2-3h-,ctrl
11n,ctrl
RAW CstF-64 2,pert
"Immortalized MEFs WC, v-src expression retroviral vector infected, rep3",pert
Parkinson's disease sample x190,pert
esophageal squamous cell carcinoma from patient E1603,pert
"AG825-treated, Sham UV, Replicate E",pert
"vector d2, rep 2",ctrl
colonic_mucosa_non_inflamed_877,pert
n5t6h,pert
U937_ROS_untreated_18h_rep1,ctrl
T21_4,pert
GIST_PDGFRA_2,pert
Normal subject 2,ctrl
strain: C57Bl6;	age: 4 weeks;	cell type: BCR-ABL1 transformed pre-B cells;	disease state: BCR-ABL1-driven ALL;	genotype/variation: Wild-type;	treatment: Imatinib (2uM for 16h),pert
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
amygdala no access to cocaine replicate 1,ctrl
"Cadmium 0.55 µM, biological rep3",pert
"SPC-c-raf transgenic mice, 10 month old, male, tumor",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 58;	Sex: male;	region: CB (cerebellum);	genotype: Y/Mecp2-;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,pert
colon_CRC_1377,pert
control6,ctrl
RTX3 T12,pert
normal control,ctrl
Control LM2 Cell on HMVEC-L Replicate 2,ctrl
SLE CD4 T cells 4,pert
Healthy2-CD4,ctrl
"age at diagnosis: 47;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: 0;	pgr: NA;	dfs-month: 13;	dfs-event: 0;	distant metastasis: 0",pert
control-4,pert
strain: B6/C3H F1 hybrid;	gender: male;	age: 30-month-old,pert
AKO-rep3,pert
RV64.03_CONTROL_day25_Slide51,ctrl
Control replicate 5,ctrl
Silberg2 (11) 130701NE,ctrl
n11t24h,pert
Cyclophosphamide-treated spleen 1 day - Biological Replicate 3 - Technical Replicate 1,pert
Glioblastoma_6,pert
GFP Zfx wt 3,ctrl
Pancreatic Cancer PBMC Sample 3,pert
"wild-type DP cells, biological rep 3",ctrl
Mic29_muscle_control,ctrl
"Patient 999, baseline",ctrl
WT-Fibr2 5,ctrl
"DMSO-treated, 6h after UV, Replicate E",ctrl
Panc0403 rep-2,pert
KU_45T,pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6.2;	colon weight (mg): 170;	colon ratio (mg/mm): 2.742;	myeloperoxidase activity (u/mg): 0.643;	tissue: colon;	treatment: 5% DSS,pert
cell line: LNCaP,pert
cell line: bj-fib_1: BJ (CRL-2522) fibroblasts were purchased from ATCC.,ctrl
siHic5_2_2h_1,pert
"Normal subject (45 year old caucasian female, SAK_1290231506)",ctrl
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G63,pert
WT 2 mon replicate 2,ctrl
pediatric AML S29,pert
KO_TER119+_rep3,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
"Male, 34 years old, HIV infection of 9 years",pert
2 hr EE repl 1,pert
8 week old control mouse diaphragm,ctrl
19A;pretreatment;female;breast tumor,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 47, stage IIB, HPV 16",pert
brain_control_sampleid_mr276,ctrl
SZ6,pert
cell type: Primary hepatocytes;	donor: 5;	agent: control;	time: 24h;	gender: Male;	age: 73 years old,ctrl
Klf9WT_jejunum_PND30_4,ctrl
disease unaffected colon of a adult with ulcerative colitis (UC).,pert
"age at diagnosis: 35;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 0;	dfs-month: 65;	dfs-event: 0;	distant metastasis: 0",pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Liver",pert
"age at diagnosis: 37;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIC;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N3b;	er: 1;	pgr: 0;	dfs-month: 65;	dfs-event: 0;	distant metastasis: 0",pert
whole tissue section from case 1045,ctrl
umbilical cord_bpd: 9F,pert
Individual_4177_PP_sample,pert
"Metastatic, prostate cancer",pert
482MM,pert
"hepatic gene expression at ""0 hr"", rep2",ctrl
Weight:High;	CFstatus:knockout;	Sex:Male,pert
MIC5,ctrl
tDEA005.CEL,pert
PGA_MI_nilv_1h_392,pert
HF1185_U133P2,pert
"A pool of two pure subsets of peripheral blood CD8+ T cells (CD19- CD3+ CD4- CD8+ CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
gender: female;	age (years): 60;	evolution time (years): 29;	disease extension: Pancolitis;	treatment: 5-ASA,pert
MBD1 WT #2,ctrl
Cerebellum_nontransgenic control S46_3.5 months_replicate 3,ctrl
1000uM H2O2 rep3,pert
PTEN25+_rep2,pert
tissue: Hippocampus;	age: 77;	Sex: M,ctrl
cell line: bj-ipsc_1: BJ normal human fibroblasts (CRL-2522) were from ATCC and reprogrammed to iPSC with the protocol defined below,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-sp1,pert
Sex: male;	Age: 13;	SL: 6.36;	House: 1;	Severity: SS;	Ashworth: 4;	Zancolli: 3;	PEFF: -5;	PESF: -90;	AEFF: -70,pert
"Estradiol, rep 3",pert
"metastasis: none;	Stage: 1;	tissue: normal, homogenized",ctrl
3886-1 E2F1 Null,pert
A2_C2_nasal_stem_cell_rep1,ctrl
TL3 LAMC2 KO 2,pert
Klf9 wild type (Klf9WT) mice jejunum; Age: PND 30,ctrl
FVB_8W_2_2,ctrl
Ulk1/2+/+ + IFNβ 2,ctrl
"alveolar macrophages, smoker 058",pert
strain: C57BL/6J;	day: 15;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
MDS patient 157,pert
0105-01-A,pert
10.5 Months Heart Control rep 2,ctrl
"Exp A, Animal #243, control (0mg/kg) D-Serine",ctrl
"fibroblast, MFS subject FB969 rep 2",pert
"Age: 56;	Sex: M;	Ancestry: African;	Smoking status: smoker, 80 pack-years",pert
"WT LSC, biological rep1",ctrl
Control spleen - Biological Replicate 5 - Technical Replicate 1,ctrl
"ALL_NDS, K48 011409",ctrl
MCF-7 cell_DMSO_12hr_biological rep2,ctrl
BAL_20a_A1B1,pert
Liver GPR120KO HFD #428,pert
LNCaP.FoxA1.5,pert
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 6",pert
p300+/- Rep1,pert
KN-smoke-low-5 month+1d-R4,pert
genetic modification:;	tissue: breast adenocarcinoma,pert
phenotype: control;	gender: male;	case_id: 366;	age: 69;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 16;	brain ph at time of freezing: 6.6;	labeling_batch: 2,ctrl
Subject #8022-Preinfection,ctrl
14-0002A_Day1_36,pert
A2058 Ctrl siRNA Rep3,ctrl
Diaphragm 56 Day control rep 2,ctrl
wt_P2_rep4,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 2 month;	treatment: fresh air, treatment over 2 month, 4x1h exposure per day",pert
"tissue: neurectoderm derived from embryonic stem cells;	treatment: Geminin knockdown, shRNAmir #9;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",pert
systolic heart failure due to ischemic cardiomyopathy,pert
A5_scrb,ctrl
cell type: HUVEC;	treatment: RAF1 WT,ctrl
umbilical cord_bpd: 1C,pert
Mutant biological rep3,pert
D_Kin_2,pert
CuFi cell line biological rep1,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 3,pert
colon_0h_rep2,ctrl
Ishikawa_HighDose_BPA_48h_rep4,pert
subject id: 42;	infection: DENV;	status: DF;	tissue: whole blood,pert
"General population, Male",ctrl
H13_S_B2,pert
strain: C57BL/6;	tissue: Skin;	cell type: keratinocyte;	gender: female;	age: E18.5;	genotype/variation: Control;	treatment: calcium,ctrl
scan batch: Batch 1;	group: autism;	subject age: 3;	paternal age: 26;	maternal age: 24,pert
Tumor_18w_erlotinib2_DEN_138,pert
age: 66;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"Organism: Homo sapiens (human) Morphology: lymphoblast;	Source: Organ: bone marrow;	Disease: chronic myelogenous leukemia (CML) ;	Age: 53 years ;	Gender: female ;	Cytogenetic Analysis: The stemline chromosome number is triploid with the 2S component occurring at 4.2%. Fifteen markers (M1 and M(15)) occurred in nearly all S metaphases. Spontaneous non-specific dicentrics occurred, but rarely. Unstable markers were also rarely seen. The X was disomic, and N9 was nullisomic. ",ctrl
newborn (P0) Krt1+/+ skin_replicate 2,ctrl
"JAG1 overexpressed CL1-0, biological rep2",pert
"NPTX1 shRNA Day 2, biological rep1",pert
strain: C57BL/6J;	genotype: HDC-EGFP;	age: 7 months;	tissue: colon tumor;	cell type: CD11b+Gr-1+ myeloid cells in the tumor stroma,ctrl
"Wild-type myeloid-derived suppressor cell from colon tumor, rep1",ctrl
healthy control H05,ctrl
11417 UC Uninflamed ascending colon,pert
T115 U133p2,pert
"Atm-/- 30 min post IR, B",ctrl
Testis WT 0h batch 2 [TeWTh00.13],ctrl
APOE_KO_DM_9W_1,ctrl
whole blood_101872,pert
Ring1b_KD_2,pert
wt-Gfp 4 weeks replicate 1,ctrl
Thyroid_papillary carcinoma 77,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 24 yr;	population: white;	dsm-iv: 295.9;	age of onset: 20 yr,pert
"gender: Male;	age: 75;	post-mortem delay: 9h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
cell line: HEK293E,ctrl
"IKK2 -/- tumor, biological replicate 4",pert
AR-CO-24-2-548,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: control; biological replicate: 1,ctrl
strain background: 129/B6 hybrid;	cell type: embryonic stem cells;	genotype/variation: wild-type control,ctrl
wild-type MEF 2,ctrl
Individual_4162_PN_sample,pert
HeLa_06_21_04 TP-5,pert
No or early 2 rep10 (OHN),pert
Disease_status: Bipolar disorder;	Age (years): 29;	Gender: Male;	Age of onset (years): 17;	Duration of illness (years): 12;	Brain pH: 6.70;	Post mortem interval (hours): 60;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
"ALL_NDS, K51 011509",ctrl
n5t7d,pert
Healthy control c1,ctrl
whole tissue section from case 1419,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 2 days adipocyte differentiation,pert
osteoblast_5azatreated_rep1,pert
"MCF7, shRNA knockdown PDEF, biological rep1",pert
cell line: BaF3;	infected with: MPLW515L3;	pretreated with: normal condition (Naïve);	treated with: DMSO for 4 hrs;	sample type: control,ctrl
"female Spargue-Dawley rats, 9-cis-retinoic-acid, 100 mg/kg diet for 7 days,  tissue: liver",pert
104A,ctrl
NMRI_6h_Wy,pert
Diaphragm 56 Day mdx rep 2,pert
gender: male;	batch: 1;	age (years): 33;	patient id: Control_5;	fev1 (% predicted): 78;	fvc (% predicted): 77;	medication: None;	cell type: CD8+ T-cells,ctrl
B12 - non-infected BALB/cByJ fibroblasts,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 40;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: post-UV,pert
midbrain_wild type_12 weeks_replicate 1,ctrl
CAST/EiJTCE liver sample batch 1,pert
AL Chip#28,pert
MCF7 cell line _vehicle (control)_biological replicate 2,ctrl
ErbB2 2,pert
PC-3_overexpresshTERT_LongTelomeres_LhTERTL_4,pert
Psoriasis-9 baseline,pert
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 105;	medication: Flixotide 500mcg 2pbd,Oxis 12 1pbd,Loratadine 1 tab od,Beconase 2pbd;	cell type: CD8+ T-cells",pert
HCT116 non-recombinant clone 27 (STAG2 wild-type),ctrl
cell line: HL-60;	replicate: Replicate2;	treatment: shLuciferase,ctrl
heart-wt-2,ctrl
476MM,pert
RS-final,pert
Nerve_Diabetic_Vehicle_706,pert
"peripheral ganglion, unknown: nicotine 1hr",pert
H4-II-E-C3_high_rep2,pert
Psoriasis-Patient-M,pert
IFN/Vit-WT,ctrl
rd1_P6_rep3,pert
CF knockout LMCF CHN531,pert
age: 37;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Liver_WildType_1,ctrl
blood_day6_patient6,pert
Liver_nash metformin_no.3,pert
PBMC from T cell LGL leukemia patient #111 (TLGL111),pert
CD11b+Gr1+ cell sample_4 (derived from wild type mouse),ctrl
P85 dilated cardiomyopathy heart biopsy,pert
"DBA/2J ACU, Rep3",pert
WT2-iPS 2,ctrl
shRNA2-4-noDox-rep2,ctrl
mutant_POST_PDE_036,pert
multiple sclerosis_1,pert
"Cell type: endothelial, age:42, gender:male, diagnostic group: schizophrenia, PMI:19h",pert
tissue: Brain;	genotype: Npc1+/-;	age: 25 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
"fibroblast, control subject NF6 rep 1",ctrl
ApoD transgenic mouse rep_3 (CTG3),pert
Embryonal carcinoma 0502,pert
17beta estradiol: 60 pM,pert
JIA PBMC Pre treatment A235_L221,ctrl
Subject 1 Post allergen challenge,pert
2120-03-A,pert
Control 14,ctrl
"heterozygous, control, biological rep2",pert
disease state: healthy;	tissue: tibialis anterior;	age at biopsy: 80;	Sex: male;	individual identifier: 2,ctrl
chip number: 16;	transfection plate: 3B;	target gene: EP300;	kd level: 0.72;	rin: 9.5;	transfection date: 2012-03-26,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: tumor;	sample name: 1-tu2,ctrl
"HCT116 cells with enforced miR-34a expression, technical replicate 1",pert
"Pancreas from adult WT mice, biological replicate 2",pert
PGA-RMM-6h-1aA-s2,pert
C2C12 myotubes 1000uM H2O2 rep3,pert
"Pancreatic tumor cells, replicate 5",pert
Liver Tro2,pert
Sham 1,ctrl
Carbo Day14 (454L),pert
"CBFb-SMMHC animal 2, replicate 3",ctrl
"affected status (disease state): control;	gender: female;	age-at-examination: 65;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension, hypercholesterolemia",ctrl
Subtype: RARS;	Karyotype: normal,pert
gender: Male;	age (y): 36;	tissue: prolactinoma,pert
Wild Type Time 0 replicate 3,ctrl
endothelial_rep6,pert
061J4_CTRL,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 62, stage IIIB, HPV 45",pert
patient: 32054;	disease state: LGSC;	component: Invasive,pert
MiaPaCa2 rep-1,ctrl
Aldosterone-producing adenoma (APA5),pert
MA_63,pert
affected sister,pert
normal scar treated with hydrocortisone-3,pert
V5-P213,ctrl
"shCDK19, normal growth, replicate 2",pert
Time:0 day; condition:LaminA ko;,pert
age: 68;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Substantia nigra PD rep14,pert
CD4+ cells IL1RN wild type 1 month rep3,ctrl
wt-Gfp P2 replicate 1,ctrl
ctrl_518,ctrl
Strain: BALB/c;	Age: postnatal day 0;	Genotype: Ctip2 null mutant,pert
strain: C57BL/6J;	day: 15;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 2,ctrl
NM3 healthy control,ctrl
"FOXP3, WT, REP1, 72h",ctrl
"PCOS, biological rep 4",pert
subset: HDAC2 siRNA subset;	cell line: HCC cell line Huh7;	treatment: HDAC2 siRNA,pert
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 64",pert
01_NML,ctrl
NPC23,pert
human esophageal squamous cell carcinoma cell line_KYSE220,pert
fibroblast_Normal_D133_Media_3,ctrl
brain_co_6M_rep1,ctrl
cell line: HCT116;	clone: 28;	genotype: Knockout,pert
strain: 131;	Disorder: normal;	Condition: no hydrocortisone,ctrl
Differentiation of hES cells line VUB03_DM1 towards neural rosettes;	Neural precursor phenotype,pert
WT_TER119+_rep2,ctrl
24C-M4,ctrl
MDS patient 37,pert
sal-PVH_1,ctrl
9161PBMC,pert
subject: 2;	disease: TD;	muscle: GR;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
KO - 5 mo - repeat 5 - Cy3 - mAdbID:74141,pert
genotype/variation: wildtype;	strain: C57BL/6;	age: newborn,ctrl
cell line: H1299;	agent: decitabine;	dose: 1 uM,pert
"SLE patient, 1011V1",pert
AA_Case9_CD8,pert
Bicalutamide_1,pert
Kidney_KO_baseline_rep3,pert
Pfeiffer BCL6siRNA 2,pert
WT White adipose tissue (WAT)_HFD_rep5,ctrl
BIO586219,ctrl
4472-3 E2F3 Heterozygous,pert
Liver_Nrf2 KO_rep1.,pert
"MAT1A knockout at 15 month age, peritumoral tissues, biological replicate 2",pert
IMR-32_pCMV_48hr_rep 2,ctrl
Adrenal CREMKO 0h batch 3 [AdKOh00.18],pert
MDS patient 27,pert
Panc1 rep-2,ctrl
Nerve_Control_Vehicle_703,ctrl
"3 uM EPZ004777 treated, DAY 4, biological rep.1, MV4-11 cells",pert
EA_Control4_CD20,ctrl
genotype: WT;	agent: DMSO,ctrl
N51294,ctrl
9n,ctrl
"human failing LV myocardium, Ischemic9",pert
"WT mice, 6 weeks old",ctrl
Obese Control-2,ctrl
LKO_092612,pert
MacularDegen-healthy-11aAv2-s2,ctrl
Trastuzumab treated after 4 days (T3_2),pert
7d-IR-44,pert
heart_QH2_14M_rep3,pert
transfected with FoxP1 siRNA_3,pert
F-IIP(NSIP)5_Cy3,pert
"Patient 112, baseline",ctrl
"Crohn's Disease subject (33 year old caucasian male, SAK_1288174788)",pert
Empty vector control (RNAi 1B)_1of3,ctrl
Karyotype: normal;	Age: unknown;	Gender: unknown,ctrl
Ishikawa_HighDose_BPA_8h_rep2,pert
Nerve_Diabetic_Vehicle_708,ctrl
MLL_PTD11,pert
WT3R2,pert
Leg 23 Day control rep 2,ctrl
cell type: induced pluripotent stem cells,ctrl
"FACS-sorted Lin-, c-kit+, Sca-1+ HSC from the bone marrow of PU.1 knockdown mice with targeted disruption of the distal enhancer (URE) –14kb upstream of the PU.1 gene.",pert
H_LS_Wk4,pert
KO kidney pool 2,pert
SHR-vehicle pool sample1,pert
Hippocampus 2002 2 month Old,ctrl
KM_075T,pert
"acutely admitted, severely psychotic schizophrenia patient  A12",pert
"Normal ear skin from control mouse, biological replicate 1",ctrl
"NC1, biological replicate 1",ctrl
Infergen_24hr_rep3,pert
"siSCR ES, biological rep2",ctrl
"P50_C-DGCR8 KO cones, replicate 1 [array]",pert
"1833 shHMGA2, biological replicate 1",pert
Treg cells WT replicate 2,ctrl
11088 Normal Uninflamed descending colon,ctrl
FRD1 1,pert
cell line: H69;	treatment: TGX221,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 5d ID293,pert
Run7.aUa.010110d.SkMDbt1155D.CEL-DB stimulate,pert
tissue: Biceps muscle;	patient: C.b.2;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 1y 11m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
FVB_MMTV_Wnt1_iFGFR1_2549_4L_ROSEN,pert
NTG 2,ctrl
T4,pert
MCF7 cyclin D1 siRNA Estradiol Rep2,pert
VIN_B109,pert
"BOEC, normal 8",ctrl
cell type: PBMC;	group: Patient;	patient treatment: Mtx,pert
S3,pert
erStress_twins_AA_1725twin1_DMSO_4h,ctrl
"2 months, ipsilateral group, biological replicate 2",pert
patient: 267;	current medication: Mesalazine 800mg TDS;	birth date: 8/16/74;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/05;	diagnosis date: 5/10/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 8/15/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/20/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 9/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 5/1/03;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
S015_Scz_M_56,pert
mouse B6xCF-1  RNAi transgenic,pert
"fibroblast, MFS subject 60FR rep 2",pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 46;	donor: 29;	disease state: Lesional,pert
S6_Sham_wildtype_8,ctrl
B6C3F1/JTCE liver sample batch 5,pert
HIF-1-/- control 3,pert
CUTLL1 wash2h-CHX_rep1,pert
m1-carcinoma5,pert
untreated Rb-/- MEFs-3,pert
"genetic background: B6;	genotype/variation: wildtype;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",ctrl
gender: male;	age (years): 20;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
"Human hepatoma cell line (HepG2), grown for 6 or 12 hours, and then total RNA harvested with Trizol and Qiagen Rneasy kit.",ctrl
"C57BL/6, Female, CF",pert
Aldosterone-producing adenoma (APA13),pert
"Control lung tissue, biological replicate 1",ctrl
27 year old female,ctrl
BCell_resting_sample3,pert
N4_Cy3,ctrl
TSC1KO QSC Technical Rep.2,pert
E14.5_Mutant_Kidney_array1,pert
"gender: Female;	age: 94;	post-mortem delay: 9.5h;	ph: 6.3;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
stomach_1h_rep2,pert
Obese rat 1,pert
cerebellum_KO_1,pert
gender: Male;	strain: C57BL/10;	genotype: WT;	tissue: Kidney;	surgery: Sham;	reperfusion time: 4hr,ctrl
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 69;	age-at-onset: 65;	geographical origin: Mirandela;	clinical characteristics: Hypertension, diabetes, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
"rat hippocampus (CA1 region), sham, 18 months old, subject 10",ctrl
459MM,pert
Control (shControl-1),ctrl
mouse model: 3xTG-AD;	gender: female;	age: 14 months old,ctrl
"Monuron-treated NRK-52E cells at 6h, biological rep 2",pert
Genotype: wild-type;	Age: 6-8 weeks,ctrl
"brain, hippocampus: Wt #3405 Cort_e1_le1",ctrl
Human skeletal muscle biopsy sample;	Patient #218 with NORM,ctrl
coc-16_A,pert
KU_43T,pert
"BCL-3 vector, biological rep3",pert
"CFU-PreB colonies Wildtype littermate, biological replicate 1",ctrl
Wild-type standard cage Rep5,ctrl
Age: 35;	Sex: M;	Ancestry: African;	Smoking status: non-smoker,ctrl
treatment: Vamp7 knockdown siRNA;	cell line: NTERA2/D1,pert
Human Non-progressor HIV Sample L015-CD8+ T cells,pert
Series 3; Young; 3 Days after fracture,pert
3_DMSO-3,ctrl
A673 cell line that has been treated with cytarabine (ARA-C) for 24 hours with concentration of 0.34 uM (2 x EC50).,pert
N51315,ctrl
Control subject 26_biological replicate 1,ctrl
Psoriatic arthritis PsA 14,pert
cell type: HVS-transformed T cells;	genotype/variation: ITK wild type,ctrl
"pt. HCL A treated with Vemurafenib 1000 nM for 48h, replicate2",pert
cerebellum_wild type_6 weeks_replicate 3,ctrl
Control subject 95_biological replicate 1,ctrl
"depression, BA10-2",pert
11_0012C_Day1_24,ctrl
control8,ctrl
heart-30 months of age-resveratrol diet-biological replicate4,pert
"Control cells unstimulated, biological rep2",ctrl
HA00-13A,pert
FSH-NHM-2UA-S2,ctrl
57SMOKEH,ctrl
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: EGFP,ctrl
Disease_status: Healthy control;	Age (years): 42;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 37;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
"gender: Male;	age: 54;	post-mortem delay: 12h;	ph: 6.6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p29;	strain: E14,pert
"Du145-PCAT1 cMyc siRNA #3, replicate 2",pert
AL Chip#41,pert
3DKD_SerumStarved_rep1,pert
"Acute Myeloid Leukemia, sample 17",pert
"650nM MLN4924 after 4hr, replicate 3",pert
n8t6h,pert
strain: ICR/B6D2;	tissue type: back skin,ctrl
A673_CloneAsp14_Dox_0h_2,ctrl
"Grape extract group, 6 months, patient number 11",ctrl
"bipolar disorder, BA10-51",pert
race: caucasian;	age (years): 51;	stage: IA;	grade: 1;	histology: endometrioid,pert
ccRCC tumor of patient T84,pert
"650nM MLN4924 after 24hr, replicate 2",pert
"schizophrenia, BA46-12",pert
"brain, frontal cortex: Sample49_e1_le1",pert
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: gun shot wound,ctrl
IM CD34+ Pool II,pert
48A,pert
"hepatic gene expression at ""6 hr"" (rep3)",pert
Strain: C57BL/6;	Gender: Male;	Age: 8 weeks;	Tissue: Large Intestine (Distal and Proximal),ctrl
"MCF7, non specific control, biological rep1",ctrl
"Gender: Female, Age: 27, BMI: 21, Tissue: luteinized cumulus cells",ctrl
38A;pretreatment;female;breast tumor,ctrl
RV64.10_CHF_day25_Slide47,pert
SKMEL28_t48h_rep1,pert
NSC_FBS_V3,ctrl
"age at diagnosis: 59;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N1a;	er: 1;	pgr: 0;	dfs-month: 25;	dfs-event: 0;	distant metastasis: 0",pert
Normal cortex of patient 325,ctrl
"5mg/kg/day PFOA, Rep 4, Block 3, liver (high dose)",pert
ES_Suz12KO_rep2,pert
Sample Group: HD patient; Gender: female; Age: 50; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,pert
CON7,ctrl
sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta;	agent: control (saline);	time: 14d,ctrl
"Prkaca+/- caudal vertebral bone, rep3",pert
60A;pretreatment;female;breast tumor,ctrl
"A pool of RNA from lung from three female mice with SM22-rtTA transgene on an FVB/N background, raised at Denver altitude (nearly normoxic), fed doxycycline for 8 weeks.",ctrl
NoKD_SerumStarved->1hrEGF_rep4,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 70, stage IIB, HPV negative",pert
midbrain_wild type_24 weeks_replicate 1,ctrl
Sham 14 replicate 2,ctrl
Eed KO J1 ESCs on day 0 #2,pert
1056-03-A,pert
Tendon_non-lesional_rep2,ctrl
A549 siRNA FAM60A CNTRL 2,ctrl
MDA-MB-231_siScramble_rep.1,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: D;	experimental sample name: PC9-R,pert
"MaF pre-iPSC9P2, Vc+, D6",pert
E14-99+/-vector-1,pert
"U373-MAML1-dn, rep 1",pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M1;	flt3 status: internal tandem duplication (ITD),pert
129/BSw het2 heart,pert
F/F.ES. rep2,ctrl
Kidney_saline_6,ctrl
Fibroblasts_HealthyControl_1,ctrl
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_5,ctrl
PC-3 human prostate cancer cell line,pert
Individual_4697_PP_sample,pert
ILD Study Number 908,pert
LNCaP EtOH rep 2,ctrl
L425-PAX5+MAT_rep1,pert
MOLM14_shSYK_2_Replicate2,pert
Elf4 KO2 naive CD8 T cells,pert
FVB; No Treatment #6,ctrl
OC1-WT embryo 2,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A19",pert
HDAC2 KO E17.5 Ventricle 2B,pert
Invasive cancer originating in IPMN 3,pert
cell type: mouse embryonic stem cells 3x passaged without feeder cells;	genotype: TRPM7-/-;	genetic background: C57BL/6,pert
6B,pert
"ES cell line, RNA 68",pert
11_PAH,pert
"Fourth ventricular choroid plexus from wildtype mice at E13, biological replicate 2",ctrl
B6.IL10 48 air 2,pert
NALT_sham_24h_rep3,ctrl
Wild-type mice rep1,ctrl
Cervical cancer_892T,pert
42A;pretreatment;female;breast tumor,ctrl
BMM_BalbC_time21h,pert
CD4DecTp1-4,pert
E14 - Lis1cko/ko 1,pert
type_of_rx: AF;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 56;	baseline tumor size (cm): 8x7;	patient id (to identify the 2 chips from the same patient): 16281659,pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,pert
tissue: Murine small intestine (jejunum);	genotype/variation: VillinCreERT2+_Brg1fl/fl,pert
Pancreatic Sample 29-Tumor,pert
Ls174T-pTER-β-catenin dox1,pert
S-IIP(UIP)16_Cy3,pert
ic patient 2,pert
3886-2 E2F1 Null,ctrl
"Placebo treated, HIV-1 positive male, day 14 (3)",ctrl
FHCRCAML169016,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: DMSO for 72h,ctrl
Leptin treated mouse gallbladder 6,ctrl
WFS1 WT USHT_05_318_ko,pert
LOX1 Untreated 2hr 282295543,pert
"Pancreatic tumor cells, replicate 3",pert
mouse colon_hnf4control_rep2,ctrl
Ishikawa_HighDose_BPA_24h_rep2,pert
cell type: endometrial stromal cells;	growth phase: early passage,pert
mouse cerebellar granule cells wild type 4,ctrl
normal 1455,ctrl
8_c,ctrl
M10KOepi_infect_0h_rep2,pert
12 hr KLF4 Time Course Control,ctrl
"Strain: PolgD257A/D257A mice;	Gender: male;	Age: 9 month-old ;	Tissue: cochlea;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Typical antipsychotic Haloperidol, Dose: 1.6mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking Water, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation.",pert
Bone-Marrow_MM_M896,pert
"Pancreatic tumor cells, replicate 2",pert
"brain, brainstem: PB4_e1_le1",pert
WFS1 KO USHT_06_333_wt,pert
"3mg/kg/day PFOA, Rep 4, Block 4, lung (low dose)",pert
Wt Mouse_cerebellum_Young_saline treatment_Replicate-2,ctrl
coc-42_A,pert
HC-KO-28A,pert
Mnk_3133-S-B,ctrl
chip number: 7;	transfection plate: 1;	target gene: ARNTL2;	kd level: 0.84;	rin: 9.7;	transfection date: 2011-03-29,pert
"SWR/J SAL, Rep3",ctrl
subject: 21U;	cohort: 21;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 63kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
H19 HA 12h 3,pert
"strain background: 129/B6 mixed;	cell type: Ada3FL/FL MEF, immortalized;	infected with: control adenovirus",ctrl
gender: Male;	age: 56;	post-mortem delay: 16.5h;	ph: 6.4,pert
"Control #6, Untreated",ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 2,pert
Control_Time_30_1,ctrl
HIF-1-/- control 1,pert
V5-P075,pert
V5-P420,pert
siLRH-1_#2_rep_2,pert
Nonlesional Epithelium Atopic Dermatitis rep4,pert
siCtrlVeh24h_3501,ctrl
Pancreatic Sample 7-Tumor,pert
Series 2; Older; 3 days,pert
eDeaf,pert
female;	29 yr old;	Hispanic,ctrl
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; PtenloxP/loxP,pert
IM16_case,pert
negative control inhibitor (NTC1)_24-10,ctrl
duration of untreated disease in month:6.6;	age at onset:6.1,pert
Sex: female;	Age at operation: 76 years;	Site: thigh;	Size in cm: 38.5x17.5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
Subject #8019-8hr Postinfection,pert
Preglaucoma control rep5 (OHN),ctrl
FoxM1 A,pert
siGL3Veh 2,ctrl
Normal heart_G38,ctrl
"brain, cochlea: [13] Sample #13_le1",ctrl
wildtype HUES6 3,ctrl
TSC1KO QSC Technical Rep.1,pert
pancreatic cancer cell line MiaPaCa2 stabley transfected with AGR2 overexpressing vector pCEP4 -AGR2,pert
HA98-146A,pert
Brain CD8 T cells that are IL-10- rep2,pert
"Control, replicate 4",ctrl
"Infected with H37Rv and treated with 1,25D, replicate 3",pert
WT osteoclasts treated 1,pert
C57BL/10-SJL.Dysf QF replicate 2,pert
Angiopoietin-1(confluent)-1,pert
Strain: C57BL/6;	Gender: Male;	Age: 8 weeks;	Tissue: Large Intestine (Distal and Proximal);	C57BL/6 Winnie G9492A,pert
CUTLL1 GSI-rep2,ctrl
Gene expression profiling of Phgdh knockout embryo wild3,ctrl
whole tissue section from case 823,pert
01N14_PolyRF-,pert
KN-smoke-med-5 month-R2,pert
GB 6 NTB +LPA,pert
WT KLS 1,ctrl
"SLE patient, 1020V1",pert
ethanol_ethanol_16,ctrl
CTCF-depleted fully-grown GV oocyte from transgenic mice,pert
"Cell type: neuronal, age:32, gender:male, diagnostic group: control, PMI:13h",ctrl
"age at diagnosis: 37;	diagnosis: Adenocarcinoma of breast, ductal, medullary features;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 0;	pgr: 0;	dfs-month: 51;	dfs-event: 0;	distant metastasis: 0",pert
FTO2_D4_ni,ctrl
A HID I_B048,pert
Cell line MCF-7_c-myc KD_expt2,pert
"Wild-type MEFs, biological rep2",ctrl
tissue: brain;	genotype: WT mix background B;	age: P14,ctrl
WT P10 replicate 4,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 110min;	race: Black/African American;	Sex: Male;	fstl-1 (ng/ml): 222,pert
P0 Quadriceps Klhl40 WT 1,ctrl
"human nonfailing LV myocardium, NonFailing12",ctrl
11P-M4,pert
patient: 460A;	disease state: LGSC;	component: Invasive,pert
"Nrl-ko-Gfp, Gfp+ photoreceptor cells",pert
cell line: rtTA-Dmrt5;	differentiation: 9 days;	treatment: -Dox,ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 1,ctrl
phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject K,ctrl
CD34+ cells of CML patient after 7 days of Glivec therapy,pert
Gastric_cancer_patient_28,pert
"20B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"human nonfailing LV myocardium, NonFailing4",ctrl
brain_DLPFC_bipolar C_mr532,pert
HCC015T,pert
Individual_4269_PP_sample,pert
GIST_PDGFRA_4,pert
061J0_CTRL,ctrl
FHCRCAML3653,pert
cell type: E9.0 embryonic cardiac progenitors,ctrl
cell line: Embryonic kidney cell line HEK;	genotype/variation: mutant channel;	agent: untreated,pert
"Wild type fibroblasts, biological rep3",ctrl
"Control 11, NC11",ctrl
Control liver_4 pm_rep2,ctrl
Muscle KO Adult 0706,pert
GIST_KIT_3,pert
race: african american;	age (years): 65;	stage: IC;	grade: 2;	histology: endometrioid,pert
HTB58_controlsiRNA_2,ctrl
OSCE-9T,pert
15d control_Pool 9,ctrl
cell line: ARPE-19;	clone: 25;	genotype: Knockout,pert
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: undifferentiated,ctrl
"S1P3-KO-hippocampus, biological rep4 (female)",pert
3789-scrape,pert
cerebellum wild type 6 month replicate 2,pert
patient: 51722;	sample: tumor,pert
Sirt1 siRNA control 2,ctrl
HepG2_Hg rep1,pert
"RORalpha1delDE, 1",pert
Subject #8035-8hr Postinfection,pert
strain: C57BL/6;	genotype/variation: RORasg/sg;	gender: male;	age: 5 Month old;	tissue: Liver;	diet: 35% Fat Diet (High Fat Diet; HFD),pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S25_3 months_replicate 1,pert
"Autoimmune pancreatic islets, day 3 cyclophosphamide treatment, rep 3",pert
PPAR WT_ctr_53,ctrl
patient: 205;	current medication: Pentaza 3g/d;	birth date: 6/8/79;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/03;	diagnosis date: 8/30/04;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 15;	crp: 19;	hb: 110;	wcc: 5;	neutrophils: 3;	albumin: 43;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: NEW;	smoking status: ex;	smoking start date: 1/1/85;	smoking stop date: 3/1/03;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
age_years: 56;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
cerebellum_Pink1 knockout_12 weeks_replicate 3,pert
Low_M_2,pert
46B,pert
SeroNeg-12,ctrl
cell type: Primary hepatocytes;	donor: 4;	agent: control;	time: 6h;	gender: Female;	age: 54 years old,ctrl
V5-P347,pert
SCC25+doxorubicin_rep1,pert
ILD_2,pert
Uninjured Control - Epicenter Rep1,ctrl
A HID I_B044,pert
"human failing LV myocardium, Ischemic92",pert
F-IIP(NSIP)2_Cy3,pert
H1med,ctrl
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 21;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Bronchial Epithelial Cells MMA biological 1708X,pert
"Peripheral blood, patient without recurrent events [N43]",pert
TREx_Flp_FTO_siRNA_1,pert
C57BL10 EDL sample 2,ctrl
Normal_2010,ctrl
V5-P575,pert
siEGR4 (48 hr) _1,pert
homozygous_TGFb_4hr_1,pert
"115, MUSCLE, After",pert
E9_Embryo_Wild Type_2,ctrl
ILD Study Number 545,pert
"Knockout Heart with no treatment, biological rep1",pert
umbilical cord_nobpd: 4D,ctrl
Brain CD8 T cells that are IL-10+ rep1,ctrl
Normospermic individual: Sample N9,ctrl
"human failing LV myocardium, Ischemic24",pert
"NC1, biological replicate 6",ctrl
Muscle PCOS pioglitazon 251,ctrl
"Wild-type-neocortex, biological rep7 (female)",ctrl
Liver_hyperglycima_no.1,pert
A549_Control_rep2,ctrl
strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: phenobarbitol,pert
"strain: C57BL/6;	tissue: heart, left ventricle;	gender: male;	genotype/variation: Hsp22 WT;	stress: control",ctrl
treatment: PLX4720;	time: Day3;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,pert
colon_Runx1-KO_Cy3_15514,pert
ATCC CRL-1555,ctrl
"Liver, Normoxia 3",ctrl
tissue: skin;	individual: Patient P7;	condition: ANL;	eczema severity: SCORAD: 0,pert
WT - Cre Control - 5 mo - repeat 5 - Cy5 - mAdbID:74105,ctrl
01N1E: new onset sJIA,pert
"brain, frontal cortex: Sample60_e1_le1",ctrl
LJMJDW18,pert
DUSP1+/+ control replicate 2,ctrl
Strain: Btk KO/CBA were created by back-crossing Btk KO/SW129 mice on CBA background strain for 9 generations,pert
WT-sham-1 day-R3,ctrl
"ES cells: E14 (129P2/OlaHsd background),;	Genotype: Wild (Phgdh+/+), C57BL/6J background,;	Gestation: 13.5 days,;	Tissue: head",ctrl
LT 342 +/T untreated,ctrl
Control Day14 (460L),ctrl
Individual_5093_NN_sample,ctrl
rd1_P4_rep1,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_10 months_replicate 2,pert
PGA_MI_nilv_4h_390,pert
DNGM-14,pert
adenosquamous carcinoma 001,pert
"8B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
"Pancreas from adult Rkip-1 KO mice, biological replicate 2",ctrl
EA_Case19_CD20,pert
"Mouse LV, akt2-/- 1",pert
patient: 40875;	sample: tumor,pert
LJMJDW16,pert
Aurka_R_+Dox_rep1,pert
V5-P599,pert
brain_DLPFC_bipolar B_mr279,pert
age at diagnosis: NA;	diagnosis: Within normal limits;	tumor grade: NA;	mininal stage grouping: NA;	t (extent of primary tumor): NA;	n (lymph node metastasis): NA;	er: NA;	pgr: NA;	dfs-month: NA;	dfs-event: NA;	distant metastasis: NA,ctrl
age: 18 month postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 208,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day1,pert
t08,pert
gender: male;	individual: patient 2;	treatment: paclitaxel-eluting stent,pert
At Risk: +;	Age: 10;	Sex: F,pert
Fog2flox/delta; no Cre biological replicate 1,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 05/07/06;	# cells: 60;	Sex: male;	region: M1;	age: 45;	genotype: Y/X;G42/-,ctrl
T40875,pert
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep6,pert
expression array - BRAIN 2,ctrl
LRRK2 (G2019S) homozygous fibroblast sample 1,pert
"male,23,Caucasian",pert
Muscle JDM (YJD-JDM-1UA-s2),pert
A2780-(1),ctrl
C_Kin_1,pert
"E2A CLP LY6D-, biological rep1",pert
"BMMCs from NTAL WT, NTAL shRNA infected, nonactivated, biological rep3",pert
YFP-pos GMP Dicer het rep1,pert
0191-01-C,ctrl
E14-99+/-vector-2,pert
FVB_24h_DMSO,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 62 years,ctrl
strain: C57BL/6;	tissue: Lung;	agent: bleomycin;	genotype/variation: wild type,ctrl
01_PAH,pert
Monocytes from buffy coat preparation,ctrl
"129/B6 background, 6-10 weeks",ctrl
V5-P266,pert
Saline treated mouse gallbladder 3,ctrl
MDS41,pert
"ME16C, 12h, 0.5uM DOX B",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.626;	OD280: 0.845;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 75;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Post Transduction:12 hr; treatment:Mut;,pert
"1mg/kg/day PFOA, Rep 1, Block 2, liver (low dose)",pert
MEF E2F4 KO 4-rep2,pert
"All mice (C57BL/6) were free of Helicobacter species, housed in a specific pathogen free facility with 12-h light/dark cycles with free access to standard food and water.",pert
HUVEC_control_rep2,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shControl,ctrl
untreated AML 14 blasts,ctrl
siNS_2h_2,ctrl
BTBR-ob/ob;	Liver ;	Age: 14 weeks;	Gender: Male,pert
"E12.5 Ret-deficient embryonic kidney, biological rep3",pert
MCF7 - Control_3,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 0,ctrl
RV16;	Age = 18;	Sex = M,pert
VEC A,ctrl
Genotype: B6.Pdss2loxP/loxP;	Age: 213-day-old male;	40 mg liver used for RNA extraction,ctrl
Diagnosis: AML M0;	Age: 61y ;	Gender: Female;	Blast %: 94;	Source: PB;	Cyto: tris4;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
Replicate 1 - CDB4124,pert
gender: Male;	age: 82;	post-mortem delay: 5h;	ph: 6.2,pert
genotype: Villin-Cre + / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 81,pert
Panc1005 rep-1,pert
LT 344 +/T untreated,ctrl
Ngn3 EB3 ON replicate 1,pert
cDNA scc 07,pert
V5-P502,pert
N40645,ctrl
"Overexpress TFPIbeta, biological rep. 3",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 3;	psoriasis duration: 3.8507871321013;	age of psoriasis onset: 30,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.678;	OD280: 1.857;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 7.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 352;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"Histidine decarboxylase null myeloid-derived suppressor cell from bone marrow, rep2",pert
Mouse E10.5 urogenital epithelium -/- #1,pert
gender: Male;	cell type: hESC H1 cells;	genotype/variation: B2M KO,pert
"Exp A, Animal #248, 500mg/kg D-Serine",pert
high grade serous carcinoma_patient 1,pert
4-HPR_LUNG_2,pert
Sex: female;	genotype: sst +/+;	tissue: liver;	genetic background: C57BL/6,ctrl
FHCRCAML169011,pert
cell type: Endothelial cell;	agent: ethanol;	dose: 0.1%,ctrl
con-37_C,ctrl
batch: A;	knock-in: VEC;	cell line: MycCap prostate cancer cells,ctrl
MCI-002,pert
"atRA RARaKO, set 3",pert
OE-SOX2_2,pert
"imr-32,ccnd1 siRNA,t=48,3",pert
subject: 6;	disease: TD;	muscle: ST;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
cell line: non-small cell lung carcinoma cell line H1299;	protocol: control;	time: 12hr,ctrl
tissue: Temporal cortex;	age: 87;	Sex: F,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 19d ID73,ctrl
Thyroid_papillary carcinoma 86,pert
RENT1-1,pert
NOD2-L1007fsinsC_0h_MDP_biological replicate 1,pert
HeTH-4 +DOX rep-2,pert
MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ Control Sample A,pert
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 8hr,pert
GM19238_Kd_JUND_2,pert
"Endometrium, postmenopausal, estradiol, 8",pert
5257 UC Uninflamed sigmoid colon,pert
"Epidydimal white adipose tissue from WT after 16 weeks of high fat diet feeding, replicate 3",ctrl
APPsa_R6_rep3,pert
whole tissue section from case 843,pert
Monocyte-RCC-untreated-2,pert
11411 UC Inflamed sigmoid colon,pert
12478 UC Inflamed descending colon,pert
Zfx wt MA9 cells + 4-OHT [10977],pert
midbrain_Pink1 knockout_12 weeks_replicate 1,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 33;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
asthma_OVA24h_3,pert
cardiomyocyte SRF-null 2,pert
"Aorta, saline 7d, #4",ctrl
KO - knock-out Treated - 24 hrs - repeat 1 - Cy3 - mAdbID:61776,pert
KO_cycling_rep1,pert
01MLE_Oligo,pert
cell line: NCI-H2009;	cell type: lung cancer cells;	transfected with: control hairpins targeting luciferase,ctrl
"E18.5 ERRg +/+ heart, biological rep 3",ctrl
HC-WT-15A,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_8_38_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
"Fibroblasts from UIP histology lung tissue, IPF-22",pert
Subject #8015-2d Postinfection,ctrl
07_C57_KO,pert
E14 - WTMixA 3,ctrl
P14 - nudelkoMix/+ 2,pert
[Aiolos]-2,pert
AZ-521_uninduced_18h_rep2,ctrl
"schizophrenia, BA46-31",pert
"BOEC, at_risk 12",pert
"human failing LV myocardium, Idiopathic84",pert
sirt7 allele: wild-type,ctrl
"Aorta, Ang II 14d, #2",pert
shRNA control R2 T5,ctrl
Peripheral blood mononuclear cells;	TTF=120min;	Race=White;	Sex=Male,pert
cell line: Hep G2;	genotype: HCC-THRA mutant bN;	treatment: with 100 nM T3 for 6h,pert
"PCB77 treated HepG2 cells at T0.5, biological replicate 1",pert
GIST Pre Treatment Biopsy 50,pert
C2C12 myotubes 100uM H2O2 rep 3,pert
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 2h,ctrl
"Crohn's Disease subject (62 year old caucasian female, SAK_1287995940)",pert
"AD_HI, biological rep3",pert
Megacaryocyte-Erythrocyte Progenitors,ctrl
"vastus lateralis biopsy, 56 year-old healthy trained male (#56)",ctrl
Heart_WT_01,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: tumor;	sample name: 3-tu3,pert
HSC-Evi1-KO-2,pert
OSCE-6T,pert
Individual_4334_PP_sample,pert
DES D1,pert
20C-M4-D,ctrl
A549_Nrf2 siRNA_biological rep3,pert
siNonTarget replicate1,ctrl
C_Ctrl_1,ctrl
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P15;	genotype: Igf1 +/+,ctrl
Cancer 2,pert
"mouse aorta cross strain comparison, C3H_T00_NC_03",ctrl
E9.5 FVB/N erythroid cells-4,ctrl
3748-lcm,pert
"WT CD8 memory T cells, biological rep1",ctrl
RatLung_H72h_1,pert
Muscle 50 eccentric contractions 12 hours KO Adult 0706,pert
Against CDK8-2 rep1,pert
race: caucasian;	age (years): 60;	stage: IB;	grade: 1;	histology: endometrioid,pert
EOM 28 Day mdx rep 1,pert
Mening UNSTIM WB SW 12b,ctrl
"SS gland, early, patient 20, batch 2",pert
C33KD2_with doxycycline_3,pert
IFC 05,pert
"Autism no regression, Female",pert
KN-smoke-high-5 month+1d-R3,pert
MCF7/c p.6,ctrl
abl siEZH2 at VEH rep 2,pert
Human prolactinoma 240,pert
Control subject 95_biological replicate 2,ctrl
ccRCC tumor of patient 26,ctrl
Biceps_Control_5,ctrl
A HID B_B014,pert
Strain:C57BL/6J;	Gender: male;	Age:2-3 months;	Tissue:heart,ctrl
Knockout cre_ppar_beta_floxed_rep2,pert
DU145/MYB siRNA #1,pert
Human prostate cancer primary culture C28dx,pert
Muscle JDM (YJD-JDM-18UA-s2),pert
Heart_WT_4,ctrl
Rapamycin treated_1 3h,pert
Lung dnCREB-PBS replicate 2,pert
4013-3 E2F2 Null,pert
patient: 40741;	sample: normal,ctrl
C_AN12137_F,ctrl
"SDC1-silenced group, replicate 3",pert
"Pancreas from adult WT mice, biological replicate 3",pert
untreated_6hr,ctrl
Liver_TAK1KO_Rep4,pert
OE33 siRNA rep1,pert
jzo034-rp1-v5_u74av2-met,pert
"72 hour-treated wild-type NB4, biological rep1",ctrl
Heart left ventricle WT-PBS replicate 2,ctrl
tissue: primary skin cells;	genotype/variation: Adam10 wildtype,ctrl
strain: C57Bl/6;	cell type: Regulatory T-cells CD4+CD25+;	genotype/variation: Foxp3cre control,ctrl
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: M;	transfectant type: stably transfected with scramble control,ctrl
Anti-mir-210 replicate 1,pert
mouse_islets_ctrl_01,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 0 hrs;	time course: 3,pert
"Neuroretina 8-week lean non-diabetic, Biological replica_4",ctrl
GEIM45-NORM,ctrl
4h 4OHT-treated-sample2,pert
tissue: white blood cells;	age: 8.38;	Sex: male,pert
Wildtype_TAC_Rep4,pert
Strain: C57BL/6J;	Gender: M;	Age: 8 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
colon_C57mouse_6weeks_rep1,ctrl
striatum SNCA knockout 6 month replicate 3,pert
"Control shRNA cells passage 7, rep 1",ctrl
treatment: control esiRNA;	cell line: HeLa,ctrl
age: 35;	sex: F;	disease status: Marfan subject;	Filter number: 33;	Usage number: 4;	Exposures: 2,pert
"Normal T-cells, CD3+, donor 2",ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: normal,pert
disease affected colon of an adult with Crohn's disease (CD). Replicate-1,pert
RNA from HCC_12T,pert
cell line: Huh7.5.1;	tissue: liver;	agent: PBS,ctrl
Tobacco_abuse_2,pert
"A549, +TNFα, control siRNA, rep1",ctrl
Individual_4089_PN_sample,pert
Tissue: Spleen;	Type: Sham;	Strain: C57BL/6;	Batch: 12/1/03,pert
disease state: endometrioma;	patient: M4,pert
"24B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
renal_vesicle_wild_type_1,ctrl
autism with FMR1-FM AU066704,pert
180C3,ctrl
VIN_B116,pert
01N4H_PolyRF-,pert
"C57BL/6J female number 2, untreated control ear (#2_Wt-C-4)",ctrl
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 1;	dfs-event: 1;	distant metastasis: 1",pert
ILD_17,pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 2",ctrl
Control treated cells Rep2,ctrl
"GFPMYC negative GC B cells, Biological replicate 3",ctrl
"Patient 13, baseline",ctrl
cell line: MCF7 breast cancer cells;	genotype/variation: estrogen receptor alpha (ESR1) knockdown,pert
healthy control H02,ctrl
cell line: SA-01;	treatment: with DMSO (0.1 % final),ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 25.86575,pert
LY2 SRC1-siRNA tamoxifen treated rep3,pert
Ctrl PGC rep2,ctrl
"control + L-Arg colon tissue, biological rep2",ctrl
Healthy individual of twinpair #10,ctrl
HCC PBMC_sample 6,pert
Healthy Donors 1,ctrl
"BOEC, normal 24",ctrl
C_AN01125_T,ctrl
renal_vesicle_wild_type_2,ctrl
tissue: colon;	genotype/variation: HDAC2 KO,pert
CD4DecTp1-1,pert
SCD1 -/- liver rep4,pert
P59 Non failing heart biopsy,ctrl
KO - 3 mo - repeat 1 - Cy3 - mAdbID:74592,pert
patient: 40899;	sample: normal,ctrl
28A;pretreatment;female;breast tumor,ctrl
ASO T00278949,pert
Insig1 ∆/∆ /Insig2 -/- InsigKO_E1,pert
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 55;	gender: m;	treatment: NSAIDs/colchicine,ctrl
CD11b+Gr1+ cell sample_1 (derived from wild type mouse),ctrl
subject: 37;	disease: CP;	muscle: ST;	gender: M;	age: 8.7;	gmfcs: 2;	popliteal angle: 95,pert
PGC-1a-/- rep2,ctrl
19 saline,ctrl
Arid3a OE-Pool replicate 2,pert
MB231 PIAS1 shRNA-SCM,pert
Cal27_CETU2,pert
Heart_KO_3,pert
"cell line: MDA-MB-231;	disease state: Breast adenocarcinoma, estrogen receptor-negative;	genotype/variation: MTDH_WT_KD",pert
Patient no. 7: treated,pert
Dendritic cells generated from blood of donor 2,ctrl
MO32_11,pert
healthy control H19,ctrl
type 2 diabetes subject 06,pert
O_LS_Wk12,pert
H4-II-E-C3_high_rep4,pert
NTG replicate 5,ctrl
"Sfrp5 KO HFD 8 weeks, biological rep1",pert
"ZR-75-1, 12h, sham B",ctrl
Postmenopausal female. Estradiol treated. Patient 23.,pert
MGHU3 Cells_TAK1 siRNA + PD173074_Biological Replicate 1,pert
"Untreated TG2 knockout NB4, biological rep2",pert
type 2 diabetes subject 09,pert
"shRNA-PGC1a #65, rep-1",pert
age: 21 month postnatal;	tissue: striatum;	genotype: SNCA knockout,pert
"Patient B, uninvolved skin",ctrl
PGA-HMO-Obese-1aUA-s2,pert
Sample ID: TP26;	Twin Pair ID: CCN4.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 29;	Current Age (2007): 32;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
initial tumor increase/(-)decrease: n/a;	kit mutation: exon 9;	tissue: GIST Tumor,pert
BAL_47c_A0B1,ctrl
Control (C88),ctrl
"fibroblast, MFS subject GDO1051 rep 3",pert
"MAT1A knockout at 3 month age, biological replicate 3",pert
Muscle PCOS 1,pert
cell line: HEK293;	sirna: control;	condition: confluent cell density,ctrl
cell line: SUDHL-1 Cells derived from the a patient with Anaplastic Large Cell Lymphoma;	agent: control,ctrl
"NF-YB KD ES cells 96hr, replicate 3",pert
P4_PMP22KO_3,pert
"209, ADIPOOSE TISSUE, Before",ctrl
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 3;	gender: male,pert
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 5",pert
Phytohemagglutinin-activated PBMCs from normal control subject K (KAcPBMC),ctrl
"Mouse Embryonice Stem Cells, control si RNA, Rep2",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 93;	Sex: male;	region: M1;	age: 39;	genotype: Y/Mecp2-;YFPH/-,pert
"WT MEFs, biological rep2",ctrl
Trained diabetic 5 weeks DT5,pert
5407-lcm,pert
180D1,pert
AA_Control3_CD8,ctrl
agent: Nickel 140 µM,pert
age: 28dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
Spleen_wt_1m_rep3,ctrl
genotype: E-mu-BRD2;	cell-type: resting;	splenomegaly: none;	Ig clonality: polyclonal,pert
A3_tumor,pert
N30308,ctrl
E12 distal retina progenitors_control_rep 1,ctrl
KO - knock-out Treated - 24 hrs - repeat 3 - Cy3 - mAdbID:54822,pert
microdissected breast cancer cells from case 849,pert
CH2222,ctrl
"YPFH cells from M1, wild type control, biological replicate 3",ctrl
"Ulcerative Colitis (60 year old caucasian male, SAK_1305668541)",pert
Clinically localized primary prostate cancer P4,pert
THRA aI mutant + vehicle replicate 2,ctrl
wt Ang3,pert
strain: Sprague-Dawley;	tissue: Dorsal root ganglia;	postnatal age: 2 months;	surgery type: Spare nerve injury;	experimetal group: Adult Ipsilateral,pert
ARF1 siRNA knockdown MDA-MB-231 sample 3,pert
E10.5_otic_vesicle_mut_replicate1,pert
Control 874D,ctrl
array 4 plus E,ctrl
T4B-LU,pert
"cochlea at P3, wt, biological rep 3",ctrl
Aldosterone-producing adenoma (APA19),pert
Clinically localized primary prostate cancer tissue pool PX1,pert
Human Neural Stem Cell Line F3 Wild Type (replicate),ctrl
T51292,pert
SZ19,pert
"Mice_non trans, biological rep4",ctrl
Control for EGF 12h replicate 3,ctrl
White adipose tissue in Fsp27 knockout mice (rep2),pert
Superior Frontal Gyrus from a 2year-old girl not suffering from Rett Syndrome and therefore considered as a normal subject.,ctrl
HA96-37A,pert
"strain: C57BL6/10J;	genotype: Cmah KO, mdx;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle",pert
sample: #3;	subject: Control case #2;	brain: T-346;	age: 84;	sex: Male;	region: Dorsal motor nucleus of the vagus,ctrl
pediatric AML GP5,pert
scram_hi_7,ctrl
CLL 11-18 Control,ctrl
M238_R1_A_PLX,pert
Rosi-treated diabetic-2,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_6h_Con_HG-U133A_2_YCHSUP501,ctrl
S259A-1,pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: Rosiglitazone,pert
strain: C57BL/6J;	day: 24;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
Kidney_50 mg/kg VCM ip_mouse #069,pert
KU_28T,pert
"Acute Myeloid Leukemia, sample 26",pert
T129 U133p2,pert
224 Day 3 siMut10 transfected biological rep3,pert
HL60-shGSK3B-Construct1-rep1,pert
MacularDegen-healthy-11bAv2-s2,ctrl
01LQE: normal control,ctrl
12 hr KLF4 Time Course Induced,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT3B knockout, U0126-treated",pert
Carboplatin 24 hours set 2,pert
patient14,pert
C26_skeletal 2,pert
THRA 6a mutant + vehicle replicate 2,pert
Tsc1-deficient CD4 naïve cells KAI273,pert
mouse liver D2,pert
HF0201_U133P2,ctrl
CCC103A,ctrl
mouse_islets_VhlhKO_01,pert
U133A_B1,pert
"WM1205, no treatment",ctrl
Normal PBMC_sample 4,ctrl
3587-ls,pert
Strain: C57BL/6JNIA;	Age: 15 months;	Gender: Male;	Tissue: Whole hippocampus,pert
cell line: MOLM-14;	replicate: Replicate2;	treatment: shSYK_2,pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: not treated,ctrl
MDS17,pert
HepG2_VehicleB_24hr,ctrl
female_alcoholic_337,pert
CLL15-CD8,pert
cell line: MCF-7 breast cancer cell line;	sirna: control (scrambled siRNA);	agent: control (vehicle);	dose: n/a,ctrl
T16,pert
"Fibroblasts, formoterol, time 6h, patient 2, rep 1",pert
siPsmd14 replicate1,pert
untreated AML 9 blasts,ctrl
patient: 112;	current medication: None;	birth date: 7/5/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 5",pert
KL3_muscle_control,ctrl
"Spi-60, biological rep 6",pert
Wildtype 1 (jos1523),ctrl
Ishikawa_HighDose_BPA_8h_rep1,pert
"metastasis: none;	Stage: 3b;	tissue: normal, homogenized",ctrl
KU_42N,ctrl
GM19238_Kd_STAT2_3,pert
"129P3/J ACU, Rep2",pert
CRC_nodrug_M4868,ctrl
RE550_DU145_Un3,ctrl
NOD2wt_0h_MDP_biological replicate 3,ctrl
subject id: c4;	infection: control;	status: control;	tissue: whole blood,ctrl
"C57BL/6J female number 3, 2 months old, whole ear tissue, untreated control ear",ctrl
Strain: C57BL/6;	Age: E14;	Retrovirus: MSCV-GFP control,pert
GIST_KIT_5,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: C;	experimental sample name: PC5-R,ctrl
MCL_IGHV_MUT (R1302),pert
strain: C57/Bl6;	gender: male;	genotype: Egr-1 knock-out;	age: 42 days;	tissue: retina,pert
Interleukin_6_2,pert
"GATA6 knockout, biological rep 3",pert
"human failing LV myocardium, Ischemic43",pert
heart of mouse subjected 2 week to chronic intermittent hypoxia (2A),pert
HL60_shSYK_2_Replicate1,pert
Pax_C5,ctrl
female JAK2 KO liver sample 102,pert
erStress_twins_AA_1720twin2_DMSO_4h,ctrl
Liver GPR120KO ND #719,pert
"siNC-BMSCs , biological rep2",ctrl
cell type: Primary hepatocytes;	donor: 4;	agent: Wy14643;	time: 6h;	gender: Female;	age: 54 years old,pert
"human failing LV myocardium, Ischemic54",pert
Liver_Wild Type+Quercetin_3,pert
"Uninfected, replicate 1",ctrl
sample =XCGD6 treatment=Control time=0 (min),pert
Kidney_KO_baseline_rep2,pert
"PPARg2 expression construct, 2 hrs, No Rosiglitazone (PPAR_2_1)",pert
B2KO; No Treatment #1,pert
WT - Cre Control - 3 mo - repeat 3 - Cy5 - mAdbID:74590,ctrl
P5B Progranulin-cerebellum,pert
HCT116 PTEN +/+,ctrl
Grid2 deleted mouse 2,pert
Mut3,pert
C57_HF_3,ctrl
t19,pert
Strain: C57BL/6J;	Gender: male	;	Age: day3;	Genotype: KO;	Tissue: brown fat ,pert
Gender: Female;	AJCC Stage: IV;	Pathological T: 4;	Pathological N: 0;	Pathological M: 1;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: YES,pert
brain_QH2_6M_rep1,pert
Skinbiopsy_96hoursnickel_controlsubject_k2,ctrl
Healthy control_sample14,ctrl
"P201 HCT-116, DNMT wildtype, DMSO-treated",ctrl
6L,pert
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, peripheral blood;;	disease: (severe) aplastic anemia (SAA)",pert
Gastric_cancer_patient_8_dye_swap,ctrl
HepG2_Cr rep2,pert
Kidney_400 mg/kg VCM iv_mouse #048,pert
Muscle PCOS 10,pert
Atm+/+ untreated B,pert
OCT4 shRNA_2 Days knockdown_rep2,pert
Mening SWB WB SW 12a,pert
"Control siRNA - 5 days osteoblast differentiation, rep3",ctrl
HLA risk: High;	Height: 183 cm;	Weight: 93.5 kg;	BMI: 27.8;	Age: 57.76 years;	Gender: Male;	Race: White;	Glucose: 104 mg/dl;	HbA1c: NA,ctrl
MA_303,pert
@52055800697862121408403718160373,pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATM-1,pert
ATF2 KO-1,pert
remitted schizophrenia patient  S14,pert
PTC BRAF mut 14,pert
Control 2 medium only,ctrl
diagnosis: UIP/IPF;	fvc-group: FVC3;	tissue: lung,pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of SUZ12. Sample A,pert
cell type: HUVEC;	treatment: empty lentiviral vector pLVX-IRES-puro,ctrl
Parkinson's disease sample x106,pert
"dy/dy dystrophic diaphragm 4, 8 week",pert
patient: 51572;	sample: tumor,pert
cell line: SV589;	knockdown (days): 3;	treatment: Serum Starved; 3h EGF,pert
HeLa_TP082505-30_HG-U133A_2_IMFGN0023,ctrl
MCF7 cells treated with 2uM Doxorubicin for 24 hours Array 2,pert
"129P3/J SAL, Rep3",ctrl
Mouse old brain C30-Br-2,ctrl
saline ctr003,ctrl
Human hepatocellular carcinoma cell line infected with GFP protein (control) 3,ctrl
MRL/MpJ heart left ventrical (LAD ligation 60 day),pert
SC263_CETU3,pert
strain: F1 littermate of TCL1 (C3H/B6) and ID4+/+ (CD1) mice;	genotype/variation: ID4+/+TCL1-tg;	tissue type: spleen;	cell type: CD19+ B;	age of the mice: 1 month old,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 30 min after intravenous endotoxin challenge""",pert
"Aorta, Ang II 14d, #4",pert
E40C,ctrl
Muscle JDM (YJD-JDM-16UA-s2),pert
"Rat liver, treated with NMF, 1000 mg/kg in saline i.p., extrated 48 hours after treatment, biological rep3",pert
"42B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
tetracycline inducible Ngn3 ESC differentiated for 3 days as EB without doxycycline,pert
MDS patient 77,pert
cell line: KJD;	transformation: SV40 virus transformed;	cell type: epidermal keratinocyte,ctrl
N51783,ctrl
RNA from HCC_8N,ctrl
C57 24 air 1,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.644;	OD280: 1.383;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 68;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
RNA from HCC_17T,pert
NTB_heart 3,ctrl
WT-smoke-high-5 month+1d-R3,ctrl
HCC007T,pert
subject: 09A;	cohort: 9;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 25kb;	age (y): 31;	Sex: F;	batch: Batch_2,pert
HepG2_control rep1,ctrl
cell line: REH E/R positive leukemia;	treatment: treated with specific E/R targeting shRNA,pert
Muscle_control_2,ctrl
Age: 46;	Cycle: Luteal;	BRCA1/2 mutation: BRCA2 C5910G;	Family History: Yes,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 52 yr;	population: white;	dsm-iv: 295.1;	age of onset: 28 yr,pert
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: tamoxifen for 120 min,pert
MIY_day_5-3,ctrl
WT Brain 67d Mouse1,ctrl
02_C57_KO,pert
mESC_undifferentiated_wild type_rep1,ctrl
AKR/J Vehicle liver sample batch 5,ctrl
SC263_PBS1,ctrl
N6_Cy3,ctrl
CF (D508) subject4,pert
El-Ashry 001.CEL,ctrl
"Healthy control, biological rep2",ctrl
HepG2 cells control 4h,ctrl
224 Day 3 siSC transfected biological rep3,ctrl
"schizophrenia, BA46-47",pert
"strain: C57BL/Ka-CD45.2:Thy-1.1;	genotype: wild-type;	tissue: bone marrow from femoral and tibial bones;	cell type: LSK (Lin-, Sca-1+, c-Kit+) cells",ctrl
EosWTCD25+#2,ctrl
Wildtype 1 (jos0532),ctrl
"Normal subject (28 year old caucasian female, SAK_1265909540)",ctrl
lesion_midUV_patient6,pert
chip number: 12;	transfection plate: 4;	target gene: IRF3;	kd level: 0.91;	rin: 9.5;	transfection date: 2011-10-17,pert
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 2",pert
gender: female;	age (years): 60;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
ILD Study Number 774,pert
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 2;	gender: male,ctrl
"WT, PR04M009v0",ctrl
"Biceps, control, cohort 09, subject 09U",ctrl
MOLM14-shGSK3A-Construct6-rep2,pert
Ishikawa_VeryHighDose_BPA_8h_rep4,pert
V5-P446,pert
tissue: pancreas;	cell type: epithelial cells;	disease status: intraductal papillary-mucinous carcinoma (IPMC),pert
Mouse fetal liver_E14.5_WT_rep4,ctrl
Mtb infected-42d-6,pert
"male, 275-300g",ctrl
tissue: kidney;	protocol: intravenous;	agent: vancomycin;	dose: 50 mg/kg,pert
PGA-MAH-OuJAir-1aAv2-s1,ctrl
PGA-MAH-C3H_PBS24h-3aA-s2,ctrl
age_years: 50;	sex: M;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
WKY20-4,ctrl
"Fibroblasts from UIP histology lung tissue, IPF-19",pert
"Normal subject (42 year old caucasian male, SAK_1254621275)",ctrl
OVCAR3_rep1//CD157_DS,ctrl
pSuper vector control 1,ctrl
Wild-type_macrophages_0h,ctrl
genotype: Pxr knockout;	Sex: Male;	tissue: Liver;	compound: Vehicle;	route: IP;	dose: 0 mg/kg,pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate 5,pert
n22,ctrl
RA3,ctrl
tumor cell line HepG2 with knockdown of HIF-1α rep4,pert
Mut-/- rep2,pert
FHCRCAML4653,pert
HL60-shControl-rep2,pert
DEX1_6HR,pert
tissue: retina;	age: postnatal day 8;	genotype: rd1,pert
"acutely admitted, severely psychotic schizophrenia patient  A05",pert
disease status: CML chronic phase (CP);	cell source: leukapheresis products (LP);	cell type: CD34+ mononuclear cells,pert
"schizophrenia, BA46-39",pert
CME-Ctr_LaminA3d-1MA-S2,ctrl
Mening SWB WB NP 3b,pert
condition: Psoriasis;	patient: 292;	tissue: LS skin biopsy;	kit: Ovation,pert
Cmah KO_kidney_2,pert
siEGFP (24 hr) _1,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 76 years,ctrl
NuLi cell line biological rep3,ctrl
Human prostate cancer primary culture C3dx,pert
Cell line MCF-7_control_expt1,ctrl
"diet: AIN-76A;	sodium arsenite added to drinking water: 10 ppb, 5wk",pert
Hunk WT rep2,ctrl
reduction mammoplasty patient 334,ctrl
NE-rep1,ctrl
Control subject 29_biological replicate 1,ctrl
C final PC3 AA 2hr,pert
"Normal diaphragm 1, 8 week",ctrl
SIRT4 WT liver_7591,ctrl
11083 Normal Uninflamed descending colon,ctrl
age_years: 44;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
Strain: 129Sv/C57BL/6,pert
cell type: CD43+/41+/235+ progenitors generated from Trisomy 21 iPSCs,pert
Zfx wt MA9 cells + Vehicle [10980],ctrl
CAST/EiJ Vehicle liver sample batch 4,ctrl
cell type: umbilical cord endothelial cells (HUVEC);	passage: 4,pert
Parkinson's disease sample x019,pert
CA96-116B,ctrl
chondrocyte_control_rep3,ctrl
HeLa_01-04-05 TP1_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
liver_QH2_14M_rep1,pert
"A673 treated with Puromycin for 5 days with concentration of 0.09 uM (EC50), biological rep2",pert
11_0037C_Day1_31,ctrl
PGA_MI_nilv_1w_670,pert
KO - knock-out Treated - 12 hrs - repeat 1 - Cy5 - mAdbID:61759,pert
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 2h,pert
"brain, hippocampus: KA-1h-P15-II_e1_le1",pert
2008 cells_rep1,ctrl
NLGN3_3,pert
siHIRA 2,pert
Striatum of 8-10 week old 129P3/J mice,pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: n/a;	maternal age: n/a,ctrl
cell line: HCC1954 cells;	subtype: HER2 Positive;	treatment type: TBK1 inhibitor II;	treatment time: 3 Days,pert
Pancreatic Sample 24-Normal,ctrl
siSox2 replicate1,pert
AGS control biological rep 2,ctrl
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 69;	gender: m;	treatment: NSAIDs,ctrl
ESC_Zfx-null_Replicate1,pert
treatment: control;	cell line: CuFi;	genotype: Cystic Fibrosis deltaF508 mutation,ctrl
Wtepi_infect_0h_rep3,ctrl
MIG control biological replicate 3,ctrl
SynovAcAr_022EACIE_151.txt,pert
Phan_004_WT.bleomycin rep1,ctrl
cell type: peripheral blood mononuclear;	disease state: multiple sclerosis,pert
HT-KO-8B,pert
AZ-521_doxycycline_24h_rep1,pert
cell line: HEK293;	sirna: control;	condition: sparse,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 72;	tissue: Blood,pert
"Patient C, lesional skin",pert
"Normal skin from lmq_control mouse, biological replicate 3",ctrl
4 hour tunicamycin wild type D,ctrl
P4 Patient None,pert
Gadd45a-/-_MEF_rep1,pert
01J47_PolyRF-,pert
BxPC3-WT rep 6,ctrl
strain: C57BL/6;	tissue: colon;	genotype: PPAR g fl/fl; Lysozyme M cre+;	phenotype: PPAR gamma deficient;	treatment: dextran sodium sulfate (DSS),pert
isoflurane 05,pert
Extract:LOX-1:113401;	Extract Description:GFP_Untreated_12hr:113401;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.56;	Quality: Background Mean Dev.:0.03;	Quality: Absent (%):57.6;	Quality: Absent (%) Dev.:0.5;	Quality: Scaling Factor:0.61;	Quality: Scaling Factor Dev.:0;	Pretreatment [C]:GFP;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113401;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_12hr;	RNA extraction source key [A]:282295713,ctrl
"Aorta, Ang II 7d, #2",pert
siGL3E2 2,ctrl
MDS35,pert
LmnaG609G/G609G KI #1. 461,pert
age: 43;	sex: M;	disease status: control subject;	Filter number: 80;	Usage number: 4;	Exposures: 3,ctrl
Septic shock;	gender: Female;	Survivor;	organism: Staph aureus,pert
01_NOR,ctrl
LC1026ni,pert
shRNA4-1-noDox-rep3,pert
Lung-sarcoidosis-rep5,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 54,pert
K562 cells control replicate 2,ctrl
20SAGEA2,pert
24h Lipofection GAPDH siRNA (SAMPLE 12),pert
KO-Nrf2-Female-2,pert
GB 9 65A NO LPA,pert
"brain, hippocampus: Wt #3396 Cort_e1_le1",ctrl
RV64.04_CONTROL_day25_Slide50,ctrl
cell line: HEK001,ctrl
"control endometrium, patient 4",ctrl
sample: #1;	subject: Control case #1;	brain: T-199;	age: 82;	sex: Female;	region: Dorsal motor nucleus of the vagus,ctrl
liver_STZ treated diabetic_rep6,ctrl
"siDsRed-1, biological rep1",ctrl
pt. HCL F treated with DMSO for 48h,ctrl
cell type: CD4+ T;	strain: C57BL/6J;	genotype/variation: C57BL6-STAT1<tm1Dlv> (STAT1KO);	treatment: stimulated for 3 hours with medium alone,pert
Astrocytoma_4,pert
strain: C57BL/6;	cell type: bone marrow-derived mast cells;	treatment: interleukin 3,ctrl
"brain, hippocampus: Ctr-6h-P15-III_e1_le1",ctrl
cortex_WT_rep3,ctrl
CD4+_Tcells_non_severe_asthmatic_4,pert
A_AN00764_C,pert
siFOXM1Veh24h rep2,pert
strain background: Mixed background;	genotype/variation: Otx2 k.o.;	developmental stage: E13;	gender: not determined,pert
Mouse old heart w/ a-tocopherol aT-Ht-3,pert
human esophageal squamous cell carcinoma cell line_KYSE270,pert
cKO_P55,pert
"NF-YC KD ES cells 96hr, replicate 1",pert
CH1811,ctrl
"Pb-Cre+;PtenL/W;K-rasG12D/W, biological rep1",ctrl
"seminoma specimen, pT1, patient age: 29y",pert
"Normal subject (44 year old caucasian female, SAK_1279948644)",ctrl
TP06-612,ctrl
1% dmso batch 2,ctrl
White adipose tissue in wild-type mice (rep2),ctrl
CLL 69-04 Control,ctrl
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 7 hours,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: scrambled;	transfection time: 48h,ctrl
Txnip deficient tumor 24 months sample 2,pert
"shControl, normal growth, replicate 3",ctrl
KN-smoke-low-5 month+1d-R1,pert
"WI-38 cells, at 24 h after exposure to 0.1 uM BPDE, biological rep2",pert
"10mg/kg/day PFOA, Rep 2, Block 1, liver (high dose)",pert
"patient 8, baseline",ctrl
HepG2_Vehicle_24hr_prep4,ctrl
"AG825-treated, Sham UV, Replicate B",pert
age: 36;	gender: female;	ejection fraction: 68;	left ventricular end diastolic diameter: 47;	inflammation/PVB19: negative,ctrl
human_hepatocyte_gatifloxacin_donorA_24hr_prep1,pert
human esophageal squamous cell carcinoma cell line_KYSE150,pert
"Gender: male;	Age: 74;	Source: skin, left ear",pert
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: a SD supplemented with 100 mg/kgchow resveratrol ad libitum,pert
5214 UC Inflamed descending colon,pert
23C-M4-D,ctrl
KO STR Veh 28,pert
Male mice from mdx (C57BL/10ScSn-Dmdmdx/J) line were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,pert
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_5;	fev1 (% predicted): 44;	fvc (% predicted): 61;	medication: Prednisolone 5mg od,Montelukast 10mg od,Symbicort 400/12 2pbd,Omeprazole 20mg od,Uniphyllin 400mg bd,Bricanyl prn;	cell type: CD8+ T-cells",pert
"RES-enriched Grape extract group, 12 months, patient number 62",pert
Psoriasis-6 baseline,pert
1uM H2O2,pert
Sample Group: control; Gender: male; Age: 50; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
cell line: PC-3;	transfection: pre-miR-221,pert
Peripheral blood mononuclear cells;	TTF=135min;	Race=White;	Sex=Male,pert
KO_IL-6_100_rep1,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M2;	flt3 status: D835 mutation,pert
sirna: control;	plate: plastic;	cell line: MCF10A,ctrl
Normal_Kidney_Biopsy_8,ctrl
cell line: SNU-398;	cell type: Hepatocellular carcinoma (HCC);	genotype/variation: scrambled control,ctrl
strain: C57BL/6J;	cell type: bone marrow derived macrophage,ctrl
healthy myeloid cells 1,ctrl
"Control Distal, Small Intestine 2 17 days old",ctrl
Prostate Cancer_MS 36C4,pert
tetO-Satb2 #3 +DOX,pert
PFC FVB/N control 4,ctrl
"vehicle, biological rep4",ctrl
"Control_TA, C3",ctrl
MF-36,pert
WT P10 replicate 3,ctrl
Control [G1],ctrl
transfection: control shRNA;	cell line: Stable F1 Rif1 knockdown ES cells at passage 16;	background strain: C57BL/6xC3H,ctrl
strain: CD-1;	age: 20 week;	genotype: Wild type;	tissue: lung,ctrl
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 8week,pert
H21 Ctrl 24h 1,ctrl
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 49;	tissue: Blood,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 2;	psoriasis duration: 13.2375085557837;	age of psoriasis onset: 8,pert
Cpr-low_pool 1,pert
shCDK8_Time_30_1,pert
"Cervical cancer, adenocarcinoma, microdissected, age 46, stage IB2, HPV 16",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day1,ctrl
tissue: freshly isolated human monocyte;	gender:female; age: 19 yr; weight: 65 kg,ctrl
PBMCs_Control_17 [IS],ctrl
DW91.2_Tg_M,pert
background strain: C57Bl6;	genotype: Polgtm1Lrsn-/-;	tissue: Mouse bone marrow;	age: 32 weeks;	gender: female,pert
patient: 127;	current medication: Prednisolone 10mg Heparin Questran Gabapentin FA;	birth date: 9/9/36;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: Pseudomembranous Colitis;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,ctrl
MLL_00107,ctrl
KO 0h TPA rep1,pert
"twin pair: #2;	individual: diseased individual, inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",pert
siERK2Veh4h_2650,ctrl
V5-P053,pert
Reference RNA e17.5 embryo,ctrl
NSC_FOXO_NULL-3,pert
patient: 23;	disease state: hypertension;	tissue: Atheroma plaque,pert
Monocyte ATV rep 3,pert
Cont subject 03,ctrl
PND28 Rat Testis_Rat230-2_6hr Corn Oil_Animal#34_04005,ctrl
Bronchial Epithelial Cells SA biological 1997E,pert
"anN1 P9 hair follicle, biological rep2",pert
"breast tumor epithelium,9",pert
A549_Cisplatin_rep3,pert
BL Day 1 siMut12 transfected biological rep2,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_24_35_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
Rat fatty liver4,pert
"FOXP3, mut, REP2, 72h",pert
b105,ctrl
H295R_Group_C_Dose_100_TIMEPT1_031,pert
S017_Scz_F_85,pert
Strain: Top2b+/+ in 129SvEv (minor 129SvJ) background;;	Age: E14.5 embryo;;	Gender: male;;	Tissue: whole brain,ctrl
Atm+/+ untreated C,ctrl
"TNFa-OMe siRNA-B, replicate 4",pert
EP32_adipose_pcos,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 33,pert
agent: Cadmium 0.55 µM,pert
HEK293_A263insGG_#5_uninduced,ctrl
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119-;	genotype/variation: wildtype,ctrl
Wild Type nr 658,ctrl
U937_ROS_curcumin_18h_rep1,pert
"Control cell, Replicate 1",ctrl
1uM H2O2 rep 3,pert
NSC13,pert
Untreated WT - repeat 1 - mAdbID:102765,ctrl
Intronic WT control rep2,ctrl
"Strain: B6CF1 x C57BL/6, Tissue: Bone marrow, Age: 7 weeks",pert
"RWPE1 cells, vehicle, 24h, biological rep1",ctrl
HF0914_U133P2,pert
01LMJ: new onset sJIA,pert
"rat hippocampus (CA1 region), sham, 18 months old, subject 5",ctrl
V5-P366,pert
Globin_S1,pert
MDS patient 20,pert
"MEKi 4 days, biological rep3",pert
"MaF pre-iPSC9P2, Vc+, D3",pert
"normal nasopharyngeal tissue, specimen N3",ctrl
Brain (Inferior Olivary Nucleus)_Control_case1,ctrl
colon_IBD_923,pert
Md02h028,pert
wt Ang4,pert
Ctr MCF10A.B2 1,ctrl
Reh_mock1,ctrl
WT KLS 2,ctrl
cadmium_16hr_rep1,pert
A_AN08873_T,pert
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 11",pert
mouse cerebellum at P30 wild type 3,ctrl
"Distal and Proximal Large Intestine, 8week old Winnie mouse 1",pert
ethnic background: Caucasian;	gender: male;	age: 45-65 years;	tissue: vastus lateralis muscle,ctrl
"118, ADIPOOSE TISSUE, After",pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 26;	maternal age: 33,ctrl
Individual_3171_PN_sample,pert
mock-3,ctrl
Clint-Dhh-1-011411,pert
EA_Case18_CD4,pert
Mtb infected-63d-2,ctrl
"Mbd3 KD, replicate B",pert
"AD_FC, biological rep13",pert
WT biological replicate 1,ctrl
THP1-shControl-rep3,ctrl
strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: corn oil,pert
strain: C57BL/6;	tissue: small intestine;	genotype: cftr-tm1Unc (cftr null);	treatment: lubiprostone,pert
whole blood_100265,pert
4032-1 E2F3 Heterozygous,pert
Teratoma 1282,pert
Patient: I;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
Individual_3586_PP_sample,pert
"31B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
mouse colon_hnf4control_rep3,ctrl
phenotype: alcoholic;	gender: male;	case_id: 313;	age: 70;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 62;	brain ph at time of freezing: 6.82;	labeling_batch: 2,pert
KL1_muscle_control,ctrl
"human failing LV myocardium, Ischemic65",pert
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep4,pert
30A;pretreatment;female;breast tumor,ctrl
"Donor 1, Ebola infected 1hr",pert
CUTLL1 wash2h-CHX_rep3,pert
cell line: RUES2;	cell type: human embryonic stem cells;	transduced with: control shRNA;	time point: Day 5 of cardiac differentiation; cardiovascular progenitor cell stage,ctrl
sample =XCGD1 treatment=Stimulated time=180 (min),pert
571.KO,pert
e_M75,pert
HTB58_antiEvi1siRNA_2,pert
Bone-Marrow_MM_M1062,pert
wild-type_CITCO_rep2,ctrl
strain: C57BL/6;	genotype: Ppif-/- (global gene knockout);	tissue: heart;	age: 8 weeks,pert
H2_SS11_01Nov07,pert
"Setd2 knockout mESCs, biological rep1",pert
Tumor-KO-rep2,pert
PA-1+(2),pert
01-0043A_Day1_2,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M2;	flt3 status: internal tandem duplication (ITD),ctrl
0949-01-A,pert
individual: patient8;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"Patient 4, control tissue",ctrl
06R006 Control,ctrl
"male,23,Caucasian",ctrl
"human nonfailing LV myocardium, NonFailing6",ctrl
"Autoimmune pancreatic islets, no cyclophosphamide treatment, rep 6",ctrl
wild-type mouse 2,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 218,pert
CF knockout HMCF CHN539,pert
Cav1KO 1762,pert
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14533;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
brain_co_14M_rep3,ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 6h ID283,pert
Normal mucosa 16,ctrl
"Lens epithelium, WT, #6L",ctrl
CLL7-CD8,pert
siEGR4 (48 hr) _2,pert
Muscle WT Aged 12171,ctrl
"endometrioma, patient M3",pert
H4-II-E-C3_high_rep3,pert
27 weeks male,ctrl
13A;pretreatment;female;breast tumor; responder,ctrl
DMN-NF1Hippo15d-2dAv2-s2,pert
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 2;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
21C-M4-ND,ctrl
"liver, WT mouse, sample WT6",ctrl
Dental pulp cells control sample triplicate 1,ctrl
Diagnosis: ET/AML;	Age: 51y ;	Gender: Male;	Blast %: 70;	Source: PB;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: No data,pert
X_p8_rep1,pert
humanMBC_ctrl overexpression_1,ctrl
liver_Pink1 knockout_12 weeks_replicate_3,pert
shRNA2-4-noDox-rep3,ctrl
age_years: 43;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
"A673 treated with Puromycin for 5 days with concentration of 0.09 uM (EC50), biological rep3",pert
Md02h022,ctrl
cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: Vehicle (0.1% ethanol);	time point: 6 hours,ctrl
"seminoma specimen, pT1, patient age: 56y; W02 151",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.808;	OD280: 0.956;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 77;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 46;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
04_NML,ctrl
Pt34_Pre,ctrl
patient: 34208;	disease state: LGSC;	component: Invasive,pert
"Foxd3 conditional knockout cells treated with Tamoxifen, biological rep1",pert
tissue: lung;	genotype/variation: Tmem1002loxP/2loxp,ctrl
strain: BALB/c;	gender: female;	type: TSG-6 knockout;	treatment: none,pert
Psoriasis-1 baseline,pert
"eye, retina: Control 1_le1",ctrl
4mo wt3,ctrl
treatment: PLX4720;	time: Day1;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,pert
non-treated CCRPKO_rep-3,pert
"Rat_Tracheal_Dex_2hr, rep1",pert
P14 - nudelko/+ 2,pert
db/m 6-3,pert
PGA-HMO-Obese-3aUA-s2,pert
Low weight gainer KOZAK2_ABI_HYP_L3,ctrl
Mouse WT mandibular molar [ABH_25A],ctrl
Ngn3 EB3 OFF replicate 1,ctrl
untreated_2,ctrl
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 42 dpi,pert
HES2_Mir122Mut_rep2,ctrl
tissue: ankle joint;	genotype/variation: MMP-8 wild type;	strain: C57BL/6,ctrl
disease state: psoriasis;	group: baseline,pert
SLE7-TC,pert
VehVeh2,ctrl
"wildtype white adipose tissue, biological rep 3",ctrl
A516 MI 7 day,pert
SRF Mut. IgM+IgD+ (GBF0552),pert
Normospermic individual: Sample N7,ctrl
RAW_0.7mM_HOCl_#1,pert
HCC003N,ctrl
"Immortalized MEFs WC, v-src expression retroviral vector infected, rep2",pert
Undifferentiated Dicer +/- (D4) ES cell line replicate_2,ctrl
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: vehicle,ctrl
cell line: BxPC3;	genotype: wild type;	beta-catenin gene (ctnnb1): wild type,ctrl
"Control group, replicate 3 [GY_Con3]",ctrl
Control_2h_rep1,ctrl
siCONTROL no DNA Damage experiment 2,ctrl
DMSO1_6H,ctrl
Adipose-5 month-Myc heterozygous-technical replicate 3,pert
Control Day7 (420R),ctrl
Aurka_R_-Dox_rep2,ctrl
Strain: 129SV/EV;	Gender: Female;	Age: 8-12weeks;	Tissue: Lymph node B cell;	Noninfected;		,ctrl
Human skeletal muscle biopsy sample;	Patient #110 with NORM,ctrl
Keratinocytes treated with EphB2 for 48h,pert
age: 29;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
DRG_DMSO_0.1%_Rep2,ctrl
ILD Study Number 1274,pert
36SMOKEH,ctrl
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_5,pert
Nrl-ko-Gfp P2 replicate 2,pert
heart_Q10_6M_rep1,pert
"P50_wt cones, replicate 2 [array]",ctrl
"RNF40 siRNA - 5 days osteoblast differentiation, rep1",pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 4x1h exposure per day",pert
Btk KO1,pert
strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue: gallbladder,pert
WT-EtOH-1 (DFW),pert
TN 6,ctrl
Mouse fetal liver_E14.5_KO_rep1,pert
sample =XCGD3 treatment=Control time=0 (min),pert
heart of mouse subjected 2 week to chronic intermittent hypoxia (2B),pert
strain: HNF4LoxP/LoxP AlfpCre;	age: E18.5;	tissue: Fetal Liver,pert
Mnk_3176-R-B,ctrl
Ezh2-Cre2,pert
Normal mucosa 6,ctrl
Untreated diabetic-4,ctrl
50SageA,pert
MDA_PR_Paclitaxel_4,pert
LT345 wild-type untreated,ctrl
Kidney_Aqp11+/+_P7_3-1,ctrl
SLE CD4 T cells 7,pert
S004_Scz_F_88,pert
Hippocampus 2003 2 month Old,ctrl
"human ES cells line from AZ-VUB laboratory, Belgium; derived from normal embryos;	Karyotype: X,Y",ctrl
Day: 18; Drug: Saline; Phase: Withdrawal; Replicate: 2,ctrl
gender: Female;	age: 33;	cell type: PBMC;	individual: Patient 108;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
"human nonfailing LV myocardium, NonFailing13",ctrl
Squamous cell carcinoma 006,pert
3583-lcm,pert
cell line: LNCaP-abl (abl) prostate cancer cells;	genotype/variation: transfected with control siRNA;	treatment protocol: under hormone depleted conditions,ctrl
Squamous cell carcinoma 023,pert
patient: 51315;	sample: normal,ctrl
T92 U133p2,pert
individual: Control10;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
Healthy control 15,ctrl
PND28 Rat Testis_Rat230-2_2hr Corn Oil_Animal#7_04005,ctrl
"Hdh knock-in embryonic stem cells, Q20 line, biological replicate 2",pert
Ischemic cardiomyopathy_G42,pert
Vit A sufficient 4b,ctrl
cell type: dermal fibroblast;	genotype: healthy control,ctrl
"MCF7/BUS, 0 pM E2, 48 hours, biological replication 5",ctrl
MCI-011,pert
01LN8: new onset sJIA,pert
Normal mucosa 7,ctrl
Day6 Estrogen treatment replicate 2,pert
KD control 13A,ctrl
KM_028N,ctrl
cerebellum_wildtype_2,ctrl
WT-VILI replicate 1,ctrl
"brain, hippocampus: Ctr-72h-P15-III_e1_le1",ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T3, N2, M0, G4",pert
P61 Non failing heart biopsy,ctrl
2092N,ctrl
T162 U133p2,pert
Sample 03 Kidney Hyp Mouse - Control Diet,pert
Mouse old brain w/ a-tocopherol aT-Br-3,pert
"shControl, normal growth, replicate 2",ctrl
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: MEDIUM;	genome/variation: PDGFRA mutation detected,pert
WKY20-2,ctrl
PBMCs_Control_5 [IS],ctrl
m1-adenoma2,pert
D2-Gpnmb+ control rep9 (retina),ctrl
Ribavirin Treated Cells 1,pert
HCC1937_2,ctrl
BP28,pert
Muscle PCOS 4,pert
original diagnosis: ERA;	cell type: Peripheral blood mononuclear cells,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 40 yr;	population: white,ctrl
"brain, frontal cortex: Sample51_e1_le1",pert
K562 cells control replicate 9,ctrl
OSCE-12T,pert
"Lesion Skin, LS-2",pert
cell line: M12;	treatment: control,ctrl
siRNA Med12 [K1],pert
Mouse_WT_ES_clone 1,ctrl
PTEN deletion Replicate2,pert
Gnmt_WT_2,ctrl
PBMC from T cell LGL leukemia patient #130 (TLGL130),pert
H2009_shPTK7-1,pert
GIST_KIT_13,pert
01JME: new onset sJIA,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 23;	gender: male,pert
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:wildtype,Treatment:cornoil,Batch:Batch1",ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 8d ID299,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 3,ctrl
Cell line expressing inducible GFP-progerin. Induction: day 5. Replicate A,pert
remitted schizophrenia patient  S04,pert
HCC002T,pert
strain: C57BL/6;	tissue type: back skin,ctrl
"Uninvolved Skin, NS-28",pert
"infected primary RPE, biological replicate 3",pert
osteoblast_control_rep1,ctrl
organ: Liver;	age: 14-week-old;	genotype: Wild-Type,ctrl
SeroNeg-3,ctrl
0196-01-C,ctrl
Treg cells Ptenfl/flFoxp3-Cre replicate 1,pert
HNF6_2+,pert
AP-2 gamma targetting siRNA 3: CCACACUGGAGUCGCCGAAUA Technical Replicate 3,pert
"cochlea at P7, wt, biological rep 1",ctrl
kidney_Q10_14M_rep2,pert
condition: Psoriasis;	patient: PS-N;	tissue: LS skin biopsy;	kit: Affy,pert
Exercised-7,pert
tissue: cervical cancer cell line HeLa,pert
"mouse liver sample, KO strain, biological replicate 1",pert
"10mg/kg/day PFOA, Rep 5, Block 5, liver (high dose)",pert
cerebellum SNCA knockout 6 month replicate 3,ctrl
5A;pretreatment;female;breast tumor,ctrl
Aged 8,pert
strain: 129SV;	gender: male;	age: 6 months;	tissue: right ventricle;	genotype: plakoglobin (+/-),pert
"3T3-L1 siControl 48h, biological rep 3",ctrl
ab069 IM,pert
LIVER_diclofenac_repl1,pert
HLA risk: High;	Height: 170.4 cm;	Weight: 51.5 kg;	BMI: 17.6;	Age: 13.88 years;	Gender: Male;	Race: White;	Glucose: 196 mg/dl;	HbA1c: 6.2%,pert
"DMSO Control after 8hr, replicate 2",ctrl
"P30_C-DGCR8 KO cones, replicate 1 [array]",pert
tissue: skin;	individual: Patient N-6;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
"brain, frontal cortex: Sample58_e1_le1",ctrl
PTC BRAF mut 6,pert
C_AN19442_C,ctrl
cell line: A549;	cell type: adenocarcinomic human alveolar basal epithelial cells;	transfected with: siRNA against STAT3,pert
"acutely admitted, severely psychotic schizophrenia patient  A26",pert
NINDS-RHS-Kainate_240h-3aUA-s2,pert
HUVEC/NmenMC58_pilD_1h_rep1_1103,pert
patient: 260;	current medication: asacol 800mg TDS Asprin coproxamol;	birth date: 1/1/54;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/79;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/9/05;	indictation for procedure: ;	ucss: 12;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/9/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Arthritis Depression Alcohol excess;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
BCells_Transgenic_day0_REP3,pert
s42,ctrl
4 hour tunicamycin CHOP-/- D,pert
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:knockout,Treatment:cornoil,Batch:Batch1",pert
Individual_4162_PP_sample,pert
Empty vector replicate 3,ctrl
GFP Untreated 12hr 282295733,ctrl
01MLT_Oligo,pert
Native ko biological replicate 3,pert
age: 13.5 day;	strain: 129;	genotype/variation: Chsy-1 knockout,pert
Diseased individual (ulcerative colitis) of twinpair #3,pert
MCF7_Control_Array_2,ctrl
JIA PBMC Post treatment A235_287(2),pert
24h 4OHT-treated-sample1,pert
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.34 uM (2 x EC50), biological rep2",pert
"Gender: Female, Age: 27, BMI: 29, Tissue: luteinized cumulus cells",pert
Muscle WT Adult 07271,ctrl
normal adjacent esophageal tissue from patient E1796,ctrl
"Wild type used for MAT1A 3 month, replicate 1",ctrl
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14508;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
NCI-H716_YAP1.3,pert
"SLE patient, 1015V1",pert
KU_37N,ctrl
Bone-Marrow_SMM_S1335,pert
"Aorta, Ang II 14d, #1",pert
liver_WT_replicate2,ctrl
2008-Ets1 cells_rep1,pert
PGA-MAH-C3H_OVA6h-1aA-s2,pert
Endometrium-Normal 2,ctrl
"disease group: Nonatopic Control;	Sex: m;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 130;	ige (kiu/l): normal (0-48.5 kIU/L): 34.7;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
Individual_5295_NN_sample,ctrl
BP patient 48_biological replicate 1,pert
CD25+Xbp1WT,ctrl
PTC BRAF wt 10,pert
hES_VUB01_2,ctrl
ACC Xenograft X12,pert
Nonlesional Epithelium Atopic Dermatitis rep3,pert
"brain, brainstem: CB1_e1_le1",ctrl
disease state: Healthy Control;	gender: Male,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 uM;	treatment time: 48 hours,pert
cbp+/- standard cage Rep3,pert
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14455;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
cell line,pert
RKO_NEGsiRNA_6hDMSO_REP1,ctrl
H9_d15_hepatic differentiated_2,ctrl
brain_DLPFC_bipolar C_mr284,pert
"Control siRNA - 5 days adipocyte differentiation, rep2",ctrl
tissue: white blood cells;	age: 15.15;	Sex: male,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 62;	tissue: Blood,pert
Low weight gainer Kozak1_ABI_ING_L1,ctrl
3T3F442A-shGFP-rep2,ctrl
30 year old female,ctrl
"human failing LV myocardium, Idiopathic79",pert
astrocytes normoxia batch 1,ctrl
cell type: Bone marrow cells;	genotype: control rtTA mouse;	strain: C57BL/6,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 8 hrs;	time course: 1,pert
NIXKO2 SPLEEN,pert
strain: C57BL/6;	genotype/variation: Nrf2 Control;	gender: Female;	tissue: Liver;	age: 6weeks,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
BTBR_Liver_rep2,pert
tissue: skin;	individual: Patient P12;	condition: ANL;	eczema severity: SCORAD: 0,pert
"nasopharyngeal carcinoma, specimen T17",pert
11383 Normal Uninflamed ascending colon,ctrl
"Patient I-c852T, MSI colorectal tumor",pert
Low Glucose Transcriptome Profiling,ctrl
GIST_PDGFRA_7,pert
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Mesenchymal Cell,ctrl
PsOEt-13-LS,ctrl
strain: C57BL/6;	genotype/variation: Smchd1 null;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: B,pert
WT-MAC-SEV-1,pert
B10.H2g7 Idd3_T2,ctrl
Errb mutant stria vascularis replicate 3,pert
Integrin alpha7 transgenic mouse rep3,pert
"Control, biological rep4",ctrl
Ileum_POR-null_2,ctrl
Ero1-WT non-induced biological repA,ctrl
Phan_006_WT.bleomycin rep3,ctrl
patient: CAB10;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Supraoptic nucleus,pert
"Patient 8, Atheroma plaque",pert
subject id: 68;	infection: DENV;	status: DF;	tissue: whole blood,pert
G392E_on_rep2,pert
cell line: SW1736;	time point: 6h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 6 h,pert
"sirna: siRNA2 (Dhamacon);	cell line: Human epithelial colonic adenocarcinoma, Caco-2",pert
CTL2 AO 48hr,ctrl
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: scrambled;	transfection time: 48h,pert
strain: ICR/B6D2;	tissue type: back skin,pert
autism with dup(15q) AU006504,pert
Myoblast-GATA4-OE-day3-2,pert
Waldenström’s macroglobulinemia (WM-BL 32131),pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
liver_control_diet_rep5,ctrl
NonIR-KO_Rep2,pert
CD47 null Endothelial cells 1,pert
tissue: muscle;	sample group: calorie restrictive;	treatment: before;	gender: Female,ctrl
subject: 07U;	cohort: 7;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 34kb;	age (y): 49;	Sex: F;	batch: Batch_2,ctrl
wt Ang3,ctrl
3 wks TAC-1,pert
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 63;	Sex: male;	region: LC (locus coeruleus);	age: P22;	genotype: Y/X;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,ctrl
"LacZ, #1 repeat",ctrl
F-IIP(UIP)9_Cy3,pert
tg-2,pert
Pten cKO rep3,pert
Huh7 cells_JFH-1 Infected 24 hours_ rep3,pert
strain background: ICR;	genotype/variation: Pax6 flox alpha-cre;	developmental stage: E12;	tissue: Embryonic retina/optic cup,pert
muscle_Wt_35wk_rep4,ctrl
Untreated 979-CLA-26,ctrl
Control 10,ctrl
kontrolli_DC_A,ctrl
01LPM,pert
Bronchial Epithelial Cells SA biological 1964P,pert
c 2-1,pert
gender: male;	batch: 1;	age (years): 56;	patient id: Control_8;	fev1 (% predicted): 111;	fvc (% predicted): 111;	medication: None;	cell type: CD8+ T-cells,ctrl
Cervical cancer_1509T,pert
healthy control,ctrl
MDS patient 50,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 4;	psoriasis duration: 48.0;	age of psoriasis onset: 19,pert
BP patient 91_biological replicate 2,pert
EUR12_T3_PP_day1_045,pert
Dgcr8 KO replicate 1,pert
RNAi -Transgenic replicate 12,pert
RAW_2.1mM_HOCl_#1,pert
"RWPE1 cells, vehicle, 24h, biological rep4",ctrl
"Cerebral Palsy, Gracilis, Patient Replicate 1",pert
B10.H2g7_S1,ctrl
Cardian muscle Trained 5 week T5,ctrl
Muscle control 18,ctrl
Fetal heart 3.0 ug/kg TCDD rep3,pert
wild type; 6 months,ctrl
cell line: Hep G2;	genotype: RCCC-THRA mutant 6a;	treatment: with 100 nM T3 for 6h.,pert
Rat heart ventricle,pert
Strain: C57BL/6J;	Gender: male;	Age: 2-3 months;	Tissue: heart,pert
Patient identifyier: Z;	Sex: female;	Age of patient: 42 years;	Duration of psoriasis: 36 years;	Body surface area: 5 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
Pool Eu_P30_hyb2,ctrl
LPS-PVH_2,pert
age	54;	gender	female;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	5.1;	hemoglobin (g/dl)	13.8;	platelet count (/nl)	284,ctrl
WTT 160 bleomycin treated.,pert
"Murine 3T3-L1 progenitor adipocytes cell cultures, Control 3 (untreated with resveratrol)",ctrl
WT3-2,ctrl
A1_scrb,ctrl
"human failing LV myocardium, Idiopathic55",pert
WT-Fibr2 1,ctrl
NOD/LtJ Vehicle liver sample batch 2,ctrl
WT - Cre Control - 5 mo - repeat 5 - Cy3 - mAdbID:74106,ctrl
Healthy12-CD8,ctrl
10_MLN8237-1,pert
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep1,pert
E17.5 preB cells_Smchd1 wildtype_Rep 1,ctrl
subject: 12B;	cohort: 12;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 49;	Sex: M;	batch: Batch_3,pert
"Untreated Testes, biological rep 2",ctrl
"DEX-treated embryonic primary chondrocyte cultures, incubated for 6hr",pert
Muscle Experiment 1,pert
tissue: liver;	genotype: p14 KO;	genetic background: C57BL/6,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 34 yr;	population: white,ctrl
HF0467_U133P2,ctrl
5237 UC Uninflamed ascending colon,pert
L-540_Perifosine 10µM_24hrs_2C,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: control;	other: FRAG.cRNA-IB,ctrl
tumor cell line HepG2 rep3,ctrl
Time 120 mins rep 1,pert
"liver_LDLr-KO, biological replicate 2",ctrl
"Untreated, biological rep5",ctrl
HC CJ 2 alcohol,pert
"E2-treated cells (3hr), biological rep_2",pert
Experiment TOX3 transient transfection replicate 2,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
VehVeh1,ctrl
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 39;	Usage number: 1;	Exposures: 4,pert
Patient no. 4: treated,pert
wild-type mouse kidney - 3,ctrl
T5E-LU,pert
sex: Male;	Age: 22 months;	additional patient information found in Series supplementary file,pert
HET Brain 25d Mouse1,ctrl
MDS50,pert
THP1-shGSK3B-Construct1-rep1,pert
Gata-1 Knock Down C,pert
CLS14_T3_PP_day1_057,pert
E_LS_Wk12,pert
"SS gland, early, patient 4, batch 1",pert
Control Day0 (395L),ctrl
wt-Gfp P6 replicate 4,ctrl
CONTROL 1,ctrl
Liver TG replicate 3,pert
harmane 1uM batch 2,pert
"PBMC, patient. Mtx rep11",pert
HF0813_U133P2,pert
wt-Gfp P6 replicate 1,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: P2,pert
TTF=100min;	Race=Caucasian/White;	Sex=Female;	Group=Con;	Prototype_N,pert
colon_adenoma_1138,pert
E3C,ctrl
Whisker pad WT biological rep1,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 73;	baseline tumor size (cm): 7x6;	patient id (to identify the 2 chips from the same patient): 15751594,pert
Immortilised monocyte cell line,pert
S9B Sporadic-cerebellum,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 5 days adipocyte differentiation,ctrl
siRNA Smc3 [M3],pert
S-IIP(UIP)15_Cy3,pert
WT / Reference_13425476,ctrl
H05_S_B1,ctrl
"control, BA10-55",ctrl
p53r2 siRNA 2,pert
n3_lo_6,pert
Neuroblastoma SH-SY5Y cells_cloneH_scramble control_replicate1,ctrl
"CD14+ after 2 wk quercetin supplementation, biological replicate 2",pert
"64B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"Nickel 400 µM, biologcial rep4, repeated microarray",pert
wild type MEF time 48 replicate 2,ctrl
"fibroblast, MFS subject FB1040 rep 1",pert
tissue: Fallopian tube;	cell type: epithelium;	cell line: OE-E6/E7,pert
"PC from MM patient, isolated using CD38-APC",pert
NSC_FBS_L3,pert
Hes6_Castrated OWJ39,pert
Gender: Male;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 1;	Pathological M: 1;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: YES,pert
NICM pool 1 (n=2),pert
"Acute Myeloid Leukemia, sample 20",pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: dominant-negative Tcf4 transgene;	time: 24hr,pert
"patient 032b, normal, homogenized",ctrl
11384 Normal Uninflamed ascending colon,ctrl
Knockdown Cell on HMVEC-L Replicate 1,pert
P1 mouse eyeball extracted total RNA_Brg1_cKO3_GSM618320,pert
disease: AML;	bcor mutation: wild-type;	karyotype: normal karyotype,ctrl
"array 17, xenograft, 0.3% Tween-20 vehicle",pert
"Biceps, control, cohort 03, subject 03U",ctrl
"Lesion Skin, LS-9",pert
NLGN3_2,pert
447MM,pert
293TsiScram-2,ctrl
Ischemic cardiomyopathy_G55,pert
lung_control_2,ctrl
MDS patient 174,pert
K562 cells CREB Knock-out replicate 8,pert
02SAGEA2,pert
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Female;	Age of onset (years): 34;	Duration of illness (years): 16;	Brain pH: 6.1;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: 12000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 5;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
2097-03-A,pert
fibroblast_5azatreated_rep2,pert
autism with FMR1-FM AU039305,pert
"Uninvolved Skin, NS-21",pert
disease state: control;	patient: 12,ctrl
"Control siRNA, 2",ctrl
"PBMC, healthy control, biological rep6",ctrl
Vit A sufficient 1b,ctrl
"Patient 108, baseline",ctrl
134B,ctrl
Cbx2_KO_XY_3,pert
SA_12,pert
condition: Psoriasis;	patient: PS-H;	tissue: LS skin biopsy;	kit: Affy,pert
sample type: normal breast cell line with stably transfected full-length chimeric human HER2 receptor with FKBP and HA tags;	cell line: MCF10A;	treatment: Heregulin,pert
Aire WT,ctrl
220/0,pert
TTE3 cells treated with BPA for 0 h-2,ctrl
"spinal cord, ventral spinal cord: EP131/L - hSOD1(Chan)/e14-wildtype hSOD1",ctrl
PE_N_M169,ctrl
strain: C57BL/6J;	genotype/variation: Asc -/-;	cell type: bone marrow derived dendritic cells,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 4.0;	age of psoriasis onset: 69,pert
GC resistant clone C7H2-R19E7 treated for 6 hours with GC,pert
WT-smoke-med-5 month+1d-R1,ctrl
"metastasis: metastatic recurrence;	Stage: 3b;	tissue: normal, homogenized",ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 9.8;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 61;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 7 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
HT29 sensitive cells replicate 2,ctrl
Placebo treated ipsilateral to stroke replicate P6IC-2a,ctrl
heart_Q10_14M_rep3,pert
PBMCs_IS_1 [IS],pert
strain: C57BL/6;	genotype: wildtype;	tissue: lung;	age: 12 weeks,ctrl
DMN-CtrHippo15d-2cAv2-s2,ctrl
Array Type: HG-U133A_2;	Ratio: 2.01;	RNA Integrity Number: 9.5;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Ngn3 EB10 ON replicate 1,pert
cell line: SV589;	knockdown (days): 8;	treatment: no treatment,ctrl
"1833 expressing Tet1, biological replicate 3",pert
"Patient I-c800T, MSI colorectal tumor",pert
tissue: blood;	control: 2;	gender: male;	age: 48,ctrl
UV-SeV 3661,ctrl
"PC from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE, CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
Caries 1,pert
Bronchial Epithelial Cells SA biological 1987B,pert
Early Secretory Phase Normal,ctrl
n9t6h,pert
Kidney_200 mg/kg VCM iv_mouse #026,pert
platelet_sickle_6,pert
2795-lcm,pert
MeCP2_3,pert
sex: Male;	Age: 2.5 months;	additional patient information found in Series supplementary file,pert
FW_8a_BV8865,pert
AZ-521_doxycycline_8h_rep1,pert
individual: patient14;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
RA6,ctrl
Ls174T-pTER-β-catenin con1,pert
neuron_rep3,ctrl
EDL-n7; normal extensor digitorum longus 7 month,ctrl
heterozygot FH P265,pert
"Cerebral Palsy, Gracilis, Patient Replicate 6",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 140min;	race: White;	sex: Male,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 126;	genotype/variation: WT;	age: 8 weeks,ctrl
"NASP siRNA treatment, sample #3",ctrl
OCI-Ly10_siFOXP1,pert
BACH2+/+ ALL (Sample1),ctrl
LNCaP + AR-shRNA rep2,pert
Individual_4689_NN_sample,ctrl
Teratozoospermic individual: Sample T3,pert
MDA-MB-231 cells siLuc (control) transfected rep1 HG-U133A,ctrl
vehicle treated experiment A (4mM HCL/1% BSA) 24 hours,ctrl
cell line: MDA-MB-231 1833;	cell type: breast cancer cells;	genotype/variation: expressing HMGA2 shRNA,pert
HepG2-PARP2 depleted-3,pert
"PPARg d0, rep 2",pert
"Patient 998, 3 month of BETAFERON",pert
MIY_day_3-3,ctrl
Individual_5346_NN_sample,ctrl
224 Day 2 siMut10 transfected biological rep3,pert
"human failing LV myocardium, Ischemic76",pert
BALB/c control (198msn),ctrl
Expression data from BAT of the KRAP deficient mice (WT2),ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 31.51233,ctrl
"Strain: Wistar, Sex: male",ctrl
t07,pert
Nfix_depleted_rep1,pert
cell type: Immortalized human neural stem cell;	cell line: HB-1;	treatment: Nurr1 overexpression,pert
Strain: DBA/2J;	Sex: Male;	Age: 8-10 weeks;	Treatment: Control,ctrl
"gender: Male;	age: 81;	post-mortem delay: 5h;	ph: 6.1;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
mouselung_scid_control_rep03,pert
"Spi-21, biological rep 8",pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.81;	choa: 112;	fata: 80;	eea: 1440;	wtkg: 99;	perfat: 57.6;	lbm: 38.9;	fat_mass: 5702.4,ctrl
S025_Scz_M_41,pert
59A;pretreatment;female;breast tumor,ctrl
F2,pert
wt-Gfp E16 replicate 3,ctrl
"spleen follicular B in WT, biological rep1",ctrl
NoKD_SerumStarved_rep2,pert
Clozapine treated 12weeks AffyGC RMA rep6,pert
strain: C57BL/6;	genotype/variation: Nrf2 KO;	gender: Female;	tissue: Liver;	age: 6weeks,pert
WT J1 ESCs on day 7 #2,ctrl
INSENS 5 4hr,pert
NSC miR-Control 3,ctrl
"Mice_non trans, biological rep3",ctrl
Normospermic individual: Sample N6,ctrl
mammary_16wkWT_ker75,ctrl
brain_OFC_bipolar B_mr384,pert
cell type: tumor nodule cells;	ikk2 status: WT,ctrl
TL3 SCR 3,ctrl
male JAK2 WT liver sample 126,ctrl
Healthy control 10,ctrl
Left ventricular myocardium in patients with Dilated cardiomyopathty (1),pert
142B,ctrl
cRNA;	embryonic day 18;	WT,ctrl
"DMD skeletal muscle, biological rep13",pert
neuron_rep1,pert
PBMC from T cell LGL leukemia patient #113 (TLGL113),pert
Tissue: HepG2 Cells;	Gender: male;	Source: ATCC;	Vehicle Treated 0.1N KOH (at equivalent volume as treated) in media,ctrl
EA_Case9_CD8,pert
Control peripheral blood leukocytes - Biological Replicate 3 - Technical Replicate 2,ctrl
brain_DLPFC_bipolar C_mr539,ctrl
01UNZ_PolyRF+,pert
Patient no. 1: treated,pert
CD34+ hemopoietic progenitors purified from peripheral blood of Idiopathic Myelofibrosis (IM) patients,pert
genotype: tg/wt;	treatment: CaNrf2;	gender: female;	background strain: FVB/N/C57BL/6 mixed,pert
Healthy control_sample10,ctrl
tissue: Aorta;	genotype/variation: SRF-flex2neo;	genotype/variation: SRF-flex2neo littermates (control);	age: 4 month-old,ctrl
Injured 7 day Rat Retina 3,pert
"Control cell, Replicate 3",ctrl
RA_y,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 226;	age-at-biopsy-years: 61,pert
Strain: C57Bl/6; Tissue: liver,ctrl
cell line: AT2 E/R positive leukemia;	treatment: treated with non targeting lacZ shRNA,ctrl
APBMNC.LPS-.3,ctrl
tissue: Whole Brain;	developemental stage: E 18.5;	genotype/variation: Meg3 knock-out,pert
"Age: 8 months, Sex: Female, Retina: right, Final IOP (mm Hg): 26.5, Strain:DBA/2J",pert
Normal PBMC Sample 8,ctrl
Pediatric_GBM_15,pert
"129P3/J SAL, Rep1",ctrl
normal control 1,ctrl
HNF4a2_2+,pert
remitted schizophrenia patient  S09,pert
"brain, cerebellum: RNA#35_le1",ctrl
S1_S010228,pert
4 h (2),pert
BCell_resting_sample4,pert
8 week old leg MDX rep 5,pert
Healthy control 14,ctrl
thyroid_normal_3,ctrl
Bronchial Epithelial Cells SA biological 1771E,pert
3735-lcm,pert
colon_IL10mouse_12weeks_rep4,pert
Kidney_50 mg/kg VCM ip_mouse #067,pert
P4_Ovary_NT3_biological rep3,pert
G392E_off_rep3,pert
3985-2 E2F1 Null,pert
AR-CO-24-3-570,ctrl
Tendon_non-lesional_rep5,ctrl
WT - Thymus - biological repeat 1,ctrl
2d-IR-69,pert
condition: Psoriasis;	patient: PS-L;	tissue: LS skin biopsy;	kit: Affy,pert
Tendon_lesional_rep11,pert
"Histopathological diagnostic: oligodendroglioma, grade 3",pert
IR-KO_Rep3,pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 19; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.,pert
159B,ctrl
Jurkat cell line transfected with SIV Nef,pert
healthy control sample x192,ctrl
"MAT1A knockout at 8 month age, biological replicate 5",pert
Wild Type Mice fed Low fat diet 3,ctrl
Tissue: normal thyroid; Gender:female; Age:43,ctrl
Conditional Sample 1,ctrl
USF1 replicate 2,pert
"brain, cerebellum: RNA#12S_le1",ctrl
CD19_selected_B-cells_after_R_rep6,pert
"Control_TP, C1",ctrl
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 68,ctrl
"Patient 97N, normal colonic mucosa",ctrl
erStress_twins_AA_1733twin2_500nM_thapsigargin_4h,pert
sex: Male;	Age: 18 months;	additional patient information found in Series supplementary file,ctrl
disease state: paediatric glioblastoma;	age: 12;	gender: F;	h3.3_status: wt,ctrl
"patient: 115;	current medication: Frusemide, Codine Phosphate;	birth date: 9/14/28;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: Diarrhoea, Also has Prostate Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
R6/1 18 week wildtype_15E8,ctrl
26 weeks female,ctrl
Cardiac Progenitor WT2,ctrl
Normal Cervix N8,ctrl
Spleen_wt_1m_rep1,ctrl
"EtOH, RARaKO, set 4",ctrl
"testis with regular spermatogenesis with status after vasectomy, patient age: 34y",ctrl
H3f3b WT 3966,ctrl
Ero1-C104A/C131A non-induced biological repA,ctrl
disease group: normal;	cell type: chondrocytes;	cell culture: 3-D,ctrl
DND41 Control 2,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-Tg;	tissue: Skeletal muscle (quadriceps),ctrl
CAB10_T6_PP_day14_036,pert
Patient no. 2: treated,pert
MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ Sample B,pert
strain: 131;	Disorder: normal scar;	Condition: +hydrocortisone,pert
breast normal 2,ctrl
T8,pert
"brain, cochlea: [6] Sample #6_le1",pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 19d ID233,pert
"SIRT7 Knockout Liver, replicate3",pert
MDS patient 23,pert
MacularDegen-healthy-7aAv2-s2,ctrl
shRNA 691 R6 T5,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 59;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: mid-UV,pert
"HIV-1 positive male, 18-60 years old, weight loss of 5-15% in preceding 6 months, stable anti-retroviral therapy. CD4+ T-cells >50/ml, HIV copies =< 10,000/ml, free testosterone <50pg/ml.",pert
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA1-dox,ctrl
genotype: Wild-type;	replicate: 1;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,ctrl
chip number: 12;	transfection plate: 5;	target gene: TAF1;	kd level: 0.73;	rin: 9;	transfection date: 2011-10-17,pert
CLL13-CD8,pert
ancestral background: African-American (AA);	gender: Female;	subject condition: healthy control;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,ctrl
NTG replicate 3,ctrl
5274 UC Inflamed descending colon,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q plus monosomy7/del7q plus other,pert
Normal cervix_03-5611,ctrl
ILD Study Number 998,pert
Aldosterone-producing adenoma (APA4),pert
E10.5 ko.3,pert
Normal PBMC_sample 3,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 29;	sex: M,ctrl
Backskin_Get1_e18_KO1,pert
"Bmi1 shRNA, biological rep3",pert
Luciferase shRNA_3 Days knockdown_rep1,ctrl
"Typically Developing Control, Semitendinosus, Patient Replicate 10",ctrl
model: Fischer 344;	gender: Male;	age: 7 to 8 months old,ctrl
Replicate 1 - R5020,pert
Subject #8041-2d Postinfection,pert
PGA_MI_nilv_48h_351,pert
4010-2 E2F2 Null,pert
tumor cell line HepG2 rep4,ctrl
"Overexpress TFPIalpha, biological rep. 2",pert
"Chromium 10 µM, biological rep1",pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 7.97878165639973;	age of psoriasis onset: 47,pert
gender: Male;	age: 44;	post-mortem delay: 4h;	ph: 6.3,pert
Tendon_non-lesional_rep3,ctrl
PTC BRAF wt 4,pert
"ERaKO mouse aorta with placebo, biological rep3",pert
HC-KO-21B,pert
Strain: FVB/N;	Genotype:mCftr+|+,ctrl
MKK7D transgenic female replicate 15 late timepoint,pert
"G42 cells from M1, wild type control, biological replicate 2",ctrl
3 h-apra-2 nM,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: tibialis anterior;	age at biopsy: 48;	Sex: male,pert
gender: male;	age (years): 58;	evolution time (years): 10;	disease extension: Left-sided colitis;	treatment: No treatment,pert
"A549, -TNFα, Claudin 1 siRNA, rep3",pert
patient: 3;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
V5-P418,pert
diet: AIN-76A,ctrl
CTRL_1_CMP,ctrl
32054.INV,pert
"GNMT knockout at 8 month age, biological replicate 2",pert
s3t2c,ctrl
G029-lcm,pert
human_hepatocyte_vehicle_donorB_24hr_prep1,ctrl
Tretinoin2,pert
Lck LIGHT Tg;	Age: 4-8 wks,pert
control participant P307,ctrl
sepsis patient #7,ctrl
A431 PR 1,pert
C1F-LU,ctrl
diseased_IL-13 2,pert
chip number: 16;	transfection plate: 3B;	target gene: KLF13;	kd level: 0.87;	rin: 9.8;	transfection date: 2012-03-26,pert
"Autism with regression, Female",pert
hNHEPS_10 μM_6 h_rep4,pert
Pancreatic Sample 6-Tumor,pert
tissue type: Lesional skin;	time: Week12_etanercept,pert
"Biceps, control, cohort 12, subject 12U",ctrl
ab134 N,ctrl
Placenta_nl2,ctrl
Untreated Control 12weeks AffyGC RMA rep1,ctrl
ADHC1,pert
siRNA LMG4 treated HeLa cells 1,pert
MA_14,pert
strain: C57BL/6;	genotype/variation: IkkβΔ,pert
age: 57;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
SKBR3-R_0.1uM_Lapatinib_2,pert
"108, ADIPOOSE TISSUE, Before",ctrl
Sex: male;	Age: 10;	SL: 3.37;	House: -;	Severity: C;	Ashworth: 1;	Zancolli: 0;	PEFF: 90;	PESF: 90;	AEFF: 90,ctrl
"121, ADIPOOSE TISSUE, Before",ctrl
"age at diagnosis: 81;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIC;	t (extent of primary tumor): T1b;	n (lymph node metastasis): N3a;	er: 1;	pgr: 1;	dfs-month: 31;	dfs-event: 1;	distant metastasis: 1",pert
80 year old male,pert
MF-26,pert
Testicular seminoma 1748,pert
WT-control-3,ctrl
lrrk2 genotype: WT / WT,ctrl
cbp+/- standard cage Rep4,pert
NE-rep7,ctrl
healthy control sample x044a,ctrl
platelet_Ctrl_8,ctrl
3985-2 E2F1 Null,ctrl
"IGF-treated cells (24hr), biological rep2",pert
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: Control shRNA (GFP),ctrl
mouse_islets_VhlhKO_03,pert
PGA-FVB_3m_1f-m5,ctrl
Clozapine treated 12weeks AffyGC RMA rep5,pert
Lmna H222P homozygous male 2,pert
"mouse aorta cross strain comparison, C3H_T08_NC_01",ctrl
HUVEC_TNF-stimulated experiment 4,pert
treatment: treated with R1881 and ELK1-shRNA;	cell line: LNCaP,pert
HDAC2_B10-rep1,pert
chip number: 19;	transfection plate: 3B;	target gene: BCL3;	kd level: 0.6;	rin: 9.2;	transfection date: 2012-03-26,pert
Septic shock;	gender: Male;	Survivor;	organism: Staph aureus,pert
scan batch: Batch 1;	group: autism;	subject age: 7;	paternal age: 33;	maternal age: 29,pert
patient: 51677;	sample: normal,ctrl
WT replicate 3,ctrl
subject: 18U;	cohort: 18;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 37;	Sex: M;	batch: Batch_4,ctrl
Myh11-CreERT2.Tgfbr2f/f Knockout 3,pert
cell line: HCT116;	clone: 10;	genotype: Knockout,pert
Muscle 50 eccentric contractions 12 hours KO Adult 0713,pert
Series 3; old; 4 weeks after fracture,pert
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
Run8.aUa.010615d.SkMInS1076D.CEL-IS basal,ctrl
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; PtenF341V/loxP,pert
Intronic WT control rep1,ctrl
CH1814,ctrl
Strain: C3HeB/FeJ;	Age: 10-12 weeks at the beginning of the feeding regimen,pert
endothelial_rep10,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 29;	sex: M,ctrl
strain: C57BL/6J;	genotype/variation: Ifng-/-;	tissue: Bone marrow;	cell type: CD71+ cells (MACS-enriched),pert
HEL_Control shRNA (GFP)_1,ctrl
MDS patient 81,pert
"125, MUSCLE, After",pert
Run1.a10a.000607jd.2.SkMNor916.CEL-IS stimulate,pert
PTEN-111 (-/-),ctrl
EA_Case3_CD4,pert
cells: spleen follicular B cells;	genotype: IRF8 KO;	genetic background: C57BL/6J-lrf8-/- x CD19-Cre,pert
3278-scrape,pert
cell type: embryonic stem cells;	genetic modification: Dgcr8 knockout,pert
CRC_celecoxib_M4866,pert
"brain, lateral and medial ganglionic eminences: Arx-/Y #2_le1",pert
gender: male;	tissue: gastrocnemius muscle;	age: 7.5 months;	genotype: wild-type,ctrl
Normal Sample 3,ctrl
Array Type: HG-U133A_2;	Ratio: 1.98;	RNA Integrity Number: 9.9;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep5,pert
ab020 IM,pert
"EBF1 d2, rep 3",pert
Sample: alpha-TM180;	Replicate: 1;	Pool: NP,pert
Wt1-null MEFs-1,pert
strain: C57BL/6J;	Sex: male;	expression: sh-scr;	agent: none,ctrl
Globin_S2,pert
Muscle PCOS 16,pert
01LM1_PolyRF+,pert
gender: male;	batch: 1;	age (years): 56;	patient id: Control_8;	fev1 (% predicted): 111;	fvc (% predicted): 111;	medication: None;	cell type: CD4+ T-cells,ctrl
HC JL 2 alcohol,pert
5P-ER,pert
AO C1,ctrl
PGA-MAH-C3H_PBS6h-3bA-s2,ctrl
tissue: testis;	genotype: wt;	age: 17dpp,ctrl
type_of_rx: AF;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 50;	baseline tumor size (cm): missing;	patient id (to identify the 2 chips from the same patient): 22332259,ctrl
cadmium_16hr_rep2,pert
genotype: Wild-type;	replicate: 2;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,ctrl
Treated with 50uM Zinc for 4 hrs -- replicate #1,pert
Subject #8008-2d Postinfection,ctrl
cell line: non-clonal BMSC cultures;	transfection: negative control (siNC) construct,ctrl
MS-proband,pert
tissue: amnion;	cell type: mesenchymal;	agent: interleukin-1-beta;	time: 1 hr,pert
DBA control (124-5msn),ctrl
IGROV-1-(2),ctrl
AGS cells - Celecoxib treated biological rep 2,pert
genotype/variation: Fbn1 wild-type;	tgfbr2 status: intact TGF-β signaling;	tissue: ascending aorta;	age: 6 weeks,ctrl
tissue type: Primary lung tumor;	histology: SQ,pert
m1-adenoma4,pert
c 2-2,pert
"Patient 24, Atheroma plaque",pert
Phan_005_WT.bleomycin rep2,ctrl
Pertuzumab treated after 4 days (P3_1),pert
"Heart, MAT1 control, 4 wk, sample 1",ctrl
WT - Cre Treated - 12 hrs - repeat 1 - Cy3 - mAdbID:61756,ctrl
"BMDC, Asc-/-, replicate 2",pert
MDS patient 167,pert
prostate tumor 6,pert
P60 Vax2-/- 1,pert
Embryonal carcinoma 0564,pert
age: adult;	gender: male;	tissue: lung,pert
Cdh1_cKO_2,pert
RE550_DU145_Un1,ctrl
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14509;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
"brain, frontal cortex: Sample59_e1_le1",ctrl
WT - Cre Untreated - 0 hrs - repeat 3 - Cy3 - mAdbID:54711,ctrl
Tumor_Ker52,pert
19SAGEA,pert
"Mepenzolate treatment, 25 hours (replication 2)",pert
T91,pert
Non_Target_2,ctrl
Healthy-9 baseline,ctrl
"C3H/HeJBir, sample-1",ctrl
WT_P57,ctrl
DW301_WT_M,ctrl
"gene expression of wild type oocyte, replicate 1",ctrl
"PPARg d2, rep 2",pert
C2C12 myotubes 1000uM H2O2 rep1,pert
Zfx fl MA9 cells + 4-OHT [10950],pert
HA96-112A,pert
"Autoimmune pancreatic islets, day 3 cyclophosphamide treatment, rep 2",pert
2IDC_tumor_ductal,pert
224 Day 1 siMut10 transfected biological rep1,pert
Skinbiopsy_48hoursnickel_controlsubject_k1,ctrl
sample: #14;	subject: PD case #2;	brain: T-1982;	age: 79;	sex: Male;	region: Inferior olivary nucleus,pert
Strain: top2b-/- in 129SvEv (minor 129SvJ) background;;	Age: E16.5 embryo;;	Gender: female;;	Tissue: whole brain,pert
Control_2,ctrl
11082 Normal Uninflamed descending colon,ctrl
"CL1-0, biological rep3",ctrl
Sedentary-16,ctrl
Day: 12; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 3,pert
"MTDH knockdown, biological replicate 1",pert
Cerebellum_transgenic nuclear localization signal Htt exon1 18Q x50_16 months_replicate 1,pert
Hippocampus_Soman_96h_rep3,pert
"siPRMT1 neuron, biological rep3",pert
patient: 22;	disease state: hypertension;	tissue: Atheroma plaque,pert
"brain, hippocampus: LH1_e1_le1",pert
Hippocampus 1984 15 month Old,pert
IFN_Gamma_24hr_rep2,pert
"Epidydimal white adipose tissue from Casp1-/- after 16 weeks of high fat diet feeding, replicate 2",pert
PGA-MLS-Dex-1bAv2-s1,pert
pMX-Oct4 and pMX-jhdm1b vitamin C O+Jhdm1BVc+_2,pert
PGA-RMM-Ctr-3aA-s2,ctrl
Bone Marrow Mononuclear Cells;	24y Female,ctrl
NoKD_rep3,ctrl
secondary glioblastoma_1,pert
cell line: HL-60;	shRNA construct: GSK3B Construct 1,pert
"mouse aorta cross strain comparison, C3H_T04_HF_01",pert
chronic lymphocytic leukemia (CLL 13651),pert
Subject 4 / lung subsegment instillated by LPS,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 141;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
"TH cells from LC, wild type control, biological replicate 1",ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case5,pert
B_Kin_2,pert
"Mutant, biological rep2",pert
24h 4OHT-treated-sample2,pert
healthy control C5,ctrl
strain: C57BL6/J;	Sex: female;	genotype: WT;	cell type: mouse embryonic fibroblasts,ctrl
GM19238_Kd_WHSC1_3,pert
colonic_mucosa_inflamation_125,pert
Cancer 9,pert
"S1P2-KO-hippocampus, biological rep10 (female)",pert
Human Uninfected Sample N110-CD8+ T cells,ctrl
Adrenal WT 0h batch 4 [AdWTh00.26],ctrl
"fibroblast, control subject NM6 rep 1",ctrl
tissue: heart;	gender: male;	genotype: VAChT KD;	age: 3 months;	strain: C57BL/6,pert
cell type: Primary hepatocytes;	strain: BL6;	agent: control;	time: 24h;	gender: Male;	age: 2 months,ctrl
"Crohn's Disease subject (50 year old caucasian female, SAK_1288040656)",pert
HMEC_50 vs MDA_MB_468,pert
15_0001C_Day1_40,ctrl
N13,ctrl
OVCA420-(3),ctrl
RNA from HCC_10T,pert
TTP_KO_0ActD_BioRep4,ctrl
HT29 DMSO Day8 rep1,ctrl
GIST_PDGFRA_6,pert
whole tissue section from case 849,pert
CONTROL;	Age = 20;	Sex = F,ctrl
P1 mouse eyeball extracted total RNA_Snf2h_cKO1,pert
Muscle PCOS case 121,pert
Patient identifyier: G;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 19 years;	Body surface area: 12 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
lesion_preUV_patient4,pert
GIST_KIT_6,pert
"Deltoid, control, cohort 12, subject 12U",ctrl
Proliferative Phase Normal,ctrl
T8C-LU,pert
strain: Sprague-Dawley;	tissue: Dorsal root ganglia;	postnatal age: 2 months;	surgery type: Spare nerve injury;	experimetal group: Adult Contralateral,pert
"10mg/kg/day PFOA, Rep 5, Block 5, lung (high dose)",pert
H69_Ctr_3,ctrl
"110, ADIPOOSE TISSUE, Before",ctrl
Squamous cell carcinoma 022,pert
Satb1-/- clone 1-1,pert
"brain, hippocampus: KA24-I_e1_le1",pert
patient: 30068;	sample: tumor,pert
HEK293_hCdc73siRNAConfluent_rep1,pert
LJMJDW7,pert
ALI patient #11,pert
background strain: C57BL/6J;	cell type: Lin- hematopoietic progenitors,ctrl
B/OVX/P4/6h/UTX 129/SvImJ WT,pert
SCARKO d10 (4),pert
IRAK2 KO_macrophages_4h,pert
age: 66;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Muscle PCOS control 12,ctrl
OSE_475,ctrl
status: autism,pert
HCT 116 control rep2,ctrl
Individual_5050_NN_sample,ctrl
cultured LNCaP cells;	refer to ATTC,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 41 yr;	population: white;	dsm-iv: 296.72;	age of onset: 14 yr,pert
ACI DES-treated replicate 1,pert
healthy control H11,ctrl
CLL1-CD4,pert
Cell line: MDA-MB-231,pert
Bronchial Epithelial Cells control biological 1925F,ctrl
"AD_HI, biological rep2",pert
6 STAT6KO control macrophage,pert
HP-12,pert
erStress_twins_AA_1757twin1_DMSO_4h,ctrl
RNA from HCC_32N,ctrl
wild type MEF(1),ctrl
"2 months, sham group, biological replicate 1",ctrl
3DKD,ctrl
genotype: Smad3-/-;	strain: mixed strains of C57BL/6 and NIH Black Swiss females (Taconic);	treatment: regular diet,pert
TTF=140min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
SKBR3-R_Control_3,ctrl
Active ITP chip A,pert
At Risk: -;	Age: 17;	Sex: M,pert
"Patient I-c840T, MSI colorectal tumor",pert
GFP Zfx ko 2,pert
Control d10 (1),ctrl
RNA from HCC_41N,ctrl
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIa;	Sex: F;	age: 56,pert
age (days old): 10;	genotype: wild type,ctrl
TGFb1 treated experiment A (10ng/ml 24 hours),pert
"Pineal gland from NeuroD1 cKO mouse at ZT20, biological rep 1",pert
155B,ctrl
P6 Patient None,pert
"breast tumor epithelium,57",pert
wt_P8_rep1,ctrl
mESC_undifferentiated_Alkb1-/-_rep1,pert
RA1,ctrl
Large cell carcinoma 004,pert
"shZBP-89, biological rep2",pert
WFS1 KO USHT_10_322_ko,pert
GBM_stem_4 days_3,ctrl
PGC-1a-/-bf/f/MerCre rep1,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_2h_Con_HG-U133A_2_YCHSUP501,ctrl
"Patient F, uninvolved skin",ctrl
Disease_status: Healthy control;	Age (years): 53;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.40;	Post mortem interval (hours): 9;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
braak stage: BR12;	rin: 66;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
"TLR4 null sham kidney, biological rep1",pert
ccRCC tumor of patient 260,ctrl
CCl4_CT20,ctrl
TP07-726B,ctrl
"Peripheral blood, patient without recurrent events [N26]",pert
prefrontal cortex (BA10);	bipolar disorder,pert
Mtb infected-42d-3,pert
Gastrocnemius Muscle_Cmah KO_mdx_rep1,pert
0h Kin Cel.40,pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: PTEN shRNA,pert
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 3,ctrl
"RNF40 siRNA - 5 days osteoblast differentiation, rep2",pert
N/A,ctrl
V5-P508,pert
"Crohn's Disease subject (54 year old caucasian male, SAK_1316666829)",pert
cell line: 344SQ lung cancer cell line;	genotype.variation: PIK3CA knockdown,pert
Amniocytes_trisomy 21_1551,pert
T-ALL1 Control 2,ctrl
Untreated CLL3,ctrl
"siRNA, collagen plate, rep1",pert
"tissue: lung, lower lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 58",pert
"EBF1 d10, rep 2",pert
minor non-tumor10,pert
"RISC-free control transfected, biological rep 1",ctrl
Subject #8007-Preinfection,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 24h ID58,ctrl
WT P10 replicate 2,ctrl
Subtype: RAEB1;	Karyotype: other,pert
Liver_WT_Rep5,ctrl
PGA-MAH-C3H_PBS24h-4aA-s2,ctrl
Bronchial Epithelial Cells SA biological 1921X,pert
Myoblast-GATA4-KO-day3-1,pert
DBA d18 (119msn),pert
"Untreated, biological rep3",ctrl
BCell_activated_sample1,ctrl
"Peripheral blood, patient without recurrent events [N50]",pert
Trastuzumab treated after 4 days (T1_1),pert
"KM-H2 cells, Non-silencing control, replicate 1",ctrl
E9.5 FVB/N erythroid cells-1,ctrl
ic10 -- Cell line 2 treated with mock APF#1,ctrl
3729-lcm,pert
endothelial_rep5,pert
brain_DLPFC_bipolar C_mr682,pert
"60B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
sample 1:;	age: 58;	gender: male;	sample 2;	age: 58;	gender: male;	sample 3:;	age: 57;	gender: male;	sample 4;	age: unknown;	gender: unknown,ctrl
MPZ-Tfam Knockout - rep1,pert
cell line: COV434;	transfection: Mutant,pert
G93A 60 days sample 3,pert
T40726,pert
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: Vehicle treated,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 26.55342,ctrl
"endometrioma, patient M2",pert
HA00-13B,pert
tissue: colon;	genotype/variation: control,ctrl
"human nonfailing LV myocardium, NonFailing5",ctrl
23GOBMUC2H,ctrl
"Pineal gland from NeuroD1 cKO mouse at ZT6, biological rep 1",pert
A549 siRNA FAM60A 3,pert
4n,ctrl
"ShamC-21, biological rep 5",ctrl
reduction mammoplasty patient 278,ctrl
GM19238_Kd_NS1_22,ctrl
Retina wt/wt rep1,ctrl
"human failing LV myocardium, Idiopathic80",pert
E14.5 Top2b+/+ brain,ctrl
Endometrium/Ovary-Disease 2,pert
CME-Emerin4d-3MA-S2,pert
phenotype: alcoholic;	gender: male;	case_id: 466;	age: 57;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 43;	brain ph at time of freezing: 6.46;	labeling_batch: 2,pert
BP22,pert
wt_off_rep2,ctrl
E9.0 wt.1,ctrl
"cochlea at P3, ko, biological rep 1",pert
Healthy control,ctrl
cell line: MCF10A;	gender: female;	tissue: breast;	expression: none,ctrl
chip number: 23;	transfection plate: 3B;	target gene: POU2F1;	kd level: 0.74;	rin: 9.6;	transfection date: 2012-03-26,pert
RNA-DHL6-R406-2H-3,pert
whole blood_100923,pert
gender: Male;	strain: C57BL/6;	genotype/variation: B1+/+;	tissue: Epididymal fat;	age: 3 month-old,ctrl
LICR_HN2_PBS3,ctrl
4128-1 E2F2 Null,pert
strain: FVB/N;	age: 13.5 days;	tissue: whole body;	cell type: Fibroblasts;	genotype: Pten+/+,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 208,ctrl
220C6,ctrl
Mnk_3206-R-B,ctrl
G007,pert
untreated-sample2,ctrl
U2OS shCHK1-4 replicate 1 [set 4],pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: other,pert
timepoint: 2h;	drug: Morphine;	group no.: 4;	large batch: X;	plate: 1953348002;	hybridization batch: III,pert
GIST Pre Treatment Biopsy 10,pert
C3H/HeJTCE liver sample batch 2,pert
Liver control pool3 Affy,ctrl
transfection: control shRNA;	cell line: J1 ES Cells;	background strain: 129S4/SvJae,ctrl
T7B-LU,pert
V5-P368,pert
CEM11_T4_PP_day3_040,pert
NSC_FOXO_NULL-1,pert
Sample: nontransgenic control (NTG);	Replicate: 2;	Pool: NP,ctrl
Age: 37;	Sex: F;	Ancestry: African;	Smoking status: non-smoker,ctrl
"Control, sample 4",ctrl
liver 1.0% quercetin diet rep5,pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: GATA3 and GFP;	rep: 1,pert
gender: F;	age at blood draw: 48;	tissue: whole blood,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 46.16712,pert
"siRNA, plastic plate, rep2",pert
3979-2 E2F1 Null,pert
jzo029-rp1-v5_u74av2-met,ctrl
"Knockout Heart with no treatment, biological rep2",pert
DNGM-7,pert
"D425-shOTX2_2, t=8",pert
strain background: (BALB/c x C57BL/6J) F1 obtained by breeding heterozygote mice(+/-) with a C57BL/6J and BALB/cA background;	genotype/variation: Shn2 deficient;	age: adult;	gender: male;	tissue: hippocampus,pert
shRNA-control-rep-1,ctrl
01-0062A_Day1_8,pert
cerebellum_wild type_24 weeks_replicate 3,ctrl
Series 3; old; 2 weeks after fracture,pert
Peripheral blood mononuclear cells;	TTF=117min;	Race=White;	Sex=Male,pert
"granulocyte, patient. Mtx rep6",pert
tissue: blood;	control: 7;	gender: female;	age: 35,ctrl
N1C Normal-hippocampus,ctrl
non-CF subject 41,ctrl
L425-PAX5+MAT_rep2,pert
siIPMK no DNA Damage experiment 1,pert
liver_STZ 0.1% quercetin diet_rep5,pert
NPC_p5ko_rep4,pert
8DKD_SerumStarved->1hrEGF_rep3,pert
"PC-3 Luteolin, biological rep2 [mRNA]",pert
P 29 Si RNA,pert
Control at 28 days of age,ctrl
c.2,ctrl
Eed KO E14 ESCs on day 7 #1,pert
"NPTX1 shRNA Day 5, biological rep3",pert
"BL6/C57 mouse heart, control, rep2",ctrl
striatum_wildtype_1,ctrl
WT_cells_rep2,ctrl
SCLC cell line COR-L88,pert
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ scramble;	treatment: Ca 0.6mM, 72 h",ctrl
ID: MLL_00110;	cell type: PBMC;	disease state: control,ctrl
8 week old leg control rep 5,ctrl
"SDC1-silenced group, replicate 1",pert
"human failing LV myocardium, Ischemic29",pert
Severe rep1 (retina),pert
liver_Q10_14M_rep3,pert
mixed reference (CRG + FR),pert
SLE8-TC,pert
"patient 033b, normal, homogenized",ctrl
prostate_Klf5 ko_rep1,pert
39SAGEA,pert
3586-1 E2F1 Null,pert
Luciferase shRNA_2 Days knockdown_rep2,ctrl
OE Sirt1 3,pert
"eye, cornea: TRizol Extraction_le1 6",ctrl
Control 4_Huh7 [HDAC2 siRNA subset],ctrl
Plate vs. Nail:  1 Week Plate,pert
"Gender: female, Age: 45 years, Tissue: VIN 3",pert
22A,pert
"WT, PR04M002v0",ctrl
"human failing LV myocardium, Ischemic39",pert
H1P_1,ctrl
HDAC1_G10-rep1,pert
CML_3_CMP,pert
BAL_46_A2B0,pert
P0 - nudelcko/ko 2,pert
ccRCC tumor of patient 324,ctrl
mouse: 6;	strain: C57Bl/6;	genotype/variation: STAT6 KO;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,pert
HeyC2-(1),ctrl
Tendon_non-lesional_rep13,ctrl
CCRPKO-PB_rep-1,pert
MS25_5A_LV_220307,ctrl
H02_P_B1,ctrl
Reh_mock2,ctrl
2908-lcm,pert
"amnion mesenchymal cells, no treatment, biological rep1",ctrl
5269 UC Uninflamed terminal ileum,pert
control female replicate 4,ctrl
"Normal subject (33 year old caucasian male, SAK_1274807443)",ctrl
sepsis patient #14,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: UKmin;	race: White;	sex: Male,ctrl
T40843,pert
Parkinson's disease sample x122,pert
"gender: Female;	age: 28;	post-mortem delay: 11h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
PlagL2WT1,ctrl
strain: v6.5;	cell_type: ES cells;	transfection protocol: GFP shRNA transfected;	culture media: ES,ctrl
jejunum_0h_rep2,ctrl
cumulus_nonPCOS_Lean_rep5,ctrl
Liver FC2,ctrl
TTE3 cells treated with BPA for 12 h-1,pert
vMyb virus-infected replicate 2 (MCF7),pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 13.0;	age of psoriasis onset: 31,pert
Individual_4379_NN_sample,ctrl
Pool 2 Acute stage,ctrl
multiple myeloma (MM 36),pert
normal arterial tissue: sample #3,ctrl
LOX1 0hr 282295463,pert
Subject #8015-8hr Postinfection,ctrl
A549_NS siRNA_biological rep3,ctrl
SENS 4 0hr,ctrl
Mock_cells_rep2,ctrl
diseased_media 2,ctrl
non-CF subject 33,ctrl
Normal Adrenal Gland (AN15),ctrl
Bronchial Epithelial Cells SA biological 1989F,pert
pSUPER-scramble replicate 1,ctrl
U937-shGSK3A-Construct6-rep2,pert
CD46+ hippo - Untreated-D,ctrl
Neocortex_Eomes_WT.6,ctrl
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: GATA3 and GFP;	rep: 3,pert
E11_SostKOSostLKO_1,pert
Individual_4708_NN_sample,ctrl
"BMMCs from NTAL WT, noninfected, 2 h activated, biological rep2",ctrl
unstimulated(sparse)-2,ctrl
mixed reference (FR + CRG),pert
WT11,pert
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 24 months;	genotype: Myc heterozygous,pert
WT GMP rep2,ctrl
"Ctrl OBCs, post doxycyclin withdrawal, rep5",ctrl
KN-smoke-high-5 month+1d-R2,pert
"CTLA-4 KO 5C.C7 T cells, biological rep3",pert
Ileum_POR-null_3,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 60;	tissue: Blood,pert
GIST_KIT_8,pert
"Biceps, control, cohort 07, subject 07U",ctrl
"CCALD patient fibroblast, biological rep4",pert
Parkinson's disease sample x016,pert
cell type: Peripheral blood leukocytes;	strain: DBA/2,pert
"human failing LV myocardium, Ischemic66",pert
Carbo Day14 (349R),pert
Tissue:  Primary human hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use: Yes,ctrl
control IgG_rep4,ctrl
Liver_Wild Type+Quercetin_1,pert
Neuroblastoma SH-SY5Y cells_cloneG_stably transfected with RNAi against DJ-1_replicate2,pert
Mouse_ATF6bKO_colon_UT_rep2,pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 35,ctrl
FW_18c_BV3965,ctrl
"Ulcerative Colitis (41 year old black female, SAK_1304707354)",pert
ATP-treated AML 9 blasts,pert
subject: 19U;	cohort: 19;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 79kb;	age (y): 41;	Sex: F;	batch: Batch_4,ctrl
Placenta Adra2bWT 1,ctrl
U-87MG-V8 set 1,ctrl
strain background: C57BL/6J;	genotype/variation: Nod2-/-;	age: 8 weeks;	tissue: small intestine;	cell type: laser captured Paneth cells,pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 43;	Usage number: 1;	Exposures: 3,pert
Individual_5247_NN_sample,ctrl
1.25uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate A,pert
subjectid: 5258;	imatinib: IM;	lbh589: NoLBH,pert
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 3 - Technical Replicate 1,pert
Series 3; adult; 3 days after fracture,pert
LJMJDW6,pert
At Risk: +;	Age: 19;	Sex: F,pert
01LLC_PolyRF-,pert
VMM-WT_MyoD12h-2MP-s2,ctrl
testis wild type replicate2,ctrl
"58B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
age_years: 47;	sex: F;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
colon_epithelium_IL10mouse_12weeks_rep1,pert
E14 - Lis1ko/+ 2,pert
12494 UC Inflamed sigmoid colon,pert
Parkinson's disease sample x029,pert
Normal PBMC_sample 2,ctrl
WKY12-2,ctrl
C2C12 myotubes 0uM H2O2 rep 2,ctrl
Cal27_PBS2,ctrl
"tissue: liver;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: control 72 hr",ctrl
Control 1 c,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.29041,pert
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-4,ctrl
4A,pert
Hippocampus_Soman_6h_rep2,pert
Bone-Marrow_NPC_N1362,ctrl
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/8,ctrl
liver 0.1% quercetin diet rep2,pert
"Male, 43 years old",ctrl
scan batch: Batch 2;	group: control;	subject age: n/a;	paternal age: n/a;	maternal age: n/a,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A01",pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: control siRNA;	agent (treatment): R1881,pert
No or early 1 rep7 (retina),pert
FHCRCAML1355,pert
LJMJDW22,pert
SP-KO-Nrf2-Female-2,pert
T119 U133p2,pert
normal adjacent esophageal tissue from patient E1566,ctrl
ovary_cultured_progesterone_rep1,pert
NME2 induced A549 cell Replicate2,pert
age: 42;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
treatment: transfected with Ambion Silencer Select SOX2 siRNA;	cell type: embryonal carcinoma;	cell line: NTera-2;	passage: 40-50,pert
Sample Group: control; Gender: male; Age: 38; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
race: caucasian;	age (years): 57;	stage: IB;	grade: 2;	histology: endometrioid,pert
4041-4 E2F3 Heterozygous,pert
"0mg/kg/day PFOA, Rep 2, Block 1 lung (high dose)",ctrl
NINDS-RHS-Kainate_24h-3aUA-s2,pert
Strain: B6.V-lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,ctrl
Common Myeloid Progenitors,ctrl
"vestibualr organ at P15 of Igf1 -/-, biological rep 1",pert
Disease_status: Healthy control;	Age (years): 42;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 37;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,ctrl
Hunk Knock-Out rep 6,pert
HT29 PLX Day3 rep1,pert
breast cancer patient 226,pert
umbilical cord_bpd: 6H,pert
Gastrocnemius Muscle_WT_rep3,ctrl
sample =Healthy2 treatment=Stimulated time=360 (min),ctrl
Pancreatic Sample 9-Tumor,pert
"CD44 siRNA, 1",pert
WT - Cre Control - 5 mo - repeat 2 - Cy3 - mAdbID:74100,ctrl
Age: 50;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
Day: 24; Drug: Heroin; Phase: Withdrawal; Replicate: 2,pert
220C1,ctrl
Cancer 3,pert
heart wild type replicate3,pert
CDK9 Knock Down2,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-11;	Primary Site:Tongue;	Age:32;	Sex:M;	TNM:T3N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
Carboplatin;	Carboplatin 24 hours set 1,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: spleen;	sample name: 1-sp1,ctrl
Leg 7 Day Control rep 1,ctrl
Liver_POR-null+quercetin_3,pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 50;	donor: 24;	disease state: Lesional,pert
Bone-Marrow_SMM_S1384,pert
"Peripheral blood, patient without recurrent events [N33]",pert
Setdb1 2lox/1lox/Cre plus tamoxifen 2,pert
TTF=120min;	Race=Asian;	Sex=Female;	Group=A;	Prototype_N,pert
H1993 BRMS1 KD_1,pert
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: female;	age: 20 weeks;	genotype/variation: control",ctrl
MOLM14-shGSK3B-Construct2-rep1,pert
ko 13.5d replicate 2,pert
CTRL_5_CMP,ctrl
"ME16C, 12h, 0.5uM DOX",pert
"siYAP RNA #1 transfected, biological rep 4",pert
Postnatal 3 weeks mutant heart biological rep1,pert
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep2,pert
cerebellum wild type 6 month replicate 1,pert
WT liver_HFD_rep2,ctrl
Vehicle-Control 24 hours set 2,ctrl
01LNL_CTRL,ctrl
EOM 14 Day Control rep 1,ctrl
WT heart 1,ctrl
"Fibroblasts, baseline, time 0, patient 1, rep 2",ctrl
individual: patient3;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
12 h-apra-2 nM,pert
Control for EGF 12h replicate 2,ctrl
T6F-LU,pert
MCF7_siRNA_GCMedControl_24h_AM0002_57.1,ctrl
"Patient 6, lesion tissue",pert
"Wild type, snap frozen, gastrocnemus muscle, 10 month age animal",ctrl
strain: Swiss;	tissue: Ovary;	agent: Methoxychlor (50uM);	replicate: 1;	age: Post natal day 3-10,pert
MDS39,pert
agent: pristane;	time: 3 days;	strain: BALB/c;	tissue: mesentery,pert
microdissected breast cancer cells from case 1205,ctrl
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: control (none);	timepoint: 24 hours,ctrl
"Healthy volunteer, Control_11698",ctrl
10 days TAC-1,pert
7d-sham-80,ctrl
human_LIMA_artery_patient4_paclitaxel-eluting_stent,pert
colon_normal_1431,ctrl
TIG3 diploid lung embryonic fibroblasts,pert
treatment: DMNQ;	cell line: NuLi;	genotype: no-Cystic Fibrosis deltaF508 mutation,pert
Atopic eczema,ctrl
"Pou4f1-/- cells, transduced with control virus_KO_MSCV_86",pert
PFR3K650E_replicate_3,pert
liver_WT_replicate1,ctrl
LNCaP.FoxA1.1,pert
CUTLL1 DNMAML1 GSI-rep2,ctrl
control participant P313,ctrl
cell line: SV589;	knockdown (days): 15;	treatment: Serum Starved; no EGF,pert
Pre-frontal cortex from male C57Bl/6 mice 31 d after i.d. injection of Type II collagen in Complete Freunds adjuvant,pert
"Crohn 04, CD04",pert
B4_pseudomonas_overexpressor_422,pert
Untreated after 4 days (C2_2),ctrl
"patient: 202;	current medication: Sulphasalazine 3g/d, Folic Acid 5mg/d, HRT, DF118;	birth date: 10/3/50;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/68;	diagnosis date: 1/1/69;	joint problems: TRUE;	uc flare up: TRUE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Polymyalgia rheumatica;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",pert
diet_Lung_4,ctrl
sex: Male;	Age: 33 months;	additional patient information found in Series supplementary file,ctrl
cell line: MOLM-14;	shRNA construct: GSK3A Construct 6,pert
brain_DLPFC_bipolar C_mr544,pert
NOD Aire KO MEC rep1,pert
pediatric AML PP1,pert
"gender: Male;	age: 25;	post-mortem delay: 17h;	ph: 6.9;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
infection: MIR517A and GFP protein,pert
MDS patient 15,pert
"mouse aorta cross strain comparison, C3H_T00_NC_01",ctrl
U2-OS-ERb vehicle control 1,ctrl
strain: FVB;	developmental stage: adult (3-month-old);	tissue: hippocampus;	genotype/variation: Prnp0/0,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: A;	genotype/variation: NET1 present;	agent: LPA,pert
jzo033-rp1-v5_u74av2-met,ctrl
WT J1 ESCs on day 3 #1,ctrl
TF_1_control_d2.5_rep2,ctrl
11104 UC Uninflamed descending colon,pert
Fat FC2,ctrl
SCHT control 1,ctrl
11381 Normal Uninflamed ascending colon,ctrl
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 40;	Usage number: 1;	Exposures: 3,pert
"Acute Myeloid Leukemia, sample 22",pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: spleen;	sample name: 6-sp1,pert
Cardiac Muscle_mdx_rep2,pert
"Empty vector, collagen plate, rep2",ctrl
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes;	2nd technical replicate,pert
"Fourth ventricular choroid plexus from wildtype mice at E13, biological replicate 3",ctrl
23A,pert
28_C57_WT,ctrl
"105, ADIPOOSE TISSUE, Before",ctrl
OSE_448,ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 26;	maternal age: 30,pert
"human failing LV myocardium, Idiopathic78",pert
CON17,ctrl
cell line: Raji;	cell type: human Burkitt's lymphoma;	gender: male;	treatment: expression of control mimic;	treatment duration: 24 hrs,ctrl
NPC_p5ko_rep1,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep11,ctrl
"DBA/2J CHR, Rep3",pert
4_CD34+_12h_TCDD+,pert
lung_CLP_PPTA knockout_rep1,pert
ICM pool 2 (n=2),pert
status: Normal;	age: 75;	gender: male;	tissue: cultured human fibroblasts,ctrl
"Patient 29, Atheroma plaque",pert
normal control_CTL3,pert
"experiment I, passage 13, replicate 2",ctrl
Balb/c WT_1,ctrl
Calu3-Parental_1,ctrl
tumor cell line HepG2 with knockdown of HIF-2α rep4,pert
"WT MEFs, biological rep1",ctrl
RAW Untreated 2,ctrl
"Liver from control mice, biological replicate 1",ctrl
"S1P2-KO-hippocampus, biological rep5 (male)",pert
Mammary gland R1 8 hr rep2,pert
BIO586227,pert
"mouse aorta cross strain comparison, C3H_T04_HF_02",pert
"human failing LV myocardium, Ischemic49",pert
patient16,pert
a_NY36,pert
RatLung_H6h_1,pert
Nasal Epithelium Inhalation Formaldehyde 15ppm 6h ID342,pert
"control pancreas, biological rep3",ctrl
EOM 56 Day mdx rep 3,pert
17A;pretreatment;female;breast tumor; responder,ctrl
129S1/SvImJTCE liver sample batch 2,pert
Control Endometrium Epithelial Cell_014.UC182_EpCAM,ctrl
"WT caudal vertebral bone, rep3",ctrl
"IKK2 WT cell line, biological replicate 1",ctrl
Wild Type nr 663,ctrl
Seguin_IDR_BrownNorway_Liver_treated4,pert
Jejunum_POR-null_2,ctrl
Caco2-siRNA2-rep2,pert
gender: female;	strain: C3H/HeN;	genotype/variation: WT;	tissue: liver;	age: Five-weeks-old;	agent: control,ctrl
sample =Healthy3 treatment=Control time=0 (min),ctrl
Human normal pituitary -N6,ctrl
PGC-1a KO 1,pert
healthy control sample x120,ctrl
LECs from cirrhotic rats 3,pert
0992-01-c,ctrl
GBM_stem_4 days_1,ctrl
L428+MAT_rep1,pert
"Chromium 1 µM, biological rep4",pert
Neo-1 Ctl HG-U133 Plus 2.0,ctrl
"Cervical cancer cell line, HeLa",pert
"DOCK8 knockout, thymic, NK1.1+ NKT cells replicate2",pert
06R029 RA,pert
"WT mouse skin treated once with acetone and collected 24 hr later, replicate 1",pert
Duoden022KAF6T_066.txt,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-12;	Primary Site:Maxilla;	Age:46;	Sex:Male;	TNM:T4N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	;	",pert
Skinbiopsy_7hoursnickel_controlsubject_k1,ctrl
microdissected breast cancer cells from case 1125,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.84;	choa: 41.3;	fata: 38;	eea: 1290;	wtkg: 70.3;	perfat: 35.5;	lbm: 42.7;	fat_mass: 2495.65,ctrl
gender: female;	age (years): 36;	evolution time (years): 0;	disease extension: Left-sided colitis;	treatment: No treatment,ctrl
Liver_PXR KO_Vehicle_Rep2,pert
umbilical cord_nobpd: 9A,ctrl
"brain, hippocampus: Aldh5a1-/- #3363 Hippo_e1_le1",pert
"control E14, rep2",ctrl
"CTLA-4 KO 5C.C7 T cells, biological rep2",pert
"215, ADIPOOSE TISSUE, Before",ctrl
heart_co_14M_rep3,ctrl
cell line: MCF7 breast cancer;	treatment: RL silenced and LIF-stimulated,ctrl
mammary stoma-4w-wt-rep3,ctrl
"PPARg2 expression construct, 72 hrs, No Rosiglitazone (PPAR_72_2)",pert
9-cis-retinoic-acid_mammary_2,pert
cell line: MCF7;	treatment: PDEF knockdown,pert
HWS23,pert
n04,ctrl
THRB 15b mutant + vehicle replicate 2,pert
HMEC X MCF7-NCI,pert
Subtype: RARS;	Karyotype: del(5q),pert
17 saline,ctrl
C_AN19442_T,ctrl
Empty control #1,ctrl
n9t0h,pert
tissue: Liver;	genotype/variation: Hmgn1-/-;	treatment: injection of 10 µg/g body weight of saline,pert
C_AN15566_F,ctrl
BL6_24h_Wy,pert
NHE3+/+ replicate 3,ctrl
Psoriasis-Patient-N,pert
"SLE patient, 1012V1",pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-9;	Primary Site:Tongue;	Age:66;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
MPM tumor 32,pert
BP patient 55_biological replicate 1,pert
tissue type: Bone Marrow;	cell type: Smoldering Multiple Myeloma (SMM) plasma cells,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 39 yr;	population: white,ctrl
Panc-1 Untreated Control 2,ctrl
wt_1,ctrl
"BOEC, at_risk 2",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-tu2,pert
"Wt, biological rep2",ctrl
29B,pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 6h,pert
"DMSO Control after 2hr, replicate 2",ctrl
"0mg/kg/day PFOA, Rep 4, Block 4, lung (low dose)",ctrl
myoblast_untreated_rep2,ctrl
Md02h027,pert
BATF_KO_P14_D3_Effector_rep4,pert
"C57BL/6 BMDM infected with WA(pTTS,pP60)",pert
"Ulcerative Colitis (62 year old caucasian female, SAK_1305735600)",pert
tissue: Frontal cortex;	age: 100;	Sex: F,ctrl
HDAC2 KO E17.5 Ventricle 1B,pert
A673 cell line that has been treated with Puromycin for 3 days with concentration of 0.18 uM (2 x EC50).,pert
MO32_15,ctrl
DMN-NF1Hippo10d-1aAv2-s2,pert
strain: 129SvEv;	developmental stage: E11.5;	tissue: ventricle,ctrl
Control Endometrium Epithelial Cell_030.UC208_EpCAM,ctrl
"TAMs sorted from vehicle control tumors, biological replicate#1",ctrl
umbilical cord_bpd: 1D,pert
SZ1,pert
long-Rif1 KD rep1,pert
Individual_4397_PN_sample,pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 45;	Usage number: 1;	Exposures: 3,pert
3578M patient’s mucosa,pert
"Ctrl OBCs, post doxycyclin withdrawal, rep1",ctrl
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 72;	gender: f;	treatment: -,ctrl
"Atm-/- untreated, C",ctrl
VMM-MUT_MyoD12h-3MP-s2,pert
ANL Chip#33,pert
BT474_Lap_24-3,pert
SLE CD4 T cells 2,pert
genetic background: C57BL/6;	gender: female;	tissue: left hippocampus;	age: P100;	genotype: wild type;	treatment: control,ctrl
"vector d4, rep 3",ctrl
Cerebellum_nontransgenic control S46_3.5 months_replicate 4,ctrl
Insm1 mutant #6,pert
"TMD_EHL, T4",pert
Ileum_Wild Type_2,ctrl
n7t0h,pert
Gender:M;	Age:41;	Tissue: Mucosa,ctrl
"Cell type: neuronal, age:47, gender:male, diagnostic group: control, PMI:11h",ctrl
INSENS 7 4hr,pert
cell line: MCF-10A,pert
TTF=120min;	Race=Black or African American;	Sex=Female;	Group=A;	Prototype_Y,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: RNAi-4A,pert
Control Endometrium Endothelial Cell_ETB65 +-,ctrl
NSC_FBS_V1,ctrl
ColonProx_0227AFAS_070.txt,ctrl
Patient: H;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
wt_P6_rep1,ctrl
MF-12,ctrl
"BL from healthy donors, isolated using CD19-PE-Cy7.",ctrl
0651-01-C,ctrl
"human failing LV myocardium, Ischemic50",pert
sample =Healthy3 treatment=Stimulated time=360 (min),ctrl
Mtb infected-42d-1,pert
lymphocytes_ctl_M_50y,ctrl
Normal cortex of patient 1393,ctrl
"Wild type, snap frozen, extensor digitorum longus muscle, 10 month age animal",ctrl
CEMC1 cells treated with 10 nm rapamycin for 3 hours,pert
strain: CBA,ctrl
status: Control;	gender: Male;	age: 45;	tissue: Blood,ctrl
E9.0 wt.2,ctrl
"Ulcerative Colitis (55 year old black female, SAK_1285134540)",pert
tissue: 2B1 cell line;	genotype/variation: N/A;	age: 4 days post-differentiation in-vitro,pert
genotype/variation: Wildtype_XY;	tissue: gonads;	age: E11.5,ctrl
Pancreatic Cancer PBMC Sample 1,pert
"WT CD8 memory T cells, biological rep2",ctrl
SA_292,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 29.26301,pert
Control 1b,ctrl
G93A 60 days sample 2,pert
"KM-H2 PTPN1 Knockdown, technical rep2",pert
H_LS_Wk1,pert
Cmah KO_kidney_3,pert
"brain, hippocampus: inhibitor-1 KO 2_e1_le1",pert
treatment: vehicle;	genotype: wild type;	treatement time: 40 hours,ctrl
testis wild type replicate1,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Jejunum",ctrl
Cerebellum_transgenic nuclear localization signal Htt exon1 18Q x50_16 months_replicate 3,pert
Liver_Wild Type_3,ctrl
atopic eczema P1,pert
normal 1473,ctrl
U133A_G1,ctrl
Retina ko/ko rep3,pert
"TCF-1 KO CD8 memory T cells, biological rep3",pert
HT29 DMSO Day3 rep2,ctrl
T51681,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 32;	maternal age: 31,pert
CD positive WT T cell TCR-stimulated rep3,ctrl
X50 WT3	F2/33	X50	wild type	Mouse	16 months	Cerebellum	Male,ctrl
"AD_TC, biological rep4",pert
humanMBC_ctrl overexpression_2,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATR-4,pert
MDS patient 130,pert
Normal-BM 4,ctrl
OCI-Ly10_FOXP1 overexpression,ctrl
background mouse strain: C57B16;	genotype: Jak2VF;	treatment: Vehicle,pert
status: Normal;	age: 64;	gender: female;	tissue: cultured human fibroblasts,ctrl
ovary_cultured_progesterone_rep2,pert
MDS patient 106,pert
MDS patient 55,pert
Mist1KO caerulein rep2,pert
CD-49-Aff1,pert
liver_wild type_6 weeks_replicate_2,ctrl
"PCB153 treated HepG2 cells at T1.5, biological replicate 2",pert
"CCM3 shRNA cells passage 7, rep 3",pert
48 hrs sham-1,ctrl
KO PBS3,pert
immortalized cells derived from brown fat of PGC-1alpha KO mouse (mixed background). passage number: 4.,pert
NSC_ DMSO_24h_biological rep1,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-sp3,pert
cell line: Panc1005;	cell type: dasatinib-sensitive pancreatic cancer cell line,pert
Individual_4389_PN_sample,pert
Control gray matter 3,ctrl
diet_LIVER_1,ctrl
breast cancer patient 237,pert
BS2011051054_2,ctrl
AL Chip#24,pert
ME180 3 hours rep 4,pert
CD4IncTp2-8,pert
"Trip12 mut/mut, biological rep1",pert
Adult 7d SNI; Biological replicate 3,pert
HT29 sensitive cells replicate 2,pert
siLMO3_oligo1_FM_rep1,pert
"brain, Entorhinal Cortex: 99-33 tangle_e1_le1",pert
tissue: Brain;	genotype: Npc1-/-;	age: 54 days;	subject: Mouse5;	genetic background: BALB/c,pert
"patient 10, arm treated with pimecrolimus",pert
"metastasis: metastasis;	Stage: 4;	tissue: normal, homogenized",ctrl
Gastrocnemius muscle wild-type mouse - control mouse for PPARalpha overexpressing -rep 2,ctrl
DC1 RSG,pert
Ngn3 ES3 ON replicate 1,pert
genotype: Fog2flox/delta;	treatment: no Cre;	age: 6-7 wks old;	gender: male;	tissue: heart,ctrl
Hippocampus_Soman_168h_rep2,pert
WT rep2,ctrl
background: C57BL/6x129Sv/B6 hybrid;	genotype: WT;	age: 9 months;	tissue: caudal vertebral bone,ctrl
S2B Sporadic-cerebellum,ctrl
Clozapine treated 12weeks AffyGC RMA rep2,pert
"strain: B6.129P2-Il10tmlCgn/J;	genotype variation: Il10-/-;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 48 hours;	agent: air;	exposure dose: 0 ppm O3",pert
Endometrial stromal cell - control/vector 2,ctrl
"Patient 21, Macroscopically intact tissue",ctrl
HLA risk: Medium;	Height: 175 cm;	Weight: 70 kg;	BMI: 22.9;	Age: 24.4 years;	Gender: Male;	Race: White;	Glucose: 288 mg/dl;	HbA1c: 8.8%,pert
striatum_wildtype_3,ctrl
SRF silenced EtOH rep 1,ctrl
"MCF-7, 12h, 0.9uM DOX",pert
female_control_477,ctrl
PGA-RMM-12h-3aA-s2,pert
P4_PMP22TG_1,pert
"brain, brainstem: LB1_e1_le1",pert
23A;pretreatment;female;breast tumor,ctrl
Sox3 null Sample 1,pert
"Cell type: endothelial, age:54, gender:female, diagnostic group: schizophrenia, PMI:42h",pert
Bmpr2-Delx4 1,pert
3886-2 E2F1 Null,pert
Rb-/-PrE serumfree 2,pert
Mock_cells_rep3,ctrl
tissue: skeletal muscle;	status: diabetic;	agent: insulin,pert
NL D,ctrl
age: 52;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Untreated CHOP-/- A,pert
"Immortalized MEFs WC, empty retroviral vector infected, rep3",ctrl
db/db 8 wk 1,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 120min;	race: White;	sex: Male,pert
Gender:M;	Age:41;	Tissue: Mucosa,pert
BL121,ctrl
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: DMEM,pert
gastrocnemius-30 months of age-resveratrol diet-biological replicate4,pert
M325 C,pert
cerebellum SNCA knockout 6 month replicate 2,pert
Control 1 at age 35-day,ctrl
V5-P405,pert
"Lesion Skin, LS-29",pert
Knockout CS_2_15_KO_2,pert
"A673 treated with Doxorubicin for 24 hours with concentration of 119.76 nM (2 x EC50), biological rep2",pert
Control pool 3 (n=5),ctrl
Run1.a10a.000607jd.2.SkMNor920.CEL-IS stimulate,pert
Run5.aUa.010110d.SkMDbt1152D.CEL-DB basal,ctrl
T30057,pert
"FA6 transiently transfected with AGR2 siRNA, transfection C",pert
tissue: muscle;	genotype: WT;	genetic background: C57BL/6,ctrl
MDS patient 43,pert
Seltzer 21d replicate 1,pert
3598,pert
ve_2m41,pert
PGA-MAH-HeJAir-1bAv2-s1,pert
"Murine 3T3-L1 progenitor adipocytes cell cultures,T3 (treated with resveratrol)",pert
remitted schizophrenia patient  S22,pert
tissue: liver;	strain: C57BL/6JBomTac;	genotype/variation: wildtype,ctrl
"Spi-60, biological rep 2",pert
Akt1-deficient 1,pert
HEL_JAK2 knockdown (Jak2-9 shRNA)_3,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.741;	Ratio: 2.11,pert
SENS 6 0hr,ctrl
B4 394 wild-type untreated,ctrl
"3T3-L1 siControl 24h, biological rep 1",pert
Normal control 1,ctrl
gender: Male;	age: 71;	post-mortem delay: 6.5h;	ph: 6,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 16 hrs;	time course: 2,pert
Mouse embryonic stem cell line E14,ctrl
strain: C57BL/6J;	tissue: WAT;	genotype/variation: Fsp27 knockout;	gender: male;	age: 3 month,pert
age: E14.5;	gender: male;	tissue: dorsal telencephalon;	genotype: wt;	genetic background: C57BL\6,ctrl
"C57BL/6J SAL, Rep1",ctrl
0844-01-A,pert
"ADAM17 cKO skin, rep2",pert
Nrl ko P2 replicate 3,pert
NIH3T3,pert
"NeuroD1 knockout mouse, P0 Pineal Tissue, Sample 2, 05-23-06",pert
phenotype: control;	gender: female;	case_id: 410;	age: 78;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 11;	brain ph at time of freezing: 6.3;	labeling_batch: 1,ctrl
PsOEt-19-Week 2,pert
age_years: 59;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
adenosquamous carcinoma 002,pert
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep4,pert
CDF1-c (195msn),ctrl
A2AR_KO_saline_24h_rep1,pert
b36+,pert
nmd untreated 2,pert
"ERRa wt baseline heart, sample 1",pert
ACI control replicate 3,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 1 day;	treatment: fresh air, treatment over 1 day, 3x1h exposure per day",ctrl
Bone-Marrow_SMM_S1259,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 14 months,pert
lesion_midUV_patient5,pert
"Wild type used for MAT1A 8 month, replicate 1",ctrl
Ileum_Wild Type+Quercetin_2,pert
Leptin treated mouse gallbladder 7,ctrl
GM19238_Kd_RELA_2,pert
hBSMC_vitamin D_rep1,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 55.22192,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.8;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 60;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
GM19238_Kd_STAT2_2,pert
colon_IBD_1670,pert
Strain:C57BL/6;	Gender:male;	Age:8 weeks,ctrl
Leg 28 Day mdx rep 2,pert
Individual_4426_PN_sample,pert
heart female CVD3 10 dpi rep2,pert
MA_94,pert
"fibroblast, MFS subject FB881 rep 2",pert
disease state: Schizophrenic;	gender: Female,pert
Disease_status: Healthy control;	Age (years): 59;	Gender: Male;	Post mortem interval (hours): 47;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
EA_Case17_CD20,pert
"age at diagnosis: 63;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 12;	dfs-event: 0;	distant metastasis: 0",pert
Diaphragm 7 day control rep 3,ctrl
NOMO-1_SCR,ctrl
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.93;	Post mortem interval (hours): 23;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
"Pou4f1-/- cells, transduced with control virus_KO_MSCV_83",pert
GEIM193-U133A-Norm,ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: pineal gland;	time: ZT20,pert
SENS 2 0hr,ctrl
MCF10A_SFN_rep2,pert
T51677,pert
A39 NES 142Q TG7	F2/13	A39	NES Htt exon 1 142Q	Mouse	10 months	Cerebellum	Male,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 90min;	race: White;	sex: Female,ctrl
genotype: Wildtype;	tissue: Liver;	genetic background: C57;	Sex: Female,ctrl
gender: Female;	age: 46;	post-mortem delay: 4h;	ph: 6.6,ctrl
Striatum of 8-10 week old C57BL/6J mice,ctrl
"SS gland, moderate, patient 9, batch 1",pert
ACI control replicate 1,ctrl
Psoriasis-292,pert
BM_02303,ctrl
"Liver from STZ-treated mice, biological replicate 5",pert
AVC_mutant_rep4,pert
Nonlesional Epithelium Nonatopic Control rep2a,ctrl
High weight gainer Kozak1_ABI_ING_H3,pert
"10mg/kg/day PFOA, Rep 2, Block 1, lung (high dose)",pert
e_NY204,pert
8 hour tunicamycin CHOP-/- A,pert
cardiomyocyte control 1,ctrl
"ESCs overexpressed vector control, biological rep2",ctrl
Frontal_Cerebrocortex_Vehicle_6hr_rep6,ctrl
"ERRa wt baseline heart, sample 2",pert
RTX12 T12,pert
"imr-32,ccnd1 siRNA,T=48, 1",pert
Run1.a10a.000607jd.2.SkMNor915.CEL-IS basal,ctrl
Braak α-synuclein stages 5-6  BR56_3SN,pert
CAB10_T2_PP_day0_032,ctrl
Subject 4_t=30days_placebo,ctrl
AtT20 cells overexpressing NSBP1WT protein rep1,pert
T130 U133p2,pert
cell line: GIST882;	agent: DMSO (control);	replicate: Rep1,ctrl
E81-/-vector-1,pert
MF_II_3,pert
RNA-DHL4-R406-2H-1,pert
GIST Pre Treatment Biopsy 11,pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: WT;	treatment: untreated,ctrl
"non-AD_FC, biological rep8",ctrl
11425 UC Uninflamed ascending colon,pert
Mist1KO saline rep2,pert
PGA-HMO-MObese-8aUA-s2,pert
vacht KD 1,pert
brain knock out replicate1,ctrl
genotype: mcad -/-;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: vehicle;	tissue: liver,pert
KM_069N,ctrl
cell line: KYSE270;	cell type: squamous cell carcinoma,pert
Sex: female;	Age at operation: 78 years;	Site: thigh;	Size in cm: 13x10x6;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: high;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
pediatric AML GP9,pert
Silberg2 (10) 130701BE,pert
Healthy control 17,ctrl
BP2,pert
tissue: Brain;	genotype: Npc1+/-;	age: 82 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
disease state: paediatric glioblastoma;	age: 5;	gender: M;	h3.3_status: K27M,pert
BCell_lymphoma_aggressive_sample5,pert
Strain: 129S2/SvPasCrlf;	Sex: male ;	Genotype: L1CAM knockout (-/Y),pert
T4C-LU,pert
C2 patient,ctrl
"Neurons overexpressing Hes1 and GFP, biological rep3",pert
JIA PBMC Pre treatment A235_L003,ctrl
GM19238_Kd_E2F6_3,pert
01UN0,pert
"fibroblast, MFS subject FB1211 rep 2",pert
OV90+(2),pert
"Rat_Tracheal_Control_2hr, rep4",ctrl
BN control replicate 1,ctrl
PBMC from T cell LGL leukemia patient #128 (TLGL128),pert
E10.5_otic_vesicle_wt_replicate2,ctrl
RNA-DHL6-R406-48H-3,pert
"WT-UN1,experimental replicate 1",ctrl
"Liver from Nrf2 wt mice, biological replicate 3",ctrl
Young 9,ctrl
scan batch: Batch 1;	group: control;	subject age: 10;	paternal age: 32;	maternal age: n/a,ctrl
P60_PMP22TG_2,pert
"Control lung tissue, biological replicate 4",ctrl
"genetic background/strain: C57BL/6;	genotype: wild type;	cell type: embryonic stem cells;	developmental stage: day 0, undifferentiated;	passage: 8",ctrl
"Control shRNA cells passage 11, rep 5",ctrl
high grade serous carcinoma_patient 11,pert
neuron_rep14,pert
"Patient 10, Atheroma plaque",pert
brain_DLPFC_bipolar C_mr444,pert
Cells: HCT116 colon cancer cell line,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 30.47945,pert
Liver-Cpr-null_pool 1,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 100min;	race: White;	sex: Female,ctrl
"disease group: Nonatopic Control;	Sex: m;	age: 40s;	race: African American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 160;	ige (kiu/l): normal (0-48.5 kIU/L): 2.9;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-1,pert
age: 31;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
heart control 1,ctrl
HEK293_A08_R3,pert
"wdNHBE with KY/180 at 36hpi, biological rep1",pert
Disease_status: Bipolar disorder;	Age (years): 41;	Gender: Female;	Age of onset (years): 14;	Duration of illness (years): 27;	Brain pH: 6.44;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: 3000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
Ischemia-reperfusion #2,pert
Mening SWB WB SW 24a,pert
wt_P2_rep1,ctrl
NPC Brain 40d MOuse1,pert
Tissue: striatum;	Age: 6 months;	Gender: F,ctrl
C57BL10 gastroc sample 2,ctrl
HW_475,pert
tissue: Frontal cortex;	age: 84;	Sex: M,pert
patient: 12;	disease state: hypertension;	tissue: Atheroma plaque,pert
B4 365 b4-/- untraeted,pert
BP patient 51_biological replicate 2,pert
GAS-n7; normal gastrocnemus 7 month,ctrl
"IkB, LPS 0hr",ctrl
SFM,pert
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 3,pert
ACI DES-treated replicate 2,pert
UM1_Mut_rep1,pert
U138MG shVEGFR-2 1,pert
Muscle control 17,ctrl
No or early 1 rep1 (OHN),pert
tissue: Frontal cortex;	age: 94;	Sex: M,pert
PFC FVB/N control 1,ctrl
VMM-MUT_MyoD12h-2MP-s2,pert
SNB19 scramble siRNA replicate 1,ctrl
51A;pretreatment;female;breast tumor,ctrl
parental biological replicate 2,ctrl
1118-01-C,ctrl
ARF1 siRNA knockdown MDA-MB-231 sample 4,pert
H720 cell line control 2,ctrl
ES_WT_rep1,ctrl
J_LS_Wk12,pert
gender: M;	age at blood draw: 57;	tissue: whole blood,ctrl
112A,ctrl
colon_CRC_1499,pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Cortisol;	genotype: CTNNB1 mutation (S45P),pert
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Troglitazone,pert
"human failing LV myocardium, Idiopathic30",pert
S7A Sporadic-frontal,ctrl
strain: Sprague-Dawley;	gender: Female;	tissue: ovary;	developmental stage: day P4 cultured for 2 more days,ctrl
U2OS_control_shRNA_pLenti_1_2007,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.38904,pert
Bone-Marrow_MGUS_G1559,pert
Genotype: C57Bl/6 mice;	Age: 8-12 weeks old,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 24.95342,pert
patient: 9;	disease state: hypertension;	tissue: Atheroma plaque,pert
LT-HSC Zbtb7a F/+ Mx1-Cre+ #1,ctrl
T145 U133p2,pert
normal control_CTL4,pert
SENS 5 4hr,pert
Human_macrophages_hypoxia_repA,pert
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14535;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Subject 3_t=30days_placebo,ctrl
"Crohn 08, CD08",pert
"WT mouse heart at 6-weeks old, biological rep1",ctrl
44A;pretreatment;female;breast tumor; nonresponder,ctrl
Mist1KO caerulein rep1,pert
s2t3c,ctrl
RKO_rep_3,pert
01LR3_ERA,pert
Control Day14 (440L),ctrl
Squamous cell carcinoma 028,pert
cell line: CAL27;	treatment: 15 nm Cetuximab for 13 hours,pert
chip number: 9;	transfection plate: 2;	target gene: NS;	kd level: NA;	rin: 9.9;	transfection date: 2011-03-29,ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: heart;	age: 8 weeks,ctrl
MDS patient 38,pert
HTB58_controlsiRNA_3,ctrl
Haloperidol treated 12weeks AffyGC RMA rep10,pert
"siYAP RNA #2 transfected, biological rep 3",pert
strain: Ts65Dn;	tissue: skeletal muscle;	Sex: male;	age: 5 months,pert
"diet: LRD-5001;	sodium arsenite added to drinking water: 100 ppb, 5wk",pert
"non-AD_FC, biological rep13",ctrl
5263 UC Inflamed sigmoid colon,pert
"ALL_DS, K30 012109",pert
Dilated cardiomyopathy_G21,pert
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 47;	gender: m;	treatment: NSAIDs,ctrl
cell line: T47D;	treatment: R5020 [10nM],pert
Wild type mice on a high fat diet (CH 4),ctrl
A_LS_Wk1,pert
Subject #8012-Preinfection,pert
untreated_6hr_rep4,ctrl
"215, MUSCLE, Before",ctrl
GEIM195-U133A-DM,pert
KO - 3 mo - repeat 4 - Cy5 - mAdbID:74670,pert
"cochlea at P3, wt, biological rep 2",ctrl
HP-81,pert
"EBF1 d2, rep 2",pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 26;	maternal age: 23,pert
HC IF 2 water,ctrl
cell type: T cell;	treatment: 37C;	genotype: HSF1+/+;	genetic background: mixed 129Sv.BALB/c background,ctrl
PB_DON086,ctrl
Healthy-2 baseline,ctrl
WT HSC 3,ctrl
"Endometrium, postmenopausal, control, 12-2",ctrl
DS2-iPS 5,pert
Cell line expressing inducible wt-GFP-lamin A. Induction: day 10. Replicate B,ctrl
age: 37;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
AT2_shG1_rep1,pert
BC1 TC,ctrl
Esophagus CTR replicate 2,ctrl
gender: Male;	tissue: Tendon;Biceps;	age: 45;	donor: 5;	disease state: Lesional,pert
Cells:U-33 cells stably transfected with a PPARg2 expression construct (U-33/g2 cells);	Time: 24 hrs;	Drug: No Rosiglitazone present,pert
5259 UC Inflamed sigmoid colon,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 1,pert
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: SCM,ctrl
b86-,pert
"BOEC, normal 5",ctrl
Normal myocardium sold commercially (G),ctrl
"Immortalized MEFs WA, v-src expression retroviral vector infected, rep3",pert
TP06-963,ctrl
gender: Female;	age: 71;	post-mortem delay: 13h;	ph: 6.3,ctrl
CD4IncTp1-9,pert
human_LIMA_artery_patient1_paclitaxel-eluting_stent,pert
WT vehicle (7991003028_A),ctrl
USF1 replicate 3,pert
Mouse_Retina_P7_Rs1h_KO 3,pert
"lymphoblastoid cell line from T4.02, one out of seven of insensitive group, 50*10e6 cells",pert
WT - Cre Treated - 0.5 hrs - repeat 1 - Cy3 - mAdbID:62541,ctrl
TN3b-control,ctrl
Untreated Myd88 knockout - repeat 4 - mAdbID:102774,pert
"SKO-transduced MEFs, Vc-, D5",ctrl
Biceps_Pompe_6,pert
RatLung_H48h_3,pert
"Patient 15, Macroscopically intact tissue",ctrl
VCaP/NC siRNA #3,ctrl
NPC_VUB01_1,ctrl
SKBR3 WT 1,ctrl
ILD Study Number S035,ctrl
high grade serous carcinoma_patient 10,pert
patient: 253;	current medication: Asacol 800mg BD;	birth date: 3/14/58;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 8/24/97;	diagnosis date: 9/4/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/24/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/24/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/3/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
CH2124,ctrl
HUVEC/NmenMC58_WT_4h_rep3_1117,pert
Human normal pituitary -N1,ctrl
15C-ER-D,ctrl
Squamous cell carcinoma 021,pert
whole blood_100537,pert
Run7.aUa.001206d.SkMInS1091D.CEL-IS stimulate,pert
MLL1-KO MEF CT18-1,pert
MCF10A_HER2_2,pert
No or early 2 rep3 (retina),pert
Carrier-inj_Mip-1a-KO_rep1,pert
ILD Study Number 1113,pert
strain background: Mixed;	genotype/variation: wild type;	tissue: ventromedial hypothalamus (VMH),ctrl
subject id: 33;	infection: DENV;	status: DF;	tissue: whole blood,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.475;	OD280: 0.755;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 155;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 4x1h exposure per day",ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_2h_1mM_HG-U133A_2_YCHSUP501,pert
disease state: Schizophrenic;	gender: Male,pert
HCT116-Neo124 PTEN +/+,pert
U-87MG-PK25 set 3,pert
Moderate rep2 (retina),pert
N40726,ctrl
41SAGEA,pert
"human failing LV myocardium, Ischemic58",pert
"Sfrp5 KO HFD 8 weeks, biological rep3",pert
Ainv15 EB10 replicate 1,ctrl
HNF1b_1a+,pert
breast cancer patient 274,pert
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 3,ctrl
2B1_empty_vector_replicate1,ctrl
microdissected breast cancer cells from case 868,ctrl
colon_epithelium_C57 mouse_12weeks_rep5,ctrl
age: 71;	sex: M;	disease status: control subject;	Filter number: 100;	Usage number: 1;	Exposures: 3,ctrl
Individual_5936_NN_sample,ctrl
M229_R5_A_PLX,pert
Mouse fetal liver_E14.5_WT_rep1,ctrl
"DMD skeletal muscle, biological rep18",pert
KO - knock-out Treated - 12 hrs - repeat 2 - Cy5 - mAdbID:61760,pert
tissue: 2B1 cell line;	genotype/variation: N/A;	age: 4 days post-differentiation in-vitro,ctrl
Hippocampus_Soman_3h_rep3,pert
PGA-RMM-48h-2aA-s2,pert
PKBa-/- MEF time 24 replicate 3,pert
PTEN_2,pert
Sample from retroviral MSCV-GFP control infected cyclin D1 knockout 3T3 cells (line 1).,pert
8A;pretreatment;female;breast tumor,ctrl
unstimulated(confluent)-1,ctrl
strain background: C57BL/6;	gender: male;	tissue: thymus;	cell type: CD4 single-positive thymocytes;	genotype/variation: Bach2 knock out;	genotype/variation: Ly5.1-,pert
"111, ADIPOOSE TISSUE, Before",ctrl
MKK7D transgenic female replicate 13 late timepoint,pert
"C57BL/6J SAL, Rep2",ctrl
"prdm-Rosi, biological rep1",pert
GM19238_Kd_NS2_23,ctrl
baseline control 07,ctrl
tissue: liver tissue;	disease state: adjacent non-tumorous,ctrl
normal;	Adjacent pair of T7,ctrl
Bronchial Epithelial Cells control biological 1818E,ctrl
db/db 11-1,pert
JIA PBMC Pre treatment A235_L027,ctrl
Control subject 34_biological replicate 1,ctrl
tissue: Frontal cortex;	age: 91;	Sex: F,pert
Healthy-4 baseline,ctrl
KO_TER119-_rep4,pert
"53B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
db/db 11-2,pert
PKBa-/- MEF time 48 replicate 1,pert
16SAGEA2,pert
CD8+_Tcells_severe_asthmatic_2,pert
Large cell carcinoma 007,pert
Wild type day 3 Air replicate 1,ctrl
Liver_normoglycima_no.2,ctrl
Knockout cre_ppar_beta_floxed_rep3,pert
untreated-sample1,ctrl
FVB; No Treatment #7,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 29 yr;	population: white;	dsm-iv: 296.89;	age of onset: 17 yr,pert
PFR3K650E_replicate_1,pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days. . The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
"Wild type sham, biological rep3",ctrl
MLL_00119,ctrl
"tissue: lung, lower lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 68",pert
PEC control - replicate 1,ctrl
age: 45;	gender: female,pert
healthy myeloid cells 7,ctrl
"Ovol2 KO, biological rep1",pert
age: 65;	gender: female,pert
181C0,ctrl
"C57BL/6J-Il10tm1Cgn, sample 1",pert
"MCF-7 cells-control, biological rep 1",ctrl
T40836,pert
Bc_p60_3,pert
"C57BL6J-backcrossed, male",ctrl
GFP Zfx ko 1,pert
"human failing LV myocardium, Idiopathic59",pert
Hunk WT rep4,ctrl
CTRL_siRNA_rep2,ctrl
LCCS sample 20 weeks,pert
Mammary Gland_WT_rep2,ctrl
Control2,ctrl
strain: E14Tg2A;	cell type: mouse ES cells;	knockdown: control;	overexpression: none,ctrl
Infected Jurkat cells (replicate 1),pert
affected status (disease state): control;	gender: female;	age-at-examination: 47;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension,ctrl
Tendon_non-lesional_rep15,ctrl
"Gender: female;	Age: 62;	Source: skin, hip",ctrl
"patient: 202;	current medication: Sulphasalazine 3g/d, Folic Acid 5mg/d, HRT, DF118;	birth date: 10/3/50;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/68;	diagnosis date: 1/1/69;	joint problems: TRUE;	uc flare up: TRUE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Polymyalgia rheumatica;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
PsOEt-10-LS,ctrl
Age: 39;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
p53_siRNA_0c,pert
Saline treated mouse gallbladder 4,ctrl
"brain, cerebellum: KCb12w#1_e1_le1",pert
"brain, cerebellum: RNA#18_le1",pert
RNA-DHL6-R406-24H-1,pert
"Nickel 140 µM, biological rep2",pert
S25 WT3	F41/391	S25	wild type	Mouse	2.5 months	Cerebellum	Female,ctrl
tissue: white blood cells;	age: 9.78;	Sex: female,pert
"sodium arsenite added to food: 10 ppb, 5wk;	diet: AIN-76A",pert
"IN1760 siPD treated, Biological replicate1",pert
S8C Sporadic-hippocampus,ctrl
"Biceps, FSHD, cohort 12, subject 12B",pert
"nTreg Foxo1 WT, rep1",ctrl
Striatum of 8-10 week old DBA/2J mice,ctrl
gender: female;	mean age: 41.3;	mean bmi: 28.9;	depot: abdomen;	type: white adipose tissue;	ethnicity: Caucasian,ctrl
"Sh2b3 KO, biological rep1",pert
T10,pert
"schizophrenia, BA46-92",pert
PGC-1a KO 2,pert
Papilloma_tumour_epithelial_cells_Sox2cKO_rep3,pert
Retina wildtype 42 days 1,ctrl
BP patient 79_biological replicate 1,pert
"HeLa control, biological rep3",ctrl
Bone-Marrow_MM_M833,pert
Nonlesional Epithelium Psoriasis rep2,pert
PBMC from T cell LGL leukemia patient #112 (TLGL112),pert
45A;pretreatment;female;breast tumor,ctrl
Testis_KO_rep2,pert
plasma;	patient with Acute Lung Injury,pert
patient: 218;	current medication: Sulphasalazine Asprin Metoprolol Atorvastatin;	birth date: 9/27/24;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/58;	diagnosis date: 1/1/58;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/3/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Breast cancer;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 63, stage IB, HPV 16, HPV 18",pert
"GSL30, PR04M008v0",pert
"genetic background: B6/129;	genotype: WT;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor High CD34 positive expressing bone marrow progenitors GMP",ctrl
Run8.aUa.010615d.SkMInS1084D.CEL-IS basal,ctrl
jzo014-rp1-v5-u74av2-met,pert
"Crohn's Disease subject (42 year old black female, SAK_1287526311)",pert
Huh7 cells_Mock Infected 24 hours_ rep3,ctrl
Mouse_WT_ES_clone 2,ctrl
Haloperidol treated 12weeks AffyGC RMA rep2,pert
KU_21N,ctrl
MCF-10A shCHK2-2 replicate 2 [set 5],pert
CC1 21d replicate 1,pert
"Crohn's Disease subject (29 year old caucasian female, SAK_1280865117)",pert
Control_liver_2,ctrl
CEPI_IIIc_242,pert
Huh-7/IRF1 rep2,pert
3DKD_SerumStarved->1hrEGF_rep1,pert
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 3,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.86;	choa: 161;	fata: 49;	eea: 1360;	wtkg: 52;	perfat: 39.5;	lbm: ;	fat_mass: 2054,ctrl
MDS patient 183,pert
CA2 NoCre Sox17D,ctrl
Neuroblastoma SH-SY5Y cells_cloneB_stably transfected with RNAi against DJ-1_replicate1,pert
KU_36T,pert
batch: B;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 7",ctrl
WT HSC 1,ctrl
"Peripheral blood, normal control [N61]",ctrl
HCC009N,ctrl
Male 8week AJ CBDLrep3,pert
RORasg/sg WAT_HFD_rep3,pert
S2C Sporadic-hippocampus,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 29.490;	Ratio: 2.12,ctrl
genetic modification: Cd19-cre mediated deletion of the SRF Gene;	tissue:  spleen: FACS sorted IgM+IgD+ cells,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 33;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
ND_7,ctrl
WT 2 sample A,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, mock",ctrl
liver 0.1% quercetin diet rep1,pert
Subject #8028-Preinfection,pert
1104_CNTL,ctrl
"Du145-PCAT1 NT siRNA, replicate 1",ctrl
Nrl-ko-Gfp 4 weeks retina replicate 1,ctrl
cell line: cervical cancer (HeLa) cells;	agent: control,ctrl
very advanced HCC,pert
normal with no hydrocortisone treatment-4,ctrl
MRF control Oligodendrocyte Replicate 3,ctrl
60A;pretreatment;female;breast tumor; responder,ctrl
Diagnosis: MDS/AML;	Age: 83y ;	Gender: Female;	Blast %: 90;	Source: PB;	Cyto: tris8;	FLT3 ITD: 1;	FLT3 TKD: 1,pert
RTX4 T0,ctrl
t15,pert
"Control #1, Untreated",ctrl
X_p4_rep1,pert
mock-2,ctrl
Insm1 control #6,ctrl
MDS patient 10,pert
"Empty vector, plastic plate, rep1",ctrl
RNA from HCC_30N,ctrl
KN-sham-5 month+1d-R4,pert
"Uninvolved Skin, NS-29",pert
HUVEC_6h_rep2_1107,ctrl
"42B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
"Vehicle treated,  doxycycline treated; biological replicate 2",pert
MS patient 8,pert
"Normal Skin, Normal-10",ctrl
"Gender: Female, Age: 30, BMI: 24, Tissue: luteinized cumulus cells",ctrl
TREx_Flp_FTO_siRNA_2,pert
4T1.2-BV-2,ctrl
patient: 460A;	disease state: LGSC;	component: Borderline,ctrl
cell line: SKM-1,ctrl
cell line: THP-1;	shRNA construct: GSK3B Construct 2,pert
subject: 38;	disease: CP;	muscle: ST;	gender: M;	age: 9.4;	gmfcs: 2;	popliteal angle: 100,pert
Kyoto rat liver tissue following animal exposure to orotic acid for 3 days,pert
"non-AD_TC, biological rep8",ctrl
7 wt,ctrl
"NTera-2 cells negative control, biological replicate 1",ctrl
SC263_CETU2,pert
H15_S_B1,ctrl
Sample Group: control; Gender: male; Age: 46; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
MCF-10A shCHK2-1 replicate 2 [set 5],pert
Strain: top2b-/- in 129SvEv (minor 129SvJ) background;;	Age: E14.5 embryo;;	Gender: male;;	Tissue: whole brain,pert
strain: C57/Bl6;	gender: N/A;	age: 4 month;	weight: 25-30g;	tissue: whole trachea,ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 6,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 49.34795,ctrl
gender: Female;	tissue: Tendon;Subscapularis;	age: 64;	donor: 23;	disease state: Non-lesional,ctrl
SCHT control 3,ctrl
D_LS_Wk4,pert
8h 4OHT-treated-sample1,pert
KO - knock-out Treated - 12 hrs - repeat 3 - Cy5 - mAdbID:61761,pert
Vehicle-Control;	Vehicle-Control 24 hours set 1,ctrl
3: FCHL patient #98-1405,pert
Tumor-KO-rep3,pert
Liver_PXR KO_Vehicle_Rep1,pert
Oga_WT_MEF_E8_rep2,ctrl
tissue type: normal thyroid;	matched/unmatched: matched to T14,ctrl
"Normal tail skin from control mouse, biological replicate 1",ctrl
Control 15,ctrl
Patient 1 c,pert
BAL_18_A1B0,ctrl
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-jhdm1b retrovirus,pert
P1C Progranulin-hippocampus,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: E18.5;	genotype: Igf1 -/-,pert
phenotype: alcoholic;	gender: male;	case_id: 330;	age: 53;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 59.5;	brain ph at time of freezing: 6.75;	labeling_batch: 2,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/18/05;	# cells: 65;	Sex: male;	region: M1;	age: 40;	genotype: Y/Mecp2-;YFPH/-,pert
"Cell line:  Fibroblast TTP KO cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",ctrl
MDS49,pert
Cre_day_5-4,pert
Ileum_POR-null+quercetin_2,pert
H12 HA 6h 2,pert
B7m6,pert
PBMC from T cell Large granular lymphocyte leukemia patient#107,pert
duration of untreated disease in month:2.2;	age at onset:7.2,pert
sex: Male;	Age: 5 months;	additional patient information found in Series supplementary file,ctrl
scan batch: Batch 2;	group: autism;	subject age: 2;	paternal age: 28;	maternal age: 31,pert
aa.2,pert
"A673 treated with Puromycin for 3 days with concentration of 0.09 uM (EC50), biological rep3",pert
strain: Wistar;	agent (mother exposed to): vehicle;	gender (pup): male;	age (pup): PND70;	tissue (pup): hypothalamus,ctrl
strain: C57BL6;	genotype: WT;	tissue: striatum;	treatment: PDE10i,pert
1061-03-A-b,pert
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Female;	Age of onset (years): 25;	Duration of illness (years): 25;	Brain pH: 6.3;	Post mortem interval (hours): 62;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"BMDC, wt, replicate 1",ctrl
Tumor from MYF-5 CRE/SSM2 mouse CC17-A,pert
gastrocnemius-30 months of age-control diet-biological replicate1,ctrl
cerebrum_PSNA_ 0d_rep1,pert
BP13,pert
Diaphragm 14 day mdx rep 3,pert
race: african american;	age (years): 47;	stage: IA;	grade: 2;	histology: endometrioid,pert
control-1,ctrl
"Normal subject (56 year old caucasian female, SAK_1290052750)",ctrl
6 Etoh 2,pert
HMEC -EGF then refed EGF for 1.5hrs,ctrl
Weight:Low;	CFstatus:knockout;	Sex:Male,pert
imanitib1,pert
AO 1hr,ctrl
colonic_mucosa_non_inflamed_744,pert
MSE_N_G98A,ctrl
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 7.4;	colon weight (mg): 161;	colon ratio (mg/mm): 2.18;	myeloperoxidase activity (u/mg): 0.014;	tissue: colon;	treatment: 5% DSS,ctrl
"EAE, placebo-treated #1",pert
SCC-40_siZMPSTE24_rep.2,pert
SeV 3658,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 17;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
FK1,ctrl
FVB_MMTV_Wnt1_iFGFR1_3851_5L_ROSEN,pert
